PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Radogna, F; Cerella, C; Gaigneaux, A; Christov, C; Dicato, M; Diederich, M				Radogna, F.; Cerella, C.; Gaigneaux, A.; Christov, C.; Dicato, M.; Diederich, M.			Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma	ONCOGENE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; CARDIAC-GLYCOSIDES; CALOTROPIS-PROCERA; JNK ACTIVATION; AUTOPHAGY; DEATH; UNBS1450; TARGET; CROSSTALK	A limiting factor in the therapeutic outcome of children with high-risk neuroblastoma is the intrinsic and acquired resistance to common chemotherapeutic treatments. Here we investigated the molecular mechanisms by which the hemisynthetic cardiac glycoside UNBS1450 overcomes this limitation and induces differential cell death modalities in both neuroblastic and stromal neuroblastoma through stimulation of a cell-type-specific autophagic response eventually leading to apoptosis or necroptosis. In neuroblastic SH-SY5Y cells, we observed a time-dependent production of reactive oxygen species that affects lysosomal integrity inducing lysosome-associated membrane protein 2 degradation and cathepsin B and L activation. Subsequent mitochondrial membrane depolarization and accumulation of mitochondria in phagophores occurred after 8h of UNBS1450 treatment. Results were confirmed by mitochondrial mass analysis, electron microscopy and co-localization of mitochondria with GFP-LC3, suggesting the impaired clearance of damaged mitochondria. Thus, a stress-induced defective autophagic flux and the subsequent lack of clearance of damaged mitochondria sensitized SH-SY5Y cells to UNBS1450-induced apoptosis. Inhibition of autophagy with small inhibitory RNAs against ATG5, ATG7 and Beclin-1 protected SH-SY5Y cells against the cytotoxic effect of UNBS1450 by inhibiting apoptosis. In contrast, autophagy progression towards the catabolic state was observed in stromal SK-N-AS cells: here reactive oxygen species (ROS) generation remained undetectable preserving intact lysosomes and engulfing damaged mitochondria after UNBS1450 treatment. Moreover, autophagy inhibition determined sensitization of SK-N-AS to apoptosis. We identified efficient mitophagy as the key mechanism leading to failure of activation of the apoptotic pathway that increased resistance of SK-N-AS to UNBS1450, triggering rather necroptosis at higher doses. Altogether we characterize here the differential modulation of ROS and mitophagy as a main determinant of neuroblastoma resistance with potential relevance for personalized anticancer therapeutic approaches.	[Radogna, F.; Cerella, C.; Gaigneaux, A.; Dicato, M.] Hop Kirchberg, Lab Biol Mol & Cellulaire Canc, Luxembourg, Luxembourg; [Christov, C.] Univ Lorraine Vandoeuvre Les Nancy, Med Nancy, Nancy, France; [Diederich, M.] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Universite de Lorraine; Seoul National University (SNU)	Diederich, M (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Pharm, Seoul 151742, South Korea.	marcdiederich@snu.ac.kr	Diederich, Marc/O-7335-2015; Radogna, Flavia/AAL-5698-2020	Diederich, Marc/0000-0003-0115-4725; Radogna, Flavia/0000-0003-0385-3335; Cerella, Claudia/0000-0001-9308-8176	ThinkPinkLux; Europadonna Luxembourg; Televie grant (Fonds National de la Recherche Scientifique, Belgium); 'Waxweiler grant for cancer prevention research' from the Action LIONS 'Vaincre le Cancer'; Fondation de Recherche Cancer et Sang; Recherches Scientifiques Luxembourg association; 'Een Haerz fir kriibskrank Kanner' association; Action LIONS 'Vaincre le Cancer' association; Televie Luxembourg; National Research Foundation (NRF) by the MEST of Korea for Tumor Microenvironment Global Core Research Center (GCRC) grant [2012-0001184]; Brain Korea (BK21) PLUS program	ThinkPinkLux; Europadonna Luxembourg; Televie grant (Fonds National de la Recherche Scientifique, Belgium); 'Waxweiler grant for cancer prevention research' from the Action LIONS 'Vaincre le Cancer'; Fondation de Recherche Cancer et Sang; Recherches Scientifiques Luxembourg association; 'Een Haerz fir kriibskrank Kanner' association; Action LIONS 'Vaincre le Cancer' association; Televie Luxembourg; National Research Foundation (NRF) by the MEST of Korea for Tumor Microenvironment Global Core Research Center (GCRC) grant; Brain Korea (BK21) PLUS program	FR thanks 'Een Haerz fir kriibskrank Kanner' association for initial support. This manuscript is dedicated to the memory of Marian Aldred. The authors are very thankful to ThinkPinkLux and Europadonna Luxembourg for their generous support. FR and AG are supported by a Televie grant (Fonds National de la Recherche Scientifique, Belgium). CC is supported by a 'Waxweiler grant for cancer prevention research' from the Action LIONS 'Vaincre le Cancer'. Research at LBMCC is financially supported by the Fondation de Recherche Cancer et Sang, the Recherches Scientifiques Luxembourg association, the 'Een Haerz fir kriibskrank Kanner' association, the Action LIONS 'Vaincre le Cancer' association and the Televie Luxembourg. Research at SNU is supported by the National Research Foundation (NRF) by the MEST of Korea for Tumor Microenvironment Global Core Research Center (GCRC) grant (grant number 2012-0001184) and by Brain Korea (BK21) PLUS program. The authors thank Justine Paoli for technical assistance with electron microscopy.	Abhari BA, 2013, ONCOGENE, V32, P3263, DOI 10.1038/onc.2012.337; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Castino R, 2011, TOXICOL SCI, V123, P523, DOI 10.1093/toxsci/kfr179; Cerella C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.134; Cerella C, 2015, CANCER LETT, V356, P251, DOI 10.1016/j.canlet.2014.02.008; Cerella C, 2014, BIOTECHNOL ADV, V32, P1111, DOI 10.1016/j.biotechadv.2014.03.006; Cerella Claudia, 2013, Int J Cell Biol, V2013, P639401, DOI 10.1155/2013/639401; Cerella C, 2013, MITOCHONDRION, V13, P225, DOI 10.1016/j.mito.2012.06.003; Cerella C, 2009, APOPTOSIS, V14, P641, DOI 10.1007/s10495-009-0328-8; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Cheng P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.17; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Goldsmith KC, 2005, CANCER LETT, V228, P133, DOI 10.1016/j.canlet.2005.01.048; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hashem SI, 2015, STEM CELLS, V33, P2343, DOI 10.1002/stem.2015; Hu FL, 2014, APOPTOSIS, V19, P210, DOI 10.1007/s10495-013-0914-7; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Juncker T, 2011, BIOCHEM PHARMACOL, V81, P13, DOI 10.1016/j.bcp.2010.08.025; Juncker T, 2009, BIOCHEM PHARMACOL, V78, P1, DOI 10.1016/j.bcp.2009.01.018; Klose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095970; Lang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129196; Lefranc F, 2008, NEUROSURGERY, V62, P211, DOI 10.1227/01.NEU.0000311080.43024.0E; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Li Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093928; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Menger L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003807; Mijatovic T, 2006, MOL CANCER THER, V5, P391, DOI 10.1158/1535-7163.MCT-05-0367; Mora J, 2001, CANCER RES, V61, P6892; Muller F, 2015, CURR MED CHEM, V22, P3447, DOI 10.2174/0929867322666150716115435; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Olenych SG., 2007, CURR PROTOC CELL BIO, V33; Ostenfeld MS, 2008, AUTOPHAGY, V4, P487, DOI 10.4161/auto.5774; Parganlija D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095288; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Radogna F, 2015, MITOCHONDRION, V21, P113, DOI 10.1016/j.mito.2015.02.003; Radogna F, 2009, TOXICOL APPL PHARM, V238, P170, DOI 10.1016/j.taap.2009.05.011; Radogna F, 2015, BIOCHEM PHARMACOL, V94, P1, DOI 10.1016/j.bcp.2014.12.018; Radogna F, 2009, TOXICOL APPL PHARM, V239, P37, DOI 10.1016/j.taap.2009.05.012; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Van Quaquebeke E, 2005, J MED CHEM, V48, P849, DOI 10.1021/jm049405a; Vucicevic L, 2014, AUTOPHAGY, V10, P2362, DOI 10.4161/15548627.2014.984270; Wang Y, 2015, MOL CARCINOGEN, V54, pE26, DOI 10.1002/mc.22147; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867	51	54	59	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3839	3853		10.1038/onc.2015.455	http://dx.doi.org/10.1038/onc.2015.455			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26640148				2022-12-26	WOS:000380753200009
J	Ruscetti, M; Dadashian, EL; Guo, W; Quach, B; Mulholland, DJ; Park, JW; Tran, LM; Kobayashi, N; Bianchi-Frias, D; Xing, Y; Nelson, PS; Wu, H				Ruscetti, M.; Dadashian, E. L.; Guo, W.; Quach, B.; Mulholland, D. J.; Park, J. W.; Tran, L. M.; Kobayashi, N.; Bianchi-Frias, D.; Xing, Y.; Nelson, P. S.; Wu, H.			HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer	ONCOGENE			English	Article							ANDROGEN RECEPTOR; DNA-BINDING; INCREASED SURVIVAL; HMGI-C; ACETYLATION; ACTIVATION; CELLS; P53; SENSITIVITY; TRANSITION	PI3K (phosphoinositide 3-kinase)/AKT and RAS/MAPK (mitogen-activated protein kinase) pathway coactivation in the prostate epithelium promotes both epithelial-mesenchymal transition (EMT) and metastatic castration-resistant prostate cancer (mCRPC), which is currently incurable. To study the dynamic regulation of the EMT process, we developed novel genetically defined cellular and in vivo model systems from which epithelial, EMT and mesenchymal-like tumor cells with Pten deletion and Kras activation can be isolated. When cultured individually, each population has the capacity to regenerate all three tumor cell populations, indicative of epithelial-mesenchymal plasticity. Despite harboring the same genetic alterations, mesenchymal-like tumor cells are resistant to PI3K and MAPK pathway inhibitors, suggesting that epigenetic mechanisms may regulate the EMT process, as well as dictate the heterogeneous responses of cancer cells to therapy. Among differentially expressed epigenetic regulators, the chromatin remodeling protein HMGA2 is significantly upregulated in EMT and mesenchymal-like tumors cells, as well as in human mCRPC. Knockdown of HMGA2, or suppressing HMGA2 expression with the histone deacetylase inhibitor LBH589, inhibits epithelial-mesenchymal plasticity and stemness activities in vitro and markedly reduces tumor growth and metastasis in vivo through successful targeting of EMT and mesenchymal-like tumor cells. Importantly, LBH589 treatment in combination with castration prevents mCRPC development and significantly prolongs survival following castration by enhancing p53 and androgen receptor acetylation and in turn sensitizing castration-resistant mesenchymal-like tumor cells to androgen deprivation therapy. Taken together, these findings demonstrate that cellular plasticity is regulated epigenetically, and that mesenchymal-like tumor cell populations in mCRPC that are resistant to conventional and targeted therapies can be effectively treated with the epigenetic inhibitor LBH589.	[Ruscetti, M.; Wu, H.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Ruscetti, M.; Dadashian, E. L.; Quach, B.; Mulholland, D. J.; Tran, L. M.; Kobayashi, N.; Wu, H.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Guo, W.; Wu, H.] Peking Univ, Sch Life Sci, Room 106,Jin Guang Life Sci Bldg,5 Yiheyuan Rd, Beijing 100871, Peoples R China; [Park, J. W.; Xing, Y.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Bianchi-Frias, D.; Nelson, P. S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Bianchi-Frias, D.; Nelson, P. S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Ruscetti, M.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Mulholland, D. J.] Mt Sinai Hosp, Icahn Sch Med, Div Hematol & Med Oncol, New York, NY 10029 USA; [Park, J. W.] Univ Louisville, KBRIN Bioinformat Core, Comp Engn & Comp Sci, Louisville, KY 40292 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Peking University; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; University of Louisville	Wu, H (corresponding author), Peking Univ, Sch Life Sci, Room 106,Jin Guang Life Sci Bldg,5 Yiheyuan Rd, Beijing 100871, Peoples R China.	hongwu@pku.edu.cn	Guo, Weilong/AAP-2880-2021	Guo, Weilong/0000-0001-5199-1359; Ruscetti, Marcus/0000-0002-4394-2087	NIH [T32 CA009056, F32 CA112988-01, P50 CA097186, P01 CA163227, P50 CA092131, R01 CA107166, RO1 CA121110, U01 CA164188]; General Financial Grant from the China Postdoctoral Science Foundation [2015M570010]; Peking-Tsinghua Center for Life Sciences; CIRM [TG2-01169]; Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA107166, F32CA112988, U01CA164188, P50CA097186, P01CA163227, P50CA092131, T32CA009056, R01CA121110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Financial Grant from the China Postdoctoral Science Foundation; Peking-Tsinghua Center for Life Sciences; CIRM(California Institute for Regenerative Medicine); Prostate Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Hong Wu lab for their critical comments and suggestions. We also thank Drs Yang Zong and Owen Witte for generously supplying us with HMGA2 antibodies, and Dr Shumin Wu for supplying protein lysates from mouse ES cells. MR was supported by NIH T32 CA009056. WG was supported by a General Financial Grant from the China Postdoctoral Science Foundation (2015M570010), and in part by the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences. DJM was supported by NIH F32 CA112988-01, CIRM TG2-01169 and a Prostate Cancer Foundation Young Investigator Award. This work has been supported, in part, by awards from the Prostate Cancer Foundation (to HW), and grants from the NIH (P50 CA097186 and P01 CA163227 to PSN, P50 CA092131 to YX and HW, and R01 CA107166, RO1 CA121110 and U01 CA164188 to HW).	Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Attard G, 2011, CLIN CANCER RES, V17, P3867, DOI 10.1158/1078-0432.CCR-11-0943; Baca Sylvan C, 2012, Front Endocrinol (Lausanne), V3, P69, DOI 10.3389/fendo.2012.00069; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; Bradley D, 2009, CANCER-AM CANCER SOC, V115, P5541, DOI 10.1002/cncr.24597; Brannon AR, 2013, J CLIN INVEST, V123, P4568, DOI 10.1172/JCI70935; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gu L, 2015, NAT GENET, V47, P22, DOI 10.1038/ng.3165; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Langelotz C, 2003, BRIT J CANCER, V88, P1406, DOI 10.1038/sj.bjc.6600935; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Liu XM, 2010, PROSTATE, V70, P179, DOI 10.1002/pros.21051; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Luo YZ, 2013, ONCOL LETT, V5, P1353, DOI 10.3892/ol.2013.1193; Marin-Aguilera M, 2014, MOL CANCER THER, V13, P1270, DOI 10.1158/1535-7163.MCT-13-0775; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Rathkopf D, 2010, CANCER CHEMOTH PHARM, V66, P181, DOI 10.1007/s00280-010-1289-x; Rathkopf DE, 2013, CANCER CHEMOTH PHARM, V72, P537, DOI 10.1007/s00280-013-2224-8; Rescigno P, 2012, CURR DRUG TARGETS, V13, P1676, DOI 10.2174/138945012803529956; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Ruscetti M, 2015, CANCER RES, V75, P2149; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Zha L, 2012, MOL CELL BIOCHEM, V364, P243, DOI 10.1007/s11010-012-1224-z; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	50	85	86	2	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3781	3795		10.1038/onc.2015.444	http://dx.doi.org/10.1038/onc.2015.444			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26640144	Green Accepted			2022-12-26	WOS:000380753200004
J	Kado, Y; Mizohata, E; Nagatoishi, S; Iijima, M; Shinoda, K; Miyafusa, T; Nakayama, T; Yoshizumi, T; Sugiyama, A; Kawamura, T; Lee, YH; Matsumura, H; Doi, H; Fujitani, H; Kodama, T; Shibasaki, Y; Tsumoto, K; Inoue, T				Kado, Yuji; Mizohata, Eiichi; Nagatoishi, Satoru; Iijima, Mariko; Shinoda, Keiko; Miyafusa, Takamitsu; Nakayama, Taisuke; Yoshizumi, Takuma; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Matsumura, Hiroyoshi; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu; Tsumoto, Kouhei; Inoue, Tsuyoshi			Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5 STRUCTURAL, FUNCTIONAL, AND MOLECULAR DYNAMICS SIMULATION ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; FACTOR RECEPTOR; CANCER-CELLS; FACTOR-ALPHA; AMPHIREGULIN; INHIBITORS; REFINEMENT; LIGANDS	Epiregulin (EPR) is a ligand of the epidermal growth factor (EGF) family that upon binding to its epidermal growth factor receptor (EGFR) stimulates proliferative signaling, especially in colon cancer cells. Here, we describe the three-dimensional structure of the EPR antibody (the 9E5(Fab) fragment) in the presence and absence of EPR. Among the six complementarity-determining regions (CDRs), CDR1-3 in the light chain and CDR2 in the heavy chain predominantly recognize EPR. In particular, CDR3 in the heavy chain dramatically moves with cis-trans isomerization of Pro(103). A molecular dynamics simulation and mutational analyses revealed that Arg(40) in EPR is a key residue for the specific binding of 9E5 IgG. From isothermal titration calorimetry analysis, the dissociation constant was determined to be 6.5 nM. Surface plasmon resonance analysis revealed that the dissociation rate of 9E5 IgG is extremely slow. The superimposed structure of 9E5(Fab).EPR on the known complex structure of EGF.EGFR showed that the 9E5(Fab) paratope overlaps with Domains I and III on the EGFR, which reveals that the 9E5(Fab).EPR complex could not bind to the EGFR. The 9E5 antibody will also be useful in medicine as a neutralizing antibody specific for colon cancer.	[Kado, Yuji; Mizohata, Eiichi; Nakayama, Taisuke; Yoshizumi, Takuma; Matsumura, Hiroyoshi; Inoue, Tsuyoshi] Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan; [Kado, Yuji] Osaka Univ, Interdisciplinary Program Biomed Sci, Inst Acad Initiat, 1-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Nagatoishi, Satoru; Miyafusa, Takamitsu; Tsumoto, Kouhei] Univ Tokyo, Med Prote Lab, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Iijima, Mariko; Shinoda, Keiko; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Number 34 Komaba, Tokyo 1538904, Japan; [Nakayama, Taisuke] Ritsumeikan Univ, Coll Life Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan	Osaka University; Osaka University; University of Tokyo; University of Tokyo; Ritsumeikan University	Inoue, T (corresponding author), Osaka Univ, Grad Sch Engn, Div Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Med Prote Lab, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tsumoto@ims.u-tokyo.ac.jp; inouet@chem.eng.osaka-u.ac.jp	Satoru, NAGATOISHI/AAY-8198-2021; Miyafusa, Takamitsu/N-2753-2016	Satoru, NAGATOISHI/0000-0002-0794-3963; Miyafusa, Takamitsu/0000-0001-9819-1519	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) [24770096, 25282230]; MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants [hp130006, hp140228]; Grants-in-Aid for Scientific Research [24109017] Funding Source: KAKEN	Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program); Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI); MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, and Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Grants-in-aid for Scientific Research (KAKENHI) 24770096 and 25282230. The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by MEXT Strategic Programs for Innovative Research Supercomputational Life Science Grants hp130006 and hp140228.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baba I, 2000, CANCER RES, V60, P6886; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DEFEOJONES D, 1989, MOL CELL BIOL, V9, P4083, DOI 10.1128/MCB.9.9.4083; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLER DA, 1992, J BIOL CHEM, V267, P2274; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Freimann S, 2004, BIOCHEM PHARMACOL, V68, P989, DOI 10.1016/j.bcp.2004.05.027; Fujitani H, 2009, J CHEM THEORY COMPUT, V5, P1155, DOI 10.1021/ct8005437; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Komurasaki T, 1997, ONCOGENE, V15, P2841, DOI 10.1038/sj.onc.1201458; Lee YH, 2013, BIOCHEM BIOPH RES CO, V441, P1011, DOI 10.1016/j.bbrc.2013.11.014; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Moulin A, 2014, PROTEIN SCI, V23, P1698, DOI 10.1002/pro.2548; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen DL, 2013, BREAST, V22, P1, DOI 10.1016/j.breast.2012.09.008; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sato K, 2003, FEBS LETT, V553, P232, DOI 10.1016/S0014-5793(03)01005-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Staelens S, 2006, J BIOL CHEM, V281, P2225, DOI 10.1074/jbc.M508191200; Torring N, 2005, PROSTATE, V64, P1, DOI 10.1002/pros.20214; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	10	10	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2319	2330		10.1074/jbc.M115.656009	http://dx.doi.org/10.1074/jbc.M115.656009			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26627827	Green Published, hybrid			2022-12-26	WOS:000369610400022
J	Ehrhardt, A; Chung, WJ; Pyle, LC; Wang, W; Nowotarski, K; Mulvihill, CM; Rannjeesingh, M; Hong, J; Velu, SE; Lewis, HA; Atwell, S; Aller, S; Bear, CE; Lukacs, GL; Kirk, KL; Sorscher, EJ				Ehrhardt, Annette; Chung, W. Joon; Pyle, Louise C.; Wang, Wei; Nowotarski, Krzysztof; Mulvihill, Cory M.; Rannjeesingh, Mohabir; Hong, Jeong; Velu, Sadanandan E.; Lewis, Hal A.; Atwell, Shane; Aller, Steve; Bear, Christine E.; Lukacs, Gergely L.; Kirk, Kevin L.; Sorscher, Eric J.			Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; CHLORIDE CHANNEL; CHRONIC RHINOSINUSITIS; ALTERNATING ACCESS; DOMAIN; POTENTIATOR; ACTIVATORS; MUTATIONS; SUBUNIT; COMPLEX	In this study, we present data indicating a robust and specific domain interaction between the cystic fibrosis transmembrane conductance regulator (CFTR) first cytosolic loop (CL1) and nucleotide binding domain 1 (NBD1) that allows ion transport to proceed in a regulated fashion. We used co-precipitation and ELISA to establish the molecular contact and showed that binding kinetics were not altered by the common clinical mutation F508del. Both intrinsic ATPase activity and CFTR channel gating were inhibited severely by CL1 peptide, suggesting that NBD1/CL1 binding is a crucial requirement for ATP hydrolysis and channel function. In addition to cystic fibrosis, CFTR dysregulation has been implicated in the pathogenesis of prevalent diseases such as chronic obstructive pulmonary disease, acquired rhinosinusitis, pancreatitis, and lethal secretory diarrhea (e.g. cholera). On the basis of clinical relevance of the CFTR as a therapeutic target, a cell-free drug screen was established to identify modulators of NBD1/CL1 channel activity independent of F508del CFTR and pharmacologic rescue. Our findings support a targetable mechanism of CFTR regulation in which conformational changes in the NBDs cause reorientation of transmembrane domains via interactions with CL1 and result in channel gating.	[Ehrhardt, Annette; Chung, W. Joon; Pyle, Louise C.; Hong, Jeong; Aller, Steve; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Chung, W. Joon] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Wang, Wei; Nowotarski, Krzysztof; Hong, Jeong; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cellular Integrat & Dev Biol, Birmingham, AL 35294 USA; [Aller, Steve] Univ Alabama Birmingham, Dept Pharmacol, Birmingham, AL 35294 USA; [Velu, Sadanandan E.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Ehrhardt, Annette; Sorscher, Eric J.] Emory Univ, Dept Pediat, 1760 Haygood Dr,Suite 280, Atlanta, GA 30322 USA; [Mulvihill, Cory M.; Rannjeesingh, Mohabir; Bear, Christine E.] Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Lewis, Hal A.] Bristol Myers Squibb Co, Princeton, NJ 08543 USA; [Atwell, Shane] Eli Lilly & Co, San Diego, CA 92121 USA; [Bear, Christine E.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Bristol-Myers Squibb; Eli Lilly; University of Toronto; University of Toronto; McGill University	Sorscher, EJ (corresponding author), Emory Univ, Dept Pediat, 1760 Haygood Dr,Suite 280, Atlanta, GA 30322 USA.	esorscher@emory.edu	Pyle, Louise C/AAR-3513-2021	Pyle, Louise C/0000-0002-8933-9320; Sorscher, Eric J./0000-0001-9341-3354; Lukacs, Gergely/0000-0003-0900-0675; Velu, Sadanandan/0000-0002-0342-2378; Aller, Stephen/0000-0003-0379-5534	Cystic Fibrosis Foundation; National Institutes of Health [P30DK72482]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cystic Fibrosis Foundation and National Institutes of Health Grant P30DK72482 (to E. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Brymora A., 2004, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB1705S22; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; CSERHATI T, 1995, PEPTIDES, V16, P165, DOI 10.1016/0196-9781(94)00134-R; Dahan I, 2002, J BIOL CHEM, V277, P8421, DOI 10.1074/jbc.M109778200; Dalmas O, 2005, J BIOL CHEM, V280, P36857, DOI 10.1074/jbc.M503266200; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Howell LD, 2004, BIOCHEM J, V378, P151, DOI 10.1042/BJ20021428; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KOPITO RR, 1999, PHYSIOL REV, V79, P167; Lerch MM, 2010, DIGEST DIS, V28, P324, DOI 10.1159/000319408; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Namkung W, 2013, MOL PHARMACOL, V84, P384, DOI 10.1124/mol.113.086348; Naren Anjaparavanda P, 2002, Methods Mol Med, V70, P175; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2011, J BIOL CHEM, V286, P15215, DOI 10.1074/jbc.M110.184267; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Pinto JM, 2008, LARYNGOSCOPE, V118, P2067, DOI 10.1097/MLG.0b013e3181805147; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Stanwood GD, 2008, MOL PHARMACOL, V74, P317, DOI 10.1124/mol.108.049098; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang WY, 2012, J BIOL CHEM, V287, P10156, DOI 10.1074/jbc.M112.342972; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005	53	12	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1854	1865		10.1074/jbc.M115.704809	http://dx.doi.org/10.1074/jbc.M115.704809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627831	hybrid, Green Published			2022-12-26	WOS:000368620700025
J	Zhao, AH; Tu, LN; Mukai, C; Sirivelu, MP; Pillai, VV; Morohaku, K; Cohen, R; Selvaraj, V				Zhao, Amy H.; Tu, Lan N.; Mukai, Chinatsu; Sirivelu, Madhu P.; Pillai, Viju V.; Morohaku, Kanako; Cohen, Roy; Selvaraj, Vimal			Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; PERMEABILITY TRANSITION PORE; PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID; MEMBRANE-PROTEIN; OUTER-MEMBRANE; COPROPORPHYRINOGEN OXIDASE; ERYTHROLEUKEMIA-CELLS; PHOTODYNAMIC THERAPY	Function of the mammalian translocator protein (TSPO; previously known as the peripheral benzodiazepine receptor) remains unclear because its presumed role in steroidogenesis and mitochondrial permeability transition established using pharmacological methods has been refuted in recent genetic studies. Protoporphyrin IX (PPIX) is considered a conserved endogenous ligand for TSPO. In bacteria, TSPO was identified to regulate tetrapyrrole metabolism and chemical catalysis of PPIX in the presence of light, and in vertebrates, TSPO function has been linked to porphyrin transport and heme biosynthesis. Positive correlation between high TSPO expression in cancer cells and susceptibility to photodynamic therapy based on their increased ability to convert the precursor 5-aminolevulinic acid (ALA) to PPIX appeared to reinforce this mechanism. In this study, we used TSPO knock-out (Tspo(-/-)) mice, primary cells, and different tumor cell lines to examine the role of TSPO in erythropoiesis, heme levels, PPIX biosynthesis, phototoxic cell death, and mitochondrial bioenergetic homeostasis. In contrast to expectations, our results demonstrate that TSPO deficiency does not adversely affect erythropoiesis, heme biosynthesis, bio-conversion of ALA to PPIX, and porphyrin-mediated phototoxic cell death. TSPO expression levels in cancer cells do not correlate with their ability to convert ALA to PPIX. In fibroblasts, we observed that TSPO deficiency decreased the oxygen consumption rate and mitochondrial membrane potential (Delta psi m) indicative of a cellular metabolic shift, without a negative impact on porphyrin biosynthetic capability. Based on these findings, we conclude that mammalian TSPO does not have a critical physiological function related to PPIX and heme biosynthesis.	[Zhao, Amy H.; Tu, Lan N.; Pillai, Viju V.; Morohaku, Kanako; Selvaraj, Vimal] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA; [Mukai, Chinatsu; Cohen, Roy] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Sirivelu, Madhu P.] Univ Penn, Coll Vet Med, Dept Clin Pathol, Philadelphia, PA 19104 USA; [Selvaraj, Vimal] Cornell Univ, Dept Anim Sci, 204 Morrison Hall,507 Tower Rd, Ithaca, NY 14853 USA	Cornell University; Cornell University; University of Pennsylvania; Cornell University	Selvaraj, V (corresponding author), Cornell Univ, Dept Anim Sci, 204 Morrison Hall,507 Tower Rd, Ithaca, NY 14853 USA.	vs88@cornell.edu	Pillai, Viju/L-7557-2019; Selvaraj, Vimal/AAC-2853-2022	Pillai, Viju/0000-0002-2696-0451; Mukai, Chinatsu/0000-0003-0080-9371	Cornell College of Agriculture and Life Sciences; Jane E Brody undergraduate research award; Dextra undergraduate research endowment fund; Vietnam Education Foundation; Cornell Center for Vertebrate Genomics	Cornell College of Agriculture and Life Sciences; Jane E Brody undergraduate research award; Dextra undergraduate research endowment fund; Vietnam Education Foundation; Cornell Center for Vertebrate Genomics	This work was supported by funds from the Cornell College of Agriculture and Life Sciences (startup funds to V. S.); the Jane E Brody undergraduate research award and the Dextra undergraduate research endowment fund (to A. H. Z.); and fellowships from the Vietnam Education Foundation and the Cornell Center for Vertebrate Genomics (to L. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Austin CJD, 2013, INT J BIOCHEM CELL B, V45, P1212, DOI 10.1016/j.biocel.2013.03.004; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Bisland SK, 2007, LASER SURG MED, V39, P678, DOI 10.1002/lsm.20544; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chelli B, 2001, BIOCHEM PHARMACOL, V61, P695, DOI 10.1016/S0006-2952(00)00588-8; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; CLARKE GD, 1980, NATURE, V287, P160, DOI 10.1038/287160a0; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Frank W, 2007, PLANT J, V51, P1004, DOI 10.1111/j.1365-313X.2007.03198.x; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Galiegue S, 2004, CLIN CANCER RES, V10, P2058, DOI 10.1158/1078-0432.CCR-03-0988; Gavish M, 1999, PHARMACOL REV, V51, P629; Ginter C, 2013, BIOCHEMISTRY-US, V52, P3609, DOI 10.1021/bi400364z; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hardwick M, 1999, CANCER RES, V59, P831; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Kawasaki N, 1996, ARCH BIOCHEM BIOPHYS, V328, P289, DOI 10.1006/abbi.1996.0175; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; LARCHER JC, 1989, EUR J PHARMACOL, V161, P197, DOI 10.1016/0014-2999(89)90843-1; Li F, 2015, PHARMACOL RES, V99, P404, DOI 10.1016/j.phrs.2015.03.022; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Li G, 1999, BRIT J CANCER, V80, P676, DOI 10.1038/sj.bjc.6690409; Lin R, 2014, AGING CELL, V13, P507, DOI 10.1111/acel.12200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maaser K, 2002, CLIN CANCER RES, V8, P3205; Maaser K, 2005, CLIN CANCER RES, V11, P1751, DOI 10.1158/1078-0432.CCR-04-1955; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Morohaku K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074509; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; Nakazawa F, 2009, GENE EXPR PATTERNS, V9, P114, DOI 10.1016/j.gep.2008.09.005; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; RATCLIFFE SL, 1995, BRIT J CANCER, V71, P300, DOI 10.1038/bjc.1995.60; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Selvaraj V, 2015, MOL ENDOCRINOL, V29, P490, DOI 10.1210/me.2015-1033; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Sileikyte J, 2011, J BIOL CHEM, V286, P1046, DOI 10.1074/jbc.M110.172486; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875, DOI 10.1093/oxfordjournals.jbchem.a124790; Taketani S, 2001, EUR J BIOCHEM, V268, P1705, DOI 10.1046/j.1432-1327.2001.02045.x; Tu LN, 2015, ENDOCRINOLOGY, V156, P1033, DOI 10.1210/en.2014-1707; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Verma A, 1998, MOL MED, V4, P40, DOI 10.1007/BF03401728; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; WANG JKT, 1984, P NATL ACAD SCI-BIOL, V81, P3770, DOI 10.1073/pnas.81.12.3770; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Yeliseev AA, 1999, J BIOL CHEM, V274, P21234, DOI 10.1074/jbc.274.30.21234	60	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1591	1603		10.1074/jbc.M115.686360	http://dx.doi.org/10.1074/jbc.M115.686360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627829	Green Published, hybrid			2022-12-26	WOS:000368620700004
J	El-Ashram, S; Yin, Q; Liu, HB; Al Nasr, I; Liu, XY; Suo, X; Barta, J				El-Ashram, Saeed; Yin, Qing; Liu, Hongbin; Al Nasr, Ibrahim; Liu, Xianyong; Suo, Xun; Barta, John			From the Macro to the Micro: Gel Mapping to Differentiate between Sporozoites of Two Immunologically Distinct Strains of Eimeria maxima (Strains M6 and Guelph)	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RHOPTRY PROTEINS; FAMILY; EMTFP250	Two immunologically distinct strains of E. maxima were examined in this study: the M6 strain and the Guelph strain. The differential expression between the sporozoites of the two strains of E. maxima was determined by image analysis of 100 mu g of protein from each strain separated by standard one-and conventional two-dimensional polyacrylamide gel electrophoresis. In addition to differences in both molecular weight and the electrophoretic mobility, differences in the intensity of polypeptide bands for example, GS 136.4 and M6 169 were explored. Pooled gels were prepared from each strain. A representative 2D-PAGE gel spanning a non-linear pH range of 3-10 of E. maxima strain M6 consisted of approximately 694 polypeptide spots with about 67 (9.6%) of the polypeptide spots being unique relative to the other strain. E. maxima strain GS had about 696 discernable polypeptide spots with 69 spots (9.9%) that differed from those of the M6 strain. In-depth characterization of the variable polypeptide spots; unique polypeptide spots (absence or presence) and shared polypeptide spots with modifications may lead to novel vaccine target in the form of multicomponent, multi-stage, multi-immunovariant strains, multi-species subunit vaccine, and diagnostic probe for E. maxima.	[El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [El-Ashram, Saeed; Yin, Qing; Liu, Xianyong; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [El-Ashram, Saeed] Kafr El Sheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt; [El-Ashram, Saeed; Barta, John] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Liu, Hongbin] Hebei North Univ, Dept Pharmacol, Zhangjiakou, Hebei, Peoples R China; [Al Nasr, Ibrahim] Qassim Univ, Coll Appl Hlth Sci arras, Buraydah, Saudi Arabia	China Agricultural University; China Agricultural University; China Agricultural University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; University of Guelph; Hebei North University; Qassim University	Suo, X (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn; jbarta@uoguelph.ca	Nasr, Ibrahim Al/AFP-8105-2022; El-Ashram, Saeed/AAC-6060-2021; Barta, John/L-7508-2019; sulaiman, ibrahim/GQZ-6901-2022	El-Ashram, Saeed/0000-0003-0389-1980; AL NASR, IBRAHIM/0000-0003-4690-1050; LIU, XIANYONG/0000-0001-9425-6784	National Basic Science Research Program (973 program) of China [2015CB150300]; Special Fund for Agroscientific Research in the Public Interest [201303042]; National Natural Science Foundation of China [31172309]; Open Project of the State Key Laboratory of Veterinary Etiological Biology [SKLVEB2011KFKT001]	National Basic Science Research Program (973 program) of China(National Basic Research Program of China); Special Fund for Agroscientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of the State Key Laboratory of Veterinary Etiological Biology	This research was supported by the National Basic Science Research Program (973 program) of China (2015CB150300), the Special Fund for Agroscientific Research in the Public Interest (201303042), the National Natural Science Foundation of China (31172309), and the Open Project of the State Key Laboratory of Veterinary Etiological Biology (SKLVEB2011KFKT001). Additionally, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1981, P NATL ACAD SCI-BIOL, V78, P3784, DOI 10.1073/pnas.78.6.3784; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bottje W, 2011, Compositions and methods of enhancing immune responses to Eimeria, Patent No. 61K39002; Choi SH, 2010, KOREAN J PARASITOL, V48, P195, DOI 10.3347/kjp.2010.48.3.195; de Venevelles P, 2004, INT J PARASITOL, V34, P1321, DOI 10.1016/j.ijpara.2004.08.002; Dlugonska Henryka, 2003, Wiadomosci Parazytologiczne, V49, P3; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; El-Ashram S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121647; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; KOGUT MH, 1984, Z PARASITENKD, V70, P287, DOI 10.1007/BF00927814; Kurien BT, 2012, HUMANA, V869, P465; Lal K, 2009, PROTEOMICS, V9, P4566, DOI 10.1002/pmic.200900305; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Martin AG, 1997, INT J PARASITOL, V27, P527, DOI 10.1016/S0020-7519(97)00027-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; SUTTON CA, 1989, PARASITOLOGY, V99, P175, DOI 10.1017/S0031182000058613; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; TOMLEY FM, 1994, INFECT IMMUN, V62, P4656, DOI 10.1128/IAI.62.10.4656-4658.1994; Westermeier R, 2005, BIOSCIENCE REP, V25, P19, DOI 10.1007/s10540-005-2845-1; Witcombe DA, 2003, INT J PARASITOL, V33, P691, DOI 10.1016/S0020-7519(03)00086-9; Witcombe DM, 2004, INT J PARASITOL, V34, P861, DOI 10.1016/j.ijpara.2004.03.006	23	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143232	10.1371/journal.pone.0143232	http://dx.doi.org/10.1371/journal.pone.0143232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641262	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700013
J	Pandey, S; Patel, MK; Mishra, A; Jha, B				Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath			Physio-Biochemical Composition and Untargeted Metabolomics of Cumin (Cuminum cyminum L.) Make It Promising Functional Food and Help in Mitigating Salinity Stress	PLOS ONE			English	Article							ESSENTIAL OIL COMPOSITION; ANTIOXIDANT ACTIVITIES; FATTY-ACID; EXTINCTION COEFFICIENTS; SCAVENGING ACTIVITY; LIPID-PEROXIDATION; CHLOROPHYLL-A; SALT STRESS; TOLERANCE; WATER	Cumin is an annual, aromatic, herbaceous, medicinal, spice plant, most widely used as a food additive and flavoring agent in different cuisines. The study is intended to comprehensively analyse physiological parameters, biochemical composition and metabolites under salinity stress. Seed germination index, rate of seed emergence, rate of seed germination, mean germination time, plant biomass, total chlorophyll and carotenoid contents decreased concomitantly with salinity. In contrast, total antioxidant activity, H2O2, proline and MDA contents increased concurrently with stress treatments. Total phenolic and flavonoid contents were decreased initially about 1.4-fold at 50 mM, and thereafter increased about 1.2-fold at 100 mM NaCl stress. Relative water content remained unchanged up to 50 mM NaCl stress, and thereafter decreased significantly. About 2.8-fold electrolyte leakage was found in 50 mM, which increases further 4-fold at 100 mM NaCl stress. Saturated fatty acids (FAs) increased gradually with salinity, whereas unsaturation index and degree of unsaturation change arbitrarily along with the percent quantity of unsaturated FAs. Total lipid and fatty acid composition were significantly influenced by salinity stress. A total of 45 differentially expressed metabolites were identified, including luteolin, salvianolic acid, kaempferol and quercetin, which are phenolic, flavonoid or alkaloids in nature and contain antioxidant activities. Additionally, metabolites with bioactivity such as anticancerous ( docetaxel) and antimicrobial ( megalomicin) properties were also identified. The study evidenced that plant shoots are a rich source of metabolites, essential amino acids, phenolic compounds and fatty acids, which unveil the medicinal potential of this plant, and also provide useful insight about metabolic responses under salinity stress.	[Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Div Marine Biotechnol & Ecol, Bhavnagar, Gujarat, India; [Pandey, Sonika; Mishra, Avinash; Jha, Bhavanath] CSIR, Acad Sci & Innovat Res, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Mishra, A (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Div Marine Biotechnol & Ecol, G B Marg, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019; Mishra, Avinash/C-3210-2009	Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, ANALYST, V118, P1089; ARUNA K, 1992, FOOD CHEM TOXICOL, V30, P953, DOI 10.1016/0278-6915(92)90180-S; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bettaieb I, 2011, J AGR FOOD CHEM, V59, P328, DOI 10.1021/jf1037618; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; CHEN GX, 1990, J BIOL CHEM, V265, P2775; D'Souza MR, 2010, ACTA PHYSIOL PLANT, V32, P341, DOI 10.1007/s11738-009-0412-2; De Lorenzo A, 2001, DIABETES NUTR METAB, V14, P181; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Deepak, 2013, INDIAN J TRADIT KNOW, V12, P300; Dhanalakshmi GS, 2003, NUTR CANCER, V47, P171, DOI 10.1207/s15327914nc4702_10; Ellis R. H., 1980, Seed production., P605; Epstein E, 2005, MINERAL NUTR PLANTS, P342; FAO, 2008, 91 FAO; FERGUSON IB, 1983, PLANT PHYSIOL, V71, P182, DOI 10.1104/pp.71.1.182; Gachkar L, 2007, FOOD CHEM, V102, P898, DOI 10.1016/j.foodchem.2006.06.035; Hajlaoui H, 2010, FOOD CHEM TOXICOL, V48, P2186, DOI 10.1016/j.fct.2010.05.044; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; Hassanzadehdelouei M., 2013, Cercetari Agronomice in Moldova, V46, P89; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Iacobellis NS, 2005, J AGR FOOD CHEM, V53, P57, DOI 10.1021/jf0487351; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Kaewseejan N, 2015, J FUNCT FOODS, V12, P120, DOI 10.1016/j.jff.2014.11.001; Katembe WJ, 1998, ANN BOT-LONDON, V82, P167, DOI 10.1006/anbo.1998.0663; Khan MSA, 1997, J AGRON CROP SCI, V179, P163, DOI 10.1111/j.1439-037X.1997.tb00512.x; Kholova J, 2009, BIOL PLANTARUM, V53, P249, DOI 10.1007/s10535-009-0047-6; Kitajima J, 2003, PHYTOCHEMISTRY, V62, P115, DOI 10.1016/S0031-9422(02)00438-7; Kwanyuen P, 2010, J AM OIL CHEM SOC, V87, P127, DOI 10.1007/s11746-009-1484-2; Li XM, 2012, PLANT SOIL, V352, P377, DOI 10.1007/s11104-011-1003-8; Lopez-Cobo A, 2015, J FUNCT FOODS, V18, P1167, DOI 10.1016/j.jff.2014.10.023; Lu YR, 2001, TETRAHEDRON LETT, V42, P8223, DOI 10.1016/S0040-4039(01)01738-5; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Matthews S, 2011, SEED SCI TECHNOL, V39, P501, DOI 10.15258/sst.2011.39.2.21; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2009, BIORESOURCE TECHNOL, V100, P3382, DOI 10.1016/j.biortech.2009.02.006; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mnif S, 2015, CHEM BIODIVERS, V12, P733, DOI 10.1002/cbdv.201400305; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murillo-Amador B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094870; Navarro JM, 2006, FOOD CHEM, V96, P66, DOI 10.1016/j.foodchem.2005.01.057; Neffati M, 2011, FOOD CHEM, V124, P221, DOI 10.1016/j.foodchem.2010.06.022; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Panuccio MR, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu047; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; Poerschmann J, 2004, MICROB ECOL, V48, P78, DOI 10.1007/s00248-003-0144-6; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; POWELL AA, 1978, J EXP BOT, V29, P1215, DOI 10.1093/jxb/29.5.1215; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rebey IB, 2012, IND CROP PROD, V36, P238, DOI 10.1016/j.indcrop.2011.09.013; Saeed N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-221; Sangwan NS, 2001, PLANT GROWTH REGUL, V34, P3, DOI 10.1023/A:1013386921596; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; Shahidi F, 2015, J FUNCT FOODS, V18, P757, DOI 10.1016/j.jff.2015.01.047; Shi J, 2010, TREE PHYSIOL, V30, P914, DOI 10.1093/treephys/tpq030; Shobbar MS, 2012, J PLANT NUTR, V35, P1037, DOI 10.1080/01904167.2012.671407; Shoor M, 2014, RES J AGR ENV MANAGE, V3, P340; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Sowbhagya HB, 2013, CRIT REV FOOD SCI, V53, P1, DOI 10.1080/10408398.2010.500223; Takayanagi T, 2003, PHYTOCHEMISTRY, V63, P479, DOI 10.1016/S0031-9422(03)00103-1; Tiwari V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131567; Vallverdu-Queralt A, 2014, FOOD CHEM, V154, P299, DOI 10.1016/j.foodchem.2013.12.106; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Verpoorte R., 2002, Phytochemistry Reviews, V1, P13, DOI 10.1023/A:1015871916833; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Xu XQ, 1997, PHYTOCHEMISTRY, V45, P655, DOI 10.1016/S0031-9422(96)00868-0; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yu XY, 2012, BIORESOURCE TECHNOL, V121, P256, DOI 10.1016/j.biortech.2012.07.002; Zhang W, 2014, J FUNCT FOODS, V10, P427, DOI 10.1016/j.jff.2014.07.015; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004	86	49	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144469	10.1371/journal.pone.0144469	http://dx.doi.org/10.1371/journal.pone.0144469			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641494	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700131
J	Bockhorst, T; Homberg, U				Bockhorst, Tobias; Homberg, Uwe			Compass Cells in the Brain of an Insect Are Sensitive to Novel Events in the Visual World	PLOS ONE			English	Article							CENTRAL COMPLEX; NEURONS; POLARIZATION; MEMORY; ORIENTATION; NAVIGATION; DYNAMICS; NEUROARCHITECTURE; INFORMATION; INTEGRATION	The central complex of the insect brain comprises a group of neuropils involved in spatial orientation and memory. In fruit flies it mediates place learning based on visual landmarks and houses neurons that encode the orientation for goal-directed locomotion, based on landmarks and self-motion cues for angular path-integration. In desert locusts, the central complex holds a compass-like representation of head directions, based on the polarization pattern of skylight. Through intracellular recordings from immobilized locusts, we investigated whether sky compass neurons of the central complex also represent the position or any salient feature of possible landmarks, in analogy to the observations in flies. Neurons showed strongest responses to the novel appearance of a small moving square, but we found no evidence for a topographic representation of object positions. Responses to an individual square were independent of direction of motion and trajectory, but showed rapid adaptation to successive stimulation, unaffected by changing the direction of motion. Responses reappeared, however, if the moving object changed its trajectory or if it suddenly reversed moving direction against the movement of similar objects that make up a coherent background-flow as induced by ego-motion. Response amplitudes co-varied with the precedent state of dynamic background activity, a phenomenon that has been related to attention-dependent saliency coding in neurons of the mammalian primary visual cortex. The data show that neurons of the central complex of the locust brain are visually bimodal, signaling sky compass direction and the novelty character of moving objects. These response properties might serve to attune compass-aided locomotor control to unexpected events in the environment. The difference to data obtained in fruit flies might relate to differences in the lifestyle of landmark learners (fly) and compass navigators (locust), point to the existence of parallel networks for the two orientation strategies, or reflect differences in experimental conditions.	[Bockhorst, Tobias; Homberg, Uwe] Univ Marburg, Fac Biol, Anim Physiol, Marburg, Germany	Philipps University Marburg	Homberg, U (corresponding author), Univ Marburg, Fac Biol, Anim Physiol, Marburg, Germany.	homberg@biologie.uni-marburg.de	Homberg, Uwe/AFH-8214-2022	Homberg, Uwe/0000-0002-8229-7236	Deutssche Forschungsgemeinschaft [HO 950/21-1, HO 950/23-1]	Deutssche Forschungsgemeinschaft	Deutssche Forschungsgemeinschaft (http://www.dfg.de/) grant numbers HO 950/21-1 and HO 950/23-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bech M, 2014, CURR BIOL, V24, P2124, DOI 10.1016/j.cub.2014.07.045; Bockhorst T, 2015, J NEUROPHYSIOL, V113, P3291, DOI 10.1152/jn.00742.2014; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Cheng K, 2012, J EXP BIOL, V215, P3169, DOI 10.1242/jeb.070417; CLEMENTS AN, 1974, J EXP BIOL, V60, P673; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; COYNE JA, 1982, AM NAT, V119, P589, DOI 10.1086/283936; el Jundi B, 2014, J COMP PHYSIOL A, V200, P575, DOI 10.1007/s00359-014-0890-6; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; Foucaud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015231; GEWECKE M, 1990, BIOL CYBERN, V63, P411, DOI 10.1007/BF00199573; Gewecke M., 1993, SENSORY SYSTEMS ARTH, P119; Gray JR, 2005, J EXP BIOL, V208, P2515, DOI 10.1242/jeb.01640; Gutfreund Y, 2012, BIOL CYBERN, V106, P657, DOI 10.1007/s00422-012-0497-3; Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Heinze S, 2009, J NEUROSCI, V29, P11783, DOI 10.1523/JNEUROSCI.1870-09.2009; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Homberg U, 2011, PHILOS T R SOC B, V366, P680, DOI 10.1098/rstb.2010.0199; Kreuz T, 2011, J NEUROSCI METH, V195, P92, DOI 10.1016/j.jneumeth.2010.11.020; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Merlin C, 2011, CURR OPIN NEUROBIOL, V22, P1; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Netser S, 2011, J NEUROSCI, V31, P17811, DOI 10.1523/JNEUROSCI.4790-11.2011; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; OSHEA M, 1975, NATURE, V254, P53, DOI 10.1038/254053a0; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Ritzmann RE, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00097; Rosner R, 2013, J NEUROSCI, V33, P8122, DOI 10.1523/JNEUROSCI.5390-12.2013; ROWELL CHF, 1977, J EXP BIOL, V68, P157; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Super H, 2003, J NEUROSCI, V23, P3407; Weir PT, 2012, CURR BIOL, V22, P21, DOI 10.1016/j.cub.2011.11.026; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wiederman SD, 2011, J NEUROSCI, V31, P7141, DOI 10.1523/JNEUROSCI.0970-11.2011	47	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144501	10.1371/journal.pone.0144501	http://dx.doi.org/10.1371/journal.pone.0144501			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636334	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800094
J	Xu, YT; Yu, S; Zou, JW; Hu, GX; Rahman, NABD; Othman, RB; Tao, X; Huang, ML				Xu, Yongtao; Yu, Shui; Zou, Jian-Wei; Hu, Guixiang; Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti; Tao, Xia; Huang, Meilan			Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MEMBRANE-FUSION PROTEINS; TYPE-1 GLYCOPROTEIN-H; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PEPTIDES; SYNTHETIC PEPTIDES; HIV-1 GP41; ENTRY; PREDICTION; DESIGN	The peptides derived from envelope proteins have been shown to inhibit the protein-protein interactions in the virus membrane fusion process and thus have a great potential to be developed into effective antiviral therapies. There are three types of envelope proteins each exhibiting distinct structure folds. Although the exact fusion mechanism remains elusive, it was suggested that the three classes of viral fusion proteins share a similar mechanism of membrane fusion. The common mechanism of action makes it possible to correlate the properties of self-derived peptide inhibitors with their activities. Here we developed a support vector machine model using sequence-based statistical scores of self-derived peptide inhibitors as input features to correlate with their activities. The model displayed 92% prediction accuracy with the Matthew's correlation coefficient of 0.84, obviously superior to those using physicochemical properties and amino acid decomposition as input. The predictive support vector machine model for self-derived peptides of envelope proteins would be useful in development of antiviral peptide inhibitors targeting the virus fusion process.	[Xu, Yongtao; Yu, Shui; Huang, Meilan] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland; [Xu, Yongtao] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China; [Zou, Jian-Wei; Hu, Guixiang] Zhejiang Univ, Ningbo Inst Technol, Sch Biotechnol & Chem Engn, Ningbo, Zhejiang, Peoples R China; [Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Rahman, Noorsaadah A. B. D.; Othman, Rozana Binti] Univ Malaya, Drug Design & Dev Res Grp, Kuala Lumpur, Malaysia; [Othman, Rozana Binti] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Tao, Xia] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China	Queens University Belfast; Xinxiang Medical University; Zhejiang University; Universiti Malaya; Universiti Malaya; Universiti Malaya; Beijing University of Chemical Technology	Huang, ML (corresponding author), Queens Univ Belfast, Sch Chem & Chem Engn, David Keir Bldg,Stranmillis Rd, Belfast, Antrim, North Ireland.	m.huang@qub.ac.uk	Rahman, Noorsaadah Abd./B-9291-2010; Othman, Rozana/B-9628-2010	Rahman, Noorsaadah Abd./0000-0001-5847-8961; Othman, Rozana/0000-0002-8260-9252				Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Alhoot MA, 2013, INT J MED SCI, V10, P719, DOI 10.7150/ijms.5037; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Cantisani M, 2013, J MED CHEM, V56, P8366, DOI 10.1021/jm400771k; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cherkasov A, 2004, MOLECULES, V9, P1034, DOI 10.3390/91201034; Corinna C, 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Costin JM, 2010, PLOS NEGLECT TROP D, V4, P1; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fjell CD, 2011, CHEM BIOL DRUG DES, V77, P48, DOI 10.1111/j.1747-0285.2010.01044.x; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Frecer V, 2004, ANTIMICROB AGENTS CH, V48, P3349, DOI 10.1128/AAC.48.9.3349-3357.2004; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gadkari RA, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-17; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; HSU CW, 2010, PRACTICAL GUIDE SUPP, V1, P1; Janin J, 2003, CURR OPIN STRUC BIOL, V13, P383, DOI 10.1016/S0959-440X(03)00064-2; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Koedel Y, 2011, J VIROL, V85, P7037, DOI 10.1128/JVI.02366-10; Koehler J, 2013, PLOS NEGLECT TROP D, V7, P1, DOI DOI 10.1371/JOURNAL.PNTD.0002430; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Li C, 2012, ANTIVIR RES, V94, P179, DOI 10.1016/j.antiviral.2012.03.002; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lo Conte L, 1999, J MOL BIOL, V285, P2177; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Melnik LI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-76; Moult J, 1997, CURR OPIN STRUC BIOL, V7, P194, DOI 10.1016/S0959-440X(97)80025-5; Ngan Shing-Chung, 2008, V413, P243; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; QURESHI NM, 1990, AIDS, V4, P553, DOI 10.1097/00002030-199006000-00009; Sabahi A, 2008, THESIS; Sainz B, 2006, VIRUS RES, V120, P146, DOI 10.1016/j.virusres.2006.03.001; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Si YH, 2012, HEPATOLOGY, V56, P507, DOI 10.1002/hep.25685; Spence J, 2013, THESIS; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Taboureau O, 2006, CHEM BIOL DRUG DES, V68, P48, DOI 10.1111/j.1747-0285.2006.00405.x; Teissier E, 2011, MOLECULES, V16, P221, DOI 10.3390/molecules16010221; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Torrent M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-373; Tsai CJ, 1997, PROTEIN SCI, V6, P53; Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475; Vondrasek J, 2009, J PHYS CHEM B, V113, P9041, DOI 10.1021/jp902377q; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1994, P NATL ACAD SCI USA, V91, P12676, DOI 10.1073/pnas.91.26.12676; Xu YT, 2012, PROTEINS, V80, P2154, DOI 10.1002/prot.24105; Yuan KH, 2004, BIOCHEM BIOPH RES CO, V319, P746, DOI 10.1016/j.bbrc.2004.05.046; Zheng BJ, 2005, ANTIVIR THER, V10, P393; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	71	1	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144171	10.1371/journal.pone.0144171	http://dx.doi.org/10.1371/journal.pone.0144171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636321	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800052
J	Sweeney, LA; Molloy, GJ; Byrne, M; Murphy, AW; Morgan, K; Hughes, CM; Ingham, R				Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly; Murphy, Andrew W.; Morgan, Karen; Hughes, Carmel M.; Ingham, Roger			A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists	PLOS ONE			English	Article							ACTING REVERSIBLE CONTRACEPTION; EMERGENCY CONTRACEPTION; UNINTENDED PREGNANCY; ATTITUDES; ADHERENCE; HEALTH; WOMEN	Background The oral contraceptive pill (OCP) remains the most popular form of prescription contraception in many countries, despite adherence difficulties for many. Uptake of long acting reversible contraceptives (LARCs), which are less reliant on user adherence, remains low. The aim of this study was to explore the experiences of, and attitudes towards, prescription contraception amongst samples of contraception users, general practitioners (GPs) and pharmacists. Methodology and Findings We conducted a qualitative study using semi-structured interviews with 18 contraception users, 18 GPs and 9 pharmacists. The study took place in Galway, Republic of Ireland between June and September 2014. Thematic analysis was used to analyse the data. Overall, contraception users were more familiar with the OCP, and all the women interviewed began their prescription contraception journey using this method. All participants identified episodes of poor adherence throughout the reproductive life course. The identified barriers for use of LARCs were lack of information, misconceptions, lack of access and high cost. In contrast, GPs believed that adherence to the OCP was good and stated they were more likely to prescribe the OCP than other methods, as they were most familiar with this option. Barriers to prescribing LARCSs were time, cost to practice, training and deskilling. Pharmacists also believed that adherence to the OCP was generally good and that their role was limited to dispensing medication and providing information when asked. Discussion and Conclusion There are contrasting perspectives between contraception service providers and contraceptive users. Training for healthcare providers is required to support informed contraceptive choice and adherence. It is necessary to address the practice barriers of cost and lack of time, to promote better communication around adherence issues and prescription contraception options. There is a need for more easily-accessible public health information to promote awareness on all methods of prescription contraception.	[Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Sweeney, Leigh-Ann; Molloy, Gerard J.; Byrne, Molly] Natl Univ Ireland, Whitaker Inst Innovat & Societal Change, Galway, Ireland; [Murphy, Andrew W.] Natl Univ Ireland, Sch Med, Discipline Gen Practice, Galway, Ireland; [Morgan, Karen] Royal Coll Surgeons Ireland, Dept Psychol, Dublin 2, Ireland; [Morgan, Karen] Perdana Univ, Royal Coll Surg Ireland, Sch Med, Kuala Lumpur, Malaysia; [Hughes, Carmel M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Ingham, Roger] Univ Southampton, Ctr Sexual Hlth Res, Southampton, Hants, England	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Royal College of Surgeons - Ireland; University College Dublin; Perdana University; Royal College of Surgeons - Ireland; Queens University Belfast; University of Southampton	Molloy, GJ (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	gerry.molloy@nuigalway.ie	morgan, karen/C-3846-2012; Molloy, Gerard J/AAV-2634-2021; Molloy, Gerard J/C-5721-2008	morgan, karen/0000-0001-6193-1747; Molloy, Gerard J/0000-0002-7718-9898; Molloy, Gerard J/0000-0002-7718-9898; Murphy, Andrew/0000-0001-5549-8246; Byrne, Molly/0000-0001-8900-4320	Health Service Executive Crisis Pregnancy Programme [RPG2013-5]	Health Service Executive Crisis Pregnancy Programme	This study was funded by a project grant (Reference: RPG2013-5) awarded by the Health Service Executive Crisis Pregnancy Programme and administered by the Irish Research Council in December 2013 to Dr Gerry Molloy (Principal Investigator), Dr Karen Morgan, Dr Molly Byrne and Dr Andrew Murphy (Co-Investigators). Professor Carmel Hughes, Professor Roger Ingham and Professor Richard Layte were members of the steering committee for this study. Funder website: http://www.crisispregnancy.ie. Funding administered by: http://research.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2013, WORLD CONTR PATT 201; Arrowsmith ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092205; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Biggs MA, 2014, OBSTET GYNECOL, V123, P593, DOI 10.1097/AOG.0000000000000137; Bracken J, 2014, EUR J CONTRACEP REPR, V19, P276, DOI 10.3109/13625187.2014.917623; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buhling KJ, 2014, CONTRACEPTION, V89, P162, DOI 10.1016/j.contraception.2013.11.011; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Castano PM, 2013, CONTRACEPTION, V88, P475, DOI 10.1016/j.contraception.2013.08.002; Corden A., 2006, USING VERBATIM QUOTA; Dombrowski SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039852; El-Ibiary SY, 2007, EUR J CONTRACEP REPR, V12, P58, DOI 10.1080/13625180601092537; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Glasier A, 2008, J FAM PLAN REPROD H, V34, P213, DOI 10.1783/147118908786000497; Halpern V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub4; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; McBride O, 2012, IRISH CONTRACEPTION; Michie L, 2014, CONTRACEPTION, V90, P447, DOI 10.1016/j.contraception.2014.05.004; Michie L, 2013, Minerva Ginecol, V65, P241; Molloy GJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007794; Molloy GJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-838; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; O'Donoghue C, 2011, CAMB J ECON, V35, P59, DOI 10.1093/cje/beq010; Okpo E, 2014, PUBLIC HEALTH, V128, P934, DOI 10.1016/j.puhe.2014.08.012; Potter L, 1996, FAM PLANN PERSPECT, V28, P154, DOI 10.2307/2136191; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Weedle PB, 2011, PHARM MED LAW IRELAN; Wellings K, 2007, CONTRACEPTION, V76, P208, DOI 10.1016/j.contraception.2007.05.085; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1	31	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144074	10.1371/journal.pone.0144074	http://dx.doi.org/10.1371/journal.pone.0144074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633191	Green Accepted, gold, Green Published			2022-12-26	WOS:000366040000051
J	Weller, SA; Stokes, MGM; Lukaszewski, RA				Weller, Simon A.; Stokes, Margaret G. M.; Lukaszewski, Roman A.			Observations on the Inactivation Efficacy of a MALDI-TOF MS Chemical Extraction Method on Bacillus anthracis Vegetative Cells and Spores	PLOS ONE			English	Article							MASS-SPECTROMETRY; IDENTIFICATION; MICROBIOLOGY; BACTERIA; TIME	A chemical (ethanol; formic acid; acetonitrile) protein extraction method for the preparation of bacterial samples for matrix assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) identification was evaluated for its ability to inactivate bacterial species. Initial viability tests (with and without double filtration of the extract through 0.2 mu M filters), indicated that the method could inactivate Escherichia coli MRE 162 and Klebsiella pneumoniae ATCC 35657, with or without filtration, but that filtration was required to exclude viable, avirulent, Bacillus anthracis UM23CL2 from extracts. Multiple, high stringency, viability experiments were then carried out on entire filtered extracts prepared from virulent B. anthracis Vollum vegetative cells and spores ranging in concentration from 10(6)-10(8)cfu per extract. B. anthracis was recovered in 3/18 vegetative cell extracts and 10/18 spore extracts. From vegetative cell extracts B. anthracis was only recovered from extracts that had undergone prolonged Luria (L)-broth (7 day) and L-agar plate (a further 7 days) incubations. We hypothesise that the recovery of B. anthracis in vegetative cell extracts is due to the escape of individual sub-lethally injured cells. We discuss our results in view of working practises in clinical laboratories and in the context of recent inadvertent releases of viable B. anthracis.	[Weller, Simon A.; Stokes, Margaret G. M.; Lukaszewski, Roman A.] Minist Def, CBR Div, Def Sci & Technol Lab, Salisbury, Wilts, England	Defence Science & Technology Laboratory	Weller, SA (corresponding author), Minist Def, CBR Div, Def Sci & Technol Lab, Salisbury, Wilts, England.	sweller@dstl.gov.uk		Weller, Simon/0000-0001-9286-2991	Headquarters Surgeon General, UK Ministry of Defence	Headquarters Surgeon General, UK Ministry of Defence	This study was funded by Headquarters Surgeon General, UK Ministry of Defence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper may not reflect those of the UK Ministry of Defence.	Bourbeau PP, 2013, J CLIN MICROBIOL, V51, P1658, DOI 10.1128/JCM.00301-13; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Centers for Disease Control and Prevention, 2014, REP POT EXP ANTHR; Corning Inc, 2013, CORN FILTR GUID; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Cunningham SA, 2013, J CLIN MICROBIOL, V51, P1639, DOI 10.1128/JCM.00267-13; Daltonics B., 2011, REVISION, V2, P157; Department of Defense, 2015, REV COMM REP IN SHIP; Drevinek M, 2012, LETT APPL MICROBIOL, V55, P40, DOI 10.1111/j.1472-765X.2012.03255.x; Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Parsons TM., 2013, J BIOTERR BIODEF, VS3, P009, DOI [10.4172/2157-2526.S3-009, DOI 10.4172/2157-2526.S3-009]; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Smither SJ, 2015, J CLIN MICROBIOL, V53, P3148, DOI 10.1128/JCM.01449-15; Varughese EA, 2007, J MICROBIOL METH, V71, P66, DOI 10.1016/j.mimet.2007.07.011	17	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143870	10.1371/journal.pone.0143870	http://dx.doi.org/10.1371/journal.pone.0143870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633884	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000027
J	Yang, Y; Pang, DL; Hu, CH; Lv, YJ; He, T; An, YL; Tang, ZG; Deng, ZH				Yang, Yi; Pang, Danlin; Hu, Chenghu; Lv, Yajie; He, Tao; An, Yulin; Tang, Zhangui; Deng, Zhihong			Nestin Positive Bone Marrow Derived Cells Responded to Injury Mobilize into Peripheral Circulation and Participate in Skin Defect Healing	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM; PROGENITOR CELLS; STROMAL CELLS; MOUSE MODEL; BLOOD; RECRUITMENT; EXPRESSION; MIGRATION	Exogenously infused mesenchymal stem cells (MSCs) are thought to migrate to injury site through peripheral blood stream and participate in tissue repair. However, whether and how endogenous bone marrow MSCs mobilized to circulating and targeted to tissue injury has raised some controversy, and related studies were restricted by the difficulty of MSCs identifying in vivo. Nestin, a kind of intermediate filament protein initially identified in neuroepithelial stem cells, was recently reported as a credible criteria for MSCs in bone marrow. In this study, we used a green fluorescent protein (GFP) labeled bone marrow replacement model to trace the nestin positive bone marrow derived cells (BMDCs) of skin defected-mice. We found that after skin injured, numbers of nestin(+) cells in peripheral blood and bone marrow both increased. A remarkable concentration of nestin(+) BMDCs around skin wound was detected, while few of these cells could be observed in uninjured skin or other organs. This recruitment effect could not be promoted by granulocyte colony-stimulating factor (G-CSF), suggests a different mobilization mechanism from ones G-CSF takes effect on hematopoietic cells. Our results proposed nestin(+) BMDCs as mobilized candidates in skin injury repair, which provide a new insight of endogenous MSCs therapy.	[Yang, Yi; Pang, Danlin; Hu, Chenghu; He, Tao; An, Yulin; Deng, Zhihong] Fourth Mil Med Univ, Sch Stomatol, Ctr Tissue Engn, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China; [Pang, Danlin; Tang, Zhangui] Cent S Univ, Xiangya Stomatol Hosp, Changsha, Hunan, Peoples R China; [Deng, Zhihong] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol, Xian 710032, Shaanxi, Peoples R China; [Hu, Chenghu] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Lv, Yajie] Fourth Mil Med Univ, Tangdu Hosp, Dept Dermatol, Xian 710032, Shannxi, Peoples R China; [Yang, Yi] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Prosthodont, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University; Central South University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Tang, ZG (corresponding author), Cent S Univ, Xiangya Stomatol Hosp, Changsha, Hunan, Peoples R China.	tangzhanguixiangya@163.com; dengzh@fmmu.edu.cn	Hu, Cheng-Hu/I-4210-2013	Hu, Cheng-Hu/0000-0003-2443-6485	Nature Science Foundation of China [81271065, 81470679]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Nature Science Foundation of China (81271065, 81470679; http://www.nsfc.gov.cn/). The funder was the main designer of the study.; This study was supported by the funding support from the Nature Science Foundation of China (81271065, 81470679). The authors are thankful to Mrs. Congye Li, Cardiac Department of Internal Medicine, Xijing Hospital, Fourth Military Medical University, for the technical assistance of in vivo imaging.	Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bian ZY, 2009, ARCH MED RES, V40, P163, DOI 10.1016/j.arcmed.2009.01.002; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Deng J, 2011, NEUROL SCI, V32, P641, DOI 10.1007/s10072-011-0608-2; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Epstein RJ, 2004, NAT REV CANCER, V4, P901, DOI 10.1038/nrc1473; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Goldberg ED, 2007, B EXP BIOL MED+, V144, P802, DOI 10.1007/s10517-007-0435-x; Griffin MD, 2013, STEM CELLS, V31, P2033, DOI 10.1002/stem.1452; Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Hoogduijn MJ, 2014, STEM CELLS DEV, V23, P2328, DOI 10.1089/scd.2014.0269; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jin SZ, 2012, HEPATOB PANCREAT DIS, V11, P66, DOI 10.1016/S1499-3872(11)60127-6; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lazarus HM, 1997, J HEMATOTHER, V6, P447, DOI 10.1089/scd.1.1997.6.447; Li N, 2013, BIOL CELL, V105, P261, DOI 10.1111/boc.201200064; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Mazo IB, 2011, TRENDS IMMUNOL, V32, P493, DOI 10.1016/j.it.2011.06.011; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Oyama M, 1999, GENE THER, V6, P321, DOI 10.1038/sj.gt.3300839; Pacini S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00020; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007; Shirley D, 2005, J ORTHOP RES, V23, P1013, DOI 10.1016/j.orthres.2005.01.013; Stich S, 2009, CELL TISSUE RES, V336, P225, DOI 10.1007/s00441-009-0768-z; Tatsumi K, 2008, CIRC J, V72, P1351, DOI 10.1253/circj.72.1351; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Zhou J, 2011, J CELL PHYSIOL, V226, P2081, DOI 10.1002/jcp.22538; Zvaifler NJ, 2000, ARTHRITIS RES, V2, P477, DOI 10.1186/ar130	47	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143368	10.1371/journal.pone.0143368	http://dx.doi.org/10.1371/journal.pone.0143368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633897	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000013
J	Barros, B; Sakai, Y; Pereira, PHC; Gasset, E; Buchet, V; Maamaatuaiahutapu, M; Ready, JS; Oliveira, Y; Giarrizzo, T; Vallinoto, M				Barros, Breno; Sakai, Yoichi; Pereira, Pedro H. C.; Gasset, Eric; Buchet, Vincent; Maamaatuaiahutapu, Moana; Ready, Jonathan S.; Oliveira, Yrlan; Giarrizzo, Tommaso; Vallinoto, Marcelo			Comparative Allometric Growth of the Mimetic Ephippid Reef Fishes Chaetodipterus faber and Platax orbicularis	PLOS ONE			English	Article							FORAGING BEHAVIOR; SHAPE CHANGES; PERCIFORMES; MORPHOLOGY; JUVENILES; TELEOSTEI; ONTOGENY; ECOLOGY; MIMICRY; ESTUARY	Mimesis is a relatively widespread phenomenon among reef fish, but the ontogenetic processes relevant for mimetic associations in fish are still poorly understood. In the present study, the allometric growth of two allopatric leaf-mimetic species of ephippid fishes, Chaetodipterus faber from the Atlantic and Platax orbicularis from the Indo-Pacific, was analyzed using ten morphological variables. The development of fins was considered owing to the importance of these structures for mimetic behaviors during early life stages. Despite the anatomical and behavioral similarities in both juvenile and adult stages, C. faber and P. orbicularis showed distinct patterns of growth. The overall shape of C. faber transforms from a rounded-shape in mimetic juveniles to a lengthened profile in adults, while in P. orbicularis, juveniles present an oblong profile including dorsal and anal fins, with relative fin size diminishing while the overall profile grows rounder in adults. Although the two species are closely-related, the present results suggest that growth patterns in C. faber and P. orbicularis are different, and are probably independent events in ephippids that have resulted from similar selective processes.	[Barros, Breno; Oliveira, Yrlan; Vallinoto, Marcelo] Fed Univ Para, Inst Estudos Costeiros, Lab Evolucao, Campus Braganca,Alameda Leandro Ribeiro S-N, BR-68600000 Braganca, Para, Brazil; [Barros, Breno; Sakai, Yoichi] Hiroshima Univ, Lab Aquat Resources, Grad Sch Biosphere Sci, Higashihiroshima 7390046, Japan; [Pereira, Pedro H. C.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Gasset, Eric; Buchet, Vincent] IFREMER, Ctr Oceanol Pacific, Unite Ressources Marines Polynesie Francaise, F-98719 Taravao, France; [Maamaatuaiahutapu, Moana] Direct Ressources Maritimes & Minieres, Papeete, France; [Ready, Jonathan S.; Giarrizzo, Tommaso] Fed Univ Para, Lab Biol Pesqueira Manejo Recursos Aquat, BR-66040170 Belem, Para, Brazil; [Vallinoto, Marcelo] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, P-4485661 Vairao, Portugal	Universidade Federal do Para; Hiroshima University; James Cook University; Ifremer; Universidade Federal do Para; Universidade do Porto	Barros, B (corresponding author), Fed Univ Para, Inst Estudos Costeiros, Lab Evolucao, Campus Braganca,Alameda Leandro Ribeiro S-N, BR-68600000 Braganca, Para, Brazil.	breno_eduardo@terra.com.br	Ready, Jonathan S/J-2964-2012; Barros, Breno/B-9898-2015; Vallinoto, Marcelo/ABF-9834-2021; Vallinoto, Marcelo/J-3086-2012; Giarrizzo, Tommaso/G-8482-2016; Sakai, Yoichi/Y-6674-2018	Ready, Jonathan S/0000-0002-9374-8661; Barros, Breno/0000-0002-4344-9372; Vallinoto, Marcelo/0000-0002-3465-3830; Vallinoto, Marcelo/0000-0002-3465-3830; Giarrizzo, Tommaso/0000-0002-5116-5206; Sakai, Yoichi/0000-0002-9602-1601; Buchet, Vincent/0000-0001-7377-446X; Gasset, Eric/0000-0002-7545-4037	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) [6718-10-8]; CNPq/FAPESPA [456780/2012]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/FAPESPA	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), providing the scholarship to the first author due to period of 2004-2007; the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES, process #6718-10-8), providing the scholarship to the author during the period of 2011; CNPq/FAPESPA (process #456780/2012), providing the scholarship to the author during the period of 2013-2014.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Barros B, 2012, J FISH BIOL, V81, P1032, DOI 10.1111/j.1095-8649.2012.03377.x; Barros B, 2011, J COASTAL RES, P1950; Barros B, 2013, ARE EPHIPPID FISH SL, P33; Barros B, 2008, J ETHOL, V26, P287, DOI 10.1007/s10164-007-0066-8; Barros B, 2013, HYDROBIOLOGIA, V717, P161, DOI 10.1007/s10750-013-1574-x; Barros B, 2011, ENVIRON BIOL FISH, V91, P177, DOI 10.1007/s10641-011-9770-x; Barros Breno, 2007, Kempffiana, V3, P18; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; BREDER C. M., 1955, ZOOLOGICA [NEW YORK], V40, P85; Breder Charles M., 1946, BULL BINGHAM OCEANOGR COLL PEABODY MUS NAT HIST YALE UNIV, V10, P1; Burgess W, 1978, FAO SPECIES IDENTIFI, P1799; Catarino MF, 2010, NEOTROP ICHTHYOL, V8, P183, DOI 10.1590/S1679-62252010000100022; Cavalluzzi MR, 2000, LARVAE INDOPACIFIC C, P660; Cavalluzzi MR, 2000, THESIS; Cheney KL, 2014, ANIM BEHAV, V88, P85, DOI 10.1016/j.anbehav.2013.11.006; Pereira PHC, 2015, REV FISH BIOL FISHER, V25, P245, DOI 10.1007/s11160-014-9378-2; Pereira PHC, 2012, CYBIUM, V36, P361; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Diana J. S., 1995, BIOL ECOLOGY FISHES; DITTY JG, 1994, FISH B-NOAA, V92, P262; Fulton CJ, 2002, MAR ECOL PROG SER, V236, P255, DOI 10.3354/meps236255; Gagliano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055938; Gorley C.K., 2006, GETTING STARTED PRIM; Hayse JW, 1987, FISHERY B, V88, P67; Heemstra P. C., 2001, FAO SPECIES IDENTIFI, V6, P3611; Hildebrand M., 1998, ANAL VERTEBRATE STRU; Humann P., 2002, REEF FISH IDENTIFICA; Jenkins J.A., 2014, GUIDELINES USE FISHE; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kuiter R.H., 2001, SURGEONFISHES RABBIT; Lauder GV, 2004, IEEE J OCEANIC ENG, V29, P556, DOI 10.1109/JOE.2004.833219; Leis JM, 2013, J FISH BIOL, V83, P466, DOI 10.1111/jfb.12182; Leis JM, 2009, MAR ECOL PROG SER, V379, P163, DOI 10.3354/meps07904; Liem K. F., 1970, COMP FUNCTIONAL ANAT, DOI 10.5962/bhl.title.3081; Loy A, 2001, J MORPHOL, V250, P24, DOI 10.1002/jmor.1056; Loy A, 1998, J MORPHOL, V237, P137, DOI 10.1002/(SICI)1097-4687(199808)237:2<137::AID-JMOR5>3.0.CO;2-Z; Moland E, 2005, OCEANOGR MAR BIOL, V43, P455; Nakabo T., 2002, FISHES JAPAN PICTORI; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Norton SF, 1995, ROLE ECOMORPHOLOGICA, P287; Pasteur G, 1982, ANNU REV ECOL SYST, P169; Pereira PHC, 2013, J FISH BIOL, V82, P1226, DOI 10.1111/jfb.12054; RANDALL JE, 1971, ZOOLOGICA-NEW YORK, V56, P115; Randall JE, 2005, ZOOL STUD, V44, P299; RANDALL JOHN E., 1960, BULL MAR SCI GULF AND CARIBBEAN, V10, P444; Remoissenet G, 2012, PARAHA PEUE PLATAX O; Richards WJ, 2005, EARLY STAGES ATLANTI, P1759; Robertson DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054939; Russo T, 2008, J FISH BIOL, V73, P809, DOI 10.1111/j.1095-8649.2008.01964.x; SCHMITT RJ, 1984, MAR ECOL PROG SER, V18, P225, DOI 10.3354/meps018225; Tang KL, 1999, MOL PHYLOGENET EVOL, V11, P415, DOI 10.1006/mpev.1998.0596; Team RC, 2014, R LANG ENV STAT COMP; Walker JA, 2004, IEEE J OCEANIC ENG, V29, P572, DOI 10.1109/JOE.2004.833217; WICKLER W, 1965, NATURE, V208, P519, DOI 10.1038/208519a0; Wickler W., 1968, MIMICRY PLANTS ANIMA	58	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143838	10.1371/journal.pone.0143838	http://dx.doi.org/10.1371/journal.pone.0143838			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630347	Green Published, gold, Green Accepted			2022-12-26	WOS:000365926300108
J	Bolson, M; Smidt, ED; Brotto, ML; Silva-Pereira, V				Bolson, Monica y; Smidt, Eric de Camargo; Brotto, Marcelo Leandro; Silva-Pereira, Viviane			ITS and trnH-psbA as Efficient DNA Barcodes to Identify Threatened Commercial Woody Angiosperms from Southern Brazilian Atlantic Rainforests	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MATK PRIMERS; LAND PLANTS; EVOLUTION; PHYLOGENY; SEQUENCES; REGIONS; MARKERS; RBCL; LAURACEAE	The Araucaria Forests in southern Brazil are part of the Atlantic Rainforest, a key hotspot for global biodiversity. This habitat has experienced extensive losses of vegetation cover due to commercial logging and the intense use of wood resources for construction and furniture manufacturing. The absence of precise taxonomic tools for identifying Araucaria Forest tree species motivated us to test the ability of DNA barcoding to distinguish species exploited for wood resources and its suitability for use as an alternative testing technique for the inspection of illegal timber shipments. We tested three cpDNA regions (matK, trnH-psbA, and rbcL) and nrITS according to criteria determined by The Consortium for the Barcode of Life (CBOL). The efficiency of each marker and selected marker combinations were evaluated for 30 commercially valuable woody species in multiple populations, with a special focus on Lauraceae species. Inter-and intraspecific distances, species discrimination rates, and ability to recover species-specific clusters were evaluated. Among the regions and different combinations, ITS was the most efficient for identifying species based on the 'best close match' test; similarly, the trnH-psbA + ITS combination also demonstrated satisfactory results. When combining trnH-psbA + ITS, Maximum Likelihood analysis demonstrated a more resolved topology for internal branches, with 91% of species-specific clusters. DNA barcoding was found to be a practical and rapid method for identifying major threatened woody angiosperms from Araucaria Forests such as Lauraceae species, presenting a high confidence for recognizing members of Ocotea. These molecular tools can assist in screening those botanical families that are most targeted by the timber industry in southern Brazil and detecting certain species protected by Brazilian legislation and could be a useful tool for monitoring wood exploitation.	[Bolson, Monica y; Smidt, Eric de Camargo; Silva-Pereira, Viviane] Univ Fed Parana, Dept Bot, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil; [Brotto, Marcelo Leandro] Museu Bot Municipal Curitiba, Curitiba, Parana, Brazil	Universidade Federal do Parana	Silva-Pereira, V (corresponding author), Univ Fed Parana, Dept Bot, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil.	visilvapereira@gmail.com	Smidt, Eric C/F-7632-2011; Silva-Pereira, Viviane/A-7136-2013	Smidt, Eric C/0000-0002-1177-1682; Silva-Pereira, Viviane/0000-0003-4543-178X	Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI)/FUNDACAO ARAUCARIA de Apoio ao Desenvolvimento Cientifico e Tecnologico do Parana [483/2010-19068]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI)/FUNDACAO ARAUCARIA de Apoio ao Desenvolvimento Cientifico e Tecnologico do Parana; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior (SETI)/FUNDACAO ARAUCARIA de Apoio ao Desenvolvimento Cientifico e Tecnologico do Parana - VSP - 483/2010-19068 http://www.fappr.pr.gov.br/ Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) - MB - http://www.capes.gov.br/ Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - ECS - http://www.cnpq.br/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bleeker W, 2008, BIOL CONSERV, V141, P692, DOI 10.1016/j.biocon.2007.12.015; Brotto Marcelo Leandro, 2013, Rodriguésia, V64, P495; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Correa MC, 2002, ARAUCARIA A FLORESTA; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; De Mattia F, 2011, FOOD RES INT, V44, P693, DOI 10.1016/j.foodres.2010.12.032; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Doyle J. J., 1987, PHYTOCHEM B, P11; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071710; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Fu YM, 2011, J SYST EVOL, V49, P237, DOI 10.1111/j.1759-6831.2011.00126.x; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2013, PLOS ONE, V4; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Inoue MT, 1984, PROJETO MADEIRA DO P; Isernhagen I, 2001, THESIS, P511; Kass E, 1997, PLANT SYST EVOL, V208, P139, DOI 10.1007/BF00985439; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2011, FOOD CHEM, V127, P1335, DOI 10.1016/j.foodchem.2011.01.094; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lavin M, 1999, SYST BOT, V56, P1, DOI DOI 10.2307/; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li Y, 2011, J SYST EVOL, V49, P169, DOI 10.1111/j.1759-6831.2011.00128.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Z, 2012, PHARMACOGN MAG, V8, P4, DOI 10.4103/0973-1296.93301; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Ministerio do Meio Ambiente-MMA, 2008, INSTRUCAO NORMATIVA; Moraes MA, 2013, LIVRO VERMELHO DA FL, P1120; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Pires PTL, 2006, PERSPECTIVAS DE RECU, P53; Reitz R, 1979, MADEIRAS DO BRASIL; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Staden R, 2003, INTRODUCTION TO BIOI; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Stehmann JR, 2009, PLANTAS DA FLORESTA; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JA, 2003, SYST BOT, V28, P723; Theodoridis S, 2012, MOL ECOL RESOUR, V12, P620, DOI 10.1111/j.1755-0998.2012.03129.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; VANDERWERFF H, 1991, ANN MO BOT GARD, V78, P377, DOI 10.2307/2399567; Veloso HP, 1991, CLASSIFICACAO DA VEG; Vivas CV, 2014, GENET MOL BIOL, V37, P662, DOI 10.1590/S1415-47572014000500009; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Yue JX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-242	79	44	51	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143049	10.1371/journal.pone.0143049	http://dx.doi.org/10.1371/journal.pone.0143049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630282	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300027
J	Kim, MG; Kim, SC; Ko, YS; Lee, HY; Jo, SK; Cho, W				Kim, Myung-Gyu; Kim, Sun Chul; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Wonyong			The Role of M2 Macrophages in the Progression of Chronic Kidney Disease following Acute Kidney Injury	PLOS ONE			English	Article							RENAL FIBROSIS; CELLS; INFLAMMATION; CONTRIBUTE; RECOVERY	Introduction Acute kidney injury (AKI) is a major risk factor in the development of chronic kidney disease (CKD). However, the mechanisms linking AKI to CKD remain unclear. We examined the alteration of macrophage phenotypes during an extended recovery period following ischemia/reperfusion injury (IRI) and determine their roles in the development of fibrosis. Methods The left renal pedicle of mice was clamped for 40 min. To deplete monocyte/macrophage, liposome clodronate was injected or CD11b-DTR and CD11c-DTR transgenic mice were used. Results Throughout the phase of IRI recovery, M2-phenotype macrophages made up the predominant macrophage subset. On day 28, renal fibrosis was clearly shown with increased type IV collagen and TGF-beta. The depletion of macrophages induced by the liposome clodronate injection improved renal fibrosis with a reduction of kidney IL-6, type IV collagen, and TGF-beta levels. Additionally, the adoptive transfer of the M2c macrophages partially reversed the beneficial effect of macrophage depletion, whereas the adoptive transfer of the M1 macrophages did not. M2 macrophages isolated from the kidneys during the recovery phase expressed 2.5 fold higher levels of TGF-beta than the M1 macrophages. The injection of the diphtheria toxin into CD11b or CD11c-DTR transgenic mice resulted in lesser depletion or no change in M2 macrophages and had little impact on renal fibrosis. Conclusion Although M2 macrophages are known to be indispensible for short-term recovery, they are thought to be main culprit in the development of renal fibrosis following IRI.	[Kim, Myung-Gyu; Kim, Sun Chul; Ko, Yoon Sook; Lee, Hee Young; Jo, Sang-Kyung; Cho, Wonyong] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Jo, SK (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea.	sang-kyung@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A1062586]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A1062586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Canaud G, 2015, NEPHROL DIAL TRANSPL, V30, P575, DOI 10.1093/ndt/gfu230; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Hanke ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042476; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Kim MG, 2010, NEPHROL DIAL TRANSPL, V25, P2908, DOI 10.1093/ndt/gfq183; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Ko GJ, 2008, NEPHROL DIAL TRANSPL, V23, P842; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135; Sedrakyan S, 2012, J AM SOC NEPHROL, V23, P661, DOI 10.1681/ASN.2011030243; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang T, 2007, TRANSL RES, V150, P40, DOI 10.1016/j.trsl.2007.01.006; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	21	84	85	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143961	10.1371/journal.pone.0143961	http://dx.doi.org/10.1371/journal.pone.0143961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630505	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300130
J	van Lummel, RC; Walgaard, S; Pijnappels, M; Elders, PJM; Garcia-Aymerich, J; van Dieen, JH; Beek, PJ				van Lummel, Rob C.; Walgaard, Stefan; Pijnappels, Mirjam; Elders, Petra J. M.; Garcia-Aymerich, Judith; van Dieen, Jaap H.; Beek, Peter J.			Physical Performance and Physical Activity in Older Adults: Associated but Separate Domains of Physical Function in Old Age	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DAILY-LIFE; ACTIVITY MONITORS; COPD; COMMUNITY; VALIDITY; MOBILITY; GO	Background Physical function is a crucial factor in the prevention and treatment of health conditions in older adults and is usually measured objectively with physical performance tests and/or physical activity monitoring. Objective To examine whether 1) physical performance (PP) and physical activity (PA) constitute separate domains of physical function; 2) differentiation of PA classes is more informative than overall PA. Design Cross-sectional study to explore the relationships within and among PP and PA measures. Methods In 49 older participants (83 +/- 7 years; M +/- SD), performance-based tests were conducted and PA was measured for one week. Activity monitor data were reduced in terms of duration, periods, and mean duration of periods of lying, sitting, standing and locomotion. The relation between and within PP scores and PA outcomes were analysed using rank order correlation and factor analysis. Results Factor structure after varimax rotation revealed two orthogonal factors explaining 78% of the variance in the data: one comprising all PA variables and one comprising all PP variables. PP scores correlated moderately with PA in daily life. Differentiation of activity types and quantification of their duration, intensity and frequency of occurrence provided stronger associations with PP, as compared to a single measure of acceleration expressing overall PA. Limitations For independent validation, the conclusions about the validity of the presented conceptual framework and its clinical implications need to be confirmed in other studies. Conclusions PP and PA represent associated but separate domains of physical function, suggesting that an improvement of PP does not automatically imply an increase of PA, i.e. a change to a more active lifestyle. Differentiation of activity classes in the analysis of PA provides more insights into PA and its association with PP than using a single overall measure of acceleration.	[van Lummel, Rob C.; Walgaard, Stefan] McRoberts BV, NL-2596 HN The Hague, Netherlands; [Walgaard, Stefan] Hague Univ Appl Sci, Movement Technol, The Hague, Netherlands; [van Lummel, Rob C.; Pijnappels, Mirjam; van Dieen, Jaap H.; Beek, Peter J.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam, Med Ctr, EMGO, Amsterdam, Netherlands; [Garcia-Aymerich, Judith] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Garcia-Aymerich, Judith] CIBERESP, Barcelona, Spain; [Garcia-Aymerich, Judith] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University	van Lummel, RC (corresponding author), McRoberts BV, Raamweg 43, NL-2596 HN The Hague, Netherlands.	r.vanlummel@mcroberts.nl	van Dieen, Jaap/B-3937-2013; J, Garcia-Aymerich/G-6867-2014	van Dieen, Jaap/0000-0002-7719-5585; J, Garcia-Aymerich/0000-0002-7097-4586; Beek, Peter/0000-0002-0917-8548; Elders, Petra/0000-0002-5907-7219; Pijnappels, Mirjam/0000-0001-8416-2602	Netherlands Organization for Scientific Research (NWO TOP NIG) [91209021]; Innovation Fund of Agis/Achmea (Innovatiefonds), a Dutch health insurance company [499256]; McRoberts BV	Netherlands Organization for Scientific Research (NWO TOP NIG); Innovation Fund of Agis/Achmea (Innovatiefonds), a Dutch health insurance company; McRoberts BV	This work was supported by the Netherlands Organization for Scientific Research (NWO TOP NIG grant 91209021). The grant was for the development of new instruments: A novel instrument to support fall prevention in extramural care. There has not been any involvement of NWO in the study. JD. This work was supported with a grant from the Innovation Fund of Agis/Achmea (Innovatiefonds grant 499256), a Dutch health insurance company. The aim was to develop a fall prevention program for inhabitants of a care home and the community. There has not been any involvement of Agis/Achmea in the study. RvL. McRoberts BV provided support in the form of salaries for authors [RvL, SW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brodie M., 2015, MED BIOL ENG COMPUT; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Fayers PM, 1997, QUAL LIFE RES, V6, P139; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gimeno-Santos E, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-86; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haskell WL, 2009, PREV MED, V49, P280, DOI 10.1016/j.ypmed.2009.05.002; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Morie M, 2010, J AM GERIATR SOC, V58, P1727, DOI 10.1111/j.1532-5415.2010.03012.x; Nicolai S, 2010, J AGING PHYS ACTIV, V18, P75, DOI 10.1123/japa.18.1.75; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Pitta F, 2005, ARCH PHYS MED REHAB, V86, P1979, DOI 10.1016/j.apmr.2005.04.016; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; PROMIS, DYN TOOLS MEAS HLTH; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Troosters T, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-115; U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health, 2009, GUID IND PAT REP OUT; Van Hees VT, 2009, MED SCI SPORT EXER, V41, P810, DOI 10.1249/MSS.0b013e31818ff636; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; van Schooten KS, 2015, J AGING PHYS ACTIV, V23, P9, DOI [10.1123/japa.2013-0103, 10.1123/JAPA.2013-0103]; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Veltink P H, 1996, IEEE Trans Rehabil Eng, V4, P375, DOI 10.1109/86.547939; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	34	67	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144048	10.1371/journal.pone.0144048	http://dx.doi.org/10.1371/journal.pone.0144048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630268	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300147
J	Wang, J; Wu, CP; Peng, J; Patel, N; Huang, YY; Gao, XX; Aljarallah, S; Eubanks, JH; McDonald, R; Zhang, L				Wang, Justin; Wu, Chiping; Peng, Jessie; Patel, Nisarg; Huang, Yayi; Gao, Xiaoxing; Aljarallah, Salman; Eubanks, James H.; McDonald, Robert; Zhang, Liang			Early-Onset Convulsive Seizures Induced by Brain Hypoxia-Ischemia in Aging Mice: Effects of Anticonvulsive Treatments	PLOS ONE			English	Article							ACUTE NONCONVULSIVE SEIZURES; CEREBRAL-ARTERY OCCLUSION; TERM VIDEO-EEG; STATUS EPILEPTICUS; THERAPEUTIC HYPOTHERMIA; INTRALUMINAL FILAMENT; POSTISCHEMIC SEIZURES; PERIAQUEDUCTAL GRAY; ACUTE-PHASE; STROKE	Aging is associated with an increased risk of seizures/epilepsy. Stroke (ischemic or hemorrhagic) and cardiac arrest related brain injury are two major causative factors for seizure development in this patient population. With either etiology, seizures are a poor prognostic factor. In spite of this, the underlying pathophysiology of seizure development is not well understood. In addition, a standardized treatment regimen with anticonvulsants and outcome assessments following treatment has yet to be established for these post-ischemic seizures. Previous studies have modeled post-ischemic seizures in adult rodents, but similar studies in aging/aged animals, a group that mirrors a higher risk elderly population, remain sparse. Our study therefore aimed to investigate early-onset seizures in aging animals using a hypoxia-ischemia (HI) model. Male C57 black mice 18-20-month-old underwent a unilateral occlusion of the common carotid artery followed by a systemic hypoxic episode (8% O-2 for 30 min). Early-onset seizures were detected using combined behavioral and electroencephalographic (EEG) monitoring. Brain injury was assessed histologically at different times post HI. Convulsive seizures were observed in 65% of aging mice post-HI but not in control aging mice following either sham surgery or hypoxia alone. These seizures typically occurred within hours of HI and behaviorally consisted of jumping, fast running, barrel-rolling, and/or falling (loss of the righting reflex) with limb spasms. No evident discharges during any convulsive seizures were seen on cortical-hippocampal EEG recordings. Seizure development was closely associated with acute mortality and severe brain injury on brain histological analysis. Intra-peritoneal injections of lorazepam and fosphenytoin suppressed seizures and improved survival but only when applied prior to seizure onset and not after. These findings together suggest that seizures are a major contributing factor to acute mortality in aging mice following severe brain ischemia and that early anticonvulsive treatment may prevent seizure genesis and improve overall outcomes.	[Wang, Justin; Wu, Chiping; Peng, Jessie; Patel, Nisarg; Huang, Yayi; Gao, Xiaoxing; Aljarallah, Salman; Eubanks, James H.; Zhang, Liang] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Zhang, Liang] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Eubanks, James H.] Univ Toronto, Dept Surg Neurosurg, Toronto, ON, Canada; [McDonald, Robert] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Aljarallah, Salman] King Saud Univ, Dept Med, Neurol Unit, Riyadh, Saudi Arabia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Lethbridge; King Saud University	Zhang, L (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.	liangz@uhnres.utoronto.ca		Aljarallah, Salman/0000-0003-0138-7924; Zhang, Liang/0000-0002-7888-5043; Eubanks, James/0000-0001-8595-2024	Canadian Institute of Health Research [219171]; Ontario Brain Institute Eplink Program; Natural Science and Engineering Research Council of Canada [RGPIN-2015-04153]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute Eplink Program; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute of Health Research to LZ and RM (Grant # 219171); from Ontario Brain Institute Eplink Program to JE and LZ; and from Natural Science and Engineering Research Council of Canada to LZ (RGPIN-2015-04153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Bakker A, 2015, NEUROIMAGE-CLIN, V7, P688, DOI 10.1016/j.nicl.2015.02.009; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Balami JS, NEUROLOGICAL COMPLIC; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Bladin Christopher F, 2009, Handb Clin Neurol, V93, P613, DOI 10.1016/S0072-9752(08)93030-X; Boller Manuel, 2011, Resuscitation, V82 Suppl 2, pS27, DOI 10.1016/S0300-9572(11)70148-4; Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Chung JM, 2014, NEUROL RES, V36, P403, DOI 10.1179/1743132814Y.0000000352; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Cuaycong M, 2011, DEV NEUROSCI-BASEL, V33, P241, DOI 10.1159/000331646; Cuomo O, 2013, PLOS ONE, V13, DOI [10.1371/journal.pone.0080852, DOI 10.1371/J0URNAL.P0NE.0080852]; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Devi L, 2013, NEUROBIOL LEARN MEM, V102, P7, DOI 10.1016/j.nlm.2013.02.001; Dudek FE, 2006, MODELS OF SEIZURES AND EPILEPSY, P415, DOI 10.1016/B978-012088554-1/50036-0; El-Hayek YH, 2011, CEREB CORTEX, V21, P2863, DOI 10.1093/cercor/bhr080; El-Hayek YH, 2011, EXP NEUROL, V231, P295, DOI 10.1016/j.expneurol.2011.07.003; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GALE K, 1992, J CLIN NEUROPHYSIOL, V9, P264, DOI 10.1097/00004691-199204010-00007; GARCIA JH, 1993, AM J PATHOL, V142, P623; Gooshe M, 2015, EUR J PHARMACOL, V746, P6, DOI 10.1016/j.ejphar.2014.11.005; Guekht A., 2012, HDB CLIN NEUROLOGY, V108, P570; Gursoy-Ozdemir Y, 1999, BRAIN RES, V822, P260, DOI 10.1016/S0006-8993(99)01175-0; Guth JC, 2014, J STROKE CEREBROVASC, V23, P2809, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.023; Han F, 2010, RESUSCITATION, V81, P93, DOI 10.1016/j.resuscitation.2009.09.018; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hofmeijer J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00039; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Huang CW, 2014, NEUROLOGY, V82, P768, DOI 10.1212/WNL.0000000000000166; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeffrey M, 2014, NEUROSCIENCE, V257, P65, DOI 10.1016/j.neuroscience.2013.10.074; Jetter GM, 2008, SEMIN NEUROL, V28, P336, DOI 10.1055/s-2008-1079338; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Kanthasamy AG, 2000, MOVEMENT DISORD, V15, P31, DOI 10.1002/mds.870150707; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Karhunen H, 2006, EPILEPSY RES, V72, P25, DOI 10.1016/j.eplepsyres.2006.07.003; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly KM, 2011, EXP NEUROL, V232, P15, DOI 10.1016/j.expneurol.2011.07.004; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Klahr AC, 2015, TRANSL STROKE RES, V6, P29, DOI 10.1007/s12975-014-0361-y; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Lam A, 2010, EPILEPSIA, V51, P1736, DOI 10.1111/j.1528-1167.2010.02551.x; LEVINE S, 1960, AM J PATHOL, V36, P1; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Mani R, 2012, RESUSCITATION, V83, P840, DOI 10.1016/j.resuscitation.2012.02.015; Mazarati AM, 2006, MODELS OF SEIZURES AND EPILEPSY, P449, DOI 10.1016/B978-012088554-1/50038-4; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Mecarelli O, 2011, CEREBROVASC DIS, V31, P191, DOI 10.1159/000321872; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Menon B, 2009, EPILEPSY RES, V87, P1, DOI 10.1016/j.eplepsyres.2009.08.007; MILLER JW, 1992, PROG NEUROBIOL, V39, P155, DOI 10.1016/0301-0082(92)90009-4; Olson EE, 2004, J NEUROL SCI, V227, P7, DOI 10.1016/j.jns.2004.07.021; Omori N, 2001, BRAIN RES, V903, P162, DOI 10.1016/S0006-8993(01)02436-2; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Peng J, 2015, EPILEPSY RES, V111, P142, DOI 10.1016/j.eplepsyres.2015.01.009; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Procaccianti G, 2012, NEUROEPIDEMIOLOGY, V39, P45, DOI 10.1159/000338374; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rittenberger JC, 2012, NEUROCRIT CARE, V16, P114, DOI 10.1007/s12028-011-9565-0; Robitsek J, 2015, HIPPOCAMPUS IN PRESS; Rowe AS, 2014, PHARMACOTHERAPY, V34, P396, DOI 10.1002/phar.1374; Sampath D, 2014, EPILEPSIA, V55, P985, DOI 10.1111/epi.12646; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; Shorvon S, 2011, CURR OPIN NEUROL, V24, P165, DOI 10.1097/WCO.0b013e3283446f31; Sicard Kenneth M, 2009, Exp Transl Stroke Med, V1, P7, DOI 10.1186/2040-7378-1-7; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; Spiegel AM, 2013, J COMP NEUROL, V521, P3508, DOI 10.1002/cne.23367; Sykes L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub3; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Veliskova J, 2006, MODELS OF SEIZURES AND EPILEPSY, P601, DOI 10.1016/B978-012088554-1/50050-5; Wais M, 2009, NEUROSCIENCE, V161, P599, DOI 10.1016/j.neuroscience.2009.03.036; Waterhouse EJ, 2001, DRUG AGING, V18, P133, DOI 10.2165/00002512-200118020-00006; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Wither RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035396; Wu C, 2008, J NEUROSCI METH, V171, P126, DOI 10.1016/j.jneumeth.2008.03.001; Wu CP, 2015, EXP NEUROL, V271, P1, DOI 10.1016/j.expneurol.2015.04.018; Yang L, 2003, NEUROPHARMACOLOGY, V44, P275, DOI 10.1016/S0028-3908(02)00367-2; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150	99	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144113	10.1371/journal.pone.0144113	http://dx.doi.org/10.1371/journal.pone.0144113			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630670	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300161
J	Chesnel, C; Genet, F; Almangour, W; Denormandie, P; Parratte, B; Schnitzler, A				Chesnel, Camille; Genet, Franois; Almangour, Waleed; Denormandie, Philippe; Parratte, Bernard; Schnitzler, Alexis			Effectiveness and Complications of Percutaneous Needle Tenotomy with a Large Needle for Muscle Contractures: A Cadaver Study	PLOS ONE			English	Article							KNEE FLEXION CONTRACTURE; DUPUYTRENS DISEASE; ADDUCTOR TENOTOMY; CLUBFOOT; PREVALENCE; MANAGEMENT; RELEASE; PAIN; APONEUROTOMY; DEFINITION	Background Twenty-two percent of institutionalised elderly persons have muscle contractures. Contractures have important functional consequences, rendering hygiene and positioning in bed or in a chair difficult. Medical treatment (such as botulinum toxin injections, physiotherapy or positioning) is not very effective and surgery may be required. Surgery is carried out in the operating theatre, under local or general anaesthesia but is often not possible in fragile patients. Mini-invasive tenotomy could be a useful alternative as it can be carried out in ambulatory care, under local anaesthesia. Objective To evaluate the effectiveness of percutaneous needle tenotomy and the risks of damage to adjacent structures in cadavers. Method Thirty two doctors who had never practiced the technique (physical medicine and rehabilitation specialists, geriatricians and orthopaedic surgeons) carried out 401 tenotomies on the upper and lower limbs of 8 fresh cadavers. A 16G needle was used percutaneous following location of the tendons. After each tenotomy, a neuro-orthopaedic surgeon and an anatomist dissected the area in order to evaluate the success of the tenotomy and any adjacent lesions which had occurred. Results Of the 401 tenotomies, 72% were complete, 24.9% partial and 2.7% failed. Eight adjacent lesions occurred (2%): 4 (1%) in tendons or muscles, 3 (0.7%) in nerves and 1 (0.2%) in a vessel. Conclusion This percutaneous needle technique effectively ruptured the desired tendons, with few injuries to adjacent structures. Although this study was carried out on cadavers, the results suggest it is safe to carry out on patients.	[Chesnel, Camille; Genet, Franois; Almangour, Waleed; Denormandie, Philippe; Schnitzler, Alexis] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, CIC IT 1429, Garches, France; [Genet, Franois; Denormandie, Philippe] Univ Versailles St Quentin Yvelines, Endicap, INSERM, U1179,UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France; [Genet, Franois; Denormandie, Philippe; Parratte, Bernard; Schnitzler, Alexis] European Sch Surg, Paris, France; [Parratte, Bernard] Univ Franche Comte, Jean Minjoz Hosp, Dept Phys Med & Rehabil, Lab Anat,UE 3920, F-25030 Besancon, France; [Denormandie, Philippe; Schnitzler, Alexis] Univ Versailles St Quentin Yvelines, Handiresp, EA4047, UFR Sci Sante Simone Veil, Montigny Le Bretonneux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; CHU Besancon; UDICE-French Research Universities; Universite Paris Saclay	Schnitzler, A (corresponding author), Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, CIC IT 1429, 104 Blvd Raymond Poincare, Garches, France.	alexis.schnitzler@rpc.aphp.fr			Allergan	Allergan(AbbVieAllergan)	The authors wish to thank Allergan for financing the translation and editing of this article which was carried out by Johanna Robertson. The authors wish to thank European School of Surgery Paris ECC and Body donation center Paris-Descartes University for their contribution to the organisation of the training courses. The authors have no commercial interest relevant to the subject of this manuscript.	Atkinson HDE, 2010, ARCH ORTHOP TRAUM SU, V130, P965, DOI 10.1007/s00402-009-1032-4; Beaudreuil J, 2012, J HAND SURG-EUR VOL, V37E, P795, DOI 10.1177/1753193412439170; Bergerault F, 2013, ORTHOP TRAUMATOL-SUR, V99, pS150, DOI 10.1016/j.otsr.2012.11.001; Bor N, 2006, CLIN ORTHOP RELAT R, P224, DOI 10.1097/01.blo.0000201147.12292.6b; Botte M J, 2000, Foot Ankle Clin, V5, P381; Changulani M, 2007, ARCH ORTHOP TRAUM SU, V127, P429, DOI 10.1007/s00402-006-0267-6; Cipriano C, 2007, CLIN ORTHOP RELAT R, P150, DOI 10.1097/BLO.0b013e3180ca8e96; Decq P, NEUROCHIR PARIS ELLI, P679; Dehail P., 2014, Annals of Physical and Rehabilitation Medicine, V57, P11, DOI 10.1016/j.rehab.2013.11.001; Denormandie P, 2003, NEUROCHIRURGIE, V49, P339; Diaz R, 2014, HAND CLIN, V30, P33, DOI 10.1016/j.hcl.2013.09.005; Diong J, 2012, SPINAL CORD, V50, P579, DOI 10.1038/sc.2012.25; El Hage S, 2010, J PEDIATR ORTHOPED, V30, P485, DOI 10.1097/BPO.0b013e3181df619d; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; KEENAN MAE, 1988, CLIN ORTHOP RELAT R, P221; Lakhey S, 2007, Kathmandu Univ Med J (KUMJ), V5, P446; Lebel E, 2012, J PEDIATR ORTHOPED, V32, P412, DOI 10.1097/BPO.0b013e31825611a6; Lu HS, 1999, J ARTHROPLASTY, V14, P775, DOI 10.1016/S0883-5403(99)90024-4; Rojo-Manaute JM, 2010, J ULTRAS MED, V29, P1517, DOI 10.7863/jum.2010.29.11.1517; Martin JN, 2006, J BONE JOINT SURG AM, V88A, P840, DOI 10.2106/JBJS.E.00717; Minkowitz Barbara, 2004, J Foot Ankle Surg, V43, P263, DOI 10.1053/j.jfas.2004.05.012; MOLLINGER LA, 1993, PHYS THER, V73, P437, DOI 10.1093/ptj/73.7.437; Namdari S, 2012, J SHOULDER ELB SURG, V21, P1357, DOI 10.1016/j.jse.2011.09.029; Offenbacher M, 2014, DISABIL REHABIL, V36, P529, DOI 10.3109/09638288.2013.800596; Sackley C, 2008, STROKE, V39, P3329, DOI 10.1161/STROKEAHA.108.518563; Schnitzler A, 2013, ANN PHYS REHABIL MED, V56, pe385; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Thevenin-Lemoine C, 2013, J BONE JOINT SURG AM, V95A, P446, DOI 10.2106/JBJS.K.00190; Wagner LM, 2008, GERIATR NURS, V29, P259, DOI 10.1016/j.gerinurse.2007.09.002; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143495	10.1371/journal.pone.0143495	http://dx.doi.org/10.1371/journal.pone.0143495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624990	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600032
J	Gormley, K; Mackenzie, C; Robins, P; Coscia, I; Cassidy, A; James, J; Hull, A; Piertney, S; Sanderson, W; Porter, J				Gormley, Kate; Mackenzie, Clara; Robins, Peter; Coscia, Ilaria; Cassidy, Andrew; James, Jenny; Hull, Angela; Piertney, Stuart; Sanderson, William; Porter, Joanne			Connectivity and Dispersal Patterns of Protected Biogenic Reefs: Implications for the Conservation of Modiolus modiolus (L.) in the Irish Sea	PLOS ONE			English	Article							SMALL-SCALE VARIATION; LARVAL DISPERSAL; BIVALVIA REEF; GENETIC DIVERSITY; BENTHIC HABITAT; MARINE; EPIFAUNA; MOLLUSCA; BIODIVERSITY; MANAGEMENT	Biogenic reefs created by Modiolus modiolus (Linnaeus, 1758) (horse mussel reefs) are marine habitats which support high levels of species biodiversity and provide valuable ecosystem services. Currently, M. modiolus reefs are listed as a threatened and/or declining species and habitat in all OSPAR regions and thus are highlighted as a conservation priority under the EU Marine Strategy Framework Directive (MSFD). Determining patterns of larval dispersal and genetic connectivity of remaining horse mussel populations can inform management efforts and is a critical component of effective marine spatial planning (MSP). Larval dispersal patterns and genetic structure were determined for several M. modiolus bed populations in the Irish Sea including those in Wales (North Pen Llyn), Isle of Man (Point of Ayre) and Northern Ireland (Ards Peninsula and Strangford Lough). Simulations of larval dispersal suggested extant connectivity between populations within the Irish Sea. Results from the genetic analysis carried out using newly developed microsatellite DNA markers were consistent with those of the biophysical model. Results indicated moderately significant differentiation between the Northern Ireland populations and those in the Isle of Man and Wales. Simulations of larval dispersal over a 30 day pelagic larval duration (PLD) suggest that connectivity over a spatial scale of 150km is possible between some source and sink populations. However, it appears unlikely that larvae from Northern Ireland will connect directly with sites on the Llyn or Isle of Man. It also appears unlikely that larvae from the Llyn connect directly to any of the other sites. Taken together the data establishes a baseline for underpinning management and conservation of these important and threatened marine habitats in the southern part of the known range.	[Gormley, Kate; Mackenzie, Clara; James, Jenny; Sanderson, William; Porter, Joanne] Heriot Watt Univ, Sch Life Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Coscia, Ilaria] Univ Leuven, Lab Biodivers & Evolutionary Genom, B-3000 Leuven, Belgium; [Cassidy, Andrew] Univ Dundee, Ninewells Hosp & Med Sch, Human Genet Unit, Med Res Inst, Dundee DD1 9SY, Scotland; [Hull, Angela] Heriot Watt Univ, Sch Built Environm, Edinburgh EH14 4AS, Midlothian, Scotland; [Robins, Peter] Bangor Univ, Sch Ocean Sci, Menai Bridge LL59 5AB, Gwynedd, Wales; [Piertney, Stuart] Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland	Heriot Watt University; KU Leuven; University of Dundee; Heriot Watt University; Bangor University; University of Aberdeen	Porter, J (corresponding author), Heriot Watt Univ, Sch Life Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	J.S.Porter@hw.ac.uk	; Porter, Joanne/B-8060-2011	Mackenzie, Clara/0000-0002-5797-6106; Porter, Joanne/0000-0002-5878-3912; Coscia, Ilaria/0000-0001-5768-4675; Sanderson, William/0000-0003-1686-0585; Cassidy, Andrew/0000-0003-4309-6981	Heriot-Watt University; Marine Alliance for Science and Technology for Scotland (MASTS) [HR09011]; Northern Ireland Environmental Agency, Natural Resources Wales and Isle of Man Government (Fiona Gell)	Heriot-Watt University; Marine Alliance for Science and Technology for Scotland (MASTS); Northern Ireland Environmental Agency, Natural Resources Wales and Isle of Man Government (Fiona Gell)	This project was a PhD Scholarship funded by Heriot-Watt University. Partial funding was supplied by a Marine Alliance for Science and Technology for Scotland (MASTS) small grant fund ref: HR09011. Northern Ireland Environmental Agency, Natural Resources Wales and Isle of Man Government (Fiona Gell) also provided some additional funding for sample collection. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chust G, 2013, ESTUAR COAST SHELF S, V131, P52, DOI 10.1016/j.ecss.2013.08.005; Cochrane S.K.J., 2010, MARINE STRATEGY FRAM; Cook R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069904; Coscia I, 2013, CONSERV GENET, V14, P451, DOI 10.1007/s10592-012-0404-4; DEFRA, 2011, MAR STRAT FRAM DIR D; Diz AP, 2009, AQUACULTURE, V287, P278, DOI 10.1016/j.aquaculture.2008.10.029; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elsasser B, 2013, J SEA RES, V77, P11, DOI 10.1016/j.seares.2012.12.006; Emsley SM, 2005, FISH OCEANOGR, V14, P161, DOI 10.1111/j.1365-2419.2005.00327.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farinas-Franco JM, 2016, AQUAT CONSERV, V26, P76, DOI 10.1002/aqc.2496; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gonzalez-Wanguemert M, 2015, MEDITERR MAR SCI, V16, P31, DOI 10.12681/mms.949; Gonzalez-Wanguemert M, 2014, HELGOLAND MAR RES, V68, P357, DOI 10.1007/s10152-014-0396-1; Gormley KSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068263; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Halanych KM, 2013, J MAR BIOL ASSOC UK, V93, P1857, DOI 10.1017/S0025315413000404; Harrald M, 2010, SALTIRE PRIZE PROJEC; Hartnett M, 2007, J ENVIRON MONITOR, V9, P403, DOI 10.1039/b617035h; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Henry LA, 2013, BIOL CONSERV, V161, P67, DOI 10.1016/j.biocon.2013.03.002; Horsburgh KJ, 2003, J PHYS OCEANOGR, V33, P343, DOI 10.1175/1520-0485(2003)033<0343:ATDMOD>2.0.CO;2; Jiale L, 2009, AQUACULTURE, V287, P286; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jordi A, 2012, ENVIRON MODELL SOFTW, V38, P59, DOI 10.1016/j.envsoft.2012.05.013; Kaiser MJ, 2000, CONSERV BIOL, V14, P1512, DOI 10.1046/j.1523-1739.2000.99264.x; Kamenos NA, 2004, J EXP MAR BIOL ECOL, V313, P241, DOI 10.1016/j.jembe.2004.08.007; Kopelman NM, 2015, MOL ECOLOGY RESOURCE; Lindenbaum C, 2008, J MAR BIOL ASSOC UK, V88, P133, DOI 10.1017/S0025315408000374; Ljungberg P, 2013, MAR BIOL, V160, P667, DOI 10.1007/s00227-012-2122-3; MacLeod E, 2009, FRONT ECOL ENVIRON, P7; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Miller AD, 2013, ECOL EVOL, V3, P1248, DOI 10.1002/ece3.535; Morris E., 2014, INT WORKSH MARCH 4 5; Neill SP, 2010, OCEAN DYNAM, V60, P1139, DOI 10.1007/s10236-010-0313-3; OSPAR, 2009, OSPAR BIOD SER; OSPAR Commission, 2004, 200807 OSPAR COMM; Palumbi SR, 2003, ECOL APPL, V13, pS146; Phelps JJC, 2015, MAR ECOL PROG SER, V518, P177, DOI 10.3354/meps11040; Pritchard JK, 2000, GENETICS, V155, P945; QIAGEN, 2006, DNEASY BLOOD TISS HD; Ragnarsson SA, 2012, J SEA RES, V72, P55, DOI 10.1016/j.seares.2012.05.011; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rees E., 2009, OSPAR BIOD SER; Rees EIS, 2008, J MAR BIOL ASSOC UK, V88, P151, DOI 10.1017/S0025315408000052; Roberts D, 1975, UNDERWATER ASS, V1, P27; Roberts D, 2011, MODIOLUS RESTORATION; Roberts D., 2004, STRANGFORD LOUGH ECO; Robins PE, 2013, LIMNOL OCEANOGR, V58, P505, DOI 10.4319/lo.2013.58.2.0505; Sanderson WG, 2008, J MAR BIOL ASSOC UK, V88, P143, DOI 10.1017/S0025315408000040; Schunter C, 2011, J EXP MAR BIOL ECOL, V401, P126, DOI 10.1016/j.jembe.2011.01.021; SCHWEINITZ EHD, 1976, BIOL BULL, V150, P348; Simmons A., 2006, ECMWF NEWSLETTER, V110, P25, DOI DOI 10.21957/pocnex23c6; Sundelof A, 2012, MAR ECOL-EVOL PERSP, V33, P183, DOI 10.1111/j.1439-0485.2011.00485.x; Thomas Y, 2012, MAR POLLUT BULL, V65, P441, DOI 10.1016/j.marpolbul.2011.12.027; Thrush SF, 1998, ECOL APPL, V8, P866, DOI 10.2307/2641273; von der Heyden S, 2014, B MAR SCI, V90, P123, DOI 10.5343/bms.2012.1079; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wang YH, 2013, MAR GENOM, V9, P63, DOI 10.1016/j.margen.2012.06.003; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wildish DJ, 1998, HYDROBIOLOGIA, V375-76, P369, DOI 10.1023/A:1017080116103; Wright S., 1978, EVOLUTION GENETIC PO; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	71	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143337	10.1371/journal.pone.0143337	http://dx.doi.org/10.1371/journal.pone.0143337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625263	Green Submitted, gold, Green Published			2022-12-26	WOS:000365891600026
J	Li, J; Naeem, MS; Wang, XP; Liu, LX; Chen, C; Ma, N; Zhang, CL				Li, Jun; Naeem, Muhammad Shahbaz; Wang, Xiuping; Liu, Lixin; Chen, Chang; Ma, Ni; Zhang, Chunlei			Nano-TiO2 Is Not Phytotoxic As Revealed by the Oilseed Rape Growth and Photosynthetic Apparatus Ultra-Structural Response	PLOS ONE			English	Article							SALINITY-INDUCED CHANGES; NANO-ANATASE TIO2; OXIDATIVE STRESS; WATERLOGGING DAMAGE; BRASSICA-NAPUS; WINTER RAPE; NANOPARTICLES; L.; SPINACH; CHLOROPLASTS	Recently nano-materials are widely used but they have shown contrasting effects on human and plant life. Keeping in view the contrasting results, the present study has evaluated plant growth response, antioxidant system activity and photosynthetic apparatus physiological and ultrastructural changes in Brassica napus L. plants grown under a wide range (0, 500, 2500, 4000 mg/l) of nano-TiO2 in a pot experiment. Nano-TiO2 has significantly improved the morphological and physiological indices of oilseed rape plants under our experimental conditions. All the parameters i-e morphological (root length, plant height, fresh biomass), physiological (photosynthetic gas exchange, chlorophyll content, nitrate reductase activity) and antioxidant system (Superoxide dismutase, SOD; Guaiacol peroxidase, POD; Catalase, CAT) recorded have shown improvement in their performance by following nano-TiO2 dose-dependent manner. No significant chloroplast ultra-structural changes were observed. Transmission electron microscopic images have shown that intact & typical grana and stroma thylakoid membranes were in the chloroplast, which suggest that nano-TiO2 has not induced the stressful environment within chloroplast. Finally, it is suggested that, nano-TiO2 have growth promoting effect on oilseed rape plants.	[Li, Jun; Naeem, Muhammad Shahbaz; Liu, Lixin; Chen, Chang; Ma, Ni; Zhang, Chunlei] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Wang, Xiuping] Hebei Normal Univ Sci & Technol, Coll Life Sci & Technol, Qinhuangdao, Peoples R China; [Naeem, Muhammad Shahbaz] Univ Agr Faisalabad, Dept Agron, Faisalabad, Pakistan	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Hebei Normal University of Science & Technology; University of Agriculture Faisalabad	Zhang, CL (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.	zhangchunlei@caas.cn	Naeem, Muhammad Shahbaz/B-4892-2013	Naeem, Muhammad Shahbaz/0000-0002-2996-1927	National Natural Science Foundation of China [31101124]; Natural Science Foundation of Hebei Province [C2014407061]; PhD Research Startup Foundation of Hebei Normal University of Science and Technology [2013YB005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); PhD Research Startup Foundation of Hebei Normal University of Science and Technology	This study was supported by the National Natural Science Foundation of China (31101124), Natural Science Foundation of Hebei Province (C2014407061), and PhD Research Startup Foundation of Hebei Normal University of Science and Technology (2013YB005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Bor M, 2003, PLANT SCI, V164, P77, DOI 10.1016/S0168-9452(02)00338-2; Buchanan B. B., 2002, BIOCH MOL BIOL PLANT; Castiglione MR, 2011, J NANOPART RES, V13, P2443, DOI 10.1007/s11051-010-0135-8; Harrison CC, 1996, PHYTOCHEMISTRY, V41, P37, DOI 10.1016/0031-9422(95)00576-5; Hong FH, 2005, BIOL TRACE ELEM RES, V104, P249, DOI 10.1385/BTER:104:3:249; Iavicoli I, 2011, EUR REV MED PHARMACO, V15, P481; Jbir N, 2001, CR ACAD SCI III-VIE, V324, P863, DOI 10.1016/S0764-4469(01)01355-5; Kong SJ, 2008, ENVIRON MOL MUTAGEN, V49, P399, DOI 10.1002/em.20399; Kutik J, 2001, PHOTOSYNTHETICA, V39, P497, DOI 10.1023/A:1015639609268; Leul M, 1998, FIELD CROP RES, V59, P121, DOI 10.1016/S0378-4290(98)00112-9; Liu QL, 2009, NANO LETT, V9, P1007, DOI 10.1021/nl803083u; MAURINO SG, 1986, J PLANT PHYSIOL, V124, P123, DOI 10.1016/S0176-1617(86)80184-5; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Momoh EJJ, 2002, WEED RES, V42, P446, DOI 10.1046/j.1365-3180.2002.00308.x; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nohynek GJ, 2008, SKIN PHARMACOL PHYS, V21, P136, DOI 10.1159/000131078; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Paramonova NV, 2004, RUSS J PLANT PHYSL+, V51, P86, DOI 10.1023/B:RUPP.0000011307.95130.8f; Pei ZF, 2010, J PLANT GROWTH REGUL, V29, P106, DOI 10.1007/s00344-009-9120-9; Seeger E, 2009, J SOIL SEDIMENT, V9, P46, DOI 10.1007/s11368-008-0034-0; Shalata A, 2001, PHYSIOL PLANTARUM, V112, P487, DOI 10.1034/j.1399-3054.2001.1120405.x; Song U, 2013, BIOL TRACE ELEM RES, V155, P93, DOI 10.1007/s12011-013-9765-x; Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108; Vranova E, 2000, J EXP BOT, V51, P1763, DOI 10.1093/jexbot/51.351.1763; WOOLHOUSE HW, 1984, CAN J BOT, V62, P2934, DOI 10.1139/b84-392; Yang F, 2007, BIOL TRACE ELEM RES, V119, P77, DOI 10.1007/s12011-007-0046-4; Yang F, 2006, BIOL TRACE ELEM RES, V110, P179, DOI 10.1385/BTER:110:2:179; Yusuf M, 2008, J INTEGR PLANT BIOL, V50, P1096, DOI 10.1111/j.1744-7909.2008.00697.x; Zheng L, 2005, BIOL TRACE ELEM RES, V104, P83, DOI 10.1385/BTER:104:1:083; Zhou W, 1997, J PLANT GROWTH REGUL, V16, P47, DOI 10.1007/PL00006974; Zhou WJ, 1999, PLANT GROWTH REGUL, V27, P99, DOI 10.1023/A:1006165603300	34	28	30	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143885	10.1371/journal.pone.0143885	http://dx.doi.org/10.1371/journal.pone.0143885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624621	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600066
J	Kaifu, Y; Kono, RT; Sutikna, T; Saptomo, EW; Jatmiko; Awe, RD				Kaifu, Yousuke; Kono, Reiko T.; Sutikna, Thomas; Saptomo, Emanuel Wahyu; Jatmiko; Awe, Rokus Due			Unique Dental Morphology of Homo floresiensis and Its Evolutionary Implications	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; PLIO-PLEISTOCENE HOMINIDS; LIANG-BUA; TAXONOMIC AFFINITIES; AUSTRALOPITHECUS-ANAMENSIS; PLIOPLEISTOCENE HOMINIDS; MANDIBULAR PREMOLAR; FOURIER DESCRIPTORS; ROOT MORPHOLOGY; MODERN HUMANS	Homo floresiensis is an extinct, diminutive hominin species discovered in the Late Pleistocene deposits of Liang Bua cave, Flores, eastern Indonesia. The nature and evolutionary origins of H. floresiensis' unique physical characters have been intensively debated. Based on extensive comparisons using linear metric analyses, crown contour analyses, and other trait-by-trait morphological comparisons, we report here that the dental remains from multiple individuals indicate that H. floresiensis had primitive canine-premolar and advanced molar morphologies, a combination of dental traits unknown in any other hominin species. The primitive aspects are comparable to H. erectus from the Early Pleistocene, whereas some of the molar morphologies are more progressive even compared to those of modern humans. This evidence contradicts the earlier claim of an entirely modern human-like dental morphology of H. floresiensis, while at the same time does not support the hypothesis that H. floresiensis originated from a much older H. habilis or Australopithecus-like small-brained hominin species currently unknown in the Asian fossil record. These results are however consistent with the alternative hypothesis that H. floresiensis derived from an earlier Asian Homo erectus population and experienced substantial body and brain size dwarfism in an isolated insular setting. The dentition of H. floresiensis is not a simple, scaled-down version of earlier hominins.	[Kaifu, Yousuke; Kono, Reiko T.] Natl Museum Nat & Sci, Dept Anthropol, Tokyo, Japan; [Kaifu, Yousuke] Univ Tokyo, Dept Biol Sci, Tokyo, Japan; [Sutikna, Thomas; Saptomo, Emanuel Wahyu; Jatmiko; Awe, Rokus Due] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Sutikna, Thomas; Saptomo, Emanuel Wahyu; Jatmiko; Awe, Rokus Due] Natl Res & Dev Ctr Archaeol, Jakarta, Indonesia	National Museum of Nature and Science; University of Tokyo; University of Wollongong; National Research & Development Centre for Archaeology - Indonesia	Kaifu, Y (corresponding author), Natl Museum Nat & Sci, Dept Anthropol, Tokyo, Japan.	kaifu@kahaku.go.jp	; Sutikna, Thomas/C-4709-2018	Kaifu, Yousuke/0000-0003-0483-104X; Sutikna, Thomas/0000-0002-9742-4226	Japan Society for the Promotion of Science [24247044]; National Museum of Nature and Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Museum of Nature and Science	This work was supported by funding from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/), No. 24247044, YK; National Museum of Nature and Science, YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Aiello L, 1990, INTRO HUMAN EVOLUTIO; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Baab KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069119; Baba H., 2013, RECENT PROGR STUDY C; Bae CJ, 2010, AM J PHYS ANTHROPOL, P75, DOI 10.1002/ajpa.21442; Bailey SE, 2005, AM J PHYS ANTHROPOL, V126, P268, DOI 10.1002/ajpa.20037; Bailey SE, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-1-4020-5845-5; Bailey SE, 2013, ANTHR PERSPECTIVES T, P222, DOI DOI 10.1017/CBO9780511984464.010; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; BRACE CL, 1987, EVOLUTION, V41, P705, DOI 10.1111/j.1558-5646.1987.tb05847.x; Brown Barbara, 1993, P161; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; Daegling DJ, 2014, J HUM EVOL, V68, P36, DOI 10.1016/j.jhevol.2014.01.001; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Delezene LK, 2011, J HUM EVOL, V60, P711, DOI 10.1016/j.jhevol.2011.01.006; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Haile-Selassie Y, 2015, J HUM EVOL, V78, P44, DOI 10.1016/j.jhevol.2014.08.005; Holliday Trenton W., 2012, Paleoanthropology, V2012, P1; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Jungers WL, 2013, BLACKW COMPANION ANT, P582; Jungers William L., 2009, P93, DOI 10.1007/978-1-4020-9980-9_9; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2006, ANTHROPOL SCI, V114, P35, DOI 10.1537/ase.040729; Kaifu Y, 2015, ANTHROPOL SCI, V123, P129, DOI 10.1537/ase.150501; Kaifu Y, 2011, J HUM EVOL, V61, P644, DOI 10.1016/j.jhevol.2011.08.008; Kaifu Y, 2011, J HUM EVOL, V61, P270, DOI 10.1016/j.jhevol.2011.04.002; Kaifu Y, 2010, VERTEBR PALEOBIOL PA, P143, DOI 10.1007/978-90-481-9094-2_11; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kubo D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0338; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; Le Cabec A, 2012, J HUM EVOL, V63, P667, DOI 10.1016/j.jhevol.2012.07.003; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lestrel PE, 2013, HOMO, V64, P247, DOI 10.1016/j.jchb.2013.05.001; Lordkipanidze D, 2013, SCIENCE, V342, P326, DOI 10.1126/science.1238484; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Martinon-Torres M, 2008, J HUM EVOL, V55, P249, DOI 10.1016/j.jhevol.2007.12.008; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Matsumura H, 2005, AM J PHYS ANTHROPOL, V127, P182, DOI 10.1002/ajpa.20067; Moggi-Cecchi J, 2006, J HUM EVOL, V50, P239, DOI 10.1016/j.jhevol.2005.08.012; Montgomery SH, 2013, J HUM EVOL, V65, P750, DOI 10.1016/j.jhevol.2013.08.006; Moore MW, 2009, J HUM EVOL, V57, P503, DOI 10.1016/j.jhevol.2008.10.006; Morwood MJ, 2009, J HUM EVOL, V57, P640, DOI 10.1016/j.jhevol.2009.08.003; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Orr CM, 2013, J HUM EVOL, V64, P109, DOI 10.1016/j.jhevol.2012.10.003; Perinetti G., 2018, S EUR J ORTHOD DENTO, V5, P3; Robinson JT, 1956, DENTITION AUSTRALOPI; Rosas A, 1998, AM J PHYS ANTHROPOL, V107, P145, DOI 10.1002/(SICI)1096-8644(199810)107:2<145::AID-AJPA2>3.3.CO;2-8; Scott G. R, 1997, ANTHR MODEM HUMAN TE; Shields ED, 2005, AM J PHYS ANTHROPOL, V128, P299, DOI 10.1002/ajpa.20110; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; Suwa G., 1990, THESIS; Tobias P. V., 1991, OLDUVAI GORGE; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; van den Bergh GD, 2009, J HUM EVOL, V57, P527, DOI 10.1016/j.jhevol.2008.08.015; van Heteren AH, 2012, CR PALEVOL, V11, P169, DOI 10.1016/j.crpv.2011.04.001; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Ward CV, 2013, J HUM EVOL, V65, P501, DOI 10.1016/j.jhevol.2013.05.006; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; WEIDENREICH F, 1937, PALAEONTOL SINICA D, V1, P1; WOLPOFF MH, 1971, METRIC TRENDS HOMINI; Wood B., 1991, 4 KOOB FOR RES PROJ; WOOD BA, 1988, J ANAT, V161, P1; WOOD BA, 1987, J ANAT, V154, P121; WOOD BA, 1988, J ANAT, V156, P107; WOOD BA, 1983, J ANAT, V137, P287; WOOD BA, 1983, J ANAT, V136, P197; Wood B, 2014, NATURE, V508, P31, DOI 10.1038/508031a; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067233	100	28	29	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141614	10.1371/journal.pone.0141614	http://dx.doi.org/10.1371/journal.pone.0141614			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26624612	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600017
J	Kim, N; Yoo, JJ; Atala, A; Lee, SJ				Kim, NaJung; Yoo, James J.; Atala, Anthony; Lee, Sang Jin			Combination of small RNAs for skeletal muscle regeneration	FASEB JOURNAL			English	Article						RNAi; siRNA; miR; regeneration; tissue engineering	MYOSTATIN; TISSUE; DELIVERY; INTERFERENCE; EXPRESSION; PROGRESS; GROWTH; MASS; MICE	Selectively controlling the expression of the target genes through RNA interference (RNAi) has significant therapeutic potential for injuries or diseases of tissues. We used this strategy to accelerate and enhance skeletal muscle regeneration for the treatment of muscular atrophy. In this study, we used myostatin small interfering (si)RNA (siGDF-8), a major inhibitory factor in the development and postnatal regeneration of skeletal muscle and muscle-specific microRNAs (miR-1 and -206) to further accelerate muscle regeneration. This combination of 3 small RNAs significantly improved the gene expression of myogenic regulatory factors in vitro, suggesting myogenic activation. Moreover, cell proliferation and myotube formation improved without compromising each other, which indicates the myogenic potential of this combination of small RNAs. The recovery of chemically injured tibialis anterior muscles in rats was significantly accelerated, both functionally and structurally. This novel combination of siRNA and miRNAs has promising therapeutic potential to improve in situ skeletal muscle regeneration.	[Kim, NaJung; Yoo, James J.; Atala, Anthony; Lee, Sang Jin] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA	Wake Forest University	Lee, SJ (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sjlee@wakehealth.edu	Lee, Sang Jin/S-4056-2019; Yoo, James J./L-4850-2017	Lee, Sang Jin/0000-0002-3899-1909; 	Armed Forces Institute of Regenerative Medicine Grant [X81XWH-08-2-0032]; Musculoskeletal Transplant Foundation	Armed Forces Institute of Regenerative Medicine Grant; Musculoskeletal Transplant Foundation	The authors thank Dr. H. Hatcher for editorial assistance and Dr. S. H. Kim (both from Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine) for technical assistance. This study was supported by Armed Forces Institute of Regenerative Medicine Grant X81XWH-08-2-0032 and the Musculoskeletal Transplant Foundation. The authors declare no conflicts of interest.	Amthor H, 2002, DEV BIOL, V251, P241, DOI 10.1006/dbio.2002.0812; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Cheema SK, 2007, WOUND REPAIR REGEN, V15, P286, DOI 10.1111/j.1524-475X.2007.00228.x; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frith JE, 2014, STEM CELL TRANSL MED, V3, P969, DOI 10.5966/sctm.2014-0032; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Ju YM, 2014, ACTA BIOMATER, V10, P4332, DOI 10.1016/j.actbio.2014.06.022; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim N, 2012, INT J PHARMACEUT, V427, P123, DOI 10.1016/j.ijpharm.2011.08.014; Liu CM, 2007, CANCER GENE THER, V14, P945, DOI 10.1038/sj.cgt.7701091; Magee TR, 2006, J GENE MED, V8, P1171, DOI 10.1002/jgm.946; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Nelson CE, 2013, ADV WOUND CARE, V2, P93, DOI 10.1089/wound.2011.0327; Phalon C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001584; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Salem A. K., 2010, RNA INTERFERENCE APP; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wu XW, 2012, BIORESEARCH OPEN ACC, V1, P280, DOI 10.1089/biores.2012.0271	29	9	9	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1198	1206		10.1096/fj.15-271809	http://dx.doi.org/10.1096/fj.15-271809			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26625904				2022-12-26	WOS:000370387800017
J	Park, YG; Jung, MC; Song, H; Jeong, KW; Bang, E; Hwang, GS; Kim, Y				Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Bang, Eunjung; Hwang, Geunn-Sook; Kim, Yangmee			Novel Structural Components Contribute to the High Thermal Stability of Acyl Carrier Protein from Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; BACKBONE DYNAMICS; NMR; HOLO; RESIDUES; BIOSYNTHESIS; RESISTANCE; RELAXATION; FAECIUM; INSIGHT	Enterococcus faecalis is a Gram-positive, commensal bacterium that lives in the gastrointestinal tracts of humans and other mammals. It causes severe infections because of high antibiotic resistance. E. faecalis can endure extremes of temperature and pH. Acyl carrier protein (ACP) is a key element in the biosynthesis of fatty acids responsible for acyl group shuttling and delivery. In this study, to understand the origin of high thermal stabilities of E. faecalis ACP (Ef-ACP), its solution structure was investigated for the first time. CD experiments showed that the melting temperature of Ef-ACP is 78.8 degrees C, which is much higher than that of Escherichia coliACP(67.2 degrees C). The overall structure of Ef-ACP shows the common ACP folding pattern consisting of four alpha-helices (helix I (residues 3-17), helix II (residues 39-53), helix III (residues 60-64), and helix IV (residues 68-78)) connected by three loops. Unique Ef-ACP structural features include a hydrophobic interaction between Phe(45) in helix II and Phe(18) in the alpha(1)alpha(2) loop and a hydrogen bonding between Ser(15) in helix I and Ile(20) in the alpha(1)alpha(2) loop, resulting in its high thermal stability. Phe(45)-mediated hydrophobic packing may block acyl chain binding subpocket II entry. Furthermore, Ser(58) in the alpha(2)alpha(3) loop in Ef-ACP, which usually constitutes a proline in other ACPs, exhibited slow conformational exchanges, resulting in the movement of the helix III outside the structure to accommodate a longer acyl chain in the acyl binding cavity. These results might provide insights into the development of antibiotics against pathogenic drug-resistant E. faecalis strains.	[Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Kim, Yangmee] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Park, Young-Guen; Jung, Min-Cheol; Song, Heesang; Jeong, Ki-Woong; Kim, Yangmee] Konkuk Univ, Bio Mol Informat Ctr, Seoul 143701, South Korea; [Bang, Eunjung; Hwang, Geunn-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Seoul 120140, South Korea	Konkuk University; Konkuk University; Korea Basic Science Institute (KBSI)	Kim, Y (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea.	ymkim@konkuk.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2058021]; Priority Research Centers Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2009-0093824]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Priority Research Centers Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by Basic Science Research Program Grant 2013R1A1A2058021 and Priority Research Centers Program Grant 2009-0093824 through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREC M, 1995, PROTEIN SCI, V4, P983; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Brusic Vladimir, 2005, Expert Rev Clin Immunol, V1, P145, DOI 10.1586/1744666X.1.1.145; Chan DI, 2010, J BIOL CHEM, V285, P30558, DOI 10.1074/jbc.M110.128298; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cronan JE, 2006, NAT CHEM BIOL, V2, P232, DOI 10.1038/nchembio0506-232; Cronan JE, 2004, CHEM BIOL, V11, P1601, DOI 10.1016/j.chembiol.2004.11.011; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GEIGER O, 1991, J BACTERIOL, V173, P2872, DOI 10.1128/JB.173.9.2872-2878.1991; Goddard T.D., 2004, SPARKY 3; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HEATON MP, 1994, J BACTERIOL, V176, P681, DOI 10.1128/jb.176.3.681-690.1994; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P6135, DOI 10.1021/bi00416a046; HORVATH LA, 1994, PROTEIN SCI, V3, P103; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jeong KW, 2014, BIOCHEMISTRY-US, V53, P4814, DOI 10.1021/bi5003844; Jeong KW, 2009, J NAT PROD, V72, P719, DOI 10.1021/np800698d; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Kuch A, 2012, J ANTIMICROB CHEMOTH, V67, P551, DOI 10.1093/jac/dkr544; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; Laport MS, 2003, CURR MICROBIOL, V46, P313, DOI 10.1007/s00284-002-3828-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee JY, 2012, EUR J MED CHEM, V47, P261, DOI 10.1016/j.ejmech.2011.10.052; Lee J, 2013, BIOCHEMISTRY-US, V52, P2492, DOI 10.1021/bi301641b; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Lim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020549; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Nallapareddy SR, 2011, INFECT IMMUN, V79, P2901, DOI 10.1128/IAI.00038-11; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Orr KE, 2002, J HOSP INFECT, V50, P133, DOI 10.1053/jhin.2001.1137; Park SJ, 2004, J BIOCHEM, V135, P337, DOI 10.1093/jb/mvh041; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Perez DR, 2015, BIOCHEMISTRY-US, V54, P2205, DOI 10.1021/bi5014563; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Seedat J, 2006, ANTIMICROB AGENTS CH, V50, P4217, DOI 10.1128/AAC.00518-06; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Uauy R, 2000, P NUTR SOC, V59, P3, DOI 10.1017/S0029665100000021; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Wade JJ, 1997, EUR J CLIN MICROBIOL, V16, P113, DOI 10.1007/BF01709469; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200	66	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1692	1702		10.1074/jbc.M115.674408	http://dx.doi.org/10.1074/jbc.M115.674408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631734	hybrid, Green Published			2022-12-26	WOS:000368620700013
J	Lai, BQ; Qiu, XC; Zhang, K; Zhang, RY; Jin, H; Li, G; Shen, HY; Wu, JL; Ling, EA; Zeng, YS				Lai, Bi-Qin; Qiu, Xue-Chen; Zhang, Ke; Zhang, Rong-Yi; Jin, Hui; Li, Ge; Shen, Hui-Yong; Wu, Jin-Lang; Ling, Eng-Ang; Zeng, Yuan-Shan			Cholera Toxin B Subunit Shows Transneuronal Tracing after Injection in an Injured Sciatic Nerve	PLOS ONE			English	Article							SPINAL-CORD TRANSECTION; LEUKOAGGLUTININ PHA-L; HORSERADISH-PEROXIDASE; ENDOPLASMIC-RETICULUM; PSEUDORABIES VIRUS; TRANSPORT; RAT; NEURONS; LOCALIZATION; MORPHOLOGY	Cholera toxin B subunit (CTB) has been extensively used in the past for monosynaptic mapping. For decades, it was thought to lack the ability of transneuronal tracing. In order to investigate whether biotin conjugates of CTB (b-CTB) would pass through transneurons in the rat spinal cord, it was injected into the crushed left sciatic nerve. For experimental control, the first order afferent neuronal projections were defined by retrograde transport of fluorogold (FG, a non-transneuronal labeling marker as an experimental control) injected into the crushed right sciatic nerve in the same rat. Neurons containing b-CTB or FG were observed in the dorsal root ganglia (DRG) at the L4-L6 levels ipsilateral to the tracer injection. In the spinal cord, b-CTB labeled neurons were distributed in all laminae ipsilaterally between C7 and S1 segments, but labeling of neurons at the cervical segment was abolished when the T10 segment was transected completely. The interneurons, distributed in the intermediate gray matter and identified as gamma-aminobutyric acid-ergic (GABAergic), were labeled by b-CTB. In contrast, FG labeling was confined to the ventral horn neurons at L4-L6 spinal segments ipsilateral to the injection. b-CTB immunoreactivity remained to be restricted to the soma of neurons and often appeared as irregular patches detected by light and electron microscopy. Detection of monosialoganglioside (GM1) in b-CTB labeled neurons suggests that GM1 ganglioside may specifically enhance the uptake and transneuronal passage of b-CTB, thus supporting the notion that it may be used as a novel transneuronal tracer.	[Lai, Bi-Qin; Qiu, Xue-Chen; Jin, Hui; Li, Ge; Zeng, Yuan-Shan] Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Ke; Zhang, Rong-Yi; Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou 510080, Guangdong, Peoples R China; [Shen, Hui-Yong; Zeng, Yuan-Shan] Sun Yat Sen Univ, Inst Spinal Cord Injury, Guangzhou 510120, Guangdong, Peoples R China; [Zeng, Yuan-Shan] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China; [Shen, Hui-Yong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Jin-Lang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Electron Microscope, Guangzhou 510080, Guangdong, Peoples R China; [Ling, Eng-Ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore; [Zeng, Yuan-Shan] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Nantong University; Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Sun Yat Sen University	Zeng, YS (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou 510080, Guangdong, Peoples R China.	zengysh@mail.sysu.edu.cn		Qiu, Xuecheng/0000-0001-9540-5104; Li, Ge/0000-0001-9030-884X	Chinese National Natural Science Foundation [81330028, U1301223]; National 863 Project [2013AA020106]; Foundation of the Education Ministry of China [201300193035]; Foundation of Guangzhou City [201508020215]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 863 Project(National High Technology Research and Development Program of China); Foundation of the Education Ministry of China(Ministry of Education, China); Foundation of Guangzhou City	This research was supported by grants from the Chinese National Natural Science Foundation (No. 81330028; U1301223), National 863 Project (No. 2013AA020106), the Foundation of the Education Ministry of China (No. 201300193035) and the Foundation of Guangzhou City (No. 201508020215) to YSZ.	Alioto OE, 2008, AUTON NEUROSCI-BASIC, V140, P80, DOI 10.1016/j.autneu.2008.04.006; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Billig I, 2000, J NEUROSCI, V20, P7446; CHEN LL, 1995, ANAL BIOCHEM, V227, P168, DOI 10.1006/abio.1995.1267; CHEN S, 1995, BRAIN RES, V674, P107, DOI 10.1016/0006-8993(95)00020-Q; Conte WL, 2009, BRAIN STRUCT FUNCT, V213, P367, DOI 10.1007/s00429-009-0212-x; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Iglesias-Bartolome R, 2009, BBA-BIOMEMBRANES, V1788, P2526, DOI 10.1016/j.bbamem.2009.09.018; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; KRISTENSSON K, 1971, BRAIN RES, V29, P363, DOI 10.1016/0006-8993(71)90044-8; Lai BQ, 2014, STEM CELLS DEV, V23, P910, DOI 10.1089/scd.2013.0426; Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046; Lancaster KZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000791; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171; MCBRIDE RL, 1988, EXP NEUROL, V102, P236, DOI 10.1016/0014-4886(88)90099-4; MESULAM MM, 1979, NEUROSCIENCE, V4, P1107, DOI 10.1016/0306-4522(79)90192-1; Miana-Mena FJ, 2003, ACTA NEUROBIOL EXP, V63, P211; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; SCHOFIELD BR, 1990, J NEUROSCI METH, V35, P47, DOI 10.1016/0165-0270(90)90093-U; Shehab SAS, 2003, BRAIN RES, V964, P218, DOI 10.1016/S0006-8993(02)04001-5; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Tong YG, 1999, J COMP NEUROL, V404, P143; Ullah M, 2007, J ANAT, V210, P428, DOI 10.1111/j.1469-7580.2007.00709.x; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wu CC, 1999, NEUROSCIENCE, V92, P665, DOI 10.1016/S0306-4522(99)00018-4	32	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144030	10.1371/journal.pone.0144030	http://dx.doi.org/10.1371/journal.pone.0144030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640949	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700047
J	Celestino-Soper, PBS; Doytchinova, A; Steiner, HA; Uradu, A; Lynnes, TC; Groh, WJ; Miller, JM; Lin, H; Gao, HY; Wang, ZP; Liu, YL; Chen, PS; Vatta, M				Celestino-Soper, Patricia B. S.; Doytchinova, Anisiia; Steiner, Hillel A.; Uradu, Andrea; Lynnes, Ty C.; Groh, William J.; Miller, John M.; Lin, Hai; Gao, Hongyu; Wang, Zhiping; Liu, Yunlong; Chen, Peng-Sheng; Vatta, Matteo			Evaluation of the Genetic Basis of Familial Aggregation of Pacemaker Implantation by a Large Next Generation Sequencing Panel	PLOS ONE			English	Article							CARDIAC CONDUCTION DISEASE; SICK SINUS SYNDROME; LONG QT SYNDROME; COMPLETE ATRIOVENTRICULAR-BLOCK; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; MUTATIONS; SCN5A; ABCC9; SUSCEPTIBILITY	Background The etiology of conduction disturbances necessitating permanent pacemaker (PPM) implantation is often unknown, although familial aggregation of PPM (faPPM) suggests a possible genetic basis. We developed a pan-cardiovascular next generation sequencing (NGS) panel to genetically characterize a selected cohort of faPPM. Materials and Methods We designed and validated a custom NGS panel targeting the coding and splicing regions of 246 genes with involvement in cardiac pathogenicity. We enrolled 112 PPM patients and selected nine (8%) with faPPM to be analyzed by NGS. Results Our NGS panel covers 95% of the intended target with an average of 229x read depth at a minimum of 15-fold depth, reaching a SNP true positive rate of 98%. The faPPM patients presented with isolated cardiac conduction disease (ICCD) or sick sinus syndrome (SSS) without overt structural heart disease or identifiable secondary etiology. Three patients (33.3%) had heterozygous deleterious variants previously reported in autosomal dominant cardiac diseases including CCD: LDB3 (p.D117N) and TRPM4 (p.G844D) variants in patient 4; TRPM4 (p.G844D) and ABCC9 (p.V734I) variants in patient 6; and SCN5A (p.T220I) and APOB (p.R3527Q) variants in patient 7. Conclusion FaPPM occurred in 8% of our PPM clinic population. The employment of massive parallel sequencing for a large selected panel of cardiovascular genes identified a high percentage (33.3%) of the faPPM patients with deleterious variants previously reported in autosomal dominant cardiac diseases, suggesting that genetic variants may play a role in faPPM.	[Celestino-Soper, Patricia B. S.; Lynnes, Ty C.; Lin, Hai; Gao, Hongyu; Liu, Yunlong; Vatta, Matteo] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA; [Doytchinova, Anisiia; Steiner, Hillel A.; Uradu, Andrea; Groh, William J.; Miller, John M.; Chen, Peng-Sheng; Vatta, Matteo] Indiana Univ, Krannert Inst Cardiol, Div Cardiol, Dept Med,Sch Med, Indianapolis, IN 46204 USA; [Lin, Hai; Wang, Zhiping; Liu, Yunlong] Indiana Univ Purdue Univ, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Steiner, Hillel A.] Poriya MP Lower Galilee, Baruch Padeh Med Ctr, Safed, Israel; [Steiner, Hillel A.] Bar Ilan Univ, Fac Med Galilee, Safed, Israel	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Bar Ilan University	Vatta, M (corresponding author), Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA.	mvatta@iu.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Lin, Hai/N-3860-2016	Lin, Hai/0000-0002-2094-758X	American Physicians Fellowship for Medicine in Israel; Mark and Anna Ruth Hasten Family Foundation; National Institute of Health (NIH)/NHLBI [P01 HL78931, R01 HL71140]; Medtronic-Zipes Endowment of Indiana University; Indiana University Health/Indiana University School of Medicine Strategic Research Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108, UL1TR000006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071140, P01HL078931] Funding Source: NIH RePORTER	American Physicians Fellowship for Medicine in Israel; Mark and Anna Ruth Hasten Family Foundation; National Institute of Health (NIH)/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medtronic-Zipes Endowment of Indiana University; Indiana University Health/Indiana University School of Medicine Strategic Research Initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Steiner is a recipient of a Fellowship Grant from The American Physicians Fellowship for Medicine in Israel and the Mark and Anna Ruth Hasten Family Foundation. This study was supported in part by National Institute of Health (NIH)/NHLBI research grants P01 HL78931 and R01 HL71140 (PSC), the Medtronic-Zipes Endowment of Indiana University (PSC), and the Indiana University Health/Indiana University School of Medicine Strategic Research Initiative (PCS, TCL, PSC, and MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; [Anonymous], HUM GEN MUT DAT HGMD; Balmer C, 2002, EUROPACE, V4, P345, DOI 10.1053/eupc.2002.0266; Baskar S, 2014, J PEDIATR-US, V165, P1050, DOI 10.1016/j.jpeds.2014.07.036; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chow GV, 2012, CLIN GERIATR MED, V28, P539, DOI 10.1016/j.cger.2012.07.003; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Gourraud JB, 2012, HEART, V98, P1305, DOI 10.1136/heartjnl-2012-301872; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hu D, 2014, INT J CARDIOL, V171, P431, DOI 10.1016/j.ijcard.2013.12.084; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Lee KT, 2012, PACE, V35, P544, DOI 10.1111/j.1540-8159.2012.03355.x; Lin XY, 2014, J BIOL CHEM, V289, P13615, DOI 10.1074/jbc.M114.550418; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; MICHAELSSON M, 1995, CIRCULATION, V92, P442, DOI 10.1161/01.CIR.92.3.442; Minoretti P, 2006, CLIN CHIM ACTA, V370, P124, DOI 10.1016/j.cca.2006.02.007; Olesen MS, 2012, CIRC-CARDIOVASC GENE, V5, P450, DOI 10.1161/CIRCGENETICS.111.962597; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; SENGES J, 1981, J MOL CELL CARDIOL, V13, P253, DOI 10.1016/0022-2828(81)90314-X; Smith KJ, 2013, INT J CARDIOL, V168, P3506, DOI 10.1016/j.ijcard.2013.04.210; Smits JPP, 2005, EUROPACE, V7, P122, DOI 10.1016/j.eupc.2004.11.004; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Xi YT, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1017, DOI 10.1161/CIRCEP.111.969220; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198	35	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143588	10.1371/journal.pone.0143588	http://dx.doi.org/10.1371/journal.pone.0143588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636822	gold, Green Published			2022-12-26	WOS:000366143800020
J	Verdone, L; La Fortezza, M; Ciccarone, F; Caiafa, P; Zampieri, M; Caserta, M				Verdone, Loredana; La Fortezza, Marco; Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele; Caserta, Micaela			Poly(ADP-Ribosyl)ation Affects Histone Acetylation and Transcription	PLOS ONE			English	Article							POLY(ADENOSINE DIPHOSPHATE RIBOSYLATION); POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; PARP-1; MODULATION; ACTIVATION; COACTIVATION; RECRUITMENT; INTERPLAY	Poly(ADP-ribosyl) ation (PARylation) is a posttranslational protein modification catalyzed by members of the poly(ADP-ribose) polymerase (PARP) enzyme family. PARylation regulates a wide variety of biological processes in most eukaryotic cells including energy metabolism and cell death, maintenance of genomic stability, chromatin structure and transcription. Inside the nucleus, cross-talk between PARylation and other epigenetic modifications, such as DNA and histone methylation, was already described. In the present work, using PJ34 or ABT888 to inhibit PARP activity or over-expressing poly(ADP-ribose) glycohydrolase (PARG), we show decrease of global histone H3 and H4 acetylation. This effect is accompanied by a reduction of the steady state mRNA level of p300, Pcaf, and Tnf alpha, but not of Dnmt1. Chromatin immunoprecipitation (ChIP) analyses, performed at the level of the Transcription Start Site (TSS) of these four genes, reveal that changes in histone acetylation are specific for each promoter. Finally, we demonstrate an increase of global deacetylase activity in nuclear extracts from cells treated with PJ34, whereas global acetyltransferase activity is not affected, suggesting a role for PARP in the inhibition of histone deacetylases. Taken together, these results show an important link between PARylation and histone acetylation regulated transcription.	[Verdone, Loredana; Caserta, Micaela] Univ Roma La Sapienza, CNR, Ist Biol & Patol Mol, Dipartimento Biol & Biotecnol, I-00185 Rome, Italy; [La Fortezza, Marco] Univ Munich, Planegg Martinsried, Germany; [Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, I-00185 Rome, Italy; [Ciccarone, Fabio; Caiafa, Paola; Zampieri, Michele] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Munich; Sapienza University Rome; Fondazione Cenci Bolognetti	Zampieri, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	zampieri@bce.uniroma1.it; micaela.caserta@uniroma1.it	La Fortezza, Marco/AGY-1631-2022; Verdone, Loredana/AGG-5450-2022; Ciccarone, Fabio/AAR-9128-2021; Zampieri, Michele/AGF-5460-2022; Zampieri, Michele/F-7099-2013; CICCARONE, FABIO/K-4225-2016	La Fortezza, Marco/0000-0002-4485-9840; Ciccarone, Fabio/0000-0002-2425-2240; Zampieri, Michele/0000-0002-6799-2492; Zampieri, Michele/0000-0002-6799-2492; Verdone, Loredana/0000-0002-8854-1068	FIRB, Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8]	FIRB, Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by FIRB, Fondo per gli Investimenti della Ricerca di Base (Grant RBIN06E9Z8).	Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Bartke T, 2011, CELL CYCLE, V10, P182, DOI 10.4161/cc.10.2.14477; BOULIKAS T, 1990, J BIOL CHEM, V265, P14638; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; Du JM, 2014, BBA-GENE REGUL MECH, V1839, P719, DOI 10.1016/j.bbagrm.2014.04.011; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gerace E, 2015, NEUROPHARMACOLOGY, V92, P125, DOI 10.1016/j.neuropharm.2015.01.008; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guastafierro T, 2013, BIOCHEM J, V449, P623, DOI 10.1042/BJ20121429; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hottiger MO, 2011, FEBS LETT, V585, P1595, DOI 10.1016/j.febslet.2011.03.031; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; MALIK N, 1984, BIOCHEMISTRY-US, V23, P3721, DOI 10.1021/bi00311a023; Martinez-Zamudio R, 2012, MOL CELL BIOL, V32, P2490, DOI 10.1128/MCB.06667-11; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/B978-0-12-380866-0.60005-8, 10.1016/S0065-2660(10)70005-5]; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Sala A, 2008, PLOS BIOL, V6, P2329, DOI 10.1371/journal.pbio.0060252; Scobie KN, 2014, P NATL ACAD SCI USA, V111, P2005, DOI 10.1073/pnas.1319703111; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; WONG M, 1984, BIOCHEMISTRY-US, V23, P3726, DOI 10.1021/bi00311a024; Yang ZY, 2014, J IMMUNOL, V193, P6114, DOI 10.4049/jimmunol.1400359; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 2002, FASEB J, V16, P1319, DOI 10.1096/fj.01-0827fje; Zhang T, 2012, J BIOL CHEM, V287, P12405, DOI 10.1074/jbc.M111.304469	46	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144287	10.1371/journal.pone.0144287	http://dx.doi.org/10.1371/journal.pone.0144287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636673	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800068
J	Yue, Y; Yu, HH; Li, RF; Xing, RG; Liu, S; Li, PC				Yue, Yang; Yu, Huahua; Li, Rongfeng; Xing, Ronge; Liu, Song; Li, Pengcheng			Exploring the Antibacterial and Antifungal Potential of Jellyfish-Associated Marine Fungi by Cultivation-Dependent Approaches	PLOS ONE			English	Article							SEA-DERIVED FUNGUS; STOMOLOPHUS-MELEAGRIS; ASPERGILLUS-FUMIGATUS; CHEMICAL DEFENSE; CULTURABLE FUNGI; A-E; METABOLITES; DIVERSITY; COCULTURE; ALKALOIDS	Fungi isolated from marine invertebrates are of considerable importance as new promising sources of unique secondary metabolites with significant biomedical potential. However, the cultivable fungal community harbored in jellyfish was less investigated. In this work, we seek to recover symbiotic fungi from different tissues of jellyfish Nemopilema nomurai. A total of seven morphotypes were isolated, which were assigned into four genera (Aspergillus, Cladosporium, Purpureocillium, and Tilletiopsis) from two phyla (Ascomycota and Basidiomycota) by comparing the rDNA-ITS sequences with the reference sequences in GenBank. The most fungi were found in the inner tissues of subumbrella. Two of the cultivation- independent procedures, changing media type and co-cultivation, were employed to maximize the complexity of metabolites. Thus, thirteen EtOAc gum were obtained and fingerprinted by High Performance Liquid Chromatography (HPLC) equipped with a photodiode array (PDA) detector. Antibacterial and antifungal activities of these complex mixtures were tested against a panel of bacterial and fungal pathogens. The antimicrobial results showed that all of the 13 EtOAc extracts displayed different levels of antibacterial activity, three of which exhibited strong to significant antibacterial activity to the bacterial pathogens Staphylococcus aureus and Salmonella entrica. Antifungal activity indicated that the EtOAc extracts from pure culture of Aspergillus versicolor and co-culture of A. versicolor and Tilletiopsis sp. in rice media were promising for searching new compounds, with the maximal mycelial growth inhibition of 82.32% +/- 0.61% for Rhizoctonia solani and 48.41% +/- 11.02% for Botrytis cinerea at 200 mu g/ml, respectively. This study is the first report on the antibacterial and antifungal activity of jellyfish-associated fungi and allows the first sight into cultivable fungal community residing in jellyfish. Induced metabolites by cultivation-dependent approaches provides a new reservoir for drug discovery from jellyfish-derived fungi.	[Yue, Yang; Yu, Huahua; Li, Rongfeng; Xing, Ronge; Liu, Song; Li, Pengcheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Yue, Yang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, HH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	yuhuahua@qdio.ac.cn; pcli@qdio.ac.cn			National Key Technologies RD Program [2011BAE06B04]; National Natural Science Foundation of China [41376004, 41406152]; Public Science and Technology Research Funds Projects of Ocean [201305016-2]	National Key Technologies RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean	The authors gratefully acknowledge financial grants: the National Key Technologies R&D Program (2011BAE06B04), the National Natural Science Foundation of China (41376004, 41406152), and the Public Science and Technology Research Funds Projects of Ocean (201305016-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Bertrand S, 2013, J NAT PROD, V76, P1157, DOI 10.1021/np400258f; Bruce A. J., 1995, Beagle, V12, P61; CLSI, 2012, M02A11 CLSI; Denker E, 2008, CURR BIOL, V18, pR858, DOI 10.1016/j.cub.2008.07.031; Doepke H, 2012, HELGOLAND MAR RES, V66, P43, DOI 10.1007/s10152-011-0245-4; Guo WQ, 2013, J NAT PROD, V76, P2106, DOI 10.1021/np4006647; Hanif N, 2010, J NAT PROD, V73, P1318, DOI 10.1021/np100221k; Jacqueline A., 1994, J AM CHEM SOC, V116, P757, DOI DOI 10.1021/ja00081a042; Alvarez-Tello FJ, 2013, HIDROBIOLOGICA, V23, P138; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; La Kim E, 2012, CHEM PHARM BULL, V60, P1590; La Kim E, 2012, BIOORG MED CHEM LETT, V22, P3126, DOI 10.1016/j.bmcl.2012.03.058; Lampert KP, 2012, MAR ECOL-EVOL PERSP, V33, P364, DOI 10.1111/j.1439-0485.2011.00488.x; Li RF, 2014, J PROTEOMICS, V106, P17, DOI 10.1016/j.jprot.2014.04.011; Li RF, 2013, TOXICOL IN VITRO, V27, P1620, DOI 10.1016/j.tiv.2013.04.004; Li RF, 2012, INT J BIOL MACROMOL, V51, P274, DOI 10.1016/j.ijbiomac.2012.05.015; Liu J, 2014, ORGANIC LETT, DOI [10.1021/ol500243k, DOI 10.1021/0L500243K]; Liu J, 2011, J NAT PROD, V74, P1826, DOI 10.1021/np200350b; Luangsa-Ard J, 2011, FEMS MICROBIOL LETT, V321, P141, DOI 10.1111/j.1574-6968.2011.02322.x; Mellas RE, 2014, J EXP MAR BIOL ECOL, V459, P38, DOI 10.1016/j.jembe.2014.04.026; Moore BS, 1999, J ORG CHEM, V64, P1145, DOI 10.1021/jo9814391; Nonaka K, 2011, J ANTIBIOT, V64, P769, DOI 10.1038/ja.2011.91; PALINCSAR EE, 1989, BIOL BULL, V177, P130, DOI 10.2307/1541840; Peng JX, 2014, J ORG CHEM, V79, P7895, DOI 10.1021/jo5010179; Peng JX, 2013, J NAT PROD, V76, P1133, DOI 10.1021/np400200k; Peraud O, 2006, THESIS; Piel J, 2006, CURR MED CHEM, V13, P39, DOI 10.2174/092986706775197971; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Rateb ME, 2013, RSC ADV, V3, P14444, DOI 10.1039/c3ra42378f; Moyano MPS, 2012, MAR BIOL, V159, P1933, DOI 10.1007/s00227-012-1980-z; Schuett C, 2007, HELGOLAND MAR RES, V61, P211, DOI 10.1007/s10152-007-0069-4; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Singh P, 2010, FUNGAL DIVERS, V40, P89, DOI 10.1007/s13225-009-0009-5; Song FH, 2012, ORG LETT, V14, P4770, DOI 10.1021/ol302051x; STIERLE AC, 1988, EXPERIENTIA, V44, P1021, DOI 10.1007/BF01939910; Takahashi JA, 2013, PHYTOCHEM REV, V12, P773, DOI 10.1007/s11101-013-9305-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsukamoto S, 2009, J AM CHEM SOC, V131, P3834, DOI 10.1021/ja810029b; Turk T, 2009, TOXICON, V54, P1031, DOI 10.1016/j.toxicon.2009.06.031; Vervoort HC, 1998, MAR ECOL PROG SER, V164, P221, DOI 10.3354/meps164221; Wang YN, 2011, MAR DRUGS, V9, P1379, DOI 10.3390/md9081379; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223; Wright AD, 2003, ORG BIOMOL CHEM, V1, P507, DOI 10.1039/b208588g; Wu GW, 2014, J NAT PROD, V77, P270, DOI 10.1021/np400833x; Yu Huahua, 2014, Biomed Res Int, V2014, P315853, DOI 10.1155/2014/315853; Zhang F., 2008, THESIS; Zhang XY, 2012, MICROB ECOL, V64, P617, DOI 10.1007/s00248-012-0050-x; Zhang YL, 2013, J AGR FOOD CHEM, V61, P1521, DOI 10.1021/jf305210u; Zuck KM, 2011, J NAT PROD, V74, P1653, DOI 10.1021/np200255f	52	17	19	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144394	10.1371/journal.pone.0144394	http://dx.doi.org/10.1371/journal.pone.0144394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637162	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800085
J	Bashir, A; Gropler, R; Ackerman, J				Bashir, Adil; Gropler, Robert; Ackerman, Joseph			Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient	PLOS ONE			English	Article							P-31 MR SPECTROSCOPY; RESONANCE-SPECTROSCOPY; NMR-SPECTROSCOPY; SURFACE-COIL; CIRRHOSIS; DISEASE; QUANTITATION; HOMEOSTASIS	Purpose Absolute concentrations of high-energy phosphorus (P-31) metabolites in liver provide more important insight into physiologic status of liver disease compared to resonance integral ratios. A simple method for measuring absolute concentrations of P-31 metabolites in human liver is described. The approach uses surface spoiling inhomogeneous magnetic field gradient to select signal from liver tissue. The technique avoids issues caused by respiratory motion, chemical shift dispersion associated with linear magnetic field gradients, and increased tissue heat deposition due to radiofrequency absorption, especially at high field strength. Methods A method to localize signal from liver was demonstrated using superficial and highly non-uniform magnetic field gradients, which eliminate signal(s) from surface tissue(s) located between the liver and RF coil. A double standard method was implemented to determine absolute P-31 metabolite concentrations in vivo. 8 healthy individuals were examined in a 3 T MR scanner. Results Concentrations of metabolites measured in eight healthy individuals are: gamma-adenosine triphosphate (ATP) = 2.44 +/- 0.21 (mean +/- sd) mmol/l of wet tissue volume, alpha-ATP = 3.2 +/- 0.63 mmol/l, beta-ATP = 2.98 +/- 0.45 mmol/l, inorganic phosphates (Pi) = 1.87 +/- 0.25 mmol/l, phosphodiesters (PDE) = 10.62 +/- 2.20 mmol/l and phosphomonoesters (PME) = 2.12 +/- 0.51 mmol/l. All are in good agreement with literature values. Conclusions The technique offers robust and fast means to localize signal from liver tissue, allows absolute metabolite concentration determination, and avoids problems associated with constant field gradient (linear field variation) localization methods.	[Bashir, Adil; Gropler, Robert; Ackerman, Joseph] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Ackerman, Joseph] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Ackerman, J (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.	bashir.adil@gmail.com			National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering [K01 EB010171]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB010171] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by grant # K01 EB010171, National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering (http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Boer VO, 2015, MAGN RESON MED, V73, P2062, DOI 10.1002/mrm.25331; BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523; BUCHLI R, 1994, MAGN RESON MED, V32, P453, DOI 10.1002/mrm.1910320405; BUESS ML, 1991, J MAGN RESON, V92, P348, DOI 10.1016/0022-2364(91)90276-Y; Chen W, 1990, NMR Biomed, V3, P147, DOI 10.1002/nbm.1940030402; Chen W, 1990, NMR Biomed, V3, P158, DOI 10.1002/nbm.1940030403; Chmelik M, 2008, MAGN RESON MED, V60, P796, DOI 10.1002/mrm.21762; Corbin IR, 2004, AM J PHYSIOL-GASTR L, V287, pG379, DOI 10.1152/ajpgi.00418.2003; CROWLEY MG, 1985, J MAGN RESON, V65, P522, DOI 10.1016/0022-2364(85)90140-4; DEBISSCHOP E, 1992, NMR BIOMED, V5, P341, DOI 10.1002/nbm.1940050604; Dezortova M, 2005, WORLD J GASTROENTERO, V11, P6926, DOI 10.3748/wjg.v11.i44.6926; Hashemi R. H., 2004, MRI BASICS, P141; Jalan R, 1996, GUT, V39, P141, DOI 10.1136/gut.39.1.141; JEHENSON P, 1991, J MAGN RESON, V94, P59, DOI 10.1016/0022-2364(91)90294-4; Laufs A, 2014, MAGN RESON MED, V71, P1670, DOI 10.1002/mrm.24835; Li CW, 1996, NMR BIOMED, V9, P141, DOI 10.1002/(SICI)1099-1492(199606)9:4<141::AID-NBM403>3.0.CO;2-P; Lim AKP, 2003, HEPATOLOGY, V37, P788, DOI 10.1053/jhep.2003.50149; MENON DK, 1995, GASTROENTEROLOGY, V108, P776, DOI 10.1016/0016-5085(95)90451-4; Meyerhoff D J, 1990, NMR Biomed, V3, P17, DOI 10.1002/nbm.1940030103; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Noren B, 2005, EUR RADIOL, V15, P148, DOI 10.1007/s00330-004-2434-x; OBERHAENSLI R, 1990, GUT, V31, P463, DOI 10.1136/gut.31.4.463; ORDIDGE RJ, 1986, J MAGN RESON, V66, P283, DOI 10.1016/0022-2364(86)90031-4; Schaller B, 2015, SUPRESSION SKELETAL, DOI [10.1002/mrm.25755, DOI 10.1002/MRM.25755]; Schmid AI, 2008, NMR BIOMED, V21, P437, DOI 10.1002/nbm.1207; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Sevastianova K, 2010, RADIOLOGY, V256, P466, DOI 10.1148/radiol.10091351; Sijens PE, 1998, MAGN RESON IMAGING, V16, P205, DOI 10.1016/S0730-725X(97)00246-4; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; TaylorRobinson SD, 1997, LIVER, V17, P198; Tosner Z, 2001, MAGN RESON MATER PHY, V13, P40, DOI 10.1007/BF02668649; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wiesler DG, 1998, JMRI-J MAGN RESON IM, V8, P981, DOI 10.1002/jmri.1880080429; YAMANE Y, 1994, DIGEST DIS SCI, V39, P33, DOI 10.1007/BF02090057	35	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143239	10.1371/journal.pone.0143239	http://dx.doi.org/10.1371/journal.pone.0143239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633549	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000010
J	Cluny, NL; Keenan, CM; Reimer, RA; Le Foll, B; Sharkey, KA				Cluny, Nina L.; Keenan, Catherine M.; Reimer, Raylene A.; Le Foll, Bernard; Sharkey, Keith A.			Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Delta(9)-Tetrahydrocannabinol	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; GASTROINTESTINAL TRANSIT; AKKERMANSIA-MUCINIPHILA; ENDOCANNABINOID SYSTEM; FOOD-INTAKE; MOTILITY; OLIGOFRUCTOSE; CANNABIS; AGONISTS; NAUSEA	Objective Acute administration of cannabinoid CB1 receptor agonists, or the ingestion of cannabis, induces short-term hyperphagia. However, the incidence of obesity is lower in frequent cannabis users compared to non-users. Gut microbiota affects host metabolism and altered microbial profiles are observed in obese states. Gut microbiota modifies adipogenesis through actions on the endocannabinoid system. This study investigated the effect of chronic THC administration on body weight and gut microbiota in diet-induced obese (DIO) and lean mice. Methods Adult male DIO and lean mice were treated daily with vehicle or THC (2mg/kg for 3 weeks and 4 mg/kg for 1 additional week). Body weight, fat mass, energy intake, locomotor activity, whole gut transit and gut microbiota were measured longitudinally. Results THC reduced weight gain, fat mass gain and energy intake in DIO but not lean mice. DIO-induced changes in select gut microbiota were prevented in mice chronically administered THC. THC had no effect on locomotor activity or whole gut transit in either lean or DIO mice. Conclusions Chronic THC treatment reduced energy intake and prevented high fat diet-induced increases in body weight and adiposity; effects that were unlikely to be a result of sedation or altered gastrointestinal transit. Changes in gut microbiota potentially contribute to chronic THC-induced actions on body weight in obesity.	[Cluny, Nina L.; Keenan, Catherine M.; Sharkey, Keith A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Cluny, Nina L.; Keenan, Catherine M.; Sharkey, Keith A.] Univ Calgary, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Le Foll, Bernard] CAMH, Campbell Family Mental Hlth Res Inst, Translat Addict Res Lab, Toronto, ON, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Sharkey, KA (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	ksharkey@ucalgary.ca	; Le Foll, Bernard/K-2952-2014	Reimer, Raylene/0000-0001-5088-7947; Sharkey, Keith/0000-0001-9560-1711; Le Foll, Bernard/0000-0002-6406-4973	Canadian Institutes of Health Research [MOP38185]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number MOP38185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barte JCM, 2010, OBES REV, V11, P899, DOI 10.1111/j.1467-789X.2010.00740.x; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Chambers AP, 2007, AM J PHYSIOL-REG I, V293, pR2185, DOI 10.1152/ajpregu.00663.2007; Cluny NL, 2010, BRIT J PHARMACOL, V161, P629, DOI 10.1111/j.1476-5381.2010.00908.x; Cluny NL, 2009, NEUROGASTROENT MOTIL, V21, P420, DOI 10.1111/j.1365-2982.2008.01248.x; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Esfandyari T, 2006, NEUROGASTROENT MOTIL, V18, P831, DOI 10.1111/j.1365-2982.2006.00834.x; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Izzo AA, 1999, N-S ARCH PHARMACOL, V360, P221, DOI 10.1007/s002109900054; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 1999, N-S ARCH PHARMACOL, V359, P65, DOI 10.1007/PL00005325; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jarbe TUC, 2005, BEHAV PHARMACOL, V16, P373; Klein C, 2011, PSYCHOPHARMACOLOGY, V218, P443, DOI 10.1007/s00213-011-2342-0; Krowicki ZK, 2012, J PHYSIOL PHARMACOL, V63, P581; Krowicki ZK, 1999, EUR J PHARMACOL, V371, P187, DOI 10.1016/S0014-2999(99)00165-X; Landi M, 2002, EUR J PHARMACOL, V450, P77, DOI 10.1016/S0014-2999(02)02053-8; Le Foll B, 2013, MED HYPOTHESES, V80, P564, DOI 10.1016/j.mehy.2013.01.019; Le Strat Y, 2011, AM J EPIDEMIOL, V174, P929, DOI 10.1093/aje/kwr200; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; LUTHRA YK, 1975, TOXICOL APPL PHARM, V32, P418, DOI 10.1016/0041-008X(75)90232-X; MANNING FJ, 1971, SCIENCE, V174, P424, DOI 10.1126/science.174.4007.424; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; National Toxicology Program, 1996, Natl Toxicol Program Tech Rep Ser, V446, P1; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Pertwee RG, 2012, PHILOS T R SOC B, V367, P3353, DOI 10.1098/rstb.2011.0381; Sink KS, 2008, NEUROPSYCHOPHARMACOL, V33, P946, DOI 10.1038/sj.npp.1301476; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Timofeeva E, 2009, J NEUROENDOCRINOL, V21, P982, DOI 10.1111/j.1365-2826.2009.01921.x; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583	40	74	74	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144270	10.1371/journal.pone.0144270	http://dx.doi.org/10.1371/journal.pone.0144270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633823	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000075
J	Li, X; Wang, RJ; Xun, XG; Jiao, WQ; Zhang, MR; Wang, SY; Wang, S; Zhang, LL; Huang, XT; Hu, XL; Bao, ZM				Li, Xue; Wang, Ruijia; Xun, Xiaogang; Jiao, Wenqian; Zhang, Mengran; Wang, Shuyue; Wang, Shi; Zhang, Lingling; Huang, Xiaoting; Hu, Xiaoli; Bao, Zhenmin			The Rho GTPase Family Genes in Bivalvia Genomes: Sequence, Evolution and Expression Analysis	PLOS ONE			English	Article							CELL-MIGRATION; NADPH OXIDASE; AXON GUIDANCE; RAC; DUPLICATIONS; EXPANSION; PROTEINS; ORGANIZATION; SUPERFAMILY; DIVERGENCE	Background Rho GTPases are important members of the Ras superfamily, which represents the largest signaling protein family in eukaryotes, and function as key molecular switches in converting and amplifying external signals into cellular responses. Although numerous analyses of Rho family genes have been reported, including their functions and evolution, a systematic analysis of this family has not been performed in Mollusca or in Bivalvia, one of the most important classes of Mollusca. Results In this study, we systematically identified and characterized a total set (Rho, Rac, Mig, Cdc42, Tc10, Rnd, RhoU, RhoBTB and Miro) of thirty Rho GTPase genes in three bivalve species, including nine in the Yesso scallop Patinopecten yessoensis, nine in the Zhikong scallop Chlamys farreri, and twelve in the Pacific oyster Crassostrea gigas. Phylogenetic analysis and interspecies comparison indicated that bivalves might possess the most complete types of Rho genes in invertebrates. A multiple RNA-seq dataset was used to investigate the expression profiles of bivalve Rho genes, revealing that the examined scallops share more similar Rho expression patterns than the oyster, whereas more Rho mRNAs are expressed in C. farreri and C. gigas than in P. yessoensis. Additionally, Rho, Rac and Cdc42 were found to be duplicated in the oyster but not in the scallops. Among the expanded Rho genes of C. gigas, duplication pairs with high synonymous substitution rates (Ks) displayed greater differences in expression. Conclusion A comprehensive analysis of bivalve Rho GTPase family genes was performed in scallop and oyster species, and Rho genes in bivalves exhibit greater conservation than those in any other invertebrate. This is the first study focusing on a genome-wide characterization of Rho GTPase genes in bivalves, and the findings will provide a valuable resource for a better understanding of Rho evolution and Rho GTPase function in Bivalvia.	[Li, Xue; Wang, Ruijia; Xun, Xiaogang; Jiao, Wenqian; Zhang, Mengran; Wang, Shuyue; Wang, Shi; Zhang, Lingling; Huang, Xiaoting; Hu, Xiaoli; Bao, Zhenmin] Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China	Ocean University of China	Wang, RJ (corresponding author), Ocean Univ China, Coll Marine Life Sci, Key Lab Marine Genet & Breeding, Minist Educ, Qingdao 266003, Peoples R China.	rjwang@ouc.edu.cn; hxl707@ouc.edu.cn	zhang, lingling/HDM-2189-2022	Wang, Ruijia/0000-0002-4211-5207; Li, Xue/0000-0002-7501-4445	National High-Tech R&D Program (863 Program) [2012AA10A405]; Doctoral Fund of Ministry of Education of China [20120132130002]	National High-Tech R&D Program (863 Program); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This project was supported by the National High-Tech R&D Program (863 Program, 2012AA10A405, www.863.gov.cn) and Doctoral Fund of Ministry of Education of China (20120132130002, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the National High-Tech R&D Program (863 Program, 2012AA10A405) and Doctoral Fund of Ministry of Education of China (20120132130002).	Abascal F, 2015, GENOME BIOL EVOL; Aguirre-Armenta B, 2011, DEV GROWTH DIFFER, V53, P704, DOI 10.1111/j.1440-169X.2011.01280.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Babic M, 2015, J NEUROSCI, V35, P5754, DOI 10.1523/JNEUROSCI.1035-14.2015; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Gerdol M, 2015, DEV COMP IMMUNOL, V49, P59, DOI 10.1016/j.dci.2014.11.007; Guo X, 2015, FISH SHELLFISH IMMUN; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Kawano Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00522; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Lacoste A, 2002, J CELL SCI, V115, P761; Lei L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-51; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Paduch M, 2001, ACTA BIOCHIM POL, V48, P829; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Peng T, 2015, AQUAT TOXICOL, V163, P89, DOI 10.1016/j.aquatox.2015.03.023; Ponder WF, 2008, PHYLOGENY EVOLUTION; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Ramos S, 2002, GENE, V298, P147, DOI 10.1016/S0378-1119(02)00980-0; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Ridley AJ, 2001, J CELL SCI, V114, P2713; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Swope D, 2014, DEV BIOL, V392, P221, DOI 10.1016/j.ydbio.2014.05.024; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Talakhun W, 2014, COMP BIOCHEM PHYS D, V11, P9, DOI 10.1016/j.cbd.2014.05.002; Thibaud-Nissen F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-317; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wherlock M, 2002, J CELL SCI, V115, P239; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	59	8	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143932	10.1371/journal.pone.0143932	http://dx.doi.org/10.1371/journal.pone.0143932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633655	gold, Green Submitted, Green Published			2022-12-26	WOS:000366040000032
J	Patil, KS; Basak, I; Pal, R; Ho, HP; Alves, G; Chang, EJ; Larsen, JP; Moller, SG				Patil, Ketan S.; Basak, Indranil; Pal, Ramavati; Ho, Hsin-Pin; Alves, Guido; Chang, Emmanuel J.; Larsen, Jan Petter; Moller, Simon Geir			A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; EARLY-ONSET PARKINSONISM; OXIDATIVE STRESS; DOWN-REGULATION; GLUCOCORTICOID-RECEPTOR; ALZHEIMERS-DISEASE; DIPHOSPHATE KINASE; STRUCTURAL BASIS; ALPHA-ENOLASE; EXPRESSION	MicroRNAs are key regulators associated with numerous diseases. In HEK293 cells, miR-153-3p and miR-205-5p down-regulate alpha-synuclein (SNCA) and Leucine-rich repeat kinase 2 (LRRK2), two key proteins involved in Parkinson's disease (PD). We have used two-dimensional gel electrophoresis (2D-PAGE) coupled to mass spectrometry (MS) to identify a spectrum of miR-153-3p and miR-205-5p targets in neuronal SH-SY5Y cells. We overexpressed and inhibited both microRNAs in SH-SY5Y cells and through comparative proteomics profiling we quantified similar to 240 protein spots from each analysis. Combined, thirty-three protein spots were identified showing significant (p-value < 0.05) changes in abundance. Modulation of miR-153-3p resulted in seven up-regulated proteins and eight down-regulated proteins. miR-205 modulation resulted in twelve up-regulated proteins and six down-regulated proteins. Several of the proteins are associated with neuronal processes, including peroxiredoxin-2 and -4, cofilin-1, prefoldin 2, alpha-enolase, human nucleoside diphosphate kinase B (Nm23) and 14-3-3 protein epsilon. Many of the differentially expressed proteins are involved in diverse pathways including metabolism, neurotrophin signaling, actin cytoskeletal regulation, HIF-1 signaling and the proteasome indicating that miR-153-3p and miR-205-5p are involved in the regulation of a wide variety of biological processes in neuroblastoma cells.	[Patil, Ketan S.; Basak, Indranil; Pal, Ramavati; Moller, Simon Geir] St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY York Coll, Dept Chem, New York, NY 11451 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY, Grad Ctr, New York, NY 11451 USA; [Alves, Guido; Larsen, Jan Petter; Moller, Simon Geir] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway	Saint John's University; City University of New York (CUNY) System; City University of New York (CUNY) System; Stavanger University Hospital	Moller, SG (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.	mollers@stjohns.edu	Alves, Guido/AAB-4015-2020; Basak, Indranil/P-9279-2016; Basak, Indranil/AAH-2593-2020	Basak, Indranil/0000-0001-5009-2845; Moller, Simon/0000-0002-0460-3592; Alves, Guido/0000-0003-0630-2870	Norwegian Research Council; Western Norway Health Authority; Norwegian Center for Movement Disorders	Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Health Authority; Norwegian Center for Movement Disorders	This work was funded by grants from The Norwegian Research Council, The Western Norway Health Authority and The Norwegian Center for Movement Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by grants from The Norwegian Research Council, The Western Norway Health Authority and The Norwegian Center for Movement Disorders. We thank Dr. Katja Becker, Dr. Christina Fernandez-Valle and Dr. Suzanne Hradetkzy for antibodies. The authors declare that they have no competing interests.	Abdullah R, 2015, EXP GERONTOL, V68, P33, DOI 10.1016/j.exger.2014.09.014; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Basak I, 2014, J BIOL CHEM, V289, P14458, DOI 10.1074/jbc.M114.548156; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Bergamaschi A, 2012, ONCOGENE, V31, P39, DOI 10.1038/onc.2011.223; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Cho HJ, 2013, HUM MOL GENET, V22, P608, DOI 10.1093/hmg/dds470; Choudhuri T, 2010, CANCER BIOL THER, V9, P1065, DOI 10.4161/cbt.9.12.11995; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042818; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kwon JH, 2012, J IMMUNOL, V188, P5665, DOI 10.4049/jimmunol.1102306; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Moller I, 1998, FEBS LETT, V441, P1, DOI 10.1016/S0014-5793(98)01440-9; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Patil KS, 2014, J NEUROSCI RES, V92, P1167, DOI 10.1002/jnr.23396; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Rege Shraddha D, 2013, ISRN Neurol, V2013, P375852, DOI 10.1155/2013/375852; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Skaper SD, 2011, CNS NEUROL DISORD-DR, V10, P44; Song Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-65; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Vural B, 2011, J NEUROIMMUNOL, V239, P91, DOI 10.1016/j.jneuroim.2011.08.008; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	57	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143969	10.1371/journal.pone.0143969	http://dx.doi.org/10.1371/journal.pone.0143969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633009	Green Published, gold			2022-12-26	WOS:000366040000036
J	Vainik, U; Dube, L; Lu, J; Fellows, LK				Vainik, Uku; Dube, Laurette; Lu, Ji; Fellows, Lesley K.			Personality and Situation Predictors of Consistent Eating Patterns	PLOS ONE			English	Article							WITHIN-SUBJECT VARIATION; FOOD-INTAKE; NUTRIENT INTAKE; EXTERNAL CUES; OBESITY; ENERGY; BEHAVIOR; SELF; VARIABILITY; WEIGHT	Introduction A consistent eating style might be beneficial to avoid overeating in a food-rich environment. Eating consistency entails maintaining a similar dietary pattern across different eating situations. This construct is relatively under-studied, but the available evidence suggests that eating consistency supports successful weight maintenance and decreases risk for metabolic syndrome and cardiovascular disease. Yet, personality and situation predictors of consistency have not been studied. Methods A community-based sample of 164 women completed various personality tests, and 139 of them also reported their eating behaviour 6 times/day over 10 observational days. We focused on observations with meals (breakfast, lunch, or dinner). The participants indicated if their momentary eating patterns were consistent with their own baseline eating patterns in terms of healthiness or size of the meal. Further, participants described various characteristics of each eating situation. Results Eating consistency was positively predicted by trait self-control. Eating consistency was undermined by eating in the evening, eating with others, eating away from home, having consumed alcohol and having undertaken physical exercise. Interactions emerged between personality traits and situations, including punishment sensitivity, restraint, physical activity and alcohol consumption. Conclusion Trait self-control and several eating situation variables were related to eating consistency. These findings provide a starting point for targeting interventions to improve consistency, suggesting that a focus on self-control skills, together with addressing contextual factors such as social situations and time of day, may be most promising. This work is a first step to provide people with the tools they need to maintain a consistently healthy lifestyle in a food-rich environment.	[Vainik, Uku; Fellows, Lesley K.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Vainik, Uku] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Dube, Laurette] McGill Univ, Desautels Fac Management, Montreal, PQ, Canada; [Lu, Ji] Dalhousie Univ, Fac Agr, Truro, NS, Canada	McGill University; University of Tartu; McGill University; Dalhousie University	Vainik, U (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	uku.vainik@gmail.com	Vainik, Uku/H-8888-2019; Fellows, Lesley K/B-1778-2018; Lu, Ji/AAR-2726-2021	Vainik, Uku/0000-0002-9375-9520; Fellows, Lesley/0000-0002-9144-092X; Lu, Ji/0000-0003-1048-235X	Social Sciences and Humanities Research Council [410-2003-1362, 410-2010-2258, 435-2014-1964]; Fond de Recherche du Quebec - Societe et Culture Team Grant [2015-SE-179342]; National Institutes for Health [U01 HD061973-03]; Estonian Ministry of Education and Science [IUT2-13]; Canadian Institutes of Health Research [MOP 97821]; Fonds de Recherche en Sante du Quebec Chercheur-Boursier; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061973] Funding Source: NIH RePORTER	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Fond de Recherche du Quebec - Societe et Culture Team Grant; National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec Chercheur-Boursier(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Laurette Dube has been supported by Social Sciences and Humanities Research Council Grant dossier no. 410-2003-1362, 410-2010-2258 and 435-2014-1964, as well as Fond de Recherche du Quebec - Societe et Culture Team Grant #: 2015-SE-179342. Laurette Dube and Uku Vainik have been supported by National Institutes for Health grant no. U01 HD061973-03. Uku Vainik has also been supported by an institutional research funding (IUT2-13) from the Estonian Ministry of Education and Science. Lesley K Fellows has been supported by Canadian Institutes of Health Research grant no. MOP 97821, and a Fonds de Recherche en Sante du Quebec Chercheur-Boursier salary award.	ACHESON KJ, 1980, AM J CLIN NUTR, V33, P1147, DOI 10.1093/ajcn/33.5.1147; Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; [Anonymous], SJPLOT DATA VISUALIZ; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bandura A, 1996, PSYCHOL INQ, V7, P20, DOI 10.1207/s15327965pli0701_3; Barr L., 2005, REV EVALUATION EMERG; Bates D.M., 2010, LME4 MIXED EFFECTS M; Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Beeken RJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-667; BEM DJ, 1974, PSYCHOL REV, V81, P506, DOI 10.1037/h0037130; BLOCK J, 1961, J CONSULT PSYCHOL, V25, P392, DOI 10.1037/h0042979; Blundell JE, 2011, NUTR BULL, V36, P356, DOI 10.1111/j.1467-3010.2011.01911.x; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Carriquiry AL, 2003, J NUTR, V133, p601S, DOI 10.1093/jn/133.2.601S; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CELLIER KM, 1963, AM J CLIN NUTR, V13, P55, DOI 10.1093/ajcn/13.1.55; Chandon P, 2007, J MARKETING RES, V44, P84, DOI 10.1509/jmkr.44.1.84; Chandon P, 2010, FOUND TRENDS MARKET, V5, P113, DOI 10.1561/1700000016; Christensen T. C., 2003, J HAPPINESS STUD, V4, P53, DOI [10.1023/A:1023609306024, DOI 10.1023/A:1023609306024]; Chun OK., 2012, J NUTR DISORD THER; Cohen Deborah, 2008, Prev Chronic Dis, V5, pA23; Conner T., 2013, EXPERIENCE SAMPLING; Costa PT, 2007, REVISED NEO PERSONAL; DaCoTA, 2012, TRAFF SAF BAS FACTS; de Castro JM, 2000, NUTRITION, V16, P800, DOI 10.1016/S0899-9007(00)00414-7; de Castro JM, 2012, APPETITE, V59, P204, DOI 10.1016/j.appet.2012.04.020; DONAHUE EM, 1993, J PERS SOC PSYCHOL, V64, P834, DOI 10.1037/0022-3514.64.5.834; Drewnowski A, 2009, NUTR REV, V67, pS36, DOI 10.1111/j.1753-4887.2009.00157.x; Dube L, 2005, PHYSIOL BEHAV, V86, P559, DOI 10.1016/j.physbeh.2005.08.023; EDHOLM OG, 1970, BRIT J NUTR, V24, P1091, DOI 10.1079/BJN19700112; Eidehall A, 2012, Method and system for collision avoidance, Patent No. [US 8112225 B2, 8112225]; Eidehall A, 2007, IEEE T INTELL TRANSP, V8, P84, DOI 10.1109/TITS.2006.888606; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Elder SJ, 2007, NUTR REV, V65, P1, DOI 10.1111/j.1753-4887.2007.tb00263.x; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gelman A., 2014, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Genne-Bacon Elizabeth A., 2014, Yale Journal of Biology and Medicine, V87, P99; Gerlach G, 2015, OBES REV, V16, P32, DOI 10.1111/obr.12235; Gorin AA, 2004, INT J OBESITY, V28, P278, DOI 10.1038/sj.ijo.0802550; Government of Canada SC, 2003, CAN COMM HLTH SURV C; Grano N, 2004, PERS INDIV DIFFER, V37, P1693, DOI 10.1016/j.paid.2004.03.004; Gray J. A, 1987, COGNITIVE NEUROCHEMI, P171; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Guerrieri R., 2008, PSIHOLOGIJSKE TEME, V17, P265; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; HANKIN JH, 1967, AM J CLIN NUTR, V20, P935, DOI 10.1093/ajcn/20.9.935; Herman CP, 2008, PHYSIOL BEHAV, V94, P722, DOI 10.1016/j.physbeh.2008.04.014; Hofmann W, 2012, J PERS SOC PSYCHOL, V102, P1318, DOI 10.1037/a0026545; HUNT WC, 1983, NUTR RES, V3, P433, DOI 10.1016/S0271-5317(83)80005-0; HUNTER DJ, 1988, AM J EPIDEMIOL, V127, P1240, DOI 10.1093/oxfordjournals.aje.a114916; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Johnson F, 2014, ADV NUTR, V5, P851, DOI 10.3945/an.114.007120; Jokela M, 2012, OBES REV; Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170; Jones NRV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109343; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Khare A, 2006, J CONSUM RES, V32, P567, DOI 10.1086/500487; Kouchaki M, 2014, PSYCHOL SCI, V25, P95, DOI 10.1177/0956797613498099; Lakdawalla D., 2002, NBER WORKING PAPERS, V8946; Leikas S, 2012, J PERS SOC PSYCHOL, V103, P1007, DOI 10.1037/a0030385; Levitsky DA, 2005, PHYSIOL BEHAV, V86, P623, DOI 10.1016/j.physbeh.2005.08.053; Lewin K., 1936, PRINCIPLES TOPOLOGIC, DOI [https://doi.org/10.1037/10019-000, DOI 10.1037/10019-000]; Liu C., 2009, FACTORS RELATED FATA; Lu J, 2011, AM J CLIN NUTR, V94, P254, DOI 10.3945/ajcn.110.006361; Lunn TE, 2014, NUTRITION, V30, P403, DOI 10.1016/j.nut.2013.08.012; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; MacKenzie A., 2014, GIZMAG          0725; Martins C, 2008, INT J OBESITY, V32, P1337, DOI 10.1038/ijo.2008.98; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; NEEL JV, 1962, AM J HUM GENET, V14, P353; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; NEUHAUS JM, 1991, EPIDEMIOLOGY, V2, P447, DOI 10.1097/00001648-199111000-00011; NHTSA, 2012, FARS ENCY STAT CRASH; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pachucki MA, 2012, INT J OBESITY, V36, P686, DOI 10.1038/ijo.2011.133; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; POLIVY J, 1978, J ABNORM PSYCHOL, V87, P497, DOI 10.1037/0021-843X.87.5.497; POLIVY J, 1976, ADDICT BEHAV, V1, P121, DOI 10.1016/0306-4603(76)90004-6; POLIVY J, 1976, J ABNORM PSYCHOL, V85, P601, DOI 10.1037/0021-843X.85.6.601; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; Price M, SELF REPORT IN PRESS; Quetelet L.A.J, 1842, HIST PSYCHOL SERIESA, DOI DOI 10.1037/11993-000; R Core Team, 2021, R LANGUAGE ENV STAT; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Rauthmann JF, 2014, J PERS SOC PSYCHOL, V107, P677, DOI 10.1037/a0037250; Revelle W., 2014, PSYCH PROCEDURES PSY; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Robinson E, 2014, J ACAD NUTR DIET, V114, P414, DOI 10.1016/j.jand.2013.11.009; ROLLS BJ, 1986, NUTR REV, V44, P93, DOI 10.1111/j.1753-4887.1986.tb07593.x; Rudis B, 2015, INTRO STREAMGRAPH HT; SCHACHTER S, 1968, SCIENCE, V161, P751, DOI 10.1126/science.161.3843.751; Seacat JD, 2016, J HEALTH PSYCHOL, V21, P228, DOI 10.1177/1359105314525067; SEMPOS CT, 1985, AM J EPIDEMIOL, V121, P120, DOI 10.1093/oxfordjournals.aje.a113974; Sherman RA, 2010, J PERS SOC PSYCHOL, V99, P330, DOI 10.1037/a0019796; Sierra-Johnson J, 2008, OBESITY, V16, P1302, DOI 10.1038/oby.2008.203; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; STUFF JE, 1983, AM J CLIN NUTR, V37, P300, DOI 10.1093/ajcn/37.2.300; TARASUK V, 1991, AM J CLIN NUTR, V54, P464, DOI 10.1093/ajcn/54.3.464; TARASUK V, 1992, APPETITE, V18, P43, DOI 10.1016/0195-6663(92)90209-O; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Tucker LA, 2000, OBES RES, p86S; Vainik U, 2015, EUR J PERSONALITY, V29, P622, DOI 10.1002/per.2009; Vainik U, 2015, APPETITE, V90, P229, DOI 10.1016/j.appet.2015.03.004; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; van der Laan LN, 2015, CURR OPIN FOOD SCI, V3, P11, DOI 10.1016/j.cofs.2014.11.001; van Strien T, 2002, PERS INDIV DIFFER, V33, P791, DOI 10.1016/S0191-8869(01)00192-1; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Victor T., 2005, US Patent, Patent No. [6,974,414, 6974414, 6974414 B2]; Wagerman SA, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P27; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wickham H, 2011, J STAT SOFTW, V40; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson A, 2005, NSW INJ RISK MANAG R; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	122	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144134	10.1371/journal.pone.0144134	http://dx.doi.org/10.1371/journal.pone.0144134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633707	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000060
J	Chan, MPL; Weinhold, RS; Thomas, R; Gohlke, JM; Portier, CJ				Chan, Melissa P. L.; Weinhold, Robert S.; Thomas, Reuben; Gohlke, Julia M.; Portier, Christopher J.			Environmental Predictors of US County Mortality Patterns on a National Basis	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; SELF-RATED HEALTH; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INCOME INEQUALITY; LIFE EXPECTANCY; UNITED-STATES; RESIDENTIAL SEGREGATION; SOCIOECONOMIC-STATUS; MULTILEVEL ANALYSIS	A growing body of evidence has found that mortality rates are positively correlated with social inequalities, air pollution, elevated ambient temperature, availability of medical care and other factors. This study develops a model to predict the mortality rates for different diseases by county across the US. The model is applied to predict changes in mortality caused by changing environmental factors. A total of 3,110 counties in the US, excluding Alaska and Hawaii, were studied. A subset of 519 counties from the 3,110 counties was chosen by using systematic random sampling and these samples were used to validate the model. Step-wise and linear regression analyses were used to estimate the ability of environmental pollutants, socio-economic factors and other factors to explain variations in county-specific mortality rates for cardiovascular diseases, cancers, chronic obstructive pulmonary disease (COPD), all causes combined and lifespan across five population density groups. The estimated models fit adequately for all mortality outcomes for all population density groups and, adequately predicted risks for the 519 validation counties. This study suggests that, at local county levels, average ozone (0.07 ppm) is the most important environmental predictor of mortality. The analysis also illustrates the complex inter-relationships of multiple factors that influence mortality and lifespan, and suggests the need for a better understanding of the pathways through which these factors, mortality, and lifespan are related at the community level.	[Chan, Melissa P. L.] So Illinois Univ, Environm Sci Program, Edwardsville, IL 62026 USA; [Thomas, Reuben] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA USA; [Gohlke, Julia M.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Portier, Christopher J.] US Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; [Portier, Christopher J.] US Ctr Dis Control & Prevent, Agcy Toxic Subst & Dis Registry, Atlanta, GA 30341 USA	Southern Illinois University System; Southern Illinois University Edwardsville; University of California System; University of California Berkeley; University of Alabama System; University of Alabama Birmingham; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Chan, MPL (corresponding author), So Illinois Univ, Environm Sci Program, Edwardsville, IL 62026 USA.	pchan@siue.edu	; Portier, Christopher/A-3160-2010	Gohlke, Julia/0000-0002-6984-2893; Portier, Christopher/0000-0002-0954-0279				Acevedo-Garcia D, 2003, AM J PUBLIC HEALTH, V93, P215, DOI 10.2105/AJPH.93.2.215; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Araya R, 2006, SOC SCI MED, V62, P3072, DOI 10.1016/j.socscimed.2005.11.037; Bell ML, 2008, AM J EPIDEMIOL, V167, P986, DOI 10.1093/aje/kwm396; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; Cooper R, 2000, CIRCULATION, V102, P3137; Cooper RS, 2001, PUBLIC HEALTH REP, V116, P464, DOI 10.1016/S0033-3549(04)50074-2; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; Deaton A, 2003, SOC SCI MED, V56, P1139, DOI 10.1016/S0277-9536(02)00115-6; Deaton A, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.2.13; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dray-Spira R, 2008, J GEN INTERN MED, V23, P1634, DOI 10.1007/s11606-008-0727-5; Ebi KL, 2008, ENVIRON HEALTH PERSP, V116, P1449, DOI 10.1289/ehp.11463; Ezzati M, 2008, PLOS MED, V5, P557, DOI 10.1371/journal.pmed.0050066; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Forastiere F, 2007, AM J IND MED, V50, P208, DOI 10.1002/ajim.20368; Goldberg MS, 2013, SCI TOTAL ENVIRON, V463, P931, DOI 10.1016/j.scitotenv.2013.06.095; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Hahn RA, 1996, INT J HEALTH SERV, V26, P673, DOI 10.2190/967K-LC4F-DU66-W5P9; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Inagami S, 2006, J URBAN HEALTH, V83, P406, DOI 10.1007/s11524-006-9035-8; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Jaffe DH, 2005, ANN EPIDEMIOL, V15, P804, DOI 10.1016/j.annepidem.2004.09.014; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Jhun I, 2014, ENVIRON INT, V73, P128, DOI 10.1016/j.envint.2014.07.009; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kim D, 2006, J URBAN HEALTH, V83, P813, DOI 10.1007/s11524-006-9082-1; Kinney PL, 2008, AM J PREV MED, V35, P459, DOI 10.1016/j.amepre.2008.08.025; Knowlton K, 2004, ENVIRON HEALTH PERSP, V112, P1557, DOI 10.1289/ehp.7163; Krewski D, 2009, NEW ENGL J MED, V360, P413, DOI 10.1056/NEJMe0809178; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; LeClere FB, 2000, AM J PUBLIC HEALTH, V90, P1892, DOI 10.2105/AJPH.90.12.1892; Lobmayer P, 2002, J EPIDEMIOL COMMUN H, V56, P183, DOI 10.1136/jech.56.3.183; Lynch J, 2005, AM J PUBLIC HEALTH, V95, P1424, DOI 10.2105/AJPH.2004.048439; Martikainen P, 2003, J EPIDEMIOL COMMUN H, V57, P210, DOI 10.1136/jech.57.3.210; Moore K, 2008, ENVIRON HEALTH PERSP, V116, P1063, DOI 10.1289/ehp.10497; Muntaner C, 2004, EUR J EPIDEMIOL, V19, P777, DOI 10.1023/B:EJEP.0000036569.39399.68; Murray CJ, 2012, INHAL TOXICOL, V24, P89, DOI 10.3109/08958378.2011.638947; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Murray CJL, 2005, AM J PREV MED, V29, P4, DOI 10.1016/j.amepre.2005.07.031; National Center for Environmental Assessment, 2004, AIR QUAL CRIT PART M; National Research Council, 2004, RES PRIOR AIRB PART, P127; O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Poortinga W, 2006, SOC SCI MED, V62, P292, DOI 10.1016/j.socscimed.2005.06.008; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Putnam R.D., 2000, BOWLING ALONE COLLAP; Ram R, 2005, SOC SCI MED, V61, P2568, DOI 10.1016/j.socscimed.2005.04.038; Ramsay S, 2008, ANN EPIDEMIOL, V18, P476, DOI 10.1016/j.annepidem.2007.12.007; Rettenmaier AJ, 2013, EUR J HEALTH ECON, V14, P821, DOI 10.1007/s10198-012-0429-0; RUPASINGHA A, 2006, J SOCIOECONOMICS, V0035; Rupasingha A., 2008, US COUNTY LEVEL SOCI; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Singh GK, 2004, CAN J PUBLIC HEALTH, V95, pI14, DOI 10.1007/BF03403660; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; Skrabski A, 2003, J EPIDEMIOL COMMUN H, V57, P114, DOI 10.1136/jech.57.2.114; Sundquist J, 2006, SOC SCI MED, V62, P954, DOI 10.1016/j.socscimed.2005.06.049; Sundquist K, 2007, HEALTH PLACE, V13, P324, DOI 10.1016/j.healthplace.2006.02.002; Tagaris E, 2010, INT J ENV RES PUB HE, V7, P2222, DOI 10.3390/ijerph7052222; U.S. Department of Health and Human Services, 1999, OFF WOM HLTH; U.S. Department of Health and Human Services, 2008, HLTH PEOPL 2010 COM; U.S. Environmental Protection Agency, 2007, AIR QUAL MON INF AIR; U.S. Environmental Protection Agency, 1996, 1996 NAT AIR TOX ASS; U.S. Environmental Protection Agency, 2002, AIRDATA ACC AIR POLL; US Census Bureau, 2000, CENS 2000 DEM PROF H; US Department of Health and Human Services, 2009, COMM HLTH STAT IND; van Hooijdonk C, 2008, INT J EPIDEMIOL, V37, P1384, DOI 10.1093/ije/dyn181; Weaver RR, 2006, OMEGA-J DEATH DYING, V54, P19; Wen M, 2005, HEALTH SERV RES, V40, P1108, DOI 10.1111/j.1475-6773.2005.00398.x; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; WOOLCOCK M, 2001, ISUMA CANADIAN J POL, V0002	80	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0137832	10.1371/journal.pone.0137832	http://dx.doi.org/10.1371/journal.pone.0137832			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26629706	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300001
J	Houghton, J; Holt, MM; Giles, DA; Hanson, MB; Emmons, CK; Hogan, JT; Branch, TA; VanBlaricom, GR				Houghton, Juliana; Holt, Marla M.; Giles, Deborah A.; Hanson, M. Bradley; Emmons, Candice K.; Hogan, Jeffrey T.; Branch, Trevor A.; VanBlaricom, Glenn R.			The Relationship between Vessel Traffic and Noise Levels Received by Killer Whales (Orcinus orca)	PLOS ONE			English	Article							UNDERWATER NOISE; WATCHING BOATS; PATTERNS; BEHAVIOR	Whale watching has become increasingly popular as an ecotourism activity around the globe and is beneficial for environmental education and local economies. Southern Resident killer whales (Orcinus orca) comprise an endangered population that is frequently observed by a large whale watching fleet in the inland waters of Washington state and British Columbia. One of the factors identified as a risk to recovery for the population is the effect of vessels and associated noise. An examination of the effects of vessels and associated noise on whale behavior utilized novel equipment to address limitations of previous studies. Digital acoustic recording tags (DTAGs) measured the noise levels the tagged whales received while laser positioning systems allowed collection of geo-referenced data for tagged whales and all vessels within 1000 m of the tagged whale. The objective of the current study was to compare vessel data and DTAG recordings to relate vessel traffic to the ambient noise received by tagged whales. Two analyses were conducted, one including all recording intervals, and one that excluded intervals when only the research vessel was present. For all data, significant predictors of noise levels were length (inverse relationship), number of propellers, and vessel speed, but only 15% of the variation in noise was explained by this model. When research-vessel-only intervals were excluded, vessel speed was the only significant predictor of noise levels, and explained 42% of the variation. Simple linear regressions (ignoring covariates) found that average vessel speed and number of propellers were the only significant correlates with noise levels. We conclude that vessel speed is the most important predictor of noise levels received by whales in this study. Thus, measures that reduce vessel speed in the vicinity of killer whales would reduce noise exposure in this population.	[Houghton, Juliana; Branch, Trevor A.; VanBlaricom, Glenn R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Holt, Marla M.; Hanson, M. Bradley; Emmons, Candice K.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Giles, Deborah A.] Univ Calif Davis, Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Hogan, Jeffrey T.] Cascadia Res Collect, Olympia, WA USA; [VanBlaricom, Glenn R.] US Geol Survey, Washington Cooperat Fish & Wildlife Res Unit, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey	Houghton, J (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	stephj5@uw.edu			National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; NOAA Fisheries Ocean Acoustics Program; NOAA Northwest Regional Office through Cascadia Research Collective; University of Washington (UW) School of Aquatic and Fishery Sciences; UW College of Environment; Motion Picture Exhibitors of WA, AK OR Scholarship	National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center; NOAA Fisheries Ocean Acoustics Program; NOAA Northwest Regional Office through Cascadia Research Collective; University of Washington (UW) School of Aquatic and Fishery Sciences; UW College of Environment; Motion Picture Exhibitors of WA, AK OR Scholarship	This work has been funded by the National Oceanic and Atmospheric Administration-Northwest Fisheries Science Center, NOAA Fisheries Ocean Acoustics Program, NOAA Northwest Regional Office through Cascadia Research Collective, the University of Washington (UW) School of Aquatic and Fishery Sciences, the UW College of the Environment, and the Motion Picture Exhibitors of WA, AK & OR Scholarship. MMH, MBH, and CKE are employees of Northwest Fisheries Science Center. The other funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JK, 2012, J ACOUST SOC AM, V132, pEL229, DOI 10.1121/1.4739251; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BarrettLennard LG, 1996, ANIM BEHAV, V51, P553, DOI 10.1006/anbe.1996.0059; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans PGH, 1996, EXPLOITATION MAMMAL; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Foote AD, 2008, ETHOLOGY, V114, P599, DOI 10.1111/j.1439-0310.2008.01496.x; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; FORD JKB, 1989, CAN J ZOOL, V67, P727, DOI 10.1139/z89-105; Frid A, 2002, CONSERV ECOL, V6; Giles D. A., 2012, Journal of International Wildlife Law & Policy, V15, P125, DOI 10.1080/13880292.2012.678792; Giles DA, 2014, THESIS; Giles DA, AB133F07SE3026 NOAAN; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Hauser DDW, 2007, MAR ECOL PROG SER, V351, P301, DOI 10.3354/meps07117; Heitmeyer RM, 2003, MAR TECHNOL SOC J, V37, P54, DOI 10.4031/002533203787537023; Hildebrand JA, 2006, NA17RJ1231 JOINT I M; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Hoelzel A.R., 2009, MARINE MAMMAL BIOL E; Holt MM, 2011, J ACOUST SOC AM, V130, P3100, DOI 10.1121/1.3641446; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Hoyt E., 2001, WHALE WATCHING 2001; JANZEN DH, 1974, NAT HIST, V83, P48; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Jones CD, 2006, TM306 APLUW; Koski KL, 2009, FINAL PROGRAM REPORT; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Lusseau David, 2009, Endangered Species Research, V6, P211, DOI 10.3354/esr00154; McKenna MF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01760; McKenna MF, 2012, J ACOUST SOC AM, V131, P92, DOI 10.1121/1.3664100; NOAA, 2011, FED REG, V76, P72; NOAA, 2008, REC PLAN SO RES KILL; NOAA, 2006, FR; Noren D. P., 2009, Endangered Species Research, V8, P179, DOI 10.3354/esr00205; O'Connor S, 2009, WHALE WATCHING WORLD; Osborne R, 2002, TRENDS WHALE WATCHIN; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Ross D., 1976, MECH UNDERWATER NOIS; Starfield AM, 1997, J WILDLIFE MANAGE, V61, P261, DOI 10.2307/3802581; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; Trevorrow MV, 2008, J ACOUST SOC AM, V124, P767, DOI 10.1121/1.2939128; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Wieland M, 2010, MAR MAMMAL SCI, V26, P195, DOI 10.1111/j.1748-7692.2009.00351.x; Williams R, 2002, J ZOOL, V256, P255, DOI 10.1017/S0952836902000298; Williams Rob, 2002, Journal of Cetacean Research and Management, V4, P305; Williams R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026738; Williams Rob, 2009, Endangered Species Research, V6, P199, DOI 10.3354/esr00150; Young R.W., 1960, NOISE CONT, V6, P22, DOI [10.1121/1.2369403, DOI 10.1121/1.2369403]	54	22	23	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0140119	10.1371/journal.pone.0140119	http://dx.doi.org/10.1371/journal.pone.0140119			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629916	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300004
J	Kloting, N; Hesselbarth, N; Gericke, M; Kunath, A; Biemann, R; Chakaroun, R; Kosacka, J; Kovacs, P; Kern, M; Stumvoll, M; Fischer, B; Rolle-Kampczyk, U; Feltens, R; Otto, W; Wissenbach, DK; von Bergen, M; Bluher, M				Kloeting, Nora; Hesselbarth, Nico; Gericke, Martin; Kunath, Anne; Biemann, Ronald; Chakaroun, Rima; Kosacka, Joanna; Kovacs, Peter; Kern, Matthias; Stumvoll, Michael; Fischer, Bernd; Rolle-Kampczyk, Ulrike; Feltens, Ralph; Otto, Wolfgang; Wissenbach, Dirk K.; von Bergen, Martin; Blueher, Matthias			Di-(2-Ethylhexyl)-Phthalate (DEHP) Causes Impaired Adipocyte Function and Alters Serum Metabolites	PLOS ONE			English	Article							INSULIN SENSITIVITY; ADIPOSE-TISSUE; PHTHALATE METABOLITES; DIETARY EXPOSURE; BISPHENOL-A; ESTROGEN; RESISTANCE; EXPRESSION; ENDOCRINE; CELLS	Di-(2-ethylhexyl)-phthalate (DEHP), an ubiquitous environmental contaminant, has been shown to cause adverse effects on glucose homeostasis and insulin sensitivity in epidemiological studies, but the underlying mechanisms are still unknown. We therefore tested the hypothesis that chronic DEHP exposure causes impaired insulin sensitivity, affects body weight, adipose tissue (AT) function and circulating metabolic parameters of obesity resistant 129S6 mice in vivo. An obesity-resistant mouse model was chosen to reduce a potential obesity bias of DEHP effects on metabolic parameters and AT function. The metabolic effects of 10-weeks exposure to DEHP were tested by insulin tolerance tests and quantitative assessment of 183 metabolites in mice. Furthermore, 3T3-L1 cells were cultured with DEHP for two days, differentiated into mature adipocytes in which the effects on insulin stimulated glucose and palmitate uptake, lipid content as well as on mRNA/protein expression of key adipocyte genes were investigated. We observed in female mice that DEHP treatment causes enhanced weight gain, fat mass, impaired insulin tolerance, changes in circulating adiponectin and adipose tissue Pparg, adiponectin and estrogen expression. Serum metabolomics indicated a general increase in phospholipid and carnitine concentrations. In vitro, DEHP treatment increases the proliferation rate and alters glucose uptake in adipocytes. Taken together, DEHP has significant effects on adipose tissue (AT) function and alters specific serum metabolites. Although, DEHP treatment led to significantly impaired insulin tolerance, it did not affect glucose tolerance, HOMA-IR, fasting glucose, insulin or triglyceride serum concentrations. This may suggest that DEHP treatment does not cause impaired glucose metabolism at the whole body level.	[Kloeting, Nora; Kovacs, Peter; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, IFB AdiposityDis, D-04109 Leipzig, Germany; [Hesselbarth, Nico; Chakaroun, Rima; Kosacka, Joanna; Kern, Matthias; Stumvoll, Michael; Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Gericke, Martin] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Kunath, Anne] German Ctr Diabet Res DZD, Leipzig, Germany; [Biemann, Ronald] Univ Magdeburg, Inst Clin Chem, D-39106 Magdeburg, Germany; [Fischer, Bernd] Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06108 Halle, Saale, Germany; [Rolle-Kampczyk, Ulrike; Feltens, Ralph; Otto, Wolfgang; Wissenbach, Dirk K.; von Bergen, Martin] Helmholtz Ctr Environm Res Leipzig, Dept Metabol, Leipzig, Germany; [von Bergen, Martin] Helmholtz Ctr Environm Res Leipzig, Dept Prote, Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Biotechnol & Environm Engn,Univ, Aalborg, Denmark	Leipzig University; Leipzig University; Leipzig University; Otto von Guericke University; Martin Luther University Halle Wittenberg; Aalborg University	Bluher, M (corresponding author), Univ Leipzig, IFB AdiposityDis, D-04109 Leipzig, Germany.	bluma@medizin.uni-leipzig.de	von Bergen, Martin/D-7960-2011; Stumvoll, Michael/ABE-1121-2021; Chakaroun, Rima/AAU-3660-2020; Gericke, Martin/AAI-8637-2020; Rolle-Kampczyk, Ulrike E./D-4786-2015	von Bergen, Martin/0000-0003-2732-2977; Stumvoll, Michael/0000-0001-6225-8240; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Kovacs, Peter/0000-0002-0290-5423; Chakaroun, Rima/0000-0001-9901-1815	German United Association for Clinical Chemistry and Laboratory Medicine; Deutsche Forschungsgemeinschaft [SFB1052]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases through the Initiative and Networking Fund of the Helmholtz Association; German Research Foundation (DFG); Universitat Leipzig	German United Association for Clinical Chemistry and Laboratory Medicine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases through the Initiative and Networking Fund of the Helmholtz Association; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	This work was supported by the German United Association for Clinical Chemistry and Laboratory Medicine (DGKL), by Deutsche Forschungsgemeinschaft SFB1052: projects B1 (to MB) and B4 (to NK), by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001 (N. Kloting) and by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. We acknowledge support from the German Research Foundation (DFG) and the Universitat Leipzig within the program Open Access Publishing.	Bernal CA, 2002, FOOD ADDIT CONTAM, V19, P1091, DOI 10.1080/02652030210157709; Biemann R, 2014, OBESITY FACTS, V7, P48, DOI 10.1159/000358913; Biemann R, 2012, BIOCHEM BIOPH RES CO, V417, P747, DOI 10.1016/j.bbrc.2011.12.028; Bluher M, 2006, J CLIN ENDOCR METAB, V91, P2310, DOI 10.1210/jc.2005-2556; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Carbone S, 2012, NEUROTOXICOLOGY, V33, P78, DOI 10.1016/j.neuro.2011.11.009; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Chen HH, 2015, INT J OBESITY, V39, P1241, DOI 10.1038/ijo.2015.65; Chen X, 2013, FOOD CHEM TOXICOL, V59, P325, DOI 10.1016/j.fct.2013.06.016; Cho YJ, 2015, MOL CELL ENDOCRINOL, V407, P9, DOI 10.1016/j.mce.2015.03.003; CONNICK JH, 1985, MED HYPOTHESES, V18, P371, DOI 10.1016/0306-9877(85)90104-5; David RM, 2000, TOXICOL SCI, V55, P433, DOI 10.1093/toxsci/55.2.433; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Holmes TJ, 2001, LIFE SCI, V69, P2975, DOI 10.1016/S0024-3205(01)01406-0; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1; Kern M, 2014, DIABETES, V63, P3295, DOI 10.2337/db13-0933; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; KLOTING N, 2010, ENDOCRINOL METAB, V3, pE506, DOI DOI 10.1152/AJPENDO.00586.2009; Kralisch S, 2007, REGUL PEPTIDES, V139, P84, DOI 10.1016/j.regpep.2006.10.009; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; KUMAGAI S, 1993, ACTA PHYSIOL SCAND, V149, P91, DOI 10.1111/j.1748-1716.1993.tb09596.x; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lind PM, 2012, DIABETES CARE, V35, P1519, DOI 10.2337/dc11-2396; Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x; Martinelli MI, 2006, HUM EXP TOXICOL, V25, P531, DOI 10.1191/0960327106het651oa; Mocchiutti NO, 1997, FOOD CHEM TOXICOL, V35, P1017, DOI 10.1016/S0278-6915(97)87270-5; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; MUSHTAQ M, 1980, TOXICOLOGY, V16, P153, DOI 10.1016/0300-483X(80)90045-1; Nilsson M, 2007, INT J OBESITY, V31, P900, DOI 10.1038/sj.ijo.0803528; Nilsson M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-73; Oberbach A, 2012, J LAPAROENDOSC ADV S, V22, P184, DOI 10.1089/lap.2011.0115; Oxenkrug GF, 2015, MOL NEUROBIOL, V52, P805, DOI 10.1007/s12035-015-9232-0; Park Sun Kyun, 2010, J Prev Med Public Health, V43, P1, DOI 10.3961/jpmph.2010.43.1.1; Rajesh P, 2013, J CELL BIOCHEM, V114, P558, DOI 10.1002/jcb.24399; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Schafer N, 2014, METABOLOMICS, V10, P461, DOI 10.1007/s11306-013-0590-1; Schmidt JS, 2012, ENVIRON HEALTH PERSP, V120, P1123, DOI 10.1289/ehp.1104016; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; Shelby MD, 2006, NTP CERHR MON, V18, pvii; Shelby Michael D, 2006, NTP CERHR MON, pvii; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Stern JH, 2015, NAT REV ENDOCRINOL, V11, P71, DOI 10.1038/nrendo.2014.219; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; van Ravenzwaay B, 2010, TOXICOL LETT, V198, P159, DOI 10.1016/j.toxlet.2010.06.009; Wagner JD, 1998, J CLIN ENDOCR METAB, V83, P896, DOI 10.1210/jc.83.3.896; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x	54	45	46	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143190	10.1371/journal.pone.0143190	http://dx.doi.org/10.1371/journal.pone.0143190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630026	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300035
J	Chinomona, A; Mwambi, HG				Chinomona, Amos; Mwambi, Henry Godwell			Estimating HIV Prevalence in Zimbabwe Using Population-Based Survey Data	PLOS ONE			English	Article							LOGISTIC-REGRESSION ANALYSIS; TO-CHILD TRANSMISSION; BEHAVIOR	Estimates of HIV prevalence computed using data obtained from sampling a subgroup of the national population may lack the representativeness of all the relevant domains of the population. These estimates are often computed on the assumption that HIV prevalence is uniform across all domains of the population. Use of appropriate statistical methods together with population-based survey data can enhance better estimation of national and subgroup level HIV prevalence and can provide improved explanations of the variation in HIV prevalence across different domains of the population. In this study we computed design-consistent estimates of HIV prevalence, and their respective 95% confidence intervals at both the national and subgroup levels. In addition, we provided a multivariable survey logistic regression model from a generalized linear modelling perspective for explaining the variation in HIV prevalence using demographic, socio-economic, socio-cultural and behavioural factors. Essentially, this study borrows from the proximate determinants conceptual framework which provides guiding principles upon which socio-economic and socio-cultural variables affect HIV prevalence through biological behavioural factors. We utilize the 2010-11 Zimbabwe Demographic and Health Survey (2010-11 ZDHS) data (which are population based) to estimate HIV prevalence in different categories of the population and for constructing the logistic regression model. It was established that HIV prevalence varies greatly with age, gender, marital status, place of residence, literacy level, belief on whether condom use can reduce the risk of contracting HIV and level of recent sexual activity whereas there was no marked variation in HIV prevalence with social status (measured using a wealth index), method of contraceptive and an individual's level of education.	[Chinomona, Amos] Rhodes Univ, Dept Stat, ZA-6140 Grahamstown, South Africa; [Chinomona, Amos; Mwambi, Henry Godwell] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa	Rhodes University; University of Kwazulu Natal	Chinomona, A (corresponding author), Rhodes Univ, Dept Stat, ZA-6140 Grahamstown, South Africa.	a.chinomona@ru.ac.za			Rhodes University	Rhodes University	This work was supported by a Rhodes University research grant.	AGRESTI A, 2007, WILEY SERIES PROBABI; Anderson R, 1999, TRENDS HIV INCIDENCE; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Breslow NE, 1997, STAT MED, V16, P103, DOI 10.1002/(SICI)1097-0258(19970115)16:1<103::AID-SIM474>3.0.CO;2-P; Calcagno V, 2010, J STAT SOFTW, V34, P1; Champredon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082906; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; HOSMER DW, 2000, WILEY PS TX, P1; Lele SR, 2014, RESOURCE SELCTION FU; Little R. J. A., 1987, STAT ANAL MISSING DA; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; Maheswaran H, 2009, FUTURE VIROL, V4, P165, DOI 10.2217/17460794.4.2.165; McCullah P, 1989, GEN LINEAR MODELS; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Park MY, 2010, STEPPLR L2 PENALIZED; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; R Core Team, 2013, R COR TEAM LANG ENV; Ramjee G, 2003, SEXUALLY TRANSMITTED, V29, P44; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; ROBERTS G, 1987, BIOMETRIKA, V74, P1; Royall R., 2003, ANAL SURVEY DATA, P59; Wiegert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098236; Wolter KM, 1985, SPRINGER SERIES STAT; WOODRUFF RS, 1971, J AM STAT ASSOC, V66, P411, DOI 10.2307/2283947	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0140896	10.1371/journal.pone.0140896	http://dx.doi.org/10.1371/journal.pone.0140896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624280	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600003
J	Isami, S; Sakamoto, N; Nishimori, H; Awazu, A				Isami, Shuhei; Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori			Simple Elastic Network Models for Exhaustive Analysis of Long Double-Stranded DNA Dynamics with Sequence Geometry Dependence	PLOS ONE			English	Article							NUCLEIC-ACID FLEXIBILITY; COARSE-GRAINED MODEL; MOLECULAR-DYNAMICS; B-DNA; DODECAMER D(CGCGAATTCGCG); CHROMATIN INSULATORS; SOFTWARE PACKAGE; WEB SERVER; BASE-PAIR; SIMULATIONS	Simple elastic network models of DNA were developed to reveal the structure-dynamics relationships for several nucleotide sequences. First, we propose a simple all-atom elastic network model of DNA that can explain the profiles of temperature factors for several crystal structures of DNA. Second, we propose a coarse-grained elastic network model of DNA, where each nucleotide is described only by one node. This model could effectively reproduce the detailed dynamics obtained with the all-atom elastic network model according to the sequence-dependent geometry. Through normal-mode analysis for the coarse-grained elastic network model, we exhaustively analyzed the dynamic features of a large number of long DNA sequences, approximately similar to 150 bp in length. These analyses revealed positive correlations between the nucleosome-forming abilities and the inter-strand fluctuation strength of double-stranded DNA for several DNA sequences.	[Isami, Shuhei; Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Sakamoto, Naoaki; Nishimori, Hiraku; Awazu, Akinori] Hiroshima Univ, Res Ctr Math Chromatin Live Dynam, Higashihiroshima 7398526, Japan	Hiroshima University; Hiroshima University	Awazu, A (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Kagami Yama 1-3-1, Higashihiroshima 7398526, Japan.	awa@hiroshima-u.ac.jp	Sakamoto, Naoaki/G-7070-2019; Awazu, Akinori/G-8980-2019	Sakamoto, Naoaki/0000-0003-0546-4018; 	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); MEXT of Japan [3306, 24115515, 4503, 26120525, 25430169]	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED). Grant-in-Aid for Scientific Research on Innovative Areas "Spying minority in biological phenomena" (No. 3306) (24115515) and "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" (No. 4503) (26120525) of MEXT of Japan (A. A) Grants-in-Aid for Scientific Research (C) (No. 25430169) of MEXT of Japan (N. S).	Albert B., 2008, MOL BIOL CELL; Apostolou E, 2013, CELL STEM CELL, V13, P1; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Atilgan C, 2012, ANNU REV BIOPHYS, V41, P205, DOI [10.1146/annurev-biophys-050511-102305, 10.1146/annurev-biophys-050511-102385]; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Beveridge DL, 2012, J BIOSCIENCES, V37, P379, DOI 10.1007/s12038-012-9222-6; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bomble YJ, 2008, BIOPOLYMERS, V89, P722, DOI 10.1002/bip.21000; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Cheatham TE, 2013, BIOPOLYMERS, V99, P969, DOI 10.1002/bip.22331; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Dans PD, 2012, NUCLEIC ACIDS RES, V40, P10668, DOI 10.1093/nar/gks884; Dans PD, 2010, J CHEM THEORY COMPUT, V6, P1711, DOI 10.1021/ct900653p; David Allis C., 2007, EPIGENETICS-US; Dehouck Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003209; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Dykeman EC, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/42/423202; Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107; Freeman GS, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897649; Freeman GS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.168101; Freeman GS, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3652956; Fujii S, 2007, NUCLEIC ACIDS RES, V35, P6063, DOI 10.1093/nar/gkm627; Fukue Y, 2004, NUCLEIC ACIDS RES, V32, P5834, DOI 10.1093/nar/gkh905; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Geyer PK, 2002, CELL MOL LIFE SCI, V59, P2112, DOI 10.1007/s000180200011; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Goni JR, 2008, BIOINFORMATICS, V24, P1731, DOI 10.1093/bioinformatics/btn259; Gonzalez O, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789411; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; HAHN M, 1993, ACTA CRYSTALLOGR D, V49, P468, DOI 10.1107/S0907444993004858; Hinsen K, 2000, CHEM PHYS, V261, P25, DOI 10.1016/S0301-0104(00)00222-6; HOLBROOK SR, 1985, ACTA CRYSTALLOGR B, V41, P255, DOI 10.1107/S0108768185002087; Hospital A, 2013, NUCLEIC ACIDS RES, V41, pW47, DOI 10.1093/nar/gkt378; KNEALE G, 1985, J MOL BIOL, V186, P805, DOI 10.1016/0022-2836(85)90398-5; Knotts TA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431804; Korolev N, 2014, POLYMERS-BASEL, V6, P1655, DOI 10.3390/polym6061655; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Latchman D., 2010, GENE CONTROL; Lavery R, 2010, NUCLEIC ACIDS RES, V38, P299, DOI 10.1093/nar/gkp834; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lin DH, 1997, J CHEM PHYS, V107, P3684, DOI 10.1063/1.474724; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Matsumoto A, 2002, BIOPHYS J, V83, P22, DOI 10.1016/S0006-3495(02)75147-3; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Moritsugu K, 2007, BIOPHYS J, V93, P3460, DOI 10.1529/biophysj.107.111898; Morozov AV, 2009, NUCLEIC ACIDS RES, V37, P4707, DOI 10.1093/nar/gkp475; Morriss-Andrews A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3269994; Naome A, 2014, J CHEM THEORY COMPUT, V10, P3541, DOI 10.1021/ct500222s; Ng HL, 2000, P NATL ACAD SCI USA, V97, P2035, DOI 10.1073/pnas.040571197; Ohyama T., 2005, DNA CONFORMATION TRA; Olson W. K., 2006, COMPUTATIONAL STUDIE, P235; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Orozco M, 2008, CURR OPIN STRUC BIOL, V18, P185, DOI 10.1016/j.sbi.2008.01.005; Pasi M, 2014, NUCLEIC ACIDS RES, V42, P12272, DOI 10.1093/nar/gku855; Perez A, 2008, NUCLEIC ACIDS RES, V36, P2379, DOI 10.1093/nar/gkn082; Petkeviciute D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku825; Pinamonti G, 2015, NUCLEIC ACIDS RES, V43, P7260, DOI 10.1093/nar/gkv708; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; SADASIVAN C, 1995, J MOL BIOL, V248, P918, DOI 10.1006/jmbi.1995.9894; Savelyev A, 2010, P NATL ACAD SCI USA, V107, P20340, DOI 10.1073/pnas.1001163107; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Setny P, 2013, J CHEM THEORY COMPUT, V9, P5460, DOI 10.1021/ct400814n; Stolz RC, 2010, NUCLEIC ACIDS RES, V38, pW254, DOI 10.1093/nar/gkq496; Takagi H, 2012, J BIOCHEM, V151, P75, DOI 10.1093/jb/mvr118; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; TIMSIT Y, 1991, NATURE, V354, P167, DOI 10.1038/354167a0; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Turner B., 2001, CHROMATIN GENE REGUL; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Van Wynsberghe AW, 2006, STRUCTURE, V14, P1647, DOI 10.1016/j.str.2006.09.003; WESTHOF E, 1987, J BIOMOL STRUCT DYN, V5, P581, DOI 10.1080/07391102.1987.10506414; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106	81	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143760	10.1371/journal.pone.0143760	http://dx.doi.org/10.1371/journal.pone.0143760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624614	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600048
J	Poojan, S; Kumar, S; Verma, V; Dhasmana, A; Lohani, M; Verma, MK				Poojan, Shiv; Kumar, Sushil; Verma, Vikas; Dhasmana, Anupam; Lohani, Mohtashim; Verma, Mukesh K.			Disruption of Skin Stem Cell Homeostasis following Transplacental Arsenicosis; Alleviation by Combined Intake of Selenium and Curcumin	PLOS ONE			English	Article							EARLY-LIFE EXPOSURE; P38 MAP KINASE; DRINKING-WATER; IN-UTERO; CHILDHOOD EXPOSURE; YOUNG-ADULTS; HEALTH; LUNG; BANGLADESH; CANCER	Of late, a consirable interest has grown in literature on early development of arsenicosis and untimely death in humans after exposure to iAs in drinking water in utero or during the childhood. The mechanism of this kind of intrauterine arsenic poisoning is not known; however it is often suggested to involve stem cells. We looked into this possibility by investigating in mice the influence of chronic in utero exposure to arsenical drinking water preliminarily on multipotent adult stem cell and progenitor cell counts at the beginning of neonatal age. We found that repeated intake of 42.5 or 85ppm iAs in drinking water by pregnant BALB/c mice substantially changed the counts of EpASCs, the progenitor cells, and the differentiated cells in epidermis of their zero day old neonates. EpASCs counts decreased considerably and the differentiated / apoptosed cell counts increased extensively whereas the counts of progenitor cell displayed a biphasic effect. The observed trend of response was dose-dependent and statistically significant. These observations signified a disruption in stem cell homeostasis. The disorder was in parallel with changes in expression of biomarkers of stem cell and progenitor (TA) cell besides changes in expression of pro-inflammatory and antioxidant molecules namely Nrf2, NFkB, TNF-a, and GSH. The biological monitoring of exposure to iAs and the ensuing transplacental toxicity was verifiable correspondingly by the increase in iAs burden in hair, kidney, skin, liver of nulliparous female mice and the onset of chromosomal aberrations in neonate bone marrow cells. The combined intake of selenite and curcumin in utero was found to prevent the disruption of homeostasis and associated biochemical changes to a great extent. The mechanism of prevention seemed possibly to involve (a) curcumin and Keap-1 interaction, (b) consequent escalated de novo GSH biosynthesis, and (c) the resultant toxicant disposition. These observations are important with respect to the development of vulnerability to arsenicosis and other morbidities later in life after repeated in utero or postnatal exposure to iAs in drinking water that may occur speculatively through impairment of adult stem cell dependent innate tissue repair mechanism.	[Poojan, Shiv; Kumar, Sushil; Verma, Vikas; Verma, Mukesh K.] CSIR Indian Inst Toxicol Res, Div Environm Carcinogenesis, Lucknow 226001, Uttar Pradesh, India; [Dhasmana, Anupam] Integral Univ, Dept Bioengn, Environm Carcinogenesis & Toxicoinformat Lab, Lucknow 226026, Uttar Pradesh, India; [Lohani, Mohtashim] Integral Univ, Dept Biosci, Environm Carcinogenesis & Toxicoinformat Lab, Lucknow 226026, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Integral University; Integral University	Kumar, S (corresponding author), Hind Inst Med Sci, Cent Res Lab, Barabanki, UP, India.	sushilkumar.iitr@gmail.com	Lohani, Mohtashim/AAR-3394-2021; Dhasmana, Anupam/K-6043-2019	Dhasmana, Anupam/0000-0002-8042-940X; Lohani, Mohtashim/0000-0001-9414-4539; Poojan, Shiv/0000-0003-4702-5785	Council of Scientific and Industrial Research, New Delhi [BSC-0302]; Indian Council of Medical Research New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research New Delhi(Indian Council of Medical Research (ICMR))	Authors are grateful to the Council of Scientific and Industrial Research, New Delhi for providing financial assistance (grant BSC-0302), a Senior Project Fellowship to VV, and a Senior Research Fellowship to SP. Acknowledgments are due also to the Indian Council of Medical Research New Delhi for providing a Senior Research Fellowship to MKV.	Akbal A, 2014, AGING MALE, V17, P256, DOI 10.3109/13685538.2013.819326; Biswas S, 1999, MUTAT RES-GEN TOX EN, V441, P155, DOI 10.1016/S1383-5718(99)00028-5; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boekelheide K, 2012, ENVIRON HEALTH PERSP, V120, P1353, DOI 10.1289/ehp.1204934; Carmona-Ramirez I, 2013, J NUTR BIOCHEM, V24, P14, DOI 10.1016/j.jnutbio.2011.12.010; Cordova EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088069; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dani SU, 2013, BONE, V53, P541, DOI 10.1016/j.bone.2013.01.017; Dauphine DC, 2011, INT ARCH OCC ENV HEA, V84, P591, DOI 10.1007/s00420-010-0591-6; Davila JC, 2004, TOXICOL SCI, V79, P214, DOI 10.1093/toxsci/kfh100; Duan GL, 2013, METALLOMICS, V5, P784, DOI 10.1039/c3mt20277a; Farzan SF, 2013, TOXICOL APPL PHARM, V272, P384, DOI 10.1016/j.taap.2013.06.030; Fry RC, 2007, PLOS GENET, V3, P2180, DOI 10.1371/journal.pgen.0030207; Gao S, 2013, FOOD CHEM TOXICOL, V59, P739, DOI 10.1016/j.fct.2013.07.032; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC MONOGR EVAL CAR, V84, P269; Jackson BP, 2012, ENVIRON HEALTH PERSP, V120, P623, DOI 10.1289/ehp.1104619; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Klimecki WT, 1997, TOXICOL IN VITRO, V11, P89, DOI 10.1016/S0887-2333(97)00006-4; Kotz S, 1992, ENCY STAT SCI, P424; Lau A, 2013, J BIOCHEM MOL TOXIC, V27, P99, DOI 10.1002/jbt.21463; McCarty Kathleen M., 2011, Reviews on Environmental Health, V26, P71, DOI 10.1515/REVEH.2011.010; McCarty KM, 2006, ENVIRON HEALTH PERSP, V114, P334, DOI 10.1289/ehp.7916; Meharg AA, 2003, ENVIRON SCI TECHNOL, V37, P229, DOI 10.1021/es0259842; Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Paul P C, 2000, Indian J Pathol Microbiol, V43, P257; Peifer C, 2006, CURR TOP MED CHEM, V6, P113, DOI 10.2174/156802606775270323; Pesola GR, 2012, EUR RESPIR J, V39, P1076, DOI 10.1183/09031936.00042611; Poojan S, 2010, PROTOCOL EXCHANGE 20; Poojan S, 2011, CELL BIOL INT, V35, P147, DOI [10.1042/CB20100335, 10.1042/CBI20100335]; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rahman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055014; Garcia-Nino WR, 2014, FOOD CHEM TOXICOL, V69, P182, DOI 10.1016/j.fct.2014.04.016; Ramsey KA, 2013, ENVIRON HEALTH PERSP, V121, P1187, DOI 10.1289/ehp.1306748; Ramsey KA, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-13; Rosas-Castor JM, 2014, SCI TOTAL ENVIRON, V488, P176, DOI 10.1016/j.scitotenv.2014.04.075; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Smith AH, 2012, ENVIRON HEALTH PERSP, V120, P1527, DOI 10.1289/ehp.1104867; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Sokal R. R., 1987, INTRO BIOSTATISTICS; States JC, 2011, ENVIRON HEALTH PERSP, V119, P1356, DOI 10.1289/ehp.1103441; Steinmaus C, 2014, CANCER EPIDEM BIOMAR, V23, P1529, DOI 10.1158/1055-9965.EPI-14-0059; Tokar EJ, 2010, ENVIRON HEALTH PERSP, V118, P108, DOI 10.1289/ehp.0901059; Vahter M, 2008, BASIC CLIN PHARMACOL, V102, P204, DOI 10.1111/j.1742-7843.2007.00168.x; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Waalkes MP, 2004, TOXICOL APPL PHARM, V198, P377, DOI 10.1016/j.taap.2003.10.028; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Yadav RS, 2009, TOXICOL APPL PHARM, V240, P367, DOI 10.1016/j.taap.2009.07.017; Yoshida T, 2004, TOXICOL APPL PHARM, V198, P243, DOI 10.1016/j.taap.2003.10.022; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Zhou JX, 2004, CELL BIOL INT, V28, P523, DOI 10.1016/j.cellbi.2004.04.007; Zhou L, 2007, CELL CYCLE, V6, P534, DOI 10.4161/cc.6.5.3921	57	9	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142818	10.1371/journal.pone.0142818	http://dx.doi.org/10.1371/journal.pone.0142818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624291	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600011
J	Scaccabarozzi, D; Deroost, K; Lays, N; Sale, FO; Van den Steen, PE; Taramelli, D				Scaccabarozzi, Diletta; Deroost, Katrien; Lays, Natacha; Sale, Fausta Omodeo; Van den Steen, Philippe E.; Taramelli, Donatella			Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							PLASMODIUM-VIVAX MALARIA; PULMONARY SURFACTANT; FALCIPARUM-MALARIA; ADIPOSE-TISSUE; CELLS; MODEL; ACID; PEROXIDATION; INHIBITION; ASPIRATION	Malaria-associated acute lung injury (MA-ALI) and its more severe form malaria-associated acute respiratory distress syndrome (MA-ARDS) are common, often fatal complications of severe malaria infections. However, little is known about their pathogenesis. In this study, biochemical alterations of the lipid composition of the lungs were investigated as possible contributing factors to the severity of murine MA-ALI/ARDS. C57BL/6J mice were infected with Plasmodium berghei NK65 to induce lethal MA-ARDS, or with Plasmodium chabaudi AS, a parasite strain that does not induce lung pathology. The lipid profile of the lung tissue from mice infected with Plasmodium berghei NK65 developing MA-ALI/ARDS, but not that from mice without lung pathology or controls, was characterized by high levels of phospholipids -mainly phosphatidylcholine-and esterified cholesterol. The high levels of polyunsaturated fatty acids and the linoleic/oleic fatty acid ratio of the latter reflect the fatty acid composition of plasma cholesterol esters. In spite of the increased total polyunsaturated fatty acid pool, which augments the relative oxidability of the lung membranes, and the presence of hemozoin, a known pro-oxidant, no excess oxidative stress was detected in the lungs of Plasmodium berghei NK65 infected mice. The bronchoalveolar lavage (BAL) fluid of Plasmodium berghei NK65 infected mice was characterized by high levels of plasma proteins. The phospholipid profile of BAL large and small aggregate fractions was also different from uninfected controls, with a significant increase in the amounts of sphingomyelin and lysophosphatidylcholine and the decrease in phosphatidylglycerol. Both the increase of proteins and lysophosphatidylcholine are known to decrease the intrinsic surface activity of surfactant. Together, these data indicate that an altered lipid composition of lung tissue and BAL fluid, partially ascribed to oedema and lipoprotein infiltration, is a characteristic feature of murine MA-ALI/ARDS and possibly contribute to lung dysfunction.	[Scaccabarozzi, Diletta; Sale, Fausta Omodeo; Taramelli, Donatella] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Deroost, Katrien; Lays, Natacha; Van den Steen, Philippe E.] Univ Leuven, KU Leuven, Rega Inst Med Res, Leuven, Belgium	University of Milan; KU Leuven	Taramelli, D (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	donatella.taramelli@unimi.it	Van den Steen, Philippe E/K-5132-2012; Taramelli, Donatella/H-5768-2017	Van den Steen, Philippe E/0000-0002-7334-9145; Taramelli, Donatella/0000-0001-5108-4492; Deroost, Katrien/0000-0001-7580-2479	"Geconcerteerde OnderzoeksActies" of the Research Fund of the KU Leuven [GOA 2013/014]; Fund for Scientific Research (F.W.O.-Vlaanderen) [KAN2013 1.5.235.13, G.0664.10, G.0862.15N]; project PRIN [2010C2LKKJ]; Doctorate School of Molecular Medicine, University of Milan", Milan Italy	"Geconcerteerde OnderzoeksActies" of the Research Fund of the KU Leuven; Fund for Scientific Research (F.W.O.-Vlaanderen)(FWO); project PRIN(Ministry of Education, Universities and Research (MIUR)); Doctorate School of Molecular Medicine, University of Milan", Milan Italy	This work was supported by the "Geconcerteerde OnderzoeksActies" (GOA 2013/014 to PVDS) of the Research Fund of the KU Leuven (www.kuleuven.be) and the Fund for Scientific Research (F.W.O.-Vlaanderen, [www.FWO.be], grant numbers KAN2013 1.5.235.13, G.0664.10 and G.0862.15N, to PVDS). DS was supported by the project PRIN 2010/11 to DT (2010C2LKKJ) and by a fellowship of the Doctorate School of Molecular Medicine, University of Milan", Milan Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken EH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-230; Ampawong S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0922-x; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bursten SL, 1996, CRIT CARE MED, V24, P1129, DOI 10.1097/00003246-199607000-00011; CHAROENPAN P, 1990, CHEST, V97, P1190, DOI 10.1378/chest.97.5.1190; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; D'Alessandro S, 2011, BIOCHEM PHARMACOL, V82, P476, DOI 10.1016/j.bcp.2011.06.002; Davidson BA, 2005, AM J PHYSIOL-LUNG C, V288, pL699, DOI 10.1152/ajplung.00229.2004; Deroost K, AM J RESP CELL MOL B; Deroost K, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-166; Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FELDMAN RM, 1987, REV INFECT DIS, V9, P134; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gunther A, 2002, EUR RESPIR J, V19, P797, DOI 10.1183/09031936.02.00243302; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Gupta D, 2001, Respirology, V6, P125, DOI 10.1046/j.1440-1843.2001.00324.x; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Holm BA, 1999, PEDIATR RES, V46, P85, DOI 10.1203/00006450-199907000-00015; HOLM BA, 1988, CHEM PHYS LIPIDS, V49, P49, DOI 10.1016/0009-3084(88)90063-1; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Lema G, 1997, BBA-LIPID LIPID MET, V1345, P86, DOI 10.1016/S0005-2760(96)00180-4; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; McGready R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-191; Memon RA, 1998, ARTERIOSCL THROM VAS, V18, P1257, DOI 10.1161/01.ATV.18.8.1257; Milner D, 2013, HUM PATHOL, V44, P2719, DOI 10.1016/j.humpath.2013.07.018; Mohan A, 2008, ASIAN PAC J CANCER P, V9, P557; Muller B, 2003, THORAX, V58, P127, DOI 10.1136/thorax.58.2.127; Nakos G, 2005, CRIT CARE MED, V33, P772, DOI 10.1097/01.CCM.0000158519.80090.74; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Ochiai R, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0091-6; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Quinlan GJ, 1996, CRIT CARE MED, V24, P241, DOI 10.1097/00003246-199602000-00010; Raghavendran K, 2008, SHOCK, V30, P508, DOI 10.1097/SHK.0b013e3181673fc5; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Schwarzer E, 1996, FEBS LETT, V388, P119, DOI 10.1016/0014-5793(96)00523-6; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Taylor WRJ, 2012, CHEST, V142, P492, DOI 10.1378/chest.11-2655; Tibboel J, 2014, CHEST, V145, P120, DOI 10.1378/chest.13-0967; Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; VANGOLDE LMG, 1985, BIOCHEM SOC T, V13, P1087, DOI 10.1042/bst0131087; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; VELDHUIZEN RAW, 1995, AM J RESP CRIT CARE, V152, P1867, DOI 10.1164/ajrccm.152.6.8520748; Viviano CJ, 1995, BBA-LIPID LIPID MET, V1259, P235, DOI 10.1016/0005-2760(95)00167-0; Wang ZD, 1998, AM J RESP CRIT CARE, V158, P28, DOI 10.1164/ajrccm.158.1.9709041; WHO, 2010, GUID TREATM MAL, V2nd; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Wu GS, 2004, AM J PHYSIOL-ENDOC M, V286, pE711, DOI 10.1152/ajpendo.00257.2003; Zhao CZ, 2010, RESP MED, V104, P1391, DOI 10.1016/j.rmed.2010.06.018	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143195	10.1371/journal.pone.0143195	http://dx.doi.org/10.1371/journal.pone.0143195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624290	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600020
J	Anadon, C; Guil, S; Simo-Riudalbas, L; Moutinho, C; Setien, F; Martinez-Cardus, A; Moran, S; Villanueva, A; Calaf, M; Vidal, A; Lazo, PA; Zondervan, I; Savola, S; Kohno, T; Yokota, J; de Pouplana, LR; Esteller, M				Anadon, C.; Guil, S.; Simo-Riudalbas, L.; Moutinho, C.; Setien, F.; Martinez-Cardus, A.; Moran, S.; Villanueva, A.; Calaf, M.; Vidal, A.; Lazo, P. A.; Zondervan, I.; Savola, S.; Kohno, T.; Yokota, J.; Ribas de Pouplana, L.; Esteller, M.			Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER; TRANSCRIPTOME; SITES; CELLS	The introduction of new therapies against particular genetic mutations in non-small-cell lung cancer is a promising avenue for improving patient survival, but the target population is small. There is a need to discover new potential actionable genetic lesions, to which end, non-conventional cancer pathways, such as RNA editing, are worth exploring. Herein we show that the adenosine-to-inosine editing enzyme ADAR1 undergoes gene amplification in non-small cancer cell lines and primary tumors in association with higher levels of the corresponding mRNA and protein. From a growth and invasion standpoint, the depletion of ADAR1 expression in amplified cells reduces their tumorigenic potential in cell culture and mouse models, whereas its overexpression has the opposite effects. From a functional perspective, ADAR1 overexpression enhances the editing frequencies of target transcripts such as NEIL1 and miR-381. In the clinical setting, patients with early-stage lung cancer, but harboring ADAR1 gene amplification, have poor outcomes. Overall, our results indicate a role for ADAR1 as a lung cancer oncogene undergoing gene amplification-associated activation that affects downstream RNA editing patterns and patient prognosis.	[Anadon, C.; Guil, S.; Simo-Riudalbas, L.; Moutinho, C.; Setien, F.; Martinez-Cardus, A.; Moran, S.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Catalonia, Spain; [Villanueva, A.; Calaf, M.] IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona, Catalonia, Spain; [Vidal, A.] Bellvitge Unvivers Hosp, Dept Pathol Anat, Barcelona, Catalonia, Spain; [Lazo, P. A.] Univ Salamanca, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc, CSIC, Salamanca, Spain; [Lazo, P. A.] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Zondervan, I.; Savola, S.] MRC Holland, Amsterdam, Netherlands; [Kohno, T.; Yokota, J.] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo, Japan; [Yokota, J.] Inst Predict & Personalized Med Canc IMPPC, Genom & Epigen Canc Predict Program, Badalona, Catalonia, Spain; [Ribas de Pouplana, L.; Esteller, M.] IRB, C Baldiri Reixac 10, Barcelona 08028, Catalonia, Spain; [Ribas de Pouplana, L.] ICREA, Barcelona, Catalonia, Spain; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); National Cancer Center - Japan; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Barcelona	Esteller, M (corresponding author), Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, 3rd Floor,Avda Gran Via Km 2-7, Barcelona 08908, Spain.	mesteller@idibell.cat	Guil, Sonia/M-8036-2015; Moran, Sebastian/G-5293-2013; Esteller, Manel/L-5956-2014; Lazo, Pedro A./M-6435-2014; Vidal, August/N-4662-2016; Martinez, Anna/AAA-4939-2020	Guil, Sonia/0000-0002-2257-3331; Moran, Sebastian/0000-0003-4192-8983; Esteller, Manel/0000-0003-4490-6093; Lazo, Pedro A./0000-0001-8997-3025; Vidal, August/0000-0001-5727-2099; Savola, Suvi/0000-0002-6221-8617; Anadon Galindo, Carmen Maria/0000-0002-8851-4545	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [268626-EPINORC, HEALTH-F2-2010-258677-CURELUNG]; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2011-22803, PI13-01339, SAF2014-55000-R]; Institute of Health Carlos III (ISCIII) [PI10/02992]; Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935]; Cellex Foundation; National Cancer Center Research and Development Fund (NCC Biobank) [23 A-1]; Health and Science Departments of the Catalan Government (Generalitat de Catalunya) AGAUR [2009SGR1315, 2014SGR633]; ICREA Funding Source: Custom	European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness (MINECO); Institute of Health Carlos III (ISCIII); Ministerio de Educacion, Ciencia e Innovacion; Cellex Foundation(Foundation CELLEX); National Cancer Center Research and Development Fund (NCC Biobank); Health and Science Departments of the Catalan Government (Generalitat de Catalunya) AGAUR; ICREA(ICREA)	This work was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268626-EPINORC project, the Grant agreement number HEALTH-F2-2010-258677-CURELUNG project, the Spanish Ministry of Economy and Competitiveness (MINECO Projects no. SAF2011-22803, PI13-01339 and SAF2014-55000-R), the Institute of Health Carlos III (ISCIII)-PI10/02992, Ministerio de Educacion, Ciencia e Innovacion Grant SAF2010-14935, the Cellex Foundation, the National Cancer Center Research and Development Fund (NCC Biobank: 23 A-1) and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya) AGAUR-project no. 2009SGR1315 and 2014SGR633. We thank the staff of the Animal Core Facility of IDIBELL for mouse care and maintenance. LRdP and ME are ICREA Research Professors.	Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Avesson L, 2014, BBA-REV CANCER, V1845, P308, DOI 10.1016/j.bbcan.2014.03.001; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Buettner R, 2013, J CLIN ONCOL, V31, P1858, DOI 10.1200/JCO.2012.45.9867; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Daniel C, 2012, NUCLEIC ACIDS RES, V40, P9876, DOI 10.1093/nar/gks691; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451; Jiang QF, 2013, P NATL ACAD SCI USA, V110, P1041, DOI 10.1073/pnas.1213021110; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Rommel PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069208; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Wang ZY, 2015, ONCOTARGET, V6, P3147, DOI 10.18632/oncotarget.3061; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yeo JC, 2010, P NATL ACAD SCI USA, V107, P20715, DOI 10.1073/pnas.1009231107	23	59	59	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	33					4407	4413		10.1038/onc.2015.469	http://dx.doi.org/10.1038/onc.2015.469			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3ZU	26640150	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000382152100012
J	Obermeier, K; Sachsenweger, J; Friedl, TWP; Pospiech, H; Winqvist, R; Wiesmuller, L				Obermeier, K.; Sachsenweger, J.; Friedl, T. W. P.; Pospiech, H.; Winqvist, R.; Wiesmueller, L.			Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients	ONCOGENE			English	Article							FANCONI-ANEMIA PATHWAY; REPLICATION FORKS; BRCA2; SUSCEPTIBILITY; RISK; RECOMBINATION; MECHANISM; PARTNER; PROTEIN; GENES	Hereditary heterozygous mutations in a variety of DNA double-strand break (DSB) repair genes have been associated with increased breast cancer risk. In the Finnish population, PALB2 (partner and localizer of BRCA2) represents a major susceptibility gene for female breast cancer, and so far, only one mutation has been described, c.1592delT, which leads to a sixfold increased disease risk. PALB2 is thought to participate in homologous recombination (HR). However, the effect of the Finnish founder mutation on DSB repair has not been investigated. In the current study, we used a panel of lymphoblastoid cell lines (LCLs) derived from seven heterozygous female PALB2 c.1592delT mutation carriers with variable health status and six wild-type matched controls. The results of our DSB repair analysis showed that the PALB2 mutation causes specific changes in pathway usage, namely increases in error-prone single-strand annealing (SSA) and microhomology-mediated end-joining (MMEJ) compared with wild-type LCLs. These data indicated haploinsufficiency regarding the suppression of error-prone DSB repair in PALB2 mutation carriers. To the contrary, neither reduced HR activities, nor impaired RAD51 filament assembly, nor sensitization to PARP inhibition were consistently observed. Expression of truncated mutant versus wild-type PALB2 verified a causal role of PALB2 c.1592delT in the shift to error-prone repair. Discrimination between healthy and malignancy-presenting PALB2 mutation carriers revealed a pathway shift particularly in the breast cancer patients, suggesting interaction of PALB2 c.1592delT with additional genomic lesions. Interestingly, the studied PALB2 mutation was associated with 53BP1 accumulation in the healthy mutation carriers but not the patients, and 53BP1 was limiting for error-prone MMEJ in patients but not in healthy carriers. Our study identified a rise in error-prone DSB repair as a potential threat to genomic integrity in heterozygous PALB2 mutation carriers. The used phenotypic marker system has the capacity to capture dysfunction caused by polygenic mechanisms and therefore offers new strategies of cancer risk prediction.	[Obermeier, K.; Sachsenweger, J.; Friedl, T. W. P.; Wiesmueller, L.] Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany; [Pospiech, H.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Pospiech, H.] Leibniz Inst Age Res, Fritz Lipmann Inst, Res Grp Biochem, Jena, Germany; [Winqvist, R.] Univ Oulu, Lab Canc Genet & Tumor Biol, Canc & Translat Med Res Unit, Aapistie 5A, SF-90220 Oulu, Finland; [Winqvist, R.] Univ Oulu, Bioctr Oulu, Aapistie 5A, SF-90220 Oulu, Finland; [Winqvist, R.] Northern Finland Lab Ctr NordLab, Oulu, Finland	Ulm University; University of Oulu; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Oulu; University of Oulu	Wiesmuller, L (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany.; Winqvist, R (corresponding author), Univ Oulu, Lab Canc Genet & Tumor Biol, Canc & Translat Med Res Unit, Aapistie 5A, SF-90220 Oulu, Finland.; Winqvist, R (corresponding author), Univ Oulu, Bioctr Oulu, Aapistie 5A, SF-90220 Oulu, Finland.	robert.winqvist@oulu.fi; lisa.wiesmueller@uni-ulm.de	Friedl, Thomas W.P./K-5305-2013	Friedl, Thomas W.P./0000-0002-4773-8067; Wiesmuller, Lisa/0000-0002-2397-5041; Winqvist, Robert/0000-0003-0932-9104	International Graduate School in Molecular Medicine Ulm, Germany; University of Oulu; Finnish Cancer Foundation; Sigrid Juselius Foundation; Academy of Finland Center of Excellence [251314]; Biocenter Oulu; Cancer Foundation Finland sr [150147] Funding Source: researchfish	International Graduate School in Molecular Medicine Ulm, Germany; University of Oulu; Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence(Academy of Finland); Biocenter Oulu; Cancer Foundation Finland sr	We cordially thank Leena Keskitalo, Annika Vantanen and Meeri Otsukka for the initial preparation and culturing of the Northern Finnish PALB2 mutation carrier and the matched wild-type healthy control LCLs as well as their shipment to Ulm for the current study. We are grateful to Daniela Salles, Ulm, for experimental help during the initial phase of the project, and Jeremy M Stark, Department of Cancer Biology, Division of Radiation Biology, Beckmann Research Institute of the City of Hope, Duarte, CA, USA, for the NHEJ reporter EJ5SceGFP. This project was supported by the International Graduate School in Molecular Medicine Ulm, Germany (to LW). KO was and JS is a member of the International Graduate School in Molecular Medicine Ulm. RW was supported by the University of Oulu and Biocenter Oulu, the Finnish Cancer Foundation, Sigrid Juselius Foundation and the Academy of Finland Center of Excellence funding (grant 251314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Bohringer M, 2013, ONCOGENE, V32, P5458, DOI 10.1038/onc.2013.38; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, MOL CELL, V39, P164, DOI 10.1016/j.molcel.2010.07.016; Burkovics P, 2014, NUCLEIC ACIDS RES, V42, P1711, DOI 10.1093/nar/gkt1040; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Currall Benjamin B, 2013, Curr Genet Med Rep, V1, P81; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Deng XY, 2009, BIOCHEMISTRY-US, V48, P6633, DOI 10.1021/bi900564k; Do K, 2013, CLIN CANCER RES, V19, P977, DOI 10.1158/1078-0432.CCR-12-0163; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Haanpaa M, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-82; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Ho TV, 2002, ENVIRON MOL MUTAGEN, V51, P552; Hucl T, 2011, PHYSIOL RES, V60, P453, DOI 10.33549/physiolres.932115; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Ireno IC, 2014, CARCINOGENESIS, V35, P2273, DOI 10.1093/carcin/bgu160; Keimling M, 2012, FASEB J, V26, P2094, DOI 10.1096/fj.11-200790; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Keka IS, 2015, NUCLEIC ACIDS RES, V43, P6359, DOI 10.1093/nar/gkv621; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Murphy AK, 2014, J CELL BIOL, V206, P493, DOI 10.1083/jcb.201404111; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Park JY, 2014, ONCOGENE, V33, P4803, DOI 10.1038/onc.2013.421; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Ribeiro E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066243; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shahid T, 2014, NAT STRUCT MOL BIOL, V21, P962, DOI 10.1038/nsmb.2899; Siaud N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002409; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, FERROALLOYS, V1, P1, DOI DOI 10.1155/2009/514306; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	59	24	24	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3796	3806		10.1038/onc.2015.448	http://dx.doi.org/10.1038/onc.2015.448			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26640152	Green Published, hybrid			2022-12-26	WOS:000380753200005
J	Jiang, H; Salmon, RM; Upton, PD; Wei, ZQ; Lawera, A; Davenport, AP; Morrell, NW; Li, W				Jiang, He; Salmon, Richard M.; Upton, Paul D.; Wei, Zhenquan; Lawera, Aleksandra; Davenport, Anthony P.; Morrell, Nicholas W.; Li, Wei			The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY ARTERIAL-HYPERTENSION; BMP9; ALK1; IDENTIFICATION; ACTIVATION; EXPRESSION; RECEPTORS; GROWTH; QUIESCENCE; COMPLEX	BMP10 is highly expressed in the developing heart and plays essential roles in cardiogenesis. BMP10 deletion in mice results in embryonic lethality because of impaired cardiac development. In adults, BMP10 expression is restricted to the right atrium, though ventricular hypertrophy is accompanied by increased BMP10 expression in a rat hypertension model. However, reports of BMP10 activity in the circulation are inconclusive. In particular, it is not known whether in vivo secreted BMP10 is active or whether additional factors are required to achieve its bioactivity. It has been shown that high-affinity binding of the BMP10 prodomain to the mature ligand inhibits BMP10 signaling activity in C2C12 cells, and it was proposed that prodomain-bound BMP10 (pBMP10) complex is latent. In this study, we demonstrated that the BMP10 prodomain did not inhibit BMP10 signaling activity in multiple endothelial cells, and that recombinant human pBMP10 complex, expressed in mammalian cells and purified under native conditions, was fully active. In addition, both BMP10 in human plasma and BMP10 secreted from the mouse right atrium were fully active. Finally, we confirmed that active BMP10 secreted from mouse right atrium was in the prodomain-bound form. Our data suggest that circulating BMP10 in adults is fully active and that the reported vascular quiescence function of BMP10 in vivo is due to the direct activity of pBMP10 and does not require an additional activation step. Moreover, being an active ligand, recombinant pBMP10 may have therapeutic potential as an endothelial-selective BMP ligand, in conditions characterized by loss of BMP9/10 signaling.	[Jiang, He; Salmon, Richard M.; Upton, Paul D.; Wei, Zhenquan; Lawera, Aleksandra; Davenport, Anthony P.; Morrell, Nicholas W.; Li, Wei] Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England; [Wei, Zhenquan] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Shanghai Jiao Tong University	Morrell, NW (corresponding author), Univ Cambridge, Dept Med, Sch Clin Med, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	nwm23@cam.ac.uk; wl225@cam.ac.uk	wei, wei/HHR-8613-2022; Davenport, Anthony Peter/A-5773-2008	Salmon, Richard/0000-0001-6327-5341; Morrell, Nicholas/0000-0001-5700-9792; Davenport, Anthony Peter/0000-0002-2096-3117	British Heart Foundation [PG/12/54/29734, CH/09/001/25945]; Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease; MRC [G1000847, G0800784] Funding Source: UKRI; British Heart Foundation [PG/15/39/31519] Funding Source: researchfish; Medical Research Council [G1000847, G0800784] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grants PG/12/54/29734 (to W. L., P. D. U., and N. W. M.) and CH/09/001/25945 (to N. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Cambridge Wellcome Trust 4-year Ph.D Programme in Metabolic and Cardiovascular Disease.	Bendell JC, 2014, CLIN CANCER RES, V20, P480, DOI 10.1158/1078-0432.CCR-13-1840; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Li W, 1997, J BIOL CHEM, V272, P22253, DOI 10.1074/jbc.272.35.22253; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Nakano N, 2007, AM J PHYSIOL-HEART C, V293, pH3396, DOI 10.1152/ajpheart.00311.2007; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Panchenko MP, 1996, AM J PHYSIOL-LUNG C, V270, pL547, DOI 10.1152/ajplung.1996.270.4.L547; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2003, CIRC RES, V93, P682, DOI 10.1161/01.RES.0000095246.40391.3B; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; WALLIS R, 1995, BIOCHEMISTRY-US, V34, P13743, DOI 10.1021/bi00042a004; Wei ZQ, 2014, J BIOL CHEM, V289, P31150, DOI 10.1074/jbc.M114.579771; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001	32	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2954	2966		10.1074/jbc.M115.683292	http://dx.doi.org/10.1074/jbc.M115.683292			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26631724	Green Published, hybrid			2022-12-26	WOS:000369626900032
J	Brocherie, F; Millet, GP; Hauser, A; Steiner, T; Wehrlin, JP; Rysman, J; Girard, O				Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Steiner, Thomas; Wehrlin, Jon P.; Rysman, Julien; Girard, Olivier			Association of Hematological Variables with Team-Sport Specific Fitness Performance	PLOS ONE			English	Article							REPEATED-SPRINT ABILITY; TOTAL HEMOGLOBIN MASS; EXPLORATORY FACTOR-ANALYSIS; BLOOD-VOLUME; IRON STATUS; ALTITUDE; EXERCISE; HEMORHEOLOGY; HEMATOCRIT; PLASMA	Purpose We investigated association of hematological variables with specific fitness performance in elite team-sport players. Methods Hemoglobin mass (Hb(mass)) was measured in 25 elite field hockey players using the optimized (2 min) CO-rebreathing method. Hemoglobin concentration ([Hb]), hematocrit and mean corpuscular hemoglobin concentration (MCHC) were analyzed in venous blood. Fitness performance evaluation included a repeated-sprint ability (RSA) test (8 x 20 m sprints, 20 s of rest) and the Yo-Yo intermittent recovery level 2 (YYIR2). Results Hb(mass) was largely correlated (r = 0.62, P<0.01) with YYIR2 total distance covered (YYIR2TD) but not with any RSA-derived parameters (r ranging from -0.06 to -0.32; all P>0.05). [Hb] and MCHC displayed moderate correlations with both YYIR2TD (r = 0.44 and 0.41; both P<0.01) and RSA sprint decrement score (r = -0.41 and -0.44; both P<0.05). YYIR2TD correlated with RSA best and total sprint times (r = -0.46, P<0.05 and -0.60, P<0.01; respectively), but not with RSA sprint decrement score (r = -0.19, P>0.05). Conclusion Hb(mass) is positively correlated with specific aerobic fitness, but not with RSA, in elite teamsport players. Additionally, the negative relationships between YYIR2 and RSA tests performance imply that different hematological mechanisms may be at play. Overall, these results indicate that these two fitness tests should not be used interchangeably as they reflect different hematological mechanisms.	[Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Girard, Olivier] Univ Lausanne, ISSUL, Inst Sports Sci, Lausanne, Switzerland; [Brocherie, Franck; Millet, Gregoire P.; Hauser, Anna; Girard, Olivier] Univ Lausanne, Dept Physiol, Fac Biol & Med, Lausanne, Switzerland; [Hauser, Anna; Steiner, Thomas; Wehrlin, Jon P.] Sect Elite Sport, Swiss Fed Inst Sport, Magglingen, Switzerland; [Rysman, Julien] Univ Libre Bruxelles, Fac Motor Sci, Brussels, Belgium; [Girard, Olivier] Athlete Hlth & Performance Res Ctr, ASPETAR, Orthopaed & Sports Med Hosp, Doha, Qatar	University of Lausanne; University of Lausanne; Universite Libre de Bruxelles; Aspetar Orthopaedic & Sports Medicine Hospital	Brocherie, F (corresponding author), Univ Lausanne, ISSUL, Inst Sports Sci, Lausanne, Switzerland.	franck.brocherie@unil.ch	Millet, Gregoire P/F-4104-2012; Wehrlin, Jon Peter/P-1984-2019; Wehrlin, Jon Peter/G-5101-2011; Millet, Grégoire/M-3220-2019	Millet, Gregoire P/0000-0001-8081-4423; Wehrlin, Jon Peter/0000-0002-8854-7937; Wehrlin, Jon Peter/0000-0002-8854-7937; Millet, Grégoire/0000-0001-8081-4423; Steiner, Thomas/0000-0002-3809-1230; Brocherie, Franck/0000-0002-0808-7986; girard, olivier/0000-0002-4797-182X	Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar [AF/C/ASP1905/11]	Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar	This research was funded by a Grant awarded by Aspetar (Qatar Orthopedic and Sports Medicine Hospital) at the Aspire Zone Foundation, Qatar (AF/C/ASP1905/11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis R, 2014, J SPORTS MED PHYS FI, V2014; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bishop D, 2004, J SPORT MED PHYS FIT, V44, P1; Bishop D, 2011, SPORTS MED, V41, P741, DOI 10.2165/11590560-000000000-00000; Bodary PF, 1999, MED SCI SPORT EXER, V31, P543, DOI 10.1097/00005768-199904000-00008; Boning D, 2008, EUR J APPL PHYSIOL, V103, P127, DOI 10.1007/s00421-008-0675-0; Boning D, 2004, INT J SPORTS MED, V25, P561, DOI 10.1055/s-2004-820963; Brun JF, 2000, CLIN HEMORHEOL MICRO, V22, P287; Bruna JF, 2013, CLIN HEMORHEOL MICRO, V55, P15, DOI 10.3233/CH-131686; Connes P, 2013, CLIN HEMORHEOL MICRO, V53, P187, DOI 10.3233/CH-2012-1643; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; El-Sayed MS, 2005, SPORTS MED, V35, P649, DOI 10.2165/00007256-200535080-00001; Gaudard A, 2003, CLIN HEMORHEOL MICRO, V28, P161; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Gore CJ, 2013, BRIT J SPORT MED, V47, P80; Gore CJ, 1997, INT J SPORTS MED, V18, P477; Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613; Hinrichs T, 2010, J STRENGTH COND RES, V24, P629, DOI 10.1519/JSC.0b013e3181a5bc59; Ingebrigtsen J, 2014, J STRENGTH COND RES, V28, P942, DOI 10.1519/JSC.0b013e3182a1f861; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P340, DOI 10.1080/24748668.2013.11868652; Lythe J, 2011, INT J SPORTS MED, V32, P523, DOI 10.1055/s-0031-1273710; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; McLean BD, 2013, BRIT J SPORT MED, V47, P51; Meister S, 2014, J SPORT SCI, V32, P1328, DOI 10.1080/02640414.2014.927070; Preacher KJ, 2002, BEHAV GENET, V32, P153, DOI 10.1023/A:1015210025234; Prommer N, 2007, EUR J APPL PHYSIOL, V100, P383, DOI 10.1007/s00421-007-0439-2; Pyne DB, 2008, J STRENGTH COND RES, V22, P1633, DOI 10.1519/JSC.0b013e318181fe7a; Rietjens GJWM, 2005, INT J SPORTS MED, V26, P16, DOI 10.1055/s-2004-817914; Rusko HK, 2004, J SPORT SCI, V22, P928, DOI 10.1080/02640410400005933; SCHMIDT W, 1989, EUR J APPL PHYSIOL O, V58, P453, DOI 10.1007/BF02330696; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Schmidt W, 1999, MED SCI SPORTS EXERC, V31, P50; Schmidt W, 2010, EXERC SPORT SCI REV, V38, P68, DOI 10.1097/JES.0b013e3181d4957a; Schumacher YO, 2000, INT J SPORTS MED, V21, P380, DOI 10.1055/s-2000-3785; Schumacher YO, 2002, MED SCI SPORT EXER, V34, P869; Schuster S, 2014, BBA-GEN SUBJECTS, V1840, P271, DOI 10.1016/j.bbagen.2013.08.026; Stark H, 2012, J APPL PHYSIOL, V113, P355, DOI 10.1152/japplphysiol.00369.2012; Steiner T, 2011, SCAND J CLIN LAB INV, V71, P19, DOI 10.3109/00365513.2010.534174; Takeno Y, 2001, J APPL PHYSIOL, V91, P1520, DOI 10.1152/jappl.2001.91.4.1520; Wachsmuth N, 2013, BRIT J SPORT MED, V47, P93, DOI 10.1136/bjsports-2013-092761	44	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144446	10.1371/journal.pone.0144446	http://dx.doi.org/10.1371/journal.pone.0144446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641647	Green Published, gold			2022-12-26	WOS:000366902700123
J	Mei, H; Guo, BB; Yin, BM; Liang, X; Adair, L; Thompson, A; Zhang, JD				Mei, Hong; Guo, Bingbing; Yin, Baomin; Liang, Xiong; Adair, Linda; Thompson, Amanda; Zhang, Jianduan			Interactive Effects of Early Exclusive Breastfeeding and Pre-Pregnancy Maternal Weight Status on Young Children's BMI - A Chinese Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; SELF-REPORTED HEIGHT; FED INFANTS; GROWTH; OBESITY; OVERWEIGHT; CHILDHOOD; ADULTS; DURATION; FORMULA	Objectives To assess if the maternal pre-pregnancy weight status (MPWS) alters the association of early infant feeding pattern (at one and third months) with infant body mass index (BMI) in the first two years of life. Methods A cohort of 2,220 neonates were recruited in a community-based study conducted in China. Body weight and length were measured at birth, at age one and two, with BMI calculated accordingly. The BMI z-scores (BMI-Z) were computed according to the World Health Organization Growth Standard (2006). Feeding patterns were classified as exclusive breast-feeding (EBF), mixed feeding (MF), and formula feeding (FF). General linear models (GLM) were employed to estimate main and interaction effects of EBF and MPWS on children's BMI-Z. Results No main effect of MPWS was found on child BMI-Z at ages one and two, nor the feeding patterns. An interaction between MPWS and feeding patterns was detected (p<0.05). For children who were formula fed during the first month, those who were born to overweight/obesity (OW/OB) mothers had a significantly greater BMI-Z at ages one and two, compared with those with underweight/normal weight (UW/NW) mothers. FF children had greater BMI-Z at ages one and two compared with their EBF and MF counterparts, when they were born to OW/OB mothers. Conclusions Maternal pre-pregnancy weight control and early initiation of EBF for children are essential for healthy development in children's BMI, hence the prevention of early life obesity.	[Mei, Hong; Guo, Bingbing; Zhang, Jianduan] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Yin, Baomin] Maternal & Child Hlth Hosp Zhuhai City, Zhuhai, Guangdong, Peoples R China; [Liang, Xiong] Peoples Hosp Zhuhai City, Zhuhai, Guangdong, Peoples R China; [Adair, Linda] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Thompson, Amanda] Univ N Carolina, Dept Anthropol, Chapel Hill, NC USA	Huazhong University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, JD (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	jd_zh@hust.edu.cn			National Natural Science Foundation of China (NSFC) [30800917, 81373017]; Special Fund for Basic Scientific Research of Central Colleges [2013T009]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	This work was supported by 1: National Natural Science Foundation of China (NSFC) (Contract grant number: 30800917); 2: The Special Fund for Basic Scientific Research of Central Colleges (Contract grant number: 2013T009); 3: National Natural Science Foundation of China (NSFC) (Contract grant number: 81373017).	Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; [Anonymous], 1986, PEDIATRICS, V78, P521; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Baker JL, 2008, AM J CLIN NUTR, V88, P1543, DOI 10.3945/ajcn.2008.26379; Bolton-Smith C, 2000, J EPIDEMIOL COMMUN H, V54, P143, DOI 10.1136/jech.54.2.143; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Cai L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098744; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chomtho S, 2008, AM J CLIN NUTR, V87, P1776, DOI 10.1093/ajcn/87.6.1776; Chu LS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/293821; Council S, 2009, NAT PROGR ACT CHILD; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DEWEY KG, 1992, PEDIATRICS, V89, P1035; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Gillman MW, 2010, NESTLE NUTR WORKS SE, V65, P13, DOI 10.1159/000281141; Gunther ALB, 2007, AM J CLIN NUTR, V86, P1765, DOI 10.1093/ajcn/86.6.1765; Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222; Hawkins SS, 2009, J EPIDEMIOL COMMUN H, V63, P147, DOI 10.1136/jech.2008.077917; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; HITCHCOCK NE, 1985, ACTA PAEDIATR SCAND, V74, P240, DOI 10.1111/j.1651-2227.1985.tb10957.x; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Jones-Smith JC, 2012, INT J OBESITY, V36, P866, DOI 10.1038/ijo.2011.134; Kabir Z, 2005, INT J EPIDEMIOL, V34, P481, DOI 10.1093/ije/dyi017; Kamudoni P, 2015, EUR J CLIN NUTR, V69, P96, DOI 10.1038/ejcn.2014.148; Kitsantas P, 2015, J MATERN-FETAL NEO M, P1; Krause KM, 2011, MATERN CHILD HLTH J, V15, P367, DOI 10.1007/s10995-010-0667-7; Kuchenbecker J, 2015, PAEDIATR INT CHILD H, V35, P14, DOI 10.1179/2046905514Y.0000000134; Lawlor DA, 2006, INT J EPIDEMIOL, V35, P3, DOI 10.1093/ije/dyi309; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Li CY, 2005, OBES RES, V13, P362, DOI 10.1038/oby.2005.48; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Makela J, 2014, EUR J CLIN NUTR, V68, P43, DOI 10.1038/ejcn.2013.229; Martin FPJ, 2014, PEDIATR RES, V75, P535, DOI 10.1038/pr.2013.250; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; PERSSON LA, 1985, ANN HUM BIOL, V12, P41, DOI 10.1080/03014468500007551; Poston WSC, 2014, OCCUP MED-OXFORD, V64, P246, DOI 10.1093/occmed/kqu040; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; SALMENPERA L, 1985, PEDIATR RES, V19, P307, DOI 10.1203/00006450-198503000-00011; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; UNICEF, 2013, STAT WORLDS CHILDR 2; Wada K, 2005, INT J OBESITY, V29, P1093, DOI 10.1038/sj.ijo.0803012; WHO, 2011, WHO ANTHRO VERSION 3; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542	54	6	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144357	10.1371/journal.pone.0144357	http://dx.doi.org/10.1371/journal.pone.0144357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641272	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700103
J	Free, CL; Baxter, GS; Dickman, CR; Lisle, A; Leung, LKP				Free, C. L.; Baxter, G. S.; Dickman, C. R.; Lisle, A.; Leung, L. K. -P.			Diversity and Community Composition of Vertebrates in Desert River Habitats	PLOS ONE			English	Article							POPULATION-DYNAMICS; SMALL MAMMALS; SPATIAL ECOLOGY; ARID AUSTRALIA; AGAMID LIZARDS; RAINFALL; MOVEMENTS; SELECTION; ASSEMBLAGES; IRRUPTIONS	Animal species are seldom distributed evenly at either local or larger spatial scales, and instead tend to aggregate in sites that meet their resource requirements and maximise fitness. This tendency is likely to be especially marked in arid regions where species could be expected to concentrate at resource-rich oases. In this study, we first test the hypothesis that productive riparian sites in arid Australia support higher vertebrate diversity than other desert habitats, and then elucidate the habitats selected by different species. We addressed the first aim by examining the diversity and composition of vertebrate assemblages inhabiting the Field River and adjacent sand dunes in the Simpson Desert, western Queensland, over a period of two and a half years. The second aim was addressed by examining species composition in riparian and sand dune habitats in dry and wet years. Vertebrate species richness was estimated to be highest (54 species) in the riverine habitats and lowest on the surrounding dune habitats (45 species). The riverine habitats had different species pools compared to the dune habitats. Several species, including the agamid Gowidon longirostris and tree frog Litoria rubella, inhabited the riverine habitats exclusively, while others such as the skinks Ctenotus ariadnae and C. dux were captured only in the dune habitats. The results suggest that, on a local scale, diversity is higher along riparian corridors and that riparian woodland is important for tree-dependent species. Further, the distribution of some species, such as Mus musculus, may be governed by environmental variables (e.g. soil moisture) associated with riparian corridors that are not available in the surrounding desert environment. We conclude that inland river systems may be often of high conservation value, and that management should be initiated where possible to alleviate threats to their continued functioning.	[Free, C. L.; Leung, L. K. -P.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Baxter, G. S.; Lisle, A.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia; [Dickman, C. R.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia	University of Queensland; University of Queensland; University of Sydney	Free, CL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia.	carissa.free@uqconnect.edu.au	Baxter, Greg/AAQ-5364-2021; Dickman, Christopher/Q-4662-2019	Baxter, Greg/0000-0003-1816-4970; Dickman, Christopher/0000-0002-1067-3730; Leung, Luke/0000-0002-8829-4925				[Anonymous], 2007, PRIMER E PRIMER 6 6; BOMFORD M, 1987, AUST WILDLIFE RES, V14, P183; Breed WG, 1995, MAMMALS AUSTR; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; Cogger H., 2014, REPTILES AMPHIBIANS; Cogger H, 2000, REPTILES AMPHIBIANS; Cowell R. K., 2005, ESTIMATES STAT ESTIM; Daly BG, 2008, ECOLOGY, V89, P65, DOI 10.1890/06-1991.1; Daly BG, 2007, AUSTRAL ECOL, V32, P825, DOI 10.1111/j.1442-9993.2007.01768.x; DAVIES SJJF, 1984, J ARID ENVIRON, V7, P183; Denny MJS, 1982, CARNIVOROUS MARSUPIA, V1, P131; Department of Environment and Water Resources, 2007, AUSTR BIOG REG COMM; Dickman CR, 2010, J MAMMAL, V91, P798, DOI 10.1644/09-MAMM-S-205.1; Dickman CR, 1999, WILDLIFE RES, V26, P389, DOI 10.1071/WR97057; Dickman CR, 1995, J ARID ENVIRON, V31, P441, DOI 10.1016/S0140-1963(05)80127-2; DICKMAN CR, 1993, BIOL CONSERV, V65, P219, DOI 10.1016/0006-3207(93)90056-7; Dickman CR, 2001, WILDLIFE RES, V28, P493, DOI 10.1071/WR00023; Duguid A, 2002, WETLANDS ARID NO TER; Fennessy J, 2009, AFR J ECOL, V47, P318, DOI 10.1111/j.1365-2028.2008.00963.x; Free CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072690; FRIEND GR, 1989, AUST WILDLIFE RES, V16, P1; Graf W. L., 1988, FLUVIAL PROCESSES DR; Greenville AC, 2013, AUSTRAL ECOL, V38, P754, DOI 10.1111/aec.12033; Greenville AC, 2009, BIOL J LINN SOC, V97, P531, DOI 10.1111/j.1095-8312.2009.01241.x; Jones H. A., 2007, P132; KAVANAGH RP, 1995, WILDLIFE RES, V22, P359, DOI 10.1071/WR9950359; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Letnic M, 2010, BIOL REV, V85, P501, DOI 10.1111/j.1469-185X.2009.00113.x; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MASTERS P, 1993, WILDLIFE RES, V20, P803, DOI 10.1071/WR9930803; MCGARIGAL K, 1992, J WILDLIFE MANAGE, V56, P10, DOI 10.2307/3808786; McIntyre RES, 2009, J ARID ENVIRON, V73, P48, DOI 10.1016/j.jaridenv.2008.09.011; Milstead WB, 2007, J MAMMAL, V88, P1532, DOI 10.1644/16-MAMM-A-407R.1; Morton S.R., 1990, Proceedings of the Ecological Society of Australia, V16, P201; MORTON SR, 1988, AUST WILDLIFE RES, V15, P571; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; MURRAY BR, 1994, WILDLIFE RES, V21, P647, DOI 10.1071/WR9940647; MURRAY BR, 1994, OECOLOGIA, V99, P216, DOI 10.1007/BF00627733; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; NSW Department of Primary Industries, 2005, AN ETH INFOLINK; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Pastro LA, 2013, OECOLOGIA, V173, P603, DOI 10.1007/s00442-013-2642-7; Pavey CR, 2014, J MAMMAL, V95, P615, DOI 10.1644/13-MAMM-A-183; Pianka E., 1986, ECOLOGY NATURAL HIST; PIANKA ER, 1969, ECOLOGY, V50, P1012, DOI 10.2307/1936893; PREDAVEC M, 1994, WILDLIFE RES, V21, P569, DOI 10.1071/WR9940569; Prinsloo GL, 1990, TRANSVAAL MUSEUM MON, P67; Purdie R., 1984, LAND SYSTEMS SIMPSON; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Shephard M., 1992, SIMPSON DESERT NATUR; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; Thompson GG, 2003, AUSTRAL ECOL, V28, P355, DOI 10.1046/j.1442-9993.2003.01294.x; Tongeren OFR, 1995, DATA ANAL COMMUNITY; Unmack PJ, 2001, J ARID ENVIRON, V49, P653, DOI 10.1006/jare.2001.0813; Williams Amy J., 2004, Australian Mammalogy, V26, P205; Woinarski JCZ, 2000, J BIOGEOGR, V27, P843, DOI 10.1046/j.1365-2699.2000.00439.x	60	7	7	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144258	10.1371/journal.pone.0144258	http://dx.doi.org/10.1371/journal.pone.0144258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637127	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800064
J	Labadorf, A; Hoss, AG; Lagomarsino, V; Latourelle, JC; Hadzi, TC; Bregu, J; MacDonald, ME; Gusella, JF; Chen, JF; Akbarian, S; Weng, ZP; Myers, RH				Labadorf, Adam; Hoss, Andrew G.; Lagomarsino, Valentina; Latourelle, Jeanne C.; Hadzi, Tiffany C.; Bregu, Joli; MacDonald, Marcy E.; Gusella, James F.; Chen, Jiang-Fan; Akbarian, Schahram; Weng, Zhiping; Myers, Richard H.			RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; ACTIVATION; CALCIUM; PROTEIN; ONSET; PROGRESSION; MUTATION; PATHWAY; ACCUMULATION	Huntington's Disease (HD) is a devastating neurodegenerative disorder that is caused by an expanded CAG trinucleotide repeat in the Huntingtin (HTT) gene. Transcriptional dysregulation in the human HD brain has been documented but is incompletely understood. Here we present a genome-wide analysis of mRNA expression in human prefrontal cortex from 20 HD and 49 neuropathologically normal controls using next generation high-throughput sequencing. Surprisingly, 19% (5,480) of the 28,087 confidently detected genes are differentially expressed (FDR<0.05) and are predominantly up-regulated. A novel hypothesis-free geneset enrichment method that dissects large gene lists into functionally and transcriptionally related groups discovers that the differentially expressed genes are enriched for immune response, neuroinflammation, and developmental genes. Markers for all major brain cell types are observed, suggesting that HD invokes a systemic response in the brain area studied. Unexpectedly, the most strongly differentially expressed genes are a homeotic gene set (represented by Hox and other homeobox genes), that are almost exclusively expressed in HD, a profile not widely implicated in HD pathogenesis. The significance of transcriptional changes of developmental processes in the HD brain is poorly understood and warrants further investigation. The role of inflammation and the significance of non-neuronal involvement in HD pathogenesis suggest anti-inflammatory therapeutics may offer important opportunities in treating HD.	[Labadorf, Adam; Hoss, Andrew G.; Lagomarsino, Valentina; Latourelle, Jeanne C.; Hadzi, Tiffany C.; Bregu, Joli; Chen, Jiang-Fan; Myers, Richard H.] Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA; [Labadorf, Adam; Myers, Richard H.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [MacDonald, Marcy E.; Gusella, James F.] Harvard Univ, Ctr Human Genet Res, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Weng, Zhiping] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA; [Myers, Richard H.] Boston Univ, Genome Sci Inst, Sch Med, Boston, MA 02215 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Myers, RH (corresponding author), Boston Univ, Dept Neurol, Sch Med, Boston, MA 02215 USA.	rmyers@bu.edu		Labadorf, Adam/0000-0002-0753-8992; Chen, Jiang-Fan/0000-0002-0446-3956	Jerry McDonald HD Research Fund; Public Health Service, National Institutes of Health grants; National Institute of Neurological disorders and stroke [R01-NS073947, R01-NS32765, PHY-1444389]; NSF-EArly-concept Grants for Exploratory Research (EAGER) [PHY-1444389]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947, R01NS032765] Funding Source: NIH RePORTER; Division Of Physics [1444389] Funding Source: National Science Foundation	Jerry McDonald HD Research Fund; Public Health Service, National Institutes of Health grants; National Institute of Neurological disorders and stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF-EArly-concept Grants for Exploratory Research (EAGER); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Jerry McDonald HD Research Fund (RHM) and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke, R01-NS073947 (RHM) and R01-NS32765 (MEM) and PHY-1444389 NSF-EArly-concept Grants for Exploratory Research (EAGER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Ms. Jayalakshmi Mysore for her help with the HD postmortem brains and the HTT CAG genotyping. This work was supported by the Jerry McDonald HD Research Fund (RHM) and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke, R01-NS073947 (RHM) and R01NS32765 (MEM) and PHY-1444389 NSF-EArly-concept Grants for Exploratory Research (EAGER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2014, TOPGO ENRICHMENT ANA; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blumkin L, 2014, NEUROGENETICS, V15, P107, DOI 10.1007/s10048-014-0392-2; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; D'Aversa TG, 2013, NEUROPATH APPL NEURO, V39, P270, DOI 10.1111/j.1365-2990.2012.01279.x; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Djousse L, 2004, NEUROGENETICS, V5, P109, DOI 10.1007/s10048-004-0175-2; Ellrichmann G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/541259; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Giacomello M, 2011, BIOFACTORS, V37, P206, DOI 10.1002/biof.162; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hayashida N, 2010, EMBO J, V29, P3459, DOI 10.1038/emboj.2010.225; Hobbs NZ, 2010, AM J NEURORADIOL, V31, P1036, DOI 10.3174/ajnr.A2018; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huntington G., 1872, MED SURG REP, V26, P320; Jackson Brian C., 2010, Human Genomics, V4, P345; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Myers RH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P301; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Ponomarev EA, 2006, J IMMUNOL, V176, P1402, DOI 10.4049/jimmunol.176.3.1402; R Core Team, 2018, R LANG ENV STAT COMP; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Selemon LD, 2004, J COMP NEUROL, V468, P190, DOI 10.1002/cne.10938; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; SOTREL A, 1993, NEUROLOGY, V43, P2088, DOI 10.1212/WNL.43.10.2088; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Squitieri F, 2009, CNS NEUROSCI THER, V15, P1, DOI 10.1111/j.1755-5949.2008.00068.x; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; van Roon-Mom WMC, 2002, MOL BRAIN RES, V109, P1, DOI 10.1016/S0169-328X(02)00450-3; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91	67	97	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143563	10.1371/journal.pone.0143563	http://dx.doi.org/10.1371/journal.pone.0143563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636579	Green Published, gold			2022-12-26	WOS:000366143800018
J	Carter, JM; Gibbs, M; Breuker, CJ				Carter, Jean-Michel; Gibbs, Melanie; Breuker, Casper J.			Divergent RNA Localisation Patterns of Maternal Genes Regulating Embryonic Patterning in the Butterfly Pararge aegeria	PLOS ONE			English	Article							GERM-CELL SPECIFICATION; MESSENGER-RNA; DROSOPHILA EMBRYO; BEETLE TRIBOLIUM; BICOID PROTEIN; AXIS FORMATION; WASP NASONIA; BOMBYX-MORI; POSTERIOR; SEGMENTATION	The maternal effect genes responsible for patterning the embryo along the antero-posterior (AP) axis are broadly conserved in insects. The precise function of these maternal effect genes is the result of the localisation of their mRNA in the oocyte. The main developmental mechanisms involved have been elucidated in Drosophila melanogaster, but recent studies have shown that other insect orders often diverge in RNA localisation patterns. A recent study has shown that in the butterfly Pararge aegeria the distinction between blastodermal embryonic (i.e. germ band) and extra-embryonic tissue (i.e. serosa) is already specified in the oocyte during oogenesis in the ovariole, long before blastoderm cellularisation. To examine the extent by which a female butterfly specifies and patterns the AP axis within the region fated to be the germ band, and whether she specifies a germ plasm, we performed in situ hybridisation experiments on oocytes in P. aegeria ovarioles and on early embryos. RNA localisation of the following key maternal effect genes were investigated: caudal (cad), orthodenticle (otd), hunchback (hb) and four nanos (nos) paralogs, as well as TDRD7 a gene containing a key functional domain (OST-HTH/LOTUS) shared with oskar. TDRD7 was mainly confined to the follicle cells, whilst hb was exclusively zygotically transcribed. RNA of some of the nos paralogs, otd and cad revealed complex localisation patterns within the cortical region prefiguring the germ band (i.e. germ cortex). Rather interestingly, otd was localised within and outside the anterior of the germ cortex. Transcripts of nos-O formed a distinct granular ring in the middle of the germ cortex possibly prefiguring the region where germline stem cells form. These butterfly RNA localisation patterns are highly divergent with respect to other insects, highlighting the diverse ways in which different insect orders maternally regulate early embryogenesis of their offspring.	[Carter, Jean-Michel; Breuker, Casper J.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Oxford OX3 0BP, England; [Gibbs, Melanie] NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Oxford Brookes University; UK Centre for Ecology & Hydrology (UKCEH)	Breuker, CJ (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Evolutionary Dev Biol Res Grp, Gipsy Lane, Oxford OX3 0BP, England.	cbreuker@brookes.ac.uk	Gibbs, Melanie/E-6771-2012; Breuker, Casper/P-8270-2019	Gibbs, Melanie/0000-0002-4091-9789; Breuker, Casper/0000-0001-7909-1950; Carter, Jean-Michel/0000-0001-7932-2368	Oxford Brookes University [Jnl 105595, 103324]; Natural Environment Research Council Studentship; Nigel Groome Studentship (Oxford Brookes University); Oxford Brookes University; NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Oxford Brookes University; Natural Environment Research Council Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Nigel Groome Studentship (Oxford Brookes University); Oxford Brookes University; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by Oxford Brookes University (https://www.brookes.ac.uk/homepage/, Jnl 105595 and 103324 to CJB), a Natural Environment Research Council Studentship (http://www.nerc.ac.uk to JMC), and a Nigel Groome Studentship (Oxford Brookes University to JMC). Oxford Brookes University kindly made funds available for Open Access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2014, DEV GENES EVOL, V224, P65, DOI 10.1007/s00427-013-0463-7; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Callebaut I, 2010, BIOINFORMATICS, V26, P1140, DOI 10.1093/bioinformatics/btq122; Carter JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-283; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Ewen-Campen B, 2013, BIOL OPEN, V2, P556, DOI 10.1242/bio.20134390; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Ewen-Campen B, 2012, CURR BIOL, V22, P2278, DOI 10.1016/j.cub.2012.10.019; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Ferguson L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004698; FOE VE, 1983, J CELL SCI, V61, P31; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Heasman J, 2001, DEV BIOL, V240, P377, DOI 10.1006/dbio.2001.0495; JARNOT B, 1988, Molecular Reproduction and Development, V1, P35, DOI 10.1002/mrd.1080010107; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; KASTERN WH, 1990, DEVELOPMENT, V108, P497; Kimelman D, 2012, WIRES DEV BIOL, V1, P253, DOI 10.1002/wdev.25; King R. C., 1970, OVARIAN DEV DROSOPHI; Klomp J, 2015, SCIENCE, V348, P1040, DOI 10.1126/science.aaa7105; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Kobayashi Y., 2003, LEPIDOPTERA MOTHS BU, V2, P495; Kotkamp K, 2010, DEVELOPMENT, V137, P1853, DOI 10.1242/dev.047043; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2012, WIRES DEV BIOL, V1, P16, DOI 10.1002/wdev.3; Lynch JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002029; McGregor AP, 2006, BIOESSAYS, V28, P683, DOI 10.1002/bies.20429; MYOHARA M, 1994, DEVELOPMENT, V120, P2869; Nagy LM, 2006, MOL MODEL SYSTEMS LE, P139; Nakao H, 2006, DEV GENES EVOL, V216, P94, DOI 10.1007/s00427-005-0033-8; Nakao H, 2008, EVOL DEV, V10, P546, DOI 10.1111/j.1525-142X.2008.00270.x; Nakao H, 2012, DEV BIOL, V371, P293, DOI 10.1016/j.ydbio.2012.08.029; Nakao H, 2010, J EXP ZOOL PART B, V314B, P224, DOI 10.1002/jez.b.21328; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; Patel NH, 2001, DEVELOPMENT, V128, P3459; Peel AD, 2010, DEV DYNAM, V239, P2875, DOI 10.1002/dvdy.22423; Pflanz R, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140161; POKRYWKA NJ, 1994, DEV BIOL, V166, P210, DOI 10.1006/dbio.1994.1308; Quah S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142243; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Schoppmeier M, 2009, CURR BIOL, V19, P1811, DOI 10.1016/j.cub.2009.09.026; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Solana J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-2; Telfer WH, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5001; Wilson MJ, 2010, DEV BIOL, V339, P200, DOI 10.1016/j.ydbio.2009.12.015; XU X, 1994, DEVELOPMENT, V120, P277	56	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144471	10.1371/journal.pone.0144471	http://dx.doi.org/10.1371/journal.pone.0144471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633019	Green Accepted, gold, Green Published			2022-12-26	WOS:000366040000085
J	Gueuvoghlanian-Silva, BY; Cordeiro, FB; Lobo, TF; Cataldi, TR; Lo Turco, EG; Bertolla, RP; Mattar, R; Torloni, MR; Daher, S				Gueuvoghlanian-Silva, Barbara Yasmin; Cordeiro, Fernanda Bertuccez; Lobo, Thalita Frutuoso; Cataldi, Thais Regiani; Lo Turco, Edson Guimaraes; Bertolla, Ricardo Pimenta; Mattar, Rosiane; Torloni, Maria Regina; Daher, Silvia			Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-RESISTANCE; LOW-CARBOHYDRATE; BIOLOGICAL SAMPLES; RANDOMIZED-TRIAL; FASTING LIPIDS; PREGNANCY; METABOLISM; NEED; ASSOCIATION; CHOLESTEROL	The blood serum lipid profile of women with Gestational Diabetes Mellitus (GDM) is still under study. There are no data on the serum lipid profile of GDM patients with more severe (insulin treated) compared to milder forms (diet treated) GDM. The aim of our study was to analyze the blood serum lipid profile of patients with milder versus more severe forms of GDM and to compare these findings with those of healthy pregnant women. This cross-sectional analytical study included 30 insulin-treated GDM, 30 diet-only GDM and 30 healthy pregnant women. Serum lipid was extracted from the 90 participants and their lipid profiles were analyzed by lipid fingerprinting using liquid-chromatography-mass spectrometry. A total of 143 parent ions were differentially represented in each of the three groups, belonging to the following classes: Glycerophospholipids, Sterol Lipids, Sphingolipids, Prenol Lipids, Fatty Acyls and Glycerolipids. There were significant differences in the lipid profiles of healthy pregnant women compared to GDM patients and also between milder versus more severe forms of GDM. There are marked differences in lipid fingerprinting between healthy pregnant women compared to those with GDM in the third trimester. Moreover, the lipid profile of women with more severe forms of GDM differs considerably from that of women with milder forms of GDM. These findings may be useful to help clarify the pathogenesis of milder and more severe forms of GDM.	[Gueuvoghlanian-Silva, Barbara Yasmin; Lobo, Thalita Frutuoso; Mattar, Rosiane; Torloni, Maria Regina; Daher, Silvia] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil; [Cordeiro, Fernanda Bertuccez; Lo Turco, Edson Guimaraes; Bertolla, Ricardo Pimenta] Univ Fed Sao Paulo, Div Urol, Human Reprod Sect, Dept Surg, Sao Paulo, SP, Brazil; [Cataldi, Thais Regiani] Univ Sao Paulo, Dept Genet ESALQ USP, Piracicaba, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Daher, S (corresponding author), Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil.	daher@unifesp.br	Bertolla, Ricardo Pimenta/D-2316-2009; Turco, Edson Lo/B-8719-2009; DAHER, SILVIA/D-2180-2012; Cataldi, Thais/H-5430-2018	Bertolla, Ricardo Pimenta/0000-0001-6892-9244; Turco, Edson Lo/0000-0002-3509-847X; DAHER, SILVIA/0000-0001-5312-7804; Cataldi, Thais/0000-0002-9827-2017; Cordeiro, Fernanda/0000-0002-5690-9665	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/14554-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SD received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 11/14554-2). BYG-S received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (doctoral scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Bakiner Okan, 2013, J Clin Med Res, V5, P381, DOI 10.4021/jocmr1515w; Bayraktar F, 2012, INTERNAL MED, V51, P839, DOI 10.2169/internalmedicine.51.5846; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bhatti HN, 2012, STEROIDS, V77, P1267, DOI 10.1016/j.steroids.2012.07.018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Cohn JS, 2008, CURR OPIN LIPIDOL, V19, P257, DOI 10.1097/MOL.0b013e3282ffaf96; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; De Oliveira L, 2012, CLIN BIOCHEM, V45, P852, DOI 10.1016/j.clinbiochem.2012.04.012; Durn JH, 2010, PROSTAG LEUKOTR ESS, V82, P21, DOI 10.1016/j.plefa.2009.11.002; Giuffrida FMA, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-156; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Ikeda K, 2009, J CHROMATOGR B, V877, P2639, DOI 10.1016/j.jchromb.2009.03.047; Karkkainen H, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-9; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; Kullenberg D, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-3; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lau ANC, 2012, CAN MED ASSOC J, V184, P767, DOI 10.1503/cmaj.110779; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Markovic TP, 2016, DIABETES CARE, V39, P31, DOI 10.2337/dc15-0572; Mendez-Figueroa H, 2014, AM J PERINAT, V31, P105, DOI 10.1055/s-0033-1338174; Merzouk H, 2000, J LAB CLIN MED, V136, P441, DOI 10.1067/mlc.2000.111004; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Murakami M, 2011, EXP ANIM TOKYO, V60, P7, DOI 10.1538/expanim.60.7; Murphy RC, 2011, BBA-MOL CELL BIOL L, V1811, P776, DOI 10.1016/j.bbalip.2011.06.019; Pertot T, 2011, DIABETES CARE, V34, P2214, DOI 10.2337/dc11-0499; Ponssen HH, 2000, CLIN THER, V22, P709, DOI 10.1016/S0149-2918(00)90005-5; Riemens SC, 2001, SCAND J CLIN LAB INV, V61, P1; Sahebkar A, 2013, BBA-MOL CELL BIOL L, V1831, P887, DOI 10.1016/j.bbalip.2013.01.013; Saisho Y, 2010, ENDOCR J, V57, P973, DOI 10.1507/endocrj.K10E-231; Schroeder N, 2015, J ACAD NUTR DIET, V115, P1083, DOI 10.1016/j.jand.2015.03.023; Sharman MJ, 2004, J NUTR, V134, P880, DOI 10.1093/jn/134.4.880; Sokup A, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-21; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Vinter CA, 2014, DIABETIC MED, V31, P1323, DOI 10.1111/dme.12548; Volek JS, 2004, J AM COLL NUTR, V23, P177, DOI 10.1080/07315724.2004.10719359; Zhao C, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S12	47	6	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144027	10.1371/journal.pone.0144027	http://dx.doi.org/10.1371/journal.pone.0144027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633694	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000046
J	Mazzacavallo, MG; Kulmatiski, A				Mazzacavallo, Michael G.; Kulmatiski, Andrew			Modelling Water Uptake Provides a New Perspective on Grass and Tree Coexistence	PLOS ONE			English	Article							SOIL-WATER; SEASONAL PATTERNS; SAVANNA; CLIMATE; DEPTH; PRODUCTIVITY; VEGETATION; DIVERSITY; DOMINANCE; RESOURCE	Root biomass distributions have long been used to infer patterns of resource uptake. These patterns are used to understand plant growth, plant coexistence and water budgets. Root biomass, however, may be a poor indicator of resource uptake because large roots typically do not absorb water, fine roots do not absorb water from dry soils and roots of different species can be difficult to differentiate. In a sub-tropical savanna, Kruger Park, South Africa, we used a hydrologic tracer experiment to describe the abundance of active grass and tree roots across the soil profile. We then used this tracer data to parameterize a water movement model (Hydrus 1D). The model accounted for water availability and estimated grass and tree water uptake by depth over a growing season. Most root biomass was found in shallow soils (0-20 cm) and tracer data revealed that, within these shallow depths, half of active grass roots were in the top 12 cm while half of active tree roots were in the top 21 cm. However, because shallow soils provided roots with less water than deep soils (20-90 cm), the water movement model indicated that grass and tree water uptake was twice as deep as would be predicted from root biomass or tracer data alone: half of grass and tree water uptake occurred in the top 23 and 43 cm, respectively. Niche partitioning was also greater when estimated from water uptake rather than tracer uptake. Contrary to long-standing assumptions, shallow grass root distributions absorbed 32% less water than slightly deeper tree root distributions when grasses and trees were assumed to have equal water demands. Quantifying water uptake revealed deeper soil water uptake, greater niche partitioning and greater benefits of deep roots than would be estimated from root biomass or tracer uptake data alone.	[Mazzacavallo, Michael G.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Kulmatiski, Andrew] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Kulmatiski, Andrew] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	University of Alaska System; University of Alaska Anchorage; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu			Andrew W. Mellon Foundation; Alaska EPSCoR NSF award [EPS-0701898]; state of Alaska; Utah Agricultural Experiment Station; Utah State University	Andrew W. Mellon Foundation; Alaska EPSCoR NSF award; state of Alaska; Utah Agricultural Experiment Station; Utah State University	The Andrew W. Mellon Foundation, Alaska EPSCoR NSF award #EPS-0701898 and the state of Alaska funded the research. This research was also supported by the Utah Agricultural Experiment Station and Utah State University and approved as journal paper number 8801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1995, ZIMBABWE B FORESTRY; Asbjornsen H, 2008, PLANT SOIL, V308, P69, DOI 10.1007/s11104-008-9607-3; Bhattachan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033996; BISHOP K, 1995, CAN J FOREST RES, V25, P286, DOI 10.1139/x95-033; Bradford JB, 2006, ECOSYSTEMS, V9, P934, DOI 10.1007/s10021-004-0164-1; Buitenwerf R, 2014, KOEDOE, V56; Chen XY, 2004, J TROP ECOL, V20, P221, DOI 10.1017/S0266467403001135; DAWSON TE, 1993, GEOCHIM COSMOCHIM AC, V57, P3487, DOI 10.1016/0016-7037(93)90554-A; Donzelli D, 2013, J THEOR BIOL, V332, P181, DOI 10.1016/j.jtbi.2013.04.003; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Entsminger G.L., 2014, ECOSIM PROFESSIONAL; February EC, 2010, S AFR J BOT, V76, P517, DOI 10.1016/j.sajb.2010.04.001; Feddes RA, 2001, B AM METEOROL SOC, V82, P2797, DOI 10.1175/1520-0477(2001)082<2797:MRWUIH>2.3.CO;2; Flint AL, 2002, SOIL SCI SOC AM J, V66, P1439, DOI 10.2136/sssaj2002.1439; FRASER S W, 1987, Koedoe, P19; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Green SR, 1997, AGR FOREST METEOROL, V83, P1, DOI 10.1016/S0168-1923(96)02362-3; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Holdo RM, 2014, J ECOL, V102, P1171, DOI 10.1111/1365-2745.12290; Holdo RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069625; Jackson PC, 1999, TREE PHYSIOL, V19, P717; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Kulmatiski A, 2004, SOIL BIOL BIOCHEM, V36, P383, DOI 10.1016/j.soilbio.2003.10.004; Kulmatiski A, 2013, OECOLOGIA; Kulmatiski A, 2013, NATURE CLIMATE CHANG; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; LANDSBERG JJ, 1973, AGR METEOROL, V12, P169, DOI 10.1016/0002-1571(73)90017-4; LEROUX X, 1995, OECOLOGIA, V104, P147, DOI 10.1007/BF00328579; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Morillas L, 2013, WATER RESOUR RES, V49, P6572, DOI 10.1002/wrcr.20468; Mueller KE, 2013, ECOLOGY, V94, P787, DOI 10.1890/12-1399.1; Newman BD, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004141; Ogle K, 2004, ECOLOGY, V85, P1967, DOI 10.1890/03-0346; Peek MS, 2005, NEW PHYTOL, V165, P171, DOI 10.1111/j.1469-8137.2004.01186.x; Pereira AR, 2006, AGR WATER MANAGE, V83, P153, DOI 10.1016/j.agwat.2005.11.004; Peters DPC, 2002, ECOL MODEL, V152, P5, DOI 10.1016/S0304-3800(01)00460-4; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Ramoelo A, 2014, REMOTE SENS-BASEL, V6, P7406, DOI 10.3390/rs6087406; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; SAXTON KE, 1986, SOIL SCI SOC AM J, V50, P1031, DOI 10.2136/sssaj1986.03615995005000040039x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Scott RL, 2014, GLOBAL CHANGE BIOL, V20, P2198, DOI 10.1111/gcb.12511; Sillmann J, 2013, J GEOPHYS RES-ATMOS, V118, P2473, DOI 10.1002/jgrd.50188; Simunek J., 2005, U CALIFORNIA RIVERSI, V3, P1, DOI DOI 10.1016/J.CEJ.2013.12.061; Smith NG, 2014, REV GEOPHYS, V52, P412, DOI 10.1002/2014RG000458; Smith PP, 1998, BOTHALIA, V28, P197, DOI 10.4102/abc.v28i2.641; Smithwick EAH, 2014, ECOL MODEL, V291, P193, DOI 10.1016/j.ecolmodel.2014.07.023; THORPE MR, 1980, PLANT CELL ENVIRON, V3, P23, DOI 10.1111/1365-3040.ep11580508; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; Verweij RT, 2009, THESIS; Walter H., 1971, ECOLOGY TROPICAL SUB; Ward D, 2013, OECOLOGIA, V172, P617, DOI 10.1007/s00442-012-2538-y; Warren CP, 2015, J ARID ENVIRON, V121, P67, DOI 10.1016/j.jaridenv.2015.06.001; Wigley BJ, 2013, ACTA OECOL, V51, P17, DOI 10.1016/j.actao.2013.05.007; Wilske B, 2010, J ARID ENVIRON, V74, P1461, DOI 10.1016/j.jaridenv.2010.05.013; WINEMILLER KO, 1990, ECOL MONOGR, V60, P27, DOI 10.2307/1943025	62	32	35	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144300	10.1371/journal.pone.0144300	http://dx.doi.org/10.1371/journal.pone.0144300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633177	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000079
J	Choi, ER; Han, BK; Ko, ES; Ko, EY; Choi, JS; Cho, EY; Nam, SJ				Choi, E-Ryung; Han, Boo-Kyung; Ko, Eun Sook; Ko, Eun Young; Choi, Ji Soo; Cho, Eun Yoon; Nam, Seok Jin			Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device	PLOS ONE			English	Article							CORE NEEDLE-BIOPSY; CARCINOMA IN-SITU; ATYPICAL DUCTAL HYPERPLASIA; HAND-HELD DEVICE; HISTOLOGIC UNDERESTIMATION; LESIONS; ACCURACY; MASSES; RATES	Objective To determine the imaging characteristic of frequent target lesions of wireless ultrasound (US)-guided, vacuum-assisted breast biopsy (Wi-UVAB) and to evaluate diagnostic yield, accuracy and complication of the device in indeterminate breast lesions. Materials and Methods From March 2013 to October 2014, 114 women (age range, 29-76 years; mean age, 50.0 years) underwent Wi-UVAB using a 13-gauge needle (Mammotome Elite (R); Devicor Medical Products, Cincinnati, OH, USA). In 103 lesions of 96 women with surgical (n = 81) or follow- up (n = 22) data, complications, biopsy procedure, imaging findings of biopsy targets and histologic results were reviewed. Results Mean number of biopsy cores was 10 (range 4-25). Nine patients developed moderate bleeding. All lesions were suspicious on US, and included non-mass lesions (67.0%) and mass lesions (33.0%). Visible calcifications on US were evident in 57.3% of the target lesions. Most of the lesions (93.2%) were nonpalpable. Sixty-six (64.1%) were malignant [ductal carcinoma in situ (DCIS) rate, 61%] and 12 were high-risk lesions (11.7%). Histologic underestimation was identified in 11 of 40 (27.5%). DCIS cases and in 3 of 9 (33.3%) high-risk lesions necessitating surgery. There was no false-negative case. Conclusion Wi-UVAB is very handy and advantageous for US-unapparent non-mass lesions to diagnose DCIS, especially for calcification cases. Histologic underestimation is unavoidable; still, Wi-UVAB is safe and accurate to diagnose a malignancy.	[Choi, E-Ryung; Han, Boo-Kyung; Ko, Eun Sook; Ko, Eun Young; Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Choi, E-Ryung; Han, Boo-Kyung; Ko, Eun Sook; Ko, Eun Young; Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Cho, Eun Yoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Gen Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Han, BK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	bkhan@skku.edu						Bagnera S, 2013, OPEN J RADIOL, V3, P174; Brem RF, 1999, AM J ROENTGENOL, V172, P1405, DOI 10.2214/ajr.172.5.10227526; Cassano E, 2007, BREAST CANCER RES TR, V102, P103, DOI 10.1007/s10549-006-9305-x; Cho N, 2005, KOREAN J RADIOL, V6, P102, DOI 10.3348/kjr.2005.6.2.102; Fine RE, 2002, AM J SURG, V184, P332, DOI 10.1016/S0002-9610(02)00951-0; Helbich TH, 1997, RADIOLOGY, V203, P684, DOI 10.1148/radiology.203.3.9169689; Helbich TH, 2002, ROFO-FORTSCHR RONTG, V174, P517; Jackman RJ, 2001, RADIOLOGY, V218, P497, DOI 10.1148/radiology.218.2.r01fe35497; Lee JW, 2008, J SURG ONCOL, V98, P15, DOI 10.1002/jso.21077; Lee SH, 2014, ULTRASONOGRAPHY, V33, P259, DOI 10.14366/usg.14020; LIBERMAN L, 1995, AM J ROENTGENOL, V164, P1111, DOI 10.2214/ajr.164.5.7717215; Lourenco AP, 2007, AM J ROENTGENOL, V189, pW275, DOI 10.2214/AJR.07.2165; Memarsadeghi M, 2003, ROFO-FORTSCHR RONTG, V175, P374, DOI 10.1055/s-2003-37822; Park HS, 2013, BREAST, V22, P869, DOI 10.1016/j.breast.2013.03.009; PARKER SH, 1993, RADIOLOGY, V187, P507, DOI 10.1148/radiology.187.2.8475299; PARKER SH, 1994, RADIOLOGY, V193, P359, DOI 10.1148/radiology.193.2.7972743; Parker SH, 2001, AM J ROENTGENOL, V177, P405, DOI 10.2214/ajr.177.2.1770405; Perez-Fuentes JA, 2001, AM J ROENTGENOL, V177, P1459, DOI 10.2214/ajr.177.6.1771459; Philpotts LE, 2000, AM J ROENTGENOL, V175, P1047, DOI 10.2214/ajr.175.4.1751047; Pijnappel RM, 2004, BRIT J CANCER, V90, P595, DOI 10.1038/sj.bjc.6601559; Rosenblatt R, 1996, RADIOLOGY, V201, P67, DOI 10.1148/radiology.201.1.8816522; Schoonjans JM, 2001, J ULTRAS MED, V20, P967; Schueller G, 2008, EUR RADIOL, V18, P1761, DOI 10.1007/s00330-008-0955-4; Schueller G, 2008, RADIOLOGY, V248, P406, DOI 10.1148/radiol.2482071994; Schulz-Wendtland R, 1998, ANTICANCER RES, V18, P2145; Smith DN, 2001, J ULTRAS MED, V20, P43; Youk JH, 2008, AM J ROENTGENOL, V190, P202, DOI 10.2214/AJR.07.2419	27	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144046	10.1371/journal.pone.0144046	http://dx.doi.org/10.1371/journal.pone.0144046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630136	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300146
J	Duan, HX; Wang, L; Zhang, L; Liu, J; Zhang, K; Wu, JH				Duan, Hongxia; Wang, Li; Zhang, Liang; Liu, Jing; Zhang, Kan; Wu, Jianhui			The Relationship between Cortisol Activity during Cognitive Task and Posttraumatic Stress Symptom Clusters	PLOS ONE			English	Article							RESEARCH DOMAIN CRITERIA; TRAIT ANXIETY INVENTORY; SALIVARY CORTISOL; PTSD SYMPTOMS; PHENOTYPIC HETEROGENEITY; PSYCHOMETRIC PROPERTIES; MOMENTARY ASSESSMENT; EARTHQUAKE VICTIMS; LATENT STRUCTURE; NEGATIVE AFFECT	Background The latest development in the dimensional structure of posttraumatic stress disorder (PTSD) is a novel 6-factor model, which builds on the newly released DSM-5. One notable gap in the literature is that little is known about how distinct symptom clusters of PTSD are related to hypothalamic-pituitary-adrenal (HPA) axis activity when people perform a relatively less stressful cognitive task. The purpose of this study was to investigate the relationship between cortisol activity when individuals perform cognitive tasks in the laboratory and a contemporary phenotypic model of posttraumatic stress symptomatology in earthquake survivors. Methods Salivary cortisol while performing cognitive tasks was collected and analyzed in 89 adult earthquake survivors. The PTSD Checklist for the DSM-5 (PCL-5) was used to assess the severity of total PTSD as well as six distinct symptom clusters. Regression analyses were conducted to examine the associations between the six distinct PTSD symptom clusters and cortisol profiles. Results The results showed that the score of the negative affect symptom cluster, but not anhedonia or other clusters, was positively associated with cortisol levels before and during the cognitive tasks. Conclusion The results showed that higher cortisol levels before and during cognitive tasks might be specifically linked to a distinct symptom cluster of PTSD-negative affect symptomatology. This suggests that a distinction should be made between negative affect and anhedonia symptom clusters, as the 6-factor model proposed.	[Duan, Hongxia; Zhang, Liang; Liu, Jing; Zhang, Kan; Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Duan, Hongxia; Liu, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Wu, JH (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	wujh@psych.ac.cn		wang, li/0000-0002-1459-3412	National Key Technology Research and Development Program of China [2013BAI08B02]; Chinese Academy of Sciences [KJZD-EW-L04]; National Natural Science Foundation of China [91124003, 81371203, 31271099]	National Key Technology Research and Development Program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Technology Research and Development Program of China (No. 2013BAI08B02), the Key Research Program of the Chinese Academy of Sciences (No. KJZD-EW-L04), and the National Natural Science Foundation of China (91124003, 81371203, and 31271099).	Almela M, 2012, PSYCHONEUROENDOCRINO, V37, P1929, DOI 10.1016/j.psyneuen.2012.04.009; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Blevins C. A., 2012, 28 ANN M INT SOC TRA; Bremner JD, 2003, PSYCHONEUROENDOCRINO, V28, P733, DOI 10.1016/S0306-4530(02)00067-7; Broman-Fulks JJ, 2009, J TRAUMA STRESS, V22, P146, DOI 10.1002/jts.20399; Broman-Fulks JJ, 2006, BEHAV THER, V37, P364, DOI 10.1016/j.beth.2006.02.006; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Craske MG, 2012, DEPRESS ANXIETY, V29, P253, DOI 10.1002/da.21930; Cuthbert BN, 2013, J ABNORM PSYCHOL, V122, P928, DOI 10.1037/a0034028; Cuthbert BN, 2010, SCHIZOPHRENIA BULL, V36, P1061, DOI 10.1093/schbul/sbq108; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; Dekel S, 2013, J TRAUMA STRESS, V26, P621, DOI 10.1002/jts.21839; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Doane LD, 2014, J ADOLESCENT HEALTH, V54, P536, DOI 10.1016/j.jadohealth.2013.10.007; Elzinga BM, 2003, NEUROPSYCHOPHARMACOL, V28, P1656, DOI 10.1038/sj.npp.1300226; Fang CY, 2014, J INT MED RES, V42, P444, DOI 10.1177/0300060513504696; Gotlib I. H., 1989, ANXIETY DEPRESSION D, P131; Hawk LW, 2000, PSYCHOSOM MED, V62, P423, DOI 10.1097/00006842-200005000-00016; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; Jacobs N, 2007, BIOL PSYCHOL, V74, P60, DOI 10.1016/j.biopsycho.2006.07.002; Jacobson L, 2014, COMPR PHYSIOL, V4, P715, DOI 10.1002/cphy.c130036; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; Li HH, 2010, PSYCHOL REP, V107, P733, DOI 10.2466/03.15.20.PR0.107.6.733-739; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Liu P, 2014, J ANXIETY DISORD, V28, P345, DOI 10.1016/j.janxdis.2014.03.008; LOVALLO WR, 1990, PSYCHOSOM MED, V52, P17, DOI 10.1097/00006842-199001000-00002; LOVALLO WR, 1985, PSYCHOPHYSIOLOGY, V22, P283, DOI 10.1111/j.1469-8986.1985.tb01602.x; Ma WF, 2013, J PSYCHIATR MENT HLT, V20, P499, DOI 10.1111/j.1365-2850.2012.01945.x; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McNally RJ, 2006, TRENDS COGN SCI, V10, P271, DOI 10.1016/j.tics.2006.04.007; Pietrzak RH, 2013, MOL PSYCHIATR, V18, P399, DOI 10.1038/mp.2012.60; Pietrzak RH, 2013, JAMA PSYCHIAT, V70, P1199, DOI 10.1001/jamapsychiatry.2013.399; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Putman P, 2011, PSYCHONEUROENDOCRINO, V36, P439, DOI 10.1016/j.psyneuen.2010.12.001; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RANKIN SH, 1993, PSYCHOL REP, V73, P1291, DOI 10.2466/pr0.1993.73.3f.1291; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Rutter M., 1990, RISK PROTECTIVE FACT, P181, DOI DOI 10.1017/CBO9780511752872; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; SHEK DTL, 1993, J CLIN PSYCHOL, V49, P349, DOI 10.1002/1097-4679(199305)49:3<349::AID-JCLP2270490308>3.0.CO;2-J; Simeon D, 2007, BIOL PSYCHIAT, V61, P966, DOI 10.1016/j.biopsych.2006.07.030; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steptoe A, 2007, PSYCHONEUROENDOCRINO, V32, P56, DOI 10.1016/j.psyneuen.2006.10.001; Stoppelbein L, 2015, ANXIETY STRESS COPIN, V28, P17, DOI 10.1080/10615806.2014.923844; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; Wang L, 2015, BIOL PSYCHIAT, V77, pE21, DOI 10.1016/j.biopsych.2014.05.026; Wang L, 2011, J ANXIETY DISORD, V25, P771, DOI 10.1016/j.janxdis.2011.03.011; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Watson D, 2011, INT J CLIN HLTH PSYC, V11, P429; Watson D, 2009, ANNU REV CLIN PSYCHO, V5, P221, DOI 10.1146/annurev.clinpsy.032408.153510; Weathers FW, 2013, THEPTSDCHECKLISTFORD; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zhou XB, 2013, COMPR PSYCHIAT, V54, P493, DOI 10.1016/j.comppsych.2012.12.010	59	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144315	10.1371/journal.pone.0144315	http://dx.doi.org/10.1371/journal.pone.0144315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630485	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300179
J	Heroux, ME; Taylor, JL; Gandevia, SC				Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.			The Use and Abuse of Transcranial Magnetic Stimulation to Modulate Corticospinal Excitability in Humans	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; THETA-BURST STIMULATION; PUBLICATION BIAS; MOTOR CORTEX; PLASTICITY; INDUCTION; PREVALENCE; SCIENCE; SIZE	The magnitude and direction of reported physiological effects induced using transcranial magnetic stimulation (TMS) to modulate human motor cortical excitability have proven difficult to replicate routinely. We conducted an online survey on the prevalence and possible causes of these reproducibility issues. A total of 153 researchers were identified via their publications and invited to complete an anonymous internet-based survey that asked about their experience trying to reproduce published findings for various TMS protocols. The prevalence of questionable research practices known to contribute to low reproducibility was also determined. We received 47 completed surveys from researchers with an average of 16.4 published papers (95% CI 10.8-22.0) that used TMS to modulate motor cortical excitability. Respondents also had a mean of 4.0 (2.5-5.7) relevant completed studies that would never be published. Across a range of TMS protocols, 45-60% of respondents found similar results to those in the original publications; the other respondents were able to reproduce the original effects only sometimes or not at all. Only 20% of respondents used formal power calculations to determine study sample sizes. Others relied on previously published studies (25%), personal experience (24%) or flexible post-hoc criteria (41%). Approximately 44% of respondents knew researchers who engaged in questionable research practices (range 32-70%), yet only 18% admitted to engaging in them (range 6-38%). These practices included screening subjects to find those that respond in a desired way to a TMS protocol, selectively reporting results and rejecting data based on a gut feeling. In a sample of 56 published papers that were inspected, not a single questionable research practice was reported. Our survey revealed that approximately 50% of researchers are unable to reproduce published TMS effects. Researchers need to start increasing study sample size and eliminating-or at least reporting-questionable research practices in order to make the outcomes of TMS research reproducible.	[Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Neurosci Res Australia, Randwick, NSW, Australia; [Heroux, Martin E.; Taylor, Janet L.; Gandevia, Simon C.] Univ New S Wales, Randwick, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	s.gandevia@neura.edu.au	Taylor, Janet L/C-9667-2011; Heroux, Martin/AAD-7694-2021; Gandevia, Simon/D-5009-2011	Taylor, Janet L/0000-0001-8976-5162; Heroux, Martin/0000-0002-3354-7104; Gandevia, Simon/0000-0002-1345-3821	Australian Government, National Health and Medical Research Council [APP1055084]	Australian Government, National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Government, National Health and Medical Research Council, Program Grant (APP1055084) (https://www.nhmrc.gov.au/).	Alberts B, 2015, SCIENCE, V348, P1420, DOI 10.1126/science.aab3847; Anderson WP, 2015, NATURE, V519, P158, DOI 10.1038/519158a; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; BARKER AT, 1985, LANCET, V1, P1106; Begley CG, 2015, NATURE, V525, P25, DOI 10.1038/525025a; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Cunningham CT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0016-z; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; Di Lazzaro V, 2014, J PHYSIOL-LONDON, V592, P4115, DOI 10.1113/jphysiol.2014.274316; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hayslett MM, 2004, LIBR INFORM SCI RES, V26, P73, DOI 10.1016/j.lisr.2003.11.005; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Holman L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002190; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kaplan RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132382; Kline R.B., 2013, SIGNIFICANCE TESTING; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Martin PG, 2006, CLIN NEUROPHYSIOL, V117, P2684, DOI 10.1016/j.clinph.2006.08.008; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Mervis J, 2014, SCIENCE, V345, P992, DOI 10.1126/science.345.6200.992; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Sale MV, 2007, EXP BRAIN RES, V181, P615, DOI 10.1007/s00221-007-0960-x; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Vallence AM, 2015, NEUROSCIENCE, V304, P266, DOI 10.1016/j.neuroscience.2015.07.043; Vallence AM, 2014, CORTEX, V58, P261, DOI 10.1016/j.cortex.2013.12.006; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	46	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144151	10.1371/journal.pone.0144151	http://dx.doi.org/10.1371/journal.pone.0144151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629998	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300165
J	Jin, YY; Andrade, J; Wickstrom, E				Jin, Yuan-Yuan; Andrade, Jade; Wickstrom, Eric			Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity	PLOS ONE			English	Article							NUCLEIC-ACID; MICRORNA; EXPRESSION; TARGET; RNA; SIMULATIONS; PATTERNS; REVEAL	Conventional wisdom holds that only one of the two strands in a micro ribonucleic acid (miRNA) precursor duplex is selected as the active miRNA guide strand. The complementary miRNA passenger strand, however, is thought to be inactive. High levels of the oncogenic miRNA (oncomiR) guide strand called miR-17-5p is overexpressed in triple negative breast cancer (TNBC) and can inhibit ribosomal translation of tumor suppressor gene mRNAs, such as programmed cell death 4 (PDCD4) or phosphatase and tensin homolog (PTEN). We hypothesized that knocking down the oncogenic microRNA (oncomiR) miR-17-5p might restore the expression levels of PDCD4 and PTEN tumor suppressor proteins, illustrating a route to oligonucleotide therapy of TNBC. Contrary to conventional wisdom, antisense knockdown of oncomiR miR-17-5p guide strand reduced PDCD4 and PTEN proteins by 1.8 +/- 0.3 fold in human TNBC cells instead of raising them. Bioinformatics analysis and folding energy calculations revealed that mRNA targets of miR-17-5p guide strand, such as PDCD4 and PTEN, could also be regulated by miR-17-3p passenger strand. Due to high sequence homology between the antisense molecules and miR-17-3p passenger strand, as well as the excess binding sites for the passenger strand on the 3'UTR of PDCD4 and PTEN mRNAs, introducing a miR-17-3p DNA-LNA mimic to knock down miR-17-5p reduced PDCD4 and PTEN protein expression instead of raising them. Our results imply that therapeutic antisense sequences against miRNAs should be designed to target the miRNA strand with the greatest number of putative binding sites in the target mRNAs, while minimizing affinity for the minor strand.	[Jin, Yuan-Yuan; Wickstrom, Eric] Thomas Jefferson Univ, Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Andrade, Jade] Haverford Coll, Chem, Haverford, PA 19041 USA; [Wickstrom, Eric] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Haverford College; Jefferson University	Wickstrom, E (corresponding author), Thomas Jefferson Univ, Biochem & Mol Biol, Philadelphia, PA 19107 USA.	eric@wickstromlab.org			National Institutes of Health [CA148565]; NATIONAL CANCER INSTITUTE [R01CA148565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by a National Institutes of Health grant CA148565 to EW [www.cancer.gov].	Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Case DA, 2012, AMBER 12; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dong GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0057-x; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Enright AJ, 2004, GENOME BIOL, V5; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Guennewig B, 2014, RNA, V20, P61, DOI 10.1261/rna.038968.113; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020517; Iqbal J, 2012, HISTOPATHOLOGY, V61, P652, DOI 10.1111/j.1365-2559.2012.04255.x; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Sanders JM, 2013, J PHYS CHEM B, V117, P11584, DOI 10.1021/jp4064966; Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sonar MV, 2014, BIOCONJUGATE CHEM, V25, P1697, DOI 10.1021/bc500304m; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang DJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011932; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078259; Xia Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00569; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142574	10.1371/journal.pone.0142574	http://dx.doi.org/10.1371/journal.pone.0142574			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629823	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300013
J	Yi, S; Zhang, HH; Gong, LL; Wu, JC; Zha, GB; Zhou, SL; Gu, XS; Yu, B				Yi, Sheng; Zhang, Honghong; Gong, Leilei; Wu, Jiancheng; Zha, Guangbin; Zhou, Songlin; Gu, Xiaosong; Yu, Bin			Deep Sequencing and Bioinformatic Analysis of Lesioned Sciatic Nerves after Crush Injury	PLOS ONE			English	Article							WALLERIAN DEGENERATION; MACROPHAGE RECRUITMENT; AXONAL REGENERATION; NATURAL-KILLER; SCHWANN-CELLS; GROWTH-FACTOR; IGF-I; INFLAMMATION; MODEL; CYTOKINES	The peripheral nerve system has an intrinsic regenerative capacity in response to traumatic injury. To better understand the molecular events occurring after peripheral nerve injury, in the current study, a rat model of sciatic nerve crush injury was used. Injured nerves harvested at 0, 1, 4, 7, and 14 days post injury were subjected to deep RNA sequencing for examining global gene expression changes. According to the temporally differential expression patterns of a huge number of genes, 3 distinct phases were defined within the post-injury period of 14 days: the acute, sub-acute, and post-acute stages. Each stage showed its own characteristics of gene expression, which were associated with different categories of diseases and biological functions and canonical pathways. Ingenuity pathway analysis revealed that genes involved in inflammation and immune response were significantly up-regulated in the acute phase, and genes involved in cellular movement, development, and morphology were up-regulated in the sub-acute stage, while the up-regulated genes in the post-acute phase were mainly involved in lipid metabolism, cytoskeleton reorganization, and nerve regeneration. All the data obtained in the current study may help to elucidate the molecular mechanisms underlying peripheral nerve regeneration from the perspective of gene regulation, and to identify potential therapeutic targets for the treatment of peripheral nerve injury.	[Yi, Sheng; Zhang, Honghong; Gong, Leilei; Wu, Jiancheng; Zha, Guangbin; Zhou, Songlin; Gu, Xiaosong; Yu, Bin] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China	Nantong University	Yu, B (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China.	yubin@ntu.edu.cn	Yi, Sheng/AAA-6017-2020	Yi, Sheng/0000-0003-1316-3370	National Key Basic Research Program of China [2014CB542202]; 863 Program [2012AA020502]; National Natural Science Foundation of China [81130080]; New Century Excellent Talents in University [NCET-12-0742]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Key Basic Research Program of China (Grant No. 2014CB542202), 863 Program (Grant No. 2012AA020502), National Natural Science Foundation of China (Grant No. 81130080), the New Century Excellent Talents in University (NCET-12-0742), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Bauder AR, 2012, JOVE-J VIS EXP, DOI 10.3791/3606; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Bryan DJ, 1999, J RECONSTR MICROSURG, V15, P591, DOI 10.1055/s-2007-1000143; Buckley G, 2011, J ANAT, V218, P163, DOI 10.1111/j.1469-7580.2010.01313.x; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Chang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053444; Chen KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072567; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; de Chaves EIP, 2000, J BIOL CHEM, V275, P19883, DOI 10.1074/jbc.275.26.19883; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dubovy P, 2013, INT REV NEUROBIOL, V108, P173, DOI 10.1016/B978-0-12-410499-0.00007-1; Fansa H, 2002, MUSCLE NERVE, V26, P87, DOI 10.1002/mus.10165; Filbin MT, 2006, NAT NEUROSCI, V9, P715, DOI 10.1038/nn0606-715; Fregnan F, 2012, NEURAL REGEN RES, V7, P2259, DOI 10.3969/j.issn.1673-5374.2012.29.003; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Hosoya S, 2013, AM J PHYSIOL-GASTR L, V304, pG293, DOI 10.1152/ajpgi.00083.2012; KRAWCZYK M, 1976, Archivum Immunologiae et Therapiae Experimentalis, V24, P379; Li MY, 2014, MUSCLE NERVE, V50, P73, DOI 10.1002/mus.24082; Li SY, 2015, MOL THER, V23, P423, DOI 10.1038/mt.2014.220; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Liu F, 2014, NEURAL REGEN RES, V9, P602, DOI 10.4103/1673-5374.130101; MacLennan AJ, 1999, NEUROSCIENCE, V91, P1401, DOI 10.1016/S0306-4522(98)00717-9; Magill CK, 2007, EXP NEUROL, V207, P64, DOI 10.1016/j.expneurol.2007.05.028; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; PODHAJSKY RJ, 1994, BRAIN RES, V662, P88, DOI 10.1016/0006-8993(94)90799-4; Ralainirina N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015053; Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109; Savastano LE, 2014, J NEUROSCI METH, V227, P166, DOI 10.1016/j.jneumeth.2014.01.020; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Terasawa T, 1985, Rinsho Ketsueki, V26, P661; Tiangco DA, 2001, J RECONSTR MICROSURG, V17, P247, DOI 10.1055/s-2001-14516; Toews AD, 1998, J NEUROSCI RES, V53, P260, DOI 10.1002/(SICI)1097-4547(19980715)53:2<260::AID-JNR15>3.0.CO;2-A; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; VENEZIE RD, 1995, J NEUROSCI RES, V40, P99, DOI 10.1002/jnr.490400111; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Yao DB, 2013, NEUROSCI BULL, V29, P321, DOI 10.1007/s12264-013-1340-0; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612	44	66	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143491	10.1371/journal.pone.0143491	http://dx.doi.org/10.1371/journal.pone.0143491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629691	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300052
J	Furo, ID; Monte, AA; dos Santos, MD; Tagliarini, MM; O'Brien, PCM; Ferguson-Smith, MA; de Oliveira, EHC				Furo, Ivanete de Oliveira; Monte, Amanda Almeida; dos Santos, Michelly da Silva; Tagliarini, Marcella Mergulhao; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.; de Oliveira, Edivaldo H. C.			Cytotaxonomy of Eurypyga helias (Gruiformes, Eurypygidae): First Karyotypic Description and Phylogenetic Proximity with Rynochetidae	PLOS ONE			English	Article							BIRDS; CHICKEN; CHROMOSOMES; EVOLUTION; REARRANGEMENTS; CONSERVATION; BIOGEOGRAPHY; CYTOGENETICS; CALEDONIA; GENOME	The sunbittern (Eurypyga helias) is a South American Gruiformes, the only member of Family Eurypigidae. In most phylogenetic proposals, it is placed in a more distant position than other families of the so-called "core Gruiformes". Different studies based on molecular, morphological and biogeographical data suggest that the Eurypigidae is closely related to the kagu (Rhynochetos jubatus), the only species in Rynochetidae, another family not included in the core Gruiformes. Here, the karyotype of the sunbittern is described for the first time, by classical and molecular cytogenetics, using whole chromosome probes derived from Gallus gallus and Leucopternis albicollis. We found a diploid number of 80, with only one pair of biarmed autosomal macrochromosomes, similar to that observed in the kagu. Chromosome painting revealed that most syntenies found in the avian putative ancestral karyotype (PAK) were conserved in the sunbittern. However, PAK1, PAK2, and PAK5 corresponded to two chromosome pairs each. Probes derived from L. albicollis confirm that fissions in PAK1 and PAK2 were centric, whereas in PAK5 the fission is interstitial. In addition, there is fusion of segments homologous to PAK2q and PAK5. From a phylogenetic point of view, comparisons of our results with two other Gruiformes belonging to family Rallidae suggest that the PAK5q fission might be a synapomorphy for Gruiformes. Fissions in PAK1 and PAK2 are found only in Eurypigidae, and might also occur in Rynochetidae, in view of the similar chromosomal morphology between the sunbittern and the kagu. This suggests a close phylogenetic relationship between Eurypigidae and Rynochetidae, whose common ancestor was separated by the Gondwana vicariancy in South America and New Caledonia, respectively.	[Furo, Ivanete de Oliveira; dos Santos, Michelly da Silva] Fed Univ Para, Programa Posgrad Genet & Biol Mol, BR-66059 Belem, Para, Brazil; [Furo, Ivanete de Oliveira; dos Santos, Michelly da Silva; de Oliveira, Edivaldo H. C.] Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil; [Monte, Amanda Almeida] Fed Univ Para, Fac Biol, ICB, BR-66059 Belem, Para, Brazil; [Tagliarini, Marcella Mergulhao] Fed Univ Para, Programa Posgrad Neurociencias & Biol Celular, BR-66059 Belem, Para, Brazil; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [de Oliveira, Edivaldo H. C.] Fed Univ Para, Inst Ciencias Exatas & Nat, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para; University of Cambridge; Universidade Federal do Para	de Oliveira, EHC (corresponding author), Inst Evandro Chagas, SAMAM, Lab Cultura Tecidos & Citogenet, Ananindeua, PA, Brazil.	ehco@ufpa.br	de Oliveira, Edivaldo H. C./C-3368-2013; Furo, Ivanete/P-1180-2018	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; FURO, IVANETE DE OLIVEIRA/0000-0001-5404-6029; Monte, Amanda/0000-0001-7871-3404	CNPq (Brazil) [307520/2012-9]	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supportedby the CNPq (Brazil): grant 307520/2012-9 for EHCO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin OL., 1983, BIRDS OF THE WORLD; BELTERMAN RHR, 1984, GENETICA, V65, P39, DOI 10.1007/BF00056765; Christidis L., 1990, ANIMAL CYTOGENETICS; Oliveira EHC, 2010, CHROMOSOME RES, V18, P349, DOI 10.1007/s10577-010-9117-z; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Cracraft J., 1982, Geobios Memoire Special (Lyon), P393; CRACRAFT J, 1981, AUK, V98, P681; Derjusheva S, 2004, CHROMOSOME RES, V12, P715, DOI 10.1023/B:CHRO.0000045779.50641.00; Dobigny G, 2004, SYST BIOL, V53, P470, DOI 10.1080/10635150490445698; dos Santos MD, 2015, GENETICA, V143, P535, DOI 10.1007/s10709-015-9851-4; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2007, MOL PHYLOGENET EVOL, V43, P515, DOI 10.1016/j.ympev.2007.02.015; Fain MG, 2004, EVOLUTION, V58, P2558; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; GIANNONI ML, 1983, REV BRAS GENET, V6, P649; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Guttenbach M, 2003, CYTOGENET GENOME RES, V103, P173, DOI 10.1159/000076309; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Kaewmad P, 2013, CYTOLOGIA, V78, P205, DOI 10.1508/cytologia.78.205; Kretschmer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103338; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Marceliano MLV, 2007, B MUSEU PARAENSE EMI, V2, P69; Nanda I, 2006, CYTOGENET GENOME RES, V112, P286, DOI 10.1159/000089883; Nanda I, 2011, CYTOGENET GENOME RES, V132, P165, DOI 10.1159/000322358; SASAKI M, 1968, EXPERIENTIA, V24, P1292, DOI 10.1007/BF02146680; Sasaki M, 1981, P INT CRAN S SAPP, P19; Schauensee RMD., 1970, GUIDE BIRDS S AM; Shibusawa M, 2004, CYTOGENET GENOME RES, V106, P111, DOI 10.1159/000078570; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sick H, 2001, ORNITOLOGIA BRASILEI; Swenson U, 2001, CLADISTICS, V17, P28, DOI 10.1006/clad.2000.0146; Tagliarini MM, 2009, GENETICA, V135, P299, DOI 10.1007/s10709-008-9278-2; Tagliarini MM, 2006, REV BRAS ORNITOL, V15, P167; TAKAGI N, 1974, CHROMOSOMA, V46, P91, DOI 10.1007/BF00332341; THOMAS BT, 1990, CONDOR, V92, P576, DOI 10.2307/1368675; WADA MY, 1993, CARYOLOGIA, V46, P91, DOI 10.1080/00087114.1993.10797251	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143982	10.1371/journal.pone.0143982	http://dx.doi.org/10.1371/journal.pone.0143982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624624	Green Published, gold			2022-12-26	WOS:000365891600084
J	van Vliet, D; Bruinenberg, VM; Mazzola, PN; van Faassen, MHJR; de Blaauw, P; Kema, IP; Heiner-Fokkema, MR; van Anholt, RD; van der Zee, EA; van Spronsen, FJ				van Vliet, Danique; Bruinenberg, Vibeke M.; Mazzola, Priscila N.; van Faassen, Martijn H. J. R.; de Blaauw, Pim; Kema, Ido P.; Heiner-Fokkema, M. Rebecca; van Anholt, Rogier D.; van der Zee, Eddy A.; van Spronsen, Francjan J.			Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GLUTAMATERGIC SYNAPTIC-TRANSMISSION; EARLY-TREATED PHENYLKETONURIA; PHENYLALANINE; TRANSPORT; PKU; DYSFUNCTION; DOPAMINE; PLASMA; DIET	Background Phenylketonuria (PKU) was the first disorder in which severe neurocognitive dysfunction could be prevented by dietary treatment. However, despite this effect, neuropsychological outcome in PKU still remains suboptimal and the phenylalanine-restricted diet is very demanding. To improve neuropsychological outcome and relieve the dietary restrictions for PKU patients, supplementation of large neutral amino acids (LNAA) is suggested as alternative treatment strategy that might correct all brain biochemical disturbances caused by high blood phenylalanine, and thereby improve neurocognitive functioning. Objective As a proof-of-principle, this study aimed to investigate all hypothesized biochemical treatment objectives of LNAA supplementation (normalizing brain phenylalanine, non-phenylalanine LNAA, and monoaminergic neurotransmitter concentrations) in PKU mice. Methods C57Bl/6 Pah-enu2 (PKU) mice and wild-type mice received a LNAA supplemented diet, an isonitrogenic/isocaloric high-protein control diet, or normal chow. After six weeks of dietary treatment, blood and brain amino acid and monoaminergic neurotransmitter concentrations were assessed. Results In PKU mice, the investigated LNAA supplementation regimen significantly reduced blood and brain phenylalanine concentrations by 33% and 26%, respectively, compared to normal chow (p<0.01), while alleviating brain deficiencies of some but not all supplemented LNAA. Moreover, LNAA supplementation in PKU mice significantly increased brain serotonin and norepinephrine concentrations from 35% to 71% and from 57% to 86% of wild-type concentrations (p<0.01), respectively, but not brain dopamine concentrations (p = 0.307). Conclusions This study shows that LNAA supplementation without dietary phenylalanine restriction in PKU mice improves brain biochemistry through all three hypothesized biochemical mechanisms. Thereby, these data provide proof-of-concept for LNAA supplementation as a valuable alternative dietary treatment strategy in PKU. Based on these results, LNAA treatment should be further optimized for clinical application with regard to the composition and dose of the LNAA supplement, taking into account all three working mechanisms of LNAA treatment.	[van Vliet, Danique; Mazzola, Priscila N.; van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [van Vliet, Danique; Bruinenberg, Vibeke M.; Mazzola, Priscila N.; van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [van Faassen, Martijn H. J. R.; de Blaauw, Pim; Kema, Ido P.; Heiner-Fokkema, M. Rebecca] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Spronsen, FJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands.	f.j.van.spronsen@umcg.nl	Mazzola, Priscila N./AAK-9752-2021; van der Zee, Eddy/AAZ-2120-2020	Mazzola, Priscila N./0000-0001-9683-4744; Van Faassen, Martijn/0000-0002-9142-6263	Arla Foods; Merck Serono; Nutricia Research	Arla Foods; Merck Serono(Merck & Company); Nutricia Research(Danone Nutricia)	R. D. van Anholt, in the past, received salary from Nutricia. E. A. van der Zee has received advisory board fees from Arla Foods. F. J. van Spronsen has received research grants, advisory board fees, and speaker's honoraria from Merck Serono and Nutricia Research, has received speaker's honoraria from Vitaflo, and has received advisory board fees from Arla Foods. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bachmanov AA, 2001, PHYSIOL BEHAV, V72, P603, DOI 10.1016/S0031-9384(01)00412-7; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Christ SE, 2010, MOL GENET METAB, V99, pS22, DOI 10.1016/j.ymgme.2009.10.007; COULOMBE JT, 1983, J INHERIT METAB DIS, V6, P58, DOI 10.1007/BF02338972; de Groot MJ, 2010, MOL GENET METAB, V99, pS86, DOI 10.1016/j.ymgme.2009.10.016; de Groot MJ, 2015, J CEREBR BLOOD F MET, V35, P200, DOI 10.1038/jcbfm.2014.183; de Groot MJ, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-133; de Rezende MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105704; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Glushakov AV, 2005, BRAIN, V128, P300, DOI 10.1093/brain/awh354; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; HOMMES FA, 1990, J INHERIT METAB DIS, V13, P37, DOI 10.1007/BF01799331; Horster F, 2006, PEDIATR RES, V59, P544, DOI 10.1203/01.pdr.0000203091.45988.8d; IKEDA M, 1967, ARCH BIOCHEM BIOPHYS, V120, P420, DOI 10.1016/0003-9861(67)90259-7; Jahja R, 2014, J PEDIATR-US, V164, P895, DOI 10.1016/j.jpeds.2013.12.015; Knudsen GM, 1995, J INHERIT METAB DIS, V18, P653, DOI 10.1007/BF02436753; Koch R, 2003, MOL GENET METAB, V79, P110, DOI 10.1016/S1096-7192(03)00078-7; MacDonald A, 2000, EUR J PEDIATR, V159, pS136, DOI 10.1007/PL00014375; Martynyuk AE, 2010, MOL GENET METAB, V99, pS100, DOI 10.1016/j.ymgme.2009.10.181; Martynyuk AE, 2005, MOL GENET METAB, V86, pS34, DOI 10.1016/j.ymgme.2005.06.014; Matalon R, 2007, J INHERIT METAB DIS, V30, P153, DOI 10.1007/s10545-007-0556-4; Matalon R, 2006, J INHERIT METAB DIS, V29, P732, DOI 10.1007/s10545-006-0395-8; Matalon R, 2003, PEDIATRICS, V112, P1570; Moats RA, 2003, PEDIATRICS, V112, P1575; Ogawa S, 2006, NEUROSCI LETT, V401, P261, DOI 10.1016/j.neulet.2006.03.031; OLDENDORF WH, 1971, ARCH NEUROL-CHICAGO, V24, P524, DOI 10.1001/archneur.1971.00480360058007; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; Pascucci T, 2009, INT J NEUROPSYCHOPH, V12, P1067, DOI 10.1017/S1461145709990381; Pietz J, 1999, J CLIN INVEST, V103, P1169, DOI 10.1172/JCI5017; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roseboom PH, 1998, MOL BRAIN RES, V63, P189, DOI 10.1016/S0169-328X(98)00273-3; Sanjurjo P, 2003, J PEDIATR GASTR NUTR, V36, P23, DOI 10.1097/00005176-200301000-00007; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schindeler S, 2007, MOL GENET METAB, V91, P48, DOI 10.1016/j.ymgme.2007.02.002; Shefer S, 2000, J NEUROSCI RES, V61, P549, DOI 10.1002/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0; SHULKIN BL, 1995, J NEUROCHEM, V64, P1252; Smith CB, 2000, P NATL ACAD SCI USA, V97, P11014, DOI 10.1073/pnas.97.20.11014; Smith I, 2000, EUR J PEDIATR, V159, pS89, DOI 10.1007/PL00014392; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; Surtees R, 2000, EUR J PEDIATR, V159, pS109, DOI 10.1007/PL00014370; van de Merbel NC, 2011, BIOANALYSIS, V3, P1949, DOI [10.4155/BIO.11.170, 10.4155/bio.11.170]; van Spronsen FJ, 2009, J INHERIT METAB DIS, V32, P46, DOI 10.1007/s10545-008-0946-2; van Spronsen FJ, 2010, J INHERIT METAB DIS, V33, P671, DOI 10.1007/s10545-010-9216-1; Yano S, 2013, J PEDIATR-US, V162, P999, DOI 10.1016/j.jpeds.2012.10.015	44	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143833	10.1371/journal.pone.0143833	http://dx.doi.org/10.1371/journal.pone.0143833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624009	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600055
J	Walters, BT; Jensen, PF; Larraillet, V; Lin, K; Patapoff, T; Schlothauer, T; Rand, KD; Zhang, J				Walters, Benjamin T.; Jensen, Pernille F.; Larraillet, Vincent; Lin, Kevin; Patapoff, Thomas; Schlothauer, Tilman; Rand, Kasper D.; Zhang, Jennifer			Conformational Destabilization of Immunoglobulin G Increases the Low pH Binding Affinity with the Neonatal Fc Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM HALF-LIFE; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; STRUCTURAL DYNAMICS; DEPENDENT BINDING; PROTEIN; RESOLUTION; PHARMACOKINETICS	Crystallographic evidence suggests that the pH-dependent affinity of IgG molecules for the neonatal Fc receptor (FcRn) receptor primarily arises from salt bridges involving IgG histidine residues, resulting in moderate affinity at mildly acidic conditions. However, this view does not explain the diversity in affinity found in IgG variants, such as the YTE mutant (M252Y,S254T,T256E), which increases affinity to FcRn by up to 10 x. Here we compare hydrogen exchange measurements at pH 7.0 and pH 5.5 with and without FcRn bound with surface plasmon resonance estimates of dissociation constants and FcRn affinity chromatography. The combination of experimental results demonstrates that differences between an IgG and its cognate YTE mutant vary with their pH-sensitive dynamics prior to binding FcRn. The conformational dynamics of these two molecules are nearly indistinguishable upon binding FcRn. We present evidence that pH-induced destabilization in the CH2/3 domain interface of IgG increases binding affinity by breaking intramolecular H-bonds and increases side-chain adaptability in sites that form intermolecular contacts with FcRn. Our results provide new insights into the mechanism of pH-dependent affinity in IgG-FcRn interactions and exemplify the important and often ignored role of intrinsic conformational dynamics in a protein ligand, to dictate affinity for biologically important receptors.	[Walters, Benjamin T.; Zhang, Jennifer] Genentech Inc, Dept Protein Anal Chem, San Francisco, CA 94080 USA; [Walters, Benjamin T.; Patapoff, Thomas] Genentech Inc, Dept Early Stage Pharmaceut Dev, San Francisco, CA 94080 USA; [Lin, Kevin] Genentech Inc, Dept Analyt Operat, San Francisco, CA 94080 USA; [Larraillet, Vincent; Schlothauer, Tilman] Roche Innovat Ctr, Roche Pharma Res & Early Dev pRED, DE-82377 Penzberg, Germany; [Jensen, Pernille F.; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, DK-1165 Copenhagen, Denmark	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Copenhagen	Walters, BT (corresponding author), Genentech Inc, Early Stage Pharmaceut Dev, 1 DNA Way,Mail Stop 56-1A, San Francisco, CA 94080 USA.	Walters.Benjamin@gene.com	Rand, Kasper/ABG-7446-2021	Rand, Kasper/0000-0002-6337-5489; Walters, Benjamin/0000-0001-5400-0696	Genentech, Inc.; Roche, Inc.; Marie Curie Actions Programme of the European Union [PCIG09-GA-2011-294214]; Danish Council for Independent Research/Natural Sciences [11-104058]	Genentech, Inc.(Roche HoldingGenentech); Roche, Inc.(Roche Holding); Marie Curie Actions Programme of the European Union; Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by Genentech, Inc. and Roche, Inc. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Grant PCIG09-GA-2011-294214 from the Marie Curie Actions Programme of the European Union and Steno Grant 11-104058 from the Danish Council for Independent Research/Natural Sciences.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; Coales SJ, 2010, RAPID COMMUN MASS SP, V24, P3585, DOI 10.1002/rcm.4814; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Gouridis G, 2015, NAT STRUCT MOL BIOL, V22, P57, DOI 10.1038/nsmb.2929; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110; HVIDT A, 1963, CR TRAV LAB CARLSB, V34, P299; Jensen PF, 2015, MOL CELL PROTEOMICS, V14, P148, DOI 10.1074/mcp.M114.042044; Kabat Elvin A, 1914, SEQUENCES PROTEINS I; Kan ZY, 2011, J AM SOC MASS SPECTR, V22, P1906, DOI 10.1007/s13361-011-0236-3; Kastritis PL, 2013, CURR OPIN STRUC BIOL, V23, P868, DOI 10.1016/j.sbi.2013.07.001; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mayne L, 2011, J AM SOC MASS SPECTR, V22, P1898, DOI 10.1007/s13361-011-0235-4; Mercier E, 2015, SCI REP-UK, V5, DOI 10.1038/srep07677; Monnet C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00039; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; Schoch A, 2015, P NATL ACAD SCI USA, V112, P5997, DOI 10.1073/pnas.1408766112; Seo MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4724; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Walters B. T., 2014, 62 ANN ASMS C MASS S; Walters BT, 2013, P NATL ACAD SCI USA, V110, P18898, DOI 10.1073/pnas.1319482110; Walters BT, 2012, J AM SOC MASS SPECTR, V23, P2132, DOI 10.1007/s13361-012-0476-x; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453	38	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1817	+		10.1074/jbc.M115.691568	http://dx.doi.org/10.1074/jbc.M115.691568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627822	Green Published, hybrid			2022-12-26	WOS:000368620700022
J	Hashiguchi, M; Imai, S; Uehara, K; Maruyama, J; Shimizu, M; Mochizuki, M				Hashiguchi, Masayuki; Imai, Shungo; Uehara, Keiko; Maruyama, Junya; Shimizu, Mikiko; Mochizuki, Mayumi			Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions	PLOS ONE			English	Article							EVENT REPORTING SYSTEM; PHARMACOVIGILANCE; SAFETY	We investigated factors affecting the timing of signal detection by comparing variations in reporting time of known and unknown ADRs after initial drug release in the USA. Data on adverse event reactions (AERs) submitted to U.S. FDA was used. Six ADRs associated with 6 drugs (rosuvastatin, aripiprazole, teriparatide, telithromycin, exenatide, varenicline) were investigated: Changes in the proportional reporting ratio, reporting odds ratio, and information component as indexes of signal detection were followed every 3 months after each drugs release, and the time for detection of signals was investigated. The time for the detection of signal to be detected after drug release in the USA was 2-10 months for known ADRs and 19-44 months for unknown ones. The median lag time for known and unknown ADRs was 99.0-122.5 days and 185.5-306.0 days, respectively. When the FDA released advisory information on rare but potentially serious health risks of an unknown ADR, the time lag to report from the onset of ADRs to the FDA was shorter. This study suggested that one factor affecting signal detection time is whether an ADR was known or unknown at release.	[Hashiguchi, Masayuki; Imai, Shungo; Maruyama, Junya; Mochizuki, Mayumi] Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Minato Ku, Tokyo, Japan; [Uehara, Keiko] Japan Pharmaceut Informat Ctr JAPIC, Shibuya Ku, Tokyo, Japan; [Shimizu, Mikiko] Keio Univ, Fac Pharm, Dept Hygien Chem, Minato Ku, Tokyo, Japan	Keio University; Keio University	Hashiguchi, M (corresponding author), Keio Univ, Fac Pharm, Div Evaluat & Anal Drug Informat, Minato Ku, Tokyo, Japan.	hashiguchi-ms@pha.keio.ac.jp		Imai, Shungo/0000-0001-5706-613X				Almenoff J, 2005, DRUG SAFETY, V28, P981, DOI 10.2165/00002018-200528110-00002; Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; [Anonymous], 2006, PUBL HLTH ADV KET TE; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Bate A, 2002, DRUG SAFETY, V25, P393, DOI 10.2165/00002018-200225060-00002; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; DuMouchel W., 2001, P 7 ACM SIGKDD INT C, P67, DOI DOI 10.1145/502512.502526; Evans SJ, 2011, PHARMACOEPIDEM DR S, V10, P483; Gould AL, 2003, PHARMACOEPIDEM DR S, V12, P559, DOI 10.1002/pds.771; Hauben M, 2006, PHARMACOEPIDEM DR S, V15, P775, DOI 10.1002/pds.1275; Hoffman KB, 2014, DRUG SAFETY, V37, P971, DOI 10.1007/s40264-014-0225-0; Kubota K, 2011, JPN J PHARMACOEPIDEM, V16, P27; Kubota K, 2003, J PRACT PHARM, V54, P59; Noren GN, 2006, STAT MED, V25, P3740, DOI 10.1002/sim.2473; Pharmaceuticals and Medical Devices Agency, 2007, REP INTR DAT MIN TEC; Sakaeda T, 2013, INT J MED SCI, V10, P796, DOI 10.7150/ijms.6048; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Tatonetti NP, 2012, J AM MED INFORM ASSN, V19, P79, DOI 10.1136/amiajnl-2011-000214; *US FDA, 2007, EARL COMM ONG SAF RE; *US FDA, 2008, INF HEALTHC PROF EX; US Food and Drug Administration, 2008, PUBL HLTH ADV IMP IN; US Food and Drug Administration (FDA), 2007, INF HEALTHC PROF EX; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144263	10.1371/journal.pone.0144263	http://dx.doi.org/10.1371/journal.pone.0144263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641634	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700087
J	Mussini, C; Lorenzini, P; Puoti, M; Lichtner, M; Lapadula, G; Di Giambenedetto, S; Antinori, A; Madeddu, G; Cozzi-Lepri, A; Monforte, AD; De Luca, A				Mussini, Cristina; Lorenzini, Patrizia; Puoti, Massimo; Lichtner, Miriam; Lapadula, Giuseppe; Di Giambenedetto, Simona; Antinori, Andrea; Madeddu, Giordano; Cozzi-Lepri, Alessandro; Monforte, Antonella d'Arminio; De Luca, Andrea		ICONA Fdn Study Grp	Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus	PLOS ONE			English	Article							LIVER FIBROSIS; COINFECTED INDIVIDUALS; NONINVASIVE INDEX; HIV; COHORT; MORTALITY; MARKERS; COMBINATION; PREDICTION; EVOLUTION	Objective To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART). Design Retrospective analysis of a prospective cohort study. Setting Italian HIV care centers participating to the ICONA Foundation cohort. Participants Treatment-naive patients enrolled in ICONA were selected who: initiated cART, had hepatitis C virus (HCV) serology results, were HBsAg negative, had an available FIB-4 index at cART start and during follow up. Methods Cox regression models were used to determine the association of FIB4 with the risk of major LRE (gastrointestinal bleeding, ascites, hepatic encephalopathy, hepato-renal syndrome or hepatocellular carcinoma) or LRD. Results Three-thousand four-hundred seventy-five patients were enrolled: 73.3% were males, 27.2% HCV seropositive. At baseline (time of cART initiation) their median age was 39 years, had a median CD4+ T cell count of 260 cells/uL, and median HIV RNA 4.9 log copies/mL, 65.9% had a FIB-4 < 1.45, 26.4% 1.45-3.25 and 7.7% > 3.25. Over a follow up of 18,662 person-years, 41 events were observed: 25 major LRE and 16 LRD (incidence rate, IR, 2.2 per 1,000 PYFU [95% confidence interval, CI 1.6-3.0]). IR was higher in HCV sero-positives as compared to negatives (5.9 vs 0.5 per 1,000 PYFU). Higher baseline FIB-4 category as compared to < 1.45 (FIB-4 1.45-3.25: HR 3.55, 95% CI 1.09-11.58; FIB-4>3.25: HR 4.25, 1.21-14.92) and time-updated FIB-4 (FIB-4 1.45-3.25: HR 3.40, 1.02-11.40; FIB4>3.25: HR 21.24, 6.75-66.84) were independently predictive of major LRE/LRD, after adjusting for HIV- and HCV-related variables, alcohol consumption and type of cART. Conclusions The FIB-4 index at cART initiation, and its modification over time are risk factors for major LRE or LRD, independently of infection with HCV and could be used to monitor patients on cART.	[Mussini, Cristina] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy; [Lorenzini, Patrizia; Antinori, Andrea] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Puoti, Massimo] Maggiore Hosp, Clin Infect Dis, Milan, Italy; [Lichtner, Miriam] Univ Roma La Sapienza, Clin Infect Dis, Rome, Italy; [Lapadula, Giuseppe] San Gerardo Hosp, Dept Infect Dis, Monza, Italy; [Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, Rome, Italy; [Madeddu, Giordano] Univ Sassari, Clin Malattie Infett, I-07100 Sassari, Italy; [Cozzi-Lepri, Alessandro] UCL, Dept Infect & Populat Hlth, Div Populat Hlth, London, England; [Monforte, Antonella d'Arminio] San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis, Milan, Italy; [De Luca, Andrea] Univ Siena, Dept Med Biotechnol, Div Infect Dis, I-53100 Siena, Italy; [De Luca, Andrea] Siena Univ Hosp, Siena, Italy	Universita di Modena e Reggio Emilia; IRCCS Lazzaro Spallanzani; IRCCS Ca Granda Ospedale Maggiore Policlinico; Sapienza University Rome; San Gerardo Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Sassari; University of London; University College London; San Paolo-Polo Universitaria Hospital; University of Siena; University of Siena; University Hospital of Siena	De Luca, A (corresponding author), Univ Siena, Dept Med Biotechnol, Div Infect Dis, Via Laterina 8, I-53100 Siena, Italy.	a.deluca@ao-siena.toscana.it	De Luca, Andrea/G-8810-2011; nicastri, emanuele/K-7780-2016; Rusconi, Stefano/H-9263-2012; Ippolito, Giuseppe/J-7207-2017; Puoti, Massimo/AAA-6580-2020; Castagna, Antonella/K-3280-2018; Baldin, Gianmaria/A-8562-2019; Mussini, Cristina/K-8672-2016; digiambenedetto, simona/AAL-4429-2020; Saracino, Annalisa/F-5084-2017; Ursini, Tamara/AAB-3891-2019; Lapadula, Giuseppe/J-5163-2012; MADEDDU, Giordano/AAP-4342-2020; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Antinori, Andrea/K-7125-2016; SANTORO, MARIA/K-3250-2018; perno, carlo federico/O-1544-2016; Di Biagio, Antonio/J-4901-2019; MARCHETTI, GIULIA CARLA/K-4384-2018; Balotta, Claudia/L-7295-2017; GALLI, MASSIMO/L-7282-2017; LAZZARIN, Adriano/K-3607-2018; QUIROS ROLDAN, Maria Eugenia/K-7586-2015	De Luca, Andrea/0000-0002-9561-9193; nicastri, emanuele/0000-0002-5606-8712; Rusconi, Stefano/0000-0002-0375-9990; Castagna, Antonella/0000-0002-8338-9714; Baldin, Gianmaria/0000-0003-4623-9976; Mussini, Cristina/0000-0002-6615-4198; Saracino, Annalisa/0000-0001-9558-208X; Ursini, Tamara/0000-0002-6012-0667; MADEDDU, Giordano/0000-0001-6099-2273; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Antinori, Andrea/0000-0003-2121-4684; SANTORO, MARIA/0000-0002-6228-1114; Di Biagio, Antonio/0000-0003-1436-5089; Ammassari, Adriana/0000-0002-0284-0340; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; Girardi, Enrico/0000-0001-8182-5896; Puoti, Massimo/0000-0003-3278-7138; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Calcagno, Andrea/0000-0003-2534-8815; Cinque, Paola/0000-0003-2448-5957; LAPADULA, Giuseppe/0000-0002-9976-8102; Nozza, Silvia/0000-0002-2673-2731; MONNO, Laura/0000-0002-2713-4258; COSTANTINI, ANDREA/0000-0003-1588-7030; Segala, Daniela/0000-0001-6133-0386; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Castelli, Francesco/0000-0001-9161-7804; Vanino, Elisa/0000-0003-3510-1429; Bandera, Alessandra/0000-0003-1626-0328; Gianotti, Nicola/0000-0002-7182-5080; Balotta, Claudia/0000-0002-1107-9119; GALLI, MASSIMO/0000-0001-8887-6215; LAZZARIN, Adriano/0000-0003-2551-7754; Guaraldi, Giovanni/0000-0002-5724-3914; BANDERA, ALESSANDRA/0000-0001-9440-4601; PUZZOLANTE, CINZIA/0000-0002-1179-1341; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; Ippolito, Giuseppe/0000-0002-1076-2979; Bonfanti, Paolo/0000-0001-7289-8823; Capobianchi, Maria Rosaria/0000-0003-3465-0071; CAUDA, Roberto/0000-0002-1498-4229	Abbvie Italy; Bristol-Myers Squibb Italy; Gilead Italy; Janssen Italy; ViiV Healthcare Italy	Abbvie Italy(AbbVie); Bristol-Myers Squibb Italy(Bristol-Myers Squibb); Gilead Italy(Gilead Sciences); Janssen Italy; ViiV Healthcare Italy	The authors received no specific funding for this work. However, the ICONA Foundation Study is sponsored by unrestricted grants from Abbvie Italy, Bristol-Myers Squibb Italy, Gilead Italy, Janssen Italy, ViiV Healthcare Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121; Berenguer J, 2014, CLIN INFECT DIS; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Boursier J, 2014, ALIMENT PHARM THER, V40, P178, DOI 10.1111/apt.12813; Bruno R, 2011, DIGEST LIVER DIS, V43, P575, DOI 10.1016/j.dld.2011.03.009; Chinnaratha MA, 2014, LIVER INT, V34, P720, DOI 10.1111/liv.12306; Grint D, 2013, HIV MED, V14, P614, DOI 10.1111/hiv.12068; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Jain MK, 2012, AIDS PATIENT CARE ST, V26, P73, DOI 10.1089/apc.2011.0191; Lim JK, 2014, CLIN INFECT DIS, V58, P1449, DOI 10.1093/cid/ciu097; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582; Resino S, 2012, CURR OPIN INFECT DIS, V25, P564, DOI 10.1097/QCO.0b013e32835635df; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068953; Rohrbach J, 2014, ANTIVIR THER, V19, P149, DOI 10.3851/IMP2686; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Tahiri M, 2013, WORLD J HEPATOL, V5, P584, DOI 10.4254/wjh.v5.i10.584; Tamaki N, 2014, J GASTROENTEROL, V49, P1495, DOI 10.1007/s00535-013-0914-y; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; WHO, 2014, GUID SCREEN CAR TREA; Zinkernagel AS, 2006, ANTIVIR THER, V11, P131	26	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0140877	10.1371/journal.pone.0140877	http://dx.doi.org/10.1371/journal.pone.0140877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640953	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700002
J	Pearson, SF; Giovanini, J; Jones, JE; Kroll, AJ				Pearson, Scott F.; Giovanini, Jack; Jones, Jay E.; Kroll, Andrew J.			Breeding Bird Community Continues to Colonize Riparian Buffers Ten Years after Harvest	PLOS ONE			English	Article							PACIFIC-NORTHWEST; SPECIES RICHNESS; FOREST HARVEST; CONSERVATION STRATEGY; HABITAT SELECTION; MIXTURE-MODELS; WIDTH; FRAGMENTATION; ABUNDANCE; ASSEMBLAGES	Riparian ecosystems integrate aquatic and terrestrial communities and often contain unique assemblages of flora and fauna. Retention of forested buffers along riparian habitats is a commonly employed practice to reduce potential negative effects of land use on aquatic systems. However, very few studies have examined long-term population and community responses to buffers, leading to considerable uncertainty about effectiveness of this practice for achieving conservation and management outcomes. We examined short-(1-2 years) and long-term (similar to 10 years) avian community responses (occupancy and abundance) to riparian buffer prescriptions to clearcut logging silvicultural practices in the Pacific Northwest USA. We used a Before-After-Control-Impact experimental approach and temporally replicated point counts analyzed within a Bayesian framework. Our experimental design consisted of forested control sites with no harvest, sites with relatively narrow (similar to 13m) forested buffers on each side of the stream, and sites with wider (similar to 30m) and more variable width unharvested buffer. Buffer treatments exhibited a 31-44% increase in mean species richness in the post-harvest years, a pattern most evident 10 years post-harvest. Post-harvest, species turnover was much higher on both treatments (63-74%) relative to the controls (29%). We did not find evidence of local extinction for any species but found strong evidence (no overlap in 95% credible intervals) for an increase in site occupancy on both Narrow (short-term: 7%; long-term 29%) and Wide buffers (short-term: 21%; long-term 93%) relative to controls after harvest. We did not find a treatment effect on total avian abundance. When assessing relationships between buffer width and site level abundance of four riparian specialists, we did not find strong evidence of reduced abundance in Narrow or Wide buffers. Silviculture regulations in this region dictate average buffer widths on small and large permanent streams that range from similar to 22-25 m. Guidelines for this region are within the range of buffers included in our study, in which we observed no evidence for avian species loss or for a decline in species abundance (including riparian associated species).	[Pearson, Scott F.] Washington Dept Fish & Wildlife, Wildlife Res Div, Olympia, WA 98501 USA; [Giovanini, Jack; Jones, Jay E.; Kroll, Andrew J.] Weyerhaeuser, Fed Way, DC USA	Washington Department of Fish & Wildlife (WDFW)	Pearson, SF (corresponding author), Washington Dept Fish & Wildlife, Wildlife Res Div, Olympia, WA 98501 USA.	scott.pearson@dfw.wa.gov	Kroll, Andrew/ABB-3724-2020	Kroll, Andrew/0000-0001-7747-830X; Pearson, Scott/0000-0003-4960-3956	Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources; Washington Department of Fish and Wildlife; Weyerhaeuser	Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources; Washington Department of Fish and Wildlife; Weyerhaeuser	All funding sources: The Cooperative Monitoring, Evaluation, and Research (CMER) Committee under Washington Department of Natural Resources provided the 10 year resample data to the authors and provided funding to Washington Department of Fish and Wildlife to pay for Scott Pearson's salary associated with data analysis, writing and report preparation (Interagency Agreement 12-118). Other funding sources included Washington Department of Fish and Wildlife funding of Scott Pearson's salary associated with manuscript preparation and Weyerhaeuser who funded Jack Giovanini, Jay E. Jones, and Andrew J. Kroll's salaries while they analyzed data and co-authored the manuscript. Revised funders website: http://www.dnr.wa.gov/.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2006, SAS MIXED MODELS; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Bennett AF, 2014, J APPL ECOL, V51, P514, DOI 10.1111/1365-2664.12200; Bilby RE, 2003, T AM FISH SOC, V132, P733, DOI 10.1577/T02-089; Blinn CR, 2001, J FOREST, V99, P11; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Bull EL, 1978, TECHNICAL REPORT; CAREY AB, 1991, US FOR SERV T R PNW, V285, P123; Chaloner DT, 2002, CAN J FISH AQUAT SCI, V59, P1257, DOI 10.1139/F02-084; CHAMBERLIN TW, 1991, AM FISH SOC SPEC PUB, V19, P181; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Christensen R., 1996, ANAL VARIANCE DESIGN; DARVEAU M, 1995, J WILDLIFE MANAGE, V59, P67, DOI 10.2307/3809117; Davidson AS, 2001, J WILDLIFE MANAGE, V65, P334, DOI 10.2307/3802913; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Evans KO, 2014, CONSERV BIOL, V28, P892, DOI 10.1111/cobi.12311; FETHERSTON KL, 1995, GEOMORPHOLOGY, V13, P133, DOI 10.1016/0169-555X(95)00033-2; Franklin J.F., 1973, GTRPNW8 USDA US FOR; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2007, SOCIOL METHODOL, V37, P23, DOI 10.1111/j.1467-9531.2007.00181.x; Gimenez O, 2008, AM NAT, V172, P441, DOI 10.1086/589520; Giovanini J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059900; Guzy MJ, 1997, BIRDS N AM; Hagar JC, 1999, J WILDLIFE MANAGE, V63, P484, DOI 10.2307/3802633; Hannon SJ, 2002, ECOL APPL, V12, P1457; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Hanowski J, 2003, FOREST ECOL MANAG, V174, P315, DOI 10.1016/S0378-1127(02)00040-3; Harper KA, 2001, ECOLOGY, V82, P649, DOI 10.1890/0012-9658(2001)082[0649:SACORB]2.0.CO;2; Hawkes VC, 2012, FOREST ECOL MANAG, V274, P67, DOI 10.1016/j.foreco.2012.02.015; Helfield JM, 2002, OECOLOGIA, V133, P573, DOI 10.1007/s00442-002-1070-x; Hepinstall JA, 2008, LANDSCAPE ECOL, V23, P1257, DOI 10.1007/s10980-008-9296-6; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Jones JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043290; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kiffney PM, 2004, J N AM BENTHOL SOC, V23, P542, DOI 10.1899/0887-3593(2004)023&lt;0542:ELAACM&gt;2.0.CO;2; Kilgo JC, 1998, J WILDLIFE MANAGE, V62, P72, DOI 10.2307/3802265; KNOPF FL, 1988, WILSON BULL, V100, P272; Kroll AJ, 2014, FOREST ECOL MANAG, V326, P46, DOI 10.1016/j.foreco.2014.04.011; Kroll AJ, 2012, J WILDLIFE MANAGE, V76, P1188, DOI 10.1002/jwmg.353; Kuglerova L, 2014, FOREST ECOL MANAG, V334, P74, DOI 10.1016/j.foreco.2014.08.033; Lee P, 2004, J ENVIRON MANAGE, V70, P165, DOI 10.1016/j.jenvman.2003.11.009; Leu M., 2000, BREEDING TERRITORY S; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Marczak LB, 2010, ECOL APPL, V20, P126, DOI 10.1890/08-2064.1; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; MCGARIGAL K, 1992, J WILDLIFE MANAGE, V56, P10, DOI 10.2307/3808786; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Miller JR, 2003, ECOL APPL, V13, P1041, DOI 10.1890/1051-0761(2003)13[1041:EOHSOB]2.0.CO;2; MORRISON ML, 1981, AUK, V98, P578; Naiman R.J., 1998, RIVER ECOLOGY MANAGE; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; National Research Council, 2002, RIP AR FUNCT STRAT M; Oakley A.L., 1985, MANAGEMENT WILDLIFE; Osmundson DB, 2002, ECOL APPL, V12, P1719, DOI 10.1890/1051-0761(2002)012[1719:FSBRIF]2.0.CO;2; Peak RG, 2006, J WILDLIFE MANAGE, V70, P173, DOI 10.2193/0022-541X(2006)70[173:FAASRA]2.0.CO;2; Pearson SF, 1998, AUK, V115, P739, DOI 10.2307/4089421; Pearson SF, 2001, ECOL APPL, V11, P840, DOI 10.1890/1051-0761(2001)011[0840:BBRTRB]2.0.CO;2; Perry RW, 2011, BIODIVERS CONSERV, V20, P625, DOI 10.1007/s10531-010-9971-1; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; Plummer M., 2003, PROC 3 INT WORK DIST, P1; Richardson JS, 2012, FRESHW SCI, V31, P232, DOI 10.1899/11-031.1; Richardson JS, 2009, CONSERV BIOL SER, P244; Richardson JS, 2005, J AM WATER RESOUR AS, V41, P935, DOI 10.1111/j.1752-1688.2005.tb04471.x; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodewald AD, 2006, BIOL CONSERV, V128, P193, DOI 10.1016/j.biocon.2005.09.041; Rohwer S, 1998, AUK, V115, P284, DOI 10.2307/4089188; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHIECK J, 1995, CONSERV BIOL, V9, P1072, DOI [10.1046/j.1523-1739.1995.9051072.x, 10.1046/j.1523-1739.1995.9051059.x-i1]; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Shirley SM, BIOL CONS, V125, P475; SPACKMAN SC, 1995, BIOL CONSERV, V71, P325, DOI 10.1016/0006-3207(94)00055-U; STAUFFER DF, 1980, J WILDLIFE MANAGE, V44, P1; Steedman RJ, 2000, WATER AIR SOIL POLL, V122, P139, DOI 10.1023/A:1005235604087; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Su Y-S, R2JAGS PACKAGE RUNNI; Swanson FJ, 1982, US IBP SYNTH SER, V14, P233; Tewksbury JJ, 1998, ECOLOGY, V79, P2890, DOI 10.1890/0012-9658(1998)079[2890:BPDNDW]2.0.CO;2; THOMAS JW, 1979, USDA FOREST SERVICE, V553, P40; TRIQUET AM, 1990, J SOIL WATER CONSERV, V45, P500; VanderHaegen WM, 1996, J WILDLIFE MANAGE, V60, P542, DOI 10.2307/3802071; Verner J., 1985, Current Ornithology, V2, P247; WESCHE T A, 1987, North American Journal of Fisheries Management, V7, P151, DOI 10.1577/1548-8659(1987)7<151:CORVTT>2.0.CO;2; Whitaker DM, 1999, J WILDLIFE MANAGE, V63, P167, DOI 10.2307/3802498; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x; [No title captured]	95	7	7	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143241	10.1371/journal.pone.0143241	http://dx.doi.org/10.1371/journal.pone.0143241			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637120	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800008
J	Berry, SM; Pezzi, HM; Williams, ED; Loeb, JM; Guckenberger, DJ; Lavanway, AJ; Puchalski, AA; Kityo, CM; Mugyenyi, PN; Graziano, FM; Beebe, DJ				Berry, Scott M.; Pezzi, Hannah M.; Williams, Eram D.; Loeb, Jennifer M.; Guckenberger, David J.; Lavanway, Alex J.; Puchalski, Alice A.; Kityo, Cissy M.; Mugyenyi, Peter N.; Graziano, Franklin M.; Beebe, David J.			Using Exclusion-Based Sample Preparation (ESP) to Reduce Viral Load Assay Cost	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CHILDREN	Viral load (VL) measurements are critical to the proper management of HIV in developing countries. However, access to VL assays is limited by the high cost and complexity of existing assays. While there is a need for low cost VL assays, performance must not be compromised. Thus, new assays must be validated on metrics of limit of detection (LOD), accuracy, and dynamic range. Patient plasma samples from the Joint Clinical Research Centre in Uganda were de-identified and measured using both an existing VL assay (Abbott RealTime HIV-1) and our assay, which combines low cost reagents with a simplified method of RNA isolation termed Exclusion-Based Sample Preparation (ESP). 71 patient samples with VLs ranging from < 40 to > 3,000,000 copies/mL were used to compare the two methods. We demonstrated equivalent LOD (similar to 50 copies/mL) and high accuracy (average difference between methods of 0.08 log, R-2 = 0.97). Using expenditures from this trial, we estimate that the cost of the reagents and consumables for this assay to be approximately $5 USD. As cost is a significant barrier to implementation of VL testing, we anticipate that our assay will enhance access to this critical monitoring test in developing countries.	[Berry, Scott M.; Pezzi, Hannah M.; Loeb, Jennifer M.; Guckenberger, David J.; Lavanway, Alex J.; Puchalski, Alice A.; Mugyenyi, Peter N.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Williams, Eram D.; Kityo, Cissy M.; Graziano, Franklin M.] Joint Clin Res Ctr, Kampala, Uganda	University of Wisconsin System; University of Wisconsin Madison; Joint Clinic Research Center - United Arab Emirates	Berry, SM (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	Berry3@wisc.edu			Bill and Melinda Gates Foundation [OPP1028788]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for this study was provided by the Bill and Melinda Gates Foundation (www.gatesfoundation.org) Global Health Grant Number OPP1028788. SB, HP, JL, DG, AL, AP, and DB received materials and salary support from this grant. EW, CK, PM, and FG received materials support from this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ABBOTT REALTIME HIV; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Berry SM, 2014, J MOL DIAGN, V16, P297, DOI 10.1016/j.jmoldx.2014.01.004; Berry SM, 2013, JALA-J LAB AUTOM, V18, P206, DOI 10.1177/2211068212462023; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Guckenberger DJ, 2014, JALA-J LAB AUTOM, V19, P267, DOI 10.1177/2211068213518312; Howard A, 2013, J LAB AUTOM IN PRESS; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kekitiinwa A, 2012, PEDIATR INFECT DIS J, V31, pE117, DOI 10.1097/INF.0b013e31825cb9d6; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Sachs J.D., 2001, MACROECONOMICS HLTH; WHO, CONGUID UANT DRU; WHO, 2014, MARCH 2014 S 2013 CO	15	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143631	10.1371/journal.pone.0143631	http://dx.doi.org/10.1371/journal.pone.0143631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630135	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300076
J	Cuadrado, E; Booiman, T; van Hamme, JL; Jansen, MH; van Dort, KA; Vanderver, A; Rice, GI; Crow, YJ; Kootstra, NA; Kuijpers, TW				Cuadrado, Eloy; Booiman, Thijs; van Hamme, John L.; Jansen, Machiel H.; van Dort, Karel A.; Vanderver, Adeline; Rice, Gillian I.; Crow, Yanick J.; Kootstra, Neeltje A.; Kuijpers, Taco W.			ADAR1 Facilitates HIV-1 Replication in Primary CD4(+) T Cells	PLOS ONE			English	Article							AICARDI-GOUTIERES-SYNDROME; IMMUNODEFICIENCY-VIRUS TYPE-1; INNATE IMMUNE-RESPONSE; DEAMINASE ADAR1; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA; DENDRITIC CELLS; PROTEIN-KINASE; RNA; MUTATIONS	Unlike resting CD4(+) T cells, activated CD4(+) T cells are highly susceptible to infection of human immunodeficiency virus 1 (HIV-1). HIV-1 infects T cells and macrophages without activating the nucleic acid sensors and the anti-viral type I interferon response. Adenosine deaminase acting on RNA 1 (ADAR1) is an RNA editing enzyme that displays antiviral activity against several RNA viruses. Mutations in ADAR1 cause the autoimmune disorder Aicardi-Goutieeres syndrome (AGS). This disease is characterized by an inappropriate activation of the interferon-stimulated gene response. Here we show that HIV-1 replication, in ADAR1-deficient CD4(+) T lymphocytes from AGS patients, is blocked at the level of protein translation. Furthermore, viral protein synthesis block is accompanied by an activation of interferon-stimulated genes. RNA silencing of ADAR1 in Jurkat cells also inhibited HIV-1 protein synthesis. Our data support that HIV-1 requires ADAR1 for efficient replication in human CD4(+) T cells.	[Cuadrado, Eloy; Booiman, Thijs; van Hamme, John L.; Jansen, Machiel H.; van Dort, Karel A.; Kootstra, Neeltje A.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Booiman, Thijs; van Hamme, John L.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Sanquin Res, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Booiman, Thijs; van Hamme, John L.; van Dort, Karel A.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Vanderver, Adeline] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Rice, Gillian I.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England; [Crow, Yanick J.] Hop Necker Enfants Malad, INSERM, UMR 1163, Lab Neurogenet & Neuroinflammat,Inst Imagine, Paris, France; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Hematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Children's National Health System; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Cuadrado, E (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.cuadrado@sanquin.nl	Rice, Gillian I/G-3128-2015; Vanderver, Adeline/CAG-5072-2022; Crow, Yanick J/N-6120-2014	Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; van Hamme, John/0000-0003-0765-9441; Vanderver, Adeline/0000-0002-6290-6751; Kootstra, Neeltje A./0000-0001-9429-7754	European Union (EU) [241779]	European Union (EU)(CGIAREuropean Commission)	This work was supported by European Union (EU) Seventh Framework Programme [Grant number: 241779] (Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity (http://ec.europa.eu/research/health/medical-research/rare-diseases/projects/nimbl_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger A, 2011, PLOS PATHOG, P7; Biswas N, 2012, VIROLOGY, V422, P265, DOI 10.1016/j.virol.2011.10.024; Cachat A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0093-9; Clerzius G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-96; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08; Polson AG, 1998, MOL CELL BIOL, V18, P1919, DOI 10.1128/MCB.18.4.1919; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sato S, 2001, J VIROL, V75, P8547, DOI 10.1128/JVI.75.18.8547-8555.2001; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tang YD, 2015, VIROLOGY, V476, P364, DOI 10.1016/j.virol.2014.12.038; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; TERSMETTE M, 1989, VIROLOGY, V171, P149, DOI 10.1016/0042-6822(89)90521-7; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143613	10.1371/journal.pone.0143613	http://dx.doi.org/10.1371/journal.pone.0143613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629815	gold, Green Published			2022-12-26	WOS:000365926300073
J	Garvican-Lewis, LA; Clark, B; Martin, DT; Schumacher, YO; McDonald, W; Stephens, B; Ma, FH; Thompson, KG; Gore, CJ; Menaspa, P				Garvican-Lewis, Laura A.; Clark, Bradley; Martin, David T.; Schumacher, Yorck Olaf; McDonald, Warren; Stephens, Brian; Ma, Fuhai; Thompson, Kevin G.; Gore, Christopher J.; Menaspa, Paolo			Impact of Altitude on Power Output during Cycling Stage Racing	PLOS ONE			English	Article							EXERCISE PERFORMANCE; THEORETICAL-ANALYSIS; SEA-LEVEL; FATIGUE; ACCLIMATIZATION; OXYGENATION; PROFILE	Purpose The purpose of this study was to quantify the effects of moderate-high altitude on power output, cadence, speed and heart rate during a multi-day cycling tour. Methods Power output, heart rate, speed and cadence were collected from elite male road cyclists during maximal efforts of 5, 15, 30, 60, 240 and 600 s. The efforts were completed in a laboratory power-profile assessment, and spontaneously during a cycling race simulation near sea-level and an international cycling race at moderate-high altitude. Matched data from the laboratory power-profile and the highest maximal mean power output (MMP) and corresponding speed and heart rate recorded during the cycling race simulation and cycling race at moderate-high altitude were compared using paired t-tests. Additionally, all MMP and corresponding speeds and heart rates were binned per 1000m (<1000m, 1000-2000, 2000-3000 and >3000m) according to the average altitude of each ride. Mixed linear modelling was used to compare cycling performance data from each altitude bin. Results Power output was similar between the laboratory power-profile and the race simulation, however MMPs for 5-600 s and 15, 60, 240 and 600 s were lower (p <= 0.005) during the race at altitude compared with the laboratory power-profile and race simulation, respectively. Furthermore, peak power output and all MMPs were lower (>= 11.7%, p <= 0.001) while racing >3000 m compared with rides completed near sea-level. However, speed associated with MMP 60 and 240 s was greater (p < 0.001) during racing at moderate-high altitude compared with the race simulation near sea-level. Conclusion A reduction in oxygen availability as altitude increases leads to attenuation of cycling power output during competition. Decrement in cycling power output at altitude does not seem to affect speed which tended to be greater at higher altitudes.	[Garvican-Lewis, Laura A.; Clark, Bradley; Thompson, Kevin G.] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT 2601, Australia; [Garvican-Lewis, Laura A.; Clark, Bradley; Martin, David T.; Gore, Christopher J.; Menaspa, Paolo] Australian Inst Sport, Physiol, Canberra, ACT, Australia; [Schumacher, Yorck Olaf] Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar; [McDonald, Warren; Stephens, Brian] Cycling Australia, Adelaide, SA, Australia; [Ma, Fuhai] Qinghai Inst Sport Sci, Duoba, Peoples R China; [Gore, Christopher J.] Flinders Univ S Australia, Exercise Physiol Lab, Adelaide, SA 5001, Australia; [Menaspa, Paolo] Edith Cowan Univ, Perth, WA, Australia	University of Canberra; Australian Institute of Sport; Aspetar Orthopaedic & Sports Medicine Hospital; Flinders University South Australia; Edith Cowan University	Garvican-Lewis, LA (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT 2601, Australia.	laura.garvican@ausport.gov.au	Menaspà, Paolo/D-1542-2015	Menaspà, Paolo/0000-0002-0094-9596; Thompson, Kevin/0000-0003-3985-1622; McDonald, Warren/0000-0002-3337-2922; Clark, Bradley/0000-0003-2277-0463; Martin, David/0000-0002-3051-2811	Australian Institute of Sport High Performance Research Grant fund; University of Canberra; Aspetar/Aspire Zone Research Fund; Qinghai Sports Science Institute	Australian Institute of Sport High Performance Research Grant fund; University of Canberra; Aspetar/Aspire Zone Research Fund; Qinghai Sports Science Institute	Funding was received from the Australian Institute of Sport High Performance Research Grant fund (LAG, CJG), the University of Canberra (KGT), Aspetar/Aspire Zone Research Fund (YOS), and Qinghai Sports Science Institute (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Aughey RJ, 2013, BRIT J SPORT MED, V47, P107; Bassett DR, 1999, MED SCI SPORT EXER, V31, P1665, DOI 10.1097/00005768-199911000-00025; Beidleman BA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-8; Billaut F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077297; Buchheit M, 2013, BRIT J SPORT MED, V47, P100, DOI 10.1136/bjsports-2013-092749; Calbet JAL, 2003, J APPL PHYSIOL, V94, P668, DOI 10.1152/japplphysiol.00128.2002; Clark SA, 2007, EUR J APPL PHYSIOL, V102, P45, DOI 10.1007/s00421-007-0554-0; Dekerle J, 2012, EUR J APPL PHYSIOL, V112, P327, DOI 10.1007/s00421-011-1979-z; Ebert TR, 2006, INT J SPORT PHYSIOL, V1, P324, DOI 10.1123/ijspp.1.4.324; Gardner AS, 2004, MED SCI SPORT EXER, V36, P1252, DOI 10.1249/01.MSS.0000132380.21785.03; Garvican LA, 2014, INT J SPORT PHYSIOL, V9, P397, DOI [10.1123/IJSPP.2012-0375, 10.1123/ijspp.2012-0375]; Garvican-Lewis LA, 2014, J APPL PHYSIOL, V117, P463, DOI 10.1152/japplphysiol.00242.2014; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gore CJ, 1997, EUR J APPL PHYSIOL, V75, P136, DOI 10.1007/s004210050138; Gore CJ, 1996, J APPL PHYSIOL, V80, P2204, DOI 10.1152/jappl.1996.80.6.2204; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; MCCOLE SD, 1990, J APPL PHYSIOL, V68, P748, DOI 10.1152/jappl.1990.68.2.748; Menaspa P, 2014, INT J SPORT PHYSIOL, V9, P884, DOI [10.1123/IJSPP.2013-0232, 10.1123/ijspp.2013-0232]; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Olds T, 2001, SPORTS MED, V31, P497, DOI 10.2165/00007256-200131070-00005; Olds T, 1995, Aust J Sci Med Sport, V27, P29; Padilla S, 2001, MED SCI SPORT EXER, V33, P796; PERONNET F, 1991, J APPL PHYSIOL, V70, P399, DOI 10.1152/jappl.1991.70.1.399; PRAMPERO PED, 1979, J APPL PHYSIOL, V47, P201, DOI 10.1152/jappl.1979.47.1.201; Quod MJ, 2010, INT J SPORTS MED, V31, P397, DOI 10.1055/s-0030-1247528; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Valli G, 2011, RESP PHYSIOL NEUROBI, V177, P333, DOI 10.1016/j.resp.2011.05.014; Vogt S, 2007, INT J SPORTS MED, V28, P756, DOI 10.1055/s-2007-964982; Vogt S, 2006, MED SCI SPORT EXER, V38, P147, DOI 10.1249/01.mss.0000183196.63081.6a; Vogt S, 2007, J SPORT SCI, V25, P1299, DOI 10.1080/02640410601001632; Wagner PD, 1996, RESP PHYSIOL, V106, P329, DOI 10.1016/S0034-5687(96)00086-2; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9	34	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143028	10.1371/journal.pone.0143028	http://dx.doi.org/10.1371/journal.pone.0143028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629912	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300024
J	Lang, K; Zhang, MY; Yuan, YB				Lang, Kun; Zhang, Mingyuan; Yuan, Yongbo			Improved Neural Networks with Random Weights for Short-Term Load Forecasting	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; SUPPORT VECTOR MACHINES	An effective forecasting model for short-term load plays a significant role in promoting the management efficiency of an electric power system. This paper proposes a new forecasting model based on the improved neural networks with random weights (INNRW). The key is to introduce a weighting technique to the inputs of the model and use a novel neural network to forecast the daily maximum load. Eight factors are selected as the inputs. A mutual information weighting algorithm is then used to allocate different weights to the inputs. The neural networks with random weights and kernels (KNNRW) is applied to approximate the nonlinear function between the selected inputs and the daily maximum load due to the fast learning speed and good generalization performance. In the application of the daily load in Dalian, the result of the proposed INNRW is compared with several previously developed forecasting models. The simulation experiment shows that the proposed model performs the best overall in short-term load forecasting.	[Lang, Kun; Zhang, Mingyuan; Yuan, Yongbo] Dalian Univ Technol, Fac Infrastruct Engn, Dalian 116024, Peoples R China	Dalian University of Technology	Zhang, MY (corresponding author), Dalian Univ Technol, Fac Infrastruct Engn, Dalian 116024, Peoples R China.	myzhang@dlut.edu.cn	ZHANG, Mingyuan/AAJ-4616-2020		National Natural Science Foundation of China [51208081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	MZ received funding from National Natural Science Foundation of China with Grant No. 51208081. http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan MF, 2006, MACH LEARN, V65, P79, DOI 10.1007/s10994-006-7550-1; Blum A, 2006, LECT NOTES COMPUT SC, V3940, P52; Chen BJ, 2004, IEEE T POWER SYST, V19, P1821, DOI 10.1109/TPWRS.2004.835679; Chen X, 2012, IEEE T POWER SYST, V27, P2055, DOI 10.1109/TPWRS.2012.2190627; Espinoza M, 2007, IEEE CONTR SYST MAG, V27, P43, DOI 10.1109/MCS.2007.904656; Frenzel S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.204101; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; He ZJ, 2005, LECT NOTES COMPUT SC, V3611, P324; Hippert HS, 2001, IEEE T POWER SYST, V16, P44, DOI 10.1109/59.910780; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; IGELNIK B, 1995, IEEE T NEURAL NETWOR, V6, P1320, DOI 10.1109/72.471375; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; LEE KY, 1992, IEEE T POWER SYST, V7, P124, DOI 10.1109/59.141695; Lian C, 2014, STOCH ENV RES RISK A, V28, P1957, DOI 10.1007/s00477-014-0875-6; Nizar AH, 2008, IEEE T POWER SYST, V23, P946, DOI 10.1109/TPWRS.2008.926431; Ortiz-Arroyo D., 2005, P INT C COMP INT MOD, V1, P94; Pai PF, 2005, ENERG CONVERS MANAGE, V46, P2669, DOI 10.1016/j.enconman.2005.02.004; Pai PF, 2005, ELECTR POW SYST RES, V74, P417, DOI 10.1016/j.epsr.2005.01.006; PAO YH, 1994, NEUROCOMPUTING, V6, P163, DOI 10.1016/0925-2312(94)90053-1; PAO YH, 1992, COMPUTER, V25, P76, DOI 10.1109/2.144401; PARK DC, 1991, IEEE T POWER SYST, V6, P442, DOI 10.1109/59.76685; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; SCHMIDT WF, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL II, P1, DOI 10.1109/ICPR.1992.201708; Taylor JW, 2002, IEEE T POWER SYST, V17, P626, DOI 10.1109/TPWRS.2002.800906; Yan J, 2013, 2013 IEEE INTERNATIONAL WORKSHOP ON INTELLIGENT ENERGY SYSTEMS (IWIES), P173, DOI 10.1109/IWIES.2013.6698581; Yu X., 2001, ISCAS 2001. The 2001 IEEE International Symposium on Circuits and Systems (Cat. No.01CH37196), P700, DOI 10.1109/ISCAS.2001.921407; Yu XH, 2002, IEEE T NEURAL NETWOR, V13, P251, DOI 10.1109/72.977323	30	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143175	10.1371/journal.pone.0143175	http://dx.doi.org/10.1371/journal.pone.0143175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629825	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300033
J	Saint-Maurice, PF; Welk, GJ				Saint-Maurice, Pedro F.; Welk, Gregory J.			Validity and Calibration of the Youth Activity Profile	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; DAILY ENERGY-EXPENDITURE; DOUBLY LABELED WATER; SEDENTARY BEHAVIOR; ACTIVITY MONITOR; HEART-RATE; CHILDREN; VALIDATION; ACCELEROMETRY; COSTS	Purpose The purpose of this study was to calibrate and cross-validate the Youth Activity Profile (YAP), a self-report tool designed to capture physical activity (PA) and sedentary behaviors (SB) in youth. Methods Eight schools in the Midwest part of the U.S. were involved and a total of 291 participants from grades 4-12 agreed to wear an accelerometer (SWA Armband) and complete the YAP in two separate weeks (5-7 days apart). Individual YAP items capture PA behavior during specific segments of the week and these items were combined with temporally matched estimates of moderate-to-vigorous PA (MVPA) and sedentary time from the SWA to enable calibration. Quantile regression procedures yielded YAP prediction algorithms that estimated MVPA at School, MVPA at Out-of-School, MVPA on Weekend, as well as time spent in SB. The YAP estimates of time spent in MVPA and SB were cross-validated using Pearson product correlations and limits of agreement, as indicative of individual error and, equivalence testing techniques as indicative of group-level error. Result Following calibration, the correlations between YAP and SWA estimates of MVPA were low to moderate (r(range) =.19 to.58) and individual-level YAP estimates of MVPA ranged from -134.9% to + 110.0% of SWA MVPA values. Differences between aggregated YAP and SWA MVPA ranged from -3.4 to 21.7 minutes of MVPA at the group-level and predicted YAP MVPA estimates were within 15%, 20%, and 30%, of values from the SWA for the School, Out-of-School, and Weekend time periods, respectively. Estimates of time spent in SB were highly correlated with each other (r =.75). The individual estimates of SB ranged from -54.0% to + 44.0% of SWA sedentary time, and the aggregated group-level estimates differed by 49.7 minutes (within 10% of the SWA aggregated estimates). Conclusions This study provides preliminary evidence that the calibration procedures enabled the YAP to provide estimates of MVPA and SB that approximated values from an objective monitor. The YAP provides a simple, low-cost and educationally sound method to accurately estimate children's MVPA and SB at the group level.	[Saint-Maurice, Pedro F.; Welk, Gregory J.] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA	Iowa State University	Saint-Maurice, PF (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	pedrosm@iastate.edu		Saint-Maurice, Pedro F./0000-0002-8752-2340	European Social Fund/Fundacao para a Ciencia e Tecnologia [SFRH/BD/60396/2009]	European Social Fund/Fundacao para a Ciencia e Tecnologia	This work has been partially funded by a grant from the European Social Fund/Fundacao para a Ciencia e Tecnologia (SFRH/BD/60396/2009), http://www.fct.pt/index.phtml.pt. There was no additional funding used in this study.	Arvidsson D, 2007, MED SCI SPORT EXER, V39, P2076, DOI 10.1249/mss.0b013e31814fb439; Arvidsson D, 2009, CLIN NUTR, V28, P305, DOI 10.1016/j.clnu.2009.03.006; Bailey DA, 1997, INT J SPORTS MED, V18, pS191, DOI 10.1055/s-2007-972713; BARANOWSKI T, 1994, AM J CLIN NUTR, V59, p212S, DOI 10.1093/ajcn/59.1.212S; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bowles HR, 2012, J PHYS ACT HEALTH, V9, pS1, DOI 10.1123/jpah.9.s1.s1; BULPITT CJ, 1987, LANCET, V1, P494; Calabro MA, 2013, MED SCI SPORTS EXERC; Calabro MA, 2009, MED SCI SPORT EXER, V41, P1714, DOI 10.1249/MSS.0b013e3181a071cf; Centers for Disease Control and Prevention, 2008, PHYS ACT GUID ADV CO; Chinapaw MJM, 2010, SPORTS MED, V40, P539, DOI 10.2165/11530770-000000000-00000; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Ekelund U, 1999, SCAND J MED SCI SPOR, V9, P257; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Eston RG, 1998, J APPL PHYSIOL, V84, P362, DOI 10.1152/jappl.1998.84.1.362; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; GIERE RN, 1972, BRIT J PHILOS SCI, V23, P170, DOI 10.1093/bjps/23.2.170; Harrell JS, 2005, MED SCI SPORT EXER, V37, P329, DOI 10.1249/01.MSS.0000153115.33762.3F; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Koplan J., 2005, PREVENTING CHILDHOOD; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P342, DOI 10.1123/pes.9.4.342; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; LIVINGSTONE MBE, 1992, AM J CLIN NUTR, V56, P343, DOI 10.1093/ajcn/56.2.343; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Midha KK, 2009, AAPS J, V11, P664, DOI 10.1208/s12248-009-9142-z; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Ridley K, 2008, MED SCI SPORT EXER, V40, P1439, DOI 10.1249/MSS.0b013e31817279ef; Saint-Maurice PF, 2014, J MED INTERNET RES, V16, P71, DOI 10.2196/jmir.3626; Saint-Maurice PF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-461; Saint-Maurice PF, 2015, EUR J APPL PHYSL; Schmitz KH, 2005, MED SCI SPORT EXER, V37, P155, DOI 10.1249/01.MSS.0000150084.97823.F7; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P370, DOI [10.1139/h2012-019, 10.1139/H2012-019, 10.1139/h2012-029, 10.1139/H2012-029]; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002	46	86	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143949	10.1371/journal.pone.0143949	http://dx.doi.org/10.1371/journal.pone.0143949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630346	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300128
J	Sen Majumder, S; Bhadra, A				Sen Majumder, Sreejani; Bhadra, Anindita			When Love Is in the Air: Understanding Why Dogs Tend to Mate when It Rains	PLOS ONE			English	Article							REPRODUCTIVE-ORGANS; FOOD QUALITY; PATTERNS; SEASONALITY; ECOLOGY; LIGHT; WARM	Seasonality of reproduction is observed in many species of organisms, across taxa, and is influenced by both biotic and abiotic factors. While such seasonality is easy to understand in temperate species exposed to extreme climates, it is more difficult to explain in the tropics. In many tropical species offspring are born during the season of high precipitation, which also coincides with high resource availability. Interestingly, in India, free-ranging dogs seem to mate, and not whelp, when it rains-an observation that cannot be explained by the resource abundance hypothesis. We carried out an extensive study to identify the mating seasons of free-ranging dogs, and observed a strong correlation between both the incidence and frequency of mating related behaviours of dogs, and precipitation levels. There are two clear mating seasons, of which the primary mating season coincides with the monsoon (rainy season) and the secondary mating season coincides with the nor'westerlies in this part of India. We speculate that this strong correlation is an effect of chemistry, rather than biology. While male dogs can mate round the year, females come into estrous seasonally. In the urban environment, dogs are exposed to a lot of olfactory noise, which can dilute the signal present in sex pheromones of the females in heat. A shower leads to increased humidity and reduced temperature of the air, leading to intensification of pheromone signals that trigger a sexual response in the dogs.	[Sen Majumder, Sreejani; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Kolkata, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Kolkata, India.	abhadra@iiserkol.ac.in	Bhadra, Anindita/H-6899-2019	Bhadra, Anindita/0000-0002-3717-9732	Women's Excellence Award by the Science and Engineering Board, Department of Science and Technology, India [SB/WEA-005/2013]; Indian Institute of Science Education and Research Kolkata, India	Women's Excellence Award by the Science and Engineering Board, Department of Science and Technology, India; Indian Institute of Science Education and Research Kolkata, India	The work was funded by the Women's Excellence Award No. SB/WEA-005/2013 by the Science and Engineering Board, Department of Science and Technology, India to AB; Indian Institute of Science Education and Research Kolkata, India provided infrastructural support.	Altmann J., 1980, BABOON MOTHERS INFAN; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Beaver B.V., 2009, CANINE BEHAV INSIGHT, Vsecond; Beck AM, 1973, ECOLOGY STRAY DOGS P; Bhadra A, 2016, ETHOL ECOL EVOL, V28, P427, DOI 10.1080/03949370.2015.1076526; Bodenheimer FS, 1954, PROBLEMS PHYSL ECOLO, P162; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Bronson F.H., 1989, Mammalian Reproductive Biology, P51; Bronson F.H., 1994, PHYSL REPROD, V2nd; BRONSON FH, 1995, Q REV BIOL, V70, P141, DOI 10.1086/418980; Chandola-Saklani A, 2004, CHRONOBIOL INT, V21, P553, DOI 10.1081/CBI-200025991; Clouet M, 2003, REV ECOL-TERRE VIE, V58, P419; Conover M. R., 2007, PREDATOR PREY DYNAMI; Di Bitetti MS, 2000, AM J PRIMATOL, V50, P109, DOI 10.1002/(SICI)1098-2345(200002)50:2<109::AID-AJP2>3.3.CO;2-N; DUNBAR IF, 1977, BEHAV BIOL, V20, P471, DOI 10.1016/S0091-6773(77)91079-3; Eiceman GA, 2014, ION MOBILITY SPECTROMETRY, 3RD EDITION, P1; ENGLE ET, 1946, J MAMMAL, V27, P79, DOI 10.2307/1375144; Ensminger JohnJ., 2012, POLICE MILITARY DOGS; Foxes Adlerton D., 1994, FOXES WOLVES WILD DO; GUTZWILLER KJ, 1990, WILDLIFE SOC B, V18, P351; HALL-MARTIN A J, 1975, East African Wildlife Journal, V13, P237; Hamlett G. W. D., 1938, Technical Bulletin United States Department of Agriculture, Vno. 616, P1; Hart RC, 2004, HYDROBIOLOGIA, V526, P99, DOI 10.1023/B:HYDR.0000041610.56021.63; HILL HH, 1990, ANAL CHEM, V62, pA1201, DOI 10.1021/ac00222a716; Hill Jr HH, 1990, REV ANAL CHEM, V21, P321, DOI [10.1080/10408349008050848, DOI 10.1080/10408349008050848]; Holekamp KE, 1999, J REPROD FERTIL, V116, P87; IMD, 2010, MET MONOGRAPH NO ENV, P1, DOI DOI 10.1007/S12524-010-0015-9; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Joseph PV, 2012, MONSOON MONOGRAPH, VI, P284; Kuehn M, 2008, EUR ARCH OTO-RHINO-L, V265, P299, DOI 10.1007/s00405-007-0446-2; KUMAR BS, 1991, GEN COMP ENDOCR, V83, P354, DOI 10.1016/0016-6480(91)90140-2; Lampo M, 1996, J TROP ECOL, V12, P321, DOI 10.1017/S0266467400009500; Lancaster J. B., 1965, P486; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Makinen M, 2011, MASS SPECTROM REV, V30, P940, DOI 10.1002/mas.20308; MARTIN GB, 1995, J REPROD FERTIL, P437; Mayer W, 2012, PHYSL MAMMALOGY, V2; Ortega-Pacheco A, 2006, REPROD DOMEST ANIM, V41, P429, DOI 10.1111/j.1439-0531.2006.00688.x; Pal SK, 2001, ACTA THERIOL, V46, P69, DOI 10.1007/BF03192418; Pal SK, 2001, INT J ZOOLOGY; Pankhurst NW, 2003, FISH PHYSIOL BIOCHEM, V28, P385, DOI 10.1023/B:FISH.0000030602.51939.50; PATTERSON JW, 1991, OECOLOGIA, V86, P419, DOI 10.1007/BF00317611; Paul M, 2014, J ETHOL, V32, P75, DOI 10.1007/s10164-014-0396-2; Paul M, 2014, BEHAV PROCESS, V103, P17, DOI 10.1016/j.beproc.2013.10.006; Perl T, 2009, BRIT J ANAESTH, V103, P822, DOI 10.1093/bja/aep312; Prakash I., 1960, INDIA J MAMMAL, V41, P386, DOI DOI 10.2307/1377497; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Rubenstein DR, 2003, ECOLOGY, V84, P3013, DOI 10.1890/02-0354; Sampson J, 2001, GENETICS DOGS; Seager S.W.J., 1986, P852; Simpson G, 1997, CAPABILITIES LIMITAT; Skinner J. D., 2002, Transactions of the Royal Society of South Africa, V57, P25; SMITH NS, 1973, J WILDLIFE MANAGE, V37, P524, DOI 10.2307/3800318; Solanki GS, 2013, CURR SCI INDIA, V104, P1081; Spotte S, 2012, SOCIETIES OF WOLVES AND FREE-RANGING DOGS, P1, DOI 10.1017/CBO9781139057769; Sreedevi MB, 2007, SMALL CARNIV CONSERV, V36; Tecot SR, 2010, INT J PRIMATOL, V31, P715, DOI 10.1007/s10764-010-9423-5; Tinney GM, 2001, AFR ZOOL, V36, P23; Tripp AC, 2003, P SOC PHOTO-OPT INS, V5089, P983, DOI 10.1117/12.485637; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Vanak AT, 2009, BEHAV ECOL SOCIOBIOL, V64, P279, DOI 10.1007/s00265-009-0845-z; Vanak AT, 2009, J MAMMAL, V90, P1058, DOI 10.1644/09-MAMM-A-107.1; VANDENBERGH JG, 1968, J REPROD FERTIL, V15, P71, DOI 10.1530/jrf.0.0150071; Vautz W, 2004, ANAL CHIM ACTA, V513, P393, DOI 10.1016/j.aca.2004.03.016; Verdolin J, 2005, SEASONALITY PRIMATE; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; WOOLPY JH, 1967, AM ZOOL, V7, P305; Xie Z, 2000, IJIMS, V4, P78; Xie Z., 2000, INT J ION MOBILITY S, V4, P77; Yeomans MR, 2006, J EXP PSYCHOL ANIM B, V32, P215, DOI 10.1037/0097-7403.32.3.215	72	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143501	10.1371/journal.pone.0143501	http://dx.doi.org/10.1371/journal.pone.0143501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629906	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300054
J	Wang, XZ; Liu, ZM; Liu, JC; Huo, MX; Huo, HL; Yang, W				Wang, Xianze; Liu, Zhongmou; Liu, Jiancong; Huo, Mingxin; Huo, Hongliang; Yang, Wu			Removing Phosphorus from Aqueous Solutions Using Lanthanum Modified Pine Needles	PLOS ONE			English	Article							ACTIVATED CARBON-FIBER; PHOSPHATE ADSORPTION; WASTE-WATER; METHYLENE-BLUE; IONIC-STRENGTH; KINETICS; BEHAVIOR; HYDROXIDE; MECHANISM; EQUILIBRIUM	The renewable pine needles was used as an adsorbent to remove phosphorus from aqueous solutions. Using batch experiments, pine needles pretreated with alkali-isopropanol (AI) failed to effectively remove phosphorus, while pine needles modified with lanthanum hydroxide (LH) showed relatively high removal efficiency. LH pine needles were effective at a wide pH ranges, with the highest removal efficiency reaching approximately 85% at a pH of 3. The removal efficiency was kept above 65% using 10 mg/L phosphorus solutions at desired pH values. There was no apparent significant competitive behavior between coexisting anions of sulfate, nitrate, and chloride (SO42-, NO3- and Cl-); however, CO32- exhibited increased interfering behavior as concentrations increased. An intraparticle diffusion model showed that the adsorption process occurred in three phases, suggesting that a boundary layer adsorption phenomena slightly affected the adsorption process, and that intraparticle diffusion was dominant. The adsorption process was thermodynamically unfavorable and non-spontaneous; temperature increases improved phosphorus removal. Total organic carbon (TOC) assays indicated that chemical modification reduced the release of soluble organic compounds from 135.6 mg/L to 7.76 mg/L. This new information about adsorption performances provides valuable information, and can inform future technological applications designed to remove phosphorus from aqueous solutions.	[Wang, Xianze; Liu, Zhongmou; Liu, Jiancong; Huo, Mingxin; Huo, Hongliang; Yang, Wu] NE Normal Univ, Sch Environm, Changchun, Peoples R China; [Huo, Mingxin; Huo, Hongliang; Yang, Wu] Jilin Engn Res Ctr Municipal Wastewater Treatment, Changchun, Peoples R China	Northeast Normal University - China	Huo, HL (corresponding author), NE Normal Univ, Sch Environm, Changchun, Peoples R China.	huohl001@163.com; yangw104@nenu.edu.cn			National Natural Science Foundation of China [51238001]; Fundamental Research Funds for the Central Universities [2412015KJ025]; China Scholarship Council [201404480081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Scholarship Council(China Scholarship Council)	This research was supported by the National Natural Science Foundation of China (No. 51238001), the Fundamental Research Funds for the Central Universities (2412015KJ025) and the China Scholarship Council (No. 201404480081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Degs YS, 2008, DYES PIGMENTS, V77, P16, DOI 10.1016/j.dyepig.2007.03.001; Association EFM, 2000, PHOSPH ESS EL FOOD P; Benyoucef Salah, 2011, Environmentalist, V31, P200, DOI 10.1007/s10669-011-9313-1; Berg B., 1980, Ecological Bulletins, V32, P373; Biswas BK, 2007, J COLLOID INTERF SCI, V312, P214, DOI 10.1016/j.jcis.2007.03.072; Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a; Carvalho WS, 2011, BIOMASS BIOENERG, V35, P3913, DOI 10.1016/j.biombioe.2011.06.014; Chen Guang-yin, 2010, Huanjing Kexue, V31, P2208; Chitrakar R, 2006, J COLLOID INTERF SCI, V297, P426, DOI 10.1016/j.jcis.2005.11.011; Cooper J, 2011, RESOUR CONSERV RECY, V57, P78, DOI 10.1016/j.resconrec.2011.09.009; Dawson CJ, 2011, FOOD POLICY, V36, pS14, DOI 10.1016/j.foodpol.2010.11.012; de-Bashan LE, 2004, WATER RES, V38, P4222, DOI 10.1016/j.watres.2004.07.014; Eberhardt TL, 2008, BIORESOURCE TECHNOL, V99, P626, DOI 10.1016/j.biortech.2006.12.037; Egal M, 2008, CELLULOSE, V15, P361, DOI 10.1007/s10570-007-9185-1; Feng NC, 2009, J HAZARD MATER, V164, P1286, DOI 10.1016/j.jhazmat.2008.09.096; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Frisoni G, 2001, BIOMACROMOLECULES, V2, P476, DOI 10.1021/bm0056409; Ghosh D, 2002, APPL CLAY SCI, V20, P295, DOI 10.1016/S0169-1317(01)00081-3; Han JS, 2005, FOREST PROD J, V55, P48; Huang WY, 2014, CHEM ENG J, V236, P191, DOI 10.1016/j.cej.2013.09.077; Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0; Kuyucak N, 1990, BIOSORPTION HEAVY ME, P372; Lewis L., 2008, TIMES, V23; Li H, 2009, J HAZARD MATER, V168, P326, DOI 10.1016/j.jhazmat.2009.02.025; Liu JY, 2013, CHEM ENG J, V215, P859, DOI 10.1016/j.cej.2012.11.067; Liu JY, 2011, J COLLOID INTERF SCI, V364, P490, DOI 10.1016/j.jcis.2011.08.067; Loganathan P, 2014, CRIT REV ENV SCI TEC, V44, P847, DOI 10.1080/10643389.2012.741311; Lu JB, 2013, POWDER TECHNOL, V233, P146, DOI 10.1016/j.powtec.2012.08.024; Luo P, 2010, WATER RES, V44, P1489, DOI 10.1016/j.watres.2009.10.042; Mezenner NY, 2009, CHEM ENG J, V147, P87, DOI 10.1016/j.cej.2008.06.024; Mohan SV, 2002, J HAZARD MATER, V90, P189, DOI 10.1016/S0304-3894(01)00348-X; Morse GK, 1998, SCI TOTAL ENVIRON, V212, P69, DOI 10.1016/S0048-9697(97)00332-X; NAKAMURA S, 1992, J APPL POLYM SCI, V45, P265, DOI 10.1002/app.1992.070450207; Namasivayam C, 2004, J COLLOID INTERF SCI, V280, P359, DOI 10.1016/j.jcis.2004.08.015; Nguyen TAH, 2013, BIORESOURCE TECHNOL, V150, P42, DOI 10.1016/j.biortech.2013.09.133; Pappa A, 2000, J ANAL APPL PYROL, V55, P195, DOI 10.1016/S0165-2370(99)00099-6; Pitakteeratham N, 2013, WATER RES, V47, P3583, DOI 10.1016/j.watres.2013.04.006; Tian SL, 2009, CHEM ENG J, V151, P141, DOI 10.1016/j.cej.2009.02.006; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; Wasay SA, 1996, WATER ENVIRON RES, V68, P295, DOI 10.2175/106143096X127730; White JG, 1999, FIELD CROP RES, V60, P11, DOI 10.1016/S0378-4290(98)00130-0; Xu X, 2010, BIORESOURCE TECHNOL, V101, P8558, DOI 10.1016/j.biortech.2010.06.060; Yoon SY, 2014, CHEM ENG J, V236, P341, DOI 10.1016/j.cej.2013.09.053; Yue QY, 2010, WATER ENVIRON RES, V82, P374, DOI 10.2175/106143009X12529484815719; Zach-Maor A, 2011, J COLLOID INTERF SCI, V363, P608, DOI 10.1016/j.jcis.2011.07.062; Zhang JD, 2011, J HAZARD MATER, V186, P76, DOI 10.1016/j.jhazmat.2010.10.076; Zhang JD, 2010, J ENVIRON SCI-CHINA, V22, P507, DOI 10.1016/S1001-0742(09)60141-8; Zhang L, 2012, CHEM ENG J, V185, P160, DOI 10.1016/j.cej.2012.01.066	48	13	13	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142700	10.1371/journal.pone.0142700	http://dx.doi.org/10.1371/journal.pone.0142700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630014	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300015
J	Holthuijzen, MF; Veblen, KE				Holthuijzen, Maike F.; Veblen, Kari E.			Grass-Shrub Associations over a Precipitation Gradient and Their Implications for Restoration in the Great Basin, USA	PLOS ONE			English	Article							SAGEBRUSH STEPPE; HYDRAULIC LIFT; POSITIVE INTERACTIONS; ARTEMISIA-TRIDENTATA; RETAMA-SPHAEROCARPA; PLANT INTERACTIONS; SPATIAL-PATTERNS; FACILITATION; COMPETITION; STRESS	As environmental stress increases positive (facilitative) plant interactions often predominate. Plant-plant associations (or lack thereof) can indicate whether certain plant species favor particular types of microsites (e.g., shrub canopies or plant-free interspaces) and can provide valuable insights into whether "nurse plants" will contribute to seeding or planting success during ecological restoration. It can be difficult, however, to anticipate how relationships between nurse plants and plants used for restoration may change over large-ranging, regional stress gradients. We investigated associations between the shrub, Wyoming big sagebrush (Artemisia tridentata ssp. wyomingensis), and three common native grasses (Poa secunda, Elymus elymoides, and Pseudoroegneria spicata), representing short-, medium-, and deep-rooted growth forms, respectively, across an annual rainfall gradient (220-350 mm) in the Great Basin, USA. We hypothesized that positive shrub-grass relationships would become more frequent at lower rainfall levels, as indicated by greater cover of grasses in shrub canopies than vegetation-free interspaces. We sampled aerial cover, density, height, basal width, grazing status, and reproductive status of perennial grasses in canopies and interspaces of 25-33 sagebrush individuals at 32 sites along a rainfall gradient. We found that aerial cover of the shallow rooted grass, P. secunda, was higher in sagebrush canopy than interspace microsites at lower levels of rainfall. Cover and density of the medium-rooted grass, E. elymoides were higher in sagebrush canopies than interspaces at all but the highest rainfall levels. Neither annual rainfall nor sagebrush canopy microsite significantly affected P. spicata cover. E. elymoides and P. spicata plants were taller, narrower, and less likely to be grazed in shrub canopy microsites than interspaces. Our results suggest that exploring sagebrush canopy microsites for restoration of native perennial grasses might improve plant establishment, growth, or survival (or some combination thereof), particularly in drier areas. We suggest that land managers consider the nurse plant approach as a way to increase perennial grass abundance in the Great Basin. Controlled experimentation will provide further insights into the life stage-specific effectiveness and practicality of a nurse plant approach for ecological restoration in this region.	[Veblen, Kari E.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Veblen, KE (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	kari.veblen@usu.edu	Veblen, Kari E./D-1439-2012	Veblen, Kari E./0000-0001-7523-3368	National Science Foundation; Utah State University Ecology Center; Utah Agricultural Experiment Station [UTA01071]; Great Basin Native Plant Selection and Increase Project	National Science Foundation(National Science Foundation (NSF)); Utah State University Ecology Center; Utah Agricultural Experiment Station; Great Basin Native Plant Selection and Increase Project	The following entities contributed to funding our research: the National Science Foundation Graduate Research Fellowship Program (MFH) https://www.nsfgrfp.org/, Utah State University Ecology Center http://www.usu.edu/ecology/, Utah Agricultural Experiment Station http://uaes.usu.edu/ (grant #UTA01071), and the Great Basin Native Plant Selection and Increase Project http://www.fs.fed.us/rm/boise/research/shrub/greatbasin.shtml, for funding. The funders had no role in study design,	Anderson JE, 2001, ECOL MONOGR, V71, P531, DOI 10.1890/0012-9615(2001)071[0531:LSCIPS]2.0.CO;2; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Cardon ZG, 2013, P NATL ACAD SCI USA, V110, P18988, DOI 10.1073/pnas.1311314110; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; Chambers JC, 2000, ECOL APPL, V10, P1400, DOI 10.2307/2641294; Chambers JC, 2001, J VEG SCI, V12, P27, DOI 10.1111/j.1654-1103.2001.tb02614.x; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; Chambers JC, 2014, ECOSYSTEMS, V17, P360, DOI 10.1007/s10021-013-9725-5; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Daly C., 2013, PRISM CLIMATE WEATHE; Davies KW, 2007, J ARID ENVIRON, V69, P441, DOI 10.1016/j.jaridenv.2006.10.017; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Dibble MS, 1987, CELL WATER POTENTIAL, P73; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gasque M, 2004, FOREST ECOL MANAG, V189, P251, DOI 10.1016/j.foreco.2003.08.014; Giladi I, 2013, J ECOL, V101, P97, DOI 10.1111/1365-2745.12019; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Griffith AB, 2010, ECOLOGY, V91, P141, DOI 10.1890/08-1446.1; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hironaka M, 1973, GROWTH DEV SITANION; Howard J, 1999, ARTEMISIA TRIDENTATA; Howard J, 1997, POA SECUNDA; Huber-Sannwald E, 2005, RESTOR ECOL, V13, P292, DOI 10.1111/j.1526-100X.2005.00037.x; Jankju M, 2013, J ARID ENVIRON, V89, P103, DOI 10.1016/j.jaridenv.2012.09.008; Jones TA, 1998, J RANGE MANAGE, V51, P326, DOI 10.2307/4003419; Knutson KC, 2014, J APPL ECOL; Liu N, 2013, RESTOR ECOL, V21, P578, DOI 10.1111/j.1526-100X.2012.00937.x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Noss R.F., 1995, ENDANGERED ECOSYSTEM; NRCS, 2015, MLRA DEF; NRCS, 2006, LAND RES REG MAJ LAN, P669; Poulos JM, 2014, PLANT ECOL, V215, P417, DOI 10.1007/s11258-014-0312-4; Prieto I, 2014, TREE PHYSIOL; Prieto I, 2011, PERSPECT PLANT ECOL, V13, P181, DOI 10.1016/j.ppees.2011.05.002; Purves WK, 2003, LIFE SCI BIOL; Rayburn AP, 2011, RANGELAND ECOL MANAG, V64, P276, DOI 10.2111/REM-D-10-00130.1; Reisner MD, 2010, DRIVERS PLANT COMMUN; Reisner MD, 2015, J VEG SCI, V26, P1212, DOI 10.1111/jvs.12327; Reisner MD, 2013, J APPL ECOL, V50, P1039, DOI 10.1111/1365-2664.12097; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Rodhouse TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00169.1; SAS, 2010, N CAR; Schleicher J, 2011, J VEG SCI, V22, P1038, DOI 10.1111/j.1654-1103.2011.01310.x; Simonin K, 2001, ELYMUS ELYMOIDES; Soliveres S, 2013, J ARID ENVIRON, V91, P104, DOI 10.1016/j.jaridenv.2012.12.011; Soliveres S, 2015, BIOL REV, V90, P297, DOI 10.1111/brv.12110; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tilley D., 2013, PLANT FACT SHEET BLU; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; VALIENTEBANUET A, 1991, J ECOL, V79, P961, DOI 10.2307/2261091; Veblen KE, 2008, ECOLOGY, V89, P1532, DOI 10.1890/07-0973.1; Veblen KE, 2010, J ECOL, V98, P993, DOI 10.1111/j.1365-2745.2010.01705.x; WELCH B, 2005, BIG SAGEBRUSH SEA FR; Ziffer-Berger J, 2014, J ARID ENVIRON, V102, P27, DOI 10.1016/j.jaridenv.2013.11.006; Zlatnick E, 1999, PSEUDOROEGNERIA SPIC	65	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143170	10.1371/journal.pone.0143170	http://dx.doi.org/10.1371/journal.pone.0143170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625156	Green Published, gold			2022-12-26	WOS:000365891600016
J	Lam, W; Dawson, A; Fowler, C				Lam, Winsome; Dawson, Angela; Fowler, Cathrine			The Health Literacy of Hong Kong Chinese Parents with Preschool Children in Seasonal Influenza Prevention: A Multiple Case Study at Household Level	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SUBTROPICAL CITY; ORAL-HEALTH; FACE MASKS; INTERNET; INFORMATION; TRANSMISSION; BEHAVIORS; HOSPITALIZATION; VACCINATION	Background Health literacy influences individual and family health behaviour, health services use, and ultimately health outcomes and health care costs. In Hong Kong, people are at risk of seasonal influenza infection twice a year for three-month periods. Seasonal influenza is significantly associated with an increased number of hospitalized children. There is no research that provides an understanding of parents' health knowledge and their access to health information concerning seasonal influenza, nor their capacity to effectively manage influenza episodes in household. Such knowledge provides valuable insight into enhancing parents' health literacy to effectively communicate health messages to their children and support healthy behaviour development through role modelling. Methods A multiple case study was employed to gain a multifaceted understanding of parents' health literacy regarding seasonal influenza prevention. Purposive intensity sampling was adopted to recruit twenty Hong Kong Chinese parents with a healthy three-to-five year old preschool child from three kindergartens. A content analysis was employed to categorize, tabulate and combine data to address the propositions of the study. Comprehensive comparisons were made across cases to reveal the commonalities and differences. Results Four major themes were identified: inadequate parents' knowledge and reported skills and practices related to seasonal influenza prevention; parental knowledge seeking and exchange practices through social connection; parents' approaches to health information and limited enabling environments including shortage of health resources and uneven resource allocation for health promotion. Conclusions The findings recommend that community health professionals can play a critical role in increasing parents' functional, interactive and critical health literacy; important elements when planning and implementing seasonal influenza health promotion.	[Lam, Winsome] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Dawson, Angela; Fowler, Cathrine] Univ Technol Sydney, Fac Hlth, Sydney, NSW 2007, Australia	Hong Kong Polytechnic University; University of Technology Sydney	Lam, W (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	winsome.lam@polyu.edu.hk	Fowler, Cathrine/F-8091-2017	Fowler, Cathrine/0000-0002-7838-8434; , lam winsome/0000-0001-9155-6036				Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bhandari N, 2014, J AM MED INFORM ASSN, V21, P1113, DOI 10.1136/amiajnl-2013-002350; Brigham EL, 2016, CLIN PEDIATR, V55, P111, DOI 10.1177/0009922815587089; Centre for Health Promotion of Hong Kong, 2010, STRAT PLAN 2010 2014; Centre of Health Protection of Hong Kong, 2014, US MASK PROP PROT OU; Centre of Health Protection of Hong Kong, 2012, INFL; Centre of Health Protection of Hong Kong, 2014, HAND HYG EAS EFF WAY; Chan PKS, 2013, CLIN INFECT DIS, V56, P677, DOI 10.1093/cid/cis885; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Creswell J. W., 2007, QUALITATIVE INQUIRY; Crotty, 1998, FDN SOCIAL RES MEANI; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; [Department of Health of Hong Kong Health HKDo], 2015, HONG KONG HONG KONG; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Fiksdal AS, 2014, J MED INTERNET RES, V16, P185, DOI 10.2196/jmir.3341; Gilmour JA, 2007, INT J NURS STUD, V44, P1270, DOI 10.1016/j.ijnurstu.2006.05.007; Green LW., 2005, HLTH PROGRAMME PLANN, V4th; Gussy MG, 2008, AUST DENT J, V53, P52, DOI 10.1111/j.1834-7819.2007.00010.x; Healy JC, 2006, INT J MED INFORM, V75, P5, DOI 10.1016/j.ijmedinf.2005.07.030; Huber JT, 2012, LIBR QUART, V82, P429, DOI 10.1086/667438; Lam W, 2014, COMPR CHILD ADOLES N, V37, P250, DOI 10.3109/01460862.2014.951132; Lam W, 2015, J CLIN NURS, V24, P891, DOI 10.1111/jocn.12646; Lau JTF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1026; Leung SF, 2013, J ADV NURS, V69, P66, DOI 10.1111/j.1365-2648.2012.05988.x; Loo PW, 2012, ASIA-PAC PSYCHIAT, V4, P113, DOI 10.1111/j.1758-5872.2012.00198.x; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Morrison G, 2008, EARLY CHILDHOOD ED T; Morse JM., 2002, QUALITATIVE RES METH, V3rd; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D., 2010, THEORY NUTSHELL PRAC; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Parker R, 2000, HEALTH PROMOT INT, V15, P277, DOI 10.1093/heapro/15.4.277; Pilot DF, 2004, NURSING RES PRINCIPL; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Public Opinion Programme, 2013, PERS HYG AW 10 YEARS; Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032; Schor E, 1995, FAMILY PATHWAYS CHIL; Simmerman JM, 2011, INFLUENZA OTHER RESP, V5, P256, DOI 10.1111/j.1750-2659.2011.00205.x; Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80; Stake R. E., 1995, ART CASE STUDY RES; Stockwell MS, 2012, JAMA-J AM MED ASSOC, V307, P1702, DOI 10.1001/jama.2012.502; Uwemedimo OT, 2012, J COMMUN HEALTH, V37, P663, DOI 10.1007/s10900-011-9497-9; von Wagner C, 2009, PATIENT EDUC COUNS, V75, P352, DOI 10.1016/j.pec.2009.03.015; WHO, 2009, INFL SEAS; WHO, 2015, HLTH LIT HLTH BEH 20; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong HM, 2013, INT J PAEDIATR DENT, V23, P366, DOI 10.1111/ipd.12021; World Health Organisation, 2009, INF CONTR MEAS HLTH; World Health Organization, 2010, WHAT IS PANDEMIC H1N; Ybarra ML, 2006, INT J MED INFORM, V75, P29, DOI 10.1016/j.ijmedinf.2005.07.029; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Yin R. K., 2012, APPL CASE STUDY RES, V3rd	54	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143844	10.1371/journal.pone.0143844	http://dx.doi.org/10.1371/journal.pone.0143844			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26624284	Green Published, gold			2022-12-26	WOS:000365891600056
J	Tachibana, Y; Koizumi, T; Takehara, K; Kakee, N; Tsujii, H; Mori, R; Inoue, E; Ota, E; Yoshida, K; Kasai, K; Okuyama, M; Kubo, T				Tachibana, Yoshiyuki; Koizumi, Tomoe; Takehara, Kenji; Kakee, Naoko; Tsujii, Hiromi; Mori, Rintaro; Inoue, Eisuke; Ota, Erika; Yoshida, Keiko; Kasai, Keiko; Okuyama, Makiko; Kubo, Takahiko			Antenatal Risk Factors of Postpartum Depression at 20 Weeks Gestation in a Japanese Sample: Psychosocial Perspectives from a Cohort Study in Tokyo	PLOS ONE			English	Article							POSTNATAL DEPRESSION; SOCIAL SUPPORT; MENTAL-HEALTH; PERINATAL DEPRESSION; MATERNAL DEPRESSION; PREGNANT-WOMEN; LOW-INCOME; SYMPTOMS; IMPACT; METAANALYSIS	Background Prevalence of postnatal depression (PND) is high (Western countries, 10-15%; Japan, 17%). PND can cause parenting impairment and affect family health (e.g. child behaviors, cognitive development and physical health). This study aimed to reveal the risk factors of PND during the pregnancy period in a Japanese sample, and to identify the psychosocial risk factors of PND that should be appended to existing obstetric interview sheets. A cohort study with a Japanese sample was conducted. Methods All 14 obstetrics hospitals in the Setagaya ward, Tokyo, Japan, participated in this study. Pregnant women who booked their delivery between December 2012 and May 2013 were enrolled. Data used for this study were collected at 20 weeks gestation, a few days and one month postnatal. The questionnaires consisted of psychosocial factors and the Edinburgh Postnatal Depression Scale (EPDS). To identify PND risk factors, multivariate analyses were performed. Results A total of 1,775 women participated in this study. Eventually, the data of 1,133 women were used for the multivariate analyses. The demonstrated significant risk factors include EPDS score, primipara, "a perceived lack of family cohesion", "current physical illness treatment" and "current psychiatric illness treatment". Conclusion This study highlights the importance of mental health screening using psychological measures during the pregnancy period. In addition, family environment, parity, physical and psychiatric illness should be paid attention by professionals in maternal and child health. The results also suggest that mothers' feelings of developing their families should be supported.	[Tachibana, Yoshiyuki] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Infant & Toddler Mental Hlth, Tokyo, Japan; [Koizumi, Tomoe] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Takehara, Kenji; Mori, Rintaro; Ota, Erika] Natl Res Inst Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Kakee, Naoko] Natl Ctr Child Hlth & Dev, Div Bioeth, Tokyo, Japan; [Tsujii, Hiromi; Okuyama, Makiko] Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Tokyo, Japan; [Inoue, Eisuke] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Dept Biostat, Tokyo, Japan; [Kasai, Keiko] Japanese Midw Assoc, Tokyo, Japan; [Yoshida, Keiko] Kyushu Univ Hosp, Dept Child Psychiat, Fukuoka 812, Japan; [Kubo, Takahiko] Shirota Obstetr & Gynecol Hosp, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Kyushu University	Tachibana, Y (corresponding author), Natl Ctr Child Hlth & Dev, Dept Psychosocial Med, Div Infant & Toddler Mental Hlth, Tokyo, Japan.	tachibana-y@ncchd.go.jp	Koizumi, Tomoe/ABB-9080-2020	Koizumi, Tomoe/0000-0002-5905-0737; Takehara, Kenji/0000-0002-5957-600X; Mori, Rintaro/0000-0001-7656-6156; Ota, Erika/0000-0002-3945-7441	Ministry of Health, Labor and Welfare of Japan [H24-Jisedai-Shitei-006, H25-Seisin-Wakate-013]; National Center for Child Health and Development [H26-48]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was conducted under the title, "Research on the assessment of the mental health condition of women during the prenatal and postnatal periods, and appropriate interventions", supported by the Health and Labor Sciences Research Grant on Children, Youth and Families (H24-Jisedai-Shitei-006), and the title "Research on the promotion for networks cooperating with hospitals, public health, and welfare to support women with depression in the perinatal periods" (H25-Seisin-Wakate-013) by the Health and Labor Science Research Grant on Psychiatry and Neurological Disease and Mental Health, provided by the Ministry of Health, Labor and Welfare of Japan, and the title "Research on child abuse prevention and follow-up for families at high risk of child abuse" by Research Development Grant for Child Health and Development from National Center for Child Health and Development (H26-48).	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; Allison P., 1999, LOGISTIC REGRESSION, P167; Barbarin O, 1984, MEASURING BASI UNPUB; Barber BK, 1996, J MARRIAGE FAM, V58, P433, DOI 10.2307/353507; Barnett B, 2005, SCREENING PERINATAL, P68; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Boyce P M, 2003, Arch Womens Ment Health, V6 Suppl 2, pS43, DOI 10.1007/s00737-003-0005-9; Brand SR, 2009, CLIN OBSTET GYNECOL, V52, P441, DOI 10.1097/GRF.0b013e3181b52930; Cadzow SP, 1999, CHILD ABUSE NEGLECT, V23, P845, DOI 10.1016/S0145-2134(99)00063-0; Chee CYI, 2005, J AFFECT DISORDERS, V89, P157, DOI 10.1016/j.jad.2005.09.004; Condon JT, 2004, AUST NZ J PSYCHIAT, V38, P56, DOI 10.1177/000486740403800102; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; de Tychey C, 2005, J AFFECT DISORDERS, V85, P323, DOI 10.1016/J.JAD.2004.11.004; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Dorheim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094674; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Flykt M, 2010, INFANT CHILD DEV, V19, P530, DOI 10.1002/icd.679; Furukawa TA, 1999, SOC PSYCH PSYCH EPID, V34, P216, DOI 10.1007/s001270050136; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Gress-Smith JL, 2012, MATERN CHILD HLTH J, V16, P887, DOI 10.1007/s10995-011-0812-y; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kitamura T, 2006, ARCH WOMEN MENT HLTH, V9, P121, DOI 10.1007/s00737-006-0122-3; Kitamura T, 1996, PSYCHOTHER PSYCHOSOM, V65, P117, DOI 10.1159/000289062; Kokubu M, 2012, ARCH WOMEN MENT HLTH, V15, P211, DOI 10.1007/s00737-012-0279-x; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lebra TS., 1985, JAPANESE WOMEN CONST; Lee D. T. S., 2000, Hong Kong Medical Journal, V6, P349; Leung SSK, 2005, RES NURS HEALTH, V28, P27, DOI 10.1002/nur.20053; Lydsdottir LB, 2014, J CLIN PSYCHIAT, V75, P393, DOI 10.4088/JCP.13m08646; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Ministry of Health LaW, 2013, YB JAPANESE MINISTRY; Miyake Y, 2011, J AFFECT DISORDERS, V130, P133, DOI 10.1016/j.jad.2010.10.024; Moos RH, 1980, SOCIAL CLIMATE SCALE; Morikawa M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10520; Morse CA, 2000, J PSYCHOSOM OBST GYN, V21, P109, DOI 10.3109/01674820009075616; Munk-Olsen T, 2014, BIPOLAR DISORD, V16, P300, DOI 10.1111/bdi.12145; Murakami M, 2010, STATISTICS, P13; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Okano T, 1996, ARCH PSYCHIATR DIAGN, V7, P525; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; RICKHAM PP, 1964, BRIT MED J, V2, P173; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Tachibana Y, 2013, RES REPORT PROMOTION, P1; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Yoshida K, 2001, PEDIATR INT, V43, P189, DOI 10.1046/j.1442-200x.2001.01370.x	53	22	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142410	10.1371/journal.pone.0142410	http://dx.doi.org/10.1371/journal.pone.0142410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26625132	gold, Green Submitted, Green Published			2022-12-26	WOS:000365891600007
J	Cheng, H; Liu, P; Ohlson, C; Xu, E; Symonds, L; Isabella, A; Muller, WJ; Lin, NU; Krop, IE; Roberts, TM; Winer, EP; Arteaga, CL; Zhao, JJ				Cheng, H.; Liu, P.; Ohlson, C.; Xu, E.; Symonds, L.; Isabella, A.; Muller, W. J.; Lin, N. U.; Krop, I. E.; Roberts, T. M.; Winer, E. P.; Arteaga, C. L.; Zhao, J. J.			PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling	ONCOGENE			English	Article							HUMAN BREAST-CANCER; PIK3CA MUTATIONS; TRASTUZUMAB RESISTANCE; ADJUVANT CHEMOTHERAPY; METABOLIC-REGULATION; UP-REGULATION; INHIBITION; EXPRESSION; PATHWAY; IMPACT	Human breast cancers that have HER2 amplification/overexpression frequently carry PIK3CA mutations, and are often associated with a worse prognosis. However, the role of PIK3CA mutations in the initiation and maintenance of these breast cancers remains elusive. In the present study, we generated a compound mouse model that genetically mimics HER2-positive breast cancer with coexisting PIK3CA(H1047R). Induction of PIK3CA(H1047R) expression in mouse mammary glands with constitutive expression of activated Her2/Neu resulted in accelerated mammary tumorigenesis with enhanced metastatic potential. Interestingly, inducible expression of mutant PIK3CA resulted in a robust activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling but attenuation of Her2/Her3 signaling, and this can be reversed by deinduction of PIK3CA(H1047R) expression. Strikingly, although these Her2(+) PIK3CA(H1047R) initiated primary mammary tumors are refractory to HER2-targeted therapy, all tumors responded to inactivation of the oncogenic PIK3CA(H1047R), a situation closely mimicking the use of a highly effective inhibitor specifically targeting the mutant PIK3CA/p110a. Notably, these tumors eventually resumed growth, and a fraction of them escaped PI3K dependence by compensatory ERK activation, which can be blocked by combined inhibition of Her2 and MEK. Together, these results suggest that PIK3CA-specific inhibition as a monotherapy followed by combination therapy targeting MAPK and HER2 in a timely manner may be an effective treatment approach against HER2-positive cancers with coexisting PIK3CA-activating mutations.	[Cheng, H.] Dalian Med Univ, Hosp 2, Inst Canc, Dalian 116023, Peoples R China; [Cheng, H.; Liu, P.; Ohlson, C.; Xu, E.; Symonds, L.; Isabella, A.; Roberts, T. M.; Zhao, J. J.] Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave Smith 936, Boston, MA 02215 USA; [Muller, W. J.] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ, Canada; [Lin, N. U.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Krop, I. E.; Winer, E. P.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Arteaga, C. L.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA	Dalian Medical University; Harvard University; Dana-Farber Cancer Institute; McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Cheng, H (corresponding author), Dalian Med Univ, Hosp 2, Inst Canc, Dalian 116023, Peoples R China.; Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave Smith 936, Boston, MA 02215 USA.	hailingcheng_dmu@163.com; jean_zhao@dfci.harvard.edu			Susan G. Komen Breast Cancer Foundation [CCR12225834]; Susan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation; ACS [CRP-07-234-06-COUN]; NIH [CA187918, CA172461-01, 1P50CA168504]; NATIONAL CANCER INSTITUTE [R01CA187918, P50CA168504, R01CA172461] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Roderick Bronson and the Dana-Farber/Harvard Cancer Center Rodent Histoplathology Core for histopathological analyses. We thank L. Chodosh (University of Pennsylvania School of Medicine) for providing MMTVrtTAmice. This work was supported by the Susan G. Komen Breast Cancer Foundation CCR12225834 (HC), Susan G. Komen Breast Cancer Foundation (IEK), Breast Cancer Research Foundation (NUL, EPW and JJZ), ACS grant CRP-07-234-06-COUN (CLA), NIH grants CA187918 (TMR and JJZ), CA172461-01 (JJZ) and 1P50CA168504 (TMR, IEK, EPW, NUL and JJZ).	Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Baselga J, 2013, P 104 ANN M AM ASS C; Baselga J, 2013, 27 SEPT 1 OCT 2013 E; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cizkova M, 2013, BRIT J CANCER, V108, P1807, DOI 10.1038/bjc.2013.164; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Hynes NE, 2009, CANCER CELL, V15, P353, DOI 10.1016/j.ccr.2009.04.004; Jensen JD, 2012, ANN ONCOL, V23, P2034, DOI 10.1093/annonc/mdr546; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lerma E, 2008, VIRCHOWS ARCH, V453, P133, DOI 10.1007/s00428-008-0643-4; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Perez EA, 2013, J CLIN ONCOL, V31, P2115, DOI 10.1200/JCO.2012.42.2642; Perez EA, 2012, JNCI-J NATL CANCER I, V104, P159, DOI 10.1093/jnci/djr490; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Stachler MD, 2015, APPL IMMUNOHISTOCHEM; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105	36	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 9	2016	35	23					2961	2970		10.1038/onc.2015.377	http://dx.doi.org/10.1038/onc.2015.377			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO0NB	26640141	Green Accepted			2022-12-26	WOS:000377474500002
J	Ham, SJ; Lee, SY; Song, S; Chung, JR; Choi, S; Chung, J				Ham, Su Jin; Lee, Soo Young; Song, Saera; Chung, Ju-Ryung; Choi, Sekyu; Chung, Jongkyeong			Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE 63-LINKED POLYUBIQUITINATION; E3 LIGASE PARKIN; PATHOGENIC MUTATIONS; DAMAGED MITOCHONDRIA; DEPOLARIZED MITOCHONDRIA; AUTOINHIBITED STATE; MEDIATED MITOPHAGY; PROTEASOME SYSTEM; MONOGENIC FORMS; ACTIVATE PARKIN	Parkin is an E3 ligase that contains a ubiquitin-like (UBL) domain in the N terminus and an R1-in-between-ring-RING2 motif in the C terminus. We showed that the UBL domain specifically interacts with the R1 domain and negatively regulates Parkin E3 ligase activity, Parkin-dependent mitophagy, and Parkin translocation to the mitochondria. The binding between the UBL domain and the R1 domain was suppressed by carbonyl cyanide m-chlorophenyl hydrazone treatment or by expression of PTEN-induced putative kinase 1 (PINK1), an upstream kinase that phosphorylates Parkin at the Ser-65 residue of the UBL domain. Moreover, we demonstrated that phosphorylation of the UBL domain at Ser-65 prevents its binding to the R1 domain and promotes Parkin activities. We further showed that mitochondrial translocation of Parkin, which depends on phosphorylation at Ser-65, and interaction between the R1 domain and a mitochondrial outer membrane protein, VDAC1, are suppressed by binding of the UBL domain to the R1 domain. Interestingly, Parkin with missense mutations associated with Parkinson disease (PD) in the UBL domain, such as K27N, R33Q, and A46P, did not translocate to the mitochondria and induce E3 ligase activity by m-chlorophenyl hydrazone treatment, which correlated with the interaction between the R1 domain and the UBL domain with those PD mutations. These findings provide a molecular mechanism of how Parkin recruitment to the mitochondria and Parkin activation as an E3 ubiquitin ligase are regulated by PINK1 and explain the previously unknown mechanism of how Parkin mutations in the UBL domain cause PD pathogenesis.	[Ham, Su Jin; Chung, Jongkyeong] Seoul Natl Univ, Interdisciplinary Grad Program Genet Engn, Seoul 51742, South Korea; [Ham, Su Jin; Lee, Soo Young; Song, Saera; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 51742, South Korea; [Ham, Su Jin; Lee, Soo Young; Song, Saera; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 51742, South Korea; [Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 51742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, 1 Gwanak Ro, Seoul 51742, South Korea.	jkc@snu.ac.kr	Ham, Su Jin/AAL-6391-2021	Ham, Su Jin/0000-0001-5230-3386; Choi, Sekyu/0000-0003-2928-0942	National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea [2010-0018291]; BK21 Plus Program from Ministry of Education, Republic of Korea	National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea; BK21 Plus Program from Ministry of Education, Republic of Korea	Supported by the National Creative Research Initiatives grant through the National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT, and Future Planning (MSIP), the Republic of Korea (2010-0018291). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by BK21 Plus Program from Ministry of Education, Republic of Korea.	Aguileta MA, 2015, J BIOL CHEM, V290, P7492, DOI 10.1074/jbc.M114.614925; Baba Y, 2006, ARCH NEUROL-CHICAGO, V63, P579, DOI 10.1001/archneur.63.4.579; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Beasley SA, 2012, PROTEIN SCI, V21, P1085, DOI 10.1002/pro.2080; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Bonifati V, 2001, FUNCT NEUROL, V16, P35; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Choi P, 2000, NEUROREPORT, V11, P2635, DOI 10.1097/00001756-200008210-00006; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Fiesel FC, 2014, J CELL SCI, V127, P3488, DOI 10.1242/jcs.147520; Gao J, 2015, ACTA BIOCH BIOPH SIN, V47, P522, DOI 10.1093/abbs/gmv044; Gegg ME, 2011, AUTOPHAGY, V7, P243, DOI 10.4161/auto.7.2.14332; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2014, J CELL SCI, V127, P3280, DOI 10.1242/jcs.146035; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2015, BBA-MOL CELL RES, V1853, P2791, DOI 10.1016/j.bbamcr.2015.02.009; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lim KL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S13; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ozawa K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02202; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004861; Shiba-Fukushima K, 2014, J BIOL CHEM, V289, P33131, DOI 10.1074/jbc.C114.580944; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Strappazzon F, 2015, CELL DEATH DIFFER, V22, P517, DOI 10.1038/cdd.2014.190; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Terreni L, 2001, NEUROLOGY, V56, P463, DOI 10.1212/WNL.56.4.463; Tomoo K, 2008, BBA-PROTEINS PROTEOM, V1784, P1059, DOI 10.1016/j.bbapap.2008.04.009; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zheng XD, 2015, CELL RES, V25, P1087, DOI 10.1038/cr.2015.97; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	82	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1803	1816		10.1074/jbc.M115.687319	http://dx.doi.org/10.1074/jbc.M115.687319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631732	hybrid, Green Published			2022-12-26	WOS:000368620700021
J	Luo, P; He, XY; Liu, QT; Hu, CQ				Luo, Peng; He, Xiangyan; Liu, Qiuting; Hu, Chaoqun			Developing Universal Genetic Tools for Rapid and Efficient Deletion Mutation in Vibrio Species Based on Suicide T-Vectors Carrying a Novel Counterselectable Marker, vmi480	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; CHOLERAE; FAMILY; TRANSFORMATION; TEMPERATURE; INFECTIONS; EXPRESSION	Despite that Vibrio spp. have a significant impact on the health of humans and aquatic animals, the molecular basis of their pathogenesis is little known, mainly due to the limited genetic tools for the functional research of genes in Vibrio. In some cases, deletion of target DNAs in Vibrio can be achieved through the use of suicide vectors. However, these strategies are time-consuming and lack universality, and the widely used counterselectable gene sacB does not work well in Vibrio cells. In this study, we developed universal genetic tools for rapid and efficient deletion mutations in Vibrio species based on suicide T-Vectors carrying a novel counterselectable marker, vmi480. We explored two uncharacterized genes, vmi480 and vmi470, in a genomic island from Vibrio mimicus VM573 and confirmed that vmi480 and vmi470 constitute a two-component toxin-antitoxin system through deletion and expression of vmi480 and vmi470. The product of vmi480 exhibited strong toxicity to Escherichia coli cells. Based on vmi480 and the PBAD or PTAC promoter system, we constructed two suicide T-vectors, pLP11 and pLP12, and each of these vectors contained a multiple cloning region with two AhdI sites. Both vectors linearized by AhdI digestion could be stored and directly ligated with purified PCR products without a digestion step. By using pLP11 and pLP12 coupled with a highly efficient conjugation system provided by E. coli beta 2163, six genes from four representative Vibrio species were easily deleted. By using the counterselective marker vmi480, we obtained 3-12 positive colonies (deletion mutants) among no more than 20 colonies randomly selected on counterselection plates. The strategy does not require the digestion of PCR products and suicide vectors every time, and it avoids large-scale screening colonies on counterselective plates. These results demonstrate that we successfully developed universal genetic tools for rapid and efficient gene deletion in Vibrio species.	[Luo, Peng; He, Xiangyan; Liu, Qiuting; Hu, Chaoqun] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Luo, Peng; Hu, Chaoqun] Chinese Acad Sci, Guangdong Key Lab Appl Marine Biol, Guangzhou, Guangdong, Peoples R China; [Luo, Peng; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [He, Xiangyan; Liu, Qiuting] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, CQ (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hucq@scsio.ac.cn			Natural Science Foundation of China [31370149]; Comprehensive Strategic Cooperation Project of Guangdong Province; Chinese Academy of Sciences [2012B091100269]; Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-G-12B]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Comprehensive Strategic Cooperation Project of Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	Funded by Natural Science Foundation of China (31370149), http://www.nsfc.gov.cn/, Comprehensive Strategic Cooperation Project of Guangdong Province and Chinese Academy of Sciences (2012B091100269), http://gdcas.gdstc.gov.cn/, and Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-G-12B), http://www.cas.cn/.	Baumann P, 1984, BERGEYS MANUAL SYSTE, V1, P516; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; Bhunia AK, 2008, FOOD SCI TEXT SER, P241; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; Bordeleau E, 2010, ENVIRON MICROBIOL, V12, P510, DOI 10.1111/j.1462-2920.2009.02094.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Carraro N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004714; Chatterjee S., 2012, J MAR SCI RES DEV, V1, P1, DOI DOI 10.4172/2155-9910.S1-002; Chen C, 2010, BIOFOULING, V26, P595, DOI 10.1080/08927014.2010.499511; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Daniels NA, 2000, INFECT MED, V17, P665; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Direkbusarakom S, 1998, J MAR BIOTECHNOL, V6, P266; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; FUKAMI K, 1985, MAR ECOL PROG SER, V21, P7, DOI 10.3354/meps021007; Gulig PA, 2009, APPL ENVIRON MICROB, V75, P4936, DOI 10.1128/AEM.02564-08; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen LH, 1998, CURR MICROBIOL, V36, P341, DOI 10.1007/s002849900320; HOWARD RJ, 1993, ANN SURG, V217, P525, DOI 10.1097/00000658-199305010-00013; Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15; Jin CY, 2013, ANTON LEEUW INT J G, V103, P989, DOI 10.1007/s10482-013-9878-4; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Karlsson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108521; Kasari V, 2010, J BACTERIOL, V192, P2908, DOI 10.1128/JB.01266-09; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu CH, 2004, DIS AQUAT ORGAN, V61, P169, DOI 10.3354/dao061169; Lo Scrudato M, 2013, NUCLEIC ACIDS RES, V41, P3644, DOI 10.1093/nar/gkt041; Luo P, 2008, DIS AQUAT ORGAN, V82, P209, DOI 10.3354/dao01984; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Mahbub KR, 2011, J ADV SCI RES, V2, P74; Marbach A, 2012, J BIOTECHNOL, V157, P82, DOI 10.1016/j.jbiotec.2011.10.009; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Nakashima N, 2014, INT J MOL SCI, V15, P2773, DOI 10.3390/ijms15022773; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Reilly GD, 2011, EUROSURVEILLANCE, V16, P10; Reyrat JM, 1998, INFECT IMMUN, V66, P4011; STIBITZ S, 1994, METHOD ENZYMOL, V235, P458; Turner JW, 2014, ENVIRON MICROBIOL, V16, P1019, DOI 10.1111/1462-2920.12246; Vandenberghe J, 2003, AQUACULTURE, V219, P9, DOI 10.1016/S0044-8486(02)00312-5; Yamaichi Y, 2007, P NATL ACAD SCI USA, V104, P630, DOI 10.1073/pnas.0608341104; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P5831, DOI 10.1128/AEM.01147-12	48	38	45	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144465	10.1371/journal.pone.0144465	http://dx.doi.org/10.1371/journal.pone.0144465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641275	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700130
J	Bourke, L; McCormick, J; Taylor, V; Pericleous, C; Blanchet, B; Costedoat-Chalumeau, N; Stuckey, D; Lythgoe, MF; Stephanou, A; Ioannou, Y				Bourke, Lauren; McCormick, James; Taylor, Valerie; Pericleous, Charis; Blanchet, Benoit; Costedoat-Chalumeau, Nathalie; Stuckey, Daniel; Lythgoe, Mark F.; Stephanou, Anastasis; Ioannou, Yiannis			Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; THERAPEUTIC TARGET; KINASE; APOPTOSIS; AUTOPHAGY; BAD; CELLS; HEART; SLE	An increasing number of investigations including human studies demonstrate that pharmacological ischaemic preconditioning is a viable way to protect the heart from myocardial ischaemia/reperfusion (I/R) injury. This study investigated the role of hydroxychloroquine (HCQ) in the heart during I/R injury. In vitro and in vivo models of myocardial I/R injury were used to assess the effects of HCQ. It was found that HCQ was protective in neonatal rat cardiomyocytes through inhibition of apoptosis, measured by TUNEL and cleaved caspase-3. This protection in vitro was mediated through enhancement of ERK1/2 phosphorylation mediated by HCQ in a dose-dependent fashion. A decrease in infarct size was observed in an in vivo model of myocardial I/R injury in HCQ treated animals and furthermore this protection was blocked in the presence of the ERK1/2 inhibitor U0126. For the first time, we have shown that HCQ promotes a preconditioning like protection in an in vivo simulated rat myocardial I/R injury model. Moreover, it was shown that HCQ is protective via enhanced phosphorylation of the pro-survival kinase ERK1/2.	[Bourke, Lauren; Pericleous, Charis; Ioannou, Yiannis] UCL, Ctr Rheumatol, Div Med, Rayne Inst, London, England; [Bourke, Lauren; Ioannou, Yiannis] UCL, Arthrit Res UK, Ctr Adolescent Rheumatol, London, England; [McCormick, James] UCL, Biochem Res Grp, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [McCormick, James] UCL, Great Ormond St Hosp, London, England; [Taylor, Valerie; Stuckey, Daniel; Lythgoe, Mark F.] UCL, Ctr Adv Biomed Imaging, Div Med, London, England; [Blanchet, Benoit] Hop Cochin, Assistance Publ Hop Paris, Unite Fonctionnelle Pharmacocinet & Pharmacochimi, F-75674 Paris, France; [Costedoat-Chalumeau, Nathalie] Univ Paris 05, Ctr Reference Malad Autoimmunes & Syst Rares, Serv Med Interne, Pole Med,Hop Cochin,AP HP, Paris, France; [Stephanou, Anastasis] UCL, Med & Mol Biol Unit, London, England	University of London; King's College London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Ioannou, Y (corresponding author), UCL, Ctr Rheumatol, Div Med, Rayne Inst, London, England.	y.ioannou@ucl.ac.uk		Pericleous, Charis/0000-0001-8804-0493; stuckey, daniel/0000-0001-8888-627X; Blanchet, Benoit/0000-0003-3096-4305; , nathalie/0000-0002-1555-9021; Lythgoe, Mark/0000-0002-4945-0171	Grand Challenge PhD Studentship Programme, UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK [20164]; Arthritis Research UK Programme [19423]; Versus Arthritis [19423] Funding Source: researchfish	Grand Challenge PhD Studentship Programme, UCL; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK(Versus Arthritis); Arthritis Research UK Programme(Versus Arthritis); Versus Arthritis(Versus Arthritis)	LB is supported by the Grand Challenge PhD Studentship Programme, UCL. YI is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK Grant 20164. CP is supported by Arthritis Research UK Programme Grant 19423.; LB is supported by the Grand Challenge PhD Studentship Programme, UCL. YI is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre and Arthritis Research UK Grant 20164. CP is supported by Arthritis Research UK Programme Grant 19423.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ban KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076790; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bourke Lauren T, 2013, JAKSTAT, V2, pe25666, DOI 10.4161/jkst.25666; Bullard AJ, 2005, BASIC RES CARDIOL, V100, P397, DOI 10.1007/s00395-005-0537-4; Carr CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025669; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Costedoat-Chalumeau N, 2006, ARTHRITIS RHEUM, V54, P3284, DOI 10.1002/art.22156; Das A, 2009, ERK PHOSPHORYLATION, pH1236; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; FOX RI, 1993, SEMIN ARTHRITIS RHEU, V23, P82, DOI 10.1016/S0049-0172(10)80012-5; Garg S, 2003, CURR OPIN CARDIOL, V18, P372, DOI 10.1097/00001573-200309000-00009; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hausenloy DJ, 2012, CLIN RES CARDIOL, V101, P339, DOI 10.1007/s00392-011-0397-x; Hausenloy DJ, 2010, BASIC RES CARDIOL, V105, P677, DOI 10.1007/s00395-010-0121-4; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hausenloy DJ, 2004, CARDIOVASC RES, P305; Hayakawa J, 2000, CANCER RES, V60, P5988; Hetz CA, 2002, J CELL SCI, V115, P4671, DOI 10.1242/jcs.00153; Jing Zhou GL, 2013, EXP CLIN CARDIOL, V18, P95; Jung HJ, 2010, ARTHRITIS RHEUM-US, V62, P863, DOI 10.1002/art.27289; Lee SJ, 2011, NAT REV NEPHROL, V7, P718, DOI 10.1038/nrneph.2011.150; Ma S, 2015, BBA-MOL BASIS DIS, V1852, P271, DOI 10.1016/j.bbadis.2014.05.010; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Martin ED, 2012, CIRCULATION, V126, P357, DOI 10.1161/CIRCULATIONAHA.111.071886; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Morris SJ, 2011, ARTHRIT CARE RES, V63, P530, DOI 10.1002/acr.20393; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Le NT, 2014, J IMMUNOL, V193, P3803, DOI 10.4049/jimmunol.1400571; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Schmajuk G, 2010, ARTHRIT CARE RES, V62, P386, DOI 10.1002/acr.20002; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Todorovic Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092673; Willis R, 2012, LUPUS, V21, P830, DOI 10.1177/0961203312437270; Yang CW, 2003, TRANSPLANTATION, V75, P20, DOI 10.1097/01.TP.0000040002.12912.65; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yaoita H, 2000, APOPTOSIS RELEVANT C, P630	44	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143771	10.1371/journal.pone.0143771	http://dx.doi.org/10.1371/journal.pone.0143771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636577	gold, Green Published, Green Submitted			2022-12-26	WOS:000366143800025
J	Nolting, S; Maurer, J; Spottl, G; Prada, ETA; Reuther, C; Young, K; Korbonits, M; Goke, B; Grossman, A; Auernhammer, CJ				Noelting, Svenja; Maurer, Julian; Spoettl, Gerald; Prada, Elke Tatjana Aristizabal; Reuther, Clemens; Young, Karen; Korbonits, Marta; Goeke, Burkhard; Grossman, Ashley; Auernhammer, Christoph J.			Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; STATINS; AGENTS; GLYCOSYLATION; RESISTANCE; SORAFENIB; MODEL; LINES	Background The mTORC1-inhibitor everolimus shows limited efficacy in treating patients with gastro-entero-pancreatic or pulmonary neuroendocrine tumors (NETs), and poor outcome in patients with malignant pheochromocytoma or hepatic carcinoma. We speculated that any effect may be enhanced by antogonising other signaling pathways. Methods Therefore, we tested the effect of lovastatin-known to inhibit both ERK and AKT signaling-and everolimus, separately and in combination, on cell viability and signaling pathways in human midgut (GOT), pancreatic (BON1), and pulmonary (H727) NET, hepatocellular carcinoma (HepG2, Huh7), and mouse pheochromocytoma (MPC, MTT) cell lines. Results Lovastatin and everolimus separately significantly reduced cell viability in H727, HepG2, Huh7, MPC and MTT cells at clinically relevant doses (P <= 0.05). However, high doses of lovastatin were necessary to affect GOT or BON1 cell viability. Clinically relevant doses of both drugs showed additive anti-tumor effects in H727, HepG2, Huh7, MPC and MTT cells (P <= 0.05), but not in BON1 or GOT cells. In all cell lines investigated, lovastatin inhibited EGFR and AKT signaling. Subsequently, combination treatment more strongly inhibited EGFR and AKT signaling than everolimus alone, or at least attenuated everolimus-induced EGFR or AKT activation. Vice versa, everolimus constantly decreased pp70S6K and combination treatment more strongly decreased pp70S6K than lovastatin alone, or attenuated lovastatin-induced p70S6K activation: in BON1 cells lovastatin-induced EGFR inhibition was least pronounced, possibly explaining the low efficacy and consequent absent additive effect. Conclusion In summary, clinically relevant doses of lovastatin and everolimus were effective separately and showed additive effects in 5 out of 7 cell lines. Our findings emphasize the importance of targeting several interacting signaling pathways simultaneously when attempting to attenuate tumor growth. However, the variable reactions of the different cell lines highlight the necessity to understand the unique molecular aberrations in any tumor. Nevertheless, this combination seems worthy of being tested in vivo.	[Noelting, Svenja; Maurer, Julian; Spoettl, Gerald; Prada, Elke Tatjana Aristizabal; Reuther, Clemens; Goeke, Burkhard; Auernhammer, Christoph J.] Univ Munich, Univ Hosp, Dept Internal Med 2, Munich, Germany; [Young, Karen; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Dept Endocrinol, London, England; [Goeke, Burkhard] Univ Hosp Hamburg Eppendorf, Hamburg, Germany; [Grossman, Ashley] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Dept Endocrinol, Oxford, England	University of Munich; University of London; Queen Mary University London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford	Nolting, S (corresponding author), Univ Munich, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Munich, Germany.	svenja.noelting@med.uni-muenchen.de		Korbonits, Marta/0000-0002-4101-9432; Nolting, Svenja/0000-0002-7064-590X	Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe] [865/829]	Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe]	This work was supported by a research grant from the Ludwig-Maximilians University of Munich (Forderprogramm fur Forschung und Lehre [FoFoLe], grant number 865/829).; We thank the statistician Dr. Michael Lauseker for assistance with the statistical analysis. This work was funded by a research grant from the Ludwig-Maximilians University of Munich [Forderprogramm fur Forschung und Lehre (FoFoLe), grant number 865/829].	Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Altwairgi AK, 2015, ONCOL REP, V33, P1019, DOI 10.3892/or.2015.3741; Ampuero J, 2015, WORLD J HEPATOL, V7, P1105, DOI 10.4254/wjh.v7.i8.1105; Auernhammer CJ, 2011, GUT, V60, P1009, DOI 10.1136/gut.2009.204453; Bil J, 2010, CANCER LETT, V288, P57, DOI 10.1016/j.canlet.2009.06.022; Cakir M, 2011, EXPERT OPIN THER TAR, V15, P457, DOI 10.1517/14728222.2011.555403; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cemeus C, 2008, J NEURO-ONCOL, V90, P9, DOI 10.1007/s11060-008-9627-0; Dimitroulakos J, 2006, CLIN CANCER RES, V12, p4426S, DOI 10.1158/1078-0432.CCR-06-0089; Druce MR, 2009, HORM METAB RES, V41, P697, DOI 10.1055/s-0029-1220687; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Fiala O, 2015, TUMOR BIOL, V36, P5801, DOI 10.1007/s13277-015-3249-x; Fliedner SMJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097712; Frilling A, 2012, ENDOCR-RELAT CANCER, V19, pR163, DOI 10.1530/ERC-12-0024; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Holstein SA, 2001, MOL CANCER THER, V1, P141; Holstein SA, 2001, LEUKEMIA RES, V25, P651, DOI 10.1016/S0145-2126(00)00162-4; Hwang KE, 2014, EXP CELL RES, V323, P288, DOI 10.1016/j.yexcr.2014.02.026; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; McGlynn KA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv009; Mohammed AA, 2014, ONCOL REV, V8, P67, DOI 10.4081/oncol.2014.249; Nielsen SF, 2013, NEW ENGL J MED, V368, P576, DOI 10.1056/NEJMc1214827; Nolting S, 2014, ENDOCRINOLOGY, V155, P2377, DOI 10.1210/en.2014-1027; Nolting S, 2012, J MOL ENDOCRINOL, V49, P79, DOI 10.1530/JME-12-0028; Nolting S, 2012, ENDOCR PATHOL, V23, P21, DOI 10.1007/s12022-012-9199-6; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Park IH, 2010, INVEST NEW DRUG, V28, P791, DOI 10.1007/s10637-009-9319-4; Pavel M, 2013, NEUROENDOCRINOLOGY, V97, P99, DOI 10.1159/000336089; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Rozados VR, 2008, ONCOL REP, V19, P1205; SLIEKER LJ, 1986, J BIOL CHEM, V261, P5233; Spampatti M, 2014, WORLD J GASTROENTERO, V20, P10038, DOI 10.3748/wjg.v20.i29.10038; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Zhao TT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012563; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189; Zitzmann K, 2007, NEUROENDOCRINOLOGY, V85, P54, DOI 10.1159/000100057; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018	43	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143830	10.1371/journal.pone.0143830	http://dx.doi.org/10.1371/journal.pone.0143830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636335	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800031
J	Pathak, HB; Zhou, Y; Sethi, G; Hirst, J; Schilder, RJ; Golemis, EA; Godwin, AK				Pathak, Harsh B.; Zhou, Yan; Sethi, Geetika; Hirst, Jeff; Schilder, Russell J.; Golemis, Erica A.; Godwin, Andrew K.			A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SRC FAMILY KINASES; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; FALLOPIAN-TUBE; CELL-LINES; INHIBITOR; RESISTANCE; EXPRESSION; CX-4945	Molecular targeted therapies have been the focus of recent clinical trials for the treatment of patients with recurrent epithelial ovarian cancer (EOC). The majority have not fared well as monotherapies for improving survival of these patients. Poor bioavailability, lack of predictive biomarkers, and the presence of multiple survival pathways can all diminish the success of a targeted agent. Dasatinib is a tyrosine kinase inhibitor of the Src-family kinases (SFK) and in preclinical studies shown to have substantial activity in EOC. However, when evaluated in a phase 2 clinical trial for patients with recurrent or persistent EOC, it was found to have minimal activity. We hypothesized that synthetic lethality screens performed using a cogently designed siRNA library would identify second-site molecular targets that could synergize with SFK inhibition and improve dasatinib efficacy. Using a systematic approach, we performed primary siRNA screening using a library focused on 638 genes corresponding to a network centered on EGFR, HER2, and the SFK-scaffolding proteins BCAR1, NEDD9, and EFS to screen EOC cells in combination with dasatinib. We followed up with validation studies including deconvolution screening, quantitative PCR to confirm effective gene silencing, correlation of gene expression with dasatinib sensitivity, and assessment of the clinical relevance of hits using TCGA ovarian cancer data. A refined list of five candidates (CSNK2A1, DAG1, GRB2, PRKCE, and VAV1) was identified as showing the greatest potential for improving sensitivity to dasatinib in EOC. Of these, CSNK2A1, which codes for the catalytic alpha subunit of protein kinase CK2, was selected for additional evaluation. Synergistic activity of the clinically relevant inhibitor of CK2, CX-4945, with dasatinib in reducing cell proliferation and increasing apoptosis was observed across multiple EOC cell lines. This overall approach to improving drug efficacy can be applied to other targeted agents that have similarly shown poor clinical activity.	[Pathak, Harsh B.; Hirst, Jeff; Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Zhou, Yan] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA; [Sethi, Geetika] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Schilder, Russell J.] Thomas Jefferson Univ, Dept Gynecol Med Oncol, Philadelphia, PA 19107 USA; [Golemis, Erica A.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center; Drexel University; Jefferson University; Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center	Pathak, HB (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	hpathak@kumc.edu		Golemis, Erica/0000-0003-3618-3673	National Cancer Institute [CA140323, CA181287]; Kansas Bioscience Authority Eminent Scholar Program; National Institute of Child Health and Human Development [K12 HD052027]; Madison & Lila Self Graduate Fellowship; National Cancer Institute Cancer Center Support grants [P30 CA168524, P30 CA006927]; University of Kansas Cancer Center [P30 CA168524]; Fox Chase Cancer Center [P30 CA006927]; NCI [CA140323]; NICHD [K12 HD052027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA140323, P30CA168524, R21CA181287] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kansas Bioscience Authority Eminent Scholar Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Madison & Lila Self Graduate Fellowship; National Cancer Institute Cancer Center Support grants; University of Kansas Cancer Center; Fox Chase Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded in part by a grant from the National Cancer Institute (http://www.cancer.gov/) (CA140323) and the Kansas Bioscience Authority (http://www.kansasbioauthority.org/) Eminent Scholar Program to AKG. HBP is an Interdisciplinary Women's Health Research Scholar through the BIRCWH K12 Program at the University of Kansas Medical Center sponsored by a grant from the National Institute of Child Health and Human Development (http://www.nichd.nih.gov) (K12 HD052027). JH is a recipient of the Madison & Lila Self Graduate Fellowship (http://selfgraduate.ku.edu/). EAG's work is supported by a grant from the National Cancer Institute (http://www.cancer.gov/) (CA181287). The authors acknowledge support from the National Cancer Institute (http://www.cancer.gov/) Cancer Center Support grants P30 CA168524 (University of Kansas Cancer Center) and P30 CA006927 (Fox Chase Cancer Center). AKG is the Chancellors Distinguished Chair in Biomedical Sciences Endowed Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded in part by a grant from the NCI (CA140323) and the Kansas Bioscience Authority Eminent Scholar Program to A.K.G. H.B.P. is an Interdisciplinary Women's Health Research Scholar through the BIRCWH K12 Program at the University of Kansas Medical Center sponsored by a grant from the NICHD (K12 HD052027). J.H. is a recipient of the Madison & Lila Self Graduate Fellowship. E.A.G's work is supported by CA181287. The authors would like to thank Lisa Vanderveer for her technical assistance; Dr. Margret Einarson for assistance with the siRNA screenings; Dr. Brooke Fridley for assistance with annotating the ovarian TCGA data. The authors acknowledge support from the University of Kansas Cancer Center (P30 CA168524) and Fox Chase Cancer Center (P30 CA006927). A.K.G. is the Chancellors Distinguished Chair in Biomedical Sciences Endowed Professor.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Alper O, 2005, CURR PHARM DESIGN, V11, P1119, DOI 10.2174/1381612053507576; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Baccarani M, 2015, ANN HEMATOL, V94, pS141, DOI 10.1007/s00277-015-2322-2; Bast R C Jr, 2011, Ann Oncol, V22 Suppl 8, pviii5, DOI 10.1093/annonc/mdr516; Baumann KH, 2012, FUTURE ONCOL, V8, P1135, DOI [10.2217/FON.12.112, 10.2217/fon.12.112]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bookman MA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju029; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buchdunger E, 1996, CANCER RES, V56, P100; BUDDE RJA, 1994, CANCER BIOCHEM BIOPH, V14, P171; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chang Tai-Tsung, 2000, Acta Paediatrica Taiwanica, V41, P294; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 1996, CALCUSYN WINDOWS SOF; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Cozza G, 2013, CURR MED CHEM, V20, P671, DOI 10.2174/092986713804999312; Dancey J, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mdt473; Deneka A, 2015, GENE, V570, P25, DOI 10.1016/j.gene.2015.06.062; Donella-Deana A, 2003, BIOCHEM J, V372, P841, DOI 10.1042/BJ20021905; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Erickson BK, 2013, AM J OBSTET GYNECOL, V209, P409, DOI 10.1016/j.ajog.2013.04.019; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Fuss H, 2008, BIOPHYS J, V94, P1995, DOI 10.1529/biophysj.107.115022; Gambacorti-Passerini C, 2015, AM J HEMATOL, V90, P156, DOI 10.1002/ajh.23887; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Hamilton T C, 1989, Cancer Treat Res, V48, P151; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hochhaus A, 2015, ANN HEMATOL, V94, pS133, DOI 10.1007/s00277-015-2323-1; Huang YW, 2013, MOL CELL BIOCHEM, V376, P73, DOI 10.1007/s11010-012-1550-1; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Jabbour E, 2015, CL LYMPH MYELOM LEUK, V15, P323, DOI 10.1016/j.clml.2015.03.006; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kessler M, 2013, INT J MOL SCI, V14, P6571, DOI 10.3390/ijms14046571; KITAS EA, 1990, BIOCHEM BIOPH RES CO, V170, P635, DOI 10.1016/0006-291X(90)92139-Q; Le XF, 2011, CANCER BIOL THER, V12, P260, DOI 10.4161/cbt.12.4.16430; Ledermann JA, 2010, GYNECOL ONCOL, V119, P151, DOI 10.1016/j.ygyno.2010.05.008; Lindauer M, 2014, RECENT RESULTS CANC, V201, P27, DOI 10.1007/978-3-642-54490-3_2; Little JL, 2014, ONCOGENE, V33, P411, DOI 10.1038/onc.2012.607; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mantia-Smaldone Gina M, 2011, Cancer Manag Res, V3, P25, DOI 10.2147/CMR.S8759; Matsuo K, 2011, CLIN CANCER RES, V17, P5367, DOI 10.1158/1078-0432.CCR-10-3176; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; O'Shannessy DJ, 2013, INT J MOL SCI, V14, P13687, DOI 10.3390/ijms140713687; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pierre F, 2011, MOL CELL BIOCHEM, V356, P37, DOI 10.1007/s11010-011-0956-5; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Pujade-Lauraine E, 2011, Ann Oncol, V22 Suppl 8, pviii61, DOI 10.1093/annonc/mdr518; Reade CJ, 2014, J OBSTET GYNAECOL CA, V36, P133, DOI 10.1016/S1701-2163(15)30659-9; Rizzieri David, 2012, P T, V37, P640; Schilder RJ, 2012, GYNECOL ONCOL, V127, P70, DOI 10.1016/j.ygyno.2012.06.009; Sethi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047086; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shigetomi H, 2012, ONCOL REP, V28, P395, DOI 10.3892/or.2012.1833; Siddiqui-Jain A, 2012, MOL CANCER THER, V11, P994, DOI 10.1158/1535-7163.MCT-11-0613; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stordal B, 2013, MOL ONCOL, V7, P567, DOI 10.1016/j.molonc.2012.12.007; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; TOYOSHIMA K, 1992, CIBA F SYMP, V164, P240; Toyoshima K, 1986, Princess Takamatsu Symp, V17, P11; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Wong AST, 2001, GYNECOL ONCOL, V82, P305, DOI 10.1006/gyno.2001.6280; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokoyama T, 2004, BIOL PHARM BULL, V27, P1895, DOI 10.1248/bpb.27.1895	79	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144126	10.1371/journal.pone.0144126	http://dx.doi.org/10.1371/journal.pone.0144126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637171	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800044
J	Manning, K; Timpson, A; Shennan, S; Crema, E				Manning, Katie; Timpson, Adrian; Shennan, Stephen; Crema, Enrico			Size Reduction in Early European Domestic Cattle Relates to Intensification of Neolithic Herding Strategies	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; BODY-MASS; SHEEP; EVOLUTION; SELECTION; HUSBANDRY; DYNAMICS; ORIGINS; HISTORY; FRANCE	Our analysis of over 28,000 osteometric measurements from fossil remains dating between c. 5600 and 1500 BCE reveals a substantial reduction in body mass of 33% in Neolithic central European domestic cattle. We investigate various plausible explanations for this phenotypic adaptation, dismissing climatic change as a causal factor, and further rejecting the hypothesis that it was caused by an increase in the proportion of smaller adult females in the population. Instead we find some support for the hypothesis that the size decrease was driven by a demographic shift towards smaller newborns from sub-adult breeding as a result of intensifying meat production strategies during the Neolithic.	[Manning, Katie; Shennan, Stephen; Crema, Enrico] UCL, Inst Archaeol, London, England; [Timpson, Adrian] UCL, Res Dept Genet Evolut & Environm, London, England; [Crema, Enrico] Univ Pompeu Fabra, Dept Humanities, CaSEs Complex & Socioecol Dynam Res Grp, Barcelona, Spain	University of London; University College London; University of London; University College London; Pompeu Fabra University	Shennan, S (corresponding author), UCL, Inst Archaeol, London, England.	s.shennan@ucl.ac.uk	Crema, Enrico/Q-3220-2017	Crema, Enrico/0000-0001-6727-5138; timpson, adrian/0000-0003-0292-8729	European Research Council [249390]	European Research Council(European Research Council (ERC)European Commission)	This research was funded by the European Research Council by an Advanced Grant (# 249390) to Stephen Shennan for the EUROEVOL Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 2001, GEOARCHAEOLOGY, V16, P687, DOI 10.1002/gea.1016; Albarella U, 2008, J ARCHAEOL SCI, V35, P1828, DOI 10.1016/j.jas.2007.11.016; Albarella U, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P209; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], 2003, ANTHROPOZOOLOGICA; Audoin-Rouzeau F., 1995, HOMME ANIMAL LANTIQU, P79; Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Balasse M, 2012, ENVIRON ARCHAEOL, V17, P29, DOI 10.1179/1461410312Z.0000000003; Balasse Marie, 2007, Anthropozoologica, V42, P71; Boessneck J., 1971, AUSGRABUNGEN MANCHIN, V6; Bokonyi S., 1974, HIST DOMESTIC ANIMAL; Bokonyi Sandor, 1969, DOMEST EXPLOIT PLANT, P607; Bollongino R, 2012, MOL BIOL EVOL, V29, P2101, DOI 10.1093/molbev/mss092; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Breslawski RP, 2015, J ARCHAEOL SCI, V53, P235, DOI 10.1016/j.jas.2014.10.001; Colledge S., 2017, ORIGINS SPREAD DOMES, DOI [10.4324/9781315417615, DOI 10.4324/9781315417615]; Colominas L, 2014, ARCHAEOL ANTHROP SCI, V6, P1, DOI 10.1007/s12520-013-0116-9; Dahl G, 1976, STOCKHOLM STUDIES SO, V2; Delhon C, 2008, J ARCHAEOL SCI, V35, P89; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Estes S, 2007, AM NAT, V169, P227, DOI 10.1086/510633; Evin A, 2013, J ARCHAEOL SCI, V40, P735, DOI 10.1016/j.jas.2012.08.005; Fraser D., 2005, ANIMAL WELFARE INTEN, V2; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gillis R, 2013, WORLD ARCHAEOL, V45, P447, DOI 10.1080/00438243.2013.820652; Gingerich PD, 2001, GENETICA, V112, P127, DOI 10.1023/A:1013311015886; Giroux MA, 2014, ECOLOGY, V95, P1332, DOI 10.1890/13-0956.1; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Helmer Daniel, 2005, P86; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Hongo Hitomi, 2000, ARCHAEOZOOLOGY NEAR, P121; Ijzereef GF, 1981, NEDERLANSE OUDHEDEN; Kaeuffer R, 2008, P B SOC B, V274, P527; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Lari M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-32; Lasota-Moskalewska A., 1980, WIAD ARCHEOL, V45, P119; Luff RM., 1993, COLCH ARCHAEOL REP 1; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Lyman RL, 2009, AM ANTIQUITY, V74, P485, DOI 10.1017/S0002731600048721; MacKinnon M, 2010, WORLD ARCHAEOL, V42, P55, DOI 10.1080/00438240903429730; Manning K, 2014, ANTIQUITY, V88, P1065, DOI 10.1017/S0003598X00115327; Manning K, 2013, ANTIQUITY, V87, P1046, DOI 10.1017/S0003598X00049851; Martin JL, 2007, J ANIM SCI, V85, P841, DOI 10.2527/jas.2006-337; Meadow R. H., 1999, HIST ANAMALIUM EX OS, V8, P285; Meadow R.H., 1978, APPROACHES FAUNAL AN, P41; Meadow R.H, 1989, WALKING LARDER PATTE, P80; Meadow RH, 1984, BAR INT SERIES, V3, P309; Meniel P., 1984, REV ARCHEOLOGIQUE PI; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Peters Joris, 2000, Paleorient, V25, P27; Poplin F, 1986, NEOLITHIQUE FRANCE, P37; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Purugganan MD, 2011, EVOLUTION, V65, P171, DOI 10.1111/j.1558-5646.2010.01093.x; Rasmussen P., 1989, ACTA ARCHAEOL-DEN, V60, P71; REINHARDT C, 1986, APPL ANIM BEHAV SCI, V15, P125, DOI 10.1016/0168-1591(86)90058-4; Rieseberg LH, 2002, P NATL ACAD SCI USA, V99, P12242, DOI 10.1073/pnas.192360899; Rowley-Conwy P, 2013, PUBL INST ARCHAEOL, V59, P161; Sacks BN, 2013, MOL BIOL EVOL, V30, P1103, DOI 10.1093/molbev/mst027; Schibler J, 2007, SCHWEIZ ARCH TIERH, V149, P23, DOI 10.1024/0036-7281.149.1.23; Schibler J, 2013, PUBL INST ARCHAEOL, V59, P253; Schlumbaum A, 2003, ANTIQUITY, V77, P298; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; Timpson A, 2014, J ARCHAEOL SCI, V52, P549, DOI 10.1016/j.jas.2014.08.011; Tresset A., 2000, BRIT ARCHAEOLOGICAL, P17; Tresset A., 1996, THESIS; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Vigne JD, 1988, MAMMIFERES POSTGLACI; Vigne Jean-Denis, 2005, P1; Von Den Driesch A., 1976, GUIDE MEASUREMENT AN; von den Driesch A, 1978, TIERKNOCHENFUNDE NEO; Zimmermann A, 2013, EC ARCHAEOLOGY STRUC, P109; Zohary D, 1998, J ZOOL, V245, P129, DOI 10.1111/j.1469-7998.1998.tb00082.x	79	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0141873	10.1371/journal.pone.0141873	http://dx.doi.org/10.1371/journal.pone.0141873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX8BI	26630287	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300007
J	Park, J; Yang, PS; Kim, TH; Uhm, JS; Kim, JY; Joung, B; Lee, MH; Hwang, C; Pak, HN				Park, Junbeom; Yang, Pil-sung; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Joung-Youn; Joung, Boyoung; Lee, Moon-Hyoung; Hwang, Chun; Pak, Hui-Nam			Low Left Atrial Compliance Contributes to the Clinical Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Structurally and Functionally Normal Heart	PLOS ONE			English	Article							PRESSURES	Stiff left atrial (LA) syndrome was initially reported in post-cardiac surgery patients and known to be associated with low LA compliance. We investigated the physiological and clinical implications of LA compliance by estimating LA pulse pressure (LApp) among patients with atrial fibrillation (AF) and structurally and functionally normal heart. Among 1038 consecutive patients with LA pressure measurements before AF ablation, we included 334 patients with structurally and functionally normal heart (81.7% male, 54.1 +/- 10.6 years, 77.0% paroxysmal AF) after excluding those with hypertension, diabetes, and previous ablation or cardiac surgery. We measured LApp (peak-nadir LA pressure) at the beginning of the ablation procedure and compared the values with clinical parameters and the AF recurrence rate. AF patients with normal heart were younger and more frequently male and had paroxysmal AF, a lower body mass index, and a lower LApp compared to others (all p<0.05). Based on the median value, the low LA compliance group (LApp >= 13mmHg) had a smaller LA volume index and lower LA voltage (all p<0.05) compared to the high LA compliance group. During a mean follow-up of 16.7 +/- 11.8 months, low LA compliance was independently associated with two fold-higher risk of clinical AF recurrence (HR: 2.202; 95% CI: 1.077-4.503; p = 0.031). Low LA compliance, as determined by an elevated LApp, was associated with a smaller LA volume index and lower LA voltage and independently associated with higher clinical recurrence after catheter ablation in AF patients with structurally and functionally normal heart.	[Park, Junbeom; Yang, Pil-sung; Kim, Tae-Hoon; Uhm, Jae-Sun; Kim, Joung-Youn; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea; [Hwang, Chun] Utah Valley Med Ctr, Provo, UT USA	Yonsei University; Yonsei University Health System	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.	hnpak@yuhs.ac	Stefanadis, Christodoulos/ABH-2232-2020; Pak, Hui-Nam/C-4266-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; Lee, Moon-Hyoung/0000-0002-7268-0741; Uhm, Jae-Sun/0000-0002-1611-8172; Kim, Tae-Hoon/0000-0003-4200-3456; Pak, Hui-Nam/0000-0002-3256-3620; Kim, Jong-Youn/0000-0001-7040-8771; Joung, Boyoung/0000-0001-9036-7225	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [7-2013-0362]	Korea Health 21 R&D Project, Ministry of Health and Welfare; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP)	This work was supported by a grant (A085136) from the Korea Health 21 R&D Project, Ministry of Health and Welfare and a grant (7-2013-0362) from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP).	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Cha YM, 2004, CIRCULATION, V109, P2839, DOI 10.1161/01.CIR.0000132470.78896.A8; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Elayi CS, 2008, HEART RHYTHM, V5, P1658, DOI 10.1016/j.hrthm.2008.09.016; Gibson DN, 2011, HEART RHYTHM, V8, P1364, DOI 10.1016/j.hrthm.2011.02.026; Hammerstingl C, 2012, J CARDIOVASC ELECTR, V23, P247, DOI 10.1111/j.1540-8167.2011.02177.x; Kapa S, 2014, J CARDIOVASC ELECTRO; Lee G, 2012, LANCET, V380, P1509, DOI 10.1016/S0140-6736(12)61463-9; Lee JS, 2013, CIRC J, V77, P697, DOI 10.1253/circj.CJ-12-1009; LEISTAD E, 1993, AM J PHYSIOL, V264, pH1093, DOI 10.1152/ajpheart.1993.264.4.H1093; MANNING WJ, 1993, J AM COLL CARDIOL, V22, P221, DOI 10.1016/0735-1097(93)90838-R; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Park JH, 2009, J CARDIOVASC ELECTR, V20, P1349, DOI 10.1111/j.1540-8167.2009.01557.x; Park J, 2014, HEART RHYTHM, V11, P953, DOI 10.1016/j.hrthm.2014.03.009; PILOTE L, 1988, CAN J CARDIOL, V4, P255; Shim J, 2013, INT J CARDIOL, V167, P2667, DOI 10.1016/j.ijcard.2012.06.120; Stefanadis C, 1998, J AM COLL CARDIOL, V31, P426, DOI 10.1016/S0735-1097(97)00517-2; Stefanadis C, 2001, EUR HEART J, V22, P22, DOI 10.1053/euhj.1999.2581; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143853	10.1371/journal.pone.0143853	http://dx.doi.org/10.1371/journal.pone.0143853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624617	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600057
J	Lommel, MJ; Trairatphisan, P; Gabler, K; Laurini, C; Muller, A; Kaoma, T; Vallar, L; Sauter, T; Schaffner-Reckinger, E				Lommel, Maiti J.; Trairatphisan, Panuwat; Gaebler, Karoline; Laurini, Christina; Muller, Arnaud; Kaoma, Tony; Vallar, Laurent; Sauter, Thomas; Schaffner-Reckinger, Elisabeth			L-plastin Ser5 phosphorylation in breast cancer cells and in vitro is mediated by RSK downstream of the ERK/MAPK pathway	FASEB JOURNAL			English	Article						invasion; migration; signal transduction; actin cytoskeleton	PROTEIN-KINASE-C; INTEGRIN ACTIVATION; EXPRESSION PATTERNS; MELANOMA-CELLS; LUNG-CANCER; GENE; LINES; INVASION; MODELS; CAMP	Deregulated cell migration and invasion are hallmarks of metastatic cancer cells. Phosphorylation on residue Ser5 of the actin-bundling protein L-plastin activates L-plastin and has been reported to be crucial for invasion and metastasis. Here, we investigate signal transduction leading to L-plastin Ser5 phosphorylation using 4 human breast cancer cell lines. Whole-genome microarray analysis comparing cell lines with different invasive capacities and corresponding variations in L-plastin Ser5 phosphorylation level revealed that genes of the ERK/MAPK pathway are differentially expressed. It is note-worthy that in vitro kinase assays showed that ERK/MAPK pathway downstream ribosomal protein S6 kinases alpha-1 (RSK1) and alpha-3 (RSK2) are able to directly phosphorylate L-plastin on Ser5. Small interfering RNA- or short hairpin RNA-mediated knockdown and activation/inhibition studies followed by immunoblot analysis and computational modeling confirmed that ribosomal S6 kinase (RSK) is an essential activator of L-plastin. Migration and invasion assays showed that RSK knockdown led to a decrease of up to 30% of migration and invasion of MDA-MB-435S cells. Although the presence of L-plastin was not necessary for migration/invasion of these cells, immunofluorescence assays illustrated RSK-dependent recruitment of Ser5-phosphorylated L-plastin to migratory structures. Altogether, we provide evidence that the ERK/MAPK pathway is involved in L-plastin Ser5 phosphorylation in breast cancer cells with RSK1 and RSK2 kinases able to directly phosphorylate L-plastin residue Ser5.	[Lommel, Maiti J.; Gaebler, Karoline; Laurini, Christina; Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Campus Limpertsberg,162a,Ave Faiencerie, L-1511 Luxembourg, Luxembourg; [Trairatphisan, Panuwat; Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, L-1511 Luxembourg, Luxembourg; [Muller, Arnaud; Kaoma, Tony; Vallar, Laurent] Luxembourg Inst Hlth, Genom Res Unit, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg; Luxembourg Institute of Health	Schaffner-Reckinger, E (corresponding author), Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Campus Limpertsberg,162a,Ave Faiencerie, L-1511 Luxembourg, Luxembourg.	elisabeth.schaffner@uni.lu		Muller, Arnaud/0000-0002-3841-4722; Trairatphisan, Panuwat/0000-0001-9015-5855; Vallar, Laurent/0000-0002-4404-1010; Sauter, Thomas/0000-0001-8225-2954	UL (Internal Research Project: PhosphoPlast); Fonds National de la Recherche (Aides a la Formation-Recherche) [2748401, 1233900]	UL (Internal Research Project: PhosphoPlast); Fonds National de la Recherche (Aides a la Formation-Recherche)(Luxembourg National Research Fund)	The authors are grateful to Alexandre Baron (University of Luxembourg, UL) for his meaningful contribution to the revision of this manuscript and to Nicolas Beaume (UL) and Aurelien Ginolhac (UL) for help with statistical data analysis. The authors thank Maria Koffa (Democritus University of Thrace, Alexandroupoli, Greece) and Serge Haan (UL) for proofreading the manuscript and constructive discussions as well as Evelyne Friederich (UL) as an initiator of this research project. The authors also thank Francois Bernardin (Luxembourg Institute of Health) and Andreas Girod (UL) for assistance with microarray and confocal microscopy experiments, respectively. In addition, the authors thank Joe W. Ramos (University of Hawaii, Honolulu, HI, USA) for providing the ribosomal protein S6 kinase alpha-3 constructs. This work was supported by a grant from the UL (Internal Research Project: PhosphoPlast). M.J.L. and P.T. are recipients of fellowships allocated by the Fonds National de la Recherche (Aides a la Formation-Recherche Grants 2748401 and 1233900, respectively). The authors declare no conflicts of interest.	Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Gawecka JE, 2012, J BIOL CHEM, V287, P43424, DOI 10.1074/jbc.M112.423046; Hagi A, 2006, MICROBIOL IMMUNOL, V50, P331, DOI 10.1111/j.1348-0421.2006.tb03801.x; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Janji B, 2010, J CELL MOL MED, V14, P1264, DOI 10.1111/j.1582-4934.2009.00918.x; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kazanietz MG, 2000, MOL CARCINOGEN, V28, P5, DOI 10.1002/(SICI)1098-2744(200005)28:1<5::AID-MC2>3.0.CO;2-G; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Klemke M, 2007, INT J CANCER, V120, P2590, DOI 10.1002/ijc.22589; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Goff E, 2010, CYTOSKELETON, V67, P286, DOI 10.1002/cm.20442; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Li D, 2013, J BIOL CHEM, V288, P32528, DOI 10.1074/jbc.M113.500561; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; MATSUSHIMA K, 1987, J IMMUNOL, V139, P3367; Mok TSK, 2011, NAT REV CLIN ONCOL, V8, P661, DOI 10.1038/nrclinonc.2011.126; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Paclet MH, 2004, BIOCHEM J, V377, P469, DOI 10.1042/BJ20031114; Pazdrak K, 2011, J IMMUNOL, V186, P6485, DOI 10.4049/jimmunol.1001868; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Riplinger SM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-10; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Shinomiya Hiroto, 2012, Int J Cell Biol, V2012, P213492, DOI 10.1155/2012/213492; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Sugita S, 1997, J NEUROSCI, V17, P7237; Sulzmaier FJ, 2013, CANCER RES, V73, P6099, DOI 10.1158/0008-5472.CAN-13-1087; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Trairatphisan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098001; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Vial D, 2012, J BIOL CHEM, V287, P40371, DOI 10.1074/jbc.M112.389577; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zheng JP, 1999, AM J PATHOL, V155, P115, DOI 10.1016/S0002-9440(10)65106-1	67	24	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1218	1233		10.1096/fj.15-276311	http://dx.doi.org/10.1096/fj.15-276311			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631483				2022-12-26	WOS:000370387800019
J	Mizutani, T; Ishizaka, A; Nihei, C				Mizutani, Taketoshi; Ishizaka, Aya; Nihei, Coh-ichi			Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSGENIC MICE; RETROGRADE TRANSPORT; TISSUE TROPISM; BARRIER; POLIOMYELITIS; INTERFERON; EXPRESSION; COMPLEX; SYSTEM	As a possible route for invasion of the CNS, circulating poliovirus (PV) in the blood is believed to traverse the blood-brain barrier (BBB), resulting in paralytic poliomyelitis. However, the underlying mechanism is poorly understood. In this study, we demonstrated that mouse transferrin receptor 1 (mTfR1) is responsible for PV attachment to the cell surface, allowing invasion into the CNS via the BBB. PV interacts with the apical domain of mTfR1 on mouse brain capillary endothelial cells (MBEC4) in a dose-dependent manner via its capsid protein (VP1). Wefound that F-G, G-H, and H-I loops in VP1 are important for this binding. However, C-D, D-E, and E-F loops in VP1-fused Venus proteins efficiently penetrate MBEC4 cells. These results imply that the VP1 functional domain responsible for cell attachment is different from that involved in viral permeation of the brain capillary endothelium. We observed that co-treatment of MBEC4 cells with excess PV particles but not dextran resulted in blockage of transferrin transport into cells. Using the Transwell in vitro BBB model, transferrin co-treatment inhibited permeation of PV into MBEC4 cells and delayed further viral permeation via mTfR1 knockdown. With mTfR1 as a positive mediator of PV-host cell attachment and PV permeation of MBEC4 cells, our results indicate a novel role of TfR1 as a cellular receptor for human PV receptor/CD155-independent PV invasion of the CNS.	[Mizutani, Taketoshi; Ishizaka, Aya; Nihei, Coh-ichi] Microbial Chem Res Fdn BIKAKEN, Inst Microbial Chem, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan		Mizutani, T (corresponding author), Microbial Chem Res Fdn BIKAKEN, Inst Microbial Chem, Virol Lab, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo 1410021, Japan.	mizutanit@bikaken.or.jp		Mizutani, Taketoshi/0000-0002-1329-6512; Ishizaka, Aya/0000-0003-2800-2430	Japan Society for the Promotion of Science KAKENHI Grants [25670221, 15K14413, 15K19117, 21790437, 23659235]; Japan Agency for Medical Research and Development [15545492]	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by The Japan Society for the Promotion of Science KAKENHI Grants 25670221 and 15K14413 (to T. M.), 15K19117 (to A. I.), and 21790437 and 23659235 (to C. N.) and Japan Agency for Medical Research and Development Grant 15545492 (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AOKI J, 1994, J BIOL CHEM, V269, P8431; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bordin ES, 1955, J CONSULT PSYCHOL, V19, P9, DOI 10.1037/h0047986; BRIGHTMAN MW, 1977, EXP EYE RES, V25, P1, DOI 10.1016/S0014-4835(77)80008-0; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Dohgu S, 2000, CELL MOL NEUROBIOL, V20, P781, DOI 10.1023/A:1007015228318; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; Flanagan ML, 2008, J VIROL, V82, P938, DOI 10.1128/JVI.01397-07; FRIDEN PM, 1991, P NATL ACAD SCI USA, V88, P4771, DOI 10.1073/pnas.88.11.4771; Gromeier M, 1998, J VIROL, V72, P5056, DOI 10.1128/JVI.72.6.5056-5060.1998; HASHIDA R, 1986, CELL STRUCT FUNCT, V11, P343, DOI 10.1247/csf.11.343; HORIE H, 1994, J VIROL, V68, P681, DOI 10.1128/JVI.68.2.681-688.1994; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Ishizaka A, 2012, J BIOL CHEM, V287, P11924, DOI 10.1074/jbc.M111.322792; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; KAJIGAYA S, 1985, VIROLOGY, V142, P307, DOI 10.1016/0042-6822(85)90339-3; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; KOIKE S, 1994, ARCH VIROL, V139, P351, DOI 10.1007/BF01310797; Levy HC, 2010, J VIROL, V84, P4426, DOI 10.1128/JVI.02393-09; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Mizutani T, 2015, J BIOL CHEM, V290, P18391, DOI 10.1074/jbc.M115.657155; Mizutani T, 2014, FEBS LETT, V588, P1630, DOI 10.1016/j.febslet.2014.01.067; MUNOZ A, 1984, J GEN VIROL, V65, P377, DOI 10.1099/0022-1317-65-2-377; Nakamura Y, 2012, NEUROCHEM INT, V60, P448, DOI 10.1016/j.neuint.2011.08.018; Ohka S, 1998, VIROLOGY, V250, P67, DOI 10.1006/viro.1998.9360; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; Ohka S, 2009, J VIROL, V83, P4995, DOI 10.1128/JVI.02225-08; Palermo LA, 2003, J VIROL, V77, P8915, DOI 10.1128/JVI.77.16.8915-8923.2003; PARDRIDGE WM, 1986, ENDOCR REV, V7, P314, DOI 10.1210/edrv-7-3-314; PARDRIDGE WM, 1987, METABOLISM, V36, P892, DOI 10.1016/0026-0495(87)90099-0; PARDRIDGE WM, 1985, J NEUROCHEM, V45, P1141, DOI 10.1111/j.1471-4159.1985.tb05534.x; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PUTNAK JR, 1981, MICROBIOL REV, V45, P287, DOI 10.1128/MMBR.45.2.287-315.1981; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; REN R, 1992, J VIROL, V66, P296, DOI 10.1128/JVI.66.1.296-304.1992; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; SABIN AB, 1956, SCIENCE, V123, P1151, DOI 10.1126/science.123.3209.1151; SCRABA DG, 1967, J MOL BIOL, V26, P67, DOI 10.1016/0022-2836(67)90261-6; Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Yang WX, 1997, VIROLOGY, V229, P421, DOI 10.1006/viro.1997.8450; Zhang SH, 1997, J VIROL, V71, P4915, DOI 10.1128/JVI.71.7.4915-4920.1997	48	18	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2829	2836		10.1074/jbc.M115.690941	http://dx.doi.org/10.1074/jbc.M115.690941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26637351	hybrid, Green Published			2022-12-26	WOS:000369626900022
J	Chauhan, N; Han, GS; Somashekarappa, N; Gable, K; Dunn, T; Kohlwein, SD				Chauhan, Neha; Han, Gongshe; Somashekarappa, Niranjanakumari; Gable, Kenneth; Dunn, Teresa; Kohlwein, Sepp D.			Regulation of Sphingolipid Biosynthesis by the Morphogenesis Checkpoint Kinase Swe1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; LONG-CHAIN BASES; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; HEAT-STRESS; SERINE PALMITOYLTRANSFERASE; YEAST SPHINGOLIPIDS; ORMDL3 EXPRESSION; GLOBAL ANALYSIS; PHOSPHORYLATION	Sphingolipid (SL) biosynthesis is negatively regulated by the highly conserved endoplasmic reticulum-localized Orm family proteins. Defective SL synthesis in Saccharomyces cerevisiae leads to increased phosphorylation and inhibition of Orm proteins by the kinase Ypk1. Here we present evidence that the yeast morphogenesis checkpoint kinase, Swe1, regulates SL biosynthesis independent of the Ypk1 pathway. Deletion of the Swe1 kinase renders mutant cells sensitive to serine palmitoyltransferase inhibition due to impaired sphingoid long-chain base synthesis. Based on these data and previous results, we suggest that Swe1 kinase perceives alterations in SL homeostasis, activates SL synthesis, and may thus represent the missing regulatory link that controls the SL rheostat during the cell cycle.	[Chauhan, Neha; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, BioTechMed Graz, Humboldtstr 50-2, A-8010 Graz, Austria; [Han, Gongshe; Somashekarappa, Niranjanakumari; Gable, Kenneth; Dunn, Teresa] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Chauhan, Neha] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	University of Graz; Uniformed Services University of the Health Sciences - USA; Cornell University	Kohlwein, SD (corresponding author), Graz Univ, Inst Mol Biosci, BioTechMed Graz, Humboldtstr 50-2, A-8010 Graz, Austria.; Dunn, T (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA.	teresa.dunn-giroux@usuhs.edu; sepp.kohlwein@uni-graz.at	Chauhan, Neha/X-2271-2019	Chauhan, Neha/0000-0003-1497-3359; Kohlwein, Sepp Dieter/0000-0002-1030-0598	Austrian Science Funds (FWF) [SFB F 3005, W903]; NAWI Graz; National Institutes of Health [R21HD080181]; Austrian Science Fund (FWF) [W 901, F 3005] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080181] Funding Source: NIH RePORTER	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); NAWI Graz; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Austrian Science Funds (FWF) Projects SFB F 3005 LIPOTOX and Ph.D. program W903 Molecular Enzymology and NAWI Graz (to S. D. K.) and by National Institutes of Health Grant R21HD080181 (to T. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Ahn SH, 2001, MOL BIOL CELL, V12, P3589, DOI 10.1091/mbc.12.11.3589; Anastasia SD, 2012, J CELL BIOL, V197, P89, DOI 10.1083/jcb.201108108; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Baerends RJS, 2000, J BIOL CHEM, V275, P9986, DOI 10.1074/jbc.275.14.9986; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Chauhan N, 2015, P NATL ACAD SCI USA, V112, pE1077, DOI 10.1073/pnas.1423175112; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Epstein S, 2012, MOL MICROBIOL, V84, P1018, DOI 10.1111/j.1365-2958.2012.08087.x; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gomez-Munoz A, 2013, BBA-MOL CELL BIOL L, V1831, P1060, DOI 10.1016/j.bbalip.2013.02.001; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Humphrey Tim, 2004, V296, P3; Iwaki S, 2005, J BIOL CHEM, V280, P6520, DOI 10.1074/jbc.M410908200; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lee JY, 1998, BIOCHEM J, V334, P457, DOI 10.1042/bj3340457; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Lester RL, 2013, BBA-MOL CELL BIOL L, V1831, P726, DOI 10.1016/j.bbalip.2012.12.012; Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Matmati N, 2013, J BIOL CHEM, V288, P17272, DOI 10.1074/jbc.M112.444802; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; Miyakawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P633, DOI 10.1271/bbb.60495; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Sawai H, 2005, CURR PHARM DESIGN, V11, P2479, DOI 10.2174/1381612054367463; Sharifpoor S, 2012, GENOME RES, V22, P791, DOI 10.1101/gr.129213.111; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; Sinclair DA, 2006, SCIENCE, V312, P195; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Theesfeld CL, 2003, MOL BIOL CELL, V14, P3280, DOI 10.1091/mbc.e03-03-0154; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; ZHAO C, 1994, J BIOL CHEM, V269, P21480	90	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2524	2534		10.1074/jbc.M115.693200	http://dx.doi.org/10.1074/jbc.M115.693200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26634277	Green Published, hybrid			2022-12-26	WOS:000369610400039
J	Wu, K; Hoy, MA				Wu, Ke; Hoy, Marjorie A.			Cloning and Functional Characterization of Two BTB Genes in the Predatory Mite Metaseiulus occidentalis	PLOS ONE			English	Article							DROSOPHILA OVARY MORPHOGENESIS; GENETICALLY-IMPROVED STRAINS; BTB/POZ DOMAIN PROTEINS; ZINC-FINGER PROTEINS; BRIC-A-BRAC; UBIQUITIN LIGASES; TETRAMERIZATION DOMAIN; ACARI PHYTOSEIIDAE; SEXUAL ORIENTATION; POTASSIUM CHANNELS	Proteins containing the BTB (Bric-a-brac, tramtrack, and Broad Complex) domain typically share low sequence similarities and are involved in a wide range of cellular functions. We previously identified two putative and closely related BTB genes, BTB1 and BTB2, in the genome of the predatory mite Metaseiulus occidentalis. In the current study, full-length BTB1 and BTB2 cDNAs were cloned and sequenced. BTB1 and BTB2 encode proteins of 380 and 401 amino acids, respectively. BTB1 and BTB2 proteins each contain an N-terminal BTB domain and no other identifiable domains. Thus, they belong to a large category of BTB-domain proteins that are widely distributed in eukaryotes, yet with largely unknown function(s). BTB1 and BTB2 gene knockdowns in M. occidentalis females using RNAi reduced their fecundity by approximately 40% and 73%, respectively, whereas knockdown had no impact on their survival or the development of their offspring. These findings suggest these two proteins may be involved in processes related to egg production in this predatory mite, expanding the list of functions attributed to these diverse proteins.	[Wu, Ke; Hoy, Marjorie A.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, POB 11620, Gainesville, FL 32611 USA.	kewu@ufl.edu			Davies; Fischer; Eckes Endowment in Biological Control	Davies; Fischer; Eckes Endowment in Biological Control	This research was supported in part by the Davies, Fischer and Eckes Endowment in Biological Control to MAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Godfrey Maina for assistance in rearing the colonies. This research was supported in part by the Davies, Fischer and Eckes Endowment in Biological Control to MAH.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Couderc JL, 2002, DEVELOPMENT, V129, P2419; Cushman SJ, 2000, NAT STRUCT BIOL, V7, P403; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; FIELD RP, 1985, ENTOMOL EXP APPL, V38, P113, DOI 10.1007/BF00361921; FIELD RP, 1986, HILGARDIA, V54, P1; Field RP, 1978, AUSTR J ZOOL, V26, P519; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GODT D, 1995, DEVELOPMENT, V121, P173; HEADLEY JC, 1987, J ECON ENTOMOL, V80, P555, DOI 10.1093/jee/80.3.555; HOY MA, 1985, ANNU REV ENTOMOL, V30, P345, DOI 10.1146/annurev.en.30.010185.002021; HOY MA, 1982, ENTOMOL EXP APPL, V31, P316, DOI 10.1111/j.1570-7458.1982.tb03151.x; HOYT SC, 1969, J ECON ENTOMOL, V62, P74, DOI 10.1093/jee/62.1.74; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Liu HL, 2005, J BIOMOL STRUCT DYN, V22, P387, DOI 10.1080/07391102.2005.10507011; Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lours C, 2003, NUCLEIC ACIDS RES, V31, P5389, DOI 10.1093/nar/gkg724; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MCMURTRY JA, 1970, HILGARDIA, V40, P331, DOI 10.3733/hilg.v40n11p331; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; NUMOTO M, 1993, NUCLEIC ACIDS RES, V21, P3767, DOI 10.1093/nar/21.16.3767; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Pomerantz AF, 2015, EXP APPL ACAROL, V65, P1, DOI 10.1007/s10493-014-9855-2; ROUSH RT, 1981, J ECON ENTOMOL, V74, P142, DOI 10.1093/jee/74.2.142; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SAHUTBARNOLA I, 1995, DEV BIOL, V170, P127, DOI 10.1006/dbio.1995.1201; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stogios PJ, 2010, J MOL BIOL, V400, P983, DOI 10.1016/j.jmb.2010.05.028; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110874; Wu K, 2014, BIOL CONTROL, V77, P59, DOI 10.1016/j.biocontrol.2014.06.008; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Wu K, 2012, J INVERTEBR PATHOL, V109, P20, DOI 10.1016/j.jip.2011.09.005; Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	51	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144291	10.1371/journal.pone.0144291	http://dx.doi.org/10.1371/journal.pone.0144291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640898	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700092
J	Hyvarinen, S; Jokiranta, TS				Hyvarinen, Satu; Jokiranta, T. Sakari			Minor Role of Plasminogen in Complement Activation on Cell Surfaces	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-H; PLATELET ACTIVATION; CLASSICAL PATHWAY; ENDOTHELIAL-CELLS; BLOOD-PLATELETS; FACTOR-B; FIBRINOLYSIS; MECHANISMS; MUTATIONS	Atypical hemolytic uremic syndrome (aHUS) is a rare, but severe thrombotic microangiopathy. In roughly two thirds of the patients, mutations in complement genes lead to uncontrolled activation of the complement system against self cells. Recently, aHUS patients were described with deficiency of the fibrinolytic protein plasminogen. This zymogen and its protease form plasmin have both been shown to interact with complement proteins in the fluid phase. In this work we studied the potential of plasminogen to restrict complement propagation. In hemolytic assays, plasminogen inhibited complement activation, but only when it had been exogenously activated to plasmin and when it was used at disproportionately high concentrations compared to serum. Addition of only the zymogen plasminogen into serum did not hinder complement-mediated lysis of erythrocytes. Plasminogen could not restrict deposition of complement activation products on endothelial cells either, as was shown with flow cytometry. With platelets, a very weak inhibitory effect on deposition of C3 fragments was observed, but it was considered too weak to be significant for disease pathogenesis. Thus it was concluded that plasminogen is not an important regulator of complement on self cells. Instead, addition of plasminogen was shown to clearly hinder platelet aggregation in serum. This was attributed to plasmin causing disintegration of formed platelet aggregates. We propose that reduced proteolytic activity of plasmin on structures of growing thrombi, rather than on complement activation fragments, explains the association of plasminogen deficiency with aHUS. This adds to the emerging view that factors unrelated to the complement system can also be central to aHUS pathogenesis and suggests that future research on the mechanism of the disease should expand beyond complement dysregulation.	[Hyvarinen, Satu] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland	University of Helsinki; University of Helsinki	Hyvarinen, S (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.	satu.hyvarinen@helsinki.fi			Sigrid Juselius Foundation [128646]; Academy of Finland [259793]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by research grants from the Sigrid Juselius Foundation (grant 128646 to TSJ; http://www.sigridjuselius.fi/foundation) and the Academy of Finland (grant 259793 to TSJ; http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Bruneau S, 2015, BLOOD, V125, P1038, DOI 10.1182/blood-2014-06-579953; Bu FX, 2014, J AM SOC NEPHROL, V25, P55, DOI 10.1681/ASN.2013050453; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Deryugina EI, 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/564259, DOI 10.1155/2012/564259]; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Endo Y, 2010, J INNATE IMMUN, V2, P33, DOI 10.1159/000227805; Foley JH, 2015, J THROMB HAEMOST, V13, P610, DOI 10.1111/jth.12837; GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898; Gushiken FC, 2009, J THROMB HAEMOST, V7, P865, DOI 10.1111/j.1538-7836.2009.03334.x; HOFFMANN JJML, 1992, THROMB RES, V67, P711, DOI 10.1016/0049-3848(92)90075-L; IKARI N, 1981, FEBS LETT, V131, P143, DOI 10.1016/0014-5793(81)80906-4; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Kavanagh D, 2010, PEDIATR NEPHROL, V25, P2431, DOI 10.1007/s00467-010-1555-5; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Licht C, 2009, BLOOD, V114, P4538, DOI 10.1182/blood-2009-03-205096; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; LOSCALZO J, 1995, THROMB HAEMOSTASIS, V74, P291; LOSCALZO J, 1987, J CLIN INVEST, V79, P1749, DOI 10.1172/JCI113015; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Matsukuma E, 2011, CLIN EXP NEPHROL, V15, P269, DOI 10.1007/s10157-010-0375-z; Mehta R, 2008, HAEMOPHILIA, V14, P1261, DOI 10.1111/j.1365-2516.2008.01825.x; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1986, J CLIN INVEST, V77, P2001, DOI 10.1172/JCI112529; Modde F, 2013, VIRCHOWS ARCH, V462, P455, DOI 10.1007/s00428-013-1386-4; MULLEREBERHARD HJ, 1960, J EXP MED, V111, P201, DOI 10.1084/jem.111.2.201; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; NUNN DL, 1987, BIOCHEM J, V243, P809, DOI 10.1042/bj2430809; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x; Peerschke EIB, 2003, THROMB HAEMOSTASIS, V89, P331; PILLEMER L, 1953, J EXP MED, V97, P573, DOI 10.1084/jem.97.4.573; POLLEY MJ, 1983, J EXP MED, V158, P603, DOI 10.1084/jem.158.2.603; POLLEY MJ, 1978, J EXP MED, V147, P1713, DOI 10.1084/jem.147.6.1713; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Saggu G, 2013, J IMMUNOL, V190, P6457, DOI 10.4049/jimmunol.1300610; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; SCHREIBER RD, 1974, J EXP MED, V140, P1324, DOI 10.1084/jem.140.5.1324; SEYA T, 1985, Complement, V2, P165; SHATSTSEYTLINA EA, 1994, BLOOD COAGUL FIBRIN, V5, P529; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; TAUBMAN SB, 1971, IMMUNOCHEMISTRY, V8, P951, DOI 10.1016/0019-2791(71)90433-2; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143707	10.1371/journal.pone.0143707	http://dx.doi.org/10.1371/journal.pone.0143707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637181	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800023
J	Agrebi, B; Tkatchuk, V; Hlila, N; Mouelhi, E; Belhani, A				Agrebi, Brahim; Tkatchuk, Vladimir; Hlila, Nawel; Mouelhi, Emna; Belhani, Ali			Impact of specific training and competition on myocardial structure and function in different age ranges of male handball players	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; PHYSIOLOGICAL CARDIAC-HYPERTROPHY; ATHLETES HEART; DIASTOLIC FUNCTION; SOCCER PLAYERS; UPPER LIMIT; ELITE; BOYS; ECHOCARDIOGRAPHY; ADAPTATION	Handball activity involves cardiac changes and demands a mixture of both eccentric and concentric remodeling within the heart. This study seeks to explore heart performance and cardiac remodeling likely to define cardiac parameters which influence specific performance in male handball players across different age ranges. Forty three players, with a regular training and competitive background in handball separated into three groups aged on average 11.78 +/- 0.41 for youth players aka "schools", "elite juniors" 15.99 +/- 0.81 and "elite adults" 24.46 +/- 2.63 years, underwent echocardiography and ECG examinations. Incremental ergo-cycle and specific field (SFT) tests have also been conducted. With age and regular training and competition, myocardial remodeling in different age ranges exhibit significant differences in dilatation's parameters between "schools" and "juniors" players, such as the end-diastolic diameter (LVEDD) and the end-systolic diameter of the left ventricle (LVESD), the root of aorta (Ao) and left atrial (LA), while significant increase is observed between "juniors" and "adults" players in the interventricular septum (IVS), the posterior wall thicknesses (PWT) and LV mass index. ECG changes are also noted but NS differences were observed in studied parameters. For incremental maximal test, players demonstrate a significant increase in duration and total work between "schools" and "juniors" and, in total work only, between "juniors" and "seniors". The SFT shows improvement in performance which ranged between 26.17 +/- 1.83 sec to 31.23 +/- 2.34 sec respectively from "seniors" to "schools". The cross-sectional approach used to compare groups with prior hypothesis that there would be differences in exercise performance and cardiac parameters depending on duration of prior handball practice, leads to point out the early cardiac remodeling within the heart as adaptive change. Prevalence of cardiac chamber dilation with less hypertrophy remodeling was found from "schools" to "juniors" while a prevalence of cardiac hypertrophy with less pronounced chamber dilation remodeling was noted later.	[Agrebi, Brahim] Inst Sports & Phys Educ, Dept Team Sports, Tunis, Tunisia; [Tkatchuk, Vladimir] Natl Univ Pedag Dragomanov MP, Dept Biol Bases Phys Training & Sport Disciplines, Kiev, Ukraine; [Hlila, Nawel; Mouelhi, Emna; Belhani, Ali] Charles Nicolle Hosp, Tunis, Tunisia	Ministry of Education & Science of Ukraine; National Pedagogical Dragomanov University; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Agrebi, B (corresponding author), Inst Sports & Phys Educ, Dept Team Sports, Tunis, Tunisia.	agrebi_brahim@yahoo.fr						Agrebi B, 1997, THESIS; Akova B, 2005, J SPORT SCI MED, V4, P185; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Baker JS, 2009, J EXERC SCI FIT, V7, pS51, DOI 10.1016/S1728-869X(09)60023-X; Beneke R, 2005, J APPL PHYSIOL, V99, P499, DOI 10.1152/japplphysiol.00062.2005; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Chevalier L, 2004, SCI SPORT, V19, P69, DOI 10.1016/j.scispo.2003.08.005; Corrado D, 2009, BRIT J SPORT MED, V43, P669, DOI 10.1136/bjsm.2008.054759; Cubero GI, 2000, INT J CARDIOL, V75, P261; CUNNINGHAM DA, 1984, J APPL PHYSIOL, V56, P302, DOI 10.1152/jappl.1984.56.2.302; D'Andrea A, 2010, AM J CARDIOL, V105, P1629, DOI 10.1016/j.amjcard.2010.01.028; De Luca A, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-27; DEVEREUX RB, 1987, HYPERTENSION, V9, P19; DEVEREUX RB, 1983, CIRCULATION, V67, P907, DOI 10.1161/01.CIR.67.4.907; Dickhuth HH, 2004, HERZ, V29, P373, DOI 10.1007/s00059-004-2582-4; Dzudie A, 2007, EUR J ECHOCARDIOGR, V8, P122, DOI 10.1016/j.euje.2006.02.006; Granados C, 2007, INT J SPORTS MED, V28, P860, DOI 10.1055/s-2007-964989; Griffet V, 2013, ANN CARDIOL ANGEIOL, V62, P116, DOI 10.1016/j.ancard.2013.02.003; Kaczor JJ, 2005, PEDIATR RES, V57, P331, DOI 10.1203/01.PDR.0000150799.77094.DE; Kororos P., 2009, OPEN SPORTS SCI J, V2, P22, DOI [10.2174/1875399X00902010022, DOI 10.2174/1875399X00902010022]; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Makan J, 2005, HEART, V91, P495, DOI 10.1136/hrt.2004.035121; Manolas MV, 2002, THESIS; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; MARON BJ, 1986, J AM COLL CARDIOL, V7, P190, DOI 10.1016/S0735-1097(86)80282-0; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Naylor LH, 2008, SPORTS MED, V38, P69, DOI 10.2165/00007256-200838010-00006; Nottin S, 2004, MED SCI SPORT EXER, V36, P1507, DOI 10.1249/01.MSS.0000139900.67704.07; Obert P, 2001, INT J SPORTS MED, V22, P90, DOI 10.1055/s-2001-11343; Obert P, 1998, INT J SPORTS MED, V19, P149, DOI 10.1055/s-2007-971897; Pavlik G, 2001, BRIT J SPORT MED, V35, P95, DOI 10.1136/bjsm.35.2.95; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pelliccia A, 2010, CIRCULATION, V122, P698, DOI 10.1161/CIRCULATIONAHA.109.901074; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Rannou F, 2001, J SPORT MED PHYS FIT, V41, P349; Ratel S, 2002, J APPL PHYSIOL, V92, P479, DOI 10.1152/japplphysiol.00495.2001; Rizzo M, 2003, MED SCI SPORT EXER, V35, P1986, DOI 10.1249/01.MSS.0000098993.51693.0B; Rowland T, 1997, MED SCI SPORT EXER, V29, P1146, DOI 10.1097/00005768-199709000-00005; Sharma S, 1999, BRIT J SPORT MED, V33, P319, DOI 10.1136/bjsm.33.5.319; Sharma S, 2002, J AM COLL CARDIOL, V40, P1431, DOI 10.1016/S0735-1097(02)02270-2; Somauroo JD, 2001, HEART, V85, P649, DOI 10.1136/heart.85.6.649; SPIRITO P, 1994, AM J CARDIOL, V74, P802, DOI 10.1016/0002-9149(94)90439-1; Stein R, 2002, J AM COLL CARDIOL, V39, P1033, DOI 10.1016/S0735-1097(02)01722-9; Triposkiadis F, 2002, EUR J CLIN INVEST, V32, P16, DOI 10.1046/j.0014-2972.2001.00939.x; Urhausen A, 1996, INT J SPORTS MED, V17, pS145, DOI 10.1055/s-2007-972916; van Buuren F, 2013, INT J SPORTS MED, V34, P200, DOI 10.1055/s-0032-1316313; Vasiliauskas D, 2006, EUR J CARDIOV PREV R, V13, P985, DOI 10.1097/01.hjr.0000238394.04600.fc; Whyte GP, 2004, EUR J APPL PHYSIOL, V92, P592, DOI 10.1007/s00421-004-1052-2; Woo EJ, 1992, KOREAN CIRC J, V22, P939; Zdravkovic M, 2010, J SCI MED SPORT, V13, P602, DOI 10.1016/j.jsams.2010.03.005	52	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143609	10.1371/journal.pone.0143609	http://dx.doi.org/10.1371/journal.pone.0143609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630561	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300070
J	Laughinghouse, HD; Muller, KM; Adey, WH; Lara, Y; Young, R; Johnson, G				Laughinghouse, Haywood Dail; Mueller, Kirsten M.; Adey, Walter H.; Lara, Yannick; Young, Robert; Johnson, Gabriel			Evolution of the Northern Rockweed, Fucus distichus, in a Regime of Glacial Cycling: Implications for Benthic Algal Phylogenetics	PLOS ONE			English	Article							MORPHOLOGICAL VARIATION; BIOGEOGRAPHY; MODEL; PHYLOGEOGRAPHY; PHAEOPHYCEAE; SEAWEEDS; RANGE; TIME; DNA	Northern hemisphere rockweeds (Fucus) are thought to have evolved in the North Pacific and then spread to the North Atlantic following the opening of the Bering Strait. They have dispersed and widely speciated in the North Atlantic and its tributary seas. Fucus distichus is likely near the ancestral member of this genus, and studies have shown that there are several species/subspecies in this complex (i. e. F. evanescens and F. gardneri). We used phylogenetic and haplotype analyses to test the phylogenetic relationships and biogeography of F. distichus. Our data and subsequent analyses demonstrate that, unlike previous studies that lacked samples from an extensive geographical area of the Arctic and Subarctic, there is a distinct Arctic haplotype that is the source of subspecies in both the North Pacific and North Atlantic. Fucus distichus occupies a low tide zone habitat, and in Arctic/Subarctic regions it is adapted to the severe stress of sea ice coverage and disturbance during many months per year. We hypothesize that the very large geographic area of Arctic and Subarctic rocky shores available to this species during interglacials, supported by large Arctic/Subarctic fringe areas as well as unglaciated refugia during glacial cycles, provided a robust population and gene pool (described by the Thermogeographic Model). This gene pool dilutes that of the more fragmented and area-limited Temperate/Boreal area populations when they are brought together during glacial cycles. We suggest that similar subspecies complexes for a variety of Arctic/Subarctic shore biota should be examined further in this context, rather than arbitrarily being split up into numerous species.	[Laughinghouse, Haywood Dail; Adey, Walter H.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Mueller, Kirsten M.; Young, Robert] Univ Waterloo, Dept Biol, Waterloo, ON N2T 2T4, Canada; [Lara, Yannick] Univ Liege, Ctr Prot Engn, B-4000 Liege, Belgium; [Johnson, Gabriel] Smithsonian Inst, Museum Support Ctr, Dept Bot, Suitland, MD 20746 USA; [Johnson, Gabriel] Smithsonian Inst, Museum Support Ctr, Labs Analyt Biol, Suitland, MD 20746 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Waterloo; University of Liege; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Muller, KM (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2T 2T4, Canada.	kirsten.muller@uwaterloo.ca	Laughinghouse, H. Dail/M-5836-2016	Laughinghouse, H. Dail/0000-0003-1018-6948; Adey, Walter/0000-0001-9823-2501	National Science and Engineering Research Council of Canada (NSERC) [RGPin 238619-2012 32709]; Dept. of Botany, Smithsonian Institution; Statoil; FRS-FNRS; NSERC Discovery Grant Program	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dept. of Botany, Smithsonian Institution; Statoil; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); NSERC Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research by K. Muller was supported by an National Science and Engineering Research Council of Canada (NSERC) Discovery grant: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp, Grant Number -RGPin 238619-2012 32709. W. Adey received internal funding from the Dept. of Botany, Smithsonian Institution for DNA extraction and sequencing and H.D. Laughinghouse IV was funded by grants from Statoil and FRS-FNRS during different parts of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. J Coyer for his exceptional support during this study, from sharing his "Rosetta Stone" to reviewing an earlier version of this manuscript. We would also like to thank Chris MacTaggart for drawing our map, Dr. M Wynne for his view on current taxonomy of Fucus species, to RM Fischer for proofreading our manuscript, and to two anonymous reviewers for their comments. K. Muller received funding from the NSERC Discovery Grant Program, W. Adey received internal funding from the Dept. of Botany, Smithsonian Institution for DNA extraction and sequencing, and H.D. Laughinghouse IV was funded by grants from Statoil and FRS-FNRS during different parts of this study.	ABBOTT I A, 1976, P827; Adey WH, 2011, NORTHEAST NAT, V18, P1; Adey WH, 2008, J PHYCOL, V44, P1384, DOI 10.1111/j.1529-8817.2008.00605.x; Adey WH, 2005, CRYPTOGAMIE ALGOL, V26, P35; Adey WH, 2001, J PHYCOL, V37, P677, DOI 10.1046/j.1529-8817.2001.00176.x; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; Coyer JA, 2011, J BIOGEOGR, V38, P756, DOI 10.1111/j.1365-2699.2010.02437.x; Drummond A. J., 2011, GENEIOUS V5 4; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fenberg PB, 2014, ECOL EVOL, V4, P3244, DOI 10.1002/ece3.1181; Gabrielson P.W., 2006, PHYCOLOGICAL CONTRIB; Gabrielson PW, 2000, PHYCOL CONTRIB, V5, P1; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Holden PB, 2010, CLIM PAST, V6, P431, DOI 10.5194/cp-6-431-2010; Huson DH, 2011, GENOME BIOL EVOL, V3, P23, DOI 10.1093/gbe/evq077; Kalvas A, 1998, J MAR BIOL ASSOC UK, V78, P985, DOI 10.1017/S0025315400044921; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Lindstrom SC, 2009, J BIOGEOGR, V36, P401, DOI 10.1111/j.1365-2699.2007.01855.x; Lindstrom SC, 2001, J BIOGEOGR, V28, P243, DOI 10.1046/j.1365-2699.2001.00529.x; Luning K., 1990, SEAWEEDS THEIR ENV B; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; Miller M.A., 2010, P GAT COMP ENV WORKS; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RICE EL, 1985, MAR BIOL, V88, P207, DOI 10.1007/BF00397168; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruuskanen AT, 2005, ANN BOT FENN, V42, P27; Scagel RF, 1989, PHYCOL CONTRIB, P3; Scott GW, 2001, EUR J PHYCOL, V36, P43, DOI 10.1017/S0967026201003055; Sears J, 2002, NE ALGAL SOC CONTRIB, V2, P1; Serrao EA, 1999, J PHYCOL, V35, P382, DOI 10.1046/j.1529-8817.1999.3520382.x; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Silva PC, 1953, WASMANN J BIOL, V11, P221; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor W.R, 1957, MARINE ALGAE NE COAS; VANOPPEN MJH, 1995, MAR BIOL, V123, P179, DOI 10.1007/BF00350338; Villalard-Bohnsack M, 1995, ILLUSTRATED KEY SEAW; Wilce RT, 2014, ARCTIC, V67, P43, DOI 10.14430/arctic4360; Witt JDS, 2011, J BIOGEOGR, V38, P1557, DOI 10.1111/j.1365-2699.2011.02497.x	43	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143795	10.1371/journal.pone.0143795	http://dx.doi.org/10.1371/journal.pone.0143795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630571	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300100
J	Lazzaroni-Tealdi, E; Barad, DH; Albertini, DF; Yu, Y; Kushnir, VA; Russell, H; Wu, YG; Gleicher, N				Lazzaroni-Tealdi, Emanuela; Barad, David H.; Albertini, David F.; Yu, Yao; Kushnir, Vitaly A.; Russell, Helena; Wu, Yan-Guang; Gleicher, Norbert			Oocyte Scoring Enhances Embryo-Scoring in Predicting Pregnancy Chances with IVF Where It Counts Most	PLOS ONE			English	Article							POLAR BODY MORPHOLOGY; PERIVITELLINE SPACE; QUALITY; ICSI; GRANULARITY; THICKNESS; TIME; AGE	Context Our center's quality improvement optimization process on many occasions anecdotally suggested that oocyte assessments might enhance embryo assessment in predicting pregnancy chances with in vitro fertilization (IVF). Objective To prospectively compare a morphologic oocyte grading system to standard day-3 morphologic embryo assessment. Design, Setting, Patients We prospectively investigated in a private academically-affiliated infertility center 94 consecutive IVF cycles based on 6 criteria for oocyte quality: morphology, cytoplasm, perivitelline space (PVS), zona pellucida (ZP), polar body (PB) and oocyte size, each assigned a value of -1 (worst), 0 (average) or +1 (best), so establishing an average total oocyte score (TOS). Embryo assessment utilized grade and cell numbers of each embryo on day-3 after oocyte retrieval. Clinical pregnancy was defined by presence of at least one intrauterine gestational sac. Interventions Standard IVF cycles in infertile women. Main Outcome Measures Predictability of pregnancy based on oocyte and embryo-grading systems. Results Average age for all patients was 36.5 +/- 7.3 years; mean oocyte yield was 7.97 +/- 5.76; Patient specific total oocyte score (PTOS) was -1.05 +/- 2.24. PTOS, adjusted for patient age, was directly related to odds of increased embryo cell numbers (OR 1.12, P = 0.025), embryo grade (OR 1.19, P < 0.001) and clinical pregnancy [OR 1.58 (95% CI 1.23 to 2.02), P < 0.001]. Restricting the analysis to day three embryos of high quality (8-cell/good grades), TOS was still predictive of clinical pregnancy (OR 2.08 (95% CI 1.26 to 3.44, P = 0.004). Among the 69 patients with embryos of Grade 4 or better available for transfer 23 achieved Clinical Pregnancy. When the analysis was restricted to the 69 transfers with good quality embryos (>= Grade 4) the Oocyte Scoring System (TOS) (AUC +/- SE 0.863 +/- 0.044, oocyte score) provided significantly greater predictive value for clinical pregnancy compared to the embryo grade alone (AUC 0.646 +/- 0.072, embryo grade) p = 0.015. Conclusions Oocyte-scoring, thus, provides useful clinical information especially in good prognosis patients with large numbers of high quality embryos. This finding appears of particular importance at a time when many IVF centers are committing sizable investments to closed incubation systems with time-lapse photography, which are exclusively meant to define embryo morphology.	[Lazzaroni-Tealdi, Emanuela; Barad, David H.; Albertini, David F.; Yu, Yao; Kushnir, Vitaly A.; Wu, Yan-Guang; Gleicher, Norbert] Ctr Human Reprod, New York, NY 10021 USA; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA; [Albertini, David F.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Kushnir, Vitaly A.] Wake Forest Univ, Dept Obstet & Gynecol, Winston Salem, NC 27109 USA; [Russell, Helena] Eastern Virginia Med Sch, Sch Hlth Profess, Norfolk, VA 23501 USA; [Gleicher, Norbert] Rockefeller Univ, Stem Cell & Mol Embryol Lab, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; University of Kansas; University of Kansas Medical Center; Wake Forest University; Eastern Virginia Medical School; Rockefeller University	Gleicher, N (corresponding author), Ctr Human Reprod, New York, NY 10021 USA.	ngleicher@thechr.com	Yu, Yao/O-3224-2016; Barad, David/AAF-4332-2021; Albertini, David/AAD-3856-2021	Albertini, David/0000-0001-6536-2828	Foundation for Reproductive Medicine and intramural from the Center for Human Reproduction (CHR) - New York	Foundation for Reproductive Medicine and intramural from the Center for Human Reproduction (CHR) - New York	This work was supported by the Foundation for Reproductive Medicine and intramural grants from the Center for Human Reproduction (CHR) - New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakier H, 2002, HUM REPROD, V17, P2394, DOI 10.1093/humrep/17.9.2394; Balakier H, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.015; Catala MG, 2012, FERTIL STERIL, V97, P1004, DOI 10.1016/j.fertnstert.2011.12.043; Ciotti PM, 2004, HUM REPROD, V19, P2334, DOI 10.1093/humrep/deh433; Ebner T, 1999, FERTIL STERIL, V72, P599, DOI 10.1016/S0015-0282(99)00315-5; Ebner T, 2008, HUM REPROD, V23, P62, DOI 10.1093/humrep/dem280; Esfandiari N, 2006, FERTIL STERIL, V86, P1522, DOI 10.1016/j.fertnstert.2006.03.056; Fancsovits P, 2012, ACTA BIOL HUNG, V63, P189, DOI 10.1556/ABiol.63.2012.2.3; Fancsovits P, 2011, REPROD BIOMED ONLINE, V23, P513, DOI 10.1016/j.rbmo.2011.06.008; Farhi J, 2002, J ASSIST REPROD GEN, V19, P545, DOI 10.1023/A:1021243530358; Figueira RDS, 2010, FERTIL STERIL, V94, P1115, DOI 10.1016/j.fertnstert.2009.11.039; Garside WT, 1997, MOL REPROD DEV, V47, P99, DOI 10.1002/(SICI)1098-2795(199705)47:1<99::AID-MRD13>3.0.CO;2-V; Gleicher N, 2015, REPROD BIOL ENDOCRIN, V13, P1, DOI 10.1186/1477-7827-13-3; Hassan-Ali H, 1998, HUM REPROD, V13, P3425, DOI 10.1093/humrep/13.12.3425; Herrero J, 2013, FERTIL STERIL, V99, P1030, DOI 10.1016/j.fertnstert.2013.01.089; Kahraman S, 2000, HUM REPROD, V15, P2390, DOI 10.1093/humrep/15.11.2390; Kaser DJ, 2012, FERTIL STERIL, V97, P338, DOI 10.1016/j.fertnstert.2011.11.013; Loutradis D, 1999, FERTIL STERIL, V72, P240, DOI 10.1016/S0015-0282(99)00233-2; Marteil G, 2009, REPROD BIOL, V9, P203, DOI 10.1016/S1642-431X(12)60027-8; Navarro PA, 2009, INT J GYNECOL OBSTET, V104, P226, DOI 10.1016/j.ijgo.2008.11.008; Nel-Themaat L, 2011, PLACENTA, V32, pS257, DOI 10.1016/j.placenta.2011.05.011; Nichi M, 2011, ARCH MED SCI, V7, P315, DOI 10.5114/aoms.2011.22084; Otsuki J, 2004, HUM REPROD, V19, P1591, DOI 10.1093/humrep/deh258; Otsuki J, 2007, J ASSIST REPROD GEN, V24, P263, DOI 10.1007/s10815-007-9130-0; Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024; Saith RR, 1998, HUM REPROD UPDATE, V4, P121, DOI 10.1093/humupd/4.2.121; Setti AS, 2011, EUR J OBSTET GYN R B, V159, P364, DOI 10.1016/j.ejogrb.2011.07.031; Wallbutton S, 2010, J ASSIST REPROD GEN, V27, P183, DOI 10.1007/s10815-010-9399-2	28	51	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143632	10.1371/journal.pone.0143632	http://dx.doi.org/10.1371/journal.pone.0143632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630267	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300077
J	Park, YS; Bae, DW; Ryu, CM				Park, Yong-Soon; Bae, Dong-Won; Ryu, Choong-Min			Aboveground Whitefly Infestation Modulates Transcriptional Levels of Anthocyanin Biosynthesis and Jasmonic Acid Signaling-Related Genes and Augments the Cope with Drought Stress of Maize	PLOS ONE			English	Article							DEFENSE; TOLERANCE; RESPONSES; ACCUMULATION; ARABIDOPSIS; MECHANISM; VOLATILE; HORMONES; PLANTS	Up to now, the potential underlying molecular mechanisms by which maize (Zea mays L.) plants elicit defense responses by infestation with a phloem feeding insect whitefly [Bemisia tabaci (Genn.)] have been barely elucidated against (a) biotic stresses. To fill this gap of current knowledge maize plants were infested with whitefly and these plants were subsequently assessed the levels of water loss. To understand the mode of action, plant hormone contents and the stress-related mRNA expression were evaluated. Whitefly-infested maize plants did not display any significant phenotypic differences in aboveground tissues (infested site) compared with controls. By contrast, root (systemic tissue) biomass was increased by 2-fold by whitefly infestation. The levels of endogenous indole-3-acetic acid (IAA), jasmonic acid (JA), and hydrogen peroxide (H2O2) were significantly higher in whitefly-infested plants. The biosynthetic or signaling-related genes for JA and anthocyanins were highly up-regulated. Additionally, we found that healthier plants were obtained in whitefly-infested plants under drought conditions. The weight of whitefly-infested plants was approximately 20% higher than that of control plants at 14 d of drought treatment. The drought tolerance-related genes, ZmbZIP72, ZmSNAC1, and ZmABA1, were highly expressed in the whitefly-infected plants. Collectively, our results suggest that IAA/JA-derived maize physiological changes and correlation of H2O2 production and water loss are modulated by above-ground whitefly infestation in maize plants.	[Park, Yong-Soon; Ryu, Choong-Min] KRIBB, Mol Phytobacteriol Lab, Daejeon 305806, South Korea; [Park, Yong-Soon] RDA, Natl Acad Agr Sci, Agr Microbiol Div, Wonju 565851, South Korea; [Bae, Dong-Won] Gyeongsang Natl Univ, Cent Instrument Facil, Jinju 660701, South Korea; [Ryu, Choong-Min] Univ Sci & Technol UST, Biosyst & Bioengn Program, Daejeon 305350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Rural Development Administration (RDA); Gyeongsang National University; University of Science & Technology (UST)	Ryu, CM (corresponding author), KRIBB, Mol Phytobacteriol Lab, Daejeon 305806, South Korea.	cmryu@kribb.re.kr		Ryu, Choong-Min/0000-0002-7276-1189	BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project [H-GUARD_2013M3A6B2078953]; Woo Jang-Choon project of the Rural Development Administration (RDA) [PJ01093904]; KRIBB initiative program, South Korea	BioNano Health-Guard Research Center - Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project; Woo Jang-Choon project of the Rural Development Administration (RDA); KRIBB initiative program, South Korea	This research was supported by grants from BioNano Health-Guard Research Center funded by the Ministry of Science, ICT, and Future Planning of Korea as a Global Frontier Project (Grant H-GUARD_2013M3A6B2078953), the Woo Jang-Choon project (PJ01093904) of the Rural Development Administration (RDA), and from the KRIBB initiative program, South Korea.	Assmann SM, 2009, PLANT MOL BIOL, V69, P451, DOI [10.1007/s11103-008-9427-0, DOI 10.1007/S11103-008-9427-0]; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Bengoa JM, 2001, PUBLIC HEALTH NUTR, V4, P1425, DOI 10.1079/PHN2001232; Bonaventure G, 2012, PLANT BIOLOGY, V14, P872, DOI 10.1111/j.1438-8677.2012.00650.x; Bosque-Perez NA, 2000, VIRUS RES, V71, P107, DOI 10.1016/S0168-1702(00)00192-1; BROADBENT AB, 1989, CAN ENTOMOL, V121, P1027, DOI 10.4039/Ent1211027-11; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Cai GH, 2014, PLANT SCI, V214, P57, DOI 10.1016/j.plantsci.2013.09.014; Chalker-Scott L, 2002, ADV BOT RES, V37, P103, DOI 10.1016/S0065-2296(02)37046-0; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; DO CB, 1990, PLANT CELL REP, V9, P143, DOI 10.1007/BF00232091; Gilbert N, 2012, NATURE MAGAZINE; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hughes NM, 2013, J PLANT PHYSIOL, V170, P230, DOI 10.1016/j.jplph.2012.09.006; Hughes NM, 2011, NEW PHYTOL, V190, P573, DOI 10.1111/j.1469-8137.2011.03662.x; Hughes NM, 2010, J EXP BOT, V61, P1699, DOI 10.1093/jxb/erq042; Inbar M, 1999, J CHEM ECOL, V25, P1961, DOI 10.1023/A:1020998219928; Jia ZW, 2009, AFR J BIOTECHNOL, V8, P6764; JIMENEZ DR, 1995, PHYSIOL MOL PLANT P, V46, P227, DOI 10.1006/pmpp.1995.1018; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kang JH, 2014, PLANT PHYSIOL, V164, P1161, DOI 10.1104/pp.113.233395; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Liu XX, 2013, PLANT CELL ENVIRON, V36, P1037, DOI 10.1111/pce.12040; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Lu M, 2012, PLANT CELL REP, V31, P1701, DOI 10.1007/s00299-012-1284-2; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Nieva C, 2005, PLANT MOL BIOL, V58, P899, DOI 10.1007/s11103-005-8407-x; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Park YS, 2014, BIOCHEM BIOPH RES CO, V443, P272, DOI 10.1016/j.bbrc.2013.11.105; Perefarres F, 2012, VIRUSES-BASEL, V4, P3665, DOI 10.3390/v4123665; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Tohge T, 2013, CRIT REV BIOCHEM MOL, V48, P123, DOI 10.3109/10409238.2012.758083; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Zhang X, 2008, J EXP BOT, V59, P839, DOI 10.1093/jxb/erm364; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x	49	8	10	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143879	10.1371/journal.pone.0143879	http://dx.doi.org/10.1371/journal.pone.0143879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630288	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300117
J	Zeller, M; Held, M; Bender, J; Berz, A; Heinloth, T; Hellfritz, T; Pfeiffer, K				Zeller, Maximilian; Held, Martina; Bender, Julia; Berz, Annuska; Heinloth, Tanja; Hellfritz, Timm; Pfeiffer, Keram			Transmedulla Neurons in the Sky Compass Network of the Honeybee (Apis mellifera) Are a Possible Site of Circadian Input	PLOS ONE			English	Article							PIGMENT-DISPERSING HORMONE; ANTERIOR OPTIC TUBERCLE; DORSAL RIM AREA; POLARIZATION-SENSITIVE INTERNEURONS; LOCUST SCHISTOCERCA-GREGARIA; 2 PARALLEL PATHWAYS; IMMUNOREACTIVE NEURONS; CENTRAL COMPLEX; COMPOUND EYE; VISUAL INTERNEURONS	Honeybees are known for their ability to use the sun's azimuth and the sky's polarization pattern for spatial orientation. Sky compass orientation in bees has been extensively studied at the behavioral level but our knowledge about the underlying neuronal systems and mechanisms is very limited. Electrophysiological studies in other insect species suggest that neurons of the sky compass system integrate information about the polarization pattern of the sky, its chromatic gradient, and the azimuth of the sun. In order to obtain a stable directional signal throughout the day, circadian changes between the sky polarization pattern and the solar azimuth must be compensated. Likewise, the system must be modulated in a context specific way to compensate for changes in intensity, polarization and chromatic properties of light caused by clouds, vegetation and landscape. The goal of this study was to identify neurons of the sky compass pathway in the honeybee brain and to find potential sites of circadian and neuromodulatory input into this pathway. To this end we first traced the sky compass pathway from the polarization-sensitive dorsal rim area of the compound eye via the medulla and the anterior optic tubercle to the lateral complex using dye injections. Neurons forming this pathway strongly resembled neurons of the sky compass pathway in other insect species. Next we combined tracer injections with immunocytochemistry against the circadian neuropeptide pigment dispersing factor and the neuromodulators serotonin, and.-aminobutyric acid. We identified neurons, connecting the dorsal rim area of the medulla to the anterior optic tubercle, as a possible site of neuromodulation and interaction with the circadian system. These neurons have conspicuous spines in close proximity to pigment dispersing factor-, serotonin-, and GABA-immunoreactive neurons. Our data therefore show for the first time a potential interaction site between the sky compass pathway and the circadian clock.	[Zeller, Maximilian; Held, Martina; Bender, Julia; Berz, Annuska; Heinloth, Tanja; Hellfritz, Timm; Pfeiffer, Keram] Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany	Philipps University Marburg	Pfeiffer, K (corresponding author), Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany.	keram.pfeiffer@staff.uni-marburg.de	Pfeiffer, Keram/AAQ-1812-2020	Pfeiffer, Keram/0000-0001-5348-2304; Berz, Annuska/0000-0002-5522-0188				Aptekar JW, 2015, J NEUROSCI, V35, P7587, DOI 10.1523/JNEUROSCI.0652-15.2015; Baschong W, 1999, METHOD ENZYMOL, V307, P173; Bech M, 2014, CURR BIOL, V24, P2124, DOI 10.1016/j.cub.2014.07.045; Bloch G, 2003, J COMP NEUROL, V464, P269, DOI 10.1002/cne.10778; BONOMELLI SL, 1988, AM ZOOL, V28, pA117; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Brockmann A, 2007, BRAIN BEHAV EVOLUT, V70, P125, DOI 10.1159/000102974; BULTHOFF H, 1987, BRAIN RES, V407, P152, DOI 10.1016/0006-8993(87)91230-3; Chen B, 1999, J COMP PHYSIOL A, V185, P393, DOI 10.1007/s003590050400; COEMANS MAJM, 1994, VISION RES, V34, P1461, DOI 10.1016/0042-6989(94)90148-1; Coulson K. L., 1988, POLARIZATION INTENSI; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; el Jundi B, 2015, P NATL ACAD SCI USA, V112, P11395, DOI 10.1073/pnas.1501272112; el Jundi B, 2014, J EXP BIOL, V217, P2422, DOI 10.1242/jeb.101154; el Jundi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027855; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; Frisch B, 1996, CELL TISSUE RES, V286, P411, DOI 10.1007/s004410050711; Frisch K.v., 1949, Experientia Basel, V5, P142, DOI 10.1007/BF02174424; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Hamanaka Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041109; Hassaneen E, 2011, J BIOL RHYTHM, V26, P3, DOI 10.1177/0748730410388746; Heinze S, 2013, J COMP NEUROL, V521, P267, DOI 10.1002/cne.23214; Heinze S, 2012, J COMP NEUROL, V520, P1599, DOI 10.1002/cne.23054; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; HERTEL H, 1987, J EXP BIOL, V133, P301; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; HOMBERG U, 1991, J COMP NEUROL, V303, P35, DOI 10.1002/cne.903030105; Homberg U, 2002, ARTHROPOD STRUCT DEV, V30, P271, DOI 10.1016/S1467-8039(02)00010-5; Homberg U, 1999, J COMP NEUROL, V409, P495, DOI 10.1002/(SICI)1096-9861(19990705)409:3<495::AID-CNE12>3.0.CO;2-F; HOMBERG U, 1991, CELL TISSUE RES, V266, P343, DOI 10.1007/BF00318190; HOMBERG U, 1987, CELL TISSUE RES, V248, P1, DOI 10.1007/BF01239957; HOSKINS SG, 1986, CELL TISSUE RES, V244, P243; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kinoshita M, 2007, J EXP BIOL, V210, P1350, DOI 10.1242/jeb.02744; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KLOPPENBURG P, 1995, J COMP PHYSIOL A, V176, P119, DOI 10.1007/BF00197758; Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; LABHART T, 1980, J COMP PHYSIOL, V141, P19, DOI 10.1007/BF00611874; Labhart T, 2001, J EXP BIOL, V204, P2423; Labhart T, 1999, J EXP BIOL, V202, P757; Lebhardt F, 2015, J COMP PHYSIOL A, V201, P599, DOI 10.1007/s00359-014-0928-9; LEHRER M, 1997, ORIENTATION COMMUNIC; Leitinger G, 2004, J COMP NEUROL, V480, P89, DOI 10.1002/cne.20333; LINDAUER M, 1954, NATURWISSENSCHAFTEN, V41, P506, DOI 10.1007/BF00631843; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Montgomery SH, 2015, J COMP NEUROL, V523, P869, DOI 10.1002/cne.23711; Mota T, 2013, J NEUROSCI, V33, P4, DOI 10.1523/JNEUROSCI.1412-12.2013; Mota T, 2011, J NEUROSCI, V31, P11443, DOI 10.1523/JNEUROSCI.0995-11.2011; Neumann E, 1999, BIOELECTROCH BIOENER, V48, P3, DOI 10.1016/S0302-4598(99)00008-2; Otsuna H, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00008; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; Pfeiffer K, 2007, CURR BIOL, V17, P960, DOI 10.1016/j.cub.2007.04.059; Pfeiffer K, 2012, J COMP NEUROL, V520, P212, DOI 10.1002/cne.22776; Pfeiffer K, 2011, J NEUROPHYSIOL, V105, P28, DOI 10.1152/jn.00480.2010; Pyza E, 1996, J COMP PHYSIOL A, V178, P33, DOI 10.1007/BF00189588; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; Saifullah ASM, 2003, J INSECT PHYSIOL, V49, P231, DOI 10.1016/S0022-1910(02)00270-6; Saifullah ASM, 2002, J EXP BIOL, V205, P1305; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Schmeling F, 2015, J COMP PHYSIOL A, V201, P427, DOI 10.1007/s00359-015-0990-y; Schmitt F, 2016, DEV NEUROBIOL, V76, P390, DOI 10.1002/dneu.22322; Sehadova H, 2003, CELL TISSUE RES, V312, P113, DOI 10.1007/s00441-003-0705-5; Shafer OT, 2014, CURR OPIN INSECT SCI, V1, P73, DOI 10.1016/j.cois.2014.05.002; STENGL M, 1994, J COMP PHYSIOL A, V175, P203, DOI 10.1007/BF00215116; Strausfeld NJ, 2007, J COMP NEUROL, V500, P166, DOI 10.1002/cne.21196; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Strutt H J, 1871, PHILOS MAG, V41, P274; Sumiyoshi M, 2011, ZOOL SCI, V28, P897, DOI 10.2108/zsj.28.897; TOMIOKA K, 1993, NATURWISSENSCHAFTEN, V80, P137, DOI 10.1007/BF01131019; Trager U, 2008, J COMP NEUROL, V506, P288, DOI 10.1002/cne.21512; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; VONFRISCH K, 1950, EXPERIENTIA, V6, P210, DOI 10.1007/BF02173654; VONFRISCH K, 1948, NATURWISSENSCHAFTEN, V35, P12; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; Wei HY, 2010, J COMP NEUROL, V518, P4113, DOI 10.1002/cne.22471; Weiss R, 2009, J INSECT PHYSIOL, V55, P479, DOI 10.1016/j.jinsphys.2009.01.016	87	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143244	10.1371/journal.pone.0143244	http://dx.doi.org/10.1371/journal.pone.0143244			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630286	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300037
J	Kulke, L; Atkinson, J; Braddick, O				Kulke, Louisa; Atkinson, Janette; Braddick, Oliver			Automatic Detection of Attention Shifts in Infancy: Eye Tracking in the Fixation Shift Paradigm	PLOS ONE			English	Article							VISUAL-ATTENTION; TERM INFANTS; CHILDREN; DISENGAGEMENT; TARGETS; FACES	This study measured changes in switches of attention between 1 and 9 months of age in 67 typically developing infants. Remote eye-tracking (Tobii X120) was used to measure saccadic latencies, related to switches of fixation, as a measure of shifts of attention, from a central stimulus to a peripheral visual target, measured in the Fixation Shift Paradigm. Fixation shifts occur later if the central fixation stimulus stays visible when the peripheral target appears (competition condition), than if the central stimulus disappears as the peripheral target appears (non-competition condition). This difference decreases with age. Our results show significantly faster disengagement in infants over 4 months than in the younger group, and provide more precise measures of fixation shifts, than behavioural observation with the same paradigm. Reduced saccadic latencies in the course of a test session indicate a novel learning effect. The Fixation Shift Paradigm combined with remote eye-tracking measures showed improved temporal and spatial accuracy compared to direct observation by a trained observer, and allowed an increased number of trials in a short testing time. This makes it an infant-friendly non-invasive procedure, involving minimal observational training, suitable for use in future studies of clinical populations to detect early attentional abnormalities in the first few months of life.	[Kulke, Louisa; Atkinson, Janette] UCL, Fac Brain Sci, Div Psychol & Language Sci, London, England; [Atkinson, Janette; Braddick, Oliver] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; University College London; University of Oxford	Kulke, L (corresponding author), UCL, Fac Brain Sci, Div Psychol & Language Sci, London, England.	louisa.kulke.12@ucl.ac.uk	Kulke, Louisa/N-7842-2018; Braddick, Oliver/O-2507-2019	Kulke, Louisa/0000-0002-9696-8619; Braddick, Oliver/0000-0002-7540-171X	German Academic Exchange Service (DAAD) [91522396-57044644]; Leverhulme Trust [EM-2012-053]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Leverhulme Trust(Leverhulme Trust)	The work was supported by a stipend from the German Academic Exchange Service (DAAD, https://www.daad.de/en/, grant number 91522396-57044644) to LK, and an Emeritus Fellowship from the Leverhulme Trust (https://www.leverhulme.ac.uk/, grant number: EM-2012-053) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; Atkinson J, 2008, ARCH DIS CHILD-FETAL, V93, pF292, DOI 10.1136/adc.2007.116988; ATKINSON J, 1992, PERCEPTION, V21, P643, DOI 10.1068/p210643; Atkinson J, 2003, DEV NEUROPSYCHOL, V23, P139, DOI 10.1207/S15326942DN231&2_7; ATKINSON J, 1985, PERCEPTION, V14, pA25; ATKINSON J, 1988, PERCEPTION, V17, P367; Atkinson J, 2011, BRAIN LESION LOCALIZ; Atkinson J., 2000, DEV VISUAL BRAIN; Atkinson J, 2007, PROG BRAIN RES, V164, P123, DOI 10.1016/S0079-6123(07)64007-2; Atkinson J, 2012, DEV MED CHILD NEUROL, V54, P589, DOI 10.1111/j.1469-8749.2012.04294.x; BRADDICK O, 1992, NATURE, V360, P461, DOI 10.1038/360461a0; Colombo J, 2001, ANNU REV PSYCHOL, V52, P337, DOI 10.1146/annurev.psych.52.1.337; Elsabbagh M, 2013, BIOL PSYCHIAT, V74, P189, DOI 10.1016/j.biopsych.2012.11.030; Elsabbagh M, 2009, J CHILD PSYCHOL PSYC, V50, P637, DOI 10.1111/j.1469-7610.2008.02051.x; Farroni T, 1999, DEVELOPMENTAL SCI, V2, P174, DOI 10.1111/1467-7687.00066; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; HARRIS P, 1974, J EXP CHILD PSYCHOL, V18, P340, DOI 10.1016/0022-0965(74)90113-1; HOOD B, 1990, DEV MED CHILD NEUROL, V32, P1067; Hood BM, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P219; HOOD BM, 1993, INFANT BEHAV DEV, V16, P405, DOI 10.1016/0163-6383(93)80001-O; Hunnius S, 2004, INFANT BEHAV DEV, V27, P397, DOI 10.1016/j.infbeh.2004.02.003; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Kano F, 2011, VISION RES, V51, P2348, DOI 10.1016/j.visres.2011.09.006; Kulke L, 2015, J VISION, V15, P737, DOI [10.1167/15.12.737, DOI 10.1167/15.12.737]; Kulke LV, 2014, PERCEPTION, V43, P63; Leppanen JM, 2015, BEHAV RES METHODS, V47, P538, DOI 10.3758/s13428-014-0473-z; Matsuzawa M, 1997, INFANT BEHAV DEV, V20, P449, DOI 10.1016/S0163-6383(97)90035-7; Mercuri E, 1997, NEUROPEDIATRICS, V28, P155, DOI 10.1055/s-2007-973693; Mercuri E, 1999, ARCH DIS CHILD-FETAL, V80, pF99, DOI 10.1136/fn.80.2.F99; Morgante JD, 2012, INFANCY, V17, P9, DOI 10.1111/j.1532-7078.2011.00089.x; Peltola MJ, 2009, EMOTION, V9, P560, DOI 10.1037/a0015806; Pratesi A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0076-7; Tobii Technology I, 2010, PRODUCT DESCRIPTION; Tummeltshammer KS, 2014, PSYCHOL SCI, V25, P1730, DOI 10.1177/0956797614540178; Wass S. V., 2012, BEHAV RES METHODS, P1	35	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142505	10.1371/journal.pone.0142505	http://dx.doi.org/10.1371/journal.pone.0142505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26625161	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600008
J	Petrek, J; Zitka, O; Adam, V; Bartusek, K; Anjum, NA; Pereira, E; Havel, L; Kizek, R				Petrek, Jiri; Zitka, Ondrej; Adam, Vojtech; Bartusek, Karel; Anjum, Naser A.; Pereira, Eduarda; Havel, Ladislav; Kizek, Rene			Are Early Somatic Embryos of the Norway Spruce (Picea abies (L.) Karst.) Organised?	PLOS ONE			English	Article							DIPLOID PARTHENOGENESIS; BIOCHEMICAL PARAMETERS; PLANT-REGENERATION; EMBRYOGENESIS; GROWTH; CADMIUM; APOPTOSIS; PROTEINS; REVEALS; SYSTEM	Background Somatic embryogenesis in conifer species has great potential for the forestry industry. Hence, a number of methods have been developed for their efficient and rapid propagation through somatic embryogenesis. Although information is available regarding the previous process-mediated generation of embryogenic cells to form somatic embryos, there is a dearth of information in the literature on the detailed structure of these clusters. Methodology/Principal Findings The main aim of this study was to provide a more detailed structure of the embryogenic tissue clusters obtained through the in vitro propagation of the Norway spruce (Picea abies (L.) Karst.). We primarily focused on the growth of early somatic embryos (ESEs). The data on ESE growth suggested that there may be clear distinctions between their inner and outer regions. Therefore, we selected ESEs collected on the 56th day after sub-cultivation to dissect the homogeneity of the ESE clusters. Two colourimetric assays (acetocarmine and fluorescein diacetate/propidium iodide staining) and one metabolic assay based on the use of 2,3,5-triphenyltetrazolium chloride uncovered large differences in the metabolic activity inside the cluster. Next, we performed nuclear magnetic resonance measurements. The ESE cluster seemed to be compactly aggregated during the first four weeks of cultivation; thereafter, the difference between the H-1 nuclei concentration in the inner and outer clusters was more evident. There were clear differences in the visual appearance of embryos from the outer and inner regions. Finally, a cluster was divided into six parts (three each from the inner and the outer regions of the embryo) to determine their growth and viability. The innermost embryos (centripetally towards the cluster centre) could grow after sub-cultivation but exhibited the slowest rate and required the longest time to reach the common growth rate. To confirm our hypothesis on the organisation of the ESE cluster, we investigated the effect of cluster orientation on the cultivation medium and the influence of the change of the cluster's three-dimensional orientation on its development. Maintaining the same position when transferring ESEs into new cultivation medium seemed to be necessary because changes in the orientation significantly affected ESE growth. Conclusions and Significance This work illustrated the possible inner organisation of ESEs. The outer layer of ESEs is formed by individual somatic embryos with high metabolic activity (and with high demands for nutrients, oxygen and water), while an embryonal group is directed outside of the ESE cluster. Somatic embryos with depressed metabolic activity were localised in the inner regions, where these embryonic tissues probably have a very important transport function.	[Petrek, Jiri; Zitka, Ondrej; Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic; [Petrek, Jiri; Havel, Ladislav] Mendel Univ Brno, Dept Plant Biol, CZ-61300 Brno, Czech Republic; [Zitka, Ondrej; Adam, Vojtech; Kizek, Rene] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic; [Bartusek, Karel] Acad Sci Czech Republ, Inst Sci Instruments, CZ-61264 Brno, Czech Republic; [Anjum, Naser A.; Pereira, Eduarda] Univ Aveiro, CESAM Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal; [Anjum, Naser A.; Pereira, Eduarda] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal	Mendel University in Brno; Mendel University in Brno; Brno University of Technology; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Universidade de Aveiro; Universidade de Aveiro	Kizek, R (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.	kizek@sci.muni.cz	Zitka, Ondrej/E-1107-2012; Zitka, Ondrej/L-5588-2019; Anjum, Naser A./F-7415-2011; Adam, Vojtech/D-7686-2012; Bartusek, Karel/D-3389-2012; Havel, Ladislav/C-8954-2012	Zitka, Ondrej/0000-0001-7607-5058; Zitka, Ondrej/0000-0001-7607-5058; Anjum, Naser A./0000-0001-9953-0703; Adam, Vojtech/0000-0002-8527-286X; Bartusek, Karel/0000-0002-6598-5424; Kizek, Rene/0000-0002-0467-6169; Pereira, Eduarda/0000-0002-6046-5243; Havel, Ladislav/0000-0003-3378-2785	CEITEC [CZ.1.05/1.1.00/02.0068]; FCT (Government of Portugal) [SFRH/BPD/84671/2012]; Aveiro University Research Institute/CESAM [UID/AMB/50017/2013]; "COMPETE" [FCOMP-01-0124-FEDER-02800, FCT PTDC/AGR-PRO/4091/2012]; Ministry of Education, Youth and Sports of the Czech Republic [LO1212]	CEITEC; FCT (Government of Portugal)(Portuguese Foundation for Science and Technology); Aveiro University Research Institute/CESAM; "COMPETE"; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Financial support from CEITEC CZ.1.05/1.1.00/02.0068 is highly acknowledged. NAA and EP gratefully acknowledge the partial financial support received from FCT (Government of Portugal) through contract (SFRH/BPD/84671/2012), the Aveiro University Research Institute/CESAM (UID/AMB/50017/2013), and "COMPETE" through Project n.o FCOMP-01-0124-FEDER-02800 (FCT PTDC/AGR-PRO/4091/2012). This work was also supported by a grant from the Ministry of Education, Youth and Sports of the Czech Republic (LO1212).	Blazquez S, 2009, PLANT CELL TISS ORG, V97, P49, DOI 10.1007/s11240-009-9497-y; Boo KH, 2015, BIOSCI BIOTECH BIOCH, V79, P725, DOI 10.1080/09168451.2014.996202; Capataz-Tafur J, 2010, ACTA PHYSIOL PLANT, V32, P757, DOI 10.1007/s11738-010-0460-7; CHI CM, 1994, BIOTECHNOL BIOENG, V44, P368, DOI 10.1002/bit.260440315; Chi CM, 1996, BIOTECHNOL BIOENG, V50, P65, DOI 10.1002/(SICI)1097-0290(19960405)50:1&lt;65::AID-BIT8&gt;3.0.CO;2-#; DURZAN DJ, 1994, INT J PLANT SCI, V155, P677, DOI 10.1086/297207; Duval I, 2014, J EXP BOT, V65, P2319, DOI 10.1093/jxb/eru116; Elloumi N, 2015, ENVIRON SCI POLLUT R, V22, P14829, DOI 10.1007/s11356-015-4716-z; Feher A, 2015, BBA-GENE REGUL MECH, V1849, P385, DOI 10.1016/j.bbagrm.2014.07.005; Garcia-Mendiguren O, 2015, PLOS ONE, V10, P1; Gomez-Garay A, 2014, FOREST SYST, V23, P191, DOI 10.5424/fs/2014232-05829; HAMALAINEN JJ, 1993, BIOTECHNOL BIOENG, V41, P35, DOI 10.1002/bit.260410106; Havel L, 1996, INT J PLANT SCI, V157, P8, DOI 10.1086/297315; Havel L, 1996, BOT ACTA, V109, P268, DOI 10.1111/j.1438-8677.1996.tb00573.x; Hazubska-Przybyl T, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1735-1; Honda H, 1999, J BIOSCI BIOENG, V87, P700, DOI 10.1016/S1389-1723(99)80138-8; Huska D, 2010, INT J ELECTROCHEM SC, V5, P1535; Karcz W, 2007, BIOL PLANTARUM, V51, P713, DOI 10.1007/s10535-007-0147-0; Kumar V, 2015, PLANT CELL TISS ORG, V121, P571, DOI 10.1007/s11240-015-0726-2; Leljak-Levanic D, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1875-y; Letarte J, 2006, PLANT CELL REP, V24, P691, DOI 10.1007/s00299-005-0013-5; Ling H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118444; Nada E, 2007, ACTA PHYSIOL PLANT, V29, P57, DOI 10.1007/s11738-006-0009-y; Nic-Can GI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126414; OLOFSDOTTER M, 1993, PLANT CELL REP, V12, P216, DOI 10.1007/BF00237057; Padmanabhan K, 1998, PLANT CELL REP, V17, P681, DOI 10.1007/s002990050465; Petrek J, 2005, ANAL BIOANAL CHEM, V383, P576, DOI 10.1007/s00216-005-0028-3; Raju CS, 2015, PLANT CELL TISS ORG, V122, P79, DOI 10.1007/s11240-015-0751-1; Rejon JD, 2013, J EXP BOT, V64, P5695, DOI 10.1093/jxb/ert345; Sala K, 2013, BIOL PLANTARUM, V57, P410, DOI 10.1007/s10535-013-0304-6; Schroder P, 2003, ENVIRON SCI POLLUT R, V10, P225, DOI 10.1065/espr2002.10.138; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; Tillman-Sutela E, 2014, FLORA, V209, P45, DOI 10.1016/j.flora.2013.10.001; Tukaj Z, 2007, ENVIRON EXP BOT, V60, P291, DOI 10.1016/j.envexpbot.2006.12.002; Vatankhah E, 2014, BIOL PLANTARUM, V58, P201, DOI 10.1007/s10535-013-0388-z; Vitecek J, 2007, SENSORS-BASEL, V7, P222, DOI 10.3390/s7030222; Von Arnold S.J., 1987, PLANT PHYSIOL, V128, P233; Vondrakova Z, 2015, PLANT GROWTH REGUL, V75, P405, DOI 10.1007/s10725-014-0001-2; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411	39	3	4	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144093	10.1371/journal.pone.0144093	http://dx.doi.org/10.1371/journal.pone.0144093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624287	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600092
J	Tong, XL; Aoyama, H; Sudhakar, S; Chen, HH; Shilton, BH; Bai, DL				Tong, Xiaoling; Aoyama, Hiroshi; Sudhakar, Swathy; Chen, Honghong; Shilton, Brian H.; Bai, Donglin			The First Extracellular Domain Plays an Important Role in Unitary Channel Conductance of Cx50 Gap Junction Channels	PLOS ONE			English	Article							ICHTHYOSIS-DEAFNESS SYNDROME; INCREASED HEMICHANNEL ACTIVITY; 3.5 ANGSTROM RESOLUTION; PORE-LINING RESIDUES; VOLTAGE-DEPENDENCE; CONFORMATIONAL-CHANGES; CONNEXIN HEMICHANNELS; FUNCTIONAL-PROPERTIES; CA2+ REGULATION; AMINO-TERMINUS	Gap junction (GJ) channels provide direct passage for ions and small molecules to be exchanged between neighbouring cells and are crucial for many physiological processes. GJ channels can be gated by transjunctional voltage (known as V-j-gating) and display a wide range of unitary channel conductance (gamma(j)), yet the domains responsible for Vj-gating and gamma(j) are not fully clear. The first extracellular domain (E1) of several connexins has been shown to line part of their GJ channel pore and play important roles in Vj-gating properties and/or ion permeation selectivity. To test roles of the E1 of Cx50 GJ channels, we generated a chimera, Cx50Cx36E1, where the E1 domain of Cx50 was replaced with that of Cx36, a connexin showing quite distinct Vj-gating and gamma(j) from those of Cx50. Detailed characterizations of the chimera and three point mutants in E1 revealed that, although the E1 domain is important in determining gamma(j), the E1 domain of Cx36 is able to effectively function within the context of the Cx50 channel with minor changes in Vj-gating properties, indicating that sequence differences between the E1 domains in Cx36 and Cx50 cannot account for their drastic differences in Vj-gating and gamma(j). Our homology models of the chimera and the E1 mutants revealed that electrostatic properties of the pore-lining residues and their contribution to the electric field in the pore are important factors for the rate of ion permeation of Cx50 and possibly other GJ channels.	[Tong, Xiaoling; Sudhakar, Swathy; Chen, Honghong; Bai, Donglin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Aoyama, Hiroshi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario); Osaka University; Western University (University of Western Ontario)	Bai, DL (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	donglin.bai@schulich.uwo.ca	Bai, Donglin/ABB-9924-2021; Shilton, Brian H/A-6667-2011; Bai, Donglin/A-5799-2008	Bai, Donglin/0000-0003-1112-6947; Bai, Donglin/0000-0003-1112-6947; Aoyama, Hiroshi/0000-0001-7915-8975	Natural Sciences and Engineering Research Council of Canada [288241, 217494]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26440029]; Grants-in-Aid for Scientific Research [26440029] Funding Source: KAKEN	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from Natural Sciences and Engineering Research Council of Canada to D.B. (288241) and B.H.S. (217494). This work was also supported by Grants-in-Aid for Scientific Research (26440029 to H.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Al-Ubaidi MR, 2000, J NEUROSCI RES, V59, P813, DOI 10.1002/(SICI)1097-4547(20000315)59:6<813::AID-JNR14>3.3.CO;2-R; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Bai DL, 2014, BIOCHEM J, V458, P1, DOI 10.1042/BJ20131162; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bargiello Thaddeus, 2009, P103, DOI 10.1007/978-1-59745-489-6_4; Bargiello TA, 2012, BBA-BIOMEMBRANES, V1818, P1807, DOI 10.1016/j.bbamem.2011.09.019; Beyer EC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00043; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; DeLano W., 2006, PYMOL MOL GRAPHICS S; Geng YY, 2011, J GEN PHYSIOL, V137, P533, DOI 10.1085/jgp.201110616; Gerido DA, 2007, AM J PHYSIOL-CELL PH, V293, pC337, DOI 10.1152/ajpcell.00626.2006; Gong XQ, 2013, J CELL SCI, V126, P3113, DOI 10.1242/jcs.123430; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Haubrich S, 1996, MOL BIOL CELL, V7, P1995, DOI 10.1091/mbc.7.12.1995; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kwon T, 2013, J GEN PHYSIOL, V141, P243, DOI 10.1085/jgp.201210839; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mese G, 2011, MOL BIOL CELL, V22, P4776, DOI 10.1091/mbc.E11-09-0778; Mhaske PV, 2013, AM J PHYSIOL-CELL PH, V304, pC1150, DOI 10.1152/ajpcell.00374.2012; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Nakagawa S, 2011, J BIOL CHEM, V286, P19672, DOI 10.1074/jbc.M110.204958; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Palacios-Prado N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5667; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Pfahnl A, 1997, PFLUG ARCH EUR J PHY, V433, P773, DOI 10.1007/s004240050344; RUBIN JB, 1992, BIOPHYS J, V62, P183, DOI 10.1016/S0006-3495(92)81804-0; Rubinos C, 2014, AM J PHYSIOL-CELL PH, V306, pC212, DOI 10.1152/ajpcell.00098.2013; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Srinivas M, 2005, BIOPHYS J, V88, P1725, DOI 10.1529/biophysj.104.054023; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Srinivas M, 1999, J NEUROSCI, V19, P9848; Suga M, 2009, ACTA CRYSTALLOGR D, V65, P758, DOI 10.1107/S0907444909014711; Sun WM, 2011, MOL VIS, V17, P1508; Teubner B, 2000, J MEMBRANE BIOL, V176, P249, DOI 10.1007/s002320001094; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Tong XL, 2014, J PHYSIOL-LONDON, V592, P5187, DOI 10.1113/jphysiol.2014.280636; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; WILDERS R, 1992, BIOPHYS J, V63, P942, DOI 10.1016/S0006-3495(92)81664-8; Xin L, 2010, BIOPHYS J, V99, P2077, DOI 10.1016/j.bpj.2010.07.032; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	50	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143876	10.1371/journal.pone.0143876	http://dx.doi.org/10.1371/journal.pone.0143876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625162	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600062
J	Bartholomew, AJ; Meck, WH; Cirulli, ET				Bartholomew, Alex J.; Meck, Warren H.; Cirulli, Elizabeth T.			Analysis of Genetic and Non-Genetic Factors Influencing Timing and Time Perception	PLOS ONE			English	Article							AGE-RELATED-CHANGES; INTERNAL CLOCK; DURATION JUDGMENTS; SCALAR PROPERTY; ATTENTION; MEMORY; MECHANISMS; REPRODUCTION; PERFORMANCE; ACTIVATION	Performance on different psychophysical tasks measuring the sense of time indicates a large amount of individual variation in the accuracy and precision of timing in the hundredths of milliseconds-to-minutes range. Quantifying factors with an influence on timing is essential to isolating a biological (genetic) contribution to the perception and estimation of time. In the largest timing study to date, 647 participants completed a duration-discrimination task in the sub-second range and a time-production task in the supra-second range. We confirm the stability of a participant's time sense across multiple sessions and substantiate a modest sex difference on time production. Moreover, we demonstrate a strong correlation between performance on a standardized cognitive battery and performance in both duration-discrimination and time-production tasks; we further show that performance is uncorrelated with age after controlling for general intelligence. Additionally, we find an effect of ethnicity on time sense, with African Americans and possibly Hispanics in our cohort differing in accuracy and precision from other ethnic groups. Finally, a preliminary genome-wide association and exome chip study was performed on 148 of the participants, ruling out the possibility for a single common variant or groups of low-frequency coding variants within a single gene to explain more than similar to 18% of the variation in the sense of time.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA; [Meck, Warren H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA	Duke University; Duke University	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	etc3@duke.edu		Meck, Warren/0000-0002-6120-4790; Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2011, FRONTIERS INTEGRATIV, P5; Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Anderson JW, 2014, INT J AGING HUM DEV, V78, P259, DOI 10.2190/AG.78.3.c; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Balci F, 2013, NEUROPSYCHOLOGIA, V51, P293, DOI 10.1016/j.neuropsychologia.2012.08.002; Bartholomew AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091773; Battery AIT, 1944, MAN DIR SCOR; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Benton AL., 1983, MULTILINGUAL APHASIA; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Bonnot O, 2011, J PHYSIOL-PARIS, V105, P164, DOI 10.1016/j.jphysparis.2011.07.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broadway JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025422; Buonomano DV, 2007, NAT CHEM BIOL, V3, P594, DOI 10.1038/nchembio1007-594; Buonomano DV, 2014, ADV EXP MED BIOL, V829, P101, DOI 10.1007/978-1-4939-1782-2_6; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Cirulli E. T., 2015, SCIENCE; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Coelho M, 2004, J INT NEUROPSYCH SOC, V10, P332, DOI 10.1017/S1355617704103019; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Espinosa-Fernandez L, 2003, ACTA PSYCHOL, V112, P221, DOI 10.1016/S0001-6918(02)00093-8; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; FORTIN C, 1993, PERCEPT PSYCHOPHYS, V53, P536, DOI 10.3758/BF03205202; FORTIN C, 2003, METH NE FRO NEUROSCI, P235; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gilaie-Dotan S, 2011, FRONTIERS INTEGRATIV, P5; GOLDEN CJ, 1975, J PERS ASSESS, V39, P502, DOI 10.1207/s15327752jpa3905_9; Gooch CM, 2009, AGING NEUROPSYCHOL C, V16, P285, DOI 10.1080/13825580802592771; Grassi M, 2009, BEHAV RES METHODS, V41, P20, DOI 10.3758/BRM.41.1.20; GREEN DM, 1990, J ACOUST SOC AM, V87, P2662, DOI 10.1121/1.399058; GREEN DM, 1993, J ACOUST SOC AM, V93, P2096, DOI 10.1121/1.406696; Green P., 2005, STORY RECALL TEST; Grondin S, 2012, J EXP PSYCHOL HUMAN, V38, P880, DOI 10.1037/a0027188; Gu BM, 2011, NEUROSCIENCE, V179, P143, DOI 10.1016/j.neuroscience.2011.01.048; Gu B- M, 2015, BAYESIAN MODELS INTE, P284; Hancock PA, 2010, ACTA PSYCHOL, V133, P170, DOI 10.1016/j.actpsy.2009.11.005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hass J, 2014, ADV EXP MED BIOL, V829, P49, DOI 10.1007/978-1-4939-1782-2_4; Henley SMD, 2014, NEUROPSYCHOLOGIA, V65, P88, DOI 10.1016/j.neuropsychologia.2014.10.009; Hinton SC, 2004, PSYCHON B REV, V11, P24, DOI 10.3758/BF03206456; KITAMURA T, 1983, ACTA PSYCHIAT SCAND, V68, P15, DOI 10.1111/j.1600-0447.1983.tb06976.x; Lake JI, 2013, NEUROPSYCHOLOGIA, V51, P284, DOI 10.1016/j.neuropsychologia.2012.09.014; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2012, PSYCHOLOGIST, V25, P594; Lustig C., 2003, METH NE FRO NEUROSCI, P261; Lustig C, 2011, BRAIN COGNITION, V77, P298, DOI 10.1016/j.bandc.2011.07.007; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; Meck WH, 2012, NEUROPHARMACOLOGY, V62, P1221, DOI 10.1016/j.neuropharm.2011.01.042; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; Morita T, 2005, PHYSIOL BEHAV, V85, P93, DOI 10.1016/j.physbeh.2005.02.024; Oberfeld D, 2014, FRONT PSYCHOL, P5; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Penney TB, 2005, BRAIN COGNITION, V58, P109, DOI 10.1016/j.bandc.2004.09.012; Perbal S, 2005, BRAIN COGNITION, V58, P35, DOI 10.1016/j.bandc.2005.02.003; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; Pleil KE, 2011, FRONTIERS INTEGRATIV, P5; Poryazova R, 2013, J SLEEP RES, V22, P625, DOI 10.1111/jsr.12069; Pouthas V, 2004, ACTA NEUROBIOL EXP, V64, P367; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakitin BC, 1998, J EXP PSYCHOL-ANIM B, V24, P15, DOI 10.1037/0097-7403.24.1.15; Rakitin BC, 2008, BRAIN RES BULL, V75, P23, DOI 10.1016/j.brainresbull.2007.07.014; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2002, J RES PERS, V36, P507, DOI 10.1016/S0092-6566(02)00006-5; Rammsayer TH, 2007, INTELLIGENCE, V35, P123, DOI 10.1016/j.intell.2006.04.007; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Sato T, 2005, J PSYCHOL, V139, P545, DOI 10.3200/JRLP.139.6.545-552; Schulz R, 2014, CEREB CORTEX; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; StataCorp, 2013, STAT STAT SOFTW REL; Sysoeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012650; Teki S, 2011, FRONTIERS INTEGRATIV, P5; Thones S, 2015, J AFFECTIVE DISORDER; Treisman M., 2013, TIMING TIME PERCEPTI, V1, P131, DOI [10.1163/22134468-00002017, DOI 10.1163/22134468-00002017]; Troche SJ, 2009, INTELLIGENCE, V37, P479, DOI 10.1016/j.intell.2009.06.001; Tucci V, 2011, FRONTIERS INTEGRATIV, P5; Tucci V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0470; Ullen F, 2008, J NEUROSCI, V28, P4238, DOI 10.1523/JNEUROSCI.0825-08.2008; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; Viau-Quesnel C, 2014, TIMING TIME PERCEPTI, V2, P129, DOI [10.1163/22134468-00002019, DOI 10.1163/22134468-00002019]; Wearden JH, 1997, J EXP PSYCHOL HUMAN, V23, P962; Wechsler D, 1997, SCALE WAI WAIS 3 WMS; Wiener M, 2014, NEUROIMAGE, V89, P10, DOI 10.1016/j.neuroimage.2013.11.019; Wittmann M, 2005, PSYCHOL REP, V97, P921, DOI 10.2466/pr0.97.3.921-935	96	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143873	10.1371/journal.pone.0143873	http://dx.doi.org/10.1371/journal.pone.0143873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641268	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700031
J	Hirbo, J; Eidem, H; Rokas, A; Abbot, P				Hirbo, Jibril; Eidem, Haley; Rokas, Antonis; Abbot, Patrick			Integrating Diverse Types of Genomic Data to Identify Genes that Underlie Adverse Pregnancy Phenotypes	PLOS ONE			English	Article							WIDE ASSOCIATION ANALYSIS; RECENT POSITIVE SELECTION; HUMAN-DISEASE GENES; GROWTH-FACTOR; POPULATION DIFFERENTIATION; ACCELERATED EVOLUTION; NONCODING SEQUENCES; NATURAL-SELECTION; GESTATIONAL-AGE; EXPRESSED GENES	Progress in understanding complex genetic diseases has been bolstered by synthetic approaches that overlay diverse data types and analyses to identify functionally important genes. Pre-term birth (PTB), a major complication of pregnancy, is a leading cause of infant mortality worldwide. A major obstacle in addressing PTB is that the mechanisms controlling parturition and birth timing remain poorly understood. Integrative approaches that overlay datasets derived from comparative genomics with function-derived ones have potential to advance our understanding of the genetics of birth timing, and thus provide insights into the genes that may contribute to PTB. We intersected data from fast evolving coding and non-coding gene regions in the human and primate lineage with data from genes expressed in the placenta, from genes that show enriched expression only in the placenta, as well as from genes that are differentially expressed in four distinct PTB clinical subtypes. A large fraction of genes that are expressed in placenta, and differentially expressed in PTB clinical subtypes (23-34%) are fast evolving, and are associated with functions that include adhesion neurodevelopmental and immune processes. Functional categories of genes that express fast evolution in coding regions differ from those linked to fast evolution in non-coding regions. Finally, there is a surprising lack of overlap between fast evolving genes that are differentially expressed in four PTB clinical subtypes. Integrative approaches, especially those that incorporate evolutionary perspectives, can be successful in identifying potential genetic contributions to complex genetic diseases, such as PTB.	[Hirbo, Jibril; Eidem, Haley; Rokas, Antonis; Abbot, Patrick] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Abbot, P (corresponding author), Vanderbilt Univ, Dept Biol Sci, Box 35164,Stn B, Nashville, TN 37235 USA.	patrick.abbot@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551; Hirbo, Jibril/0000-0002-8932-7311	March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative	March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative	This work was supported by the March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge thoughtful contributions from the members of the Ohio Collaborative. Research on this project was supported by the March of Dimes through the March of Dimes Prematurity Research Center Ohio Collaborative.	Abdel-Salam G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-12; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bao SH, 2013, CLIN EXP IMMUNOL, V172, P437, DOI 10.1111/cei.12066; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bednarek AK, 2001, CANCER RES, V61, P8068; Behrman, 2007, PRETERM BIRTH CAUSES; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown EA, 2013, TRENDS GENET, V29, P585, DOI 10.1016/j.tig.2013.03.001; Browne VA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0068; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cai JJ, 2009, GENOME BIOL EVOL, V1, P131, DOI 10.1093/gbe/evp013; Cai Z, 2011, EUR J HUM GENET, V19, P667, DOI 10.1038/ejhg.2010.257; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Chen Q, 2009, MOL HUM REPROD, V15, P215, DOI 10.1093/molehr/gap009; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Chhabra A, 2012, DEV CELL, V22, P651, DOI 10.1016/j.devcel.2011.12.022; Cordeaux Y, 2009, J PHARMACOL EXP THER, V328, P682, DOI 10.1124/jpet.108.143040; Crisci JL, 2011, GENOME BIOL EVOL, V3, P791, DOI 10.1093/gbe/evr075; Crosley EJ, 2013, PLACENTA, V34, P127, DOI 10.1016/j.placenta.2012.12.001; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Davis JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004241; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Dickerson JE, 2012, MOL BIOL EVOL, V29, P2284, DOI 10.1093/molbev/mss195; Dissanayake VHW, 2007, MOL HUM REPROD, V13, P425, DOI 10.1093/molehr/gam011; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Dumas LJ, 2012, AM J HUM GENET, V91, P444, DOI 10.1016/j.ajhg.2012.07.016; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eidem HR, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0099-8; Elliot MG, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0069; Enard D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000840; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Faxen M, AM J PERINATOL, V15, P9; FONDACCI C, 1994, J CLIN INVEST, V93, P1149, DOI 10.1172/JCI117067; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; Gaya-Vidal M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-599; George RD, 2011, GENOME RES, V21, P1686, DOI 10.1101/gr.121327.111; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gogat K, 2004, INVEST OPHTH VIS SCI, V45, P7, DOI 10.1167/iovs.02-1096; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haasl RJ, 2014, GENOME BIOL EVOL, V6, P1843, DOI 10.1093/gbe/evu134; Hakonen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093651; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942; Johansson A, 2008, HEREDITAS, V145, P126, DOI 10.1111/j.0018-0661.2008.02054.x; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jukic AM, 2013, HUM REPROD, V28, P2848, DOI 10.1093/humrep/det297; Jurccoviccova J, PLACENTA, V19, P423; Keeney JG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00427; Kelly CR, 2006, J PHARMACOL EXP THER, V317, P1254, DOI 10.1124/jpet.105.100172; KIELER H, 1995, ULTRASOUND OBST GYN, V6, P353, DOI 10.1046/j.1469-0705.1995.06050353.x; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kitazawa T, 1998, BRIT J PHARMACOL, V123, P173, DOI 10.1038/sj.bjp.0701583; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Large MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004451; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li Q, 2014, ELECTRON J DIFFER EQ; LINDSAY D, 1963, J ENDOCRINOL, V26, P85, DOI 10.1677/joe.0.0260085; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Lui JLC, 2012, HUM MOL GENET, V21, P5193, DOI 10.1093/hmg/dds347; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Mallaret M, 2014, BRAIN, V137, P411, DOI 10.1093/brain/awt338; Manuck TA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.010; Marie PJ, 2013, BONEKEY REP, V2; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Maxwell EK, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0212-1; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mignot C, 2015, J MED GENET, V52, P61, DOI 10.1136/jmedgenet-2014-102748; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Mizuno H, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-27; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffett A, 2015, PHILOS T R SOC LON B, V370; Nassar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056238; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nilsson UW, 2013, OBSTET GYNECOL, V122, P737, DOI 10.1097/AOG.0b013e3182a1ba56; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ozcelik T, 2008, P NATL ACAD SCI USA, V105, P4232, DOI 10.1073/pnas.0804078105; Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839; Phillips Julie Baker, 2015, Evolution Medicine and Public Health, P136, DOI 10.1093/emph/eov010; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rafajlovic M, 2014, THEOR POPUL BIOL, V95, P1, DOI 10.1016/j.tpb.2014.05.002; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Redies C, 2011, CEREBELLUM, V10, P393, DOI 10.1007/s12311-010-0207-4; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Rockwell LC, 2003, AM J HUM BIOL, V15, P330, DOI 10.1002/ajhb.10151; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schwenke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054336; Shi P, 2006, TRENDS GENET, V22, P608, DOI 10.1016/j.tig.2006.09.001; Su MT, 2011, HUM REPROD, V26, P758, DOI 10.1093/humrep/deq401; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Swaggart KA, 2015, COLD SPRING HARB PER, V5; Synofzik M, 2011, J MED GENET, V48, P407, DOI 10.1136/jmg.2010.087023; Talwar P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-199; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tuteja G, 2012, PLACENTA, V33, P1055, DOI 10.1016/j.placenta.2012.09.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uzun A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar069; Venny, INTERACTIVE TOOL COM; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weiner S, 2008, CLIN PERINATOL, V35, P469, DOI 10.1016/j.clp.2008.06.003; Wells JCK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0067; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Wu W, 2013, F1000RESEARCH, V2; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zhang Z, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-17; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	160	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144155	10.1371/journal.pone.0144155	http://dx.doi.org/10.1371/journal.pone.0144155			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641094	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700066
J	Cardoso, THS; Freitas, ACO; Andrade, BS; de Sousa, AO; Santiago, AD; Koop, DM; Gramacho, KP; Alvim, FC; Micheli, F; Pirovani, CP				Santana Cardoso, Thyago Hermylly; Oliveira Freitas, Ana Camila; Andrade, Bruno Silva; de Sousa, Aurizangela Oliveira; Santiago, Andre da Silva; Koop, Daniela Martins; Gramacho, Karina Peres; Alvim, Fatima Cerqueira; Micheli, Fabienne; Pirovani, Carlos Priminho			TcCYPR04, a Cacao Papain-Like Cysteine-Protease Detected in Senescent and Necrotic Tissues Interacts with a Cystatin TcCYS4	PLOS ONE			English	Article							WITCHES-BROOM DISEASE; PROGRAMMED CELL-DEATH; THEOBROMA-CACAO; MONILIOPHTHORA-PERNICIOSA; CRINIPELLIS-PERNICIOSA; MEROPS DATABASE; GENE-EXPRESSION; CAUSAL AGENT; SWISS-MODEL; RESISTANCE	The interaction amongst papain-like cysteine-proteases (PLCP) and their substrates and inhibitors, such as cystatins, can be perceived as part of the molecular battlefield in plant-pathogen interaction. In cacao, four cystatins were identified and characterized by our group. We identified 448 proteases in cacao genome, whereof 134 were cysteine-proteases. We expressed in Escherichia coli a PLCP from cacao, named TcCYSPR04. Immunoblottings with anti-TcCYSPR04 exhibited protein increases during leaf development. Additional isoforms of TcCYSPR04 appeared in senescent leaves and cacao tissues infected by Moniliophthora perniciosa during the transition from the biotrophic to the saprophytic phase. TcCYSPR04 was induced in the apoplastic fluid of Catongo and TSH1188 cacao genotypes, susceptible and resistant to M. perniciosa, respectively, but greater intensity and additional isoforms were observed in TSH1188. The fungal protein MpNEP induced PLCP isoform expression in tobacco leaves, according to the cross reaction with anti-TcCYSPR04. Several protein isoforms were detected at 72 hours after treatment with MpNEP. We captured an active PLCP from cacao tissues, using a recombinant cacao cystatin immobilized in CNBr-Sepharose. Mass spectrometry showed that this protein corresponds to TcCYSPR04. A homology modeling was obtained for both proteins. In order to become active, TcCYSPR04 needs to lose its inhibitory domain. Molecular docking showed the physical-chemical complementarities of the interaction between the cacao enzyme and its inhibitor. We propose that TcCYSPR04 and its interactions with cacao cystatins are involved in the senescence and necrosis events related to witches' broom symptoms. This molecular interaction may be the target for future interventions to control witches' broom disease.	[Santana Cardoso, Thyago Hermylly; Oliveira Freitas, Ana Camila; de Sousa, Aurizangela Oliveira; Santiago, Andre da Silva; Koop, Daniela Martins; Alvim, Fatima Cerqueira; Micheli, Fabienne; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [Andrade, Bruno Silva] UESB, Jequie, BA, Brazil; [Gramacho, Karina Peres] Comissao Execut Plano Lavoura Cacaueira CEPLAC, Ctr Pesquisa Cacau CEPEC, Ilheus, BA, Brazil; [Micheli, Fabienne] CIRAD, UMR AGAP, Montpellier, France	Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia; CIRAD; Universite de Montpellier	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Rodovia Ilheus Itabuna,Km 16, Ilheus, BA, Brazil.	pirovani@uesc.br	GRAMACHO, KARINA PERES/J-3868-2014; Pirovani, Carlos Priminho/N-1153-2019; Pirovani, Carlos P/J-3426-2017; Andrade, Bruno S/C-8170-2013; Micheli, Fabienne/AAL-9895-2021; Andrade, Bruno/AAP-8926-2020; GRAMACHO, KARINA PERES/AAO-8862-2020	GRAMACHO, KARINA PERES/0000-0003-4037-1554; Pirovani, Carlos Priminho/0000-0002-6176-4069; Pirovani, Carlos P/0000-0002-6176-4069; Andrade, Bruno/0000-0002-8031-9454; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Micheli, Fabienne/0000-0002-9031-362X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305309/2012-9]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); CNPq (PRONEM) [PNE0005/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); FAPESB	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CNPq (PRONEM)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	THSC was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CPP was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [http://www.cnpq.br], process number 305309/2012-9). The authors thank Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [http://www.fapesb.ba.gov.br/] and the CNPq (PRONEM, process number PNE0005/2011) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of THS Cardoso and DM Koop was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) and the FAPESB, respectively. We are thankful to Xavier Sabau (Cirad, France) for granting TcCYSPR04 cDNA clones, Claudia Fortes Ferreira (Embrapa, Cruz das Almas-BA, Brazil) for the critical reading of the manuscript, and Juliano Oliveira Santana for figure edition.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andebrhan T, 1999, EUR J PLANT PATHOL, V105, P167, DOI 10.1023/A:1008716000479; [Anonymous], [No title captured]; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Barrett AJ, 2001, J STRUCT BIOL, V134, P95, DOI 10.1006/jsbi.2000.4332; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JS, 2005, J AM SOC HORTIC SCI, V130, P366, DOI 10.21273/JASHS.130.3.366; Cambra I, 2012, J EXP BOT, V63, P4615, DOI 10.1093/jxb/ers137; Cappetta M, 2002, BIOL CHEM, V383, P1215, DOI 10.1515/BC.2002.134; CASE DA, 2004, AMBER 8; Ceita GD, 2007, PLANT SCI, V173, P106, DOI 10.1016/j.plantsci.2007.04.006; Chan YL, 2010, PLANT CELL REP, V29, P231, DOI 10.1007/s00299-009-0815-y; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Eason JR, 2005, PLANT MOL BIOL, V57, P645, DOI 10.1007/s11103-005-0999-7; Faleiro FG, 2006, EUPHYTICA, V149, P227, DOI 10.1007/s10681-005-9070-7; Freitas AC, 2015, ACTIVITY TCCYS4 MODI, V10, DOI [10.1371/journal.pone.0121519, DOI 10.1371/JOURNAL.PONE.0121519]; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gesteira AS, 2007, ANN BOT-LONDON, V100, P129, DOI 10.1093/aob/mcm092; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hayden DM, 2004, PLANT SCI, V166, P779, DOI 10.1016/j.plantsci.2003.11.019; Hayik SA, 2010, J CHEM THEORY COMPUT, V6, P3079, DOI 10.1021/ct100315g; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mans BJ, 2002, INSECT BIOCHEM MOLEC, V32, P821, DOI 10.1016/S0965-1748(01)00169-2; MCINTYRE GF, 1993, P NATL ACAD SCI USA, V90, P10588, DOI 10.1073/pnas.90.22.10588; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Michaud D, 1998, ANAL CHIM ACTA, V372, P173, DOI 10.1016/S0003-2670(98)00349-3; Nandy SK, 2013, J BIOMOL STRUCT DYN, V31, P649, DOI 10.1080/07391102.2012.706403; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nooden LD, 1997, PHYSIOL PLANTARUM, V101, P746, DOI 10.1111/j.1399-3054.1997.tb01059.x; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pietra D, 2014, CHEM BIOL DRUG DES, V84, P648, DOI 10.1111/cbdd.12357; Pirovani CP, 2008, ELECTROPHORESIS, V29, P2391, DOI 10.1002/elps.200700743; Pirovani CP, 2010, PLANTA, V232, P1485, DOI 10.1007/s00425-010-1272-0; Pirovani CP, 2002, EUR J BIOCHEM, V269, P3998, DOI 10.1046/j.1432-1033.2002.03089.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Salas CE, 2008, PHYTOCHEMISTRY, V69, P2263, DOI 10.1016/j.phytochem.2008.05.016; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santana LS, 2014, GENET MOL RES, V13, P7636, DOI 10.4238/2014.September.26.1; Schafmeister C. E. A. F., 1995, LEAP; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Surujdeo-Maharaj S, 2003, PLANT PATHOL, V52, P464, DOI 10.1046/j.1365-3059.2003.00865.x; Tajima T, 2011, PHYSIOL PLANTARUM, V141, P97, DOI 10.1111/j.1399-3054.2010.01425.x; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van der Hoorn RAL, 2004, PLANT PHYSIOL, V135, P1170, DOI 10.1104/pp.104.041467; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; van der Linde K, 2012, PLANT SIGNAL BEHAV, V7, P1397, DOI 10.4161/psb.21902; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691	70	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144440	10.1371/journal.pone.0144440	http://dx.doi.org/10.1371/journal.pone.0144440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641247	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700121
J	Slunge, D				Slunge, Daniel			The Willingness to Pay for Vaccination against Tick-Borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden	PLOS ONE			English	Article							CONTINGENT VALUATION; FOLLOW-UP; DEMAND	The increasing incidence of tick-borne encephalitis (TBE) in Sweden and several other European countries has sparked a discussion about the need for a public vaccination strategy. However, TBE vaccination coverage is incomplete and there is little knowledge about the factors influencing vaccination behavior. Based on a survey of 1,500 randomly selected respondents in Sweden, we estimate vaccination coverage in areas with different TBE risk levels and analyze the role of vaccine price and other factors influencing the demand for vaccination. First, we find that the average rate of TBE vaccination in Sweden is 33% in TBE risk areas and 18% elsewhere. Income, age and risk-related factors such as incidence of TBE in the area of residence, frequency of visits to areas with TBE risk, and experience with tick bites are positively associated with demand for TBE vaccine. Next, using contingent valuation methodology, we estimate the willingness to pay for TBE vaccination among the unvaccinated respondents and the effect of a possible subsidy. Among the unvaccinated respondents in TBE risk areas, we estimate the mean willingness to pay for the recommended three doses of TBE vaccine to be 465 SEK (approximately 46 euros or 40% of the current market price). We project that a subsidy making TBE vaccines free of charge could increase the vaccination rate in TBE risk areas to around 78%, with a larger effect on low-income households, whose current vaccination rate is only 15% in risk areas. However, price is not the only factor affecting demand. We find significant effects on vaccination behavior associated with trust in vaccine recommendations, perceptions about tick bite-related health risks and knowledge about ticks and tick-borne diseases. Hence, increasing knowledge and trust, as well as ease of access to vaccinations, can also be important measures for public health agencies that want to increase the vaccination rate.	[Slunge, Daniel] Univ Gothenburg, Dept Econ, Gothenburg, Sweden	University of Gothenburg	Slunge, D (corresponding author), Univ Gothenburg, Dept Econ, Gothenburg, Sweden.	daniel.slunge@economics.gu.se		Slunge, Daniel/0000-0002-6219-3376	University of Gothenburg, Centre for Environment and Sustainability; Region Vastra Gotaland	University of Gothenburg, Centre for Environment and Sustainability; Region Vastra Gotaland	Support was provided by the University of Gothenburg, Centre for Environment and Sustainability [http://gmv.gu.se/] and Region Vastra Gotaland [http://www.vgregion.se/en]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askling HH, 2015, VACCINE, V33, P4962, DOI 10.1016/j.vaccine.2015.07.030; Blomquist GC, 2009, ENVIRON RESOUR ECON, V43, P473, DOI 10.1007/s10640-008-9242-8; Carson RT, 2012, J ECON PERSPECT, V26, P27, DOI 10.1257/jep.26.4.27; Cropper ML, 2004, J DEV ECON, V75, P303, DOI 10.1016/j.jdeveco.2003.02.006; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Desjeux G, 2005, PHARMACOECONOMICS, V23, P913, DOI 10.2165/00019053-200523090-00004; Engman ML, 2012, PEDIATR INFECT DIS J, V31, P570, DOI 10.1097/INF.0b013e31824f23c0; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; European Centre for Disease Prevention and Control, 2012, DALNEVOSTOCHNYJ ZH I, DOI 10.2900/62311; Finnish Institute of Public Health, 2013, REPORT TICK BORNE EN, V44, P1; Freeman A.M., 2014, MEASUREMENT ENV RESO; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Haab T. C., 2002, VALUING ENV NATURAL; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Haglund M, 1996, SCAND J INFECT DIS, V28, P217, DOI 10.3109/00365549609027160; HANEMANN WM, 1984, AM J AGR ECON, V66, P332, DOI 10.2307/1240800; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Kosnik IG, 2013, VACCINE, V31, P732, DOI 10.1016/j.vaccine.2012.12.005; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; Morrison M, 2009, ENVIRON RESOUR ECON, V44, P307, DOI 10.1007/s10640-009-9287-3; Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011; Rapola S, 2007, NATL IMMUNIZATION PR, V2007, P66, DOI [10.3402/ijch.v66i5.18310, DOI 10.3402/IJCH.V66I5.18310]; Schwarz B, 1993, Wien Med Wochenschr, V143, P551; Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Suraratdecha C, 2005, HEALTH POLICY, V73, P272, DOI [10.1016/j.healthpol.2004.11.019, 10.1016/j.healthpol.2004.05.005]; Whittington D, 2009, WORLD DEV, V37, P399, DOI 10.1016/j.worlddev.2008.04.002; Who Publication, 2011, Vaccine, V29, P8769, DOI 10.1016/j.vaccine.2011.07.024; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766	32	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143875	10.1371/journal.pone.0143875	http://dx.doi.org/10.1371/journal.pone.0143875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641491	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700032
J	White, JS; Null, SE; Tarboton, DG				White, James S.; Null, Sarah E.; Tarboton, David G.			How Do Changes to the Railroad Causeway in Utah's Great Salt Lake Affect Water and Salt Flow?	PLOS ONE			English	Article							MODEL; BIOACCUMULATION; MERCURY	Managing terminal lake elevation and salinity are emerging problems worldwide. We contribute to terminal lake management research by quantitatively assessing water and salt flow for Utah's Great Salt Lake. In 1959, Union Pacific Railroad constructed a rock-filled causeway across the Great Salt Lake, separating the lake into a north and south arm. Flow between the two arms was limited to two 4.6 meter wide rectangular culverts installed during construction, an 88 meter opening (referred to locally as a breach) installed in 1984, and the semi porous material of the causeway. A salinity gradient developed between the two arms of the lake over time because the south arm receives approximately 95% of the incoming streamflow entering Great Salt Lake. The north arm is often at, or near, salinity saturation, averaging 317 g/L since 1966, while the south is considerably less saline, averaging 142 g/L since 1966. Ecological and industrial uses of the lake are dependent on long-term salinity remaining within physiological and economic thresholds, although optimal salinity varies for the ecosystem and between diverse stakeholders. In 2013, Union Pacific Railroad closed causeway culverts amid structural safety concerns and proposed to replace them with a bridge, offering four different bridge designs. As of summer 2015, no bridge design has been decided upon. We investigated the effect that each of the proposed bridge designs would have on north and south arm Great Salt Lake elevation and salinity by updating and applying US Geological Survey's Great Salt Lake Fortran Model. Overall, we found that salinity is sensitive to bridge size and depth, with larger designs increasing salinity in the south arm and decreasing salinity in the north arm. This research illustrates that flow modifications within terminal lakes cannot be separated from lake salinity, ecology, management, and economic uses.	[White, James S.; Null, Sarah E.] Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA; [Tarboton, David G.] Utah State Univ, Dept Civil & Environm Engn, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	White, JS (corresponding author), Utah State Univ, Dept Watershed Sci, Logan, UT 84322 USA.	whitej33@gmail.com	Ioda, Julia/P-1722-2015; Null, Sarah/E-4422-2011; Tarboton, David/G-8972-2011	Ioda, Julia/0000-0002-7320-0666; Null, Sarah/0000-0001-7451-7908; Tarboton, David/0000-0002-1998-3479; White, James/0000-0002-7255-3785	Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council; Utah Division of Forestry, Fire State Lands; Office Of The Director [1208732] Funding Source: National Science Foundation	Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council; Utah Division of Forestry, Fire State Lands; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a research grant from the Utah Department of Natural Resource's Great Salt Lake Technical Advisory Council. A summary of the authors' grant can be found at: http://ffsl.utah.gov/images/statelands/greatsaltlake/techteam/RFP/2014/Coversheets/Null-USU-Cover-dnd.pdf. This research was also funded by the Utah Division of Forestry, Fire & State Lands. As per grant requirements, a report to the state was submitted, and published on their website: http://ffsl.utah.gov/images/statelands/greatsaltlake/techteam/RFP/2014/FinalReports/Null_Final_Report_GSL_Causeway_Modeling_UDNR-dnd.pdf. The scope of this report is smaller than the one the authors present here, and no figure, table, or text has been reused. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Utah Division of Forestry, Fire & State Lands. We thank Wayne Wurtsbaugh for providing a wealth of knowledge about the Great Salt Lake ecosystem and history. We also thank Taiye Sangoyomi and two anonymous reviewers for providing feedback to improve our paper.	Aldrich T.W., 2002, GREAT SALT LAKE OVER, P343; Arnow T., 1990, US GEOLOGICAL SURVEY, V2332, P32; Barnes BD, 2015, CAN J FISH AQUAT SCI, V72, P807, DOI 10.1139/cjfas-2014-0396; Beisner K, 2009, SCI TOTAL ENVIRON, V407, P5263, DOI 10.1016/j.scitotenv.2009.06.005; Benduhn F, 2004, J MARINE SYST, V47, P35, DOI 10.1016/j.jmarsys.2003.12.007; Bioeconomics Inc, 2012, SIGN GREAT SALT LAK; FFSL (Utah Division of Natural Resources Division of Forestry Fire & State Lands), 2013, FIN GREAT SALT LAK C; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Hahl DC, 1964, TECHNICAL REPORT; HOLLEY ER, 1976, J HYDR ENG DIV-ASCE, V102, P969; Jones EF, 2014, LIMNOL OCEANOGR, V59, P141, DOI 10.4319/lo.2014.59.1.0141; Kebede S, 2006, J HYDROL, V316, P233, DOI 10.1016/j.jhydrol.2005.05.011; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Loving BL, 2000, 004221 US DEP INT US; Mohammed IN, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011908; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Null S., 2013, FRIENDS GREAT SALT L, V19, P14; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; POST FJ, 1977, MICROB ECOL, V3, P143, DOI 10.1007/BF02010403; Price D., 1985, 2232 US GEOL SURV; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts Anthony J., 2013, Human-Wildlife Interactions, V7, P158; STEPHENS DW, 1990, HYDROBIOLOGIA, V197, P139, DOI 10.1007/BF00026946; Troin M, 2010, J HYDROL, V393, P233, DOI 10.1016/j.jhydrol.2010.08.019; Vorster P., 1985, THESIS; Waddell KM, 1973, EFFECTS RESTRICTED C; Waddell KM, 2014, BRIDGE EVALUATION RE; White JS., 2014, MODELED CHANGES GREA; Williams W. D., 1999, Lakes Reservoirs Research and Management, V4, P85, DOI 10.1046/j.1440-1770.1999.00089.x; Wold SR, 1997, US GEOLOGICAL SURVEY, P1; WURTSBAUGH WA, 1990, CAN J FISH AQUAT SCI, V47, P100, DOI 10.1139/f90-010; Wurtsbaugh WA, 2011, SCI TOTAL ENVIRON, V409, P4425, DOI 10.1016/j.scitotenv.2011.07.027	33	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144111	10.1371/journal.pone.0144111	http://dx.doi.org/10.1371/journal.pone.0144111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641101	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700057
J	Devleesschauwer, B; Haagsma, JA; Angulo, FJ; Bellinger, DC; Cole, D; Dopfer, D; Fazil, A; Fevre, EM; Gibb, HJ; Hald, T; Kirk, MD; Lake, RJ; de Noordhout, CM; Mathers, CD; McDonald, SA; Pires, SM; Speybroeck, N; Thomas, MK; Torgerson, PR; Wu, F; Havelaar, AH; Praet, N				Devleesschauwer, Brecht; Haagsma, Juanita A.; Angulo, Frederick J.; Bellinger, David C.; Cole, Dana; Doepfer, Doerte; Fazil, Aamir; Fevre, Eric M.; Gibb, Herman J.; Hald, Tine; Kirk, Martyn D.; Lake, Robin J.; de Noordhout, Charline Maertens; Mathers, Colin D.; McDonald, Scott A.; Pires, Sara M.; Speybroeck, Niko; Thomas, M. Kate; Torgerson, Paul R.; Wu, Felicia; Havelaar, Arie H.; Praet, Nicolas			Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; DISABILITY WEIGHTS	Background The Foodborne Disease Burden Epidemiology Reference Group (FERG) was established in 2007 by the World Health Organization to estimate the global burden of foodborne diseases (FBDs). This paper describes the methodological framework developed by FERG's Computational Task Force to transform epidemiological information into FBD burden estimates. Methods and Findings The global and regional burden of 31 FBDs was quantified, along with limited estimates for 5 other FBDs, using Disability-Adjusted Life Years in a hazard-and incidence-based approach. To accomplish this task, the following workflow was defined: outline of disease models and collection of epidemiological data; design and completion of a database template; development of an imputation model; identification of disability weights; probabilistic burden assessment; and estimating the proportion of the disease burden by each hazard that is attributable to exposure by food (i.e., source attribution). All computations were performed in R and the different functions were compiled in the R package 'FERG'. Traceability and transparency were ensured by sharing results and methods in an interactive way with all FERG members throughout the process. Conclusions We developed a comprehensive framework for estimating the global burden of FBDs, in which methodological simplicity and transparency were key elements. All the tools developed have been made available and can be translated into a user-friendly national toolkit for studying and monitoring food safety at the local level.	[Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Insitute Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht; Praet, Nicolas] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Haagsma, Juanita A.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Angulo, Frederick J.; Cole, Dana] Ctr Dis Control & Prevent, Atlanta, GA USA; [Bellinger, David C.] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Bellinger, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Doepfer, Doerte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Fazil, Aamir; Thomas, M. Kate] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, England; [Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya; [Gibb, Herman J.] Gibb Epidemiol Consulting, Arlington, VA USA; [Hald, Tine; Pires, Sara M.] Danish Tech Univ, Natl Food Inst, Lyngby, Denmark; [Kirk, Martyn D.] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Mathers, Colin D.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [McDonald, Scott A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Torgerson, Paul R.] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland; [Wu, Felicia] Michigan State Univ, Dept Agr Food & Resource Econ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Havelaar, Arie H.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Havelaar, Arie H.] Univ Utrecht, Utrecht, Netherlands	Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Erasmus University Rotterdam; Erasmus MC; Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Public Health Agency of Canada; University of Liverpool; CGIAR; International Livestock Research Institute (ILRI); Technical University of Denmark; Australian National University; Institute of Environmental Science & Research (ESR) - New Zealand; World Health Organization; Netherlands National Institute for Public Health & the Environment; University of Zurich; Michigan State University; Netherlands National Institute for Public Health & the Environment; Utrecht University	Devleesschauwer, B (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	brechtdv@gmail.com	Havelaar, Arie H./P-8495-2014; Torgerson, Paul R/M-4447-2013; Pires, Sara/M-2506-2019; Hald, Tine/B-5477-2016; Devleesschauwer, Brecht/G-9895-2018; Torgerson, Paul R/A-7510-2010	Havelaar, Arie H./0000-0002-6456-5460; Torgerson, Paul R/0000-0003-4277-9983; Pires, Sara/0000-0002-7751-1509; Hald, Tine/0000-0002-1115-9792; Devleesschauwer, Brecht/0000-0002-2867-6892; Torgerson, Paul R/0000-0003-4277-9983; Kirk, Martyn/0000-0001-5432-5984; Fevre, Eric/0000-0001-8931-4986; Mathers, Colin/0000-0002-0617-6731; Speybroeck, Niko/0000-0003-3322-3502	World Health Organization (WHO); Gibb Epidemiology Consulting, LLC; European Centre for Disease Control and Prevention (Solna, Sweden); Medical Research Council [G1100783] Funding Source: researchfish; MRC [G1100783] Funding Source: UKRI	World Health Organization (WHO)(World Health Organization); Gibb Epidemiology Consulting, LLC; European Centre for Disease Control and Prevention (Solna, Sweden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was commissioned and paid for by the World Health Organization (WHO). Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. Gibb Epidemiology Consulting, LLC, provided support in the form of salaries for author [HJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; We would like to acknowledge the assistance of the WHO Secretariat over the life of the FERG initiative, particularly Claudia Stein, Tanja Kuchenmuller, Amy Cawthorne, Yuki Minato, Tim Corrigan, Kurt Straif (IARC), Philippe Verger, Arve Lee Willingham and Danilo Lo Fo Wong. We acknowledge the Institute for Health Metrics and Evaluation (Seattle, WA, USA) for providing data on the global burden of selected diseases. The European Centre for Disease Control and Prevention (Solna, Sweden) supported the work by providing their outcome trees and sponsoring a study on disability weights. The findings and conclusions of this report are those of the authors and do not necessarily represent the official views, decisions or policies of the World Health Organization, US Centers for Disease Control and Prevention, the US Government or other institutions listed. FJA and DC are employees of the US Government. This work was part of their official duties.	[Anonymous], 2010, WHO IN EST GLOB BURD; [Anonymous], 2011, WHO IN EST GLOB BURD; [Anonymous], 2013, 5 FORM M FOOD BORN D; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; Devleesschauwer B, 2015, INT J PARASITOL, V45, P95, DOI 10.1016/j.ijpara.2014.05.006; Devleesschauwer B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1196; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gibb HJ, 2010, WHO ESTIMATES UNPUB; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Hald T, ESTIMATES RELA UNPUB; Havelaar AH, 2010, WHO ESTIMATES UNPUB; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Kirk MD, 2010, WHO ESTIMAT IN PRESS; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Kuchenmuller T, 2009, EUROSURVEILLANCE, V14, P19; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; McDonald SA, 2015, B WORLD HEALTH ORGAN, V93, P228, DOI 10.2471/BLT.14.139972; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Pires SM, AETIOLOGY SPEC UNPUB; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Plummer M, 2014, R PACKAGE VERSION 3; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Pruss-Ustun A., 2003, WHO ENV BURDEN DIS S; R Core Team, 2013, R LANG ENV STAT COMP; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; Torgerson P, 2010, WHO ESTIMAT IN PRESS; United Nations Population Division, 2013, WORLD POP PROSP 2012; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization, 2017, WHO METHODS DATA SOU; World Health Organization, 2014, WHOHTMTB201311	49	66	67	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142498	10.1371/journal.pone.0142498	http://dx.doi.org/10.1371/journal.pone.0142498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633883	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000366040000006
J	Zheng, JY; Liu, Y; Hao, ZX				Zheng, Jingyun; Liu, Yang; Hao, Zhixin			Annual Temperature Reconstruction by Signal Decomposition and Synthesis from Multi-Proxies in Xinjiang, China, from 1850 to 2001	PLOS ONE			English	Article							SURFACE AIR-TEMPERATURE	We reconstructed the annual temperature anomaly series in Xinjiang during 1850-2001 based on three kinds of proxies, including 17 tree-ring width chronologies, one tree-ring delta C-13 series and two delta O-18 series of ice cores, and instrumental observation data. The low- and high-frequency signal decomposition for the raw temperature proxy data was obtained by a fast Fourier transform filter with a window size of 20 years, which was used to build a good relationship that explained the high variance between the temperature and the proxy data used for the reconstruction. The results showed that for 1850-2001, the temperature during most periods prior to the 1920s was lower than the mean temperature in the 20th century. Remarkable warming occurred in the 20th century at a rate of 0.85 degrees C/100a, which was higher than that during the past 150 years. Two cold periods occurred before the 1870s and around the 1910s, and a relatively warm interval occurred around the 1940s. In addition, the temperature series showed a warming hiatus of approximately 20 years around the 1970s, and a rapid increase since the 1980s.	[Zheng, Jingyun; Liu, Yang; Hao, Zhixin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China; [Liu, Yang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, ZX (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing 100101, Peoples R China.	haozx@igsnrr.ac.cn	Zheng, Jingyun/M-5789-2015	LIU, Yang/0000-0001-9683-9123	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05090104, KJZD-EW-TZ-G10]; National Natural Science Foundation of China [41430528]; Basic Research Project of the Ministry of Science and Technology [2011FY120300]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of the Ministry of Science and Technology	Funding provided by XDA05090104, KJZD-EW-TZ-G10, the Strategic Priority Research Program of the Chinese Academy of Sciences, http://www.cas.cn/; 41430528, National Natural Science Foundation of China, http://www.nsfc.gov.cn/; 2011FY120300, Basic Research Project of the Ministry of Science and Technology, http://www.most.cn/.	[Anonymous], 2011, 2 CHIN NAT ASS REP C, P79; Cao LJ, 2013, J GEOPHYS RES-ATMOS, V118, P8197, DOI 10.1002/jgrd.50615; [陈峰 CHEN Feng], 2009, [中国沙漠, Journal of Desert Research], V29, P162; Chen J, 2009, CHINESE SCI BULL, V54, P2300, DOI 10.1007/s11434-009-0051-4; CHEN JY, 1989, SCI CHINA SER B, V32, P1487; Cook ER, 2013, CLIM DYNAM, V41, P2957, DOI 10.1007/s00382-012-1611-x; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; [段建平 DUAN Jianping], 2009, [地理科学进展, Progress in Geography], V28, P231; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; [范敏杰 FAN Minjie], 2008, [干旱区研究, Arid Zone Research], V25, P75, DOI 10.3724/SP.J.1148.2008.00075; [郭允允 Guo Yunyun], 2007, [第四纪研究, Quaternary Sciences], V27, P322; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; [胡义成 Hu Yicheng], 2012, [中国沙漠, Journal of Desert Research], V32, P1003; Jiayinaguli W, 2013, PLATEAU MOUNTAIN MET, V33, P48; Jones PD, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017139; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; Li QX, 2010, CHINESE SCI BULL, V55, P1974, DOI 10.1007/s11434-010-3209-1; Lin X. C., 1995, SCI ATMOS SIN, V19, P525, DOI DOI 10.3878/J.ISSN.1006-9895.1995.05.02.(IN; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Michaelsen J., 1981, J CLIM APPL METEOROL, V26, P1589; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; PAGES, 2009, 57 IGBP SECR; [潘娅婷 PAN Yating], 2007, [中国沙漠, Journal of Desert Research], V27, P159; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/2327-4581.1000101, 10.4172/gigs.1000101]; Shang HM, 2013, DESERT OASIS METEORO, V7, P7; [尚华明 Shang Huaming], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P116; Shi F, 2015, CLIMATIC CHANGE, V131, P663, DOI 10.1007/s10584-015-1413-3; Shi F, 2012, SCI CHINA EARTH SCI, V55, P2058, DOI 10.1007/s11430-012-4374-7; Tang G. L., 1992, METEOROL MONOGR, V18, P3; Tang G. L, 2005, ENVIRON RES, V10, P791, DOI DOI 10.3969/J.ISSN.1006-9585.2005.04.010.(IN; [唐国利 Tang Guoli], 2009, [气候变化研究进展, Advances in Climate Change Research], V5, P71; Tao S., 1991, ORNLCDIAC47; Wang CY, 1990, BIMONTHLY XINJIANG M, V13, P19; Wang CY, 1996, ARID LAND GEOGRAPHY, V19, P37; Wang NL, 1997, J GLACIOL GEOCRYOL, V19, P17; Wang SW, 1998, Q J APPL METEOROLOGY, V9, P9; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Xu YF, 2009, ADV ATMOS SCI, V26, P265, DOI 10.1007/s00376-009-0265-z; Yan HM, 2004, CHINESE ASTRON ASTR, V28, P120, DOI 10.1016/j.chinastron.2004.01.014; Yang B, 2011, THEOR APPL CLIMATOL, V106, P489, DOI 10.1007/s00704-011-0451-7; Yao TD, 1996, SCI CHINA SER D, V39, P587; [喻树龙 YU Shulong], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P374; Yuan YJ, 1999, J GLACIOLOGY GEOCRYO, V21, P64; [张同文 Zhang Tongwen], 2011, [第四纪研究, Quaternary Sciences], V31, P1011; Zhang Xian-gong, 1982, Acta Meteorologica Sinica, V40, P198; Zhang Z.H., 1998, ACTA METEOROL SIN, V56, P77, DOI [10.11676/qxxb1998.007, DOI 10.11676/QXXB1998.007]; Zhao HB, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015735	48	5	5	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144210	10.1371/journal.pone.0144210	http://dx.doi.org/10.1371/journal.pone.0144210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632814	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000070
J	Hernandez, JA; Hernandez-Sanchez, M; Rodriguez-Vicente, AE; Grossmann, V; Collado, R; Heras, C; Puiggros, A; Martin, AA; Puig, N; Benito, R; Robledo, C; Delgado, J; Gonzalez, T; Queizan, JA; Galende, J; de la Fuente, I; Martin-Nunez, G; Alonso, JM; Abrisqueta, P; Luno, E; Marugan, I; Gonzalez-Gason, I; Bosch, F; Kohlmann, A; Gonzalez, M; Espinet, B; Hernandez-Rivas, JM				Angel Hernandez, Jose; Hernandez-Sanchez, Maria; Eugenia Rodriguez-Vicente, Ana; Grossmann, Vera; Collado, Rosa; Heras, Cecilia; Puiggros, Anna; Africa Martin, Ana; Puig, Noemi; Benito, Rocio; Robledo, Cristina; Delgado, Julio; Gonzalez, Teresa; Antonio Queizan, Jose; Galende, Josefina; de la Fuente, Ignacio; Martin-Nunez, Guillermo; Maria Alonso, Jose; Abrisqueta, Pau; Luno, Elisa; Marugan, Isabel; Gonzalez-Gason, Isabel; Bosch, Francesc; Kohlmann, Alexander; Gonzalez, Marcos; Espinet, Blanca; Maria Hernandez-Rivas, Jesus		Grp Cooperativo Espanol; GELLC	A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							LRF CLL4 TRIAL; IN-SITU HYBRIDIZATION; SF3B1 MUTATIONS; ATM MUTATIONS; PROGNOSTIC-SIGNIFICANCE; INDEPENDENT PREDICTOR; TP53 MUTATIONS; DELETION; SURVIVAL; NOTCH1	To analyze the impact of the 11q deleted (11q-) cells in CLL patients on the time to first therapy (TFT) and overall survival (OS), 2,493 patients with CLL were studied. 242 patients (9.7%) had 11q-. Fluorescence in situ hybridization (FISH) studies showed a threshold of 40% of deleted cells to be optimal for showing that clinical differences in terms of TFT and OS within 11q-CLLs. In patients with >= 40% of losses in 11q (11q-H) (74%), the median TFT was 19 months compared with 44 months in CLL patients with <40% del(11q) (11q-L) (P<0.0001). In the multivariate analysis, only the presence of 11q-L, mutated IGHV status, early Binet stage and absence of extended lymphadenopathy were associated with longer TFT. Patients with 11q-H had an OS of 90 months, while in the 11q-L group the OS was not reached (P = 0.008). The absence of splenomegaly (P = 0.02), low LDH (P = 0.018) or beta 2M (P = 0.006), and the presence of 11q-L (P = 0.003) were associated with a longer OS. In addition, to detect the presence of mutations in the ATM, TP53, NOTCH1, SF3B1, MYD88, FBXW7, XPO1 and BIRC3 genes, a select cohort of CLL patients with losses in 11q was sequenced by next-generation sequencing of amplicons. Eighty % of CLLs with 11q-showed mutations and fewer patients with low frequencies of 11q-had mutations among genes examined (50% vs 94.1%, P = 0.023). In summary, CLL patients with <40% of 11q-had a long TFT and OS that could be associated with the presence of fewer mutated genes.	[Angel Hernandez, Jose; Heras, Cecilia; Gonzalez-Gason, Isabel] Univ Complutense Madrid, Dept Hematol, Hosp Univ Infanta Leonor, Madrid, Spain; [Hernandez-Sanchez, Maria; Eugenia Rodriguez-Vicente, Ana; Benito, Rocio; Robledo, Cristina; Gonzalez, Marcos; Maria Hernandez-Rivas, Jesus] Univ Salamanca, Hosp Univ Salamanca, CSIC, IBSAL,IBMCC,Ctr Invest Canc, E-37008 Salamanca, Spain; [Grossmann, Vera; Kohlmann, Alexander] MLL Munich, Munich, Germany; [Collado, Rosa] Gen Hosp, Dept Hematol, Valencia, Spain; [Puiggros, Anna] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Africa Martin, Ana; Puig, Noemi; Gonzalez, Marcos; Maria Hernandez-Rivas, Jesus] Univ Hosp, Dept Hematol, Salamanca, Spain; [Delgado, Julio] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Gonzalez, Teresa] Fdn Publ Galega Med Xenom, Santiago De Compostela, Spain; [Antonio Queizan, Jose] Gen Hosp, Dept Hematol, Segovia, Spain; [Galende, Josefina] Hosp Bierzo, Dept Hematol, Leon, Spain; [de la Fuente, Ignacio] Hosp Univ Rio Hortega, Dept Hematol, Valladolid, Spain; [Martin-Nunez, Guillermo] Hosp Virgen del Puerto, Dept Hematol, Plasencia, Caceres, Spain; [Maria Alonso, Jose] Hosp Rio Carrion, Dept Hematol, Palencia, Spain; [Abrisqueta, Pau; Bosch, Francesc] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain; [Luno, Elisa] Univ Oviedo, Hosp Cent Asturias, Dept Hematol, E-33080 Oviedo, Spain; [Marugan, Isabel] Hosp Clin, Dept Hematol, Valencia, Spain; [Kohlmann, Alexander] AstraZeneca, Personalized Healthcare & Biomarkers, Innovat Med, Macclesfield, Cheshire, England	Complutense University of Madrid; Hospital Universitario Infanta Leonor; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; MLL Munich Leukemia Laboratory; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; Hospital del Rio Hortega; Hospital Universitari Vall d'Hebron; Central University Hospital Asturias; University of Oviedo; AstraZeneca	Hernandez, JA (corresponding author), Univ Complutense Madrid, Dept Hematol, Hosp Univ Infanta Leonor, Madrid, Spain.	fbosch@vhebron.net; BEspinet@parcdesalutmar.cat; jmhr@usal.es	Bosch, Francesc/AAE-7052-2019; Hernández, Jesus M/B-5459-2017; Hernández-Sánchez, María/I-9045-2016; BENITO, ROCIO/B-4271-2017; Collado Nieto, Rosa María/GZK-9557-2022; Rodriguez, Ana E/B-5462-2017; Rodríguez-Vicente, Ana E/AAP-5504-2021; Delgado, Julio/D-4891-2013; Robledo Montero, Cristina/B-4495-2017; Hernandez-Rivas, Jose-Angel/ADF-6441-2022	Bosch, Francesc/0000-0001-9241-2886; Hernández, Jesus M/0000-0002-9661-9371; Hernández-Sánchez, María/0000-0001-9968-2782; BENITO, ROCIO/0000-0001-9781-4198; Rodriguez, Ana E/0000-0001-6516-2172; Rodríguez-Vicente, Ana E/0000-0001-6516-2172; Delgado, Julio/0000-0002-5157-4376; Robledo Montero, Cristina/0000-0003-0445-3210; Hernandez-Rivas, Jose-Angel/0000-0003-4550-757X; Abrisqueta, Pau/0000-0001-9625-7422; Collado, Rosa/0000-0002-8205-6192; Gonzalez-Gascon y Marin, Isabel/0000-0001-6329-1704; Galende del Canto, Josefina/0000-0001-6542-4961; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Espinet, Blanca/0000-0002-4294-8145; Puiggros, Anna/0000-0001-9627-4978; DE LA FUENTE GRACIANI, IGNACIO/0000-0001-5381-820X	Spanish Fondo de Investigaciones Sanitarias FIS [09/01543, PI12/00281, PI15/01471]; Instituto de Salud Carlos III (ISCIII); European Regional Development Fund (ERDF) "Una manera de hacer Europa"; Proyectos de Investigacion del SACYL [355/A/09, GRS/1172/A15]; COST Action EuGESMA [BM0801]; Fundacion Manuel Solorzano; Obra Social Banca Civica; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness [RD12/0036/0069, RD12/0036/0044]; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa" [CEI 2010-1-0010]; European Union [306242-NGS-PTL]; Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo [JCYL-EDU/346/2013]; MLL Munich; AstraZeneca	Spanish Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission); Proyectos de Investigacion del SACYL; COST Action EuGESMA(European Cooperation in Science and Technology (COST)); Fundacion Manuel Solorzano; Obra Social Banca Civica; Fundacion Espanola de Hematologia y Hemoterapia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) "Una manera de hacer Europa"(European Commission); European Union(European Commission); Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo; MLL Munich; AstraZeneca(AstraZeneca)	This work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias FIS 09/01543, PI12/00281 and PI15/01471, Instituto de Salud Carlos III (ISCIII), European Regional Development Fund (ERDF) "Una manera de hacer Europa", Proyectos de Investigacion del SACYL 355/A/09, GRS/1172/A15, COST Action EuGESMA (BM0801), Fundacion Manuel Solorzano, Obra Social Banca Civica (Caja Burgos), Fundacion Espanola de Hematologia y Hemoterapia (FEHH), and by grants (RD12/0036/0069 and RD12/0036/0044) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) "Una manera de hacer Europa" (CEI 2010-1-0010). The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no 306242-NGS-PTL. Mutation analyses were performed using oligonucleotide primer plates designed as part of the IRON-II collaborative network of hematological laboratories applying 454 amplicon next-generation deep-sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maria Hernandez-Sanchez is fully supported by an Ayuda Predoctoral de la Junta de Castilla y Leon from the Fondo Social Europeo (JCYL-EDU/346/2013 Ph.D. scholarship). Vera Grossmann was supported by MLL Munich and Alexander Kohlmann was supported by MLL Munich and AstraZeneca in terms of salary. These funders provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Austen B, 2007, J CLIN ONCOL, V25, P5448, DOI 10.1200/JCO.2007.11.2649; Bullrich F, 1999, CANCER RES, V59, P24; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Dal Bo M, 2011, GENE CHROMOSOME CANC, V50, P633, DOI 10.1002/gcc.20885; Dicker F, 2009, LEUKEMIA, V23, P117, DOI 10.1038/leu.2008.274; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gonzalez MB, 2004, HAEMATOLOGICA, V89, P1213; Gonzalez-Gascon YMI, 2015, HEMATOL ONCOL, DOI [10.1002/hon.2196, DOI 10.1002/HON.2196]; Greipp PT, 2013, BRIT J HAEMATOL, V163, P326, DOI 10.1111/bjh.12534; Grossmann V, 2013, J MOL DIAGN, V15, P473, DOI 10.1016/j.jmoldx.2013.03.003; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hernandez JA, 2009, HAEMATOL-HEMATOL J, V94, P364, DOI 10.3324/haematol.13862; Jain P, 2015, AM J HEMATOL, V90, P471, DOI 10.1002/ajh.23978; Jeromin S, 2014, LEUKEMIA, V28, P108, DOI 10.1038/leu.2013.263; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Mansouri L, 2013, LEUKEMIA, V27, P512, DOI 10.1038/leu.2012.307; Marasca R, 2013, HEMATOL ONCOL, V31, P348, DOI 10.1002/hon.2028; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Navrkalova V, 2013, HAEMATOLOGICA, V98, P1124, DOI 10.3324/haematol.2012.081620; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Oscier DG, 2013, BLOOD, V121, P468, DOI 10.1182/blood-2012-05-429282; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Puiggros A, 2013, BRIT J HAEMATOL, V163, P47, DOI 10.1111/bjh.12479; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rodriguez-Vicente AE, 2013, CANCER GENET-NY, V206, P49, DOI 10.1016/j.cancergen.2013.01.003; Rose-Zerilli MJJ, 2014, HAEMATOLOGICA, V99, P736, DOI 10.3324/haematol.2013.098574; Rossi D, 2013, BLOOD, V121, P1403, DOI 10.1182/blood-2012-09-458265; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Rossi D, 2009, CLIN CANCER RES, V15, P995, DOI 10.1158/1078-0432.CCR-08-1630; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Skowronska A, 2012, J CLIN ONCOL, V30, P4524, DOI 10.1200/JCO.2011.41.0852; Stilgenbauer S, 1996, P NATL ACAD SCI USA, V93, P11837, DOI 10.1073/pnas.93.21.11837; Tam CS, 2009, BLOOD, V114, P957, DOI 10.1182/blood-2009-03-210591; Tsimberidou AM, 2009, CANCER-AM CANCER SOC, V115, P373, DOI 10.1002/cncr.23993; Van Dyke DL, 2010, BRIT J HAEMATOL, V148, P544, DOI 10.1111/j.1365-2141.2009.07982.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Weissmann S, 2013, LEUKEMIA, V27, P2393, DOI 10.1038/leu.2013.218	41	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143073	10.1371/journal.pone.0143073	http://dx.doi.org/10.1371/journal.pone.0143073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630574	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300030
J	Elgendi, M; Kumar, S; Guo, L; Rutledge, J; Coe, JY; Zemp, R; Schuurmans, D; Adatia, I				Elgendi, Mohamed; Kumar, Shine; Guo, Long; Rutledge, Jennifer; Coe, James Y.; Zemp, Roger; Schuurmans, Dale; Adatia, Ian			Detection of Heart Sounds in Children with and without Pulmonary Arterial Hypertension-Daubechies Wavelets Approach	PLOS ONE			English	Article							WIGNER-VILLE DISTRIBUTION; ACCELERATION PHOTOPLETHYSMOGRAM; SPECTRAL-ANALYSIS; DIAGNOSIS; SEGMENTATION; WAVES	Background Automatic detection of the 1st (S1) and 2nd (S2) heart sounds is difficult, and existing algorithms are imprecise. We sought to develop a wavelet-based algorithm for the detection of S1 and S2 in children with and without pulmonary arterial hypertension (PAH). Method Heart sounds were recorded at the second left intercostal space and the cardiac apex with a digital stethoscope simultaneously with pulmonary arterial pressure (PAP). We developed a Daubechies wavelet algorithm for the automatic detection of S1 and S2 using the wavelet coefficient 'D-6' based on power spectral analysis. We compared our algorithm with four other Daubechies wavelet-based algorithms published by Liang, Kumar, Wang, and Zhong. We annotated S1 and S2 from an audiovisual examination of the phonocardiographic tracing by two trained cardiologists and the observation that in all subjects systole was shorter than diastole. Results We studied 22 subjects (9 males and 13 females, median age 6 years, range 0.25-19). Eleven subjects had a mean PAP < 25 mmHg. Eleven subjects had PAH with a mean PAP >= 25 mmHg. All subjects had a pulmonary artery wedge pressure <= 15 mmHg. The sensitivity (SE) and positive predictivity (+P) of our algorithm were 70% and 68%, respectively. In comparison, the SE and +P of Liang were 59% and 42%, Kumar 19% and 12%, Wang 50% and 45%, and Zhong 43% and 53%, respectively. Our algorithm demonstrated robustness and outperformed the other methods up to a signal-to-noise ratio (SNR) of 10 dB. For all algorithms, detection errors arose from low-amplitude peaks, fast heart rates, low signal-to-noise ratio, and fixed thresholds. Conclusion Our algorithm for the detection of S1 and S2 improves the performance of existing Daubechies-based algorithms and justifies the use of the wavelet coefficient 'D-6' through power spectral analysis. Also, the robustness despite ambient noise may improve real world clinical performance.	[Elgendi, Mohamed; Schuurmans, Dale] Univ Alberta, Dept Math & Comp Sci, Edmonton, AB, Canada; [Kumar, Shine; Guo, Long; Adatia, Ian] Univ Alberta, Mazankowski Heart Inst, Stollery childrens Hosp, Pediat Pulm Hypertens Serv, Edmonton, AB, Canada; [Kumar, Shine; Guo, Long; Adatia, Ian] Univ Alberta, Mazankowski Heart Inst, Stollery childrens Hosp, Cardiac Crit Care, Edmonton, AB, Canada; [Rutledge, Jennifer; Coe, James Y.; Adatia, Ian] Univ Alberta, Dept Pediat, Stollery Childrens Hosp, Edmonton, AB, Canada; [Zemp, Roger] Univ Alberta, Dept Biomed Elect & Comp Engn, Edmonton, AB, Canada	University of Alberta; Stollery Children's Hospital; University of Alberta; Stollery Children's Hospital; University of Alberta; Stollery Children's Hospital; University of Alberta; University of Alberta	Adatia, I (corresponding author), Univ Alberta, Mazankowski Heart Inst, Stollery childrens Hosp, Pediat Pulm Hypertens Serv, Edmonton, AB, Canada.	iadatia@ualberta.ca	Elgendi, Mohamed/I-8596-2016	Elgendi, Mohamed/0000-0003-1831-0202	Cardiovascular Medical Research Education Fund for Pulmonary Hypertension [RES0016083]	Cardiovascular Medical Research Education Fund for Pulmonary Hypertension	This study was supported by Cardiovascular Medical Research Education Fund for Pulmonary Hypertension, http://www.ipahresearch.org/, RES0016083, IA RZ DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobhate P, 2015, PEDIATR CARDIOL, V36, P873, DOI 10.1007/s00246-015-1100-1; Debbal SM, 2008, COMPUT BIOL MED, V38, P263, DOI 10.1016/j.compbiomed.2007.09.006; Djebbari A, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-37; El-Segaier M, 2007, ACTA PAEDIATR, V96, P1036, DOI 10.1111/j.1651-2227.2007.00318.x; Elgendi M, 2014, PULM CIRC, V4, P685, DOI 10.1086/678513; Elgendi M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-139; Elgendi M, 2014, COMPUT METH PROG BIO, V117, P125, DOI 10.1016/j.cmpb.2014.08.001; Elgendi M, 2014, INT J CARDIOL, V173, P92, DOI 10.1016/j.ijcard.2014.02.025; Elgendi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073557; Emmanuel Babatunde S., 2012, Journal of Medical Engineering & Technology, V36, P303, DOI 10.3109/03091902.2012.684831; Gavrovska A, 2014, COMPUT METH PROG BIO, V113, P515, DOI 10.1016/j.cmpb.2013.11.018; Hebden J. E., 1996, IEE C ART INT METH B, V1996, P3; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Kumar D, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1410; Kumar D., 2006, 2006 IEEE INT C AC S, V2; Liang H, 1997, COMPUT CARDIOL, V24, P105, DOI 10.1109/CIC.1997.647841; Liang HY, 1997, P ANN INT IEEE EMBS, V19, P1630, DOI 10.1109/IEMBS.1997.757028; Nigam V, 2005, PHYSIOL MEAS, V26, P1005, DOI 10.1088/0967-3334/26/6/010; Ning TK, 2013, IEEE ENG MED BIO, P2555, DOI 10.1109/EMBC.2013.6610061; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Sepehri AA, 2008, COMPUT METH PROG BIO, V92, P186, DOI 10.1016/j.cmpb.2008.06.015; Sepehri AA, 2010, COMPUT METH PROG BIO, V99, P43, DOI 10.1016/j.cmpb.2009.10.006; Stasis AC, 2003, ENG MED BIOL SOC ANN, P354; Wang X., 2009, BIOMEDICAL ENG INFOR, P1; Zhong J, 2013, INT J ENG SCI, V2, P50	25	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143146	10.1371/journal.pone.0143146	http://dx.doi.org/10.1371/journal.pone.0143146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629704	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300032
J	Juraschek, SP; Moliterno, AR; Checkley, W; Miller, ER				Juraschek, Stephen P.; Moliterno, Alison R.; Checkley, William; Miller, Edgar R., III			The Gamma Gap and All-Cause Mortality	PLOS ONE			English	Article							LONG-TERM MORTALITY; RISK-FACTORS; POSTOPERATIVE PNEUMONIA; GLOBULIN RATIO; SERUM; ALBUMIN; PROTEIN; CANCER; PREDICTION; DISEASE	Background The difference between total serum protein and albumin, i.e. the gamma gap, is a frequently used clinical screening measure for both latent infection and malignancy. However, there are no studies defining a positive gamma gap. Further, whether it is an independent risk factor of mortality is unknown. Methods and Findings This study examined the association between gamma gap, all-cause mortality, and specific causes of death (cardiovascular, cancer, pulmonary, or other) in 12,260 participants of the National Health and Nutrition Examination Survey (NHANES) from 1999-2004. Participants had a comprehensive metabolic panel measured, which was linked with vital status data from the National Death Index. Cause of death was based on ICD10 codes from death certificates. Analyses were performed with Cox proportional hazards models adjusted for mortality risk factors. The mean (SE) age was 46 (0.3) years and the mean gamma gap was 3.0 (0.01) g/dl. The population was 52% women and 10% black. During a median follow-up period of 4.8 years (IQR: 3.3 to 6.2 years), there were 723 deaths. The unadjusted 5-year cumulative incidences across quartiles of the gamma gap (1.7-2.7, 2.8-3.0, 3.1-3.2, and 3.3-7.9 g/dl) were 5.7%, 4.2%, 5.5%, and 7.8%. After adjustment for risk factors, participants with a gamma gap of >= 3.1 g/dl had a 30% higher risk of death compared to participants with a gamma gap < 3.1 g/dl (HR: 1.30; 95% CI: 1.08, 1.55; P = 0.006). Gamma gap (per 1.0 g/dl) was most strongly associated with death from pulmonary causes (HR 2.22; 95% CI: 1.19, 4.17; P = 0.01). Conclusions The gamma gap is an independent risk factor for all-cause mortality at values as low as 3.1 g/dl (in contrast to the traditional definition of 4.0 g/dl), and is strongly associated with death from pulmonary causes. Future studies should examine the biologic pathways underlying these associations.	[Juraschek, Stephen P.; Miller, Edgar R., III] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemioloy, Baltimore, MD 21205 USA; [Juraschek, Stephen P.; Miller, Edgar R., III] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Juraschek, Stephen P.; Miller, Edgar R., III] Johns Hopkins Med Inst, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Moliterno, Alison R.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Checkley, William] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Checkley, William] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Juraschek, SP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemioloy, Baltimore, MD 21205 USA.	spj@jhmi.edu		Juraschek, Stephen/0000-0003-4168-2696; Checkley, William/0000-0003-1106-8812	NIH/NIDDK [T32DK007732-20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007732] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SPJ is supported by a NIH/NIDDK T32DK007732-20 Renal Disease Epidemiology Training Grant.	Apple FS, 2005, CLIN CHEM, V51, P2198, DOI 10.1373/clinchem.2005.052886; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Centers for Disease Control, 2010, NHANES NHANES 1999 2; Dispenzieri A, 2001, MAYO CLIN PROC, V76, P476, DOI 10.4065/76.5.476; Duran AO, 2014, ASIAN PAC J CANCER P, V15, P6449, DOI 10.7314/APJCP.2014.15.15.6449; Egan BM, 2010, JAMA-J AM MED ASSOC, P2043, DOI DOI 10.1001/JAMA.2010.650]; FAN ST, 1987, BRIT J SURG, V74, P408, DOI 10.1002/bjs.1800740530; FUJITA T, 1995, AM J SURG, V169, P304, DOI 10.1016/S0002-9610(99)80163-9; Fulks Michael, 2014, J Insur Med, V44, P93; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GARIBALDI RA, 1981, AM J MED, V70, P677, DOI 10.1016/0002-9343(81)90595-7; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; KILLINGSWORTH LM, 1979, CRC CR REV CL LAB SC, V11, P1, DOI 10.3109/10408367909105852; Kumar P, 2010, ANN PLAS SURG, V65, P74, DOI 10.1097/SAP.0b013e3181c47d71; LEHTINEN K, 1983, SCAND J RHEUMATOL, V12, P3, DOI 10.3109/03009748309101994; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Pirruccello J, GAMMA GAP; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P273, DOI 10.1002/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-X; SALT HB, 1956, CLIN CHEM, V2, P35; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Sogaard KK, 2015, J INTERN MED, V277, P429, DOI 10.1111/joim.12270; Sormani MP, 2003, BONE MARROW TRANSPL, V32, P205, DOI 10.1038/sj.bmt.1704085; Suh B, 2014, ANN ONCOL, V25, P2260, DOI 10.1093/annonc/mdu274; Thakkinstian A, 2008, J GEN INTERN MED, V23, P1688, DOI 10.1007/s11606-008-0712-z; Torisu T, 2009, GERONTOLOGY, V55, P179, DOI 10.1159/000162260; VOLLERTSEN RS, 1986, MEDICINE, V65, P365, DOI 10.1097/00005792-198611000-00002; WHEELER WB, 1984, J PEDIATR-US, V104, P695, DOI 10.1016/S0022-3476(84)80946-4; WINDSOR JA, 1988, ANN SURG, V208, P209, DOI 10.1097/00000658-198808000-00013; WOO J, 1992, POSTGRAD MED J, V68, P954, DOI 10.1136/pgmj.68.806.954	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143494	10.1371/journal.pone.0143494	http://dx.doi.org/10.1371/journal.pone.0143494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629820	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300053
J	Kjartansdottir, KR; Reda, A; Panula, S; Day, K; Hultenby, K; Soder, O; Hovatta, O; Stukenborg, JB				Kjartansdottir, Kristin Ros; Reda, Ahmed; Panula, Sarita; Day, Kelly; Hultenby, Kjell; Soder, Olle; Hovatta, Outi; Stukenborg, Jan-Bernd			A Combination of Culture Conditions and Gene Expression Analysis Can Be Used to Investigate and Predict hES Cell Differentiation Potential towards Male Gonadal Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELL; PRIMORDIAL GERM-CELLS; TESTIS DEVELOPMENT; SERTOLI-CELLS; FEEDER CELLS; HUMAN FIBROBLASTS; DERIVATION; LINES; FETAL; GENERATION	Human embryonic stem cell differentiation towards various cell types belonging to ecto-, endo-and mesodermal cell lineages has been demonstrated, with high efficiency rates using standardized differentiation protocols. However, germ cell differentiation from human embryonic stem cells has been very inefficient so far. Even though the influence of various growth factors has been evaluated, the gene expression of different cell lines in relation to their differentiation potential has not yet been extensively examined. In this study, the potential of three male human embryonic stem cell lines to differentiate towards male gonadal cells was explored by analysing their gene expression profiles. The human embryonic stem cell lines were cultured for 14 days as monolayers on supporting human foreskin fibroblasts or as spheres in suspension, and were differentiated using BMP7, or spontaneous differentiation by omitting exogenous FGF2. TLDA analysis revealed that in the undifferentiated state, these cell lines have diverse mRNA profiles and exhibit significantly different potentials for differentiation towards the cell types present in the male gonads. This potential was associated with important factors directing the fate of the male primordial germ cells in vivo to form gonocytes, such as SOX17 or genes involved in the NODAL/ACTIVIN pathway, for example. Stimulation with BMP7 in suspension culture resulted in up-regulation of cytoplasmic SOX9 protein expression in all three lines. The observation that human embryonic stem cells differentiate towards germ and somatic cells after spontaneous and BMP7-induced stimulation in suspension emphasizes the important role of somatic cells in germ cell differentiation in vitro.	[Kjartansdottir, Kristin Ros; Reda, Ahmed; Soder, Olle; Stukenborg, Jan-Bernd] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, SE-17176 Stockholm, Sweden; [Kjartansdottir, Kristin Ros; Reda, Ahmed; Soder, Olle; Stukenborg, Jan-Bernd] Univ Hosp, SE-17176 Stockholm, Sweden; [Kjartansdottir, Kristin Ros; Panula, Sarita; Day, Kelly; Hovatta, Outi] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, SE-14186 Huddinge, Sweden; [Kjartansdottir, Kristin Ros] Horsens Hosp, Sci Unit, Reprod Biol Lab, DK-8700 Horsens, Denmark; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Div Clin Res Ctr, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Aarhus University; Karolinska Institutet	Stukenborg, JB (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Endocrinol Unit, Q2 08, SE-17176 Stockholm, Sweden.	jan-bernd.stukenborg@ki.se		Reda, Ahmed/0000-0001-7053-7979; Stukenborg, Jan-bernd/0000-0002-2839-1870	Stiftelsen Frimurare Barnhuset in Stockholm; Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; Emil och Wera Cornells Stiftelse; German Research Foundation (DFG) [STU 506/3-1]	Stiftelsen Frimurare Barnhuset in Stockholm; Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; Emil och Wera Cornells Stiftelse; German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support was received from Stiftelsen Frimurare Barnhuset in Stockholm; the Paediatric Research Foundation; Sallskapet Barnavard in Stockholm; Stiftelsen Sigurd och Elsa Goljes Minne, Barnforskningen vid ALB; the Swedish Research Council/Finnish Academy of Science; Tore Nilsons Stiftelse for Medical Research, Stiftelsen for Barnendokrinologkisk Forskning Laboratory; and Emil och Wera Cornells Stiftelse. JBS was supported by the German Research Foundation (DFG-Grant No.: STU 506/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; AMLANI S, 1988, ANAT REC, V220, P143, DOI 10.1002/ar.1092200206; Annab LA, 2012, DIFFERENTIATION, V84, P330, DOI 10.1016/j.diff.2012.07.006; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Santa Barbara P, 2000, DEV DYNAM, V217, P293, DOI 10.1002/(SICI)1097-0177(200003)217:3<293::AID-DVDY7>3.0.CO;2-P; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Eguizabal C, 2009, DIFFERENTIATION, V78, P116, DOI 10.1016/j.diff.2009.07.001; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; FRANKE WW, 1979, EXP CELL RES, V123, P25, DOI 10.1016/0014-4827(79)90418-X; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Gunesdogan U, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0543; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kee K, 2008, CSH PROTOC, DOI [10.1101/pdb.prot5048, DOI 10.1101/PDB.PR0T5048]; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kjartansdottir KR, 2012, SYST BIOL REPROD MED, V58, P330, DOI 10.3109/19396368.2012.694009; Krentz AD, 2013, DEV BIOL, V377, P67, DOI 10.1016/j.ydbio.2013.02.014; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu CX, 2014, MOL REPROD DEV, V81, P470, DOI 10.1002/mrd.22312; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; Melichar H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019854; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park Y, 2011, STEM CELLS DEV, V20, P1901, DOI 10.1089/scd.2010.0496; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Rao M, 2008, GENE THER, V15, P82, DOI 10.1038/sj.gt.3303061; Russel L. D., 1990, HISTOLOGICAL HISTOPA; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Simard J, 2000, ENDOCR RES, V26, P761, DOI 10.3109/07435800009048597; Sonne SB, 2010, INT J DEV BIOL, V54, P755, DOI 10.1387/ijdb.082668ss; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Spiller CM, 2013, INT J DEV BIOL, V57, P211, DOI 10.1387/ijdb.130028pk; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Stukenborg JB, 2010, SEX DEV, V4, P199, DOI 10.1159/000317090; Stukenborg JB, 2014, HORM RES PAEDIAT, V81, P2, DOI 10.1159/000355599; Stukenborg JB, 2009, MOL HUM REPROD, V15, P521, DOI 10.1093/molehr/gap052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Viger RS, 2005, VITAM HORM, V70, P387, DOI 10.1016/S0083-6729(05)70013-3; Vo BT, 2011, PROSTATE, V71, P1084, DOI 10.1002/pros.21326; West FD, 2010, HUM REPROD, V25, P168, DOI 10.1093/humrep/dep338; West FD, 2011, STEM CELLS DEV, V20, P1079, DOI 10.1089/scd.2010.0255; West FD, 2008, STEM CELLS, V26, P2768, DOI 10.1634/stemcells.2008-0124; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	63	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144029	10.1371/journal.pone.0144029	http://dx.doi.org/10.1371/journal.pone.0144029			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630562	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300140
J	Liu, GL; Pi, HC; Hao, L; Li, DD; Wu, YG; Dong, J				Liu, Gui-Ling; Pi, Hai-Chen; Hao, Li; Li, Dan-Dan; Wu, Yong-Gui; Dong, Jie			Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; 25-HYDROXYVITAMIN D; D INSUFFICIENCY; CHOLECALCIFEROL; ASSOCIATION; PERFORMANCE; DECLINE; ADULTS	Objective Vitamin D (VD) deficiency is an independent risk factor for cognitive impairment (CI) in the general population, but VD status in peritoneal dialysis (PD) patients has not been investigated. In this study, we aimed to investigate the relationship between serum VD levels and global and specific cognitive functions in PD patients. Design and Setting Cross-sectional study, simultaneously conducted at two PD centers. Patients Clinically stable patients (n = 273) undergoing PD for at least 3 months were enrolled over a period of one year. Main outcome Measures Demographic and comorbidity data were recorded, and routine biochemical parameters and serum 25-hydroxyvitamin D (25(OH) D) levels of overnight fasted patients were determined. Global cognitive function was assessed by the Modified Mini-Mental State Examination (3MS) score; executive function, by the trail making tests (Trails A and B); and immediate memory, delayed memory, and language ability by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) sub-tests. Results In the univariate analysis, serum 25(OH) D levels significantly correlated with 3MS scores (r = -0.139; P = 0.02), and Trail A (r = -0.188; P = 0.002) and B (r = -0.154; P = 0.01) completion times. In the multivariate analysis, 25(OH) D was found to be independently associated with global CI, but not with executive dysfunction. Serum 25(OH) D could not predict scores of immediate/delayed memory and language ability. Conclusions VD deficiency is highly prevalent in PD patients and is an independent risk factor for global CI in this patient cohort.	[Liu, Gui-Ling; Hao, Li; Li, Dan-Dan; Wu, Yong-Gui] Anhui Med Univ, Hosp 2, Div Renal, Hefei, Anhui, Peoples R China; [Pi, Hai-Chen; Dong, Jie] Peking Univ, Div Renal, Dept Med,Minist Educ, Hosp 1,Inst Nephrol,Key Lab Renal Dis,Minist Hlth, Beijing 100871, Peoples R China	Anhui Medical University; Peking University	Wu, YG (corresponding author), Anhui Med Univ, Hosp 2, Div Renal, Hefei, Anhui, Peoples R China.	guilingliu369@yeah.net	Dong, Jie/AFM-0048-2022					Afsar B, 2013, GEN HOSP PSYCHIAT, V35, P28, DOI 10.1016/j.genhosppsych.2012.08.007; Andreeva VA, 2014, ANN NUTR METAB, V65, P81, DOI 10.1159/000365154; Annweiler C, 2012, COGN BEHAV NEUROL, V25, P121, DOI 10.1097/WNN.0b013e31826df647; Armas LAG, 2012, CLIN J AM SOC NEPHRO, V7, P1428, DOI 10.2215/CJN.12761211; Bossola M, 2011, J PSYCHOSOM RES, V71, P50, DOI 10.1016/j.jpsychores.2011.01.001; Breitling LP, 2012, EXP GERONTOL, V47, P122, DOI 10.1016/j.exger.2011.11.004; Chei CL, 2014, J AM GERIATR SOC, V62, P2125, DOI 10.1111/jgs.13082; Dong J, 2014, PERITON DIALYSIS INT, V34, P447, DOI 10.3747/pdi.2013.00001; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; Erbas O, 2014, LIFE SCI, V103, P68, DOI 10.1016/j.lfs.2014.03.035; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Hanna K, 2015, J HUM NUTR DIET, V28, P209, DOI 10.1111/jhn.12234; Hooshmand B, 2014, J GERONTOL A-BIOL, V69, P1132, DOI 10.1093/gerona/glu022; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P3799, DOI 10.1093/ndt/gfp370; Kalirao P, 2011, AM J KIDNEY DIS, V57, P612, DOI 10.1053/j.ajkd.2010.11.026; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Llewellyn DJ, 2011, J GERONTOL A-BIOL, V66, P59, DOI 10.1093/gerona/glq185; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Mason DL, 2013, HEMODIAL INT, V17, P3, DOI 10.1111/j.1542-4758.2012.00727.x; Milman S, 2014, J AM GERIATR SOC, V62, P153, DOI 10.1111/jgs.12601; Minasyan A, 2007, J STEROID BIOCHEM, V104, P274, DOI 10.1016/j.jsbmb.2007.03.032; Murray AM, 2007, AM J KIDNEY DIS, V50, P270, DOI 10.1053/j.ajkd.2007.05.010; Peterson A, 2012, J NUTR HEALTH AGING, V16, P898, DOI 10.1007/s12603-012-0378-4; Pettersen JA, 2014, CAN J NEUROL SCI, V41, P459, DOI 10.1017/S0317167100018497; Post JB, 2010, NEPHRON CLIN PRACT, V116, pC247, DOI 10.1159/000317206; Przybelski RJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P202, DOI 10.1016/j.abb.2006.12.018; Raphael KL, 2012, AM J NEPHROL, V35, P49, DOI 10.1159/000334872; Sarnak MJ, 2013, NEUROLOGY, V80, P471, DOI 10.1212/WNL.0b013e31827f0f7f; Shaffi K, 2013, CLIN J AM SOC NEPHRO, V8, P979, DOI 10.2215/CJN.10651012; Slinin Y, 2012, J GERONTOL A-BIOL, V67, P1092, DOI 10.1093/gerona/gls075; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stilley CS, 2010, HEALTH PSYCHOL, V29, P50, DOI 10.1037/a0016940; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Tamura MK, 2010, CLIN J AM SOC NEPHRO, V5, P1429, DOI 10.2215/CJN.01090210; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tokmak F, 2008, NEPHROL DIAL TRANSPL, V23, P4016, DOI 10.1093/ndt/gfn367; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Yaffe K, 2013, AM J KIDNEY DIS, V61, P219, DOI 10.1053/j.ajkd.2012.10.006; [杨贵刚 Yang Guigang], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P926; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143782	10.1371/journal.pone.0143782	http://dx.doi.org/10.1371/journal.pone.0143782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630385	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300098
J	Mullany, LE; Wolff, RK; Herrick, JS; Buas, MF; Slattery, ML				Mullany, Lila E.; Wolff, Roger K.; Herrick, Jennifer S.; Buas, Matthew F.; Slattery, Martha L.			SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk	PLOS ONE			English	Article							BINDING-SITE POLYMORPHISMS; COLORECTAL-CANCER; FUNCTIONAL POLYMORPHISM; GENETIC-VARIATION; PROMOTER REGION; CERVICAL-CANCER; BREAST-CANCER; LUNG-CANCER; VARIANT; SUSCEPTIBILITY	Introduction MicroRNAs (miRNAs) regulate messenger RNAs (mRNAs) and as such have been implicated in a variety of diseases, including cancer. MiRNAs regulate mRNAs through binding of the miRNA 5' seed sequence (similar to 7-8 nucleotides) to the mRNA 3' UTRs; polymorphisms in these regions have the potential to alter miRNA-mRNA target associations. SNPs in miRNA genes as well as miRNA-target genes have been proposed to influence cancer risk through altered miRNA expression levels. Methods MiRNA-SNPs and miRNA-target gene-SNPs were identified through the literature. We used SNPs from Genome-Wide Association Study (GWAS) data that were matched to individuals with miRNA expression data generated from an Agilent platform for colon tumor and non-tumor paired tissues. These samples were used to evaluate 327 miRNA-SNP pairs for associations between SNPs and miRNA expression levels as well as for SNP associations with colon cancer. Results Twenty-two miRNAs expressed in non-tumor tissue were significantly different by genotype and 21 SNPs were associated with altered tumor/non-tumor differential miRNA expression across genotypes. Two miRNAs were associated with SNP genotype for both non-tumor and tumor/non-tumor differential expression. Of the 41 miRNAs significantly associated with SNPs all but seven were significantly differentially expressed in colon tumor tissue. Two of the 41 SNPs significantly associated with miRNA expression levels were associated with colon cancer risk: rs8176318 (BRCA1), ORAA 1.31 95% CI 1.01, 1.78, and rs8905 (PRKAR1A), ORGG 2.31 95% CI 1.11, 4.77. Conclusion Of the 327 SNPs identified in the literature as being important because of their potential regulation of miRNA expression levels, 12.5% had statistically significantly associations with miRNA expression. However, only two of these SNPs were significantly associated with colon cancer.	[Mullany, Lila E.; Wolff, Roger K.; Herrick, Jennifer S.; Slattery, Martha L.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Buas, Matthew F.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center	Mullany, LE (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.	Lila.Mullany@hsc.utah.edu		Herrick, Jennifer/0000-0001-9257-8843; Buas, Matthew F/0000-0002-8524-3428	National Cancer Institute [CA163683, CA48998]; MLS; NATIONAL CANCER INSTITUTE [U01CA048998, R01CA163683, R01CA048998] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MLS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was received by the National Cancer Institute (http://www.cancer.gov). The grant numbers are: CA163683 and CA48998. Funding was received by MLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agilent Technologies I, 2013, AG GENESPRING US MAN; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Bae JS, 2012, DIG LIVER DIS; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buas MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128617; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Davison AC, 1997, BOOTSTRAP METHODS TH; Dikaiakos P, 2015, CANCER BIOMARK, V15, P157, DOI 10.3233/CBM-140449; Ding LF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/373252; Dorairaj JJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-421; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Gong J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav029; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081967; Li LJ, 2013, HUM IMMUNOL, V74, P993, DOI 10.1016/j.humimm.2013.04.019; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032230; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Ma XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079584; Mao YY, 2014, TUMOR BIOL, V35, P6961, DOI 10.1007/s13277-014-1916-y; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Murray BS, 2010, MOL BIOSYST, V6, P1853, DOI 10.1039/c003961f; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Pardini B, 2015, CARCINOGENESIS, V36, P82, DOI 10.1093/carcin/bgu224; Pellatt DF, 2015, EXPRESSION PRO UNPUB; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Slattery ML, 1997, CANCER RES, V57, P75; Slattery ML, 2015, MICRORNA PROFI UNPUB; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Wu DJ, 2015, CELL IMMUNOL, V293, P41, DOI 10.1016/j.cellimm.2014.11.006; Xie WQ, 2014, J DIGEST DIS, V15, P647, DOI 10.1111/1751-2980.12201; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yu Q, 2012, WORLD J GASTROENTERO, V18, P383, DOI 10.3748/wjg.v18.i4.383; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhang S, 2012, ONCOGENE, DOI 10.1038; Zhang XF, 2010, CARCINOGENESIS, V31, P2118, DOI 10.1093/carcin/bgq177; Zheng H, 2011, INT J ONCOL, V38, P1153, DOI 10.3892/ijo.2011.940; Zhou XY, 2010, GYNECOL ONCOL, V117, P287, DOI 10.1016/j.ygyno.2010.01.020	56	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143894	10.1371/journal.pone.0143894	http://dx.doi.org/10.1371/journal.pone.0143894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630397	Green Published, gold			2022-12-26	WOS:000365926300118
J	Nakagawa, Y; Nagasawa, M; Medina, J; Kojima, I				Nakagawa, Yuko; Nagasawa, Masahiro; Medina, Johan; Kojima, Itaru			Glucose Evokes Rapid Ca2+ and Cyclic AMP Signals by Activating the Cell-Surface Glucose-Sensing Receptor in Pancreatic beta-Cells	PLOS ONE			English	Article							SWEET TASTE RECEPTOR; PROTEIN-KINASE-C; INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; ISLETS; EXPRESSION; CAMP; COINCIDENCE	Glucose is a primary stimulator of insulin secretion in pancreatic beta-cells. High concentration of glucose has been thought to exert its action solely through its metabolism. In this regard, we have recently reported that glucose also activates a cell-surface glucose-sensing receptor and facilitates its own metabolism. In the present study, we investigated whether glucose activates the glucose-sensing receptor and elicits receptor-mediated rapid actions. In MIN6 cells and isolated mouse beta-cells, glucose induced triphasic changes in cytoplasmic Ca2+ concentration ([Ca2+](c)); glucose evoked an immediate elevation of [Ca2+](c), which was followed by a decrease in [Ca2+](c), and after a certain lag period it induced large oscillatory elevations of [Ca2+](c). Initial rapid peak and subsequent reduction of [Ca2+](c) were independent of glucose metabolism and reproduced by a nonmetabolizable glucose analogue. These signals were also blocked by an inhibitor of T1R3, a subunit of the glucose-sensing receptor, and by deletion of the T1R3 gene. Besides Ca2+, glucose also induced an immediate and sustained elevation of intracellular cAMP ([cAMP](c)). The elevation of [cAMP](c) was blocked by transduction of the dominant-negative G(s), and deletion of the T1R3 gene. These results indicate that glucose induces rapid changes in [Ca2+](c) and [cAMP](c) by activating the cell-surface glucose-sensing receptor. Hence, glucose generates rapid intracellular signals by activating the cell-surface receptor.	[Nakagawa, Yuko; Nagasawa, Masahiro; Medina, Johan; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 371, Japan	Gunma University	Kojima, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 371, Japan.	ikojima@gunma-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25670431]; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Grant-in-Aid for Exploratory Research from the Ministry of Education, Science, Sports and Culture of Japan and #25670431, Japan Society for the Promotion of Science (https://www.jsps.go.jp) to IK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi E, 2009, PFLUG ARCH EUR J PHY, V459, P227, DOI 10.1007/s00424-009-0705-8; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Cerasi E, 1973, FEBS LETT, V33, P311; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DEAN PM, 1968, NATURE, V219, P389, DOI 10.1038/219389a0; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Furman B, 2010, ADV EXP MED BIOL, V654, P281, DOI 10.1007/978-90-481-3271-3_13; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; GRAPENGIESSER E, 1988, BIOCHEM BIOPH RES CO, V151, P1299, DOI 10.1016/S0006-291X(88)80503-5; Hamano K, 2015, J ENDOCRINOL, V226, P57, DOI 10.1530/JOE-15-0102; Hellman B, 2014, ACTA PHYSIOL, V210, P479, DOI 10.1111/apha.12217; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Kim JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002127; Kojima I, 2015, J DIABETES INVEST, V6, P256, DOI 10.1111/jdi.12304; Kyriazis GA, 2014, ENDOCRINOLOGY, V155, P2112, DOI 10.1210/en.2013-2015; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Medina A, 2014, ENDOCR J, V61, P797, DOI 10.1507/endocrj.EJ14-0221; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mogami H, 2003, J BIOL CHEM, V278, P9896, DOI 10.1074/jbc.M210653200; Murovets VO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130997; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Nakagawa Y, 2014, ENDOCR J, V61, P119, DOI 10.1507/endocrj.EJ13-0431; Nakagawa Y, 2013, ENDOCR J, V60, P1191, DOI 10.1507/endocrj.EJ13-0282; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Ohtsu Y, 2014, MOL CELL ENDOCRINOL, V394, P70, DOI 10.1016/j.mce.2014.07.004; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; ROE MW, 1994, AM J PHYSIOL, V266, pE852, DOI 10.1152/ajpendo.1994.266.6.E852; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; RORSMAN P, 1985, PFLUG ARCH EUR J PHY, V405, P305, DOI 10.1007/BF00595682; RORSMAN P, 1984, FEBS LETT, V170, P196, DOI 10.1016/0014-5793(84)81398-8; Suzuki Y, 2006, J BIOL CHEM, V281, P28499, DOI 10.1074/jbc.M604291200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463; YADA T, 1992, CELL CALCIUM, V13, P69, DOI 10.1016/0143-4160(92)90031-M; Yaekura K, 1998, AM J PHYSIOL-CELL PH, V274, pC513, DOI 10.1152/ajpcell.1998.274.2.C513	49	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144053	10.1371/journal.pone.0144053	http://dx.doi.org/10.1371/journal.pone.0144053			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630567	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300150
J	Chen, YF; Manchester, SR				Chen, Yunfa; Manchester, Steven R.			Winged Fruits of Deviacer in the Oligocene from the Ningming Basin in Guangxi, South China	PLOS ONE			English	Article							SAMARAS	Deviacer guangxiensis Chen & Manchester sp. nov. is described based on asymmetric samaras from the Oligocene Ningming Formation in Guangxi, South China, representing the first documentation of Deviacer fossils in Asia. The Oligocene species, with relatively large fruits, represents the youngest record of the genus so far known; all other records are from the Paleocene and Eocene, or late Eocene-early Oligocene in western North America and Europe. It indicates that the extinct genus, Deviacer, was widely distributed in the northern hemisphere during the Paleogene.	[Chen, Yunfa] Guangxi Museum Nat Hist, Nanning 530012, Guangxi, Peoples R China; [Manchester, Steven R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Chen, YF (corresponding author), Guangxi Museum Nat Hist, Nanning 530012, Guangxi, Peoples R China.	chenyunfa@163.com			National Natural Science Foundation of China [41162002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (No. 41162002) to YFC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Brown R. W., 1962, 375 US GEOL SURV; Chen Geng-Jiao, 2004, Vertebrata Palasiatica, V42, P81; Chen GJ, 2011, SCI CHINA EARTH SCI, V54, P481, DOI 10.1007/s11430-011-4182-5; Chen GJ, 2005, J VERTEBR PALEONTOL, V25, P492, DOI 10.1671/0272-4634(2005)025[0492:ANCCRT]2.0.CO;2; Chen YF, 2005, BOT J LINN SOC, V147, P437, DOI 10.1111/j.1095-8339.2005.00373.x; Chen YF., 2014, INT J LATEST RES SCI, V3, P13; Huang, 2004, J STRATIGRAPHY, V28, P362; [李浩敏 Li Haomin], 2003, [古生物学报, Acta Palaeontologica Sinica], V42, P537; Manchester S.R., 1994, PALEONTOGRAPHICA AM, V58, P1; Manchester S. R., 2001, PROC DENVER MUS NAT, V4, P137; MATHEWES R W, 1971, Syesis, V4, P209; Mirle C, 1999, BRITTONIA, V51, P1, DOI 10.2307/2666549; Myers JA, 2015, INT J PLANT SCI, V176, P259, DOI 10.1086/679759; Myers Jeffrey A., 2006, PaleoBios, V26, P11; Ning Z.S., 1994, TERTIARY PETROLIFERO, P13; Pigg K, 2006, 7 EUR PAL PAL C SEPT; Pigg KB, 2008, INT J PLANT SCI, V169, P1304, DOI 10.1086/591981; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Shi GL, 2014, PALAEOWORLD, V23, P336, DOI 10.1016/j.palwor.2014.08.001; Shi GL, 2012, AM J BOT, V99, P108, DOI 10.3732/ajb.1100331; Shi GL, 2011, REV PALAEOBOT PALYNO, V166, P325, DOI 10.1016/j.revpalbo.2011.06.005; Shi GL, 2010, REV PALAEOBOT PALYNO, V161, P179, DOI 10.1016/j.revpalbo.2010.04.002; Song ZQ, 2014, ACTA PALAEONTOLOGICA, V53, P199; Wang Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-88; [王伟铭 Wang Weiming], 2003, [地层学杂志, Journal of Stratigraphy], V27, P324; Wehr WC, 1995, WASHINGTON GEOL, V23, P3; WOLFE J A, 1987, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V22, P1	27	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144009	10.1371/journal.pone.0144009	http://dx.doi.org/10.1371/journal.pone.0144009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624897	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600085
J	Magalon, J; Maiers, M; Kurtzberg, J; Navarrete, C; Rubinstein, P; Brown, C; Schramm, C; Larghero, J; Katsahian, S; Chabannon, C; Picard, C; Platz, A; Schmidt, A; Katz, G				Magalon, Jeremy; Maiers, Martin; Kurtzberg, Joanne; Navarrete, Cristina; Rubinstein, Pablo; Brown, Colin; Schramm, Catherine; Larghero, Jerome; Katsahian, Sandrine; Chabannon, Christian; Picard, Christophe; Platz, Alexander; Schmidt, Alexander; Katz, Gregory			Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks	PLOS ONE			English	Article							UNITED-STATES; TRANSPLANTATION; HLA; SELECTION; LEUKEMIA; OUTCOMES; GRAFTS; COST	Background Cord blood is an important source of stem cells. However, nearly 90% of public cord blood banks have declared that they are struggling to maintain their financial sustainability and avoid bankruptcy. The objective of this study is to evaluate how characteristics of cord blood units influence their utilization, then use this information to model the economic viability and therapeutic value of different banking strategies. Methods Retrospective analysis of cord blood data registered between January 1st, 2009 and December 31st, 2011 in Bone Marrow Donor Worldwide. Data were collected from four public banks in France, Germany and the USA. Samples were eligible for inclusion in the analysis if data on cord blood and maternal HLA typing and biological characteristics after processing were available (total nucleated and CD34+ cell counts). 9,396 banked cord blood units were analyzed, of which 5,815 were Caucasian in origin. A multivariate logistic regression model assessed the influence of three parameters on the CBU utilization rate: ethnic background, total nucleated and CD34+ cell counts. From this model, we elaborated a Utilization Score reflecting the probability of transplantation for each cord blood unit. We stratified three Utilization Score thresholds representing four different banking strategies, from the least selective (scenario A) to the most selective (scenario D). We measured the cost-effectiveness ratio for each strategy by comparing performance in terms of number of transplanted cord blood units and level of financial deficit. Results When comparing inputs and outputs over three years, Scenario A represented the most extreme case as it delivered the highest therapeutic value for patients (284 CBUs transplanted) along with the highest financial deficit (USD 5.89 million). We found that scenario C resulted in 219 CBUs transplanted with a limited deficit (USD 0.98 million) that charities and public health could realistically finance over the long term. We also found that using a pre-freezing level of 18 x 10(8) TNC would be the most cost-effective strategy for a public bank. Conclusion Our study shows that a swift transition from strategy A to C can play a vital role in preventing public cord blood banks worldwide from collapsing.	[Magalon, Jeremy; Katz, Gregory] ESSEC Business Sch, Paris, France; [Magalon, Jeremy] Assistance Publ Hop Marseille, CIC BT 1409, Marseille, France; [Magalon, Jeremy] Aix Marseille Univ, Vasc Res Ctr Marseille, Marseille, France; [Maiers, Martin] Natl Marrow Donor Program, Minneapolis, MN USA; [Kurtzberg, Joanne] Duke Univ, Carolinas Cord Blood Bank, Durham, NC USA; [Navarrete, Cristina; Brown, Colin] NHS Blood & Transplant, NHS Cord Blood Bank, London, England; [Rubinstein, Pablo] New York Blood Ctr, Natl Cord Blood Program, New York, NY 10021 USA; [Schramm, Catherine; Katsahian, Sandrine] Paris Descartes Univ, UPMC, INSERM, U1138, Paris, France; [Larghero, Jerome; Katsahian, Sandrine] AP HP, Paris, France; [Chabannon, Christian] Inst J Paoli I Calmettes, CIC BT 1409, F-13009 Marseille, France; [Picard, Christophe] EFS Alpes Mediterranee, Marseille, France; [Platz, Alexander; Schmidt, Alexander] DKMS Cord Blood Bank, Dresden, Germany	ESSEC Business School; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; National Marrow Donor Program; Duke University; New York Blood Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UNICANCER; Institut Paoli-Calmette (IPC)	Katz, G (corresponding author), ESSEC Business Sch, Paris, France.	katz@essec.edu	Schramm, Catherine/AAB-5104-2021	Schramm, Catherine/0000-0002-1185-8809; KATSAHIAN, Sandrine/0000-0002-7261-0671; Maiers, Martin/0000-0002-0198-2064	National Institute for Health Research [RP-PG-0310-1003] Funding Source: researchfish; Department of Health [RP-PG-0310-1003] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Allan D, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/463031; [Anonymous], 2013, WMDA ANN REPORT CORD; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Barker JN, 2010, BIOL BLOOD MARROW TR, V16, P1541, DOI 10.1016/j.bbmt.2010.08.011; Bart T, 2013, TRANSFUS MED HEMOTH, V40, P14, DOI 10.1159/000345690; Bordoni C, 2015, BONE MARROW TRANSPL, V50, P531, DOI 10.1038/bmt.2014.314; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Eapen M, 2011, LANCET ONCOL, V12, P1214, DOI 10.1016/S1470-2045(11)70260-1; El-Cheikh J, 2015, CANCER; Foeken L, 2015, CORD BLOOD STEM CELL, P279; Gragert L, 2014, NEW ENGL J MED, V371, P339, DOI 10.1056/NEJMsa1311707; Horwitz ME, 2014, J CLIN INVEST, V124, P3121, DOI 10.1172/JCI74556; Katz Benichou G, 2007, INT J HEALTHCARE TEC, V5, P464; Katz G, 2015, CORD BLOOD STEM CELL, P325; Katz G, 2010, TRANSFUS APHER SCI, V42, P307, DOI 10.1016/j.transci.2010.03.002; Lauber S, 2010, TRANSFUS MED HEMOTH, V37, P90, DOI 10.1159/000289589; Lee YH, 2013, BLOOD RES, V48, P5, DOI 10.5045/br.2013.48.1.5; Magalon J, 2014, TRANSFUSION, V54, P1046, DOI 10.1111/trf.12379; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Olson AL, 2015, CORD BLOOD CELLS CLI, P141; Page KM, 2014, TRANSFUSION, V54, P340, DOI 10.1111/trf.12257; Page KM, 2012, TRANSFUSION, V52, P272, DOI 10.1111/j.1537-2995.2011.03278.x; Querol S, 2009, HAEMATOL-HEMATOL J, V94, P536, DOI 10.3324/haematol.2008.002741; Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Schmidt AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086605; Stavropoulos-Giokas C, 2015, N CORD BLOOD STEM CE, P291; Sun JM, 2015, EMERGING USES CORD B, P167; Van der Zanden HGM, 2014, BIOL BLOOD MARROW TR, V20, P1791, DOI 10.1016/j.bbmt.2014.07.011; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	32	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143440	10.1371/journal.pone.0143440	http://dx.doi.org/10.1371/journal.pone.0143440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624279	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600029
J	Qiu, HL; Zhong, JS; Luo, L; Liu, N; Kang, K; Qu, JL; Peng, WD; Gou, DM				Qiu, Huiling; Zhong, Jiasheng; Luo, Lan; Liu, Nian; Kang, Kang; Qu, Junle; Peng, Wenda; Gou, Deming			A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition	PLOS ONE			English	Article							CELL-CYCLE; IN-VIVO; MICRORNAS; DIFFERENTIATION; PROGRESSION; ROLES	DNA vector-encoded Tough Decoy (TuD) miRNA inhibitor is attracting increased attention due to its high efficiency in miRNA suppression. The current methods used to construct TuD vectors are based on synthesizing long oligonucleotides (similar to 90 mer), which have been costly and problematic because of mutations during synthesis. In this study, we report a PCR-based method for the generation of double Tough Decoy (dTuD) vector in which only two sets of shorter oligonucleotides (<60 mer) were used. Different approaches were employed to test the inhibitory potency of dTuDs. We demonstrated that dTuD is the most efficient method in miRNA inhibition in vitro and in vivo. Using this method, a mini dTuD library against 88 human miRNAs was constructed and used for a high-throughput screening (HTS) of AP-1 pathway-related miRNAs. Seven miRNAs (miR-18b-5p, -101-3p, -148b-3p, -130b-3p, -186-3p, -187-3p and -1324) were identified as candidates involved in AP-1 pathway regulation. This novel method allows for an accurate and cost-effective generation of dTuD miRNA inhibitor, providing a powerful tool for efficient miRNA suppression in vitro and in vivo.	[Qiu, Huiling; Zhong, Jiasheng; Luo, Lan; Liu, Nian; Gou, Deming] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Guangdong, Peoples R China; [Qiu, Huiling; Qu, Junle; Peng, Wenda] Shenzhen Univ, Key Lab Optoelect Devices & Syst, Minist Educ & Guangdong Prov, Coll Optoelect Engn, Shenzhen 518060, Guangdong, Peoples R China; [Kang, Kang] Shenzhen Univ, Dept Physiol, Hlth Sci Ctr, Shenzhen 518000, Guangdong, Peoples R China	Shenzhen University; Shenzhen University; Shenzhen University	Gou, DM (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Guangdong, Peoples R China.	dmgou@szu.edu.cn		zhong, jiasheng/0000-0001-6864-2294	National Natural Science Foundation of China [81170047, 81370151]; National Basic Research Program of China 973 Program [2012CB124701]; Shenzhen Municipal Basic Research Program [JC201006010725A, JCYJ20130329120507746]; Shenzhen Overseas High-Level Talents Innovation Program [YFZZ20111009]; Shenzhen High-tech Development Project [CXZZ20140828163951592]; Ministry of Agriculture [2014ZX08009-051B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China); Shenzhen Municipal Basic Research Program; Shenzhen Overseas High-Level Talents Innovation Program; Shenzhen High-tech Development Project; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	Funding provided by National Natural Science Foundation of China 81170047 and 81370151 to DG, http://www.nsfc.gov.cn/publish/portal1/tab131/; National Basic Research Program of China 973 Program 2012CB124701 to DG, http://www.most.gov.cn/eng/index.htm; Shenzhen Municipal Basic Research Program JC201006010725A to DG, http://www.szsti.gov.cn/; Shenzhen Overseas High-Level Talents Innovation Program YFZZ20111009 to DG, http://www.szsti.gov.cn/; Shenzhen High-tech Development Project CXZZ20140828163951592 to DG, http://www.szsti.gov.cn/; Transgenic project from the Ministry of Agriculture 2014ZX08009-051B to DG, http://english.agri.gov.cn/; Shenzhen Municipal Basic Research Program JCYJ20130329120507746 to KK, http://www.szsti.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak RO, 2013, RNA, V19, P280, DOI 10.1261/rna.034850.112; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gonzalez S, 2005, MOL THER, V11, P811, DOI 10.1016/j.ymthe.2004.12.023; Gou D, 2007, PHYSIOL GENOMICS, V31, P554, DOI 10.1152/physiolgenomics.00005.2007; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Haraguchi T, 2012, NUCLEIC ACIDS RES, V40, P17; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, P17; He JQ, 2001, J BIOL CHEM, V276, P26814, DOI 10.1074/jbc.M101820200; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hollensen AK, 2013, RNA BIOL, V10, P406, DOI 10.4161/rna.23543; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Lu L, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-28; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Satoh J, 2010, J PHARMACOL SCI, V114, P269, DOI 10.1254/jphs.10R11FM; Scherr M, 2007, NUCLEIC ACIDS RES, V35, P19; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.216; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143864	10.1371/journal.pone.0143864	http://dx.doi.org/10.1371/journal.pone.0143864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624995	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600059
J	Salamon, J; Papp, L; Toth, Z; Laqmani, A; Apostolova, I; Adam, G; Mautner, VF; Derlin, T				Salamon, Johannes; Papp, Laszlo; Toth, Zoltan; Laqmani, Azien; Apostolova, Ivayla; Adam, Gerhard; Mautner, Victor F.; Derlin, Thorsten			Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT	PLOS ONE			English	Article							TOTAL LESION GLYCOLYSIS; PROGNOSTIC VALUE; PLEXIFORM NEUROFIBROMAS; CELL CARCINOMA; VOLUME; MRI; BIOMARKER; SURVIVAL	Purpose To determine the metabolically active whole-body tumor volume (WB-MTV) on F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in individuals with neurofibromatosis type 1 (NF1) using a three-dimensional (3D) segmentation and computerized volumetry technique, and to compare PET WB-MTV between patients with benign and malignant peripheral nerve sheath tumors (PNSTs). Patients and Methods Thirty-six NF1 patients (18 patients with malignant PNSTs and 18 age-and sex-matched controls with benign PNSTs) were examined by F-18-FDG PET/CT. WB-MTV, whole-body total lesion glycolysis (WB-TLG) and a set of semi-quantitative imaging-based parameters were analyzed both on a per-patient and a per-lesion basis. Results On a per-lesion basis, malignant PNSTs demonstrated both a significantly higher MTV and TLG than benign PNSTs (p < 0.0001). On a per-patient basis, WB-MTV and WB-TLG were significantly higher in patients with malignant PNSTs compared to patients with benign PNSTs (p < 0.001). ROC analysis showed that MTV and TLG could be used to differentiate between benign and malignant tumors. Conclusions WB-MTV and WB-TLG may identify malignant change and may have the potential to provide a basis for investigating molecular biomarkers that correlate with metabolically active disease manifestations. Further evaluation will determine the potential clinical impact of these PET-based parameters in NF1.	[Salamon, Johannes; Laqmani, Azien; Adam, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Papp, Laszlo] Mediso Med Imaging Syst, Budapest, Hungary; [Toth, Zoltan] Scanomed Ltd, Budapest, Hungary; [Apostolova, Ivayla] Otto Von Guericke Univ, Dept Radiol & Nucl Med, Magdeburg, Germany; [Mautner, Victor F.] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Derlin, Thorsten] Hannover Med Sch, Dept Nucl Med, Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Scanomed; Otto von Guericke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Salamon, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany.	j.salamon@uke.de	Apostolova, Ivayla/A-2518-2015; Papp, Laszlo/AFT-0975-2022	Apostolova, Ivayla/0000-0003-0290-7186; Papp, Laszlo/0000-0002-9049-9989; Derlin, Thorsten/0000-0002-8786-4105				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Benz MR, 2010, CANCER-AM CANCER SOC, V116, P451, DOI 10.1002/cncr.24755; Cai WL, 2009, RADIOLOGY, V250, P665, DOI 10.1148/radiol.2503080700; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; Derlin T, 2013, CLIN NUCL MED, V38, pE19, DOI 10.1097/RLU.0b013e318266ce84; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Evans DGR, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-17; Ferner RE, 2002, CANCER RES, V62, P1573; Hummel TR, 2010, CLIN CANCER RES, V16, P5048, DOI 10.1158/1078-0432.CCR-10-0613; Hyun SH, 2014, EUR J NUCL MED MOL I, V41, P50, DOI 10.1007/s00259-013-2530-8; Khiewvan B, 2014, EUR J NUCL MED MOL I, V41, P1756, DOI 10.1007/s00259-014-2756-0; Kluwe L, 2012, GENE CHROMOSOME CANC, V51, P447, DOI 10.1002/gcc.21931; Kolanczyk M, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-82; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Lee JW, 2014, EUR J NUCL MED MOL I, V41, P1898, DOI 10.1007/s00259-014-2803-x; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Lee SJ, 2012, KOREAN J RADIOL, V13, P752, DOI 10.3348/kjr.2012.13.6.752; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Mautner VF, 2006, NEURORADIOLOGY, V48, P160, DOI 10.1007/s00234-005-0033-4; Meany H, 2013, PEDIATR BLOOD CANCER, V60, P59, DOI 10.1002/pbc.24212; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Nguyen R, 2014, J NEURO-ONCOL, V116, P307, DOI 10.1007/s11060-013-1293-1; Oh JR, 2012, EUR J NUCL MED MOL I, V39, P925, DOI 10.1007/s00259-011-2059-7; Plotkin SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035711; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Ryu IS, 2014, EUR J NUCL MED MOL I, V41, P452, DOI 10.1007/s00259-013-2571-z; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Smith MJ, 2013, CLIN BIOCHEM, V46, P698, DOI 10.1016/j.clinbiochem.2012.12.007; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Urban T, 2014, CLIN NUCL MED, V39, pE301, DOI 10.1097/RLU.0b013e3182a757d3; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; Yoon HJ, 2013, ANN NUCL MED, V27, P748, DOI 10.1007/s12149-013-0742-4; Zsoter N, 2012, IEEE ENG MED BIO, P4974, DOI 10.1109/EMBC.2012.6347109	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143305	10.1371/journal.pone.0143305	http://dx.doi.org/10.1371/journal.pone.0143305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625155	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600025
J	Bajpai, R; Matulis, SM; Wei, C; Nooka, AK; Von Hollen, HE; Lonial, S; Boise, LH; Shanmugam, M				Bajpai, R.; Matulis, S. M.; Wei, C.; Nooka, A. K.; Von Hollen, H. E.; Lonial, S.; Boise, L. H.; Shanmugam, M.			Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax	ONCOGENE			English	Article							ANTITUMOR-ACTIVITY; CELL-SURVIVAL; MCL-1; INHIBITOR; APOPTOSIS; EXPRESSION; DEPENDENCE; RITONAVIR; ABT-199; POTENT	Multiple myeloma (MM) is a plasma cell malignancy that is largely incurable due to development of resistance to therapy-elicited cell death. Nutrients are intricately connected to maintenance of cellular viability in part by inhibition of apoptosis. We were interested to determine if examination of metabolic regulation of BCL-2 proteins may provide insight on alternative routes to engage apoptosis. MM cells are reliant on glucose and glutamine and withdrawal of either nutrient is associated with varying levels of apoptosis. We and others have demonstrated that glucose maintains levels of key resistance-promoting BCL-2 family member, myeloid cell leukemic factor 1 (MCL-1). Cells continuing to survive in the absence of glucose or glutamine were found to maintain expression of MCL-1 but importantly induce pro-apoptotic BIM expression. One potential mechanism for continued survival despite induction of BIM could be due to binding and sequestration of BIM to alternate pro-survival BCL-2 members. Our investigation revealed that cells surviving glutamine withdrawal in particular, enhance expression and binding of BIM to BCL-2, consequently sensitizing these cells to the BH3 mimetic venetoclax. Glutamine deprivation-driven sensitization to venetoclax can be reversed by metabolic supplementation with TCA cycle intermediate alpha-ketoglutarate. Inhibition of glucose metabolism with the GLUT4 inhibitor ritonavir elicits variable cytotoxicity in MM that is marginally enhanced with venetoclax treatment, however, targeting glutamine metabolism with 6-diazo-5-oxo-L-norleucine uniformly sensitized MM cell lines and relapse/refractory patient samples to venetoclax. Our studies reveal a potent therapeutic strategy of metabolically driven synthetic lethality involving targeting glutamine metabolism for sensitization to venetoclax in MM.	[Bajpai, R.; Matulis, S. M.; Wei, C.; Nooka, A. K.; Von Hollen, H. E.; Lonial, S.; Boise, L. H.; Shanmugam, M.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Shanmugam, M (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	mala.shan@emory.edu	Shanmugam, Mala/M-6491-2019; Boise, Lawrence/AAD-2314-2019; Bajpai, Richa/H-6404-2019	Shanmugam, Mala/0000-0002-4415-8083; Boise, Lawrence/0000-0001-9436-8815	American Cancer Society Research scholar grant [RSG-11-254-01-CSM]; TJ Martell Foundation;  [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER	American Cancer Society Research scholar grant(American Cancer Society); TJ Martell Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the American Cancer Society Research scholar grant (RSG-11-254-01-CSM) to MS. LHB is a Georgia Research Alliance distinguished cancer scientist and also received support from the TJ Martell Foundation and P30CA138292.	Accardi F, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.2067.2067; Barlogie B, 2014, BLOOD, V124, P3043, DOI 10.1182/blood-2014-07-552059; Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Dalva-Aydemir S, 2015, CLIN CANCER RES, V21, P1161, DOI 10.1158/1078-0432.CCR-14-1088; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Eguchi T, 2009, MOL CANCER THER, V8, P1460, DOI 10.1158/1535-7163.MCT-08-1159; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Liu ZQ, 2014, BLOOD, V124, P2061, DOI 10.1182/blood-2014-03-557298; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Mishra RK, 2015, J BIOL CHEM, V290, P14441, DOI 10.1074/jbc.M114.628826; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Olsen RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116998; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pepper C, 1997, BRIT J CANCER, V76, P935, DOI 10.1038/bjc.1997.487; Podar K, 2008, ONCOGENE, V27, P721, DOI 10.1038/sj.onc.1210679; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Prideaux Steven M, 2014, Adv Hematol, V2014, P864058, DOI 10.1155/2014/864058; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; ROBERTS RS, 1976, J CELL SCI, V21, P609; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646; SHAPIRO RA, 1979, J BIOL CHEM, V254, P2835; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Touzeau C, 2014, LEUKEMIA, V28, P210, DOI 10.1038/leu.2013.216; Tuffy LP, 2010, MOL CELL BIOL, V30, P5484, DOI 10.1128/MCB.00575-10; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vyas AK, 2010, J BIOL CHEM, V285, P36395, DOI 10.1074/jbc.M110.176321; Wensveen FM, 2010, IMMUNITY, V32, P754, DOI 10.1016/j.immuni.2010.06.005; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	49	58	60	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3955	3964		10.1038/onc.2015.464	http://dx.doi.org/10.1038/onc.2015.464			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26640142	Green Accepted			2022-12-26	WOS:000381013100007
J	Valente, LJ; Grabow, S; Vandenberg, CJ; Strasser, A; Janic, A				Valente, L. J.; Grabow, S.; Vandenberg, C. J.; Strasser, A.; Janic, A.			Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53	ONCOGENE			English	Article							CELL-CYCLE ARREST; TUMOR SUPPRESSION; TRANSGENIC MICE; P21(WAF1/CIP1); GENE; MUTATIONS; P27(KIP1); ABSENCE; CANCER; DELAYS	The tumor suppressor p53 is mutated in similar to 50% of human cancers. P53 is activated by a range of stimuli and regulates several cellular processes, including apoptotic cell death, cell cycle arrest, senescence and DNA repair. P53 induces apoptosis via transcriptional induction of the BH3-only proteins PUMA (p53-upregulated modulator of apoptosis) and NOXA, and cell cycle arrest via p21. Induction of these processes was proposed to be critical for p53-mediated tumor suppression. It is therefore surprising that mice lacking PUMA, NOXA and p21, as well as mice bearing mutations in p53 that impair the transcriptional activation of these genes, are not tumor prone, unlike mice lacking p53 function, which spontaneously develop tumors with 100% incidence. These p53 target genes and the processes they regulate may, however, impact differently on tumor development depending on the oncogenic drivers. For example, loss of PUMA enhances c-MYC-driven lymphoma development in mice, but, interestingly, the acceleration was less impressive compared with that caused by the loss of even a single p53 allele. Different studies have reported that loss of p21 can accelerate, delay or have no impact on tumorigenesis. In an attempt to resolve this controversy, we examined whether loss of p21-mediated cell cycle arrest cooperates with PUMA deficiency in accelerating lymphoma development in E mu-Myc mice (overexpressing c-MYC in B-lymphoid cells). We found that E mu-Myc mice lacking both p21 and PUMA (E mu-Myc; Puma(-/-); p21(-/-)) developed lymphoma at a rate comparable to E mu-Myc; Puma(-/-) animals, notably with considerably longer latency than E mu-Myc; p53(+/-) mice. Loss of p21 had no impact on the numbers, cycling or survival of pre-leukemic E mu-Myc B-lymphoid cells, even when PUMA was lost concomitantly. These results demonstrate that even in the context of deregulated c-MYC expression, p53 must suppress tumor development by activating processes apart from, or in addition to, PUMA-mediated apoptosis and p21-induced cell cycle arrest.	[Valente, L. J.; Grabow, S.; Vandenberg, C. J.; Strasser, A.; Janic, A.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, 1G Royal Parade, Melbourne, Vic 3052, Australia; [Valente, L. J.; Grabow, S.; Vandenberg, C. J.; Strasser, A.; Janic, A.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Valente, L. J.] Stanford Univ, Dept Radiat Oncol, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA	University of Melbourne; Stanford University	Strasser, A; Janic, A (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, 1G Royal Parade, Melbourne, Vic 3052, Australia.	strasser@wehi.edu.au; janic@wehi.edu.au	Janic, Ana/AAR-4783-2020; Strasser, Andreas/C-7581-2013	Janic, Ana/0000-0002-4200-2560; Strasser, Andreas/0000-0002-5020-4891; Valente, Liz J/0000-0002-5591-7700; Grabow, Stephanie/0000-0003-0467-7871	Cancer Council of Victoria; Leukaemia Foundation Australia; Lady Tata Memorial Trust Research Award; Leukemia & Lymphoma Society of America; Beatriu de Pinos Foundation; Cancer Australia; Cure Cancer Australia Foundation [1067571]; National Health and Medical Research Council (NHMRC) [1016701, 1020363]; Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR)) [7001-13]; Australian Government Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS); Victorian State Government Operational Infrastructure Support (OIS)	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation Australia; Lady Tata Memorial Trust Research Award; Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Beatriu de Pinos Foundation; Cancer Australia; Cure Cancer Australia Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR)); Australian Government Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS)(Australian Government); Victorian State Government Operational Infrastructure Support (OIS)	The authors thank Drs GL Kelly, ARD Delbridge, BJ Aubrey, S Cory and JM Adams for discussions and gifts of mice; K Walker, J Mansheim, C Gatt, G Siciliano and S O'Connor for expert animal care; B Helbert, H Ierino, K Mackwell and C Young for help with genotyping; J Corbin and J McManus for automated blood cell analysis. This work was supported by a PhD scholarship and Postdoctoral Fellowships from the Cancer Council of Victoria to SG and LV, by Postdoctoral Fellowships from the Leukaemia Foundation Australia to SG, from the Lady Tata Memorial Trust Research Award to AJ and SG, from the Leukemia & Lymphoma Society of America and the Beatriu de Pinos Foundation to AJ and by grants from Cancer Australia and Cure Cancer Australia Foundation (grant no. 1067571), the National Health and Medical Research Council (NHMRC; program grant no. 1016701, NHMRC Senior Principal Research Fellow (SPRF) Fellowship 1020363 to AS) and the Leukemia & Lymphoma Society of America (Specialized Center of Research (SCOR) grant no. 7001-13). This work was made possible by operational infrastructure grants through the Australian Government Independent Medical Research Institutes Infrastructure Support Scheme (IRIISS) and the Victorian State Government Operational Infrastructure Support (OIS).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Bearss DJ, 2002, CANCER RES, V62, P2077; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson RJ, 2002, ONCOGENE, V21, P8486, DOI 10.1038/sj.onc.1205946; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang DD, 2011, P NATL ACAD SCI USA, V108, P17123, DOI 10.1073/pnas.1111245108; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; McKenzie KE, 1997, CLIN CANCER RES, V3, P1669; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Newbold A, 2014, ONCOGENE, V33, P5415, DOI 10.1038/onc.2013.482; Patino-Garcia A, 1998, PEDIATR RES, V43, P393, DOI 10.1203/00006450-199803000-00014; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 1996, EMBO J, V15, P3823, DOI 10.1002/j.1460-2075.1996.tb00756.x; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590; Yang WC, 2001, CANCER RES, V61, P565; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	46	24	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3866	3871		10.1038/onc.2015.457	http://dx.doi.org/10.1038/onc.2015.457			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26640149				2022-12-26	WOS:000380753200011
J	Zheng, T; Jiang, P; Cao, B; Cheng, QX; Kong, LX; Zheng, XQ; Hu, QH; You, DL				Zheng, Tao; Jiang, Pan; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; Hu, Qinghai; You, Delin			DndEi Exhibits Helicase Activity Essential for DNA Phosphorothioate Modification and ATPase Activity Strongly Stimulated by DNA Substrate with a GAAC/GTTC Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-LIVIDANS; RESTRICTION SYSTEM; S-MODIFICATION; IN-VITRO; SALMONELLA; BACTERIA; MECHANISM; BACKBONE; PROTEIN; SULFUR	Phosphorothioate (PT) modification of DNA, in which the non-bridging oxygen of the backbone phosphate group is replaced by sulfur, is governed by the DndA-E proteins in prokaryotes. To better understand the biochemical mechanism of PT modification, functional analysis of the recently found PT-modifying enzyme DndEi, which has an additional domain compared with canonical DndE, from Riemerella anatipestifer is performed in this study. The additional domain is identified as a DNA helicase, and functional deletion of this domain in vivo leads to PT modification deficiency, indicating an essential role of helicase activity in PT modification. Subsequent analysis reveals that the additional domain has an ATPase activity. Intriguingly, the ATPase activity is strongly stimulated by DNA substrate containing a GAAC/GTTC motif (i.e. the motif at which PT modifications occur in R. anatipestifer) when the additional domain and the other domain (homologous to canonical DndE) are co-expressed as a full-length DndEi. These results reveal that PT modification is a biochemical process with DNA strand separation and intense ATP hydrolysis.	[Zheng, Tao; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zheng, Tao; Cao, Bo; Cheng, Qiuxiang; Kong, Lingxin; Zheng, Xiaoqing; You, Delin] Chinese Acad Agr Sci, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Jiang, Pan; Hu, Qinghai] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200240, Peoples R China; [You, Delin] Shanghai Jiao Tong Univ, Joint Int Res Lab Metab & Dev Sci, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Shanghai Jiao Tong University	Hu, QH (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200240, Peoples R China.	huqinghai@caas.cn; dlyou@sjtu.edu.cn		Cao, Bo/0000-0002-7011-1676	National Natural Science Foundation of China [30570400, 31170085, 31070058, 31470183, 31472224, 31272590, 31400029]; Ministry of Science and Technology [2006AA02Z224, 2012CB721004, 2009ZX09501-008]; Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality [12PJD021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality	This work was supported by grants from the National Natural Science Foundation of China (30570400, 31170085, 31070058, 31470183, 31472224, 31272590, and 31400029), the Ministry of Science and Technology (2006AA02Z224, 2012CB721004, and 2009ZX09501-008), and the Shanghai Pujiang Program from the Science and Technology Commission of Shanghai Municipality (12PJD021). The authors declare that they have no conflicts of interest with the contents of this article.	An XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051265; Barbier P, 2013, FEMS MICROBIOL LETT, V348, P26, DOI 10.1111/1574-6968.12239; Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Cao B, 2015, SCI REP-UK, V5, DOI 10.1038/srep12513; Cao B, 2014, MOL MICROBIOL, V93, P776, DOI 10.1111/mmi.12692; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Cheng QX, 2015, MOL MICROBIOL, V97, P1186, DOI 10.1111/mmi.13096; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; Eckstein F, 2007, NAT CHEM BIOL, V3, P689, DOI 10.1038/nchembio1107-689; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Hu QH, 2013, J MICROBIOL METH, V95, P262, DOI 10.1016/j.mimet.2013.09.011; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu W, 2012, CELL RES, V22, P1203, DOI 10.1038/cr.2012.66; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tani H, 2010, BIOCHEM BIOPH RES CO, V393, P131, DOI 10.1016/j.bbrc.2010.01.100; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1849, DOI 10.1111/j.1432-1033.2004.04094.x; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; Yao F, 2009, FEBS LETT, V583, P729, DOI 10.1016/j.febslet.2009.01.029; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	31	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1492	1500		10.1074/jbc.M115.694018	http://dx.doi.org/10.1074/jbc.M115.694018			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631733	hybrid, Green Published			2022-12-26	WOS:000368068300039
J	Wu, B; Zheng, JX; Zhou, M; Xi, XH; Wang, Q; Hua, J; Hu, XF; Liu, JQ				Wu, Bin; Zheng, Jinxia; Zhou, Ming; Xi, Xiaohong; Wang, Qin; Hua, Jing; Hu, Xuefeng; Liu, Jiang-Qin			Improvement of Expressed Breast Milk in Mothers of Preterm Infants by Recording Breast Milk Pumping Diaries in a Neonatal Center in China	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; TRIAL	Objectives Because inadequate expression of human milk (EBM) in mothers of hospitalized infants were noticed in a neonatal center of our hospital, family education program was carried out to increase the EBM. Methods A breast milk pumping diary was introduced to the mothers with preterm infant(s) admitted in the NICU. The ratios of EBM (days of EBM to NICU/hospitalized days), breast milk feeding (BMF) (days of infants fed with exclusive human milk/hospitalized days), mixed feeding (MF) (days of infants fed with partial breast milk and partial formula/hospitalized days), and formula feeding (FF) (days of infants fed with preterm formula/hospitalized days) were evaluated. Results During January to April, 2014, the ratios of EBM to the NICU, BMF, MF and FF were 28.11%, 6.6%, 32.8% and 60.6%, respectively. After the introduction of breast milk pumping diary to the mothers from May 2014, the ratio of EBM to the NICU increased significantly to 53.3% (p<0.01) within the following eight months. Both the ratios of BMF and MF also rose to 23.8% and MF 55.3%, respectively. Consequently, the ratio of FF was reduced to 20.9%. Exclusive breast milk feeding also significantly reduce the duration of nil per oral (NPO) of the very low birth weight infants during hospital stay as compared to those fed with mixed feeding and formula feeding. Conclusion The introduction of a breast milk pumping diary was associated with a significant increase in the intake of EBM of the hospitalized preterm newborns.	[Wu, Bin; Zheng, Jinxia; Zhou, Ming; Xi, Xiaohong; Wang, Qin; Hu, Xuefeng; Liu, Jiang-Qin] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China; [Hua, Jing] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Maternal & Child Hlth, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Liu, JQ (corresponding author), Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Neonatol, Shanghai 200092, Peoples R China.	jiangqinliu@yahoo.com						Acuna-Muga J, 2014, J HUM LACT, V30, P41, DOI 10.1177/0890334413509140; Arslanoglu S, 2013, J PERINAT MED, V41, P129, DOI 10.1515/jpm-2012-0196; Boucher CA, 2011, NEONATAL NETW, V30, P21, DOI 10.1891/0730-0832.30.1.21; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Dougherty D, 2008, NEONATAL NETW, V27, P371, DOI 10.1891/0730-0832.27.6.371; Flacking R, 2006, SOC SCI MED, V62, P70, DOI 10.1016/j.socscimed.2005.05.026; Flaherman VJ, 2013, PEDIATR CLIN N AM, V60, P227, DOI 10.1016/j.pcl.2012.10.003; Furman L, 2003, ARCH PEDIAT ADOL MED, V157, P66, DOI 10.1001/archpedi.157.1.66; Hill P D, 2001, J Hum Lact, V17, P9, DOI 10.1177/089033440101700103; Hill PD, 2005, J HUM LACT, V21, P22, DOI 10.1177/0890334404272407; Hylander M A, 2001, J Perinatol, V21, P356, DOI 10.1038/sj.jp.7210548; Jones E, 2001, ARCH DIS CHILD-FETAL, V85, pF91, DOI 10.1136/fn.85.2.F91; Jones E, 2007, ARCH DIS CHILD-FETAL, V92, P236, DOI 10.1136/adc.2006.100941; Josephson CD, 2014, JAMA PEDIATR, V168, P1054, DOI 10.1001/jamapediatrics.2014.1360; Kavanaugh K, 1997, J Hum Lact, V13, P15, DOI 10.1177/089033449701300111; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Meier PP, 2007, NEOREVIEWS, V8, P467, DOI DOI 10.1542/NEO.8-11-E467; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Sweet L, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-30; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382	22	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144123	10.1371/journal.pone.0144123	http://dx.doi.org/10.1371/journal.pone.0144123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637118	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800043
J	Chu, YW; Liu, ST; Cheng, HC; Huang, SM; Chang, YL; Chiang, CP; Liu, YC; Wang, WM				Chu, Yu-Wen; Liu, Shu-Ting; Cheng, Hsiao-Chun; Huang, Shih-Ming; Chang, Yung-Lung; Chiang, Chien-Ping; Liu, Ying-Chun; Wang, Wei-Ming			Opposing Effects of Zac1 and Curcumin on AP-1-Regulated Expressions of S100A7	PLOS ONE			English	Article							NF-KAPPA-B; PSORIASIN S100A7; GENE-EXPRESSION; EPIDERMAL DIFFERENTIATION; ATOPIC-DERMATITIS; PROTEIN PSORIASIN; PHORBOL ESTER; AP-1; SKIN; TRANSCRIPTION	ZAC, an encoding gene mapped at chromosome 6q24-q25 within PSORS1, was previously found over-expressed in the lower compartment of the hyperplastic epidermis in psoriatic lesions. Cytokines produced in the inflammatory dermatoses may drive AP-1 transcription factor to induce responsive gene expressions. We demonstrated that mZac1 can enhance AP-1-responsive S100A7 expression of which the encoding gene was located in PSORS4 with HaCaT keratinocytes. However, the mZac1-enhanced AP-1 transcriptional activity was suppressed by curcumin, indicating the anti-inflammatory property of this botanical agent and is exhibited by blocking the AP-1-mediated cross-talk between PSORS1 and PSORS4. Two putative AP-1-binding sites were found and demonstrated to be functionally important in the regulation of S100A7 promoter activity. Moreover, we found curcumin reduced the DNA-binding activity of AP-1 to the recognition element located in the S100A7 promoter. The S100A7 expression was found to be upregulated in the lesioned epidermis of atopic dermatitis and psoriasis, which is where this keratinocyte-derived chemoattractant engaged in the pro-inflammatory feedback loop. Understanding the regulatory mechanism of S100A7 expression will be helpful to develop therapeutic strategies for chronic inflammatory dermatoses via blocking the reciprocal stimuli between the inflammatory cells and keratinocytes.	[Chu, Yu-Wen; Wang, Wei-Ming] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chu, Yu-Wen] Taichung Vet Gen Hosp, Dept Pharm, Taichung, Taiwan; [Liu, Shu-Ting; Cheng, Hsiao-Chun; Huang, Shih-Ming; Chang, Yung-Lung; Chiang, Chien-Ping; Wang, Wei-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Liu, Ying-Chun] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Liu, Ying-Chun] Natl Yang Ming Univ, Sch Nursing, Taipei 112, Taiwan; [Chiang, Chien-Ping; Wang, Wei-Ming] Triserv Gen Hosp, Dept Dermatol, Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center; Taichung Veterans General Hospital; National Defense Medical Center; National Defense Medical Center; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Huang, SM (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan.	shihming@ndmctsgh.edu.tw; ades0431@ms38.hinet.net			National Science Council [NSC 99-2314-B-016-005-MY3, NSC 102-2314-B-016-011-MY2, MOST 104-2314-B-016-031-MY3]; Tri-Service General Hospital, Taiwan, ROC [TSGH-C103-040]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan, ROC	This work was supported by grants from the National Science Council [NSC 99-2314-B-016-005-MY3, NSC 102-2314-B-016-011-MY2 and MOST 104-2314-B-016-031-MY3 to W-M Wang] and the Tri-Service General Hospital [TSGH-C103-040 to W-M Wang], Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript in this revision version.	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Albanesi C, 2010, CURR OPIN ALLERGY CL, V10, P452, DOI 10.1097/ACI.0b013e32833e08ae; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Basyuk E, 2005, MOL CANCER RES, V3, P483, DOI 10.1158/1541-7786.MCR-05-0019; Buchau AS, 2007, CLIN DERMATOL, V25, P616, DOI 10.1016/j.clindermatol.2007.08.016; CELIS JE, 1990, ELECTROPHORESIS, V11, P242, DOI 10.1002/elps.1150110308; Chand S, 2012, CURR PHARM DESIGN, V18, P4725, DOI 10.2174/138161212802651625; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eckert RL, 2006, J INVEST DERMATOL, V126, P1442, DOI 10.1038/sj.jid.5700265; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glaser R, 2011, J DTSCH DERMATOL GES, V9, P897, DOI [10.1111/j.1610-0387.2011.07683.x, 10.1111/j.1610-0387.2011.07718_suppl.x]; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gross SR, 2014, CELL MOL LIFE SCI, V71, P1551, DOI 10.1007/s00018-013-1400-7; Guilloteau K, 2010, J IMMUNOL; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hegyi Z, 2012, J INVEST DERMATOL, V132, P1416, DOI 10.1038/jid.2011.486; Hsu L, 2014, BRIT J DERMATOL, V170, P261, DOI 10.1111/bjd.12654; Jullien D, 2006, J EUR ACAD DERMATOL, V20, P42, DOI 10.1111/j.1468-3083.2006.01772.x; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Kurd SK, 2008, J AM ACAD DERMATOL, V58, P625, DOI 10.1016/j.jaad.2007.12.035; Liang Y, 2014, EUR J IMMUNOL, V44, P1265, DOI 10.1002/eji.201344369; Liu PY, 2011, EXP CELL RES, V317, P2925, DOI 10.1016/j.yexcr.2011.09.018; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Lynch M, 2014, EXPERT REV CLIN IMMU, V10, P269, DOI 10.1586/1744666X.2014.873701; Ma H, 1999, MOL CELL BIOL, V19, P6164; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Michalek M, 2009, DEV COMP IMMUNOL, V33, P740, DOI 10.1016/j.dci.2008.12.005; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nickoloff BJ, 2006, TRENDS MOL MED, V12, P102, DOI 10.1016/j.molmed.2006.01.001; Oh IY, 2014, J INVEST DERMATOL, V134, P2371, DOI 10.1038/jid.2014.44; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; Semprini S, 1999, HUM GENET, V104, P130, DOI 10.1007/s004390050925; Sun WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092927; Surh YJ, 2000, BIOFACTORS, V12, P107, DOI 10.1002/biof.5520120117; Tsuchisaka A, 2014, J INVEST DERMATOL, V134, P1194, DOI 10.1038/jid.2014.15; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Wang WM, 2011, DERMATOL SIN, V29, P115, DOI 10.1016/j.dsi.2011.09.001; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; Wang WM, 2011, BBA-MOL CELL RES, V1813, P2050, DOI 10.1016/j.bbamcr.2011.08.005; Watson PH, 1998, INT J BIOCHEM CELL B, V30, P567, DOI 10.1016/S1357-2725(97)00066-6; West NR, 2010, ONCOGENE, V29, P2083, DOI 10.1038/onc.2009.488; Wolf R, 2006, J INVEST DERMATOL, V126, P1600, DOI 10.1038/sj.jid.5700210; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Zhao W, 1997, J VIROL, V71, P8832, DOI 10.1128/JVI.71.11.8832-8840.1997; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144175	10.1371/journal.pone.0144175	http://dx.doi.org/10.1371/journal.pone.0144175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633653	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000067
J	Silva, DN; Duplessis, S; Talhinhas, P; Azinheira, H; Paulo, OS; Batista, D				Silva, Diogo N.; Duplessis, Sebastien; Talhinhas, Pedro; Azinheira, Helena; Paulo, Octavio S.; Batista, Dora			Genomic Patterns of Positive Selection at the Origin of Rust Fungi	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; PATHOGENIC FUNGUS; NATURAL-SELECTION; MODEL; EVOLUTION; ADAPTATION; ALIGNMENT; VIRULENCE; OBLIGATE; SEQUENCE	Understanding the origin and evolution of pathogenicity and biotrophic life-style of rust fungi has remained a conundrum for decades. Research on the molecular mechanisms responsible for rust fungi evolution has been hampered by their biotrophic life-style until the sequencing of some rust fungi genomes. With the availability of multiple whole genomes and EST data for this group, it is now possible to employ genome-wide surveys and investigate how natural selection shaped their evolution. In this work, we employed a phylogenomics approach to search for positive selection and genes undergoing accelerated evolution at the origin of rust fungi on an assembly of single copy genes conserved across a broad range of basidiomycetes. Up to 985 genes were screened for positive selection on the phylogenetic branch leading to rusts, revealing a pervasive signal of positive selection throughout the data set with the proportion of positively selected genes ranging between 19.6-33.3%. Additionally, 30 genes were found to be under accelerated evolution at the origin of rust fungi, probably due to a mixture of positive selection and relaxation of purifying selection. Functional annotation of the positively selected genes revealed an enrichment in genes involved in the biosynthesis of secondary metabolites and several metabolism and transporter classes.	[Silva, Diogo N.; Talhinhas, Pedro; Azinheira, Helena; Batista, Dora] Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal; [Silva, Diogo N.; Paulo, Octavio S.; Batista, Dora] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, CE3c Ctr Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Silva, Diogo N.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Silva, Diogo N.] Univ Aveiro, CESAM Centro Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Duplessis, Sebastien] Univ Lorraine Interact Arbres Microorganismes, INRA, UMR 1136, Champenoux, France; [Duplessis, Sebastien] Univ Lorraine Interact Arbres Microorganismes, INRA, Univ Lorraine, UMR 1136, Vandoeuvre Les Nancy, France; [Talhinhas, Pedro; Azinheira, Helena] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, LEAF, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; INRAE; Universite de Lorraine; INRAE; Universite de Lorraine; Universidade de Lisboa	Silva, DN (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Invest Ferrugens Cafeeiro, Oeiras, Portugal.	o.diogosilva@gmail.com	Paulo, Octávio/D-9921-2011; , DUPLESSIS/G-4150-2011; Azinheira, Helena/ADX-1184-2022; Batista, Dora/N-7385-2013	Paulo, Octávio/0000-0001-5408-5212; , DUPLESSIS/0000-0002-2072-2989; Azinheira, Helena/0000-0002-9007-0082; Batista, Dora/0000-0003-4031-8999; Silva, Diogo/0000-0002-6827-2673	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/AGR-GPL/119943/2010]; FCT [UID/BIA/00329/2013, SFRH/BD/86736/2012, SFRH/BPD/88994/2012, SFRH/BPD/104629/2014]; Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR))	The project was funded by project grant PTDC/AGR-GPL/119943/2010 from the Fundacao para a Ciencia e Tecnologia (FCT) (http://www.fct.pt/) and by FCT Unit funding UID/BIA/00329/2013. DNS acknowledges the FCT grant SFRH/BD/86736/2012. SD acknowledges the Agence Nationele de la Recherche (France) "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). PT acknowledges the FCT grant SFRH/BPD/88994/2012. DB acknowledges the FCT grant SFRH/BPD/104629/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; Aguileta G, 2012, INFECT GENET EVOL, V12, P987, DOI 10.1016/j.meegid.2012.02.012; Aguileta G, 2009, INFECT GENET EVOL, V9, P656, DOI 10.1016/j.meegid.2009.03.010; Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Aime M. Catherine, 2006, Mycoscience, V47, P112, DOI 10.1007/s10267-006-0281-0; Anisimova M, 2007, HEREDITY, V99, P567, DOI 10.1038/sj.hdy.6801052; Bailey A, 2000, J BIOL CHEM, V275, P14242, DOI 10.1074/jbc.275.19.14242; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Benner Steven A., 2007, V75, P1; Cantu Dario, 2013, BMC Genomics, V14, P270, DOI 10.1186/1471-2164-14-270; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fernandez D, 2013, MYCOTA; Goldstein AL, 2001, GENETICS, V159, P499; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jordan G, 2012, MOL BIOL EVOL, V29, P1125, DOI 10.1093/molbev/msr272; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lee CM, 2004, MOL MICROBIOL, V51, P691, DOI 10.1111/j.1365-2958.2003.03879.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebmann B, 2004, ARCH MICROBIOL, V181, P378, DOI 10.1007/s00203-004-0667-3; Link T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00587; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Maier W, 2007, MYCOL RES, V111, P176, DOI 10.1016/j.mycres.2006.11.005; Maor BP, 2004, BIOCHEM J, V381, P131, DOI 10.1042/BJ20031075; Miller M.A., 2010, P GAT COMP ENV WORKS; Nemri A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00098; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Pendleton AL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00299; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Roux J, 2014, MOL BIOL EVOL, V31, P1661, DOI 10.1093/molbev/msu141; RUIZHERRERA J, 1994, CRIT REV MICROBIOL, V20, P143, DOI 10.3109/10408419409113553; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Spanu PD, 2012, ANNU REV PHYTOPATHOL, V50, P91, DOI 10.1146/annurev-phyto-081211-173024; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Staples RC, 2000, ANNU REV PHYTOPATHOL, V38, P49, DOI 10.1146/annurev.phyto.38.1.49; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talhinhas P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00088; Tellier A, 2014, EVOLUTION, V68, P2211, DOI 10.1111/evo.12427; Valdes-Santiago Laura, 2012, J Amino Acids, V2012, P837932, DOI 10.1155/2012/837932; Valdes-Santiago L, 2012, MICROBIOL-SGM, V158, P674, DOI 10.1099/mic.0.055954-0; Valle M, 2014, BIOINFORMATICS, V30, P1129, DOI 10.1093/bioinformatics/btt760; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Van der Merwe MM, 2009, P ROY SOC B-BIOL SCI, V276, P2913, DOI 10.1098/rspb.2009.0328; Van Dongen S.M., 2000, THESIS UTRECHT U; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Wang XX, 2004, HUM MOL GENET, V13, P2671, DOI 10.1093/hmg/ddh289; Wang Y, 2013, PLANT J, V76, P557, DOI 10.1111/tpj.12313; Wei RX, 2011, J INTEGR PLANT BIOL, V53, P682, DOI 10.1111/j.1744-7909.2011.01058.x; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xiao JH, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r141; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064642	74	9	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143959	10.1371/journal.pone.0143959	http://dx.doi.org/10.1371/journal.pone.0143959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632820	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000035
J	Stockley, J; Nisar, SP; Leo, VC; Sabi, E; Cunningham, MR; Eikenboom, JC; Lethagen, S; Schneppenheim, R; Goodeve, AC; Watson, SP; Mundell, SJ; Daly, ME				Stockley, Jacqueline; Nisar, Shaista P.; Leo, Vincenzo C.; Sabi, Essa; Cunningham, Margaret R.; Eikenboom, Jeroen C.; Lethagen, Stefan; Schneppenheim, Reinhard; Goodeve, Anne C.; Watson, Steve P.; Mundell, Stuart J.; Daly, Martina E.		GAPP Study; MCMDM-1VWD Study Gp	Identification and Characterization of Novel Variations in Platelet G-Protein Coupled Receptor (GPCR) Genes in Patients Historically Diagnosed with Type 1 von Willebrand Disease	PLOS ONE			English	Article							THROMBOXANE A(2) RECEPTOR; VARIANT; MUTATION; DYSFUNCTION; HEMOSTASIS; ACTIVATION; MCMDM-1VWD; GENOTYPE; FAMILIES; DENSITY	The clinical expression of type 1 von Willebrand disease may be modified by co-inheritance of other mild bleeding diatheses. We previously showed that mutations in the platelet P2Y12 ADP receptor gene (P2RY12) could contribute to the bleeding phenotype in patients with type 1 von Willebrand disease. Here we investigated whether variations in platelet G protein-coupled receptor genes other than P2RY12 also contributed to the bleeding phenotype. Platelet G protein-coupled receptor genes P2RY1, F2R, F2RL3, TBXA2R and PTGIR were sequenced in 146 index cases with type 1 von Willebrand disease and the potential effects of identified single nucleotide variations were assessed using in silico methods and heterologous expression analysis. Seven heterozygous single nucleotide variations were identified in 8 index cases. Two single nucleotide variations were detected in F2R; a novel c.-67G> C transversion which reduced F2R transcriptional activity and a rare c. 1063C> T transition predicting a p. L355F substitution which did not interfere with PAR1 expression or signalling. Two synonymous single nucleotide variations were identified in F2RL3 (c. 402C> G, p. A134 =; c. 1029 G> C p. V343 =), both of which introduced less commonly used codons and were predicted to be deleterious, though neither of them affected PAR4 receptor expression. A third single nucleotide variation in F2RL3 (c. 65 C> A; p. T22N) was co-inherited with a synonymous single nucleotide variation in TBXA2R (c. 6680 C> T, p. S218 =). Expression and signalling of the p. T22N PAR4 variant was similar to wild-type, while the TBXA2R variation introduced a cryptic splice site that was predicted to cause premature termination of protein translation. The enrichment of single nucleotide variations in G protein-coupled receptor genes among type 1 von Willebrand disease patients supports the view of type 1 von Willebrand disease as a polygenic disorder.	[Stockley, Jacqueline; Leo, Vincenzo C.; Sabi, Essa; Goodeve, Anne C.; Daly, Martina E.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Nisar, Shaista P.; Cunningham, Margaret R.; Mundell, Stuart J.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Eikenboom, Jeroen C.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Lethagen, Stefan] Rigshosp, Univ Hosp, Natl Haemophilia Ctr, DK-2100 Copenhagen, Denmark; [Schneppenheim, Reinhard] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Watson, Steve P.] Univ Birmingham, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Sheffield; University of Bristol; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rigshospitalet; University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Birmingham	Daly, ME (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	m.daly@sheffield.ac.uk	Eikenboom, Jeroen/F-9156-2018; Tosetto, Alberto/AAM-3200-2020; Watson, Stephen P/Q-6292-2016	Eikenboom, Jeroen/0000-0002-3268-5759; Tosetto, Alberto/0000-0002-0119-5204; Watson, Stephen P/0000-0002-7846-7423; Stockley, Jacqueline/0000-0001-6601-5107; Cunningham, Margaret/0000-0001-6454-8671	British Heart Foundation [RG/09/007/27917]; European Community under the Fifth Framework Programme [QLG1-CT-2000-00387]; British Heart Foundation [FS/11/49/28751] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Community under the Fifth Framework Programme; British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation, www.bhf.org.uk/ (RG/09/007/27917). SPW holds a BHF Chair. The MCMDM-1VWD study was supported by the European Community under the Fifth Framework Programme (QLG1-CT-2000-00387).	Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cumming A, 2006, THROMB HAEMOSTASIS, V96, P630, DOI 10.1160/TH06-07-0383; Cunningham MR, 2012, J BIOL CHEM, V287, P16656, DOI 10.1074/jbc.M111.315911; Daly ME, 2009, BLOOD, V113, P4110, DOI 10.1182/blood-2008-11-190850; Dupont A, 2003, BLOOD, V101, P1833, DOI 10.1182/blood-2002-07-2149; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; GILL JC, 1987, BLOOD, V69, P1691; Goodeve A, 2007, BLOOD, V109, P112, DOI 10.1182/blood-2006-05-020784; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; James PD, 2007, BLOOD, V109, P145, DOI 10.1182/blood-2006-05-021105; Kamae T, 2011, J THROMB HAEMOST, V9, P1040, DOI 10.1111/j.1538-7836.2011.04245.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Knobe KE, 2008, HAEMOPHILIA, V14, P723, DOI 10.1111/j.1365-2516.2008.01753.x; Lillicrap D, 2013, BLOOD, V122, P3735, DOI 10.1182/blood-2013-06-498303; Mumford AD, 2013, J THROMB HAEMOST, V11, P547, DOI 10.1111/jth.12117; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Nisar S, 2011, BLOOD, V118, P5641, DOI 10.1182/blood-2011-02-336826; Nisar SP, 2014, THROMB HAEMOSTASIS, V111, P923, DOI 10.1160/TH13-08-0672; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ramstrom S, 2008, THROMB RES, V121, P681, DOI 10.1016/j.thromres.2007.06.010; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Tosetto A, 2006, J THROMB HAEMOST, V4, P766, DOI 10.1111/j.1538-7836.2006.01847.x; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	28	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143913	10.1371/journal.pone.0143913	http://dx.doi.org/10.1371/journal.pone.0143913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630678	Green Published, gold, Green Accepted			2022-12-26	WOS:000365926300121
J	Stieber, B; Monecke, S; Muller, E; Buchler, J; Ehricht, R				Stieber, Bettina; Monecke, Stefan; Mueller, Elke; Buechler, Joseph; Ehricht, Ralf			Direct, Specific and Rapid Detection of Staphylococcal Proteins and Exotoxins Using a Multiplex Antibody Microarray	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; AUREUS ENTEROTOXINS; HEPTAMERIC PORE; MECA HOMOLOG; ALPHA-TOXIN; GENES; IDENTIFICATION; COLONIZATION; HEMOLYSIN; DENMARK	Background S. aureus is a pathogen in humans and animals that harbors a wide variety of virulence factors and resistance genes. This bacterium can cause a wide range of mild to life-threatening diseases. In the latter case, fast diagnostic procedures are important. In routine diagnostic laboratories, several genotypic and phenotypic methods are available to identify S. aureus strains and determine their resistances. However, there is a demand for multiplex routine diagnostic tests to directly detect staphylococcal toxins and proteins. Methods In this study, an antibody microarray based assay was established and validated for the rapid detection of staphylococcal markers and exotoxins. The following targets were included: staphylococcal protein A, penicillin binding protein 2a, alpha-and beta-hemolysins, Panton Valentine leukocidin, toxic shock syndrome toxin, enterotoxins A and B as well as staphylokinase. All were detected simultaneously within a single experiment, starting from a clonal culture on standard media. The detection of bound proteins was performed using a new fluorescence reading device for microarrays. Results 110 reference strains and clinical isolates were analyzed using this assay, with a DNA microarray for genotypic characterization performed in parallel. The results showed a general high concordance of genotypic and phenotypic data. However, genotypic analysis found the hla gene present in all S. aureus isolates but its expression under given conditions depended on the clonal complex affiliation of the actual isolate. Conclusions The multiplex antibody assay described herein allowed a rapid and reliable detection of clinically relevant staphylococcal toxins as well as resistance-and species-specific markers.	[Stieber, Bettina; Monecke, Stefan; Mueller, Elke; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Stieber, Bettina; Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Stieber, Bettina; Monecke, Stefan; Mueller, Elke; Ehricht, Ralf] Infectognost Forsch Campus, Jena, Germany; [Buechler, Joseph] Alere San Diego Inc, San Diego, CA USA	Alere; Technische Universitat Dresden; Alere	Stieber, B (corresponding author), Alere Technol GmbH, Jena, Germany.	Bettina.Stieber@clondiag.com			Alere Technologies GmbH; Alere San Diego, Inc.; Infectognostics Forschungscampus	Alere Technologies GmbH; Alere San Diego, Inc.; Infectognostics Forschungscampus	The authors received no specific funding for this work. Alere Technologies GmbH, Alere San Diego, Inc. and Infectognostics Forschungscampus provided support in the form of salaries for authors BS, SM, EM, RE and JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aiello AE, 2006, LANCET INFECT DIS, V6, P335, DOI 10.1016/S1473-3099(06)70491-1; BETLEY MJ, 1985, SCIENCE, V229, P185, DOI 10.1126/science.3160112; Bokarewa MI, 2006, INT J BIOCHEM CELL B, V38, P504, DOI 10.1016/j.biocel.2005.07.005; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brown DFJ, 2005, J ANTIMICROB CHEMOTH, V56, P1000, DOI 10.1093/jac/dki372; COLEMAN D, 1991, MOL MICROBIOL, V5, P933, DOI 10.1111/j.1365-2958.1991.tb00768.x; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; da Cunha MDRS, 2007, MICROBIOL IMMUNOL, V51, P381, DOI 10.1111/j.1348-0421.2007.tb03925.x; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; DUBEL S, 1993, GENE, V128, P97, DOI 10.1016/0378-1119(93)90159-Z; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V60, P402, DOI 10.1093/jac/dkm206; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frenay HM, 1996, MOL TYPING METHICILL, V15, P60; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; GEISS HK, 2003, MIKROBIOLOGIE, V13, P222; Gilligan K, 2000, MOL CELL PROBE, V14, P71, DOI 10.1006/mcpr.2000.0286; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Katayama Y, 2013, J BACTERIOL, V195, P1194, DOI 10.1128/JB.01786-12; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kloppot P, 2015, PROTEOM CLIN APPL, V9, P1003, DOI 10.1002/prca.201400123; LAYER F, 2013, EPIDEMIOL B, V2013, P187; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; MONECKE S., 2014, PLOS ONE, V9; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; Pinchuk IV, 2010, TOXINS, V2, P2177, DOI 10.3390/toxins2082177; Rasigade JP, 2015, EUR J CLIN MICROBIOL, V34, P927, DOI 10.1007/s10096-014-2307-4; Roberts MC, 2011, AM J INFECT CONTROL, V39, P382, DOI 10.1016/j.ajic.2010.09.008; Schaumburg F, 2011, CLIN MICROBIOL INFEC; SCHLIEVERT PM, 1991, J INFECT DIS, V164, P1245, DOI 10.1093/infdis/164.6.1245; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; SHAFER WM, 1978, INFECT IMMUN, V20, P273, DOI 10.1128/IAI.20.1.273-278.1978; Sharma-Kuinkel BK, 2015, J CLIN MICROBIOL, V53, P227, DOI 10.1128/JCM.02023-14; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Stieber B, 2014, MOL CELL PROBES; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Valeva A, 1997, BIOCHEMISTRY-US, V36, P13298, DOI 10.1021/bi971075r; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wehner J, 2001, BRIT J DERMATOL, V145, P302, DOI 10.1046/j.1365-2133.2001.04352.x	51	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143246	10.1371/journal.pone.0143246	http://dx.doi.org/10.1371/journal.pone.0143246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624622	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600021
J	Jansson, F; Eriksson, K				Jansson, Fredrik; Eriksson, Kimmo			Cooperation and Shared Beliefs about Trust in the Assurance Game	PLOS ONE			English	Article							MODERATING ROLE; GROUP IDENTITY; INCENTIVES; STRANGERS; EXCHANGE	Determinants of cooperation include ingroup vs. outgroup membership, and individual traits, such as prosociality and trust. We investigated whether these factors can be overridden by beliefs about people's trust. We manipulated the information players received about each other's level of general trust, "high" or "low". These levels were either measured (Experiment 1) or just arbitrarily assigned labels (Experiment 2). Players' choices whether to cooperate or defect in a stag hunt (or an assurance game)-where it is mutually beneficial to cooperate, but costly if the partner should fail to do so-were strongly predicted by what they were told about the other player's trust label, as well as by what they were told that the other player was told about their own label. Our findings demonstrate the importance for cooperation in a risky coordination game of both first-and second-order beliefs about how much people trust each other. This supports the idea that institutions can influence cooperation simply by influencing beliefs.	[Jansson, Fredrik] Linkoping Univ, Inst Analyt Sociol, SE-60174 Norrkoping, Sweden; [Eriksson, Kimmo] Stockholm Univ, Ctr Study Cultural Evolut, SE-10691 Stockholm, Sweden; [Eriksson, Kimmo] Malardalen Univ, Sch Educ Culture & Commun, SE-72123 Vasteras, Sweden	Linkoping University; Stockholm University; Malardalen University	Jansson, F (corresponding author), Linkoping Univ, Inst Analyt Sociol, SE-60174 Norrkoping, Sweden.	fredrik.jansson@liu.se; kimmo.eriksson@mdh.se	Jansson, Fredrik/B-7616-2011; Eriksson, Kimmo/F-6253-2013	Jansson, Fredrik/0000-0001-8357-0276; Eriksson, Kimmo/0000-0002-7164-0924	Swedish Research Council [2009-2390]; European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant [324233]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC))	This work was supported by Swedish Research Council grant number 2009-2390 (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 324233 (http://ec.europa.eu/research/fp7/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ECON PSYCHOL, V28, P324, DOI 10.1016/j.joep.2007.01.007; Argyle M., 1991, COOPERATION BASIS SO; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; Boone C, 2010, J CONFLICT RESOLUT, V54, P799, DOI 10.1177/0022002710372329; BRECHNER KC, 1977, J EXP SOC PSYCHOL, V13, P552, DOI 10.1016/0022-1031(77)90054-3; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Charness G, 2006, ECONOMETRICA, V74, P1579, DOI 10.1111/j.1468-0262.2006.00719.x; Clark K, 2000, INT J GAME THEORY, V29, P495; COLEMAN JS, 1986, AM J SOCIOL, V91, P1309, DOI 10.1086/228423; Cooper R., 1999, COORDINATION GAMES C; Cooper R., 1994, PROBLEMS COORDINATIO, P129; DAWES RM, 1988, ACTA PSYCHOL, V68, P83, DOI 10.1016/0001-6918(88)90047-9; De Kwaadsteniet EW, 2012, GROUP PROCESS INTERG, V15, P257, DOI 10.1177/1368430211410235; DIEKMANN A, 1993, INT J GAME THEORY, V22, P75, DOI 10.1007/BF01245571; Diekmann A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10321; Dufwenberg M, 2011, GAME ECON BEHAV, V73, P459, DOI 10.1016/j.geb.2011.02.003; Eriksson K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040325; Foddy M, 2009, PSYCHOL SCI, V20, P419, DOI 10.1111/j.1467-9280.2009.02312.x; Gambetta D., 1988, TRUST MAKING BREAKIN, P213; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; He JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103931; Jansson F, 2015, J THEOR BIOL, V373, P100, DOI 10.1016/j.jtbi.2015.03.008; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kramer Roderick, 1995, TRUST ORG, P357; North D. C., 1998, EC VALUES ORG, P491; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Platow MJ, 2012, EUR J SOC PSYCHOL, V42, P30, DOI 10.1002/ejsp.852; Rothstein B, 2009, RATION SOC, V21, P81, DOI 10.1177/1043463108099349; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; Schelling T., 1957, CONFLICT RESOLUTION, V1, P19, DOI [10.1177/002200275700100104, DOI 10.1177/002200275700100104]; Schelling T.C., 1960, STRATEGY CONFLICT; SEN AK, 1967, Q J ECON, V81, P112, DOI 10.2307/1879675; Simpson B, 2008, SOC NETWORKS, V30, P1, DOI 10.1016/j.socnet.2007.04.004; Skyrms B, 2003, STAG HUNT EVOLUTION; Vanberg C, 2008, ECONOMETRICA, V76, P1467, DOI 10.3982/ECTA7673; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	38	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144191	10.1371/journal.pone.0144191	http://dx.doi.org/10.1371/journal.pone.0144191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26640892	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700074
J	Petrova, A; Smith, CM				Petrova, Adelina; Smith, Charles Michael			Application of Brown Planthopper Salivary Gland Extract to Rice Plants Induces Systemic Host mRNA Patterns Associated with Nutrient Remobilization	PLOS ONE			English	Article							SENESCENCE-ASSOCIATED GENES; LEAF SENESCENCE; AMINO-ACID; GLUTAMINE-SYNTHETASE; SIGNALING PATHWAYS; GLYOXALASE PATHWAY; CALCIUM; DEFENSE; EXPRESSION; APHIDS	Insect saliva plays an important role in modulation of plant-insect interactions. Although this area of research has generated much attention in recent years, mechanisms of how saliva affects plant responses remain poorly understood. To address this void, the present study investigated the impact of the brown planthopper (Nilaparvata lugens, Stal; hereafter BPH) salivary gland extract (SGE) on rice (Oryza sativa) systemic responses at the mRNA level. Differentially expressed rice mRNAs were generated through suppression subtractive hybridization (SSH) and classified into six functional groups. Those with the most representatives were from the primary metabolism (28%), signaling-defense (22%) and transcription-translation-regulation group (16%). To validate SSH library results, six genes were further analyzed by One-Step Real-Time Reverse Transcriptase-PCR. Five of these genes exhibited up-regulation levels of more than 150% of those in the control group in at least one post-application time point. Results of this study allow assignment of at least two putative roles of BPH saliva: First, application of SGE induces immediate systemic responses at the mRNA level, suggesting that altering of the rice transcriptome at sites distant to hoppers feeding locations may play an important role in BPH-rice interactions. Second, 58% of SGE-responsive up-regulated genes have a secondary function associated with senescence, a process characterized by remobilization of nutrients. This suggests that BPH salivary secretions may reprogram the rice transcriptome for nutritional enhancement. When these findings are translated onto 'whole plant' scale, they indicate that BPH saliva may play the 'wise investment' role of 'minimum input today, maximum output tomorrow'.	[Petrova, Adelina] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Smith, Charles Michael] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Washington State University; Kansas State University	Petrova, A (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	adelina.petrova@wsu.edu	Petrova, Adelina/H-4976-2019		RB Cooke scholarship, Newcastle University, UK; Yorkshire Agricultural Society, UK; Adelina Petrova, Washington State University, US	RB Cooke scholarship, Newcastle University, UK; Yorkshire Agricultural Society, UK; Adelina Petrova, Washington State University, US	This work has been sponsored by RB Cooke scholarship, Newcastle University, UK, Yorkshire Agricultural Society, UK, and Adelina Petrova, Washington State University, US.	Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bissoli G, 2012, PLANT J, V70, P704, DOI 10.1111/j.1365-313X.2012.04921.x; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Burd JD, 2002, J ECON ENTOMOL, V95, P463, DOI 10.1603/0022-0493-95.2.463; Cheng XY, 2013, MOL PLANT, V6, P621, DOI 10.1093/mp/sst030; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DORSCHNER KW, 1987, ENVIRON ENTOMOL, V16, P1007, DOI 10.1093/ee/16.4.1007; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; FUKUMORITA T, 1983, SOIL SCI PLANT NUTR, V29, P185, DOI 10.1080/00380768.1983.10432419; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; Heinrichs EA, 1999, GLOBAL PLANT GENETIC RESOURCES FOR INSECT-RESISTANT CROPS, P3; Huang WH, 2013, MOL PLANT, V6, P1673, DOI 10.1093/mp/sst069; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Jimenez A, 1998, PLANT PHYSIOL, V118, P1327, DOI 10.1104/pp.118.4.1327; KAMACHI K, 1992, PLANT PHYSIOL, V98, P1323, DOI 10.1104/pp.98.4.1323; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Knight H, 2000, INT REV CYTOL, V195, P269; Knoblauch M, 2004, CELL MOTIL CYTOSKEL, V58, P137, DOI 10.1002/cm.20006; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Koch W, 2003, PLANT J, V33, P211, DOI 10.1046/j.1365-313X.2003.01618.x; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; LARSON KC, 1991, OECOLOGIA, V88, P15, DOI 10.1007/BF00328398; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Liu CX, 2010, J PROTEOME RES, V9, P6774, DOI 10.1021/pr100970q; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MILES PW, 1989, J INSECT PHYSIOL, V35, P865, DOI 10.1016/0022-1910(89)90102-9; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Miranda M, 2001, PLANT J, V28, P61, DOI 10.1046/j.1365-313X.2001.01129.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Park SJ, 2006, PLANTA, V223, P932, DOI 10.1007/s00425-005-0148-1; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Petrova A, 2014, INSECT MOL BIOL, V23, P13, DOI 10.1111/imb.12058; Petrova A, 2000, THESIS; Petrova A, 2009, THESIS; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Sogawa K., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P125; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Steinhorst L, 2013, PLANT PHYSIOL, V163, P471, DOI 10.1104/pp.113.222950; Telang A, 1999, ENTOMOL EXP APPL, V91, P403, DOI 10.1023/A:1003617523820; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Vreden G. van, 1986, Pests of rice and their natural enemies in Peninsular Malaysia.; WALLSGROVE RM, 1987, PLANT PHYSIOL, V83, P155, DOI 10.1104/pp.83.1.155; Wang YC, 2008, ENTOMOL EXP APPL, V129, P295, DOI 10.1111/j.1570-7458.2008.00785.x; White PJ, 2000, BBA-BIOMEMBRANES, V1465, P171, DOI 10.1016/S0005-2736(00)00137-1; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Yuan HY, 2005, PLANTA, V221, P105, DOI 10.1007/s00425-004-1422-3; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	66	11	11	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141769	10.1371/journal.pone.0141769	http://dx.doi.org/10.1371/journal.pone.0141769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641488	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700005
J	Sanna, D; Barbato, M; Hadjisterkotis, E; Cossu, P; Decandia, L; Trova, S; Pirastru, M; Leoni, GG; Naitana, S; Francalacci, P; Masala, B; Manca, L; Mereu, P				Sanna, Daria; Barbato, Mario; Hadjisterkotis, Eleftherios; Cossu, Piero; Decandia, Luca; Trova, Sandro; Pirastru, Monica; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Francalacci, Paolo; Masala, Bruno; Manca, Laura; Mereu, Paolo			The First Mitogenome of the Cyprus Mouflon (Ovis gmelini ophion): New Insights into the Phylogeny of the Genus Ovis	PLOS ONE			English	Article							SHEEP AMMOTRAGUS-LERVIA; MITOCHONDRIAL-DNA; CONTROL REGION; COMPREHENSIVE ANALYSIS; Y-CHROMOSOME; CLUSTAL-W; DOMESTICATION; EVOLUTION; SEQUENCE; WILD	Sheep are thought to have been one of the first livestock to be domesticated in the Near East, thus playing an important role in human history. The current whole mitochondrial genome phylogeny for the genus Ovis is based on: the five main domestic haplogroups occurring among sheep (O. aries), along with molecular data from two wild European mouflons, three urials, and one argali. With the aim to shed some further light on the phylogenetic relationship within this genus, the first complete mitochondrial genome sequence of a Cypriot mouflon (O. gmelini ophion) is here reported. Phylogenetic analyses were performed using a dataset of whole Ovis mitogenomes as well as D-loop sequences. The concatenated sequence of 28 mitochondrial genes of one Cypriot mouflon, and the D-loop sequence of three Cypriot mouflons were compared to sequences obtained from samples representatives of the five domestic sheep haplogroups along with samples of the extant wild and feral sheep. The sample included also individuals from the Mediterranean islands of Sardinia and Corsica hosting remnants of the first wave of domestication that likely went then back to feral life. The divergence time between branches in the phylogenetic tree has been calculated using seven different calibration points by means of Bayesian and Maximum Likelihood inferences. Results suggest that urial (O. vignei) and argali (O. ammon) diverged from domestic sheep about 0.89 and 1.11 million years ago (MYA), respectively; and dates the earliest radiation of domestic sheep common ancestor at around 0.3 MYA. Additionally, our data suggest that the rise of the modern sheep haplogroups happened in the span of time between six and 32 thousand years ago (KYA). A close phylogenetic relationship between the Cypriot and the Anatolian mouflon carrying the X haplotype was detected. The genetic distance between this group and the other ovine haplogroups supports the hypothesis that it may be a new haplogroup never described before. Furthermore, the updated phylogenetic tree presented in this study determines a finer classification of ovine species and may help to classify more accurately new mitogenomes within the established haplogroups so far identified.	[Sanna, Daria; Cossu, Piero; Francalacci, Paolo] Univ Sassari, Dipartimento Sci Nat & Terr, I-07100 Sassari, Italy; [Barbato, Mario] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hadjisterkotis, Eleftherios] Minist Interior, Nicosia, Cyprus; [Decandia, Luca; Trova, Sandro; Pirastru, Monica; Masala, Bruno; Manca, Laura; Mereu, Paolo] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Decandia, Luca; Trova, Sandro; Pirastru, Monica; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Masala, Bruno; Manca, Laura; Mereu, Paolo] Univ Sassari, Ctr Excellence Biotechnol Dev & Res Biodivers, I-07100 Sassari, Italy	University of Sassari; Cardiff University; University of Sassari; University of Sassari; University of Sassari	Mereu, P (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	pmereu@uniss.it	BARBATO, Mario/AAG-5854-2019; Mereu, Paolo/AAE-7100-2019; Cossu, Piero/B-8528-2019	BARBATO, Mario/0000-0002-7203-1549; Mereu, Paolo/0000-0001-6615-4828; Cossu, Piero/0000-0002-8946-8261; Trova, Sandro/0000-0002-0367-5463	Fondazione Banco di Sardegna [2013.1313]	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported by 2013.1313 http://www.fondazionebancodisardegna.it/ Fondazione Banco di Sardegna to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2012, FORENSIC SCI INT-GEN, V6, P671, DOI 10.1016/j.fsigen.2011.12.001; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bruford MW, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P306; Bunch TD, 2006, J HERED, V97, P21, DOI 10.1093/jhered/esi127; Bunch TD, 1998, J HERED, V89, P266, DOI 10.1093/jhered/89.3.266; Cetti F, 1774, QUADRUPEDI SARDEGNA; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Davidson A, 2006, OXFORD COMPANION FOO; Demirci S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081952; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Francalacci P, 2008, J ANTHROPOL SCI, V86, P59; Frisina M.R., 2013, Taprobanica, V5, P157; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; Hadjinicolaou P, 2011, REG ENVIRON CHANGE, V11, P441, DOI 10.1007/s10113-010-0153-1; Hadjisterkotis E., 1997, P89; Hadjisterkotis E, 1996, Z JAGDWISS, V42, P104, DOI 10.1007/BF02240505; Hadjisterkotis E, 2008, EUR J WILDLIFE RES, V54, P122, DOI 10.1007/s10344-007-0121-3; Hadjisterkotis Eleftherios, 2012, P49; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Helmer Daniel, 2005, P86; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN/SSC Caprine Specialist Group, 2000, WORKSH CAPR TAX MAY; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2006, NUCL ACID M, V18, P149; Lancioni H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073712; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; Manca L, 2006, COMP BIOCHEM PHYS B, V145, P214, DOI 10.1016/j.cbpb.2006.07.010; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Mereu P, 2008, DNA SEQUENCE, V19, P241, DOI 10.1080/10425170701550599; Meyer S, 1999, GENETICS, V152, P1103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NADLER C F, 1973, Zeitschrift fuer Saeugetierkunde, V38, P109; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2013, MOL PHYLOGENET EVOL, V67, P436, DOI 10.1016/j.ympev.2013.02.008; Parma P, 2004, DNA SEQUENCE, V15, P369, DOI 10.1080/10425170400019318; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Peters Joris, 2005, P96; Pirastru M, 2009, COMP BIOCHEM PHYS D, V4, P168, DOI 10.1016/j.cbd.2009.02.002; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rezaei HR, 2010, MOL PHYLOGENET EVOL, V54, P315, DOI 10.1016/j.ympev.2009.10.037; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ryder M.L., 1983, SHEEP AND MAN; Ryder ML, 1984, EVOLUTION DOMESTICAT, P63; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shackleton D.M., 1997, P9; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdez R, 1982, WILD SHEEP WORLD; Vigne J. D., 2014, EURASIAN PREHISTORY, V10, P157; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Wilkens Barbara, 2003, Sardinia Corsica et Baleares Antiquae, V1, P181; Xu Shu-Qing, 2005, Genomics Proteomics & Bioinformatics, V3, P5; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeuner MA, 1963, HIST DOMESTICATED AN	82	23	23	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144257	10.1371/journal.pone.0144257	http://dx.doi.org/10.1371/journal.pone.0144257			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636977	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800063
J	Gage, BK; Asadi, A; Baker, RK; Webber, TD; Wang, R; Itoh, M; Hayashi, M; Miyata, R; Akashi, T; Kieffer, TJ				Gage, Blair K.; Asadi, Ali; Baker, Robert K.; Webber, Travis D.; Wang, Rennian; Itoh, Masayuki; Hayashi, Masaharu; Miyata, Rie; Akashi, Takumi; Kieffer, Timothy J.			The Role of ARX in Human Pancreatic Endocrine Specification	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; BETA-CELLS; HOMEOBOX GENE; MICE LACKING; ABNORMAL GENITALIA; PROGENITOR CELLS; MOUSE PANCREAS; ALPHA-CELL; IN-VITRO	The in vitro differentiation of human embryonic stem cells (hESCs) offers a model system to explore human development. Humans with mutations in the transcription factor Aristaless Related Homeobox (ARX) often suffer from the syndrome X-linked lissencephaly with ambiguous genitalia (XLAG), affecting many cell types including those of the pancreas. Indeed, XLAG pancreatic islets lack glucagon and pancreatic polypeptide-positive cells but retain somatostatin, insulin, and ghrelin-positive cells. To further examine the role of ARX in human pancreatic endocrine development, we utilized genomic editing in hESCs to generate deletions in ARX. ARX knockout hESCs retained pancreatic differentiation capacity and ARX knockout endocrine cells were biased toward somatostatin-positive cells (94% of endocrine cells) with reduced pancreatic polypeptide (rarely detected), glucagon (90% reduced) and insulin-positive (65% reduced) lineages. ARX knockout somatostatin-positive cells shared expression patterns with human fetal and adult delta-cells. Differentiated ARX knockout cells upregulated PAX4, NKX2.2, ISL1, HHEX, PCSK1, PCSK2 expression while downregulating PAX6 and IRX2. Re-expression of ARX in ARX knockout pancreatic progenitors reduced HHEX and increased PAX6 and insulin expression following differentiation. Taken together these data suggest that ARX plays a key role in pancreatic endocrine fate specification of pancreatic polypeptide, somatostatin, glucagon and insulin positive cells from hESCs.	[Gage, Blair K.; Asadi, Ali; Baker, Robert K.; Webber, Travis D.; Kieffer, Timothy J.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol, Child Hlth Res Inst, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Pharmacol, Child Hlth Res Inst, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Med, Child Hlth Res Inst, London, ON, Canada; [Itoh, Masayuki] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Hayashi, Masaharu; Miyata, Rie] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Akashi, Takumi] Tokyo Med & Dent Univ, Tokyo, Japan; [Kieffer, Timothy J.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Medical Science; Tokyo Medical & Dental University (TMDU); University of British Columbia	Kieffer, TJ (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	tim.kieffer@ubc.ca			Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF); Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council; Michael Smith Foundation for Health Research; University of British Columbia; JDRF; Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative; STEMCELL Technologies Inc.	Stem Cell Network (SCN); STEMCELL Technologies; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); University of British Columbia; JDRF(Juvenile Diabetes Research Foundation); Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative(Canadian Institutes of Health Research (CIHR)); STEMCELL Technologies Inc.	This work was funded by the Stem Cell Network (SCN), STEMCELL Technologies, Juvenile Diabetes Research Foundation (JDRF) and Canadian Institutes of Health Research (CIHR). BKG has received PhD funding from the Natural Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research, and the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Stem Cell Network (SCN), JDRF and the Canadian Institutes of Health Research (CIHR) Regenerative Medicine and Nanomedicine Initiative. BKG received Ph.D. funding from the Natural Sciences and Engineering Research Council, the Michael Smith Foundation for Health Research and the University of British Columbia. We thank Dr. Jenny Bruin for critical suggestions on this manuscript and Dr. P. Collombat, Dr. J. Habener, Dr. A. Rezania, Dr. L. Devi, the Beta Cell Biology Consortium, and the Developmental Studies Hybridoma Bank for the contribution of antibodies used in this study and STEMCELL Technologies Inc. for financial support.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; BERSANI M, 1989, J BIOL CHEM, V264, P10633; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; BRAKCH N, 1995, FEBS LETT, V362, P143, DOI 10.1016/0014-5793(95)00229-3; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Caron NJ, 2013, BIOTECHNOL BIOENG, V110, P2706, DOI 10.1002/bit.24936; Cho G, 2012, NEUROGENETICS, V13, P23, DOI 10.1007/s10048-011-0304-7; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fujita Y, 2010, AM J PHYSIOL-GASTR L, V298, pG608, DOI 10.1152/ajpgi.00024.2010; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gage BK, 2014, ISLETS OF LANGERHANS, P1; Gage BK, 2014, ISLETS, V6, DOI 10.4161/isl.29236; Gage BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082076; Goudet G, 1999, J BIOL CHEM, V274, P4067, DOI 10.1074/jbc.274.7.4067; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Li H, 1999, NAT GENET, V23, P67; Liew CG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001783; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Mastracci TL, 2011, DEV BIOL, V359, P1, DOI 10.1016/j.ydbio.2011.08.001; McKenzie O, 2007, NEUROSCIENCE, V146, P236, DOI 10.1016/j.neuroscience.2007.01.038; Metzger DE, 2014, DIABETES, V63, P1804, DOI 10.2337/db13-0867; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyata R, 2009, BRAIN DEV-JPN, V31, P456, DOI 10.1016/j.braindev.2008.08.008; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ohira R, 2002, MOL GENET METAB, V77, P179, DOI 10.1016/S1096-7192(02)00126-9; Pan FC, 2015, DEVELOPMENT, V142, P3637, DOI 10.1242/dev.126011; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shoubridge C, 2010, HUM MUTAT, V31, P889, DOI 10.1002/humu.21288; Shoubridge Cheryl, 2010, Pathogenetics, V3, P1, DOI 10.1186/1755-8417-3-1; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Wilcox CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078741; Zhang J, 2014, GENE DEV, V28, P829, DOI 10.1101/gad.235499.113	54	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144100	10.1371/journal.pone.0144100	http://dx.doi.org/10.1371/journal.pone.0144100			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633894	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000055
J	Wang, JY; Sun, HY; Wang, JT; Hung, CC; Yu, MC; Lee, CH; Lee, LN				Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching; Yu, Ming-Chih; Lee, Chih-Hsin; Lee, Li-Na			Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan	PLOS ONE			English	Article							ACQUIRED RIFAMYCIN RESISTANCE; TUBERCULOSIS; HIV; MOXIFLOXACIN; ETHAMBUTOL; RIFABUTIN; RELAPSE	Background Human immunodeficiency virus (HIV)-infected patients are at an increased risk of tuberculosis (TB) and its recurrence following completion of anti-TB treatment. We investigated whether extending anti-TB treatment to 9 months or longer reduces TB recurrence. Methods HIV-infected patients who were diagnosed with pulmonary TB between 1997 and 2009 and who received anti-TB treatment for a duration between 5.5 and 12.5 months were identified from the National Health Insurance Research Database in Taiwan. Those who received any non-fluoroquinolone second-line anti-TB drug for >28 days were excluded. Factors associated with TB recurrence within 2 years after completion of anti-TB treatment were explored using Cox regression analysis. Sensitivity analysis was performed for a subpopulation fulfilling strict diagnostic criteria for HIV infection. Results TB recurrence was observed in 18 (3.5%) of 508 HIV-infected patients. The recurrence rate declined from 5.4% to 1.0% after the implementation of directly observed therapy, short course (DOTS) in 2006 (p = 0.014). The recurrence rate was 5.9%, 5.2%, and 1.6% in patients who received anti-TB treatment for < 195, 195-270, and > 270 days, respectively (p = 0.066). Cox regression analysis revealed that TB diagnosed in the DOTS era (hazard ratio [HR]: 0.18 [0.04-0.77]) and anti-TB treatment for > 270 days (HR: 0.24 [0.06-0.89]) were associated with a reduced risk of TB recurrence. Sensitivity analysis of 449 selected patients revealed that anti-TB treatment for > 270 days was a significant factor. Conclusion In Taiwan, the 2-year TB recurrence rate in HIV-infected patients declined after implementation of DOTS. The risk of TB recurrence in HIV-infected patients can be further reduced by extending anti-TB treatment to 9-12.5 months.	[Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Jann-Yuan; Sun, Hsin-Yun; Wang, Jann-Tay; Hung, Chien-Ching; Lee, Li-Na] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yu, Ming-Chih; Lee, Chih-Hsin] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lee, Chih-Hsin] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Yu, Ming-Chih] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University	Lee, CH (corresponding author), Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan.	chlee.tw@gmail.com	; Lee, Chih-Hsin/D-2697-2014	WANG, JANN-YUAN/0000-0003-3406-366X; LEE, LI-NA/0000-0002-7654-2450; Lee, Chih-Hsin/0000-0003-1492-3044; WANG, JANN-TAY/0000-0002-0924-3469; SUN, HSIN-YUN/0000-0003-0074-7721; Hung, Chien-Ching/0000-0001-7345-0836	National Science Council, Taiwan [NSC 99-2314-B-002-088-MY2, NSC 101-3114-Y-002-003]; Centers for Disease Control, Taiwan [DOH-101-DC-1101, DOH-102-DC-1301, MOHW-103-CDC-C-114-112302]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Centers for Disease Control, Taiwan	This study was supported by the National Science Council, Taiwan (grant NSC 99-2314-B-002-088-MY2; NSC 101-3114-Y-002-003; http://web1.nsc.gov.tw/) and the Centers for Disease Control, Taiwan (grant DOH-101-DC-1101; DOH-102-DC-1301; MOHW-103-CDC-C-114-112302). The funders had no role in the study design, conduct, data collection and analysis, preparation of the manuscript, or decision of submission.	[Anonymous], 1986, Tubercle, V67, P5; [Anonymous], 1982, Am Rev Respir Dis, V126, P460; [Anonymous], 2011, GLOB TUB CONTR; [Anonymous], GUID US ANT AG HIV 1; Bureau of National Health Insurance, 2011, NAT HLTH INS STAT 20; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Centers for Disease Control Taiwan, 2012, TAIW TUB CONTR REP 2; Centers for Disease Control Taiwan, 2010, GUID DIAGN TREATM HI; Chan PC, 2014, J FORMOS MED ASSOC, V113, P775, DOI 10.1016/j.jfma.2014.03.003; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Driver CR, 2001, CLIN INFECT DIS, V33, P1762, DOI 10.1086/323784; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Huang SK, 2014, J FORMOS MED ASSOC, V113, P1, DOI 10.1016/j.jfma.2013.08.010; Hung CC, 2003, JAIDS-J ACQ IMM DEF, V34, P437, DOI 10.1097/00126334-200312010-00012; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Lien YC, 2013, BRIT J CANCER, V109, P2933, DOI 10.1038/bjc.2013.538; Luh KT, 2013, TAIWAN GUIDELINES TB; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Nettles RE, 2004, CLIN INFECT DIS, V38, P731, DOI 10.1086/381675; PERRIENS JH, 1995, NEW ENGL J MED, V332, P779, DOI 10.1056/NEJM199503233321204; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918; Weiner M, 2005, CLIN INFECT DIS, V41, P1343, DOI 10.1086/496980; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; WHO, 2009, TREATM TUB GUID; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144136	10.1371/journal.pone.0144136	http://dx.doi.org/10.1371/journal.pone.0144136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633835	gold, Green Published			2022-12-26	WOS:000366040000061
J	Bartlett, TE; Jones, A; Goode, EL; Fridley, BL; Cunningham, JM; Berns, EMJJ; Wik, E; Salvesen, HB; Davidson, B; Trope, CG; Lambrechts, S; Vergote, I; Widschwendter, M				Bartlett, Thomas E.; Jones, Allison; Goode, Ellen L.; Fridley, Brooke L.; Cunningham, Julie M.; Berns, Els M. J. J.; Wik, Elisabeth; Salvesen, Helga B.; Davidson, Ben; Trope, Claes G.; Lambrechts, Sandrina; Vergote, Ignace; Widschwendter, Martin			Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; SMARCA4 MUTATIONS; CLASS DISCOVERY; EXPRESSION; BINDING; REGULARIZATION; TRANSCRIPTION; ELEMENTS; EVENTS; SITES	We introduce a novel per-gene measure of intra-gene DNA methylation variability (IGV) based on the Illumina Infinium HumanMethylation450 platform, which is prognostic independently of well-known predictors of clinical outcome. Using IGV, we derive a robust gene-panel prognostic signature for ovarian cancer (OC, n = 221), which validates in two independent data sets from Mayo Clinic (n = 198) and TCGA (n = 358), with significance of p = 0.004 in both sets. The OC prognostic signature gene-panel is comprised of four gene groups, which represent distinct biological processes. We show the IGV measurements of these gene groups are most likely a reflection of a mixture of intra-tumour heterogeneity and transcription factor (TF) binding/activity. IGV can be used to predict clinical outcome in patients individually, providing a surrogate read-out of hard-to-measure disease processes.	[Bartlett, Thomas E.; Jones, Allison; Widschwendter, Martin] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Dept Womens Canc, London, England; [Bartlett, Thomas E.] UCL, Deparment Math, London, England; [Bartlett, Thomas E.] UCL, CoMPLEX, London, England; [Goode, Ellen L.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Berns, Els M. J. J.] Erasmus MC Canc Ctr, Dept Med Oncol, Rotterdam, Netherlands; [Wik, Elisabeth; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway; [Davidson, Ben] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol,Fac Med,Inst Clin Med, Oslo, Norway; [Trope, Claes G.] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway; [Lambrechts, Sandrina; Vergote, Ignace] Katholieke Univ Leuven, Univ Hosp Leuven, Div Gynecol Oncol, Dept Obstet & Gynecol, Leuven, Belgium; [Lambrechts, Sandrina; Vergote, Ignace] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium	University of London; University College London; University of London; University College London; University of London; University College London; Mayo Clinic; University of Kansas; University of Kansas Medical Center; Mayo Clinic; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Widschwendter, M (corresponding author), UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Dept Womens Canc, London, England.	M.Widschwendter@ucl.ac.uk	Wik, E./AAA-9105-2020; salvesen, Helga B/C-1187-2017	salvesen, Helga B/0000-0002-4438-8831; Bartlett, Thomas/0000-0003-0831-9713; Widschwendter, Martin/0000-0002-7778-8380	European Union [305428]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Eve Appeal and the European Network Translational Research in Gynaecological Oncology (ENTRIGO) of the European Society of Gynaecological Oncology (ESGO); UK Engineering and Physical Sciences Research Council (ESPRC); UK Medical Research Council (MRC) via UCL CoMPLEX; Fred C. and Katherine B. Andersen Foundation, NIH [R01-CA122443, P50-CA136393, P30-CA15083]; Medical Research Council [1297534] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA122443, P30CA015083, P50CA136393] Funding Source: NIH RePORTER	European Union(European Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Eve Appeal and the European Network Translational Research in Gynaecological Oncology (ENTRIGO) of the European Society of Gynaecological Oncology (ESGO); UK Engineering and Physical Sciences Research Council (ESPRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Medical Research Council (MRC) via UCL CoMPLEX(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fred C. and Katherine B. Andersen Foundation, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded (MW, AJ) by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 305428 (Project EpiFemCare), by the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and by the Eve Appeal and the European Network Translational Research in Gynaecological Oncology (ENTRIGO) of the European Society of Gynaecological Oncology (ESGO). TEB received funding from the UK Engineering and Physical Sciences Research Council (ESPRC) and the UK Medical Research Council (MRC) via UCL CoMPLEX. ELG received funding from the Fred C. and Katherine B. Andersen Foundation, NIH grants R01-CA122443, P50-CA136393 (the Mayo Clinic Ovarian Cancer SPORE) and P30-CA15083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attanasio C, 2014, GENOME RES, V24, P920, DOI 10.1101/gr.168930.113; Bartlett TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084573; Bartlett TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068285; Beck AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001794; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brocks D, 2014, CELL REP, V8, P798, DOI 10.1016/j.celrep.2014.06.053; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Coulson JM, 2005, CURR BIOL, V15, pR665, DOI 10.1016/j.cub.2005.08.032; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gartel AL, 2006, ONCOGENE, V25, P1989, DOI 10.1038/sj.onc.1209101; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gustems M, 2014, NUCLEIC ACIDS RES, V42, P3059, DOI 10.1093/nar/gkt1323; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Jelinic P, 2014, NAT GENET, V46, P424, DOI 10.1038/ng.2922; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Malone CS, 2001, P NATL ACAD SCI USA, V98, P10404, DOI 10.1073/pnas.181206898; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Ng CW, 2013, P NATL ACAD SCI USA, V110, P2354, DOI 10.1073/pnas.1221292110; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Simon N, 2011, J STAT SOFTW, V39, P1; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yokomori N, 1998, MOL ENDOCRINOL, V12, P1241, DOI 10.1210/me.12.8.1241; Zechner U, 2012, P ANN M AM SOC HUM G; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003; Zhuang J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002517; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	48	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143178	10.1371/journal.pone.0143178	http://dx.doi.org/10.1371/journal.pone.0143178			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629914	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300034
J	Chivers, ML; Bouchard, KN; Timmers, AD				Chivers, Meredith L.; Bouchard, Katrina N.; Timmers, Amanda D.			Straight but Not Narrow; Within-Gender Variation in the Gender-Specificity of Women's Sexual Response	PLOS ONE			English	Article							VOLUNTEER BIAS; HETEROSEXUAL WOMEN; VISUAL-ATTENTION; VIEWING TIMES; AROUSAL; ORIENTATION; MEN; PATTERNS; STIMULI; ATTRACTION	Gender differences in the specificity of sexual response have been a primary focus in sexual psychophysiology research, however, within-gender variability suggests sexual orientation moderates category-specific responding among women; only heterosexual women show gender-nonspecific genital responses to sexual stimuli depicting men and women. But heterosexually-identified or "straight" women are heterogeneous in their sexual attractions and include women who are exclusively androphilic (sexually attracted to men) and women who are predominantly androphilic with concurrent gynephilia (sexually attracted to women). It is therefore unclear if gender-nonspecific responding is found in both exclusively and predominantly androphilic women. The current studies investigated within-gender variability in the gender-specificity of women's sexual response. Two samples of women reporting concurrent andro/gynephilia viewed (Study 1, n = 29) or listened (Study 2, n = 30) to erotic stimuli varying by gender of sexual partner depicted while their genital and subjective sexual responses were assessed. Data were combined with larger datasets of predominantly gyne-and androphilic women (total N = 78 for both studies). In both studies, women reporting any degree of gynephilia, including those who self-identified as heterosexual, showed significantly greater genital response to female stimuli, similar to predominantly gynephilic women; gender-nonspecific genital response was observed for exclusively androphilic women only. Subjective sexual arousal patterns were more variable with respect to sexual attractions, likely reflecting stimulus intensity effects. Heterosexually-identified women are therefore not a homogenous group with respect to sexual responses to gender cues. Implications for within-gender variation in women's sexual orientation and sexual responses are discussed.	[Chivers, Meredith L.; Bouchard, Katrina N.; Timmers, Amanda D.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Chivers, ML (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	Meredith.Chivers@Queensu.ca		Bouchard, Katrina/0000-0001-9159-7663	Canadian Institutes of Health Research; Council of Ontario Universities; Social Sciences and Humanities Research Council of Canada; Canadian Foundation for Innovation; American Institute of Bisexuality	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Council of Ontario Universities; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); American Institute of Bisexuality	This research was supported by: 1) Post-doctoral fellowships awarded to the first author (MLC) from the Canadian Institutes of Health Research, (www.cihr.ca), the Council of Ontario Universities (http://cou.on.ca/), and the Social Sciences and Humanities Research Council of Canada (www.sshrc.ca); 2) Graduate fellowships from the Social Sciences and Humanities Research Council of Canada (www.sshrc.ca) awarded to ADT and KNB; and 3) Grants from the Canadian Foundation for Innovation (www.innovation.ca) and the American Institute of Bisexuality (www.americaninstituteofbisexuality.org) awarded to MLC.	Aboyoun DC, 1998, SOC BEHAV PERSONAL, V26, P415, DOI 10.2224/sbp.1998.26.4.415; Alho J, 2015, BIOL PSYCHOL, V109, P103, DOI 10.1016/j.biopsycho.2015.04.010; [Anonymous], 2011, NATL HLTH STAT REPOR; Austin SB, 2008, AM J PUBLIC HEALTH, V98, P1015, DOI 10.2105/AJPH.2006.099473; Bailey JM, 2009, NEBR SYM MOTIV, V54, P43; Brom M, 2014, NEUROSCI BIOBEHAV R, V38, P38, DOI 10.1016/j.neubiorev.2013.10.014; Burri A, 2015, J SEX MED, V12, P1004, DOI 10.1111/jsm.12847; Chivers ML, 2010, SEX RELATSH THER, V25, P415, DOI 10.1080/14681994.2010.518727; Chivers ML, 2007, J PERS SOC PSYCHOL, V93, P1108, DOI 10.1037/0022-3514.93.6.1108; Chivers ML, 2014, ARCH SEX BEHAV, V43, P931, DOI 10.1007/s10508-013-0174-1; Chivers ML, 2012, ARCH SEX BEHAV, V41, P185, DOI 10.1007/s10508-012-9937-3; Chivers ML, 2010, SEX RELATSH THER, V25, P407, DOI 10.1080/14681994.2010.495979; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Chivers ML, 2005, BIOL PSYCHOL, V70, P115, DOI 10.1016/j.biopsycho.2004.12.002; Costa M, 2003, BIOL PSYCHOL, V63, P129, DOI 10.1016/S0301-0511(03)00054-1; COSTELL RM, 1972, SCIENCE, V177, P718, DOI 10.1126/science.177.4050.718; Dawson SJ, 2014, J SEX MED, V11, P980, DOI 10.1111/jsm.12430; Dawson SJ, 2012, ARCH SEX BEHAV, V41, P173, DOI 10.1007/s10508-012-9939-1; Diamond L. M., 2008, SEXUAL FLUIDITY; Diamond LM, 2005, FEM PSYCHOL, V15, P104, DOI 10.1177/0959353505049712; Ebsworth M, 2012, ARCH SEX BEHAV, V41, P161, DOI 10.1007/s10508-012-9923-9; ELLIS L, 1987, PSYCHOL BULL, V101, P233, DOI 10.1037/0033-2909.101.2.233; Gangestad SW, 2000, J PERS SOC PSYCHOL, V78, P1109, DOI 10.1037//0022-3514.78.6.1109; Geer J. H., 2000, HDB PSYCHOPHYSIOLOGY, P315; Harris GT., 1992, PSYCHOL ASSESSMENT, V4, P502, DOI [10.1037/1040-3590.4.4.502, DOI 10.1037/1040-3590.4.4.502]; HATCH JP, 1979, ARCH SEX BEHAV, V8, P357, DOI 10.1007/BF01541879; Hietanen JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024408; Huberman JS, 2015, J SEX RES, V52, P983, DOI 10.1080/00224499.2014.951424; Huberman JS, 2015, PSYCHOPHYSIOLOGY, V52, P1382, DOI 10.1111/psyp.12466; Huberman JS, 2013, CAN J BEHAV SCI, V45, P259, DOI 10.1037/a0033397; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; Kukkonen T.M., 2014, CURR SEX HEALTH REP, V6, P30, DOI [10.1007/s11930-013-0010-6, DOI 10.1007/S11930-013-0010-6]; LAAN E, 1995, PSYCHOPHYSIOLOGY, V32, P476, DOI 10.1111/j.1469-8986.1995.tb02099.x; LAAN E, 1995, PSYCHOPHYSIOLOGY, V32, P444, DOI 10.1111/j.1469-8986.1995.tb02095.x; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Lippa RA, 2013, ARCH SEX BEHAV, V42, P187, DOI 10.1007/s10508-012-9981-z; Lippa RA, 2012, ARCH SEX BEHAV, V41, P149, DOI 10.1007/s10508-011-9898-y; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Maner JK, 2007, J PERS SOC PSYCHOL, V93, P389, DOI 10.1037/0022-3514.93.3.389; Maner JK, 2007, EVOL HUM BEHAV, V28, P28, DOI 10.1016/j.evolhumbehav.2006.05.006; Maner JK, 2009, J PERS SOC PSYCHOL, V97, P74, DOI 10.1037/a0014055; Meston CM, 2000, ARCH GEN PSYCHIAT, V57, P1012, DOI 10.1001/archpsyc.57.11.1012; Morgan EM, 2011, J SEX RES, V48, P16, DOI 10.1080/00224490903370594; MOROKOFF PJ, 1986, J SEX RES, V22, P35, DOI 10.1080/00224498609551288; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Peplau L A, 1999, Annu Rev Sex Res, V10, P70; Peterson ZD, 2010, ARCH SEX BEHAV, V39, P880, DOI 10.1007/s10508-009-9546-y; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Rahman Q, 2003, PERS INDIV DIFFER, V34, P1337, DOI 10.1016/S0191-8869(02)00140-X; Rieger G, 2015, BIOL PSYCHOL, V104, P56, DOI 10.1016/j.biopsycho.2014.11.009; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rullo JE, 2010, ARCH SEX BEHAV, V39, P874, DOI 10.1007/s10508-009-9497-3; Rupp HA, 2008, ARCH SEX BEHAV, V37, P206, DOI 10.1007/s10508-007-9217-9; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Savin-Williams RC, 2013, DEV REV, V33, P58, DOI 10.1016/j.dr.2013.01.001; SINTCHAK G, 1975, PSYCHOPHYSIOLOGY, V12, P113, DOI 10.1111/j.1469-8986.1975.tb03074.x; Spape J, 2014, BIOL PSYCHOL, V102, P1, DOI 10.1016/j.biopsycho.2014.07.008; STEINMAN DL, 1981, ARCH SEX BEHAV, V10, P529, DOI 10.1007/BF01541588; STRASSBERG DS, 1995, ARCH SEX BEHAV, V24, P369, DOI 10.1007/BF01541853; Suschinsky K.D., 2011, CAN J HUM SEX, V20, P93; Suschinsky KD, 2011, PSYCHOL SCI, V22, P159, DOI 10.1177/0956797610394660; Suschinsky KD, 2009, ARCH SEX BEHAV, V38, P559, DOI 10.1007/s10508-008-9339-8; Sylva D, 2013, HORM BEHAV, V64, P673, DOI 10.1016/j.yhbeh.2013.08.003; Thompson EM, 2008, DEV PSYCHOL, V44, P15, DOI 10.1037/0012-1649.44.1.15; Timmers A. D., 2012, CAN J HUM SEX, V21, P135; Toates F, 2009, J SEX RES, V46, P168, DOI 10.1080/00224490902747768; Tsujimura A, 2009, J SEX MED, V6, P1011, DOI 10.1111/j.1743-6109.2008.01031.x; Vrangalova Z, 2012, ARCH SEX BEHAV, V41, P85, DOI 10.1007/s10508-012-9921-y; WINCZE JP, 1984, ARCH SEX BEHAV, V13, P361, DOI 10.1007/BF01541908; WOLCHIK SA, 1983, ARCH SEX BEHAV, V12, P399, DOI 10.1007/BF01542883; WOLCHIK SA, 1985, ARCH SEX BEHAV, V14, P93, DOI 10.1007/BF01541656; WRIGHT LW, 1994, J PSYCHOPATHOL BEHAV, V16, P221, DOI 10.1007/BF02229209; Wright LW, 1999, J SEX RES, V36, P145, DOI 10.1080/00224499909551979	77	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142575	10.1371/journal.pone.0142575	http://dx.doi.org/10.1371/journal.pone.0142575			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26629910	Green Published, gold			2022-12-26	WOS:000365926300014
J	Krug, S; Boch, M; Daniel, H; Nimphius, W; Muller, D; Michl, P; Rinke, A; Gress, TM				Krug, Sebastian; Boch, Michael; Daniel, Hanna; Nimphius, Wilhelm; Mueller, Daniela; Michl, Patrick; Rinke, Anja; Gress, Thomas Matthias			Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms - Predictive and Prognostic Markers for Treatment Stratification	PLOS ONE			English	Article							ISLET-CELL CARCINOMA; PANCREATIC ENDOCRINE CARCINOMAS; ENETS CONSENSUS GUIDELINES; GASTROENTEROPANCREATIC TUMORS; CHROMOGRANIN-A; DOXORUBICIN; SURVIVAL; FLUOROURACIL; MANAGEMENT; EVEROLIMUS	Background and Aim Chemotherapy with streptozocin (STZ) in combination with 5-FU or doxorubicin (Dox) represents a standard of care for patients with metastatic pancreatic neuroendocrine neoplasms (pNEN). However, predictive markers for patient selection are still missing. The aim of this study was a retrospective evaluation of the clinicopathological characteristics of pNEN patients receiving STZ-based chemotherapies and to identify predictive and prognostic markers. Patients and Methods We retrospectively analyzed 77 patients treated at our center between 1995 and 2013. The median overall survival (OS) and progression-free survival (PFS) were calculated using Kaplan-Meier and Cox regression methods, respectively. Uni-and multivariate analyses were performed. Results The median PFS (mPFS) in patients receiving STZ/5-FU/Dox was 16 months with a median OS (mOS) of 28 months. Objective response rate (ORR) and disease control rate (DCR) were 34% and 72%, respectively. Biochemical response and positive octreotide scintigraphy predicted objective response. Univariate analysis revealed Ki-67 > 10% and the absence of biochemical or objective response by imaging as independent risk factors for shorter PFS. Additionally, performance status (PS) and resection of the primary tumor were observed to influence mOS. Treatment was well tolerated with less than 10% grade 3 and 4 toxicities. Conclusions STZ-based chemotherapy is an effective and well-tolerated treatment option in patients with well differentiated neuroendocrine neoplasms. Positive octreotide scintigraphy and biochemical response predict objective response.	[Krug, Sebastian; Boch, Michael; Mueller, Daniela; Rinke, Anja; Gress, Thomas Matthias] Univ Marburg, Dept Gastroenterol, Marburg, Germany; [Daniel, Hanna] Univ Marburg, Inst Med Biometry, Marburg, Germany; [Nimphius, Wilhelm] Univ Marburg, Inst Pathol, Marburg, Germany; [Michl, Patrick] Univ Halle Wittenberg, Dept Gastroenterol & Hepatol, D-06108 Halle, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Martin Luther University Halle Wittenberg	Rinke, A (corresponding author), Univ Marburg, Dept Gastroenterol, Marburg, Germany.	sprengea@uni-marburg.de	Krug, Sebastian/ABE-2890-2020; Michl, Patrick/HDN-4172-2022; Michl, Patrick/AAG-3987-2021	Krug, Sebastian/0000-0003-1672-7995; Gress, Thomas/0000-0002-9333-5461	Rhon-Forschungsforderung	Rhon-Forschungsforderung	This work was supported by internal funding from Rhon-Forschungsforderung.	Arnold R, 2008, CLIN GASTROENTEROL H, V6, P820, DOI 10.1016/j.cgh.2008.02.052; Cheng PNM, 1999, CANCER, V86, P944, DOI 10.1002/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.3.CO;2-G; COX DR, 1972, J R STAT SOC B, V34, P187; Delaunoit T, 2004, EUR J CANCER, V40, P515, DOI 10.1016/j.ejca.2003.09.035; Duffaud F, 2000, B CANCER, V87, P881, DOI 10.1093/jnci/92.3.205; Ekeblad S, 2008, CLIN CANCER RES, V14, P7798, DOI 10.1158/1078-0432.CCR-08-0734; Falconi M, 2012, NEUROENDOCRINOLOGY, V95, P120, DOI 10.1159/000335587; Fjallskog MLH, 2008, NEUROENDOCRINOLOGY, V88, P53, DOI 10.1159/000117575; Jann H, 2011, CANCER-AM CANCER SOC, V117, P3332, DOI 10.1002/cncr.25855; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaplan E, 1958, J AM STAT ASSOC, V53, P281; Khan MS, 2013, J CLIN ONCOL, V31, P365, DOI 10.1200/JCO.2012.44.2905; Kloppel G, 2010, PATHOLOGE, V31, P353, DOI 10.1007/s00292-010-1385-z; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; Kwekkeboom DJ, 2008, J CLIN ONCOL, V26, P2124, DOI 10.1200/JCO.2007.15.2553; Larghi A, 2012, GASTROINTEST ENDOSC, V76, P570, DOI 10.1016/j.gie.2012.04.477; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Marinoni I, 2014, GASTROENTEROLOGY, V146, P453, DOI 10.1053/j.gastro.2013.10.020; McCollum AD, 2004, AM J CLIN ONCOL-CANC, V27, P485, DOI 10.1097/01.coc.0000135343.06038.eb; MOERTEL CG, 1992, NEW ENGL J MED, V326, P519, DOI 10.1056/NEJM199202203260804; MOERTEL CG, 1980, NEW ENGL J MED, V303, P1189, DOI 10.1056/NEJM198011203032101; O'Toole D, 2010, ENDOCR-RELAT CANCER, V17, P847, DOI 10.1677/ERC-09-0204; Oberg K, 2012, ANN ONCOL, V23, P124, DOI 10.1093/annonc/mds295; Panzuto F, 2011, J CLIN ONCOL, V29, P2372, DOI 10.1200/JCO.2010.33.0688; Pape UF, 2008, ENDOCR-RELAT CANCER, V15, P1083, DOI 10.1677/ERC-08-0017; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Rindi G, 2012, JNCI-J NATL CANCER I, V104, P764, DOI 10.1093/jnci/djs208; Rindi G, 2010, WHO CLASSIFICATION O; Scarpa A, 2010, MODERN PATHOL, V23, P824, DOI 10.1038/modpathol.2010.58; Schmitt AM, 2014, NEUROENDOCRINOLOGY, V100, P35, DOI 10.1159/000365514; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Strosberg JR, 2012, ANN SURG, V256, P321, DOI 10.1097/SLA.0b013e31824e6108; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Vilar E, 2007, ENDOCR-RELAT CANCER, V14, P221, DOI 10.1677/ERC-06-0074; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, J CLIN ENDOCR METAB, V96, P3741, DOI 10.1210/jc.2011-0666; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	39	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143822	10.1371/journal.pone.0143822	http://dx.doi.org/10.1371/journal.pone.0143822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630134	Green Published, gold			2022-12-26	WOS:000365926300106
J	Mody, KT; Mahony, D; Cavallaro, AS; Zhang, J; Zhang, B; Mahony, TJ; Yu, CZ; Mitter, N				Mody, Karishma T.; Mahony, Donna; Cavallaro, Antonino S.; Zhang, Jun; Zhang, Bing; Mahony, Timothy J.; Yu, Chengzhong; Mitter, Neena			Silica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 Protein	PLOS ONE			English	Article							NANOPARTICLES; VACCINE; ANTIGEN; BVDV; STABILIZATION; STABILITY; ADJUVANTS	Bovine Viral Diarrhoea Virus (BVDV) is one of the most serious pathogen, which causes tremendous economic loss to the cattle industry worldwide, meriting the development of improved subunit vaccines. Structural glycoprotein E2 is reported to be a major immunogenic determinant of BVDV virion. We have developed a novel hollow silica vesicles (SV) based platform to administer BVDV-1 Escherichia coli-expressed optimised E2 (oE2) antigen as a nanovaccine formulation. The SV-140 vesicles (diameter 50 nm, wall thickness 6 nm, perforated by pores of entrance size 16 nm and total pore volume of 0.934 cm(3)g(-1)) have proven to be ideal candidates to load oE2 antigen and generate immune response. The current study for the first time demonstrates the ability of freeze-dried (FD) as well as non-FD oE2/SV140 nanovaccine formulation to induce long-term balanced antibody and cell mediated memory responses for at least 6 months with a shortened dosing regimen of two doses in small animal model. The in vivo ability of oE2 (100 mu g)/SV-140 (500 mu g) and FD oE2 (100 mu g)/SV-140 (500 mu g) to induce long-term immunity was compared to immunisation with oE2 (100 mu g) together with the conventional adjuvant Quil-A from the Quillaja saponira (10 mu g) in mice. The oE2/SV-140 as well as the FD oE2/SV-140 nanovaccine generated oE2-specific antibody and cell mediated responses for up to six months post the final second immunisation. Significantly, the cell-mediated responses were consistently high in mice immunised with oE2/SV-140 (1,500 SFU/million cells) at the six-month time point. Histopathology studies showed no morphological changes at the site of injection or in the different organs harvested from the mice immunised with 500 mu g SV-140 nanovaccine compared to the unimmunised control. The platform has the potential for developing single dose vaccines without the requirement of cold chain storage for veterinary and human applications.	[Mody, Karishma T.; Mahony, Donna; Cavallaro, Antonino S.; Mahony, Timothy J.; Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia; [Zhang, Jun; Yu, Chengzhong] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Zhang, Bing] Queensland Dept Agr & Fisheries, Anim Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Yu, CZ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	c.yu@uq.edu.au; n.mitter@uq.edu.au	Yu, Chengzhong/I-8663-2012; Mahony, Timothy J./C-9307-2013; mitter, neena/D-1862-2013	Yu, Chengzhong/0000-0003-3707-0785; Mahony, Timothy J./0000-0003-4573-7906; mitter, neena/0000-0001-6146-6179; Mody, Karishma/0000-0002-7499-7988; Zhang, Jun/0000-0001-7030-2686; Cavallaro, Tony/0000-0002-3601-3386	Queensland Government Research Partnership [2012001137]; Queensland Alliance for Agriculture and Food Innovation, The University of Queensland	Queensland Government Research Partnership; Queensland Alliance for Agriculture and Food Innovation, The University of Queensland	The work was facilitated by a Queensland Government Research Partnership grant 2012001137. Karishma Mody's PhD was supported by Queensland Alliance for Agriculture and Food Innovation, The University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhorn MG, 2008, INT J PHARMACEUT, V363, P162, DOI 10.1016/j.ijpharm.2008.07.004; Baheti A., 2010, J EXCIPIENTS FOOD CH, V1, P41; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; Divers TJ, 2008, REBUHNS DIS DAIRY CA, V2nd; Gard JA, 2007, THERIOGENOLOGY, V68, P434, DOI 10.1016/j.theriogenology.2007.04.003; Guo HC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-108; Liu LH, 2009, VIROLOGY, V385, P351, DOI 10.1016/j.virol.2008.12.004; Liu W, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060223; Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; Mahony TJ., 2012, DRUG DELIV LETT, V2, P83, DOI [DOI 10.2174/2210304X11202020083, 10.2174/2210304x11202020083]; McGowan M, 2008, GUIDELINES HET INVES; Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515; Mody KT, 2014, BIOMATERIALS, V35, P9972, DOI 10.1016/j.biomaterials.2014.08.044; Mody KT, 2014, INT J PHARMACEUT, V465, P325, DOI 10.1016/j.ijpharm.2014.01.037; Mody KT, 2013, NANOSCALE, V5, P5167, DOI 10.1039/c3nr00357d; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Aguirreburualde MSP, 2013, VET IMMUNOL IMMUNOP, V151, P315, DOI 10.1016/j.vetimm.2012.12.004; Ridpath JF, 2000, VET MICROBIOL, V77, P145, DOI 10.1016/S0378-1135(00)00271-6; Sameti M, 2003, INT J PHARMACEUT, V266, P51, DOI 10.1016/S0378-5173(03)00380-6; Snider M, 2014, VACCINE, V32, P6758, DOI 10.1016/j.vaccine.2014.10.010; Tonnis WF, 2014, EUR J PHARM SCI, V55, P36, DOI 10.1016/j.ejps.2014.01.005; Zhang J, 2014, SMALL, V10, P5068, DOI 10.1002/smll.201401538	24	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143507	10.1371/journal.pone.0143507	http://dx.doi.org/10.1371/journal.pone.0143507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630001	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000365926300055
J	Qin, Z; Wang, YP; Wang, QM; Li, AX; Hou, FY; Zhang, LM				Qin, Zhen; Wang, Yanping; Wang, Qingmei; Li, Aixian; Hou, Fuyun; Zhang, Liming			Evolution Analysis of Simple Sequence Repeats in Plant Genome	PLOS ONE			English	Article							TANDEM REPEATS; MUTATION-RATES; WIDE ANALYSIS; MICROSATELLITES; DUPLICATION; DIVERGENCE; GENES; MAIZE; DNA; CHLAMYDOMONAS	Simple sequence repeats (SSRs) are widespread units on genome sequences, and play many important roles in plants. In order to reveal the evolution of plant genomes, we investigated the evolutionary regularities of SSRs during the evolution of plant species and the plant kingdom by analysis of twelve sequenced plant genome sequences. First, in the twelve studied plant genomes, the main SSRs were those which contain repeats of 1-3 nucleotides combination. Second, in mononucleotide SSRs, the A/T percentage gradually increased along with the evolution of plants (except for P. patens). With the increase of SSRs repeat number the percentage of A/T in C. reinhardtii had no significant change, while the percentage of A/T in terrestrial plants species gradually declined. Third, in dinucleotide SSRs, the percentage of AT/TA increased along with the evolution of plant kingdom and the repeat number increased in terrestrial plants species. This trend was more obvious in dicotyledon than monocotyledon. The percentage of CG/GC showed the opposite pattern to the AT/TA. Forth, in trinucleotide SSRs, the percentages of combinations including two or three A/T were in a rising trend along with the evolution of plant kingdom; meanwhile with the increase of SSRs repeat number in plants species, different species chose different combinations as dominant SSRs. SSRs in C. reinhardtii, P. patens, Z. mays and A. thaliana showed their specific patterns related to evolutionary position or specific changes of genome sequences. The results showed that, SSRs not only had the general pattern in the evolution of plant kingdom, but also were associated with the evolution of the specific genome sequence. The study of the evolutionary regularities of SSRs provided new insights for the analysis of the plant genome evolution.	[Qin, Zhen; Wang, Qingmei; Li, Aixian; Hou, Fuyun; Zhang, Liming] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Peoples R China; [Wang, Yanping] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Zhang, LM (corresponding author), Shandong Acad Agr Sci, Crop Res Inst, Jinan, Peoples R China.	zhanglm11@sina.com			National Nature Science Foundation of China [31401460]; China Agriculture Research System of Sweetpotato [CARS-11-B-06, CARS-11-B-11]; Nature Science Foundation of Shandong province [ZR2014YL015]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System of Sweetpotato; Nature Science Foundation of Shandong province(Natural Science Foundation of Shandong Province)	This work was supported by the National Nature Science Foundation of China (31401460; http://isisn.nsfc.gov.cn/egrantweb/), the China Agriculture Research System of Sweetpotato (CARS-11-B-06 and CARS-11-B-11) and the Nature Science Foundation of Shandong province (ZR2014YL015).	Akagi H, 2001, MOL GENET GENOMICS, V266, P471, DOI 10.1007/s004380100563; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; CRANE PR, 1989, SCIENCE, V246, P675, DOI 10.1126/science.246.4930.675; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Haasl RJ, 2013, MOL BIOL EVOL, V30, P285, DOI 10.1093/molbev/mss247; Harr B, 2002, MOL CELL, V10, P199, DOI 10.1016/S1097-2765(02)00575-0; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Hou L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126794; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Loire E, 2013, GENOME BIOL EVOL, V5, P283, DOI 10.1093/gbe/evt003; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Proost S, 2011, PLANT J, V66, P58, DOI 10.1111/j.1365-313X.2011.04521.x; Pumpernik D, 2008, MOL GENET GENOMICS, V279, P53, DOI 10.1007/s00438-007-0294-1; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rensing SA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-130; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schug MD, 1998, MOL BIOL EVOL, V15, P1751, DOI 10.1093/oxfordjournals.molbev.a025901; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Shankar R, 2007, MOL GENET GENOMICS, V277, P441, DOI 10.1007/s00438-007-0210-8; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; Siddle KJ, 2011, BIOINFORMATICS, V27, P895, DOI 10.1093/bioinformatics/btr067; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Vigouroux Y, 2003, MOL BIOL EVOL, V20, P1480, DOI 10.1093/molbev/msg156; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Xie Chuanxiao, 2007, Journal of Genetics and Genomics, V34, P738, DOI 10.1016/S1673-8527(07)60083-6; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhao ZX, 2014, G3-GENES GENOM GENET, V4, P67, DOI 10.1534/g3.113.008524	59	28	28	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144108	10.1371/journal.pone.0144108	http://dx.doi.org/10.1371/journal.pone.0144108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630570	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300160
J	Treerat, P; Alwis, P; D'Cruze, T; Cullinane, M; Vadivelu, J; Devenish, RJ; Prescott, M; Adler, B; Boyce, JD				Treerat, Puthayalai; Alwis, Priyangi; D'Cruze, Tanya; Cullinane, Meabh; Vadivelu, Jamunarani; Devenish, Rodney J.; Prescott, Mark; Adler, Ben; Boyce, John D.			The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ACYL CARRIER PROTEIN; LYTIC TRANSGLYCOSYLASES; INTRACELLULAR SURVIVAL; GENE-EXPRESSION; REAL-TIME; PATHOGENIC BACTERIA; ESCHERICHIA-COLI; III EFFECTORS; SYSTEM	Many Gram-negative pathogens use a type III secretion system (TTSS) for the injection of bacterial effector proteins into host cells. The injected effector proteins play direct roles in modulation of host cell pathways for bacterial benefit. Burkholderia pseudomallei, the causative agent of melioidosis, expresses three different TTSSs. One of these systems, the TTSS3, is essential for escape from host endosomes and therefore intracellular survival and replication. Here we have characterized three putative TTSS3 proteins; namely BapA, BapB and BapC. By employing a tetracysteine (TC)-FlAsH (TM) labelling technique to monitor the secretion of TC-tagged fusion proteins, BapA and BapC were shown to be secreted during in vitro growth in a TTSS3-dependant manner, suggesting a role as TTSS3 effectors. Furthermore, we constructed B. pseudomallei bapA, bapB and bapC mutants and used the well-characterized TTSS3 effector BopE as a marker of secretion to show that BapA, BapB and BapC are not essential for the secretion process. However, BopE transcription and secretion were significantly increased in the bapB mutant, suggesting that BapB levels modulate BopE expression. In a BALB/c mouse model of acute melioidosis, the bapA, bapB and bapC mutants showed a minor reduction of in vivo fitness. Thus, this study defines BapA and BapC as novel TTSS3 effectors, BapB as a regulator of BopE production, and all three as necessary for full B. pseudomallei in vivo fitness.	[Treerat, Puthayalai; Alwis, Priyangi; D'Cruze, Tanya; Vadivelu, Jamunarani; Devenish, Rodney J.; Prescott, Mark; Adler, Ben; Boyce, John D.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Treerat, Puthayalai; Alwis, Priyangi; D'Cruze, Tanya; Vadivelu, Jamunarani; Devenish, Rodney J.; Prescott, Mark; Adler, Ben; Boyce, John D.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia; [Treerat, Puthayalai; Alwis, Priyangi; Cullinane, Meabh; Vadivelu, Jamunarani; Adler, Ben; Boyce, John D.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [D'Cruze, Tanya; Devenish, Rodney J.; Prescott, Mark] Monash Univ, Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; Monash University	Boyce, JD (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	john.boyce@monash.edu	VADIVELU, JAMUNARANI S/B-8696-2010; Boyce, John D/F-5058-2012	VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Boyce, John D/0000-0002-8614-3074; Cullinane, Meabh/0000-0003-4947-1826	Australian Research Council (AU), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics [CE0562063]; National Health and Medical Research Council (AU) [545855]; Australia-Malaysia Institute; University of Malaya High Impact Research (HIR)-MOHE project [E000013-20001]	Australian Research Council (AU), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council (AU); Australia-Malaysia Institute; University of Malaya High Impact Research (HIR)-MOHE project	This work was funded by Australian Research Council (AU), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics (Grant number CE0562063); National Health and Medical Research Council (AU) (Project Grant number 545855). Jamunarani Vadivelu gratefully acknowledges receipt of a travel fellowship from the Australia-Malaysia Institute and University of Malaya High Impact Research (HIR)-MOHE project (E000013-20001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Allwood EM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00170; Arnold U, 1999, ANAL BIOCHEM, V271, P197, DOI 10.1006/abio.1999.4149; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Buttner D, 2009, PLANT PHYSIOL, V150, P1656, DOI 10.1104/pp.109.139089; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; CHANG YC, 1992, ANAL BIOCHEM, V205, P22, DOI 10.1016/0003-2697(92)90573-P; Chen YH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0206-6; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; D'Cruze T, 2011, INFECT IMMUN, V79, P3659, DOI 10.1128/IAI.01351-10; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Enninga J, 2009, CELL MICROBIOL, V11, P1462, DOI 10.1111/j.1462-5822.2009.01360.x; Eom JS, 2012, J BACTERIOL, V194, P4332, DOI 10.1128/JB.00076-12; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gong L, 2015, INFECT IMMUN, V83, P1276, DOI 10.1128/IAI.03070-14; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Harper M, 2004, INFECT IMMUN, V72, P3436, DOI 10.1128/IAI.72.6.3436-3443.2004; Harper M, 2003, INFECT IMMUN, V71, P5440, DOI 10.1128/IAI.71.9.5440-5446.2003; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hung CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034220; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kang WT, 2015, J INFECT DIS, V211, P827, DOI 10.1093/infdis/jiu492; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06; Logue CA, 2009, J MICROBIOL METH, V76, P320, DOI 10.1016/j.mimet.2008.12.007; Machleidt T, 2007, METH MOL B, V356, P209; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIRAS I, 1995, RES MICROBIOL, V146, P17, DOI 10.1016/0923-2508(96)80267-1; Muangman S, 2011, FEMS MICROBIOL LETT, V323, P75, DOI 10.1111/j.1574-6968.2011.02359.x; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Noel L, 2002, J BACTERIOL, V184, P1340, DOI 10.1128/JB.184.5.1340-1348.2002; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Simpson N, 2010, METHODS MOL BIOL, V619, P241, DOI 10.1007/978-1-60327-412-8_14; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Sun GW, 2010, TRENDS MICROBIOL, V18, P561, DOI 10.1016/j.tim.2010.09.002; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Szpirer CY, 2001, J BACTERIOL, V183, P2101, DOI 10.1128/JB.183.6.2101-2110.2001; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Vander Broek CW, 2015, MOL CELL PROTEOMICS, V14, P905, DOI 10.1074/mcp.M114.044875; VanEngelenburg SB, 2008, CHEM BIOL, V15, P619, DOI 10.1016/j.chembiol.2008.04.014; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Winstanley C, 2001, J MED MICROBIOL, V50, P116, DOI 10.1099/0022-1317-50-2-116; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0; Zhu WG, 2000, J BACTERIOL, V182, P1844, DOI 10.1128/JB.182.7.1844-1853.2000	80	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143916	10.1371/journal.pone.0143916	http://dx.doi.org/10.1371/journal.pone.0143916			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624293	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600074
J	Lin, FY; Zhu, JH; Eng, ET; Hudson, NE; Springer, TA				Lin, Fu-Yang; Zhu, Jianghai; Eng, Edward T.; Hudson, Nathan E.; Springer, Timothy A.			beta-Subunit Binding Is Sufficient for Ligands to Open the Integrin alpha(IIb)beta(3) Headpiece	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-MOLECULAR-WEIGHT; PLATELET RECEPTOR; GAMMA-CHAIN; HUMAN-FIBRINOGEN; STRUCTURAL BASIS; RECOGNITION; COMPLEX; AFFINITY; PEPTIDE; SEGMENT	The platelet integrin alpha(IIb)beta(3) binds to a KQAGDV motif at the fibrinogen gamma-chain C terminus and to RGD motifs present in loops in many extracellular matrix proteins. These ligands bind in a groove between the integrin alpha and beta-subunits; the basic Lys or Arg side chain hydrogen bonds to the alpha(IIb)-subunit, and the acidic Asp side chain coordinates to a metal ion held by the beta(3)-subunit. Ligand binding induces headpiece opening, with conformational change in the beta-subunit. During this opening, RGDslides in the ligand-binding pocket toward alpha(IIb), with movement of the beta I-domain beta 1-alpha 1 loop toward alpha(IIb), enabling formation of direct, charged hydrogen bonds between the Arg side chain and alpha(IIb). Here we test whether ligand interactions with beta(3) suffice for stable ligand binding and headpiece opening. We find that the AGDV tetrapeptide from KQAGDV binds to the alpha(IIb)beta(3) headpiece with affinity comparable with the RGDSP peptide from fibronectin. AGDV induced complete headpiece opening in solution as shown by increase in hydrodynamic radius. Soaking of AGDV into closed alpha(IIb)beta(3) headpiece crystals induced intermediate states similarly to RGDSP. AGDV has very little contact with the alpha-subunit. Furthermore, as measured by epitope exposure, AGDV, like the fibrinogen gamma C-terminal peptide and RGD, caused integrin extension on the cell surface. Thus, pushing by the beta(3)-subunit on Asp is sufficient for headpiece opening and ligand sliding, and no pulling by the alpha(IIb) subunit on Arg is required.	[Lin, Fu-Yang; Zhu, Jianghai; Eng, Edward T.; Hudson, Nathan E.; Springer, Timothy A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA; [Eng, Edward T.] New York Struct Biol Ctr, New York, NY 10027 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu		Hudson, Nathan/0000-0003-0573-7661; Eng, Edward/0000-0002-8014-7269	NCI [ACB-12002]; NIGMS [AGM-12006]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526, R01HL131729] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the staff of the GM/CA beamline of the Advanced Photon Source (APS). GM/CA@APS has been funded in whole or in part with Federal funds from the NCI (ACB-12002) and the NIGMS (AGM-12006). This research used resources of the Advanced Photon Source, a U. S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract Number DE-AC02-06CH11357. We thank Dr. Paul B. Gillespie from Roche for providing Ro-435054. We also thank Drs. Xianchi Dong and Adem Koksal for collecting part of the x-ray diffraction data, and finally Dr. Jieqing Zhu for helpful discussions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALIG L, 1992, J MED CHEM, V35, P4393, DOI 10.1021/jm00101a017; ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258; Bednar RA, 1998, J PHARMACOL EXP THER, V285, P1317; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; Geremia S, 2006, STRUCTURE, V14, P393, DOI 10.1016/j.str.2005.12.007; Holmback K, 1996, EMBO J, V15, P5760, DOI 10.1002/j.1460-2075.1996.tb00962.x; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KLOCZEWIAK M, 1989, BIOCHEMISTRY-US, V28, P2915, DOI 10.1021/bi00433a025; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Sanchez-Cortes J, 2009, CHEM BIOL, V16, P990, DOI 10.1016/j.chembiol.2009.08.012; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STRONG DD, 1985, BIOCHEMISTRY-US, V24, P92, DOI 10.1021/bi00322a014; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	28	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4537	4546		10.1074/jbc.M115.705624	http://dx.doi.org/10.1074/jbc.M115.705624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26631735	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000371604600023
J	Yu, W; Denu, RA; Krautkramer, KA; Grindle, KM; Yang, DT; Asimakopoulos, F; Hematti, P; Denu, JM				Yu, Wei; Denu, Ryan A.; Krautkramer, Kimberly A.; Grindle, Kreg M.; Yang, David T.; Asimakopoulos, Fotis; Hematti, Peiman; Denu, John M.			Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cancer; cell proliferation; superoxide dismutase (SOD); Warburg effect; B cell; ROS; isocitrate dehydrogenase; sirtuins	CHRONIC LYMPHOCYTIC-LEUKEMIA; CALORIE RESTRICTION; ISOCITRATE DEHYDROGENASE; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASE; PROTEIN EXPRESSION; OXIDATIVE DAMAGE; CANCER; SUPPRESSOR; STRESS	B cell malignancies comprise a diverse group of cancers that proliferate in lymph nodes, bone marrow, and peripheral blood. SIRT3 (sirtuin 3) is the major deacetylase within the mitochondrial matrix that promotes aerobic metabolism and controls reactive oxygen species (ROS) by deacetylating and activating isocitrate dehydrogenase 2 (IDH2) and superoxide dismutase 2 (SOD2). There is controversy as to whether SIRT3 acts as an oncogene or a tumor suppressor, and here we investigated its role in B cell malignancies. In mantle cell lymphoma patient samples, we found that lower SIRT3 protein expression was associated with worse overall survival. Further, SIRT3 protein expression was reduced in chronic lymphocytic leukemia primary samples and malignant B cell lines compared to primary B cells from healthy donors. This lower level of expression correlated with hyperacetylation of IDH2 and SOD2 mitochondrial proteins, lowered enzymatic activities, and higher ROS levels. Overexpression of SIRT3 decreased proliferation and diminished the Warburg-like phenotype in SIRT3-deficient cell lines, and this effect is largely dependent on deacetylation of IDH2 and SOD2. Lastly, depletion of SIRT3 from malignant B cell lines resulted in greater susceptibility to treatment with an ROS scavenger but did not result in greater sensitivity to inhibition of the hypoxia-inducible factor-1 pathway, suggesting that loss of SIRT3 increases proliferation via ROS-dependent but hypoxia-inducible factor-1-independent mechanisms. Our study suggests that SIRT3 acts as a tumor suppressor in B cell malignancies, and activating the SIRT3 pathway might represent a novel therapeutic approach for treating B cell malignancies.	[Yu, Wei; Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Yu, Wei; Krautkramer, Kimberly A.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Denu, Ryan A.; Krautkramer, Kimberly A.] Univ Wisconsin, Med Scientist Training Program, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Denu, Ryan A.; Grindle, Kreg M.; Asimakopoulos, Fotis; Hematti, Peiman] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Yang, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Asimakopoulos, Fotis; Hematti, Peiman; Denu, John M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hematti, P (corresponding author), Univ Wisconsin, 4033 WIMR,1111 Highland Ave, Madison, WI 53705 USA.; Denu, JM (corresponding author), Univ Wisconsin, 2178 WID,330 N Orchard St, Madison, WI 53715 USA.	pxh@medicine.wisc.edu; jmdenu@wisc.edu	Krautkramer, Kimberly/AAR-7014-2020	Krautkramer, Kimberly/0000-0002-9227-0977; YU, WEI/0000-0001-9898-4607	University of Wisconsin Carbone Cancer Center; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, TL1TR000429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038679] Funding Source: NIH RePORTER	University of Wisconsin Carbone Cancer Center; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Special thanks to the Forward Lymphoma Group at the University of Wisconsin-Madison. We thank the University of Wisconsin Carbone Cancer Center for funding to complete this project and the University of Wisconsin Translational Research Initiatives in Pathology Laboratory, in part supported by the University of Wisconsin Department of Pathology and Laboratory Medicine and University of Wisconsin Carbone Cancer Center Grant P30 CA014520, for use of its facilities and services.	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hoster E, 2008, BLOOD, V111, P558, DOI 10.1182/blood-2007-06-095331; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lilienthal N, 2011, LEUKEMIA LYMPHOMA, V52, P1407, DOI 10.3109/10428194.2011.568077; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu CY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/871263; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miyamoto S, 2001, INT J ONCOL, V18, P705; Oberley MJ, 2013, HISTOPATHOLOGY, V63, P499, DOI 10.1111/his.12207; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Schedel J, 2004, ANN RHEUM DIS, V63, P1205, DOI 10.1136/ard.2003.006312; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tong L, 2009, J BIOL CHEM, V284, P11256, DOI 10.1074/jbc.M809790200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Van Damme M, 2012, EPIGENETICS-US, V7, P1403, DOI 10.4161/epi.22674; Wang JC, 2011, ONCOLOGY-BASEL, V81, P325, DOI 10.1159/000334577; Wang JX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-297; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yan SM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0103-8; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V423, P26, DOI 10.1016/j.bbrc.2012.05.053; Zwiebel JA, 1998, SEMIN ONCOL, V25, P42	49	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3268	3279		10.1074/jbc.M115.702076	http://dx.doi.org/10.1074/jbc.M115.702076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26631723	Green Published, hybrid			2022-12-26	WOS:000370854500013
J	Grimsey, NJ; Coronel, LJ; Cordova, IC; Trejo, J				Grimsey, Neil J.; Coronel, Luisa J.; Cordova, Isabel Canto; Trejo, JoAnn			Recycling and Endosomal Sorting of Protease-activated Receptor-1 Is Distinctly Regulated by Rab11A and Rab11B Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELL INVASION; COUPLED RECEPTOR; INTRACELLULAR TRAFFICKING; THROMBIN RECEPTORS; EPITHELIAL-CELLS; DOWN-REGULATION; TP-BETA; PHOSPHORYLATION; INTERNALIZATION; RESENSITIZATION	Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor that undergoes proteolytic irreversible activation by coagulant and anti-coagulant proteases. Given the irreversible activation of PAR1, signaling by the receptor is tightly regulated through desensitization and intracellular trafficking. PAR1 displays both constitutive and agonist-induced internalization. Constitutive internalization of PAR1 is important for generating an internal pool of naive receptors that replenish the cell surface and facilitate resensitization, whereas agonist-induced internalization of PAR1 is critical for terminating G protein signaling. We showed that PAR1 constitutive internalization is mediated by the adaptor protein complex-2 (AP-2), whereas AP-2 and epsin control agonist-induced PAR1 internalization. However, the mechanisms that regulate PAR1 recycling are not known. In the present study we screened a siRNA library of 140 different membrane trafficking proteins to identify key regulators of PAR1 intracellular trafficking. In addition to known mediators of PAR1 endocytosis, we identified Rab11B as a critical regulator of PAR1 trafficking. We found that siRNA-mediated depletion of Rab11B and not Rab11A blocks PAR1 recycling, which enhanced receptor lysosomal degradation. Although Rab11A is not required for PAR1 recycling, depletion of Rab11A resulted in intracellular accumulation of PAR1 through disruption of basal lysosomal degradation of the receptor. Moreover, enhanced degradation of PAR1 observed in Rab11B-deficient cells is blocked by depletion of Rab11A and the autophagy related-5 protein, suggesting that PAR1 is shuttled to an autophagic degradation pathway in the absence of Rab11B recycling. Together these findings suggest that Rab11A and Rab11B differentially regulate intracellular trafficking of PAR1 through distinct endosomal sorting mechanisms.	[Grimsey, Neil J.; Coronel, Luisa J.; Cordova, Isabel Canto; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Orlando, Luisa/0000-0002-3177-5242; TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [R01 GM090689]; American Heart Association; University of California Tobacco-related Disease Research Program Dissertation Award; Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of California Tobacco-related Disease Research Program Dissertation Award; Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (to J. T.) The authors declare they have no conflict of interest with the contents of this article.r Supported by an American Heart Association Postdoctoral Fellowship Award.r Supported by University of California Tobacco-related Disease Research Program Dissertation Award.r Supported by the Initiative for Maximizing Student Development at University of California, San Diego, La Jolla, CA.	Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Bowman SL, 2015, PROG MOL BIOL TRANSL, V132, P189, DOI 10.1016/bs.pmbts.2015.03.005; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Canto I, 2012, MINI-REV MED CHEM, V12, P804, DOI 10.2174/138955712800959116; Canto I, 2013, J BIOL CHEM, V288, P15900, DOI 10.1074/jbc.M113.469866; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Ellis CA, 1999, AM J PHYSIOL-CELL PH, V276, pC38, DOI 10.1152/ajpcell.1999.276.1.C38; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kommaddi RP, 2015, J BIOL CHEM, V290, P8888, DOI 10.1074/jbc.M114.630541; Lapierre LA, 2003, EXP CELL RES, V290, P322, DOI 10.1016/S0014-4827(03)00340-9; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Scapin SMN, 2006, J STRUCT BIOL, V154, P260, DOI 10.1016/j.jsb.2006.01.007; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Theriault C, 2004, BIOCHEMISTRY-US, V43, P5600, DOI 10.1021/bi036268v; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	46	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2223	2236		10.1074/jbc.M115.702993	http://dx.doi.org/10.1074/jbc.M115.702993			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26635365	Green Published, hybrid			2022-12-26	WOS:000369610400014
J	Yuan, YY; Hakimi, P; Kao, C; Kao, A; Liu, RF; Janocha, A; Boyd-Tressler, A; Hang, X; Alhoraibi, H; Slater, E; Xia, K; Cao, PX; Shue, Q; Ching, TT; Hsu, AL; Erzurum, SC; Dubyak, GR; Berger, NA; Hanson, RW; Feng, ZY				Yuan, Yiyuan; Hakimi, Parvin; Kao, Clara; Kao, Allison; Liu, Ruifu; Janocha, Allison; Boyd-Tressler, Andrea; Hang, Xi; Alhoraibi, Hanna; Slater, Erin; Xia, Kevin; Cao, Pengxiu; Shue, Quinn; Ching, Tsui-Ting; Hsu, Ao-Lin; Erzurum, Serpil C.; Dubyak, George R.; Berger, Nathan A.; Hanson, Richard W.; Feng, Zhaoyang			Reciprocal Changes in Phosphoenolpyruvate Carboxykinase and Pyruvate Kinase with Age Are a Determinant of Aging in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; EXTENDS LIFE-SPAN; DIETARY RESTRICTION; CALORIE RESTRICTION; IN-VIVO; ENERGY-METABOLISM; PHYSICAL-ACTIVITY; GENE-EXPRESSION; C-ELEGANS; LONGEVITY	Aging involves progressive loss of cellular function and integrity, presumably caused by accumulated stochastic damage to cells. Alterations in energy metabolism contribute to aging, but how energy metabolism changes with age, how these changes affect aging, and whether they can be modified to modulate aging remain unclear. In locomotory muscle of post-fertile Caenorhabditis elegans, weidentified a progressive decrease in cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C), a longevity-associated metabolic enzyme, and a reciprocal increase in glycolytic pyruvate kinase (PK) that were necessary and sufficient to limit lifespan. Decline in PEPCK-C with age also led to loss of cellular function and integrity including muscle activity, and cell ularsenescence. Genetic and pharmacologic interventions of PEPCK-C, muscle activity, and AMPK signaling demonstrate that declines in PEPCK-C and muscle function with age interacted to limit reproductive life and lifespan via disrupted energy homeostasis. Quantifications of metabolic flux show that reciprocal changes in PEPCK-Cand PK with age shunted energy metabolism toward glycolysis, reducing mitochondrial bioenergetics. Last, calorie restriction countered changes in PEPCK-C and PK with age to elicit antiaging effects via TOR inhibition. Thus, a programmed metabolic event involving PEPCK-Cand PK is a determinan to faging that can be modified to modulate aging.	[Yuan, Yiyuan; Kao, Clara; Kao, Allison; Liu, Ruifu; Boyd-Tressler, Andrea; Hang, Xi; Xia, Kevin; Cao, Pengxiu; Shue, Quinn; Dubyak, George R.; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Boyd-Tressler, Andrea; Dubyak, George R.] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA; [Hakimi, Parvin; Alhoraibi, Hanna; Slater, Erin; Berger, Nathan A.; Hanson, Richard W.] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Berger, Nathan A.] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44106 USA; [Janocha, Allison; Erzurum, Serpil C.] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Hang, Xi] Suzhou Hlth Coll, Sch Pharm, Suzhou 215009, Jiangsu, Peoples R China; [Ching, Tsui-Ting; Hsu, Ao-Lin] Univ Michigan, Dept Internal Med, Div Geriatr Med, Ann Arbor, MI 48109 USA; [Hsu, Ao-Lin] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feng, ZY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Hakimi, Parvin/AAB-1643-2021; Hsu, Ao-Lin Allen/AAX-1856-2020	Ching, Tsui-Ting/0000-0001-7650-1766; Dubyak, George/0000-0001-9720-4226; Hsu, Ao-Lin/0000-0002-2864-3134; CAO, PENGXIU/0000-0002-5900-5645	Transdisciplinary Research on Energetics and Cancer Grant [U54-CA-116867]; Whitehall Foundation [2013-08-02]; Ellison Foundation [AG-SS-2420-10]; National Institutes of Health [P20-CA-103736, 1R01AG028516, HL103453, HL60917, HL081064]; NATIONAL CANCER INSTITUTE [U54CA116867, P20CA103736] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109250, R01HL060917, P01HL081064, P01HL103453, R24HL123767, R37HL060917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028516] Funding Source: NIH RePORTER	Transdisciplinary Research on Energetics and Cancer Grant; Whitehall Foundation; Ellison Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Transdisciplinary Research on Energetics and Cancer Grant U54-CA-116867 (directed by Dr. Nathan A. Berger, Nutrition Obesity Research Center, Case Western Reserve University), and Whitehall Foundation Grant 2013-08-02 (to Z. F.), Ellison Foundation Grant AG-SS-2420-10 (to R. W. H. and N. A. B.), and National Institutes of Health Grants P20-CA-103736 (to R. W. H.), 1R01AG028516 (to A. L. H.) and HL103453, HL60917, and HL081064 (to S. C. E.). The authors indicate no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Blouin JM, 2010, BIOCHIMIE, V92, P1772, DOI 10.1016/j.biochi.2010.07.011; Boron W. F., 2003, MED PHYSL CELLULAR M, P858; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Canto C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Ching TT, 2010, AGING CELL, V9, P545, DOI 10.1111/j.1474-9726.2010.00580.x; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Coyle EF, 2000, AM J CLIN NUTR, V72, p512S, DOI 10.1093/ajcn/72.2.512S; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Depuydt G, 2014, J PROTEOME RES, V13, P1938, DOI 10.1021/pr401081b; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; dos Santos JM, 2012, CELL BIOCHEM FUNCT, V30, P191, DOI 10.1002/cbf.1834; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; EVANS WJ, 1995, CLIN GERIATR MED, V11, P725, DOI 10.1016/S0749-0690(18)30267-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jadiya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087635; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kil DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013319; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; MARSHALL CG, 1990, J PHYSIOL-LONDON, V428, P155, DOI 10.1113/jphysiol.1990.sp018205; Meissner B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019937; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Moroz N, 2014, AGING CELL, V13, P1075, DOI 10.1111/acel.12273; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Murshid A, 2013, INT J HYPERTHER, V29, P442, DOI 10.3109/02656736.2013.798873; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Novak CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005869; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Sadasivam M, 2014, GENE, V552, P249, DOI 10.1016/j.gene.2014.09.043; Salom D, 2012, FASEB J, V26, P492, DOI 10.1096/fj.11-197780; SALON C, 1988, J BIOL CHEM, V263, P12278; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Shimada N, 2008, GENES CELLS, V13, P245, DOI 10.1111/j.1365-2443.2008.01165.x; STROEHER VL, 1994, DEV BIOL, V163, P367, DOI 10.1006/dbio.1994.1155; Tan W, 2015, J CELL BIOCHEM, V116, P1583, DOI 10.1002/jcb.25112; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Voet D., 1995, BIOCHEMISTRY; Vukoti K, 2015, J PROTEOME RES, V14, P1483, DOI 10.1021/acs.jproteome.5b00021; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/NMETH.1929, 10.1038/nmeth.1929]; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Xu WL, 2014, REDOX BIOL, V2, P513, DOI 10.1016/j.redox.2014.01.004; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; Yuan YY, 2012, J BIOL CHEM, V287, P31414, DOI 10.1074/jbc.M112.377275; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013	86	18	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1307	1319		10.1074/jbc.M115.691766	http://dx.doi.org/10.1074/jbc.M115.691766			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631730	Green Published, hybrid			2022-12-26	WOS:000368068300025
J	De Fanti, S; Barbieri, C; Sarno, S; Sevini, F; Vianello, D; Tamm, E; Metspalu, E; van Oven, M; Hubner, A; Sazzini, M; Franceschi, C; Pettener, D; Luiselli, D				De Fanti, Sara; Barbieri, Chiara; Sarno, Stefania; Sevini, Federica; Vianello, Dario; Tamm, Erika; Metspalu, Ene; van Oven, Mannis; Huebner, Alexander; Sazzini, Marco; Franceschi, Claudio; Pettener, Davide; Luiselli, Donata			Fine Dissection of Human Mitochondrial DNA Haplogroup HV Lineages Reveals Paleolithic Signatures from European Glacial Refugia	PLOS ONE			English	Article							NEAR-EASTERN; HUMAN MTDNA; POPULATION EXPANSIONS; PHYLOGEOGRAPHY; EVOLUTION; SELECTION; SOUTH; ASIA; RECOLONIZATION; SETTLEMENT	Genetic signatures from the Paleolithic inhabitants of Eurasia can be traced from the early divergent mitochondrial DNA lineages still present in contemporary human populations. Previous studies already suggested a pre-Neolithic diffusion of mitochondrial haplogroup HV*(xH, V) lineages, a relatively rare class of mtDNA types that includes parallel branches mainly distributed across Europe and West Asia with a certain degree of structure. Up till now, variation within haplogroup HV was addressed mainly by analyzing sequence data from the mtDNA control region, except for specific sub-branches, such as HV4 or the widely distributed haplogroups H and V. In this study, we present a revised HV topology based on full mtDNA genome data, and we include a comprehensive dataset consisting of 316 complete mtDNA sequences including 60 new samples from the Italian peninsula, a previously underrepresented geographic area. We highlight points of instability in the particular topology of this haplogroup, reconstructed with BEAST-generated trees and networks. We also confirm a major lineage expansion that probably followed the Late Glacial Maximum and preceded Neolithic population movements. We finally observe that Italy harbors a reservoir of mtDNA diversity, with deep-rooting HV lineages often related to sequences present in the Caucasus and the Middle East. The resulting hypothesis of a glacial refugium in Southern Italy has implications for the understanding of late Paleolithic population movements and is discussed within the archaeological cultural shifts occurred over the entire continent.	[De Fanti, Sara; Barbieri, Chiara; Sarno, Stefania; Sazzini, Marco; Pettener, Davide; Luiselli, Donata] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Sevini, Federica; Vianello, Dario; Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Sevini, Federica; Vianello, Dario; Franceschi, Claudio] Univ Bologna, CIG Interdepartmental Ctr L Galvani Integrated St, Bologna, Italy; [Tamm, Erika; Metspalu, Ene; van Oven, Mannis] Evolutionary Biol Grp, Estonian Bioctr, Tartu, Estonia; [Tamm, Erika; Metspalu, Ene] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [van Oven, Mannis] Erasmus MC Univ Med Ctr Rotterdam, Dept Forens Mol Biol, Rotterdam, Netherlands; [Huebner, Alexander] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Franceschi, Claudio] Osped Bellaria, Inst Neurol Sci Bologna, IRCCS, Bologna, Italy; [Franceschi, Claudio] CNR, Inst Organ Synth & Photoreact ISOF, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; Estonian Biocentre; University of Tartu; Erasmus University Rotterdam; Erasmus MC; Max Planck Society; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Barbieri, C (corresponding author), Max Planck Inst Sci Human Hist, Dept Linguist & Cultural Evolut, Jena, Germany.	barbieri.chiara@gmail.com; donata.luiselli@unibo.it	Tamm, Erika/G-2818-2017; Pettener, Davide/E-1576-2017; Franceschi, Claudio/L-4484-2017	Tamm, Erika/0000-0003-0694-3598; Franceschi, Claudio/0000-0001-9841-6386; Hubner, Alexander/0000-0003-3572-9996; van Oven, Mannis/0000-0003-0026-7998; Barbieri, Chiara/0000-0001-8827-5655; SAZZINI, MARCO/0000-0001-5382-7827; Vianello, Dario/0000-0003-1350-7284	PRIN Progetti di Ricerca di Interesse Nazionale [2010EL8TXP_006]; European Research Council [ERC-2011-AdG 295733]; Estonian Research Council [IUT24-1]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; European Regional Development Fund (European Union) through University of Tartu; Estonian Biocentre EBC ECOGENE student fellowship	PRIN Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Research Council(European Research Council (ERC)European Commission); Estonian Research Council(Estonian Research Council); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; European Regional Development Fund (European Union) through University of Tartu; Estonian Biocentre EBC ECOGENE student fellowship	This work was supported by the PRIN Progetti di Ricerca di Interesse Nazionale 2010EL8TXP_006 grant to DL, http://prin.miur.it/; the European Research Council ERC-2011-AdG 295733 (Langelin) to DP and CB, http://erc.europa.eu/; the Institutional Research Funding from the Estonian Research Council [IUT24-1], http://www.etag.ee/en/estonian-research-council/; and by the European Regional Development Fund (European Union), http://ec.europa.eu/regional_policy/index.cfm/en/funding/erdf/, through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu, http://genomics.ebc.ee/. MvO was supported in part by an Estonian Biocentre EBC ECOGENE student fellowship, https://edukad.etag.ee/project/3010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Benazzi S, 2015, SCIENCE, V348, P793, DOI 10.1126/science.aaa2773; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Canestrelli D, 2007, MOL ECOL, V16, P4808, DOI 10.1111/j.1365-294X.2007.03534.x; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Darriba D, 2012, MOL BIOL EVOL, V9, P239; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duggan AT, 2013, AM J HUM GENET, V92, P279, DOI 10.1016/j.ajhg.2012.12.004; Farjadian S, 2011, HUM HERED, V72, P73, DOI 10.1159/000330166; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Forster P, 1996, AM J HUM GENET, V59, P935; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gvozdik V, 2013, MOL PHYLOGENET EVOL, V69, P1077, DOI 10.1016/j.ympev.2013.05.004; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jochim M., 1987, PLEISTOCENE OLD WORL, P317, DOI DOI 10.1007/978-1-4613-1817-020; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 2002, HUM GENET, V111, P46, DOI 10.1007/s00439-002-0740-4; Mannino MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049802; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mussi M., 1992, POPOLI CIVILTA ITALI; Nenadic O, 2007, J STAT SOFTW, V20; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Ottoni C, 2011, EUR J HUM GENET, V19, P571, DOI 10.1038/ejhg.2010.230; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rieux A, 2014, MOL BIOL EVOL, V31, P2780, DOI 10.1093/molbev/msu222; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Sazzini M, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P529, DOI 10.1007/978-94-007-6704-1_31; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	76	19	19	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144391	10.1371/journal.pone.0144391	http://dx.doi.org/10.1371/journal.pone.0144391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640946	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700110
J	Desoti, VC; Lazarin-Bidoia, D; Ribeiro, FM; Martins, SC; Rodrigues, JHD; Ueda-Nakamura, T; Nakamura, CV; Ximenes, VF; Silva, SD				Desoti, Vania Cristina; Lazarin-Bidoia, Danielle; Ribeiro, Fabianne Martins; Martins, Solange Cardoso; da Silva Rodrigues, Jean Henrique; Ueda-Nakamura, Tania; Nakamura, Celso Vataru; Ximenes, Valdecir Farias; Silva, Sueli de Oliveira			The Combination of Vitamin K-3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process	PLOS ONE			English	Article							KILLS CANCER-CELLS; OXIDATIVE STRESS; CHAGAS-DISEASE; TRYPANOCIDAL ACTION; CARCINOMA-CELLS; TRYPANOTHIONE REDUCTASE; ANTITUMOR-ACTIVITY; CYCLE ARREST; IN-VITRO; DEATH	Chagas' disease is an infection that is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. Because of severe side effects and variable efficacy, the current treatments for Chagas' disease are unsatisfactory, making the search for new chemotherapeutic agents essential. Previous studies have reported various biological activities of naphthoquinones, such as the trypanocidal and antitumor activity of vitamin K-3. The combination of this vitamin with vitamin C exerted better effects against various cancer cells than when used alone. These effects have been attributed to an increase in reactive oxygen species generation. In the present study, we evaluated the activity of vitamin K-3 and vitamin C, alone and in combination, against T. cruzi. The vitamin K-3 + vitamin C combination exerted synergistic effects against three forms of T. cruzi, leading to morphological, ultrastructural, and functional changes by producing reactive species, decreasing reduced thiol groups, altering the cell cycle, causing lipid peroxidation, and forming autophagic vacuoles. Our hypothesis is that the vitamin K-3 + vitamin C combination induces oxidative imbalance in T. cruzi, probably started by a redox cycling process that leads to parasite cell death.	[Desoti, Vania Cristina; Lazarin-Bidoia, Danielle; Ribeiro, Fabianne Martins; Ueda-Nakamura, Tania; Nakamura, Celso Vataru; Silva, Sueli de Oliveira] Univ Estadual Maringa, Programa Pos Grad Ciencias Farmaceut, Maringa, PR, Brazil; [Martins, Solange Cardoso; da Silva Rodrigues, Jean Henrique; Nakamura, Celso Vataru] Univ Estadual Maringa, Programa Pos Grad Ciencias Biol Biol Celular & Mo, Maringa, PR, Brazil; [Ximenes, Valdecir Farias] Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual Paulista	Silva, SD (corresponding author), Univ Estadual Maringa, Programa Pos Grad Ciencias Farmaceut, Maringa, PR, Brazil.	lautenschlager@uem.br	Rodrigues, Jean Henrique/G-6277-2017; Desoti, Vania/AAC-6414-2020; Ueda-Nakamura, Tania/P-8250-2015; Ximenes, Valdecir/A-5323-2008; Nakamura, Celso Vataru/AAA-5620-2019; Lautenschlager, Sueli OS/P-2164-2017; Bidoia, Danielle Lazarin/AAQ-2024-2020	Rodrigues, Jean Henrique/0000-0003-2902-4578; Ueda-Nakamura, Tania/0000-0001-5057-3518; Ximenes, Valdecir/0000-0003-2636-3080; Lautenschlager, Sueli OS/0000-0001-9303-0804; DESOTI, VANIA/0000-0002-2087-5248	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria); Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa; Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM)	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Capacitacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Programa de Nucleos de Excelencia (PRONEX/Fundacao Araucaria), Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa, and Complexo de Centrais de Apoio a Pesquisa (COMCAP-UEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2009, CANCER CHEMOTH PHARM, V65, P143, DOI 10.1007/s00280-009-1016-7; Ariyanayagam MR, 2003, J BIOL CHEM, V278, P27612, DOI 10.1074/jbc.M302750200; Beck R, 2011, INVEST NEW DRUG, V29, P891, DOI 10.1007/s10637-010-9441-3; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bothiraja C, 2013, THER DELIV, V4, P1247, DOI [10.4155/TDE.13.92, 10.4155/tde.13.92]; BOVERIS A, 1978, COMP BIOCHEM PHYS C, V61, P327, DOI 10.1016/0306-4492(78)90063-1; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Caballero AB, 2011, J INORG BIOCHEM, V105, P770, DOI 10.1016/j.jinorgbio.2011.03.015; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Chagas C, 1909, MEM I O CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciccarelli AB, 2012, ANTIMICROB AGENTS CH, V56, P5315, DOI 10.1128/AAC.00481-12; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; CROFT SL, 1992, J ANTIMICROB CHEMOTH, V30, P827, DOI 10.1093/jac/30.6.827; da Silva AO, 2013, EUR J MED CHEM, V60, P51, DOI 10.1016/j.ejmech.2012.11.034; Rodrigues JHD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085706; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Faundez M, 2005, ANTIMICROB AGENTS CH, V49, P126, DOI 10.1128/AAC.49.1.126-130.2005; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Gilloteaux J, 2005, ULTRASTRUCT PATHOL, V29, P221, DOI 10.1080/01913120590951239; Gilloteaux J, 2004, TISSUE CELL, V36, P197, DOI 10.1016/j.tice.2004.01.006; Gilloteaux J, 1998, SCANNING, V20, P564; Gilloteaux J, 2010, ULTRASTRUCT PATHOL, V34, P140, DOI 10.3109/01913121003662304; Graciani FS, 2012, BRAZ J MED BIOL RES, V45, P701, DOI 10.1590/S0100-879X2012007500078; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Uc-Cachon AH, 2014, PULM PHARMACOL THER, V27, P114, DOI 10.1016/j.pupt.2013.08.001; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Jamison JM, 2004, BIOCHEM PHARMACOL, V67, P337, DOI 10.1016/j.bcp.2003.08.040; Jamison JM, 2001, J NUTR, V131, p158S, DOI 10.1093/jn/131.1.158S; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Lazarin-Bidoia D, 2013, FREE RADICAL BIO MED, V60, P17, DOI 10.1016/j.freeradbiomed.2013.01.008; Macao LB, 2007, INT J CARDIOL, V123, P43, DOI 10.1016/j.ijcard.2006.11.118; Maguire JH, 2006, NEW ENGL J MED, V355, P760, DOI 10.1056/NEJMp068130; Marquez VE, 2014, BIOCHIMIE, V106, P56, DOI 10.1016/j.biochi.2014.07.027; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Munafo DB, 2001, J CELL SCI, V114, P3619; NOTO V, 1989, CANCER, V63, P901, DOI 10.1002/1097-0142(19890301)63:5<901::AID-CNCR2820630518>3.0.CO;2-G; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pelizzaro-Rocha KJ, 2010, PHYTOMEDICINE, V18, P36, DOI 10.1016/j.phymed.2010.09.005; Pereira-da Silva L. H., 1953, Folia Clinica et Biologica Sao Paulo, V20, P191; Piacenza L, 2009, INT J PARASITOL, V39, P1455, DOI 10.1016/j.ijpara.2009.05.010; Pinto AV, 2009, MOLECULES, V14, P4570, DOI 10.3390/molecules14114570; Polanco-Hernandez G, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/435398; POMPELLA A, 1987, LIPIDS, V22, P206, DOI 10.1007/BF02537304; Salmon-Chemin L, 2001, J MED CHEM, V44, P548, DOI 10.1021/jm001079l; Salomao K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-196; Shukla AK, 2012, EUR J MED CHEM, V54, P49, DOI 10.1016/j.ejmech.2012.04.034; Taper HS, 2001, J HISTOCHEM CYTOCHEM, V49, P109, DOI 10.1177/002215540104900111; Tareen Basir, 2008, Int J Med Sci, V5, P62; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Venugopal M, 1996, CELL BIOL INT, V20, P787, DOI 10.1006/cbir.1996.0102; Verrax J, 2004, APOPTOSIS, V9, P223, DOI 10.1023/B:APPT.0000018804.26026.1a; Verrax J, 2003, EUR J MED CHEM, V38, P451, DOI 10.1016/S0223-5234(03)00082-5; Verrax J, 2006, BIOCHEM PHARMACOL, V72, P671, DOI 10.1016/j.bcp.2006.05.025; Wilkinson SR, 2000, J BIOL CHEM, V275, P8220, DOI 10.1074/jbc.275.11.8220; Wilkinson SR, 2005, P NATL ACAD SCI USA, V102, P11645, DOI 10.1073/pnas.0504251102; World Health Organization, 2015, CHAG DIS AM TRYP; Wu FYH, 1999, EUR J CANCER, V35, P1388, DOI 10.1016/S0959-8049(99)00156-2; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	63	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144033	10.1371/journal.pone.0144033	http://dx.doi.org/10.1371/journal.pone.0144033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641473	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700050
J	Tennstaedt, A; Mastropietro, A; Nelles, M; Beyrau, A; Hoehn, M				Tennstaedt, Annette; Mastropietro, Alfonso; Nelles, Melanie; Beyrau, Andreas; Hoehn, Mathias			In Vivo Fate Imaging of Intracerebral Stem Cell Grafts in Mouse Brain	PLOS ONE			English	Article							VITRO DIFFERENTIATION; AXONAL-TRANSPORT; SURVIVAL; MRI; STROKE; NANOPARTICLES; MIGRATION; RAT; PROTEIN; CNS	We generated transgenic human neural stem cells (hNSCs) stably expressing the reporter genes Luciferase for bioluminescence imaging (BLI) and GFP for fluorescence imaging, for multimodal imaging investigations. These transgenic hNSCs were further labeled with a clinically approved perfluoropolyether to perform parallel F-19 MRI studies. In vitro validation demonstrated normal cell proliferation and differentiation of the transgenic and additionally labeled hNSCs, closely the same as the wild type cell line, making them suitable for in vivo application. Labeled and unlabeled transgenic hNSCs were implanted into the striatum of mouse brain. The time profile of their cell fate after intracerebral grafting was monitored during nine days following implantation with our multimodal imaging approach, assessing both functional and anatomical condition. The F-19 MRI demarcated the graft location and permitted to estimate the cell number in the graft. BLI showed a pronounce cell loss during this monitoring period, indicated by the decrease of the viability signal. The in vivo obtained cell fate results were further validated and confirmed by immunohistochemistry. We could show that the surviving cells of the graft continued to differentiate into early neurons, while the severe cell loss could be explained by an inflammatory reaction to the graft, showing the graft being surrounded by activated microglia and macrophages. These results are different from earlier cell survival studies of our group where we had implanted the identical cells into the same mouse strain but in the cortex and not in the striatum. The cortical transplanted cells did not show any loss in viability but only pronounced and continuous neuronal differentiation.	[Tennstaedt, Annette; Mastropietro, Alfonso; Nelles, Melanie; Beyrau, Andreas; Hoehn, Mathias] Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany; [Mastropietro, Alfonso] IRCCS Fdn Neurol Inst C Besta, Sci Direct Unit, Milan, Italy; [Mastropietro, Alfonso] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Hoehn, Mathias] Leiden Univ, Leiden Univ Med Ctr, Dept Radiol, Leiden, Netherlands	Polytechnic University of Milan; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoehn, M (corresponding author), Max Planck Inst Metab Res, In Vivo NMR Lab, Cologne, Germany.	mathias@sf.mpg.de	Mastropietro, Alfonso/AAY-7271-2020	Mastropietro, Alfonso/0000-0003-3358-7111	European Union [PIAPP-GA-2013-612360, HEALTH-F2-2012-279017]; Deutsche Forschungsgemeinschaft [AS-464/1-1]; MIUR [RBAP1183B5]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by European Union PIAPP-GA-2013-612360 and HEALTH-F2-2012-279017; Deutsche Forschungsgemeinschaft AS-464/1-1; MIUR RBAP1183B5.	Ahrens ET, 2013, NMR BIOMED, V26, P860, DOI 10.1002/nbm.2948; Almad AA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt128; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Aswendt M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00226; Aswendt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055662; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; De Vocht N, 2013, IMMUNOBIOLOGY, V218, P696, DOI 10.1016/j.imbio.2012.08.266; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Gaudet JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118544; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Himmelreich U, 2005, MOL IMAGING, V4, P1; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Janowski M, 2014, CELL TRANSPLANT, V23, P253, DOI 10.3727/096368912X661328; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; McNeish J, 2010, J BIOL CHEM, V285, P17209, DOI 10.1074/jbc.M109.098814; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Muhammad G, 2015, ACTA NEUROBIOL EXP, V75, P144; Praet J, 2012, CELL TRANSPLANT, V21, P1867, DOI 10.3727/096368912X636920; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Reekmans K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt147; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Sijbers J, 2007, PHYS MED BIOL, V52, P1335, DOI 10.1088/0031-9155/52/5/009; Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Takahashi Y, 2011, CELL TRANSPLANT, V20, P727, DOI 10.3727/096368910X536554; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Wang JH, 2005, MAGN RESON MED, V53, P408, DOI 10.1002/mrm.20354; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	38	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144262	10.1371/journal.pone.0144262	http://dx.doi.org/10.1371/journal.pone.0144262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641453	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700086
J	Manuel, DG; Tuna, M; Perez, R; Tanuseputro, P; Hennessy, D; Bennett, C; Rosella, L; Sanmartin, C; van Walraven, C; Tu, JV				Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Hennessy, Deirdre; Bennett, Carol; Rosella, Laura; Sanmartin, Claudia; van Walraven, Carl; Tu, Jack V.			Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADMINISTRATIVE DATA; COMPETING RISKS; GUIDELINES; MODELS; PREVENTION; COUNTRIES; VALIDITY	Background Health behaviours, important factors in cardiovascular disease, are increasingly a focus of prevention. We appraised whether stroke risk can be accurately assessed using self-reported information focused on health behaviours. Methods Behavioural, sociodemographic and other risk factors were assessed in a population-based survey of 82 259 Ontarians who were followed for a median of 8.6 years (688 000 person-years follow-up) starting in 2001. Predictive algorithms for 5-year incident stroke resulting in hospitalization were created and then validated in a similar 2007 survey of 28 605 respondents (median 4.2 years follow-up). Results We observed 3 236 incident stroke events (1 551 resulting in hospitalization; 1 685 in the community setting without hospital admission). The final algorithms were discriminating (C-stat: 0.85, men; 0.87, women) and well-calibrated (in 65 of 67 subgroups for men; 61 of 65 for women). An index was developed to summarize cumulative relative risk of incident stroke from health behaviours and stress. For men, each point on the index corresponded to a 12% relative risk increase (180% risk difference, lowest (0) to highest (9) scores). For women, each point corresponded to a 14% relative risk increase (340% difference, lowest (0) to highest (11) scores). Algorithms for secondary stroke outcomes (stroke resulting in death; classified as ischemic; excluding transient ischemic attack; and in the community setting) had similar health behaviour risk hazards. Conclusion Incident stroke can be accurately predicted using self-reported information focused on health behaviours. Risk assessment can be performed with population health surveys to support population health planning or outside of clinical settings to support patient-focused prevention.	[Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Hennessy, Deirdre; Bennett, Carol; van Walraven, Carl] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Bennett, Carol; Rosella, Laura; van Walraven, Carl; Tu, Jack V.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Manuel, Douglas G.; Tuna, Meltem; Perez, Richard; Tanuseputro, Peter; Bennett, Carol; Rosella, Laura; van Walraven, Carl; Tu, Jack V.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Hennessy, Deirdre; Sanmartin, Claudia] STAT Canada, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Tanuseputro, Peter; van Walraven, Carl] Univ Ottawa, Epidemiol & Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Bruyere Res Inst, Ottawa, ON, Canada; [Rosella, Laura] Publ Hlth Ontario, Toronto, ON, Canada; [Rosella, Laura] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [van Walraven, Carl] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Tu, Jack V.] Univ Toronto, Sunnybrook Schulich Heart Ctr, Toronto, ON, Canada; [Tu, Jack V.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Statistics Canada; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	dmanuel@ohri.ca	; Manuel, Doug/D-7100-2014	Bennett, Carol/0000-0002-3033-9860; Tanuseputro, Peter/0000-0002-4409-0795; Manuel, Doug/0000-0003-0912-0845	Public Health Agency of Canada; Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care; Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research [TCA 118349]; Heart and Stroke Foundation; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Public Health Agency of Canada; Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care; Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was supported by funding from the Public Health Agency of Canada, the Population Health Improvement Research Program of the Ontario Ministry of Health and Long-term Care and the Cardiovascular Health in Ambulatory Research Team (CANHEART) from the Canadian Institutes of Health Research (TCA 118349). At the time of this research, DGM held a Chair in Applied Population Health from the Canadian Institutes of Health Research and the Public Health Agency of Canada. JVT holds a Tier 1 Canada Research Council Chair in Health Services Research and A Career Investigator award from the Heart and Stroke Foundation. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2013, STAT MED, V32, P1877, DOI 10.1002/sim.5736; Beland Yves, 2002, Health Rep, V13, P9; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chiuve SE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000954; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; CSS Information & Evaluation Working Group, 2010, CAN STROK STRAT COR, P1; Dalton Andrew R H, 2011, Inform Prim Care, V19, P225; DIAMOND GA, 1989, J AM COLL CARDIOL, V14, pA12, DOI 10.1016/0735-1097(89)90157-5; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Garriguet D, 2014, HEALTH REP, V25, P3; Garriguet Didier, 2009, Health Rep, V20, P41; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manuel D, 2008, ICES INVESTIGATIVE R; Manuel DG, 2012, AN ICES PHO REPORT; Manuel DG, 2014, 900 000 DAYS HOSP AN; Manuel DG, 2012, J EPIDEMIOL COMMUN H, V66, P859, DOI 10.1136/jech-2012-200971; Manuel DG, 2010, CURR OPIN LIPIDOL, V21, P359, DOI 10.1097/MOL.0b013e32833c1f2b; MOZAFFARIAN D, 2011, CIRCULATION, V123, P2870, DOI [DOI 10.1161/CIRCULATI0NAHA.110.968735, 10.1161/circulationaha.110.968735]; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; Nardo M., 2005, HDB CONSTRUCTING COM, P17, DOI [10.1787/533411815016, DOI 10.1787/533411815016]; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pintilie M, 2002, STAT MED, V21, P3317, DOI 10.1002/sim.1271; Qiao Q, 2012, INT J STROKE, V7, P662, DOI 10.1111/j.1747-4949.2011.00692.x; Rabar S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4356; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rose GA, 2008, ROSES STRATEGY OF PR; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schulte JM, 2014, NEW ENGL J MED, V371, DOI 10.1056/NEJMclde1407177; Sheridan SL, 2010, ARCH INTERN MED, V170, P230, DOI 10.1001/archinternmed.2009.516; Shields Margot, 2008, Health Rep, V19, P61; Steyerberg E., 2009, CLIN PREDICTION MODE; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taljaard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006701; Tripepi G, 2010, NEPHROL DIAL TRANSPL, V25; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Veerman L., 2010, ASSESSING COST EFFEC; Wong SL, 2012, HEALTH REP, V23, P47; World Health Organization, 2007, PREV CARD DIS GUID A	49	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143342	10.1371/journal.pone.0143342	http://dx.doi.org/10.1371/journal.pone.0143342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637172	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800009
J	Li, ZF; Liu, YJ; Feng, ZL; Feng, HJ; Klosterman, SJ; Zhou, FF; Zhao, LH; Shi, YQ; Zhu, HQ				Li, Zhi-Fang; Liu, Yi-Jie; Feng, Zi-Li; Feng, Hong-Jie; Klosterman, Steven J.; Zhou, Fang-Fang; Zhao, Li-Hong; Shi, Yong-Qiang; Zhu, He-Qin			VdCYC8, Encoding CYC8 Glucose Repression Mediator Protein, Is Required for Microsclerotia Formation and Full Virulence in Verticillium dahliae	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REPRESSION; HYDROPHOBIN GENE; CROP-ROTATION; KINASE GENE; WILT; GROWTH; PATHOGENICITY; SSN6; BIOSYNTHESIS	Verticillium dahliae is the primary causal agent for Verticillium wilt disease on a diverse array of economically important crops, including cotton. In previous research, we obtained the low-pathogenicity mutant T286 from the T-DNA insertional mutant library of the highly virulent isolate Vd080 derived from cotton. In this study, the target disrupted gene VdCYC8 was identified by TAIL-PCR, encoding a homolog of CYC8 proteins involved in glucose repression. The deletion mutant Delta CYC8 exhibited several developmental deficiencies, including reduced microsclerotia formation, reduced sporulation, and slower growth. Moreover, compared with the wild type strain Vd080, the pathogenicity of strain Delta CYC8 was significantly decreased on cotton seedlings. However, the complementary mutants Delta CYC8-C led to restoration of the wild type phenotype or near wild type levels of virulence on cotton. Interestingly, pathogenicity of the strains was correlated with VdCYC8 gene expression levels in complemented mutants. Gene expression analyses in the wild type strain Vd080, the Delta CYC8-45 strain, and complemented strain Delta CYC8-C26 indicated that VdCYC8 regulates the transcription levels of several genes in V. dahliae that have roles in melanin and production.	[Li, Zhi-Fang; Liu, Yi-Jie; Feng, Zi-Li; Feng, Hong-Jie; Zhou, Fang-Fang; Zhao, Li-Hong; Shi, Yong-Qiang; Zhu, He-Qin] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China; [Klosterman, Steven J.] ARS, USDA, Salinas, CA 93905 USA	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; United States Department of Agriculture (USDA)	Zhu, HQ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	zhuheqin2012@163.com			National Natural Science Foundation of China [31201466]; National High-Tech Program [2013AA102601]; ARS [ARS-0426096] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was financially supported by the National Natural Science Foundation of China (No. 31201466) and the National High-Tech Program (No. 2013AA102601).; This work was financially supported by the National Natural Science Foundation of China (No. 31201466) and the National High-tech program (No. 2013AA102601). We thank Prof. Dai Xiaofeng for providing A. tumefaciens strain AGL1 and plasmid pCTHyg.	BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; Chen Y, 2015, MOL PLANT PATHOL, V16, P799, DOI 10.1111/mpp.12235; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Debode J, 2007, J APPL MICROBIOL, V103, P1184, DOI 10.1111/j.1365-2672.2007.03348.x; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Hu DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100046; Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x; Ikeda K, 2015, J GEN PLANT PATHOL, V81, P77, DOI 10.1007/s10327-014-0559-6; Johnson DA, 2015, PLANT DIS, V99, P257, DOI 10.1094/PDIS-03-14-0271-RE; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2006, THESIS; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lee JE, 2015, FEBS LETT, V589, P513, DOI 10.1016/j.febslet.2015.01.011; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin X, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0093-4; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; [刘义杰 Liu Yijie], 2015, [植物病理学报, Acta Phytopathologica Sinica], V45, P258; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pegg GF, 1989, VASCULAR WILT DIS PL, P51; Puhalla J. E., 1981, FUNGAL WILT DIS PLAN, P146; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; Schnathorst WC, 1981, FUNGAL WILT DIS PLAN, P81, DOI DOI 10.1016/B978-0-12-464450-2.50009-7; Short DPG, 2015, PHYTOPATHOLOGY, V105, P80, DOI 10.1094/PHYTO-02-14-0046-R; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjamos EC, 1989, VASCULAR WILT DIS PL, P51; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Woo PCY, 2010, FEBS J, V277, P3750, DOI 10.1111/j.1742-4658.2010.07776.x; Xia ZJ, 1998, EUR J PLANT PATHOL, V104, P871, DOI 10.1023/A:1008628209867; Xiao CL, 1998, PHYTOPATHOLOGY, V88, P1046, DOI 10.1094/PHYTO.1998.88.10.1046; Xiong DG, 2015, GENE, V562, P169, DOI 10.1016/j.gene.2015.02.063; Yamashiro CT, 1996, MOL CELL BIOL, V16, P6218; Yu Zhang, 2015, 2015 IEEE MTT-S International Microwave Symposium (IMS2015), P1, DOI 10.1109/MWSYM.2015.7166999; Zhang Y., 2015, CRIM JUSTICE REV, V40, P340, DOI DOI 10.1177/0734016815573309; Zhu HQ, 2013, J PHYTOPATHOL, V161, P70, DOI 10.1111/jph.12027	52	9	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144020	10.1371/journal.pone.0144020	http://dx.doi.org/10.1371/journal.pone.0144020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633180	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000044
J	Anjomshoaa, I; Briseno-Ruiz, J; Deeley, K; Poletta, FA; Mereb, JC; Leite, AL; Barreta, PATM; Silva, TL; Dizak, P; Ruff, T; Patir, A; Koruyucu, M; Abbasoglu, Z; Casado, PL; Brown, A; Zaky, SH; Bayram, M; Kuchler, EC; Cooper, ME; Liu, K; Marazita, ML; Tanboga, I; Granjeiro, JM; Seymen, F; Castilla, EE; Orioli, IM; Sfeir, C; Owyang, H; Buzalaf, MAR; Vieira, AR				Anjomshoaa, Ida; Briseno-Ruiz, Jessica; Deeley, Kathleen; Poletta, Fernardo A.; Mereb, Juan C.; Leite, Aline L.; Barreta, Priscila A. T. M.; Silva, Thelma L.; Dizak, Piper; Ruff, Timothy; Patir, Asli; Koruyucu, Mine; Abbasoglu, Zerrin; Casado, Priscila L.; Brown, Andrew; Zaky, Samer H.; Bayram, Merve; Kuechler, Erika C.; Cooper, Margaret E.; Liu, Kai; Marazita, Mary L.; Tanboga, Ilknur; Granjeiro, Jose M.; Seymen, Figen; Castilla, Eduardo E.; Orioli, Ieda M.; Sfeir, Charles; Owyang, Hongjiao; Buzalaf, Marilia A. R.; Vieira, Alexandre R.			Aquaporin 5 Interacts with Fluoride and Possibly Protects against Caries	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENTAL-CARIES; SALIVARY-GLANDS; EXPRESSION; POLYMORPHISM; GENES; SCAN; LOCALIZATION; EXPERIENCE; SECRETION	Aquaporins (AQP) are water channel proteins and the genes coding for AQP2, AQP5, and AQP6 are clustered in 12q13. Since AQP5 is expressed in serous acinar cells of salivary glands, we investigated its involvement in caries. DNA samples from 1,383 individuals from six groups were studied. Genotypes of eight single nucleotide polymorphisms covering the aquaporin locus were tested for association with caries experience. Interaction with genes involved in enamel formation was tested. The association between enamel microhardness at baseline, after creation of artificial caries lesion, and after exposure to fluoride and the genetic markers in AQP5 was tested. Finally, AQP5 expression in human whole saliva, after exposure to fluoride in a mammary gland cell line, which is known to express AQP5, and in Wistar rats was also verified. Nominal associations were found between caries experience and markers in the AQP5 locus. Since these associations suggested that AQP5 may be inhibited by levels of fluoride in the drinking water that cause fluorosis, we showed that fluoride levels above optimal levels change AQP5 expression in humans, cell lines, and rats. We have shown that AQP5 is involved in the pathogenesis of caries and likely interacts with fluoride.	[Anjomshoaa, Ida; Briseno-Ruiz, Jessica; Deeley, Kathleen; Dizak, Piper; Ruff, Timothy; Brown, Andrew; Zaky, Samer H.; Kuechler, Erika C.; Cooper, Margaret E.; Marazita, Mary L.; Sfeir, Charles; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Poletta, Fernardo A.; Castilla, Eduardo E.] CEMIC Ctr Med Educ & Clin Res, ECLAMC Latin Amer Collaborat Study Congenital Mal, Buenos Aires, DF, Argentina; [Mereb, Juan C.] Hosp Area El Bolson, ECLAMC, El Bolson, RN, Argentina; [Leite, Aline L.; Barreta, Priscila A. T. M.; Silva, Thelma L.; Buzalaf, Marilia A. R.] Univ Sao Paulo, Bauru Sch Dent, Bauru, SP, Brazil; [Patir, Asli; Bayram, Merve] Medipol Istanbul Univ, Dept Pedodont, Istanbul, Turkey; [Koruyucu, Mine; Seymen, Figen] Istanbul Univ, Dept Pedodont, Istanbul, Turkey; [Abbasoglu, Zerrin] Yeditepe Univ, Dept Pediat Dent, Fac Dent, Istanbul, Turkey; [Casado, Priscila L.; Granjeiro, Jose M.] Univ Fed Fluminense, Sch Dent, Clin Res Unit, Niteroi, RJ, Brazil; [Casado, Priscila L.] Univ Fed Fluminense, Inst Biol, Niteroi, RJ, Brazil; [Liu, Kai] Univ Pittsburgh, Sch Dent Med, Dept Endodont, Pittsburgh, PA USA; [Tanboga, Ilknur; Owyang, Hongjiao] Marmara Univ, Dept Pediat Dent, Fac Dent, Istanbul, Turkey; [Granjeiro, Jose M.] Natl Inst Metrol INMETRO, Niteroi, RJ, Brazil; [Castilla, Eduardo E.] Fundacao Oswaldo Cruz, Natl Inst Populat Med Genet, Dept Genet, ECLAMC,INAGEMP,CNPq, Rio De Janeiro, Brazil; [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Natl Inst Populat Med Genet, Dept Genet, ECLAMC,INAGEMP,CNPq Inst Biol,Ctr Hlth Sci, Rio De Janeiro, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Universidade de Sao Paulo; Medipol Hospital; Istanbul University; Yeditepe University; Universidade Federal Fluminense; Universidade Federal Fluminense; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Marmara University; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA.	arv11@pitt.edu	Leite, Aline/J-9748-2012; Koruyucu, M/AAC-6713-2020; Seymen, Figen/AAC-6736-2020; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Küchler, Erika C/B-4669-2014; Bayram, Merve/B-1230-2018; casado, priscila ladeira/E-6401-2014; Granjeiro, Jose/D-8289-2012	Leite, Aline/0000-0002-2112-1309; Koruyucu, M/0000-0002-2077-5095; Seymen, Figen/0000-0001-7010-2035; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Bayram, Merve/0000-0002-8440-367X; casado, priscila ladeira/0000-0002-7551-0190; Kuchler, Erika/0000-0001-5351-2526; Zaky, Samer/0000-0001-5550-5450; Granjeiro, Jose/0000-0002-8027-8293; Abbasoglu, Zerrin/0000-0002-0077-5581; Poletta, Fernando/0000-0002-6102-8416	NIH/NIDCR [R01-DE18914]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018914] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH/NIDCR grant R01-DE18914. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abbasoglu Z, 2014, CARIES RES IN PRESS; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; [Anonymous], EUR J DENT; Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Deeley K, 2008, CARIES RES, V42, P8, DOI 10.1159/000111744; Felszeghy S, 2004, ARCH ORAL BIOL, V49, P247, DOI 10.1016/j.archoralbio.2003.09.011; Flueck WT, 2013, J WILDLIFE DIS, V49, P355, DOI 10.7589/2012-11-272; Funaki H, 1998, AM J PHYSIOL-CELL PH, V275, pC1151, DOI 10.1152/ajpcell.1998.275.4.C1151; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hamilton IR, 1977, CARIES RES S1, V11, P321; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ishida N, 1997, BIOCHEM BIOPH RES CO, V238, P891, DOI 10.1006/bbrc.1997.7396; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Kato MT, 2014, J DENT RES, V93, P74, DOI 10.1177/0022034513511820; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kuchler EC, 2012, J APPL ORAL SCI, V20, P467, DOI 10.1590/S1678-77572012000400013; Kulkarni GV, 2013, CARIES RES, V47, P219, DOI 10.1159/000345652; Kumari SS, 2012, MOL VIS, V18, P957; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Menezes-Silva R, 2012, J ENDODONT, V38, P604, DOI 10.1016/j.joen.2012.02.009; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Pan Y, 2009, BBA-GEN SUBJECTS, V1790, P49, DOI 10.1016/j.bbagen.2008.08.009; Patir A, 2008, CARIES RES, V42, P394, DOI 10.1159/000154785; Perez Carrera A., 2004, InVet - Investigacion Veterinaria, V6, P51; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2001, GENOME RES, V11, P1262; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; Shaffer JR, 2013, J DENT RES, V92, P38, DOI 10.1177/0022034512463579; Shaffer JR, 2011, J DENT RES, V90, P1457, DOI 10.1177/0022034511422910; Shimizu T, 2013, CARIES RES, V47, P273, DOI 10.1159/000346278; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045022; Slayton RL, 2005, J DENT RES, V84, P711, DOI 10.1177/154405910508400805; Spring KR, 1998, ANNU REV PHYSIOL, V60, P105, DOI 10.1146/annurev.physiol.60.1.105; Sugimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01763; Tannure PN, 2012, CARIES RES, V46, P401, DOI 10.1159/000339379; Tannure PN, 2012, J DENT, V40, P381, DOI 10.1016/j.jdent.2012.01.015; Valarini N, 2012, CARIES RES, V46, P530, DOI 10.1159/000341188; Vieira AR, 2008, J DENT RES, V87, P435, DOI 10.1177/154405910808700506; Wang D, 2009, J MED INVESTIG, V56, P350, DOI 10.2152/jmi.56.350; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wang XJ, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-57; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; World Health Organization, 1997, ORAL HEALTH SURVEYS; Zeng Z, 2013, J DENT RES, V92, P432, DOI 10.1177/0022034513481976	52	19	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143068	10.1371/journal.pone.0143068	http://dx.doi.org/10.1371/journal.pone.0143068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630491	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000365926300029
J	Figueroa-Garcia, MD; Espinosa-Garcia, MT; Martinez-Montes, F; Palomar-Morales, M; Mejia-Zepeda, R				del Consuelo Figueroa-Garcia, Maria; Teresa Espinosa-Garcia, Maria; Martinez-Montes, Federico; Palomar-Morales, Martin; Mejia-Zepeda, Ricardo			Even a Chronic Mild Hyperglycemia Affects Membrane Fluidity and Lipoperoxidation in Placental Mitochondria in Wistar Rats	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; TRIGLYCERIDE ACCUMULATION; DIABETES-MELLITUS; FUSION; LIPASE	It is known the deleterious effects of diabetes on embryos, but the effects of diabetes on placenta and its mitochondria are still not well known. In this work we generated a mild hyperglycemia model in female wistar rats by intraperitoneal injection of streptozotocin in 48 hours-old rats. The sexual maturity onset of the female rats was delayed around 6-7 weeks and at 16 weeks-old they were mated, and sacrificed at day 19th of pregnancy. In placental total tissue and isolated mitochondria, the fatty acids composition was analyzed by gas chromatography, and lipoperoxidation was measured by thiobarbituric acid reactive substances. Membrane fluidity in mitochondria was measured with the excimer forming probe dipyrenylpropane and mitochondrial function was measured with a Clark-type electrode. The results show that even a chronic mild hyperglycemia increases lipoperoxidation and decreases mitochondrial function in placenta. Simultaneously, placental fatty acids metabolism in total tissue is modified but in a different way than in placental mitochondria. Whereas the chronic mild hyperglycemia induced a decrease in unsaturated to saturated fatty acids ratio (U/S) in placental total tissue, the ratio increased in placental mitochondria. The measurements of membrane fluidity showed that fluidity of placenta mitochondrial membranes increased with hyperglycemia, showing consistency with the fatty acids composition through the U/S index. The thermotropic characteristics of mitochondrial membranes were changed, showing lower transition temperature and activation energies. All of these data together demonstrate that even a chronic mild hyperglycemia during pregnancy of early reproductive Wistar rats, generates an increment of lipoperoxidation, an increase of placental mitochondrial membrane fluidity apparently derived from changes in fatty acids composition and consequently, mitochondrial malfunction.	[del Consuelo Figueroa-Garcia, Maria] Fac Med Vet & Zootecnia, Dept Toxicol, Mexico City, DF, Mexico; [Teresa Espinosa-Garcia, Maria; Martinez-Montes, Federico] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City, DF, Mexico; [Palomar-Morales, Martin] UNAM, Fac Estudios Super Iztacala, Unidad Morfol & Func, Tlalnepantla, State Of Mexico, Mexico; [Mejia-Zepeda, Ricardo] UNAM, Fac Estudios Super Iztacala, Unidad Biomed, Tlalnepantla, State Of Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Mejia-Zepeda, R (corresponding author), UNAM, Fac Estudios Super Iztacala, Unidad Biomed, Tlalnepantla, State Of Mexico, Mexico.	rmejia@campus.iztacala.unam.mx	Mejia-Zepeda, Ricardo/AAQ-8185-2020	Figueroa Garcia, Maria del Consuelo/0000-0003-1985-0825	Consejo Nacional de Ciencia y Tecnologia CONACYT; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica - Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico DGAPA-UNAM [PAPIIT IN-228610, 216314, IN-215414, IN211912]; Programa de Apoyo a Profesores de Carrera PAPCA of the Facultad de Estudios Superiores Iztacala - Universidad Nacional Autonoma de Mexico FESI UNAM	Consejo Nacional de Ciencia y Tecnologia CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica - Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico DGAPA-UNAM; Programa de Apoyo a Profesores de Carrera PAPCA of the Facultad de Estudios Superiores Iztacala - Universidad Nacional Autonoma de Mexico FESI UNAM	The authors acknowledge Consejo Nacional de Ciencia y Tecnologia CONACYT for the fellowship to MCFG, and the financial support for this project from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT IN-228610, 216314 (RMZ), IN-215414 (MPM), IN211912 (FMM) - Direccion General de Asuntos del Personal Academico de la Universidad Nacional Autonoma de Mexico DGAPA-UNAM, and from Programa de Apoyo a Profesores de Carrera PAPCA 2007-2008 of the Facultad de Estudios Superiores Iztacala - Universidad Nacional Autonoma de Mexico FESI UNAM (RMZ, MPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA LM, 1982, BIOCHEMISTRY-US, V21, P5972, DOI 10.1021/bi00266a038; Bakan E, 2006, ACTA DIABETOL, V43, P109, DOI 10.1007/s00592-007-0224-4; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY LJ, 1985, BIOCHEM J, V232, P445, DOI 10.1042/bj2320445; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; CHOE M, 1995, FREE RADICAL BIO MED, V18, P977, DOI 10.1016/0891-5849(94)00217-8; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X; Gauster M, 2011, DIABETES, V60, P2457, DOI 10.2337/db10-1434; Gil-Sanchez A, 2012, CURR OPIN CLIN NUTR, V15, P265, DOI 10.1097/MCO.0b013e3283523b6e; Greenman IC, 2007, J ENDOCRINOL, V192, P179, DOI 10.1677/joe.1.06898; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HONDA M, 1992, TOHOKU J EXP MED, V167, P247, DOI 10.1620/tjem.167.247; Lindegaard MLS, 2006, J LIPID RES, V47, P2581, DOI 10.1194/jlr.M600236-JLR200; MARTINEZ F, 1987, INT J BIOCHEM, V19, P275, DOI 10.1016/0020-711X(87)90031-0; MELNICK RL, 1981, BIOPHYS J, V34, P499, DOI 10.1016/S0006-3495(81)84864-3; MORRISON WR, 1964, J LIPID RES, V5, P600; Muth A, 2003, J CHROMATOGR B, V791, P235, DOI 10.1016/S1570-0232(03)00220-4; Myatt L, 2004, HISTOCHEM CELL BIOL, V122, P369, DOI 10.1007/s00418-004-0677-x; Nanetti L, 2008, BRAIN RES, V1205, P21, DOI 10.1016/j.brainres.2008.02.005; Ntambi JM, 1999, J LIPID RES, V40, P1549; Perez-Hernandez IH, 2010, ACTA DIABETOL, V47, pS47, DOI 10.1007/s00592-009-0120-9; PORTHA B, 1979, DIABETOLOGIA, V17, P371, DOI 10.1007/BF01236272; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Sergent O, 2005, J PHARMACOL EXP THER, V313, P104, DOI 10.1124/jpet.104.078634; Shivaji S, 2010, ARCH MICROBIOL, V192, P85, DOI 10.1007/s00203-009-0539-y; Silverman BL, 1998, DIABETES CARE, V21, pB142; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Soto-Arriaza MA, 2008, J COLLOID INTERF SCI, V323, P70, DOI 10.1016/j.jcis.2008.04.034; Visiedo F, 2013, AM J PHYSIOL-ENDOC M, V305, pE205, DOI 10.1152/ajpendo.00032.2013; Waczulikova I, 2007, CAN J PHYSIOL PHARM, V85, P372, DOI 10.1139/Y07-035; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113; Zabihi S, 2010, BIRTH DEFECTS RES A, V88, P779, DOI 10.1002/bdra.20704; Ziegelhoffer A, 2012, PHYSIOL RES, V61, pS11, DOI 10.33549/physiolres.932361	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143778	10.1371/journal.pone.0143778	http://dx.doi.org/10.1371/journal.pone.0143778			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630275	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300097
J	Du, J; Zheng, BS; Zheng, WW; Li, P; Kang, J; Hou, JW; Markham, R; Zhao, K; Yu, XF				Du, Juan; Zheng, Baisong; Zheng, Wenwen; Li, Peng; Kang, Jian; Hou, Jingwei; Markham, Richard; Zhao, Ke; Yu, Xiao-Fang			Analysis of Enterovirus 68 Strains from the 2014 North American Outbreak Reveals a New Clade, Indicating Viral Evolution	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; PEDIATRIC-PATIENTS; LETHAL CHALLENGE; PROTECTION; ILLNESS; VIRUS; INHIBITORS; EMERGENCE; CHILDREN; VACCINE	Enterovirus 68 (EVD68) causes respiratory illness, mostly in children. Despite a reported low-level of transmission, the occurrence of several recent outbreaks worldwide including the 2014 outbreak in North America has raised concerns regarding the pathogenesis and evolution of EVD68. To elucidate the phylogenetic features of EVD68 and possible causes for the 2014 outbreak, 216 EVD68 strain sequences were retrieved from Genbank, including 22 from the 2014 outbreak. Several geographic and genotypic origins were established for these 22 strains, 19 of which were classified as Clade B. Of these 19 strains, 17 exhibited subsequent clustering and variation in protein residues involved in host-receptor interaction and/or viral antigenicity. Approximately 18 inter-clade variations were detected in VP1, which led to the identification of a new Clade D in EVD68 strains. The classification of this new clade was also verified by the re-construction of a Neighbor-Joining tree during the phylogenetic analysis. In addition, our results indicate that members of Clade B containing highly specific alterations in VP1 protein residues were the foremost contributors to the 2014 outbreak in the US. Altered host-receptor interaction and/ or host immune recognition may explain the evolution of EVD68 as well as the global emergence and ongoing adaptation of this virus.	[Du, Juan; Zheng, Baisong; Zheng, Wenwen; Li, Peng; Kang, Jian; Hou, Jingwei; Zhao, Ke; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China; [Markham, Richard; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhao, K (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130023, Jilin, Peoples R China.	paraake@icloud.com; xfyu@tju.edu.cn	Kang, Jian/AAN-8616-2020	Kang, Jian/0000-0001-9935-4172; LI, PENG/0000-0002-7751-1146; Zheng, Wenwen/0000-0002-2817-7348	Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Chinese National Natural Science Foundation [81401654]; Norman Bethune Health Science Center of Jilin University [470110000002]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Key Laboratory of Molecular Virology, Jilin Province, China; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Norman Bethune Health Science Center of Jilin University	This work was supported in part by funding from the Chinese Ministry of Science and Technology (2012CB911100 and No. 2013ZX0001-005) to XFY, the Key Laboratory of Molecular Virology, Jilin Province (20102209), China to XFY, Chinese National Natural Science Foundation (81401654) to JD, and Norman Bethune Health Science Center of Jilin University (470110000002) to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessaud M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090624; Brown BA, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01201-14; Chang JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0474-9; Chang JL, 2015, IMMUNOL RES, V62, P306, DOI 10.1007/s12026-015-8661-1; De Colibus LG, 2014, NAT STRUCT MOL BIOL, V21, P282, DOI 10.1038/nsmb.2769; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Imamura T, 2014, INFLUENZA OTHER RESP, V8, P21, DOI 10.1111/irv.12206; Jacobson LM, 2012, PEDIATR INFECT DIS J, V31, P309, DOI 10.1097/INF.0b013e3182443eaf; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khan Feras, 2015, Emerg Med Clin North Am, V33, pe19; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Li JL, 2015, VIRUSES-BASEL, V7, P3891, DOI 10.3390/v7072803; Li JL, 2014, J GEN VIROL, V95, P1083, DOI 10.1099/vir.0.063560-0; Li Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0111174, DOI 10.1371/J0URNAL.P0NE.0111174]; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Liu Y, 2015, SCIENCE, V347, P71, DOI 10.1126/science.1261962; Lu QB, 2014, J MED MICROBIOL, V63, P408, DOI 10.1099/jmm.0.068247-0; Meijer A, 2014, EURO SURVEILL, V19; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Midgley Claire M, 2014, MMWR Morb Mortal Wkly Rep, V63, P798; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Piralla A, 2012, DIAGN MICR INFEC DIS, V73, P162, DOI 10.1016/j.diagmicrobio.2012.02.019; Plevka P, 2010, J VIROL, V84, P12665, DOI 10.1128/JVI.00837-10; POYRY T, 1994, VIROLOGY, V202, P982, DOI 10.1006/viro.1994.1423; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Renois F, 2013, J CLIN MICROBIOL, V51, P640, DOI 10.1128/JCM.02640-12; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan JZ, 2013, J VIROL, V87, P4339, DOI 10.1128/JVI.01123-12; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094746; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719	43	28	32	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144208	10.1371/journal.pone.0144208	http://dx.doi.org/10.1371/journal.pone.0144208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630383	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300168
J	Horvath, G; Kekesi, G; Petrovszki, Z; Benedek, G				Horvath, Gyongyi; Kekesi, Gabriella; Petrovszki, Zita; Benedek, Gyorgy			Abnormal Motor Activity and Thermoregulation in a Schizophrenia Rat Model for Translational Science	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ANIMAL-MODEL; BODY-TEMPERATURE; PAIN SENSITIVITY; POINCARE PLOT; LONG-TERM; DYSFUNCTION; DOPAMINE; PLASTICITY; ASYMMETRY	Background Schizophrenia is accompanied by altered motor activity and abnormal thermoregulation; therefore, the presence of these symptoms can enhance the face validity of a schizophrenia animal model. The goal was to characterize these parameters in freely moving condition of a new substrain of rats showing several schizophrenia-related alterations. Methods Male Wistar rats were used: the new substrain housed individually (for four weeks) and treated subchronically with ketamine, and naive animals without any manipulations. Adult animals were implanted with E-Mitter transponders intraabdominally to record body temperature and locomotor activity continuously. The circadian rhythm of these parameters and the acute effects of changes in light conditions were analyzed under undisturbed circumstances, and the effects of different interventions (handling, bed changing or intraperitoneal vehicle injection) were also determined. Results Decreased motor activity with fragmented pattern was observed in the new substrain. However, these animals had higher body temperature during the active phase, and they showed wider range of its alterations, too. The changes in light conditions and different interventions produced blunted hyperactivity and altered body temperature responses in the new substrain. Poincare plot analysis of body temperature revealed enhanced short-and long-term variabilities during the active phase compared to the inactive phase in both groups. Furthermore, the new substrain showed increased short-and long-term variabilities with lower degree of asymmetry suggesting autonomic dysregulation. Conclusions In summary, the new substrain with schizophrenia-related phenomena showed disturbed motor activity and thermoregulation suggesting that these objectively determined parameters can be biomarkers in translational research.	[Horvath, Gyongyi; Kekesi, Gabriella; Benedek, Gyorgy] Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary; [Petrovszki, Zita] Univ Szeged, Juhasz Gyula Fac Educ, Inst Phys Educ & Sport Med, Szeged, Hungary	Szeged University; Szeged University	Horvath, G (corresponding author), Univ Szeged, Fac Med, Dept Physiol, Szeged, Hungary.	horvath.gyongyi@med.u-szeged.hu	Horvath, Gyongyi/O-9004-2019	Horvath, Gyongyi/0000-0002-6025-4577; Kekesi, Gabriella/0000-0002-0185-2155	Hungarian Scientific Research Fund (OTKA) [K83810]; Gedeon Richter Fund [RG-IPI-2013-TP7]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Gedeon Richter Fund	This work was supported by a Hungarian Scientific Research Fund (OTKA, K83810) and Gedeon Richter Fund (RG-IPI-2013-TP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2011, PSYCHIAT RES, V189, P62, DOI 10.1016/j.psychres.2010.12.031; Ahmed A, 2011, J CARD FAIL, V17, P937, DOI 10.1016/j.cardfail.2011.07.004; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Arechiga H, 1993, Curr Opin Neurobiol, V3, P1005, DOI 10.1016/0959-4388(93)90174-W; Bar KJ, 2007, SCHIZOPHR RES, V95, P115, DOI 10.1016/j.schres.2007.05.034; Becker A, 2006, PSYCHOPHARMACOLOGY, V189, P237, DOI 10.1007/s00213-006-0557-2; Boettger S, 2006, CLIN NEUROPHYSIOL, V117, P2715, DOI 10.1016/j.clinph.2006.08.009; Bromundt V, 2011, BRIT J PSYCHIAT, V198, P269, DOI 10.1192/bjp.bp.110.078022; Chong TW, 2004, SCHIZOPHR RES, V69, P149, DOI 10.1016/S0920-9964(03)00222-6; CLARK WG, 1985, NEUROSCI BIOBEHAV R, V9, P299, DOI 10.1016/0149-7634(85)90052-1; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Duncan GE, 2006, PHARMACOL BIOCHEM BE, V85, P481, DOI 10.1016/j.pbb.2006.09.017; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; Guzik P, 2013, CIRC J, V77, P2904, DOI 10.1253/circj.CJ-13-0461; Guzik P, 2010, HYPERTENS RES, V33, P1199, DOI 10.1038/hr.2010.138; Harkin A, 2002, PHYSIOL BEHAV, V77, P65, DOI 10.1016/S0031-9384(02)00810-7; Hayashi K, 2015, CLIN NEUROPHYSIOL, V126, P404, DOI 10.1016/j.clinph.2014.04.019; Hermesh H, 2000, AM J PSYCHIAT, V157, P1327, DOI 10.1176/appi.ajp.157.8.1327; Kawakami K, 2011, BIOL PHARM BULL, V34, P590, DOI 10.1248/bpb.34.590; Kekesi G, 2015, BEHAV BRAIN RES, V284, P85, DOI 10.1016/j.bbr.2015.02.015; Kreuzer P, 2012, J CLIN PHARMACOL, V52, P1090, DOI 10.1177/0091270011409233; Middelkoop HAM, 1997, PSYCHOPHYSIOLOGY, V34, P199, DOI 10.1111/j.1469-8986.1997.tb02132.x; Moon E, 2013, CLIN PSYCHOPHARM NEU, V11, P137, DOI 10.9758/cpn.2013.11.3.137; Oliver PL, 2012, CURR BIOL, V22, P314, DOI 10.1016/j.cub.2011.12.051; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Petrovszki Z, 2014, PHYSIOL BEHAV, V125, P38, DOI 10.1016/j.physbeh.2013.11.007; Petrovszki Z, 2013, BEHAV BRAIN RES, V240, P134, DOI 10.1016/j.bbr.2012.11.022; Piskorski J, 2007, PHYSIOL MEAS, V28, P287, DOI 10.1088/0967-3334/28/3/005; Piskorski J, 2011, MED BIOL ENG COMPUT, V49, P1289, DOI 10.1007/s11517-011-0834-z; Pritchett D, 2012, J NEURAL TRANSM, V119, P1061, DOI 10.1007/s00702-012-0817-8; Radonjic NV, 2008, PHYSIOL BEHAV, V93, P437, DOI 10.1016/j.physbeh.2007.10.003; Recordati G, 2003, AUTON NEUROSCI-BASIC, V103, P1, DOI 10.1016/S1566-0702(02)00260-6; Salmi P, BRAIN RES; Schwartz PJ, 2004, PSYCHIAT RES, V127, P19, DOI 10.1016/j.psychres.2004.03.004; Shiloh R, 2005, INT J NEUROPSYCHOPH, V8, P537, DOI 10.1017/S1461145705005377; Shiloh R, 2001, EUR NEUROPSYCHOPHARM, V11, P285, DOI 10.1016/S0924-977X(01)00096-7; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; Stone JM, 2007, J PSYCHOPHARMACOL, V21, P440, DOI 10.1177/0269881106073126; Tandon R, 2009, SCHIZOPHR RES, V110, P1, DOI 10.1016/j.schres.2009.03.005; Tuboly G, 2009, PHYSIOL BEHAV, V96, P18, DOI 10.1016/j.physbeh.2008.07.030; Walther S, 2011, PSYCHIAT RES-NEUROIM, V192, P117, DOI 10.1016/j.pscychresns.2010.12.002; Wiescholleck V, 2013, NEUROPHARMACOLOGY, V74, P48, DOI 10.1016/j.neuropharm.2013.01.001; Wirz-Justice A, 2001, SCHIZOPHRENIA BULL, V27, P497, DOI 10.1093/oxfordjournals.schbul.a006890	44	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143751	10.1371/journal.pone.0143751	http://dx.doi.org/10.1371/journal.pone.0143751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629908	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300094
J	Leclerc, J; Rosenfeld, E; Trainini, M; Martin, B; Meuric, V; Bonnaure-Mallet, M; Baysse, C				Leclerc, Julia; Rosenfeld, Eric; Trainini, Mathieu; Martin, Benedicte; Meuric, Vincent; Bonnaure-Mallet, Martine; Baysse, Christine			The Cytochrome bd Oxidase of Porphyromonas gingivalis Contributes to Oxidative Stress Resistance and Dioxygen Tolerance	PLOS ONE			English	Article							IRON PROTOPORPHYRIN IX; FUNCTION SIGMA FACTORS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; CYDX PROTEIN; GENE; TRANSCRIPTOME; PARAQUAT; GROWTH; MEMBER	Porphyromonas gingivalis is an etiologic agent of periodontal disease in humans. The disease is associated with the formation of a mixed oral biofilm which is exposed to oxygen and environmental stress, such as oxidative stress. To investigate possible roles for cytochrome bd oxidase in the growth and persistence of this anaerobic bacterium inside the oral biofilm, mutant strains deficient in cytochrome bd oxidase activity were characterized. This study demonstrated that the cytochrome bd oxidase of Porphyromonas gingivalis, encoded by cydAB, was able to catalyse O-2 consumption and was involved in peroxide and superoxide resistance, and dioxygen tolerance.	[Leclerc, Julia; Trainini, Mathieu; Martin, Benedicte; Meuric, Vincent; Bonnaure-Mallet, Martine; Baysse, Christine] Univ Rennes 1, Microbiol Risques Infect EA1254, Rennes, France; [Rosenfeld, Eric; Meuric, Vincent; Bonnaure-Mallet, Martine] Univ La Rochelle, CNRS, UMR 7266, LIENSs, La Rochelle, France; [Meuric, Vincent; Bonnaure-Mallet, Martine] CHU Rennes, Rennes, France	Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; CHU Rennes	Baysse, C (corresponding author), Univ Rennes 1, Microbiol Risques Infect EA1254, Rennes, France.	christine.baysse@univ-rennes1.fr	Meuric, Vincent/AAW-7709-2020; Baysse, Christine/GLU-3438-2022	Meuric, Vincent/0000-0001-5411-4001; ERIC, ROSENFELD/0000-0003-1196-5265; Baysse, Christine/0000-0003-1318-2192; MARTIN, Benedicte/0000-0003-0897-5884; Bonnaure-Mallet, martine/0000-0001-5214-7803				Allen RJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-946; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Baughn AD, 2003, MICROBIOL-SGM, V149, P1551, DOI 10.1099/mic.0.26247-0; Borisov VB, 2013, FEBS LETT, V587, P2214, DOI 10.1016/j.febslet.2013.05.047; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Dashper S, 2010, ANTIMICROB AGENTS CH, V54, P1311, DOI 10.1128/AAC.00946-09; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Edwards SE, 2000, FEMS MICROBIOL LETT, V185, P71, DOI 10.1111/j.1574-6968.2000.tb09042.x; Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091; Giuffre A, 2012, FEBS LETT, V586, P622, DOI 10.1016/j.febslet.2011.07.035; GRENIER D, 1992, INFECT IMMUN, V60, P5298, DOI 10.1128/IAI.60.12.5298-5301.1992; Gu M, 2013, MOL MICROBIOL, V79, P1136; HASSAN HM, 1979, J BIOL CHEM, V254, P846; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Hirano T, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00079; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; Hong BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127077; Huang GTJ, 2001, INFECT IMMUN, V69, P1364, DOI 10.1128/IAI.69.3.1364-1372.2001; Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x; Kumagai Y, 2003, MICROBIOL IMMUNOL, V47, P735, DOI 10.1111/j.1348-0421.2003.tb03443.x; Leclerc J, 2011, Bull Group Int Rech Sci Stomatol Odontol, V50, P5; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Meehan BM, 2012, P NATL ACAD SCI USA, V109, P12153, DOI 10.1073/pnas.1203796109; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Morris RL, 2013, NAT REV MICROBIOL, V11, P205, DOI 10.1038/nrmicro2970; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; Onozawa S, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-4; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Smalley JW, 2000, FEMS MICROBIOL LETT, V183, P159, DOI 10.1111/j.1574-6968.2000.tb08951.x; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x; YOSHIMOTO H, 1993, ORAL MICROBIOL IMMUN, V8, P208, DOI 10.1111/j.1399-302X.1993.tb00561.x; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727	42	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143808	10.1371/journal.pone.0143808	http://dx.doi.org/10.1371/journal.pone.0143808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629705	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300102
J	Liang, JN; Brown, DA				Liang, Jing Nong; Brown, David A.			Impaired H-Reflex Gain during Postural Loaded Locomotion in Individuals Post-Stroke	PLOS ONE			English	Article							BODY-WEIGHT SUPPORT; SPINAL-CORD INTACT; HOFFMANN REFLEX; MUSCLE-ACTIVITY; DESCENDING CONTROL; INJURED SUBJECTS; MOTONEURON POOL; STRETCH REFLEX; MODULATION; WALKING	Objective Successful execution of upright locomotion requires coordinated interaction between controllers for locomotion and posture. Our earlier research supported this model in the non-impaired and found impaired interaction in the post-stroke nervous system during locomotion. In this study, we sought to examine the role of the Ia afferent spinal loop, via the H-reflex response, under postural influence during a locomotor task. We tested the hypothesis that the ability to increase stretch reflex gain in response to postural loads during locomotion would be reduced post-stroke. Methods Fifteen individuals with chronic post-stroke hemiparesis and 13 non-impaired controls pedaled on a motorized cycle ergometer with specialized backboard support system under (1) seated supported, and (2) non-seated postural-loaded conditions, generating matched pedal force outputs of two levels. H-reflexes were elicited at 90 degrees crank angle. Results We observed increased H-reflex gain with postural influence in non-impaired individuals, but a lack of increase in individuals post-stroke. Furthermore, we observed decreased H-reflex gain at higher postural loads in the stroke-impaired group. Conclusion These findings suggest an impaired Ia afferent pathway potentially underlies the defects in the interaction between postural and locomotor control post-stroke and may explain reduced ability of paretic limb support during locomotor weight-bearing in individuals post-stroke. Significance These results support the judicious use of bodyweight support training when first helping individuals post-stroke to regain locomotor pattern generation and weight-bearing capability.	[Liang, Jing Nong] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Liang, Jing Nong] Northwestern Univ, Feinberg Sch Med, Interdept Neurosci Program, Chicago, IL 60611 USA; [Liang, Jing Nong] Univ Nevada, Dept Phys Therapy, Las Vegas, NV 89154 USA; [Brown, David A.] Univ Alabama Birmingham, Sch Hlth Related Profess, Dept Phys Therapy, Birmingham, AL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Alabama System; University of Alabama Birmingham	Liang, JN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	JN-Liang@u.northwestern.edu	Liang, Jing Nong/K-9568-2013	Liang, Jing Nong/0000-0003-2497-1496	American Heart Association [11PRE54300029]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association #11PRE54300029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA K, 1982, J PHYSIOL-LONDON, V329, P553, DOI 10.1113/jphysiol.1982.sp014319; Ali AA, 2000, CLIN NEUROPHYSIOL, V111, P664, DOI 10.1016/S1388-2457(99)00304-1; Alibiglou L, 2011, EXP BRAIN RES, V211, P37, DOI 10.1007/s00221-011-2644-9; Alibiglou L, 2011, J NEUROPHYSIOL, V105, P1660, DOI 10.1152/jn.00290.2010; Alibiglou L, 2009, J NEUROPHYSIOL, V102, P2856, DOI 10.1152/jn.00211.2009; Beer RF, 2007, MUSCLE NERVE, V36, P242, DOI 10.1002/mus.20817; Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; BROOKE JD, 1992, BRAIN RES, V582, P78, DOI 10.1016/0006-8993(92)90319-5; Brown DA, 1998, STROKE, V29, P598, DOI 10.1161/01.STR.29.3.598; Brown DA, 1996, J BIOMECH, V29, P1349, DOI 10.1016/0021-9290(96)00038-3; Brown DA, 2010, 18222 SOC NEUR NEUR; Brown DA, 2011, 92311 SOC NEUR NEUR; Burgess J, 2011, INFLUENCE REDUCED BO; CAPADAY C, 1987, J NEUROSCI METH, V21, P91, DOI 10.1016/0165-0270(87)90107-5; CAPADAY C, 1986, J NEUROSCI, V6, P1308; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; CHAN CWY, 1982, NEUROSCI LETT, V33, P333, DOI 10.1016/0304-3940(82)90395-0; CRENNA P, 1987, EXP BRAIN RES, V66, P49; Faist M, 1996, EXP BRAIN RES, V109, P441; Ferris DP, 2001, J PHYSIOL-LONDON, V530, P167, DOI 10.1111/j.1469-7793.2001.0167m.x; Field-Fote E C, 2000, Electromyogr Clin Neurophysiol, V40, P459; HAYASHI R, 1992, NEUROSCI RES, V13, P227, DOI 10.1016/0168-0102(92)90062-H; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; HOFFMAN MA, 1995, BRAIN RES, V700, P303, DOI 10.1016/0006-8993(95)01082-7; Hwang IS, 2004, J ELECTROMYOGR KINES, V14, P653, DOI 10.1016/j.jelekin.2004.01.002; Hwang S, 2011, J ELECTROMYOGR KINES, V21, P445, DOI 10.1016/j.jelekin.2010.11.002; Hye-Seon J, 2007, INT J NEUROSCI, V117, P1661, DOI 10.1080/00207450601067158; Kamibayashi K, 2010, EXP BRAIN RES, V202, P385, DOI 10.1007/s00221-009-2145-2; KATZ R, 1988, BRAIN, V111, P417, DOI 10.1093/brain/111.2.417; Knikou M, 2011, CLIN NEUROPHYSIOL, V122, P1396, DOI 10.1016/j.clinph.2010.12.044; Knikou M, 2009, INT J NEUROSCI, V119, P2056, DOI 10.1080/00207450903139747; Knikou M, 2009, EXP BRAIN RES, V193, P397, DOI 10.1007/s00221-008-1636-x; Koceja DM, 1995, ELECTROMYOGR MOTOR C, V97, P387, DOI 10.1016/0924-980X(95)00163-F; KOCEJA DM, 1993, BRAIN RES, V629, P155, DOI 10.1016/0006-8993(93)90495-9; Kosak MC, 2000, NEUROREHAB NEURAL RE, V14, P13, DOI 10.1177/154596830001400102; Lavoie BA, 1997, J NEUROPHYSIOL, V78, P429, DOI 10.1152/jn.1997.78.1.429; Liang JN, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-63; Liang JN, 2013, J NEUROPHYSIOL, V110, P378, DOI 10.1152/jn.00005.2013; Loscher WN, 1996, J PHYSIOL-LONDON, V491, P271; MAGLADERY JW, 1950, B JOHNS HOPKINS HOSP, V86, P265; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; MATTHEWS PBC, 1986, J PHYSIOL-LONDON, V374, P73, DOI 10.1113/jphysiol.1986.sp016066; Miyoshi T, 2003, EXP BRAIN RES, V150, P109, DOI 10.1007/s00221-003-1414-8; MORIN C, 1982, NEUROSCI LETT, V33, P47, DOI 10.1016/0304-3940(82)90128-8; Moseley AM, 2003, STROKE, V34, P3006, DOI 10.1161/01.STR.0000102415.43108.66; Nakazawa K, 2004, CLIN NEUROPHYSIOL, V115, P1296, DOI 10.1016/j.clinph.2004.01.016; Nilsson L, 2001, CLIN REHABIL, V15, P515, DOI 10.1191/026921501680425234; Phadke CP, 2006, NEUROSCI LETT, V403, P6, DOI 10.1016/j.neulet.2006.04.058; Pierrot-Deseilligny E, 2000, NEUROPHYSIOL CLIN, V30, P67, DOI 10.1016/S0987-7053(00)00062-9; Pinar S, 2010, J ELECTROMYOGR KINES, V20, P354, DOI 10.1016/j.jelekin.2009.03.002; Rogers LM, 2011, HUM MOVEMENT SCI, V30, P1225, DOI 10.1016/j.humov.2011.03.001; Rogers LM, 2011, CLIN NEUROPHYSIOL, V122, P1211, DOI 10.1016/j.clinph.2010.11.006; ROMANO C, 1987, J PHYSIOL-LONDON, V390, P271, DOI 10.1113/jphysiol.1987.sp016699; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Schindler-Ivens S, 2004, J NEUROPHYSIOL, V92, P2207, DOI 10.1152/jn.01207.2003; Schindler-Ivens S, 2008, EXP BRAIN RES, V188, P465, DOI 10.1007/s00221-008-1373-1; Sinkjaer T, 1996, J NEUROPHYSIOL, V76, P1112, DOI 10.1152/jn.1996.76.2.1112; Sinkjaer T, 1996, J NEUROL, V243, P566, DOI 10.1007/BF00900943; Sukal TM, 2007, EXP BRAIN RES, V183, P215, DOI 10.1007/s00221-007-1029-6; VERRIER MC, 1985, ELECTROEN CLIN NEURO, V60, P492, DOI 10.1016/0013-4694(85)91109-5; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; YANG JF, 1991, CAN J NEUROL SCI, V18, P443, DOI 10.1017/S0317167100032133; Zehr EP, 1999, PROG NEUROBIOL, V58, P185, DOI 10.1016/S0301-0082(98)00081-1; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	64	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144007	10.1371/journal.pone.0144007	http://dx.doi.org/10.1371/journal.pone.0144007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629996	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300135
J	Qian, GF; Fan, W; Ahlemeyer, B; Karnati, S; Baumgart-Vogt, E				Qian, Guofeng; Fan, Wei; Ahlemeyer, Barbara; Karnati, Srikanth; Baumgart-Vogt, Eveline			Peroxisomes in Different Skeletal Cell Types during Intramembranous and Endochondral Ossification and Their Regulation during Osteoblast Differentiation by Distinct Peroxisome Proliferator-Activated Receptors	PLOS ONE			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; BETA-OXIDATION ENZYMES; IN-SITU HYBRIDIZATION; NEURONAL MIGRATION; ZELLWEGER-SYNDROME; PPAR-ALPHA; RESPONSE ELEMENT; BONE-MARROW; MOUSE MODEL; PROTEINS	Ossification defects leading to craniofacial dysmorphism or rhizomelia are typical phenotypes in patients and corresponding knockout mouse models with distinct peroxisomal disorders. Despite these obvious skeletal pathologies, to date no careful analysis exists on the distribution and function of peroxisomes in skeletal tissues and their alterations during ossification. Therefore, we analyzed the peroxisomal compartment in different cell types of mouse cartilage and bone as well as in primary cultures of calvarial osteoblasts. The peroxisome number and metabolism strongly increased in chondrocytes during endochondral ossification from the reserve to the hypertrophic zone, whereas in bone, metabolically active osteoblasts contained a higher numerical abundance of this organelle than osteocytes. The high abundance of peroxisomes in these skeletal cell types is reflected by high levels of Pex11 beta gene expression. During culture, calvarial pre-osteoblasts differentiated into secretory osteoblasts accompanied by peroxisome proliferation and increased levels of peroxisomal genes and proteins. Since many peroxisomal genes contain a PPAR-responsive element, we analyzed the gene expression of PPAR alpha/beta/gamma in calvarial osteoblasts and MC3T3-E1 cells, revealing higher levels for PPAR beta than for PPAR. and PPAR.. Treatment with different PPAR agonists and antagonists not only changed the peroxisomal compartment and associated gene expression, but also induced complex alterations of the gene expression patterns of the other PPAR family members. Studies in M3CT3-E1 cells showed that the PPAR beta agonist GW0742 activated the PPRE-mediated luciferase expression and up-regulated peroxisomal gene transcription (Pex11, Pex13, Pex14, Acox1 and Cat), whereas the PPAR beta antagonist GSK0660 led to repression of the PPRE and a decrease of the corresponding mRNA levels. In the same way, treatment of calvarial osteoblasts with GW0742 increased in peroxisome number and related gene expression and accelerated osteoblast differentiation. Taken together, our results suggest that PPAR beta regulates the numerical abundance and metabolic function of peroxisomes via Pex11 beta in parallel to osteoblast differentiation.	[Qian, Guofeng; Fan, Wei; Ahlemeyer, Barbara; Karnati, Srikanth; Baumgart-Vogt, Eveline] Univ Giessen, Med Cell Biol, Inst Anat & Cell Biol, D-35385 Giessen, Germany	Justus Liebig University Giessen	Baumgart-Vogt, E (corresponding author), Univ Giessen, Med Cell Biol, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	Eveline.Baumgart-Vogt@anatomie.med.uni-giessen.de	Baumgart-Vogt, Eveline/I-5945-2013; Karnati, Srikanth/AAP-9038-2021	Baumgart-Vogt, Eveline/0000-0002-8265-3763; Karnati, Srikanth/0000-0001-9083-2916	Leistungsorientierte Mittel der Justus-Liebig University Giessen	Leistungsorientierte Mittel der Justus-Liebig University Giessen	The work was supported by Leistungsorientierte Mittel der Justus-Liebig University Giessen.	AGAMANOLIS DP, 1995, PEDIATR PATHOL LAB M, V15, P503, DOI 10.3109/15513819509026986; Ahlemeyer B, 2007, J COMP NEUROL, V505, P1, DOI 10.1002/cne.21448; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Aleshin S, 2013, NEUROCHEM INT, V63, P322, DOI 10.1016/j.neuint.2013.06.012; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1652, DOI 10.1111/bph.12448; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P371, DOI 10.1007/s004180050178; Baumgart E, 1997, HISTOCHEM CELL BIOL, V108, P185, DOI 10.1007/s004180050160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; Braverman N, 2010, MOL GENET METAB, V99, P408, DOI 10.1016/j.ymgme.2009.12.005; Brites P, 2003, HUM MOL GENET, V12, P2255, DOI 10.1093/hmg/ddg236; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Colasante C, 2015, THROMB HAEMOSTASIS, V113, P452, DOI 10.1160/TH14-06-0497; Cook WS, 2000, BIOCHEM BIOPH RES CO, V278, P250, DOI 10.1006/bbrc.2000.3739; DEAHL ST, 1992, J BONE MINER RES, V7, P187; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; En-Nosse M, 2009, CELL TISSUE RES, V338, P203, DOI 10.1007/s00441-009-0871-1; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Fox MA, 2014, IN VITRO CELL DEV-AN, V50, P340, DOI 10.1007/s11626-013-9710-5; Fox MA, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-24; Fransen M, 1999, BIOCHEM J, V340, P561, DOI 10.1042/0264-6021:3400561; GENGE BR, 1990, J BIOL CHEM, V265, P4703; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Grabenbauer M, 2000, CELL BIOCHEM BIOPHYS, V32, P37, DOI 10.1385/CBB:32:1-3:37; Grant P, 2013, HISTOCHEM CELL BIOL, V140, P423, DOI 10.1007/s00418-013-1133-6; Hah YS, 2014, INT J MED SCI, V11, P1116, DOI 10.7150/ijms.9611; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; Huang Yen-Hua, 2014, Biomed Res Int, V2014, P195162, DOI 10.1155/2014/195162; Imai Y, 2013, PHYSIOL REV, V93, P481, DOI 10.1152/physrev.00008.2012; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Kajarabille N, 2013, SCI WORLD J, DOI 10.1155/2013/589641; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karnati S, 2008, HISTOCHEM CELL BIOL, V130, P719, DOI 10.1007/s00418-008-0462-3; Kirsch T, 2005, FRONT BIOSCI-LANDMRK, V10, P576, DOI 10.2741/1553; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Latruffe N, 1997, BIOCHIMIE, V79, P81, DOI 10.1016/S0300-9084(97)81496-4; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Lin S, 2015, MOL GENETICS PEDIAT, P56; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nardacci R, 2004, J HISTOCHEM CYTOCHEM, V52, P423, DOI 10.1177/002215540405200401; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Okuno Y, 2008, BIOCHEM BIOPH RES CO, V366, P698, DOI 10.1016/j.bbrc.2007.12.001; OSUMI T, 1990, J BIOCHEM-TOKYO, V108, P614, DOI 10.1093/oxfordjournals.jbchem.a123252; Park J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085045; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poll-The BT, 2004, AM J MED GENET A, V126A, P333, DOI 10.1002/ajmg.a.20664; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; ROBISON WG, 1977, INVEST OPHTH VIS SCI, V16, P1110; SCHEPERS L, 1988, J BIOL CHEM, V263, P2724; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Schrader M, 2012, BBA-MOL BASIS DIS, V1822, P1343, DOI 10.1016/j.bbadis.2011.12.014; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Stelzig I, 2013, HISTOCHEM CELL BIOL, V140, P443, DOI 10.1007/s00418-013-1131-8; Still K, 2008, CALCIFIED TISSUE INT, V83, P285, DOI 10.1007/s00223-008-9175-9; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Syversen U, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-10; Tugwood J D, 1998, Arch Toxicol Suppl, V20, P377; Van Veldhoven P P, 1998, Verh K Acad Geneeskd Belg, V60, P195; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Watkins BA, 2003, PROSTAG LEUKOTR ESS, V68, P387, DOI 10.1016/S0952-3278(03)00063-2; Woodyatt NJ, 1999, CARCINOGENESIS, V20, P369, DOI 10.1093/carcin/20.3.369; Wu X, 2000, BONE, V26, P21, DOI 10.1016/S8756-3282(99)00238-0; Wuthier RE, 2011, FRONT BIOSCI-LANDMRK, V16, P2812, DOI 10.2741/3887; Yamashita A, 2006, FEBS LETT, V580, P4121, DOI 10.1016/j.febslet.2006.06.057; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	85	15	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143439	10.1371/journal.pone.0143439	http://dx.doi.org/10.1371/journal.pone.0143439			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630504	Green Published, gold			2022-12-26	WOS:000365926300050
J	Vilar, E; Boltiador, C; Wong, J; Viljoen, A; Machado, A; Uthayakumar, A; Farrington, K				Vilar, Enric; Boltiador, Capella; Wong, Jonathan; Viljoen, Adie; Machado, Ashwini; Uthayakumar, Arani; Farrington, Ken			Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIGH-FLUX HEMODIALYSIS; SERUM CYSTATIN-C; PERITONEAL-DIALYSIS PATIENTS; RENAL-FUNCTION; ONLINE HEMODIAFILTRATION; BETA-2-MICROGLOBULIN LEVEL; CARDIOVASCULAR EVENTS; MORTALITY; CLEARANCE	Background Residual Kidney Function (RKF) is associated with survival benefits in haemodialysis (HD) but is difficult to measure without urine collection. Middle molecules such as Cystatin C and beta 2-microglobulin accumulate in renal disease and plasma levels have been used to estimate kidney function early in this condition. We investigated their use to estimate RKF in patients on HD. Design Cystatin C, beta 2-microglobulin, urea and creatinine levels were studied in patients on incremental high-flux HD or hemodiafiltration(HDF). Over sequential HD sessions, blood was sampled pre-and post-session 1 and pre-session 2, for estimation of these parameters. Urine was collected during the whole interdialytic interval, for estimation of residual GFR (GFR(Residual) = mean of urea and creatinine clearance). The relationships of plasma Cystatin C and beta 2-microglobulin levels to GFR(Residual) and urea clearance were determined. Results Of the 341 patients studied, 64% had urine output> 100ml/day, 32.6% were on high-flux HD and 67.4% on HDF. Parameters most closely correlated with GFR(Residual) were 1/beta 2-micoglobulin (r(2) 0.67) and 1/Cystatin C (r(2) 0.50). Both these relationships were weaker at low GFR(Residual). The best regression model for GFR(Residual), explaining 67% of the variation, was: GFR(Residual) = 160. 3 . (1/beta 2m)-4.2 Where beta 2m is the pre-dialysis beta 2 microglobulin concentration (mg/L). This model was validated in a separate cohort of 50 patients using Bland-Altman analysis. Areas under the curve in Receiver Operating Characteristic analysis aimed at identifying subjects with urea clearance >= 2ml/min/1.73m(2) was 0.91 for beta 2-microglobulin and 0.86 for Cystatin C. A plasma beta 2-microglobulin cut-off of <= 19.2mg/L allowed identification of patients with urea clearance >= 2ml/min/1.73m(2) with 90% specificity and 65% sensitivity. Conclusion Plasma pre-dialysis beta 2-microglobulin levels can provide estimates of RKF which may have clinical utility and appear superior to cystatin C. Use of cut-off levels to identify patients with RKF may provide a simple way to individualise dialysis dose based on RKF.	[Vilar, Enric; Wong, Jonathan; Machado, Ashwini; Uthayakumar, Arani; Farrington, Ken] Lister Hosp, Renal Unit, Stevenage, Herts, England; [Vilar, Enric; Wong, Jonathan; Farrington, Ken] Univ Hertfordshire, Dept Postgrad Med, Hatfield AL10 9AB, Herts, England; [Boltiador, Capella; Viljoen, Adie] Lister Hosp, Dept Pathol, Stevenage, Herts, England; [Boltiador, Capella] Univ W England, Bristol BS16 1QY, Avon, England	Lister Hospital; University of Hertfordshire; Lister Hospital; University of West England	Vilar, E (corresponding author), Lister Hosp, Renal Unit, Stevenage, Herts, England.	enric.vilar@nhs.net	Farrington, Ken/V-1531-2019		British Renal Society; Kidney Research UK [TF9/2010]; National Institute for Health Research through the Renal Research Network	British Renal Society; Kidney Research UK(Kidney Research UK (KRUK)); National Institute for Health Research through the Renal Research Network	This work was supported by the British Renal Society Grant, 9th Round Awards for EV. (http://www.britishrenal.org/getattachment/Research-for-Renal/Grants-Awarded/Summary-of-9th-Round-BRS-Grant-Awards-(2).doc.aspx) Funders reviewed the study design as part of the peer-review process for grant application but had no role in data collection, analysis, decision to publish or manuscript preparation. This work was also supported by the Kidney Research UK (www.kidneyresearchuk.org) funded EV (Fellowship TF9/2010). The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript. Support was received through the National Institute for Health Research through the Renal Research Network. The funder had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	AMICI G, 1993, NEPHRON, V65, P469, DOI 10.1159/000187533; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Bokenkamp A, 1998, PEDIATRICS, V101, P875, DOI 10.1542/peds.101.5.875; Canaud B, 2006, KIDNEY INT, V69, P2087, DOI 10.1038/sj.ki.5000447; Carter JL, 2011, NEPHROL DIAL TRANSPL, V26, P3729, DOI 10.1093/ndt/gfr112; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Depner Thomas A, 2005, Hemodial Int, V9, P241, DOI 10.1111/j.1492-7535.2005.01138.x; Diaz-Buxo JA, 1999, AM J KIDNEY DIS, V33, P523, DOI 10.1016/S0272-6386(99)70190-3; Finney H, 1997, CLIN CHEM, V43, P1016; Fry AC, 2007, BLOOD PURIFICAT, V25, P295, DOI 10.1159/000104870; Gerhardt T, 2008, NEPHROL DIAL TRANSPL, V23, P309, DOI 10.1093/ndt/gfm510; GHISO J, 1990, P NATL ACAD SCI USA, V87, P1288, DOI 10.1073/pnas.87.4.1288; Gotch FA, 1995, CLIN DIALYSIS, P156; GREIPP PR, 1988, BLOOD, V72, P219; GRUBB A, 1992, CLIN NEPHROL, V38, pS20; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hemodialysis Adequacy 2006, 2006, AM J KIDNEY DIS, V48, pS2, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051]; Hoek FJ, 2007, NEPHROL DIAL TRANSPL, V22, P1633, DOI 10.1093/ndt/gfm027; HOFMANN B, 1990, AIDS, V4, P207, DOI 10.1097/00002030-199003000-00005; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Kjaergaard KD, 2013, CLIN PHYSIOL FUNCT I, V33, P224, DOI 10.1111/cpf.12018; LEYPOLDT JK, 1991, BLOOD PURIFICAT, V9, P74, DOI 10.1159/000170000; Lopez-Menchero R, 1999, NEPHRON, V83, P219, DOI 10.1159/000045514; Lornoy W, 2000, NEPHROL DIAL TRANSPL, V15, P49, DOI 10.1093/oxfordjournals.ndt.a027964; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Marsenic O, 2013, HEMODIAL INT, V17, pS11, DOI 10.1111/hdi.12083; Merz GS, 1997, J CELL PHYSIOL, V173, P423; Mulay A, 2008, AM J KIDNEY DIS, V52, P194, DOI 10.1053/j.ajkd.2008.04.022; ODELL RA, 1991, KIDNEY INT, V39, P909, DOI 10.1038/ki.1991.114; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Shemin D, 2001, AM J KIDNEY DIS, V38, P85, DOI 10.1053/ajkd.2001.25198; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Tattersall JE, 1996, KIDNEY INT, V50, P2094, DOI 10.1038/ki.1996.534; Vilar E, 2014, CLIN J AM SOC NEPHRO, V9, P1240, DOI 10.2215/CJN.07510713; Vilar E, 2009, CLIN J AM SOC NEPHRO, V4, P1944, DOI 10.2215/CJN.05560809; Vilar E, 2009, NEPHROL DIAL TRANSPL, V24, P2502, DOI 10.1093/ndt/gfp071; Vinge E, 1999, SCAND J CLIN LAB INV, V59, P587, DOI 10.1080/00365519950185076; Ward RA, 2000, J AM SOC NEPHROL, V11, P2344, DOI 10.1681/ASN.V11122344; Xu XQ, 2001, ASAIO J, V47, P623, DOI 10.1097/00002480-200111000-00011	41	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143813	10.1371/journal.pone.0143813	http://dx.doi.org/10.1371/journal.pone.0143813			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629900	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300104
J	Li, XQ; Chen, YY				Li, Xiaoqing; Chen, Yiya			Representation and Processing of Lexical Tone and Tonal Variants: Evidence from the Mismatch Negativity	PLOS ONE			English	Article							SPOKEN WORD RECOGNITION; PHONOLOGICAL VARIATION; PLACE ASSIMILATION; PERCEPTION; LANGUAGE; CHINESE; LATERALIZATION; MECHANISMS; ATTENTION; INFERENCE	Pronunciation variation is ubiquitous in the speech signal. Different models of lexical representation have been put forward to deal with speech variability, which differ in the level as well as the nature of mental representation. We present the first mismatch negativity (MMN) study investigating the effect of allophonic variation on the mental representation and neural processing of lexical tones. Native speakers of Standard Chinese (SC) participated in an oddball electroencephalography (EEG) experiment. All stimuli have the same segments (ma) but different lexical tones: level [T1], rising [T2], and dipping [T3]. In connected speech with a T3T3 sequence, the first T3 may undergo allophonic change and is produced with a rising pitch contour (T3V), similar to the lexical T2 pitch contour. Four oddball conditions were constructed (T1/T3, T3/T1, T2/T3, T3/T2; standard/deviant). All four conditions elicited MMN effects, with the T1-T3 pair eliciting comparable MMNs, but the T2-T3 pair asymmetrical MMN effects. There were significantly greater and earlier MMN effects in the T2/T3 condition than that in the reversed T3/T2 condition. Furthermore, the T3/T2 condition showed more rightward MMN effects than the T2/T3 condition and the T1-T3 pair. Such asymmetries suggest co-activation of long-term memory representations of both T3 and T3V when T3 serves as the standard. The acoustic similarity between the activated T3V (by the standard T3) and the incoming deviant stimulus T2 induces acoustic processing of the tonal contrast in the T3/T2 condition, similar to that of within-category lexical tone processing, which is in contrast to the processing of between-category lexical tones observed in the T2/T3, T1/T3, and T3/T1 conditions.	[Li, Xiaoqing] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Li, Xiaoqing] Jiangsu Normal Univ, Jiangsu Collaborat Innovat Ctr Language Abil, Xuzhou, Peoples R China; [Chen, Yiya] LUCL, Leiden, Netherlands; [Chen, Yiya] LIBC, Leiden, Netherlands	Chinese Academy of Sciences; Institute of Psychology, CAS; Jiangsu Normal University	Chen, YY (corresponding author), LUCL, Leiden, Netherlands.	yiya.chen@hum.leidenuniv.nl			National Natural Science Foundation of China [31271091]; European Research Council [206198]; Netherlands Royal Academy of Sciences (KNAW China Exchange Program) [13CDP012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Research Council(European Research Council (ERC)European Commission); Netherlands Royal Academy of Sciences (KNAW China Exchange Program)	We acknowledge the financial support from the National Natural Science Foundation of China (31271091) to XQL, the European Research Council (Starting Grant-206198) to YC, and the Netherlands Royal Academy of Sciences (KNAW China Exchange Program 13CDP012) to YC & XQL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2011, PLOS ONE, V6, P1; Chandrasekaran B, 2007, BRAIN RES, V1128, P148, DOI 10.1016/j.brainres.2006.10.064; Chao Y. R., 1948, MANDARIN PRIMER; Chen M.Y., 2000, TONE SANDHI PATTERNS; Chen Y., 2012, OXFORD HDB LAB PHONO, P103; Chen Y., 2011, P PSYCHOLINGUISTICS, P38; Chen YY, 2008, J PHONETICS, V36, P724, DOI 10.1016/j.wocn.2008.06.003; Connine CM, 2004, PSYCHON B REV, V11, P1084, DOI 10.3758/BF03196741; Connine CM, 2008, PERCEPT PSYCHOPHYS, V70, P403, DOI 10.3758/PP.70.3.403; Connine CM, 2006, LINGUIST REV, V23, P235, DOI 10.1515/TLR.2006.009; Cornell SA, 2011, BRAIN RES, V1394, P79, DOI 10.1016/j.brainres.2011.04.001; Cowan N., 1999, MODELS WORKING MEMOR; DehaeneLambertz G, 1997, NEUROREPORT, V8, P919, DOI 10.1097/00001756-199703030-00021; Eulitz C, 2004, J COGNITIVE NEUROSCI, V16, P577, DOI 10.1162/089892904323057308; Friedrich M, 2006, PSYCHOPHYSIOLOGY, V43, P1, DOI 10.1111/j.1469-8986.2006.00381.x; Friedrich M, 2008, NEUROREPORT, V19, P1757, DOI 10.1097/WNR.0b013e328318f014; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gaskell MG, 2008, J EXP PSYCHOL HUMAN, V34, P1632, DOI 10.1037/a0011977; Gaskell MG, 1996, J EXP PSYCHOL HUMAN, V22, P144, DOI 10.1037/0096-1523.22.1.144; Gaskell MG, 1998, J EXP PSYCHOL HUMAN, V24, P380, DOI 10.1037/0096-1523.24.2.380; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Gomes H, 1997, PSYCHOPHYSIOLOGY, V34, P712, DOI 10.1111/j.1469-8986.1997.tb02146.x; Gottfried TL, 1997, J PHONETICS, V25, P207, DOI 10.1006/jpho.1997.0042; Gow DW, 2003, PERCEPT PSYCHOPHYS, V65, P575, DOI 10.3758/BF03194584; Gow DW, 2002, J EXP PSYCHOL HUMAN, V28, P163, DOI 10.1037//0096-1523.28.1.163; Gow DW, 2001, J MEM LANG, V45, P133, DOI 10.1006/jmla.2000.2764; Gumnior H, 2005, LANG COGNITIVE PROC, V20, P465, DOI 10.1080/01690960444002174; Huang T, 2010, PHONETICA, V67, P243, DOI 10.1159/000327392; Ikezawa S, 2008, INT J PSYCHOPHYSIOL, V68, P41, DOI 10.1016/j.ijpsycho.2008.01.006; Jacobsen T, 2004, BRAIN LANG, V88, P54, DOI 10.1016/S0093-934X(03)00156-1; Johnson Keith, 1997, TALKER VARIABILITY S, P145; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; KLOUDA GV, 1988, BRAIN LANG, V35, P154, DOI 10.1016/0093-934X(88)90106-X; KRATOCHVIL Paul, 1986, W LI MEMORIAL VOLUME, P253; KRAUS N, 1995, EAR HEARING, V16, P19, DOI 10.1097/00003446-199502000-00003; Kuo YC, 2007, PHONOL PHONET, V12-2, P211; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; LAHIRI A, 1991, COGNITION, V38, P245, DOI 10.1016/0010-0277(91)90008-R; Lahiri A, 2010, J PHONETICS, V38, P44, DOI 10.1016/j.wocn.2010.01.002; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mitterer H, 2011, J PHONETICS, V39, P298, DOI 10.1016/j.wocn.2010.11.009; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 1997, AUDIOL NEURO-OTOL, V2, P341; Naatanen R, 2001, PSYCHOPHYSIOLOGY, V38, P1, DOI 10.1017/S0048577201000208; Nixon J, 2014, THESIS; Nixon J, 2014, LANG COGN NEUROSCI, V30, P1; Obleser J, 2003, COGNITIVE BRAIN RES, V15, P207, DOI 10.1016/S0926-6410(02)00193-3; Obleser J, 2002, 13 INT C BIOM JEN; Peng S.-H., 2000, PAPERS LAB PHONOLOGY, P152; Poeppel D, 1996, COGNITIVE BRAIN RES, V4, P231, DOI 10.1016/S0926-6410(96)00643-X; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; Polka L, 2011, J PHONETICS, V39, P467, DOI 10.1016/j.wocn.2010.08.007; Pulvermuller F, 2006, PROG NEUROBIOL, V79, P49, DOI 10.1016/j.pneurobio.2006.04.004; Ranbom LJ, 2007, J MEM LANG, V57, P273, DOI 10.1016/j.jml.2007.04.001; Ren GQ, 2009, NEUROSCIENCE, V162, P87, DOI 10.1016/j.neuroscience.2009.04.021; ROSCH E, 1975, J EXP PSYCHOL HUMAN, V1, P303, DOI 10.1037/0096-1523.1.4.303; Sharma A, 2000, J ACOUST SOC AM, V107, P2697, DOI 10.1121/1.428655; Shtyrov Y, 2007, J PSYCHOPHYSIOL, V21, P176, DOI 10.1027/0269-8803.21.34.176; Shtyrov Y, 2010, J COGNITIVE NEUROSCI, V22, P1465, DOI 10.1162/jocn.2009.21292; Tavabi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004452; Tong YX, 2005, NEUROIMAGE, V28, P417, DOI 10.1016/j.neuroimage.2005.06.002; Tversky A., 1978, COGNITION CATEGORIZA, P79; Van Lancker D., 1980, PAPERS LINGUISTICS I, V13, P201, DOI [DOI 10.1080/08351818009370498, 10.1080/08351818009370498]; WANG WSY, 1967, J SPEECH HEAR RES, V10, P629, DOI 10.1044/jshr.1003.629; Wang XD, 2013, NEUROPSYCHOLOGIA, V51, P2238, DOI 10.1016/j.neuropsychologia.2013.07.015; Wheeldon L, 2004, BRAIN LANG, V90, P401, DOI 10.1016/S0093-934X(03)00451-6; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; Wong PCM, 2002, BRAIN RES BULL, V59, P83, DOI 10.1016/S0361-9230(02)00860-2; Wu JR, 2014, LANG COGN NEUROSCI, V29, P1317, DOI 10.1080/23273798.2014.915977; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; Yip M., 2002, TONE; Yuan JH, 2014, J CHINESE LINGUIST, V42, P218; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2008, PHIL T R SOC B, VB, P363; ZEE Eric, 1980, UCLA WORKING PAPERS, V49, P98; Zhang C., 2013, EASTWARD FLOWS GREAT, P256, DOI DOI 10.1007/S10831-007-9016-2; Zhang CC, 2015, J NEUROLINGUIST, V33, P149, DOI 10.1016/j.jneuroling.2014.07.002; Zhang J, 2010, PHONOLOGY, V27, P153, DOI 10.1017/S0952675710000060; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhou XL, 1997, COGNITIVE PROCESSING OF CHINESE AND RELATED ASIAN LANGUAGES, P3; Zimmerer F, 2009, J ACOUST SOC AM, V125, P2307, DOI 10.1121/1.3021438	85	23	23	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143097	10.1371/journal.pone.0143097	http://dx.doi.org/10.1371/journal.pone.0143097			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26625000	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600014
J	Schachtner, H; Weimershaus, M; Stache, V; Plewa, N; Legler, DF; Hopken, UE; Maritzen, T				Schachtner, Hannah; Weimershaus, Mirjana; Stache, Vanessa; Plewa, Natalia; Legler, Daniel F.; Hoepken, Uta E.; Maritzen, Tanja			Loss of Gadkin Affects Dendritic Cell Migration In Vitro	PLOS ONE			English	Article							CHEMOKINE GRADIENTS; LEUKOCYTE MIGRATION; LIGANDS; MATURATION; PROTEIN; CCR7; DEFICIENCY; EXPRESSION; COLITIS; COMPLEX	Migration is crucial for the function of dendritic cells (DCs), which act as outposts of the immune system. Upon detection of pathogens, skin-and mucosa-resident DCs migrate to secondary lymphoid organs where they activate T cells. DC motility relies critically on the actin cytoskeleton, which is regulated by the actin-related protein 2/3 (ARP2/3) complex, a nucleator of branched actin networks. Consequently, loss of ARP2/3 stimulators and upstream Rho family GTPases dramatically impairs DC migration. However, nothing is known yet about the relevance of ARP2/3 inhibitors for DC migration. We previously demonstrated that the AP-1-associated adaptor protein Gadkin inhibits ARP2/3 by sequestering it on intracellular vesicles. Consistent with a role of Gadkin in DC physiology, we here report Gadkin expression in bone marrow-derived DCs and show that its protein level and post-translational modification are regulated upon LPS-induced DC maturation. DCs derived from Gadkin-deficient mice were normal with regards to differentiation and maturation, but displayed increased actin polymerization. While the actin-dependent processes of macropinocytosis and cell spreading were not affected, loss of Gadkin significantly impaired DC migration in vitro, however, in vivo DC migration was unperturbed suggesting the presence of compensatory mechanisms.	[Schachtner, Hannah; Weimershaus, Mirjana; Plewa, Natalia; Maritzen, Tanja] Leibniz Inst Mol Pharmacol FMP, Mol Physiol & Cell Biol Sect, Berlin, Germany; [Stache, Vanessa; Hoepken, Uta E.] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, Kreuzlingen, Switzerland	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Maritzen, T (corresponding author), Leibniz Inst Mol Pharmacol FMP, Mol Physiol & Cell Biol Sect, Berlin, Germany.	maritzen@fmp-berlin.de		Legler, Daniel F./0000-0001-8610-4764; Maritzen, Tanja/0000-0003-4993-0340; Stache, Vanessa/0000-0003-3755-6793	Leibniz Association grant [SAW-2013-FMP-5 247]; Swiss National Science Foundation [SNF 31003A_143841]	Leibniz Association grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a Leibniz Association grant (SAW-2013-FMP-5 247) to TM (http://www.leibniz-gemeinschaft.de/start/) and by the Swiss National Science Foundation (SNF 31003A_143841) to DFL (http://www.snf.ch/de/Seiten/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Bouma G, 2009, IMMUNOBIOLOGY, V214, P778, DOI 10.1016/j.imbio.2009.06.009; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; de Noronha S, 2005, BLOOD, V105, P1590, DOI 10.1182/blood-2004-06-2332; Ermann J, 2011, P NATL ACAD SCI USA, V108, P7137, DOI 10.1073/pnas.1104234108; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frittoli E, 2011, IMMUNITY, V35, P388, DOI 10.1016/j.immuni.2011.07.007; Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Halvorsen B, 2014, CARDIOVASC RES, V102, P148, DOI 10.1093/cvr/cvu036; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; Maritzen T, 2010, J BIOL CHEM, V285, P4074, DOI 10.1074/jbc.M109.049197; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sullivan SK, 1999, BIOCHEM BIOPH RES CO, V263, P685, DOI 10.1006/bbrc.1999.1442; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weimershaus M, 2012, J IMMUNOL, V188, P1840, DOI 10.4049/jimmunol.1101504	32	10	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143883	10.1371/journal.pone.0143883	http://dx.doi.org/10.1371/journal.pone.0143883			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624014	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000365891600064
J	Kim, C; Smith, KE; Castillejos, A; Diaz-Aguilar, D; Saint-Geniez, M; Connor, KM				Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Saint-Geniez, Magali; Connor, Kip M.			The alternative complement pathway aids in vascular regression during the early stages of a murine model of proliferative retinopathy	FASEB JOURNAL			English	Article						Cd55; Cd59; factor b; innate immune system; OIR; Vegf	ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; NEOVASCULARIZATION; ANGIOGENESIS; MOUSE; INHIBITION; IMMUNOLOGY; ANTIBODY; SYSTEM; CELLS	Proliferative retinopathic diseases often progress in 2 phases: initial regression of retinal vasculature (phase 1) followed by subsequent neovascularization (NV) (phase 2). The immune system has been shown to aid in vascular pruning in such retinopathies; however, little is known about the role of the alternative complement pathway in the initial vascular regression phase. Using a mouse model of oxygen-induced retinopathy (OIR), we observed that alternative complement pathway-deficient mice (Fb(-/-)) exhibited a mild decrease in vascular loss at postnatal day (P)8 compared with age- and strain-matched controls (P = 0.035). Laser capture microdissection was used to isolate the retinal blood vessels. Expression of the complement inhibitors Cd55 and Cd59 was significantly decreased in blood vessels isolated from hyperoxic retinas compared with those from normoxic control mice. Vegf expression was measured at P8 and found to be significantly lower in OIR mice than in normoxic control mice (P = 0.0048). Further examination of specific Vegf isoform expression revealed a significant decrease in Vegf120 (P = 0.00032) and Vegf188 (P = 0.0092). In conjunction with the major modulating effects of Vegf during early retinal vascular development, our data suggest a modest involvement of the alternative complement pathway in targeting vessels for regression in the initial vaso-obliteration stage of OIR.	[Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Connor, Kip M.] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Kim, Clifford; Smith, Kaylee E.; Castillejos, Alexandra; Diaz-Aguilar, Daniel; Saint-Geniez, Magali; Connor, Kip M.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; [Saint-Geniez, Magali] Schepens Eye Res Inst, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Schepens Eye Research Institute	Connor, KM (corresponding author), Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol,Angiogenesis Lab, 243 Cambridge St, Boston, MA 02114 USA.	kip_connor@meei.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; Connor, Kip/0000-0002-2048-9080	U.S. National Institutes of Health/National Eye Institute [R01EY022084/S1, P30EY014104]; Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation [5-FY09-535]; Fight for Sight, Inc. Student Fellowship Award; Research to Prevent Blindness (RPB) Special Research Scholar Award; NATIONAL EYE INSTITUTE [R01EY022084, P30EY014104] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; March of Dimes Foundation(March of Dimes); Fight for Sight, Inc. Student Fellowship Award; Research to Prevent Blindness (RPB) Special Research Scholar Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by U.S. National Institutes of Health/National Eye Institute Grants R01EY022084/S1 (to K.M.C.) and P30EY014104; the Howe Laboratory endowment of the Massachusetts Eye and Ear Infirmary; the March of Dimes Foundation Grant 5-FY09-535; a Fight for Sight, Inc. Student Fellowship Award; and a Research to Prevent Blindness (RPB) Special Research Scholar Award (to K.M.C.). The authors declare no conflicts of interest.	Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Darland DC, 2011, DEV BIOL, V358, P9, DOI 10.1016/j.ydbio.2011.06.045; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Fischetti F, 2006, AUTOIMMUNITY, V39, P417, DOI 10.1080/08916930600739712; FLYNN JT, 1987, PEDIATR CLIN N AM, V34, P1487; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Good WV, 2001, OPHTHALMOLOGY, V108, P1013, DOI 10.1016/S0161-6420(01)00540-1; HAMILTON KK, 1990, BLOOD, V76, P2572; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harris CL, 1999, BIOCHEM J, V341, P821, DOI 10.1042/0264-6021:3410821; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Mechoulam Hadas, 2003, Am J Pharmacogenomics, V3, P261, DOI 10.2165/00129785-200303040-00004; Pierce EA, 1996, ARCH OPHTHALMOL-CHIC, V114, P1219, DOI 10.1001/archopht.1996.01100140419009; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stem MS, 2013, CURR MED CHEM, V20, P3241, DOI 10.2174/09298673113209990027; Sweigard JH, 2014, FASEB J, V28, P3171, DOI 10.1096/fj.14-251041; Taylor PR, 1998, J BIOL CHEM, V273, P1699, DOI 10.1074/jbc.273.3.1699; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	27	7	8	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1300	1305		10.1096/fj.15-280834	http://dx.doi.org/10.1096/fj.15-280834			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631482	Green Published			2022-12-26	WOS:000370387800025
J	Sampson, LL; Davis, AK; Grogg, MW; Zheng, Y				Sampson, Leesa L.; Davis, Ashley K.; Grogg, Matthew W.; Zheng, Yi			mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice	FASEB JOURNAL			English	Article						intestinal enteroid; mouse genetics; radiation-induced injury	CRE-MEDIATED RECOMBINATION; ADULT STEM-CELLS; PROTEIN-KINASE; PANETH CELLS; DIFFERENTIATION; GENE; ABLATION; CANCER; DOWNSTREAM; REVEALS	Intestinal stem cells (ISCs) drive small intestinal epithelial homeostasis and regeneration. Mechanistic target of rapamycin (mTOR) regulates stem and progenitor cell metabolism and is frequently dysregulated in human disease, but its physiologic functions in the mammalian small intestinal epithelium remain poorly defined. We disrupted the genes mTOR, Rptor, Rictor, or both Rptor and Rictor in mouse ISCs, progenitors, and differentiated intestinal epithelial cells (IECs) using Villin-Cre. Mutant tissues and wild-type or heterozygous littermate controls were analyzed by histologic immunostaining, immunoblots, and proliferation assays. A total of 10 Gy irradiation was used to injure the intestinal epithelium and induce subsequent crypt regeneration. We report that mTOR supports absorptive enterocytes and secretory Paneth and goblet cell function while negatively regulating chromogranin A-positive enteroendocrine cell number. Through additional Rptor, Rictor, and Rptor/Rictor mutant mouse models, we identify mechanistic target of rapamycin complex 1 as the major IEC regulatory pathway, but mechanistic target of rapamycin complex 2 also contributes to ileal villus maintenance and goblet cell size. Homeostatic adult small intestinal crypt cell proliferation, survival, and canonical wingless-int (WNT) activity are not mTOR dependent, but Olfm4(+) ISC/progenitor population maintenance and crypt regeneration postinjury require mTOR. Overall, we conclude that mTOR regulates multiple IEC lineages and promotes stem and progenitor cell activity during intestinal epithelium repair post-injury.	[Sampson, Leesa L.; Davis, Ashley K.; Grogg, Matthew W.; Zheng, Yi] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Zheng, Y (corresponding author), Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org		Kuenzi Davis, Ashley/0000-0003-1162-3994	U.S. National Institutes of Health (NIH) National Cancer Institute Grant [5T32CA117846-05]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F32DK097879-01, P30DK090971]; NIH National Institute on Aging Grant [R01AG040118]; NIH NIDDK Grant of the Digestive Disease Research Core Center [P30DK078392]; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK097879, P30DK090971, P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; NIH NIDDK Grant of the Digestive Disease Research Core Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ming Liu (Sichuan University, Chengdu, China), Yuan-Hung Lo (Baylor University, Waco, TX, USA), and James Johnson and Jeff Vallance (Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA) for sharing protocols and providing technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant 5T32CA117846-05 (to L.L.S.), NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants F32DK097879-01 (to L.L.S.) and P30DK090971 (to Y.Z.), and NIH National Institute on Aging Grant R01AG040118 (to Y.Z.). This project was supported in part by NIH NIDDK Grant P30DK078392 (Pathology Core) of the Digestive Disease Research Core Center. L.L.S. designed and performed experiments, analyzed data, wrote the manuscript, and obtained funding. A.K.D. and M.W.G. performed experiments, analyzed data, and edited the manuscript. Y.Z. designed experiments, analyzed data, wrote the manuscript, and obtained funding.	Ables ET, 2012, WIRES DEV BIOL, V1, P657, DOI 10.1002/wdev.48; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bates MD, 2002, GASTROENTEROLOGY, V122, P1467, DOI 10.1053/gast.2002.32975; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bosse T, 2006, MOL CELL BIOL, V26, P9060, DOI 10.1128/MCB.00124-06; Dailey MJ, 2014, PHYSIOL BEHAV, V136, P74, DOI 10.1016/j.physbeh.2014.03.026; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Driver I, 2014, DEVELOPMENT, V141, P1848, DOI 10.1242/dev.104018; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Francipane MG, 2014, ONCOTARGET, V5, P49, DOI 10.18632/oncotarget.1548; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fuller MK, 2012, J SURG RES, V178, P48, DOI 10.1016/j.jss.2012.03.037; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gonzalez-Estevez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002619; Gregorieff A, 2010, CURR PROTOC STEM CEL; Guo FK, 2013, HAEMATOLOGICA, V98, P1353, DOI 10.3324/haematol.2012.080424; Hansen CF, 2014, REGUL PEPTIDES, V189, P31, DOI 10.1016/j.regpep.2014.01.002; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hoist JJ, 2013, CURR OPIN PHARMACOL, V13, P983, DOI 10.1016/j.coph.2013.09.014; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klement RJ, 2014, CANCER METAST REV, V33, P217, DOI 10.1007/s10555-014-9495-3; Kong SF, 1998, PATHOL RES PRACT, V194, P741, DOI 10.1016/S0344-0338(98)80063-0; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; LaFever L, 2010, DEVELOPMENT, V137, P2117, DOI 10.1242/dev.050351; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Moran-Ramos S, 2012, ADV NUTR, V3, P8, DOI 10.3945/an.111.000976; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Rachdi L, 2012, DIABETES, V61, P409, DOI 10.2337/db11-0765; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Schuijers J, 2014, STEM CELL REP, V3, P234, DOI 10.1016/j.stemcr.2014.05.018; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; ShawSmith CJ, 1997, GUT, V40, P5, DOI 10.1136/gut.40.1.5; Shepherd NA, 2013, MORSON DAWSONS GASTR; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wang X, 2015, NATURE, V522, P173, DOI 10.1038/nature14484; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005	61	60	62	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1263	1275		10.1096/fj.15-278606	http://dx.doi.org/10.1096/fj.15-278606			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631481	Green Published			2022-12-26	WOS:000370387800022
J	Leroy, E; Defour, JP; Sato, T; Dass, S; Gryshkova, V; Shwe, MM; Staerk, J; Constantinescu, SN; Smith, SO				Leroy, Emilie; Defour, Jean-Philippe; Sato, Takeshi; Dass, Sharmila; Gryshkova, Vitalina; Shwe, Myat M.; Staerk, Judith; Constantinescu, Stefan N.; Smith, Steven O.			His(499) Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE LOCALIZATION; GROWTH-FACTOR RECEPTOR; ERYTHROPOIETIN RECEPTOR; TRANSMEMBRANE DOMAIN; CYTOKINE RECEPTORS; LEUCINE-ZIPPER; ASSOCIATION; MPL; JUXTAMEMBRANE; HORMONE	Ligand binding to the extracellular domain of the thrombopoietin receptor (TpoR) imparts a specific orientation on the transmembrane (TM) and intracellular domains of the receptors that is required for physiologic activation via receptor dimerization. To map the inactive and active dimeric orientations of the TM helices, we performed asparagine (Asn)-scanning mutagenesis of the TM domains of the murine and human TpoR. Substitution of Asn at only one position (S505N) activated the human receptor, whereas Asn substitutions at several positions activated the murine receptor. Second site mutational studies indicate that His(499) near the N terminus of the TM domain is responsible for protecting the human receptor from activation by Asn mutations. Structural studies reveal that the sequence preceding His(499) is helical in the murine receptor but non-helical in peptides corresponding to the TM domain of the inactive human receptor. The activating S505N mutation and the small molecule agonist eltrombopag both induce helix in this region of the TM domain and are associated with dimerization and activation of the human receptor. Thus, His(499) regulates the activation of human TpoR and provides additional protection against activating mutations, such as oncogenic Asn mutations in the TM domain.	[Leroy, Emilie; Defour, Jean-Philippe; Gryshkova, Vitalina; Shwe, Myat M.; Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Leroy, Emilie; Defour, Jean-Philippe; Gryshkova, Vitalina; Shwe, Myat M.; Constantinescu, Stefan N.] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Sato, Takeshi] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Leroy, Emilie; Dass, Sharmila; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Staerk, Judith] Nord European Mol Biol Lab Partnership, Stem Cell Grp, N-0318 Oslo, Norway; [Staerk, Judith] Ctr Mol Med, N-0318 Oslo, Norway	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Osaka University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Smith, SO (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	steven.o.smith@stonybrook.edu; steven.o.smith@stonybrook.edu	Smith, Steven/HDM-9496-2022	Defour, Jean-Philippe/0000-0003-3999-5861; Constantinescu, Stefan N./0000-0002-8599-2699; Leroy, Emilie/0000-0001-5897-1713; Staerk, Judith/0000-0001-8698-6998	National Institutes of Health-National Science Foundation Instrumentation [S10 RR13889, DBI-9977553]; National Institutes of Health [GM-46732]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); FRIA Ph.D. fellowship; Cliniques universitaires St. Luc; de Duve Institute postdoctoral fellowship; Belspo Interuniversity Attraction Poles fellowship; Erasmus Mundus Panacea fellowship; Ludwig Cancer Research; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique; Salus Sanguinis; Fondation contre le cancer; Project Action de Recherche Concertee of the Universite catholique de Louvain [ARC10/15-027]; PAI program Belgian Medical Genetics Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM046732, R01GM046732] Funding Source: NIH RePORTER	National Institutes of Health-National Science Foundation Instrumentation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); FRIA Ph.D. fellowship(Fonds de la Recherche Scientifique - FNRS); Cliniques universitaires St. Luc; de Duve Institute postdoctoral fellowship; Belspo Interuniversity Attraction Poles fellowship; Erasmus Mundus Panacea fellowship; Ludwig Cancer Research; Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Salus Sanguinis; Fondation contre le cancer; Project Action de Recherche Concertee of the Universite catholique de Louvain; PAI program Belgian Medical Genetics Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health-National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and National Institutes of Health Grant GM-46732 (to S. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) Ph.D. fellowship.; Supported by a FRIA Ph.D. fellowship and the Cliniques universitaires St. Luc.; Supported by a de Duve Institute postdoctoral fellowship and a Belspo Interuniversity Attraction Poles fellowship.; Supported by an Erasmus Mundus Panacea fellowship.; Supported by Ludwig Cancer Research, Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique, Salus Sanguinis, Fondation contre le cancer, Project Action de Recherche Concertee of the Universite catholique de Louvain (Grant ARC10/15-027), and the PAI program Belgian Medical Genetics Initiative.	ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; ARKIN IT, 1994, EMBO J, V13, P4757, DOI 10.1002/j.1460-2075.1994.tb06801.x; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Brooks AJ, 2014, CYTOKINE, V70, P22, DOI 10.1016/j.cyto.2014.07.227; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Defour JP, 2013, P NATL ACAD SCI USA, V110, P2540, DOI 10.1073/pnas.1211560110; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Geddis AE, 2002, CYTOKINE GROWTH F R, V13, P61, DOI 10.1016/S1359-6101(01)00030-2; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Kim MJ, 2007, J BIOL CHEM, V282, P14253, DOI 10.1074/jbc.M611616200; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Liu W, 2005, BIOPHYS J, V89, P1194, DOI 10.1529/biophysj.104.057844; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; Malinge S, 2008, BLOOD, V112, P4220, DOI 10.1182/blood-2008-01-136366; Marty C, 2009, J BIOL CHEM, V284, P11781, DOI 10.1074/jbc.M808703200; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; Matthews EE, 2011, FASEB J, V25, P2234, DOI 10.1096/fj.10-178673; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Onishi M, 1996, BLOOD, V88, P1399, DOI 10.1182/blood.V88.4.1399.bloodjournal8841399; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pecquet C, 2010, BLOOD, V115, P1037, DOI 10.1182/blood-2008-10-183558; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; ROTHSCHILD KJ, 1979, BIOPHYS J, V25, P473, DOI 10.1016/S0006-3495(79)85317-5; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sabath DF, 1999, BLOOD, V94, P365, DOI 10.1182/blood.V94.1.365.413a46_365_367; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Staerk J, 2006, BLOOD, V107, P1864, DOI 10.1182/blood-2005-06-2600; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WATOWICH SS, 1992, P NATL ACAD SCI USA, V89, P2140, DOI 10.1073/pnas.89.6.2140; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	52	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2974	2987		10.1074/jbc.M115.696534	http://dx.doi.org/10.1074/jbc.M115.696534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627830	Green Published, hybrid			2022-12-26	WOS:000369626900034
J	Chechenova, MB; Maes, S; Cripps, RM				Chechenova, Maria B.; Maes, Sara; Cripps, Richard M.			Expression of the Troponin C at 41C Gene in Adult Drosophila Tubular Muscles Depends upon Both Positive and Negative Regulatory Inputs	PLOS ONE			English	Article							MYOCYTE ENHANCER FACTOR-2; TROPONIN-C; FLIGHT-MUSCLE; MEF2; TRANSCRIPTION; MELANOGASTER; TARGET; ISOFORMS; MYOSIN; IDENTIFICATION	Most animals express multiple isoforms of structural muscle proteins to produce tissues with different physiological properties. In Drosophila, the adult muscles include tubular-type muscles and the fibrillar indirect flight muscles. Regulatory processes specifying tubular muscle fate remain incompletely understood, therefore we chose to analyze the transcriptional regulation of TpnC41C, a Troponin C gene expressed in the tubular jump muscles, but not in the fibrillar flight muscles. We identified a 300-bp promoter fragment of TpnC41C sufficient for the fiber-specific reporter expression. Through an analysis of this regulatory element, we identified two sites necessary for the activation of the enhancer. Mutations in each of these sites resulted in 70% reduction of enhancer activity. One site was characterized as a binding site for Myocyte Enhancer Factor-2. In addition, we identified a repressive element that prevents activation of the enhancer in other muscle fiber types. Mutation of this site increased jump muscle-specific expression of the reporter, but more importantly reporter expression expanded into the indirect flight muscles. Our findings demonstrate that expression of the TpnC41C gene in jump muscles requires integration of multiple positive and negative transcriptional inputs. Identification of the transcriptional regulators binding the cis-elements that we identified will reveal the regulatory pathways controlling muscle fiber differentiation.	[Chechenova, Maria B.; Maes, Sara; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu			NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research) [GM061738]; NIH/NIGMS [GM061738, T34 GM008751]; Stephanie Ruby Undergraduate Fellowship; NIH (National Institutes of Health) grant from the Institute Development Award (IDeA) Program of NIGMS [P20 GM103452]; NIEHS (National Institute of Environmental Health Sciences) [ES06694]; NIH/NCI (National Institutes of Health/National Cancer Institute) [CA023074]; BIO5 Institute of the University of Arizona; NIH grant from the Institute Development Award (IDeA) Program of NIGMS [P20 GM103452]; NIEHS grant [ES06694]; NIH/NCI grant [CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, R01GM061738, P30GM110907, T34GM008751] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stephanie Ruby Undergraduate Fellowship; NIH (National Institutes of Health) grant from the Institute Development Award (IDeA) Program of NIGMS; NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI (National Institutes of Health/National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NIH grant from the Institute Development Award (IDeA) Program of NIGMS; NIEHS grant; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by GM061738 awarded by the NIH/NIGMS (National Institutes of Health /Italian Association for Cancer Research) to RMC. SM was supported by T34 GM008751 awarded by the NIH/NIGMS and by a Stephanie Ruby Undergraduate Fellowship. The authors acknowledge technical support from the Molecular Biology Facility at the Department of Biology, UNM, supported by NIH (National Institutes of Health) grant P20 GM103452 from the Institute Development Award (IDeA) Program of NIGMS. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS (National Institute of Environmental Health Sciences) grant ES06694 to the SWEHSC (Southwest Environmental Health Sciences Center (University of Arizona)), NIH/NCI (National Institutes of Health/National Cancer Institute) grant CA023074 to the UA Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Kyle Belozerov for advice on the pull-down assays. This work was supported by GM061738 awarded by the NIH/NIGMS to RMC. SM was supported by T34 GM008751 awarded by the NIH/NIGMS and by a Stephanie Ruby Undergraduate Fellowship. We acknowledge technical support from the Molecular Biology Facility at the Department of Biology, UNM, supported by NIH grant P20 GM103452 from the Institute Development Award (IDeA) Program of NIGMS. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the UA Cancer Center and by the BIO5 Institute of the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, nor preparation of the manuscript.	Allen DL, 2001, DEV BIOL, V229, P383, DOI 10.1006/dbio.2000.9974; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; Baker PW, 2005, GENETICS, V170, P1747, DOI 10.1534/genetics.105.041749; Barrio R, 1996, DEV GENES EVOL, V206, P315, DOI 10.1007/s004270050058; Belozerov VE, 2012, MOL CELL BIOL, V32, P3695, DOI 10.1128/MCB.00232-12; BERNSTEIN SI, 1993, INT REV CYTOL, V143, P63; Bessarab DA, 2008, DEV BIOL, V323, P216, DOI 10.1016/j.ydbio.2008.08.015; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brunetti TM, 2015, DEV BIOL, V401, P299, DOI 10.1016/j.ydbio.2015.02.026; Bryantsev AL, 2012, DEV CELL, V23, P664, DOI 10.1016/j.devcel.2012.08.004; Bryantsev AL, 2012, DEV BIOL, V361, P191, DOI 10.1016/j.ydbio.2011.09.031; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Cuomo A, 2014, METHODS MOL BIOL, V1188, P293, DOI 10.1007/978-1-4939-1142-4_21; Eldred CC, 2014, J MUSCLE RES CELL M, V35, P211, DOI 10.1007/s10974-014-9387-8; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Huang Audrey M, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5198; Kawasaki H, 2005, CYTOTECHNOLOGY, V49, P67, DOI 10.1007/s10616-005-5414-3; Kelly KK, 2002, MECH DEVELOP, V110, P39, DOI 10.1016/S0925-4773(01)00586-X; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lieber RL, 2010, SKELETAL MUSCLE STRU; Lin MH, 1996, P NATL ACAD SCI USA, V93, P4623, DOI 10.1073/pnas.93.10.4623; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Mas JA, 2004, MOL BIOL CELL, V15, P1931, DOI 10.1091/mbc.e03-10-0729; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morriss GR, 2011, MYOGENESIS METHODS P; PECKHAM M, 1990, J MUSCLE RES CELL M, V11, P203, DOI 10.1007/BF01843574; Qiu F, 2003, BIOCHEM J, V371, P811, DOI 10.1042/BJ20021814; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Sartorius CA, 1998, J CELL BIOL, V141, P943, DOI 10.1083/jcb.141.4.943; Schonbauer C, 2011, NATURE, V479, P406, DOI 10.1038/nature10559; Soler C, 2012, DEVELOPMENT, V139, P1270, DOI 10.1242/dev.077875; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; Thummel CS, 1992, DROS INF SERV, V71, P150; Von Hosfstren J, 2008, DEVELOPMENT, V138, P4399; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x; Yao ZZ, 2013, BIOL OPEN, V2, P546, DOI 10.1242/bio.20133921; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144615	10.1371/journal.pone.0144615	http://dx.doi.org/10.1371/journal.pone.0144615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641463	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700149
J	Incio, J; Suboj, P; Chin, SM; Vardam-Kaur, T; Liu, H; Hato, T; Babykutty, S; Chen, I; Deshpande, V; Jain, RK; Fukumura, D				Incio, Joao; Suboj, Priya; Chin, Shan M.; Vardam-Kaur, Trupti; Liu, Hao; Hato, Tai; Babykutty, Suboj; Chen, Ivy; Deshpande, Vikram; Jain, Rakesh K.; Fukumura, Dai			Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages	PLOS ONE			English	Article							HIGH-ENERGY DIET; ANTIDIABETIC DRUG METFORMIN; SP TRANSCRIPTION-FACTORS; IN-VIVO; DUCTAL ADENOCARCINOMA; MESENCHYMAL TRANSITION; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; CARCINOMA GROWTH	Background Pancreatic ductal adenocarcinoma (PDAC) is a highly desmoplastic tumor with a dismal prognosis for most patients. Fibrosis and inflammation are hallmarks of tumor desmoplasia. We have previously demonstrated that preventing the activation of pancreatic stellate cells (PSCs) and alleviating desmoplasia are beneficial strategies in treating PDAC. Metformin is a widely used glucose-lowering drug. It is also frequently prescribed to diabetic pancreatic cancer patients and has been shown to associate with a better outcome. However, the underlying mechanisms of this benefit remain unclear. Metformin has been found to modulate the activity of stellate cells in other disease settings. In this study, we examine the effect of metformin on PSC activity, fibrosis and inflammation in PDACs. Methods/Results In overweight, diabetic PDAC patients and pre-clinical mouse models, treatment with metformin reduced levels of tumor extracellular matrix (ECM) components, in particular hyaluronan (HA). In vitro, we found that metformin reduced TGF-beta signaling and the production of HA and collagen-I in cultured PSCs. Furthermore, we found that metformin alleviates tumor inflammation by reducing the expression of inflammatory cytokines including IL-1 beta as well as infiltration and M2 polarization of tumor-associated macrophages (TAMs) in vitro and in vivo. These effects on macrophages in vitro appear to be associated with a modulation of the AMPK/STAT3 pathway by metformin. Finally, we found in our preclinical models that the alleviation of desmoplasia by metformin was associated with a reduction in ECM remodeling, epithelial-to-mesenchymal transition (EMT) and ultimately systemic metastasis. Conclusion Metformin alleviates the fibro-inflammatory microenvironment in obese/diabetic individuals with pancreatic cancer by reprogramming PSCs and TAMs, which correlates with reduced disease progression. Metformin should be tested/explored as part of the treatment strategy in overweight diabetic PDAC patients.	[Incio, Joao; Suboj, Priya; Chin, Shan M.; Vardam-Kaur, Trupti; Liu, Hao; Hato, Tai; Babykutty, Suboj; Chen, Ivy; Jain, Rakesh K.; Fukumura, Dai] Harvard Univ, Sch Med, Massachusetts Gen Hosp,Res Inst, Edwin L Steele Labs,Dept Radiat Oncol, Boston, MA 02115 USA; [Incio, Joao] Hosp Sao Joao, Dept Internal Med, Oporto, Portugal; [Incio, Joao] Univ Porto, Fac Med, Inst Innovat & Res Heath,I3S, Metab Nutr & Endocrinol Grp,Dept Biochem, P-4100 Oporto, Portugal; [Suboj, Priya] St Xaviers Coll, Dept Bot & Biotechnol, Trivandrum, Kerala, India; [Liu, Hao] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Hato, Tai] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Babykutty, Suboj] Mar Ivanios Coll, Dept Zool, Trivandrum, Kerala, India; [Chen, Ivy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Sao Joao Hospital; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Harvard University; Harvard Medical School; Keio University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Jain, RK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,Res Inst, Edwin L Steele Labs,Dept Radiat Oncol, Boston, MA 02115 USA.	jain@steele.mgh.harvard.edu; dai@steele.mgh.harvard.edu	Incio, Joao/A-1550-2017; Chen, Ivy/N-8231-2019; Hato, Tai/AAN-2940-2020; BABYKUTTY, SUBOJ/R-3723-2017; Liu, Hao/GVS-9284-2022; Jain, Rakesh K/I-1384-2017	Incio, Joao/0000-0002-0259-1356; Hato, Tai/0000-0002-1319-505X; Jain, Rakesh K/0000-0001-7571-3548; Liu, Hao/0000-0002-9262-5774; Babykutty, Suboj/0000-0002-1376-6959	National Institutes of Health [R35-CA197743, CA80124, CA85140, CA96915, CA115767, CA126642]; Lustgarten Foundation; Foundation for Science and Technology (Portugal); NATIONAL CANCER INSTITUTE [R01CA096915, P01CA080124, R01CA085140, R01CA126642, R24CA085140, R01CA115767, R35CA197743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lustgarten Foundation; Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (http://nih.gov/; R35-CA197743, CA80124, CA85140, CA96915, CA115767, and CA126642 to RKJ and DF), the Lustgarten Foundation (http://www.lustgarten.org/; research grant to RKJ) and the Foundation for Science and Technology (http://www.fct.pt/; Portugal, POPH/FSE funding program, fellowship and research grant to JI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252; American Cancer Society, 2015, CANC FACTS FIG; Bao B, 2011, BBA-REV CANCER, V1815, P135, DOI 10.1016/j.bbcan.2010.11.003; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2013, NAT MATER, V12, P958, DOI 10.1038/nmat3792; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Chen SJ, 2015, CURR ONCOL, V22, pE11, DOI 10.3747/co.22.2150; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; CHOW WH, 1995, J NATL CANCER I, V87, P930, DOI 10.1093/jnci/87.12.930; Cifarelli V, 2015, DIABETES, V64, P1632, DOI 10.2337/db14-1132; Cirri P, 2011, AM J CANCER RES, V1, P482; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Franco CCD, 2014, CELL PHYSIOL BIOCHEM, V34, P1920, DOI 10.1159/000366390; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3; Genkinger JM, 2011, INT J CANCER, V129, P1708, DOI 10.1002/ijc.25794; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Gong J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00426; Goodwin PJ, 2015, ANNU REV MED, V66, P281, DOI 10.1146/annurev-med-051613-012328; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Gutschalk CM, 2013, CANCER MED-US, V2, P117, DOI 10.1002/cam4.20; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hori M, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.5; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Ijichi H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19402; Incio J, 2013, TUMOR ANGIOGENESIS REGULATORS, P411; Inman KS, 2014, WORLD J GASTROENTERO, V20, P11160, DOI 10.3748/wjg.v20.i32.11160; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jain RK, 2014, SCI AM, V310, P46, DOI 10.1038/scientificamerican0214-46; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Joost HG, 2014, DIABETES VASC DIS RE, V11, P390, DOI 10.1177/1479164114550813; Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22; Kasenda B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-728; Kisfalvi K, 2013, PANCREAS, V42, P781, DOI 10.1097/MPA.0b013e31827aec40; Kordes S, 2015, LANCET ONCOL, V16, P839, DOI 10.1016/S1470-2045(15)00027-3; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Li HL, 2014, AM J PHYSIOL-ENDOC M, V306, pE197, DOI 10.1152/ajpendo.00202.2013; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu J, 2010, J HUAZHONG U SCI-MED, V30, P222, DOI 10.1007/s11596-010-0218-x; Liu J, 2013, UROL ONCOL-SEMIN ORI, V31, P264, DOI 10.1016/j.urolonc.2011.01.003; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3256, DOI 10.4161/cc.9.16.12553; Mashhedi H, 2011, CELL CYCLE, V10, P2770, DOI 10.4161/cc.10.16.16219; Mathsyaraja H, 2015, ONCOGENE, V34, P3651, DOI 10.1038/onc.2014.294; McCarroll JA, 2014, FRONT PHYSIOL, V5, DOI [10.3389/fphys.2014.00141, 10.3389/fphys.2014.00002]; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Mohammed A, 2013, TRANSL ONCOL, V6, P649, DOI 10.1593/tlo.13556; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nair V, 2014, J BIOL CHEM, V289, P27692, DOI 10.1074/jbc.M114.592576; Nair V, 2013, CARCINOGENESIS, V34, P2870, DOI 10.1093/carcin/bgt231; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Parhar K, 2003, IMMUNOLOGY, V108, P502, DOI 10.1046/j.1365-2567.2003.01603.x; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Phillips P., 2012, PANCREATIC CANC TUMO; Pischon T, 2008, P NUTR SOC, V67, P128, DOI 10.1017/S0029665108006976; Qu HM, 2015, CELL BIOCHEM BIOPHYS, V71, P931, DOI 10.1007/s12013-014-0287-8; Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Roongruedee Chaiteerakij DBZ, 2015, METFORMIN USE DOES N; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004974; Tan XL, 2015, PANCREAS, V44, P636, DOI 10.1097/MPA.0000000000000308; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Wang Y, 2012, CURR MOL MED, V12, P331, DOI 10.2174/156652412799218868; Wu Y, 2008, J IMMUNOL, V181, P6384, DOI 10.4049/jimmunol.181.9.6384; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu Ji Hoon, 2014, J Cancer Prev, V19, P97, DOI 10.15430/JCP.2014.19.2.97; Zechner D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1047-x; [No title captured], DOI DOI 10.1136/BMJ.G3962	97	102	105	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141392	10.1371/journal.pone.0141392	http://dx.doi.org/10.1371/journal.pone.0141392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641266	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700004
J	Alnek, K; Kisand, K; Heilman, K; Peet, A; Varik, K; Uibo, R				Alnek, Kristi; Kisand, Kalle; Heilman, Kaire; Peet, Aleksandr; Varik, Karin; Uibo, Raivo			Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY CYTOKINES; CELLS; PATHOGENESIS; ASSOCIATION; EXPRESSION; CHILDREN; MELLITUS; INTERLEUKIN-27; AUTOIMMUNITY	The production of several cytokines could be dysregulated in type 1 diabetes (T1D). In particular, the activation of T helper (Th) type 1 (Th-1) cells has been proposed to underlie the autoimmune pathogenesis of the disease, although roles for inflammatory processes and the Th-17 pathway have also been shown. Nevertheless, despite evidence for the role of cytokines before and at the onset of T1D, the corresponding findings are inconsistent across studies. Moreover, conflicting data exist regarding the blood cytokine levels in T1D patients. The current study was performed to investigate genetic and autoantibody markers in association with the peripheral blood cytokine profiles by xMap multiplex technology in newly diagnosed young T1D patients and age-matched healthy controls. The onset of young-age T1D was characterized by the upregulation of growth factors, including granulocyte macrophage-colony stimulating factor (GM-CSF) and interleukin (IL)-7, the proinflammatory cytokine IL-1 beta (but not IL-6 or tumor necrosis factor [TNF]-alpha), Th-17 cytokines, and the regulatory cytokines IL-10 and IL-27. Ketoacidosis and autoantibodies (anti-IA-2 and -ZnT8), but not human leukocyte antigen (HLA) genotype, influenced the blood cytokine levels. These findings broaden the current understanding of the dysregulation of systemic levels of several key cytokines at the young-age onset of T1D and provide a further basis for the development of novel immunoregulatory treatments in this disease.	[Alnek, Kristi; Kisand, Kalle; Uibo, Raivo] Univ Tartu, Dept Immunol, Inst Bio & Translat Med, Tartu, Estonia; [Heilman, Kaire] Tallinn Childrens Hosp, Tallinn, Estonia; [Heilman, Kaire; Peet, Aleksandr] Univ Tartu, Dept Pediat, EE-50090 Tartu, Estonia; [Peet, Aleksandr] Tartu Univ Hosp, Childrens Clin, Tartu, Estonia; [Varik, Karin] Tartu Univ Hosp, Surg Clin, Tartu, Estonia	University of Tartu; University of Tartu	Uibo, R (corresponding author), Univ Tartu, Dept Immunol, Inst Bio & Translat Med, Tartu, Estonia.	raivo.uibo@ut.ee	Kisand, Kalle/S-5958-2016; Alnek, Kristi/E-3847-2019; Kisand, Kalle/AAZ-2563-2020; Peet, Aleksandr/H-6114-2018	Kisand, Kalle/0000-0002-7789-5565; Kisand, Kalle/0000-0002-7789-5565; Uibo, Raivo/0000-0002-2298-1300	Estonian Ministry of Education and Research [SF0180035s08, IUT20-43]; European Union Regional Development Fund	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union Regional Development Fund(European Commission)	This work was supported by Estonian Ministry of Education and Research grant no SF0180035s08, IUT20-43 and by European Union Regional Development Fund.; We would like to thank all participants for donating their blood for the present study. We are also grateful to the hospital nurses for their kind help in collecting the study material. We would like to thank Prof. Jorma Ilonen (University of Turku, Finland) for HLA determinations, Dr. Ulle Einberg for collection patient's data and Mrs Kaja Metskula d Dr. Koit Reimand for islet cell autoantibodies assays performance and standardization by IASP2012. This work was supported by Estonian Ministry of Education and Research grant no SF0180035s08, IUT20- 43 and by European Union Regional Development Fund.	Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; CAVALLO MG, 1991, CLIN EXP IMMUNOL, V86, P256; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Cheatem DM University of Illinois at Chicago HSC, 2007, IMMUNOMODULATION DEN; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Di Caro V, 2011, CLIN EXP IMMUNOL, V165, P60, DOI 10.1111/j.1365-2249.2011.04334.x; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; Enzler T, 2007, BLOOD, V110, P954, DOI 10.1182/blood-2006-08-043786; Foss NT, 2007, DIABETES METAB, V33, P439, DOI 10.1016/j.diabet.2007.10.001; Fujimoto H, 2011, AM J PATHOL, V179, P2327, DOI 10.1016/j.ajpath.2011.08.001; Garrigan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076919; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gavin JR, 1999, DIABETES CARE, V22, pS5; Haller MJ, 2008, PEDIATR DIABETES, V9, P1, DOI 10.1111/j.1399-5448.2007.00364.x; Hanifi-Moghaddam P, 2003, DIABETES, V52, P1137, DOI 10.2337/diabetes.52.5.1137; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; He JS, 2014, ASIAN PAC J TROP MED, V7, P823, DOI 10.1016/S1995-7645(14)60144-9; Hekkala A, 2011, EUR J ENDOCRINOL, V165, P813, DOI 10.1530/EJE-11-0376; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; Kaas A, 2012, DIABETIC MED, V29, P734, DOI 10.1111/j.1464-5491.2011.03544.x; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kisand K, 2011, CLIN CHEM LAB MED, V49, P229, DOI 10.1515/CCLM.2011.049; Larousserie F, 2004, J PATHOL, V202, P164, DOI 10.1002/path.1508; Li CR, 2014, J IMMUNOL, V192, P1425, DOI 10.4049/jimmunol.1301742; Lohmann T, 2002, DIABETES, V51, P2474, DOI 10.2337/diabetes.51.8.2474; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Quintana FJ, 2003, J AUTOIMMUN, V21, P65, DOI 10.1016/S0896-8411(03)00064-7; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Reimers JI, 1998, DAN MED BULL, V45, P157; Rowe PA, 2011, SEMIN IMMUNOPATHOL, V33, P29, DOI 10.1007/s00281-010-0208-x; Rumore-Maton B, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/769795; Ryden A, 2014, PEDIATR RES, V75, P45, DOI 10.1038/pr.2013.167; Ryden A, 2009, DIABETES-METAB RES, V25, P335, DOI 10.1002/dmrr.958; Santos AS, 2013, CYTOKINE, V61, P349, DOI 10.1016/j.cyto.2012.12.003; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Stechova K, 2007, DIABETES-METAB RES, V23, P462, DOI 10.1002/dmrr.718; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Svensson J, 2012, HUM IMMUNOL, V73, P1116, DOI 10.1016/j.humimm.2012.07.337; Uibo R, 2008, ADV IMMUNOL, V100, P39, DOI 10.1016/S0065-2776(08)00803-1; Ustinova J, 2014, J IMMUNOL METHODS, V405, P67, DOI 10.1016/j.jim.2014.01.009; Wang R, 2008, CELL MOL LIFE SCI, V65, P3851, DOI 10.1007/s00018-008-8540-1; Watanabe M, 1999, IMMUNOL RES, V20, P251, DOI 10.1007/BF02790408; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264	50	52	53	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0142976	10.1371/journal.pone.0142976	http://dx.doi.org/10.1371/journal.pone.0142976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636339	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800003
J	Reneaux, M; Gupta, R; Karmeshu				Reneaux, Melissa; Gupta, Rahul; Karmeshu			Stochastic Mesocortical Dynamics and Robustness of Working Memory during Delay-Period	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; D-1 DOPAMINE-RECEPTORS; AGE-RELATED-CHANGES; CEREBRAL-CORTEX; RHESUS-MONKEYS; NETWORK MODEL; IN-VIVO; SCHIZOPHRENIA; MODULATION; NEURONS	The role of prefronto-mesoprefrontal system in the dopaminergic modulation of working memory during delayed response tasks is well-known. Recently, a dynamical model of the closed-loop mesocortical circuit has been proposed which employs a deterministic framework to elucidate the system's behavior in a qualitative manner. Under natural conditions, noise emanating from various sources affects the circuit's functioning to a great extent. Accordingly in the present study, we reformulate the model into a stochastic framework and investigate its steady state properties in the presence of constant background noise during delay-period. From the steady state distribution, global potential landscape and signal-to-noise ratio are obtained which help in defining robustness of the circuit dynamics. This provides insight into the robustness of working memory during delay-period against its disruption due to background noise. The findings reveal that the global profile of circuit's robustness is predominantly governed by the level of D1 receptor activity and high D1 receptor stimulation favors the working memory-associated sustained-firing state over the spontaneous-activity state of the system. Moreover, the circuit's robustness is further fine-tuned by the levels of excitatory and inhibitory activities in a way such that the robustness of sustained-firing state exhibits an inverted-U shaped profile with respect to D1 receptor stimulation. It is predicted that the most robust working memory is formed possibly at a subtle ratio of the excitatory and inhibitory activities achieved at a critical level of D1 receptor stimulation. The study also paves a way to understand various cognitive deficits observed in old-age, acute stress and schizophrenia and suggests possible mechanistic routes to the working memory impairments based on the circuit's robustness profile.	[Reneaux, Melissa; Gupta, Rahul; Karmeshu] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Karmeshu] Jawaharlal Nehru Univ, Sch Comp & Syst Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Karmeshu (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	karmeshu@mail.jnu.ac.in			Council of Scientific and Industrial Research, India [09/263(0991)/2013-EMR-I]; Council of Scientific and Industrial Research (CSIR), India [09/263(0991)/2013-EMR-I]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	MR received funding from Council of Scientific and Industrial Research, India (grant no. 09/263(0991)/2013-EMR-I, www.csirhrdg.res.in) for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors sincerely thank the referees for their critical review of the research paper. MR would like to gratefully acknowledge the financial support from Council of Scientific and Industrial Research (CSIR), India (grant no. 09/263(0991)/2013-EMR-I) to carry out this research work.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Abi-Dargham A, 2003, NEUROSCIENTIST, V9, P404, DOI 10.1177/1073858403252674; Abi-Dargham A, 2012, J PSYCHOPHARMACOL, V26, P794, DOI 10.1177/0269881111409265; AKIL M, 1995, SCHIZOPHR RES, V15, P25, DOI 10.1016/0920-9964(95)95089-R; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Ballard IC, 2011, J NEUROSCI, V31, P10340, DOI 10.1523/JNEUROSCI.0895-11.2011; BARTUS RT, 1979, EXP AGING RES, V5, P385, DOI 10.1080/03610737908257214; BARTUS RT, 1978, J GERONTOL, V33, P858, DOI 10.1093/geronj/33.6.858; BARTUS RT, 1977, BRAIN RES, V119, P233, DOI 10.1016/0006-8993(77)90103-2; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; Bjorklund A., 1984, CLASSICAL NEUROTRA 1, V2, P55; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Brunel N, 1998, J THEOR BIOL, V195, P87, DOI 10.1006/jtbi.1998.0782; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Castner SA, 2004, J NEUROSCI, V24, P1446, DOI 10.1523/JNEUROSCI.3987-03.2004; DANIEL DG, 1991, J NEUROSCI, V11, P1907; DAVIS HP, 1990, BEHAV NEUROSCI, V104, P288, DOI 10.1037/0735-7044.104.2.288; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; del Arco A, 2005, J NEURAL TRANSM, V112, P97, DOI 10.1007/s00702-004-0172-5; Driesen NR, 2008, BIOL PSYCHIAT, V64, P1026, DOI 10.1016/j.biopsych.2008.07.029; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Finlay JM, 1997, NEUROCHEM RES, V22, P1387, DOI 10.1023/A:1022075324164; Finlay JM, 2001, SCHIZOPHRENIA BULL, V27, P431, DOI 10.1093/oxfordjournals.schbul.a006885; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; GOLDMANRAKIC PS, 1981, NEUROSCIENCE, V6, P177, DOI 10.1016/0306-4522(81)90053-1; Gooding DC, 2004, SCHIZOPHR RES, V68, P189, DOI 10.1016/j.schres.2003.07.007; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Kloeden P. E., 1995, NUMERICAL SOLUTION S; KORNHUBER J, 1984, BRAIN RES, V322, P124, DOI 10.1016/0006-8993(84)91189-2; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Loh M, 2007, PHARMACOPSYCHIATRY, V40, pS78, DOI 10.1055/s-2007-990304; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; LUINE V, 1990, BRAIN RES, V537, P271, DOI 10.1016/0006-8993(90)90368-L; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Okimura T, 2015, NEUROSCIENCE, V295, P80, DOI 10.1016/j.neuroscience.2015.03.039; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; RAPP PR, 1989, J NEUROSCI, V9, P3568; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Rolls ET, 2015, NEUROBIOL LEARN MEM, V118, P150, DOI 10.1016/j.nlm.2014.12.003; Rolls ET, 2010, THE NOISY BRAIN STOC; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Sawaguchi T, 2001, NEUROSCI RES, V41, P115, DOI 10.1016/S0168-0102(01)00270-X; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; SUHARA T, 1991, PSYCHOPHARMACOLOGY, V103, P41, DOI 10.1007/BF02244071; Tabuchi Y, 2003, NEUROCOMPUTING, V52-4, P403, DOI 10.1016/S0925-2312(02)00849-4; Tanaka S, 2006, NEUROSCIENCE, V139, P153, DOI 10.1016/j.neuroscience.2005.08.070; Tanaka S, 2002, NEUROCOMPUTING, V44, P1001, DOI 10.1016/S0925-2312(02)00503-9; Tanaka S, 2002, NEURAL NETWORKS, V15, P573, DOI 10.1016/S0893-6080(02)00050-3; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yang CR, 1999, NEUROPSYCHOPHARMACOL, V21, P161, DOI 10.1016/S0893-133X(98)00112-2; Zahrt J, 1997, J NEUROSCI, V17, P8528	86	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144378	10.1371/journal.pone.0144378	http://dx.doi.org/10.1371/journal.pone.0144378			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636712	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800082
J	Ruwandeepika, HAD; Karunasagar, I; Bossier, P; Defoirdt, T				Ruwandeepika, H. A. Darshanee; Karunasagar, Indrani; Bossier, Peter; Defoirdt, Tom			Expression and Quorum Sensing Regulation of Type III Secretion System Genes of Vibrio harveyi during Infection of Gnotobiotic Brine Shrimp	PLOS ONE			English	Article							AEROMONAS-HYDROPHILA; PROTEIN SECRETION; VIRULENCE; LUMINESCENCE; ANGUILLARUM; REGULON; IMPACT	Type III secretion systems enable pathogens to inject their virulence factors directly into the cytoplasm of the host cells. The type III secretion system of Vibrio harveyi, a major pathogen of aquatic organisms and a model species in quorum sensing studies, is repressed by the quorum sensing master regulator LuxR. In this study, we found that during infection of gnotobiotic brine shrimp larvae, the expression levels of three type III secretion operons in V. harveyi increased within the first 12h after challenge and decreased again thereafter. The in vivo expression levels were highest in a mutant with a quorum sensing system that is locked in low cell density configuration (minimal LuxR levels) and lowest in a mutant with a quorum sensing system that is locked in the high cell density configuration (maximal LuxR levels), which is consistent with repression of type III secretion by LuxR. Remarkably, in vivo expression levels of the type III secretion system genes were much (> 1000 fold) higher than the in vitro expression levels, indicating that (currently unknown) host factors significantly induce the type III secretion system. Given the fact that type III secretion is energy-consuming, repression by the quorum sensing master regulators might be a mechanism to save energy under conditions where it does not provide an advantage to the cells.	[Ruwandeepika, H. A. Darshanee] Sabaragamuwa Univ Sri Lanka, Fac Agr Sci, Dept Livestock Prod, Belihuloya, Sri Lanka; [Ruwandeepika, H. A. Darshanee; Karunasagar, Indrani] Nitte Univ, UNESCO MIRCEN Med & Marine Biotechnol, Ctr Sci Educ & Res, Mangalore, India; [Bossier, Peter; Defoirdt, Tom] Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium; [Bossier, Peter; Defoirdt, Tom] Univ Ghent, Artemia Reference Ctr, B-9000 Ghent, Belgium	Sabaragamuwa University of Sri Lanka; NITTE (Deemed to be University); Nitte University Center for Science Education & Research (NUCSER); Ghent University; Ghent University	Defoirdt, T (corresponding author), Univ Ghent, Lab Aquaculture, B-9000 Ghent, Belgium.	Tom.Defoirdt@UGent.be	Bossier, Peter GM/A-8118-2008; Ruwandeepika, Darshanee/E-5288-2015; Ruwandeepika, Darshanee/ABE-7303-2020; Defoirdt, Tom/A-5120-2009	Bossier, Peter GM/0000-0002-6165-9111; Ruwandeepika, Darshanee/0000-0001-8851-5698; Defoirdt, Tom/0000-0002-7446-2246	Flemish Interuniversity Council-University Development Cooperation (VLIR); Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS)	Flemish Interuniversity Council-University Development Cooperation (VLIR); Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS)	The financial support by the Flemish Interuniversity Council-University Development Cooperation (VLIR) to the study is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support by the Flemish Interuniversity Council-University Development Cooperation (VLIR) and the Indo-Belgian Research and Technology Cooperation (project AQUAS-TRESS) to the study is gratefully acknowledged. The guidance and assistance of the staff of the Laboratory of Aquaculture & Artemia Reference Center (Ghent University, Belgium) and UNESCO MIRCEN for Marine Biotechnology, Nitte University, Mangalore is highly appreciated. The authors declare that there is no conflict of interest.	Atkinson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001250; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Defoirdt T, 2005, ENVIRON MICROBIOL, V7, P1239, DOI 10.1111/j.1462-2920.2005.00807.x; Defoirdt T, 2008, ISME J, V2, P19, DOI 10.1038/ismej.2007.92; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2007, ENVIRON MICROBIOL, V9, P2486, DOI 10.1111/j.1462-2920.2007.01367.x; Defoirdt T, 2014, REV AQUACULT, V6, P100, DOI 10.1111/raq.12030; Defoirdt T, 2012, ISME J, V6, P2314, DOI 10.1038/ismej.2012.58; Fan FX, 2014, INFECT IMMUN, V82, P1676, DOI 10.1128/IAI.01377-13; Freeman JA, 1999, MOL MICROBIOL, V31, P665, DOI 10.1046/j.1365-2958.1999.01208.x; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Kosarewicz A, 2012, PHILOS T R SOC B, V367, P1140, DOI 10.1098/rstb.2011.0205; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Li X, 2015, VET MICROBIOL, V175, P44, DOI 10.1016/j.vetmic.2014.10.033; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Ruwandeepika HAD, 2011, ENV MICROBIOL REP, V3, P597, DOI 10.1111/j.1758-2229.2011.00268.x; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Ruwandeepika HAD, 2012, REV AQUACULT, V4, P59, DOI 10.1111/j.1753-5131.2012.01061.x; Septer AN, 2013, APPL ENVIRON MICROB, V79, P1826, DOI 10.1128/AEM.03079-12; Smith H, 2000, PHILOS T R SOC B, V355, P551, DOI 10.1098/rstb.2000.0597; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; van Kessel JC, 2013, J BACTERIOL, V195, P436, DOI 10.1128/JB.01998-12; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; Waters CM, 2010, APPL ENVIRON MICROB, V76, P4996, DOI 10.1128/AEM.00886-10; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yang Q, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00584; Zhou WG, 2007, PROG BIOCHEM BIOPHYS, V34, P647	33	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143935	10.1371/journal.pone.0143935	http://dx.doi.org/10.1371/journal.pone.0143935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636765	Green Submitted, gold, Green Published			2022-12-26	WOS:000366143800034
J	Austin, SA; Santhanam, AVR; d'Uscio, LV; Katusic, ZS				Austin, Susan A.; Santhanam, Anantha Vijay R.; d'Uscio, Livius V.; Katusic, Zvonimir S.			Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE PATHOLOGY; ENDOTHELIAL DYSFUNCTION; NADPH OXIDASE; CEREBROVASCULAR DYSFUNCTION; VASCULAR-DISEASE; MICE; EXPRESSION; DEMENTIA; HUMANS	The hippocampus is one of the earliest and most affected regions in Alzheimer's disease (AD), followed by the cortex while the cerebellum is largely spared. Importantly, endothelial dysfunction is a common feature of cerebral blood vessels in AD. In this study, we sought to determine if regional heterogeneity of cerebral microvessels might help explain the susceptibility of the hippocampus and cortex as compared to the cerebellum. We isolated microvessels from wild type mice from the cerebellum, cortex, and hippocampus to characterize their vascular phenotype. Superoxide anion was significantly higher in microvessels isolated from the cortex and hippocampus as compared to the cerebellum. Importantly, protein levels of NADPH oxidase (NOX)-2 and NOX-4 were significantly higher in the cortical and hippocampal microvessels as compared to microvessels from the cerebellum. In addition, expression of manganese superoxide dismutase protein was significantly lower in microvessels from the cortex and hippocampus as compared to cerebellum while other antioxidant enzymes were unchanged. There was no difference in eNOS protein expression between the microvessels of the three brain regions; however, bioavailability of tetrahydrobiopterin (BH4), an essential cofactor for eNOS activity, was significantly reduced in microvessels from the hippocampus and cortex as compared to the cerebellum. Higher levels of superoxide and reduced tetrahydrobiopterin bioavailability may help explain the vulnerability of the hippocampus and cortical microvessels to oxidative stress and development of endothelial dysfunction.	[Katusic, Zvonimir S.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Katusic, ZS (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA.	Katusic.Zvonimir@mayo.edu		d'Uscio, Livius/0000-0001-9577-9480	American Heart Association (AHA) [14SDG20410063]; National Institutes of Health (NIH) [HL-111062]; Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111062] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association grant (AHA# 14SDG20410063 to SAA), National Institutes of Health (NIH) grant (HL-111062 to ZSK), and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2005, STROKE, V36, P1040, DOI 10.1161/01.STR.0000163111.05825.0b; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; delaTorre JC, 1997, GERONTOLOGY, V43, P26; Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Faraci FM, 2011, AM J PHYSIOL-HEART C, V300, pH1566, DOI 10.1152/ajpheart.01310.2010; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hamel E, 2008, EXP PHYSIOL, V93, P116, DOI 10.1113/expphysiol.2007.038729; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jellinger KA, 2010, J ALZHEIMERS DIS, V21, P1283, DOI 10.3233/JAD-2010-100603; Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Purnell C, 2009, ALZ DIS ASSOC DIS, V23, P1, DOI 10.1097/WAD.0b013e318187541c; Santhanam AVR, 2012, J NEUROCHEM, V122, P1211, DOI 10.1111/j.1471-4159.2012.07872.x; Saubamea B, 2012, J CEREBR BLOOD F MET, V32, P81, DOI 10.1038/jcbfm.2011.109; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009	31	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144062	10.1371/journal.pone.0144062	http://dx.doi.org/10.1371/journal.pone.0144062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629821	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300153
J	Biner, O; Trachsel, C; Moser, A; Kopp, L; Langenegger, N; Kampfer, U; von Ballmoos, C; Nentwig, W; Schurch, S; Schaller, J; Kuhn-Nentwig, L				Biner, Olivier; Trachsel, Christian; Moser, Aline; Kopp, Lukas; Langenegger, Nicolas; Kaempfer, Urs; von Ballmoos, Christoph; Nentwig, Wolfgang; Schuerch, Stefan; Schaller, Johann; Kuhn-Nentwig, Lucia			Isolation, N-glycosylations and Function of a Hyaluronidase-Like Enzyme from the Venom of the Spider Cupiennius salei	PLOS ONE			English	Article							HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; MULTICOMPONENT VENOM; CHONDROITIN SULFATE; SPREADING FACTOR; SCORPION-VENOM; CDNA CLONING; PURIFICATION; GLYCOSAMINOGLYCANS; ACID	Structure of Cupiennius salei venom hyaluronidase Hyaluronidases are important venom components acting as spreading factor of toxic compounds. In several studies this spreading effect was tested on vertebrate tissue. However, data about the spreading activity on invertebrates, the main prey organisms of spiders, are lacking. Here, a hyaluronidase-like enzyme was isolated from the venom of the spider Cupiennius salei. The amino acid sequence of the enzyme was determined by cDNA analysis of the venom gland transcriptome and confirmed by protein analysis. Two complex N-linked glycans akin to honey bee hyaluronidase glycosylations, were identified by tandem mass spectrometry. A C-terminal EGF-like domain was identified in spider hyaluronidase using InterPro. The spider hyaluronidase-like enzyme showed maximal activity at acidic pH, between 40-60 degrees C, and 0.2 M KCl. Divalent ions did not enhance HA degradation activity, indicating that they are not recruited for catalysis. Function of venom hyaluronidases Besides hyaluronan, the enzyme degrades chondroitin sulfate A, whereas heparan sulfate and dermatan sulfate are not affected. The end products of hyaluronan degradation are tetramers, whereas chondroitin sulfate A is mainly degraded to hexamers. Identification of terminal N-acetylglucosamine or N-acetylgalactosamine at the reducing end of the oligomers identified the enzyme as an endo-a-N-acetyl-D-hexosaminidase hydrolase. The spreading effect of the hyaluronidase-like enzyme on invertebrate tissue was studied by coinjection of the enzyme with the Cupiennius salei main neurotoxin CsTx-1 into Drosophila flies. The enzyme significantly enhances the neurotoxic activity of CsTx-1. Comparative substrate degradation tests with hyaluronan, chondroitin sulfate A, dermatan sulfate, and heparan sulfate with venoms from 39 spider species from 21 families identified some spider families (Atypidae, Eresidae, Araneidae and Nephilidae) without activity of hyaluronidase-like enzymes. This is interpreted as a loss of this enzyme and fits quite well the current phylogenetic idea on a more isolated position of these families and can perhaps be explained by specialized prey catching techniques.	[Biner, Olivier; Kopp, Lukas; Langenegger, Nicolas; Kaempfer, Urs; von Ballmoos, Christoph; Schuerch, Stefan; Schaller, Johann] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Trachsel, Christian] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Moser, Aline; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Schürch, Stefan/ABE-4977-2022; Biner, Olivier Felix/AAD-1086-2022	Schürch, Stefan/0000-0001-5109-4623; Biner, Olivier Felix/0000-0001-6935-2475; von Ballmoos, Christoph/0000-0002-4642-6088				Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x; BRUCKNER J, 1955, BIOCHEM J, V60, P200; Chao KL, 2007, BIOCHEMISTRY-US, V46, P6911, DOI 10.1021/bi700382g; Chatel A, 2010, MATRIX BIOL, V29, P494, DOI 10.1016/j.matbio.2010.05.005; Cherr GN, 2001, MATRIX BIOL, V20, P515, DOI 10.1016/S0945-053X(01)00171-8; Clement H, 2012, TOXICON, V60, P1223, DOI 10.1016/j.toxicon.2012.08.018; Csoka AB, 2013, GLYCOBIOLOGY, V23, P398, DOI 10.1093/glycob/cws218; da Silveira RB, 2007, TOXICON, V49, P758, DOI 10.1016/j.toxicon.2006.11.024; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DIFERRANTE N, 1956, J BIOL CHEM, V220, P303; dos Santos AVF, 2006, MICRON, V37, P41, DOI 10.1016/j.micron.2005.07.002; Duan ZG, 2013, J PROTEOMICS, V78, P416, DOI 10.1016/j.jprot.2012.10.011; Erickson M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/893947; Escoubas P, 1995, TOXICON, V33, P1549, DOI 10.1016/0041-0101(95)00107-7; Feng L, 2008, COMP BIOCHEM PHYS C, V148, P250, DOI 10.1016/j.cbpc.2008.06.003; Ferrer VP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002206; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Girish KS, 2002, MOL CELL BIOCHEM, V240, P105, DOI 10.1023/A:1020651607164; Gouveia AID, 2005, TOXICON, V45, P403, DOI 10.1016/j.toxicon.2004.11.008; Hofinger ESA, 2007, GLYCOBIOLOGY, V17, P444, DOI 10.1093/glycob/cwm003; Honda T, 2012, BIOMOLECULES, V2, P549, DOI 10.3390/biom2040549; Iacob S, 2006, INT J BIOCHEM CELL B, V38, P123, DOI 10.1016/j.biocel.2005.08.011; Jedrzejas MJ, 2005, PROTEINS, V61, P227, DOI 10.1002/prot.20592; Kakizaki I, 2010, FEBS J, V277, P1776, DOI 10.1111/j.1742-4658.2010.07600.x; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; KEMENY DM, 1984, EUR J BIOCHEM, V139, P217, DOI 10.1111/j.1432-1033.1984.tb07997.x; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; KUBELKA V, 1995, GLYCOCONJUGATE J, V12, P77, DOI 10.1007/BF00731872; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2002, J BIOL CHEM, V277, P11208, DOI 10.1074/jbc.M111099200; Kuhn-Nentwig L, 2012, J BIOL CHEM, V287, P25640, DOI 10.1074/jbc.M112.339051; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Kuhn-Nentwig L, 2011, AMINO ACIDS, V40, P69, DOI 10.1007/s00726-009-0471-0; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li MW, 2002, J ANDROL, V23, P211; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madokoro M, 2011, TOXICON, V58, P285, DOI 10.1016/j.toxicon.2011.07.014; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Menin Marcelo, 2005, Phyllomedusa, V4, P39; Morey SS, 2006, TOXICON, V47, P188, DOI 10.1016/j.toxicon.2005.10.014; Nagaraju S, 2007, TOXICON, V50, P383, DOI 10.1016/j.toxicon.2007.04.007; Nyffeler M, 2001, ECOL ENTOMOL, V26, P617, DOI 10.1046/j.1365-2311.2001.00365.x; Nyffeler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099459; Nyffeler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058120; Ospedal KZ, 2002, INT J EXP PATHOL, V83, P287, DOI 10.1046/j.1365-2613.2002.00241.x; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Horta CCR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002693; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; SCHANBAC.FL, 1973, TOXICON, V11, P21, DOI 10.1016/0041-0101(73)90147-5; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; SHIMADA E, 1984, J BIOCHEM-TOKYO, V96, P721, DOI 10.1093/oxfordjournals.jbchem.a134890; Sinnis P, 2007, J BIOL CHEM, V282, P25376, DOI 10.1074/jbc.M704698200; Smithers P, 2005, J ARACHNOL, V33, P243, DOI 10.1636/CT-05-2.1; Souza MLS, 2004, COMP BIOCHEM PHYS B, V139, P631, DOI 10.1016/j.cbpc.2004.08.017; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sutti R, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; TU AT, 1983, COMP BIOCHEM PHYS B, V76, P377, DOI 10.1016/0305-0491(83)90086-X; Veiga SS, 2000, HISTOCHEM J, V32, P397, DOI 10.1023/A:1004031019827; Vercruysse KP, 1999, CARBOHYD RES, V318, P26, DOI 10.1016/S0008-6215(99)00087-7; Violette A, 2012, MAR DRUGS, V10, P258, DOI 10.3390/md10020258; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volpi N, 2005, BIOMACROMOLECULES, V6, P3174, DOI 10.1021/bm0505033; Volpi N, 2003, BIOCHIMIE, V85, P619, DOI 10.1016/S0300-9084(03)00083-X; Wahby AF, 2012, TOXICON, V60, P1380, DOI 10.1016/j.toxicon.2012.08.016; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Young AR, 2001, TOXICON, V39, P391, DOI 10.1016/S0041-0101(00)00145-8; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	80	18	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143963	10.1371/journal.pone.0143963	http://dx.doi.org/10.1371/journal.pone.0143963			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630650	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300131
J	Liu, WN; Leung, KN				Liu, Wai Nam; Leung, Kwok Nam			The Immunomodulatory Activity of Jacaric Acid, a Conjugated Linolenic Acid Isomer, on Murine Peritoneal Macrophages	PLOS ONE			English	Article							NITRIC-OXIDE; IMMUNE FUNCTION; GAMMA; PHAGOCYTOSIS; EXPRESSION; PLASTICITY; INDUCTION; CANCER; OXYGEN; CLA	This study aims at demonstrating the immunomodulatory property of jacaric acid, a conjugated linolenic acid (CLNA) isomer that is present in jacaranda seed oil, on murine peritoneal macrophages. Our results showed that jacaric acid exhibited no significant cytotoxicity on the thioglycollate-elicited murine peritoneal macrophages as revealed by the neutral red uptake assay, but markedly increased their cytostatic activity on the T-cell lymphoma MBL-2 cells as measured by the fluorometric CyQuant (R) NF Cell Proliferation Assay Kit. Flow cytometric analysis indicated that jacaric acid could enhance the endocytic activity of macrophages and elevated their intracellular production of superoxide anion. Moreover, jacaric acid-treated macrophages showed an increase in the production of nitric oxide which was accompanied by an increase in the expression level of inducible nitric oxide synthase protein. In addition, the secretion of several pro-inflammatory cytokines, including interferon-gamma, interleukin-1 beta and tumor necrosis factor-alpha, was up-regulated. Collectively, our results indicated that the naturally-occurring CLNA isomer, jacaric acid, could exhibit immunomodulating activity on the murine peritoneal macrophages in vitro, suggesting that this CLNA isomer may act as an immunopotentiator which can be exploited for the treatment of some immunological disorders with minimal toxicity and fewer side effects.	[Liu, Wai Nam; Leung, Kwok Nam] Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Leung, KN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China.	knleung@cuhk.edu.hk						Albers R, 2003, EUR J CLIN NUTR, V57, P595, DOI 10.1038/sj.ejcn.1601585; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boussetta T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006458; Chi DS, 2003, NITRIC OXIDE-BIOL CH, V8, P127, DOI 10.1016/S1089-8603(02)00148-9; de Gaetano M, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0060-9; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; Ike K, 2005, J VET MED SCI, V67, P521, DOI 10.1292/jvms.67.521; Iwakiri Y, 2002, PROSTAG LEUKOTR ESS, V67, P435, DOI 10.1054/plef.2002.0454; Kelley DS, 2002, LIPIDS, V37, P725, DOI 10.1007/s11745-002-0954-7; Kelley DS, 2000, LIPIDS, V35, P1065, DOI 10.1007/s11745-000-0620-0; KLASSEN DK, 1980, BLOOD, V56, P985; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Lee Yunkyoung, 2008, Nutr Res Pract, V2, P326, DOI 10.4162/nrp.2008.2.4.326; LEUNG KN, 1986, ASIAN PAC J ALLERGY, V4, P111; Leung KN, 2005, CELL MOL IMMUNOL, V2, P181; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Liao XM, 2013, ONCOL REP, V29, P371, DOI 10.3892/or.2012.2094; Majdalawieh AF, 2010, J ETHNOPHARMACOL, V131, P268, DOI 10.1016/j.jep.2010.06.030; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; McClelland S, 2010, ATHEROSCLEROSIS, V211, P96, DOI 10.1016/j.atherosclerosis.2010.02.003; MCCOY JL, 1967, CANCER RES, V27, P1743; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mooney D, 2012, PROSTAG OTH LIPID M, V98, P56, DOI 10.1016/j.prostaglandins.2011.12.006; Muntane J, 2010, WORLD J HEPATOL, V2, P337, DOI 10.4254/wjh.v2.i9.337; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Palmquist Donald L, 2005, Adv Food Nutr Res, V50, P179, DOI 10.1016/S1043-4526(05)50006-8; Rao YPC, 2014, INDIAN J EXP BIOL, V52, P860; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rybicka M, 2011, J AGR FOOD CHEM, V59, P4095, DOI 10.1021/jf103647n; Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001; Song DH, 2007, CYTOKINE, V37, P227, DOI 10.1016/j.cyto.2007.04.003; Stachowska E, 2008, NUTRITION, V24, P187, DOI 10.1016/j.nut.2007.10.018; Stachowska E, 2007, LIPIDS, V42, P707, DOI 10.1007/s11745-007-3072-2; TAKAGI T, 1981, LIPIDS, V16, P546, DOI 10.1007/BF02535054; Tanaka T, 2011, INT J MOL SCI, V12, P7495, DOI 10.3390/ijms12117495; Wallace FA, 2000, IMMUNOL CELL BIOL, V78, P40, DOI 10.1046/j.1440-1711.2000.00867.x; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yamasaki M, 2006, NUTRITION, V22, P54, DOI 10.1016/j.nut.2005.03.009; Yang L, 2009, J AGR FOOD CHEM, V57, P4212, DOI 10.1021/jf900657f; Yu Y, 2002, BBA-MOL CELL BIOL L, V1581, P89, DOI 10.1016/S1388-1981(02)00126-9	41	81	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143684	10.1371/journal.pone.0143684	http://dx.doi.org/10.1371/journal.pone.0143684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629697	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300082
J	Zijlema, WL; Klijs, B; Stolk, RP; Rosmalen, JGM				Zijlema, Wilma L.; Klijs, Bart; Stolk, Ronald P.; Rosmalen, Judith G. M.			(Un)Healthy in the City: Respiratory, Cardiometabolic and Mental Health Associated with Urbanity	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; PHYSICAL-ACTIVITY; BREAST-CANCER; AIR-POLLUTION; OBESITY; NEIGHBORHOODS; URBANIZATION; ENVIRONMENTS; MORTALITY	Background Research has shown that health differences exist between urban and rural areas. Most studies conducted, however, have focused on single health outcomes and have not assessed to what extent the association of urbanity with health is explained by population composition or socioeconomic status of the area. Our aim is to investigate associations of urbanity with four different health outcomes (i. e. lung function, metabolic syndrome, depression and anxiety) and to assess whether these associations are independent of residents' characteristics and area socioeconomic status. Methods Our study population consisted of 74,733 individuals (42% males, mean age 43.8) who were part of the baseline sample of the LifeLines Cohort Study. Health outcomes were objectively measured with spirometry, a physical examination, laboratory blood analyses, and a psychiatric interview. Using multilevel linear and logistic regression models, associations of urbanity with lung function, and prevalence of metabolic syndrome, major depressive disorder and generalized anxiety disorder were assessed. All models were sequentially adjusted for age, sex, highest education, household equivalent income, smoking, physical activity, and mean neighborhood income. Results As compared with individuals living in rural areas, those in semi-urban or urban areas had a poorer lung function (beta-1.62, 95% CI -2.07;-1.16), and higher prevalence of major depressive disorder (OR 1.65, 95% CI 1.35; 2.00), and generalized anxiety disorder (OR 1.58, 95% CI 1.35; 1.84). Prevalence of metabolic syndrome, however, was lower in urban areas (OR 0.51, 95% CI 0.44; 0.59). These associations were only partly explained by differences in residents' demographic, socioeconomic and lifestyle characteristics and socioeconomic status of the areas. Conclusions Our results suggest a differential health impact of urbanity according to type of disease. Living in an urban environment appears to be beneficial for cardiometabolic health but to have a detrimental impact on respiratory function and mental health. Future research should investigate which underlying mechanisms explain the differential health impact of urbanity.	[Zijlema, Wilma L.; Klijs, Bart; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen	Zijlema, WL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	w.l.zijlema@umcg.nl	Zijlema, Wilma/AAE-2409-2021; Rosmalen, Judith G.M./F-5375-2011	Rosmalen, Judith G.M./0000-0002-6393-0032; Stolk, Ronald/0000-0002-0518-1205; Zijlema, Wilma/0000-0002-6257-5091	European Union Seventh Framework Programme (FP7) [261433]; Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; European Union Seventh Framework Programme (FP7) [261433]; Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	European Union Seventh Framework Programme (FP7); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; European Union Seventh Framework Programme (FP7); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation	The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP>261433 (Biobank Standardisation and Harmonisation for Research Excellence in the European Union-BioSHaRE-EU). The LifeLines Cohort Study, and generation and management of GWAS genotype data for the LifeLines Cohort Study was supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Been JV, 2014, LANCET, V383, P1549, DOI 10.1016/S0140-6736(14)60082-9; Bluhm GL, 2007, OCCUP ENVIRON MED, V64, P122, DOI 10.1136/oem.2005.025866; Broms K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-303; Bruner M, 2008, INT J PEDIATR OBES, V3, P205, DOI 10.1080/17477160802158477; Buhrman B., 1988, REV INCOME WEALTH, V2, P115; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; Chaix B, 2008, J HYPERTENS, V26, P1078, DOI 10.1097/HJH.0b013e3282fd991f; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chaix B, 2006, INT J EPIDEMIOL, V35, P633, DOI 10.1093/ije/dyl009; Edwards KL, 2010, J EPIDEMIOL COMMUN H, V64, P194, DOI 10.1136/jech.2009.088906; Emaus MJ, 2014, BREAST CANCER RES TR, V148, P655, DOI 10.1007/s10549-014-3205-2; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindroth M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-825; Maio S, 2009, CHEST, V135, P434, DOI 10.1378/chest.08-0252; Mujahid MS, 2008, EPIDEMIOLOGY, V19, P590, DOI 10.1097/EDE.0b013e3181772cb2; Mujahid MS, 2008, AM J EPIDEMIOL, V167, P1349, DOI 10.1093/aje/kwn047; Neovius M, 2008, OBESITY, V16, P671, DOI 10.1038/oby.2007.115; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Robert SA, 2004, EPIDEMIOLOGY, V15, P442, DOI 10.1097/01.ede.0000129512.61698.03; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Statistics Netherlands, 2013, CBS KERNC WIJK BUURT; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; UNFPA, 2007, STAT WORLD POP 2007; van Hooijdonk C, 2008, J EPIDEMIOL COMMUN H, V62, P499, DOI 10.1136/jech.2007.060145; Van Hulst A, 2012, J HYPERTENS, V30, P1336, DOI 10.1097/HJH.0b013e3283544863; Verheij RA, 1996, SOC SCI MED, V42, P923, DOI 10.1016/0277-9536(95)00190-5; Wilcox S, 2000, J EPIDEMIOL COMMUN H, V54, P667, DOI 10.1136/jech.54.9.667; Zijlema WL, 2015, INT J HYG ENVIR HEAL, V218, P543, DOI 10.1016/j.ijheh.2015.05.001	37	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143910	10.1371/journal.pone.0143910	http://dx.doi.org/10.1371/journal.pone.0143910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630577	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300120
J	Irisson, JO; Paris, CB; Leis, JM; Yerman, MN				Irisson, Jean-Olivier; Paris, Claire B.; Leis, Jeffrey M.; Yerman, Michelle N.			With a Little Help from My Friends: Group Orientation by Larvae of a Coral Reef Fish	PLOS ONE			English	Article							DECISION-MAKING; DEMERSAL FISHES; HOMING PIGEONS; ANIMAL GROUPS; SMALL FLOCKS; BEHAVIOR; ENVIRONMENTS; RECRUITMENT; LEADERSHIP; CONSEQUENCES	Theory and some empirical evidence suggest that groups of animals orient better than isolated individuals. We present the first test of this hypothesis for pelagic marine larvae, at the stage of settlement, when orientation is critical to find a habitat. We compare the in situ behaviour of individuals and groups of 10-12 Chromis atripectoralis (reef fish of the family Pomacentridae), off Lizard Island, Great Barrier Reef. Larvae are observed by divers or with a drifting image recording device. With both methods, groups orient cardinally while isolated individuals do not display significant orientation. Groups also swim on a 15% straighter course (i.e. are better at keeping a bearing) and 7% faster than individuals. A body of observations collected in this study suggest that enhanced group orientation emerges from simple group dynamics rather than from the presence of more skilful leaders.	[Irisson, Jean-Olivier; Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Irisson, Jean-Olivier] Univ Paris 06, Sorbonne Univ, CNRS, LOV, F-06230 Villefranche Sur Mer, France; [Leis, Jeffrey M.; Yerman, Michelle N.] Australian Museum, Res Inst, Sydney, NSW 2010, Australia; [Leis, Jeffrey M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7004, Australia	University of Miami; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Australian Museum; University of Tasmania	Irisson, JO (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	irisson@normalesup.org	Leis, Jeffrey M/E-7502-2012		Hermon Slade Foundation; ARC [DP110100695]; NSF [OTIC-1155698]; RSMAS	Hermon Slade Foundation; ARC(Australian Research Council); NSF(National Science Foundation (NSF)); RSMAS	The authors are grateful for The Hermon Slade Foundation (http://www.hermonslade.org.au) grant to JML and CBP, ARC (http://www.coralcoe.org.au) Discovery Grant DP110100695 to JML, CBP and U.E. Siebeck, NSF (http://www.nsf.gov) OTIC-1155698 and RSMAS (http://www.rsmas.miami.edu) Startup grant to CBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2001, AM NAT, V157, P434, DOI 10.1086/319322; Arvedlund M, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P135, DOI 10.1007/978-90-481-2406-0_5; Batschelet E, 1981, CIRCULAR STAT BIOL; Beauchamp G, 2011, BIOL LETTERS, V7, P692, DOI 10.1098/rsbl.2011.0243; Ben-Tzvi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042672; BENVENUTI S, 1985, ORNIS SCAND, V16, P45, DOI 10.2307/3676574; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Berenshtein I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088468; Bergman G., 1964, Acta Zoologica Fennica, VNo. 105, P1; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; BREITBURG DL, 1989, ENVIRON BIOL FISH, V26, P97, DOI 10.1007/BF00001026; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; de Perera TB, 1999, ETHOLOGY, V105, P13, DOI 10.1111/j.1439-0310.1999.tb01217.x; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; DOHERTY PJ, 1983, ECOLOGY, V64, P176, DOI 10.2307/1937339; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fisher R, 2002, MAR BIOL, V140, P801, DOI 10.1007/s00227-001-0758-5; Gebauer P, 1999, J EXP MAR BIOL ECOL, V238, P271, DOI 10.1016/S0022-0981(98)00219-6; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; HOUDE ED, 1993, B MAR SCI, V53, P290; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Irisson JO, 2009, LIMNOL OCEANOGR-METH, V7, P664, DOI 10.4319/lom.2009.7.664; Jorge PE, 2012, J EXP BIOL, V215, P2414, DOI 10.1242/jeb.070375; KEETON WT, 1970, AUK, V87, P797, DOI 10.2307/4083715; Kingsford MJ, 2002, B MAR SCI, V70, P309; Krebs JR, 1993, INTRO BEHAV ECOLOGY; LARKIN PA, 1969, J FISH RES BOARD CAN, V26, P1372, DOI 10.1139/f69-121; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2014, MAR ECOL PROG SER, V505, P193, DOI 10.3354/meps10792; Leis JM, 2010, ICHTHYOL RES, V57, P325, DOI 10.1007/s10228-010-0177-z; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2004, MAR FRESHW BEHAV PHY, V37, P65, DOI 10.1080/10236240410001705761; Leis JM, 1998, ENVIRON BIOL FISH, V53, P259, DOI 10.1023/A:1007424719764; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2011, INTEGR COMP BIOL, P1; Lihoreau M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1577, DOI 10.1007/s00265-010-0971-7; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; Masuda Reiji, 2009, Aqua-Bioscience Monographs, V2, P1; Mouritsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066039; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; North EW, 2009, ICES COOP RES REP; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Shima JS, 2015, ECOLOGY, V2015; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Staaterman E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0643; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Sugimoto C, 2012, FISHERIES SCI, V78, P287, DOI 10.1007/s12562-011-0464-2; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; TAMM S, 1980, BEHAV ECOL SOCIOBIOL, V7, P319, DOI 10.1007/BF00300672; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; VICTOR BC, 1986, ECOL MONOGR, V56, P145, DOI 10.2307/1942506; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Wolanski E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0209	55	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144060	10.1371/journal.pone.0144060	http://dx.doi.org/10.1371/journal.pone.0144060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625164	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600088
J	Timoh, KN; Bader, G; Fauconnier, A; Barrau, V; Delmas, V; Touboul, C				Timoh, Krystel Nyangoh; Bader, Georges; Fauconnier, Arnaud; Barrau, Vincent; Delmas, Vincent; Touboul, Cyril			Determination of a Central Avascular Triangle within the Obturator Foramen: A Radioanatomic Study	PLOS ONE			English	Article							ANTERIOR PROLIFT(R) PROCEDURE; STRESS URINARY-INCONTINENCE; CYSTOCELE REPAIR; PROLAPSE REPAIR; MESH; HEMATOMA; HEMORRHAGE; PLACEMENT; ANATOMY	Purpose To map the vascular anatomy of the obturator foramen using fixed anatomic landmarks. Method Twenty obturator regions were dissected in 10 fresh female cadavers after vascular blue dye injection in five cadavers (50%). Furthermore, 104 obturator regions were reconstructed by angiotomodensitometry from 52 women under investigation for suspected arterial disease. The anatomy of the obturator region was mapped by measuring the distance of vascular structures from the middle of the two branches of the ischiopubic bone, which were used as fixed landmarks. Results The bifurcation of the obturator artery was at a mean (SD) distance of 30.0 mm (4.5) from the middle of the ischiopubic branch (MISP). The anterior branch of the obturator vessels was 15.2 mm (10.1) from the MISP. The posterior branch of the obturator vessels was 5.5 mm (4.0) and 23.6 mm (8.7) from the middle of the outer edge of the obturator foramen (MOE) and the MISP, respectively. Using 5 degrees and 95 degrees percentiles of these measurements we defined a central avascular triangle. Conclusions Our data show that, beyond inter-individual variations, a central triangular avascular area can be identified in the obturator foramen between the posterior and anterior obturator artery using fixed landmarks.	[Timoh, Krystel Nyangoh; Touboul, Cyril] Univ Paris Est, UPEC Paris 12, Hop Intercommunal Creteil, Dept Obstet & Gynecol, Paris, France; [Bader, Georges; Fauconnier, Arnaud] Univ St Quentin En Yvelines, Hop Poissy, Dept Obstet & Gynecol & Reprod Med, Poissy, France; [Barrau, Vincent] Ctr Cardiol Nord, Dept Radiol, St Denis, France; [Delmas, Vincent] Univ Paris 05, URDIA EA 4465, Anat, Paris, France; [Touboul, Cyril] Hop Lariboisiere, UMR INSERM Angiogenese & Rech Translat U965, F-75475 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Touboul, C (corresponding author), Univ Paris Est, UPEC Paris 12, Hop Intercommunal Creteil, Dept Obstet & Gynecol, Paris, France.	cyril.touboul@gmail.com	TiÃoh, Kryste Nyangoh/ABC-8309-2020	TiÃoh, Kryste Nyangoh/0000-0003-4751-9080				Achtari C, 2006, INT UROGYNECOL J, V17, P330, DOI 10.1007/s00192-005-0004-7; Bogusiewicz M, 2011, INT UROGYNECOL J, V22, P1005, DOI 10.1007/s00192-011-1421-4; Collins SA, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.050; Coolen ALWM, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/528636; de Tayrac R, 2007, INT UROGYNECOL J, V18, P251, DOI 10.1007/s00192-006-0135-5; Delmas V, 2005, EUR UROL, V48, P793, DOI 10.1016/j.eururo.2005.02.002; Dias MM, 2015, NEUROUROL URODYN; Fatton B, 2007, INT UROGYNECOL J, V18, P743, DOI 10.1007/s00192-006-0234-3; Gangam N, 2007, OBSTET GYNECOL, V110, P463, DOI 10.1097/01.AOG.0000262900.81061.fd; Ignjatovic I, 2007, INT UROGYNECOL J, V18, P1495, DOI 10.1007/s00192-007-0396-7; Kannan K, 2010, J OBSTET GYNAECOL, V30, P524, DOI 10.3109/01443615.2010.487167; LaSala CA, 2007, OBSTET GYNECOL, V109, P569, DOI 10.1097/01.AOG.0000253224.92605.2c; Lo TS, 2015, AUST NZ J OBSTET GYN, V55, P284, DOI 10.1111/ajo.12340; Maher C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub3; Maher C, 2013, INT UROGYNECOL J, V24, P1791, DOI 10.1007/s00192-013-2170-3; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Mokrzycki ML, 2007, INT UROGYNECOL J, V18, P813, DOI 10.1007/s00192-006-0213-8; Reisenauer C, 2007, EUR J OBSTET GYN R B, V131, P214, DOI 10.1016/j.ejogrb.2006.03.020; Rouviere H, ANATOMIE HUMAINE, P319; Sparic R, 2013, VOJNOSANIT PREGL, V70, P697, DOI 10.2298/VSP1307699S; Touboul C, 2008, OBSTET GYNECOL, V111, P492, DOI 10.1097/01.AOG.0000278098.85173.61; Touboul C, 2009, BJOG-INT J OBSTET GY, V116, P708, DOI 10.1111/j.1471-0528.2008.01983.x; Whiteside JL, 2004, INT UROGYNECOL J, V15, P223, DOI 10.1007/s00192-004-1143-y	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143642	10.1371/journal.pone.0143642	http://dx.doi.org/10.1371/journal.pone.0143642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624993	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600041
J	Nakamura, K; Sano, S; Fuster, JJ; Kikuchi, R; Shimizu, I; Ohshima, K; Katanasaka, Y; Ouchi, N; Walsh, K				Nakamura, Kazuto; Sano, Soichi; Fuster, Jose J.; Kikuchi, Ryosuke; Shimizu, Ippei; Ohshima, Kousei; Katanasaka, Yasufumi; Ouchi, Noriyuki; Walsh, Kenneth			Secreted Frizzled-related Protein 5 Diminishes Cardiac Inflammation and Protects the Heart from Ischemia/Reperfusion Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; WNT SIGNALING PATHWAY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; METABOLIC DYSFUNCTION; ADIPONECTIN PROTECTS; ADIPOSE-TISSUE; SFRP5; OBESITY; HYPERTROPHY	Wnt signaling has diverse actions in cardiovascular development and disease processes. Secreted frizzled-related protein 5 (Sfrp5) has been shown to function as an extracellular inhibitor of non-canonical Wnt signaling that is expressed at relatively high levels in white adipose tissue. The aim of this study was to investigate the role of Sfrp5 in the heart under ischemic stress. Sfrp5 KO and WT mice were subjected to ischemia/reperfusion (I/R). Although Sfrp5-KO mice exhibited no detectable phenotype when compared with WT control at baseline, they displayed larger infarct sizes, enhanced cardiac myocyte apoptosis, and diminished cardiac function following I/R. The ischemic lesions of Sfrp5-KO mice had greater infiltration of Wnt5a-positive macrophages and greater inflammatory cytokine and chemokine gene expression when compared with WT mice. In bone marrow-derived macrophages, Wnt5a promoted JNK activation and increased inflammatory gene expression, whereas treatment with Sfrp5 blocked these effects. These results indicate that Sfrp5 functions to antagonize inflammatory responses after I/R in the heart, possibly through a mechanism involving non-canonical Wnt5a/JNK signaling.	[Nakamura, Kazuto; Sano, Soichi; Fuster, Jose J.; Kikuchi, Ryosuke; Shimizu, Ippei; Ohshima, Kousei; Katanasaka, Yasufumi; Ouchi, Noriyuki; Walsh, Kenneth] Boston Univ Med Campus, Whitaker Cardiovasc Inst, Belmont, MA 02178 USA; [Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan	Nagoya University	Walsh, K (corresponding author), Boston Univ Med Campus, Whitaker Cardiovasc Inst, Mol Cardiol, 700 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Fuster, José J/D-3685-2011; Kikuchi, Ryosuke/AAX-4971-2021	Fuster, José J/0000-0002-5970-629X; Shimizu, Ippei/0000-0003-3333-8131	National Institutes of Health [HL081587, HL116591, HL126141, HL120160]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126141, R01HL131006, R01HL120160, P01HL081587, R01HL116591] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860052] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institutes of Health Grants HL081587, HL116591, HL126141, and HL120160 (to K. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Anunciado-Koza RP, 2016, BIOCHIMIE, V124, P134, DOI 10.1016/j.biochi.2015.05.007; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Dawson K, 2013, J PHYSIOL-LONDON, V591, P1409, DOI 10.1113/jphysiol.2012.235382; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fuster JJ, 2015, DIABETES, V64, P1235, DOI 10.2337/db14-1164; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Hagenmueller M, 2014, FEBS LETT, V588, P2230, DOI 10.1016/j.febslet.2014.05.039; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Hu WJ, 2013, J CLIN ENDOCR METAB, V98, P290, DOI 10.1210/jc.2012-2466; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kikuchi R, 2014, NAT MED, V20, P1464, DOI 10.1038/nm.3703; Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969; Leaf I, 2006, GENESIS, V44, P573, DOI 10.1002/dvg.20248; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Malekar P, 2010, HYPERTENSION, V55, P939, DOI 10.1161/HYPERTENSIONAHA.109.141127; Mayr T, 1997, MECH DEVELOP, V63, P109, DOI 10.1016/S0925-4773(97)00035-X; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Mortensen RM, 2012, CIRCULATION, V125, P1597, DOI 10.1161/CIRCULATIONAHA.112.097832; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Ouchi N, 2012, CIRCULATION, V125, P3066, DOI 10.1161/CIRCULATIONAHA.112.114181; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Prats-Puig A, 2014, PEDIATR RES, V75, P793, DOI 10.1038/pr.2014.29; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Schulte DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032437; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Sun Y, 2013, CIRCULATION, V128, pS113, DOI 10.1161/CIRCULATIONAHA.112.000010; ter Horst P, 2012, ACTA PHYSIOL, V204, P110, DOI 10.1111/j.1748-1716.2011.02309.x; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Wang R, 2014, J MOL ENDOCRINOL, V53, P405, DOI 10.1530/JME-14-0037; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991	58	84	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2566	2575		10.1074/jbc.M115.693937	http://dx.doi.org/10.1074/jbc.M115.693937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26631720	Green Published, hybrid			2022-12-26	WOS:000369626900003
J	Pannen, D; Fabisch, M; Gausling, L; Schnetz, K				Pannen, Derk; Fabisch, Maria; Gausling, Lisa; Schnetz, Karin			Interaction of the RcsB Response Regulator with Auxiliary Transcription Regulators in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE SYNTHESIS; H-NS; ACID RESISTANCE; ANTIBIOTIC-RESISTANCE; SIGNAL-TRANSDUCTION; ENVELOPE STRESS; COLANIC ACID; MAT FIMBRIAE; BGL OPERON; PHOSPHORELAY	The Rcs phosphorelay is a two-component signal transduction system that is induced by cell envelope stress. RcsB, the response regulator of this signaling system, is a pleiotropic transcription regulator, which is involved in the control of various stress responses, cell division, motility, and biofilm formation. RcsB regulates transcription either as a homodimer or together with auxiliary regulators, such as RcsA, BglJ, and GadE in Escherichia coli. In this study, we show that RcsB in addition forms heterodimers with MatA (also known as EcpR) and with DctR. Our data suggest that the MatA-dependent transcription regulation is mediated by the MatA-RcsB heterodimer and is independent of RcsB phosphorylation. Furthermore, we analyzed the relevance of amino acid residues of the active quintet of conserved residues, and of surface-exposed residues for activity of RcsB. The data suggest that the activity of the phosphorylation-dependent dimers, such as RcsA-RcsB and RcsB-RcsB, is affected by mutation of residues in the vicinity of the phosphorylation site, suggesting that a phosphorylation-induced structural change modulates their activity. In contrast, the phosphorylation-independent heterodimers BglJ-RcsB and MatA-RcsB are affected by only very few mutations. Heterodimerization of RcsB with various auxiliary regulators and their differential dependence on phosphorylation add an additional level of control to the Rcs system that is operating at the output level.	[Pannen, Derk; Fabisch, Maria; Gausling, Lisa; Schnetz, Karin] Univ Cologne, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany	University of Cologne	Schnetz, K (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47a, D-50674 Cologne, Germany.	schnetz@uni-koeln.de		Schnetz, Karin/0000-0003-4693-6202	Deutsche Forschungsgemeinschaft [SCHN 371/10-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHN 371/10-2. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baikalov I, 1998, BIOCHEMISTRY-US, V37, P3665, DOI 10.1021/bi972365a; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho SH, 2014, CELL, V159, P1652, DOI 10.1016/j.cell.2014.11.045; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIEDERICH L, 1992, PLASMID, V28, P14, DOI 10.1016/0147-619X(92)90032-6; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Dole S, 2002, MOL MICROBIOL, V43, P217, DOI 10.1046/j.1365-2958.2002.02734.x; Ebel W, 1999, J BACTERIOL, V181, P577, DOI 10.1128/JB.181.2.577-584.1999; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENIKOFF S, 1990, METHOD ENZYMOL, V183, P111; Hu LDI, 2013, J BACTERIOL, V195, P4174, DOI 10.1128/JB.00383-13; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Lehti TA, 2013, MOL MICROBIOL, V87, P1200, DOI 10.1111/mmi.12161; Lehti TA, 2012, MICROBIOL-SGM, V158, P1444, DOI 10.1099/mic.0.056499-0; Lehti TA, 2012, J BACTERIOL, V194, P3475, DOI 10.1128/JB.06596-11; Lehti TA, 2010, MICROBIOL-SGM, V156, P2408, DOI 10.1099/mic.0.039610-0; Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Martinez-Santos VI, 2012, J BACTERIOL, V194, P5020, DOI 10.1128/JB.00915-12; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Miller JH., 1972, EXPT MOL GENETICS; Nishino K, 2003, J BACTERIOL, V185, P2667, DOI 10.1128/JB.185.8.2667-2672.2003; Pristovsek P, 2003, J BIOL CHEM, V278, P17752, DOI 10.1074/jbc.M301328200; Salscheider SL, 2014, NUCLEIC ACIDS RES, V42, P2999, DOI 10.1093/nar/gkt1298; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schnell R, 2008, ACTA CRYSTALLOGR F, V64, P1096, DOI 10.1107/S1744309108035203; SLEDJESKI D, 1995, P NATL ACAD SCI USA, V92, P2003, DOI 10.1073/pnas.92.6.2003; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Stratmann T, 2008, J BACTERIOL, V190, P926, DOI 10.1128/JB.01447-07; Stratmann T, 2012, MOL MICROBIOL, V83, P1109, DOI 10.1111/j.1365-2958.2012.07993.x; Sturny R, 2003, J BACTERIOL, V185, P4298, DOI 10.1128/JB.185.15.4298-4304.2003; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Trajtenberg F, 2014, MBIO, V5, DOI 10.1128/mBio.02105-14; Venkatesh GR, 2010, J BACTERIOL, V192, P6456, DOI 10.1128/JB.00807-10; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiebe H, 2015, J BACTERIOL, V197, P2713, DOI 10.1128/JB.00263-15; WILSON GG, 1979, NATURE, V280, P80, DOI 10.1038/280080a0; Yamanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111962; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	62	40	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2357	2370		10.1074/jbc.M115.696815	http://dx.doi.org/10.1074/jbc.M115.696815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26635367	Green Published, hybrid			2022-12-26	WOS:000369610400025
J	Cottrell, JR; Li, B; Kyung, JW; Ashford, CJ; Mann, JJ; Horvath, TL; Ryan, TA; Kim, SH; Gerber, DJ				Cottrell, Jeffrey R.; Li, Bing; Kyung, Jae Won; Ashford, Crystle J.; Mann, James J.; Horvath, Tamas L.; Ryan, Timothy A.; Kim, Sung Hyun; Gerber, David J.			Calcineurin A gamma is a Functional Phosphatase That Modulates Synaptic Vesicle Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSOCIATION; SCHIZOPHRENIA; PPP3CC; GENE; SUSCEPTIBILITY; HIPPOCAMPAL; EXPRESSION; SUBUNIT; POLYMORPHISMS; ISOFORMS	Variation in PPP3CC, the gene that encodes the gamma isoform of the calcineurin catalytic subunit, has been reported to be associated with schizophrenia. Because of its low expression level in most tissues, there has been little research devoted to the specific function of the calcineurin A gamma (CNA gamma) versus the calcineurin A alpha (CNA alpha) and calcineurin A beta (CNA beta) catalytic isoforms. Consequently, we have a limited understanding of the role of altered CNA gamma function in psychiatric disease. In this study, we demonstrate that CNA gamma is present in the rodent and human brain and dephosphorylates a presynaptic substrate of calcineurin. Through a combination of immunocytochemistry and immuno-EM, we further show that CNA gamma is localized to presynaptic terminals in hippocampal neurons. Critically, we demonstrate that RNAi-mediated knockdown of CNA gamma leads to a disruption of synaptic vesicle cycling in cultured rat hippocampal neurons. These data indicate that CNA gamma regulates a critical aspect of synaptic vesicle cycling and suggest that variation in PPP3CC may contribute to psychiatric disease by altering presynaptic function.	[Cottrell, Jeffrey R.; Li, Bing; Ashford, Crystle J.; Mann, James J.; Gerber, David J.] Galenea Corp, 50C Audubon Rd, Wakefield, MA 01880 USA; [Ryan, Timothy A.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, Comparat Med Sect, New Haven, CT 06511 USA; [Kyung, Jae Won; Kim, Sung Hyun] Kyung Hee Univ, Dept Physiol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 02447, South Korea	Cornell University; Yale University; Kyung Hee University	Gerber, DJ (corresponding author), Galenea Corp, 50C Audubon Rd, Wakefield, MA 01880 USA.; Kim, SH (corresponding author), Kyung Hee Univ, Dept Physiol, Neurodegenerat Control Res Ctr, Sch Med, Seoul 02447, South Korea.	sunghyunkim@khu.ac.kr; dgerber@galenea.com	Kim, Sung Hyun/AAI-8554-2020; Ryan, Timothy/AAO-8286-2020	Kim, Sung Hyun/0000-0002-3166-9941	Otsuka Pharmaceutical Co. Ltd.; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2013R1A1A1063174]; Kyung Hee University [KHU-20140665]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942] Funding Source: NIH RePORTER	Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; Kyung Hee University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a research and development collaboration with Otsuka Pharmaceutical Co. Ltd. J. R. C., J. J. M., and D. J. G. are employees and stockholders of Galenea Corp. B. L. and C. J. A. are stockholders of Galenea Corp. T. A. R. is a consultant and stockholder of Galenea Corp.; Supported by the National Research Foundation of Korea (Basic Science Research Program) funded by the Ministry of Science, ICT, and Future Planning (Grant NRF-2013R1A1A1063174), and Kyung Hee University in 2014 (KHU-20140665).	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; Chen Q, 2004, BIOL PSYCHIAT, V56, P177, DOI 10.1016/j.biopsych.2004.05.010; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Cottrell JR, 2013, J NEUROSCI, V33, P10938, DOI 10.1523/JNEUROSCI.5362-12.2013; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Eastwood SL, 2005, EUR J NEUROSCI, V22, P3017, DOI 10.1111/j.1460-9568.2005.04518.x; Eastwood SL, 2005, BIOL PSYCHIAT, V57, P702, DOI 10.1016/j.biopsych.2004.12.029; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gabor F, 2011, INT J DEV NEUROSCI, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Halpain S, 1998, J NEUROSCI, V18, P9835; Horiuchi Y, 2007, MOL PSYCHIATR, V12, P891, DOI 10.1038/sj.mp.4002019; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jiang HS, 1997, MOL IMMUNOL, V34, P663, DOI 10.1016/S0161-5890(97)00054-0; Kayyali U. S., 1997, J NEUROCHEM, V68, P1668; Kilka S, 2009, BIOCHEMISTRY-US, V48, P1900, DOI 10.1021/bi8019355; Kim SH, 2013, J NEUROSCI, V33, P8937, DOI 10.1523/JNEUROSCI.4288-12.2013; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lee HJ, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-15; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Maycox PR, 2009, MOL PSYCHIATR, V14, P1083, DOI 10.1038/mp.2009.18; Milekic MH, 2015, MOL PSYCHIATR, V20, P995, DOI 10.1038/mp.2014.84; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sacchetti E, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-33; Shi JJ, 2008, SCHIZOPHR RES, V104, P96, DOI 10.1016/j.schres.2008.06.016; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Waites CL, 2011, TRENDS NEUROSCI, V34, P326, DOI 10.1016/j.tins.2011.03.004; Wockner LF, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.111; Wong AHC, 2004, BIOL PSYCHIAT, V56, P24, DOI 10.1016/j.biopsych.2004.03.008; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	42	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1948	1956		10.1074/jbc.M115.705319	http://dx.doi.org/10.1074/jbc.M115.705319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627835	hybrid, Green Published			2022-12-26	WOS:000368620700032
J	Kim, H; Yang, J; Kim, MJ; Choi, S; Chung, JR; Kim, JM; Yoo, YH; Chung, J; Koh, H				Kim, Hyunjin; Yang, Jinsung; Kim, Min Ju; Choi, Sekyu; Chung, Ju-Ryung; Kim, Jong-Min; Yoo, Young Hyun; Chung, Jongkyeong; Koh, Hyongjong			Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEGANS LIFE-SPAN; OXIDATIVE STRESS; CHAPERONE TRAP1; DROSOPHILA; PARKIN; RESPIRATION; KINASE; PINK1; HSP90; DYSFUNCTION	TRAP1 (tumor necrosis factor receptor-associated protein 1), a mitochondrial Hsp90 family chaperone, has been identified as a critical regulator of cell survival and bioenergetics in tumor cells. To discover novel signaling networks regulated by TRAP1, we generated Drosophila TRAP1 mutants. The mutants successfully developed into adults and produced fertile progeny, showing that TRAP1 is dispensable in development and reproduction. Surprisingly, mutation or knockdown of TRAP1 markedly enhanced Drosophila survival under oxidative stress. Moreover, TRAP1 mutation ameliorated mitochondrial dysfunction and dopaminergic (DA) neuron loss induced by deletion of a familial Parkinson disease gene PINK1 (Pten-induced kinase 1) in Drosophila. Gamitrinib-triphenylphosphonium, a mitochondria-targeted Hsp90 inhibitor that increases cell death in HeLa and MCF7 cells, consistently inhibited cell death induced by oxidative stress and mitochondrial dysfunction induced by PINK1 mutation in mouse embryonic fibroblast cells and DA cell models such as SH-SY5Y and SN4741 cells. Additionally, gamitrinib-triphenylphosphonium also suppressed the defective locomotive activity and DA neuron loss in Drosophila PINK1 null mutants. In further genetic analyses, we showed enhanced expression of Thor, a downstream target gene of transcription factor FOXO, in TRAP1 mutants. Furthermore, deletion of FOXO almost nullified the protective roles of TRAP1 mutation against oxidative stress and PINK1 mutation. These results strongly suggest that inhibition of the mitochondrial chaperone TRAP1 generates a retrograde cell protective signal from mitochondria to the nucleus in a FOXO-dependent manner.	[Kim, Hyunjin; Kim, Min Ju; Koh, Hyongjong] Dong A Univ, Coll Med, Dept Pharmacol, Mitochondria Hub Regulat Ctr, Dongdaeshin Dong 3-1, Busan 602714, South Korea; [Kim, Jong-Min; Yoo, Young Hyun] Dong A Univ, Mitochondria Hub Regulat Ctr, Dept Anat & Cell Biol, Coll Med, Busan 602714, South Korea; [Yang, Jinsung; Choi, Sekyu; Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul 151744, South Korea; [Yang, Jinsung; Choi, Sekyu; Chung, Ju-Ryung; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151744, South Korea	Dong A University; Dong A University; Seoul National University (SNU); Seoul National University (SNU)	Koh, H (corresponding author), Dong A Univ, Coll Med, Dept Pharmacol, Mitochondria Hub Regulat Ctr, Dongdaeshin Dong 3-1, Busan 602714, South Korea.; Chung, J (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, San 56-1, Seoul 151744, South Korea.	jkc@snu.ac.kr; hjkoh@dau.ac.kr	Yang, Jinsung/ABB-7722-2021	Koh, Hyongjong/0000-0003-2594-4799; Choi, Sekyu/0000-0003-2928-0942	National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology) [NRF-2012-R1A1A1012482, NRF-2009-0093188]; National Creative Research Initiatives grant through the National Research Foundation of Korea - Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning) [2010-0018291]; BK21 Plus Program from Ministry of Education	National Research Foundation of Korea - Korean government (Ministry of Education, Science, and Technology); National Creative Research Initiatives grant through the National Research Foundation of Korea - Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning); BK21 Plus Program from Ministry of Education	This work was supported by National Research Foundation of Korea Grants NRF-2012-R1A1A1012482 and NRF-2009-0093188 funded by the Korean government (Ministry of Education, Science, and Technology) (to H. K.) and by the National Creative Research Initiatives grant through the National Research Foundation of Korea funded by Ministry of Science, Information/Communication Technology, and Future Planning (Ministry of Science, ICT, and Future Planning) Grant 2010-0018291 and BK21 Plus Program from Ministry of Education (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	BIEDLER JL, 1978, CANCER RES, V38, P3751; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cechetto JD, 2000, EXP CELL RES, V260, P30, DOI 10.1006/excr.2000.4983; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang BH, 2012, BMB REP, V45, P1, DOI 10.5483/BMBRep.2012.45.1.1; Kang BH, 2009, J CLIN INVEST, V119, P454, DOI 10.1172/JCI37613; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Koh H, 2012, J BIOL CHEM, V287, P12750, DOI 10.1074/jbc.M111.337907; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lee YN, 2012, BIOCHEM BIOPH RES CO, V420, P851, DOI 10.1016/j.bbrc.2012.03.087; Lisanti S, 2014, CELL REP, V8, P671, DOI 10.1016/j.celrep.2014.06.061; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sciacovelli M, 2013, CELL METAB, V17, P988, DOI 10.1016/j.cmet.2013.04.019; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011	33	28	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1841	1853		10.1074/jbc.M115.656934	http://dx.doi.org/10.1074/jbc.M115.656934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631731	Green Published, hybrid			2022-12-26	WOS:000368620700024
J	He, B; Tao, X; Gu, YH; Wei, CH; Cheng, XJ; Xiao, SQ; Cheng, ZQ; Zhang, YZ				He, Bin; Tao, Xiang; Gu, Yinghong; Wei, Changhe; Cheng, Xiaojie; Xiao, Suqin; Cheng, Zaiquan; Zhang, Yizheng			Transcriptomic Analysis and the Expression of Disease-Resistant Genes in Oryza meyeriana under Native Condition	PLOS ONE			English	Article							CULTIVATED RICE; SATIVA L.; GENOME; SEQUENCE; ARABIDOPSIS; GENERATION; EVOLUTION; PATHWAYS; DEFENSE; POACEAE	Oryza meyeriana (O. meyeriana), with a GG genome type (2n = 24), accumulated plentiful excellent characteristics with respect to resistance to many diseases such as rice shade and blast, even immunity to bacterial blight. It is very important to know if the diseases-resistant genes exist and express in this wild rice under native conditions. However, limited genomic or transcriptomic data of O. meyeriana are currently available. In this study, we present the first comprehensive characterization of the O. meyeriana transcriptome using RNA-seq and obtained 185,323 contigs with an average length of 1,692 bp and an N50 of 2,391 bp. Through differential expression analysis, it was found that there were most tissue-specifically expressed genes in roots, and next to stems and leaves. By similarity search against protein databases, 146,450 had at least a significant alignment to existed gene models. Comparison with the Oryza sativa (japonica-type Nipponbare and indica-type 93-11) genomes revealed that 13% of the O. meyeriana contigs had not been detected in O. sativa. Many diseases-resistant genes, such as bacterial blight resistant, blast resistant, rust resistant, fusarium resistant, cyst nematode resistant and downy mildew gene, were mined from the transcriptomic database. There are two kinds of rice bacterial blight-resistant genes (Xa1 and Xa26) differentially or specifically expressed in O. meyeriana. The 4 Xa1 contigs were all only expressed in root, while three of Xa26 contigs have the highest expression level in leaves, two of Xa26 contigs have the highest expression profile in stems and one of Xa26 contigs was expressed dominantly in roots. The transcriptomic database of O. meyeriana has been constructed and many diseases-resistant genes were found to express under native condition, which provides a foundation for future discovery of a number of novel genes and provides a basis for studying the molecular mechanisms associated with disease resistance in O. meyeriana.	[He, Bin; Tao, Xiang; Gu, Yinghong; Wei, Changhe; Cheng, Xiaojie; Zhang, Yizheng] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol, Minist Educ,Key Lab Bio Resources & Ecoenvironm, Chengdu 610064, Peoples R China; [Xiao, Suqin; Cheng, Zaiquan] Yunnan Acad Agr Sci, Biotechnol & Genet Resources Inst, Kunming 650223, Peoples R China	Sichuan University; Yunnan Academy of Agricultural Sciences	Cheng, ZQ (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Genet Resources Inst, Kunming 650223, Peoples R China.	czquan-99@163.com; yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Natural Science Foundation of China [3160067, U1302265]; scientific projects of Yunnan Province [2012FA005, 2012HA002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); scientific projects of Yunnan Province	This work was supported by National Natural Science Foundation of China (3160067 and U1302265) and the scientific projects of Yunnan Province (2012FA005 and 2012HA002) in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bon SG, 2011, PHILIPP J CROP SCI, V36, P28; Brar D, 2002, TRANSFERRING GENES W; Brar DS., 1991, RICE GENET NEWSL, V8, P91; Carels N, 2000, GENETICS, V154, P1819; Cheng Z, 2010, PLANT BREEDING, V129, P393, DOI 10.1111/j.1439-0523.2009.01701.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cho SK, 2004, PLANT CELL REP, V22, P839, DOI 10.1007/s00299-004-0764-4; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glowacki S, 2011, CELL MOL BIOL LETT, V16, P1, DOI 10.2478/s11658-010-0024-2; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1192-7; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Hernandez D, 2013, BIOINFORMATICS; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jena KK, 2010, BREEDING SCI, V60, P518, DOI 10.1270/jsbbs.60.518; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CB, 2001, THEOR APPL GENET, V103, P197, DOI 10.1007/s001220100562; Lu TT, 2008, DNA RES, V15, P285, DOI 10.1093/dnares/dsn018; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moghaddam M. R. B., 2012, J EXP BOT; Mullins IM, 2002, THEOR APPL GENET, V105, P841, DOI 10.1007/s00122-002-1056-4; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rahman ML, 2009, THEOR APPL GENET, V119, P1237, DOI 10.1007/s00122-009-1125-z; Ram T, 2007, CURR SCI INDIA, V92, P225; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Torbica A, 2010, FOOD HYDROCOLLOID, V24, P626, DOI 10.1016/j.foodhyd.2010.03.004; Wang XM, 2013, J PHYTOPATHOL, V161, P324, DOI 10.1111/jph.12066; Yan CQ, 2004, PLANT CELL REP, V22, P569, DOI 10.1007/s00299-003-0732-4; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	53	7	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144518	10.1371/journal.pone.0144518	http://dx.doi.org/10.1371/journal.pone.0144518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640944	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700137
J	Mora, AL; Detalle, L; Van Geelen, A; Davis, MS; Stohr, T; Gallup, JM; Ackermann, MR				Mora, Alejandro Larios; Detalle, Laurent; Van Geelen, Albert; Davis, Michael S.; Stohr, Thomas; Gallup, Jack M.; Ackermann, Mark R.			Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; EPITHELIAL-CELLS; DISEASE SEVERITY; VIRAL LOAD; RESPONSES; CHILDREN; INTERLEUKIN-8; PATHOGENESIS; SECRETIONS; PREVENTION	Rationale Respiratory syncytial virus (RSV) infection in preterm and newborn infants can result in severe bronchiolitis and hospitalization. The lamb lung has several key features conducive to modeling RSV infection in human infants, including susceptibility to human strains of RSV such as the A2, Long, and Memphis Strain 37 (M37). In this study, the kinetics of M37 infection was investigated in newborn lambs in order to better define clinical, viral, physiological, and immunological parameters as well as the pathology and lesions. Methods Newborn lambs were nebulized with M37 hRSV (6 mL of 1.27 x 10(7) FFU/mL), monitored daily for clinical responses, and respiratory tissues were collected from groups of lambs at days 1, 3, 4, 6, and 8 post-inoculation for the assessment of viral replication parameters, lesions and also cellular, immunologic and inflammatory responses. Results Lambs had increased expiratory effort (forced expiration) at days 4, 6, and 8 post-inoculation. Nasal wash lacked RSV titers at day 1, but titers were present at low levels at days 3 (peak), 4, and 8. Viral titers in bronchoalveolar lavage fluid (BALF) reached a plateau at day 3 (4.6 Log(10) FFU/mL), which was maintained until day 6 (4.83 Log(10) FFU/mL), and were markedly reduced or absent at day 8. Viral RNA levels (detected by RT-qPCR) in BALF were indistinguishable at days 3 (6.22 +/- 0.08 Log(10) M37 RNA copies/mL; mean +/- se) and 4 (6.20 +/- 0.16 Log(10) M37 RNA copies/mL; mean +/- se) and increased slightly on day 6 (7.15 +/- 0.2 Log(10) M37 RNA copies/mL; mean +/- se). Viral antigen in lung tissue as detected by immunohistochemistry was not seen at day 1, was present at days 3 and 4 before reaching a peak by day 6, and was markedly reduced by day 8. Viral antigen was mainly present in airways (bronchi, bronchioles) at day 3 and was increasingly present in alveolar cells at days 4 and 6, with reduction at day 8. Histopathologic lesions such as bronchitis/bronchiolitis, epithelial necrosis and hyperplasia, peribronchial lymphocyte infiltration, and syncytial cells, were consistent with those described previously for lambs and infants. Conclusion This work demonstrates that M37 hRSV replication in the lower airways of newborn lambs is robust with peak replication on day 3 and sustained until day 6. These findings, along with the similarities of lamb lung to those of infants in terms of alveolar development, airway branching and epithelium, susceptibility to human RSV strains, lesion characteristics (bronchiolitis), lung size, clinical parameters, and immunity, further establish the neonatal lamb as a model with key features that mimic RSV infection in infants.	[Mora, Alejandro Larios; Van Geelen, Albert; Gallup, Jack M.; Ackermann, Mark R.] Iowa State Univ, Dept Vet Pathol, Ames, IA 50011 USA; [Detalle, Laurent; Stohr, Thomas] Ablynx NV, Zwijnaarde, Belgium; [Davis, Michael S.] Oklahoma State Univ, Ctr Vet Hlth Sci, Stillwater, OK 74078 USA	Iowa State University; Oklahoma State University System; Oklahoma State University - Stillwater	Mora, AL (corresponding author), Iowa State Univ, Dept Vet Pathol, Ames, IA 50011 USA.	alarios@iastate.edu		Detalle, Laurent/0000-0001-8481-7736	Ablynx, NV; "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium [130562]	Ablynx, NV; "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium	This work was funded by Ablynx, NV and by the "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"- Belgium - grant No 130562. Ablynx had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; We thank Diane Gerjets, Toni Christofferson, and Jennifer Groeltz-Thrush for their technical histology assistance and expertise, as well as Diane McDonald, Kathleen Mullin, and Dale Hinderaker of the Laboratory Animal Resources (LAR) and the Livestock Infectious Disease Isolation Facility (LIDIF). The work was funded by Ablynx, NV and by the "Agentschap voor Innovatie door Wetenschap en Techniek (IWT)"-Belgium-grant No 130562.	Abu-Harb M, 1999, EUR RESPIR J, V14, P139, DOI 10.1034/j.1399-3003.1999.14a23.x; AHERNE W, 1970, J CLIN PATHOL, V23, P7, DOI 10.1136/jcp.23.1.7; Bont L, 1999, EUR RESPIR J, V14, P144, DOI 10.1034/j.1399-3003.1999.14a24.x; Bonville CA, 1999, PEDIATR ALLERGY IMMU, V10, P39, DOI 10.1034/j.1399-3038.1999.101005.x; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crowe JE, 1999, CURR TOP MICROBIOL, V236, P191; CUTLIP RC, 1979, AM J VET RES, V40, P1479; Derscheid RJ, 2013, VET PATHOL, V50, P827, DOI 10.1177/0300985813480216; Derscheid RJ, 2014, BIORESEARCH OPEN ACC, V3, P60, DOI 10.1089/biores.2013.0044; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; Derscheid RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081472; Derscheid RJ, 2013, VIRUSES-BASEL, V5, P2881, DOI 10.3390/v5112881; Derscheid RJ, 2012, VIRUSES-BASEL, V4, P2359, DOI 10.3390/v4102359; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Dudas RA, 1998, CLIN MICROBIOL REV, V11, P430, DOI 10.1128/CMR.11.3.430; Eiland Lea S, 2009, J Pediatr Pharmacol Ther, V14, P75, DOI 10.5863/1551-6776-14.2.75; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Friedman JN, 2014, PAED CHILD HEALT-CAN, V19, P484, DOI 10.1093/pch/19.9.485; Gallup JM, 2006, BIOL PROCED ONLINE, V8, P87, DOI 10.1251/bpo122; Gallup Jack M, 2008, Int J Biomed Sci, V4, P273; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Goldmann DA, 2001, EMERG INFECT DIS, V7, P249, DOI 10.3201/eid0702.010220; GRAHAM BS, 1995, AM J RESP CRIT CARE, V152, pS63, DOI 10.1164/ajrccm/152.4_Pt_2.S63; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Grosz Drew D, 2014, BMC Res Notes, V7, P158, DOI 10.1186/1756-0500-7-158; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kim YI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113100; LEHMKUHL HD, 1979, AM J VET RES, V40, P1729; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDM0D.2009.12.002, 10.1016/j.ddmod.2009.12.002]; Mellow TE, 2004, EXP LUNG RES, V30, P43, DOI 10.1080/01902140490252812; Murai Hiroki, 2007, Allergol Int, V56, P157, DOI 10.2332/allergolint.O-06-454; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olivier A, 2009, INT J EXP PATHOL, V90, P431, DOI 10.1111/j.1365-2613.2009.00643.x; Olivier AK, 2011, EXP LUNG RES, V37, P131, DOI 10.3109/01902148.2010.484518; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462; Prevention CfDCa, 2014, RESP SYNC VIR INF RS; Sacco RE, 2012, VIRUSES-BASEL, V4, P3731, DOI 10.3390/v4123731; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Sow FB, 2011, AM J PHYSIOL-LUNG C, V300, pL12, DOI 10.1152/ajplung.00169.2010; TYRRELL DAJ, 1979, INFECT IMMUN, V26, P621, DOI 10.1128/IAI.26.2.621-629.1979; van Woensel JBM, 2003, PEDIATR INFECT DIS J, V22, P721, DOI 10.1097/01.inf.0000078165.62923.15; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Wang SZ, 1998, EUR RESPIR J, V12, P612, DOI 10.1183/09031936.98.12030612; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143580	10.1371/journal.pone.0143580	http://dx.doi.org/10.1371/journal.pone.0143580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641081	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700021
J	Schill, SR; Raber, GT; Roberts, JJ; Treml, EA; Brenner, J; Halpin, PN				Schill, Steven R.; Raber, George T.; Roberts, Jason J.; Treml, Eric A.; Brenner, Jorge; Halpin, Patrick N.			No Reef Is an Island: Integrating Coral Reef Connectivity Data into the Design of Regional-Scale Marine Protected Area Networks	PLOS ONE			English	Article							CARIBBEAN CORAL; POPULATION CONNECTIVITY; LARVAL DISPERSAL; OCEAN CURRENTS; CONSERVATION; RESILIENCE; MANAGEMENT; EVOLUTION; DECLINES; COASTAL	We integrated coral reef connectivity data for the Caribbean and Gulf of Mexico into a conservation decision-making framework for designing a regional scale marine protected area (MPA) network that provides insight into ecological and political contexts. We used an ocean circulation model and regional coral reef data to simulate eight spawning events from 2008-2011, applying a maximum 30-day pelagic larval duration and 20% mortality rate. Coral larval dispersal patterns were analyzed between coral reefs across jurisdictional marine zones to identify spatial relationships between larval sources and destinations within countries and territories across the region. We applied our results in Marxan, a conservation planning software tool, to identify a regional coral reef MPA network design that meets conservation goals, minimizes underlying threats, and maintains coral reef connectivity. Our results suggest that approximately 77% of coral reefs identified as having a high regional connectivity value are not included in the existing MPA network. This research is unique because we quantify and report coral larval connectivity data by marine ecoregions and Exclusive Economic Zones (EZZ) and use this information to identify gaps in the current Caribbean-wide MPA network by integrating asymmetric connectivity information in Marxan to design a regional MPA network that includes important reef network connections. The identification of important reef connectivity metrics guides the selection of priority conservation areas and supports resilience at the whole system level into the future.	[Schill, Steven R.] Nature Conservancy, Caribbean Program, Coral Gables, FL USA; [Raber, George T.] Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA; [Roberts, Jason J.; Halpin, Patrick N.] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Durham, NC 27708 USA; [Treml, Eric A.] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia; [Brenner, Jorge] Nature Conservancy, Texas Chapter, Houston, TX USA	Nature Conservancy; University of Southern Mississippi; Duke University; University of Melbourne; Nature Conservancy	Raber, GT (corresponding author), Univ So Mississippi, Dept Geog & Geol, Hattiesburg, MS 39406 USA.	george.raber@usm.edu	Treml, Eric A/C-7580-2013	Treml, Eric A/0000-0003-4844-4420; Schill, Steven R/0000-0002-9066-434X; Brenner, Jorge/0000-0002-4962-4784	John D. and Catherine T. MacArthur Foundation;  [1715173007]	John D. and Catherine T. MacArthur Foundation; 	This project was funded by a grant from the John D. and Catherine T. MacArthur Foundation. The title of the grant was "A Vision for Protecting Shared Marine Resources across the Caribbean Biological Corridor." The URL for the funder is http://www.macfound.org/. The grant number is 1715173007. The author who received the funding was Steven R. Schill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current funding sources for this study (The Nature Conservancy has agreed to cover the cost of the PLOS ONE publication fee from their own funds. The University of Southern Mississippi has agreed to host any data sharing requirements through existing computing resources).; This work was made possible by a grant from the John D. and Catherine T. MacArthur Foundation Program on Global Security and Sustainability to develop a tri-national, Haiti-Dominican Republic-Cuba marine action plan for the Caribbean Biological Corridor.	Agardy TS, 2010, MAR POLICY, V35, P226; Agostini V.N., 2010, MARINE ZONING SAINT; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Andrefouet S, 2004, P 10 INT COR REEF S, P1732; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bastidas C, 2005, HYDROBIOLOGIA, V541, P101, DOI 10.1007/s10750-004-4672-y; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berglund M, 2012, ECOL MODEL, V240, P105, DOI 10.1016/j.ecolmodel.2012.04.011; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Burgess SC, 2014, ECOL APPL, V24, P257, DOI 10.1890/13-0710.1; Burke L., 2011, REEFS RISK REVISITED; Buston PM, 2012, P ROY SOC B-BIOL SCI, V279, P1883, DOI 10.1098/rspb.2011.2041; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Arias-Gonzalez JE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P373, DOI 10.1007/978-94-007-0114-4_21; Fischer DT, 2011, PROF GEOGR, V63, P489, DOI 10.1080/00330124.2011.585079; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Golbuu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050998; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Huggins AE, 2007, TECHNICAL REPORT; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2009, CORAL REEFS, V28, P303, DOI 10.1007/s00338-008-0440-1; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Klein CJ, 2010, FRONT ECOL ENVIRON, V8, P349, DOI 10.1890/090047; Knowles JE, 2015, MAR POLICY, V60, P84, DOI 10.1016/j.marpol.2015.05.005; Lagabrielle E, 2014, AQUAT CONSERV, V24, P94, DOI 10.1002/aqc.2500; Magris RA, 2015, ECOGRAPHY IN PRESS; Makino A, 2013, BIOL CONSERV, V165, P35, DOI 10.1016/j.biocon.2013.05.027; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; Mehra A, 2010, TERR ATMOS OCEAN SCI, V21, P211, DOI 10.3319/TAO.2009.04.16.01(IWNOP); Mendes JM, 2002, MAR ECOL PROG SER, V227, P241, DOI 10.3354/meps227241; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mora C, 2006, SCIENCE, V314, P758; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; North EW, 2009, ICES INT COUNC EXPLO; Palumbi SR, 2003, FRONT ECOL ENVIRON, V1, P73, DOI 10.2307/3868033; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Schill SR, 2012, MACARTHUR FDN PROGRA; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Strathmann RR, 2002, B MAR SCI, V70, P377; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2015, GLOBAL ENVIRON CHANG, V31, P263, DOI 10.1016/j.gloenvcha.2015.01.012; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; White JW, 2014, CONSERVATION LETT; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	75	45	45	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144199	10.1371/journal.pone.0144199	http://dx.doi.org/10.1371/journal.pone.0144199			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641083	Green Published, gold			2022-12-26	WOS:000366902700075
J	Upperman, CR; Parker, J; Jiang, CS; He, X; Murtugudde, R; Sapkota, A				Upperman, Crystal Romeo; Parker, Jennifer; Jiang, Chengsheng; He, Xin; Murtugudde, Raghuram; Sapkota, Amir			Frequency of Extreme Heat Event as a Surrogate Exposure Metric for Examining the Human Health Effects of Climate Change	PLOS ONE			English	Article							NEW-YORK-STATE; DISEASE MORTALITY; UNITED-STATES; EL-NINO; URBANIZATION; US; EPIDEMIOLOGY; IMPACT; ENSO; RISK	Epidemiological investigation of the impact of climate change on human health, particularly chronic diseases, is hindered by the lack of exposure metrics that can be used as a marker of climate change that are compatible with health data. Here, we present a surrogate exposure metric created using a 30-year baseline (1960-1989) that allows users to quantify long-term changes in exposure to frequency of extreme heat events with near unabridged spatial coverage in a scale that is compatible with national/state health outcome data. We evaluate the exposure metric by decade, seasonality, area of the country, and its ability to capture long-term changes in weather (climate), including natural climate modes. Our findings show that this generic exposure metric is potentially useful to monitor trends in the frequency of extreme heat events across varying regions because it captures long-term changes; is sensitive to the natural climate modes (ENSO events); responds well to spatial variability, and; is amenable to spatial/temporal aggregation, making it useful for epidemiological studies.	[Upperman, Crystal Romeo; Sapkota, Amir] Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [Upperman, Crystal Romeo; Jiang, Chengsheng] Univ Maryland, Marine Estuarine Environm Sci Program, College Pk, MD 20742 USA; [Parker, Jennifer] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [He, Xin] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Murtugudde, Raghuram] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Sapkota, A (corresponding author), Univ Maryland, Maryland Inst Appl Environm Hlth, Sch Publ Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu	Sapkota, Amir/A-5968-2011; He, Xin/N-6742-2016		Centers for Disease Control and Prevention (CDC); National Institute of Environmental Health Sciences [NIEHS: 1R21ES021422-01A1]; Centers for Disease Control and Prevention; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021422] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funding for this work was provided by the Centers for Disease Control and Prevention (CDC) and the National Institute of Environmental Health Sciences (NIEHS: 1R21ES021422-01A1).; The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the National Center for Health Statistics or the Centers for Disease Control and Prevention. The funding for this work was provided by the Centers for Disease Control and Prevention and the National Institute of Environmental Health Sciences (NIEHS: 1R21ES021422-01A1)	Abdi H., 2010, ENCY RES DESIGN, V3, P1, DOI DOI 10.4135/9781412961288.N178; Akinbami LJ, 2010, ENVIRON RES, V110, P294, DOI 10.1016/j.envres.2010.01.001; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; [Anonymous], EL NIN SO OSC COLD W; Barnett E, 1996, J EPIDEMIOL COMMUN H, V50, P252, DOI 10.1136/jech.50.3.252; Beniston M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037119; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Corti S, 1999, NATURE, V398, P799, DOI 10.1038/19745; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Ganeshan M, 2013, URBAN CLIM, V6, P1, DOI 10.1016/j.uclim.2013.09.004; Greene W.H, 1994, ACCOUNTING EXCESS ZE; Gutowski WJ, 2008, REPORT US CLIMATE CH; Haines A, 1997, BRIT MED J, V315, P870, DOI 10.1136/bmj.315.7112.870; Hales S., 2014, QUANTITATIVE RISK AS; Hao ZC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034014; INGRAM DD, 1989, J CLIN EPIDEMIOL, V42, P857, DOI 10.1016/0895-4356(89)90099-1; Ingram Deborah D, 2012, Vital Health Stat 2, P1; Jiang CS, 2015, ENVIRON INT, V83, P58, DOI 10.1016/j.envint.2015.06.006; Kalnay E, 2003, NATURE, V423, P528, DOI 10.1038/nature01675; Knobeloch Lynda, 2007, WMJ, V106, P137; Larkin NK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022860; Leung LR, 2005, GEOPHYS RES LETT, P32; Luber G, 2014, CLIMATE CHANGE IMPAC, P220, DOI DOI 10.7930/J0PN93H5; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; McMichael AJ, 2001, AM J PUBLIC HEALTH, V91, P1172, DOI 10.2105/AJPH.91.8.1172; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Murtugudde R, 2009, CURR OPIN ENV SUST, V1, P37, DOI 10.1016/j.cosust.2009.07.004; Parker Jennifer D, 2008, Vital Health Stat 2, P1; Parker JD, 2009, ENVIRON HEALTH PERSP, V117, P140, DOI 10.1289/ehp.11497; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Ramesh N, 2012, NAT CLIM CHANGE, V2, DOI 10.1038/NCLIMATE1600; Rossen LM, 2013, AM J PREV MED, V45, pE19, DOI 10.1016/j.amepre.2013.07.012; Savitz DA, 2014, MATERN CHILD HLTH J, V18, P829, DOI 10.1007/s10995-013-1307-9; Savitz DA, 2011, ANN EPIDEMIOL, V21, P399, DOI 10.1016/j.annepidem.2011.03.003; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724; Wolter K, 1999, J CLIMATE, V12, P3255, DOI 10.1175/1520-0442(1999)012<3255:STCEOT>2.0.CO;2; Zhai P, 2003, ACTA GEOGR SIN, P58; Zhou LM, 2004, P NATL ACAD SCI USA, V101, P9540, DOI 10.1073/pnas.0400357101; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	49	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144202	10.1371/journal.pone.0144202	http://dx.doi.org/10.1371/journal.pone.0144202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641244	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700076
J	Fan, YL; Kress, WJ; Li, QJ				Fan, Yong-Li; Kress, W. John; Li, Qing-Jun			A New Secondary Pollen Presentation Mechanism from a Wild Ginger (Zingiber densissimum) and Its Functional Roles in Pollination Process	PLOS ONE			English	Article							FLOWERING PLANTS; SELF-POLLINATION; SEXUAL SELECTION; FLORAL NECTAR; EVOLUTION; COST; CAMPANULACEAE; MARANTACEAE; ANGIOSPERMS; DISPERSAL	Background and Aims Secondary pollen presentation (SPP), a floral mechanism of reproductive adaptation, has been described for more than 200 years, with nine types SPP recorded. However, few studies have been done experimentally to link the floral mechanism of SPP to its functional roles in pollination process. This study aims to describe a new SPP mechanism from a wild ginger (Zingiber densissimum, Zingiberaceae) and explore how the pollen arrangement of SPP affects pollen removal during the interaction with different pollinators. Methodology/Principal Findings Field observations and experiments revealed that flowers lasted for less than one day. The breeding system was partially self-incompatible. Two bee species, Macropis hedini (which carried pollen dorsally) and Amegilla zonata (which carried pollen ventrally) were the primary pollinators. About a third of pollen grains were relocated from the anther to the labellum staminode of flowers through the adherence of aggregated pollen chains, while other grains were presented on the anther. In a single visit, each bee species removed pollen grains from both the labellum staminode and the anther. Macropis hedini was more effective than Amegilla zonata. Conclusions/Significance Our study describes a new SPP mechanism in angiosperms. The new SPP mode enables pollen grains presented on the anther and the labellum staminode simultaneously via the adherence of aggregated pollen chains, thus promoting pollen to be taken away by different pollinators. This SPP mechanism plays a key role during pollen removal and may have evolved under the pressure to improve male fitness.	[Fan, Yong-Li; Li, Qing-Jun] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Fan, Yong-Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fan, Yong-Li] China Forest Explorat & Design Inst Kunming, Kunming, Peoples R China; [Fan, Yong-Li; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History	Li, QJ (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	qjli@xtbg.ac.cn	Fan, Yongli/M-8841-2019	Fan, Yongli/0000-0002-2186-3011	Natural Science Foundation of China [U1202261, 31070340]; Chinese Scholarship Council [201304910290]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council)	This work was supported by the Natural Science Foundation of China (U1202261 and 31070340) granted to Q-JL and a scholarship from the Chinese Scholarship Council (201304910290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman TL, 1997, EVOL ECOL, V11, P289, DOI 10.1023/A:1018416403530; ASHMAN TL, 1994, NATURE, V371, P788, DOI 10.1038/371788a0; BELL G, 1985, PROC R SOC SER B-BIO, V224, P223, DOI 10.1098/rspb.1985.0031; BRANTJES NBM, 1983, ACTA BOT NEERL, V32, P213, DOI 10.1111/j.1438-8677.1983.tb01702.x; Castellanos MC, 2006, AM NAT, V167, P288, DOI 10.1086/498854; Castro S, 2008, AM J BOT, V95, P706, DOI 10.3732/ajb.2007329; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Duan YA, 2008, J SYST EVOL, V46, P545, DOI 10.3724/SP.J.1002.2008.08009; Faegri K., 1966, PRINCIPLES POLLINATI; Fan YL, 2012, ANN BOT-LONDON, V110, P969, DOI 10.1093/aob/mcs169; Glinos E, 2011, PLANT SYST EVOL, V291, P49, DOI 10.1007/s00606-010-0379-x; Harder L., 2006, ECOLOGY EVOLUTION FL; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; HARDER LD, 1994, EVOL ECOL, V8, P542, DOI 10.1007/BF01238257; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; HOWELL GJ, 1993, AUST J BOT, V41, P417, DOI 10.1071/BT9930417; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kennedy H., 1978, University of California Publications in Botany, V71; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; LADD PG, 1994, BOT J LINN SOC, V115, P165, DOI 10.1006/bojl.1994.1040; Larson BMH, 1999, J ECOL, V87, P371, DOI 10.1046/j.1365-2745.1999.00362.x; Ley AC, 2009, ANN BOT-LONDON, V104, P41, DOI 10.1093/aob/mcp106; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Liang YH, 1988, ACTA PHYTOTAXONOMICA, V26, P265; Lin H, 2012, FLORA, V207, P895, DOI 10.1016/j.flora.2012.10.001; Lloyd D.G., 1984, PERSPECTIVES PLANT P, P277; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; MCCONCHIE CA, 1986, ANN BOT-LONDON, V57, P155, DOI 10.1093/oxfordjournals.aob.a087102; Ordano M, 2005, J TROP ECOL, V21, P541, DOI 10.1017/S026646740500266X; PERCIVAL M. S., 1955, NEW PHYTOL, V54, P353, DOI 10.1111/j.1469-8137.1955.tb06192.x; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Sakai S, 1999, AM J BOT, V86, P56, DOI 10.2307/2656954; SEDGLEY M, 1982, AUST J BOT, V30, P601, DOI 10.1071/BT9820601; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; SLATER AT, 1991, AUST J BOT, V39, P229, DOI 10.1071/BT9910229; Specht CD, 2012, BOT REV, V78, P440, DOI 10.1007/s12229-012-9111-6; THEILADE I, 1993, GRANA, V32, P338, DOI 10.1080/00173139309428961; THOMSON JD, 1986, J ECOL, V74, P329, DOI 10.2307/2260258; Wang YQ, 2005, INT J PLANT SCI, V166, P753, DOI 10.1086/431803; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WILLSON MF, 1979, AM NAT, V113, P777, DOI 10.1086/283437; WILSON P, 1994, AM NAT, V143, P283, DOI 10.1086/285604; Wu D.L, 2000, FLORA CHINA, V24, P362; Yatomi R, 2002, GRANA, V41, P21, DOI 10.1080/00173130260045468; Yeo P. F., 1993, SECONDARY POLLEN PRE; Zhang ZQ, 2008, ANN BOT-LONDON, V102, P531, DOI 10.1093/aob/mcn136	48	5	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143812	10.1371/journal.pone.0143812	http://dx.doi.org/10.1371/journal.pone.0143812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637125	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800029
J	Dave, JA; Cohen, K; Micklesfield, LK; Maartens, G; Levitt, NS				Dave, Joel A.; Cohen, Karen; Micklesfield, Lisa K.; Maartens, Gary; Levitt, Naomi S.			Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans	PLOS ONE			English	Article							VITAMIN-D STATUS; BODY-COMPOSITION; OSTEOPOROSIS; PREVALENCE; INITIATION; DISEASE; WOMEN	Purpose We determined the prevalence and correlates of low bone mineral density (BMD) in HIV-infected South Africans as there is a paucity of such data from Africa. Methods BMD and serum 25-hydroxyvitamin D were measured in HIV-positive participants on antiretroviral therapy (ART) and in those not yet on ART (ART-naive). Results We enrolled 444 participants [median age 35(IQR: 30, 40) years; 77% women]. BMD was low (z score <-2SD) in 17% and 5% of participants at the lumbar spine and total hip, respectively. Total hip [0.909 (SD 0.123) vs 0.956 (SD 0.124) g/cm(2), p = 0.0001] and neck of femur BMD [0.796 (SD 0.130) vs 0.844 (SD 0.120) g/cm(2), p = 0.0001] were lower in the ART, compared to the ART-naive group. Vitamin D deficiency was present in 15% of participants and was associated with efavirenz use [adjusted OR 2.04 (95% CI 1.01 to 4.13)]. In a multivariate linear regression, exposure to efavirenz or lopinavir-based ART was associated with lower total hip BMD, whereas higher weight, being male and higher vitamin D concentration were associated with higher total hip BMD (adjusted R-2 = 0.28). Age, weight, sex, and the use of efavirenz-based ART were independently associated with lumbar spine BMD (adjusted R-2 = 0.13). Conclusions Vitamin D status, use of efavirenz or lopinavir/ritonavir, weight, age and sex are significantly associated with lower BMD in this young cohort of HIV-infected South Africans.	[Dave, Joel A.; Levitt, Naomi S.] Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, ZA-7925 Cape Town, South Africa; [Cohen, Karen; Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Micklesfield, Lisa K.] Univ Cape Town, UCT MRC Res Unit Exercise Sci & Sports Med, Dept Human Biol, ZA-7925 Cape Town, South Africa; [Micklesfield, Lisa K.] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Fac Hlth Sci, Johannesburg, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; University of Witwatersrand	Dave, JA (corresponding author), Univ Cape Town, Dept Med, Div Diabet Med & Endocrinol, ZA-7925 Cape Town, South Africa.	joel.dave@uct.ac.za	Cohen, Karen/D-4036-2017; Micklesfield, Lisa/AAR-8262-2021; Maartens, Gary/S-2788-2019; Maartens, Gary/F-3836-2014	Micklesfield, Lisa/0000-0002-4994-0779; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Levitt, Naomi/0000-0001-6480-8066; Cohen, Karen/0000-0002-1892-4207; Dave, joel/0000-0003-3084-7408	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa; Medical Research Council/Department for International Development (DFID) African Research Leader Scheme	World Diabetes Foundation; South African Department of Health; National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council/Department for International Development (DFID) African Research Leader Scheme	JAD and NSL received grants from the World Diabetes Foundation and the South African Department of Health. GM acknowledges partial support by the National Research Foundation of South Africa. LKM would like to acknowledge funding from the Medical Research Council/Department for International Development (DFID) African Research Leader Scheme.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Anostos K, 2007, ANTIVIR THER, V12, P1049; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bolland MJ, 2006, CLIN ENDOCRINOL, V65, P191, DOI 10.1111/j.1365-2265.2006.02572.x; Borderi M, 2009, AIDS, V23, P1297, DOI 10.1097/QAD.0b013e32832ce85a; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Calmy A, 2013, OSTEOPOROSIS INT, V24, P1843, DOI 10.1007/s00198-012-2189-1; Calmy A, 2009, J INFECT DIS, V200, P1746, DOI 10.1086/644785; Casado JL, 2014, OSTEOPOROSIS INT, V25, P1071, DOI 10.1007/s00198-013-2506-3; Castronuovo D, 2013, EUR REV MED PHARMACO, V17, P2413; Cervero M, 2012, AIDS RES HUM RETROV, V28, P763, DOI [10.1089/AID.2011.0244, 10.1089/aid.2011.0244]; Cournil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031726; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; Friedenreich CM, 1998, MED SCI SPORT EXER, V30, P266, DOI 10.1097/00005768-199802000-00015; Hamill MM, 2013, OSTEOPOROSIS INT, V24, P2855, DOI 10.1007/s00198-013-2373-y; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; McComsey GA, 2008, CLIN INFECT DIS, V46, P1290, DOI 10.1086/529384; Ofotokun I, 2012, CURR HIV-AIDS REP, V9, P16, DOI 10.1007/s11904-011-0099-z; Panayiotopoulos A, 2013, REV ENDOCR METAB DIS, V14, P119, DOI 10.1007/s11154-013-9246-8; Rothman MS, 2012, CURR OSTEOPOROS REP, V10, P270, DOI 10.1007/s11914-012-0125-0; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Yin MT, 2012, J CLIN ENDOCR METAB, V97, P554, DOI 10.1210/jc.2011-2197	26	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144286	10.1371/journal.pone.0144286	http://dx.doi.org/10.1371/journal.pone.0144286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633015	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000078
J	Emer, C; Vaughan, IP; Hiscock, S; Memmott, J				Emer, Carine; Vaughan, Ian P.; Hiscock, Simon; Memmott, Jane			The Impact of the Invasive Alien Plant, Impatiens glandulifera, on Pollen Transfer Networks	PLOS ONE			English	Article							POLLINATOR NETWORKS; DEPOSITION; VISITATION; ASTERACEAE; TOLERANCE; RECEIPT; SUCCESS; SYSTEMS; SURFACE	Biological invasions are a threat to the maintenance of ecological processes, including pollination. Plant-flower visitor networks are traditionally used as a surrogated for pollination at the community level, despite they do not represent the pollination process, which takes place at the stigma of plants where pollen grains are deposited. Here we investigated whether the invasion of the alien plant Impatiens glandulifera (Balsaminaceae) affects pollen transfer at the community level. We asked whether more alien pollen is deposited on the stigmas of plants on invaded sites, whether deposition is affected by stigma type (dry, semidry and wet) and whether the invasion of I. glandulifera changes the structure of the resulting pollen transfer networks. We sampled stigmas of plants on 10 sites invaded by I. glandulifera (hereafter, balsam) and 10 non-invaded control sites. All 20 networks had interactions with balsam pollen, although significantly more balsam pollen was found on plants with dry stigmas in invaded areas. Balsam pollen deposition was restricted to a small subset of plant species, which is surprising because pollinators are known to carry high loads of balsam pollen. Balsam invasion did not affect the loading of native pollen, nor did it affect pollen transfer network properties; networks were modular and poorly nested, both of which are likely to be related to the specificity of pollen transfer interactions. Our results indicate that pollination networks become more specialized when moving from the flower visitation to the level of pollen transfer networks. Therefore, caution is needed when inferring pollination from patterns of insect visitation or insect pollen loads as the relationship between these and pollen deposition is not straightforward.	[Emer, Carine; Hiscock, Simon; Memmott, Jane] Univ Bristol, Bristol, Avon, England; [Emer, Carine] Univ Estadual Paulista UNESP, Dept Ecol, Rio Claro, Brazil; [Vaughan, Ian P.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Hiscock, Simon] Univ Oxford, Bot Garden, Oxford, England	University of Bristol; Universidade Estadual Paulista; Cardiff University; University of Oxford	Emer, C (corresponding author), Univ Bristol, Bristol Life Sci Bldg, Bristol, Avon, England.	carine.emer@rc.unesp.br	Emer, Carine/I-4741-2015; Vaughan, Ian/A-4782-2010; Emer, Carine/AAB-6912-2020	Emer, Carine/0000-0002-1258-2816; Vaughan, Ian/0000-0002-7263-3822; Emer, Carine/0000-0002-1258-2816; Hiscock, Simon/0000-0003-0954-0540	Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil) [BEX 5706/10-5]	Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CE was funded by a studentship from the Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil), BEX 5706/10-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alberdi A, 2019, MOL ECOL RESOUR, V19, P327, DOI 10.1111/1755-0998.12960; Allen AM, 2011, ANN BOT-LONDON, V108, P687, DOI 10.1093/aob/mcr147; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Ashman TL, 2013, AM J BOT, V100, P1061, DOI 10.3732/ajb.1200496; Bartomeus I, 2008, ANN BOT-LONDON, V102, P417, DOI 10.1093/aob/mcn109; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Cawoy Valerie, 2012, Journal of Pollination Ecology, V10, P130; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Clarke D, 2013, SCIENCE, V340, P66, DOI 10.1126/science.1230883; Da Silva EM, 2011, BOTANY, V89, P141, DOI 10.1139/B11-001; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Fang Q, 2013, ECOLOGY, V94, P1176, DOI 10.1890/12-1634.1; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Gegear RJ, 2004, ETHOLOGY, V110, P793, DOI 10.1111/j.1439-0310.2004.01010.x; Gelman A., 2007, DATA ANAL USING REGR; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P1233, DOI 10.1093/oxfordjournals.aob.a085414; Hiscock SJ, 2002, INT J PLANT SCI, V163, P1, DOI 10.1086/324530; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huang ZH, 2015, J PLANT ECOL, V8, P109, DOI 10.1093/jpe/rtv015; Jakobsson A, 2008, BIOL CONSERV, V141, P136, DOI 10.1016/j.biocon.2007.09.005; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Larson DL, 2006, BIOL CONSERV, V130, P148, DOI 10.1016/j.biocon.2005.12.009; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Matsumoto T, 2010, BIOL INVASIONS, V12, P1617, DOI 10.1007/s10530-009-9574-5; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Montgomery BR, 2012, OECOLOGIA, V168, P449, DOI 10.1007/s00442-011-2094-x; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Raine NE, 2007, ENTOMOL GEN, V30, P191; Sax D. F., 2005, SPECIES INVASIONS IN; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Titze A, 2000, NORD J BOT, V20, P33, DOI 10.1111/j.1756-1051.2000.tb00729.x; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tur C, 2014, J ANIM ECOL, V83, P306, DOI 10.1111/1365-2656.12130; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Zuur Alain F., 2009, P1	56	35	37	10	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143532	10.1371/journal.pone.0143532	http://dx.doi.org/10.1371/journal.pone.0143532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633170	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000366040000016
J	Lyssimachou, A; Santos, JG; Andre, A; Soares, J; Lima, D; Guimaraes, L; Almeida, CMR; Teixeira, C; Castro, LFC; Santos, MM				Lyssimachou, Angeliki; Santos, Joana G.; Andre, Ana; Soares, Joana; Lima, Daniela; Guimaraes, Laura; Almeida, C. Marisa R.; Teixeira, Catarina; Castro, L. Filipe C.; Santos, Miguel M.			The Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of Zebrafish	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; RETINOID-X-RECEPTOR; ORGANOTIN COMPOUNDS; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; ENVIRONMENTAL LEVELS; PRENATAL EXPOSURE; PROTEIN; LIPOTOXICITY; STEATOSIS	Recent findings indicate that different Endocrine Disrupting Chemicals (EDCs) interfere with lipid metabolic pathways in mammals and promote fat accumulation, a previously unknown site of action for these compounds. The antifoulant and environmental pollutant tributyltin (TBT), which causes imposex in gastropod snails, induces an "obesogenic" phenotype in mammals, through the activation of the nuclear receptors retinoid X receptor (RXR) and peroxisome proliferator-activated receptor gamma (PPAR.). In teleosts, the effects of TBT on the lipid metabolism are poorly understood, particularly following exposure to low, environmental concentrations. In this context, the present work shows that exposure of zebrafish to 10 and 50 ng/L of TBT (as Sn) from pre-hatch to 9 months of age alters the body weight, condition factor, hepatosomatic index and hepatic triglycerides in a gender and dose related manner. Furthermore, TBT modulated the transcription of key lipid regulating factors and enzymes involved in adipogenesis, lipogenesis, glucocorticoid metabolism, growth and development in the brain and liver of exposed fish, revealing sexual dimorphic effects in the latter. Overall, the present study shows that the model mammalian obesogen TBT interferes with triglyceride accumulation and the transcriptional regulation of lipid metabolism in zebrafish and indentifies the brain lipogenic transcription profile of fish as a new target of this compound.	[Lyssimachou, Angeliki; Santos, Joana G.; Andre, Ana; Soares, Joana; Lima, Daniela; Guimaraes, Laura; Almeida, C. Marisa R.; Teixeira, Catarina; Castro, L. Filipe C.; Santos, Miguel M.] Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR AL, P-4050123 Oporto, Portugal; [Santos, Miguel M.] Univ Porto, Fac Sci, FCUP Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Lyssimachou, A (corresponding author), Interdisciplinary Ctr Marine & Environm Res, CIMAR CIIMAR AL, Rua Bragas 289, P-4050123 Oporto, Portugal.	angeliki@ciimar.up.pt; filipe.castro@ciimar.up.pt; santos@ciimar.up.pt	Guimaraes, Laura/A-6759-2011; Almeida, C. Marisa/O-8210-2019; Almeida, C. Marisa R./J-6375-2012; Santos, Miguel M./AAD-9267-2021; Soares, Joana/F-5812-2014; Teixeira, Catarina/B-1182-2013; Quality, Aquaculture Seafood/AAD-7718-2019; Castro, Filipe/AAA-2197-2022	Guimaraes, Laura/0000-0003-3360-3783; Almeida, C. Marisa/0000-0002-6836-0331; Almeida, C. Marisa R./0000-0002-6836-0331; Soares, Joana/0000-0002-7105-2815; Teixeira, Catarina/0000-0003-3842-7133; Castro, Filipe/0000-0001-7697-386X; Andre, Ana/0000-0002-0638-8304; Santos, Miguel/0000-0001-7347-0546; Lyssimachou, Angeliki/0000-0003-1438-1222	FCT-Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/115199/2009]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT-Fundacao para a Ciencia e a Tecnologia [PEst-C/MAR/LA0015/2013, SFRH/BPD/74231/2010]; Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/MAR/115199/2009]	FCT-Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This work was supported by FCT-Fundacao para a Ciencia e a Tecnologia (Portugal), through project PTDC/MAR/115199/2009, the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT-Fundacao para a Ciencia e a Tecnologia, under the project "PEst-C/MAR/LA0015/2013" and pos-doctoral fellowship SFRH/BPD/74231/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacao para a Ciencia e a Tecnologia (Portugal), through project PTDC/MAR/115199/2009, the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT-Fundacao para a Ciencia e a Tecnologia, under the project "PEst-C/MAR/LA0015/2013" and posdoctoral fellowship SFRH/BPD/74231/2010. The authors declare they have no actual or potential competing financial interests.	Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Amali AA, 2006, J BIOMED SCI, V13, P225, DOI 10.1007/s11373-005-9055-5; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Briant N, 2013, MAR POLLUT BULL, V73, P78, DOI 10.1016/j.marpolbul.2013.05.038; Calabrese EJ, 2005, TOXICOL APPL PHARM, V204, P1, DOI 10.1016/j.taap.2004.11.015; Carmona-Antonanzas G, 2014, GENE, V534, P1, DOI 10.1016/j.gene.2013.10.040; Carvalho AP, 2006, AQUAC RES, V37, P1107, DOI 10.1111/j.1365-2109.2006.01534.x; Carvalho PN, 2007, MICROCHEM J, V87, P147, DOI 10.1016/j.microc.2007.07.003; Castro LF, AQUAT TOXICOL; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Clement L, PFLUG ARCH EUR J PHY; Cooke GM, 2008, J TOXICOL ENV HEAL A, V71, P384, DOI 10.1080/15287390701801653; Cruz SA, 2010, COMP BIOCHEM PHYS A, V156, P190, DOI 10.1016/j.cbpa.2010.01.019; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Enes P, 2008, COMP BIOCHEM PHYS A, V149, P80, DOI 10.1016/j.cbpa.2007.10.012; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fent K, 1996, CRIT REV TOXICOL, V26, P3, DOI 10.3109/10408449609089891; FENT K, 1993, AQUAT TOXICOL, V24, P219, DOI 10.1016/0166-445X(93)90073-A; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Gumy C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003545; Hanson AM, 2012, AQUACULTURE, V362, P241, DOI 10.1016/j.aquaculture.2010.09.015; Her GM, 2013, BBA-MOL CELL BIOL L, V1831, P1037, DOI 10.1016/j.bbalip.2013.02.002; HOLM G, 1991, J FISH BIOL, V38, P373, DOI 10.1111/j.1095-8649.1991.tb03127.x; Ibabe A, 2005, HISTOCHEM CELL BIOL, V123, P75, DOI 10.1007/s00418-004-0737-2; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Lima D, 2011, AQUAT TOXICOL, V101, P221, DOI 10.1016/j.aquatox.2010.09.022; Liu Q, 2010, GEN COMP ENDOCR, V166, P346, DOI 10.1016/j.ygcen.2009.11.015; Lo JH, 2010, ENDOCRINOLOGY, V151, P2128, DOI 10.1210/en.2009-0960; Luquet Serge, 2009, Front Biosci (Schol Ed), V1, P448; Lyssimachou A, 2006, TOXICOL SCI, V91, P82, DOI 10.1093/toxsci/kfj136; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; McAllister BG, 2003, AQUAT TOXICOL, V65, P309, DOI 10.1016/S0166-445X(03)00154-1; McGinnis CL, 2011, AQUAT TOXICOL, V103, P25, DOI 10.1016/j.aquatox.2011.01.005; Meador JP, 2011, ENVIRON RES, V111, P50, DOI 10.1016/j.envres.2010.11.012; Morcillo Y, 1998, TRAC-TREND ANAL CHEM, V17, P109, DOI 10.1016/S0165-9936(97)00115-5; Moreno-Navarrete J. M., 2012, ADIPOSE TISSUE BIOL, P17, DOI [10.1007/978-1-4614-0965-6_2, DOI 10.1007/978-1-4614-0965-6]; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Nishikawa J, 2004, ENVIRON SCI TECHNOL, V38, P6271, DOI 10.1021/es049593u; Nogueiras R, 2008, REGUL PEPTIDES, V149, P26, DOI 10.1016/j.regpep.2007.09.034; Oberemm A, 2000, LAB ANIMAL, V29, P32; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Pai WY, 2013, TRANSGENIC RES, V22, P823, DOI 10.1007/s11248-012-9685-0; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Pavlikova N, 2010, AQUAT TOXICOL, V99, P176, DOI 10.1016/j.aquatox.2010.04.014; Payne VA, 2007, J BIOL CHEM, V282, P21005, DOI 10.1074/jbc.M702871200; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Porchas MM, 2009, PAN AM JAQ SCI, V4, P58; Radke B, 2013, SOIL SEDIMENT CONTAM, V22, P614, DOI 10.1080/15320383.2013.756448; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ribeiro CAO, 2002, ECOTOX ENVIRON SAFE, V51, P161, DOI 10.1006/eesa.2001.2121; Ribeiro C, 2012, TOXICOL MECH METHOD, V22, P47, DOI 10.3109/15376516.2011.593053; Riu A, HALOGENATED BISPHENO; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Santos MM, 2012, BIOCHEMICAL AND BIOLOGICAL EFFECTS OF ORGANOTINS, P83; Santos MM, 2006, COMP BIOCHEM PHYS C, V142, P151, DOI 10.1016/j.cbpc.2005.11.014; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Shieh YS, 2010, BBA-MOL CELL BIOL L, V1801, P721, DOI 10.1016/j.bbalip.2010.04.008; Shimasaki Y, 2003, ENVIRON TOXICOL CHEM, V22, P141, DOI 10.1002/etc.5620220118; Shimasaki Y, 2008, J FAC AGR KYUSHU U, V53, P67; Si JL, 2011, ENVIRON TOXICOL, V26, P307, DOI 10.1002/tox.20560; SMITH B S, 1971, Proceedings of the Malacological Society of London, V39, P377; Soengas JL, 2002, COMP BIOCHEM PHYS B, V131, P271, DOI 10.1016/S1096-4959(02)00022-2; Sousa A, 2009, CHEMOSPHERE, V77, P566, DOI 10.1016/j.chemosphere.2009.06.049; Tallafuss A, 2006, GENE EXPR PATTERNS, V6, P556, DOI 10.1016/j.modgep.2005.10.005; Tingaud-Sequeira A, 2011, J LIPID RES, V52, P1765, DOI 10.1194/jlr.D017012; Titley-O'Neal CP, 2011, J ENVIRON MONITOR, V13, P2360, DOI 10.1039/c1em10011d; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Weger BD, 2012, ACS CHEM BIOL, V7, P1178, DOI 10.1021/cb3000474; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Yanik SC, 2011, TOXICOL SCI, V122, P476, DOI 10.1093/toxsci/kfr140; Zhang JL, 2013, MAR ENVIRON RES, V90, P113, DOI 10.1016/j.marenvres.2013.06.004; Zhang JL, 2013, CHEMOSPHERE, V90, P1294, DOI 10.1016/j.chemosphere.2012.10.078; Zhang JL, 2009, ENVIRON TOXICOL CHEM, V28, P1528, DOI 10.1897/08-347.1; Zhang W, 2012, ENVIRON SCI TECHNOL, V46, P5175, DOI 10.1021/es300147w; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562; Zuo Z, 2009, ENVIRON TOXICOL, V26, P79, DOI DOI 10.1002/TOX.20531	92	66	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143911	10.1371/journal.pone.0143911	http://dx.doi.org/10.1371/journal.pone.0143911			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633012	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000029
J	Aubrey, W; Riley, MC; Young, M; King, RD; Oliver, SG; Clare, A				Aubrey, Wayne; Riley, Michael C.; Young, Michael; King, Ross D.; Oliver, Stephen G.; Clare, Amanda			A Tool for Multiple Targeted Genome Deletions that Is Precise, Scar-Free, and Suitable for Automation	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; MINIMAL-GENE-SET; SACCHAROMYCES-CEREVISIAE; YEAST; DNA; SYSTEM; REARRANGEMENTS; MANIPULATION; REPLACEMENT; TRANSPORTER	Many advances in synthetic biology require the removal of a large number of genomic elements from a genome. Most existing deletion methods leave behind markers, and as there are a limited number of markers, such methods can only be applied a fixed number of times. Deletion methods that recycle markers generally are either imprecise (remove untargeted sequences), or leave scar sequences which can cause genome instability and rearrangements. No existing marker recycling method is automation-friendly. We have developed a novel openly available deletion tool that consists of: 1) a method for deleting genomic elements that can be repeatedly used without limit, is precise, scar-free, and suitable for automation; and 2) software to design the method's primers. Our tool is sequence agnostic and could be used to delete large numbers of coding sequences, promoter regions, transcription factor binding sites, terminators, etc in a single genome. We have validated our tool on the deletion of non-essential open reading frames (ORFs) from S. cerevisiae. The tool is applicable to arbitrary genomes, and we provide primer sequences for the deletion of: 90% of the ORFs from the S. cerevisiae genome, 88% of the ORFs from S. pombe genome, and 85% of the ORFs from the L. lactis genome.	[Aubrey, Wayne; Clare, Amanda] Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales; [Riley, Michael C.; Young, Michael] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DD, Dyfed, Wales; [King, Ross D.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [King, Ross D.] Univ Manchester, Sch Comp Sci, Manchester M1 7DN, Lancs, England; [Oliver, Stephen G.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1GA, England; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Aberystwyth University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Manchester; University of Manchester; University of Cambridge; University of Cambridge	Aubrey, W (corresponding author), Aberystwyth Univ, Dept Comp Sci, Aberystwyth SY23 3DB, Dyfed, Wales.	waa2@aber.ac.uk	Aubrey, Wayne/AAE-7321-2021; Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; King, Ross/0000-0001-7208-4387; Clare, Amanda/0000-0001-8315-3659	Biotechnology and Biological Sciences Research Council [BB/G024782/1]; BBSRC [BB/F008228/1, BB/G024782/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008228/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), project reference BB/G024782/1 awarded to AC and a PhD funded by Biotechnology and Biological Sciences Research Council to WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Amberg DC., 2005, METHODS YEAST GENETI; BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Campo N, 2002, APPL ENVIRON MICROB, V68, P2359, DOI 10.1128/AEM.68.5.2359-2367.2002; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cross FR, 2011, YEAST, V28, P167, DOI 10.1002/yea.1822; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; David L, 2011, METHODS MOL BIOL, V759, P107, DOI 10.1007/978-1-61779-173-4_7; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Delneri D, 2001, CURR OPIN BIOTECH, V12, P87, DOI 10.1016/S0958-1669(00)00179-8; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Liu HP, 1996, GENETICS, V144, P967; Mans R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov004; Mudge DK, 2012, CURR GENET, V58, P59, DOI 10.1007/s00294-011-0360-4; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Riley MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080156; SAUER B, 1993, METHOD ENZYMOL, V225, P890; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schneider BL, 1996, YEAST, V12, P129, DOI 10.1002/(SICI)1097-0061(199602)12:2<129::AID-YEA891>3.0.CO;2-O; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Solem C, 2008, APPL ENVIRON MICROB, V74, P4772, DOI 10.1128/AEM.00134-08; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Waghmare SK, 2003, BIOTECHNIQUES, V34, P1024, DOI 10.2144/03345rr02; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang LL, 2004, METHODS, V33, P199, DOI 10.1016/j.ymeth.2003.11.014; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xu T, 2011, METHODS MOL BIOL, V765, P207, DOI 10.1007/978-1-61779-197-0_13	45	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142494	10.1371/journal.pone.0142494	http://dx.doi.org/10.1371/journal.pone.0142494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630677	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300011
J	Jiao, HH; Natoll, R; Valter, K; Provis, JM; Rutar, M				Jiao, Haihan; Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.; Rutar, Matt			Spatiotemporal Cadence of Macrophage Polarisation in a Model of Light-Induced Retinal Degeneration	PLOS ONE			English	Article							BONE-MARROW; PHOTORECEPTOR DEGENERATION; MICROGLIAL ACTIVATION; CASPASE-3 ACTIVATION; MACULAR DEGENERATION; MOUSE MODEL; CELLS; INFLAMMATION; RECRUITMENT; EXPRESSION	Background The recruitment of macrophages accompanies almost every pathogenic state of the retina, and their excessive activation in the subretinal space is thought to contribute to the progression of diseases including age-related macular degeneration. Previously, we have shown that macrophages aggregate in the outer retina following damage elicited by photo-oxidative stress, and that inhibition of their recruitment reduces photoreceptor death. Here, we look for functional insight into macrophage activity in this model through the spatiotemporal interplay of macrophage polarisation over the course of degeneration. Methods Rats were exposed to 1000 lux light damage (LD) for 24hrs, with some left to recover for 3 and 7 days post-exposure. Expression and localisation of M1-and M2-macrophage markers was investigated in light-damaged retinas using qPCR, ELISA, flow cytometry, and immunohistochemistry. Results Expression of M1- (Ccl3, Il-6, Il-12, Il-1 beta, TNF alpha) and M2- (CD206, Arg1, Igf1, Lyve1, Clec7a) related markers followed discrete profiles following light damage; up-regulation of M1 genes peaked at the early phase of cell death, while M2 genes generally exhibited more prolonged increases during the chronic phase. Moreover, Il-1 beta and CD206 labelled accumulations of microglia/macrophages which differed in their morphological, temporal, and spatial characteristics following light damage. Conclusions The data illustrate a dynamic shift in macrophage polarisation following light damage through a broad swathe of M1 and M2 markers. Pro-inflammatory M1 activation appears to dominate the early phase of degeneration while M2 responses appear to more heavily mark the chronic post-exposure period. While M1/M2 polarisation represents two extremes amongst a spectrum of macrophage activity, knowledge of their predominance offers insight into functional consequences of macrophage activity over the course of damage, which may inform the spatiotemporal employment of therapeutics in retinal disease.	[Jiao, Haihan; Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.; Rutar, Matt] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Natoll, Riccardo; Valter, Krisztina; Provis, Jan M.] Australian Natl Univ, ANU Med Sch, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Rutar, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	matt.rutar@anu.edu.au	Valter, Krisztina/L-3015-2016; Provis, Jan/C-9529-2009	Valter, Krisztina/0000-0002-2033-0408; Rutar, Matthew/0000-0002-8893-5120; Jiao, Haihan/0000-0002-5404-9307; Natoli, Riccardo/0000-0002-9350-0439; Provis, Jan/0000-0002-6405-2868	National Health and Medical Research Council (NHMRC) Project Grant; Ophthalmic Research Institute of Australia (ORIA)	National Health and Medical Research Council (NHMRC) Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia (ORIA)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant, Chief Investigators: Dr. Krisztina Valter and Prof. Jan Provis, and the Ophthalmic Research Institute of Australia (ORIA), Chief Investigators: Dr. Matt Rutar.	Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Chang CJ, 2005, OPHTHALMIC RES, V37, P202, DOI 10.1159/000086610; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chen M, 2012, GLIA, V60, P833, DOI 10.1002/glia.22315; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Ezzat MK, 2008, BRIT J OPHTHALMOL, V92, P976, DOI 10.1136/bjo.2007.129742; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; HOPPELER T, 1988, CURR EYE RES, V7, P849, DOI 10.3109/02713688808997242; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Ibrahim AS, 2010, MOL VIS, V16, P2033; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kataoka K, 2010, INVEST OPHTHALMOL VI; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kohno H, 2014, J IMMUNOL, V192, P3816, DOI 10.4049/jimmunol.1301738; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Levy O, 2015, EMBO MOL MED; Levy O, 2015, EMBO MOL MED, V7, P211, DOI 10.15252/emmm.201404524; Lewis GP, 2005, MOL VIS, V11, P491; London A, 2013, J IMMUNOL, V190, P3570, DOI 10.4049/jimmunol.1202076; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2013, NEUROBIOL AGING, V34, P2310, DOI 10.1016/j.neurobiolaging.2013.03.022; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Neufeld AH, 2004, BRAIN RES BULL, V62, P455, DOI 10.1016/j.brainresbull.2003.07.005; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Ni YQ, 2008, INVEST OPHTH VIS SCI, V49, P2589, DOI 10.1167/iovs.07-1173; Patel C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00173; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P2379, DOI 10.1167/iovs.10-6010; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; VRABEC F, 1975, A GRAEF ARCH KLIN EX, V196, P49, DOI 10.1007/BF00410026; Wong JG, 2001, INVEST OPHTH VIS SCI, V42, pS227; Yang LP, 2007, MOL VIS, V13, P2048; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65	51	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143952	10.1371/journal.pone.0143952	http://dx.doi.org/10.1371/journal.pone.0143952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630454	Green Published, gold			2022-12-26	WOS:000365926300129
J	Mbang, PA; Kowalkowski, MA; Amirian, ES; Giordano, TP; Richardson, PA; Hartman, CM; Chiao, EY				Mbang, Pamela A.; Kowalkowski, Marc A.; Amirian, E. Susan; Giordano, Thomas P.; Richardson, Peter A.; Hartman, Christine M.; Chiao, Elizabeth Y.			Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among US Male Veterans	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; ANAL CANCER; INTRAEPITHELIAL NEOPLASIA; HIV; RISK; AIDS; PREVALENCE; HAART	Protease inhibitors (PIs) have been shown to have anti-tumor activity in addition to their antiretroviral properties. We sought to assess the association between PI use and the incidence of squamous cell carcinoma of the anus (SCCA) in HIV-infected individuals. We performed a retrospective cohort study among male US veterans diagnosed with HIV who were diagnosed between 1985 and 2010, using the Veterans Affairs HIV Clinical Case Registry (CCR). We calculated hazards ratios associated with PI use (both as percent time on PI and as 12-month intervals of PI use), utilizing time-dependent Cox models. We adjusted for risk factors, including age, race, year of enrolment into CCR, recent and nadir CD4, and percent time undetectable HIV viral load. A total of 28, 886 HIV-infected men met inclusion criteria. Of these, 373 were newly diagnosed with SCCA during the study period. In multivariate analysis, increasing percent time on PIs was associated with an increased risk of SCCA (aHR 1.07; 95% CI = 1.03-1.10 per 10% increase in time on PI). Poor immunologic recovery and virologic control, a history of condylomata acuminata, and CCR enrolment in the late combined antiretroviral therapy era were also associated with increased SCCA risk. Increasing percent time on a PI-based combined antiretroviral therapy regimen may be associated with an increased risk of developing SCCA in HIV-infected male US veterans. Future studies, better accounting for HIV control and treatment compliance, are necessary to further clarify this association.	[Mbang, Pamela A.; Kowalkowski, Marc A.; Giordano, Thomas P.; Richardson, Peter A.; Hartman, Christine M.; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kowalkowski, Marc A.; Giordano, Thomas P.; Richardson, Peter A.; Hartman, Christine M.; Chiao, Elizabeth Y.] Michael E DeBakey VA Med Ctr, Houston Hlth Serv Res & Dev Ctr Innovat Qual,Effe, Houston, TX USA; [Amirian, E. Susan] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Amirian, E. Susan] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Chiao, EY (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	echiao@bcm.edu		Giordano, Thomas/0000-0002-9346-5530; Chiao, Elizabeth/0000-0001-5752-2916	Baylor College of Medicine; National Cancer Institute [K23CA124318]; NATIONAL CANCER INSTITUTE [K23CA124318] Funding Source: NIH RePORTER	Baylor College of Medicine; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This article is the result of work supported with resources and the use of facilities at the Houston Health Services Research and Development Center for Innovations in Quality, Effectiveness and Safety (CIN-13-413), Michael E. DeBakey Veterans Affairs Medical Center, and by a seed fund grant from Baylor College of Medicine. Dr. Chiao received support from the National Cancer Institute (K23CA124318). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, the National Institutes of Health, the Veterans Administration, the US government or Baylor College of Medicine. The National Cancer Institute had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; or the preparation, review or approval of the manuscript.	Andre P, 1998, P NATL ACAD SCI USA, V95, P13120, DOI 10.1073/pnas.95.22.13120; Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Barillari G, 2012, AIDS, V26, P909, DOI 10.1097/QAD.0b013e328351f7a5; Bedimo Roger, 2008, Curr HIV/AIDS Rep, V5, P140, DOI 10.1007/s11904-008-0022-4; Chao C, 2012, AIDS, V26, P2223, DOI 10.1097/QAD.0b013e32835935b3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chaturvedi AK, 2009, JNCI-J NATL CANCER I, V101, P1120, DOI 10.1093/jnci/djp205; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Dauby N, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-16; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Gervaz P, 2011, WORLD J GASTROENTERO, V17, P2987, DOI 10.3748/wjg.v17.i25.2987; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; Hillemanns P, 1996, AIDS, V10, P1641, DOI 10.1097/00002030-199612000-00008; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Pajonk F, 2002, CANCER RES, V62, P5230; Pal A, 2014, CANCER RES, V74, P4955, DOI 10.1158/0008-5472.CAN-14-1211; Palefsky J M, 1998, J Natl Cancer Inst Monogr, P15; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Seaberg EC, 2010, CANCER-AM CANCER SOC, V116, P5507, DOI 10.1002/cncr.25530; Sgadari C, 2003, LANCET ONCOL, V4, P537, DOI 10.1016/S1470-2045(03)01192-6; Sgadari C, 2002, NAT MED, V8, P225, DOI 10.1038/nm0302-225; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Simard EP, 2011, CANCER-AM CANCER SOC, V117, P1089, DOI 10.1002/cncr.25547; Toschi E, 2011, INT J CANCER, V128, P82, DOI 10.1002/ijc.25550; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watson AJM, 2006, ANZ J SURG, V76, P715, DOI 10.1111/j.1445-2197.2006.03837.x; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205	48	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142966	10.1371/journal.pone.0142966	http://dx.doi.org/10.1371/journal.pone.0142966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629701	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300022
J	Papaioannou, A; Kuyucak, S; Kuncic, Z				Papaioannou, Anastasios; Kuyucak, Serdar; Kuncic, Zdenka			Molecular Dynamics Simulations of Insulin: Elucidating the Conformational Changes that Enable Its Binding	PLOS ONE			English	Article							LIGAND-INDUCED ACTIVATION; B-CHAIN; RECEPTOR ECTODOMAIN; BIOLOGICAL-ACTIVITY; ANALOGS; ELEMENT; SITE; RESOLUTION; TERMINUS; CRYSTALS	A sequence of complex conformational changes is required for insulin to bind to the insulin receptor. Recent experimental evidence points to the B chain C-terminal (BC-CT) as the location of these changes in insulin. Here, we present molecular dynamics simulations of insulin that reveal new insights into the structural changes occurring in the BC-CT. We find three key results: 1) The opening of the BC-CT is inherently stochastic and progresses through an open and then a "wide-open" conformation-the wide-open conformation is essential for receptor binding, but occurs only rarely. 2) The BC-CT opens with a zipper-like mechanism, with a hinge at the Phe24 residue, and is maintained in the dominant closed/inactive state by hydrophobic interactions of the neighboring Tyr26, the critical residue where opening of the BC-CT (activation of insulin) is initiated. 3) The mutation Y26N is a potential candidate as a therapeutic insulin analogue. Overall, our results suggest that the binding of insulin to its receptor is a highly dynamic and stochastic process, where initial docking occurs in an open conformation and full binding is facilitated through interactions of insulin receptor residues with insulin in its wide-open conformation.	[Papaioannou, Anastasios; Kuncic, Zdenka] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Papaioannou, Anastasios; Kuyucak, Serdar; Kuncic, Zdenka] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Papaioannou, A (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	a.papaioannou@physics.usyd.edu.au	Kuyucak, Serdar/AAH-8417-2021	Kuncic, Zdenka/0000-0001-6765-3215; Papaioannou, Anastasios/0000-0002-8959-4559; Kuyucak, Serdar/0000-0003-4315-9532	University of Sydney International Scholarship (USydIS)	University of Sydney International Scholarship (USydIS)	AP acknowledges support from a University of Sydney International Scholarship (USydIS). MD simulations were carried out using the Raijin cluster at the National Computational Infrastructure (NCI, Canberra, Australia) and the Avoca cluster at the Victorian Life Sciences Computation Initiative (VLSCI, Melbourne, Australia).	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; De Meyts Pierre, 2007, P1; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Legge FS, 2006, BIOPHYS CHEM, V119, P146, DOI 10.1016/j.bpc.2005.08.002; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mueller-Dieckmann C, 2007, ACTA CRYSTALLOGR D, V63, P366, DOI 10.1107/S0907444906055624; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Vashisth H, 2013, PROTEINS, V81, P1017, DOI 10.1002/prot.24255; Vashisth H, 2010, PROTEINS, V78, P1531, DOI 10.1002/prot.22670; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	33	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144058	10.1371/journal.pone.0144058	http://dx.doi.org/10.1371/journal.pone.0144058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629689	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300152
J	Pedersen, CET; Frandsen, P; Wekesa, SN; Heller, R; Sangula, AK; Wadsworth, J; Knowles, NJ; Muwanika, VB; Siegismund, HR				Pedersen, Casper-Emil T.; Frandsen, Peter; Wekesa, Sabenzia N.; Heller, Rasmus; Sangula, Abraham K.; Wadsworth, Jemma; Knowles, Nick J.; Muwanika, Vincent B.; Siegismund, Hans R.			Time Clustered Sampling Can Inflate the Inferred Substitution Rate in Foot-And-Mouth Disease Virus Analyses	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOSAIC STRUCTURE; RECOMBINATION; SEROTYPE; SEQUENCES; LINEAGES	With the emergence of analytical software for the inference of viral evolution, a number of studies have focused on estimating important parameters such as the substitution rate and the time to the most recent common ancestor (tMRCA) for rapidly evolving viruses. Coupled with an increasing abundance of sequence data sampled under widely different schemes, an effort to keep results consistent and comparable is needed. This study emphasizes commonly disregarded problems in the inference of evolutionary rates in viral sequence data when sampling is unevenly distributed on a temporal scale through a study of the foot-and-mouth (FMD) disease virus serotypes SAT 1 and SAT 2. Our study shows that clustered temporal sampling in phylogenetic analyses of FMD viruses will strongly bias the inferences of substitution rates and tMRCA because the inferred rates in such data sets reflect a rate closer to the mutation rate rather than the substitution rate. Estimating evolutionary parameters from viral sequences should be performed with due consideration of the differences in short-term and longer-term evolutionary processes occurring within sets of temporally sampled viruses, and studies should carefully consider how samples are combined.	[Pedersen, Casper-Emil T.; Frandsen, Peter; Heller, Rasmus; Siegismund, Hans R.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wekesa, Sabenzia N.; Sangula, Abraham K.] Foot & Mouth Dis Lab, Nairobi, Kenya; [Wadsworth, Jemma; Knowles, Nick J.] Pirbright Inst, Pirbright, England; [Muwanika, Vincent B.] Makerere Univ, Dept Environm Management, Coll Agr & Environm Sci, Kampala, Uganda	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Makerere University	Pedersen, CET (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	capedersen@bio.ku.dk	Ibrahim, Essam Hassan/G-1960-2018; Heller, Rasmus/M-2580-2014; Muwanika, Vincent/AGP-2612-2022; Muwanika, Vincent/GQH-5983-2022; Frandsen, Peter/O-3698-2019; Pedersen, Casper-Emil Tingskov/M-5135-2014	Ibrahim, Essam Hassan/0000-0003-0130-2257; Heller, Rasmus/0000-0001-6583-6923; Frandsen, Peter/0000-0001-7131-0944; Pedersen, Casper-Emil Tingskov/0000-0003-2540-5373	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC [10-006KU]; Department for Environment, Food and Rural Affairs (Defra), UK [SE2939, SE2940]; Villum Fonden [00007371] Funding Source: researchfish	Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC; Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA)); Villum Fonden(Villum Fonden)	This work was supported by the Danish International Development Agency (DANIDA) under the Transboundary Animal Diseases in East Africa (TADEA) project, DFC no. 10-006KU. NJK and JW were partially funded by the Department for Environment, Food and Rural Affairs (Defra), UK (contract numbers SE2939 and SE2940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2005, CURR TOP MICROBIOL, V288, P9; Bari FD, 2014, VACCINE, V32, P5794, DOI 10.1016/j.vaccine.2014.08.033; Bastos ADS, 2001, ARCH VIROL, V146, P1537, DOI 10.1007/s007050170077; Binder H, 2005, SCHWEIZ ARCH TIERH, V147, P0143, DOI [10.1024/0036-7281.147.3.143a, DOI 10.1024/0036-7281.147.3.143A]; BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Di Nardo A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0090-y; Drummond A, 2007, TRACER V1 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2015, MOL BIOL EVOL, V32, P1895, DOI 10.1093/molbev/msv056; Duchene S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0732; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Jackson AL, 2007, J GEN VIROL, V88, P487, DOI 10.1099/vir.0.82555-0; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Murray GGR, 2015, METHODS ECOL EVOL; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roeder P, 2009, GLOB CONTROL FMD TOO; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Sangula AK, 2011, EPIDEMIOL INFECT, V139, P189, DOI 10.1017/S0950268810000580; Sangula AK, 2010, ARCH VIROL, V155, P1625, DOI 10.1007/s00705-010-0742-9; Schierup MH, 2000, GENETICS, V156, P879; SMITH JM, 1992, J MOL EVOL, V34, P126; Valdazo-Gonzalez B, 2012, J VIROL, V86, P8901, DOI 10.1128/JVI.01231-12; Vosloo W, 1996, J GEN VIROL, V77, P1457, DOI 10.1099/0022-1317-77-7-1457; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wekesa SN, 2014, INFECT GENET EVOL, V21, P408, DOI 10.1016/j.meegid.2013.12.006	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143605	10.1371/journal.pone.0143605	http://dx.doi.org/10.1371/journal.pone.0143605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630483	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300069
J	Poly, F; Serichantalergs, O; Kuroiwa, J; Pootong, P; Mason, C; Guerry, P; Parker, CT				Poly, Frederic; Serichantalergs, Oralak; Kuroiwa, Janelle; Pootong, Piyarat; Mason, Carl; Guerry, Patricia; Parker, Craig T.			Updated Campylobacter jejuni Capsule PCR Multiplex Typing System and Its Application to Clinical Isolates from South and Southeast Asia	PLOS ONE			English	Article							POLYSACCHARIDE CONJUGATE VACCINE; IRRITABLE-BOWEL-SYNDROME; GENOME SEQUENCE; DIVERSITY; SEROTYPE; IDENTIFICATION; OUTBREAK; CHILDREN; THAILAND; STRAIN	Campylobacter jejuni produces a polysaccharide capsule that is the major determinant of the Penner serotyping scheme. This passive slide agglutination typing system was developed in the early 1980's and was recognized for over two decades as the gold standard for C. jejuni typing. A preliminary multiplex PCR technique covering 17 serotypes was previously developed in order to replace this classic serotyping scheme. Here we report the completion of the multiplex PCR technology that is able to identify all the 47 Penner serotypes types known for C. jejuni. The number of capsule types represented within the 47 serotypes is 35. We have applied this method to a collection of 996 clinical isolates from Thailand, Cambodia and Nepal and were able to successfully determine capsule types of 98% of these.	[Poly, Frederic; Kuroiwa, Janelle; Guerry, Patricia] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Serichantalergs, Oralak; Pootong, Piyarat; Mason, Carl] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Parker, Craig T.] ARS, USDA, Albany, CA USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Agriculture (USDA)	Poly, F (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA.	frederic.m.poly.ctr@mail.mil	Mason, Carl J/F-3538-2010; Mason, Carl/ABH-3298-2021	Mason, Carl J/0000-0002-3676-2811; Mason, Carl/0000-0002-3676-2811; Parker, Craig/0000-0002-7719-8882	U.S. Naval Medical Research and Development Command Work Unit [6000.RAD1.DA3.A0308]; US department of agriculture-Agricultural Research Service [CRIS 5325-42000-047]; Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC	U.S. Naval Medical Research and Development Command Work Unit; US department of agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC	This work was supported by U.S. Naval Medical Research and Development Command Work Unit 6000.RAD1.DA3.A0308 (FP JK PP PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. US department of agriculture-Agricultural Research Service, CRIS 5325-42000-047 (CTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Military Infectious Diseases Research Program, Walter Reed Army Institute of Research, Washington, DC (OS PP CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Bertolo L, 2013, CARBOHYD RES, V366, P45, DOI 10.1016/j.carres.2012.11.017; Chen YH, 2008, CARBOHYD RES, V343, P1034, DOI 10.1016/j.carres.2008.02.024; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Grant AJ, 2005, APPL ENVIRON MICROB, V71, P8031, DOI 10.1128/AEM.71.12.8031-8041.2005; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Keo T, 2011, VIRULENCE, V2, P30, DOI 10.4161/viru.2.1.14752; Klena JD, 2004, J CLIN MICROBIOL, V42, P5549, DOI 10.1128/JCM.42.12.5549-5557.2004; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lee G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002036; Lesinski Gregory B., 2001, Current Drug Targets - Infectious Disorders, V1, P325, DOI 10.2174/1568005014605964; Maue AC, 2014, HUM VACC IMMUNOTHER, V10, P1499, DOI 10.4161/hv.27985; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; Pike BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067375; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Poly F, 2011, J CLIN MICROBIOL, V49, P1750, DOI 10.1128/JCM.02348-10; Pope JE, 2007, SEMIN ARTHRITIS RHEU; PRESTON MA, 1989, CAN J MICROBIOL, V35, P265, DOI 10.1139/m89-040; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Serichantalergs O, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-15; STEELE TW, 1984, PATHOLOGY, V16, P263, DOI 10.3109/00313028409068535; TAYLOR DN, 1988, J CLIN MICROBIOL, V26, P863, DOI 10.1128/JCM.26.5.863-868.1988; Thabane M, 2010, AM J GASTROENTEROL, V105, P933, DOI 10.1038/ajg.2010.74; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Alphen LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087051; Vugia D., 2007, Morbidity and Mortality Weekly Report, V56, P336	45	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144349	10.1371/journal.pone.0144349	http://dx.doi.org/10.1371/journal.pone.0144349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630669	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300181
J	Ponce-de-Leon, M; Calle-Espinosa, J; Pereto, J; Montero, F				Ponce-de-Leon, Miguel; Calle-Espinosa, Jorge; Pereto, Juli; Montero, Francisco			Consistency Analysis of Genome-Scale Models of Bacterial Metabolism: A Metamodel Approach	PLOS ONE			English	Article							FLUX COUPLING ANALYSIS; NETWORK RECONSTRUCTION; PATHWAY DATABASES; ORPHAN ENZYMES; SYSTEMS; ANNOTATION; OPTIMIZATION; GENERATION; PREDICTION; BALANCE	Genome-scale metabolic models usually contain inconsistencies that manifest as blocked reactions and gap metabolites. With the purpose to detect recurrent inconsistencies in metabolic models, a large-scale analysis was performed using a previously published dataset of 130 genome-scale models. The results showed that a large number of reactions (similar to 22%) are blocked in all the models where they are present. To unravel the nature of such inconsistencies a metamodel was construed by joining the 130 models in a single network. This metamodel was manually curated using the unconnected modules approach, and then, it was used as a reference network to perform a gap-filling on each individual genome-scale model. Finally, a set of 36 models that had not been considered during the construction of the metamodel was used, as a proof of concept, to extend the metamodel with new biochemical information, and to assess its impact on gap-filling results. The analysis performed on the metamodel allowed to conclude: 1) the recurrent inconsistencies found in the models were already present in the metabolic database used during the reconstructions process; 2) the presence of inconsistencies in a metabolic database can be propagated to the reconstructed models; 3) there are reactions not manifested as blocked which are active as a consequence of some classes of artifacts, and; 4) the results of an automatic gap-filling are highly dependent on the consistency and completeness of the metamodel or metabolic database used as the reference network. In conclusion the consistency analysis should be applied to metabolic databases in order to detect and fill gaps as well as to detect and remove artifacts and redundant information.	[Ponce-de-Leon, Miguel; Calle-Espinosa, Jorge; Montero, Francisco] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, Madrid 28045, Spain; [Pereto, Juli] Univ Valencia, Dept Bioquim & Biol Mol, Paterna 46980, Spain; [Pereto, Juli] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Paterna 46980, Spain	Complutense University of Madrid; University of Valencia; University of Valencia	Ponce-de-Leon, M (corresponding author), Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol 1, Ciudad Univ, Madrid 28045, Spain.	migponce@ucm.es	Peretó, Juli/G-5969-2015; Montero, Francisco/G-9850-2015; Ponce-de-Leon, Miguel/AAB-8124-2020	Peretó, Juli/0000-0002-5756-1517; Montero, Francisco/0000-0003-2366-3635; Ponce-de-Leon, Miguel/0000-0002-7496-844X; Calle-Espinosa, Jorge/0000-0003-2090-2768	Spanish Government - FEDER funds and Ministerio de Economia y Competitividad [BFU2012-39816-C02-01]; Generalitat Valenciana [PROMETEOII/2014/065]; Obra Social Programme of La Caixa Savings Bank	Spanish Government - FEDER funds and Ministerio de Economia y Competitividad; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Obra Social Programme of La Caixa Savings Bank	Financial support from Spanish Government (grant reference: BFU2012-39816-C02-01 co-financed by FEDER funds and Ministerio de Economia y Competitividad) and Generalitat Valenciana (grant reference: PROMETEOII/2014/065) is grateful acknowledged. Also, we obtained support from a doctoral fellowship granted to JCE from the Obra Social Programme of La Caixa Savings Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Brooks J. Paul, 2012, Advances in Bioinformatics, V2012, P323472, DOI 10.1155/2012/323472; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Haggart CR, 2011, METHOD ENZYMOL, V500, P411, DOI 10.1016/B978-0-12-385118-5.00021-9; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Heinrich R, 1998, BIOSYSTEMS, V47, P61, DOI 10.1016/S0303-2647(98)00013-6; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ish-Am O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123785; Johansson P, 1999, MICROBIOL-SGM, V145, P529, DOI 10.1099/13500872-145-3-529; Jones E., SCIPY OPEN SOURCE SC; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 1998, TRENDS BIOCHEM SCI, V23, P114, DOI 10.1016/S0968-0004(98)01184-0; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Latendresse M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-225; Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681; Lee NR, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-61; Lespinet O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-436; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Mackie A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075210; Mahadevan R, 2005, BIOPHYS J, V88, pL7, DOI 10.1529/biophysj.104.055723; Marashi SA, 2011, BIOSYSTEMS, V103, P57, DOI 10.1016/j.biosystems.2010.09.011; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pah AR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01695; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Ponce-de-Leon M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-114; Poolman MG, 2007, J THEOR BIOL, V249, P691, DOI 10.1016/j.jtbi.2007.08.005; Price ND, 2002, BIOPHYS J, V83, P2879, DOI 10.1016/S0006-3495(02)75297-1; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Thiele I, 2014, BIOINFORMATICS, V30, P2529, DOI 10.1093/bioinformatics/btu321; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Vlassis N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003424; Yamada T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.13; yWorks, 2013, YED GRAPH ED; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112	62	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143626	10.1371/journal.pone.0143626	http://dx.doi.org/10.1371/journal.pone.0143626			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629901	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300074
J	Rubenstein, R; Chang, BG; Petersen, R; Chiu, A; Davies, P				Rubenstein, Richard; Chang, Binggong; Petersen, Robert; Chiu, Allen; Davies, Peter			T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE-INFECTED MICE; CEREBROSPINAL-FLUID; PHOSPHORYLATED-TAU; DIFFERENT STRAINS; ME7 MODEL; PROTEIN; AGENT; PRP; DEGENERATION	Synaptic abnormalities are prominent in prion disease pathogenesis and are responsible for functional deficits. The microtubule associated protein, Tau, binds to and stabilizes microtubules in axons ensuring axonal transport of synaptic components. Tau phosphorylation reduces its affinity for microtubules leading to their instability and resulting in disrupted axonal transport and synaptic dysfunction. We report on the levels of total Tau (T-Tau) and phosphorylated Tau (P-Tau), measured by highly sensitive laser-based immunoassays, in the central nervous system and biofluids from experimentally transmitted prion disease in mice and natural cases of sporadic Creutzfeldt-Jakob Disease (sCJD) in humans. We found that, in contrast to sCJD where only the levels of T-Tau in brain are increased, both T-Tau and P-Tau are increased in the brains of symptomatic mice experimentally infected with the ME7, 139A and 22L mouse-adapted scrapie strains. The increased levels of T-Tau in sCJD brain, compared to control samples, were also observed in patient plasma. In contrast, there was no detectable increase in T-Tau and P-Tau in plasma from symptomatic experimentally infected mice. Furthermore, our data suggests that in mice showing clinical signs of prion disease the levels and/or ratios of T-Tau and P-Tau are only a useful parameter for differentiating the mouse-adapted scrapie strains that differ in the extent of disease. We conclude that the neuropathogenesis associated with P-Tau and synaptic dysfunction is similar for at least two of the mouse-adapted scrapie strains tested but may differ between sporadic and experimentally transmitted prion diseases.	[Rubenstein, Richard; Chang, Binggong; Chiu, Allen] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Petersen, Robert] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Res Alzheimers Dis, Manhasset, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Case Western Reserve University; Northwell Health	Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	Petersen, Robert/B-5075-2011	Petersen, Robert/0000-0002-3154-0072	State University of New York Downstate Medical Center; Los Alamos National Laboratories; NATIONAL INSTITUTE ON AGING [R01AG022102, R37AG022102] Funding Source: NIH RePORTER	State University of New York Downstate Medical Center; Los Alamos National Laboratories(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the State University of New York Downstate Medical Center (RR) and Los Alamos National Laboratories (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Asuni AA, 2010, BIOCHEM SOC T, V38, P545, DOI 10.1042/BST0380545; Bautista MJ, 2006, VET MICROBIOL, V115, P293, DOI 10.1016/j.vetmic.2006.02.017; Belichenko PV, 2000, NEUROPATH APPL NEURO, V26, P143, DOI 10.1046/j.1365-2990.2000.026002143.x; Blennow K, 2005, INT J MOL MED, V16, P1147; Brown D, 2001, NEUROREPORT, V12, P179, DOI 10.1097/00001756-200101220-00043; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Carp R I, 1989, Prog Clin Biol Res, V317, P567; CARP RI, 1984, INTERVIROLOGY, V21, P61, DOI 10.1159/000149503; Chang BG, 2009, J VIROL METHODS, V159, P15, DOI 10.1016/j.jviromet.2009.02.019; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; DICKINSON AG, 1988, CIBA F SYMP, V135, P63; DICKINSON AG, 1977, SLOW VIRUS INFECTION, P3; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Giaccone G, 2008, NEUROBIOL AGING, V29, P1864, DOI 10.1016/j.neurobiolaging.2007.04.026; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ishizawa K, 2002, ACTA NEUROPATHOL, V104, P342, DOI 10.1007/s00401-002-0547-3; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kascsak R J, 1991, Curr Top Microbiol Immunol, V172, P139; KASCSAK RJ, 1986, J VIROL, V59, P676, DOI 10.1128/JVI.59.3.676-683.1986; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; KIM YS, 1988, P SOC EXP BIOL MED, V189, P21; KIMBERLIN RH, 1983, J NEUROL SCI, V59, P355, DOI 10.1016/0022-510X(83)90021-7; Kunzi V, 2002, J NEUROSCI, V22, P7471; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Noguchi-Shinohara M, 2011, J NEUROL, V258, P1464, DOI 10.1007/s00415-011-5960-x; Riemenschneider M, 2003, MOL PSYCHIATR, V8, P343, DOI 10.1038/sj.mp.4001220; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Sarac H, 2008, COLLEGIUM ANTROPOL, V32, P199; Skillback T, 2014, JAMA NEUROL, V71, P476, DOI 10.1001/jamaneurol.2013.6455; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Everbroeck B, 2002, J NEUROL NEUROSUR PS, V73, P79, DOI 10.1136/jnnp.73.1.79; Wang XF, 2008, MOL CELL BIOCHEM, V310, P49, DOI 10.1007/s11010-007-9664-6; WISNIEWSKI HM, 1983, J NEUROPATH EXP NEUR, V42, P615, DOI 10.1097/00005072-198311000-00002	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143103	10.1371/journal.pone.0143103	http://dx.doi.org/10.1371/journal.pone.0143103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630676	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300031
J	Wang, JL; Li, HC; He, YW; Zhou, Y; Meng, JX; Zhu, WY; Chen, HY; Liao, DF; Man, YP				Wang, Jinglin; Li, Huachun; He, Yuwen; Zhou, Yang; Meng, Jingxing; Zhu, Wuyang; Chen, Hongyu; Liao, Defang; Man, Yunping			Isolation and Genetic Characterization of Mangshi Virus: A Newly Discovered Seadornavirus of the Reoviridae Family Found in Yunnan Province, China	PLOS ONE			English	Article							BANNA-VIRUS; BLUETONGUE; MOSQUITOS; IDENTIFICATION; COLTIVIRUSES; GENOME; BORNE	Background Seadornavirus is a genus of viruses in the family Reoviridae, which consists of Banna virus, Kadipiro virus, and Liao ning virus. Banna virus is considered a potential pathogen for zoonotic diseases. Here, we describe a newly discovered Seadornavirus isolated from mosquitos (Culex tritaeniorhynchus) in Yunnan Province, China, which is related to Banna virus, and referred to as Mangshi virus. Methods and Results The Mangshi virus was isolated by cell culture in Aedes albopictus C6/36 cells, in which it replicated and caused cytopathic effects, but not in mammalian BHK-21 or Vero cells. Polyacrylamide gel analysis revealed a genome consisting of 12 segments of double-stranded RNA, with a "6-4-2" pattern in which the migrating bands were different from those of the Banna virus. Complete genome sequencing was performed by full-length amplification of cDNAs. Sequence analysis showed that seven highly conserved nucleotides and three highly conserved nucleotides were present at the ends of the 5'- and 3'-UTRs in each of 12 genome segments. The amino acid identities of Mangshi virus shared with Balaton virus varied from 27.3%(VP11) to 72.3%(VP1) with Banna virus varying from 18.0%(VP11) to 63.9%(VP1). Phylogenetic analysis based on amino acid sequences demonstrated that Mangshi virus is a member of the genus Seadornavirus and is most closely related to, but distinct from, Balaton virus and Banna virus in the genus Seadornavirus of the family Reoviridae. Conclusion Mangshi virus isolated from mosquitoes (C. tritaeniorhynchus) was identified as a newly discovered virus in the genus Seadornavirus and is phylogenetically close to Banna virus, suggesting that there is genetic diversity of seadornaviruses in tropical and subtropical areas of Southeast Asia.	[Wang, Jinglin; Li, Huachun; He, Yuwen; Zhou, Yang; Meng, Jingxing; Chen, Hongyu; Liao, Defang; Man, Yunping] Yunnan Anim Sci & Vet Inst, Yunnan Trop & Subtrop Anim Viral Dis Lab, Kunming, Yunnan Province, Peoples R China; [Wang, Jinglin] State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zhu, Wuyang] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, JL (corresponding author), Yunnan Anim Sci & Vet Inst, Yunnan Trop & Subtrop Anim Viral Dis Lab, Kunming, Yunnan Province, Peoples R China.	Wangjl107@163.com; li_huachun@hotmail.com	chen, hongyu/HHS-4314-2022		open foundation of State Key Laboratory of veterinary disease pathogen biology [SKLVEB2013KFKT016]; National Natural Science Foundation of China [31460669]; Special Fund for Agro-scientific Research in the Public Interest [201303035]	open foundation of State Key Laboratory of veterinary disease pathogen biology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work is supported by grants from the open foundation of State Key Laboratory of veterinary disease pathogen biology (SKLVEB2013KFKT016), National Natural Science Foundation of China (31460669) and Special Fund for Agro-scientific Research in the Public Interest (201303035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0; Attoui H, 2005, EMERG INFECT DIS, V11, P1673, DOI 10.3201/eid1111.050868; Attoui H, 2010, VIRUS TAXONOMY, P497; Attoui H., 2005, VIRUS TAXONOMY, P504; BROWN SE, 1993, VIROLOGY, V196, P363, DOI 10.1006/viro.1993.1490; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Jaafar FM, 2005, J GEN VIROL, V86, P1141, DOI 10.1099/vir.0.80579-0; Jones RW, 2003, J CLIN VIROL, V26, P347, DOI 10.1016/S1386-6532(02)00086-0; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; Li QiPing (et al.), 1992, Endemic Diseases Bulletin, V7, P64; Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; MOSS SR, 1992, J GEN VIROL, V73, P2585, DOI 10.1099/0022-1317-73-10-2585; Nabeshima T, 2008, EMERG INFECT DIS, V14, P1276, DOI 10.3201/eid1408.080100; Omran MH, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10521; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Reuter G, 2013, ARCH VIROL, V158, P2163, DOI 10.1007/s00705-013-1712-9; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; XU LH, 2002, ZHONGGUO BING DU XUE, V17, P385; Xu PuTing, 1990, Chinese Journal of Virology, V6, P27	21	22	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143601	10.1371/journal.pone.0143601	http://dx.doi.org/10.1371/journal.pone.0143601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630378	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300068
J	Yao, Y; Zeng, QX; Deng, XQ; Tang, GN; Guo, JB; Sun, YQ; Ru, K; Rizzo, AN; Shi, JB; Fu, QL				Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Rizzo, Alicia N.; Shi, Jian-Bo; Fu, Qing-Ling			Connexin 43 Upregulation in Mouse Lungs during Ovalbumin-Induced Asthma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INNATE LYMPHOID-CELLS; AIRWAY INFLAMMATION; GAP-JUNCTIONS; CHANNELS; EXPRESSION; EPITHELIUM; DISEASE; CANCER	Background Connexin (Cx)-based gap junction channels play important roles in the inflammatory response. Cx43 is involved in the pathogenesis of some lung diseases such as acute lung injury. However, the Cx43 expression in asthma is unclear. In the present study, we used a murine model of ovalbumin (OVA)-induced allergic airway disease to examine the levels of Cx43 and analyze the relationship between Cx43 and airway inflammation in allergic airway disease. Methods Asthma was induced in mice via sensitization and challenge with OVA. Cx43 mRNA and protein expression levels were investigated via QT-PCR, western blot, and immunohistochemistry 0 h, 8 h, 1 d, 2 d and 4 d after the first challenge. The relationship between Cx43 protein levels and inflammatory cell infiltration, cytokine levels was analyzed. Results The OVA-induced mice exhibited typical pathological features of asthma, including airway hyper-responsiveness; strong inflammatory cell infiltration surrounding the bronchia and vessels; many inflammatory cells in the bronchoalveolar lavage fluid (BALF); higher IL-4, IL5 and IL-13 levels; and high OVA specific IgE levels. Low Cx43 expression was detected in the lungs of control (PBS) mice. A dramatic increase in the Cx43 mRNA and protein levels was found in the asthmatic mice. Cx43 mRNA and protein expression levels increased in a time-dependent manner in asthma mice, and Cx43 was mostly localized in the alveolar and bronchial epithelial layers. Moreover, lung Cx43 protein levels showed a significant positive correlation with inflammatory cell infiltration in the airway and IL-4 and IL-5 levels in the BALF at different time points after challenge. Interestingly, the increase in Cx43 mRNA and protein levels occurred prior to the appearance of the inflammatory cell infiltration. Conclusion Our data suggest that there is a strong upregulation of Cx43 mRNA and protein levels in the lungs in asthma. Cx43 levels also exhibited a positive correlation with allergic airway inflammation. Cx43 may represent a target to treat allergic airway diseases in the future.	[Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Shi, Jian-Bo; Fu, Qing-Ling] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Yin; Zeng, Qing-Xiang; Deng, Xue-Quan; Tang, Guan-Nan; Guo, Jie-Bo; Sun, Yue-Qi; Ru, Kun; Shi, Jian-Bo; Fu, Qing-Ling] Sun Yat Sen Univ, Otorhinolaryngol Inst, Guangzhou 510275, Guangdong, Peoples R China; [Rizzo, Alicia N.] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Sun Yat Sen University; Sun Yat Sen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fu, QL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolaryngol Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fuqingl@mail.sysu.edu.cn	Sun, Yueqi/N-4528-2018	Sun, Yueqi/0000-0002-2382-0429; Yin, Yao/0000-0002-5833-5263; Rizzo, Alicia/0000-0001-9289-4635	NSFC [81322012, NCET-13-0608, 81373174, 81170896, 81272062, 81273212, 81471832]; Science and Technology Foundation of Guangdong Province, China [2011B031800243, 2012B031800045, 2015B020226002]; Fundamental Research Funds for the Central Universities [13ykzd07]; Industry Foundation of the Ministry of Health of China [201202005]	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Guangdong Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Industry Foundation of the Ministry of Health of China	This study was supported by grants from the NSFC for Excellent Young Scholars (81322012 to Prof. QL Fu), NCET-13-0608 for Prof. QL Fu, NSFC (81373174, 81170896, 81272062, 81273212 and 81471832), the Science and Technology Foundation of Guangdong Province, China (2011B031800243, 2012B031800045 and 2015B020226002), the Fundamental Research Funds for the Central Universities (13ykzd07) and the Industry Foundation of the Ministry of Health of China (201202005).	Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051268; Cruciani V, 2007, BIOL CHEM, V388, P253, DOI 10.1515/BC.2007.028; Deckers J, 2013, TRENDS IMMUNOL, V34, P540, DOI 10.1016/j.it.2013.08.004; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jinn Y, 1998, CANCER LETT, V127, P161, DOI 10.1016/S0304-3835(98)00032-9; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Losa D, 2011, EXPERT OPIN THER TAR, V15, P989, DOI 10.1517/14728222.2011.584875; Ma KT, 2014, HYPERTENS RES, V37, P110, DOI 10.1038/hr.2013.120; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Ogawa K, 2012, CANCER SCI, V103, P860, DOI 10.1111/j.1349-7006.2012.02228.x; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Park SJ, 2007, EXP MOL MED, V39, P629, DOI 10.1038/emm.2007.69; Parthasarathi K, 2006, J CLIN INVEST, V116, P2193, DOI 10.1172/JCI26605; Saab JB, 2014, FEBS LETT, V588, P1288, DOI 10.1016/j.febslet.2014.02.059; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sarieddine MZR, 2009, J CELL MOL MED, V13, P4560, DOI 10.1111/j.1582-4934.2008.00654.x; Scheckenbach KEL, 2011, J VASC RES, V48, P91, DOI 10.1159/000316942; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Yeh TH, 2005, AM J RHINOL, V19, P59, DOI 10.1177/194589240501900110; Yu S, 2014, J ALLERGY CLIN IMMUN, V133, P943, DOI 10.1016/j.jaci.2014.02.015	34	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144106	10.1371/journal.pone.0144106	http://dx.doi.org/10.1371/journal.pone.0144106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630490	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300159
J	Lauterbach, MA; Ronzitti, E; Sternberg, JR; Wyart, C; Emiliani, V				Lauterbach, Marcel A.; Ronzitti, Emiliano; Sternberg, Jenna R.; Wyart, Claire; Emiliani, Valentina			Fast Calcium Imaging with Optical Sectioning via HiLo Microscopy	PLOS ONE			English	Article							VISUALIZATION; INDICATOR; LIGHT	Imaging intracellular calcium concentration via reporters that change their fluorescence properties upon binding of calcium, referred to as calcium imaging, has revolutionized our way to probe neuronal activity non-invasively. To reach neurons densely located deep in the tissue, optical sectioning at high rate of acquisition is necessary but difficult to achieve in a cost effective manner. Here we implement an accessible solution relying on HiLo microscopy to provide robust optical sectioning with a high frame rate in vivo. We show that large calcium signals can be recorded from dense neuronal populations at high acquisition rates. We quantify the optical sectioning capabilities and demonstrate the benefits of HiLo microscopy compared to wide-field microscopy for calcium imaging and 3D reconstruction. We apply HiLo microscopy to functional calcium imaging at 100 frames per second deep in biological tissues. This approach enables us to discriminate neuronal activity of motor neurons from different depths in the spinal cord of zebrafish embryos. We observe distinct time courses of calcium signals in somata and axons. We show that our method enables to remove large fluctuations of the background fluorescence. All together our setup can be implemented to provide efficient optical sectioning in vivo at low cost on a wide range of existing microscopes.	[Lauterbach, Marcel A.; Ronzitti, Emiliano; Emiliani, Valentina] Univ Paris 05, Sorbonne Paris Cite, Wavefront Engn Microscopy Grp, Neurophoton Lab,CNRS,UMR8250, Paris, France; [Sternberg, Jenna R.; Wyart, Claire] Univ Paris 06, Sorbonne Paris Cite, UMR S 1127, ICM,INSERM,U1127,CNRS,UMR 7225, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Emiliani, V (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Wavefront Engn Microscopy Grp, Neurophoton Lab,CNRS,UMR8250, Paris, France.	valentina.emiliani@parisdescartes.fr	Wyart, Claire/AAB-4603-2020; Wyart, Claire/H-3783-2016	Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Emiliani, Valentina/0000-0003-2992-9510; Sternberg, Jenna/0000-0002-4005-3743; Ronzitti, Emiliano/0000-0002-3146-7880	eople Programme (Marie Curie Actions) of European Union's Seventh Framework Programme [PIEF-GA2011-297917]; network Ecole des Neurosciences de Paris (ENP); INSERM; CNRS; Marie Curie Actions Framework Program 6 [277200]; European Research Council (ERC) starter [311673]; Human Frontier Science Program [RGP0013/2010]; "Fondation pour la Recherche Medicale" through the program "FRM equipe" the "Agence Nationale de la Recherche" [ANR-10-INSB-04-01]; National Institutes of Health [NIH 1-U01-NS090501-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090501] Funding Source: NIH RePORTER	eople Programme (Marie Curie Actions) of European Union's Seventh Framework Programme; network Ecole des Neurosciences de Paris (ENP); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Marie Curie Actions Framework Program 6; European Research Council (ERC) starter(European Research Council (ERC)); Human Frontier Science Program(Human Frontier Science Program); "Fondation pour la Recherche Medicale" through the program "FRM equipe" the "Agence Nationale de la Recherche"(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.A.L. received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/20072013) under REA grant agreement no. PIEF-GA2011-297917. E.R. acknowledges the "Fondation pour la Recherche Medicale". This work received financial support from the network Ecole des Neurosciences de Paris (ENP), the Atip/Avenir junior program from INSERM and CNRS, the International Reintegration Grant from Marie Curie Actions Framework Program 6 # 277200, and the European Research Council (ERC) starter grant "OptoLoco" # 311673.; This work was supported by the Human Frontier Science Program (RGP0013/2010), the "Fondation pour la Recherche Medicale" through the program "FRM equipe" the "Agence Nationale de la Recherche" (and ANR-10-INSB-04-01, France-BioImaging Infrastructure network), the FRC and the Rotary Club through the program "Espoir en Tete" 2012 and the National Institutes of Health (NIH 1-U01-NS090501-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Fidelin K, CURRENT BIO IN PRESS; Ford TN, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021105; Goodman JW, 2010, SPECKLE PHENOMENA OP; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Lim D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528656; Marvin M., 1961, US Patent, Patent No. [3013467, 3,013,467]; Masson A, 2014, OPT EXPRESS, V22, P1243, DOI 10.1364/OE.22.001243; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Muro E, 2011, BIOPHYS J, V100, P2810, DOI 10.1016/j.bpj.2011.03.047; MURPHY PK, 1986, J OPT SOC AM A, V3, P215, DOI 10.1364/JOSAA.3.000215; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Santos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130266; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Warp E, 2012, CURR BIOL, V22, P93, DOI 10.1016/j.cub.2011.12.002; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wilson T, 2011, J MICROSC-OXFORD, V242, P111, DOI 10.1111/j.1365-2818.2010.03457.x	29	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143681	10.1371/journal.pone.0143681	http://dx.doi.org/10.1371/journal.pone.0143681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625116	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600042
J	Du, YZ; Nomura, Y; Zhorov, BS; Dong, K				Du, Yuzhe; Nomura, Yoshiko; Zhorov, Boris S.; Dong, Ke			Evidence for Dual Binding Sites for 1,1,1-Trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) in Insect Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRETHROID-RECEPTOR-SITES; CRYSTAL-STRUCTURE; ION CHANNELS; MUTATIONS; PERMETHRIN; POTASSIUM; MECHANISM; LINKER	1,1,1-Trichloro-2,2-bis(p-chlorophenyl) ethane (DDT), the first organochlorine insecticide, and pyrethroid insecticides are sodium channel agonists. Although the use of DDT is banned in most of the world due to its detrimental impact on the ecosystem, indoor residual spraying of DDT is still recommended for malaria control in Africa. Development of resistance to DDT and pyrethroids is a serious global obstacle for managing disease vectors. Mapping DDT binding sites is necessary for understanding mechanisms of resistance and modulation of sodium channels by structurally different ligands. The pioneering model of the housefly sodium channel visualized the first receptor for pyrethroids, PyR1, in the II/III domain interface and suggested thatDDTbinds within PyR1. Previously, we proposed the second pyrethroid receptor, PyR2, at the I/II domain interface. However, whether DDT binds to both pyrethroid receptor sites remains unknown. Here, using computational docking of DDT into the Kv1.2-based mosquito sodium channel model, we predict that two DDT molecules can bind simultaneously within PyR1 and PyR2. The bulky trichloromethyl group of each DDT molecule fits snugly between four helices in the bent domain interface, whereas two p-chlorophenyl rings extend into two wings of the interface. Model-driven mutagenesis and electrophysiological analysis confirmed these propositions and revealed 10 previously unknown DDT-sensing residues within PyR1 and PyR2. Our study proposes a dual DDT-receptor model and provides a structural background for rational development of new insecticides.	[Du, Yuzhe; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA; [Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia	Michigan State University; McMaster University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dong, K (corresponding author), Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA.; Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.; Zhorov, BS (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.	zhorov@mcmaster.ca; dongk@msu.edu	Zhorov, Boris S./V-8072-2019; Zhorov, Boris/T-9892-2019	Zhorov, Boris/0000-0002-3630-7114	National Institutes of Health from NIGMS [GM057440]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04894]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM057440 from NIGMS (to K. D. and B. S. Z.) and the Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2014-04894 (to B. S. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Davies T. G. E., 2009, Bayer CropScience Journal, V62, P159; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Du YZ, 2015, MOL PHARMACOL, V88, P273, DOI 10.1124/mol.115.098707; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Rinkevich FD, 2015, NEUROTOXICOLOGY, V47, P99, DOI 10.1016/j.neuro.2015.02.001; Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7; Soderlund D.M., 2005, P1; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; Usherwood PNR, 2005, FEBS LETT, V579, P6317, DOI 10.1016/j.febslet.2005.09.096; Vais H, 2000, FEBS LETT, V470, P135, DOI 10.1016/S0014-5793(00)01305-3; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Wang LX, 2015, MOL PHARMACOL, V87, P421, DOI 10.1124/mol.114.094730; Wang SY, 2001, MOL PHARMACOL, V60, P620; Wrzesinska B, 2014, INSECT MOL BIOL, V23, P682, DOI 10.1111/imb.12112; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x	33	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4638	4648		10.1074/jbc.M115.678672	http://dx.doi.org/10.1074/jbc.M115.678672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26637352	hybrid, Green Published			2022-12-26	WOS:000371604600031
J	Carrella, S; Barbato, S; D'Agostino, Y; Salierno, FG; Manfredi, A; Banfi, S; Conte, I				Carrella, Sabrina; Barbato, Sara; D'Agostino, Ylenia; Salierno, Francesco Giuseppe; Manfredi, Anna; Banfi, Sandro; Conte, Ivan			TGF-beta Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CHEMOTROPIC RESPONSES; ORYZIAS-LATIPES; IN-VIVO; EXPRESSION; NEURONS; MECHANISMS; PROMOTE; MEDAKA; CONES	Retinal axon specification and growth are critically sensitive to the dosage of numerous signaling molecules and transcription factors. Subtle variations in the expression levels of key molecules may result in a variety of axonal growth anomalies. miR-181a and miR-181b are two eye-enriched microRNAs whose inactivation in medaka fish leads to alterations of the proper establishment of connectivity and function in the visual system. miR-181a/b are fundamental regulators of MAPK signaling and their role in retinal axon growth and specification is just beginning to be elucidated. Here we demonstrate that miR-181a/b are key nodes in the interplay between TGF-beta and MAPK/ERK within the functional pathways that control retinal axon specification and growth. Using a variety of in vivo and in vitro approaches in medaka fish, we demonstrate that TGF-beta signaling controls the miR-181/ERK regulatory network, which in turn strengthens the TGF-beta-mediated regulation of RhoA degradation. Significantly, these data uncover the role of TGF-beta signaling in vivo, for the first time, in defining the correct wiring and assembly of functional retina neural circuits and further highlight miR-181a/b as key factors in axon specification and growth.	[Carrella, Sabrina; Barbato, Sara; D'Agostino, Ylenia; Salierno, Francesco Giuseppe; Manfredi, Anna; Banfi, Sandro; Conte, Ivan] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Banfi, Sandro] Univ Naples 2, Med Genet, Dipartimento Biochim Biofis & Patol Generale, I-80138 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli	Banfi, S (corresponding author), Telethon Inst Genet & Med, Via Campi Flegrei 34, I-80078 Naples, Italy.	banfi@tigem.it; conte@tigem.it	Manfredi, Anna/ABC-8588-2021; Banfi, Sandro/K-3963-2018; Carrella, Sabrina/AAD-3103-2020	Banfi, Sandro/0000-0002-6541-8833; D'Agostino, Ylenia/0000-0002-1890-6682; Conte, Ivan/0000-0002-8968-9021; Carrella, Sabrina/0000-0002-3302-1698	Italian Telethon Foundation [TGM11SB2]	Italian Telethon Foundation(Fondazione Telethon)	This study was supported by the Italian Telethon Foundation (GRANT TGM11SB2 to SB), www.telethon.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avellino R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061099; Baudet ML, 2013, SEMIN CELL DEV BIOL, V24, P146, DOI 10.1016/j.semcdb.2012.11.004; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Braunger BM, 2013, J NEUROSCI, V33, P14246, DOI 10.1523/JNEUROSCI.0991-13.2013; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Carrella S, 2015, DEV NEUROBIOL, V75, P1252, DOI 10.1002/dneu.22282; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Close JL, 2005, DEVELOPMENT, V132, P3015, DOI 10.1242/dev.01882; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Conte I, 2014, NUCLEIC ACIDS RES, V42, P7793, DOI 10.1093/nar/gku498; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Del Bene F, 2007, PLOS GENET, V3, P1661, DOI 10.1371/journal.pgen.0030159; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duenker N, 2005, INT REV CYTOL, V245, P17, DOI 10.1016/S0074-7696(05)45002-0; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Harada T, 2007, GENE DEV, V21, P367, DOI 10.1101/gad.1504307; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Hocking JC, 2008, MOL CELL NEUROSCI, V37, P247, DOI 10.1016/j.mcn.2007.09.011; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kerrison JB, 2005, MOL VIS, V11, P208; Kim IJ, 2004, J NEUROSCI, V24, P3304, DOI 10.1523/JNEUROSCI.3286-03.2004; Kita EM, 2013, DEVELOPMENT, V140, P2933, DOI 10.1242/dev.088286; Kitambi SS, 2008, DEV DYNAM, V237, P3870, DOI 10.1002/dvdy.21797; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Murali D, 2011, INVEST OPHTH VIS SCI, V52, P2930, DOI 10.1167/iovs.10-5940; Neel JC, 2013, CELL SIGNAL, V25, P1556, DOI 10.1016/j.cellsig.2013.03.013; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Trousse F, 2001, J NEUROSCI, V21, P1292; Walshe TE, 2011, NEUROSCIENCE, V189, P123, DOI 10.1016/j.neuroscience.2011.05.020; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	48	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144129	10.1371/journal.pone.0144129	http://dx.doi.org/10.1371/journal.pone.0144129			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641497	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700059
J	Liu, Y; Kimura, K; Orita, T; Sonoda, KH				Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Sonoda, Koh-Hei			Necrosis-Induced Sterile Inflammation Mediated by Interleukin-1 alpha in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MOLECULAR-PATTERNS; GENE-EXPRESSION; IL-1-ALPHA; FIBROBLASTS; ACTIVATION; MECHANISMS	Endogenous danger signals released from necrotic cells contribute to retinal inflammation. We have now investigated the effects of necrotic cell extracts prepared from ARPE-19 human retinal pigment epithelial cells (ANCE) on the release of proinflammatory cytokines and chemokines by healthy ARPE-19 cells. ANCE were prepared by subjection of ARPE-19 cells to freeze-thaw cycles. The release of various cytokines and chemokines from ARPE-19 cells was measured with a multiplex assay system or enzyme-linked immunosorbent assays. The expression of interleukin (IL)-1 alpha and the phosphorylation and degradation of the endogenous nuclear factor-kappa B (NF-kappa B) inhibitor I kappa B-alpha were examined by immunoblot analysis. Among the various cytokines and chemokines examined, we found that ANCE markedly stimulated the release of the proinflammatory cytokine IL-6 and the chemokines IL-8 and monocyte chemoattractant protein (MCP)-1 by ARPE-19 cells. ANCE-induced IL-6, IL-8, and MCP-1 release was inhibited by IL-1 receptor antagonist and by an IKK2 inhibitor (a blocker of NF-kappa B signaling) in a concentration-dependent manner, but was not affected by a pan-caspase inhibitor (Z-VAD-FMK). Recombinant IL-1 alpha also induced the secretion of IL-6, IL-8, and MCP-1 from ARPE-19 cells, and IL-1 alpha was detected in ANCE. Furthermore, ANCE induced the phosphorylation and degradation of I kappa B-alpha in ARPE-19 cells. Our findings thus suggest that IL-1 alpha is an important danger signal that is released from necrotic retinal pigment epithelial cells and triggers proinflammatory cytokine and chemokine secretion from intact cells in a manner dependent on NF-kappa B signaling. IL-1 alpha is therefore a potential therapeutic target for amelioration of sterile inflammation in the retina.	[Liu, Yang; Kimura, Kazuhiro; Orita, Tomoko; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan; [Liu, Yang] Jilin Univ, Hosp 1, Dept Ophthalmol, Jilin, Peoples R China	Yamaguchi University; Jilin University	Kimura, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan.	k.kimura@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS; National Science Foundation of China [81100635]; Grants-in-Aid for Scientific Research [26861453, 26462663] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JSPS, to K.S. and Y.L.), by a JSPS postdoctoral fellowship for foreign researchers (Y.L.), and by a grant (no. 81100635) from the National Science Foundation of China (Y.L.).	Abe T, 1999, TOHOKU J EXP MED, V189, P179, DOI 10.1620/tjem.189.179; Arimura N, 2009, LAB INVEST, V89, P278, DOI 10.1038/labinvest.2008.165; Cascella R, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/582842; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Gao JY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/690243; Horn F, 2000, IMMUNOBIOLOGY, V202, P151, DOI 10.1016/S0171-2985(00)80061-3; Juel HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064619; Kawano H, 2014, LAB INVEST, V94, P569, DOI 10.1038/labinvest.2014.46; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P565, DOI 10.1167/iovs.07-0419; Kimura K, 2012, EXP EYE RES, V96, P157, DOI 10.1016/j.exer.2011.10.015; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe9; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Luo Y, 2006, INVEST OPHTH VIS SCI, V47, P3644, DOI 10.1167/iovs.06-0166; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Monteleone M, 2015, CYTOKINE, V74, P213, DOI 10.1016/j.cyto.2015.03.022; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; Owen LA, 2013, CURR DIABETES REP, V13, P476, DOI 10.1007/s11892-013-0382-z; Qin SF, 2011, EXP EYE RES, V93, P889, DOI 10.1016/j.exer.2011.10.002; Qiu YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14362; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rubartelli A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00398; Scarpa M, 2015, AM J PATHOL, V185, P1624, DOI 10.1016/j.ajpath.2015.02.018; SHYY YJ, 1993, BIOCHEM BIOPH RES CO, V192, P693, DOI 10.1006/bbrc.1993.1470; Skeie JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127567; Srivastava SK, 2009, EXP EYE RES, V88, P2, DOI 10.1016/j.exer.2008.03.012; Tian J, 2005, BRIT J OPHTHALMOL, V89, P1510, DOI 10.1136/bjo.2005.072108; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144460	10.1371/journal.pone.0144460	http://dx.doi.org/10.1371/journal.pone.0144460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641100	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700129
J	Liu, YM; Jia, LY; Liu, BB; Meng, XF; Yang, J; Li, JZ; Zhou, YH; Jiao, LQ; Hua, Y				Liu, Yumei; Jia, Lingyun; Liu, Beibei; Meng, Xiufeng; Yang, Jie; Li, Jingzhi; Zhou, Yinghua; Jiao, Liqun; Hua, Yang			Evaluation of Endarterectomy Recanalization under Ultrasound Guidance in Symptomatic Patients with Carotid Artery Occlusion	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; IMAGING-BASED SELECTION; PLASMINOGEN-ACTIVATOR; THROMBUS; THROMBOENDARTERECTOMY; THROMBOLYSIS	Rigorous screening and good imaging would help perform surgery on carotid artery occlusion CAO safely and effectively. The purpose of this study was to retrospectively evaluate carotid endarterectomy (CEA) recanalization in patients with common carotid artery occlusion (CCAO) or internal carotid artery occlusion (ICAO) with color Doppler flow imaging (CDFI). A total of 59 patients undergoing CEA were enrolled. According to the results of CEA, the patients were divided into successful recanalization (group A) and unsuccessful recanalization (group B) groups. The original diameter, lesion length, proximal-to-distal diameter ratio and echo characteristics of the lesion within the lumen of the carotid artery were recorded before CEA and compared between the two groups. In regards to the achievement of repatency by CEA, the overall success rate was 74.6% (44/59), the success rate in CCAO patients was 75.9% (22/29) and the success rate in ICAO patients was 73.3% (22/30). There was no significant difference in the success rates between the CCAO and ICAO patients (chi(2) = 0.050, P = 0.824). The overall rate of stroke and death within 30 postoperative days was 5.1% (3/59). For the CCAO patients, the lesion length in group A was shorter than that in group B (t = 3.221, P = 0.004). For the ICAO patients, the original diameter of the distal ICA was broader (t = 6.254, P = 0.000) and the proximal-to-distal ICA diameter ratio was smaller (t = 8.036, P = 0.000) in group A than in group B. The rate of recanalization for lumens with a homogeneous echo pattern (hypoecho or isoecho) was significantly higher than that for lumens with echo heterogeneity for both the CCAO and ICAO patients (chi(2) = 14.477, P = 0.001; chi(2) = 10.519, P = 0.003). However, for both the CCAO and ICAO patients, there was no difference in the rate of recanalization between patients with hypoecho and isoecho lesions (chi(2) = 0.109, P = 0.742; chi(2) = 0.836, P = 0.429). The original diameter, proximal-to-distal ICA diameter ratio, lesion length and echo characteristics may affect the success of CEA recanalization in patients with CCAO and ICAO. CDFI is helpful in screening patients with carotid artery occlusion and may improve the success rate of CEA.	[Liu, Yumei; Jia, Lingyun; Liu, Beibei; Meng, Xiufeng; Yang, Jie; Li, Jingzhi; Zhou, Yinghua; Hua, Yang] Capital Med Univ, Xuanwu Hosp, Dept Vasc Ultrasonog, Beijing, Peoples R China; [Jiao, Liqun] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Hua, Y (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Vasc Ultrasonog, Beijing, Peoples R China.	dryanghua99@163.com	hua, yang/GSE-0594-2022; Jiao, Liqun/T-5944-2017; Jiao, Liqun/AAF-9351-2020	Liu, Yumei/0000-0001-8372-0537				ARCHIE JP, 1994, J VASC SURG, V19, P23, DOI 10.1016/S0741-5214(94)70117-2; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Bryan DS, 2013, ANN VASC SURG, V27, P186, DOI 10.1016/j.avsg.2012.03.010; Demchuk AM, 2012, ANN NY ACAD SCI, V1268, P63, DOI 10.1111/j.1749-6632.2012.06732.x; Duijsens HM, 2015, J NEUROINTERV SURG, V7, P709, DOI 10.1136/neurintsurg-2014-011297; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; HUGENHOLTZ H, 1980, J NEUROSURG, V53, P776, DOI 10.3171/jns.1980.53.6.0776; Kappelhof M, 2015, J NEUROINTERV SURG, V7, P8, DOI 10.1136/neurintsurg-2013-011004; Kirchhof K, 2004, ROFO-FORTSCHR RONTG, V176, P98; Kniemeyer HW, 2007, CHIRURG, V78, P236, DOI 10.1007/s00104-006-1287-z; Kwak HS, 2013, AM J NEURORADIOL, V34, P841, DOI 10.3174/ajnr.A3304; Lee Tsong-Hai, 1992, Journal of the Formosan Medical Association, V91, P575; Li Q, 2015, J STROKE CEREBROVASC, V24, P1591, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.028; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Marder VJ, 2006, STROKE, V37, P2086, DOI 10.1161/01.STR.0000230307.03438.94; Marquering HA, 2013, CLIN NEUROL NEUROSUR, V115, P1591, DOI 10.1016/j.clineuro.2013.02.008; Mazur S H, 2012, Klin Khir, P20; MEYER FB, 1986, ANN SURG, V203, P82, DOI 10.1097/00000658-198601000-00014; Morais LT, 2013, J NEUROINTERV SURG, V5, P13, DOI 10.1136/neurintsurg-2013-010733; Morgenstern LB, 1997, NEUROLOGY, V48, P911, DOI 10.1212/WNL.48.4.911; Nielubowiczowa H, 1982, Neurol Neurochir Pol, V16, P153; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Riedel CH, 2010, STROKE, V41, P1659, DOI 10.1161/STROKEAHA.110.580662; SHUCART WA, 1976, J NEUROSURG, V45, P442, DOI 10.3171/jns.1976.45.4.0442; Weis-Muller BT, 2013, ANN VASC SURG, V27, P424, DOI 10.1016/j.avsg.2012.05.023	25	3	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144381	10.1371/journal.pone.0144381	http://dx.doi.org/10.1371/journal.pone.0144381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636827	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800083
J	Tay, SH; Ho, CS; Ho, RCM; Mak, A				Tay, Sen Hee; Ho, Chung Shun; Ho, Roger Chun-Man; Mak, Anselm			25-Hydroxyvitamin D-3 Deficiency Independently Predicts Cognitive Impairment in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; DISEASE-ACTIVITY; CHINESE PATIENTS; D-RECEPTOR; DYSFUNCTION; ABNORMALITIES; PATHOGENESIS; VALIDATION; DEMENTIA; CRITERIA	Objectives Cognitive dysfunction has been reported in 20-80% of SLE patients. Converging evidence has indicated the importance of vitamin D as a neuroimmunomodulator for cognitive function. In this study, we evaluated the relationship between vitamin D and cognitive dysfunction. Methods Consecutive age-and gender-matched SLE patients and healthy controls (HCs) were administered Automated Neuropsychological Assessment Metrics in this cross-sectional study. The primary outcome was the total throughput score (TTS). Anxiety and depression were measured using the Hospital Anxiety and Depression Scale (HADS). Levels of 25hydroxyvitamin D [25(OH)D-3 and total 25(OH)D] were measured using Liquid Chromatography-Tandem Mass Spectrometry. Results In total, 61 SLE patients and 61 HCs were studied. SLE patients scored significantly lower than HCs in the TTS (p = 0.004). There were no statistically significant differences in 25 (OH)D-3 levels, total 25(OH)D levels and total 25(OH) D deficiency between SLE patients and HCs. However, more SLE patients had 25(OH)D-3 deficiency compared to HCs [12 (19.7%) versus 2 (3.3%), p = 0.003]. Deficiency of 25(OH)D-3 (beta = -63.667, SE = 27.456, p = 0.025), but not other vitamin D variables, independently predicted worse TTS after adjusting for age, education, gender, ethnicity, HADS-Total, duration of SLE, SELENA-SLEDAI, SLICC/ACR Damage Index and cumulative steroid dose in SLE patients. Age (beta = -4.261, SE = 0.866, p < 0.001) was the only predictor of TTS after adjusting for education, gender, ethnicity, HADS-Total, vitamin D levels or status in HCs. Conclusions Deficiency of 25(OH)D-3, a potentially modifiable risk factor, independently predicted cognitive impairment in SLE patients.	[Tay, Sen Hee; Mak, Anselm] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Tay, Sen Hee; Mak, Anselm] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Med, Div Rheumatol, Singapore, Singapore; [Ho, Chung Shun] Chinese Univ Hong Kong, Dept Chem Pathol, Biomed Mass Spectrometry Unit, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Ho, Roger Chun-Man] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; Chinese University of Hong Kong; Prince of Wales Hospital; National University of Singapore	Tay, SH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	sen_hee_tay@nuhs.edu.sg	Ho, Roger C./ABD-9061-2021; Ho, Roger/ABD-8859-2021	Ho, Roger C./0000-0001-9629-4493; Tay, Sen Hee/0000-0002-7907-5288				Amital H, 2010, ANN RHEUM DIS, V69, P1155, DOI 10.1136/ard.2009.120329; Annweiler C, 2014, EUR J NEUROL, V21, P1436, DOI 10.1111/ene.12511; Annweiler C, 2009, EUR J NEUROL, V16, P1083, DOI 10.1111/j.1468-1331.2009.02755.x; Annweiler C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-230; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; Antonchak MA, 2011, J RHEUMATOL, V38, P1020, DOI 10.3899/jrheum.100560; Aranow C, 2015, ARTHRITIS RHEUMATOL, V67, P1848, DOI 10.1002/art.39108; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Brunner HI, 2013, ARTHRIT CARE RES, V65, P372, DOI 10.1002/acr.21835; Buell JS, 2009, J GERONTOL A-BIOL, V64, P888, DOI 10.1093/gerona/glp032; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hanly JG, 2015, ARTHRITIS RHEUMATOL, V67, P1837, DOI 10.1002/art.39111; Hanly JG, 2014, NAT REV RHEUMATOL, V10, P338, DOI 10.1038/nrrheum.2014.15; Hanly JG, 2012, J RHEUMATOL, V39, P1371, DOI 10.3899/jrheum.111504; Hanly JG, 2010, ARTHRITIS RHEUM-US, V62, P1478, DOI 10.1002/art.27404; Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Houghton LA, 2006, AM J CLIN NUTR, V84, P694, DOI 10.1093/ajcn/84.4.694; Jeltsch-David H, 2014, NAT REV NEUROL, V10, P579, DOI 10.1038/nrneurol.2014.148; Johansson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081989; Kozora E, 2008, ARTHRITIS RHEUM-US, V58, P3286, DOI 10.1002/art.23991; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; McGrath J, 2001, TRENDS NEUROSCI, V24, P570, DOI 10.1016/S0166-2236(00)01949-4; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Mikdashi J, 2007, LUPUS, V16, P418, DOI 10.1177/0961203307079044; Mok CC, 2012, LUPUS, V21, P36, DOI 10.1177/0961203311422094; Mok CC, 2012, RHEUMATOLOGY, V51, P644, DOI 10.1093/rheumatology/ker212; Ong L, 2012, CLIN CHIM ACTA, V413, P1127, DOI 10.1016/j.cca.2012.03.009; Panopalis P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1453, DOI 10.1002/art.23090; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2008, J RHEUMATOL, V35, P1776; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1865, DOI 10.1002/art.37953; Przybelski R, 2008, OSTEOPOROSIS INT, V19, P1621, DOI 10.1007/s00198-008-0619-x; Ramage AE, 2011, ARTHRITIS RHEUM-US, V63, P3048, DOI 10.1002/art.30458; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Robinson AB, 2012, J PEDIATR-US, V160, P297, DOI 10.1016/j.jpeds.2011.08.011; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Sarbu N, 2015, AUTOIMMUN REV, V14, P153, DOI 10.1016/j.autrev.2014.11.001; Stewart A, 2010, BEHAV PHARMACOL, V21, P420, DOI 10.1097/FBP.0b013e32833c850f; Tam LS, 2008, J RHEUMATOL, V35, P1038; Tay SH, 2015, LUPUS, V24, P1392, DOI 10.1177/0961203315591026; Tay SH, 2015, INT J MOL SCI, V16, P10281, DOI 10.3390/ijms160510281; Yap KS, 2015, INT J RHEUM DIS, V18, P242, DOI 10.1111/1756-185X.12489	54	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144149	10.1371/journal.pone.0144149	http://dx.doi.org/10.1371/journal.pone.0144149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636681	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800047
J	Albuquerque, CP; Yeung, E; Ma, S; Fu, T; Corbett, KD; Zhou, HL				Albuquerque, Claudio P.; Yeung, Eyan; Ma, Shawn; Fu, Ting; Corbett, Kevin D.; Zhou, Huilin			A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation	PLOS ONE			English	Article							PROTEIN SUMOYLATION; CONJUGATING ENZYME; SUMO CONJUGATION; DNA-REPAIR; UBIQUITIN; UBC9; IDENTIFICATION; CONTRIBUTES; ATTACHMENT; INSIGHTS	A variety of cellular pathways are regulated by protein modifications with ubiquitin-family proteins. SUMO, the Small Ubiquitin-like MOdifier, is covalently attached to lysine on target proteins via a cascade reaction catalyzed by E1, E2, and E3 enzymes. A major barrier to understanding the diverse regulatory roles of SUMO has been a lack of suitable methods to identify protein sumoylation sites. Here we developed a mass-spectrometry (MS) based approach combining chemical and enzymatic modifications to identify sumoylation sites. We applied this method to analyze the auto-sumoylation of the E1 enzyme in vitro and compared it to the GG-remnant method using Smt3-I96R as a substrate. We further examined the effect of smt3-I96R mutation in vivo and performed a proteome-wide analysis of protein sumoylation sites in Saccharomyces cerevisiae. To validate these findings, we confirmed several sumoylation sites of Aos1 and Uba2 in vivo. Together, these results demonstrate that our chemical and enzymatic method for identifying protein sumoylation sites provides a useful tool and that a combination of methods allows a detailed analysis of protein sumoylation sites.	[Albuquerque, Claudio P.; Yeung, Eyan; Ma, Shawn; Fu, Ting; Corbett, Kevin D.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Corbett, Kevin D.; Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Corbett, Kevin/0000-0001-5854-2388; Fu, Ting/0000-0003-0936-732X; Ma, Shawn/0000-0002-6286-1194; Zhou, Huilin/0000-0002-1350-4430	Ludwig Institute for Cancer Research [GM116897, GM104141]; Sidney Kimmel Foundation Kimmel Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897, R01GM104141] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; Sidney Kimmel Foundation Kimmel Scholars Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HZ is supported by the Ludwig Institute for Cancer Research and GM116897. KDC acknowledges support from the Ludwig Institute for Cancer Research, GM104141 and the Sidney Kimmel Foundation Kimmel Scholars Program.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Chicooree N, 2013, RAPID COMMUN MASS SP, V27, P2108, DOI 10.1002/rcm.6670; Chicooree N, 2013, RAPID COMMUN MASS SP, V27, P127, DOI 10.1002/rcm.6425; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hang LE, 2014, J BIOL CHEM, V289, P10308, DOI 10.1074/jbc.M113.526178; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Truong K, 2012, J BIOL CHEM, V287, P42611, DOI 10.1074/jbc.M112.420877; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Putnam C. D., 2010, COLD SPRING HARB PRO, V2010; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sarangi P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004899; Sarangi P, 2014, CELL REP, V9, P143, DOI 10.1016/j.celrep.2014.08.054; Sterner DE, 2006, BIOCHEMISTRY-US, V45, P1035, DOI 10.1021/bi051624q; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Vigasova D, 2013, NUCLEIC ACIDS RES, V41, P5341, DOI 10.1093/nar/gkt236; Wang JG, 2010, 2010 INTERNATIONAL CONFERENCE ON INFORMATION, ELECTRONIC AND COMPUTER SCIENCE, VOLS 1-3, P5; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143810	10.1371/journal.pone.0143810	http://dx.doi.org/10.1371/journal.pone.0143810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633173	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000023
J	Dehnhard, M; Kumar, V; Chandrasekhar, M; Jewgenow, K; Umapathy, G				Dehnhard, Martin; Kumar, Vinod; Chandrasekhar, Mithileshwari; Jewgenow, Katarina; Umapathy, Govindhaswamy			Non-Invasive Pregnancy Diagnosis in Big Cats using the PGFM (13,14-dihydro-15-keto-PGF(2 alpha)) Assay	PLOS ONE			English	Article							OVARIAN ACTIVITY; REPRODUCTIVE STATUS; ENZYME-IMMUNOASSAY; NONDOMESTIC FELIDS; METABOLISM; URINARY; RELAXIN; WILD; RADIOIMMUNOASSAY; PROGESTERONE	Non-invasive monitoring of hormones using feces has become a vital tool for reproductive management and reliable pregnancy diagnosis in big cats. Previous studies described the PGF(2 alpha) metabolite (PGFM) as an indicator of pregnancy in various feline species. The present study aimed to standardize pregnancy detection in big cats like the tiger (Panthera tigris), jaguar (Panthera onca) and lion (Panthera leo) using fecal samples. High-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LCMS) were performed to identify PGFM in feces. An EIA developed against 9 alpha, 11 alpha-dihydroxy-15-oxo-prost-5-en-1-oic acid-BSA was used to assay PGFM in fecal samples of the Bengal tiger, Asiatic lion and jaguar. The PGFM levels increased after 9 weeks of pregnancy and remained elevated until parturition. All animals showed elevated levels of PGFM in the last trimester of pregnancy, thus making PGFM a reliable tool for pregnancy diagnosis during this period that can be useful in captive breeding programs in these species.	[Dehnhard, Martin; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res IZW, Dept Reprod Biol, D-10315 Berlin, Germany; [Kumar, Vinod; Chandrasekhar, Mithileshwari; Umapathy, Govindhaswamy] Ctr Cellular & Mol Biol, CSIR Lab Conservat Endangered Species, Hyderabad 500007, Andhra Pradesh, India	Leibniz Institut fur Zoo und Wildtierforschung; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Umapathy, G (corresponding author), Ctr Cellular & Mol Biol, CSIR Lab Conservat Endangered Species, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	guma@ccmb.res.in		Kumar, Vinod/0000-0002-1409-770X; Jewgenow, Katarina/0000-0002-6173-840X; Umapathy, Govindhaswamy/0000-0003-4086-7445	Department of Science and Technology; Central Zoo Authority of India, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Central Zoo Authority of India, Government of India	This study was funded by the Department of Science and Technology and Central Zoo Authority of India, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Department of Science and Technology and Central Zoo Authority of India, Government of India. We thank the chief wildlife warden of Andhra Pradesh Government and the curator of Nehru Zoological Park, Hyderabad for granting permission for sample collection. Manuscript editing was performed by Barry Bavister.	Baan M, 2008, THERIOGENOLOGY, V69, P399, DOI 10.1016/j.theriogenology.2007.10.008; BARONE MA, 1994, J REPROD FERTIL, V101, P103, DOI 10.1530/jrf.0.1010103; Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; Bergfelt DR, 2014, THERIOGENOLOGY, V82, P1187, DOI 10.1016/j.theriogenology.2014.07.030; Braun BC, 2009, THERIOGENOLOGY, V71, P754, DOI 10.1016/j.theriogenology.2008.09.054; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; Brown JL, 2011, ANIM REPROD SCI, V124, P155, DOI 10.1016/j.anireprosci.2010.08.024; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; DASHMAN T, 1987, PROSTAGLANDINS, V33, P419, DOI 10.1016/0090-6980(87)90023-2; Dehnhard M, 2008, REPROD DOMEST ANIM, V43, P74, DOI 10.1111/j.1439-0531.2008.01145.x; Dehnhard M, 2014, THERIOGENOLOGY, V81, P733, DOI 10.1016/j.theriogenology.2013.12.007; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; Dehnhard M, 2003, J STEROID BIOCHEM, V84, P383, DOI 10.1016/S0960-0760(03)00056-6; DIMOV V, 1990, DRUG METAB DISPOS, V18, P107; Fanson KV, 2010, GEN COMP ENDOCR, V169, P217, DOI 10.1016/j.ygcen.2010.09.003; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Ginther OJ, 2007, BIOL REPROD, V76, P506, DOI 10.1095/biolreprod.106.057653; Graham LH, 2006, GEN COMP ENDOCR, V147, P362, DOI 10.1016/j.ygcen.2006.02.008; Harris LA, 2008, J ZOO WILDLIFE MED, V39, P170, DOI 10.1638/2007-0093R.1; Kumar V, 2014, GEN COMP ENDOCR, V201, P37, DOI 10.1016/j.ygcen.2014.03.024; LASLEY BL, 1991, J ZOO WILDLIFE MED, V22, P23; Lawson DM., 1985, HDB PHARM METHODOLOG, P385; Lee J, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100438; Li HW, 1999, P NATL ACAD SCI USA, V96, P13381, DOI 10.1073/pnas.96.23.13381; Luz MR, 2006, THERIOGENOLOGY, V66, P1436, DOI 10.1016/j.theriogenology.2006.01.036; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; MUNRO CJ, 1991, CLIN CHEM, V37, P838; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; RAMESHA CS, 1985, PROSTAGLANDINS, V29, P991, DOI 10.1016/0090-6980(85)90223-0; Roberts LJ, 1996, J BIOL CHEM, V271, P20617, DOI 10.1074/jbc.271.34.20617; SCHLEGEL W, 1982, ACTA ENDOCRINOL-COP, V100, P98, DOI 10.1530/acta.0.1000098; SCHRICK FN, 1993, BIOL REPROD, V49, P617, DOI 10.1095/biolreprod49.3.617; Schwarzenberger F., 2007, International Zoo Yearbook, V41, P52, DOI 10.1111/j.1748-1090.2007.00017.x; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Steinetz B, 2009, ANN NY ACAD SCI, V1160, P179, DOI 10.1111/j.1749-6632.2008.03824.x; SVANBORG K, 1972, EUR J BIOCHEM, V28, P127, DOI 10.1111/j.1432-1033.1972.tb01893.x; Swanson WF, 2004, ANIM REPROD SCI, V82-3, P21, DOI 10.1016/j.anireprosci.2004.05.008; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Umapathy G, 2013, GEN COMP ENDOCR, V180, P33, DOI 10.1016/j.ygcen.2012.10.009; van Dorsser FJD, 2006, BIOL REPROD, V74, P1090, DOI [10.1095/biolreprd.105.050146, 10.1095/biolreprod.105.050146]; VELEZ JS, 1993, THERIOGENOLOGY, V39, P1377, DOI 10.1016/0093-691X(93)90239-2; Verstegen J, 1992, J REPROD FERTIL S, V47, P411; Weems CW, 2006, VET J, V171, P206, DOI 10.1016/j.tvjl.2004.11.014	44	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143958	10.1371/journal.pone.0143958	http://dx.doi.org/10.1371/journal.pone.0143958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633886	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000034
J	Garziera, M; Bidoli, E; Cecchin, E; Mini, E; Nobili, S; Lonardi, S; Buonadonna, A; Errante, D; Pella, N; D'Andrea, M; De Marchi, F; De Paoli, A; Zanusso, C; De Mattia, E; Tassi, R; Toffoli, G				Garziera, Marica; Bidoli, Ettore; Cecchin, Erika; Mini, Enrico; Nobili, Stefania; Lonardi, Sara; Buonadonna, Angela; Errante, Domenico; Pella, Nicoletta; D'Andrea, Mario; De Marchi, Francesco; De Paoli, Antonino; Zanusso, Chiara; De Mattia, Elena; Tassi, Renato; Toffoli, Giuseppe			HLA-G 3 ' UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment	PLOS ONE			English	Article							LEUKOCYTE-ANTIGEN-G; COLORECTAL-CANCER PATIENTS; 3' UNTRANSLATED REGION; G MESSENGER-RNA; IMMUNE-RESPONSE; GENE; EXPRESSION; SUPPRESSION; PREDICTOR; INDICATOR	An important hallmark of CRC is the evasion of immune surveillance. HLA-G is a negative regulator of host's immune response. Overexpression of HLA-G protein in primary tumour CRC tissues has already been associated to worse prognosis; however a definition of the role of immunogenetic host background is still lacking. Germline polymorphisms in the 3'UTR region of HLA-G influence the magnitude of the protein by modulating HLA-G mRNA stability. Soluble HLA-G has been associated to 3'UTR +2960 Ins/Ins and +3035 C/T (lower levels) and +3187 G/G (high levels) genotypes. HLA-G 3'UTR SNPs have never been explored in CRC outcome. The purpose of this study was to investigate if common HLA-G 3'UTR polymorphisms have an impact on DFS and OS of 253 stage II-III CRC patients, after primary surgery and ADJ-CT based on FL. The 3'UTR was sequenced and SNPs were analyzed for their association with survival by Kaplan-Meier and multivariate Cox models; results underwent internal validation using a resampling method (bootstrap analysis). In a multivariate analysis, we estimated an association with improved DFS in Ins allele (Ins/Del +Ins/Ins) carriers (HR 0.60, 95% CI 0.38-0.93, P = 0.023) and in patients with +3035 C/T genotype (HR 0.51, 95% CI 0.26-0.99, P = 0.045). The +3187 G/G mutated carriers (G/G vs A/A+A/G) were associated to a worst prognosis in both DFS (HR 2.46, 95% CI 1.19-5.05, P = 0.015) and OS (HR 2.71, 95% CI 1.16-6.63, P = 0.022). Our study shows a prognostic and independent role of 3 HLA-G 3'UTR SNPs, +2960 14-bp INDEL, +3035 C>T, and +3187 A>G.	[Garziera, Marica; Cecchin, Erika; Zanusso, Chiara; De Mattia, Elena; Toffoli, Giuseppe] Aviano Natl Canc Inst, IRCCS, Expt & Clin Pharmacol Unit, CRO, I-33081 Aviano, Italy; [Bidoli, Ettore] Aviano Natl Canc Inst, IRCCS, Epidemiol & Biostat Unit, CRO, I-33081 Aviano, Italy; [Mini, Enrico; Tassi, Renato] Univ Florence, Dept Expt & Clin Med, Sect Internal Med, Florence, Italy; [Nobili, Stefania] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Lonardi, Sara] IRCCS, Ist Oncol Veneto, Med Oncol Unit 1, Padua, Italy; [Buonadonna, Angela] Aviano Natl Canc Inst, IRCCS, Div Med Oncol B, I-33081 Aviano, Italy; [Buonadonna, Angela] Aviano Natl Canc Inst, IRCCS, CRO, I-33081 Aviano, Italy; [Errante, Domenico] Osped Civile Vittorio Veneto, Med Oncol Unit, Vittorio Veneto, TV, Italy; [Pella, Nicoletta] Univ Hosp, Med Oncol Unit, Udine, Italy; [D'Andrea, Mario] San Filippo Neri Hosp, Med Oncol Unit, Rome, Italy; [De Marchi, Francesco] Aviano Natl Canc Inst, IRCCS, CRO, Dept Surg Oncol, I-33081 Aviano, Italy; [De Paoli, Antonino] Aviano Natl Canc Inst, IRCCS, CRO, Dept Radiotherapy, I-33081 Aviano, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of Florence; University of Florence; IRCCS Istituto Oncologico Veneto (IOV); IRCCS Aviano (CRO); ULSS 2 Marca TV; Ospedale Vittorio Veneto; San Filippo Neri Hospital; IRCCS Aviano (CRO); IRCCS Aviano (CRO)	Garziera, M (corresponding author), Aviano Natl Canc Inst, IRCCS, Expt & Clin Pharmacol Unit, CRO, Via F Gallini 2, I-33081 Aviano, Italy.	mgarziera@cro.it	Bidoli, Ettore/AAC-1762-2020; Toffoli, Giuseppe/F-6642-2018; Mini, Enrico/AAA-5908-2019; Buonadonna, Angela/ABE-2374-2020; Cecchin, Erika/K-2448-2018; De Mattia, Elena/F-6593-2018; Nobili, Stefania/AAA-5917-2019; Lonardi, Sara/F-4228-2014; Garziera, Marica/S-8383-2019	Bidoli, Ettore/0000-0001-8273-9084; Toffoli, Giuseppe/0000-0002-5323-4762; Buonadonna, Angela/0000-0002-1930-0308; Cecchin, Erika/0000-0001-7517-7490; De Mattia, Elena/0000-0003-4948-8767; Lonardi, Sara/0000-0002-7593-8138; De Paoli, Antonino/0000-0002-9512-8108; Garziera, Marica/0000-0001-6902-210X	"Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology [12214]	"Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology	This work was supported by grant "Application of advanced nanotechnology in the development of innovative cancer diagnostic tools", AIRCx1000 Special Program Molecular Oncology (Grant number 12214).	Amodio G, 2014, TISSUE ANTIGENS, V84, P255, DOI 10.1111/tan.12427; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Broadbridge VT, 2013, BRIT J CANCER, V109, P1338, DOI 10.1038/bjc.2013.388; Bukur J, 2012, SEMIN CANCER BIOL, V22, P350, DOI 10.1016/j.semcancer.2012.03.003; Cai MY, 2009, CLIN CANCER RES, V15, P4686, DOI 10.1158/1078-0432.CCR-09-0463; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Carlini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082517; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/734068; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Cecchin E, 2015, PHARMACOGENOMICS J, V15, P219, DOI 10.1038/tpj.2014.64; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Curigliano G, 2013, CLIN CANCER RES, V19, P5564, DOI 10.1158/1078-0432.CCR-12-3697; Dahl M, 2014, AM J REPROD IMMUNOL, V72, P89, DOI 10.1111/aji.12251; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Fehlker M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-64; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fukushima Y, 1998, INT J MOL MED, V2, P349; Garziera M, 2014, WORLD J GASTROENTERO, V20, P3778, DOI 10.3748/wjg.v20.i14.3778; Gimenes F, 2014, BBA-REV CANCER, V1846, P576, DOI 10.1016/j.bbcan.2014.10.004; Goel Gaurav, 2014, J Gastrointest Cancer, V45, P399, DOI 10.1007/s12029-014-9634-7; Guo ZY, 2015, CELL IMMUNOL, V293, P10, DOI 10.1016/j.cellimm.2014.10.003; Hansel Donna E, 2005, Int J Gastrointest Cancer, V35, P15, DOI 10.1385/IJGC:35:1:015; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Jeong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098284; Johnston PG, 2014, ONCOLOGIST, V19, P568, DOI 10.1634/theoncologist.2014-038; Kopetz S, 2015, ONCOLOGIST, V20, P127, DOI 10.1634/theoncologist.2014-0325; Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924; Larsen MH, 2009, HUM IMMUNOL, V70, P1026, DOI 10.1016/j.humimm.2009.07.015; Mariaselvam CM, 2015, TISSUE ANTIGENS, V85, P182, DOI 10.1111/tan.12521; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Ong CW, 2015, ONCOTARGET, V6, P12763; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Reissfelder C, 2015, J CLIN INVEST, V125, P739, DOI 10.1172/JCI74894; Rizzo R, 2014, HAEMATOLOGICA, V99, P888, DOI 10.3324/haematol.2013.095281; Rouas-Freiss N, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/359748; Roxburgh CS, 2013, BRIT J CANCER, V109, P2207, DOI 10.1038/bjc.2013.556; Sabbagh A, 2014, GENES IMMUN, V15, P95, DOI 10.1038/gene.2013.67; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stremitzer S, 2015, PHARMACOGENOMICS J, V15, P521, DOI 10.1038/tpj.2015.14; Toffoli G, 2015, INT J CANCER, V137, P2971, DOI 10.1002/ijc.29654; Ye SR, 2007, MODERN PATHOL, V20, P375, DOI 10.1038/modpathol.3800751; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Zeestraten ECM, 2014, BRIT J CANCER, V110, P459, DOI 10.1038/bjc.2013.696; Zhu CB, 2011, INT J CANCER, V128, P617, DOI 10.1002/ijc.25372; Zitvogel L, 2015, NATURE, V521, P35, DOI 10.1038/nature14388	51	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144000	10.1371/journal.pone.0144000	http://dx.doi.org/10.1371/journal.pone.0144000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633805	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000040
J	Marn, N; Klanjscek, T; Stokes, L; Jusup, M				Marn, Nina; Klanjscek, Tin; Stokes, Lesley; Jusup, Marko			Size Scaling in Western North Atlantic Loggerhead Turtles Permits Extrapolation between Regions, but Not Life Stages	PLOS ONE			English	Article							CARETTA-CARETTA; SEA-TURTLES; GROWTH-RATES; MODEL; CAROLINA; AGE	Introduction Sea turtles face threats globally and are protected by national and international laws. Allometry and scaling models greatly aid sea turtle conservation and research, and help to better understand the biology of sea turtles. Scaling, however, may differ between regions and/or life stages. We analyze differences between (i) two different regional subsets and (ii) three different life stage subsets of the western North Atlantic loggerhead turtles by comparing the relative growth of body width and depth in relation to body length, and discuss the implications. Results and Discussion Results suggest that the differences between scaling relationships of different regional subsets are negligible, and models fitted on data from one region of the western North Atlantic can safely be used on data for the same life stage from another North Atlantic region. On the other hand, using models fitted on data for one life stage to describe other life stages is not recommended if accuracy is of paramount importance. In particular, young loggerhead turtles that have not recruited to neritic habitats should be studied and modeled separately whenever practical, while neritic juveniles and adults can be modeled together as one group. Even though morphometric scaling varies among life stages, a common model for all life stages can be used as a general description of scaling, and assuming isometric growth as a simplification is justified. In addition to linear models traditionally used for scaling on log-log axes, we test the performance of a saturating (curvilinear) model. The saturating model is statistically preferred in some cases, but the accuracy gained by the saturating model is marginal.	[Marn, Nina; Klanjscek, Tin] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia; [Stokes, Lesley] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA; [Jusup, Marko] Kyushu Univ, Fac Sci, Fukuoka 812, Japan	Rudjer Boskovic Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Kyushu University	Marn, N (corresponding author), Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia.	nmarn@irb.hr	Marn, Nina/T-1105-2018; Jusup, Marko/S-8567-2018	Marn, Nina/0000-0002-5307-2521; Jusup, Marko/0000-0002-0777-0425; Klanjscek, Tin/0000-0002-9341-344X	Croatian Science Foundation [2202]; ACCTA; Croatian Ministry of Science, Education and Sports [098-0982934-2719]; Environmental Protection Agency STAR Grant [R82-9094]; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship Program for Foreign Researchers [P13380]; Grants-in-Aid for Scientific Research [13F03380] Funding Source: KAKEN	Croatian Science Foundation; ACCTA; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Environmental Protection Agency STAR Grant; Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship Program for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported in part by Croatian Science Foundation under the project 2202; ACCTA, http://www.hrzz.hr (NM, TK); Croatian Ministry of Science, Education and Sports, project 098-0982934-2719, http://public.mzos.hr (NM); Environmental Protection Agency STAR Grant (R82-9094) www.epa.gov (LS); Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowship Program for Foreign Researchers no. P13380 and an accompanying Grant-in-Aid for Scientific Research, www.jsps.go.jp (MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avens L, 2007, MAR BIOL, V152, P1309, DOI 10.1007/s00227-007-0779-9; Bjorndal KA, 2000, MAR ECOL PROG SER, V202, P265, DOI 10.3354/meps202265; Bjorndal KA, 2001, FISH B-NOAA, V99, P240; Bolten Alan B., 1999, P110; Braun-McNeill J, 2008, HERPETOL CONSERV BIO, V3, P273; Broderick AC, 2003, J EXP MAR BIOL ECOL, V288, P95, DOI 10.1016/S0022-0981(03)00003-0; Byrd Julia, 2005, Marine Turtle Newsletter, P1; Casale P, 2009, SCI MAR, V73, P589, DOI 10.3989/scimar.2009.73n3589; Ehrhart LM, 1978, FLORIDA MARINE RES P, V33, P25; Epperly SP, 2002, FISH B-NOAA, V100, P466; Epperly SP, 1999, NATL MARINE FISHERIE; Frazer N.B., 1983, Marine Turtle Newsletter, P4; FRAZER NB, 1984, B MAR SCI, V34, P485; Fulbright T, 2007, FRONTIERS WILDLIFE S, P295, DOI [10.1201/9781420007619.ch17, DOI 10.1201/9781420007619.CH17]; Glazier DS, 2014, SYSTEMS, V2, P425, DOI 10.3390/systems2040425; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hays GC, 2002, CAN J ZOOL, V80, P1299, DOI 10.1139/Z02-110; HAYS GC, 1991, J ANIM ECOL, V60, P455, DOI 10.2307/5290; Hochscheid S, 2007, COMP BIOCHEM PHYS A, V148, P360, DOI 10.1016/j.cbpa.2007.05.010; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Limpus C., 1979, Marine Turtle Newsletter, P3; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; Mazaris AD, 2006, ECOL MODEL, V198, P174, DOI 10.1016/j.ecolmodel.2006.04.012; Norton TM, 2005, GEORGIA J SCI, V63, P287; Peckham S. Hoyt, 2008, Endangered Species Research, V5, P171, DOI 10.3354/esr00123; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Rhodin AGJ, 2012, CHELONIAN RES MONOGR, V5, p000 243; Rueda M, 2007, EPGLO201GEF INVEMAR; Salmon M, 2014, ZOOLOGY, V117, P131, DOI 10.1016/j.zool.2013.11.004; Sara S. K, 2011, BYCATCH FORAGING ECO; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scott R, 2012, FUNCT ECOL, V26, P227, DOI 10.1111/j.1365-2435.2011.01915.x; Small CG, 1996, STAT THEORY SHAPE, P4; Snover, 2002, GROWTH ONTOGENY SEA; Stokes L, 2006, HERPETOL CONSERV BIO, V1, P71; STONEBURNER DL, 1980, J HERPETOL, V14, P205, DOI 10.2307/1563863; TEWG, 2009, NMFSSEFSC575 NOAA; van Dam Robert P., 1999, P149; Wabnitz C., 2008, BERTALANFFY GROWTH P, P138; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023; White CR, 2014, COMPR PHYSIOL, V4, P231, DOI 10.1002/cphy.c110049; Zug GR, 2001, BIOL AMPHIBIANS REPT; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	45	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143747	10.1371/journal.pone.0143747	http://dx.doi.org/10.1371/journal.pone.0143747			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629702	Green Published, gold			2022-12-26	WOS:000365926300092
J	Nilsson, S; Erlandsson, PG; Robinson, ND				Nilsson, Sara; Erlandsson, Per G.; Robinson, Nathaniel D.			Electroosmotic Pumps with Frits Synthesized from Potassium Silicate	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; COLUMN; GLASS	Electroosmotic pumps employing silica frits synthesized from potassium silicate as a stationary phase show strong electroosmotic flow velocity and resistance to pressure-driven flow. We characterize these pumps and measure an electroosmotic mobility of 2.5x10(-8) m(2)/V s and hydrodynamic resistance per unit length of 70 x10(17) Pa s/m(4) with a standard deviation of less than 2% even when varying the amount of water used in the potassium silicate mixture. Furthermore, we demonstrate the simple integration of these pumps into a proofof- concept PDMS lab-on-a-chip device fabricated from a 3D-printed template.	[Nilsson, Sara; Erlandsson, Per G.; Robinson, Nathaniel D.] Linkoping Univ, Dept Phys Chem & Biol, Transport & Separat Grp, Linkoping, Sweden	Linkoping University	Robinson, ND (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Transport & Separat Grp, Linkoping, Sweden.	natro@ifm.liu.se	Robinson, Nathaniel D./A-5334-2008	Robinson, Nathaniel D./0000-0002-2773-5096	Vetenskapsradet [2007-3983, 2008-7537, 2011-6404]	Vetenskapsradet(Swedish Research Council)	This work was supported by Vetenskapsradet grant numbers 2007-3983, 2008-7537, and 2011-6404, to NDR. www.vr.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Bengtsson K, 2015, PLASTICIZED PO UNPUB; Chen LX, 2004, J CHROMATOGR A, V1028, P219, DOI 10.1016/j.chroma.2003.11.071; Erlandsson PG, 2011, ELECTROPHORESIS, V32, P784, DOI 10.1002/elps.201000617; Fields SM, 1996, ANAL CHEM, V68, P2709, DOI 10.1021/ac951247v; Haynes WM, 2015, CRC HDB CHEM PHYS RE; Kirby BJ, 2004, ELECTROPHORESIS, V25, P187, DOI 10.1002/elps.200305754; Lazar IM, 2002, ANAL CHEM, V74, P6259, DOI 10.1021/ac0203950; Mala GM, 1999, INT J HEAT FLUID FL, V20, P142; Mela P, 2004, ELECTROPHORESIS, V25, P3687, DOI 10.1002/elps.200406083; Mruetusatorn P, 2009, SENSOR ACTUAT A-PHYS, V153, P237, DOI 10.1016/j.sna.2009.05.011; Nortemann K, 1997, J PHYS CHEM A, V101, P6864, DOI 10.1021/jp971623a; Sinton D, 2003, COLLOID SURFACE A, V222, P273, DOI 10.1016/S0927-7757(03)00233-4; Wang P, 2006, SENSOR ACTUAT B-CHEM, V113, P500, DOI 10.1016/j.snb.2005.03.102; Wang R, 2010, ANAL SCI, V26, P921, DOI 10.2116/analsci.26.921; Wang XY, 2009, MICROFLUID NANOFLUID, V6, P145, DOI 10.1007/s10404-008-0399-9; Yao SH, 2003, J COLLOID INTERF SCI, V268, P143, DOI 10.1016/S0021-9797(03)00730-6; Zeng SL, 2001, SENSOR ACTUAT B-CHEM, V79, P107, DOI 10.1016/S0925-4005(01)00855-3	18	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144065	10.1371/journal.pone.0144065	http://dx.doi.org/10.1371/journal.pone.0144065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629907	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300154
J	Sanchez, IM; Cantalapiedra, JL; Rios, M; Quiralte, V; Morales, J				Sanchez, Israel M.; Cantalapiedra, Juan L.; Rios, Maria; Quiralte, Victoria; Morales, Jorge			Systematics and Evolution of the Miocene Three-Horned Palaeomerycid Ruminants (Mammalia, Cetartiodactyla)	PLOS ONE			English	Article							HISPANOMERYX MAMMALIA; ARTIODACTYLA; MOSCHIDAE; PALEOMERYX; CERVOIDEA; SPAIN	Palaeomerycids were strange three-horned Eurasian Miocene ruminants known through fossils from Spain to China. We here study their systematics, offering the first cladistic phylogeny of the best-known species of the group, and also reassess their phylogenetic position among ruminants, which is currently disputed. The beautifully preserved remains of a new palaeomerycid from middle Miocene deposits of Spain, Xenokeryx amidalae gen. et sp. nov., helps us to better understand palaeomerycid anatomy, especially that of the nuchal region in the skull, significantly improving our current knowledge on these enigmatic ruminants. Our results show two main lineages of palaeomerycids, one containing the genus Ampelomeryx diagnosed by a characteristic type of cranium / cranial appendages and some dental derived traits, and another one that clusters those forms more closely related to Triceromeryx than to Ampelomeryx, characterized by a more derived dentition and a set of apomorphic cranial features. Xenokeryx branches as a basal offshoot of this clade. Also, we find that Eurasian palaeomerycids are not closely related to North American dromomerycids, thus rejecting the currently more accepted view of palaeomerycids as the Eurasian part of the dromomerycid lineage. Instead of this, palaeomerycids are nested with the African Miocene pecoran Propalaeoryx and with giraffoids. On the other hand, dromomerycids are closely related to cervids. We define a clade Giraffomorpha that includes palaeomerycids and giraffids, and propose an emended diagnosis of the Palaeomerycidae based on cranial and postcranial characters, including several features of the cranium not described so far. We also define the Palaeomerycidae as the least inclusive clade of pecorans containing Triceromeryx and Ampelomeryx. Finally, we reassess the taxonomy of several palaeomerycid taxa.	[Sanchez, Israel M.; Rios, Maria; Quiralte, Victoria; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Cantalapiedra, Juan L.] Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Leibniz Institut fur Evolutions und Biodiversitatsforschung	Sanchez, IM (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	micromeryx@gmail.com	Morales, Jorge/L-1476-2014; Cantalapiedra, Juan L/L-2135-2014	Morales, Jorge/0000-0001-5170-5754; Cantalapiedra, Juan L/0000-0003-0913-7735; Quiralte, Victoria/0000-0001-6313-0425; Sanchez, Israel M./0000-0003-2151-7693; Rios, Maria/0000-0001-7242-1259	Postdoctoral Humboldt Fellowship; Predoctoral FPI grant programme, Spanish Government MINECO; Junta de Comunidades de Castilla-La Mancha (Spanish Autonomic Government of Castilla-La Mancha); Spanish Government, MINECO [CGL2011-25754];  [CAM-UCM 910607]	Postdoctoral Humboldt Fellowship; Predoctoral FPI grant programme, Spanish Government MINECO; Junta de Comunidades de Castilla-La Mancha (Spanish Autonomic Government of Castilla-La Mancha)(Junta de Comunidades de Castilla-La Mancha); Spanish Government, MINECO; 	JLC was supported by a Postdoctoral Humboldt Fellowship (https://www.humboldt-foundation.de/web/start.html), and MR was supported by the Predoctoral FPI grant programme, Spanish Government MINECO.; JLC and MR acknowledge a Humboldt Fellowship and a FPI predoctoral grant (Spanish Government MINECO), respectively. We want to thoughtfully thank Wang Lihua (Yunnan University, Yunnan, China), Gertrud Rossner (Bayerische Staatssammlung fur Palaontologie und Geologie, Munchen, Germany), Humberto Astibia (Universidad del Pais Vasco, Spain), Daniel DeMiguel (Institut Catala de Paleontologia Miquel Crusafont, Barcelona, Spain), and their respective home institutions for giving us access to palaeomerycid fossils and / or pictures, and Faysal Bibi (Museum fur Naturkunde, Berlin, Germany) for his useful comments on the manuscript. Nicholas Matzke (University of Tennessee, USA) provided valuable assistance for using BEASTMasteR. We thank Mauricio Anton for the pencil sketches of paleomerycid heads upon which the present drawings are based. We also want to acknowledge the Junta de Comunidades de Castilla-La Mancha (Spanish Autonomic Government of Castilla-La Mancha) for funding the excavations in La Retama, and to the Willi Hennig Society for access to TNT software. Diana Llorente (MNCN, Madrid) labeled the fossils of Xenokeryx from La Retama. And we finally thank the referees of PLOS ONE for their helpful comments that greatly improved the quality of this work. This study is part of the research project CGL2011-25754 (Spanish Government, MINECO), and the Research Group CAM-UCM 910607.	Agustui J., 2002, MAMMOTHS SABERTOOTHS; Agustui J., 1997, MEMORIA TIERRA VERTE; alvarez Sierra M, 2006, ESTUD GEOL, V62, P401; Antunes M. T., 1964, Boletim da Sociedade Geologica de Portugal, V15, P123; Astibia H., 2006, Estudios Geologicos (Madrid), V62, P547; Astibia H, 1998, B SOC GEOL FR, V169, P471; Astibia H., 1987, PALEONTOLOGIA EVOLUC, V21, P75; Astibia H, 2012, MEM MUS NAT HIST NAT, V203, P201; Azanza Asensio Beatriz, 2000, Memorias del Museo Paleontologico de la Universidad de Zaragoza, V8, P1; Azanza Beatriz, 2003, Geological Survey of Namibia Memoir, V19, P345; Barmann EV, 2011, MAMM BIOL, V76, P762, DOI 10.1016/j.mambio.2011.07.002; Barone R., 1999, ANATOMIE COMPAREE MA, V1; Bibi F, 2014, ZITTELIANA B, VB32, P1; Bibi F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-166; Bohlin B, 1953, B GEOLOGICAL I UPPSA, VXXXV, P1; Bubenik A.B., 1990, P3; Cantalapiedra JL, 2014, ECOGRAPHY, V37, P1, DOI 10.1111/j.1600-0587.2013.00236.x; Cote Susanne M., 2010, P731; Davis EB, 2011, P ROY SOC B-BIOL SCI, V278, P2857, DOI 10.1098/rspb.2011.0938; DeMiguel D, 2014, INTEGR ZOOL, V9, P412, DOI 10.1111/1749-4877.12080; Diaz-Molina M, 1974, ESTUD GEOL, V30, P63; Diaz-Molina M., 1979, BIOSTRATIGRAFIA PALE, V35, P149; Drummond AJ, TRACER V 1 5 EDINBUR; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DURANTHON F, 1995, CR ACAD SCI II A, V321, P339; Gentry Alan W., 1999, P225; GINSBURG L, 1989, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V11, P201; GINSBURG L, 1966, CR ACAD SCI D NAT, V262, P979; Ginsburg L, 1999, CR ACAD SCI II A, V329, P757, DOI 10.1016/S1251-8050(00)88496-7; GINSBURG L, 1985, CR ACAD SCI II, V301, P1075; GINSBURG L, 1994, P K NED AKAD WETENSC, V97, P141; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grimm GW, 2015, SYST BIOL, V64, P396, DOI 10.1093/sysbio/syu108; Hamilton W.R., 1978, P496; HAMILTON WR, 1973, B BRIT MUS NAT HIST, V21, P76; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Janis Christine, 2000, P26; Janis Christine M., 1998, P477; Janis CM., 1987, AM MUS NOVIT, V2893, P1; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lartet E., 1851, NOTICE COLLINE SANSA; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Lydekker R., 1883, Records of the Geological Survey of lndia, Vxvi, P61; Maddison W. P, 2014, MESQUITE MODULAR SYS; McKenna MC, 1997, CLASSIFICATION MAMMA; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Morales J, 1995, CR ACAD SCI II A, V321, P1211; MORALES J, 2003, MEMOIR GEOLOGICAL SU, V19, P371; Morales J, 1999, HUELLA PASADO FOSILE, P235; Morales J., 2008, MEMOIR GEOLOGICAL SU, V20, P397; Morales Jorge, 1999, Geodiversitas, V21, P229; Oliver A, 2013, J VERTEBR PALEONTOL, V33, P943, DOI 10.1080/02724634.2013.743896; Prothero Donald R., 2008, Bulletin of the New Mexico Museum of Natural History and Science, V44, P273; Prothero Donald R., 2007, P241; Qiu Zhu-Ding, 2013, P142; QIU ZX, 1985, VERTEBRAT PALASIATIC, V23, P173; Quiralte V., 2011, THESIS; Rambaut A., FIGTREE GRAPHICAL VI; Rossner GE, 2010, PALAEONTOL Z, V84, P123, DOI 10.1007/s12542-010-0052-2; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Sanchez I. M., 1998, Estudios Geologicos (Madrid), V54, P39; Sanchez IM, 2008, J VERTEBR PALEONTOL, V28, P873, DOI 10.1671/0272-4634(2008)28[873:MASNRM]2.0.CO;2; Sanchez IM, 2011, J VERTEBR PALEONTOL, V31, P1397, DOI 10.1080/02724634.2011.618155; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Sanchez IM, 2010, J VERTEBR PALEONTOL, V30, P1306, DOI 10.1080/02724634.2010.483555; Sanchez IM, 2009, J VERTEBR PALEONTOL, V29, P567, DOI 10.1671/039.029.0223; Scott WB, 1895, T AM PHILOS SOC, V18, P55; Solounias Nikos, 2007, P257; Stirton RA, 1944, AM J SCI, V242, P633, DOI 10.2475/ajs.242.12.633; VILLALTA J, 1946, PUBLICACIONES MUSEO, P1; von Meyer H., 1834, FOSSILEN ZAHNE KNOCH; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; WEBB S D, 1980, Bulletin of the American Museum of Natural History, V167, P117; Whitworth T., 1958, Fossil Mammals of Africa British Museum (Natural History), VNo. 15, P1; [No title captured]	75	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143034	10.1371/journal.pone.0143034	http://dx.doi.org/10.1371/journal.pone.0143034			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630174	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300026
J	Skogmar, S; Schon, T; Balcha, TT; Sturegard, E; Jansson, M; Bjorkman, P				Skogmar, Sten; Schon, Thomas; Balcha, Taye Tolera; Sturegard, Erik; Jansson, Marianne; Bjorkman, Per			Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count	PLOS ONE			English	Article							IMMUNE ACTIVATION; PULMONARY TUBERCULOSIS; SERUM NEOPTERIN; SERONEGATIVE PATIENTS; INFECTED PATIENTS; PROGNOSTIC VALUE; PROGRESSION; DISEASE	Background While the risk of TB is elevated in HIV-positive subjects with low CD4 cell counts, TB may in itself be associated with CD4 lymphocytopenia. We investigated markers of immune activation (neopterin) and inflammation (CRP) in TB patients with and without HIV coinfection and their association with CD4 cell levels, and determined their predictive capacity as alternative markers of advanced immunosuppression. Methods Participants selected from a cohort of adults with TB at Ethiopian health centers (195 HIV +/TB+, 170 HIV-/TB+) and 31 controls were tested for plasma levels of neopterin and CRP. Baseline levels of neopterin and CRP were correlated to CD4 cell count before and after anti-TB treatment (ATT). The performance to predict CD4 cell strata for both markers were investigated using receiver operating curves. Results Levels of both biomarkers were elevated in TB patients (neopterin: HIV+/TB+ 54 nmol/l, HIV-/TB+ 23 nmol/l, controls 3.8 nmol/l; CRP: HIV+/TB+ 36 mu g/ml, HIV-/TB+ 33 mu g/ml, controls 0.5 mu g/ml). Neopterin levels were inversely correlated (-0.53, p<0.001) to CD4 cell count, whereas this correlation was weaker for CRP (-0.25, p<0.001). Neither of the markers had adequate predictive value for identification of subjects with CD4 cell count <100 cells/mm(3) (area under the curve [AUC] 0.64 for neopterin, AUC 0.59 for CRP). Conclusion Neopterin levels were high in adults with TB, both with and without HIV coinfection, with inverse correlation to CD4 cell count. This suggests that immune activation may be involved in TB-related CD4 lymphocytopenia. However, neither neopterin nor CRP showed promise as alternative tests for immunosuppression in patients coinfected with HIV and TB.	[Skogmar, Sten; Balcha, Taye Tolera; Bjorkman, Per] Lund Univ, Dept Clin Sci Malmo, Infect Dis Res Unit, Malmo, Sweden; [Schon, Thomas] Linkoping Univ, Dept Med Microbiol, Fac Hlth Sci, S-58185 Linkoping, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden; [Balcha, Taye Tolera] Minist Hlth, Addis Ababa, Ethiopia; [Sturegard, Erik] Lund Univ, Med Microbiol, Dept Lab Med Malmo, Malmo, Sweden; [Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden; [Jansson, Marianne] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Lund University; Linkoping University; Lund University; Lund University; Karolinska Institutet	Skogmar, S (corresponding author), Lund Univ, Dept Clin Sci Malmo, Infect Dis Res Unit, Malmo, Sweden.	sten.skogmar@med.lu.se		Jansson, Marianne/0000-0001-6536-8146	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Region Skane; Swedish Medical Association	Swedish Civil Contingency Agency; Swedish International Development Cooperation Agency; Region Skane; Swedish Medical Association	This work was supported by the Swedish Civil Contingency Agency (PB), the Swedish International Development Cooperation Agency (PB), Region Skane (SS), and the Swedish Medical Association (SS).	Andersen AB, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-66; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; AYEHUNIE S, 1993, CLIN EXP IMMUNOL, V91, P37; Balcha TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085478; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buhrer-Sekula S, 2000, J IMMUNOL METHODS, V238, P55, DOI 10.1016/S0022-1759(00)00148-4; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Federal Ministry of Health, 2008, TUBERCULOSIS LEPROSY; Federal Ministry of Health (FMoH), 2007, GUIDELINES IMPLEMENT; Goletti D, 1996, J IMMUNOL, V157, P1271; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Hanna LE, 2009, INDIAN J MED RES, V129, P548; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Immanuel C, 2005, INDIAN J MED RES, V121, P220; Immanuel C, 2001, INT J TUBERC LUNG D, V5, P185; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Mildvan D, 2005, CLIN INFECT DIS, V40, P853, DOI 10.1086/427877; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; Skogmar S, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23105; Skogmar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083270; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Vanham G, 1996, CLIN EXP IMMUNOL, V103, P30, DOI 10.1046/j.1365-2249.1996.907600.x; Wirleitner B, 2005, MOL IMMUNOL, V42, P183, DOI 10.1016/j.molimm.2004.06.017; Wolday D, 2002, ETHIOPIAN MED J, V40, P11	30	20	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144292	10.1371/journal.pone.0144292	http://dx.doi.org/10.1371/journal.pone.0144292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630153	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300176
J	Wang, M; Pan, L; Zhou, P; Lv, JL; Zhang, ZW; Wang, YL; Zhang, YG				Wang, Miao; Pan, Li; Zhou, Peng; Lv, Jianliang; Zhang, Zhongwang; Wang, Yonglu; Zhang, Yongguang			Protection against Foot-and-Mouth Disease Virus in Guinea Pigs via Oral Administration of Recombinant Lactobacillus plantarum Expressing VP1	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; POTENTIAL PROBIOTIC PROPERTIES; INDUCIBLE GENE-EXPRESSION; IMMUNE-RESPONSES; MUCOSAL DELIVERY; THERAPEUTIC PROTEINS; VACCINE DEVELOPMENT; CAPSID PROTEINS; GENOME SEQUENCE; ANTIGEN	Mucosal vaccination is an effective strategy for generating antigen-specific immune responses against mucosal infections of foot-and-mouth disease virus (FMDV). In this study, Lactobacillus plantarum strains NC8 and WCFS1 were used as oral delivery vehicles containing a pSIP411-VP1 recombinant plasmid to initiate mucosal and systemic immune responses in guinea pigs. Guinea pigs were orally vaccinated (three doses) with NC8-pSIP411, NC8-pSIP411-VP1, WCFS1-pSIP411, WCFS1-pSIP411-VP1 or milk. Animals immunized with NC8-pSIP411-VP1 and WCFS1-pSIP411-VP1 developed high levels of antigen-specific serum IgG, IgA, IgM, mucosal secretory IgA (sIgA) and neutralizing antibodies, and revealed stronger cell-mediated immune responses and enhanced protection against FMDV challenge compared with control groups. The recombinant pSIP411-VP1 effectively improved immunoprotection against FMDV in guinea pigs.	[Wang, Miao; Pan, Li; Zhou, Peng; Lv, Jianliang; Zhang, Zhongwang; Wang, Yonglu; Zhang, Yongguang] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China; [Pan, Li; Zhang, Yongguang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Pan, L (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Natl Foot & Mouth Dis Reference Lab, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	panli@caas.cn; yongguang.zhang@163.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	Chinese "863" National Programs for High Technology Research and Development [2011AA10A211]; National Pig Industrial System [CARS-36-06B]; Special Fund for Agro-scientific Research in the Public Interest [201203039]	Chinese "863" National Programs for High Technology Research and Development; National Pig Industrial System; Special Fund for Agro-scientific Research in the Public Interest	This study was financially supported by the Chinese "863" National Programs for High Technology Research and Development (Grant No.: 2011AA10A211), URL: http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm, the National Pig Industrial System (CARS-36-06B), the Special Fund for Agro-scientific Research in the Public Interest (201203039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 1998, J APPL MICROBIOL, V85, P88; ALTMEYER R, 1995, J VIROL, V69, P3193, DOI 10.1128/JVI.69.5.3193-3196.1995; Aukrust T W, 1995, Methods Mol Biol, V47, P201; Axelsson L, 2012, J BACTERIOL, V194, P2391, DOI 10.1128/JB.00141-12; Berlec Ales, 2009, Recent Pat Biotechnol, V3, P77, DOI 10.2174/187220809788700175; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Bermudez-Humaran LG, 2009, HUM VACCINES, V5, P264, DOI 10.4161/hv.5.4.7553; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Chai Z, 2013, J VIROL METHODS, V188, P175, DOI 10.1016/j.jviromet.2012.08.021; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Farsang A, 2013, BIOSECUR BIOTERROR, V11, pS115, DOI 10.1089/bsp.2013.0001; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gunaydin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096409; Ho PS, 2005, VACCINE, V23, P1335, DOI 10.1016/j.vaccine.2004.09.015; Huang HY, 2014, J MICROBIOL METH, V107, P138, DOI 10.1016/j.mimet.2014.09.005; IRVINE KR, 1995, J IMMUNOL, V154, P4651; Jiang XP, 2014, APPL MICROBIOL BIOT, V98, P8301, DOI 10.1007/s00253-014-5893-2; Jung JG, 2013, J IND MICROBIOL BIOT, V40, P705, DOI 10.1007/s10295-013-1273-7; KE Y, 1995, EUR J IMMUNOL, V25, P549, DOI 10.1002/eji.1830250237; Kechaou N, 2013, APPL ENVIRON MICROB, V79, P1491, DOI 10.1128/AEM.03075-12; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002273; Ludi A, 2013, DEV BIOLOGICALS, V135, P107, DOI 10.1159/000313913; Ma SJ, 2014, WORLD J MICROB BIOT, V30, P2379, DOI 10.1007/s11274-014-1663-7; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Lentz EM, 2010, PLANTA, V231, P387, DOI 10.1007/s00425-009-1058-4; Medina E, 2001, VACCINE, V19, P1573, DOI 10.1016/S0264-410X(00)00354-6; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Oliveira MLS, 2003, FEMS MICROBIOL LETT, V227, P25, DOI 10.1016/S0378-1097(03)00645-1; Pan L, 2014, INT J NANOMED, V9, P5603, DOI 10.2147/IJN.S72318; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; Rodriguez LL, 2009, VACCINE, V27, pD90, DOI 10.1016/j.vaccine.2009.08.039; Sasikumar P, 2014, CURR MICROBIOL, V69, P708, DOI 10.1007/s00284-014-0644-2; Sasikumar P, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0086-y; Shi SH, 2014, VIROLOGY, V464, P166, DOI 10.1016/j.virol.2014.07.011; Shi XJ, 2006, VACCINE, V24, P82, DOI 10.1016/j.vaccine.2005.07.051; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Tauer C, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0150-z; Nguyen T, 2011, J AGR FOOD CHEM, V59, P5617, DOI 10.1021/jf104755r; Villatoro-Hernandez J, 2011, EXPERT OPIN BIOL TH, V11, P261, DOI 10.1517/14712598.2011.542138; Wang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027605; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Xu W, 2011, LETT APPL MICROBIOL, V53, P641, DOI 10.1111/j.1472-765X.2011.03160.x; Xu YG, 2007, APPL ENVIRON MICROB, V73, P7041, DOI 10.1128/AEM.00436-07; Xu YG, 2011, CLIN VACCINE IMMUNOL, V18, P1979, DOI 10.1128/CVI.05204-11; Xue M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-191; Yigang XU, 2008, IMMUNOLOGY, V124, P68, DOI 10.1111/j.1365-2567.2007.02738.x; Yin CS, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-62; Zhang ZW, 2015, APPL MICROBIOL BIOT, V99, P1389, DOI 10.1007/s00253-014-6129-1; ZHOU F, 1992, J IMMUNOL, V149, P1599	55	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143750	10.1371/journal.pone.0143750	http://dx.doi.org/10.1371/journal.pone.0143750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629822	Green Published, gold			2022-12-26	WOS:000365926300093
J	Xiao, B; Imel, ZE; Georgiou, PG; Atkins, DC; Narayanan, SS				Xiao, Bo; Imel, Zac E.; Georgiou, Panayiotis G.; Atkins, David C.; Narayanan, Shrikanth S.			"Rate My Therapist": Automated Detection of Empathy in Drug and Alcohol Counseling via Speech and Language Processing	PLOS ONE			English	Article							MOTIVATIONAL INTERVIEWING FIDELITY; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; SUBSTANCE-ABUSE; SCALING-UP; INTERVENTION; METAANALYSIS; DIARIZATION; EXPERTISE; NETWORKS	The technology for evaluating patient-provider interactions in psychotherapy-observational coding-has not changed in 70 years. It is labor-intensive, error prone, and expensive, limiting its use in evaluating psychotherapy in the real world. Engineering solutions from speech and language processing provide new methods for the automatic evaluation of provider ratings from session recordings. The primary data are 200 Motivational Interviewing (MI) sessions from a study on MI training methods with observer ratings of counselor empathy. Automatic Speech Recognition (ASR) was used to transcribe sessions, and the resulting words were used in a text-based predictive model of empathy. Two supporting datasets trained the speech processing tasks including ASR (1200 transcripts from heterogeneous psychotherapy sessions and 153 transcripts and session recordings from 5 MI clinical trials). The accuracy of computationally-derived empathy ratings were evaluated against human ratings for each provider. Computationally-derived empathy scores and classifications (high vs. low) were highly accurate against human-based codes and classifications, with a correlation of 0.65 and F-score (a weighted average of sensitivity and specificity) of 0.86, respectively. Empathy prediction using human transcription as input (as opposed to ASR) resulted in a slight increase in prediction accuracies, suggesting that the fully automatic system with ASR is relatively robust. Using speech and language processing methods, it is possible to generate accurate predictions of provider performance in psychotherapy from audio recordings alone. This technology can support large-scale evaluation of psychotherapy for dissemination and process studies.	[Xiao, Bo; Georgiou, Panayiotis G.; Narayanan, Shrikanth S.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Imel, Zac E.] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA; [Atkins, David C.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Southern California; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle	Imel, ZE (corresponding author), Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA.	zac.imel@utah.edu	Imel, Zac E./AAH-9491-2019; Narayanan, Shrikanth S/D-5676-2012; Georgiou, Panayiotis Panos/E-8387-2018	Imel, Zac E./0000-0001-9645-7184; Georgiou, Panayiotis Panos/0000-0002-0790-7161; Atkins, David/0000-0002-5781-9880	National Institutes of Health / National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01/AA018673]; National Institute on Drug Abuse [R34/DA034860]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K02AA023814, R01AA018673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA034860] Funding Source: NIH RePORTER	National Institutes of Health / National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for the preparation of this manuscript was provided by the National Institutes of Health / National Institute on Alcohol Abuse and Alcoholism (NIAAA) under award number R01/AA018673 and National Institute on Drug Abuse under award number (R34/DA034860). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ana EJS, 2008, J SUBST ABUSE TREAT, V35, P369, DOI 10.1016/j.jsat.2008.01.003; Miro XA, 2012, IEEE T AUDIO SPEECH, V20, P356, DOI 10.1109/TASL.2011.2125954; Atkins DC, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-49; Atkins DC, 2012, J FAM PSYCHOL, V26, P816, DOI 10.1037/a0029607; Baer JS, 2009, J SUBST ABUSE TREAT, V37, P191, DOI 10.1016/j.jsat.2009.01.003; Baldwin S. A., 2013, BERGIN GARFIELDS HDB, P258, DOI DOI 10.1007/978; Brown P. F., 1992, Computational Linguistics, V18, P467; Campbell ANC, 2014, AM J PSYCHIAT, V171, P683, DOI 10.1176/appi.ajp.2014.13081055; Can D, 2014, ICASSP 2014 2014 IEE, P3306; Carroll KM, 2014, ANN NY ACAD SCI, V1327, P94, DOI 10.1111/nyas.12501; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohn DA, 1996, J ARTIF INTELL RES, V4, P129, DOI 10.1613/jair.295; Cohn Jeffrey F., 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPR.2009.5204260; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Georgiou PC, 2011, LECT NOTES COMPUT SC, V6974, P87, DOI 10.1007/978-3-642-24600-5_12; Ghosh PK, 2011, IEEE T AUDIO SPEECH, V19, P600, DOI 10.1109/TASL.2010.2052803; Heigold G, 2012, IEEE SIGNAL PROC MAG, V29, P58, DOI 10.1109/MSP.2012.2197232; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hoglend P, 2014, AM J PSYCHIAT, V171, P1056, DOI 10.1176/appi.ajp.2014.14010121; Holmes EA, 2014, NATURE, V511, P287, DOI 10.1038/511287a; Huang CW, 2014, INTERSPEECH, P567; Imel ZE, 2015, PSYCHOTHERAPY, V52, P19, DOI 10.1037/a0036841; Imel ZE, 2014, J COUNS PSYCHOL, V61, P146, DOI 10.1037/a0034943; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kenny P, 2010, IEEE J-STSP, V4, P1059, DOI 10.1109/JSTSP.2010.2081790; Kirschenbaum H, 2004, J COUNS DEV, V82, P116, DOI 10.1002/j.1556-6678.2004.tb00293.x; Krupski A, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-27; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Ladany N, 1996, J COUNS PSYCHOL, V43, P10, DOI 10.1037/0022-0167.43.1.10; Lee CM, 2014, J CONSULT CLIN PSYCH, V82, P189, DOI 10.1037/a0035743; Lee CM, 2013, J CONSULT CLIN PSYCH, V81, P702, DOI 10.1037/a0033285; Leichsenring F, 2013, AM J PSYCHIAT, V170, P759, DOI [10.1176/appi.ajp.2013.13060744r, 10.1176/appi.ajp.2013.12081125]; LEVINSON SE, 1983, AT&T TECH J, V62, P1035, DOI 10.1002/j.1538-7305.1983.tb03114.x; Lord SP, 2015, J SUBST ABUSE TREAT, V49, P50, DOI 10.1016/j.jsat.2014.08.005; Magill M, 2014, J CONSULT CLIN PSYCH, V82, P973, DOI 10.1037/a0036833; Miller WR, 2006, J SUBST ABUSE TREAT, V31, P25, DOI 10.1016/j.jsat.2006.03.005; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; Moyers TB, 2005, J SUBST ABUSE TREAT, V28, P19, DOI 10.1016/j.jsat.2004.11.001; Moyers TB, 2005, MOTIVATIONAL INTERVI; Narayanan S, 2013, P IEEE, V101, P1203, DOI 10.1109/JPROC.2012.2236291; Neighbors C, 2012, J CONSULT CLIN PSYCH, V80, P850, DOI 10.1037/a0029480; Oliver I, 2012, IEEE IC COMP COM NET; Povey Daniel, 2011, P ASRU BIG ISL HI US; SAMHSA, 2012, DASIS SER S; Schwalbe CS, 2014, ADDICTION, V109, P1287, DOI 10.1111/add.12558; Shin J, 2013, COMPUT SPEECH LANG, V27, P554, DOI 10.1016/j.csl.2012.02.001; Stolcke Andreas, 2002, P INTERSPEECH; Tollison SJ, 2008, BEHAV THER, V39, P183, DOI 10.1016/j.beth.2007.07.001; Tracey TJG, 2014, AM PSYCHOL, V69, P218, DOI 10.1037/a0035099; Tranter SE, 2006, IEEE T AUDIO SPEECH, V14, P1557, DOI 10.1109/TASL.2006.878256; van den Broek EL, 2009, P ACII, P1; Van Segbroeck M, 2013, INTERSPEECH, P704; Wang Wei, 2008, Acta Acustica, V33, P9; Xiao B, 2014, INTERSPEECH, P213; Xiao B, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P2489; Zhang XL, 2013, IEEE T AUDIO SPEECH, V21, P697, DOI 10.1109/TASL.2012.2229986	56	58	58	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143055	10.1371/journal.pone.0143055	http://dx.doi.org/10.1371/journal.pone.0143055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630392	Green Published, gold			2022-12-26	WOS:000365926300028
J	Nouri, K; Moll, JM; Milroy, LG; Hain, A; Dvorsky, R; Amin, E; Lenders, M; Nagel-Steger, L; Howe, S; Smits, SHJ; Hengel, H; Schmitt, L; Munk, C; Brunsveld, L; Ahmadian, MR				Nouri, Kazem; Moll, Jens M.; Milroy, Lech-Gustav; Hain, Anika; Dvorsky, Radovan; Amin, Ehsan; Lenders, Michael; Nagel-Steger, Luitgard; Howe, Sebastian; Smits, Sander H. J.; Hengel, Hartmut; Schmitt, Lutz; Muenk, Carsten; Brunsveld, Luc; Ahmadian, Mohammad R.			Biophysical Characterization of Nucleophosmin Interactions with Human Immunodeficiency Virus Rev and Herpes Simplex Virus US11	PLOS ONE			English	Article							NUCLEOLAR PHOSPHOPROTEIN B23; TEGUMENT PROTEIN US11; RNA-BINDING-PROTEIN; CORE PROTEIN; POSTTRANSCRIPTIONAL TRANSACTIVATION; PROTEOMIC ANALYSIS; NUCLEAR EXPORT; ARGININE-RICH; IN-VITRO; TYPE-1	Nucleophosmin (NPM1, also known as B23, numatrin or NO38) is a pentameric RNA-binding protein with RNA and protein chaperon functions. NPM1 has increasingly emerged as a potential cellular factor that directly associates with viral proteins; however, the significance of these interactions in each case is still not clear. In this study, we have investigated the physical interaction of NPM1 with both human immunodeficiency virus type 1 (HIV-1) Rev and Herpes Simplex virus type 1 (HSV-1) US11, two functionally homologous proteins. Both viral proteins show, in mechanistically different modes, high affinity for a binding site on the N-terminal oligomerization domain of NPM1. Rev, additionally, exhibits low-affinity for the central histone-binding domain of NPM1. We also showed that the proapoptotic cyclic peptide CIGB-300 specifically binds to NPM1 oligomerization domain and blocks its association with Rev and US11. Moreover, HIV-1 virus production was significantly reduced in the cells treated with CIGB-300. Results of this study suggest that targeting NPM1 may represent a useful approach for antiviral intervention.	[Nouri, Kazem; Moll, Jens M.; Dvorsky, Radovan; Amin, Ehsan; Ahmadian, Mohammad R.] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Milroy, Lech-Gustav; Brunsveld, Luc] Tech Univ Eindhoven, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands; [Milroy, Lech-Gustav; Brunsveld, Luc] Tech Univ Eindhoven, Dept Biomed Engn, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Hain, Anika; Muenk, Carsten] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Lenders, Michael; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany; [Nagel-Steger, Luitgard] Res Ctr Julich, ICS 6, Julich, Germany; [Nagel-Steger, Luitgard] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Howe, Sebastian; Hengel, Hartmut] Univ Dusseldorf, Inst Virol, Dusseldorf, Germany; [Hengel, Hartmut] Univ Med Ctr Freiburg, Inst Virol, Freiburg, Germany	Heinrich Heine University Dusseldorf; Eindhoven University of Technology; Eindhoven University of Technology; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Freiburg	Ahmadian, MR (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Nagel-Steger, Luitgard/H-6415-2013; Dvorsky, Radovan/ABE-3042-2020	Nagel-Steger, Luitgard/0000-0001-5232-2149; Nouri, Kazem/0000-0001-7787-1304; Brunsveld, Luc/0000-0001-5675-511X; Amin, Ehsan/0000-0003-2995-8864	International Graduate School of Protein Science and Technology (iGRASP), Research Commission of the Medical Faculty; Strategic Research Fund (SFF) of Heinrich-Heine University Dusseldorf; German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 [SFB 974]; International Research Training Group 1902 [IRTG 1902]; Heinz Ansmann foundation [GRK 1045]; Jurgen Manchot Foundation, Molecules of Infection Graduate School	International Graduate School of Protein Science and Technology (iGRASP), Research Commission of the Medical Faculty; Strategic Research Fund (SFF) of Heinrich-Heine University Dusseldorf; German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974(German Research Foundation (DFG)); International Research Training Group 1902; Heinz Ansmann foundation; Jurgen Manchot Foundation, Molecules of Infection Graduate School	This work was funded by the International Graduate School of Protein Science and Technology (iGRASP), Research Commission of the Medical Faculty and the Strategic Research Fund (SFF) of Heinrich-Heine University Dusseldorf, and the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration", the International Research Training Group 1902 (IRTG 1902) "Intra- and interorgan communication of the cardiovascular system", and GRK 1045 "Modulation of host cell function". CM is supported by the Heinz Ansmann foundation. AH is supported by the Jurgen Manchot Foundation, Molecules of Infection Graduate School.	Abraham R, 2015, J PROTEOMICS, V120, P126, DOI 10.1016/j.jprot.2015.03.007; ADACHI Y, 1993, J BIOL CHEM, V268, P13930; Ahuja R, 2015, BBA-MOL CELL RES, V1853, P1783, DOI 10.1016/j.bbamcr.2015.04.012; Aminev AG, 2003, VIRUS RES, V95, P45, DOI 10.1016/S0168-1702(03)00162-X; Attrill HL, 2002, J VIROL, V76, P8090, DOI 10.1128/JVI.76.16.8090-8100.2002; Bazot Q, 2014, NUCLEIC ACIDS RES, V42, P9700, DOI 10.1093/nar/gku697; Benboudjema L, 2003, J VIROL, V77, P9192, DOI 10.1128/JVI.77.17.9192-9203.2003; Besse S, 1996, CHROMOSOMA, V104, P434, DOI 10.1007/BF00352267; Bevington JM, 2007, VIROLOGY, V357, P102, DOI 10.1016/j.virol.2006.07.050; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROWN SM, 1987, J GEN VIROL, V68, P1, DOI 10.1099/0022-1317-68-1-1; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Catez F, 2002, MOL CELL BIOL, V22, P1126, DOI 10.1128/MCB.22.4.1126-1139.2002; COCHRANE AW, 1990, J VIROL, V64, P881, DOI 10.1128/JVI.64.2.881-885.1990; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Diaz JJ, 1996, NATURE, V379, P273, DOI 10.1038/379273a0; DiazLatoud C, 1997, CELL STRESS CHAPERON, V2, P119, DOI 10.1379/1466-1268(1997)002<0119:HSVUPE>2.3.CO;2; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Gadad SS, 2011, J MOL BIOL, V410, P997, DOI 10.1016/j.jmb.2011.04.009; Gallo A, 2012, J BIOL CHEM, V287, P26539, DOI 10.1074/jbc.M112.371013; Giraud S, 2004, J VIROL, V78, P2984, DOI 10.1128/JVI.78.6.2984-2993.2004; Greco A, 2012, J VIROL, V86, P1449, DOI 10.1128/JVI.06194-11; He JJ, 2009, RNA BIOL, V6, P384, DOI 10.4161/rna.6.4.8920; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Huang WH, 2001, J BIOL CHEM, V276, P25166, DOI 10.1074/jbc.M010087200; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Jeong H, 2014, FEBS LETT, V588, P851, DOI 10.1016/j.febslet.2014.01.020; Kelly BJ, 2009, VIRUS RES, V145, P173, DOI 10.1016/j.virusres.2009.07.007; Khoo D, 2002, J VIROL, V76, P11971, DOI 10.1128/JVI.76.23.11971-11981.2002; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Kurki S, 2004, CELL CYCLE, V3, P976; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Lee SJ, 2009, J MICROBIOL, V47, P746, DOI [10.1007/s12275-009-0272-x, 10.1007/s12275-009-2720-z]; Li WH, 2009, CHINESE MED J-PEKING, V122, P15, DOI 10.3760/cma.j.issn.0366-6999.2009.01.004; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051466; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Liu CD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003084; Lv Maojie, 2011, Weishengwu Xuebao, V51, P643; Lymberopoulos MH, 2007, VIROLOGY, V363, P397, DOI 10.1016/j.virol.2007.01.028; Lymberopoulos MH, 2011, VIROLOGY, V412, P341, DOI 10.1016/j.virol.2011.01.016; Mai RT, 2006, ONCOGENE, V25, P448, DOI 10.1038/sj.onc.1209052; Malik-Soni N, 2014, J VIROL, V88, P2323, DOI 10.1128/JVI.02521-13; Malik-Soni N, 2012, J VIROL, V86, P6999, DOI 10.1128/JVI.00194-12; MARASCO WA, 1994, ARCH VIROL, V139, P133, DOI 10.1007/BF01309460; Matthews DA, 2001, J VIROL, V75, P1031, DOI 10.1128/JVI.75.2.1031-1038.2001; Mitrea DM, 2014, P NATL ACAD SCI USA, V111, P4466, DOI 10.1073/pnas.1321007111; Miyazaki Y, 1996, BIOCHIMIE, V78, P1081, DOI 10.1016/S0300-9084(97)86733-8; Mulvey M, 2006, J VIROL, V80, P7354, DOI 10.1128/JVI.00479-06; Ning B, 2004, J VIROL, V78, P13653, DOI 10.1128/JVI.78.24.13653-13668.2004; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Oliveira AP, 2013, VIRUS RES, V177, P108, DOI 10.1016/j.virusres.2013.07.010; Perea SE, 2008, MOL CELL BIOCHEM, V316, P163, DOI 10.1007/s11010-008-9814-5; Pereira Y, 2009, MOL CANCER THER, V8, P1189, DOI 10.1158/1535-7163.MCT-08-1056; Perera Y, 2012, J PEPT SCI, V18, P215, DOI 10.1002/psc.1432; Peters GA, 2002, J VIROL, V76, P11054, DOI 10.1128/JVI.76.21.11054-11064.2002; Risse SL, 2013, BIOL CHEM, V394, P421, DOI 10.1515/hsz-2012-0246; Roller RJ, 1996, J VIROL, V70, P2842, DOI 10.1128/JVI.70.5.2842-2851.1996; ROLLER RJ, 1991, J VIROL, V65, P5873, DOI 10.1128/JVI.65.11.5873-5879.1991; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000100; Samad MA, 2007, FEBS LETT, V581, P3283, DOI 10.1016/j.febslet.2007.06.024; Samad MA, 2012, J GEN VIROL, V93, P1328, DOI 10.1099/vir.0.036665-0; Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Schaerer-Uthurralt N, 1998, J GEN VIROL, V79, P1593, DOI 10.1099/0022-1317-79-7-1593; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Szebeni A, 1999, PROTEIN SCI, V8, P905; Taha MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091465; Taneva SG, 2009, J MOL BIOL, V393, P448, DOI 10.1016/j.jmb.2009.08.005; Thakur HC, 2014, J BIOL CHEM, V289, P74, DOI 10.1074/jbc.M113.532333; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Ugai H, 2012, VIROLOGY, V432, P283, DOI 10.1016/j.virol.2012.05.028; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Widera M, 2013, J VIROL, V87, P2707, DOI 10.1128/JVI.02755-12; Xing JJ, 2010, VIRUS RES, V153, P71, DOI 10.1016/j.virusres.2010.07.009; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251	84	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143634	10.1371/journal.pone.0143634	http://dx.doi.org/10.1371/journal.pone.0143634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624888	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600040
J	Hirata, Y; Brems, H; Suzuki, M; Kanamori, M; Okada, M; Morita, R; Llano-Rivas, I; Ose, T; Messiaen, L; Legius, E; Yoshimura, A				Hirata, Yasuko; Brems, Hilde; Suzuki, Mayu; Kanamori, Mitsuhiro; Okada, Masahiro; Morita, Rimpei; Llano-Rivas, Isabel; Ose, Toyoyuki; Messiaen, Ludwine; Legius, Eric; Yoshimura, Akihiko			Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase-activating protein (GAP); human genetics; mitogen-activated protein kinase (MAPK); protein domain; Ras protein; signal transduction; negative regulation	SPROUTY-RELATED PROTEIN; GAP-RELATED DOMAIN; NF1 GENE; MOLECULAR PATHOLOGY; MUTATIONAL SPECTRUM; TYROSINE KINASE; PHENOTYPE; GROWTH; IDENTIFICATION; RASOPATHIES	Constitutional heterozygous loss-of-function mutations in the SPRED1 gene cause a phenotype known as Legius syndrome, which consists of symptoms of multiple cafe-au-lait macules, axillary freckling, learning disabilities, and macrocephaly. Legius syndrome resembles a mild neurofibromatosis type 1 (NF1) phenotype. It has been demonstrated that SPRED1 functions as a negative regulator of the Ras-ERK pathway and interacts with neurofibromin, the NF1 gene product. However, the molecular details of this interaction and the effects of the mutations identified in Legius syndrome and NF1 on this interaction have not yet been investigated. In this study, using a yeast two-hybrid system and an immunoprecipitation assay in HEK293 cells, we found that the SPRED1 EVH1 domain interacts with the N-terminal 16 amino acids and the C-terminal 20 amino acids of the GTPase-activating protein (GAP)-related domain (GRD) of neurofibromin, which form two crossing -helix coils outside the GAP domain. These regions have been shown to be dispensable for GAP activity and are not present in p120(GAP). Several mutations in these N- and C-terminal regions of the GRD in NF1 patients and pathogenic missense mutations in the EVH1 domain of SPRED1 in Legius syndrome reduced the binding affinity between the EVH1 domain and the GRD. EVH1 domain mutations with reduced binding to the GRD also disrupted the ERK suppression activity of SPRED1. These data clearly demonstrate that SPRED1 inhibits the Ras-ERK pathway by recruiting neurofibromin to Ras through the EVH1-GRD interaction, and this study also provides molecular basis for the pathogenic mutations of NF1 and Legius syndrome.	[Hirata, Yasuko; Suzuki, Mayu; Kanamori, Mitsuhiro; Okada, Masahiro; Morita, Rimpei; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Brems, Hilde; Legius, Eric] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Llano-Rivas, Isabel] Hosp Univ Cruces, BioCruces Hlth Res Inst, Dept Genet, Biscay, Spain; [Ose, Toyoyuki] Hokkaido Univ, Dept Pharmaceut Sci, N12W6, Sapporo, Hokkaido 0600812, Japan; [Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL 35294 USA	Keio University; Universite Catholique Louvain; Hospital Universitario Cruces; Hokkaido University; University of Alabama System; University of Alabama Birmingham	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Brems, Hilde/AAN-4075-2020; Ose, Toyoyuki/AAW-7821-2020; Yoshimura, Akihiko/K-5515-2013	Ose, Toyoyuki/0000-0002-2001-9388; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [25221305]; Takeda Science Foundation; Uehara Memorial Foundation; "Opening the Future" grant from KU Leuven	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); "Opening the Future" grant from KU Leuven	This work was supported by special Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan 25221305, Advanced Research and Development Programs for Medical Innovation (AMED-CREST), the Takeda Science Foundation, the Uehara Memorial Foundation, and "Opening the Future" grant from KU Leuven (to E. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; ANDERSEN LB, 1993, MOL CELL BIOL, V13, P487, DOI 10.1128/MCB.13.1.487; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Brems Hilde, 2013, Keio Journal of Medicine, V62, P107, DOI 10.2302/kjm.2013-0002-RE; Brems H, 2012, HUM MUTAT, V33, P1538, DOI 10.1002/humu.22152; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Denayer E, 2011, HUM MUTAT, V32, pE1985, DOI 10.1002/humu.21404; Endo T, 2003, J BIOCHEM, V133, P109, DOI 10.1093/jb/mvg004; Harmer NJ, 2005, FEBS LETT, V579, P1161, DOI 10.1016/j.febslet.2004.11.114; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lorenz S, 2013, HUM MOL GENET, V22, P1643, DOI 10.1093/hmg/ddt014; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Messiaen L. M., 2008, V16, P63, DOI 10.1159/000126545; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Muram-Zborovski TM, 2010, J CHILD NEUROL, V25, P1203, DOI 10.1177/0883073809359540; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pasmant E, 2015, ONCOGENE, V34, P631, DOI 10.1038/onc.2013.587; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Taniguchi K, 2009, CANCER SCI, V100, P1648, DOI 10.1111/j.1349-7006.2009.01214.x; Thomas L, 2012, HUM MUTAT, V33, P1687, DOI 10.1002/humu.22162; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73	38	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3124	3134		10.1074/jbc.M115.703710	http://dx.doi.org/10.1074/jbc.M115.703710			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26635368	Green Published, hybrid			2022-12-26	WOS:000370854500001
J	Whisenant, TC; Peralta, ER; Aarreberg, LD; Gao, NJ; Head, SR; Ordoukhanian, P; Williamson, JR; Salomon, DR				Whisenant, Thomas C.; Peralta, Eigen R.; Aarreberg, Lauren D.; Gao, Nina J.; Head, Steven R.; Ordoukhanian, Phillip; Williamson, Jamie R.; Salomon, Daniel R.			The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HNRNP-L; SITE RECOGNITION; PROTEIN; EXON; BINDING; MECHANISMS; NETWORKS; PHOSPHORYLATION; DIFFERENTIATION	Activation of CD4 T cells is a reaction to challenges such as microbial pathogens, cancer and toxins that defines adaptive immune responses. The roles of T cell receptor crosslinking, intracellular signaling, and transcription factor activation are well described, but the importance of post-transcriptional regulation by RNA-binding proteins (RBPs) has not been considered in depth. We describe a new model expanding and activating primary human CD4 T cells and applied this to characterizing activation-induced assembly of splicing factors centered on U2AF2. We immunoprecipitated U2AF2 to identify what mRNA transcripts were bound as a function of activation by TCR crosslinking and costimulation. In parallel, mass spectrometry revealed the proteins incorporated into the U2AF2-centered RNA/protein interactome. Molecules that retained interaction with the U2AF2 complex after RNAse treatment were designated as "central" interactome members (CIMs). Mass spectrometry also identified a second class of activation-induced proteins, "peripheral" interacto memembers (PIMs), that bound to the same transcripts but were not in physical association with U2AF2 or its partners. siRNA knockdown of two CIMs and two PIMs caused changes in activation marker expression, cytokine secretion, and gene expression that were unique to each protein and mapped to pathways associated with key aspects of T cell activation. While knocking down the PIM, SYNCRIP, impacts a limited but immunologically important set of U2AF2-bound transcripts, knockdown of U2AF1 significantly impairs assembly of the majority of protein and mRNA components in the activation-induced interactome. These results demonstrated that CIMs and PIMs, either directly or indirectly through RNA, assembled into activation-induced U2AF2 complexes and play roles in post-transcriptional regulation of genes related to cytokine secretion. These data suggest an additional layer of regulation mediated by the activation-induced assembly of RNA splicing interactomes that is important for understanding T cell activation.	[Whisenant, Thomas C.; Peralta, Eigen R.; Aarreberg, Lauren D.; Gao, Nina J.; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Williamson, Jamie R.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Head, Steven R.; Ordoukhanian, Phillip] Scripps Res Inst, NGS & Microarray Core Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Salomon, DR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009	Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Gao, Nina/0000-0003-4314-3805; Hatfield, Lauren D/0000-0003-0095-9863	National Institute of Health [U01 GM094653, U19 A1063603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094653] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health (www.nih.gov)-U01 GM094653 to TCW, ERP, LDA, NJG, JRW, and DRS, with additional funding from National Institute of Health (www.nih.gov)-U19 A1063603 to SRH, PO, and DRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brooks AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087361; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chiou NT, 2013, MOL CELL, V49, P972, DOI 10.1016/j.molcel.2012.12.025; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Corrionero A, 2011, RNA, V17, P401, DOI 10.1261/rna.2444811; Di Fusco D, 2014, EXPERT OPIN THER TAR, V18, P1329, DOI 10.1517/14728222.2014.945426; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Faye MD, 2013, MOL CELL BIOL, V33, P307, DOI 10.1128/MCB.00546-12; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Graber TE, 2010, CELL DEATH DIFFER, V17, P719, DOI 10.1038/cdd.2009.164; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jin WX, 2012, FEBS LETT, V586, P3852, DOI 10.1016/j.febslet.2012.09.006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Kralovicova J, 2015, NUCLEIC ACIDS RES, V43, P3747, DOI 10.1093/nar/gkv194; LEDBETTER JA, 1993, CURR OPIN IMMUNOL, V5, P334, DOI 10.1016/0952-7915(93)90050-3; Mallory MJ, 2015, P NATL ACAD SCI USA, V112, pE2139, DOI 10.1073/pnas.1423695112; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naito T, 2011, INT IMMUNOL, V23, P661, DOI 10.1093/intimm/dxr078; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Pacheco TR, 2006, MOL CELL BIOL, V26, P8183, DOI 10.1128/MCB.00350-06; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Podshivalova K, 2013, CRIT REV IMMUNOL, V33, P435, DOI 10.1615/CritRevImmunol.2013006858; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Preussner M, 2012, NUCLEIC ACIDS RES, V40, P5666, DOI 10.1093/nar/gks221; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shao CW, 2014, NAT STRUCT MOL BIOL, V21, P997, DOI 10.1038/nsmb.2906; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie Aini, 2012, J Clin Cell Immunol, VSuppl 9, P1; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	65	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144409	10.1371/journal.pone.0144409	http://dx.doi.org/10.1371/journal.pone.0144409			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641092	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700111
J	Zughaier, SM; Kandler, JL; Balthazar, JT; Shafer, WM				Zughaier, Susu M.; Kandler, Justin L.; Balthazar, Jacqueline T.; Shafer, William M.			Phosphoethanolamine Modification of Neisseria gonorrhoeae Lipid A Reduces Autophagy Flux in Macrophages	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; NORMAL HUMAN SERUM; GONOCOCCAL-INFECTION; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; HELICOBACTER-PYLORI; INNATE IMMUNITY; PROTECTIVE ROLE; RESISTANCE; INDUCTION	Autophagy, an ancient homeostasis mechanism for macromolecule degradation, performs an important role in host defense by facilitating pathogen elimination. To counteract this host defense strategy, bacterial pathogens have evolved a variety of mechanisms to avoid or otherwise dysregulate autophagy by phagocytic cells so as to enhance their survival during infection. Neisseria gonorrhoeae is a strictly human pathogen that causes the sexually transmitted infection, gonorrhea. Phosphoethanolamine (PEA) addition to the 4' position of the lipid A (PEA-lipid A) moiety of the lipooligosaccharide (LOS) produced by gonococci performs a critical role in this pathogen's ability to evade innate defenses by conferring decreased susceptibility to cationic antimicrobial (or host-defense) peptides, complement-mediated killing by human serum and intraleukocytic killing by human neutrophils compared to strains lacking this PEA decoration. Heretofore, however, it was not known if gonococci can evade autophagy and if so, whether PEA-lipid A contributes to this ability. Accordingly, by using murine macrophages and human macrophage-like phagocytic cell lines we investigated if PEA decoration of gonococcal lipid A modulates autophagy formation. We report that infection with PEA-lipid A-producing gonococci significantly reduced autophagy flux in murine and human macrophages and enhanced gonococcal survival during their association with macrophages compared to a PEA-deficient lipid A mutant. Our results provide further evidence that PEA-lipid A produced by gonococci is a critical component in the ability of this human pathogen to evade host defenses.	[Zughaier, Susu M.; Shafer, William M.] Dept Vet Affairs Med Ctr Decatur, Lab Bacterial Pathogenesis, Atlanta, GA 30033 USA; [Zughaier, Susu M.; Kandler, Justin L.; Balthazar, Jacqueline T.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Shafer, William M.] Emory Univ, Sch Med, Emory Antibiot Resistance Ctr, Atlanta, GA USA	Emory University; Emory University	Zughaier, SM (corresponding author), Dept Vet Affairs Med Ctr Decatur, Lab Bacterial Pathogenesis, Atlanta, GA 30033 USA.	szughai@emory.edu	Zughaier, Susu/GLQ-9288-2022; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	VA Merit Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs [510 1BX000112-07]; Development Research Program grant from the Henry M. Jackson Foundation through NIH grant [1U19AI113170-01]; Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113170] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000112] Funding Source: NIH RePORTER	VA Merit Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; Development Research Program grant from the Henry M. Jackson Foundation through NIH grant; Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a VA Merit Award grant (510 1BX000112-07) to WMS. from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs. SMZ was supported by a Development Research Program grant from the Henry M. Jackson Foundation through NIH grant 1U19AI113170-01 (Ann E. Jerse, PI, Uniformed Services University, Bethesda, MD). WMS was supported by a Senior Research Career Award from the Biomedical Laboratory Research and Development Service of the Department of Veterans Affairs. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Veterans Affairs or the United States Government.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Al-Younes HM, 2004, INFECT IMMUN, V72, P4751, DOI 10.1128/IAI.72.8.4751-4762.2004; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Burman C, 2010, SEMIN IMMUNOPATHOL, V32, P397, DOI 10.1007/s00281-010-0222-z; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Chong A, 2012, AUTOPHAGY, V8, P1342, DOI 10.4161/auto.20808; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Czeslick E, 2006, INFLAMM RES, V55, P511, DOI 10.1007/s00011-006-6057-3; Deuretzbacher A, 2009, J IMMUNOL, V183, P5847, DOI 10.4049/jimmunol.0804242; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fine KL, 2012, CELL MICROBIOL, V14, P1402, DOI 10.1111/j.1462-5822.2012.01804.x; Fritz T, 2011, GUT, V60, P1580, DOI 10.1136/gut.2009.206466; Guo F, 2012, CELL MOL BIOL LETT, V17, P249, DOI 10.2478/s11658-012-0009-4; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Handing JW, 2015, CELL MICROBIOL, V17, P910, DOI 10.1111/cmi.12411; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Hobbs MM, 2013, MBIO, V4, DOI 10.1128/mBio.00892-13; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jia KL, 2007, AUTOPHAGY, V3, P21, DOI 10.4161/auto.3528; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Johnson MB, 2013, CELL MICROBIOL, V15, P1323, DOI 10.1111/cmi.12117; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kandler JL, 2014, ANTIMICROB AGENTS CH, V58, P4230, DOI 10.1128/AAC.03108-14; Klose J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095970; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Lewis LA, 2013, INFECT IMMUN, V81, P33, DOI 10.1128/IAI.00751-12; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2009, METHOD ENZYMOL, V452, P363, DOI 10.1016/S0076-6879(08)03622-7; Packiam M, 2012, MUCOSAL IMMUNOL, V5, P19, DOI 10.1038/mi.2011.38; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Packiam M, 2010, INFECT IMMUN, V78, P433, DOI 10.1128/IAI.00711-09; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Raju D, 2012, AUTOPHAGY, V8, P1387, DOI 10.4161/auto.21007; Raju D, 2012, GASTROENTEROLOGY, V142, P1160, DOI 10.1053/j.gastro.2012.01.043; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Rossignol DP, 2002, J ENDOTOXIN RES, V8, P483, DOI 10.1179/096805102125001127; Sato E, 2013, J DERMATOL SCI, V70, P166, DOI 10.1016/j.jdermsci.2013.01.011; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; SHAFER WM, 1986, INFECT IMMUN, V54, P184, DOI 10.1128/IAI.54.1.184-188.1986; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shafer WM, 2002, J ENDOTOXIN RES, V8, P47, DOI 10.1179/096805102125000083; SHAFER WM, 1984, J INFECT DIS, V149, P175, DOI 10.1093/infdis/149.2.175; Shahnazari S, 2011, AUTOPHAGY, V7, P957, DOI 10.4161/auto.7.9.16435; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Stankowski RV, 2012, SEX TRANSM DIS, V39, P238, DOI 10.1097/OLQ.0b013e3182471974; Tattoli I, 2012, AUTOPHAGY, V8, P1848, DOI 10.4161/auto.21863; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Ubale RV, 2013, J MICROENCAPSUL, V30, P28, DOI 10.3109/02652048.2012.692402; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Vidal R, 2011, CURR MOL MED, V11, P1, DOI 10.2174/156652411794474419; Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; World Health Organization, 2011, EM MULT RES NEISS GO; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009165; Zughaier SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087688; Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369	82	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144347	10.1371/journal.pone.0144347	http://dx.doi.org/10.1371/journal.pone.0144347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641098	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700102
J	Birget, PLG; Koella, JC				Birget, Philip L. G.; Koella, Jacob C.			An Epidemiological Model of the Effects of Insecticide-Treated Bed Nets on Malaria Transmission	PLOS ONE			English	Article							WESTERN KENYA; VECTOR CONTROL; IMPREGNATED BEDNETS; MATHEMATICAL-MODEL; MOSQUITOS DIPTERA; FIELD-EVALUATION; CHILD-MORTALITY; IMPACT; REPELLENTS; AREA	Insecticide-treated bed nets (ITNs) have become a central tool for malaria control because they provide personal and community-wide protection through their repellent and insecticidal properties. Here we propose a model that allows to assess the relative importance of those two effects in different epidemiological contexts and we show that these two levels of protection may oppose each other. On the one hand, repellency offers personal protection to the users of ITNs. The repellent action, however, is a two-edged sword, for it diverts infectious mosquitoes to non-users, thereby increasing their risk. Furthermore, with increasing ITN coverage, the personal protection effect of repellency decreases as mosquitoes are forced to perform multiple feeding attempts even on ITN users. On the other hand, the insecticidal property, which offers community-wide protection by killing mosquitoes, requires that mosquitoes contact the insecticide on the ITN and is thus counteracted by the repellency. Our model confirms that ITNs are an effective intervention method by reducing total malaria prevalence in the population, but that there is a conflict between personal protection, offered by repellency, and community-wide protection, which relies on the ITN's insecticidal properties. Crucially, the model suggests that weak repellency allows disease elimination at lower ITN coverage levels.	[Birget, Philip L. G.] Univ London Imperial Coll Sci Technol & Med, Silwood Pk, Ascot, Berks, England; [Koella, Jacob C.] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Imperial College London; University of Neuchatel	Birget, PLG (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	p.l.g.birget@sms.ed.ac.uk						ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Aron J.L., 1982, P139; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bejon P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008321; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Birget Philip L. G., 2015, Evolution Medicine and Public Health, P205, DOI 10.1093/emph/eov019; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Chen-Hussey V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070664; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256; GUPTA RK, 1994, AM J TROP MED HYG, V50, P82, DOI 10.4269/ajtmh.1994.50.82; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hewitt S, 1997, B ENTOMOL RES, V87, P455, DOI 10.1017/S0007485300041316; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Iwashita H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-52; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-146; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Klepac P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0137; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lindblade KA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0554-1; LINDSAY SW, 1992, B ENTOMOL RES, V82, P49, DOI 10.1017/S0007485300051488; Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2; Mutuku FM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-356; Ngwa GA, 2000, MATH COMPUT MODEL, V32, P747, DOI 10.1016/S0895-7177(00)00169-2; Padonou GG, 2012, PARASITE VECTOR, V5, P1; Ross R., 1910, PREVENTION MALARIA; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026; Smith DL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0145; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Soetaert K, 2009, ROOTSOLVE NONLINEAR; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; Wagman JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0692-5	59	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144173	10.1371/journal.pone.0144173	http://dx.doi.org/10.1371/journal.pone.0144173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636568	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800053
J	Karhson, DS; Mock, JR; Golob, EJ				Karhson, Debra S.; Mock, Jeffrey R.; Golob, Edward J.			The Role of Right Inferior Parietal Cortex in Auditory Spatial Attention: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SOUND LOCALIZATION; UNILATERAL NEGLECT; VISUAL-ATTENTION; SIGNAL-DETECTION; DETECTION TASK; P300 LATENCY; HUMAN BRAIN; MECHANISMS; REPRESENTATIONS	Behavioral studies support the concept of an auditory spatial attention gradient by demonstrating that attentional benefits progressively diminish as distance increases from an attended location. Damage to the right inferior parietal cortex can induce a rightward attention bias, which implicates this region in the construction of attention gradients. This study used event-related potentials (ERPs) to define attention-related gradients before and after repetitive transcranial magnetic stimulation (rTMS) to the right inferior parietal cortex. Subjects (n = 16) listened to noise bursts at five azimuth locations (left to right: -90 degrees, -45 degrees, 0 degrees midline, +45 degrees, +90 degrees) and responded to stimuli at one target location (-90 degrees, +90 degrees, separate blocks). ERPs as a function of non-target location were examined before (baseline) and after 0.9 Hz rTMS. Results showed that ERP attention gradients were observed in three time windows (frontal 230-340, parietal 400-460, frontal 550-750 ms). Significant transient rTMS effects were seen in the first and third windows. The first window had a voltage decrease at the farthest location when attending to either the left or right side. The third window had on overall increase in positivity, but only when attending to the left side. These findings suggest that rTMS induced a small contraction in spatial attention gradients within the first time window. The asymmetric effect of attended location on gradients in the third time window may relate to neglect of the left hemispace after right parietal injury. Together, these results highlight the role of the right inferior parietal cortex in modulating frontal lobe attention network activity.	[Karhson, Debra S.; Golob, Edward J.] Tulane Univ, Program Neurosci, New Orleans, LA 70118 USA; [Mock, Jeffrey R.; Golob, Edward J.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA; [Golob, Edward J.] Tulane Univ, Ctr Aging, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Golob, EJ (corresponding author), Tulane Univ, Program Neurosci, New Orleans, LA 70118 USA.	egolob@tulane.edu		Mock, Jeffrey/0000-0003-0446-6687; Karhson, Debra/0000-0002-3850-3119	National Science Foundation [BCS-0844961]; Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program	National Science Foundation(National Science Foundation (NSF)); Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program	This study was supported by funding from National Science Foundation (BCS-0844961) and the Southern Regional Education Board - Louisiana Board of Regents Doctoral Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank John Holmes, Michael Seay, Kelsey Ward, and Drs. Kate Yurgil and Jeremy Nelson for valuable discussions and help with this study. This work was supported by the National Science Foundation (BCS-0844961).	Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Arnott SR, 2002, PSYCHOPHYSIOLOGY, V39, P625, DOI 10.1017/S0048577202394149; At A, 2011, NEUROPSYCHOLOGIA, V49, P2794, DOI 10.1016/j.neuropsychologia.2011.05.024; Barrett AM, 1998, NEUROLOGY, V51, P972, DOI 10.1212/WNL.51.4.972; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Bellmann A, 2001, BRAIN, V124, P676, DOI 10.1093/brain/124.4.676; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Blauert J., 1997, SPATIAL HEARING PSYC; CARLILE S, 1996, VIRTUAL AUDITORY SPA; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Cave KR, 1999, PSYCHON B REV, V6, P204, DOI 10.3758/BF03212327; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Clarke S, 1998, NEUROREPORT, V9, P3433, DOI 10.1097/00001756-199810260-00018; Clarke S, 2004, CORTEX, V40, P291, DOI 10.1016/S0010-9452(08)70124-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Golob EJ, 2016, PERCEPTION, V45, P165, DOI 10.1177/0301006615599906; Golob EJ, 2011, BRAIN RES, V1384, P128, DOI 10.1016/j.brainres.2011.01.089; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; HEILMAN KM, 1972, ARCH NEUROL-CHICAGO, V26, P32, DOI 10.1001/archneur.1972.00490070050007; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Kong LQ, 2014, CEREB CORTEX, V24, P773, DOI 10.1093/cercor/bhs359; LABERGE D, 1989, PSYCHOL REV, V96, P101, DOI 10.1037/0033-295X.96.1.101; Lewald J, 2004, NEUROPSYCHOLOGIA, V42, P1598, DOI 10.1016/j.neuropsychologia.2004.04.012; Lewald J, 2004, J COGNITIVE NEUROSCI, V16, P828, DOI 10.1162/089892904970834; Macaluso E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00685; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Middlebrooks JC, 1981, J NEUROSCI, V1; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Mock JR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00179; MONDOR TA, 1995, J EXP PSYCHOL HUMAN, V21, P387, DOI 10.1037/0096-1523.21.2.387; Muggleton NG, 2006, NEUROPSYCHOLOGIA, V44, P1222, DOI 10.1016/j.neuropsychologia.2005.10.004; NASH A, 1994, BIOL PSYCHOL, V37, P219, DOI 10.1016/0301-0511(94)90004-3; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Price CJ, 2001, J COGNITIVE NEUROSCI, V13, P419, DOI 10.1162/08989290152001853; PRITCHARD WS, 1986, PSYCHOPHYSIOLOGY, V23, P166, DOI 10.1111/j.1469-8986.1986.tb00611.x; Rader SK, 2008, CLIN NEUROPHYSIOL, V119, P1176, DOI 10.1016/j.clinph.2008.01.014; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; ROHRBAUGH JW, 1978, ELECTROEN CLIN NEURO, V45, P551, DOI 10.1016/0013-4694(78)90156-6; Rorden C, 2001, EXP BRAIN RES, V137, P487, DOI 10.1007/s002210100679; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; RUCHKIN DS, 1980, ELECTROEN CLIN NEURO, V50, P35, DOI 10.1016/0013-4694(80)90321-1; Rushworth MFS, 2006, NEUROPSYCHOLOGIA, V44, P2700, DOI 10.1016/j.neuropsychologia.2005.12.007; SCHARF B, 1998, ATTENTION, P75; Siebner HR, 2009, BRAIN STIMUL, V2, P58, DOI 10.1016/j.brs.2008.11.002; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; SQUIRES KC, 1975, J EXP PSYCHOL HUMAN, V1, P268, DOI 10.1037/0096-1523.1.3.268; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; Teder-Salejarvi WA, 1998, PERCEPT PSYCHOPHYS, V60, P1228, DOI 10.3758/BF03206172; Teder-Salejarvi WA, 1999, COGNITIVE BRAIN RES, V8, P213, DOI 10.1016/S0926-6410(99)00023-3; Vallar G, 1997, PHILOS T ROY SOC B, V352, P1401, DOI 10.1098/rstb.1997.0126; Vallar G, 2007, CNS SPECTRUMS, V12, P527, DOI 10.1017/S1092852900021271; YUND EW, 1990, BRAIN COGNITION, V12, P42, DOI 10.1016/0278-2626(90)90003-7	75	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144221	10.1371/journal.pone.0144221	http://dx.doi.org/10.1371/journal.pone.0144221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636333	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800059
J	Neugebauer, T; Bordeleau, E; Burrus, V; Brzezinski, R				Neugebauer, Tomasz; Bordeleau, Eric; Burrus, Vincent; Brzezinski, Ryszard			DNA Data Visualization (DDV): Software for Generating Web-Based Interfaces Supporting Navigation and Analysis of DNA Sequence Data of Entire Genomes	PLOS ONE			English	Article							TANDEM REPEATS; STREPTOMYCES; REPLICATION; ORGANIZATION; ELEMENTS; MOBILE	Data visualization methods are necessary during the exploration and analysis activities of an increasingly data-intensive scientific process. There are few existing visualization methods for raw nucleotide sequences of a whole genome or chromosome. Software for data visualization should allow the researchers to create accessible data visualization interfaces that can be exported and shared with others on the web. Herein, novel software developed for generating DNA data visualization interfaces is described. The software converts DNA data sets into images that are further processed as multi-scale images to be accessed through a web-based interface that supports zooming, panning and sequence fragment selection. Nucleotide composition frequencies and GC skew of a selected sequence segment can be obtained through the interface. The software was used to generate DNA data visualization of human and bacterial chromosomes. Examples of visually detectable features such as short and long direct repeats, long terminal repeats, mobile genetic elements, heterochromatic segments in microbial and human chromosomes, are presented. The software and its source code are available for download and further development. The visualization interfaces generated with the software allow for the immediate identification and observation of several types of sequence patterns in genomes of various sizes and origins. The visualization interfaces generated with the software are readily accessible through a web browser. This software is a useful research and teaching tool for genetics and structural genomics.	[Neugebauer, Tomasz] Concordia Univ Libraries, Montreal, PQ, Canada; [Bordeleau, Eric; Burrus, Vincent; Brzezinski, Ryszard] Univ Sherbrooke, Dept Biol, Fac Sci, Sherbrooke, PQ J1K 2R1, Canada	Concordia University - Canada; University of Sherbrooke	Neugebauer, T (corresponding author), Concordia Univ Libraries, Montreal, PQ, Canada.	tomasz.neugebauer@concordia.ca	Burrus, Vincent/H-5000-2019	Burrus, Vincent/0000-0001-6318-6904; Neugebauer, Tomasz/0000-0002-9743-5910	Concordia University Libraries; Natural Sciences and Engineering Council of Canada [326810, 412288]; Cystic Fibrosis Canada-Kin Canada Fellowship; Le Fonds de Recherche du Quebec - Sante (FRQS); Le Fonds de Recherche du Quebec-Sante (FRQS);  [2014-05177]	Concordia University Libraries; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada-Kin Canada Fellowship; Le Fonds de Recherche du Quebec - Sante (FRQS); Le Fonds de Recherche du Quebec-Sante (FRQS); 	Work at Concordia University was supported by Concordia University Libraries. Work at Sherbrooke University was supported by Discovery Grant and Discovery Acceleration Supplement from the Natural Sciences and Engineering Council of Canada [326810 and 412288] to VB and Discovery Grant 2014-05177 to RB. VB holds a Canada Research Chair in Bacterial Molecular Genetics. EB is the recipient of a Cystic Fibrosis Canada-Kin Canada Fellowship and a postdoctoral fellowship from Le Fonds de Recherche du Quebec - Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work at Concordia University was supported by Concordia University Libraries. Work at Sherbrooke University was supported by Discovery Grant and Discovery Acceleration Supplement from the Natural Sciences and Engineering Council of Canada [326810 and 412288] to VB and Discovery Grant 2014-05177 to RB. VB holds a Canada Research Chair in Bacterial Molecular Genetics. EB is the recipient of a Cystic Fibrosis Canada-Kin Canada Fellowship and a postdoctoral fellowship from Le Fonds de Recherche du Quebec-Sante (FRQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Brouwer MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023014; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Farrow KA, 2001, MICROBIOL-SGM, V147, P2717, DOI 10.1099/00221287-147-10-2717; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Garber M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r60; Hopwood DA, 2006, ANNU REV GENET, V40, P1, DOI 10.1146/annurev.genet.40.110405.090639; Isenberg P, 2011, INFORM VISUAL, V10, P310, DOI 10.1177/1473871611412817; Jankowitsch F, 2012, J BACTERIOL, V194, P6818, DOI 10.1128/JB.01592-12; Kepes F, 2012, FEBS LETT, V586, P2043, DOI 10.1016/j.febslet.2012.03.051; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Makino S, 1999, P JPN ACAD B-PHYS, V75, P311, DOI 10.2183/pjab.75.311; Martinez K, 2005, IEEE IMAGE PROC, P2485; National Library of Medicine, BAS LOC AL SEARCH TO; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; PERNODET JL, 1989, GENE, V79, P33, DOI 10.1016/0378-1119(89)90090-5; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; Seaman JD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-452; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Weaver D, 2004, MOL MICROBIOL, V51, P1535, DOI 10.1111/j.1365-2958.2003.03920.x; Wlodarczyk M, 2006, POSTEP MIKROBIOL, V45, P5; WRIGHT F, 1992, GENE, V113, P55, DOI 10.1016/0378-1119(92)90669-G; Yoshida T, 2000, J MOL BIOL, V298, P343, DOI 10.1006/jmbi.2000.3667; ZarkoPostawka M, 1997, GENE, V185, P231	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143615	10.1371/journal.pone.0143615	http://dx.doi.org/10.1371/journal.pone.0143615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636979	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000366143800021
J	Zhang, YC; Li, WJ; Dou, YJ; Zhang, JX; Jiang, GH; Miao, LX; Han, GF; Liu, YX; Li, H; Zhang, ZH				Zhang, Yuchao; Li, Weijia; Dou, Yujuan; Zhang, Junxiang; Jiang, Guihua; Miao, Lixiang; Han, Guofen; Liu, Yuexue; Li, He; Zhang, Zhihong			Transcript Quantification by RNA-Seq Reveals Differentially Expressed Genes in the Red and Yellow Fruits of Fragaria vesca	PLOS ONE			English	Article							SUPPRESSES ANTHOCYANIN; BIOSYNTHESIS; STRAWBERRY; MYB; PIGMENTATION; ACCUMULATION; IDENTIFICATION; COLORATION; PROTEIN; BLAST	Fragaria vesca (2n = 2x = 14), the woodland strawberry, is a perennial herbaceous plant with a small sequenced genome (240 Mb). It is commonly used as a genetic model plant for the Fragaria genus and the Rosaceae family. Fruit skin color is one of the most important traits for both the commercial and esthetic value of strawberry. Anthocyanins are the most prominent pigments in strawberry that bring red, pink, white, and yellow hues to the fruits in which they accumulate. In this study, we conducted a de novo assembly of the fruit transcriptome of woodland strawberry and compared the gene expression profiles with yellow (Yellow Wonder, YW) and red (Ruegen, RG) fruits. De novo assembly yielded 75,426 unigenes, 21.3% of which were longer than 1,000 bp. Among the high-quality unique sequences, 45,387 (60.2%) had at least one significant match to an existing gene model. A total of 595 genes, representing 0.79% of total unigenes, were differentially expressed in YW and RG. Among them, 224 genes were up-regulated and 371 genes were down-regulated in the fruit of YW. Particularly, some flavonoid biosynthetic pathway genes, including C4H, CHS, CHI, F3H, DFR and ANS, as well as some transcription factors (TFs), including MYB (putative MYB86 and MYB39), WDR and MADS, were down-regulated in YW fruit, concurrent with a reduction in anthocyanin accumulation in the yellow pigment phenotype, whereas a putative transcription repressor MYB1R was up-regulated in YW fruit. The altered expression levels of the genes encoding flavonoid biosynthetic enzymes and TFs were confirmed by quantitative RT-PCR. Our study provides important insights into the molecular mechanisms underlying the yellow pigment phenotype in F. vesca.	[Zhang, Yuchao; Li, Weijia; Dou, Yujuan; Zhang, Junxiang; Han, Guofen; Liu, Yuexue; Li, He; Zhang, Zhihong] Shenyang Agr Univ, Coll Hort, Shenyang 110866, Peoples R China; [Zhang, Yuchao; Jiang, Guihua; Miao, Lixiang] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou 310021, Zhejiang, Peoples R China; [Dou, Yujuan] Inst Soil & Water Conservat Liaoning Prov, Chaoyang 122000, Peoples R China	Shenyang Agricultural University; Zhejiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Zhang, ZH (corresponding author), Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Peoples R China.	zhang_sau@163.com	Zhang, Zhihong/W-1011-2017	Zhang, Zhihong/0000-0001-5935-1567	National Natural Science Foundation of China [31372037]; Science and Technology Program of Liaoning Province [2015204013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Liaoning Province	This research was supported by National Natural Science Foundation of China (Grant No. 31372037) and by Science and Technology Program of Liaoning Province (No. 2015204013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Chang L, 2007, J PHYTOPATHOL, V155, P431, DOI 10.1111/j.1439-0434.2007.01254.x; Chen JX, 2014, ACTA PHYSIOL PLANT, V36, P2441, DOI 10.1007/s11738-014-1617-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng C, 2001, THEOR APPL GENET, V103, P316, DOI 10.1007/s001220100648; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Jaakola L, 2010, PLANT PHYSIOL, V153, P1619, DOI 10.1104/pp.110.158279; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jiang F, 2013, J PLANT GROWTH REGUL, V32, P182, DOI 10.1007/s00344-012-9289-1; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lalusin AG, 2006, MOL GENET GENOMICS, V275, P44, DOI 10.1007/s00438-005-0080-x; Lalusin AG, 2011, PHILIPP J CROP SCI, V36, P30; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lin-Wang K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00651; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Miosic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112707; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakatsuka T, 2013, PLANT CELL REP, V32, P1925, DOI 10.1007/s00299-013-1504-4; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; PIRIE A, 1976, PLANT PHYSIOL, V58, P468, DOI 10.1104/pp.58.4.468; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Salvatierra A, 2013, PHYTOCHEMISTRY, V90, P25, DOI 10.1016/j.phytochem.2013.02.016; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shimada S, 2005, PLANT J, V44, P950, DOI 10.1111/j.1365-313X.2005.02574.x; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Smyth D, 2000, TRENDS PLANT SCI, V5, P315, DOI 10.1016/S1360-1385(00)01690-3; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wu J, 2013, TREE GENET GENOMES, V9, P75, DOI 10.1007/s11295-012-0534-3; Yuan YW, 2013, GENETICS, V194, P255, DOI 10.1534/genetics.112.146852; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu HF, 2009, MOL PLANT, V2, P790, DOI 10.1093/mp/ssp030	50	34	37	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144356	10.1371/journal.pone.0144356	http://dx.doi.org/10.1371/journal.pone.0144356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636322	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800080
J	Jain, V; Chang, W; Byonanebye, DM; Owaraganise, A; Twinomuhwezi, E; Amanyire, G; Black, D; Marseille, E; Kamya, MR; Havlir, DV; Kahn, JG				Jain, Vivek; Chang, Wei; Byonanebye, Dathan M.; Owaraganise, Asiphas; Twinomuhwezi, Ellon; Amanyire, Gideon; Black, Douglas; Marseille, Elliot; Kamya, Moses R.; Havlir, Diane V.; Kahn, James G.			Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+T-Cell Counts > 350 cells/uL in Rural Uganda	PLOS ONE			English	Article							CLINICAL-OUTCOMES; HEALTH WORKER; SOUTH-AFRICA; RISK-FACTORS; CARE; RETENTION; ADULTS; ELIGIBILITY; PREVENTION; INITIATION	Background Evidence favoring earlier HIV ART initiation at high CD4+ T-cell counts (CD4>350/uL) has grown, and guidelines now recommend earlier HIV treatment. However, the cost of providing ART to individuals with CD4>350 in Sub-Saharan Africa has not been well estimated. This remains a major barrier to optimal global cost projections for accelerating the scale-up of ART. Our objective was to compute costs of ART delivery to high CD4+ count individuals in a typical rural Ugandan health center-based HIV clinic, and use these data to construct scenarios of efficient ART scale-up. Methods Within a clinical study evaluating streamlined ART delivery to 197 individuals with CD4+ cell counts >350 cells/uL (EARLI Study: NCT01479634) in Mbarara, Uganda, we performed a micro-costing analysis of administrative records, ART prices, and time-and-motion analysis of staff work patterns. We computed observed per-person-per-year (ppy) costs, and constructed models estimating costs under several increasingly efficient ART scale-up scenarios using local salaries, lowest drug prices, optimized patient loads, and inclusion of viral load (VL) testing. Findings Among 197 individuals enrolled in the EARLI Study, median pre-ART CD4+ cell count was 569/uL (IQR 451-716). Observed ART delivery cost was $628 ppy at steady state. Models using local salaries and only core laboratory tests estimated costs of $529/$445 ppy (+/-VL testing, respectively). Models with lower salaries, lowest ART prices, and optimized healthcare worker schedules reduced costs by $100-200 ppy. Costs in a maximally efficient scale-up model were $320/$236 ppy (+/-VL testing). This included $39 for personnel, $106 for ART, $130/$46 for laboratory tests, and $46 for administrative/other costs. A key limitation of this study is its derivation and extrapolation of costs from one large rural treatment program of high CD4+ count individuals. Conclusions In a Ugandan HIV clinic, ART delivery costs-including VL testing-for individuals with CD4>350 were similar to estimates from high-efficiency programs. In higher efficiency scale-up models, costs were substantially lower. These favorable costs may be achieved because high CD4+ count patients are often asymptomatic, facilitating more efficient streamlined ART delivery. Our work provides a framework for calculating costs of efficient ART scale-up models using accessible data from specific programs and regions.	[Jain, Vivek; Black, Douglas; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Jain, Vivek; Byonanebye, Dathan M.; Owaraganise, Asiphas; Twinomuhwezi, Ellon; Black, Douglas; Kamya, Moses R.; Havlir, Diane V.] Makerere Univ UCSF MU UCSF Res Collaborat, Kampala, Uganda; [Chang, Wei; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Amanyire, Gideon] Makerere Univ Joint AIDS Program MJAP, Kampala, Uganda; [Marseille, Elliot] Hlth Strategies Int, Oakland, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University	Jain, V (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	vivek.jain@ucsf.edu	Byonanebye, Dathan/HDN-5435-2022; Chang, Wei/AAE-3555-2021; Chang, Wei/M-7473-2016	Owaraganise, Asiphas/0000-0002-5594-0310; Byonanebye, Dathan M/0000-0001-9862-4724; Chang, Wei/0000-0002-2949-269X	National Institutes of Health [U01 AI069502, P30 AI027763]; UCSF [R01 DA15612]; UCSF-CTSI [KL2TR000143]; Gilead Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959, U01AI069502, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; UCSF-CTSI; Gilead Sciences(Gilead Sciences); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health U01 AI069502 to DH, P30 AI027763 to Paul Volberding, UCSF, R01 DA15612 to JGK, and UCSF-CTSI KL2TR000143 and an investigator-initiated grant from Gilead Sciences to VJ. An antiretroviral medication (Truvada) was donated to the study by Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adakun SA, 2013, JAIDS-J ACQ IMM DEF, V62, P317, DOI 10.1097/QAI.0b013e3182800daf; Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; [Anonymous], 2011, EARLI STUDY EARLY AN; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Chang LVW, 2009, JAIDS-J ACQ IMM DEF, V50, P276, DOI 10.1097/QAI.0b013e3181988375; Chang Larry William, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P130, DOI 10.1177/1545109708318525; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Drummond MF, 2015, METHODS EC EVALUATIO; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Hendrich Ann, 2008, Perm J, V12, P25; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Jain V, 2014, AIDS, V28, P2241, DOI 10.1097/QAD.0000000000000401; Johns B, 2014, JAIDS-J ACQ IMM DEF, V65, pE140, DOI 10.1097/QAI.0000000000000064; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB REP UNAIDS REP, P1; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2013, ACC ANT THER AFR STA, P1; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Larson BA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18026; Matthews LT, 2015, J ACQUIR IMMUNE DEFI; Mbilinyi D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-266; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Mills FP, 2012, JAIDS-J ACQ IMM DEF, V61, P364, DOI 10.1097/QAI.0b013e318265df06; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Scott CA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-296; Sempa J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-736; Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stover J, 2014, AIDS, V28, pS225, DOI 10.1097/QAD.0000000000000235; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; U.S. Department of Labor Bureau of Labor Statistics, CPI INFL CALC 2015; Uganda Ministry of Health, 2012, UG INT NAT GUID ANT; Were MC, 2008, AIDS CARE, V20, P677, DOI 10.1080/09540120701687067; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, WORLD HEAL ORGAN, P1; World Health Organization, 2013, COMPREHENSIVE CERVIC; World Helath Organisation WHO, 2014, 2013 CONS GUID US S, P1	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143433	10.1371/journal.pone.0143433	http://dx.doi.org/10.1371/journal.pone.0143433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632823	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000014
J	Klop, C; Welsing, PMJ; Leufkens, HGM; Elders, PJM; Overbeek, JA; van den Bergh, JP; Bijlsma, JWJ; de Vries, F				Klop, Corinne; Welsing, Paco M. J.; Leufkens, Hubert G. M.; Elders, Petra J. M.; Overbeek, Jetty A.; van den Bergh, Joop P.; Bijlsma, Johannes W. J.; de Vries, Frank			The Epidemiology of Hip and Major Osteoporotic Fractures in a Dutch Population of Community-Dwelling Elderly: Implications for the Dutch FRAX (R) Algorithm	PLOS ONE			English	Article							VERTEBRAL FRACTURES; INCIDENCE RATES; HEALTH-CARE; WOMEN; TRENDS; RISK; MEN; ASSOCIATION; NETHERLANDS; CALIBRATION	Background Incidence rates of non-hip major osteoporotic fractures (MOF) remain poorly characterized in the Netherlands. The Dutch FRAX (R) algorithm, which predicts 10-year probabilities of hip fracture and MOF (first of hip, humerus, forearm, clinical vertebral), therefore incorporates imputed MOF rates. Swedish incidence rate ratios for hip fracture to MOF (Malmo 1987-1996) were used to perform this imputation. However, equality of these ratios between countries is uncertain and recent evidence is scarce. Aims were to estimate incidence rates of hip fracture and MOF and to compare observed MOF rates to those predicted by the imputation method for the Netherlands. Methods Using hospitalisation and general practitioner records from the Dutch PHARMO Database Network (2002-2011) we calculated age-and-sex-specific and age-standardized incidence rates (IRs) of hip and other MOFs (humerus, forearm, clinical vertebral) and as used in FRAX (R). Observed MOF rates were compared to those predicted among community-dwelling individuals >= 50 years by the standardized incidence ratio (SIR; 95% CI). Results Age-standardized IRs (per 10,000 person-years) of MOF among men and women >= 50 years were 25.9 and 77.0, respectively. These numbers were 9.3 and 24.0 for hip fracture. Among women 55-84 years, observed MOF rates were significantly higher than predicted (SIR ranged between 1.12-1.50, depending on age). In men, the imputation method performed reasonable. Conclusion Observed MOF incidence was higher than predicted for community-dwelling women over a wide age-range, while it agreed reasonable for men. As miscalibration may influence treatment decisions, there is a need for confirmation of results in another data source. Until then, the Dutch FRAX1output should be interpreted with caution.	[Klop, Corinne; Leufkens, Hubert G. M.; de Vries, Frank] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Welsing, Paco M. J.; Bijlsma, Johannes W. J.] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Welsing, Paco M. J.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care, Amsterdam, Netherlands; [Overbeek, Jetty A.] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands; [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands; [van den Bergh, Joop P.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands; [van den Bergh, Joop P.] Univ Hasselt, Biomed Res Inst, Hasselt, Belgium; [de Vries, Frank] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-6200 MD Maastricht, Netherlands; [de Vries, Frank] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VieCuri Medical Center; Maastricht University; Hasselt University; Maastricht University; University of Southampton	de Vries, F (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	f.devries@uu.nl	Overbeek, Jetty/AAG-1770-2019; de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van den Bergh, Joop/0000-0003-3984-2232; Elders, Petra/0000-0002-5907-7219	Netherlands Organization for Health Research and Development [ZonMw] [113101007]	Netherlands Organization for Health Research and Development [ZonMw](Netherlands Organization for Health Research and Development)	Support was provided by the Netherlands Organization for Health Research and Development [ZonMw; http://www.zonmw.nl/nl/; grant 113101007]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bruin de A, 2009, METHODE BIJSCHATTEN; Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51; CBO Kwaliteitsinstituut voor de Gezondheidszorg Nederlandse Vereniging voor Reumatologie, 2011, RICHTL OST FRACT DER; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; de Putter CE, 2013, INJURY, V44, P421, DOI 10.1016/j.injury.2012.10.025; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Finsterwald M, 2014, OSTEOPOROSIS INT, V25, P167, DOI 10.1007/s00198-013-2513-4; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Herings R., 2012, PHARMACOEPIDEM DR S, P270, DOI [10.1002/9781119959946.ch18, DOI 10.1002/9781119959946.CH18]; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; Jean S, 2013, J BONE MINER RES, V28, P1283, DOI 10.1002/jbmr.1863; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0144-1; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Klop C, 2015, OSTEOPOROSIS INT, V26, P1831, DOI 10.1007/s00198-015-3084-3; Lalmohamed A, 2012, OSTEOPOROSIS INT, V23, P861, DOI 10.1007/s00198-011-1852-2; Lam A, 2014, J BONE MINER RES, V29, P1067, DOI 10.1002/jbmr.2146; Leslie WD, 2011, OSTEOPOROSIS INT, V22, P2137, DOI 10.1007/s00198-010-1470-4; Leslie WD, 2011, J CLIN DENSITOM, V14, P272, DOI 10.1016/j.jocd.2011.03.007; Merrill R. M., INTRO EPIDEMIOLOGY, P98; National Institute for Health and Care Excellence, 2012, CG146 OST ASS RISK F; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; National Osteoporosis Guideline Group on behalf of the Bone Research Society British Geriatrics Society British Orthopaedic Association British Orthopaedics Research Society British Society of Rheumatology National Osteoporosis Society Osteoporosis 2000 Osteoporosis Dorset Primary Care Rheumatology Society Royal College of Physicians and Society for Endocrinology, 2014, OST CLIN GUID PREV T; Nilson F, 2013, J PUBLIC HEALTH-UK, V35, P125, DOI 10.1093/pubmed/fds053; Oudshoorn C, 2012, INJURY, V43, P458, DOI 10.1016/j.injury.2011.09.014; Pages-Castella A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-79; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Pfeilschifter J, 2012, OSTEOPOROSIS INT, V23, P2179, DOI 10.1007/s00198-011-1840-6; Rapp K, 2008, J BONE MINER RES, V23, P1825, DOI 10.1359/JBMR.080702; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Siggeirsdottir K, 2014, OSTEOPOROSIS INT, V25, P2445, DOI 10.1007/s00198-014-2777-3; Siggeirsdottir K, 2014, OSTEOPOROSIS INT, V25, P211, DOI 10.1007/s00198-013-2422-6; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Herk-Sukel MPP, 2012, PHARMACOEPIDEM DR S, V21, P94, DOI 10.1002/pds.2205; van Staa TP, 2006, JAMA-J AM MED ASSOC, V295, P2599, DOI 10.1001/jama.295.22.2599-a; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Warriner AH, 2011, J CLIN EPIDEMIOL, V64, P46, DOI 10.1016/j.jclinepi.2010.07.007; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143800	10.1371/journal.pone.0143800	http://dx.doi.org/10.1371/journal.pone.0143800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633011	Green Published, gold			2022-12-26	WOS:000366040000022
J	Tai, AS; Bell, SC; Kidd, TJ; Trembizki, E; Buckley, C; Ramsay, KA; David, M; Wainwright, CE; Grimwood, K; Whiley, DM				Tai, Anna Sze; Bell, Scott Cameron; Kidd, Timothy James; Trembizki, Ella; Buckley, Cameron; Ramsay, Kay Annette; David, Michael; Wainwright, Claire Elizabeth; Grimwood, Keith; Whiley, David Mark			Genotypic Diversity within a Single Pseudomonas aeruginosa Strain Commonly Shared by Australian Patients with Cystic Fibrosis	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; LUNG INFECTIONS; CROSS-INFECTION; LASR MUTANTS; ADAPTATION; AIRWAYS; IDENTIFICATION; PREVENTION; RESISTANCE; GUIDELINE	In cystic fibrosis (CF), Pseudomonas aeruginosa undergoes intra-strain genotypic and phenotypic diversification while establishing and maintaining chronic lung infections. As the clinical significance of these changes is uncertain, we investigated intra-strain diversity in commonly shared strains from CF patients to determine if specific gene mutations were associated with increased antibiotic resistance and worse clinical outcomes. Two-hundred-and-one P. aeruginosa isolates (163 represented a dominant Australian shared strain, AUST-02) from two Queensland CF centres over two distinct time-periods (2001-2002 and 2007-2009) underwent mexZ and lasR sequencing. Broth microdilution antibiotic susceptibility testing in a subset of isolates was also performed. We identified a novel AUST-02 subtype (M3L7) in adults attending a single Queensland CF centre. This M3L7 subtype was multi-drug resistant and had significantly higher antibiotic minimum inhibitory concentrations than other AUST-02 sub-types. Prospective molecular surveillance using polymerase chain reaction assays determined the prevalence of the 'M3L7' subtype at this centre during 2007-2009 (170 patients) and 2011 (173 patients). Three-year clinical outcomes of patients harbouring different strains and subtypes were compared. MexZ and LasR sequences from AUST-02 isolates were more likely in 2007-2009 than 2001-2002 to exhibit mutations (mexZ: odds ratio (OR) = 3.8; 95% confidence interval (CI): 1.1-13.5 and LasR: OR = 2.5; 95% CI: 1.3-5.0). Surveillance at the adult centre in 2007-2009 identified M3L7 in 28/509 (5.5%) P. aeruginosa isolates from 13/170 (7.6%) patients. A repeat survey in 2011 identified M3L7 in 21/519 (4.0%) P. aeruginosa isolates from 11/173 (6.4%) patients. The M3L7 subtype was associated with greater intravenous antibiotic and hospitalisation requirements, and a higher 3-year risk of death/lung transplantation, than other AUST-02 subtypes (adjusted hazard ratio [HR] = 9.4; 95% CI: 2.2-39.2) and non-AUST-02 strains (adjusted HR = 4.8; 95% CI: 1.4-16.2). This suggests ongoing microevolution of the shared CF strain, AUST-02, was associated with an emerging multi-drug resistant subtype and possibly poorer clinical outcomes.	[Tai, Anna Sze; Kidd, Timothy James; Trembizki, Ella; Buckley, Cameron; Ramsay, Kay Annette; David, Michael; Wainwright, Claire Elizabeth; Grimwood, Keith; Whiley, David Mark] Childrens Hlth Queensland, Queensland Childrens Med Res Inst, South Brisbane, Qld, Australia; [Tai, Anna Sze; Bell, Scott Cameron] Prince Charles Hosp, Dept Thorac Med, Adult Cyst Fibrosis Ctr, Chermside, Qld, Australia; [Tai, Anna Sze; Trembizki, Ella; Ramsay, Kay Annette] Univ Queensland, Sch Med, Herston, Qld, Australia; [Bell, Scott Cameron] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Kidd, Timothy James] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [David, Michael] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Wainwright, Claire Elizabeth] Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia; [Grimwood, Keith] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Grimwood, Keith] Gold Coast Univ Hosp, Gold Coast, Qld, Australia; [Whiley, David Mark] Pathol Queensland Cent Lab, Herston, Qld, Australia	Prince Charles Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Queens University Belfast; University of Queensland; Griffith University; Menzies Health Institute Queensland; Gold Coast University Hospital	Tai, AS (corresponding author), Childrens Hlth Queensland, Queensland Childrens Med Res Inst, South Brisbane, Qld, Australia.	anna.tai@uq.net.au	Trembizki, Ella/AAX-8520-2020; Whiley, David M/E-8955-2011; Bell, Scott/AAJ-4298-2020; Kidd, Timothy/F-2149-2010; Bell, Scott C/A-7241-2011; Wainwright, Claire E/G-4218-2013	Whiley, David M/0000-0001-5969-3161; Bell, Scott/0000-0001-8651-7139; Kidd, Timothy/0000-0002-6135-6364; Bell, Scott C/0000-0001-8651-7139; Wainwright, Claire E/0000-0001-8389-3809; Grimwood, Keith/0000-0003-3174-9834	Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant] [50024]; Prince Charles Hospital Foundation [MS2013-02]; National Health Medical Research Council [455919]; National Health and Medical Research Early Career Fellowship [APP1054129]; QCMRI Early Career Fellowship [50024]; Queensland Health Office of Health and Medical Research Fellowship [QCOS013795]; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round) [4571-2013]; Australian Postgraduate Award [2127932]; National Health and Medical Research Council Post-graduate Medical and Dental Scholarship [APP1017517]; Australian Cystic Fibrosis Foundation Postgraduate Scholarship; People Programme of the European Union's Seventh Framework Programme (FP7), under REA grant [600368]	Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant]; Prince Charles Hospital Foundation; National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Early Career Fellowship; QCMRI Early Career Fellowship; Queensland Health Office of Health and Medical Research Fellowship; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round); Australian Postgraduate Award(Australian Government); National Health and Medical Research Council Post-graduate Medical and Dental Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Foundation Postgraduate Scholarship; People Programme of the European Union's Seventh Framework Programme (FP7), under REA grant	This study was funded by the Children's Hospital Foundation [Queensland Children's Medical Research Institute (QCMRI) Grant 50024], a Project Grant from The Prince Charles Hospital Foundation [MS2013-02 to SCB, DMW and TJK] (http://www.tpchfoundation.org.au) and a National Health Medical Research Council Project Grant [455919 to SCB & CEW] (www.nhmrc.gov.au). DMW is a recipient of a National Health and Medical Research Early Career Fellowship [APP1054129] (www.nhmrc.gov.au) and QCMRI Early Career Fellowship [50024] (www.qcmri.org.au). SCB is a recipient of Queensland Health Office of Health and Medical Research Fellowship [QCOS013795] (www.health.qld.gov.au/ohmr/html/funding/funding.asp). TJK is the recipient of an ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship (MC RESPIRE2 first round, 4571-2013) (www.ersnet.org/ers-funding/fellowships/post-doc/eu-co-funded-respire-2), which was partly funded by the People Programme of the European Union's Seventh Framework Programme (FP7/2007-2013), under REA grant agreement 600368. KAR is the recipient of an Australian Postgraduate Award Scholarship [2127932] (https://education.gov.au/australian-postgraduate-awards). AST is the recipient of a National Health and Medical Research Council Post-graduate Medical and Dental Scholarship [APP1017517] (www.nhmrc.gov.au) and Australian Cystic Fibrosis Foundation Postgraduate Scholarship (www.cysticfibrosis.org.au/cfwa-scholarship). All aforementioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Ashish Abdul, 2013, JRSM Short Rep, V4, P1, DOI 10.1258/shorts.2012.012018; Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Chung JCS, 2012, J BACTERIOL, V194, P4857, DOI 10.1128/JB.01050-12; CLSI, 2013, PERFORMANCE STANDARD; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Foundation CF., 1994, MICR INF DIS CONS C; Foweraker JE, 2005, J ANTIMICROB CHEMOTH, V55, P921, DOI 10.1093/jac/dki146; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hoffman LR, 2009, J CYST FIBROS, V8, P66, DOI 10.1016/j.jcf.2008.09.006; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Jeukens J, 2013, GENOME ANNOUNC, V1; Jones AM, 2003, THORAX, V58, P525, DOI 10.1136/thorax.58.6.525; Jones AM, 2010, CHEST, V137, P1405, DOI 10.1378/chest.09-2406; Kidd TJ, 2015, LANCET RESP MED, V3, P640, DOI 10.1016/S2213-2600(15)00228-3; Kidd TJ, 2015, J CYST FIBROS, V14, P361, DOI 10.1016/j.jcf.2014.12.007; Kidd TJ, 2013, EUR RESPIR J, V41, P1091, DOI 10.1183/09031936.00060512; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213; Ledson MJ, 1998, THORAX, V53, P432, DOI 10.1136/thx.53.5.432; Luna RA, 2013, J CLIN MICROBIOL, V51, P1237, DOI 10.1128/JCM.02157-12; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Mogayzel Peter J Jr, 2014, Ann Am Thorac Soc, V11, P1640, DOI 10.1513/AnnalsATS.201404-166OC; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Carroll MR, 2004, EUR RESPIR J, V24, P101, DOI 10.1183/09031936.04.00122903; Qin X, 2012, ANTIMICROB AGENTS CH, V56, P5971, DOI 10.1128/AAC.01371-12; Saiman L, 2014, INFECT CONT HOSP EP, V35, pS1, DOI 10.1086/676882; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Syrmis MW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-307; Trust CF, 2011, STANDARDS CLIN CARE; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	41	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144022	10.1371/journal.pone.0144022	http://dx.doi.org/10.1371/journal.pone.0144022			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633539	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000045
J	Escarcega-Tame, MA; Martinez-Vieyra, I; Alonso-Rangel, L; Cisneros, B; Winder, SJ; Cerecedo, D				Antonio Escarcega-Tame, Marco; Martinez-Vieyra, Ivette; Alonso-Rangel, Lea; Cisneros, Bulmaro; Winder, Steve J.; Cerecedo, Doris			Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; BETA-DYSTROGLYCAN; EXTRACELLULAR-MATRIX; ALPHA-DYSTROGLYCAN; LAMININ-BINDING; HL-60 CELLS; ADHESION; EXPRESSION; PROMOTES	Background Dystroglycan has recently been characterised in blood tissue cells, as part of the dystrophin glycoprotein complex involved in the differentiation process of neutrophils. Purpose In the present study we have investigated the role of dystroglycan in the human promyelocytic leukemic cell line Kasumi-1 differentiated to macrophage-like cells. Methods We characterised the pattern expression and subcellular distribution of dystroglycans in non-differentiated and differentiated Kasumi-1 cells. Results Our results demonstrated by WB and flow cytometer assays that during the differentiation process to macrophages, dystroglycans were down-regulated; these results were confirmed with qRT-PCR assays. Additionally, depletion of dystroglycan by RNAi resulted in altered morphology and reduced properties of differentiated Kasumi-1 cells, including morphology, migration and phagocytic activities although secretion of IL-1 beta and expression of markers of differentiation are not altered. Conclusion Our findings strongly implicate dystroglycan as a key membrane adhesion protein involved in actin-based structures during the differentiation process in Kasumi-1 cells.	[Antonio Escarcega-Tame, Marco; Martinez-Vieyra, Ivette; Alonso-Rangel, Lea; Cerecedo, Doris] IPN, ENMH, Lab Hematobiol, Mexico City 07738, DF, Mexico; [Cisneros, Bulmaro] IPN, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Genet & Biol Mol, Mexico City 07738, DF, Mexico; [Winder, Steve J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Sheffield	Cerecedo, D (corresponding author), IPN, ENMH, Lab Hematobiol, Mexico City 07738, DF, Mexico.	dcereced@prodigy.net.mx	Vieyra, Ivette A. Martínez/S-7966-2018; Cerecedo, Doris/AAQ-9948-2021	Vieyra, Ivette A. Martínez/0000-0002-4414-5469; Cerecedo, Doris/0000-0002-0015-8081; Escarcega-Tame, Marco Antonio/0000-0002-1817-4004	Consejo Nacional para la Ciencia y la Tecnologia (CONACYT) [167178]	Consejo Nacional para la Ciencia y la Tecnologia (CONACYT)	Consejo Nacional para la Ciencia y la Tecnologia (CONACYT) No. 167178.	ASOU H, 1991, BLOOD, V77, P2031; Banker DE, 1998, CLIN CANCER RES, V4, P3051; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; Ervasti J M, 1993, Mol Cell Biol Hum Dis Ser, V3, P139; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; Eyermann C, 2012, J NEUROCHEM, V120, P928, DOI 10.1111/j.1471-4159.2011.07600.x; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; James M, 2000, J CELL SCI, V113, P1717; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; KOEFFLER HP, 1980, J CLIN INVEST, V66, P1101, DOI 10.1172/JCI109939; Lara-Chacon B, 2010, J CELL BIOCHEM, V110, P706, DOI 10.1002/jcb.22581; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; Martinez-Zarate AD, 2014, BIOCHEM BIOPH RES CO, V448, P274, DOI 10.1016/j.bbrc.2014.04.110; Mathew G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02792; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nilufar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-66; Olins AL, 2000, EXP CELL RES, V254, P130, DOI 10.1006/excr.1999.4727; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289; Thompson O, 2010, J CELL SCI, V123, P118, DOI 10.1242/jcs.047902; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X	31	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144078	10.1371/journal.pone.0144078	http://dx.doi.org/10.1371/journal.pone.0144078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630171	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300156
J	Bonnal, C; Leleu, C; Brugiere, O; Chochillon, C; Porcher, R; Boelle, PY; Menotti, J; Houze, S; Lucet, JC; Derouin, F				Bonnal, Christine; Leleu, Christopher; Brugiere, Olivier; Chochillon, Christian; Porcher, Raphael; Boelle, Pierre-Yves; Menotti, Jean; Houze, Sandrine; Lucet, Jean-Christophe; Derouin, Francis			Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; INFECTIONS; FUMIGATUS; INDOOR	Background Aspergillus colonisation is frequently reported after lung transplantation. The question of whether aspergillus colonisation is related to the hospital environment is crucial to prevention. Method To elucidate this question, a prospective study of aspergillus colonisation after lung transplantation, along with a mycological survey of the patient environment, was performed. Results Forty-four consecutive patients were included from the day of lung transplantation and then examined weekly for aspergillus colonisation until hospital discharge. Environmental fungal contamination of each patient was followed weekly via air and surface sampling. Twelve patients (27%) had transient aspergillus colonisation, occurring 1-13 weeks after lung transplantation, without associated manifestation of aspergillosis. Responsible Aspergillus species were A. fumigatus (6), A. niger (3), A. sydowii (1), A. calidoustus (1) and Aspergillus sp. (1). In the environment, contamination by Penicillium and Aspergillus was predominant. Multivariate analysis showed a significant association between occurrence of aspergillus colonisation and fungal contamination of the patient's room, either by Aspergillus spp. in the air or by A. fumigatus on the floor. Related clinical and environmental isolates were genotyped in 9 cases of aspergillus colonisation. For A. fumigatus (4 cases), two identical microsatellite profiles were found between clinical and environmental isolates collected on distant dates or locations. For other Aspergillus species, isolates were different in 2 cases; in 3 cases of aspergillus colonisation by A. sydowii, A. niger and A. calidoustus, similarity between clinical and environmental internal transcribed spacer and tubulin sequences was >99%. Conclusion Taken together, these results support the hypothesis of environmental risk of hospital acquisition of aspergillus colonisation in lung transplant recipients.	[Bonnal, Christine; Menotti, Jean; Derouin, Francis] Bichat Claude Bernard Hosp, AP HP, Infect Control Unit, F-75018 Paris, France; [Leleu, Christopher; Boelle, Pierre-Yves] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Leleu, Christopher; Lucet, Jean-Christophe] Univ Paris 06, Paris, France; [Brugiere, Olivier] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Pneumol B, Unite Transplantat Pulm, Paris, France; [Chochillon, Christian; Houze, Sandrine] Bichat Claude Bernard Univ Hosp, AP HP, Lab Parasitol & Mycol, Paris, France; [Porcher, Raphael] Univ Paris 05, Ctr Rech Epidemiol & Stat Sorbonne Paris Cite, INSERM, UMR 1153, Paris, France; [Boelle, Pierre-Yves] INSERM, Inst Pierre Louis Epidemiol & Sante Publ U1136, Paris, France; [Menotti, Jean; Derouin, Francis] St Louis Univ Hosp, AP HP, Lab Parasitol & Mycol, Paris, France; [Houze, Sandrine] Univ Paris 05, Fac Sci Pharmaceut & Biol, UMR 216, Mere & Enfants Face Infect Trop, Paris, France; [Lucet, Jean-Christophe] Paris Diderot Univ, IAME, UMR 1137, F-75018 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bonnal, C (corresponding author), Bichat Claude Bernard Hosp, AP HP, Infect Control Unit, F-75018 Paris, France.	christine.bonnal@aphp.fr	Menotti, Jean/AFV-1886-2022; sandrine, houze/M-3260-2017	Christine, Bonnal/0000-0003-3030-5318; Porcher, Raphael/0000-0002-5277-4679; Menotti, Jean/0000-0001-5703-8403; sandrine, houze/0000-0001-9016-3847	Programme de Recherche en Qualite Hospitaliere, PREQHOS [04Preqhos09]; Universite Pierre et Marie Curie; EHESP (Ecole des Hautes Etudes en Sante Publique, Rennes, France)	Programme de Recherche en Qualite Hospitaliere, PREQHOS; Universite Pierre et Marie Curie; EHESP (Ecole des Hautes Etudes en Sante Publique, Rennes, France)	Funded by Programme de Recherche en Qualite Hospitaliere, PREQHOS 2009 (04Preqhos09). (http://www.sante.gouv.fr/IMG/pdf/projets_retenus_Preqhos_2009.pdf) and Doctoral grant from the Universite Pierre et Marie Curie and the EHESP (Ecole des Hautes Etudes en Sante Publique, Rennes, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2001, J HOSP INFECT, V48, P198, DOI 10.1053/jhin.2001.0998; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Gangneux JP, 2006, INFECT CONT HOSP EP, V27, P1405, DOI 10.1086/508840; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guidelines for Environmental Infection Control in Flealth-Care Facilities, 2003, GUID ENV INF CONTR H; Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Husain S, 2011, J HEART LUNG TRANSPL, V30, P361, DOI 10.1016/j.healun.2011.01.701; Iversen M, 2007, EUR J CLIN MICROBIOL, V26, P879, DOI 10.1007/s10096-007-0376-3; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Klinzing S, 2014, TRANSPLANT RES, V3, DOI 10.1186/2047-1440-3-9; Liao WQ, 2004, INT J INFECT DIS, V8, P132, DOI [10.1016/j.ijid.2003.10.003, 10.1016/j/ijid.2003.10.003]; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Paterson DL, 1999, MEDICINE, V78, P123, DOI 10.1097/00005792-199903000-00003; Sautour M, 2009, SCI TOTAL ENVIRON, V407, P3766, DOI 10.1016/j.scitotenv.2009.02.024; Silveira FP, 2010, ASPERGILLOSIS: FROM DIAGNOSIS TO PREVENTION, P567, DOI 10.1007/978-90-481-2408-4_34; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Singh N, 2003, J HEART LUNG TRANSPL, V22, P258, DOI 10.1016/S1053-2498(02)00477-1; Sole A, 2005, CLIN MICROBIOL INFEC, V11, P359, DOI 10.1111/j.1469-0691.2005.01128.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	23	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144044	10.1371/journal.pone.0144044	http://dx.doi.org/10.1371/journal.pone.0144044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629994	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300145
J	Dutta, M; Shekhar, C; Prashad, L				Dutta, Mili; Shekhar, Chander; Prashad, Lokender			Level, Trend and Correlates of Mistimed and Unwanted Pregnancies among Currently Pregnant Ever Married Women in India	PLOS ONE			English	Article							UNINTENDED PREGNANCY; DETERMINANTS; CHILDBEARING; HEALTH; PREVALENCE	Unintended pregnancy accounts for more than 40% of the total pregnancies worldwide. An Unintended pregnancy can have serious implications on women and their families. With more than one-fourth of the children in India born out of unintended pregnancies such pregnancies are considered to be one of the major public health concerns today. The present study is aimed at determining major predictors of unintended pregnancy among currently pregnant ever-married women in India. The present study has used National Family Health Survey (NFHS) data, conducted by the International Institute for Population Sciences (IIPS), Mumbai, to show the trend, pattern and determinants of mistimed and unwanted pregnancies. Bivariate and multinomial logistic regression model have been used with the help of Stata 13 software. The results show that the likelihood of a mistimed pregnancy is more prevalent among young women whereas the prevalence of unwanted pregnancy is observed more among the women aged 35 years or more. The results also show that the risk of experiencing mistimed pregnancy decreases if the woman belongs to 'other' castes and has higher education. The likelihood of unwanted pregnancy decreases among married women aged 18 years and above, those women having higher education, some autonomy and access to any mode of mass communication. Knowledge of these predictors of mistimed and unwanted pregnancy will be helpful in identifying the most vulnerable group and prioritize the intervention strategies of the reproductive health programmes for the population in need.	[Dutta, Mili; Shekhar, Chander] Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India; [Prashad, Lokender] Tata Inst Social Sci, Sch Social Sci, Bombay, Maharashtra, India	International Institute for Population Sciences; Tata Institute of Social Sciences	Dutta, M (corresponding author), Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India.	duttamili90@gmail.com	Prashad, Lokender/H-5286-2016; Dutta, Mili/A-8880-2017; Shekhar, Chander/D-5275-2012	Prashad, Lokender/0000-0001-7820-8336; Dutta, Mili/0000-0001-6539-6948; Shekhar, Chander/0000-0002-6090-8470				Adetunji J, 1998, UNINTENDED CHILDBEAR; Adhikari R, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-17; [Anonymous], 2011, IMPACT CONTRACEPTIVE; Bongaarts J, 1997, STUD FAMILY PLANN, V28, P267, DOI 10.2307/2137858; Brown S.S., 1995, BEST INTENTIONS UNIN; Chaudhuri S, 2012, INT PERSPECT SEX R H, V38, P178, DOI 10.1363/3817812; Dixit P, 2012, OPEN ACCESS SCI REPO, V1; Dixit P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-84; Eggleston E, 1999, INT FAM PLAN PERSPEC, V25, P27, DOI 10.2307/2991899; Exavery A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-63; FORREST JD, 1994, AM J OBSTET GYNECOL, V170, P1485, DOI 10.1016/S0002-9378(94)05008-8; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Goto A, 2002, SOC SCI MED, V54, P1065, DOI 10.1016/S0277-9536(01)00081-8; Hardee K, 2004, J BIOSOC SCI, V36, P617, DOI 10.1017/S0021932003006321; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Herold J, 1994, J BIOSOC SCI, V26; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Lako T. K., 2011, AFRICAN POPULATION S, V26; Lara MA, 2006, SALUD MENT, V29, P55; Mbizvo MT, 1997, SOC SCI MED, V45, P937, DOI 10.1016/S0277-9536(97)00004-X; NAJMAN JM, 1991, SOC SCI MED, V32, P241, DOI 10.1016/0277-9536(91)90100-Q; Palamuleni M. E., 2014, African Population Studies, V28, P551, DOI 10.11564/28-1-507; ROSENZWEIG MR, 1993, J HUM RESOUR, V28, P205, DOI 10.2307/146201; Santhya KG, 2008, EARLY MARRIAGE SEXUA; Shaheen A, 2007, E MEDITERRANEAN HLTH, V13; Singh A, 2013, MATERN CHILD HLTH J, V17, P493, DOI 10.1007/s10995-012-1023-x; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Tebekaw Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-326; Trussell J, 2009, CONTRACEPTION, V78, P177; WHR, 2005, MAK EV MOTH CHILD CO; WILLIAMS LB, 1991, FAM PLANN PERSPECT, V23, P212, DOI 10.2307/2135755	35	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144400	10.1371/journal.pone.0144400	http://dx.doi.org/10.1371/journal.pone.0144400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26629813	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300183
J	Rosales, SM; Thurber, RV				Rosales, Stephanie M.; Thurber, Rebecca Vega			Brain Meta-Transcriptomics from Harbor Seals to Infer the Role of the Microbiome and Virome in a Stranding Event	PLOS ONE			English	Article							COXIELLA-BURNETII; MARINE MAMMALS; VIRAL METAGENOMICS; CALIFORNIA; TRENDS; TOOL; MELIOIDOSIS; ALIGNMENT; ZOONOSES; ANIMALS	Marine diseases are becoming more frequent, and tools for identifying pathogens and disease reservoirs are needed to help prevent and mitigate epizootics. Meta-transcriptomics provides insights into disease etiology by cataloguing and comparing sequences from suspected pathogens. This method is a powerful approach to simultaneously evaluate both the viral and bacterial communities, but few studies have applied this technique in marine systems. In 2009 seven harbor seals, Phoca vitulina, stranded along the California coast from a similar brain disease of unknown cause of death (UCD). We evaluated the differences between the virome and microbiome of UCDs and harbor seals with known causes of death. Here we determined that UCD stranded animals had no viruses in their brain tissue. However, in the bacterial community, we identified Burkholderia and Coxiella burnetii as important pathogens associated with this stranding event. Burkholderia were 100% prevalent and similar to 2.8 log2 fold more abundant in the UCD animals. Further, while C. burnetii was found in only 35.7% of all samples, it was highly abundant (similar to 94% of the total microbial community) in a single individual. In this harbor seal, C. burnetii showed high transcription rates of invading and translation genes, implicating it in the pathogenesis of this animal. Based on these data we propose that Burkholderia taxa and C. burnetii are potentially important opportunistic neurotropic pathogens in UCD stranded harbor seals.	[Rosales, Stephanie M.; Thurber, Rebecca Vega] Oregon State Univ, Dept Microbiol, 226 Nash Hall, Corvallis, OR 97331 USA	Oregon State University	Rosales, SM (corresponding author), Oregon State Univ, Dept Microbiol, 226 Nash Hall, Corvallis, OR 97331 USA.	srosales712@gmail.com	Rosales, Stephanie/Z-4923-2019		Oregon Sea grant [RVT. 2012136295]; GRFP, SMR;  [NA010AR4170059 NA223B R700]	Oregon Sea grant; GRFP, SMR; 	NA010AR4170059 NA223B R700, http://seagrant.oregonstate.edu/, Oregon Sea grant, RVT. 2012136295, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=6201NSF, GRFP, SMR.	Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Blomstrom AL, 2011, VET QUART, V31, P107, DOI 10.1080/01652176.2011.604971; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Branton WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054673; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COEN DONALD M., 1994, J VIROL, V69, P1389; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Drosten C, 2015, CLIN INFECT DIS, V60, P369, DOI 10.1093/cid/ciu812; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Francis OE, 2013, GENOME RES, V23, P1721, DOI 10.1101/gr.150151.112; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; GERACI JR, 1982, SCIENCE, V215, P1129; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; GRENFELL BT, 1992, SCI TOTAL ENVIRON, V115, P15, DOI 10.1016/0048-9697(92)90029-R; Gulland FMD, 2007, ECOHEALTH, V4, P135, DOI 10.1007/s10393-007-0097-1; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kersh GJ, 2012, J WILDLIFE DIS, V48, P201, DOI 10.7589/0090-3558-48.1.201; Kramer MF, 1998, J VIROL, V72, P1177, DOI 10.1128/JVI.72.2.1177-1185.1998; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapointe JM, 1999, J VET DIAGN INVEST, V11, P541, DOI 10.1177/104063879901100612; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Martinez E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004013; Myers E, 2013, VET PATHOL, V50, P622, DOI 10.1177/0300985812465323; Nelson TM, 2015, MICROBIOL AUST, V36, P8, DOI 10.1071/MA15004; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; PERTEA G, 2015, FQTRIM V0 9 4 RELEAS, DOI DOI 10.5281/ZEN0D0.20552; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Rikula U, 2001, PREV VET MED, V49, P125, DOI 10.1016/S0167-5877(01)00177-5; Rosseel T, 2015, J VIROL METHODS, V222, P72, DOI 10.1016/j.jviromet.2015.05.010; Saliki JT, 2002, ANN NY ACAD SCI, V969, P51, DOI 10.1111/j.1749-6632.2002.tb04350.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zagzebski Kathryn A., 2006, Aquatic Mammals, V32, P334, DOI 10.1578/AM.32.3.2006.334	47	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143944	10.1371/journal.pone.0143944	http://dx.doi.org/10.1371/journal.pone.0143944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630132	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300126
J	Szczesny, B; Brunyanszki, A; Ahmad, A; Olah, G; Porter, C; Toliver-Kinsky, T; Sidossis, L; Herndon, DN; Szabo, C				Szczesny, Bartosz; Brunyanszki, Attila; Ahmad, Akbar; Olah, Gabor; Porter, Craig; Toliver-Kinsky, Tracy; Sidossis, Labros; Herndon, David N.; Szabo, Csaba			Time-Dependent and Organ-Specific Changes in Mitochondrial Function, Mitochondrial DNA Integrity, Oxidative Stress and Mononuclear Cell Infiltration in a Mouse Model of Burn Injury	PLOS ONE			English	Article							ACUTE LUNG INJURY; POLY(ADP-RIBOSE) POLYMERASE; HYDROGEN-SULFIDE; PLASMA; INHIBITION; DAMAGE; ACTIVATION; RESPONSES; TRAUMA	Severe thermal injury induces a pathophysiological response that affects most of the organs within the body; liver, heart, lung, skeletal muscle among others, with inflammation and hyper-metabolism as a hallmark of the post-burn damage. Oxidative stress has been implicated as a key component in development of inflammatory and metabolic responses induced by burn. The goal of the current study was to evaluate several critical mitochondrial functions in a mouse model of severe burn injury. Mitochondrial bioenergetics, measured by Extracellular Flux Analyzer, showed a time dependent, post-burn decrease in basal respiration and ATP-turnover but enhanced maximal respiratory capacity in mitochondria isolated from the liver and lung of animals subjected to burn injury. Moreover, we detected a tissue-specific degree of DNA damage, particularly of the mitochondrial DNA, with the most profound effect detected in lungs and hearts of mice subjected to burn injury. Increased mitochondrial biogenesis in lung tissue in response to burn injury was also observed. Burn injury also induced time dependent increases in oxidative stress (measured by amount of malondialdehyde) and neutrophil infiltration (measured by myeloperoxidase activity), particularly in lung and heart. Tissue mononuclear cell infiltration was also confirmed by immunohistochemistry. The amount of poly(ADP-ribose) polymers decreased in the liver, but increased in the heart in later time points after burn. All of these biochemical changes were also associated with histological alterations in all three organs studied. Finally, we detected a significant increase in mitochondrial DNA fragments circulating in the blood immediately post-burn. There was no evidence of systemic bacteremia, or the presence of bacterial DNA fragments at any time after burn injury. The majority of the measured parameters demonstrated a sustained elevation even at 20-40 days post injury suggesting a long-lasting effect of thermal injury on organ function. The current data show that there are marked time-dependent and tissue-specific alterations in mitochondrial function induced by thermal injury, and suggest that mitochondria-specific damage is one of the earliest responses to burn injury. Mitochondria may be potential therapeutic targets in the future experimental therapy of burns.	[Szczesny, Bartosz; Brunyanszki, Attila; Ahmad, Akbar; Olah, Gabor; Toliver-Kinsky, Tracy; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Szczesny, Bartosz; Porter, Craig; Sidossis, Labros; Herndon, David N.; Szabo, Csaba] Shriners Hosp Children, Galveston, TX 77550 USA; [Porter, Craig; Sidossis, Labros; Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Toliver-Kinsky, Tracy] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Herndon, David/AAC-3354-2020; Toliver-Kinsky, Tracy/ABE-2048-2020; Sidossis, Labros/AAN-9546-2021; Szabo, Csaba/ABG-2644-2021	Sidossis, Labros/0000-0001-8313-7966; Ahmad, Akbar/0000-0003-1841-9670; porter, Craig/0000-0003-3657-6645	US National Institutes of Health [2P50 GM060338]; Shriners of North America [85800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners of North America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health 2P50 GM060338 and by a grant from the Shriners of North America (#85800) to C.S.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Asmussen S, 2011, SHOCK, V36, P402, DOI 10.1097/SHK.0b013e318228f614; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Bartha E, 2011, SHOCK, V36, P144, DOI 10.1097/SHK.0b013e318212988c; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Burkle A, 2013, MOL ASPECTS MED, V34, P1046, DOI 10.1016/j.mam.2012.12.010; Cauwels A, 2013, P NATL ACAD SCI USA, V110, pE3150, DOI 10.1073/pnas.1308333110; Cevik O, 2012, BURNS, V38, P861, DOI 10.1016/j.burns.2012.01.006; Chen XQ, 1999, CLIN CANCER RES, V5, P2297; Chiu TW, 2006, CLIN CHEM LAB MED, V44, P13, DOI 10.1515/CCLM.2006.003; Coletta C, 2015, MOL MED, V21, DOI 10.2119/molmed.2015.00035; Cree MG, 2008, AM J SURG, V196, P234, DOI 10.1016/j.amjsurg.2007.09.048; Csontos C, 2012, BURNS, V38, P428, DOI 10.1016/j.burns.2011.09.011; Cuzzocrea S, 2001, BRIT J PHARMACOL, V132, P19, DOI 10.1038/sj.bjp.0703775; Enkhbaatar P, 2011, BURNS, V37, P638, DOI 10.1016/j.burns.2010.12.011; Esechie A, 2008, CLIN SCI, V115, P91, DOI 10.1042/CS20080021; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Jeschke MG, 2001, AM J PHYSIOL-GASTR L, V280, pG1314, DOI 10.1152/ajpgi.2001.280.6.G1314; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Keck M, 2009, WIEN MED WOCHENSCHR, V159, P327, DOI 10.1007/s10354-009-0651-2; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068786; Liaudet L, 2001, AM J RESP CRIT CARE, V164, P1213, DOI 10.1164/ajrccm.164.7.2101013; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Maybauer DM, 2011, BURNS, V37, P842, DOI 10.1016/j.burns.2010.12.020; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Murakami K, 2004, SHOCK, V21, P126, DOI 10.1097/01.shk.0000108397.56565.4a; Olah G, 2011, SHOCK, V36, P18, DOI 10.1097/SHK.0b013e3182168d8f; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Porter C, 2015, J BURN CARE RES; Porter C, 2015, SHOCK, V44, P258, DOI 10.1097/SHK.0000000000000410; Porter C, 2014, AM J PHYSIOL-ENDOC M, V307, pE462, DOI 10.1152/ajpendo.00206.2014; Porter C, 2013, BURNS, V39, P1039, DOI 10.1016/j.burns.2013.03.018; Sandre C, 2006, J TRAUMA, V60, P627, DOI 10.1097/01.ta.0000205640.82459.d6; Sarma JV, 2011, COMPR PHYSIOL, V1, P1365, DOI 10.1002/cphy.c100068; Saunders FD, 2010, AM J PHYSIOL-LUNG C, V298, pL427, DOI 10.1152/ajplung.00147.2009; Sehirli O, 2008, PEPTIDES, V29, P1231, DOI 10.1016/j.peptides.2008.02.012; Sener G, 2007, BURNS, V33, P587, DOI 10.1016/j.burns.2006.10.381; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shimoda K, 2003, AM J PHYSIOL-LUNG C, V285, pL240, DOI 10.1152/ajplung.00319.2002; Silveira PCL, 2014, MAT SCI ENG C-MATER, V44, P380, DOI 10.1016/j.msec.2014.08.045; Song JQ, 2009, MOL MED, V15, P316, DOI 10.2119/molmed.2009.00048; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Yalcin AD, 2012, INT J BURNS TRAUMA, V2, P110; Yao X, 2014, AM J PHYSIOL-HEART C, V306, pH882, DOI 10.1152/ajpheart.00475.2013; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	55	52	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143730	10.1371/journal.pone.0143730	http://dx.doi.org/10.1371/journal.pone.0143730			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630679	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300091
J	Kimura, T; Wang, L; Tabu, K; Tsuda, M; Tanino, M; Maekawa, A; Nishihara, H; Hiraga, H; Taga, T; Oda, Y; Tanaka, S				Kimura, T.; Wang, L.; Tabu, K.; Tsuda, M.; Tanino, M.; Maekawa, A.; Nishihara, H.; Hiraga, H.; Taga, T.; Oda, Y.; Tanaka, S.			Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CXCR4; CANCER STEM-CELLS; PROTO-ONCOPROTEIN SYT; BREAST-CANCER; TUMOR-GROWTH; BONE-MARROW; ANTAGONIST CTCE-9908; PROSTATE-CANCER; EXPRESSION; METASTASIS	Synovial sarcoma accounts for almost 10% of all soft tissue sarcomas, and its prognosis is poor with 5-year survival rates at 36%. Thus, new treatments and therapeutic targets for synovial sarcoma are required. Tumor-initiating cells have been defined by the ability for self-renewal and multipotent differentiation, and they exhibit higher tumorigenic capacity, chemoresistance and radiation resistance, expecting to be a new therapeutic target. In synovial sarcoma, the presence of such stemness remains largely unclear; thus, we analyzed whether synovial sarcoma possessed tumor-initiating cells and explored specific markers, and we discovered that synovial sarcoma cell lines possessed heterogeneity by way of containing a sphere-forming subpopulation highly expressing NANOG, OCT4 and SOX2. By expression microarray analysis, CXCR4 was identified to be highly expressed in the sphere subpopulation and correlated with stem-cell-associated markers. Inhibition of CXCR4 suppressed the cell proliferation of synovial sarcoma cell lines in vitro. The tumor-initiating ability of CXCR4-positive cells was demonstrated by xenograft propagation assay. CXCR4-positive cells showed higher tumorigenicity than negative ones and possessed both self-renewal and multipotent differentiation ability. Immunohistochemical analysis of 39 specimens of synovial sarcoma patients revealed that CXCR4 strongly correlated with poor prognosis of synovial sarcoma. Thus, we conclude that CXCR4 is the marker of synovial sarcoma-initiating cells, a new biomarker for prognosis and a new potential therapeutic target.	[Kimura, T.; Wang, L.; Nishihara, H.] Hokkaido Univ, Grad Sch Med, Dept Translat Pathol, Sapporo, Hokkaido, Japan; [Tabu, K.; Taga, T.] Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Stem Cell Regulat, Bunkyo Ku, Tokyo, Japan; [Tsuda, M.; Tanino, M.; Tanaka, S.] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Maekawa, A.; Oda, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka, Japan; [Hiraga, H.] Natl Hosp Org Hokkaido Canc Ctr, Div Orthoped, Sapporo, Hokkaido, Japan	Hokkaido University; Tokyo Medical & Dental University (TMDU); Hokkaido University; Kyushu University	Kimura, T; Tanaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Translat Pathol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.; Kimura, T; Tanaka, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	ktaichi@syd.odn.ne.jp; tanaka@med.hokudai.ac.jp	Tanaka, Shinya/D-3586-2011; Tabu, Kouichi/AAW-1225-2020	Tabu, Kouichi/0000-0002-3524-967X; Taga, Tetsuya/0000-0002-1625-0122	Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (TMDU)	Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (TMDU)	We thank Dr T Akagi for pCX4bleo vector. This work was supported in part by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (TMDU).	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Akashi T, 2008, CANCER SCI, V99, P539, DOI 10.1111/j.1349-7006.2007.00712.x; Chapman MR, 2013, INTEGR BIOL-UK, V5, P692, DOI 10.1039/c3ib20290a; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; Dubrovska A, 2012, BRIT J CANCER, V107, P43, DOI 10.1038/bjc.2012.105; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Haldar M, 2008, CLIN ORTHOP RELAT R, V466, P2156, DOI 10.1007/s11999-008-0340-2; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Hirata K, 2013, BRIT J CANCER, V109, P379, DOI 10.1038/bjc.2013.314; Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Ito T, 2004, LAB INVEST, V84, P1484, DOI 10.1038/labinvest.3700174; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jung MJ, 2013, ONCOGENE, V32, P209, DOI 10.1038/onc.2012.37; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kim SY, 2008, CLIN EXP METASTAS, V25, P201, DOI 10.1007/s10585-007-9133-3; Kimura T, 2012, CANCER INVEST, V30, P390, DOI 10.3109/07357907.2012.672607; Kimura Y, 2013, ONCOTARGET, V4, P785, DOI 10.18632/oncotarget.1048; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Lee CG, 2012, BRIT J HAEMATOL, V158, P79, DOI 10.1111/j.1365-2141.2012.09123.x; Liu AG, 2013, INT J ONCOL, V42, P1399, DOI 10.3892/ijo.2013.1826; Minami Y, 2014, CANCER SCI, V105, P1152, DOI 10.1111/cas.12479; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Oda Y, 2009, INT J CANCER, V124, P1852, DOI 10.1002/ijc.24128; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Palmerini E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0222-5; Perani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200; Porvasnik S, 2009, PROSTATE, V69, P1460, DOI 10.1002/pros.21008; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Saigusa S, 2010, ANN SURG ONCOL, V17, P2051, DOI 10.1245/s10434-010-0970-y; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Taichman RS, 2002, CANCER RES, V62, P1832; Tan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023383; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141; Watanabe T, 2009, CELL RES, V19, P638, DOI 10.1038/cr.2009.40; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xu L, 2009, CANCER RES, V69, P7905, DOI 10.1158/0008-5472.CAN-09-2099; Yopp AC, 2012, ANN SURG ONCOL, V19, pS339, DOI 10.1245/s10434-011-1774-4; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zheng XS, 2011, ONCOL RES, V19, P555, DOI 10.3727/096504012X13340632812631	58	15	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3932	3943		10.1038/onc.2015.461	http://dx.doi.org/10.1038/onc.2015.461			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26640147				2022-12-26	WOS:000381013100005
J	Malaisse, J; Pendaries, V; Hontoir, F; De Glas, V; Van Vlaender, D; Simon, M; de Rouvroit, CL; Poumay, Y; Flamion, B				Malaisse, Jeremy; Pendaries, Valerie; Hontoir, Fanny; De Glas, Valerie; Van Vlaender, Daniel; Simon, Michel; de Rouvroit, Catherine Lambert; Poumay, Yves; Flamion, Bruno			Hyaluronan Does Not Regulate Human Epidermal Keratinocyte Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; epidermis; hyaluronan; hyaluronidase; keratinocyte; proliferation; 4-methylumbelliferone	SYNTHESIS INHIBITOR 4-METHYLUMBELLIFERONE; UDP-GLUCOSE DEHYDROGENASE; THYMIDINE PHOSPHORYLASE; DOWN-REGULATION; SYNTHASE 2; ACID; SKIN; GLYCOSAMINOGLYCANS; RECONSTRUCTION; MORPHOGENESIS	Hyaluronan (HA) is synthesized by three HA synthases (HAS1, HAS2, and HAS3) and secreted in the extracellular matrix. In human skin, large amounts of HA are found in the dermis. HA is also synthesized by keratinocytes in the epidermis, although its epidermal functions are not clearly identified yet. To investigate HA functions, we studied the effects of HA depletion on human keratinocyte physiology within in vitro reconstructed human epidermis. Inhibition of HA synthesis with 4-methylumbelliferone (4MU) did not modify the expression profile of the epidermal differentiation markers involucrin, keratin 10, and filaggrin during tissue reconstruction. In contrast, when keratinocytes were incubated with 4MU, cell proliferation was decreased. In an attempt to rescue the proliferation function, HA samples of various mean molecular masses were added to keratinocyte cultures treated with 4MU. These samples were unable to rescue the initial proliferation rate. Furthermore, treatments with HA-specific hyaluronidase, although removing almost all HA from keratinocyte cultures, did not alter the differentiation or proliferation processes. The differences between 4MU and hyaluronidase effects did not result from differences in intracellular HA, sulfated glycosaminoglycan concentration, apoptosis, or levels of HA receptors, all of which remained unchanged. Similarly, knockdown of UDP-glucose 6-dehydrogenase (UGDH) using lentiviral shRNA effectively decreased HA production but did not affect proliferation rate. Overall, these data suggest that HA levels in the human epidermis are not directly correlated with keratinocyte proliferation and differentiation and that incubation of cells with 4MU cannot equate with HA removal.	[Malaisse, Jeremy; De Glas, Valerie; Van Vlaender, Daniel; de Rouvroit, Catherine Lambert; Poumay, Yves; Flamion, Bruno] Univ Namur, NARILIS, URPHYM, B-5000 Namur, Belgium; [Pendaries, Valerie; Simon, Michel] Univ Toulouse, UDEAR, CNRS INSERM, UMR5165 U1056, F-31013 Toulouse 6, France; [Hontoir, Fanny] Univ Namur, NARILIS, URVI, B-5000 Namur, Belgium	University of Namur; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Namur	Flamion, B (corresponding author), Univ Namur, NARILIS, URPHYM, B-5000 Namur, Belgium.	Bruno.Flamion@unamur.be	Simon, Michel/B-7308-2011; Poumay, Yves/G-4525-2016	Simon, Michel/0000-0003-3655-6329; Poumay, Yves/0000-0001-5200-3367; Hontoir, Fanny/0000-0003-0847-8167	FRFC [2.4522.10F]; FNRS [1.5.003.06F]	FRFC(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by FRFC Grant 2.4522.10F and FNRS Grant 1.5.003.06F (to Y. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; De Vuyst E, 2014, METHODS MOL BIOL, V1195, P191, DOI 10.1007/7651_2013_40; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frankart A, 2012, EXP DERMATOL, V21, P871, DOI 10.1111/exd.12020; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Gu H, 2010, EXP DERMATOL, V19, pE336, DOI 10.1111/j.1600-0625.2009.01052.x; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jokela TA, 2014, J BIOL CHEM, V289, P18569, DOI 10.1074/jbc.M114.551804; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Keller KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048523; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813; Lokeshwar VB, 2010, CANCER RES, V70, P2613, DOI 10.1158/0008-5472.CAN-09-3185; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Malaisse J, 2014, J INVEST DERMATOL, V134, P2174, DOI 10.1038/jid.2014.147; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Minner F, 2010, METHODS MOL BIOL, V585, P71, DOI 10.1007/978-1-60761-380-0_6; Muto J, 2014, J CLIN INVEST, V124, P1309, DOI 10.1172/JCI67947; Nikitovic D, 2015, TOXICOL LETT, V232, P89, DOI 10.1016/j.toxlet.2014.09.026; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Piccioni F, 2012, GLYCOBIOLOGY, V22, P400, DOI 10.1093/glycob/cwr158; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; TAMMI R, 1991, EXP CELL RES, V195, P524, DOI 10.1016/0014-4827(91)90405-J; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tamura R, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0094-2; Urakawa H, 2012, INT J CANCER, V130, P454, DOI 10.1002/ijc.26014; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997	42	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6347	6358		10.1074/jbc.M115.661348	http://dx.doi.org/10.1074/jbc.M115.661348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26627828	Green Published, hybrid			2022-12-26	WOS:000372894200024
J	Syeda, R; Santos, JS; Montal, M				Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio			The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; IDIOPATHIC EPILEPSY; MAMMALIAN-CELLS; KV CHANNEL; KCNQ2; ACTIVATION; MECHANISM; MUTATION; OPENER; RECONSTITUTION	KCNQ (voltage-gated K+ channel family 7 (Kv7)) channels control cellular excitability and underlie the K+ current sensitive to muscarinic receptor signaling (the M current) in sympathetic neurons. Here we show that the novel anti-epileptic drug retigabine (RTG) modulates channel function of pore-only modules (PMs) of the human Kv7.2 and Kv7.3 homomeric channels and of Kv7.2/3 heteromeric channels by prolonging the residence time in the open state. In addition, the Kv7 channel PMs are shown to recapitulate the single-channel permeation and pharmacological specificity characteristics of the corresponding full-length proteins in their native cellular context. A mutation (W265L) in the reconstituted Kv7.3 PM renders the channel insensitive to RTG and favors the conductive conformation of the PM, in agreement to what is observed when the Kv7.3 mutant is heterologously expressed. On the basis of the new findings and homology models of the closed and open conformations of the Kv7.3 PM, we propose a structural mechanism for the gating of the Kv7.3 PM and for the site of action of RTG as a Kv7.2/Kv7.3 K+ current activator. The results validate the modular design of human Kv channels and highlight the PM as a high-fidelity target for drug screening of Kv channels.	[Syeda, Ruhma; Santos, Jose S.; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Syeda, Ruhma] Scripps Res Inst, La Jolla, CA 92037 USA; [Santos, Jose S.] DART Neurosci, San Diego, CA 92131 USA	University of California System; University of California San Diego; Scripps Research Institute	Montal, M (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health [GM-49711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-49711 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armand V, 1999, N-S ARCH PHARMACOL, V359, P33, DOI 10.1007/PL00005320; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Lamas JA, 1997, EUR J NEUROSCI, V9, P605, DOI 10.1111/j.1460-9568.1997.tb01637.x; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Orhan G, 2012, EXPERT OPIN PHARMACO, V13, P1807, DOI 10.1517/14656566.2012.706278; Porter RJ, 2007, NEUROTHERAPEUTICS, V4, P149, DOI 10.1016/j.nurt.2006.11.012; Punke MA, 2007, ANESTH ANALG, V104, P1256, DOI 10.1213/01.ane.0000260310.63117.a2; Santos JS, 2013, J BIOL CHEM, V288, P16619, DOI 10.1074/jbc.M113.468728; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Syeda R, 2014, J BIOL CHEM, V289, P4233, DOI 10.1074/jbc.M113.530055; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Tatulian L, 2003, J PHYSIOL-LONDON, V549, P57, DOI 10.1113/jphysiol.2003.039842; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419	38	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2931	2937		10.1074/jbc.M115.683185	http://dx.doi.org/10.1074/jbc.M115.683185			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627826	Green Published, hybrid			2022-12-26	WOS:000369626900030
J	Urfer, M; Bogdanovic, J; Lo Monte, F; Moehle, K; Zerbe, K; Omasits, U; Ahrens, CH; Pessi, G; Eberl, L; Robinson, JA				Urfer, Matthias; Bogdanovic, Jasmina; Lo Monte, Fabio; Moehle, Kerstin; Zerbe, Katja; Omasits, Ulrich; Ahrens, Christian H.; Pessi, Gabriella; Eberl, Leo; Robinson, John A.			A Peptidomimetic Antibiotic Targets Outer Membrane Proteins and Disrupts Selectively the Outer Membrane in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; GRAM-NEGATIVE BACTERIA; POLYMYXIN-B; CELL-ENVELOPE; LIPOPOLYSACCHARIDE TRANSPORT; CAPSULAR POLYSACCHARIDES; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; PORE FORMATION; STRESS	Increasing antibacterial resistance presents a major challenge in antibiotic discovery. One attractive target in Gram-negative bacteria is the unique asymmetric outer membrane (OM), which acts as a permeability barrier that protects the cell from external stresses, such as the presence of antibiotics. We describe a novel beta-hairpin macrocyclic peptide JB-95 with potent antimicrobial activity against Escherichia coli. This peptide exhibits no cellular lytic activity, but electron microscopy and fluorescence studies reveal an ability to selectively disrupt the OM but not the inner membrane of E. coli. The selective targeting of the OM probably occurs through interactions of JB-95 with selected beta-barrel OM proteins, including BamA and LptD as shown by photolabeling experiments. Membrane proteomic studies reveal rapid depletion of many beta-barrel OM proteins from JB-95-treated E. coli, consistent with induction of a membrane stress response and/or direct inhibition of the Bam folding machine. The results suggest that lethal disruption of the OM by JB-95 occurs through a novel mechanism of action at key interaction sites within clusters of beta-barrel proteins in the OM. These findings open new avenues for developing antibiotics that specifically target beta-barrel proteins and the integrity of the Gram-negative OM.	[Urfer, Matthias; Bogdanovic, Jasmina; Lo Monte, Fabio; Moehle, Kerstin; Zerbe, Katja; Robinson, John A.] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Omasits, Ulrich] Swiss Fed Inst Technol, Inst Mol Syst Biol, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland; [Ahrens, Christian H.] Inst Plant Prod Sci, Res Grp Mol Diagnost Genom & Bioinformat, Schloss 1, CH-8820 Wadenswil, Switzerland; [Ahrens, Christian H.] Agroscope, Swiss Inst Bioinformat, Schloss 1, CH-8820 Wadenswil, Switzerland; [Pessi, Gabriella; Eberl, Leo] Univ Zurich, Inst Plant Biol, Dept Microbiol, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope; Swiss Institute of Bioinformatics; University of Zurich	Robinson, JA (corresponding author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	robinson@oci.uzh.ch	Eberl, Leo/AAE-8165-2019; Eberl, Leo/A-8380-2012; Ahrens, Christian H./F-4656-2011; Pessi, Gabriella/AGW-2342-2022	Eberl, Leo/0000-0002-7241-0864; Ahrens, Christian H./0000-0002-8148-7257; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cunningham ML, 2013, J BIOMOL SCREEN, V18, P1018, DOI 10.1177/1087057113487208; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; Dalebroux ZD, 2014, CURR OPIN MICROBIOL, V17, P106, DOI 10.1016/j.mib.2013.12.005; Deris ZZ, 2014, BIOCONJUGATE CHEM, V25, P750, DOI 10.1021/bc500094d; DIXON RA, 1986, ANTIMICROB AGENTS CH, V29, P781, DOI 10.1128/AAC.29.5.781; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Dunstan RA, 2015, MOL MICROBIOL, V97, P616, DOI 10.1111/mmi.13055; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Galdiero S, 2015, CURR MED CHEM, V22, P1665, DOI 10.2174/0929867322666150311145632; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gogol EB, 2011, P NATL ACAD SCI USA, V108, P12875, DOI 10.1073/pnas.1109379108; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Jiang LJ, 2000, HELV CHIM ACTA, V83, P3097, DOI 10.1002/1522-2675(20001220)83:12<3097::AID-HLCA3097>3.0.CO;2-1; KOIKE M, 1969, J BACTERIOL, V97, P448, DOI 10.1128/JB.97.1.448-452.1969; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyu ZX, 2015, BIOCHEM SOC T, V43, P133, DOI 10.1042/BST20140217; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; MUHLRADT PF, 1974, EUR J BIOCHEM, V43, P533, DOI 10.1111/j.1432-1033.1974.tb03440.x; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Omasits U, 2013, GENOME RES, V23, P1916, DOI 10.1101/gr.151035.112; Page MGP, 2014, CURR OPIN PHARMACOL, V18, P91, DOI 10.1016/j.coph.2014.09.008; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pessi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072939; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rassam P, 2015, NATURE, V523, P333, DOI 10.1038/nature14461; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Roy RN, 2015, NAT STRUCT MOL BIOL, V22, P466, DOI 10.1038/nsmb.3031; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Sahalan AZ, 2008, INT J ANTIMICROB AG, V31, P224, DOI 10.1016/j.ijantimicag.2007.10.005; SCHRODER G, 1992, BIOCHEMISTRY-US, V31, P631, DOI 10.1021/bi00118a001; Seefeldt AC, 2015, NAT STRUCT MOL BIOL, V22, P470, DOI 10.1038/nsmb.3034; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Stekhoven DJ, 2014, J PROTEOMICS, V99, P123, DOI 10.1016/j.jprot.2014.01.015; Ursell TS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002680; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Werneburg M, 2012, CHEMBIOCHEM, V13, P1767, DOI 10.1002/cbic.201200276; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wiese A, 1998, J MEMBRANE BIOL, V162, P127, DOI 10.1007/s002329900350; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; YU Z, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/679109; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	73	61	63	5	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1921	+		10.1074/jbc.M115.691725	http://dx.doi.org/10.1074/jbc.M115.691725			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627837	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000368620700030
J	Li, LD; Sun, HF; Liu, XX; Gao, SP; Jiang, HL; Hu, X; Jin, W				Li, Liang-Dong; Sun, He-Fen; Liu, Xue-Xiao; Gao, Shui-Ping; Jiang, Hong-Lin; Hu, Xin; Jin, Wei			Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; COMPLEX-I; TARGET; GENES; TUMORIGENESIS; ACTIVATION; AUTOPHAGY; MOTILITY; PATHWAY	Despite advances in basic and clinical research, metastasis remains the leading cause of death in breast cancer patients. Genetic abnormalities in mitochondria, including mutations affecting complex I and oxidative phosphorylation, are found in breast cancers and might facilitate metastasis. Genes encoding complex I components have significant breast cancer prognostic value. In this study, we used quantitative proteomic analyses to compare a highly metastatic cancer cell line and a parental breast cancer cell line; and observed that NDUFB9, an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I), was down-regulated in highly metastatic breast cancer cells. Furthermore, we demonstrated that loss of NDUFB9 promotes MDA-MB-231 cells proliferation, migration, and invasion because of elevated levels of mtROS, disturbance of the NAD(+)/NADH balance, and depletion of mtDNA. We also showed that, the Akt/mTOR/p70S6K signaling pathway and EMT might be involved in this mechanism. Thus, our findings contribute novel data to support the hypothesis that misregulation of mitochondrial complex I NADH dehydrogenase activity can profoundly enhance the aggressiveness of human breast cancer cells, suggesting that complex I deficiency is a potential and important biomarker for further basic research or clinical application.	[Li, Liang-Dong; Sun, He-Fen; Gao, Shui-Ping; Jiang, Hong-Lin; Hu, Xin; Jin, Wei] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200030, Peoples R China; [Li, Liang-Dong; Sun, He-Fen; Gao, Shui-Ping; Jiang, Hong-Lin; Jin, Wei] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200030, Peoples R China; [Liu, Xue-Xiao] Lishui Cent Hosp, Dept Radiotherapy, Lishui 323000, Zhejiang, Peoples R China	Fudan University; Fudan University	Jin, W (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Key Lab Breast Canc Shanghai, Shanghai 200030, Peoples R China.	weijin7207@126.com			National Natural Science Foundation of China [81272923]; Program for New Century Excellent Talents in University [NCET-12-0127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (81272923), Program for New Century Excellent Talents in University (NCET-12-0127) http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat TA, 2015, DRUG DISCOV TODAY, V20, P635, DOI 10.1016/j.drudis.2015.03.001; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cheon H, 2010, ONCOL REP, V23, P779, DOI 10.3892/or_00000698; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; Cui HH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-110; Dong LF, 2014, PROG MOL BIOL TRANSL, V127, P211, DOI 10.1016/B978-0-12-394625-6.00008-8; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P549, DOI 10.1016/j.bbamcr.2014.12.016; Gu JZ, 1996, GENOMICS, V35, P6, DOI 10.1006/geno.1996.0316; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jiang HL, 2015, ONCOTARGET, V2015; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Lin HC, 2013, J PROTEOME RES, V12, P3423, DOI 10.1021/pr400273z; Lin X, 1999, HUM HERED, V49, P75, DOI 10.1159/000022848; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Ren W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096816; Santidrian AF, 2014, DNA REPAIR, V23, P79, DOI 10.1016/j.dnarep.2014.08.006; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schroder K, 2014, ANTIOXID REDOX SIGN, V20, P2043, DOI 10.1089/ars.2013.5633; Sun H, 2013, ANTI-CANCER AGENT ME, V13, P1048, DOI 10.2174/18715206113139990130; Tan AS, 2014, BBA-GEN SUBJECTS, V1840, P1454, DOI 10.1016/j.bbagen.2013.10.016; Tochhawng L, 2013, MITOCHONDRION, V13, P246, DOI 10.1016/j.mito.2012.08.002; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; van Horssen R, 2013, CELL MOL LIFE SCI, V70, P2175, DOI 10.1007/s00018-012-1249-1; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Wang F, 2015, DRUG DES DEV THER, V9, P537, DOI 10.2147/DDDT.S73689; Wang L, 2008, CANCER EPIDEM BIOMAR, V17, P3558, DOI 10.1158/1055-9965.EPI-08-0434; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011; Zhou W, 2015, CANCER LETT, V360, P68, DOI 10.1016/j.canlet.2015.02.004	42	49	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144441	10.1371/journal.pone.0144441	http://dx.doi.org/10.1371/journal.pone.0144441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641458	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700122
J	Martins, RST; Gomez, A; Zanuy, S; Carrillo, M; Canario, AVM				Martins, Rute S. T.; Gomez, Ana; Zanuy, Silvia; Carrillo, Manuel; Canario, Adelino V. M.			Photoperiodic Modulation of Circadian Clock and Reproductive Axis Gene Expression in the Pre-Pubertal European Sea Bass Brain	PLOS ONE			English	Article							DICENTRARCHUS-LABRAX; CONTINUOUS LIGHT; SEXUAL-MATURATION; FISH; PITUITARY; L.; GNRH; HORMONES; SYSTEM; DIFFERENTIATION	The acquisition of reproductive competence requires the activation of the brain-pituitary-gonad (BPG) axis, which in most vertebrates, including fishes, is initiated by changes in photoperiod. In the European sea bass long-term exposure to continuous light (LL) alters the rhythm of reproductive hormones, delays spermatogenesis and reduces the incidence of precocious males. In contrast, an early shift from long to short photoperiod (AP) accelerates spermatogenesis. However, how photoperiod affects key genes in the brain to trigger the onset of puberty is still largely unknown. Here, we investigated if the integration of the light stimulus by clock proteins is sufficient to activate key genes that trigger the BPG axis in the European sea bass. We found that the clock genes clock, npas2, bmal1 and the BPG genes gnrh, kiss and kissr share conserved transcription factor frameworks in their promoters, suggesting co-regulation. Other gene promoters of the BGP axis were also predicted to be co-regulated by the same frameworks. Co-regulation was confirmed through gene expression analysis of brains from males exposed to LL or AP photoperiod compared to natural conditions: LL fish had suppressed gnrh1, kiss2, galr1b and esr1, while AP fish had stimulated npas2, gnrh1, gnrh2, kiss2, kiss1rb and galr1b compared to NP. It is concluded that fish exposed to different photoperiods present significant expression differences in some clock and reproductive axis related genes well before the first detectable endocrine and morphological responses of the BPG axis.	[Martins, Rute S. T.; Canario, Adelino V. M.] Univ Algarve, Ctr Marine Sci CCMAR, Comparat Endocrinol & Integrat Biol Grp, Faro, Portugal; [Gomez, Ana; Zanuy, Silvia; Carrillo, Manuel] CSIC, Inst Acuicultura Torre La Sal, Dept Fish Physiol & Biotechnol, Torre De La Sal, Castellon, Spain	Universidade do Algarve; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Martins, RST (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Comparat Endocrinol & Integrat Biol Grp, Campus Gambelas, Faro, Portugal.	rsmartin@ualg.pt	Canario, Adelino/C-7942-2009; Gómez, Ana/K-6998-2014; Martins, Rute Sofia Tavares/AAK-4776-2021	Canario, Adelino/0000-0002-6244-6468; Gómez, Ana/0000-0003-4714-8064; Martins, Rute Sofia Tavares/0000-0001-5804-2981	European Community [222719 - LIFECYCLE]; Foundation for Science and Technology of Portugal (FCT) [SFRH/BPD/66742/2009, PEst-C/MAR/LA0015/2011]; Valencian Regional Goverment [Prometeo II/2014/051]; Spanish Ministry of Science and Innovation (MICINN) [CSD 2007-0002]	European Community(European Commission); Foundation for Science and Technology of Portugal (FCT)(Portuguese Foundation for Science and Technology); Valencian Regional Goverment; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research leading to these results was funded by European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 222719 - LIFECYCLE and by the Foundation for Science and Technology of Portugal (FCT), through project PEst-C/MAR/LA0015/2011 and Prometeo II/2014/051 from the Valencian Regional Goverment and CSD 2007-0002 (AQUAGENOMICS) Spanish Ministry of Science and Innovation (MICINN). RSTM was funded by the Foundation for Science and Technology of Portugal (FCT) under fellowship (SFRH/BPD/66742/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Choi JH, 2013, CURR OPIN ENDOCRINOL, V20, P62, DOI 10.1097/MED.0b013e32835b7ec7; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; Escobar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070177; Escobar S, 2013, J COMP NEUROL, V521, P933, DOI 10.1002/cne.23211; Espigares F, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125138; Felip A, 2008, AQUACULTURE, V275, P347, DOI 10.1016/j.aquaculture.2008.01.020; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Gillespie JMA, 2003, ENDOCRINOLOGY, V144, P5285, DOI 10.1210/en.2003-0802; Gonzalez-Martinez D, 2002, J COMP NEUROL, V446, P95, DOI 10.1002/cne.10190; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Bayarri MJ, 2009, CHRONOBIOL INT, V26, P184, DOI 10.1080/07420520902758311; Kennaway DJ, 2005, HUM REPROD UPDATE, V11, P91, DOI 10.1093/humupd/dmh054; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Klein SE, 2008, MOL CELL ENDOCRINOL, V286, P148, DOI 10.1016/j.mce.2007.08.010; Kovanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010007; Martins RST, 2014, GEN COMP ENDOCR, V205, P109, DOI 10.1016/j.ygcen.2014.06.030; Martins RST, 2013, GENE, V530, P66, DOI 10.1016/j.gene.2013.07.052; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Nabi G, 2014, J BIOL LIFE SCI, V6, P1; Nishiguchi Ryo, 2012, Front Endocrinol (Lausanne), V3, P122, DOI 10.3389/fendo.2012.00122; Parhar I, 2012, PROG NEUROBIOL, V98, P176, DOI 10.1016/j.pneurobio.2012.05.011; Prat F, 1999, J FISH BIOL, V54, P125, DOI 10.1111/j.1095-8649.1999.tb00617.x; Rodriguez L, 2004, GEN COMP ENDOCR, V136, P37, DOI 10.1016/j.ygcen.2003.11.010; Rodriguez L, 2001, AQUACULTURE, V202, P235, DOI 10.1016/S0044-8486(01)00774-8; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Rodriguez L, 2001, AQUACULTURE, V196, P159, DOI 10.1016/S0044-8486(00)00555-X; Rodriguez R, 2012, AQUACULT INT, V20, P1071, DOI 10.1007/s10499-012-9510-z; Saillant E, 2003, J ZOOL, V260, P53, DOI 10.1017/S0952836903003467; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Smarr BL, 2012, ENDOCRINOLOGY, V153, P2839, DOI 10.1210/en.2011-1857; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Volkoff H, 2010, GEN COMP ENDOCR, V167, P352, DOI 10.1016/j.ygcen.2009.09.001; Werner T, 2003, TRENDS BIOTECHNOL, V21, P9, DOI 10.1016/S0167-7799(02)00003-3; Williams WP, 2011, ENDOCRINOLOGY, V152, P595, DOI 10.1210/en.2010-0943; Xia W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03676; Zmora N, 2014, ENDOCRINOLOGY, V155, P1874, DOI 10.1210/en.2013-1894	44	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144158	10.1371/journal.pone.0144158	http://dx.doi.org/10.1371/journal.pone.0144158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641263	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700067
J	Nakamura, M; Kanda, T; Sasaki, R; Haga, Y; Jiang, X; Wu, S; Nakamoto, S; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Sasaki, Reina; Haga, Yuki; Jiang, Xia; Wu, Shuang; Nakamoto, Shingo; Yokosuka, Osamu			MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; RECEPTOR 4; NONALCOHOLIC STEATOHEPATITIS; 122 EXPRESSION; LIVER-INJURY; FIBROSIS; MIR-122; DIFFERENTIATION; IDENTIFICATION	MicroRNA-122 (miR-122) is one of the most abundant miRs in the liver. Previous studies have demonstrated that miR-122 plays a role in inflammation in the liver and functions in hepatic stellate cells (HSCs), which reside in the space of Disse. Here, we showed that the transient inhibition of PKR-activating protein (PACT) expression, by miR-122 or siRNA targeting of PACT, suppressed the production of proinflammatory cytokines, such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1) and IL-1 beta, in human HSC LX-2. Sequence and functional analyses confirmed that miR-122 directly targeted the 30-untranslated region of PACT. Immunofluorescence analysis revealed that miR-122 blocked NF-kappa B-nuclear translocation in LX-2 cells. We also showed that conditioned medium from miR-122-transfected LX-2 cells suppressed human monocyte-derived THP-1 cell migration. Taken together, our study indicates that miR-122 may downregulate cytokine production in HSCs and macrophage chemotaxis and that the targeting of miR-122 may have therapeutic potential for preventing the progression of liver diseases.	[Nakamura, Masato; Kanda, Tatsuo; Sasaki, Reina; Haga, Yuki; Jiang, Xia; Wu, Shuang; Nakamoto, Shingo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608677, Japan; [Nakamoto, Shingo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba 2608677, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608677, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20345002]; Chugai [J09KF00234]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chugai	This work was supported by a KAKEN Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (20345002 to TK) (https://kaken.nii.ac.jp/d/r/20345002.ja.html), and by a grant from Chugai (J09KF00234 to TK and OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Chen L, 2014, HEPATOLOGY, V59, P1118, DOI 10.1002/hep.26768; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Csak T, 2011, AM J PHYSIOL-GASTR L, V300, pG433, DOI 10.1152/ajpgi.00163.2009; D'Acquisto F, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.89.re1; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Estko M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0650-3; Estrabaud E, 2014, J VIROL, V88, P6394, DOI 10.1128/JVI.00016-14; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Iwamura T, 2001, BIOCHEM BIOPH RES CO, V282, P515, DOI 10.1006/bbrc.2001.4606; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Kusov Y, 2006, J VIROL, V80, P5599, DOI 10.1128/JVI.01773-05; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; Li S, 2012, NUCLEIC ACIDS RES, V40, P884, DOI 10.1093/nar/gkr715; Mandal P, 2010, J IMMUNOL, V185, P4928, DOI 10.4049/jimmunol.1002060; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; Tazi KA, 2007, J HEPATOL, V46, P1075, DOI 10.1016/j.jhep.2007.01.034; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wu SA, 2010, VIRAL IMMUNOL, V23, P467, DOI 10.1089/vim.2010.0042; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshida K, 2012, J CELL BIOCHEM, V113, P165, DOI 10.1002/jcb.23340	56	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144295	10.1371/journal.pone.0144295	http://dx.doi.org/10.1371/journal.pone.0144295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636761	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800069
J	Salgado, P; Vazquez, JA; Riobo, P; Franco, JM; Figueroa, RI; Kremp, A; Bravo, I				Salgado, Pablo; Vazquez, Jose A.; Riobo, Pilar; Franco, Jose M.; Figueroa, Rosa I.; Kremp, Anke; Bravo, Isabel			A Kinetic and Factorial Approach to Study the Effects of Temperature and Salinity on Growth and Toxin Production by the Dinoflagellate Alexandrium ostenfeldii from the Baltic Sea	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXINS; LACTIC-ACID BACTERIA; GENUS ALEXANDRIUM; SACCHAROMYCES-CEREVISIAE; SPIROLIDE PRODUCTION; PERUVIANUM BALECH; MENDIOLA BALECH; CYST FORMATION; DINOPHYCEAE; BLOOM	Alexandrium ostenfeldii is present in a wide variety of environments in coastal areas worldwide and is the only dinoflagellate known species that produces paralytic shellfish poisoning (PSP) toxins and two types of cyclic imines, spirolides (SPXs) and gymnodimines (GYMs). The increasing frequency of A. ostenfeldii blooms in the Baltic Sea has been attributed to the warming water in this region. To learn more about the optimal environmental conditions favoring the proliferation of A. ostenfeldii and its complex toxicity, the effects of temperature and salinity on the kinetics of both the growth and the net toxin production of this species were examined using a factorial design and a response-surface analysis (RSA). The results showed that the growth of Baltic A. ostenfeldii occurs over a wide range of temperatures and salinities (12.5-25.5 degrees C and 5-21, respectively), with optimal growth conditions achieved at a temperature of 25.5 degrees C and a salinity of 11.2. Together with the finding that a salinity > 21 was the only growth-limiting factor detected for this strain, this study provides important insights into the autecology and population distribution of this species in the Baltic Sea. The presence of PSP toxins, including gonyautoxin (GTX)-3, GTX-2, and saxitoxin (STX), and GYMs (GYM-A and GYM-B/-C analogues) was detected under all temperature and salinity conditions tested and in the majority of the cases was concomitant with both the exponential growth and stationary phases of the dinoflagellate's growth cycle. Toxin concentrations were maximal at temperatures and salinities of 20.9 degrees C and 17 for the GYM-A analogue and > 19 degrees C and 15 for PSP toxins, respectively. The ecological implications of the optimal conditions for growth and toxin production of A. ostenfeldii in the Baltic Sea are discussed.	[Salgado, Pablo] Inst Fomento Pesquero IFOP, Dept Medio Ambiente, Div Invest Acuicultura, Punta Arenas, Chile; [Vazquez, Jose A.] CSIC, IIM, Grp Reciclado & Valorizac Mat Residuales REVAL, Vigo, Spain; [Riobo, Pilar; Franco, Jose M.] CSIC, IIM, Vigo, Spain; [Salgado, Pablo; Figueroa, Rosa I.; Bravo, Isabel] Ctr Oceanog Vigo, IEO, Vigo, Spain; [Kremp, Anke] Finnish Environm Inst SYKE, Ctr Marine Res, Helsinki, Finland	Instituto de Fomento Pesquero (Valparaiso); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Spanish Institute of Oceanography; Finnish Environment Institute	Salgado, P (corresponding author), Inst Fomento Pesquero IFOP, Dept Medio Ambiente, Div Invest Acuicultura, Punta Arenas, Chile.	pablo.salgado@ifop.cl	Figueroa, Rosa Isabel/M-7598-2015; Bravo, Isabel/D-3147-2012; Riobó, Pilar/K-1945-2017; Vazquez Alvarez, Jose Antonio/K-5938-2014	Figueroa, Rosa Isabel/0000-0001-9944-7993; Riobó, Pilar/0000-0002-1921-6229; Salgado, Pablo/0000-0002-4168-3675; Bravo, Isabel/0000-0003-3764-745X; Vazquez Alvarez, Jose Antonio/0000-0002-1122-4726	CCVIEO project; Ministry of Economy and Competitiveness [CICAN-2013-40671-R]	CCVIEO project; Ministry of Economy and Competitiveness	This work is a contribution of the Unidad Asociada "Microalgas Nocivas" (CSIC-IEO) and was financially supported by the CCVIEO project and CICAN-2013-40671-R (Ministry of Economy and Competitiveness). P. Salgado is a researcher at IFOP, which has provided financial support for his doctoral stay.	Aasen J, 2005, CHEM RES TOXICOL, V18, P509, DOI 10.1021/tx049706n; Almandoz GO, 2014, HARMFUL ALGAE, V37, P100, DOI 10.1016/j.hal.2014.05.011; ANDERSON DM, 1990, TOXICON, V28, P885, DOI 10.1016/0041-0101(90)90018-3; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Avaria Sergio, 2003, Ciencia y Tecnologia del Mar, V26, P79; Balech E., 1977, NEOTROPICA, V23, P49; Borkman DG, 2012, HARMFUL ALGAE, V19, P92, DOI 10.1016/j.hal.2012.06.004; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Bravo I, 2006, EUR J PHYCOL, V41, P293, DOI 10.1080/09670260600810360; Brown L, 2010, EUR J PHYCOL, V45, P375, DOI 10.1080/09670262.2010.495164; Burson A, 2014, HARMFUL ALGAE, V31, P125, DOI 10.1016/j.hal.2013.10.017; Cembella AD, 2000, PHYCOLOGIA, V39, P67, DOI 10.2216/i0031-8884-39-1-67.1; Cembella Allan D., 1998, NATO ASI Series Series G Ecological Sciences, V41, P381; Ciminiello P, 2006, TOXICON, V47, P597, DOI 10.1016/j.toxicon.2006.02.003; Dantigny P, 2007, INT J FOOD MICROBIOL, V114, P17, DOI 10.1016/j.ijfoodmicro.2006.11.002; Etheridge SM, 2005, DEEP-SEA RES PT II, V52, P2491, DOI 10.1016/j.dsr2.2005.06.026; European Union Reference Laboratory for Marine Biotoxins (EURLMB), 2011, EU HARM STAND OP PRO; Figueroa RI, 2008, HARMFUL ALGAE, V7, P653, DOI 10.1016/j.hal.2008.02.005; Franco D, 2012, POULTRY SCI, V91, P487, DOI 10.3382/ps.2011-01546; Franco D, 2013, MEAT SCI, V93, P547, DOI 10.1016/j.meatsci.2012.11.018; Franco J. M., 2006, 12 INT C HARMF ALG C; Graneli E, 2006, ECOL STUD; Gribble KE, 2005, DEEP-SEA RES PT II, V52, P2745, DOI 10.1016/j.dsr2.2005.06.018; Grzebyk D, 2003, J PLANKTON RES, V25, P1185, DOI 10.1093/plankt/fbg088; Gu HF, 2011, J SYST EVOL, V49, P606, DOI 10.1111/j.1759-6831.2011.00160.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guzman L, 2013, PROGRAMA MANEJO MONI, P45; Hakanen P, 2012, HARMFUL ALGAE, V15, P91, DOI 10.1016/j.hal.2011.12.002; HANSEN PJ, 1992, J PHYCOL, V28, P597, DOI 10.1111/j.0022-3646.1992.00597.x; Harju K, 2014, 16 INT C HARMF ALG 2; Haro Daniela, 2013, Anales Instituto Patagonia (Chile), V41, P77; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Wardhani DH, 2009, J AGR FOOD CHEM, V57, P540, DOI 10.1021/jf802492s; Hwang DF, 2000, TOXICON, V38, P1491, DOI 10.1016/S0041-0101(00)00080-5; Figueroa RI, 2011, J PHYCOL, V47, P13, DOI 10.1111/j.1529-8817.2010.00937.x; Jayakar SS, 2013, BIOPROC BIOSYST ENG, V36, P1063, DOI 10.1007/s00449-012-0859-1; Jensen MO, 1997, EUR J PHYCOL, V32, P9, DOI 10.1080/09541449710001719325; Katikou P, 2010, 14 INT C HARMF ALG C; Kebreab E, 2007, J ANIM SCI, V85, P2498, DOI 10.2527/jas.2006-738; Kremp A, 2014, J PHYCOL, V50, P81, DOI 10.1111/jpy.12134; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kremp A, 2009, HARMFUL ALGAE, V8, P318, DOI 10.1016/j.hal.2008.07.004; Laabir M, 2011, J PLANKTON RES, P1; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Lembeye G., 2006, AVANCES CONOCIMIENTO, P99; Lim PT, 2005, HARMFUL ALGAE, V4, P391, DOI 10.1016/j.hal.2004.07.001; Liu JZ, 2003, BIOCHEM ENG J, V14, P137, DOI 10.1016/S1369-703X(02)00169-9; MacKinnon SL, 2006, J NAT PROD, V69, P983, DOI 10.1021/np050220w; Maclean C, 2003, BOT MAR, V46, P466, DOI 10.1515/BOT.2003.048; Marrouchi R, 2010, ADV NEW TECHNOLOGIES, P79; Medhioub W, 2011, HARMFUL ALGAE, V10, P794, DOI 10.1016/j.hal.2011.06.012; Miles CO, 2003, J AGR FOOD CHEM, V51, P4838, DOI 10.1021/jf030101r; Miles CO, 2000, J AGR FOOD CHEM, V48, P1373, DOI 10.1021/jf991031k; Molgo J., 2014, SEAFOOD FRESHWATER T, P951; Murray SA, 2014, HARMFUL ALGAE, V31, P54, DOI 10.1016/j.hal.2013.09.005; Otero P, 2010, ENVIRON TOXICOL CHEM, V29, P301, DOI 10.1002/etc.41; Paulsen O., 1904, MEDD KOMMN HAVUNDERS, V1, P1; Paz B, 2006, MAR ENVIRON RES, V62, P286, DOI 10.1016/j.marenvres.2006.04.066; Paz B, 2009, HARMFUL ALGAE, V8, P730, DOI 10.1016/j.hal.2009.03.001; Planas M, 2004, AQUACULTURE, V240, P313, DOI 10.1016/j.aquaculture.2004.07.016; Rial D, 2013, J HAZARD MATER, V263, P374, DOI 10.1016/j.jhazmat.2013.07.010; Richard D. J. A., 2000, HARMFUL ALGAL BLOOMS, P383; Rourke WA, 2008, J AOAC INT, V91, P589; Salgado P, 2015, TOXICON, V103, P85, DOI 10.1016/j.toxicon.2015.06.015; Sanchez S, 2004, 11 INT C HARMF ALG B, P227; Senft-Batoh CD, 2015, LIMNOL OCEANOGR, V00, P1; Senft-Batoh CD, 2015, HARMFUL ALGAE, V44, P20, DOI 10.1016/j.hal.2015.02.008; Smayda TJ, 2002, J OCEANOGR, V58, P281, DOI 10.1023/A:1015861725470; Spor A, 2010, INT J FOOD MICROBIOL, V142, P25, DOI 10.1016/j.ijfoodmicro.2010.05.012; Suikkanen S, 2013, HARMFUL ALGAE, V26, P52, DOI 10.1016/j.hal.2013.04.001; Tahvanainen P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053602; Tatters AO, 2012, HARMFUL ALGAE, V19, P160, DOI 10.1016/j.hal.2012.07.002; Tillmann U, 2014, HARMFUL ALGAE, V39, P259, DOI 10.1016/j.hal.2014.08.008; Tomas CR, 2012, HARMFUL ALGAE, V17, P54, DOI 10.1016/j.hal.2012.02.011; Van Wagoner RM, 2011, TETRAHEDRON LETT, V52, P4243, DOI 10.1016/j.tetlet.2011.05.137; Vazquez JA, 2008, BIORESOURCE TECHNOL, V99, P6246, DOI 10.1016/j.biortech.2007.12.006; Vazquez JA, 2008, BIOCHEM ENG J, V39, P276, DOI 10.1016/j.bej.2007.09.012; Vazquez JA, 2004, ENZYME MICROB TECH, V35, P385, DOI 10.1016/j.enzmictec.2004.02.007; Vazquez JA, 2012, J THEOR BIOL, V39, P276; Wang DZ, 2005, HARMFUL ALGAE, V4, P401, DOI 10.1016/j.hal.2004.07.002; Wang H, 2008, AQUACULTURE, V284, P68, DOI 10.1016/j.aquaculture.2008.07.008; Wardhani DH, 2010, FOOD CHEM, V118, P731, DOI 10.1016/j.foodchem.2009.05.057; WOOD AM, 1992, J PHYCOL, V28, P723, DOI 10.1111/j.0022-3646.1992.00723.x	83	7	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143021	10.1371/journal.pone.0143021	http://dx.doi.org/10.1371/journal.pone.0143021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636674	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800005
J	Giotto, N; Gerard, JF; Ziv, A; Bouskila, A; Bar-David, S				Giotto, Nina; Gerard, Jean-Francois; Ziv, Alon; Bouskila, Amos; Bar-David, Shirli			Space-Use Patterns of the Asiatic Wild Ass (Equus hemionus): Complementary Insights from Displacement, Recursion Movement and Habitat Selection Analyses	PLOS ONE			English	Article							NATIONAL-PARK; SOUTH-AFRICA; DORCATRAGUS-MEGALOTIS; FERUS-PRZEWALSKII; POPULATION-SIZE; ACTIVITY RHYTHM; FORAGING THEORY; BEIRA ANTELOPE; BIGHORN SHEEP; DESERT	The way in which animals move and use the landscape is influenced by the spatial distribution of resources, and is of importance when considering species conservation. We aimed at exploring how landscape-related factors affect a large herbivore's space-use patterns by using a combined approach, integrating movement (displacement and recursions) and habitat selection analyses. We studied the endangered Asiatic wild ass (Equus hemionus) in the Negev Desert, Israel, using GPS monitoring and direct observation. We found that the main landscape-related factors affecting the species' space-use patterns, on a daily and seasonal basis, were vegetation cover, water sources and topography. Two main habitat types were selected: high-elevation sites during the day (specific microclimate: windy on warm summer days) and streambed surroundings during the night (coupled with high vegetation when the animals were active in summer). Distribution of recursion times (duration between visits) revealed a 24-hour periodicity, a pattern that could be widespread among large herbivores. Characterizing frequently revisited sites suggested that recursion movements were mainly driven by a few landscape features (water sources, vegetation patches, high-elevation points), but also by social factors, such as territoriality, which should be further explored. This study provided complementary insights into the space-use patterns of E. hemionus. Understanding of the species' space-use patterns, at both large and fine spatial scale, is required for developing appropriate conservation protocols. Our approach could be further applied for studying the space-use patterns of other species in heterogeneous landscapes.	[Giotto, Nina; Ziv, Alon; Bouskila, Amos; Bar-David, Shirli] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Gerard, Jean-Francois] INRA, Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Ziv, Alon; Bouskila, Amos] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; INRAE; Ben Gurion University	Giotto, N (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel.	giottonina@gmail.com	Bouskila, Amos/B-4847-2010; BAR-DAVID, SHIRLI/F-1512-2012	Bouskila, Amos/0000-0002-6995-5070; BAR-DAVID, SHIRLI/0000-0001-8103-041X	Minerva Centre for Movement Ecology; Swiss Institute for Dryland Environmental and Energy Research (SIDEER); Jacob Blaustein Institutes for Desert Research of Ben-Gurion University of the Negev; United States-Israel Binational Science Foundation [2009296]; Israel Nature and Park Authority	Minerva Centre for Movement Ecology; Swiss Institute for Dryland Environmental and Energy Research (SIDEER); Jacob Blaustein Institutes for Desert Research of Ben-Gurion University of the Negev; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Nature and Park Authority	NG postdoctoral fellowships were supported by the Minerva Centre for Movement Ecology, the Swiss Institute for Dryland Environmental and Energy Research (SIDEER) and the Jacob Blaustein Institutes for Desert Research of Ben-Gurion University of the Negev. The research program was supported by United States-Israel Binational Science Foundation Grant 2009296 awarded to SBD, AB and A.R. Templeton and by the Israel Nature and Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Adrados C., 2002, THESIS; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Balhoul K, 2001, J ARID ENVIRON, V47, P309; Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; BERGER J, 1977, BEHAV ECOL SOCIOBIOL, V2, P131, DOI 10.1007/BF00361898; Berger-Tal O, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00106.1; Bleich VC, 2010, J ARID ENVIRON, V74, P638, DOI 10.1016/j.jaridenv.2009.10.019; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cain JW, 2008, J ARID ENVIRON, V72, P1518, DOI 10.1016/j.jaridenv.2008.02.010; Cain JW, 2012, J ZOOL, V286, P58, DOI 10.1111/j.1469-7998.2011.00848.x; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cox D. R., 1984, ANAL SURVIVAL DATA; Danin A, 1999, BOT REV, V65, P93, DOI 10.1007/BF02857625; Davidson A, 2013, LANDSCAPE ECOL, V28, P1465, DOI 10.1007/s10980-013-9915-8; Davis SJ, 2008, ZOOL J LINN SOC-LOND, V70, P289; Denzau G, 2007, ERFORSCH BIOL RESS M, V10, P177; Duncan P, 1992, ECOL STUD, V89, P1; English M, 2014, CURR ZOOL, V60, P551, DOI 10.1093/czoolo/60.4.551; Ensing EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106997; ESTES RD, 1991, BEHAV GUIDE AFRICAN; EVENARI M., 1971, NEGEV CHALLENGE DESE; Feh C, 2001, BIOL CONSERV, V101, P51, DOI 10.1016/S0006-3207(01)00051-9; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Giotto N, 2013, J ARID ENVIRON, V89, P5, DOI 10.1016/j.jaridenv.2012.09.004; Giotto N, 2008, EUR J WILDLIFE RES, V54, P539, DOI 10.1007/s10344-008-0177-8; Giotto N, 2009, ORYX, V43, P552, DOI 10.1017/S0030605309990494; Groves C.P., 1986, EQUIDS ANCIENT WORLD, VVolume 421, P11; Groves CP., 2011, HDB MAMMALS WORLD, P691; Gueta T, 2014, CONSERV GENET, V15, P1231, DOI 10.1007/s10592-014-0614-z; Haque MN, 1996, BIOL CONSERV, V76, P203, DOI 10.1016/0006-3207(95)00100-X; HAUSFATER G, 1982, Primates, V23, P287, DOI 10.1007/BF02381167; Henley SR, 2007, J ARID ENVIRON, V70, P39, DOI 10.1016/j.jaridenv.2006.12.007; Jenkins RKB, 2002, ORYX, V36, P161, DOI 10.1017/S0030605302000236; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; Kaczensky P., 2010, Erforschung Biologischer Ressourcen der Mongolei, V11, P291; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; KARASOV WH, 1989, PHYSIOL ZOOL, V62, P1351, DOI 10.1086/physzool.62.6.30156217; Kidron GJ, 2000, ATMOS RES, V55, P257, DOI 10.1016/S0169-8095(00)00063-6; KLINGEL H, 1977, Z TIERPSYCHOL, V44, P323; Leuthold W., 1977, AFRICAN UNGULATES CO; Li ZH, 2012, DATA MIN KNOWL DISC, V24, P355, DOI 10.1007/s10618-011-0227-9; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Lugauer B, 2010, DIFFERENCES MOVEMENT; Malone TF, 1951, COMPENDIUM METEOROLO, P655; Manly B., 1993, RESOURCE SELECTION A; Marshal JP, 2006, WILDLIFE SOC B, V34, P609, DOI 10.2193/0091-7648(2006)34[609:FAHUAD]2.0.CO;2; Martin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118461; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Mechkour F, 2008, ZOO BIOL, V27, P19, DOI [10.1002/zoo.20152, DOI 10.1002/Z00.20152]; Moehlman P.D., 2002, EQUIDS ZEBRAS ASSES; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P125, DOI 10.1016/S0168-1591(98)00162-2; Moehlman PD, 2008, IUCN 2013 IUCN RED L; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nielsen MK, 2007, VET J, V174, P23, DOI 10.1016/j.tvjl.2006.05.009; Ohashi K, 2005, BEHAV ECOL, V16, P592, DOI 10.1093/beheco/ari031; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Owen-Smith N, 2007, ISR J ECOL EVOL, V53, P423, DOI 10.1560/IJEE.53.3.423; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Pagon N, 2013, CHRONOBIOL INT, V30, P772, DOI 10.3109/07420528.2013.765887; Perez I, 2006, ORYX, V40, P295, DOI 10.1017/S0030605306000846; Pinheiro J, 2015, R PACKAGE VERSION; Pipia A, 2008, BEHAVIOUR, V145, P1723, DOI 10.1163/156853908786279628; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reading RP, 2001, J ZOOL, V254, P381, DOI 10.1017/S0952836901000887; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Riotte-Lambert L, 2013, J THEOR BIOL, V317, P238, DOI 10.1016/j.jtbi.2012.10.026; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; SALTZ D, 1995, ECOL APPL, V5, P327, DOI 10.2307/1942025; Saltz D, 2000, CONSERV BIOL, V14, P1852, DOI 10.1046/j.1523-1739.2000.99227.x; Saltz D, 2001, OIKOS, V94, P377, DOI 10.1034/j.1600-0706.2001.940220.x; Shah Nita, 2007, Erforschung Biologischer Ressourcen der Mongolei, V10, P189; Shields AV, 2012, SCI WORLD J, DOI 10.1100/2012/846218; Sinclair A., 1979, SERENGETI DYNAMICS E, P1; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Souris AC, 2007, APPL ANIM BEHAV SCI, V107, P307, DOI 10.1016/j.applanim.2006.09.023; Stephens PA, 2001, BIOL CONSERV, V100, P307, DOI 10.1016/S0006-3207(01)00035-0; Stern E., 1986, ATLAS NEGEV; Tatin L, 2003, ORYX, V37, P488; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; vanDierendonck MC, 1996, APPL ANIM BEHAV SCI, V50, P95, DOI 10.1016/0168-1591(96)01089-1; Whiting JC, 2009, WEST N AM NATURALIST, V69, P407, DOI 10.3398/064.069.0318; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x; Xia CJ, 2013, PAK J ZOOL, V45, P1241; Zangvil A, 1996, J ARID ENVIRON, V32, P361, DOI 10.1006/jare.1996.0030; Zweifel-Schielly B, 2009, ECOGRAPHY, V32, P103, DOI 10.1111/j.1600-0587.2008.05178.x; [No title captured]	94	15	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143279	10.1371/journal.pone.0143279	http://dx.doi.org/10.1371/journal.pone.0143279			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630393	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300038
J	Hew, K; Dahlroth, SL; Veerappan, S; Pan, LX; Cornvik, T; Nordlund, P				Hew, Kelly; Dahlroth, Sue-Li; Veerappan, Saranya; Pan, Lucy Xin; Cornvik, Tobias; Nordlund, Par			Structure of the Varicella Zoster Virus Thymidylate Synthase Establishes Functional and Structural Similarities as the Human Enzyme and Potentiates Itself as a Target of Brivudine	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; THYMIDINE KINASE; 5-FLUOROURACIL; INHIBITION; SUBSTRATE; DELETION; TOMUDEX; COMPLEX; SYSTEM; DRUGS	Varicella zoster virus (VZV) is a highly infectious human herpesvirus that is the causative agent for chicken pox and shingles. VZV encodes a functional thymidylate synthase (TS), which is the sole enzyme that produces dTMP from dUMP de novo. To study substrate binding, the complex structure of TSVZV with dUMP was determined to a resolution of 2.9 angstrom. In the absence of a folate co-substrate, dUMP binds in the conserved TS active site and is coordinated similarly as in the human encoded TS (TSHS) in an open conformation. The interactions between TSVZV with dUMP and a cofactor analog, raltitrexed, were also studied using differential scanning fluorimetry (DSF), suggesting that TSVZV binds dUMP and raltitrexed in a sequential binding mode like other TS. The DSF also revealed interactions between TSVZV and in vitro phosphorylated brivudine (BVDUP), a highly potent anti-herpesvirus drug against VZV infections. The binding of BVDUP to TSVZV was further confirmed by the complex structure of TSVZV and BVDUP solved at a resolution of 2.9 angstrom. BVDUP binds similarly as dUMP in the TSHS but it induces a closed conformation of the active site. The structure supports that the 5-bromovinyl substituent on BVDUP is likely to inhibit TSVZV by preventing the transfer of a methylene group from its cofactor and the subsequent formation of dTMP. The interactions between TSVZV and BVDUP are consistent with that TSVZV is indeed a target of brivudine in vivo. The work also provided the structural basis for rational design of more specific TSVZV inhibitors.	[Hew, Kelly; Dahlroth, Sue-Li; Veerappan, Saranya; Pan, Lucy Xin; Cornvik, Tobias; Nordlund, Par] Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 639798, Singapore; [Nordlund, Par] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, Stockholm, Sweden; [Nordlund, Par] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Nordlund, P (corresponding author), Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 639798, Singapore.	pnordlund@ntu.edu.sg						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adjei AA, 2004, CLIN CANCER RES, V10, p4276S, DOI 10.1158/1078-0432.CCR-040010; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Almog R, 2001, PROTEIN SCI, V10, P988, DOI 10.1110/ps.47601; Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140; BALZARINI J, 1987, MOL PHARMACOL, V32, P410; Basta T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120120; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Beck T, 2010, ACTA CRYSTALLOGR D, V66, P374, DOI 10.1107/S0907444909051609; Brunn ND, 2014, BIOSCIENCE REP, V34, P905, DOI 10.1042/BSR20140137; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG YC, 1981, MOL PHARMACOL, V20, P230; CHENG YC, 1981, ANTIMICROB AGENTS CH, V20, P420, DOI 10.1128/AAC.20.3.420; COHEN JI, 1993, P NATL ACAD SCI USA, V90, P7376, DOI 10.1073/pnas.90.15.7376; Costi MP, 2002, BBA-MOL BASIS DIS, V1587, P206, DOI 10.1016/S0925-4439(02)00083-2; De Clercq E, 2005, NAT REV DRUG DISCOV, V4, P928, DOI 10.1038/nrd1877; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; De Clercq E, 2004, NAT REV MICROBIOL, V2, P704, DOI 10.1038/nrmicro975; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Dowiercial A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945803; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; FINERMOORE J, 1993, J MOL BIOL, V232, P1101, DOI 10.1006/jmbi.1993.1463; FINERMOORE JS, 1990, BIOCHEMISTRY-US, V29, P6977, DOI 10.1021/bi00482a005; FYFE JA, 1978, J BIOL CHEM, V253, P8721; Gaspar G, 2002, J VIROL, V76, P10530, DOI 10.1128/JVI.76.20.10530-10532.2002; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gilden DH, 1983, VARICELLA ZOSTER VIR; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; JACKMAN AL, 1995, EUR J CANCER, V31A, P1277, DOI 10.1016/0959-8049(95)00166-G; KLAASSEN DJ, 1985, J CLIN ONCOL, V3, P373, DOI 10.1200/JCO.1985.3.3.373; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; Mathews II, 2003, STRUCTURE, V11, P677, DOI 10.1016/S0969-2126(03)00097-2; MATTHEWS DA, 1990, J MOL BIOL, V214, P923, DOI 10.1016/0022-2836(90)90346-N; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan JE, 2007, J SYNCHROTRON RADIAT, V14, P99, DOI 10.1107/S0909049506043251; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Noordhuis P, 2004, ANN ONCOL, V15, P1025, DOI 10.1093/annonc/mdh264; Ostrer L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00363; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERRY KM, 1993, BIOCHEMISTRY-US, V32, P7116, DOI 10.1021/bi00079a007; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Sayre PH, 2001, J MOL BIOL, V313, P813, DOI 10.1006/jmbi.2001.5074; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Stankus SJ, 2000, AM FAM PHYSICIAN, V61, P2437; Stein DS, 2001, PHARMACOTHERAPY, V21, P11, DOI 10.1592/phco.21.1.11.34439; THOMPSON R, 1987, J GEN VIROL, V68, P1449, DOI 10.1099/0022-1317-68-5-1449; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Wilk P, 2014, BIOORG CHEM, V52, P44, DOI 10.1016/j.bioorg.2013.11.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; YOKOTA T, 1994, ANTIVIR CHEM CHEMOTH, V5, P191, DOI 10.1177/095632029400500309; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109	56	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143947	10.1371/journal.pone.0143947	http://dx.doi.org/10.1371/journal.pone.0143947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630264	Green Published, gold			2022-12-26	WOS:000365926300127
J	Mattsson, K; Kallen, K; Rignell-Hydbom, A; Hansson, SR; McElrath, TF; Cantonwine, DE; Rylander, L				Mattsson, Kristina; Kallen, Karin; Rignell-Hydbom, Anna; Hansson, Stefan R.; McElrath, Thomas F.; Cantonwine, David E.; Rylander, Lars			Maternal Smoking during Pregnancy and Daughters' Preeclampsia Risk	PLOS ONE			English	Article							ADULTHOOD SOCIOECONOMIC POSITION; OWN BIRTH-WEIGHT; GESTATIONAL-AGE; HYPERTENSIVE DISORDERS; CIGARETTE-SMOKING; SUBSEQUENT RISK; OUTCOMES; COHORT; WOMEN; ASSOCIATION	Background An obstetrical paradox is that maternal smoking is protective for the development of preeclampsia. However, there are no prior studies investigating the risk of preeclampsia in women who were exposed to tobacco smoking during their own fetal period. We aimed to study the subsequent risk of preeclampsia in women who were exposed to tobacco smoke in utero, using a national population-based register. Methods Data were obtained from the Medical Birth Register of Sweden for women who were born in 1982 (smoking data first recorded) or after, who had given birth to at least one child; 153 885 pregnancies were included. Results The associations between intrauterine smoking exposure (three categories: non-smokers, 1-9 cigarettes/day [moderate exposure], and > 9 cigarettes/day [heavy exposure]) and subsequent preeclampsia (n = 5721) were assessed using logistic regressions. In models adjusted for maternal age, parity and own smoking, the odds ratios (OR) for preeclampsia were 1.06 [95% CI: 0.99,1.13 for moderate intrauterine exposure, and 1.18, [95% CI: 1.10,1.27] for heavy exposure. Estimates were slightly strengthened in non-smoking women who experienced heavy intrauterine exposure (adjusted OR 1.24 [95% CI: 1.14,1.34]). Results were no longer statistically significant after adjustment for the woman's own BMI, gestational age and birthweight Z-scores. Conclusion These data revealed some evidence of a possible weak positive association between intrauterine smoking exposure and the risk of subsequent preeclampsia, however, results were not significant over all manifestations of preeclampsia and confounder adjustment. The increased risk might be mediated through exposed women's own BMI or birthweight.	[Mattsson, Kristina; Kallen, Karin; Rignell-Hydbom, Anna; Rylander, Lars] Lund Univ, Inst Lab Med, Div Occupat & Environm Med, Lund, Sweden; [Hansson, Stefan R.] Lund Univ, Inst Clin Sci, Dept Obstet & Gynecol, Lund, Sweden; [McElrath, Thomas F.; Cantonwine, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Maternal Fetal Med,Dept Obstet & Gynecol, Boston, MA 02115 USA	Lund University; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mattsson, K (corresponding author), Lund Univ, Inst Lab Med, Div Occupat & Environm Med, Lund, Sweden.	kristina.mattsson@med.lu.se		Mattsson, Kristina/0000-0002-9850-5888; Kallen, Karin/0000-0001-5765-2630; Rylander, Lars/0000-0001-8288-8207	Medical Faculty at Lund University; networks SIMSAM Lund; Swedish Research Council; METALUND; Swedish Council for Working Life and Social Research	Medical Faculty at Lund University; networks SIMSAM Lund; Swedish Research Council(Swedish Research CouncilEuropean Commission); METALUND; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	The research was supported by the Medical Faculty at Lund University and the networks SIMSAM Lund (with funding from The Swedish Research Council) and METALUND (with funding from Swedish Council for Working Life and Social Research). The funders had no role in designing the study, data acquisition and analysis or preparation of the manuscript.	Beste LA, 2005, PAEDIATR PERINAT EP, V19, P12, DOI 10.1111/j.1365-3016.2004.00617.x; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Cupul-Uicab LA, 2012, ENVIRON HEALTH PERSP, V120, P355, DOI 10.1289/ehp.1103789; Dempsey JC, 2003, AM J OBSTET GYNECOL, V189, P494, DOI 10.1067/S0002-9378(03)00491-5; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Elsmen E, 2006, ACTA OBSTET GYN SCAN, V85, P1285, DOI 10.1080/00016340600578274; Engel SM, 2013, EPIDEMIOLOGY, V24, P379, DOI 10.1097/EDE.0b013e3182873a73; Engel SM, 2009, AM J EPIDEMIOL, V169, P33, DOI 10.1093/aje/kwn293; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Hansson SR, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00516; Heshmati A, 2013, J EPIDEMIOL COMMUN H, V67, P939, DOI 10.1136/jech-2012-202149; Hildingsson IM, 2006, AM J OBSTET GYNECOL, V195, P1366, DOI 10.1016/j.ajog.2006.03.050; Innes KE, 2003, AM J EPIDEMIOL, V158, P861, DOI 10.1093/aje/kwg211; Innes KE, 1999, EPIDEMIOLOGY, V10, P153, DOI 10.1097/00001648-199903000-00012; Kahn SR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-91; Karumanchi SA, 2010, HYPERTENSION, V55, P1100, DOI 10.1161/HYPERTENSIONAHA.109.148973; Klebanoff MA, 1999, ARCH INTERN MED, V159, P1607, DOI 10.1001/archinte.159.14.1607; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P49, DOI 10.1136/jech.2004.020560; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Luo ZC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.041; Mattsson K, 2013, DIABETOLOGIA, V56, P1689, DOI 10.1007/s00125-013-2936-7; Mattsson K, 2016, NICOTINE TOB RES, V18, P79, DOI 10.1093/ntr/ntv087; Nelson DB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.010; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Rana S, 2013, HYPERTENS PREGNANCY, V32, P189, DOI 10.3109/10641955.2013.784788; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Rogvi RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034001; Saftlas AF, 2014, J REPROD IMMUNOL, V101, P104, DOI 10.1016/j.jri.2013.07.006; Silva LM, 2008, J HUM HYPERTENS, V22, P483, DOI 10.1038/jhh.2008.22; Steen EE, 2014, J PERINAT MED, V42, P225, DOI 10.1515/jpm-2013-0147; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Zetterstrom K, 2007, BJOG-INT J OBSTET GY, V114, P319, DOI 10.1111/j.1471-0528.2006.01231.x	37	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144207	10.1371/journal.pone.0144207	http://dx.doi.org/10.1371/journal.pone.0144207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630273	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300167
J	Tamosiunas, A; Radisauskas, R; Klumbiene, J; Bernotiene, G; Petkeviciene, J; Luksiene, D; Virviciute, D; Malinauskiene, V; Vikhireva, O; Grabauskas, V				Tamosiunas, Abdonas; Radisauskas, Ricardas; Klumbiene, Jurate; Bernotiene, Gailute; Petkeviciene, Janina; Luksiene, Dalia; Virviciute, Dalia; Malinauskiene, Vilija; Vikhireva, Olga; Grabauskas, Vilius			The Prognostic Value of Family History for the Estimation of Cardiovascular Mortality Risk in Men: Results from a Long-Term Cohort Study in Lithuania	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; POPULATION; PREVALENCE; PREMATURE; DEATH; VALIDATION; SMOKING; STROKE	Aim To evaluate the additional prognostic value of family history for the estimation of cardiovascular (CVD) mortality risk in middle-aged urban Lithuanian men. Methods The association between family history of CVD and the risk of CVD mortality was examined in a population-based cohort of 6,098 men enrolled during 1972-1974 and 1976-1980 in Kaunas, Lithuania. After up to 40 years of follow-up, 2,272 deaths from CVD and 1,482 deaths from coronary heart disease (CHD) were identified. Multivariate Cox proportional hazards models were used to estimate hazard ratios (HR) for CVD and CHD mortality. Results After adjustment for traditional CVD risk factors, the HR for CVD mortality was 1.24 (95% CI 1.09-1.42) and for CHD mortality 1.20 (1.02-1.42) in men with first-degree relatives having a history of myocardial infarction (MI), compared to men without positive family history. A significant effect on the risk of CVD and CHD mortality was also observed for the family history of sudden cardiac death and any CVD. Addition of family history of MI, sudden death, and any CVD to traditional CVD risk factors demonstrated modest improvement in the performance of Cox models for CVD and CHD mortality. Conclusions Family history of CVD is associated with a risk of CVD and CHD mortality significantly and independently of other risk factors in a middle-aged male population. Addition of family history to traditional CVD risk factors improves the prediction of CVD mortality and could be used for identification of high-risk individuals.	[Tamosiunas, Abdonas; Radisauskas, Ricardas; Bernotiene, Gailute; Luksiene, Dalia; Virviciute, Dalia; Malinauskiene, Vilija] Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania; [Tamosiunas, Abdonas; Radisauskas, Ricardas; Klumbiene, Jurate; Petkeviciene, Janina; Luksiene, Dalia; Malinauskiene, Vilija; Grabauskas, Vilius] Lithuanian Univ Hlth Sci, Med Acad, Fac Publ Hlth, Kaunas, Lithuania; [Vikhireva, Olga] UCL, Dept Epidemiol & Publ Hlth, London, England	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of London; University College London	Tamosiunas, A (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Med Acad, Kaunas, Lithuania.	abdonas.tamosiunas@lsmuni.lt	Tamosiunas, Abdonas/AAD-4274-2021; Radišauskas, Ričardas/AAT-8920-2021	Radišauskas, Ričardas/0000-0002-1227-2674				Acheson LS, 2010, GENET MED, V12, P212, DOI 10.1097/GIM.0b013e3181d56ae6; Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; Chow CK, 2007, BMJ-BRIT MED J, V335, P481, DOI 10.1136/bmj.39253.577859.BE; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Germano G, 2012, EUR HEART J, V33, P137; Glasunov IS, 1981, KAUNAS ROTTERDAM INT; Guttmacher AE, 2004, NEW ENGL J MED, V351, P2333, DOI 10.1056/NEJMsb042979; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hintsa T, 2010, OCCUP ENVIRON MED, V67, P330, DOI 10.1136/oem.2009.048470; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; HUANG TC, 1961, ANAL CHEM, V33, P1405, DOI 10.1021/ac60178a040; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Klemenc-Ketis Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080333; Kuklina EV, 2010, ANN FAM MED, V8, P327, DOI 10.1370/afm.1137; Kuzmickiene I, 2013, CANCER EPIDEMIOL, V37, P133, DOI 10.1016/j.canep.2012.10.001; Long GH, 2015, PREV MED, V71, P121, DOI 10.1016/j.ypmed.2014.12.013; Merry AHH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-13; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Prineas R., 1982, MINNESOTA CODE MANUA; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Ranthe MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125896; Ranthe MF, 2012, J AM COLL CARDIOL, V60, P814, DOI 10.1016/j.jacc.2012.06.018; Reibis R, 2012, VASC HEALTH RISK MAN, V8, P473, DOI 10.2147/VHRM.S33305; Reklaitiene R, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-68; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rose G, 1982, CARDIOVASCULAR SURVE; Scheuner MT, 2010, CIRC-CARDIOVASC GENE, V3, P97, DOI 10.1161/CIRCGENETICS.109.894527; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Tamosiunas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114283; Van daele CM, 2013, PLOS ONE, V2, DOI [10.1371/journal.pone.0063185, DOI 10.1371/J0URNAL.P0NE.0063185]; van Dis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028697; Yanez ND, 2009, ANN EPIDEMIOL, V19, P858, DOI 10.1016/j.annepidem.2009.07.095; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143839	10.1371/journal.pone.0143839	http://dx.doi.org/10.1371/journal.pone.0143839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630455	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300109
J	Zhou, YL; Williams, J; Smallwood, PM; Nathans, J				Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy			Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina	PLOS ONE			English	Article							REDUNDANT ROLES; TRANSCRIPTIONAL REGULATION; PHENOTYPIC HETEROGENEITY; INTRACRANIAL ANEURYSM; TIP CELLS; ANGIOGENESIS; NOTCH; MUTATIONS; DEFECTS; SPECIFICATION	Vascular development and maintenance are controlled by a complex transcriptional program, which integrates both extracellular and intracellular signals in endothelial cells. Here we study the roles of three closely related SoxF family transcription factors-Sox7, Sox17, and Sox18-in the developing and mature mouse vasculature using targeted gene deletion on a mixed C57/129/CD1 genetic background. In the retinal vasculature, each SoxF gene exhibits a distinctive pattern of expression in different classes of blood vessels. On a mixed genetic background, vascular endothelial-specific deletion of individual SoxF genes has little or no effect on vascular architecture or differentiation, a result that can be explained by overlapping function and by reciprocal regulation of gene expression between Sox7 and Sox17. By contrast, combined deletion of Sox7, Sox17, and Sox18 at the onset of retinal angiogenesis leads to a dense capillary plexus with a nearly complete loss of radial arteries and veins, whereas the presence of a single Sox17 allele largely restores arterial identity, as determined by vascular smooth muscle cell coverage. In the developing retina, expression of all three SoxF genes is reduced in the absence of Norrin/Frizzled4-mediated canonical Wnt signaling, but SoxF gene expression is unaffected by reduced VEGF signaling in response to deletion of Neuropilin1 (Npn1). In adulthood, Sox7, Sox17, and Sox18 act in a largely redundant manner to maintain blood vessel function, as adult onset vascular endothelial-specific deletion of all three SoxF genes leads to massive edema despite nearly normal vascular architecture. These data reveal critical and partially redundant roles for Sox7, Sox17 and Sox18 in vascular growth, differentiation, and maintenance.	[Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol, Baltimore, MD 21205 USA; [Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	Howard Hughes Medical Institute and the National Eye Institute [R01EY081637]	Howard Hughes Medical Institute and the National Eye Institute	This work was supported by the Howard Hughes Medical Institute and the National Eye Institute (R01EY081637 to JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Badea TC, 2003, J NEUROSCI, V23, P2314; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Downes M, 2001, TRENDS CARDIOVAS MED, V11, P318, DOI 10.1016/S1050-1738(01)00131-1; Downes M, 2009, HUM MOL GENET, V18, P2839, DOI 10.1093/hmg/ddp219; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Foroud T, 2012, STROKE, V43, P2846, DOI 10.1161/STROKEAHA.112.656397; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hermkens DMA, 2015, DEVELOPMENT, V142, P1695, DOI 10.1242/dev.117275; Herpers R, 2008, CIRC RES, V102, P12, DOI 10.1161/CIRCRESAHA.107.166066; Hosking B, 2009, DEVELOPMENT, V136, P2385, DOI 10.1242/dev.034827; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; James K, 2003, GENESIS, V36, P1, DOI 10.1002/gene.10190; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Lal A, 2004, SEMIN HEMATOL, V41, P17, DOI 10.1053/j.seminhematol.2004.08.004; Lee SH, 2014, CIRC RES, V115, P215, DOI 10.1161/CIRCRESAHA.115.303142; Lee S, 2015, CIRCULATION, V131, P995, DOI 10.1161/CIRCULATIONAHA.114.012568; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Morini MF, 2014, CURR OPIN HEMATOL, V21, P229, DOI 10.1097/MOH.0000000000000043; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; RALEIGH JA, 1987, BRIT J CANCER, V56, P395, DOI 10.1038/bjc.1987.213; Rattner A, 2014, INVEST OPHTH VIS SCI, V55, P8614, DOI 10.1167/iovs.14-15693; Rattner A, 2013, P NATL ACAD SCI USA, V110, pE3830, DOI 10.1073/pnas.1315509110; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wu H, 2014, NEURON, V81, P103, DOI 10.1016/j.neuron.2013.10.051; Yanh H, 2013, J CLIN INVEST, V123, P418, DOI 10.1172/JCI64547; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018	51	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143650	10.1371/journal.pone.0143650	http://dx.doi.org/10.1371/journal.pone.0143650			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630461	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300079
J	Hanass-Hancock, J; Myezwa, H; Carpenter, B				Hanass-Hancock, Jill; Myezwa, Hellen; Carpenter, Bradley			Disability and Living with HIV: Baseline from a Cohort of People on Long Term ART in South Africa	PLOS ONE			English	Article							QUALITY-OF-LIFE; HIV/AIDS; REHABILITATION; HEALTH; ADULTS; RISK; PREVALENCE; DEPRESSION; INFECTION; CONTEXT	Background Through access to life saving antiretroviral treatment (ART) in southern Africa, HIV has been reconceptualised as a chronic disease. This comes with new challenges of HIV-related co-morbidities and disabilities. We still lack an understanding of the types and scope of disabilities experienced by people on long term ART and how this impacts health, adherence, and livelihood. This paper describes the results of a cohort study examining the new health-and disability-related needs of the millions of people on ART in the region. Methods Data was collected from a cohort of people who had been on ART for six months or longer in a semi-urban public health care setting in South Africa. 1042 adults (18 and older) participated in the cross-sectional study which investigated disabilities/activity limitations, health, ART adherence, depression symptoms, and livelihood. We analysed the associations between these constructs using descriptive statistics, and bivariate and multivariate analyses. Results A large number of participants (35.5%) obtained a weighted score of two or more on the WHODAS 2.0 indicating possible activity limitations. A positive relationship was found between activity limitations and depression symptoms, adherence, and worse health outcomes, while none was found for BMI or CD4 count. These associations varied by type of activity limitations and, in some cases, by gender. Conclusion Activity limitations are potentially experienced by a large portion of people on ART in southern Africa which impacts health and ART adherence negatively. These results highlight the importance of better understanding the new health-related needs of people who are on long term ART, as well as the nuances of the disability they experience. This is urgently needed in order to enable HIV-endemic countries to better prepare for the new health-related needs of the millions of people on ART in southern Africa.	[Hanass-Hancock, Jill; Carpenter, Bradley] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div HEARD, Durban, Kwazulu Natal, South Africa; [Myezwa, Hellen] Univ Witwatersrand, Fac Hlth Sci, Dept Physiotherapy, Johannesburg, Gauteng, South Africa	University of Kwazulu Natal; University of Witwatersrand	Hanass-Hancock, J (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div HEARD, Durban, Kwazulu Natal, South Africa.	hanasshj@ukzn.ac.za	Carpenter, Bradley/F-2554-2015; Hanass-Hancock, Jill/AAV-7141-2021; Myezwa, Hellen/AAH-1380-2021	Carpenter, Bradley/0000-0002-2968-1968; Hanass-Hancock, Jill/0000-0003-3662-8548; Myezwa, Hellen/0000-0003-4562-6413	HEARD's internal SIDA funding; SIDA	HEARD's internal SIDA funding; SIDA	The authors JHH and BC are employed by HEARD which receives SIDA funding to conduct research on HIV and other health conditions in Eastern and Southern Africa (general SIDA support; no grant number). HM is permanently employed by Wits University and her time is funded through this post. The funding for the fieldwork of this study was provided by HEARD's internal SIDA funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan-Isla J, 2014, DISABIL HEALTH J, V7, P78, DOI 10.1016/j.dhjo.2013.08.004; [Anonymous], 2013, ACC ANT THER AFR 201; [Anonymous], 2011, NAT STRAT PLAN HIV S; Banks LM, 2014, TROPICAL MED INT HLT; Booysen FLR, 2007, SOC INDIC RES, V81, P283, DOI 10.1007/s11205-006-9011-4; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Canadian HIV/AIDS Legal Network, 2008, UN CONV RIGHTS PERS; Canadian Working Group on HIV and Rehabilitation, 2011, E MOD EV INF HIV REH; COBALT, 2015, COM AFF DIS AIDS HIV; Cobbing S, 2014, DISABIL REHABIL, V36, P1687, DOI 10.3109/09638288.2013.872199; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Delva W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001258; Duran S, 2001, HIV Clin Trials, V2, P38; Groce NE, 2013, LANCET GLOB HEALTH, V1, pE180, DOI 10.1016/S2214-109X(13)70056-1; Hanass-Hancock J, 2015, DISABIL REHABIL; Hanass-Hancock J, 2014, ELEMENTS FINANCIAL E; Hanass-Hancock J, 2013, WORLD J AIDS, V3, P257, DOI DOI 10.4236/WJA.2013.33034; Hanass-Hancock J, 2010, HIV DISABILITY REHAB; Hanass-Hancock J, 2013, AJOD, V2, P1; Hanass-Hancock J, 2015, DISABIL REHABIL, V37, P2051, DOI 10.3109/09638288.2014.993432; Hanass-Hancock J, 2011, DISABIL REHABIL, V33, P2389, DOI 10.3109/09638288.2011.573055; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-34; Hanass-Hancock Jill, 2009, J Int AIDS Soc, V12, P28, DOI 10.1186/1758-2652-12-28; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jelsma J, 2006, SOUTH AFR J PHYSIOTH, V62, P7; Jones L, 2012, LANCET, V380, P899, DOI 10.1016/S0140-6736(12)60692-8; Kabore I, 2010, AIDS PATIENT CARE ST, V24, P581, DOI 10.1089/apc.2009.0307; Mannheimer S, 2008, AIDS CARE, V20, P161, DOI 10.1080/09540120701534699; Meintjes G, 2012, S AFR J HIV MED, DOI 10.7196/SAJHIVMED.862; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; Mutimura E, 2008, QUALITY LIFE RES; Mutimura E, 2008, AIDS RES HUM RETROV, V24, P15, DOI 10.1089/aid.2007.0023; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Myezwa H, 2011, PHYSIOTHERAPY, V97, P17, DOI 10.1016/j.physio.2010.08.015; Nakasujja N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044415; Nixon S, 2011, S AFR J HIV MED, P12; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Nixon SA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-41; Nyirenda M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-259; O'Brien KK, 2009, J INT AIDS SOC, V12, DOI [10.1186/1758-2652-12-30, 10.1186/1758-2652-2-5]; Petersen I, 2014, J AFFECT DISORDERS, V158, P78, DOI 10.1016/j.jad.2014.02.013; Petersen I., 2013, Health, V5, P557; Pollard N, 2008, DISABIL REHABIL, V30, P62, DOI 10.1080/09638280701192980; PRIME, PROGR IMPR MENT HLTH; Roos R, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.772; Rule S, 2006, DISABILITY SOCIAL CH; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Smart T, 2009, HIV AIDS TREATMENT P, V145, P1; Statistics South Africa, 2014, PROF PERS DIS CENS 2; UNAIDS, 2013, HIV AND AG S; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2014, THE GAP REP; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); van Egeraat L, 2015, AJAR-AFR J AIDS RES, V14, P285, DOI 10.2989/16085906.2015.1084938; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2010, COMM BAS REH CBR GUI; Yoshida K, 2014, DISABIL REHABIL, V36, P2161, DOI 10.3109/09638288.2014.894144; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793	61	54	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143936	10.1371/journal.pone.0143936	http://dx.doi.org/10.1371/journal.pone.0143936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26625001	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600077
J	Lin, CP; Huang, PH; Lai, CF; Chen, JW; Lin, SJ; Chen, JS				Lin, Chih-Pei; Huang, Po-Hsun; Lai, Chung Fang; Chen, Jaw-Wen; Lin, Shing-Jong; Chen, Jia-Shiong			Simvastatin Attenuates Oxidative Stress, NF-kappa B Activation, and Artery Calcification in LDLR-/- Mice Fed with High Fat Diet via Down-regulation of Tumor Necrosis Factor-alpha and TNF Receptor 1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-CONVERTING ENZYME; HMG-COA REDUCTASE; VASCULAR CALCIFICATION; ENDOTHELIAL-CELLS; AORTIC-STENOSIS; NADPH OXIDASE; IN-VITRO; CLINICAL-IMPLICATIONS	Simvastatin (SIM) is anti-inflammatory. We used low density lipoprotein receptor knockout (LDLR-/-) mice and human aortic smooth muscle cells (HASMCs) as model systems to study the effect of SIM on arterial calcification and to explore the potential mechanisms contributing to this protective effect. High-fat diet (HFD) caused the LRLR-/- to develop dyslipidemia, diabetics, atherosclerosis and aortic smooth muscle calcification. SIM, N-acetyl cysteine (NAC, a ROS scavenger) and apocynin (APO, a NADPH oxidase inhibitor) did not significantly retard the development of dyslipidemia or diabetic. However, those treatments were still effective in attenuating the HFD-induced atherosclerosis and aortic smooth muscle calcification. These findings suggest that the protective effect of SIM against aortic calcification is not contributed by the cholesterol lowering effect. SIM, NAC and APO were found to attenuate the HFD induced elevation of serum TNF-alpha, soluble TNFR1 (sTNFR1), 3-nitrotyrosine. We hypothesized that the pro-inflammatory cytokine, oxidative stress and TNFR1 played a role in inducing aortic calcification. We used HASMC to investigate the role of TNF-alpha, oxidative stress and TNFR1 in inducing aortic calcification and to elucidate the mechanism contributes the protective effect of SIM against aortic calcification. We demonstrated that treating HASMC with TNF-alpha induced cell Ca deposit and result in an increase in ALP, NADPH oxidase activity, NF-kB subunit p65, BMP2, MSX2, and RUNX2 expression. SIM suppressed the TNF-alpha induced activation of NADPH oxidase subunit p47, the above-mentioned bone markers and TNFR1 expression. Furthermore, p65, p47 and TNFR1 siRNAs inhibited the TNF-alpha-mediated stimulation of BMP-2, MSX2, RUNX2 expression. SIM, APO, and NAC either partially inhibit or completely block the TNF-alpha induced H2O2 or superoxide production. These results suggest that SIM may, independent of its cholesterol-lowering effect, suppresses the progression of vascular diseases through the inhibition of the inflammation mediators TNF-alpha and TNFR1.	[Lin, Chih-Pei] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Cent Lab, Taipei, Taiwan; [Lin, Chih-Pei] Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Lin, Chih-Pei] Inst Biotechnol Med, Taipei, Taiwan; [Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Div Cardiol, Dept Med Res, Taipei, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jia-Shiong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lai, Chung Fang] E da Hosp, Kaohsiung, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; E-Da Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Cent Lab, Taipei, Taiwan.	cplin@vghtpe.gov.tw			Taipei Veterans General Hospital [VGH-V100DHA0100344, VGH-V99DHA0100223, VGH-V98DHA0100315]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported in part by the research grants VGH-V100DHA0100344, VGH-V99DHA0100223 and VGH-V98DHA0100315 from the Taipei Veterans General Hospital. The funders had no role in the study design, data collection, or analysis, the decision to publish, or the preparation of the manuscript.	Al-Aly Ziyad, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P1; Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Ballard Kevin D, 2015, Adv Prev Med, V2015, P351059, DOI 10.1155/2015/351059; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bea F, 2002, ARTERIOSCL THROM VAS, V22, P1832, DOI 10.1161/01.ATV.0000036081.01231.16; Bellosta S, 2000, ANN MED, V32, P164, DOI 10.3109/07853890008998823; Belovici Maria Isabela, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P21; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Chen NX, 2002, KIDNEY INT, V62, P1724, DOI 10.1046/j.1523-1755.2002.00625.x; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Csiszar A, 2006, AM J PATHOL, V168, P629, DOI 10.2353/ajpath.2006.050284; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Ferreira TS, 2014, INFLAMMATION, V37, P1355, DOI 10.1007/s10753-014-9860-y; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Hadad N, 2011, J IMMUNOL, V186, P1816, DOI 10.4049/jimmunol.1000193; Hess K, 2009, BONE, V45, P367, DOI 10.1016/j.bone.2009.04.252; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jensky NE, 2010, HYPERTENSION, V55, P990, DOI 10.1161/HYPERTENSIONAHA.109.147520; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kim H, 2012, J CELL MOL MED, V16, P273, DOI 10.1111/j.1582-4934.2011.01294.x; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Lee HL, 2010, BIOCHEM BIOPH RES CO, V391, P1087, DOI 10.1016/j.bbrc.2009.12.027; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Liberman M, 2008, ARTERIOSCL THROM VAS, V28, P463, DOI 10.1161/ATVBAHA.107.156745; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Ribichini F, 2006, J AM COLL CARDIOL, V47, P1143, DOI 10.1016/j.jacc.2005.12.022; Rizos EC, 2010, CURR VASC PHARMACOL, V8, P638; Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53; Rosenson RS, 1999, LANCET, V353, P983, DOI 10.1016/S0140-6736(98)05917-0; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Shao JS, 2007, ANN NY ACAD SCI, V1117, P40, DOI 10.1196/annals.1402.075; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shavelle DM, 2002, LANCET, V359, P1125, DOI 10.1016/S0140-6736(02)08161-8; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Soor GS, 2008, PATHOLOGY, V40, P385, DOI 10.1080/00313020802036764; Sukhova GK, 2002, ARTERIOSCL THROM VAS, V22, P1452, DOI 10.1161/01.ATV.0000030360.72503.56; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047; Vinten-Johansen A, 2000, CIRC RES, V87, P170, DOI 10.1161/01.RES.87.3.170; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Williams JK, 1998, J AM COLL CARDIOL, V31, P684, DOI 10.1016/S0735-1097(97)00537-8; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532; Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x; Zhu Dongxing, 2012, Front Endocrinol (Lausanne), V3, P95, DOI 10.3389/fendo.2012.00095; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	64	51	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143686	10.1371/journal.pone.0143686	http://dx.doi.org/10.1371/journal.pone.0143686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625143	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600043
J	Liu, LB; Li, DY; Gilbert, ER; Xiao, QH; Zhao, XL; Wang, Y; Yin, HD; Zhu, Q				Liu, Lingbin; Li, Diyan; Gilbert, Elizabeth R.; Xiao, Qihai; Zhao, Xiaoling; Wang, Yan; Yin, Huadong; Zhu, Qing			Effect of Monochromatic Light on Expression of Estrogen Receptor (ER) and Progesterone Receptor (PR) in Ovarian Follicles of Chicken	PLOS ONE			English	Article							MESSENGER-RIBONUCLEIC-ACID; SPECTRAL SENSITIVITY; VISUAL PIGMENTS; BROILER GROWTH; COLOR-VISION; SECRETION; QUALITY; PROLACTIN; ESTRADIOL; ABUNDANCE	Artificial illumination is widely used in modern poultry houses and different wavelengths of light affect poultry production and behaviour. In this study, we measure mRNA and protein abundance of estrogen receptors (ERs) and progesterone receptors (PRs) in order to investigate the effect of monochromatic light on egg production traits and gonadal hormone function in chicken ovarian follicles. Five hundred and fifty-two 19-wk-old laying hens were exposed to three monochromatic lights: red (RL; 660 nm), green (GL; 560 nm), blue (BL; 480 nm) and control cool white (400-760 nm) light with an LED (light-emitting diode). There were 4 identical light-controlled rooms (n = 138) each containing 3 replicate pens (46 birds per pen). Water was supplied ad libitum and daily rations were determined according to the nutrient suggestions for poultry. Results showed that under BL conditions there was an increase in the total number of eggs at 300 days of age and egg-laying rate during the peak laying period. The BL and GL extended the duration of the peak laying period. Plasma melatonin was lowest in birds reared under BL. Plasma estradiol was elevated in the GL-exposed laying hens, and GL and BL increased progesterone at 28 wk of age. In the granulosa layers of the fifth largest preovulatory follicle (F5), the third largest preovulatory follicle (F3) and the largest preovulatory follicle (F1), ER alpha mRNA was increased by BL and GL. Treatment with BL increased ER beta mRNA in granulosa layers of F5, F3 and F1, while GL increased ER beta mRNA in F5 and F3. There was a corresponding increase in abundance of the proteins in the granulosa layers of F5, with an increase in PR-B, generated via an alternative splice site, relative to PR-A. Treatment with BL also increased expression of PR mRNA in all of the granulosa layers of follicles, while treatment with GL increased expression of PR mRNA in granulosa layers of SYF(small yellow follicle), F5 and F1. These results indicate that blue and green monochromatic lights promote egg production traits via stimulating gonadal hormone secretion and up-regulating expression of ERs and PRs. Changes in PR-B protein suggest that this form of the progesterone receptor is predominant for progesterone action in the granulosa layers of preovulatory follicles in chickens during light stimulation.	[Liu, Lingbin; Li, Diyan; Xiao, Qihai; Wang, Yan; Yin, Huadong; Zhu, Qing] Sichuan Agr Univ, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Gilbert, Elizabeth R.] Virginia Tech, Dept Anim & Poultry Sci, Blacksburg, VA USA; [Zhao, Xiaoling] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Virginia Polytechnic Institute & State University; Sichuan Agricultural University	Zhu, Q (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	Zhuqingsicau@163.com	LIU, LINGBIN/J-3564-2018	LIU, LINGBIN/0000-0001-9266-9868; Li, Diyan/0000-0001-7490-3550	China Agriculture Research System [CARS-41]; Program from Sichuan Province [2011NZ0099-7, 2011NZ0073]	China Agriculture Research System; Program from Sichuan Province	This work was financially supported by China Agriculture Research System, CARS-41 (http://cyjstx.sdny.gov.cn/) and the Program from Sichuan Province, 2011NZ0099-7 and 2011NZ0073 (http://www.sc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Camacho-Arroyo I, 2007, GEN COMP ENDOCR, V150, P381, DOI 10.1016/j.ygcen.2006.10.007; Cao J, 2008, J APPL POULTRY RES, V17, P211, DOI 10.3382/japr.2007-00043; CAVE NA, 1990, POULTRY SCI, V69, P1141, DOI 10.3382/ps.0691141; Chandrasekar Baskaran, 2004, J Invasive Cardiol, V16, P719; Chen YX, 2007, ACTA VET ZOOTECHNICA, V16, P605; Er D, 2007, J APPL POULTRY RES, V16, P605, DOI 10.3382/japr.2006-00096; Erdemtu, 2007, Scientia Agricultura Sinica, V40, P2079; Etches RJ, 1984, J ENDOCRINOLOGY, V103; FOSTER RG, 1985, J COMP PHYSIOL A, V157, P519, DOI 10.1007/BF00615153; GOVARDOVSKII VI, 1977, VISION RES, V17, P537, DOI 10.1016/0042-6989(77)90052-9; Griffin C, 1999, MOL ENDOCRINOL, V13, P1571, DOI 10.1210/me.13.9.1571; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; Hrabia A, 2004, FOLIA BIOL-KRAKOW, V52, P197, DOI 10.3409/1734916044527494; Hrabia A, 2008, FOLIA BIOL-KRAKOW, V56, P187, DOI 10.3409/fb.56_3-4.187-191; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; Jin EH, 2011, ANAT REC, V294, P1233, DOI 10.1002/ar.21408; JOENSUU TK, 1990, CELL DIFFER DEV, V30, P207, DOI 10.1016/0922-3371(90)90140-R; KATZENELLENBOGEN BS, 1980, ANNU REV PHYSIOL, V42, P17, DOI 10.1146/annurev.ph.42.030180.000313; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelestimur H, 2012, BRAIN RES, V1435, P24, DOI 10.1016/j.brainres.2011.11.040; LAUBER JK, 1965, FED PROC, V24, P701; Lewis PD, 2000, WORLD POULTRY SCI J, V56, P189, DOI 10.1079/WPS20000015; Li J, 2013, DOMEST ANIM ENDOCRIN, V45, P206, DOI 10.1016/j.domaniend.2013.09.003; Li J, 2013, INT J MOL SCI, V14, P5545, DOI 10.3390/ijms14035545; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Liu HY, 2008, POULTRY SCI, V87, P541, DOI 10.3382/ps.2007-00274; Liu LB, 2012, ASIAN J ANIM VET ADV, V7, P1183, DOI 10.3923/ajava.2012.1183.1190; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MARTIN JE, 1980, NEUROENDOCRINOLOGY, V31, P13, DOI 10.1159/000123044; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P935, DOI 10.1210/endo-122-3-935; Oktem O, 2010, HUM REPROD, V25, P2944, DOI 10.1093/humrep/deq275; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Pasanen S, 1997, MOL CELL ENDOCRINOL, V135, P79, DOI 10.1016/S0303-7207(97)00192-5; Prescott NB, 2010, SPECTRAL SENSITIVITY, V40, P332; PYRZAK R, 1987, THERIOGENOLOGY, V28, P947, DOI 10.1016/0093-691X(87)90045-8; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; Roy D, 2002, J BIOL CHEM, V277, P251, DOI 10.1074/jbc.M108890200; Rozenboim I, 1999, POULTRY SCI, V78, P135, DOI 10.1093/ps/78.1.135; Rozenboim I, 2004, POULTRY SCI, V83, P1413, DOI 10.1093/ps/83.8.1413; Rozenboim I, 2004, POULTRY SCI, V83, P842, DOI 10.1093/ps/83.5.842; Rozenboim I, 1998, POULTRY SCI, V77, P1695, DOI 10.1093/ps/77.11.1695; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; WABECK CJ, 1974, POULTRY SCI, V53, P2055, DOI 10.3382/ps.0532055; Wang Y, 2011, CHINESE J ANIMAL VET; WORTEL JF, 1987, J COMP PHYSIOL A, V160, P151, DOI 10.1007/BF00609722; Xu HY, 2012, MOL BIOL REP, V39, P8363, DOI 10.1007/s11033-012-1686-9; Yin HD, 2014, POULTRY SCI, V93, P1337, DOI 10.3382/ps.2013-03555; Yin HD, 2013, GENE, V526, P170, DOI 10.1016/j.gene.2013.05.017; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x	52	17	19	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144102	10.1371/journal.pone.0144102	http://dx.doi.org/10.1371/journal.pone.0144102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624893	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600094
J	Zhang, H; Zhang, TG; You, ZB; Zhang, YZ				Zhang, Hui; Zhang, Tingguo; You, Zongbing; Zhang, Youzhong			Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LONG-TERM RISK; FOLLOW-UP; EXCISION PROCEDURE; CANCER; RECURRENCE; INVOLVEMENT; DISEASE; LESIONS; COHORT	Objective To determine the clinicopathologic and immunohistochemical predictors of the persistence/recurrence of cervical intraepithelial neoplasia (CIN) after cervical conization. Methods Medical records of 502 patients who received cervical conization treatment of CIN between 2005 and 2012 were reviewed. The clinicopathologic parameters were analyzed using Cox hazard regression. Fifty patients with CIN persistence/recurrence were matched to 50 cases without CIN persistence/recurrence. These 100 cervical specimens were assessed for expression of insulin-like growth factor II messenger RNA (mRNA)-binding protein 3 (IMP3), targeting protein for xenopus kinesin-like protein 2 (TPX2), and programmed cell death-1 ligand-1 (PD-L1) using immunohistochemical staining. Results Multivariate analysis found that the independent predictors of CIN persistence/ recurrence were positive surgical margin (hazard ratio 5.777, 95% confidence interval 2.334-14.301, p < 0.001) and human papilloma virus persistence for 6 months (hazard ratio 20.685, 95% confidence interval 7.350-57.657, p < 0.001). Co-expression of TPX2 and PD-L1 was significantly higher in CIN persistence/recurrence group than the group without CIN persistence/recurrence (p = 0.013). The depth of glandular involvement (GI) was less than 3mm in about 86.8% (59/68) CIN2-3 lesions, However, No statistically significant associations between GI and persistence/recurrence were observed (P = 0.58). Conclusion Positive surgicalmargin, HPV persistence, and expression of both TPX2 and PD-L1 are associated with persistence/recurrence of cervical intraepithelial neoplasia after cervical conization.	[Zhang, Hui; Zhang, Youzhong] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Zhang, Hui] Taishan Med Coll, Affiliated Hosp, Dept Obstet & Gynecol, Tai An, Shandong, Peoples R China; [Zhang, Tingguo] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [You, Zongbing] Tulane Univ, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA; [You, Zongbing] Tulane Univ, Dept Orthopaed Surg, New Orleans, LA 70118 USA; [You, Zongbing] Tulane Univ, Tulane Canc Ctr, New Orleans, LA 70118 USA; [You, Zongbing] Tulane Univ, Louisiana Canc Res Consortium, New Orleans, LA 70118 USA; [You, Zongbing] Tulane Univ, Tulane Ctr Stem Cell Res & Regenerat Med, New Orleans, LA 70118 USA; [You, Zongbing] Tulane Univ, Tulane Ctr Aging, New Orleans, LA 70118 USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	You, ZB (corresponding author), Tulane Univ, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA.	zyou@tulane.edu; zhangyouzhong@sdu.edu.cn			National Natural Science Foundation [81072122]; National Institutes of Health [P20GM103518, R01CA174714]; Department of Defense [W81XWH-14-1-0050, W81XWH-14-1-0149, W81XWH-14-1-0458, OR140380]; NATIONAL CANCER INSTITUTE [R01CA174714] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103518] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y. Zhang was supported by the National Natural Science Foundation (grant no. 81072122). Z. You was supported by National Institutes of Health (P20GM103518 and R01CA174714) and Department of Defense (W81XWH-14-1-0050, W81XWH-14-1-0149, W81XWH-14-1-0458, and OR140380).	Baser E, 2014, INT J GYNECOL OBSTET, V125, P275, DOI 10.1016/j.ijgo.2013.12.012; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668; Dong HD, 1999, NAT MED, V5, P1365; Eijsink JJH, 2009, GYNECOL ONCOL, V113, P348, DOI 10.1016/j.ygyno.2008.11.022; ELLEDGE RM, 1994, CANCER RES, V54, P3752; Hamontri Suttha, 2010, J Med Assoc Thai, V93 Suppl 2, pS74; Kimura M, 2006, PATHOL INT, V56, P428, DOI 10.1111/j.1440-1827.2006.01984.x; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Lima MI, 2009, INT J GYNECOL OBSTET, V104, P100, DOI 10.1016/j.ijgo.2008.10.009; Livasy CA, 1999, MODERN PATHOL, V12, P233; Lu CH, 2006, OBSTET GYNECOL, V107, P830, DOI 10.1097/01.AOG.0000206777.28541.fc; MACGREGOR JE, 1994, BMJ-BRIT MED J, V308, P1407, DOI 10.1136/bmj.308.6941.1407; Melnikow J, 2009, JNCI-J NATL CANCER I, V101, P721, DOI 10.1093/jnci/djp089; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Papoutsis D, 2011, IN VIVO, V25, P691; Paraskevaidis E, 2004, CANCER TREAT REV, V30, P205, DOI 10.1016/j.ctrv.2003.07.008; Prato B, 2008, INT J GYNECOL CANCER, V18, P90, DOI 10.1111/j.1525-1438.2007.00965.x; Ronco G, 2007, BRIT MED J, V335, P1053, DOI 10.1136/bmj.39364.439444.80; Serati M, 2012, EUR J OBSTET GYN R B, V165, P86, DOI 10.1016/j.ejogrb.2012.06.026; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Wei QZ, 2014, HUM PATHOL, V45, P2218, DOI 10.1016/j.humpath.2014.07.006; Yang W, 2013, IMMUNOLOGY, V139, P513, DOI 10.1111/imm.12101	25	19	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142868	10.1371/journal.pone.0142868	http://dx.doi.org/10.1371/journal.pone.0142868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624896	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600013
J	Mehta, M; Rajmani, RS; Singh, A				Mehta, Mansi; Rajmani, Raju S.; Singh, Amit			Mycobacterium tuberculosis WhiB3 Responds to Vacuolar pH-induced Changes in Mycothiol Redox Potential to Modulate Phagosomal Maturation and Virulence.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MURINE MACROPHAGES; GENE-EXPRESSION; PROTON-ATPASE; ACIDIC PH; STRESS; ACIDIFICATION; SURVIVAL; GROWTH; ACTIVATION	The ability of Mycobacterium tuberculosis to resist intraphagosomal stresses, such as oxygen radicals and low pH, is critical for its persistence. Here, we show that a cytoplasmic redox sensor, WhiB3, and the major M. tuberculosis thiol, mycothiol (MSH), are required to resist acidic stress during infection. WhiB3 regulates the expression of genes involved in lipid anabolism, secretion, and redox metabolism, in response to acidic pH. Furthermore, inactivation of the MSH pathway subverted the expression of whiB3 along with other pH-specific genes in M. tuberculosis. Using a genetic biosensor of mycothiol redox potential (E-MSH), we demonstrated that a modest decrease in phagosomal pH is sufficient to generate redox heterogeneity in E-MSH of the M. tuberculosis population in a WhiB3-dependent manner. Data indicate that M. tuberculosis needs low pH as a signal to alter cytoplasmic E-MSH, which activates WhiB3-mediated gene expression and acid resistance. Importantly, WhiB3 regulates intraphagosomal pH by down-regulating the expression of innate immune genes and blocking phagosomal maturation. We show that this block in phagosomal maturation is in part due to WhiB3-dependent production of polyketide lipids. Consistent with these observations, Mtb Delta whiB3 displayed intramacrophage survival defect, which can be rescued by pharmacological inhibition of phagosomal acidification. Last, Mtb Delta whiB3 displayed marked attenuation in the lungs of guinea pigs. Altogether, our study revealed an intimate link between vacuolar acidification, redox physiology, and virulence in M. tuberculosis and discovered WhiB3 as crucial mediator of phagosomal maturation arrest and acid resistance in M. tuberculosis.	[Mehta, Mansi; Rajmani, Raju S.; Singh, Amit] Indian Inst Sci, Ctr Infect Dis Res, Dept Microbiol & Cell Biol, Bangalore 12, Karnataka, India; [Mehta, Mansi] Int Ctr Genet Engn & Biotechnol, New Delhi 67, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Singh, A (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Dept Microbiol & Cell Biol, Bangalore 12, Karnataka, India.	asingh@mcbl.iisc.ernet.in		Singh, Amit/0000-0001-6761-1664	Department of Biotechnology (DBT), Ministry of Science and Technology, India [BT/PR5020/MED/29/454/2012, BT/03/IYBA/2010]; Wellcome-DBT India Alliance [500034/Z/09/Z]; Council for Scientific and Industrial Research; Department of Biotechnology (DBT) Innovative Young Bio-technologist Award	Department of Biotechnology (DBT), Ministry of Science and Technology, India(Department of Biotechnology (DBT) India); Wellcome-DBT India Alliance(Wellcome Trust DBT India Alliance); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT) Innovative Young Bio-technologist Award	We thank the Department of Biotechnology (DBT), Ministry of Science and Technology, India BT/PR5020/MED/29/454/2012, BT/03/IYBA/2010 [AS]) and Wellcome-DBT India Alliance (500034/Z/09/Z [AS]) for financial support. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the Council for Scientific and Industrial Research.; Recipient of a Department of Biotechnology (DBT) Innovative Young Bio-technologist Award. A fellow of the Wellcome-DBT India Alliance.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Axelrod S, 2008, CELL MICROBIOL, V10, P1530, DOI 10.1111/j.1462-5822.2008.01147.x; Baker JJ, 2014, MOL MICROBIOL, V94, P56, DOI 10.1111/mmi.12688; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bhaskar A, 2015, J BIOL CHEM, V290, P1020, DOI 10.1074/jbc.M114.588913; Bhaskar A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003902; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Buchmeier NA, 2006, J BACTERIOL, V188, P6245, DOI 10.1128/JB.00393-06; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; HART P D, 1974, Infection and Immunity, V10, P742; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hostetter JM, 2002, FEMS IMMUNOL MED MIC, V34, P127, DOI 10.1111/j.1574-695X.2002.tb00613.x; Karim AF, 2011, J BIOL CHEM, V286, P40307, DOI 10.1074/jbc.M111.266239; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MAURIN M, 1992, INFECT IMMUN, V60, P5013, DOI 10.1128/IAI.60.12.5013-5016.1992; Metchnikoff E., 1905, IMMUNITY INFECT DIS, P182; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Rao M, 2001, MICROBIOL-UK, V147, P1017, DOI 10.1099/00221287-147-4-1017; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Schaible UE, 1998, J IMMUNOL, V160, P1290; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Tyagi P, 2015, FREE RADICAL BIO MED, V84, P344, DOI 10.1016/j.freeradbiomed.2015.03.008; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Venkataraman B, 2014, J MICROBIOL METH, V97, P34, DOI 10.1016/j.mimet.2013.12.009; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Via LE, 1998, J CELL SCI, V111, P897; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Woodmansee AN, 2003, MOL MICROBIOL, V49, P11, DOI 10.1046/j.1365-2958.2003.03530.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zullo AJ, 2012, J BIOL CHEM, V287, P12668, DOI 10.1074/jbc.M111.320135	49	54	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2888	2903		10.1074/jbc.M115.684597	http://dx.doi.org/10.1074/jbc.M115.684597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26637353	Green Published, hybrid			2022-12-26	WOS:000369626900027
J	Hashimoto, M; Murata, K; Ishida, J; Kanou, A; Kasuya, Y; Fukamizu, A				Hashimoto, Misuzu; Murata, Kazuya; Ishida, Junji; Kanou, Akihiko; Kasuya, Yoshitoshi; Fukamizu, Akiyoshi			Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SOX10; OLIGODENDROCYTE DIFFERENTIATION; N-METHYLTRANSFERASE; FACTOR OLIG2; HISTONE H4; METHYLATION; EXPRESSION; GENE; RECEPTOR; CELLS	Protein arginine methyltransferase 1 (PRMT1) is involved in cell proliferation, DNA damage response, and transcriptional regulation. Although PRMT1 is extensively expressed in the CNS at embryonic and perinatal stages, the physiological role of PRMT1 has been poorly understood. Here, to investigate the primary function of PRMT1 in the CNS, we generated CNS-specific PRMT1 knock-out mice by the Cre-loxP system. These mice exhibited postnatal growth retardation with tremors, and most of them died within 2 weeks after birth. Brain histological analyses revealed prominent cell reduction in the white matter tracts of the mutant mice. Furthermore, ultrastructural analysis demonstrated that myelin sheath was almost completely ablated in the CNS of these animals. In agreement with hypomyelination, we also observed that most major myelin proteins including myelin basic protein (MBP), 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase), and myelin-associated glycoprotein (MAG) were dramatically decreased, although neuronal and astrocytic markers were preserved in the brain of CNS-specific PRMT1 knock-out mice. These animals had a reduced number of OLIG2(+) oligodendrocyte lineage cells in the white matter. We found that expressions of transcription factors essential for oligodendrocyte specification and further maturation were significantly suppressed in the brain of the mutant mice. Our findings provide evidence that PRMT1 is required for CNS development, especially for oligodendrocyte maturation processes.	[Hashimoto, Misuzu; Fukamizu, Akiyoshi] Univ Tsukuba, PhD Program Human Biol, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Murata, Kazuya; Ishida, Junji; Fukamizu, Akiyoshi] Univ Tsukuba, Life Sci Ctr, TARA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Ishida, Junji; Kanou, Akihiko; Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Kasuya, Yoshitoshi] Chiba Univ, Dept Biochem & Mol Pharmacol, Grad Sch Med, 1-8-1 Inohana, Chiba 2608670, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Chiba University	Fukamizu, A (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	akif@tara.tsukuba.ac.jp	Murata, Kazuya/GLR-2334-2022	Murata, Kazuya/0000-0002-3328-069X; Kasuya, Yoshitoshi/0000-0003-0614-5836	JSPS KAKENHI [25252062]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25252062. The authors declare that they have no conflicts of interest with the contents of this article.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Chittka A, 2012, J BIOL CHEM, V287, P42995, DOI 10.1074/jbc.M112.392746; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Hamada J, 2015, AM J PHYSIOL-HEART C, V308, pH931, DOI 10.1152/ajpheart.00703.2013; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hong E, 2012, BIOGERONTOLOGY, V13, P329, DOI 10.1007/s10522-012-9379-2; Huang JH, 2011, J BIOL CHEM, V286, P44424, DOI 10.1074/jbc.M111.277046; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Kuspert M, 2011, NUCLEIC ACIDS RES, V39, P1280, DOI 10.1093/nar/gkq951; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Qi YC, 2001, DEVELOPMENT, V128, P2723; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	38	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2237	2245		10.1074/jbc.M115.684514	http://dx.doi.org/10.1074/jbc.M115.684514			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26637354	Green Published, hybrid			2022-12-26	WOS:000369610400015
J	Vleeshouwer-Neumann, T; Phelps, M; Bammler, TK; MacDonald, JW; Jenkins, I; Chen, EY				Vleeshouwer-Neumann, Terra; Phelps, Michael; Bammler, Theo K.; MacDonald, James W.; Jenkins, Isaac; Chen, Eleanor Y.			Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma	PLOS ONE			English	Article							CELL-LINES; HDAC INHIBITORS; MOUSE MODEL; IN-VITRO; DIFFERENTIATION; EXPRESSION; ALVEOLAR; RECEPTOR; THERAPY; GROWTH	Embryonal rhabdomyosarcoma (ERMS) is the most common soft tissue cancer in children. The prognosis of patients with relapsed or metastatic disease remains poor. ERMS genomes show few recurrent mutations, suggesting that other molecular mechanisms such as epigenetic regulation might play a major role in driving ERMS tumor biology. In this study, we have demonstrated the diverse roles of histone deacetylases (HDACs) in the pathogenesis of ERMS by characterizing effects of HDAC inhibitors, trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA; also known as vorinostat) in vitro and in vivo. TSA and SAHA suppress ERMS tumor growth and progression by inducing myogenic differentiation as well as reducing the self-renewal and migratory capacity of ERMS cells. Differential expression profiling and pathway analysis revealed downregulation of key oncogenic pathways upon HDAC inhibitor treatment. By gain-of-function, loss-of-function, and chromatin immunoprecipitation (ChIP) studies, we show that Notch1- and EphrinB1-mediated pathways are regulated by HDACs to inhibit differentiation and enhance migratory capacity of ERMS cells, respectively. Our study demonstrates that aberrant HDAC activity plays a major role in ERMS pathogenesis. Druggable targets in the molecular pathways affected by HDAC inhibitors represent novel therapeutic options for ERMS patients.	[Vleeshouwer-Neumann, Terra; Phelps, Michael; Chen, Eleanor Y.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Jenkins, Isaac] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Chen, EY (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	eleanor2@uw.edu	Phelps, Michael/O-6686-2018	Phelps, Michael/0000-0001-8246-0710; Jenkins, Isaac/0000-0002-3774-3823	NIH [K08 AR063165-03]; St. Baldrick's Scholar Award; Sarcoma Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063165] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Scholar Award; Sarcoma Foundation of America; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	EYC is supported by NIH K08 AR063165-03 and St. Baldrick's Scholar Award. MP and TVN are supported by Sarcoma Foundation of America.	Abraham J, 2014, GENE DEV, V28, P1578, DOI 10.1101/gad.238733.114; Aslam MI, 2014, P NATL ACAD SCI USA, V111, P6383, DOI 10.1073/pnas.1403608111; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Berardi AC, 2008, ANTICANCER RES, V28, P763; Blattmann C, 2010, INT J RADIAT ONCOL, V78, P237, DOI 10.1016/j.ijrobp.2010.03.010; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bridge JA, 2002, GENE CHROMOSOME CANC, V33, P310, DOI 10.1002/gcc.10026; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Charytonowicz E, 2012, J CLIN INVEST, V122, P886, DOI 10.1172/JCI60015; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen EY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003727; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Chen YY, 2006, GENE CHROMOSOME CANC, V45, P583, DOI 10.1002/gcc.20322; Chiappalupi S, 2014, CARCINOGENESIS, V35, P2382, DOI 10.1093/carcin/bgu176; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clifford N, 2008, J CELL BIOCHEM, V105, P1250, DOI 10.1002/jcb.21926; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; De Salvo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096238; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Gao Q, 2014, HUM PATHOL, V45, P372, DOI 10.1016/j.humpath.2013.10.001; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Goldstein M, 2006, NEOPLASIA, V8, P332, DOI 10.1593/neo.05829; Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Haydon RC, 2002, CLIN CANCER RES, V8, P1288; Hedrick E, 2015, MOL CANCER THER, V14, P2143, DOI 10.1158/1535-7163.MCT-15-0148; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Jain S, 2011, J BLOOD MED, V2, P37, DOI 10.2147/JBM.S9649; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kutko MC, 2003, CLIN CANCER RES, V9, P5749; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lopez-Atalaya JP, 2013, NUCLEIC ACIDS RES, V41, P8072, DOI 10.1093/nar/gkt590; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Mizgireuv IV, 2006, CANCER RES, V66, P3120, DOI 10.1158/0008-5472.CAN-05-3800; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Rephaeli A, 2005, INT J CANCER, V116, P226, DOI 10.1002/ijc.21030; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Satheesha S, 2016, ONCOGENE, V35, P2020, DOI 10.1038/onc.2015.267; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STONE RM, 1988, BLOOD, V71, P690; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Uhmann Anja, 2012, Sarcoma, V2012, P357040, DOI 10.1155/2012/357040; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109	57	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144320	10.1371/journal.pone.0144320	http://dx.doi.org/10.1371/journal.pone.0144320			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636678	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800075
J	Gontikaki, E; Thornton, B; Cornulier, T; Witte, U				Gontikaki, Evangelia; Thornton, Barry; Cornulier, Thomas; Witte, Ursula			Occurrence of Priming in the Degradation of Lignocellulose in Marine Sediments	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; RATIO MASS-SPECTROMETRY; MICROBIAL COMMUNITIES; COASTAL OCEAN; CARBON; TERRESTRIAL; BACTERIA; FUNGI; FATE; BIODEGRADATION	More than 50% of terrestrially-derived organic carbon (terrOC) flux from the continents to the ocean is remineralised in the coastal zone despite its perceived high refractivity. The efficient degradation of terrOC in the marine environment could be fuelled by labile marine-derived material, a phenomenon known as "priming effect", but experimental data to confirm this mechanism are lacking. We tested this hypothesis by treating coastal sediments with C-13-lignocellulose, as a proxy for terrOC, with and without addition of unlabelled diatom detritus that served as the priming inducer. The occurrence of priming was assessed by the difference in lignocellulose mineralisation between diatom-amended treatments and controls in aerobic sediment slurries. Priming of lignocellulose degradation was observed only at the initial stages of the experiment (day 7) and coincided with overall high microbial activity as exemplified by total CO2 production. Lignocellulose mineralisation did not differ consistently between diatom treatments and control for the remaining experimental time (days 14-28). Based on this pattern, we hypothesize that the faster initiation of lignocellulose mineralisation in diatom-amended treatments is attributed to the decomposition of accessible polysaccharide components within the lignocellulose complex by activated diatom degraders. The fact that diatom-degraders contributed to lignocellulose degradation was also supported by the different patterns in C-13-enrichment of phospholipid fatty acids between treatments. Although we did not observe differences between treatments in the total quantity of respired lignocellulose at the end of the experiment, differences in timing could be important in natural ecosystems where the amount of time that a certain compound is subject to aerobic degradation before burial to deeper anoxic sediments may be limited.	[Gontikaki, Evangelia; Witte, Ursula] Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh, Scotland; [Thornton, Barry] James Hutton Inst, Aberdeen, Scotland; [Cornulier, Thomas] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland	University of Aberdeen; James Hutton Institute; University of Aberdeen	Gontikaki, E (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Oceanlab, Newburgh, Scotland.	e.gontikaki@abdn.ac.uk	Cornulier, Thomas/G-6841-2014; Cornulier, Thomas/AAC-9753-2022; Gontikaki, Evina/C-5559-2017	Cornulier, Thomas/0000-0003-2738-4801; Gontikaki, Evina/0000-0003-1838-210X	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) [HR09011]; Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division	E.G. was funded by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, grant reference HR09011). B.T. received funding from the Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Niels Jobstvogt and Bruce Clark for their assistance in sampling. E.G. was funded by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, grant reference HR09011). B.T. received funding from the Scottish Government's Rural and Environment Science and Analytical Services (RESAS) Division.	[Anonymous], 2007, BIOGEOCHEMISTRY ESTU; [Anonymous], 2014, R LANG ENV STAT COMP; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; BAIRD D, 1981, ESTUAR COAST SHELF S, V13, P455, DOI 10.1016/S0302-3524(81)80041-2; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bengtsson MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05187; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; BENNER R, 1986, MICROBIAL ECOL, V12, P291, DOI 10.1007/BF02011172; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blair NE, 2012, ANNU REV MAR SCI, V4, P401, DOI 10.1146/annurev-marine-120709-142717; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Burdige DJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002368; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Danger M, 2013, ECOLOGY, V94, P1604, DOI 10.1890/12-0606.1; Darjany LE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00263; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Gihring TM, 2009, LIMNOL OCEANOGR, V54, P1073, DOI 10.4319/lo.2009.54.4.1073; Gontikaki E, 2011, MAR ECOL PROG SER, V421, P39, DOI 10.3354/meps08892; Gontikaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067722; Gonzalez JM, 2000, INT J SYST EVOL MICR, V50, P831, DOI 10.1099/00207713-50-2-831; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Guenet B, 2010, ECOLOGY, V91, P2850, DOI 10.1890/09-1968.1; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joos O, 2008, RAPID COMMUN MASS SP, V22, P4029, DOI 10.1002/rcm.3827; Kim YS, 2000, IAWA J, V21, P135, DOI 10.1163/22941932-90000241; Koch BP, 2014, BIOGEOSCIENCES, V11, P4173, DOI 10.5194/bg-11-4173-2014; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Li J., 2009, FRONT BIOL CHINA, V4, P29, DOI DOI 10.1007/S11515-008-0097-8; Loh PS, 2008, ESTUAR COAST SHELF S, V76, P566, DOI 10.1016/j.ecss.2007.07.023; Luna GM, 2002, APPL ENVIRON MICROB, V68, P3509, DOI 10.1128/AEM.68.7.3509-3513.2002; Malherbe S., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P105, DOI 10.1023/A:1020858910646; Mayor DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038582; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Moodley L, 2005, J MAR RES, V63, P457, DOI 10.1357/0022240053693662; Mook WG, 2001, IHP 5 TECHNICAL DOCU, VVI; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Raghukumar S, 2004, MARINE MICROBIOLOGY, P92; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Sanchez G., 2012, PLSDEPOT PARTIAL LEA; Santhi Velayudhan Satheeja, 2014, Biotechnol Rep (Amst), V1-2, P8, DOI 10.1016/j.btre.2014.05.002; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; Sridhar KR, 2012, MAR FRESHW BOTANY, P475; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; Thornton B, 2011, RAPID COMMUN MASS SP, V25, P2433, DOI 10.1002/rcm.5148; Turnewitsch R, 2007, J SEA RES, V57, P270, DOI 10.1016/j.seares.2006.08.001; van Nugteren P, 2009, MAR BIOL, V156, P2277, DOI 10.1007/s00227-009-1255-5; Wagner K, 2014, APPL ENVIRON MICROB, V80, P6004, DOI 10.1128/AEM.01128-14; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810	60	23	23	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143917	10.1371/journal.pone.0143917	http://dx.doi.org/10.1371/journal.pone.0143917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633175	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000030
J	Abu-Abied, M; Mordehaev, I; Kumar, GBS; Ophir, R; Wasteneys, GO; Sadot, E				Abu-Abied, Mohamad; Mordehaev, Inna; Kumar, Gujulla B. Sunil; Ophir, Ron; Wasteneys, Geoffrey O.; Sadot, Einat			Analysis of Microtubule-Associated-Proteins during IBA-Mediated Adventitious Root Induction Reveals KATANIN Dependent and Independent Alterations of Expression Patterns	PLOS ONE			English	Article							CORTICAL MICROTUBULES; CELL EXPANSION; MECHANICAL-PROPERTIES; GENE-EXPRESSION; AUXIN; GROWTH; DIVISION; ORGANIZATION; MORPHOGENESIS; INITIATION	Adventitious roots (AR) are post embryonic lateral organs that differentiate from non-root tissues. The understanding of the molecular mechanism which underlies their differentiation is important because of their central role in vegetative plant propagation. Here it was studied how the expression of different microtubule (MT)-associated proteins (MAPs) is affected during AR induction, and whether expression differences are dependent on MT organization itself. To examine AR formation when MTs are disturbed we used two mutants in the MT severing protein KATANIN. It was found that rate and number of AR primordium formed following IBA induction for three days was reduced in bot1-1 and bot1-7 plants. The reduced capacity to form ARs in bot1-1 was associated with altered expression of MAP-encoding genes along AR induction. While the expression of MAP65-4, MAP65-3, AURORA1, AURORA2 and TANGLED, increased in wild-type but not in bot1-1 plants, the expression of MAP65-8 and MDP25 decreased in wild type plants but not in the bot1-1 plant after two days of IBA-treatment. The expression of MOR1 was increased two days after AR induction in wild type and bot1-1 plants. To examine its expression specifically in AR primordium, MOR1 upstream regulatory sequence was isolated and cloned to regulate GFP. Expression of GFP was induced in the primary root tips and lateral roots, in the pericycle of the hypocotyls and in all stages of AR primordium formation. It is concluded that the expression of MAPs is regulated along AR induction and that reduction in KATANIN expression inhibits AR formation and indirectly influences the specific expression of some MAPs.	[Abu-Abied, Mohamad; Mordehaev, Inna; Kumar, Gujulla B. Sunil; Ophir, Ron; Sadot, Einat] ARO, Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel; [Wasteneys, Geoffrey O.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of British Columbia	Sadot, E (corresponding author), ARO, Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel.	vhesadot@agri.gov.il	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994	Israel Science Foundation [776/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (grant 776/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abied M, 2015, J EXP BOT, V66, P2813, DOI 10.1093/jxb/erv097; Abu-Abied M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-826; Ambrose C, 2013, DEV CELL, V24, P649, DOI 10.1016/j.devcel.2013.02.007; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL BIOL CELL, V19, P4730, DOI 10.1091/mbc.E08-06-0665; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Benkova E, 2010, CURR OPIN PLANT BIOL, V13, P677, DOI 10.1016/j.pbi.2010.09.006; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; BLAKESLEY D, 1991, PLANT GROWTH REGUL, V10, P341, DOI 10.1007/BF00024593; Casson SA, 2003, NEW PHYTOL, V158, P11, DOI 10.1046/j.1469-8137.2003.00705.x; Chen X, 2014, NATURE, V516, P90, DOI 10.1038/nature13889; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Fahn A, 1990, PLANT ANATOMY; Falasca G, 2003, PLANT BIOSYST, V137, P265, DOI 10.1080/11263500312331351511; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2011, PLANT SIGNAL BEHAV, V6, P137, DOI 10.4161/psb.6.1.14269; HARDHAM AR, 1980, PLANTA, V149, P181, DOI 10.1007/BF00380881; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Ho CMK, 2012, PLANT CELL, V24, P2071, DOI 10.1105/tpc.111.092569; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; Kumpf RP, 2013, P NATL ACAD SCI USA, V110, P5235, DOI 10.1073/pnas.1210835110; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Li JJ, 2011, PLANT CELL, V23, P4411, DOI 10.1105/tpc.111.092684; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Lucas M, 2013, P NATL ACAD SCI USA, V110, P5229, DOI 10.1073/pnas.1210807110; Mao TL, 2005, PLANT PHYSIOL, V138, P654, DOI 10.1104/pp.104.052456; Portran D, 2013, MOL BIOL CELL, V24, P1964, DOI 10.1091/mbc.E13-03-0141; Rasmussen CG, 2013, PLANT J, V75, P258, DOI 10.1111/tpj.12177; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; Riov J, 2013, PLANT ROOTS HIDD, P1111; Sampathkumar A, 2014, CURR BIOL, V24, pR475, DOI 10.1016/j.cub.2014.03.014; Sasidharan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090587; Sassi M, 2014, CURR BIOL, V24, P2335, DOI 10.1016/j.cub.2014.08.036; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Van Damme D, 2011, PLANT CELL, V23, P4013, DOI 10.1105/tpc.111.089565; Vermeer JEM, 2014, SCIENCE, V343, P178, DOI 10.1126/science.1245871; Verstraeten I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00495; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; Wasteneys GO, 2006, J PLANT RES, V119, P5, DOI 10.1007/s10265-005-0233-3; Wasteneys GO, 2004, ANNU PLANT REV, V10, P83; Wasteneys GO, 2004, CURR OPIN PLANT BIOL, V7, P651, DOI 10.1016/j.pbi.2004.09.008; Wasteneys GO, 2002, J CELL SCI, V115, P1345; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425; Xu TD, 2014, SCIENCE, V343, P1025, DOI 10.1126/science.1245125; ZANDOMENI K, 1994, PROTOPLASMA, V182, P96, DOI 10.1007/BF01403471; Zhang Q, 2013, CURR BIOL, V23, P2191, DOI 10.1016/j.cub.2013.09.018	52	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143828	10.1371/journal.pone.0143828	http://dx.doi.org/10.1371/journal.pone.0143828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630265	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300107
J	Arias-Rodil, M; Castedo-Dorado, F; Camara-Obregon, A; Dieguez-Aranda, U				Arias-Rodil, Manuel; Castedo-Dorado, Fernando; Camara-Obregon, Asuncion; Dieguez-Aranda, Ulises			Fitting and Calibrating a Multilevel Mixed-Effects Stem Taper Model for Maritime Pine in NW Spain	PLOS ONE			English	Article							MERCHANTABLE VOLUME SYSTEM; HEIGHT; DOMINANT; GROWTH; PREDICTIONS; EQUATIONS; FORESTRY; PROFILE; L.	Stem taper data are usually hierarchical (several measurements per tree, and several trees per plot), making application of a multilevel mixed-effects modelling approach essential. However, correlation between trees in the same plot/stand has often been ignored in previous studies. Fitting and calibration of a variable-exponent stem taper function were conducted using data from 420 trees felled in even-aged maritime pine (Pinus pinaster Ait.) stands in NW Spain. In the fitting step, the tree level explained much more variability than the plot level, and therefore calibration at plot level was omitted. Several stem heights were evaluated for measurement of the additional diameter needed for calibration at tree level. Calibration with an additional diameter measured at between 40 and 60% of total tree height showed the greatest improvement in volume and diameter predictions. If additional diameter measurement is not available, the fixed-effects model fitted by the ordinary least squares technique should be used. Finally, we also evaluated how the expansion of parameters with random effects affects the stem taper prediction, as we consider this a key question when applying the mixed-effects modelling approach to taper equations. The results showed that correlation between random effects should be taken into account when assessing the influence of random effects in stem taper prediction.	[Arias-Rodil, Manuel; Dieguez-Aranda, Ulises] Univ Santiago de Compostela, Dept Ingn Agroforestal, Unidad Gest Forestal Sostenible UXFS, Escuela Politecn Super, Lugo 27002, Spain; [Castedo-Dorado, Fernando] Univ Leon, Dept Ingn & Ciencias Agr, Escuela Super & Tecn Ingn Agraria, Ponferrada 24400, Spain; [Camara-Obregon, Asuncion] Univ Oviedo, Dept Biol Organismos & Sistemas, Grp Invest Sistemas Forestales Atlanticos GIS For, Mieres 33600, Spain	Universidade de Santiago de Compostela; Universidad de Leon; University of Oviedo	Arias-Rodil, M (corresponding author), Univ Santiago de Compostela, Dept Ingn Agroforestal, Unidad Gest Forestal Sostenible UXFS, Escuela Politecn Super, Campus Univ, Lugo 27002, Spain.	manuel.arias.rodil@gmail.com	Camara-Obregon, Asuncion/AAD-9033-2021; Diéguez-Aranda, Ulises/E-4302-2012; Castedo-Dorado, Fernando/E-5449-2012	Camara-Obregon, Asuncion/0000-0003-3747-1642; Diéguez-Aranda, Ulises/0000-0002-4640-6714; Castedo-Dorado, Fernando/0000-0002-1656-5255	FPU grant from the Spanish Ministry of Education, Culture and Sport [AP2012-05337]; Spanish Ministry of Science and Innovation [AGL2008-02259/FOR]; Government of the Principality of Asturias [CN-07-094, SV-PA-13-ECOEMP-58]	FPU grant from the Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of the Principality of Asturias(Principality of Asturias)	The corresponding author was in receipt of an FPU grant (AP2012-05337) from the Spanish Ministry of Education, Culture and Sport, http://www.mecd.gob.es/. This work was also supported by project no. AGL2008-02259/FOR from the Spanish Ministry of Science and Innovation, http://www.idi.mineco.gob.es/; and project nos. CN-07-094 and SV-PA-13-ECOEMP-58 from the Government of the Principality of Asturias, http://www.asturias.es/.	[Anonymous], 1986, COMMUNICATIONS I FOR; [Anonymous], 2006, SAS MIXED MODELS; Arias-Rodil M, 2015, CAN J FOREST RES, V45, P647, DOI 10.1139/cjfr-2014-0276; Burkhart H. E., 2012, MODELING FOREST TREE; Calama R., 2006, Investigacion Agraria, Sistemas y Recursos Forestales, V15, P24; Cao QV, 2015, FOREST SCI, V61, P213, DOI 10.5849/forsci.14-008; Cao QV, 2011, FOREST ECOL MANAG, V262, P671, DOI 10.1016/j.foreco.2011.04.039; Corral-Rivas JJ, 2007, FOREST ECOL MANAG, V238, P118, DOI 10.1016/j.foreco.2006.09.074; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Crecente-Campo F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009078; de-Miguel S, 2013, FOREST ECOL MANAG, V291, P249, DOI 10.1016/j.foreco.2012.11.026; De-Miguel S, 2012, CAN J FOREST RES, V42, P1383, DOI [10.1139/X2012-090, 10.1139/x2012-090]; Dieguez-Aranda U, 2006, CAN J FOREST RES, V36, P1190, DOI 10.1139/X06-008; Fang ZX, 2001, FOREST SCI, V47, P287; Fang ZX, 2000, FOREST SCI, V46, P1; Fortin M, 2013, CAN J FOREST RES, V43, P129, DOI 10.1139/cjfr-2012-0268; Giltinan DM, 1995, NONLINEAR MODELS REP, V62; Gomez-Garcia E, 2013, ANN FOREST SCI, V70, P707, DOI 10.1007/s13595-013-0313-9; Gregoire TG, 2000, BIOMETRICS, V56, P414, DOI 10.1111/j.0006-341X.2000.00414.x; GREGOIRE TG, 1995, CAN J FOREST RES, V25, P137, DOI 10.1139/x95-017; Kozak A, 2004, FOREST CHRON, V80, P507, DOI 10.5558/tfc80507-4; KOZAK A, 1988, CAN J FOREST RES, V18, P1363, DOI 10.1139/x88-213; LAPPI J, 1991, FOREST SCI, V37, P781; Lejeune G, 2009, EUR J FOREST RES, V128, P505, DOI 10.1007/s10342-009-0300-8; Li RX, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009109; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; MAGRAMA, 2010, AN EST FOR 2010; MAGRAMA, 2012, CUARTO INVENTARIO FO; MAX TA, 1976, FOREST SCI, V22, P283; Meng SX, 2009, CAN J FOREST RES, V39, P1148, DOI 10.1139/X09-039; Meng SX, 2009, FOREST SCI, V55, P238; Myers RH, 1990, CLASSICAL MODERN REG, V2; Nothdurft A, 2006, EUR J FOREST RES, V125, P281, DOI 10.1007/s10342-006-0118-6; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2001, MIXED EFFECTS MODELS; R. Core Team, 2015, R A LANGUAGE AND ENV; Rojo A, 2005, EUR J FOREST RES, V124, P177, DOI 10.1007/s10342-005-0066-6; Sabatia CO, 2015, FOREST SCI, V61, P411, DOI 10.5849/forsci.14-039; Sanz F, 2006, APLICACIONES IND MAD; Sharma M, 2007, FOREST ECOL MANAG, V249, P187, DOI 10.1016/j.foreco.2007.05.006; SHEINER LB, 1980, J PHARMACOKINET BIOP, V8, P553, DOI 10.1007/BF01060053; Sirkia S, 2015, FOREST SCI, V61, P205, DOI 10.5849/forsci.13-142; Tasissa G, 1998, FOREST ECOL MANAG, V103, P87, DOI 10.1016/S0378-1127(97)00179-5; Trincado G, 2006, FOREST SCI, V52, P670; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; Wolfinger RD, 1997, COMPUT STAT DATA AN, V25, P465, DOI 10.1016/S0167-9473(97)00012-1; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; Yang YQ, 2013, EUR J FOREST RES, V132, P727, DOI 10.1007/s10342-013-0705-2; Yang YQ, 2011, CAN J FOREST RES, V41, P1671, DOI [10.1139/x11-071, 10.1139/X11-071]; Yang YQ, 2011, FOREST SCI, V57, P102; Yang YQ, 2009, CAN J FOREST RES, V39, P2203, DOI 10.1139/X09-123; Yang YQ, 2009, EUR J FOREST RES, V128, P415, DOI 10.1007/s10342-009-0286-2	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143521	10.1371/journal.pone.0143521	http://dx.doi.org/10.1371/journal.pone.0143521			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630156	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300056
J	Peipoch, M; Jones, R; Valett, HM				Peipoch, Marc; Jones, Ryan; Valett, H. Maurice			Spatial Patterns in Biofilm Diversity across Hierarchical Levels of River-Floodplain Landscapes	PLOS ONE			English	Article							GLOBAL PATTERNS; ECOSYSTEMS; COMMUNITIES; CONNECTIVITY; SUCCESSION; ORGANISMS; SEQUENCES; FIXATION; NITROGEN; ECOLOGY	River-floodplain systems are among the most diverse and productive ecosystems, but the effects of biophysical complexity at multiple scales on microbial biodiversity have not been studied. Here, we investigated how the hierarchical organization of river systems (i.e., region, floodplain, zone, habitats, and microhabitats) influences epilithic biofilm community assemblage patterns by characterizing microbial communities using 16S rRNA gene sequence data and analyzing bacterial species distribution across local and regional scales. Results indicate that regional and local environmental filters concurrently sort bacterial species, suggesting that spatial configuration of epilithic biofilms resembles patterns of larger organisms in floodplain ecosystems. Along the hierarchical organization of fluvial systems, floodplains constitute a vector of maximum environmental heterogeneity and consequently act as a major landscape filter for biofilm species. Thus, river basins and associated floodplains may simply reflect very large scale 'patches' within which environmental conditions select for community composition of epilithic biofilms.	[Peipoch, Marc] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Peipoch, Marc; Valett, H. Maurice] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Jones, Ryan] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Montana State University System; Montana State University Bozeman	Peipoch, M (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	marc.peipoch@mso.umt.edu	Peipoch, Marc/N-6936-2013	Peipoch, Marc/0000-0002-1395-6912	National Science Foundation EPSCoR through the Montana Institute on Ecosystems [Track-1EPS-1101342 (INSTEP 3)]; Natural Resource Damage Program [900017, 2.42]; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation EPSCoR through the Montana Institute on Ecosystems; Natural Resource Damage Program; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding was provided by National Science Foundation EPSCoR Track-1EPS-1101342 (INSTEP 3) through the Montana Institute on Ecosystems to HM Valett and by Natural Resource Damage Program Contract 900017 Task Order 2.42 to HM Valett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; Barberan A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00203; BAYLEY PB, 1995, BIOSCIENCE, V45, P153, DOI 10.2307/1312554; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bellmore JR, 2014, RIVER RES APPL, V30, P617, DOI 10.1002/rra.2672; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finlay BJ, 1998, PROTIST, V149, P29, DOI 10.1016/S1434-4610(98)70007-0; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; FISHER SG, 1982, ECOL MONOGR, V52, P93, DOI 10.2307/2937346; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; GREEN JL, 2006, SPATIAL SCALING MICR; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; GRIMM N B, 1986, Journal of the North American Benthological Society, V5, P2, DOI 10.2307/1467743; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Hervas A, 2009, FEMS MICROBIOL ECOL, V67, P219, DOI 10.1111/j.1574-6941.2008.00617.x; Hillebrand H, 2002, OECOLOGIA, V132, P479, DOI 10.1007/s00442-002-0988-3; Hillebrand H, 2001, OECOLOGIA, V126, P114, DOI 10.1007/s004420000492; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kunza LA, 2014, BIOGEOCHEMISTRY, V121, P537, DOI 10.1007/s10533-014-0021-z; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Marcarelli AM, 2008, J N AM BENTHOL SOC, V27, P186, DOI 10.1899/07-027.1; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; NAIMAN RJ, 1988, J N AM BENTHOL SOC, V7, P289, DOI 10.2307/1467295; O'Neill R. V., 1986, HIERARCHICAL CONCEPT; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stanford JA, 2005, INT VER THEOR ANGEW, V29, P123; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tockner K, 1999, FRESHWATER BIOL, V41, P521, DOI 10.1046/j.1365-2427.1999.00399.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Ward JV, 2002, FRESHWATER BIOL, V47, P517, DOI 10.1046/j.1365-2427.2002.00893.x; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E	50	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144303	10.1371/journal.pone.0144303	http://dx.doi.org/10.1371/journal.pone.0144303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630382	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300178
J	Chu, X; Guo, YS; Xu, BY; Li, WY; Lin, Y; Sun, XR; Ding, CH; Zhang, X				Chu, Xi; Guo, Yusong; Xu, Bingyuan; Li, Wenya; Lin, Yue; Sun, Xiaorun; Ding, Chunhua; Zhang, Xuan			Effects of Tannic Acid, Green Tea and Red Wine on hERG Channels Expressed in HEK293 Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) GLYCOHYDROLASE; CURRENT KNOWLEDGE; DRUG DEVELOPMENT; QT PROLONGATION; K+ CHANNEL; APOPTOSIS; POLYPHENOLS; FLAVONOIDS; STRATEGIES; INHIBITOR	Tannic acid presents in varying concentrations in plant foods, and in relatively high concentrations in green teas and red wines. Human ether-a-go-go-related gene (hERG) channels expressed in multiple tissues (e.g. heart, neurons, smooth muscle and cancer cells), and play important roles in modulating cardiac action potential repolarization and tumor cell biology. The present study investigated the effects of tannic acid, green teas and red wines on hERG currents. The effects of tannic acid, teas and red wines on hERG currents stably transfected in HEK293 cells were studied with a perforated patch clamp technique. In this study, we demonstrated that tannic acid inhibited hERG currents with an IC50 of 3.4 mu M and similar to 100% inhibition at higher concentrations, and significantly shifted the voltage dependent activation to more positive potentials (Delta 23.2 mV). Remarkably, a 100-fold dilution of multiple types of tea (green tea, oolong tea and black tea) or red wine inhibited hERG currents by similar to 90%, and significantly shifted the voltage dependent activation to more positive potentials (Delta 30.8 mV and Delta 26.0 mV, respectively). Green tea Lung Ching and red wine inhibited hERG currents, with IC50 of 0.04% and 0.19%, respectively. The effects of tannic acid, teas and red wine on hERG currents were irreversible. These results suggest tannic acid is a novel hERG channel blocker and consequently provide a new mechanistic evidence for understanding the effects of tannic acid. They also revealed the potential pharmacological basis of tea-and red wine-induced biology activities.	[Li, Wenya; Lin, Yue; Zhang, Xuan] Hebei Univ Chinese Med, Dept Pharmacol, Shijiazhuang, Peoples R China; [Ding, Chunhua] Guangdong Prov Hosp Chinese Med, Arrhythmia Ctr, Guangzhou, Guangdong, Peoples R China; [Chu, Xi] Fourth Hosp Hebei Med Univ, Dept Pharm, Shijiazhuang, Peoples R China; [Guo, Yusong] Third Hosp Shijiazhuang, Dept Orthopaed Trauma Dept 2, Shijiazhuang, Peoples R China; [Xu, Bingyuan] Hebei Univ Chinese Med, Dept Biochem, Shijiazhuang, Peoples R China; [Li, Wenya] Hebei Univ Chinese Med, Dept Physiol, Shijiazhuang, Peoples R China	Hebei University of Chinese Medicine; Guangzhou University of Chinese Medicine; Hebei Medical University; Hebei University of Chinese Medicine; Hebei University of Chinese Medicine	Ding, CH (corresponding author), Guangdong Prov Hosp Chinese Med, Arrhythmia Ctr, Guangzhou, Guangdong, Peoples R China.	dingmd@gmail.com; xuan_zhangt@hotmail.com		Ding, Chunhua/0000-0003-4381-6723	National Natural Science Foundation of China [31401003]; Natural Science Foundation of Hebei Province [H2015423014]; Research Foundation of Education Bureau of Heibei Province [QN20131046]; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Research Foundation of Education Bureau of Heibei Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31401003 to XZ), Natural Science Foundation of Hebei Province (H2015423014 to XZ), Research Foundation of Education Bureau of Heibei Province (QN20131046 to XZ), and by Project Funded by China Postdoctoral Science Foundation (58th to XZ).	Altmann D, 2008, WIEN KLIN WOCHENSCHR, V120, P128, DOI 10.1007/s00508-008-0940-6; AOKI K, 1995, BIOCHEM BIOPH RES CO, V210, P329, DOI 10.1006/bbrc.1995.1665; Chen RLC, 2005, J AGR FOOD CHEM, V53, P8443, DOI 10.1021/jf051077f; Chen X, 2003, CLIN CANCER RES, V9, P3115; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Finlayson K, 2004, EUR J PHARMACOL, V500, P129, DOI 10.1016/j.ejphar.2004.07.019; Geleijnse JM, 2002, AM J CLIN NUTR, V75, P880, DOI 10.1093/ajcn/75.5.880; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; Koide T, 1999, CANCER BIOTHER RADIO, V14, P231, DOI 10.1089/cbr.1999.14.231; Ngobili TA, 2015, ANTICANCER RES, V35, P1285; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; SAVOLAINEN H, 1992, J APPL TOXICOL, V12, P191, DOI 10.1002/jat.2550120307; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; STOCKS P, 1970, BRIT J CANCER, V24, P215, DOI 10.1038/bjc.1970.25; Sun YY, 2012, ANTI-CANCER DRUG, V23, P979, DOI 10.1097/CAD.0b013e328356359f; Uchiumi F, 1998, J BIOL CHEM, V273, P12499, DOI 10.1074/jbc.273.20.12499; Wang CC, 2000, CANCER LETT, V149, P77, DOI 10.1016/S0304-3835(99)00344-4; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626; Yang LL, 2000, CANCER LETT, V157, P65, DOI 10.1016/S0304-3835(00)00477-8; Zitron E, 2005, CIRCULATION, V111, P835, DOI 10.1161/01.CIR.0000155617.54749.09	28	19	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143797	10.1371/journal.pone.0143797	http://dx.doi.org/10.1371/journal.pone.0143797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625122	gold, Green Submitted, Green Published			2022-12-26	WOS:000365891600051
J	Flores-Palacios, A; Corona-Lopez, AM; Rios, MY; Aguilar-Guadarrama, B; Toledo-Hernandez, VH; Rodriguez-Lopez, V; Valencia-Diaz, S				Flores-Palacios, Alejandro; Maria Corona-Lopez, Angelica; Yolanda Rios, Maria; Aguilar-Guadarrama, Berenice; Hugo Toledo-Hernandez, Victor; Rodriguez-Lopez, Veronica; Valencia-Diaz, Susana			Is Allelopathic Activity of Ipomoea murucoides Induced by Xylophage Damage?	PLOS ONE			English	Article							SEED-GERMINATION; PLANT; CHEMISTRY; DEFENSE; FOREST; LEAVES	Herbivory activates the synthesis of allelochemicals that can mediate plant-plant interactions. There is an inverse relationship between the activity of xylophages and the abundance of epiphytes on Ipomoea murucoides. Xylophagy may modify the branch chemical constitution, which also affects the liberation of allelochemicals with defense and allelopathic properties. We evaluated the bark chemical content and the effect of extracts from branches subjected to treatments of exclusion, mechanical damage and the presence/absence of epiphytes, on the seed germination of the epiphyte Tillandsia recurvata. Principal component analysis showed that branches without any treatment separate from branches subjected to treatments; damaged and excluded branches had similar chemical content but we found no evidence to relate intentional damage with allelopathy; however 1-hexadecanol, a defense volatile compound correlated positively with principal component (PC) 1. The chemical constitution of branches subject to exclusion plus damage or plus epiphytes was similar among them. PC2 indicated that palmitic acid (allelopathic compound) and squalene, a triterpene that attracts herbivore enemies, correlated positively with the inhibition of seed germination of T. recurvata. Inhibition of seed germination of T. recurvata was mainly correlated with the increment of palmitic acid and this compound reached higher concentrations in excluded branches treatments. Then, it is likely that the allelopathic response of I. murucoides would increase to the damage (shade, load) that may be caused by a high load of epiphytes than to damage caused by the xylophages.	[Flores-Palacios, Alejandro; Maria Corona-Lopez, Angelica; Hugo Toledo-Hernandez, Victor] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico; [Yolanda Rios, Maria; Aguilar-Guadarrama, Berenice] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico; [Rodriguez-Lopez, Veronica] Univ Autonoma Estado Morelos, Fac Farm, Cuernavaca, Morelos, Mexico; [Valencia-Diaz, Susana] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Valencia-Diaz, S (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Cuernavaca, Morelos, Mexico.	susana.valencia@uaem.mx	Valencia-díaz, Susana/ABB-4670-2020; Rios, Maria Yolanda/B-3702-2008; Aguilar-Guadarrama, A. Berenice/AGI-6299-2022; Flores-Palacios, Alejandro/T-7074-2017	Rios, Maria Yolanda/0000-0002-8875-8734; Aguilar-Guadarrama, A. Berenice/0000-0003-3667-8828; Flores-Palacios, Alejandro/0000-0002-2000-9964; Corona-Lopez, Angelica Maria/0000-0003-3445-9306; Rodriguez Lopez, Veronica/0000-0001-8379-4982; Valencia Diaz, Susana/0000-0002-0089-226X; Rodriguez Lopez, Veronica/0000-0001-7805-2693; Toledo-Hernandez, Victor H./0000-0002-1119-2189	Postdoctoral PROMEP (Programa de Mejoramiento del Profesorado); Departamento de Ecologia Evolutiva (CIByC-UAEM); Laboratorio de Productos Naturales (Facultad de Farmacia); Postdoctoral PROMEP grant	Postdoctoral PROMEP (Programa de Mejoramiento del Profesorado); Departamento de Ecologia Evolutiva (CIByC-UAEM); Laboratorio de Productos Naturales (Facultad de Farmacia); Postdoctoral PROMEP grant	This research was funded by a Postdoctoral PROMEP (Programa de Mejoramiento del Profesorado) grant to SVD (2011-2013) and by funding granted to the Cuerpo Academico Biologia del Dosel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of A. Mariel, D. Lopez-Cobos, E. Sanvicente and K. Columba in laboratory and fieldwork. We thank the Departamento de Ecologia Evolutiva (CIByC-UAEM) and Laboratorio de Productos Naturales (Facultad de Farmacia) for their support. We thank C.A Vergara-Torres for the ant identification. We thank K. MacMillan for translation and comments. We appreciate the comments of Dr. Mick Hanley of a previous version of this manuscript. This research was funded by a Postdoctoral PROMEP grant to S.V.D. and by funding granted to the Cuerpo Academico Biologia del Dosel.	Vergara-Torres CA, 2010, J TROP ECOL, V26, P563, DOI 10.1017/S0266467410000349; ANAYA AL, 1990, J CHEM ECOL, V16, P2145, DOI 10.1007/BF01026926; Becerra JX, 2001, AM ZOOL, V41, P865, DOI 10.1668/0003-1569(2001)041[0865:IBCAMD]2.0.CO;2; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Burgos-Solorio A, 2010, MADERA BOSQUES, V16, P67; Callaway RM, 2002, OECOLOGIA, V132, P221, DOI 10.1007/s00442-002-0943-3; Carranza Eleazar., 2007, FLORA BAJIO REGIONES, V151, P1; Chu HF, 1949, PICTURED KEY NATURE; Corona-Lopez MA, 2006, COMPONENTES BIOTICOS; Costa C., 1988, LARVAS COLEOPTERA BR; Dutton A, 2002, J CHEM ECOL, V28, P103, DOI 10.1023/A:1013514903036; ENZELL CR, 1965, ACTA CHEM SCAND, V19, P1875, DOI 10.3891/acta.chem.scand.19-1875; Garcia-Suarez M. D., 2006, Selbyana, V27, P54; Harshani HBC, 2014, J NATL SCI FOUND SRI, V42, P71, DOI 10.4038/jnsfsr.v42i1.6682; Hebling MJA, 2000, J APPL ENTOMOL, V124, P249, DOI 10.1046/j.1439-0418.2000.00471.x; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Inderjit, 2011, TRENDS ECOL EVOL, V26, P655, DOI 10.1016/j.tree.2011.08.003; Karban R, 2007, ECOL LETT, V10, P791, DOI 10.1111/j.1461-0248.2007.01068.x; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2007, CURR OPIN PLANT BIOL, V10, P409, DOI 10.1016/j.pbi.2007.06.001; Macias-Rubalcava ML, 2007, J CHEM ECOL, V33, P147, DOI 10.1007/s10886-006-9208-7; Meurer-Grimes B, 1997, BOT REV, V63, P356, DOI 10.1007/BF02856597; Montana C, 1997, BIOTROPICA, V29, P517, DOI 10.1111/j.1744-7429.1997.tb00046.x; NADKARNI NM, 1994, AM ZOOL, V34, P70; Ode PJ, 2004, OIKOS, V104, P388, DOI 10.1111/j.0030-1299.2004.12323.x; Pavia DL, 2005, INTRO ORGANIC LAB TE; PEREDAMIRANDA R, 1993, J NAT PROD, V56, P571, DOI 10.1021/np50094a018; Qasem RL, 2006, ALLELOPATHY PHYSL PR; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Ruiz-Rivera C.A., 2001, SAN ANDRES CAL CULTO; Rzedowski J., 1978, VEGETACION MEXICO; Sarkar N, 2015, CAN ENTOMOL, V147, P169, DOI 10.4039/tce.2014.37; Schoonhoven L. M., 2005, Insect-plant biology; Sepulveda-Jimenez G, 2003, REV MEX FITOPATOL, V21, P355; StataCorp, 2013, STAT STAT SOFTW REL; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Stunt S, 2001, THESIS; Suarez LH, 2005, REV CHIL HIST NAT, V78, P23; Thelen GC, 2005, ECOL LETT, V8, P209, DOI 10.1111/j.1461-0248.2004.00713.x; Toledo-Hernandez VH, 2006, COMPONENTES BIOTICOS; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; Valencia-Diaz S, 2013, ALLELOPATHY J, V32, P91; Valencia-Diaz S, 2014, ARTHROPOD-PLANT INTE, V8, P25, DOI 10.1007/s11829-013-9284-x; Valencia-Diaz S, 2010, J TROP ECOL, V26, P571, DOI 10.1017/S0266467410000374; Vera CLG, 2009, J ENTOMOL, V6, P109, DOI [DOI 10.3923/JE.2009.109.116, 10.3923/je.2009.109.116]; Vivanco M., 2005, INVESTIGACION CIENCI, V341, P68; Zar JH., 2010, BIOSTAT ANAL, V5th	47	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143529	10.1371/journal.pone.0143529	http://dx.doi.org/10.1371/journal.pone.0143529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625350	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600034
J	Free, CM; Jensen, OP; Mendsaikhan, B				Free, Christopher M.; Jensen, Olaf P.; Mendsaikhan, Bud			A Mixed-Method Approach for Quantifying Illegal Fishing and Its Impact on an Endangered Fish Species	PLOS ONE			English	Article							RANDOMIZED-RESPONSE TECHNIQUE; CORAL-REEF MANAGEMENT; SPATIAL-DISTRIBUTION; PROTECTED AREAS; FLORIDA-KEYS; ENFORCEMENT; FISHERIES; HOVSGOL; DEBRIS; THREAT	Illegal harvest is recognized as a widespread problem in natural resource management. The use of multiple methods for quantifying illegal harvest has been widely recommended yet infrequently applied. We used a mixed-method approach to evaluate the extent, character, and motivations of illegal gillnet fishing in Lake Hovsgol National Park, Mongolia and its impact on the lake's fish populations, especially that of the endangered endemic Hovsgol grayling (Thymallus nigrescens). Surveys for derelict fishing gear indicate that gillnet fishing is widespread and increasing and that fishers generally use 3-4 cm mesh gillnet. Interviews with resident herders and park rangers suggest that many residents fish for subsistence during the spring grayling spawning migration and that some residents fish commercially year-round. Interviewed herders and rangers generally agree that fish population sizes are decreasing but are divided on the causes and solutions. Biological monitoring indicates that the gillnet mesh sizes used by fishers efficiently target Hovsgol grayling. Of the five species sampled in the monitoring program, only burbot (Lota lota) showed a significant decrease in population abundance from 2009-2013. However, grayling, burbot, and roach (Rutilus rutilus) all showed significant declines in average body size, suggesting a negative fishing impact. Data-poor stock assessment methods suggest that the fishing effort equivalent to each resident family fishing 50-m of gillnet 11-15 nights per year would be sufficient to over-exploit the grayling population. Results from the derelict fishing gear survey and interviews suggest that this level of effort is not implausible. Overall, we demonstrate the ability for a mixed-method approach to effectively describe an illegal fishery and suggest that these methods be used to assess illegal fishing and its impacts in other protected areas.	[Free, Christopher M.; Jensen, Olaf P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Mendsaikhan, Bud] Mongolian Acad Sci, Inst Geoecol, Ulaanbaatar 15170, Mongolia	Rutgers State University New Brunswick; Mongolian Academy of Sciences	Free, CM (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	cfree@marine.rutgers.edu	Free, Christopher Michael/AAC-5103-2019	Free, Christopher Michael/0000-0002-2557-8920	National Science Foundation (NSF), Office of International Science and Engineering (OISE), International Research Experiences for Students (IRES), NSF-IRES OISE [1064843]; United States Agency for International Development (USAID), Partnerships for Enhanced Engagement in Research (PEER), SAID-PEER Project [98]; American Center for Mongolian Studies (ACMS); Grayling Research Trust (GRT), Research Grant-CMF; National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service (NMFS), NMFS-Sea Grant Population Dynamics Fellowship - CMF; NSF-IRES grant [OISE 1064843]; USAID-PEER grant [98]; American Center for Mongolian Studies and Grayling Research Trust grants; NMFS-Sea Grant Population Dynamics Fellowship	National Science Foundation (NSF), Office of International Science and Engineering (OISE), International Research Experiences for Students (IRES), NSF-IRES OISE(National Science Foundation (NSF)); United States Agency for International Development (USAID), Partnerships for Enhanced Engagement in Research (PEER), SAID-PEER Project(United States Agency for International Development (USAID)); American Center for Mongolian Studies (ACMS); Grayling Research Trust (GRT), Research Grant-CMF; National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service (NMFS), NMFS-Sea Grant Population Dynamics Fellowship - CMF; NSF-IRES grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); USAID-PEER grant(United States Agency for International Development (USAID)); American Center for Mongolian Studies and Grayling Research Trust grants; NMFS-Sea Grant Population Dynamics Fellowship	This study was supported by the National Science Foundation (NSF), Office of International Science and Engineering (OISE), International Research Experiences for Students (IRES), https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12831, NSF-IRES OISE 1064843-OPJ; United States Agency for International Development (USAID), Partnerships for Enhanced Engagement in Research (PEER), http://sites.nationalacademies.org/pga/peer/index.htm, USAID-PEER Project 98-BM; American Center for Mongolian Studies (ACMS), http://mongoliacenter.org/field, Field Research Fellowship-CMF; Grayling Research Trust (GRT), http://www.graylingresearch.org/grant, Research Grant-CMF; National Oceanic and Atmospheric Administration (NOAA), National Marine Fisheries Service (NMFS), http://seagrant.noaa.gov/FundingFellowships/NMFSSGFellowship.aspx, NMFS-Sea Grant Population Dynamics Fellowship - CMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the devoted work of our many field assistants. We also thank Steven Alexander, Talia Young, and the members of the Jensen lab for their helpful feedback on the manuscript. The Taimen Conservation Fund, Mongol Ecology Center, Sweetwater Travel, and Hovsgol Travel provided field support and assistance. This work was supported by a NSF-IRES grant (OISE 1064843) to OPJ, a USAID-PEER grant (Project 98) to BM, and American Center for Mongolian Studies and Grayling Research Trust grants to CMF. CMF is funded by a NMFS-Sea Grant Population Dynamics Fellowship.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Ahrenstorff TD, 2012, ENVIRON BIOL FISH, V94, P465, DOI 10.1007/s10641-011-9961-5; Atkinson R., 2001, SOC RES UPDATE, V33, P1, DOI DOI 10.1017/CBO9781107415324.004; Bates D., 2015, LME4 LINEAR MIXED EF; BATIMA P, 2013, CLIMATE CHANGE VULNE, P67; Bauer LJ, 2008, MAR POLLUT BULL, V56, P402, DOI 10.1016/j.marpolbul.2007.11.001; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Blank SG, 2009, ENVIRON CONSERV, V36, P112, DOI 10.1017/S037689290999004X; Bleher B, 2006, BIODIVERS CONSERV, V15, P1159, DOI 10.1007/s10531-004-3509-3; Bruun Ole, 1996, MONGOLIA TRANSITION; Chiappone M, 2004, CARIBB J SCI, V40, P312; Cinner JE, 2005, CONSERV BIOL, V19, P1714, DOI 10.1111/j.1523-1739.2005.00209.x-i1; Cinner J, 2006, ECOL SOC, V11; Crawford BR, 2004, COAST MANAGE, V32, P39, DOI 10.1080/08920750490247481; Dagvadorj D, 2009, MARCC MONGOLIA ASSES; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Goulden CE., 2006, GEOLOGY BIODIVERSITY; Guard M, 1997, MAR POLLUT BULL, V34, P758, DOI 10.1016/S0025-326X(97)00095-7; Gunderson DR, 1997, CAN J FISH AQUAT SCI, V54, P990, DOI 10.1139/cjfas-54-5-990; HILBORN R, 1992; Jachmann H, 2008, BIOL CONSERV, V141, P89, DOI 10.1016/j.biocon.2007.09.012; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jensen OP, 2009, CAN J FISH AQUAT SCI, V66, P1707, DOI 10.1139/F09-109; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jupiter SD, 2010, J MAR BIOL, V2011; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; MANN BQ, 1995, BIOL CONSERV, V74, P107, DOI 10.1016/0006-3207(95)00019-Z; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; MEGD, 2013, LAK HOVSG NAT PARK G; Miller JD, 1984, NEW SURVEY TECHNIQUE; Myagmarsuren D, 2008, SPECIAL PROTECTED AR; NORTHCOTE TG, 1995, REV FISH BIOL FISHER, V5, P141; NSOM, 2012, MONG STAT YB 2012; Nuno A, 2015, BIOL CONSERV, V189, P5, DOI 10.1016/j.biocon.2014.09.047; OCOCK J, 2006, SUMMARY CONSERVATION; Ocock J., 2006, REG RED LIST SER, V3, P1; Pauly D., 1987, ICLARM C P, V13; Petr T, 1999, FISH FISHERIES HIGHE; R Core Team, 2013, R LANG ENV STAT COMP; Renzetti C., 1993, RES SENSITIVE TOPICS; Roberts Bruce C., 1992, North American Journal of Fisheries Management, V12, P450, DOI 10.1577/1548-8675(1992)012<0450:EOAWOS>2.3.CO;2; Sideleva VG, 2006, BIO INL WAT, P357; Solomon J., 2007, HUM DIMENS WILDL, V12, P75, DOI [10.1080/10871200701195365, DOI 10.1080/10871200701195365]; Stocker TF, 2013, CONTRIBUTION WORKING; Then AY, 2015, ICES J MAR SCI, V72, P82, DOI 10.1093/icesjms/fsu136; Thomas AS, 2015, BIOL CONSERV, V189, P24, DOI 10.1016/j.biocon.2014.09.048; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Williamson DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114395; Wolter F, 2013, SOCIOL METHOD RES, V42, P321, DOI 10.1177/0049124113500474; Young T, 2015, J GREAT LAKES RES, V41, P463, DOI 10.1016/j.jglr.2015.02.010; Zhou SJ, 2012, CAN J FISH AQUAT SCI, V69, P1292, DOI 10.1139/F2012-060	57	16	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143960	10.1371/journal.pone.0143960	http://dx.doi.org/10.1371/journal.pone.0143960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625154	Green Published, gold			2022-12-26	WOS:000365891600079
J	Kinjo, T; Tanaka, M; Osanai, T; Shibutani, S; Narita, I; Tanno, T; Nishizaki, K; Ichikawa, H; Kimura, Y; Ishida, Y; Yokota, T; Shimada, M; Homma, Y; Tomita, H; Okumura, K				Kinjo, Takahiko; Tanaka, Makoto; Osanai, Tomohiro; Shibutani, Shuji; Narita, Ikuyo; Tanno, Tomohiro; Nishizaki, Kimitaka; Ichikawa, Hiroaki; Kimura, Yoshihiro; Ishida, Yuji; Yokota, Takashi; Shimada, Michiko; Homma, Yoshimi; Tomita, Hirofumi; Okumura, Ken			Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm	PLOS ONE			English	Article							PHOSPHOLIPASE-C ACTIVITY; VARIANT ANGINA-PECTORIS; ARTERY SPASM; MYOCARDIAL-INFARCTION; PRINZMETAL ANGINA; NERVOUS-SYSTEM; SMOOTH MUSCLE; PROTEIN; PATHOGENESIS; VASOSPASM	Background We previously showed that phospholipase C (PLC)-delta 1 activity was enhanced by 3-fold in patients with coronary spastic angina (CSA). We also reported that p122Rho GTPase-activating protein/deleted in liver cancer-1 (p122RhoGAP/DLC-1) protein, which was discovered as a PLC-delta 1 stimulator, was upregulated in CSA patients. We tested the hypothesis that p122RhoGAP/DLC-1 overexpression causes coronary spasm. Methods and Results We generated transgenic (TG) mice with vascular smooth muscle (VSM)-specific overexpression of p122RhoGAP/DLC-1. The gene and protein expressions of p122RhoGAP/DLC-1 were markedly increased in the aorta of homozygous TG mice. Stronger staining with anti-p122RhoGAP/DLC-1 in the coronary artery was found in TG than in WT mice. PLC activities in the plasma membrane fraction and the whole cell were enhanced by 1.43 and 2.38 times, respectively, in cultured aortic vascular smooth muscle cells from homozygous TG compared with those from WT mice. Immediately after ergometrine injection, ST-segment elevation was observed in 1 of 7 WT (14%), 6 of 7 heterozygous TG (84%), and 7 of 7 homozygous TG mice (100%) (p<0.05, WT versus TGs). In the isolated Langendorff hearts, coronary perfusion pressure was increased after ergometrine in TG, but not in WT mice, despite of the similar response to prostaglandin F-2 alpha between TG and WT mice (n = 5). Focal narrowing of the coronary artery after ergometrine was documented only in TG mice. Conclusions VSM-specific overexpression of p122RhoGAP/DLC-1 enhanced coronary vasomotility after ergometrine injection in mice, which is relevant to human CSA.	[Kinjo, Takahiko; Shibutani, Shuji; Narita, Ikuyo; Tanno, Tomohiro; Nishizaki, Kimitaka; Ichikawa, Hiroaki; Kimura, Yoshihiro; Ishida, Yuji; Yokota, Takashi; Shimada, Michiko; Tomita, Hirofumi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan; [Tanaka, Makoto; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Hypertens & Stroke Med, Hirosaki, Aomori, Japan; [Osanai, Tomohiro] Hirosaki Univ, Grad Sch Hlth Sci, Dept Hlth Promot, Hirosaki, Aomori, Japan; [Homma, Yoshimi] Fukushima Med Univ, Sch Med, Dept Biomol Sci, Fukushima, Japan	Hirosaki University; Hirosaki University; Hirosaki University; Fukushima Medical University	Okumura, K (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan.	okumura@hirosaki-u.ac.jp	Tomita, Hirofumi/E-8627-2013; Tomita, Hirofumi/AAY-5912-2020	Kinjo, Takahiko/0000-0003-4363-0259	Japan Society for the Promotion of Science of Japan [26461120, 25860577]; Takeda Science Foundation; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update	Japan Society for the Promotion of Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update	This study was supported in part by grant-in-aid for scientific research 26461120 from Japan Society for the Promotion of Science of Japan (http://www.jsps.go.jp/english/) to Dr. Okumura, and 25860577 to Dr. Yokota, the Takeda Science Foundation (http://www.takeda-sci.or.jp/) to Dr. Tomita, Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update (http://www.jhf.or.jp/josei/12_update/) to Dr. Shibutani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; CREA F, 1986, CIRCULATION, V74, P262, DOI 10.1161/01.CIR.74.2.262; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; EGASHIRA K, 1992, CIRC RES, V71, P435, DOI 10.1161/01.RES.71.2.435; Emanuele E, 2003, INT J MOL MED, V12, P509; GINSBURG R, 1981, AM HEART J, V102, P819, DOI 10.1016/0002-8703(81)90030-2; HEUPLER FA, 1978, AM J CARDIOL, V41, P631, DOI 10.1016/0002-9149(78)90810-X; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; HOSHIO A, 1989, J AM COLL CARDIOL, V14, P604, DOI 10.1016/0735-1097(89)90100-9; ITO A, 1994, CIRCULATION, V90, P2425, DOI 10.1161/01.CIR.90.5.2425; Ito K, 2003, J PHYSIOL-LONDON, V546, P823, DOI 10.1113/jphysiol.2002.030775; Kakkar R, 2006, CIRC RES, V98, P682, DOI 10.1161/01.RES.0000207498.40005.e7; Kaku Bunji, 2015, J Med Case Rep, V9, P26, DOI 10.1186/1752-1947-9-26; KASKI JC, 1986, CIRCULATION, V74, P1255, DOI 10.1161/01.CIR.74.6.1255; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; Kosugi T, 2003, J HYPERTENS, V21, P583, DOI 10.1097/00004872-200303000-00025; KUGA T, 1993, J AM COLL CARDIOL, V22, P144, DOI 10.1016/0735-1097(93)90828-O; Lanza GA, 2011, CIRCULATION, V124, P1774, DOI 10.1161/CIRCULATIONAHA.111.037283; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Malester B, 2007, FASEB J, V21, P2162, DOI 10.1096/fj.06-7821com; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; MASERI A, 1978, NEW ENGL J MED, V299, P1271, DOI 10.1056/NEJM197812072992303; Matsumoto H, 2000, EUR J BIOCHEM, V267, P46, DOI 10.1046/j.1432-1327.2000.00949.x; MCFADDEN EP, 1991, NEW ENGL J MED, V324, P648, DOI 10.1056/NEJM199103073241002; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Murakami R, 2010, ARTERIOSCL THROM VAS, V30, P1968, DOI 10.1161/ATVBAHA.110.203083; Nakano T, 2002, CIRCULATION, V105, P2024, DOI 10.1161/01.CIR.0000014613.36469.3F; Okumura K, 2000, J AM COLL CARDIOL, V36, P1847, DOI 10.1016/S0735-1097(00)00966-9; Okumura K, 1996, J AM COLL CARDIOL, V27, P45, DOI 10.1016/0735-1097(95)00432-7; OLIVA PB, 1977, CIRCULATION, V56, P366, DOI 10.1161/01.CIR.56.3.366; OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501; Pasupathy S, 2015, CIRCULATION, V131, P861, DOI 10.1161/CIRCULATIONAHA.114.011201; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Sanna T, 2009, RESUSCITATION, V80, P393, DOI 10.1016/j.resuscitation.2008.12.013; Sekimata M, 1999, J BIOL CHEM, V274, P17757, DOI 10.1074/jbc.274.25.17757; Shibutani S, 2011, HIROSAKI MED J, V62, P27; Shibutani S, 2012, CIRCULATION, V125, P1027, DOI 10.1161/CIRCULATIONAHA.111.064303; Tomita H, 2006, INT J MOL MED, V18, P589; Tsutsumi Y, 1999, J CLIN INVEST, V104, P925, DOI 10.1172/JCI7886; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074185; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1356-9597.2004.00698.x; Yamaga M, 2008, ADV ENZYME REGUL, V48, P41, DOI 10.1016/j.advenzreg.2007.11.006; YASUE H, 1974, CIRCULATION, V50, P534, DOI 10.1161/01.CIR.50.3.534; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143884	10.1371/journal.pone.0143884	http://dx.doi.org/10.1371/journal.pone.0143884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624289	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600065
J	Kim, H; Park, HC; Ryu, H; Kim, K; Kim, HS; Oh, KH; Yu, SJ; Chung, JW; Cho, JY; Kim, SH; Cheong, HI; Lee, K; Park, JH; Pei, Y; Hwang, YH; Ahn, C				Kim, Hyunsuk; Park, Hayne Cho; Ryu, Hyunjin; Kim, Kiwon; Kim, Hyo Sang; Oh, Kook-Hwan; Yu, Su Jong; Chung, Jin Wook; Cho, Jeong Yeon; Kim, Seung Hyup; Cheong, Hae Il; Lee, Kyubeck; Park, Jong Hoon; Pei, York; Hwang, Young-Hwan; Ahn, Curie			Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							LIVER INVOLVEMENT; HEPATIC CYSTS; MANAGEMENT; VOLUME; DIAGNOSIS; THERAPY	Mass effect from polycystic kidney and liver enlargement can result in significant clinical complications and symptoms in autosomal dominant polycystic kidney disease (ADPKD). In this single-center study, we examined the correlation of height-adjusted total liver volume (htTLV) and total kidney volume (htTKV) by CT imaging with hepatic complications (n = 461) and abdominal symptoms (n = 253) in patients with ADPKD. "Mass-effect" complications were assessed by review of medical records and abdominal symptoms, by a standardized research questionnaire. Overall, 91.8% of patients had 4 or more liver cysts on CT scans. Polycystic liver disease (PLD) was classified as none or mild (htTLV < 1,600 mL/m); moderate (1,600 <= htTLV < 3,200 mL/m); and severe (htTLV >= 3,200 mL/m). The prevalence of moderate and severe PLD in our patient cohort was 11.7% (n = 54/461) and 4.8%(n = 22/461), respectively, with a female predominance in both the moderate (61.1%) and severe (95.5%) PLD groups. Pressure-related complications such as leg edema (20.4%), ascites (16.6%), and hernia (3.6%) were common, and patients with moderate to severe PLD exhibited a 6-fold increased risk (compared to no or mild PLD) for these complications in multivariate analysis. Similarly, abdominal symptoms including back pain (58.8%), flank pain (53.1%), abdominal fullness (46.5%), and dyspnea/chest-discomfort (44.3%) were very common, and patients with moderate to severe PLD exhibited a 5-fold increased risk for these symptoms. Moderate to severe PLD is a common and clinically important problem in similar to 16% of patients with ADPKD who may benefit from referral to specialized centers for further management.	[Kim, Hyunsuk; Ryu, Hyunjin; Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Park, Hayne Cho] Armed Forces Capital Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Kim, Kiwon] Natl Canc Ctr, Nephrol Clin, Goyang Si, Gyeonggi Do, South Korea; [Kim, Hyo Sang] Univ Ulsan, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; [Yu, Su Jong] Seoul Natl Univ Hosp, Div Hepatol, Seoul 110744, South Korea; [Chung, Jin Wook; Cho, Jeong Yeon; Kim, Seung Hyup] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Cheong, Hae Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Cheong, Hae Il; Hwang, Young-Hwan; Ahn, Curie] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul 110744, South Korea; [Lee, Kyubeck] Kangbuk Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Jong Hoon] Sookmyoung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Pei, York] Univ Hlth Network, Div Nephrol, Dept Internal Med, Toronto, ON, Canada; [Pei, York] Univ Toronto, Toronto, ON M5S 1A1, Canada; [Hwang, Young-Hwan] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; National Cancer Center - Korea (NCC); University of Ulsan; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sookmyung Women's University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Eulji University	Ahn, C (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	Curie@snu.ac.kr		Kim, Hyunsuk/0000-0003-1889-253X; Yu, Su Jong/0000-0001-8888-7977; Hwang, Young-Hwan/0000-0001-8935-2659	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C0014]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C0014). A part of this work was presented at Kidney Week 2014 on November 12 in Philadelphia, PA. Authors greatly appreciate Yongho Song, radiological technician for his dedicated efforts in measurement of TLV.	Arnold HL, 2005, AM J GASTROENTEROL, V100, P2569, DOI 10.1111/j.1572-0241.2005.00263.x; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Bae KT, 2009, CLIN J AM SOC NEPHRO, V4, P719, DOI 10.2215/CJN.03750708; Bae K, 2013, CLIN J AM SOC NEPHRO, V8, P1089, DOI 10.2215/CJN.10561012; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Everson Gregory T, 2005, Curr Gastroenterol Rep, V7, P19, DOI 10.1007/s11894-005-0061-6; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; Hogan MC, 2015, CLIN GASTROENTEROL H, V13, P155, DOI 10.1016/j.cgh.2014.07.051; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Irazabal MV, 2015, J AM SOC NEPHROL, V26, P160, DOI 10.1681/ASN.2013101138; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; Onori P, 2013, LIVER INT, V33, P914, DOI 10.1111/liv.12177; Park HC, 2009, J KOREAN MED SCI, V24, P57, DOI 10.3346/jkms.2009.24.1.57; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Russell RT, 2007, WORLD J GASTROENTERO, V13, P5052, DOI 10.3748/wjg.v13.i38.5052; Sherstha R, 1997, HEPATOLOGY, V26, P1282; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Suwabe T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-179; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Van Keimpema L, 2009, GASTROENTEROLOGY, V137, P1661, DOI 10.1053/j.gastro.2009.07.052; Wijnands TFM, 2014, LIVER INT, V34, P1578, DOI 10.1111/liv.12430; Yu HC, 2004, LIVER TRANSPLANT, V10, P779, DOI 10.1002/lt.20188	27	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144526	10.1371/journal.pone.0144526	http://dx.doi.org/10.1371/journal.pone.0144526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641645	gold, Green Submitted, Green Published			2022-12-26	WOS:000366902700141
J	Marsh, JW; Krauland, MG; Nelson, JS; Schlackman, JL; Brooks, AM; Pasculle, AW; Shutt, KA; Doi, Y; Querry, AM; Muto, CA; Harrison, LH				Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Pasculle, A. William; Shutt, Kathleen A.; Doi, Yohei; Querry, Ashley M.; Muto, Carlene A.; Harrison, Lee H.			Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEQUENCE; SURVEILLANCE; TRANSMISSION; PKPQIL; GENE	Increased incidence of infections due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) was noted among patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) at a single hospital. An epidemiologic investigation identified KPC-Kp and non-KPC-producing, extended-spectrum beta-lactamase (ESBL)-producing Kp in cultures from 2 endoscopes. Genotyping was performed on patient and endoscope isolates to characterize the microbial genomics of the outbreak. Genetic similarity of 51 Kp isolates from 37 patients and 3 endoscopes was assessed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). Five patient and 2 endoscope isolates underwent whole genome sequencing (WGS). Two KPC-encoding plasmids were characterized by single molecule, real-time sequencing. Plasmid diversity was assessed by endonuclease digestion. Genomic and epidemiologic data were used in conjunction to investigate the outbreak source. Two clusters of Kp patient isolates were genetically related to endoscope isolates by PFGE. A subset of patient isolates were collected post-ERCP, suggesting ERCP endoscopes as a possible source. A phylogeny of 7 Kp genomes from patient and endoscope isolates supported ERCP as a potential source of transmission. Differences in gene content defined 5 ST258 subclades and identified 2 of the subclades as outbreak-associated. A novel KPC-encoding plasmid, pKp28 helped define and track one endoscope-associated ST258 subclade. WGS demonstrated high genetic relatedness of patient and ERCP endoscope isolates suggesting ERCP-associated transmission of ST258 KPC-Kp. Gene and plasmid content discriminated the outbreak from endemic ST258 populations and assisted with the molecular epidemiologic investigation of an extended KPC-Kp outbreak.	[Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Shutt, Kathleen A.; Muto, Carlene A.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA; [Marsh, Jane W.; Krauland, Mary G.; Nelson, Jemma S.; Schlackman, Jessica L.; Brooks, Anthony M.; Shutt, Kathleen A.; Muto, Carlene A.; Harrison, Lee H.] Grad Sch Publ Hlth, Pittsburgh, PA USA; [Krauland, Mary G.] Univ Pittsburgh, Grad Sch Publ Hlth, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Pasculle, A. William] Univ Pittsburgh, Med Ctr, Div Microbiol, Pittsburgh, PA USA; [Doi, Yohei] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA; [Querry, Ashley M.; Muto, Carlene A.] Univ Pittsburgh, Med Ctr, Div Hosp Epidemiol & Infect Control, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marsh, JW (corresponding author), Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15261 USA.	jwmarsh@pitt.edu		Krauland, Mary/0000-0002-1548-6221; Doi, Yohei/0000-0002-9620-2525; Nelson, Jemma/0000-0003-2846-2007; Shutt, Kathleen/0000-0003-3376-6152				BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Centers for Disease Control and Prevention, 2015, CDC STAT LOS ANG COU; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2871, DOI 10.1128/AAC.00120-14; Chevreux B, 1999, P GERM C BIOINF HANN; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V63, P427, DOI 10.1093/jac/dkn547; Epstein L, 2014, JAMA-J AM MED ASSOC, V312, P1447, DOI 10.1001/jama.2014.12720; Garcia A, 2005, J ANTIMICROB CHEMOTH, V56, P819, DOI 10.1093/jac/dki345; Gastmeier P, 2014, INFECTION, V42, P15, DOI 10.1007/s15010-013-0544-6; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Kaiser RM, 2013, DIAGN MICR INFEC DIS, V76, P356, DOI 10.1016/j.diagmicrobio.2013.03.032; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kovaleva J, 2013, CLIN MICROBIOL REV, V26, P231, DOI 10.1128/CMR.00085-12; Leavitt A, 2010, ANTIMICROB AGENTS CH, V54, P4493, DOI 10.1128/AAC.00175-10; Lee Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/352862; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marquez C, 2014, New Microbes New Infect, V2, P58, DOI 10.1002/nmi2.40; Mathers AJ, 2015, ANTIMICROB AGENTS CH, V59, P1661, DOI 10.1128/AAC.04292-14; McCool S, 2013, ID WEEK; McCool S, 2014, ID WEEK; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Robledo IE, 2011, ANTIMICROB AGENTS CH, V55, P2968, DOI 10.1128/AAC.01633-10; Rodriguez-Zuluet P, 2013, ANTIMICROB AGENTS CH, V57, P4086, DOI 10.1128/AAC.02530-12; Sambrook J., 2001, MOL CLONING LAB MANU; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; US Food and Drug Administration, 2015, END RETR CHOL ERCP D; Vimont S, 2008, J MED MICROBIOL, V57, P1308, DOI 10.1099/jmm.0.2008/003798-0	34	53	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144310	10.1371/journal.pone.0144310	http://dx.doi.org/10.1371/journal.pone.0144310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637170	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000366143800072
J	Perez-Munoz, ME; Joglekar, P; Shen, YJ; Chang, KY; Peterson, DA				Perez-Munoz, Maria Elisa; Joglekar, Payal; Shen, Yi-Ji; Chang, Kuan Y.; Peterson, Daniel A.			Identification and Phylogeny of the First T Cell Epitope Identified from a Human Gut Bacteroides Species	PLOS ONE			English	Article							MICROBIAL ECOLOGY; INTESTINAL FLORA; BACTERIA; DISEASE; REACTIVITY; ANTIGENS; COLITIS; OBESITY	Host T cell reactivity toward gut bacterial epitopes has been recognized as part of disease pathogenesis. However, the specificity of T cells that recognize this vast number of epitopes has not yet been well described. After colonizing a C57BL/6J germ-free mouse with the human gut symbiotic bacteria Bacteroides thetaiotaomicron, we isolated a T cell that recognized these bacteria in vitro. Using this T cell, we mapped the first known non-carbohydrate T cell epitope within the phylum Bacteroidetes. The T cell also reacted to two other additional Bacteroides species. We identified the peptide that stimulated the T cell by using a genetic approach. Genomic data from the epitope-positive and epitope-negative bacteria explain the cross-reactivity of the T cell to multiple species. This epitope degeneracy should shape our understanding of the T cell repertoire stimulated by the complex microbiome residing in the gastrointestinal tract in both healthy and disease states.	[Perez-Munoz, Maria Elisa; Joglekar, Payal; Peterson, Daniel A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Joglekar, Payal] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Perez-Munoz, Maria Elisa] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA; [Shen, Yi-Ji; Chang, Kuan Y.] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Keelung, Taiwan	Johns Hopkins University; Stanford University; University of Nebraska System; University of Nebraska Lincoln; National Taiwan Ocean University	Peterson, DA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	daniel.peterson@jhmi.edu	Chang, Kuan Y./AAB-3639-2020	Chang, Kuan Y./0000-0002-2262-5218	National Institutes of Health [AI097419, AI07660901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (http://www.nih.gov) grants AI097419 and AI07660901 given to DAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Ergin A, 2008, MUCOSAL IMMUNOL, V1, pS19, DOI 10.1038/mi.2008.44; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Perez-Munoz ME, 2014, GUT MICROBES, V5, P286, DOI 10.4161/gmic.28622; Peterson DA, 1999, IMMUNITY, V11, P453, DOI 10.1016/S1074-7613(00)80120-X; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; PIRZER U, 1991, LANCET, V338, P1238, DOI 10.1016/0140-6736(91)92104-A; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Sanchez E, 2011, APPL ENVIRON MICROB, V77, P5316, DOI 10.1128/AEM.00365-11; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; TerAvest MA, 2014, BIOTECHNOL BIOENG, V111, P165, DOI 10.1002/bit.24994; Vael C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-68; Vael Carl, 2008, BMC Pulm Med, V8, P19, DOI 10.1186/1471-2466-8-19; Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9	22	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144382	10.1371/journal.pone.0144382	http://dx.doi.org/10.1371/journal.pone.0144382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637014	gold, Green Published			2022-12-26	WOS:000366143800084
J	Hilario, E; Barron, L; Deng, CH; Datson, PM; De Silva, N; Davy, MW; Storey, RD				Hilario, Elena; Barron, Lorna; Deng, Cecilia H.; Datson, Paul M.; De Silva, Nihal; Davy, Marcus W.; Storey, Roy D.			Random Tagging Genotyping by Sequencing (rtGBS), an Unbiased Approach to Locate Restriction Enzyme Sites across the Target Genome	PLOS ONE			English	Article							DNA; AMPLIFICATION; PCR	Genotyping by sequencing (GBS) is a restriction enzyme based targeted approach developed to reduce the genome complexity and discover genetic markers when a priori sequence information is unavailable. Sufficient coverage at each locus is essential to distinguish heterozygous from homozygous sites accurately. The number of GBS samples able to be pooled in one sequencing lane is limited by the number of restriction sites present in the genome and the read depth required at each site per sample for accurate calling of single-nucleotide polymorphisms. Loci bias was observed using a slight modification of the Elshire et al. method: some restriction enzyme sites were represented in higher proportions while others were poorly represented or absent. This bias could be due to the quality of genomic DNA, the endonuclease and ligase reaction efficiency, the distance between restriction sites, the preferential amplification of small library restriction fragments, or bias towards cluster formation of small amplicons during the sequencing process. To overcome these issues, we have developed a GBS method based on randomly tagging genomic DNA (rtGBS). By randomly landing on the genome, we can, with less bias, find restriction sites that are far apart, and undetected by the standard GBS (stdGBS) method. The study comprises two types of biological replicates: six different kiwifruit plants and two independent DNA extractions per plant; and three types of technical replicates: four samples of each DNA extraction, stdGBS vs. rtGBS methods, and two independent library amplifications, each sequenced in separate lanes. A statistically significant unbiased distribution of restriction fragment size by rtGBS showed that this method targeted 49%(39,145) of BamH I sites shared with the reference genome, compared to only 14%(11,513) by stdGBS.	[Hilario, Elena; Barron, Lorna; Deng, Cecilia H.; Datson, Paul M.; De Silva, Nihal] New Zealand Inst Plant & Food Res Ltd, Auckland 1025, New Zealand; [Davy, Marcus W.; Storey, Roy D.] New Zealand Inst Plant & Food Res Ltd, Te Puke 3182, New Zealand	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd	Hilario, E (corresponding author), New Zealand Inst Plant & Food Res Ltd, Priv Bag 92-169, Auckland 1025, New Zealand.	elena.hilario@plantandfood.co.nz	Hilario, Elena/ABB-8574-2021; Deng, Cecilia Hong/O-2891-2017	Hilario, Elena/0000-0001-8124-8881; Deng, Cecilia Hong/0000-0002-2954-762X; , Pepe/0000-0002-8794-9985	Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant Food Research [P/111444/21]	Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant Food Research	Funding was provided by Centres of Research Excellence/Kiwifruit Royalty Investment project - Kiwifruit Germplasm at Plant & Food Research. Grant number P/111444/21.; We gratefully thank the following scientists at Plant & Food Research: Matthew Templeton for sharing an extra Illumina sequencing lane for an earlier pilot study, Benjamin Warren for bioinformatics support, and Peter Alspach, David Chagne, Zac Hanley, and Richard Newcomb for critically reviewing the manuscript. Anonymous reviewers provided valuable suggestions to improve this manuscript. Funding was provided by Centres of Research Excellence/Kiwifruit Royalty Investment project-Kiwifruit Germplasm at Plant & Food Research. We dedicate this publication to the memory of our dear colleague and friend Dr H. Nihal De Silva.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Arneson N., 2008, CSH PROTOC, V2008; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Eaton D.A.R., 2014, BIOINFORMATICS; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green MR, 2012, MOL CLONING LAB MANU, V1; GROTHUES D, 1993, NUCLEIC ACIDS RES, V21, P1321, DOI 10.1093/nar/21.5.1321; Heffelfinger C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-979; Hilario E, 2015, PLANT GENOTYPING MET; HOPPING ME, 1994, NEW ZEAL J BOT, V32, P85, DOI 10.1080/0028825X.1994.10410410; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Kasem S, 2008, PLANT GENOTYPING II: SNP TECHNOLOGY, P219, DOI 10.1079/9781845933821.0219; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; TAYLOR JM, 1976, BIOCHIM BIOPHYS ACTA, V442, P324, DOI 10.1016/0005-2787(76)90307-5; van Gurp T, 2011, DEENA BIOINFORMATICS; Venables WN., 2002, MODERN APPL STAT S 4; Wong KK, 1996, NUCLEIC ACIDS RES, V24, P3778, DOI 10.1093/nar/24.19.3778; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	26	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143193	10.1371/journal.pone.0143193	http://dx.doi.org/10.1371/journal.pone.0143193			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633193	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000009
J	Lima, VD; Rozada, I; Grebely, J; Hull, M; Lourenco, L; Nosyk, B; Krajden, M; Yoshida, E; Wood, E; Montaner, JSG				Lima, Viviane D.; Rozada, Ignacio; Grebely, Jason; Hull, Mark; Lourenco, Lillian; Nosyk, Bohdan; Krajden, Mel; Yoshida, Eric; Wood, Evan; Montaner, Julio S. G.			Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; OPIATE SUBSTITUTION THERAPY; INFECTION; COHORT; USERS; HIV; COINFECTION; METAANALYSIS; MANAGEMENT; CIRRHOSIS	Background Widely access to interferon-free direct-acting antiviral regimens (IFN-free DAA) is poised to dramatically change the impact of the HCV epidemic among people who inject drugs (PWID). We evaluated the long-term effect of increasing HCV testing, treatment and engagement into harm-reduction activities, focused on active PWID, on the HCV epidemic in British Columbia (BC), Canada. Methods We built a compartmental model of HCV disease transmission stratified by disease progression, transmission risk, and fibrosis level. We explored the effect of: (1) Increasing treatment rates from 8 to 20, 40 and 80 per 1000 infected PWID/year; (2) Increasing treatment eligibility based on fibrosis level; (3) Maximizing the effect of testing by performing it immediately upon ending the acute phase; (4) Increasing access to harm-reduction activities to reduce the risk of re-infection; (5) Different HCV antiviral regimens on the Control Reproduction Number R-c. We assessed the impact of these interventions on incidence, prevalence and mortality from 2016 to 2030. Results Of all HCV antiviral regimens, only IFN-free DAAs offered a high chance of disease elimination (i.e. R-c < 1), but it would be necessary to substantially increase the current low testing and treatment rates. Assuming a treatment rate of 80 per 1000 infected PWID per year, coupled with a high testing rate, the incidence rate, at the end of 2030, could decrease from 92.9 per 1000 susceptible PWID per year (Status Quo) to 82.8 (by treating only PWID with fibrosis level F-2 and higher) or to 65.5 (by treating PWID regardless of fibrosis level). If PWID also had access to increased harm-reduction activities, the incidence rate further decreased to 53.1 per 1000 susceptible PWID per year. We also obtained significant decreases in prevalence and mortality at the end of 2030. Conclusions The combination of increased access to HCV testing, highly efficacious antiviral treatment and harm-reduction programs can substantially decrease the burden of the HCV epidemic among PWID. However, unless we increase the current levels of treatment and testing, the HCV epidemic among PWID in BC, and in other parts of the world with similar epidemiological background, will remain a substantial public health concern for many years.	[Lima, Viviane D.; Rozada, Ignacio; Hull, Mark; Lourenco, Lillian; Nosyk, Bohdan; Wood, Evan; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Grebely, Jason] Univ New South Wales Australia, Kirby Inst, Sydney, NSW, Australia; [Krajden, Mel] British Columbia Ctr Dis Control, Publ Hlth Microbiol & Reference Lab, Vancouver, BC, Canada; [Yoshida, Eric] Univ British Columbia, Fac Med, Dept Med, Div Gastroenterol, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of New South Wales Sydney; Kirby Institute; University of British Columbia	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca			British Columbia Ministry of Health; US National Institutes of Health [R01DA036307]; US National Institute on Drug Abuse [R03DA033851]; Canadian Institutes of Health Research [MOP-125948]; Michael Institute for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851, R01DA036307] Funding Source: NIH RePORTER	British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Institute for Health Research; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Montaner is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307). Dr. Lima was funded by a grant from the US National Institute on Drug Abuse (R03DA033851) during the time this manuscript was first submitted, and she is currently funded by a grant from the Canadian Institutes of Health Research (MOP-125948) and by a Scholar Award from the Michael Institute for Health Research and a New Investigator award from the Canadian Institutes of Health Research.	Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; ANDERSON R M, 1991; Backx M, 2014, J VIRAL HEPATITIS, V21, P208, DOI 10.1111/jvh.12132; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Canada H., SUMMARY BASIS DECISI; Dalgard O, 2005, CLIN INFECT DIS, V40, pS336, DOI 10.1086/427449; De Vos AS, 2013, J THEOR BIOL, V333, P126, DOI 10.1016/j.jtbi.2013.05.017; Deans Gregory D, 2013, CMAJ Open, V1, pE68, DOI 10.9778/cmajo.20130002; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; Deuffic-Burban S, 2012, CLIN INFECT DIS, V54, P1272, DOI 10.1093/cid/cis047; Eckman MH, 2013, CLIN INFECT DIS, V56, P1382, DOI 10.1093/cid/cit069; European Association for The Study of The Liver, EASL REC TREATM HEP; Feld JJ, 2014, SEMIN LIVER DIS, V34, P37, DOI 10.1055/s-0034-1371009; Grebely J, 2011, J VIRAL HEPATITIS, V18, pe104, DOI 10.1111/j.1365-2893.2010.01370.x; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Grebely J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097726; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hajarizadeh B, 2014, J MED VIROL, V86, P1722, DOI 10.1002/jmv.24010; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Hull M, 2013, CAN J INFECT DIS MED, V24, P217, DOI 10.1155/2013/781410; Jennings CL, 2012, CURR HIV-AIDS REP, V9, P231, DOI 10.1007/s11904-012-0122-z; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Lai M, 2011, AM J GASTROENTEROL, V106, P2121, DOI 10.1038/ajg.2011.343; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; Merkinaite Simona, 2008, Central European Journal of Public Health, V16, P106; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Rolls DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078286; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Swan D, 2010, AIDS PATIENT CARE ST, V24, P753, DOI 10.1089/apc.2010.0142; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Wagner BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041212; Wendt A, 2014, CLIN PHARMACOL-ADV A, V6, P1, DOI 10.2147/CPAA.S30338	48	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143836	10.1371/journal.pone.0143836	http://dx.doi.org/10.1371/journal.pone.0143836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX9QI	26633652	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000025
J	Schaarschmidt, ML; Kromer, C; Herr, R; Schmieder, A; Sonntag, D; Goerdt, S; Peitsch, WK				Schaarschmidt, Marthe-Lisa; Kromer, Christian; Herr, Raphael; Schmieder, Astrid; Sonntag, Diana; Goerdt, Sergij; Peitsch, Wiebke K.			Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RANDOMIZED CONTROLLED-TRIALS; ANTI-TNF-THERAPY; QUALITY-OF-LIFE; IL 12/23 AGENTS; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; INSULIN SENSITIVITY; PLAQUE PSORIASIS; 2 METAANALYSES	Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time until response, sustainability of success, probability of mild and severe adverse events (AE), probability of ACR 20 response) and process attributes (treatment location, frequency, duration and delivery method) of biologicals. The influence of comorbidities on Relative Importance Scores (RIS) was determined with analysis of variance and multivariate regression. Among the 200 participants completing the study, 22.5% suffered from psoriatic arthritis, 31.5% from arterial hypertension, 15% from cardiovascular disease (myocardial infarction, stroke, coronary artery disease, and/or arterial occlusive disease), 14.5% from diabetes, 11% from hyperlipidemia, 26% from chronic bronchitis or asthma and 12.5% from depression. Participants with psoriatic arthritis attached greater importance to ACR 20 response (RIS = 10.3 vs. 5.0, p<0.001; beta = 0.278, p<0.001) and sustainability (RIS = 5.8 vs. 5.0, p = 0.032) but less value to time until response (RIS = 3.4 vs. 4.8, p = 0.045) than those without arthritis. Participants with arterial hypertension were particularly interested in a low risk of mild AE (RIS 9.7 vs. 12.1; p = 0.033) and a short treatment duration (RIS = 8.0 vs. 9.6, p = 0.002). Those with cardiovascular disease worried more about mild AE (RIS = 12.8 vs. 10, p = 0.027; beta = 0.170, p = 0.027) and severe AE (RIS = 23.2 vs. 16.2, p = 0.001; beta = 0.203, p = 0.007) but cared less about time until response (beta = -0.189, p = 0.013), treatment location (beta = -0.153, p = 0.049), frequency (beta = -0.20, p = 0.008) and delivery method (beta = -0.175, p = 0.023) than others. Patients' concerns should be addressed in-depth when prescribing biologicals to comorbid patients, keeping in mind that TNF antagonists may favourably influence cardiovascular risk.	[Schaarschmidt, Marthe-Lisa; Kromer, Christian; Schmieder, Astrid; Goerdt, Sergij; Peitsch, Wiebke K.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Herr, Raphael; Sonntag, Diana] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Med Fac Mannheim, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Peitsch, WK (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany.	wiebke.ludwig@umm.de	Herr, Raphael/GYU-5115-2022	Herr, Raphael/0000-0003-0079-2792	German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg	The study was funded by the young scientists' program of the German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg (grant to Marthe-Lisa Schaarschmidt).	Ahlehoff O, 2015, J EUR ACAD DERMATOL, V29, P1128, DOI 10.1111/jdv.12768; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Angel K, 2010, HYPERTENSION, V55, P333, DOI 10.1161/HYPERTENSIONAHA.109.143982; Armstrong AW, 2014, BRIT J DERMATOL, V170, P304, DOI 10.1111/bjd.12670; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Augustin M, 2011, DERMATOLOGY, V222, P363, DOI 10.1159/000329026; Benson MM, 2015, CARDIOL REV, V23, P312, DOI 10.1097/CRD.0000000000000048; Boehncke WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5666; Candia R, 2015, J EUR ACAD DERMATOL, V29, P656, DOI 10.1111/jdv.12847; Christophers E, 2013, J DERMATOL TREAT, V24, P193, DOI 10.3109/09546634.2012.697112; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Dommasch ED, 2014, J AM ACAD DERMATOL, V70, P381, DOI 10.1016/j.jaad.2013.10.053; Dommasch ED, 2013, J AM ACAD DERMATOL, V68, P863, DOI 10.1016/j.jaad.2013.01.011; Dowlatshahi EA, 2014, J INVEST DERMATOL, V134, P1542, DOI 10.1038/jid.2013.508; Duffin KC, 2014, BRIT J DERMATOL, V170, P672, DOI 10.1111/bjd.12745; Gerdes S, 2008, BRIT J DERMATOL, V159, P1116, DOI 10.1111/j.1365-2133.2008.08786.x; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Hugh J, 2014, J AM ACAD DERMATOL, V70, P168, DOI 10.1016/j.jaad.2013.09.020; Jokai H, 2013, J AM ACAD DERMATOL, V69, P523, DOI 10.1016/j.jaad.2013.06.019; Kannan S, 2013, J DERMATOL TREAT, V24, P148, DOI 10.3109/09546634.2011.619159; Kimball AB, 2011, J EUR ACAD DERMATOL, V25, P157, DOI 10.1111/j.1468-3083.2010.03730.x; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kromer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129120; Langley RG, 2010, J AM ACAD DERMATOL, V63, P457, DOI 10.1016/j.jaad.2009.09.014; Marra M, 2007, INT J IMMUNOPATH PH, V20, P731, DOI 10.1177/039463200702000408; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Mehta NN, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.03.028; Menter A, 2010, J AM ACAD DERMATOL, V62, P812, DOI 10.1016/j.jaad.2009.07.022; Mrowietz U, 2014, EXP DERMATOL, V23, P705, DOI 10.1111/exd.12437; Nast A, 2013, J INVEST DERMATOL, V133, P1963, DOI 10.1038/jid.2013.78; Nast A, 2012, J DTSCH DERMATOL GES, V10, DOI 10.1111/j.1610-0387.2012.07919.x; Papp KA, 2013, BRIT J DERMATOL, V168, P844, DOI 10.1111/bjd.12214; Picardi A, 2013, CLIN DERMATOL, V31, P47, DOI 10.1016/j.clindermatol.2011.11.006; Pina T, 2016, J EUR ACAD DERMATOL, V30, P92, DOI 10.1111/jdv.13005; Pina T, 2015, J EUR ACAD DERMATOL, V29, P1325, DOI 10.1111/jdv.12814; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Reich K, 2011, BRIT J DERMATOL, V164, P862, DOI 10.1111/j.1365-2133.2011.10257.x; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Schaarschmidt ML, 2013, J EUR ACAD DERMATOL, V27, P187, DOI 10.1111/j.1468-3083.2011.04440.x; Schaarschmidt ML, 2011, ARCH DERMATOL, V147, P1285, DOI 10.1001/archdermatol.2011.309; Schmieder A, 2012, J AM ACAD DERMATOL, V67, P363, DOI 10.1016/j.jaad.2011.08.023; Shlyankevich J, 2014, AM J MED, V127, P1148, DOI 10.1016/j.amjmed.2014.08.008; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Strober B, 2008, BRIT J DERMATOL, V159, P322, DOI 10.1111/j.1365-2133.2008.08628.x; Tam LS, 2014, RHEUMATOLOGY, V53, P1108, DOI 10.1093/rheumatology/ket454; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tezel N, 2015, INT J RHEUM DIS, V18, P63, DOI 10.1111/1756-185X.12283; Tzellos T, 2013, J EUR ACAD DERMATOL, V27, P622, DOI 10.1111/j.1468-3083.2012.04500.x; Tzellos T, 2014, J AM ACAD DERMATOL, V70, P380, DOI 10.1016/j.jaad.2013.07.050; Umar N, 2012, ACTA DERM-VENEREOL, V92, P341, DOI 10.2340/00015555-1304; van Cranenburgh OD, 2013, BRIT J DERMATOL, V169, P398, DOI 10.1111/bjd.12372; Westlake SL, 2011, RHEUMATOLOGY, V50, P518, DOI 10.1093/rheumatology/keq316; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144335	10.1371/journal.pone.0144335	http://dx.doi.org/10.1371/journal.pone.0144335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633680	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000081
J	Wakatsuki, Y; Shinojima, A; Kawamura, A; Yuzawa, M				Wakatsuki, Yu; Shinojima, Ari; Kawamura, Akiyuki; Yuzawa, Mitsuko			Correlation of Aging and Segmental Choroidal Thickness Measurement using Swept Source Optical Coherence Tomography in Healthy Eyes	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BRUCHS MEMBRANE; JAPANESE SUBJECTS; CHORIOCAPILLARIS; VOLUME	Purpose To assess and compare choroidal thickness changes related to aging, we determined whether changes are due to thinning of the choriocapillaris plus Sattler's (CS) layer and/or the large vessel layer in healthy eyes using swept-source optical coherence tomography (SS-OCT) at a wavelength of 1,050-nm. Methods We studied 115 normal eyes of 115 healthy volunteers, all with refractive errors of less than -6 diopters. All 115 eyes underwent analysis of choroidal thickness at the fovea, the CS layer and the large choroidal vessel layer. In 68 of the 115 eyes, choroidal thickness was determined at five sites (the fovea, and superior, inferior, nasal, and temporal sites) using SS-OCT with an Early Treatment of Diabetic Retinopathy grid scan. Results Total choroidal thicknesses at each of the five sites were related to subject age (P<0.0001). The choroid was thinnest at the nasal site, followed by the temporal, inferior, superior and finally the subfoveal site itself. The total choroidal thickness at the nasal site was significantly less than those at the other four sites (p<0.05). The CS layer showed thinning which correlated with age (P<0.0001). The thickness of the choroidal large vessel layer also decreased with age (p = 0.02). Subfoveal choroidal thickness was calculated as follows: 443.89-2.98xage (mu m) (P<0.0001). Conclusion Subfoveal choroidal thickness decreases by 2.98 mu m each year. Total choroidal thickness diminishes with age. The CS and large vessel layers of the choroid at the subfovea showed significant decreases, though only the former correlated strongly with age.	[Wakatsuki, Yu; Shinojima, Ari; Kawamura, Akiyuki; Yuzawa, Mitsuko] Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Nihon University	Shinojima, A (corresponding author), Nihon Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shinojima.ari@nihon-u.ac.jp	Shinojima, Ari/AAR-4442-2021	Shinojima, Ari/0000-0003-2322-0332				Agawa T, 2011, GRAEF ARCH CLIN EXP, V249, P1485, DOI 10.1007/s00417-011-1708-7; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan-Ling T, 2011, EXP EYE RES, V92, P361, DOI 10.1016/j.exer.2011.02.009; Chan-Ling T, 2011, INVEST OPHTH VIS SCI, V52, P399, DOI 10.1167/iovs.10-5403; Chen FK, 2012, INVEST OPHTH VIS SCI, V53, P975, DOI 10.1167/iovs.11-8771; Esmaeelpour M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099690; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Koina ME, 2015, INVEST OPHTH VIS SCI, V56, P1310, DOI 10.1167/iovs.14-15705; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; MOORE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1290; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P3430, DOI 10.1167/iovs.10-6600; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; PAULEIKHOFF D, 1990, OPHTHALMOLOGY, V97, P171; Rahman W, 2011, INVEST OPHTH VIS SCI, V52, P2267, DOI 10.1167/iovs.10-6024; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836	28	79	82	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144156	10.1371/journal.pone.0144156	http://dx.doi.org/10.1371/journal.pone.0144156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632821	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000063
J	Bornschein, MR; Firkowski, CR; Baldo, D; Ribeiro, LF; Belmonte-Lopes, R; Correa, L; Morato, SAA; Pie, MR				Bornschein, Marcos R.; Firkowski, Carina R.; Baldo, Diego; Ribeiro, Luiz F.; Belmonte-Lopes, Ricardo; Correa, Leandro; Morato, Sergio A. A.; Pie, Marcio R.			Three New Species of Phytotelm-Breeding Melanophryniscus from the Atlantic Rainforest of Southern Brazil (Anura: Bufonidae)	PLOS ONE			English	Article							AMPHIBIA; GALLARDO; BRACHYCEPHALIDAE; GERAIS; STATE; FROGS	Three new species of Melanophryniscus are described from the Serra do Mar mountain range of the state of Santa Catarina, southern Brazil. All species are found at intermediate to high altitudes and share phytotelm-breeding as their reproductive strategy. The new species are distinguished from other phytotelm-breeding Melanophryniscus based on different combinations of the following traits: snout-vent length, presence of white and/or yellow spots on forearms, mouth, belly and cloaca, pattern and arrangement of warts, and presence and number of corneous spines. The discovery of these species in a rather restricted geographical area suggests that the diversity of phytotelm-breeding species of Melanophryniscus might be severely underestimated. The conservation status of these species is of particular concern, given that one of them is at risk of extinction not only due to its restricted habitat, but also because of anthropogenic disturbances.	[Bornschein, Marcos R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Ecol Conservacao & Manejo Vida S, Belo Horizonte, MG, Brazil; [Bornschein, Marcos R.; Firkowski, Carina R.; Ribeiro, Luiz F.; Belmonte-Lopes, Ricardo; Pie, Marcio R.] Univ Fed Parana, Dept Zool, BR-80060000 Curitiba, Parana, Brazil; [Bornschein, Marcos R.; Ribeiro, Luiz F.; Correa, Leandro; Pie, Marcio R.] Mater Nat Inst Estudos Ambientais, Curitiba, Parana, Brazil; [Baldo, Diego] Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, Inst Biol Subtrop, Lab Genet Evolut, Misiones, Argentina; [Ribeiro, Luiz F.] Pontificia Univ Catolica Parana, Escola Saude, Curitiba, Parana, Brazil; [Belmonte-Lopes, Ricardo] Univ Fed Parana, Dept Zool, Programa Posgrad Zool, BR-80060000 Curitiba, Parana, Brazil; [Morato, Sergio A. A.] STCP Engn Projetos Ltda, Curitiba, Parana, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Parana; Pontificia Universidade Catolica do Parana; Universidade Federal do Parana	Bornschein, MR (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Programa Posgrad Ecol Conservacao & Manejo Vida S, Belo Horizonte, MG, Brazil.	bornschein.marcao@gmail.com	Belmonte-Lopes, Ricardo/H-5851-2012; Bornschein, Marcos R./A-1303-2013	Belmonte-Lopes, Ricardo/0000-0002-3122-0271; Bornschein, Marcos R./0000-0002-6486-7055	CAPES [2599/2010]; CNPq/MCT [141823/2011-9, 571334/2008-3]; Fundacao Grupo O Boticario de Protecao a Natureza [0895_20111]; STCP Engenharia de Projetos Ltda;  [PIP 112201101-00875];  [PICT 2007-2202];  [2011-1524];  [2011-1895];  [2012-2687];  [404-2013]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/MCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Grupo O Boticario de Protecao a Natureza; STCP Engenharia de Projetos Ltda; ; ; ; ; ; 	MRB received a PRODOC grant from CAPES (project 2599/2010) and currently receives a PNPD grant from CAPES. RBL is supported by fellowships from CNPq/MCT (141823/2011-9). MRP is supported by a grant from CNPq/MCT (571334/2008-3). DB receives financial support for Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and ANPCyT (PIP 112201101-00875, PICT 2007-2202, 2011-1524, 2011-1895, 2012-2687, and 404-2013). Fieldwork during 2011 and 2012 was partially funded by Fundacao Grupo O Boticario de Protecao a Natureza (through the project 0895_20111 conducted by Mater Natura - Instituto de Estudos Ambientais). The additional funds were obtained in the form of the other fellowships indicated to some of the authors. STCP Engenharia de Projetos Ltda provided support in the form of salaries for one of the authors (SAAM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Baldo D, 2004, J HERPETOL, V38, P393, DOI 10.1670/144-03A; Baldo D, 2014, BIOL J LINN SOC, V112, P417, DOI 10.1111/bij.12296; Baldo D, 2012, J HERPETOL, V46, P25, DOI 10.1670/10-293; BOKERMANN WC, 1967, AN ACAD BRAS CIENC, V39, P301; Cairo Samanta L., 2008, South American Journal of Herpetology, V3, P10, DOI 10.2994/1808-9798(2008)3[10:RBOMSF]2.0.CO;2; Campbell JJ, 1985, J AM BAMBOO SOC, V6, P17; Caramaschi U, 2002, ARQ MUS NAC, V60, P303; Caramaschi Ulisses, 2011, Boletim do Museu Nacional Rio de Janeiro Zoologia, P1; Cespedez JA, 1999, FACENA, V15, P57; Cespedez JA, 2007, FACENA, V23, P31; Cespedez Jorge A., 2001, Boletin de la Asociacion Herpetologica Espanola, V12, P71; Cespedez Jorge A., 2008, FACENA, V24, P35; Cruz Carlos Goncalves, 2003, Boletim do Museu Nacional Rio de Janeiro Zoologia, V500, P1; Daly JW, 2007, J CHEM ECOL, V33, P871, DOI 10.1007/s10886-007-9261-x; Di-Bernardo M, 2006, J HERPETOL, V40, P261, DOI 10.1670/05-008.1; Fabrezi M, 1996, HERPETOLOGICA, V52, P188; Fernandez K, 1927, BOLET N ACAD NACL CI, V29, P271; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Frost DR, AMPHIBIAN SPECIES WO; Gutierrez M, 1997, CUAD HERPETOL, V11, P21; Hantak MM, 2013, J CHEM ECOL, V39, P1400, DOI 10.1007/s10886-013-0361-5; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Kuppers H., 1979, ATLAS DE LOS COLORES; Kwet A, 2005, SALAMANDRA, V41, P3; Langone Jose A., 2008, South American Journal of Herpetology, V3, P1, DOI 10.2994/1808-9798(2008)3[1:ANRMIT]2.0.CO;2; Maneyro R, 2008, IHERINGIA SER ZOOL, V98, P189, DOI 10.1590/S0073-47212008000200003; Mebs D, 2007, TOXICON, V50, P166, DOI 10.1016/j.toxicon.2007.02.017; Naya DE, 2004, REV CHIL HIST NAT, V77, P593; Peloso PLV, 2012, AM MUS NOVIT, P1; Pie MR, 2015, PEERJ, V3, DOI 10.7717/peerj.1179; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Prigioni C.M., 1989, Boletin de la Sociedad Zoologica del Uruguay Segunda Epoca, V5, P13; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Ribeiro LF, 2015, PEERJ, V3, DOI 10.7717/peerj.1011; STARRETT PRISCILLA, 1967, HERPETOLOGICA, V23, P195; Steinbach-Padilha Giovanna C., 2008, Phyllomedusa, V7, P99; Vaz-Silva Wilian, 2008, South American Journal of Herpetology, V3, P36, DOI 10.2994/1808-9798(2008)3[36:ROMPMA]2.0.CO;2; Veloso H.P., 1991, CLASSIFICACAO VEGETA	39	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142791	10.1371/journal.pone.0142791	http://dx.doi.org/10.1371/journal.pone.0142791			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630281	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300017
J	Choi, S; Kim, D; Kam, TI; Yun, S; Kim, S; Park, H; Hwang, H; Pletnikova, O; Troncoso, JC; Dawson, VL; Dawson, TM; Ko, HS				Choi, Seulah; Kim, Donghoon; Kam, Tae-In; Yun, Seungpil; Kim, Sangjune; Park, Hyejin; Hwang, Heehong; Pletnikova, Olga; Troncoso, Juan C.; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok			Lysosomal Enzyme Glucocerebrosidase Protects against A beta(1-42) Oligomer-Induced Neurotoxicity	PLOS ONE			English	Article							TO-NEURON TRANSMISSION; GAUCHER-DISEASE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; CELL-DEATH; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; AMYLOID-BETA; MOUSE MODEL; A-BETA	Glucocerebrosidase (GCase) functions as a lysosomal enzyme and its mutations are known to be related to many neurodegenerative diseases, including Gaucher's disease (GD), Parkinson's disease (PD), and Dementia with Lewy Bodies (DLB). However, there is little information about the role of GCase in the pathogenesis of Alzheimer's disease (AD). Here we demonstrate that GCase protein levels and enzyme activity are significantly decreased in sporadic AD. Moreover, A beta(1-42) oligomer treatment results in neuronal cell death that is concomitant with decreased GCase protein levels and enzyme activity, as well as impairment in lysosomal biogenesis and acidification. Importantly, overexpression of GCase promotes the lysosomal degradation of A beta(1-42) oligomers, restores the lysosomal impairment, and protects against the toxicity in neurons treated with A beta(1-42) oligomers. Our findings indicate that a deficiency of GCase could be involved in progression of AD pathology and suggest that augmentation of GCase activity may be a potential therapeutic option for the treatment of AD.	[Choi, Seulah; Kim, Donghoon; Kam, Tae-In; Yun, Seungpil; Kim, Sangjune; Park, Hyejin; Hwang, Heehong; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA; [Choi, Seulah; Kim, Donghoon; Kam, Tae-In; Yun, Seungpil; Kim, Sangjune; Park, Hyejin; Hwang, Heehong; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Choi, Seulah; Kim, Donghoon; Kam, Tae-In; Yun, Seungpil; Kim, Sangjune; Park, Hyejin; Troncoso, Juan C.; Dawson, Valina L.; Dawson, Ted M.; Ko, Han Seok] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Pletnikova, Olga; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Yun, Seungpil; Dawson, Valina L.; Dawson, Ted M.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [Choi, Seulah; Kim, Donghoon; Ko, Han Seok] Diana Helis Henry Med Res Fdn, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ko, HS (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA.	hko3@jhmi.edu	Kim, Sangjune/AAA-9561-2022; Dawson, Valina/Y-9757-2019	Kim, Sangjune/0000-0003-3052-3163; Kam, Tae-In/0000-0002-7241-4902	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS) [NS38377]; Morris K. Udall Parkinson's Disease Foundation [NS082205]; Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS082205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris K. Udall Parkinson's Disease Foundation; Adrienne Helis Malvin Medical Research Foundation; Diana Helis Henry Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NINDS) NS38377 (H.S.K.); the Morris K. Udall Parkinson's Disease Foundation and NS082205 (H.S.K.); the Adrienne Helis Malvin Medical Research Foundation; and the Diana Helis Henry Medical Research Foundation (H.S.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bae EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5755; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; de Vrij FMS, 2004, PROG NEUROBIOL, V74, P249, DOI 10.1016/j.pneurobio.2004.10.001; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; GRABOWSKI GA, 1993, NEW ENGL J MED, V328, P1565; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee SJ, 2011, NEUROSCI RES, V70, P339, DOI 10.1016/j.neures.2011.05.008; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2011, P NATL ACAD SCI USA, V108, P21200, DOI 10.1073/pnas.1119181109; Lu J, 2010, P NATL ACAD SCI USA, V107, P21665, DOI 10.1073/pnas.1014376107; Maor G, 2013, HUM MOL GENET, V22, P1316, DOI 10.1093/hmg/dds535; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Murphy KE, 2014, AUTOPHAGY, V10, P1350, DOI 10.4161/auto.29074; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Orr ME, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt217; Richter F, 2014, NEUROTHERAPEUTICS, V11, P840, DOI 10.1007/s13311-014-0294-x; Ron I, 2010, HUM MOL GENET, V19, P3771, DOI 10.1093/hmg/ddq292; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Swan M, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0368-x; Tan YL, 2014, CHEM BIOL, V21, P967, DOI 10.1016/j.chembiol.2014.06.008; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Watson D, 2005, NEUROL RES, V27, P869, DOI 10.1179/016164105X49436; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Woodard CM, 2014, CELL REP, V9, P1173, DOI 10.1016/j.celrep.2014.10.023; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang CZ, 2013, P NATL ACAD SCI USA, V110, P966, DOI 10.1073/pnas.1221046110	57	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143854	10.1371/journal.pone.0143854	http://dx.doi.org/10.1371/journal.pone.0143854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629917	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300114
J	Liang, GP; Houssou, AA; Wu, HJ; Cai, DX; Wu, XP; Gao, LL; Li, J; Wang, BS; Li, SP				Liang, Guopeng; Houssou, Albert A.; Wu, Huijun; Cai, Dianxiong; Wu, Xueping; Gao, Lili; Li, Jing; Wang, Bisheng; Li, Shengping			Seasonal Patterns of Soil Respiration and Related Soil Biochemical Properties under Nitrogen Addition in Winter Wheat Field	PLOS ONE			English	Article							ORGANIC-MATTER; CARBON-DIOXIDE; WATER CONTENT; TEMPERATURE-DEPENDENCE; MICROBIAL ACTIVITY; DESERT ECOSYSTEMS; CO2 EFFLUX; LAND-USE; FOREST; GLOMALIN	Understanding the changes of soil respiration under increasing N fertilizer in cropland ecosystems is crucial to accurately predicting global warming. This study explored seasonal variations of soil respiration and its controlling biochemical properties under a gradient of Nitrogen addition during two consecutive winter wheat growing seasons (2013-2015). N was applied at four different levels: 0, 120, 180 and 240 kg N ha(-1) year(-1) (denoted as N0, N12, N18 and N24, respectively). Soil respiration exhibited significant seasonal variation and was significantly affected by soil temperature with Q10 ranging from 2.04 to 2.46 and from 1.49 to 1.53 during 2013-2014 and 2014-2015 winter wheat growing season, respectively. Soil moisture had no significant effect on soil respiration during 2013-2014 winter wheat growing season but showed a significant and negative correlation with soil respiration during 2014-2015 winter wheat growing season. Soil respiration under N24 treatment was significantly higher than N0 treatment. Averaged over the two growing seasons, N12, N18 and N24 significantly increased soil respiration by 13.4, 16.4 and 25.4% compared with N0, respectively. N addition also significantly increased easily extractable glomalin-related soil protein (EEG), soil organic carbon (SOC), total N, ammonium N and nitrate N contents. In addition, soil respiration was significantly and positively correlated with beta-glucosidase activity, EEG, SOC, total N, ammonium N and nitrate N contents. The results indicated that high N fertilization improved soil chemical properties, but significantly increased soil respiration.	[Liang, Guopeng; Houssou, Albert A.; Wu, Huijun; Cai, Dianxiong; Wu, Xueping; Gao, Lili; Li, Jing; Wang, Bisheng; Li, Shengping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Wu, HJ (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing 100193, Peoples R China.	hjwu@caas.ac.cn	Li, Shengping/ABA-7547-2021; Liang, Guopeng/AFX-5144-2022; wang, bisheng/HDO-2404-2022; Liang, Guopeng/R-4053-2019	Li, Shengping/0000-0001-6940-9179; Liang, Guopeng/0000-0001-5514-785X; Liang, Guopeng/0000-0001-5514-785X; Wu, Xueping/0000-0002-7772-0773	Science and Technology Project [2015BAD22B03]; National 863 Program of China [2013AA102901]; Special Fund for Agro-scientific Research in the Public Interest [201203077, 201203030, 201503120]	Science and Technology Project; National 863 Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the Science and Technology Project, 2015BAD22B03 (http://program.most.gov.cn/), the National 863 Program of China, 2013AA102901 (http://program.most.gov.cn/), and the Special Fund for Agro-scientific Research in the Public Interest, 201203077, 201203030, 201503120 (http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bai CM, 2009, SOIL BIOL BIOCHEM, V41, P941, DOI 10.1016/j.soilbio.2009.02.010; Bauhus J, 1998, SOIL BIOL BIOCHEM, V30, P1077, DOI 10.1016/S0038-0717(97)00213-7; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; Darenova E, 2014, CATENA, V123, P263, DOI 10.1016/j.catena.2014.08.008; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Ding WX, 2007, SOIL SCI SOC AM J, V71, P944, DOI 10.2136/sssaj2006.0160; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Escolar C, 2015, SOIL BIOL BIOCHEM, V80, P9, DOI 10.1016/j.soilbio.2014.09.019; Foereid B, 2004, SOIL BIOL BIOCHEM, V36, P1075, DOI 10.1016/j.soilbio.2004.03.002; Gao Q, 2014, SOIL BIOL BIOCHEM, V76, P297, DOI 10.1016/j.soilbio.2014.04.020; Garcia C, 1997, SOIL BIOL BIOCHEM, V29, P171, DOI 10.1016/S0038-0717(96)00294-5; Geisseler D, 2009, PEDOBIOLOGIA, V53, P87, DOI 10.1016/j.pedobi.2009.06.002; Gispert M, 2013, GEODERMA, V202, P51, DOI 10.1016/j.geoderma.2013.03.012; Gong JR, 2014, SOIL TILL RES, V144, P20, DOI 10.1016/j.still.2014.06.002; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hasselquist NJ, 2012, GLOBAL CHANGE BIOL, V18, P3596, DOI 10.1111/gcb.12001; He XL, 2010, SOIL BIOL BIOCHEM, V42, P1313, DOI 10.1016/j.soilbio.2010.03.022; Hernandez DL, 2010, PLANT SOIL, V335, P397, DOI 10.1007/s11104-010-0428-9; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Iqbal J, 2008, SOIL BIOL BIOCHEM, V40, P2324, DOI 10.1016/j.soilbio.2008.05.010; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lane RW, 2013, J ARID ENVIRON, V98, P52, DOI 10.1016/j.jaridenv.2013.07.014; Li YT, 2009, SOIL BIOL BIOCHEM, V41, P969, DOI 10.1016/j.soilbio.2009.01.021; Liang NS, 2004, AGR FOREST METEOROL, V123, P97, DOI 10.1016/j.agrformet.2003.10.002; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lovelock CE, 2004, SOIL BIOL BIOCHEM, V36, P1009, DOI 10.1016/j.soilbio.2004.02.010; Miller M, 1998, APPL ENVIRON MICROB, V64, P613; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Purin S, 2006, SOIL BIOL BIOCHEM, V38, P1831, DOI 10.1016/j.soilbio.2005.12.008; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rey A, 2011, SOIL BIOL BIOCHEM, V43, P393, DOI 10.1016/j.soilbio.2010.11.007; Rillig MC, 2001, PLANT SOIL, V233, P167, DOI 10.1023/A:1010364221169; Rosier CL, 2006, SOIL BIOL BIOCHEM, V38, P2205, DOI 10.1016/j.soilbio.2006.01.021; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; Shao R, 2014, SOIL TILL RES, V143, P164, DOI 10.1016/j.still.2014.07.003; SINSABAUGH RL, 1994, SOIL BIOL BIOCHEM, V26, P1305, DOI 10.1016/0038-0717(94)90211-9; Stott DE, 2010, SOIL SCI SOC AM J, V74, P107, DOI 10.2136/sssaj2009.0029; Sun ZZ, 2014, AGR FOREST METEOROL, V197, P103, DOI 10.1016/j.agrformet.2014.06.010; Talmon Y, 2011, GLOBAL CHANGE BIOL, V17, P1108, DOI 10.1111/j.1365-2486.2010.02285.x; Thomas AD, 2010, J ARID ENVIRON, V74, P131, DOI 10.1016/j.jaridenv.2009.07.005; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Wei SH, 2015, ENVIRON SCI POLLUT R, V22, P1999, DOI 10.1007/s11356-014-3448-9; Baena CW, 2013, FOREST ECOL MANAG, V308, P223, DOI 10.1016/j.foreco.2013.06.065; WRB, 2006, FRAM INT CLASS CORR; Wu QS, 2012, SOIL BIOL BIOCHEM, V45, P181, DOI 10.1016/j.soilbio.2011.10.002; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zhang Q, 2013, AGR FOREST METEOROL, V180, P34, DOI 10.1016/j.agrformet.2013.04.028; Zhou XB, 2012, SOIL BIOL BIOCHEM, V47, P67, DOI 10.1016/j.soilbio.2011.05.012	58	25	31	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144115	10.1371/journal.pone.0144115	http://dx.doi.org/10.1371/journal.pone.0144115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629695	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300162
J	Manugian, S; Elliott, ML; Bradley, R; Howar, J; Karnovsky, N; Saenz, B; Studwell, A; Warzybok, P; Nur, N; Jahncke, J				Manugian, Suzanne; Elliott, Meredith L.; Bradley, Russ; Howar, Julie; Karnovsky, Nina; Saenz, Benjamin; Studwell, Anna; Warzybok, Pete; Nur, Nadav; Jahncke, Jaime			Spatial Distribution and Temporal Patterns of Cassin's Auklet Foraging and Their Euphausiid Prey in a Variable Ocean Environment	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; EL-NINO; NORTHERN CALIFORNIA; PTYCHORAMPHUS-ALEUTICUS; TROPHIC RELATIONSHIPS; COMMUNITY COMPOSITION; CLIMATE VARIABILITY; DIVING BEHAVIOR; MARINE BIRDS; LA-NINA	Krill (Euphausiids) play a vital ecosystem role in many of the world's most productive marine regions, providing an important trophic linkage. We introduce a robust modeling approach to link Cassin's auklet (Ptychoramphus aleuticus) abundance and distribution to large-scale and local oceanic and atmospheric conditions and relate these patterns to similarly modeled distributions of an important prey resource, krill. We carried out at-sea strip transect bird surveys and hydroacoustic assessments of euphausiids (2004-2013). Data informed separate, spatially-explicit predictive models of Cassin's auklet abundance (zero-inflated negative binomial regression) and krill biomass (two-part model) based on these surveys. We established the type of prey responsible for acoustic backscatter by conducting net tows of the upper 50 m during surveys. We determined the types of prey fed to Cassin's auklet chicks by collecting diet samples from provisioning adults. Using time-depth-recorders, we found Cassin's auklets utilized consistent areas in the upper water column, less than 30 m, where krill could be found (99.5% of dives were less than 30 m). Birds primarily preyed upon two species of euphausiids, Euphausia pacifica and Thysanoessa spinifera, which were available in the upper water column. Cassin's auklet abundance was best predicted by both large scale and localized oceanic processes (upwelling) while krill biomass was best predicted by local factors (temperature, salinity, and fluorescence) and both large scale and localized oceanic processes (upwelling). Models predicted varying krill and bird distribution by month and year. Our work informs the use of Cassin's auklet as a valuable indicator or krill abundance and distribution and strengthens our understanding of the link between Cassin's auklet and its primary prey. We expect future increases in frequency and magnitude of anomalous ocean conditions will result in decreased availability of krill leading to declines in the Farallon Islands population of Cassin's auklets.	[Manugian, Suzanne; Elliott, Meredith L.; Bradley, Russ; Howar, Julie; Studwell, Anna; Warzybok, Pete; Nur, Nadav; Jahncke, Jaime] Calif Current Grp, Point Blue Conservat Sci, Petaluma, CA 94954 USA; [Karnovsky, Nina] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Saenz, Benjamin] Univ S Florida, Dept Biol, Tampa, FL 33620 USA; [Studwell, Anna] San Francisco State Univ, Dept Geog, San Francisco, CA 94132 USA	Claremont Colleges; Pomona College; State University System of Florida; University of South Florida; California State University System; San Francisco State University	Jahncke, J (corresponding author), Calif Current Grp, Point Blue Conservat Sci, Petaluma, CA 94954 USA.	jjahncke@pointblue.org			Bently Foundation; Boring Family Foundation; California Sea Grant; Elinor Paterson Baker Trust; Faucett Catalyst Fund; Firedoll Foundation; Hellman Family Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Resources Legacy Fund; Wendy P. McCaw Foundation	Bently Foundation; Boring Family Foundation; California Sea Grant; Elinor Paterson Baker Trust; Faucett Catalyst Fund; Firedoll Foundation; Hellman Family Foundation; Marisla Foundation; Moore Family Foundation; National Fish and Wildlife Foundation; Resources Legacy Fund; Wendy P. McCaw Foundation	The authors thank the Bently Foundation, Boring Family Foundation, California Sea Grant, Elinor Paterson Baker Trust, Faucett Catalyst Fund, Firedoll Foundation, Hellman Family Foundation, Marisla Foundation, Moore Family Foundation, National Fish and Wildlife Foundation, Resources Legacy Fund, Wendy P. McCaw Foundation, and the many Point Blue donors who have helped fund ACCESS work over the years. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CL, 2006, MAR ECOL PROG SER, V313, P271, DOI 10.3354/meps313271; Abraham CL, 2004, MAR ECOL PROG SER, V274, P235, DOI 10.3354/meps274235; Ainley D.G., 1990, SEABIRDS OF THE FARA; Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; Ainley DG, 2005, DEEP-SEA RES PT II, V52, P123, DOI 10.1016/j.dsr2.2004.08.016; Ainley DG, 1996, MAR ECOL PROG SER, V137, P1, DOI 10.3354/meps137001; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Allen SE, 2001, CAN J FISH AQUAT SCI, V58, P671, DOI 10.1139/cjfas-58-4-671; Barlow J, 2009, SERDP PROJECT S1 139; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bertram DF, 2005, CAN J FISH AQUAT SCI, V62, P2841, DOI 10.1139/F05-190; Bertram DF, 2001, PROG OCEANOGR, V49, P283, DOI 10.1016/S0079-6611(01)00027-1; Bjorkstedt EP, 2011, CAL COOP OCEAN FISH, V52, P36; BOLLENS SM, 1992, MAR BIOL, V114, P219, DOI 10.1007/BF00349522; Briggs KT, 1987, STUDIES IN AVIAN BIO, V11; BRIGGS KT, 1988, P INT ORNITHOLOGICAL, V19, P983; Brinton E., 1962, Bulletin Scripps Institution of Oceanography, V8, P51; Brinton E, 2000, EUPHAUSIIDS OF THE W; BURGER AE, 1990, CAN J ZOOL, V68, P1572, DOI 10.1139/z90-232; Chavez FP, 1996, GEOPHYS RES LETT, V23, P265, DOI 10.1029/96GL00017; Conti SG, 2006, ICES J MAR SCI, V63, P928, DOI 10.1016/j.icesjms.2006.02.007; Croll DA, 1998, DEEP-SEA RES PT II, V45, P1353, DOI 10.1016/S0967-0645(98)00031-9; Demer DA, 2003, ICES J MAR SCI, V60, P429, DOI 10.1016/S1054-3139(03)00002-X; Demer DA, 2003, ICES J MAR SCI, V60, P625, DOI 10.1016/S1054-3139(03)00063-8; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dorman JG, 2005, MAR ECOL PROG SER, V288, P183, DOI 10.3354/meps288183; Dransfield A, 2014, ENDANGER SPECIES RES, V26, P39, DOI 10.3354/esr00627; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Enfield DB, 1999, J CLIMATE, V12, P2719, DOI 10.1175/1520-0442(1999)012<2719:MVIGSS>2.0.CO;2; Falk K, 2000, AUK, V117, P522, DOI 10.1642/0004-8038(2000)117[0522:MODDID]2.0.CO;2; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Fontana RE, 2013, THESIS; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Garcia-Reyes M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005576; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Harding AMA, 2009, POLAR BIOL, V32, P785, DOI 10.1007/s00300-009-0581-x; Hewitt RP, 2004, DEEP-SEA RES PT II, V51, P1215, DOI 10.1016/j.dsr2.2004.06.011; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Hunt GL, 1998, MAR ECOL PROG SER, V167, P241, DOI 10.3354/meps167241; Hyrenbach KD, 2003, DEEP-SEA RES PT II, V50, P2537, DOI 10.1016/S0967-0645(03)00123-1; Jacobs SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054594; Jahncke J, 2008, PROG OCEANOGR, V77, P182, DOI 10.1016/j.pocean.2008.03.010; Johnston K., 2001, USING ARCGIS GEOSTAT; Ju SJ, 2009, MAR BIOL, V156, P1459, DOI 10.1007/s00227-009-1186-1; Karnovsky N, 2010, MAR ECOL PROG SER, V415, P283, DOI 10.3354/meps08749; Karnovsky NJ, 2011, MAR ECOL PROG SER, V440, P229, DOI 10.3354/meps09351; Lee DE, 2007, J ANIM ECOL, V76, P337, DOI 10.1111/j.1365-2656.2007.01198.x; Long J.S., 1997, REGRESSION MODELS FO; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mackas DL, 2002, PROG OCEANOGR, V54, P423, DOI 10.1016/S0079-6611(02)00062-9; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Manuwal D, 1993, THE BIRDS OF NORTH A, V50; Marinovic BB, 2002, PROG OCEANOGR, V54, P265, DOI 10.1016/S0079-6611(02)00053-8; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McGowan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071406; Mendelssohn R, 2002, PROG OCEANOGR, V53, P141, DOI 10.1016/S0079-6611(02)00028-9; Michael PE, 2014, FISH OCEANOGR, V23, P18, DOI 10.1111/fog.12039; Mukai T, 2004, OCEANS '04 MTS/IEEE TECHNO-OCEAN '04, VOLS 1- 2, CONFERENCE PROCEEDINGS, VOLS. 1-4, P383; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; OEHHA, 2013, INDICATORS OF CLIMAT; Palacios DM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002380; Rhein M, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324.010; RIBIC CA, 1992, MAR ECOL PROG SER, V80, P109, DOI 10.3354/meps080109; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Roemmich D, 2015, NAT CLIM CHANGE, V5, P240, DOI [10.1038/NCLIMATE2513, 10.1038/nclimate2513]; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Schmidt AE, 2014, MAR ECOL PROG SER, V499, P249, DOI 10.3354/meps10629; SIMARD Y, 1989, CAN J FISH AQUAT SCI, V46, P1238, DOI 10.1139/f89-160; SMITH SE, 1988, B MAR SCI, V42, P76; SPEICH S, 1974, AUK, V91, P291; Stevick PT, 2008, MAR ECOL PROG SER, V363, P15, DOI 10.3354/meps07475; Sydeman WJ, 2015, DEEP-SEA RES PT II, V112, P158, DOI 10.1016/j.dsr2.2014.03.008; Sydeman WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026736; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; TASKER ML, 1984, AUK, V101, P567, DOI 10.1093/auk/101.3.567; TRENBERTH KE, 1984, MON WEATHER REV, V112, P2359, DOI 10.1175/1520-0493(1984)112<2359:SEOFSS>2.0.CO;2; Tynan CT, 2005, DEEP-SEA RES PT II, V52, P145, DOI 10.1016/j.dsr2.2004.09.024; Vermeer K, 1993, THE STATUS ECOLOGY A, P18; Watkins JL, 2002, ICES J MAR SCI, V59, P1326, DOI 10.1006/jmsc.2002.1309; Wells BK, 2008, MAR ECOL PROG SER, V364, P15, DOI 10.3354/meps07486; Wilson RP, 1996, MAR BIOL, V126, P153, DOI 10.1007/BF00571387; Wolf SG, 2009, ECOLOGY, V90, P742, DOI 10.1890/07-1267.1; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zuur AF, 2013, ZERO INFLATED MODELS; Zuur Alain F., 2009, P1	89	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144232	10.1371/journal.pone.0144232	http://dx.doi.org/10.1371/journal.pone.0144232			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629818	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300173
J	Nomine, Y; Choulier, L; Trave, G; Vernet, T; Altschuh, D				Nomine, Yves; Choulier, Laurence; Trave, Gilles; Vernet, Thierry; Altschuh, Daniele			Antibody Binding Selectivity: Alternative Sets of Antigen Residues Entail High-Affinity Recognition	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; HOT-SPOT; STRUCTURAL BASIS; E6-MEDIATED DEGRADATION; E6 ONCOPROTEIN; PEPTIDE; PREDICTION; ENERGY; COMPLEX; ARCHITECTURE	Understanding the relationship between protein sequence and molecular recognition selectivity remains a major challenge. The antibody fragment scFv1F4 recognizes with sub nM affinity a decapeptide (sequence (6)TAMFQDPQER(15)) derived from the N-terminal end of human papilloma virus E6 oncoprotein. Using this decapeptide as antigen, we had previously shown that only the wild type amino-acid or conservative replacements were allowed at positions 9 to 12 and 15 of the peptide, indicating a strong binding selectivity. Nevertheless phenylalanine (F) was equally well tolerated as the wild type glutamine (Q) at position 13, while all other amino acids led to weaker scFv binding. The interfaces of complexes involving either Q or F are expected to diverge, due to the different physico-chemistry of these residues. This would imply that high-affinity binding can be achieved through distinct interfacial geometries. In order to investigate this point, we disrupted the scFv-peptide interface by modifying one or several peptide positions. We then analyzed the effect on binding of amino acid changes at the remaining positions, an altered susceptibility being indicative of an altered role in complex formation. The 23 starting variants analyzed contained replacements whose effects on scFv1F4 binding ranged from minor to drastic. A permutation analysis (effect of replacing each peptide position by all other amino acids except cysteine) was carried out on the 23 variants using the PEPperCHIP (R) Platform technology. A comparison of their permutation patterns with that of the wild type peptide indicated that starting replacements at position 11, 12 or 13 modified the tolerance to amino-acid changes at the other two positions. The interdependence between the three positions was confirmed by SPR (Biacore (R) technology). Our data demonstrate that binding selectivity does not preclude the existence of alternative high-affinity recognition modes.	[Nomine, Yves; Choulier, Laurence; Trave, Gilles; Altschuh, Daniele] Univ Strasbourg, CNRS, UMR 7242, Equipe Labellisee Ligue 2015, Illkirch Graffenstaden, France; [Vernet, Thierry] Univ Grenoble Alpes, IBS, Grenoble, France; [Vernet, Thierry] CNRS, IBS, Grenoble, France; [Vernet, Thierry] CEA Grenoble, IBS, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Altschuh, D (corresponding author), Univ Strasbourg, CNRS, UMR 7242, Equipe Labellisee Ligue 2015, Illkirch Graffenstaden, France.	daniele.altschuh@unistra.fr	TRAVE, Gilles/P-8577-2016; Altschuh, Danièle/P-8658-2016; Nominé, Yves/P-8670-2016	Nomine, Yves/0000-0002-2912-116X; Choulier, Laurence/0000-0003-1493-9775	Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and the University of Strasbourg (UdS). This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Aiello D, 2012, J MOL BIOL, V423, P257, DOI 10.1016/j.jmb.2012.06.039; Akram ON, 2014, MOL CANCER RES, V12, P967, DOI 10.1158/1541-7786.MCR-13-0611; ALTSCHUH D, 1988, PROTEIN ENG, V2, P193, DOI 10.1093/protein/2.3.193; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Ansari S, 2005, PROTEINS, V61, P344, DOI 10.1002/prot.20593; Audie J, 2013, CHEM BIOL DRUG DES, V81, P50, DOI 10.1111/cbdd.12076; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bird GH, 2014, NAT STRUCT MOL BIOL, V21, P1058, DOI 10.1038/nsmb.2922; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bonsor DA, 2011, BIOCHEMISTRY-US, V50, P2394, DOI 10.1021/bi102019c; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Choulier L, 2002, J IMMUNOL METHODS, V259, P77, DOI 10.1016/S0022-1759(01)00496-3; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dietrich S, 2012, BIOCHEMISTRY-US, V51, P5633, DOI 10.1021/bi300747r; Foloppe N, 2006, CURR MED CHEM, V13, P3583, DOI 10.2174/092986706779026165; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Giovane C, 1999, J MOL RECOGNIT, V12, P141, DOI 10.1002/(SICI)1099-1352(199903/04)12:2<141::AID-JMR453>3.3.CO;2-F; Gori A, 2013, AMINO ACIDS, V45, P257, DOI 10.1007/s00726-013-1526-9; Greenspan NS, 2010, TRENDS IMMUNOL, V31, P138, DOI 10.1016/j.it.2010.01.001; Hecht M, 2013, J MOL BIOL, V425, P3937, DOI 10.1016/j.jmb.2013.07.028; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Hugo N, 2002, PROTEIN SCI, V11, P2697, DOI 10.1110/ps.0209302; Jana B, 2014, PHYS CHEM CHEM PHYS, V16, P6496, DOI 10.1039/c3cp55275f; Kastritis PL, 2013, CURR OPIN STRUC BIOL, V23, P868, DOI 10.1016/j.sbi.2013.07.001; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; Lescar J, 1997, J MOL BIOL, V267, P1207, DOI 10.1006/jmbi.1997.0950; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Lo Conte L, 1999, J MOL BIOL, V285, P2177; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Luo Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057031; Manivel V, 2002, J IMMUNOL, V169, P888, DOI 10.4049/jimmunol.169.2.888; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Moreira IS, 2007, J PHYS CHEM B, V111, P2697, DOI 10.1021/jp067096p; Morrow JK, 2012, CURR PHARM DESIGN, V18, P1255; Moseri A, 2010, VIROLOGY, V401, P293, DOI 10.1016/j.virol.2010.03.007; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00062; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Scheerer P, 2007, J MOL RECOGNIT, V20, P263, DOI 10.1002/jmr.838; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Smeenk LEJ, 2015, CHEMBIOCHEM, V16, P91, DOI 10.1002/cbic.201402540; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Vernet T, 2015, J MOL RECOGNIT, V28, P635, DOI 10.1002/jmr.2477; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001	56	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143374	10.1371/journal.pone.0143374	http://dx.doi.org/10.1371/journal.pone.0143374			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629896	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300044
J	Wakisaka, N; Hasegawa, Y; Yoshimoto, S; Miura, K; Shiotani, A; Yokoyama, J; Sugasawa, M; Moriyama-Kita, M; Endo, K; Yoshizaki, T				Wakisaka, Naohiro; Hasegawa, Yasuhisa; Yoshimoto, Seiichi; Miura, Kouki; Shiotani, Akihiro; Yokoyama, Junkichi; Sugasawa, Masashi; Moriyama-Kita, Makiko; Endo, Kazuhira; Yoshizaki, Tomokazu			Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VEGF-C; CANCER PROGRESSION; TYROSINE KINASES; NECK DISSECTION; BREAST-CANCER; VESSELS; MIGRATION; VENULES; TONGUE	Objectives The objectives of this study were to evaluate the formation of lymphvascular niches in lymph nodes of patients with oral squamous cell carcinoma (OSCC), and investigate the roles of lymphangiogenic and angiogenic factors, such as vascular endothelial growth factor (VEGF)-A, VEGF-C, and VEGF-D, expressed in the primary tumors. Materials and Methods Forty-four patients with previously untreated clinically late T2 or T3 OSCC of cN0 were evaluated for primary tumors and 166 sentinel lymph nodes (SLNs). Primary tumors were immunohistochemically analyzed for expressions of VEGFs. Densities of lymphatic vessels (LVDpodoplanin) and high endothelial venules (HEVD) in the SLNs were also calculated using antibodies for each marker, podoplanin and MECA-79, respectively. Results In 25 patients, all lymph nodes were metastasis-negative, whereas, in 19 patients, metastasis was positive for at least one lymph node (either at SLN, non-SLN, or nodal recurrence). From the analyses of 140 SLNs without metastasis, LVDpodoplanin in 50 SLNs of metastasis-positive cases was significantly higher than that in 90 SLNs of metastasis-negative cases (p = 0.0025). HEVD was not associated with lymph node metastasis. The patients with VEGF-A-High or VEGF-D-High tumors had significantly higher LVDpodoplanin than patients with their Low counterparts (p = 0.0233 and p = 0.0209, respectively). In cases with lymph node metastasis, the VEGF-D-expression score was significantly higher than in those without lymph node metastasis (p = 0.0006). Conclusions These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A and VEGF-D play critical roles in this process. VEGF-D is a potential predictive marker of positive lymph node metastasis in cN0 patients.	[Wakisaka, Naohiro; Moriyama-Kita, Makiko; Endo, Kazuhira; Yoshizaki, Tomokazu] Kanazawa Univ, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa, Japan; [Hasegawa, Yasuhisa] Aichi Canc Ctr, Dept Head & Neck Surg, Nagoya, Aichi 464, Japan; [Yoshimoto, Seiichi] Natl Canc Ctr, Dept Head & Neck Oncol, Chuo Ku, Tokyo, Japan; [Miura, Kouki] Int Univ Hlth & Welf, Mita Hosp, Dept Head & Neck Oncol & Surg, Minato Ku, Tokyo, Japan; [Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 359, Japan; [Yokoyama, Junkichi] Juntendo Univ, Fac Med, Dept Otorhinolaryngol, Bunkyo Ku, Tokyo, Japan; [Sugasawa, Masashi] Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg & Otolaryngol, Hidaka, Saitama, Japan	Kanazawa University; Aichi Cancer Center; National Cancer Center - Japan; International University of Health & Welfare; National Defense Medical College - Japan; Juntendo University; Saitama Medical University	Wakisaka, N (corresponding author), Kanazawa Univ, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa, Japan.	wakisaka@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology of Japan [C21592189]; Astellas Foundation on Metabolic Disorders; Health and Labor Sciences Research Grant for Clinical Cancer Research [H24-Gannrinshou-Japan-006]	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation on Metabolic Disorders; Health and Labor Sciences Research Grant for Clinical Cancer Research	This work was supported by a scientific research grant from the Ministry of Education, Science, Sports, Culture and Technology of Japan (C21592189), a research grant from the Astellas Foundation on Metabolic Disorders, and a Health and Labor Sciences Research Grant for Clinical Cancer Research (H24-Gannrinshou-Japan-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Alex JC, 2000, LARYNGOSCOPE, V110, P198, DOI 10.1097/00005537-200002010-00003; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Broglie MA, 2011, ANN SURG ONCOL, V18, P2732, DOI 10.1245/s10434-011-1780-6; Chepeha DB, 2002, HEAD NECK-J SCI SPEC, V24, P432, DOI 10.1002/hed.10067; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Dellinger MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074686; Duda DG, 2010, CANCER RES, V70, P5670, DOI 10.1158/0008-5472.CAN-10-0119; Duvvuri U, 2004, LARYNGOSCOPE, V114, P2228, DOI 10.1097/01.mlg.0000149464.73080.20; Ferris RL, 2012, CLIN EXP METASTAS, V29, P729, DOI 10.1007/s10585-012-9520-2; George ML, 2001, NEOPLASIA, V3, P420, DOI 10.1038/sj.neo.7900186; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2009, CANCER SCI, V100, P983, DOI 10.1111/j.1349-7006.2009.01142.x; Hirota K, 2012, HISTOPATHOLOGY, V61, P1065, DOI 10.1111/j.1365-2559.2012.04341.x; Ishii H, 2010, ORAL ONCOL, V46, P373, DOI 10.1016/j.oraloncology.2010.02.014; Joukov V, 1996, EMBO J, V15, P290; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Lee SY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-206; Martinet L, 2011, CANCER RES, V71, P5678, DOI 10.1158/0008-5472.CAN-11-0431; Niki T, 2000, CLIN CANCER RES, V6, P2431; Paget G, 1889, Br Med J, V1, P1; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; SACKSTEIN R, 1993, SEMIN ONCOL, V20, P34; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Tanaka M, 2010, CANCER SCI, V101, P2121, DOI 10.1111/j.1349-7006.2010.01649.x; Terada A, 2011, EUR ARCH OTO-RHINO-L, V268, P429, DOI 10.1007/s00405-010-1364-2; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85	36	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144056	10.1371/journal.pone.0144056	http://dx.doi.org/10.1371/journal.pone.0144056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630663	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300151
J	Kojima, M; Takehara, H; Akagi, T; Shiono, H; Ichiki, T				Kojima, Mari; Takehara, Hiroaki; Akagi, Takanori; Shiono, Hirofumi; Ichiki, Takanori			Flexible Sheet-Type Sensor for Noninvasive Measurement of Cellular Oxygen Metabolism on a Culture Dish	PLOS ONE			English	Article							SINGLE CELLS; TECHNOLOGIES	A novel flexible sensor was developed for the noninvasive oxygen metabolism measurement of cultivated cells and tissues. This device is composed of a transparent double-layered polymer sheet of ethylene-vinyl alcohol (EVOH) and poly(dimethylsiloxane) (PDMS) having an array of microhole structures of 90 mu m diameter and 50 mu m depth on its surface. All the microhole structures were equipped with a 1-mu m-thick optical chemical sensing layer of platinum porphyrin-fluoropolymer on their bottom. The three-dimensional microstructures of the sensor were fabricated by a newly developed simple and low-cost production method named self-aligned hot embossing. The device was designed to be attached slightly above the cells cultivated on a dish to form a temporarily closed microspace over the target cells during measurement. Since the change in oxygen concentration is relatively fast in the microcompartmentalized culture medium, a rapid evaluation of the oxygen consumption rate is possible by measuring the phosphorescence lifetime of the platinum porphyrin-fluoropolymer. The combined use of the device and an automated optical measurement system enabled the high-throughput sensing of cellular oxygen consumption (100 points/min). We monitored the oxygen metabolism of the human breast cancer cell line MCF7 on a Petri dish and evaluated the oxygen consumption rate to be 0.72 +/- 0.12 fmol/min/cell. Furthermore, to demonstrate the utility of the developed sensing system, we demonstrated the mapping of the oxygen consumption rate of rat brain slices and succeeded in visualizing a clear difference among the layer structures of the hippocampus, i.e., the cornu ammonis (CA1 and CA3) and dentate gyrus (DG).	[Kojima, Mari; Takehara, Hiroaki; Akagi, Takanori; Ichiki, Takanori] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Shiono, Hirofumi] Nikon Inc, Minato Ku, Tokyo, Japan	University of Tokyo; Nikon Corporation	Ichiki, T (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 2-11-16 Yayoi, Tokyo, Japan.	ichiki@bioeng.t.u-tokyo.ac.jp	Ichiki, Takanori/E-6430-2014; Takehara, Hiroaki/M-3341-2013	Ichiki, Takanori/0000-0002-3917-7140; Takehara, Hiroaki/0000-0003-3222-8483	Nikon Corporation	Nikon Corporation	This study was funded in part by Nikon Corporation. Hirofumi Shiono is employed by Nikon Corporation, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe H, 2007, J MAMM OVA RES, V24, P70; Akagi T, 2008, ANAL BIOANAL CHEM, V391, P2433, DOI 10.1007/s00216-008-2203-9; [Anonymous], DAT SHEET SOARN; [Anonymous], 1991, PHOTOCHEMISTRY POLYP; Bambrick LL, 2011, BIOTECHNOL PROGR, V27, P1185, DOI 10.1002/btpr.622; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Fuller L., 2007, CSH PROTOC, V2007; Gillanders RN, 2004, ANAL CHIM ACTA, V502, P1, DOI 10.1016/j.aca.2003.09.053; Jacobson MK, 2007, METHODS MODULATING P; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Laermer F, 2003, MICROELECTRON ENG, V67-8, P349, DOI 10.1016/S0167-9317(03)00089-3; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P239; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Mason C, 2007, TISSUE ENG, V13, P301, DOI 10.1089/ten.2006.0177; Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036; Notingher L, 2005, J MOL STRUCT, V744, P179, DOI 10.1016/j.molstruc.2004.12.046; Ramamoorthy R, 2003, J MATER SCI, V38, P4271, DOI 10.1023/A:1026370729205; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Sinkala E, 2010, LAB CHIP, V10, P3291, DOI 10.1039/c0lc00244e; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takehara H, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045006; Utsunomiya T, 2008, J MAMM OVA RES, V25, P2; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yotter RA, 2004, IEEE SENS J, V4, P412, DOI 10.1109/JSEN.2004.830954; Yotter RA, 2004, IEEE SENS J, V4, P395, DOI 10.1109/JSEN.2004.830952	25	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143774	10.1371/journal.pone.0143774	http://dx.doi.org/10.1371/journal.pone.0143774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624889	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600049
J	Mier, P; Andrade-Navarro, MA; Perez-Pulido, AJ				Mier, Pablo; Andrade-Navarro, Miguel A.; Perez-Pulido, Antonio J.			orthoFind Facilitates the Discovery of Homologous and Orthologous Proteins	PLOS ONE			English	Article							SURVIVAL; SEQUENCE; QUEST; GENE; SMN; IDENTIFICATION; CONSERVATION; ANNOTATION; GENOMES; SPF30	Finding homologous and orthologous protein sequences is often the first step in evolutionary studies, annotation projects, and experiments of functional complementation. Despite all currently available computational tools, there is a requirement for easy-to-use tools that provide functional information. Here, a new web application called orthoFind is presented, which allows a quick search for homologous and orthologous proteins given one or more query sequences, allowing a recurrent and exhaustive search against reference proteomes, and being able to include user databases. It addresses the protein multidomain problem, searching for homologs with the same domain architecture, and gives a simple functional analysis of the results to help in the annotation process. orthoFind is easy to use and has been proven to provide accurate results with different datasets. Availability: http://www.bioinfocabd.upo.es/orthofind/.	[Mier, Pablo; Perez-Pulido, Antonio J.] Univ Pablo Olavide, Fac Ciencias Expt, Area Genet, Ctr Andaluz Biol Desarrollo CABD,CSIC,JA, ES-41013 Seville, Spain; [Andrade-Navarro, Miguel A.] Johannes Gutenberg Univ Mainz, Fac Biol, D-55122 Mainz, Germany; [Mier, Pablo; Andrade-Navarro, Miguel A.] Inst Mol Biol, Mainz, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB)	Perez-Pulido, AJ (corresponding author), Univ Pablo Olavide, Fac Ciencias Expt, Area Genet, Ctr Andaluz Biol Desarrollo CABD,CSIC,JA, ES-41013 Seville, Spain.	ajperez@upo.es	Perez-Pulido, Antonio J/K-3384-2012; Mier, Pablo/P-8916-2019	Perez-Pulido, Antonio J/0000-0003-3343-2822; Mier, Pablo/0000-0003-3663-2352	Spanish "Ministerio de Economia y Competitividad" [BFU2013-46923-P]	Spanish "Ministerio de Economia y Competitividad"(Spanish Government)	This work has been funded by the Spanish "Ministerio de Economia y Competitividad" within the BFU2013-46923-P project.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; Fallini C, 2014, DEV NEUROBIOL, V74, P319, DOI 10.1002/dneu.22111; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Hurni S, 2013, PLANT J, V76, P957, DOI 10.1111/tpj.12345; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lo WS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-22; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; Mier P, 2012, GENE, V491, P135, DOI 10.1016/j.gene.2011.10.006; Munoz-Merida A, 2014, DNA RES, V21, P341, DOI 10.1093/dnares/dsu001; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Rappsilber J, 2001, J BIOL CHEM, V276, P31142, DOI 10.1074/jbc.M103620200; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sjolander K, 2011, BRIEF BIOINFORM, V12, P413, DOI 10.1093/bib/bbr036; Talbot K, 1998, HUM MOL GENET, V7, P2149, DOI 10.1093/hmg/7.13.2149; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]	33	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143906	10.1371/journal.pone.0143906	http://dx.doi.org/10.1371/journal.pone.0143906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624019	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600073
J	Shishkina, GT; Kalinina, TS; Bulygina, VV; Lanshakov, DA; Babluk, EV; Dygalo, NN				Shishkina, Galina T.; Kalinina, Tatyana S.; Bulygina, Veta V.; Lanshakov, Dmitry A.; Babluk, Ekaterina V.; Dygalo, Nikolay N.			Anti-Apoptotic Protein Bcl-xL Expression in the Midbrain Raphe Region Is Sensitive to Stress and Glucocorticoids	PLOS ONE			English	Article							HYDROXYLASE-2 MESSENGER-RNA; TISSUE-SPECIFIC EXPRESSION; FORCED SWIM TEST; TRYPTOPHAN HYDROXYLASE-2; GENE-EXPRESSION; RAT-BRAIN; DEXAMETHASONE TREATMENT; IMMOBILIZATION STRESS; BEHAVIORAL DESPAIR; DENTATE GYRUS	Anti-apoptotic proteins are suggested to be important for the normal health of neurons and synapses as well as for resilience to stress. In order to determine whether stressful events may influence the expression of anti-apoptotic protein Bcl-xL in the midbrain and specifically in the midbrain serotonergic (5-HT) neurons involved in neurobehavioral responses to adverse stimuli, adult male rats were subjected to short-term or chronic forced swim stress. A short-term stress rapidly increased the midbrain bcl-xl mRNA levels and significantly elevated Bcl-xL immunoreactivity in the midbrain 5-HT cells. Stress-induced increase in glucocorticoid secretion was implicated in the observed effect. The levels of bcl-xl mRNA were decreased after stress when glucocorticoid elevation was inhibited by metyrapone (MET, 150 mg/kg), and this decrease was attenuated by glucocorticoid replacement with dexamethasone (DEX; 0.2 mg/kg). Both short-term stress and acute DEX administration, in parallel with Bcl-xL, caused a significant increase in tph2 mRNA levels and slightly enhanced tryptophan hydroxylase immunoreactivity in the midbrain. The increasing effect on the bcl-xl expression was specific to the short-term stress. Forced swim repeated daily for 2 weeks led to a decrease in bcl-xl mRNA in the midbrain without any effects on the Bcl-xL protein expression in the 5-HT neurons. In chronically stressed animals, an increase in tph2 gene expression was not associated with any changes in tryptophan hydroxylase protein levels. Our findings are the first to demonstrate that both short-term stress and acute glucocorticoid exposures induce Bcl-xL protein expression in the midbrain 5-HT neurons concomitantly with the activation of the 5-HT synthesis pathway in these neurons.	[Shishkina, Galina T.; Kalinina, Tatyana S.; Bulygina, Veta V.; Lanshakov, Dmitry A.; Babluk, Ekaterina V.; Dygalo, Nikolay N.] Russian Acad Sci, Inst Cytol & Genet, Fed Res Ctr, Siberian Branch, Novosibirsk 630090, Russia; [Kalinina, Tatyana S.; Dygalo, Nikolay N.] Novosibirsk State Univ, Dept Physiol, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Shishkina, GT (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Fed Res Ctr, Siberian Branch, Novosibirsk 630090, Russia.	gtshi@bionet.nsc.ru	Lanshakov, Dmitriy A/M-7975-2016; Kalinina, Tatyana/R-8412-2016; Bulygina, Veta/AAO-2539-2020	Lanshakov, Dmitriy A/0000-0002-8482-1302; Kalinina, Tatyana/0000-0002-2575-4621; Dygalo, Nikolay/0000-0002-0638-1794	Russian Scientific Fund [N 14-15-00115]; Russian Fund for Basic Research [N 15-04-07855]; Russian Science Foundation [14-15-00115] Funding Source: Russian Science Foundation	Russian Scientific Fund(Russian Science Foundation (RSF)); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Scientific Fund N 14-15-00115 and Russian Fund for Basic Research N 15-04-07855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1993, PHYSIOL BEHAV, V54, P309, DOI 10.1016/0031-9384(93)90116-W; Abumaria N, 2007, EUR NEUROPSYCHOPHARM, V17, P417, DOI 10.1016/j.euroneuro.2006.08.009; Alenina N, 2015, BEHAV BRAIN RES, V277, P49, DOI 10.1016/j.bbr.2014.07.038; AZMITIA EC, 1993, J NEUROSCI, V13, P5041, DOI 10.1523/JNEUROSCI.13-12-05041.1993; Bach H, 2011, J NEUROCHEM, V118, P1067, DOI 10.1111/j.1471-4159.2011.07379.x; Bach-Mizrachi H, 2008, MOL PSYCHIATR, V13, P507, DOI 10.1038/sj.mp.4002143; BAEZ M, 1994, PHARMACOL BIOCHEM BE, V49, P729, DOI 10.1016/0091-3057(94)90093-0; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Boldrini M, 2005, BRAIN RES, V1041, P19, DOI 10.1016/j.brainres.2005.01.083; Boyarskikh UA, 2013, MOL NEUROBIOL, V48, P13, DOI 10.1007/s12035-013-8413-y; Browne CA, 2011, NEUROPHARMACOLOGY, V60, P683, DOI 10.1016/j.neuropharm.2010.11.020; Chamas F, 1999, NEUROSCI LETT, V267, P157, DOI 10.1016/S0304-3940(99)00340-7; Chamas FM, 2004, BIOL PSYCHIAT, V55, P278, DOI 10.1016/S0006-3223(03)00788-1; Chen GL, 2013, BIOCHEM PHARMACOL, V85, P1227, DOI 10.1016/j.bcp.2013.02.018; Chen GL, 2012, AM J MED GENET B, V159B, P152, DOI 10.1002/ajmg.b.32023; Clark JA, 2008, MOL PSYCHIATR, V13, P498, DOI 10.1038/sj.mp.4002041; Commons KG, 2008, EUR J NEUROSCI, V27, P2611, DOI 10.1111/j.1460-9568.2008.06235.x; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; Dallman MF, 2000, ENDOCRINOLOGY, V141, P1590, DOI 10.1210/en.141.5.1590; Ding LS, 2014, BEHAV BRAIN RES, V268, P150, DOI 10.1016/j.bbr.2014.03.042; Donner NC, 2012, PSYCHONEUROENDOCRINO, V37, P645, DOI 10.1016/j.psyneuen.2011.08.008; Drakulic D, 2013, J NEUROENDOCRINOL, V25, P605, DOI 10.1111/jne.12037; Dygalo NN, 2012, CELL MOL NEUROBIOL, V32, P767, DOI 10.1007/s10571-011-9794-y; Ferland CL, 2014, ENDOCRINOLOGY, V155, P2942, DOI 10.1210/en.2013-1918; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Fox JH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00169; Gascoyne DM, 2003, J BIOL CHEM, V278, P18022, DOI 10.1074/jbc.M301812200; Gonzalez MMC, 2008, P NATL ACAD SCI USA, V105, P4898, DOI 10.1073/pnas.0703615105; Goswami DB, 2010, J NEUROCHEM, V112, P397, DOI 10.1111/j.1471-4159.2009.06462.x; HARFSTRAND A, 1986, P NATL ACAD SCI USA, V83, P9779, DOI 10.1073/pnas.83.24.9779; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; HENINGER GR, 1984, ARCH GEN PSYCHIAT, V41, P398; Heydendael W, 2009, BRAIN RES, V1288, P69, DOI 10.1016/j.brainres.2009.06.082; HOKFELT T, 1976, MED BIOL, V54, P427; Jahanshahi A, 2011, J CHEM NEUROANAT, V41, P227, DOI 10.1016/j.jchemneu.2011.05.015; JENKINS JS, 1958, SCIENCE, V128, P478, DOI 10.1126/science.128.3322.478-a; Jiang P, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/729827; Jonas EA, 2014, BBA-MOL BASIS DIS, V1842, P1168, DOI 10.1016/j.bbadis.2013.11.007; Kim BK, 2013, INT NEUROUROL J, V17, P114, DOI 10.5213/inj.2013.17.3.114; Kosten TA, 2008, NEUROPSYCHOPHARMACOL, V33, P1545, DOI 10.1038/sj.npp.1301527; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lee IN, 2015, J NEUROSCI RES, V93, P178, DOI 10.1002/jnr.23454; Lukkes JL, 2013, NEUROSCIENCE, V237, P139, DOI 10.1016/j.neuroscience.2013.01.070; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Malek ZS, 2005, EUR J NEUROSCI, V22, P895, DOI 10.1111/j.1460-9568.2005.04264.x; Mandelli L, 2012, J AFFECT DISORDERS, V142, P82, DOI 10.1016/j.jad.2012.03.047; McEuen JG, 2008, J NEUROSCI, V28, P8169, DOI 10.1523/JNEUROSCI.0004-08.2008; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; McKernan DP, 2009, PROG NEUROBIOL, V88, P246, DOI 10.1016/j.pneurobio.2009.04.006; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Ni Chonghaile T, 2006, APOPTOSIS, V11, P1247, DOI 10.1007/s10495-006-7233-1; Orlovsky MA, 2014, BRAIN RES, V1593, P83, DOI 10.1016/j.brainres.2014.09.059; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitychoutis PM, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-4; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Qian YH, 2009, BBA-MOL CELL RES, V1793, P764, DOI 10.1016/j.bbamcr.2009.01.017; REUL JMHM, 1987, J ENDOCRINOL, V115, P459, DOI 10.1677/joe.0.1150459; REUL JMHM, 1989, MOL ENDOCRINOL, V3, P1674, DOI 10.1210/mend-3-10-1674; SCHAPIRO S, 1962, P SOC EXP BIOL MED, V109, P935; Schweimer JV, 2010, NEUROSCIENCE, V171, P1209, DOI 10.1016/j.neuroscience.2010.09.058; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Shishkina GT, 2015, PSYCHOPHARMACOLOGY, V232, P851, DOI 10.1007/s00213-014-3718-8; Shishkina GT, 2012, NEUROPHARMACOLOGY, V62, P177, DOI 10.1016/j.neuropharm.2011.06.016; Shishkina GT, 2010, BEHAV BRAIN RES, V213, P218, DOI 10.1016/j.bbr.2010.05.003; Shishkina GT, 2008, ANN NY ACAD SCI, V1148, P148, DOI 10.1196/annals.1410.074; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; Van den Hove DLA, 2014, EUR NEUROPSYCHOPHARM, V24, P595, DOI 10.1016/j.euroneuro.2013.09.006; Viegas LR, 2004, J BIOL CHEM, V279, P9831, DOI 10.1074/jbc.M312402200; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wu XY, 2015, PHYSIOL BEHAV, V145, P118, DOI 10.1016/j.physbeh.2015.04.003; Zammit S, 2006, BRIT J PSYCHIAT, V188, P199, DOI 10.1192/bjp.bp.105.020644; Zuloaga DG, 2012, J NEUROSCI RES, V90, P1403, DOI 10.1002/jnr.23026	76	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143978	10.1371/journal.pone.0143978	http://dx.doi.org/10.1371/journal.pone.0143978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624017	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600082
J	Tanaka, Y; Aoyagi, K; Minashi, K; Komatsuzaki, R; Komatsu, M; Chiwaki, F; Tamaoki, M; Nishimura, T; Takahashi, N; Oda, I; Tachimori, Y; Arao, T; Nishio, K; Kitano, S; Narumi, K; Aoki, K; Fujii, S; Ochiai, A; Yoshida, T; Muto, M; Yamada, Y; Sasaki, H				Tanaka, Yosuke; Aoyagi, Kazuhiko; Minashi, Keiko; Komatsuzaki, Rie; Komatsu, Masayuki; Chiwaki, Fumiko; Tamaoki, Masashi; Nishimura, Takao; Takahashi, Naoki; Oda, Ichiro; Tachimori, Yuji; Arao, Tokuzo; Nishio, Kazuto; Kitano, Shigehisa; Narumi, Kenta; Aoki, Kazunori; Fujii, Satoshi; Ochiai, Atsushi; Yoshida, Teruhiko; Muto, Manabu; Yamada, Yasuhide; Sasaki, Hiroki			Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy	PLOS ONE			English	Article							DEFINITIVE CHEMORADIOTHERAPY; PHASE-II; CANCER; IRRADIATION; CHEMOTHERAPY; PHENOTYPE; PROGNOSIS; THERAPY; IMPACT	Definitive chemoradiotherapy (CRT) is a less invasive therapy for esophageal squamous cell carcinoma (ESCC). Five-year survival rate of locally advanced ESCC patients by definitive CRT were 37%. We previously reported that tumor-specific cytotoxic T-lymphocyte (CTL) activation signatures were preferentially found in long-term survivors. However, it is unknown whether the CTL activation is actually driven by CRT. We compared gene expression profiles among pre- and post-treatment biopsy specimens of 30 ESCC patients and 121 pre-treatment ESCC biopsy specimens. In the complete response (CR) cases, 999 overexpressed genes including at least 234 tumor-specific CTL-activation associated genes such as IFNG, PRF1, and GZMB, were found in post-treatment biopsy specimens. Clustering analysis using expression profiles of these 234 genes allowed us to distinguish the immune-activated cases, designating them as I-type, from other cases. However, despite the better CR rate in the I-type, overall survival was not significantly better in both these 30 cases and another 121 cases. Further comparative study identified a series of epithelial to mesenchymal transition-related genes overexpressed in the early relapse cases. Importantly, the clinical outcome of CDH2-negative cases in the I-type was significantly better than that of the CDH2-positive cases in the I-type. Furthermore, NK cells, which were activated by neutrophils-producing S100A8/S100A9, and CTLs were suggested to cooperatively enhance the effect of CRT in the CDH2-negative I-type. These results suggested that CTL gene activation may provide a prognostic advantage in ESCCs with epithelial characteristics.	[Tanaka, Yosuke; Takahashi, Naoki; Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Oda, Ichiro] Natl Canc Ctr, Dept Gastrointestinal Oncol & Endoscopy, Tokyo, Japan; [Tachimori, Yuji] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan; [Kitano, Shigehisa] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan; [Aoyagi, Kazuhiko; Komatsuzaki, Rie; Komatsu, Masayuki; Chiwaki, Fumiko; Tamaoki, Masashi; Nishimura, Takao; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Narumi, Kenta; Aoki, Kazunori] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Tokyo, Japan; [Fujii, Satoshi; Ochiai, Atsushi] Fundamental Innovat Oncol Core Ctr, Natl Canc Ctr Res Inst, Tokyo, Japan; [Arao, Tokuzo; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Minashi, Keiko] Chiba Canc Ctr, Dept Clin Trial Promot, Chiba 2608717, Japan; [Muto, Manabu] Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Kindai University (Kinki University); Chiba Cancer Center; Kyoto University	Muto, M (corresponding author), Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan.	mmuto@kuhp.kyoto-u.ac.jp; yamada0304@aol.com; hksasaki@ncc.go.jp	Yamada, Yasuhide/AAH-9124-2020		National Institute of Biomedical Innovation (the Advanced Research for Medical Products Mining Programme); Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control); National Cancer Center Research and Development Fund; Ministry of Education, Culture, Sports, Science and Technology of Japan; Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [15K14389] Funding Source: KAKEN	National Institute of Biomedical Innovation (the Advanced Research for Medical Products Mining Programme); Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control)(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The National Institute of Biomedical Innovation (the Advanced Research for Medical Products Mining Programme), Japan Agency for Medical Research and Development (Practical Research for Innovative Cancer Control), National Cancer Center Research and Development Fund, The Ministry of Education, Culture, Sports, Science and Technology of Japan, and The Princess Takamatsu Cancer Research Fund. Dr M Komatsu was the recipient of a Research Resident Fellowship from the Foundation of Promotion of Cancer Research in Japan.	AKIYAMA H, 1994, ANN SURG, V220, P364, DOI 10.1097/00000658-199409000-00012; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Ashida A, 2006, INT J ONCOL, V28, P1345; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Cho Y, 2003, CANCER RES, V63, P1555; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Komatsu M, 2014, EPIGENOMICS-UK, V6, P567, DOI [10.2217/EPI.14.56, 10.2217/epi.14.56]; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Menetrier-Caux C, 2012, TARGET ONCOL, V7, P15, DOI 10.1007/s11523-012-0208-y; Narumi K, 2015, J IMMUNOL, V194, P5539, DOI 10.4049/jimmunol.1402301; Ohtsu A, 1999, J CLIN ONCOL, V17, P2915, DOI 10.1200/JCO.1999.17.9.2915; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; ROTH JA, 1994, SEMIN ONCOL, V21, P453; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schumacher K, 2001, CANCER RES, V61, P3932; Tanabe S, 2014, INT J ONCOL, V44, P1955, DOI 10.3892/ijo.2014.2387; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069; Tsuchikawa T, 2012, ANN SURG ONCOL, V19, P1713, DOI 10.1245/s10434-011-1906-x	28	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143804	10.1371/journal.pone.0143804	http://dx.doi.org/10.1371/journal.pone.0143804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625258	Green Published, gold			2022-12-26	WOS:000365891600053
J	Ren, L; Campbell, A; Fang, HQ; Gautam, S; Elavazhagan, S; Fatehchand, K; Mehta, P; Stiff, A; Reader, BF; Mo, XK; Byrd, JC; Carson, WE; Butchar, JP; Tridandapani, S				Ren, Li; Campbell, Amanda; Fang, Huiqing; Gautam, Shalini; Elavazhagan, Saranya; Fatehchand, Kavin; Mehta, Payal; Stiff, Andrew; Reader, Brenda F.; Mo, Xiaokui; Byrd, John C.; Carson, William E., III; Butchar, Jonathan P.; Tridandapani, Susheela			Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fc gamma Receptor (Fc gamma R) Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MEDIATED PHAGOCYTOSIS OCCURS; TUMOR-NECROSIS-FACTOR; B-CELL; CROSS-LINKING; XID MICE; ACTIVATION; MACROPHAGES; PCI-32765; RITUXIMAB	The irreversible Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown efficacy against B-cell tumors such as chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Fc gamma receptors (Fc gamma R) on immune cells such as macrophages play an important role in tumor-specific antibody-mediated immune responses, but many such responses involve Btk. Here we tested the effects of ibrutinib on Fc gamma R-mediated activities in monocytes. We found that ibrutinib did not affect monocyte Fc gamma R-mediated phagocytosis, even at concentrations higher than those achieved physiologically, but suppressed Fc gamma R-mediated cytokine production. We confirmed these findings in macrophages from Xid mice in which Btk signaling is defective. Because calcium flux is a major event downstream of Btk, we tested whether it was involved in phagocytosis. The results showed that blocking intracellular calcium flux decreased Fc gamma R-mediated cytokine production but not phagocytosis. To verify this, we measured activation of the GTPase Rac, which is responsible for actin polymerization. Results showed that ibrutinib did not inhibit Rac activation, nor did the calcium chelator 1,2-bis(2-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid tetrakis( acetoxymethyl ester). We next asked whether the effect of ibrutinib on monocyte Fc gamma R-mediated cytokine production could be rescued by IFN gamma priming because NK cells produce IFN gamma in response to antibody therapy. Pretreatment of monocytes with IFN gamma abrogated the effects of ibrutinib on Fc gamma R-mediated cytokine production, suggesting that IFN gamma priming could overcome this Btk inhibition. Furthermore, in monocyte-natural killer cell co-cultures, ibrutinib did not inhibit Fc gamma R-mediated cytokine production despite doing so in single cultures. These results suggest that combining ibrutinib with monoclonal antibody therapy could enhance chronic lymphocytic leukemia cell killing without affecting macrophage effector function.	[Ren, Li] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130000, Peoples R China; [Campbell, Amanda; Fang, Huiqing; Gautam, Shalini; Elavazhagan, Saranya; Fatehchand, Kavin; Mehta, Payal; Stiff, Andrew; Reader, Brenda F.; Byrd, John C.; Carson, William E., III; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	Jilin University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP; Tridandapani, S (corresponding author), Ohio State Univ, Div Hematol, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	butchar.2@osu.edu; tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011		National Institutes of Health [P01-CA095426, R01 CA162411, R01 CA177292, R01 CA183444, T32 HL007946]; Ohio State University College of Medicine McWhinney Bridge Fund [244749]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA183444, R01CA162411, R01CA177292, P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T. and J. C. B.), R01 CA177292 and R01 CA183444 (to J. C. B.), and T32 HL007946 (to B. F. R.) and by Ohio State University College of Medicine McWhinney Bridge Fund 244749 (to J. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borge M, 2015, HAEMATOLOGICA, V100, pE140, DOI 10.3324/haematol.2014.119669; Burger JA, 2014, LANCET ONCOL, V15, P1090, DOI 10.1016/S1470-2045(14)70335-3; Cao XH, 2004, J IMMUNOL, V172, P4851, DOI 10.4049/jimmunol.172.8.4851; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Da Roit F, 2015, HAEMATOLOGICA, V100, P77, DOI 10.3324/haematol.2014.107011; Dasmahapatra G, 2013, BRIT J HAEMATOL, V161, P43, DOI 10.1111/bjh.12206; de Diego RP, 2006, J ALLERGY CLIN IMMUN, V117, P1462, DOI 10.1016/j.jaci.2006.01.037; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Herman SEM, 2014, BLOOD, V123, P3286, DOI 10.1182/blood-2014-02-548610; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Jaglowski SM, 2015, BLOOD, V126, P842, DOI 10.1182/blood-2014-12-617522; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; KARIMI K, 1995, J IMMUNOL, V155, P5786; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kohrt HE, 2014, BLOOD, V123, P1957, DOI 10.1182/blood-2014-01-547869; Kondadasula SV, 2008, BLOOD, V111, P4173, DOI 10.1182/blood-2007-01-068908; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; LENNARTZ MR, 1993, J LEUKOCYTE BIOL, V54, P389, DOI 10.1002/jlb.54.5.389; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Mehta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021175; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Mukhopadhyay S, 1999, J IMMUNOL, V163, P1786; Mukhopadhyay S, 1999, J IMMUNOL, V163, P875; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Ptak W, 1998, SCAND J IMMUNOL, V47, P136; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; RUSSELL PJ, 1983, CLIN IMMUNOL IMMUNOP, V27, P387, DOI 10.1016/0090-1229(83)90091-0; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; SCHER I, 1975, J EXP MED, V142, P637, DOI 10.1084/jem.142.3.637; SCHOLL PR, 1992, J IMMUNOL, V149, P1751; Setoguchi R, 1998, IMMUNOL LETT, V64, P109, DOI 10.1016/S0165-2478(98)00086-8; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175	53	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3043	3052		10.1074/jbc.M115.687251	http://dx.doi.org/10.1074/jbc.M115.687251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627823	hybrid, Green Published			2022-12-26	WOS:000369626900040
J	Chang, SF; Hsieh, RZ; Huang, KC; Chang, CA; Chiu, FY; Kuo, HC; Chen, CN; Su, YP				Chang, Shun-Fu; Hsieh, Rong-Ze; Huang, Kuo-Chin; Chang, Cheng Allen; Chiu, Fang-Yao; Kuo, Hsing-Chun; Chen, Cheng-Nan; Su, Yu-Ping			Upregulation of Bone Morphogenetic Protein-2 Synthesis and Consequent Collagen II Expression in Leptin-stimulated Human Chondrocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HISTONE DEACETYLASES; ARTICULAR-CARTILAGE; OSTEOARTHRITIC CHONDROCYTES; SERINE PHOSPHORYLATION; OSTEOPHYTE FORMATION; STAT3; ACTIVATION; DEGRADATION; OBESITY	Bone morphogenetic proteins (BMPs) play positive roles in cartilage development, but they can barely be detected in healthy articular cartilage. However, recent evidence has indicated that BMPs could be detected in osteoarthritic and damaged cartilage and their precise roles have not been well defined. Extremely high amounts of leptin have been reported in obese individuals, which can be associated with osteoarthritis (OA) development. The aim of this study was to investigate whether BMPs could be induced in human primary chondrocytes during leptin-stimulated OA development and the underlying mechanism. We found that expression of BMP-2 mRNA, but not BMP-4, BMP-6, or BMP-7 mRNA, could be increased in human primary chondrocytes under leptin stimulation. Moreover, this BMP-2 induction was mediated through transcription factor-signal transducer and activator of transcription (STAT) 3 activation via JAK2-ERK1/2-induced Ser727-phosphorylation. Of note, histone deacetylases (HDACs) 3 and 4 were both involved in modulating leptin-induced BMP-2 mRNA expression through different pathways: HDAC3, but not HDAC4, associated with STAT3 to form a complex. Our results further demonstrated that the role of BMP-2 induction under leptin stimulation is to increase collagen II expression. The findings in this study provide new insights into the regulatory mechanism of BMP-2 induction in leptin-stimulated chondrocytes and suggest that BMP-2 may play a reparative role in regulating leptin-induced OA development.	[Chang, Shun-Fu; Hsieh, Rong-Ze] Chang Gung Mem Hosp, Dept Med Res & Dev, Chiayi Branch, Chiayi, Taiwan; [Huang, Kuo-Chin] Chang Gung Mem Hosp, Dept Orthopaed, Chiayi Branch, Chiayi, Taiwan; [Chang, Cheng Allen] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chiu, Fang-Yao; Su, Yu-Ping] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Chiu, Fang-Yao; Su, Yu-Ping] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Kuo, Hsing-Chun] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung University of Science & Technology; National Chiayi University	Chen, CN (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	cnchen@mail.ncyu.edu.tw; ypsu@vghtpe.gov.tw	HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504; Su, Yu-Ping/0000-0002-5390-4113	National Science Council of Taiwan [NSC 101-2320-B-010-035, 102-2320-B-010-028, MOST 103-2320-B-182A-021-MY3]; Taipei Veterans General Hospital of Taiwan [V102C-194, V103C-116, V104C-155]; Chang Gung Memorial Hospital-Chiayi Branch of Taiwan [CMRPG6E0231]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital of Taiwan(Taipei Veterans General Hospital); Chang Gung Memorial Hospital-Chiayi Branch of Taiwan	This work was supported by the grants from National Science Council of Taiwan (NSC 101-2320-B-010-035, 102-2320-B-010-028, and MOST 103-2320-B-182A-021-MY3), Taipei Veterans General Hospital of Taiwan (V102C-194, V103C-116, and V104C-155), and Chang Gung Memorial Hospital-Chiayi Branch of Taiwan (CMRPG6E0231). The funders had no role in study design, data collection and analysis, or manuscript preparation.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Babaei A, 2011, HORM-INT J ENDOCRINO, V10, P16, DOI 10.14310/horm.2002.1289; Ben-Eliezer M, 2007, ENDOCRINE, V32, P235, DOI 10.1007/s12020-007-9025-y; Chen WP, 2010, MOL BIOL REP, V37, P3967, DOI 10.1007/s11033-010-0055-9; Chubinskaya S, 2007, INT ORTHOP, V31, P773, DOI 10.1007/s00264-007-0423-9; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Culley KL, 2013, ARTHRITIS RHEUM-US, V65, P1822, DOI 10.1002/art.37965; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; Davidson ENB, 2015, ANN RHEUM DIS, V74, P1257, DOI 10.1136/annrheumdis-2013-204528; Davidson ENB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2305; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Fukui N, 2003, J BONE JOINT SURG AM, V85A, P59, DOI 10.2106/00004623-200300003-00011; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Griffin TM, 2009, ARTHRITIS RHEUM-US, V60, P2935, DOI 10.1002/art.24854; Gualillo O, 2007, OSTEOARTHR CARTILAGE, V15, P857, DOI 10.1016/j.joca.2007.04.015; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Hayashi M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2521; Hui W, 2012, ANN RHEUM DIS, V71, P455, DOI 10.1136/annrheumdis-2011-200372; Im GI, 2013, EXPERT OPIN BIOL TH, V13, P713, DOI 10.1517/14712598.2013.764410; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Leah Emma, 2013, Nat Rev Rheumatol, V9, P321, DOI 10.1038/nrrheum.2013.63; Lee DY, 2012, P NATL ACAD SCI USA, V109, P1967, DOI 10.1073/pnas.1121214109; Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Nakase T, 2003, OSTEOARTHR CARTILAGE, V11, P278, DOI 10.1016/S1063-4584(03)00004-9; Ohba S, 2010, OSTEOARTHR CARTILAGE, V18, P1620, DOI 10.1016/j.joca.2010.09.006; Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Sakaguchi M, 2012, J INVEST DERMATOL, V132, P1877, DOI 10.1038/jid.2012.45; Scotece M, 2013, CURR MED CHEM, V20, P3416, DOI 10.2174/0929867311320270006; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; van Beuningen HM, 1998, OSTEOARTHR CARTILAGE, V6, P306, DOI 10.1053/joca.1998.0129; van der Kraan PM, 2010, OSTEOARTHR CARTILAGE, V18, P735, DOI 10.1016/j.joca.2010.03.001; Vuolteenaho K, 2012, ANN RHEUM DIS, V71, P1912, DOI 10.1136/annrheumdis-2011-201242; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930; Zhou BD, 2011, CARDIOVASC RES, V90, P413, DOI 10.1093/cvr/cvr003; Zhou Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-109	45	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144252	10.1371/journal.pone.0144252	http://dx.doi.org/10.1371/journal.pone.0144252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636769	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800062
J	Yui, DS; Nishida, Y; Nishina, T; Mogushi, K; Tajiri, M; Ishibashi, S; Ajioka, I; Ishikawa, K; Mizusawa, H; Murayama, S; Yokota, T				Yui, Daishi; Nishida, Yoichiro; Nishina, Tomoko; Mogushi, Kaoru; Tajiri, Mio; Ishibashi, Satoru; Ajioka, Itsuki; Ishikawa, Kinya; Mizusawa, Hidehiro; Murayama, Shigeo; Yokota, Takanori			Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; MOUSE MODEL; A(2); BRAIN; PROTEIN; DEATH; ACID; DYSFUNCTION; ACTIVATION	Oxidative stress has a ubiquitous role in neurodegenerative diseases and oxidative damage in specific regions of the brain is associated with selective neurodegeneration. We previously reported that Alzheimer disease (AD) model mice showed decreased insulindegrading enzyme (IDE) levels in the cerebrum and accelerated phenotypic features of AD when crossbred with alpha-tocopherol transfer protein knockout (Ttpa(-/-)) mice. To further investigate the role of chronic oxidative stress in AD pathophysiology, we performed DNA microarray analysis using young and aged wild-type mice and aged Ttpa(-/-) mice. Among the genes whose expression changed dramatically was Phospholipase A2 group 3 (Pla2g3); Pla2g3 was identified because of its expression profile of cerebral specific up-regulation by chronic oxidative stress in silico and in aged Ttpa(-/-) mice. Immunohistochemical studies also demonstrated that human astrocytic Pla2g3 expression was significantly increased in human AD brains compared with control brains. Moreover, transfection of HEK293 cells with human Pla2g3 decreased endogenous IDE expression in a dose-dependent manner. Our findings show a key role of Pla2g3 on the reduction of IDE, and suggest that cerebrum specific increase of Pla2g3 is involved in the initiation and/or progression of AD.	[Yui, Daishi; Nishida, Yoichiro; Nishina, Tomoko; Tajiri, Mio; Ishibashi, Satoru; Ishikawa, Kinya; Yokota, Takanori] Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Tokyo, Japan; [Mogushi, Kaoru] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Tokyo, Japan; [Ajioka, Itsuki] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan; [Mizusawa, Hidehiro] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Tokyo, Japan; [Murayama, Shigeo] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute of Gerontology	Yokota, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Tokyo, Japan.	yokonuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263; Mogushi, Kaoru/0000-0002-2618-8684	Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Dorfman VB, 2010, NEUROBIOL AGING, V31, P1743, DOI 10.1016/j.neurobiolaging.2008.09.016; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Chiricozzi E, 2010, J NEUROCHEM, V112, P1574, DOI 10.1111/j.1471-4159.2010.06567.x; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; DeCoster MA, 2003, BRAIN RES, V988, P20, DOI 10.1016/S0006-8993(03)03326-2; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Feng L, 2013, CELL MOL NEUROBIOL, V33, P759, DOI 10.1007/s10571-013-9943-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Ichijo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138029; Ikeno Y, 2005, J BIOL CHEM, V280, P28044, DOI 10.1074/jbc.M503343200; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Li Y, 2012, P NATL ACAD SCI USA, V109, P15491, DOI 10.1073/pnas.1212899109; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Martinez-Garcia A, 2010, J ALZHEIMERS DIS, V22, P1181, DOI 10.3233/JAD-2010-101348; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; Mulder SD, 2012, EXP NEUROL, V233, P373, DOI 10.1016/j.expneurol.2011.11.001; Murakami M, 2015, ALLERGOL INT, V64, P4, DOI 10.1016/j.alit.2014.07.005; Nishida Y, 2006, BIOCHEM BIOPH RES CO, V350, P530, DOI 10.1016/j.bbrc.2006.09.083; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Sato H, 2010, J CLIN INVEST, V120, P1400, DOI 10.1172/JCI40493; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sato H, 2008, J BIOL CHEM, V283, P33483, DOI 10.1074/jbc.M804628200; Schaeffer EL, 2010, PROG NEURO-PSYCHOPH, V34, P1381, DOI 10.1016/j.pnpbp.2010.08.019; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smallheiser NR, 1996, BRAIN RES, V721, P39, DOI 10.1016/0006-8993(96)00134-5; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Tetsuka K, 2001, CELL STRUCT FUNCT, V26, P197, DOI 10.1247/csf.26.197; Venkateshappa C, 2012, NEUROCHEM RES, V37, P1601, DOI 10.1007/s11064-012-0755-8; Yagami T, 2003, J NEUROCHEM, V85, P749, DOI 10.1046/j.1471-4159.2003.01712.x; Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114; Yokota T, 2001, P NATL ACAD SCI USA, V98, P15185, DOI 10.1073/pnas.261456098; Yui D, 2001, ONCOGENE, V20, P4317, DOI 10.1038/sj.onc.1204576; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143518	10.1371/journal.pone.0143518	http://dx.doi.org/10.1371/journal.pone.0143518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637123	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800015
J	Silva-Herzog, E; McDonald, EM; Crooks, AL; Detweiler, CS				Silva-Herzog, Eugenia; McDonald, Erin M.; Crooks, Amy L.; Detweiler, Corrella S.			Physiologic Stresses Reveal a Salmonella Persister State and TA Family Toxins Modulate Tolerance to These Stresses	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; GENE-EXPRESSION; ANTITOXIN LOCI; CELLS; MACROPHAGES; VIRULENCE; DEPOLARIZATION; REPLICATION	Bacterial persister cells are considered a basis for chronic infections and relapse caused by bacterial pathogens. Persisters are phenotypic variants characterized by low metabolic activity and slow or no replication. This low metabolic state increases pathogen tolerance to antibiotics and host immune defenses that target actively growing cells. In this study we demonstrate that within a population of Salmonella enterica serotype Typhimurium, a small percentage of bacteria are reversibly tolerant to specific stressors that mimic the macrophage host environment. Numerous studies show that Toxin-Antitoxin (TA) systems contribute to persister states, based on toxin inhibition of bacterial metabolism or growth. To identify toxins that may promote a persister state in response to host-associated stressors, we analyzed the six TA loci specific to S. enterica serotypes that cause systemic infection in mammals, including five RelBE family members and one VapBC member. Deletion of TA loci increased or decreased tolerance depending on the stress conditions. Similarly, exogenous expression of toxins had mixed effects on bacterial survival in response to stress. In macrophages, S. Typhimurium induced expression of three of the toxins examined. These observations indicate that distinct toxin family members have protective capabilities for specific stressors but also suggest that TA loci have both positive and negative effects on tolerance.	[Silva-Herzog, Eugenia; McDonald, Erin M.; Crooks, Amy L.; Detweiler, Corrella S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Detweiler, CS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	detweile@colorado.edu	Silva-Herzog, Eugenia/AFP-3674-2022; DETWEILER, CORRELLA S/ABG-2625-2021	DETWEILER, CORRELLA S/0000-0002-7783-0876	United States National Institutes of Health [AI095395]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095395, R21AI099593, R56AI095395] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant # AI095395 from the United States National Institutes of Health to CSD (http://projectreporter.nih.gov/reporter.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Amatore C, 2006, CHEMBIOCHEM, V7, P653, DOI 10.1002/cbic.200500359; ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Cheng HY, 2014, ENVIRON MICROBIOL, V16, P1741, DOI 10.1111/1462-2920.12373; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Dey AK, 2013, J BACTERIOL, V195, P2004, DOI 10.1128/JB.02127-12; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017962; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Horcajo P, 2013, CAN J VET RES, V77, P158; Kaspy I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4001; Katribe E, 2009, J BACTERIOL, V191, P2843, DOI 10.1128/JB.01223-08; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim J, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-84; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lobato-Marquez D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09374; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pilonieta MC, 2009, J BACTERIOL, V191, P7243, DOI 10.1128/JB.00688-09; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Silva-Herzog E, 2010, INFECT IMMUN, V78, P3369, DOI 10.1128/IAI.00292-10; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; SMITH BP, 1984, AM J VET RES, V45, P59; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Van Acker H, 2014, PATHOG DIS, V71, P326, DOI 10.1111/2049-632X.12177; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651	52	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0141343	10.1371/journal.pone.0141343	http://dx.doi.org/10.1371/journal.pone.0141343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633172	gold, Green Submitted, Green Published			2022-12-26	WOS:000366040000002
J	Tsuruya, K; Yoshida, H; Haruyama, N; Fujisaki, K; Hirakata, H; Kitazono, T				Tsuruya, Kazuhiko; Yoshida, Hisako; Haruyama, Naoki; Fujisaki, Kiichiro; Hirakata, Hideki; Kitazono, Takanari			Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; VOXEL-BASED MORPHOMETRY; BRAIN ATROPHY; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; MEMORY DYSFUNCTION; OXIDATIVE STRESS; ELDERLY JAPANESE; WORKING-MEMORY; RISK-FACTORS	Background & Objectives It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidated. The purpose of the present study is to examine the correlation between gray matter volume (GMV) and executive function in CKD patients. Design, Setting, Participants, Measurements This cross-sectional study recruited 95 patients with non-dialysis-dependent CKD (NDD-CKD) with no history of cerebrovascular disease, who underwent brain magnetic resonance imaging (MRI) and Trail Making Test (TMT) in the VCOHP Study. The subjects underwent brain MRI and TMT part A (TMT-A) and part B (TMT-B). The segmentation algorithm from Statistical Parametric Mapping 8 software was applied to every T1-weighted MRI scan to extract tissue maps corresponding to gray matter, white matter, and cerebrospinal fluid. GMV was normalized by dividing by the total intracranial volume, calculated by adding GMV, white matter volume, and cerebrospinal fluid space volume. Then, normalized whole-brain GMV was divided into four categories of brain lobes; frontal, parietal, temporal, and occipital. We assessed the correlation between normalized GMV and TMT using multivariable regression analysis. Results Normalized whole-brain GMV was significantly inversely correlated to the scores of TMT-A, TMT-B, and Delta TMT (TMT-B minus TMT-A). These correlations remained significant even after adjusting for relevant confounding factors. Normalized frontal and temporal GMV, but not parietal and occipital GMV, were significantly inversely correlated with TMT-A, TMT-B, and Delta TMT using multivariable regression analysis. Conclusions The present study demonstrates the correlation between normalized GMV, especially in the frontal and temporal lobes, and executive function, suggesting that fronto-temporal gray matter atrophy might contribute to executive dysfunction in NDD-CKD.	[Tsuruya, Kazuhiko; Yoshida, Hisako] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan; [Tsuruya, Kazuhiko; Haruyama, Naoki; Fujisaki, Kiichiro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan; [Hirakata, Hideki] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan	Kyushu University; Kyushu University	Tsuruya, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka 812, Japan.	tsuruya@intmed2.med.kyushu-u.ac.jp						Bassi A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00182; BOONE KB, 1992, ARCH NEUROL-CHICAGO, V49, P549, DOI 10.1001/archneur.1992.00530290141024; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Fujisaki K, 2014, NEPHROL DIAL TRANSPL, V29, P529, DOI 10.1093/ndt/gft327; Fukunishi I, 2002, NEPHRON, V91, P344, DOI 10.1159/000058418; Haruyama N, 2014, LIFE SCI, V113, P55, DOI 10.1016/j.lfs.2014.07.032; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hayashi K, 2011, DIABETES RES CLIN PR, V94, P180, DOI 10.1016/j.diabres.2011.07.002; HIRAKATA H, 1992, AM J PHYSIOL, V262, pF737, DOI 10.1152/ajprenal.1992.262.5.F737; Hirota C, 2010, GERIATR GERONTOL INT, V10, P40, DOI 10.1111/j.1447-0594.2009.00557.x; Hughes TM, 2013, J DIABETES COMPLICAT, V27, P558, DOI 10.1016/j.jdiacomp.2013.07.001; Jokinen H, 2012, NEUROLOGY, V78, P1785, DOI 10.1212/WNL.0b013e3182583070; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Koushik NS, 2010, NEUROPSYCHOL REV, V20, P33, DOI 10.1007/s11065-009-9110-5; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; MARSH JT, 1991, KIDNEY INT, V39, P155, DOI 10.1038/ki.1991.20; Mizumasa T, 2004, NEPHRON CLIN PRACT, V97, pC23, DOI 10.1159/000077592; Moran C, 2015, DIABETES, V64, P279, DOI 10.2337/db14-0506; Murea M, 2015, NEPHROL DIAL TRANSPL, V30, P1322, DOI 10.1093/ndt/gfv030; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Reitan RM, 1985, HALSTEAD REITAN NEUR; Roberts RO, 2014, NEUROLOGY, V82, P1132, DOI 10.1212/WNL.0000000000000269; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; SAVAZZI GM, 1995, NEPHRON, V69, P29, DOI 10.1159/000188356; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tsuruya K, 2015, AM J KIDNEY DIS, V65, P312, DOI 10.1053/j.ajkd.2014.07.011; Yakushiji Y, 2010, HYPERTENS RES, V33, P1232, DOI 10.1038/hr.2010.171; Yao H, 2011, HYPERTENS RES, V34, P1023, DOI 10.1038/hr.2011.83; Yoshimitsu T, 2000, CLIN NEPHROL, V53, P445; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143706	10.1371/journal.pone.0143706	http://dx.doi.org/10.1371/journal.pone.0143706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632813	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000021
J	Wojtal-Frankiewicz, A; Kruk, A; Frankiewicz, P; Oleksinska, Z; Izydorczyk, K				Wojtal-Frankiewicz, Adrianna; Kruk, Andrzej; Frankiewicz, Piotr; Oleksinska, Zuzanna; Izydorczyk, Katarzyna			Long-Term Patterns in the Population Dynamics of Daphnia longispina, Leptodora kindtii and Cyanobacteria in a Shallow Reservoir: A Self-Organising Map (SOM) Approach	PLOS ONE			English	Article							CLEAR-WATER PHASE; MICROCYSTIS-AERUGINOSA; PEG-MODEL; ZOOPLANKTON COMMUNITY; SEASONAL SUCCESSION; SULEJOW-RESERVOIR; PRIMARY PRODUCERS; GREEN-ALGA; BLOOMS; PHYTOPLANKTON	The recognition of long-term patterns in the seasonal dynamics of Daphnia longispina, Leptodora kindtii and cyanobacteria is dependent upon their interactions, the water temperature and the hydrological conditions, which were all investigated between 1999 and 2008 in the lowland Sulejow Reservoir. The biomass of cyanobacteria, densities of D. longispina and L. kindtii, concentration of chlorophyll a and water temperature were assessed weekly from April to October at three sampling stations along the longitudinal reservoir axis. The retention time was calculated using data on the actual water inflow and reservoir volume. A self-organising map (SOM) was used due to high interannual variability in the studied parameters and their often non-linear relationships. Classification of the SOM output neurons into three clusters that grouped the sampling terms with similar biotic states allowed identification of the crucial abiotic factors responsible for the seasonal sequence of events: cluster CL-ExSp (extreme/spring) corresponded to hydrologically unstable cold periods (mostly spring) with extreme values and highly variable abiotic factors, which made abiotic control of the biota dominant; cluster CL-StSm (stable/summer) was associated with ordinary late spring and summer and was characterised by stable non-extreme abiotic conditions, which made biotic interactions more important; and the cluster CL-ExSm (extreme/summer), was associated with late spring/summer and characterised by thermal or hydrological extremes, which weakened the role of biotic factors. The significance of the differences between the SOM sub-clusters was verified by Kruskal-Wallis and post-hoc Dunn tests. The importance of the temperature and hydrological regimes as the key plankton-regulating factors in the dam reservoir, as shown by the SOM, was confirmed by the results of canonical correlation analyses (CCA) of each cluster. The demonstrated significance of hydrology in seasonal plankton dynamics complements the widely accepted pattern proposed by the plankton succession model for lakes, the PEG (Plankton Ecology Group), and may be useful for the formulation of management decisions in dam reservoirs.	[Wojtal-Frankiewicz, Adrianna; Frankiewicz, Piotr; Oleksinska, Zuzanna] Univ Lodz, Dept Appl Ecol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Kruk, Andrzej] Univ Lodz, Dept Ecol & Vertebrate Zool, Fac Biol & Environm Protect, PL-90131 Lodz, Poland; [Frankiewicz, Piotr; Izydorczyk, Katarzyna] Polish Acad Sci, European Reg Ctr Ecohydrol, Lodz, Poland	University of Lodz; University of Lodz; Polish Academy of Sciences; European Regional Centre for Ecohydrology of the Polish Academy of Sciences	Wojtal-Frankiewicz, A (corresponding author), Univ Lodz, Dept Appl Ecol, Fac Biol & Environm Protect, PL-90131 Lodz, Poland.	adwoj@biol.uni.lodz.pl		Izydorczyk, Katarzyna/0000-0003-2056-2513; Kruk, Andrzej/0000-0003-1452-7906; Wojtal-Frankiewicz, Adrianna/0000-0003-3509-6076; Frankiewicz, Piotr/0000-0003-1782-9539	Life+EnvEurope Project [LIFE08 ENV/IT/000339]	Life+EnvEurope Project	The Sulejow Reservoir is a part of the Polish National Long-Term Ecosystem Research Network and the European LTER site. It is also a monitoring and research site of the Life+EnvEurope Project LIFE08 ENV/IT/000339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; [Anonymous], 1999, TOXIC CYANOBACTERIA; Bednarska A, 2014, J PLANKTON RES, V36, P838, DOI 10.1093/plankt/fbu009; Benndorf J, 2001, FRESHWATER BIOL, V46, P199, DOI 10.1046/j.1365-2427.2000.00657.x; Benzie J.A., 2005, GUIDES IDENTIFICATIO, V21, P1; BRANSTRATOR DK, 1991, LIMNOL OCEANOGR, V36, P483, DOI 10.4319/lo.1991.36.3.0483; Brosse S, 2001, ECOL MODEL, V146, P159, DOI 10.1016/S0304-3800(01)00303-9; Carlotti F., 2000, P571, DOI 10.1016/B978-012327645-2/50013-X; Cereghino R, 2009, ENVIRON MODELL SOFTW, V24, P945, DOI 10.1016/j.envsoft.2009.01.008; Chen CY, 1996, LIMNOL OCEANOGR, V41, P1077, DOI 10.4319/lo.1996.41.5.1077; Demott WR, 1999, FRESHWATER BIOL, V42, P263, DOI 10.1046/j.1365-2427.1999.444494.x; Droscher I, 2008, INT VER THEOR ANGEW, V30, P186; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Ferrao AS, 2002, LIMNOLOGICA, V32, P295, DOI 10.1016/S0075-9511(02)80021-4; Frankiewicz P, 1999, HYDROBIOLOGIA, V408, P47, DOI 10.1023/A:1017001803791; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; Godlewska M, 2003, HYDROBIOLOGIA, V504, P305, DOI 10.1023/B:HYDR.0000008530.31142.81; Harris GP., 1986, PHYTOPLANKTON ECOLOG; HERZIG A, 1990, HYDROBIOLOGIA, V198, P107, DOI 10.1007/BF00048627; Izydorczyk K, 2008, INT REV HYDROBIOL, V93, P257, DOI 10.1002/iroh.200710959; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Jurczak T, 2005, WATER RES, V39, P2394, DOI 10.1016/j.watres.2005.04.031; JURGENS K., 1994, REV MAR MICROB FOOD, V8, P295; Kimmel B.L., 1990, RESERVOIR LIMNOLOGY, P133; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kohonen T., 2001, SELF ORG MAPS; Komarkova J, 1995, WATER SCI TECHNOL, V32, P207, DOI 10.1016/0273-1223(95)00700-8; Lampert W, 2011, DAPHNIA DEV MODEL OR; Lampert W, 1997, LIMNOECOLOGY ECOLOGY; Lehman JT, 2007, FRESHWATER BIOL, V52, P1773, DOI 10.1111/j.1365-2427.2007.01808.x; Lek S, 2005, MODELLING COMMUNITY; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; LUNTE CC, 1990, LIMNOL OCEANOGR, V35, P1091, DOI 10.4319/lo.1990.35.5.1091; Mankiewicz-Boczek J, 2006, ENVIRON TOXICOL, V21, P380, DOI 10.1002/tox.20200; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Naselli-Flores L, 1997, HYDROBIOLOGIA, V360, P223, DOI 10.1023/A:1003108919638; Paerl H, 2008, ADV EXP MED BIOL, V619, P217, DOI 10.1007/978-0-387-75865-7_10; Paerl Hans W., 2014, Life-Basel, V4, P988, DOI 10.3390/life4040988; Persson J, 2007, OIKOS, V116, P1152, DOI 10.1111/j.2007.0030-1299.15639.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reichwaldt ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066674; Rennella AM, 2006, HYDROBIOLOGIA, V556, P181, DOI 10.1007/s10750-005-0318-y; Roelke DL, 2011, J PLANKTON RES, V33, P205, DOI 10.1093/plankt/fbq143; Rohrlack T, 1999, J PLANKTON RES, V21, P1489, DOI 10.1093/plankt/21.8.1489; Schalau K, 2008, OECOLOGIA, V157, P531, DOI 10.1007/s00442-008-1081-3; Sommer F, 2003, FRESHWATER BIOL, V48, P67, DOI 10.1046/j.1365-2427.2003.00971.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Straile D, 2015, FRESHWATER BIOL, V60, P174, DOI 10.1111/fwb.12484; Straskrabova V., 2005, Limnetica, V24, P9; Talling JF, 2003, FRESHWATER BIOL, V48, P39, DOI 10.1046/j.1365-2427.2003.00968.x; Thomton J., 1996, WATER QUALITY ASSESS, P371; Verbitsky VB, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011019; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5; VOROS L, 1991, HYDROBIOLOGIA, V215, P111, DOI 10.1007/BF00014715; Wagner A, 2007, OECOLOGIA, V151, P351, DOI 10.1007/s00442-006-0554-5; Wagner I., 2009, Ecohydrology and Hydrobiology, V9, P13, DOI 10.2478/V10104-009-0042-8; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wojtal A, 2008, ANN LIMNOL-INT J LIM, V44, P7, DOI 10.1051/limn:2008025; Wojtal A, 2004, HYDROBIOLOGIA, V515, P123, DOI 10.1023/B:HYDR.0000027324.44452.9e; Wojtal A, 1999, HYDROBIOLOGIA, V416, P215, DOI 10.1023/A:1003815520751; Wojtal A., 2000, THESIS; Wojtal-Frankiewicz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112597; Wojtal-Frankiewicz A, 2013, J LIMNOL, V72, P154, DOI 10.4081/jlimnol.2013.e13; Wojtal-Frankiewicz A, 2012, AQUAT ECOL, V46, P37, DOI 10.1007/s10452-011-9380-x; Wolfinbarger WC, 1999, HYDROBIOLOGIA, V400, P13, DOI 10.1023/A:1003738608697; Zalewski M, 2002, HYDROLOG SCI J, V47, P823, DOI 10.1080/02626660209492986; Zalewski M., 1985, P3; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; ZETTLER ER, 1986, CAN J FISH AQUAT SCI, V43, P665, DOI 10.1139/f86-080	72	10	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144109	10.1371/journal.pone.0144109	http://dx.doi.org/10.1371/journal.pone.0144109			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633032	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000057
J	Adamberg, K; Tomson, K; Talve, T; Pudova, K; Puurand, M; Visnapuu, T; Alamae, T; Adamberg, S				Adamberg, Kaarel; Tomson, Katrin; Talve, Tiina; Pudova, Ksenia; Puurand, Marju; Visnapuu, Triinu; Alamaee, Tiina; Adamberg, Signe			Levan Enhances Associated Growth of Bacteroides, Escherichia, Streptococcus and Faecalibacterium in Fecal Microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PH; FERMENTATION; DIET; IMPACT; INULIN	The role of dietary fiber in supporting healthy gut microbiota and overall well-being of the host has been revealed in several studies. Here, we show the effect of a bacterial polyfructan levan on the growth dynamics and metabolism of fecal microbiota in vitro by using isothermal microcalorimetry. Eleven fecal samples from healthy donors were incubated in phosphate-buffered defined medium with or without levan supplementation and varying presence of amino acids. The generation of heat, changes in pH and microbiota composition, concentrations of produced and consumed metabolites during the growth were determined. The composition of fecal microbiota and profile of metabolites changed in response to substrate (levan and amino acids) availability. The main products of levan metabolism were acetic, lactic, butyric, propionic and succinic acids and carbon dioxide. Associated growth of levan-degrading (e.g. Bacteroides) and butyric acid-producing (e.g. Faecalibacterium) taxa was observed in levan-supplemented media. The study shows that the capacity of levan and possibly also other dietary fibers/prebiotics to modulate the composition and function of colon microbiota can be predicted by using isothermal microcalorimetry of fecal samples linked to metabolite and consortia analyses.	[Adamberg, Kaarel; Puurand, Marju; Adamberg, Signe] Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia; [Adamberg, Kaarel; Tomson, Katrin; Talve, Tiina; Pudova, Ksenia] Competence Ctr Food & Fermentat Technol, EE-12618 Tallinn, Estonia; [Visnapuu, Triinu; Alamaee, Tiina] Univ Tartu, Inst Mol & Cell Biol, Dept Genet, EE-51010 Tartu, Estonia; [Visnapuu, Triinu] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Tallinn University of Technology; University of Tartu; Technical University of Denmark	Adamberg, K (corresponding author), Tallinn Univ Technol, Food Proc Dept, EE-19086 Tallinn, Estonia.	kaarel.adamberg@ttu.ee	Adamberg, Kaarel/AAE-3295-2019; Puurand, Marju/M-9777-2019; Adamberg, Kaarel/D-1084-2013; Visnapuu, Triinu/G-3208-2016; Puurand, Marju/E-5750-2016; Talve, Tiina/AAZ-3494-2020	Adamberg, Kaarel/0000-0002-7203-925X; Puurand, Marju/0000-0002-0083-3390; Adamberg, Kaarel/0000-0002-7203-925X; Visnapuu, Triinu/0000-0003-1778-7949; Puurand, Marju/0000-0002-0083-3390; Talve, Tiina/0000-0002-8659-5759; Adamberg, Signe/0000-0002-8198-1618	European Regional Development Fund [3.2.0701.12-0041 (SLOMR12215T), EU29994]; Estonian Science Foundation [ETF9072]; Estonian Ministry of Education and Research [IUT 19-27]	European Regional Development Fund(European Commission); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	The project has received funding from the European Regional Development Fund (projects No. 3.2.0701.12-0041 (SLOMR12215T) managed by the Archimedes Foundation and EU29994), Estonian Science Foundation through the grant ETF9072, and Institutional Research Funding (IUT 19-27) of the Estonian Ministry of Education and Research.	Adamberg K, 2015, MICROBIOL-SGM, V161, P1707, DOI 10.1099/mic.0.000146; Adamberg Signe, 2014, Front Nutr, V1, P21, DOI 10.3389/fnut.2014.00021; Aguirre M, 2015, J MICROBIOL METH, V117, P78, DOI 10.1016/j.mimet.2015.07.019; Allen-Vercoe E, 2013, EXPERT REV GASTROENT, V7, P291, DOI [10.1586/egh.13.16, 10.1586/EGH.13.16]; Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007; Belenguer A, 2007, APPL ENVIRON MICROB, V73, P6526, DOI 10.1128/AEM.00508-07; Braissant O, 2015, METHODS, V76, P27, DOI 10.1016/j.ymeth.2014.10.009; Braissant O, 2013, THERMOCHIM ACTA, V555, P64, DOI 10.1016/j.tca.2012.12.005; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; Downes J, 2003, INT J SYST EVOL MICR, V53, P1937, DOI 10.1099/ijs.0.02640-0; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; EDWARDS CA, 1985, J MED MICROBIOL, V19, P169, DOI 10.1099/00222615-19-2-169; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Garrote GL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00629; Goh YJ, 2007, APPL ENVIRON MICROB, V73, P5716, DOI 10.1128/AEM.00805-07; Hamaker BR, 2014, J MOL BIOL, V426, P3838, DOI 10.1016/j.jmb.2014.07.028; Jorup-Ronstrom C, 2012, SCAND J GASTROENTERO, V47, P548, DOI 10.3109/00365521.2012.672587; Kabanova N, 2009, THERMOCHIM ACTA, V496, P87, DOI 10.1016/j.tca.2009.07.003; Kang Soon Ah, 2009, P145; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Knight R, 2014, BR J NUTR, V113, P1, DOI DOI 10.1017/50007114514002475; Korakli M, 2003, APPL ENVIRON MICROB, V69, P2073, DOI 10.1128/AEM.69.4.2073-2079.2003; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Li Y, 1997, BBA-GENE STRUCT EXPR, V1353, P203, DOI 10.1016/S0167-4781(97)00103-6; Lopez-Siles M, 2014, INT J MED MICROBIOL, V304, P464, DOI 10.1016/j.ijmm.2014.02.009; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Martel CM, 2010, BIORESOURCE TECHNOL, V101, P4395, DOI 10.1016/j.biortech.2010.01.084; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Maskow T, 2015, METHODS, V76, P3, DOI 10.1016/j.ymeth.2014.10.035; Porras-Dominguez JR, 2014, PROCESS BIOCHEM, V49, P783, DOI 10.1016/j.procbio.2014.02.005; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; Salonen A, 2014, ANNU REV FOOD SCI T, V5, P239, DOI 10.1146/annurev-food-030212-182554; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott KP, 2015, MICROB ECOL HEALTH D, V1, P1; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2014, CELL METAB, P1; Srikanth R, 2015, CARBOHYD POLYM, V120, P102, DOI 10.1016/j.carbpol.2014.12.003; STEPHEN AM, 1980, J MED MICROBIOL, V13, P45, DOI 10.1099/00222615-13-1-45; Stulova I, 2013, INT DAIRY J, V31, P139, DOI 10.1016/j.idairyj.2013.02.004; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Visnapuu T, 2015, NEW BIOTECHNOL, V32, P597, DOI 10.1016/j.nbt.2015.01.009; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; Weitkunat K, 2015, J NUTR BIOCHEM, V26, P929, DOI 10.1016/j.jnutbio.2015.03.010; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	50	41	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144042	10.1371/journal.pone.0144042	http://dx.doi.org/10.1371/journal.pone.0144042			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629816	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300143
J	Fisher, KM; Haglund, E; Noel, JK; Hailey, KL; Onuchic, JN; Jennings, PA				Fisher, Kaitlin M.; Haglund, Ellinor; Noel, Jeffrey K.; Hailey, Kendra L.; Onuchic, Jose N.; Jennings, Patricia A.			Geometrical Frustration in Interleukin-33 Decouples the Dynamics of the Functional Element from the Folding Transition State Ensemble	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; IL-33; INTERMEDIATE; MECHANISMS; LANDSCAPE; DISEASE; MODELS; ST2	Interleukin-33 (IL-33) is currently the focus of multiple investigations into targeting pernicious inflammatory disorders. This mediator of inflammation plays a prevalent role in chronic disorders such as asthma, rheumatoid arthritis, and progressive heart disease. In order to better understand the possible link between the folding free energy landscape and functional regions in IL-33, a combined experimental and theoretical approach was applied. IL-33 is a pseudo-symmetrical protein composed of three distinct structural elements that complicate the folding mechanism due to competition for nucleation on the dominant folding route. Trefoil 1 constitutes the majority of the binding interface with the receptor whereas Trefoils 2 and 3 provide the stable scaffold to anchor Trefoil 1. We identified that IL-33 folds with a three-state mechanism, leading to a rollover in the refolding arm of its chevron plots in strongly native conditions. In addition, there is a second slower refolding phase that exhibits the same rollover suggesting similar limitations in folding along parallel routes. Characterization of the intermediate state and the rate limiting steps required for folding suggests that the rollover is attributable to a moving transition state, shifting from a post-to pre-intermediate transition state as you move from strongly native conditions to the midpoint of the transition. On a structural level, we found that initially, all independent Trefoil units fold equally well until a Q(CA) of 0.35 when Trefoil 1 will backtrack in order to allow Trefoils 2 and 3 to fold in the intermediate state, creating a stable scaffold for Trefoil 1 to fold onto during the final folding transition. The formation of this intermediate state and subsequent moving transition state is a result of balancing the difficulty in folding the functionally important Trefoil 1 onto the remainder of the protein. Taken together our results indicate that the functional element of the protein is geometrically frustrated, requiring the more stable elements to fold first, acting as a scaffold for docking of the functional element to allow productive folding to the native state.	[Fisher, Kaitlin M.; Hailey, Kendra L.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haglund, Ellinor] Univ Calif San Diego, CTBP, La Jolla, CA 92093 USA; [Haglund, Ellinor] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Haglund, Ellinor; Noel, Jeffrey K.; Onuchic, Jose N.] Rice Univ, CTBP, Houston, TX USA; [Haglund, Ellinor; Noel, Jeffrey K.; Onuchic, Jose N.] Rice Univ, Dept Phys & Astron, Chem & Biochem & Cell Biol, Houston, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rice University; Rice University	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu	Noel, Jeffrey/AAB-4432-2021	Noel, Jeffrey/0000-0003-3168-6036	Center for Theoretical Biological Physics - NSF [PHY-1427654, NSF-MCB-1214457]; Welch Foundation [C-1792]; Cancer Prevention and Research Institute of Texas; NSF [PHY-1212312]; NIH [GM-101467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101467] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1214457] Funding Source: National Science Foundation	Center for Theoretical Biological Physics - NSF; Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Center for Theoretical Biological Physics sponsored by the NSF (PHY-1427654 and by NSF-MCB-1214457) and the Welch Foundation Grant C-1792. JNO is a CPRIT scholar in Cancer Research sponsored by the Cancer Prevention and Research Institute of Texas. PAJ is supported by (NSF PHY-1212312 and by NIH GM-101467). The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan F, 1999, STRUCTURE MECH PROTE, DOI [10.1016/S0307-4412(99)00114-4, DOI 10.1016/S0307-4412(99)00114-4]; Andrews BT, 2008, P NATL ACAD SCI USA, V105, P12283, DOI 10.1073/pnas.0804039105; Andrews BT, 2013, J PHYS CHEM LETT, V4, P180, DOI 10.1021/jz301893w; Arai M, 2003, J MOL BIOL, V329, P779, DOI 10.1016/S0022-2836(03)00511-4; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Broom A, 2012, STRUCTURE, V20, P161, DOI 10.1016/j.str.2011.10.021; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; Finke JM, 2002, BIOCHEMISTRY-US, V41, P15056, DOI 10.1021/bi026197k; Gosavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061222; HABAZETTL J, 1992, NATURE, V359, P855, DOI 10.1038/359855a0; Hailey KL, 2013, J MOL BIOL, V425, P2382, DOI 10.1016/j.jmb.2013.03.016; Hedberg L, 2004, P NATL ACAD SCI USA, V101, P7606, DOI 10.1073/pnas.0308497101; Heidary DK, 1997, NAT STRUCT BIOL, V4, P725, DOI 10.1038/nsb0997-725; Hills RD, 2008, J MOL BIOL, V382, P485, DOI 10.1016/j.jmb.2008.07.007; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; Jones BE, 1994, DEV NONPOLAR SURFACE, P15250; Kern G, 1998, PROTEIN SCI, V7, P2164, DOI 10.1002/pro.5560071014; Kurowska-Stolarska M, 2011, J INTERN MED, V269, P29, DOI 10.1111/j.1365-2796.2010.02316.x; Lammert H, 2012, PLOS COMPUT BIOL, P8, DOI [10.1371/journal.pcbi.1002776, DOI 10.1371/J0URNAL.PCBI.1002776]; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Lefrancais E, 2012, EUR CYTOKINE NETW, V23, P120, DOI 10.1684/ecn.2012.0320; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Lingel A, 2009, BIOMOL NMR ASSIGN, V3, P223, DOI 10.1007/s12104-009-9180-6; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu C, 2002, CONSERVED NONCONSERV, P669, DOI [10.1110/ps.31702, DOI 10.1110/PS.31702.F0R]; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Longo LM, 2014, STRUCTURE, P1; Mizutani N, 2013, IMMUNOLOGY, V139, P205, DOI 10.1111/imm.12071; Myers JK, 1995, DENATURANT M VALUES, P2138; Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d; Noel JK, 2012, J PHYS CHEM B, V116, P6880, DOI 10.1021/jp212623d; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Onuchic N, 2008, P NATL ACAD SCI USA, DOI [10.1073/pnas.0807812105, DOI 10.1073/PNAS.0807812105]; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Pei C, 2014, IMMUNOLOGY, V141, P9, DOI 10.1111/imm.12174; Plotkin SS, 2000, P NATL ACAD SCI USA, V97, P6509, DOI 10.1073/pnas.97.12.6509; PRIESTLE JP, 1988, EMBO J, V7, P339, DOI 10.1002/j.1460-2075.1988.tb02818.x; Pushparaj PN, 2013, IMMUNOLOGY, V140, P70, DOI 10.1111/imm.12111; Rong C, 2013, RHEUMATOL INT, V33, P1377, DOI 10.1007/s00296-011-2299-7; Samuel D, 2001, J BIOL CHEM, V276, P4134, DOI 10.1074/jbc.M005921200; Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012; Smith MTJ, 2010, ENERGETICS MECH FOLD, DOI [10.1073/pnas.1008026107/-/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1008026107, DOI 10.1073/PNAS.1008026107/-/DCSUPPLEMENTAL]; STOCKMAN BJ, 1994, FEBS LETT, V349, P79, DOI 10.1016/0014-5793(94)00643-1; Sun PH, 2011, DIGEST DIS SCI, V56, P3596, DOI 10.1007/s10620-011-1760-5; Svensson AKE, 2003, J MOL BIOL, V326, P569, DOI 10.1016/S0022-2836(02)01444-4; Tripathi S, 2013, J PHYS CHEM B, V117, P800, DOI 10.1021/jp310046k; van der Spoel D, 2005, GROMACS USER MANUAL, P308; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Willems S, 2012, MINERVA MED, V103, P513	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144067	10.1371/journal.pone.0144067	http://dx.doi.org/10.1371/journal.pone.0144067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630011	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300155
J	Sanchez, A				Sanchez, Adriana			Fidelity and Promiscuity in an Ant-Plant Mutualism: A Case Study of Triplaris and Pseudomyrmex	PLOS ONE			English	Article							LENGTH DIFFERENCE TEST; MACARANGA SPECIES EUPHORBIACEAE; PHYLOGENETIC-RELATIONSHIPS; CHEWING LICE; EVOLUTION; POLYGONACEAE; FORMICIDAE; HYMENOPTERA; INCONGRUENCE; TREES	The association between the myrmecophyte Triplaris and ants of the genus Pseudomyrmex is an often-reported example of mutualism but no molecular studies have examined this association to date. In this study, the interspecific relationships of Triplaris were reconstructed using five molecular markers (two chloroplast and three nuclear), and the relationships of the associated Pseudomyrmex using two molecular regions (one mitochondrial and one nuclear). A data set including all known collections of plant hosts and resident ants was also compiled. The pattern of distribution of both organisms reveals that there are varying degrees of host specificity; most ants show broader host usage (promiscuous) but one species (P. dendroicus) is faithful to a single species of Triplaris. In most ant-plant interactions, host usage is not specific at the species level and preferences may result from geographical or ecological sorting. The specificity of P. dendroicus could be based on chemical recognition of the host they were raised on.	[Sanchez, Adriana] Univ Rosario, Programa Biol, Bogota, Colombia	Universidad del Rosario	Sanchez, A (corresponding author), Univ Rosario, Programa Biol, Bogota, Colombia.	adriana.sanchez@urosario.edu.co	Sanchez, Adriana/G-2905-2016	Sanchez, Adriana/0000-0003-2334-5741	Wake Forest University Graduate School of Arts and Sciences; Wake Forest University Department of Biology; Richter Award; American Society of Plant Taxonomists fund; Lewis and Clark exploration fund	Wake Forest University Graduate School of Arts and Sciences; Wake Forest University Department of Biology; Richter Award; American Society of Plant Taxonomists fund; Lewis and Clark exploration fund	The project was funded with several small grants (< $4000), including: 1. Wake Forest University Graduate School of Arts and Sciences: money used for laboratory work and a field trip to Peru. 2. Wake Forest University Department of Biology: money used for laboratory work. 3. Richter Award: money used for laboratory work and a field trip to Costa Rica. 4. The American Society of Plant Taxonomists fund: money used for laboratory work. 5. The Lewis and Clark exploration fund: money used for field work in Peru.	Agrawal AA, 1998, ECOLOGY, V79, P2100, DOI 10.1890/0012-9658(1998)079[2100:LDAACI]2.0.CO;2; Ayala FJ, 1996, MOL PHYLOGENET EVOL, V5, P423, DOI 10.1006/mpev.1996.0037; Banfer G, 2004, PLANT SYST EVOL, V249, P213, DOI 10.1007/s00606-004-0219-4; Banks JC, 2006, J EVOLUTION BIOL, V19, P156, DOI 10.1111/j.1420-9101.2005.00983.x; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bellota E, J HYMENOPT IN PRESS; Blattner FR, 2001, MOL PHYLOGENET EVOL, V19, P331, DOI 10.1006/mpev.2001.0941; BRANDBYGE J, 1990, NORD J BOT, V10, P155, DOI 10.1111/j.1756-1051.1990.tb01763.x; BRANDBYGE J, 1986, NORD J BOT, V6, P545, DOI 10.1111/j.1756-1051.1986.tb00454.x; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Chenuil A, 1996, MOL PHYLOGENET EVOL, V6, P270, DOI 10.1006/mpev.1996.0076; Chomicki G, 2015, NEW PHYTOL, V207, P411, DOI 10.1111/nph.13271; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Dattilo W, 2009, BIOTROPICA, V41, P642, DOI 10.1111/j.1744-7429.2009.00518.x; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; DAVIDSON DW, 1988, ECOLOGY, V69, P801, DOI 10.2307/1941029; Davies SJ, 2001, EVOLUTION, V55, P1542, DOI 10.1111/j.0014-3820.2001.tb00674.x; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Dowton M, 2002, SYST BIOL, V51, P19, DOI 10.1080/106351502753475853; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DP, 2006, INSECT SOC, V53, P172, DOI 10.1007/s00040-006-0855-z; Federle W, 2005, BIOL J LINN SOC, V84, P177, DOI 10.1111/j.1095-8312.2005.000423.x; FIALA B, 1989, OECOLOGIA, V79, P463, DOI 10.1007/BF00378662; Frederickson ME, 2006, OECOLOGIA, V149, P418, DOI 10.1007/s00442-006-0460-x; Gomez-Acevedo S, 2010, MOL PHYLOGENET EVOL, V56, P393, DOI 10.1016/j.ympev.2010.03.018; Grangier J, 2009, BIOL J LINN SOC, V97, P90, DOI 10.1111/j.1095-8312.2008.01188.x; Hammer S, 2010, MOL PHYLOGENET EVOL, V55, P1111, DOI 10.1016/j.ympev.2010.01.013; Heil M, 2010, CHEMOECOLOGY, V20, P63, DOI 10.1007/s00049-009-0036-4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howarth DG, 2002, MOL PHYLOGENET EVOL, V23, P525, DOI 10.1016/S1055-7903(02)00035-0; Htimans RI, 2012, DIVA GIS GEOGRAPHIC, V7, P476; Inui Y, 2001, J CHEM ECOL, V27, P2029, DOI 10.1023/A:1012290820150; Jackson AP, 2008, SYMBIOSIS, V45, P57; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Jurgens A, 2006, BIOCHEM SYST ECOL, V34, P97, DOI 10.1016/j.bse.2005.08.005; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larrea-Alcazar DM, 2007, ACTA OECOL, V32, P112, DOI 10.1016/j.actao.2007.03.010; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; Longino John T., 1996, Journal of Hymenoptera Research, V5, P131; MACHADO CA, 2001, P ROY SOC LOND B BIO, V268, P1; Maddison DR, 2011, MESQUITE MODULAR SYS; Mayer VE, 2014, NEW PHYTOL, V202, P749, DOI 10.1111/nph.12690; NIX HA, 1986, AUSTR FLORA FAUNA SE, V7, P415; OLIVEIRA PS, 1987, J TROP ECOL, V3, P193, DOI 10.1017/S0266467400002066; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rambaut A., 2014, TRACER V1 6; Razafimandimbison SG, 2005, MOL PHYLOGENET EVOL, V34, P334, DOI 10.1016/j.ympev.2004.10.005; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; Sanchez A, 2011, SYST BOT, V36, P702, DOI 10.1600/036364411X583664; Sanchez A, 2009, TAXON, V58, P781, DOI 10.1002/tax.583008; SCHREMMER F, 1984, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V111, P385; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Stamatakis A, 2014, BIOINFORMATICS; Swofford DL, 1998, PHYLOGENETIC ANAL US; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Ule Ernst, 1906, Botanische Jahrbuecher Leipzig, V37, P335; Venkatachalam B, 2009, LECT N BIOINFORMAT, V5542, P88, DOI 10.1007/978-3-642-01551-9_10; WARD PS, 1990, SYST ENTOMOL, V15, P449, DOI 10.1111/j.1365-3113.1990.tb00077.x; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; Ward PS, 1999, ZOOL J LINN SOC-LOND, V126, P451; Weir TL, 2012, BIOTROPICA, V44, P246, DOI 10.1111/j.1744-7429.2011.00786.x; Wheeler WM, 1942, B MUS COMP ZOOL HARV, V90, P41; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Yu DW, 1997, ECOL MONOGR, V67, P273, DOI 10.1890/0012-9615(1997)067[0273:ESOSSI]2.0.CO;2	70	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143535	10.1371/journal.pone.0143535	http://dx.doi.org/10.1371/journal.pone.0143535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630384	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300058
J	Xu, HG; Cao, MC; Wu, J; Cai, L; Ding, H; Lei, JC; Wu, Y; Cui, P; Chen, L; Le, ZF; Cao, Y				Xu, Haigen; Cao, Mingchang; Wu, Jun; Cai, Lei; Ding, Hui; Lei, Juncheng; Wu, Yi; Cui, Peng; Chen, Lian; Le, Zhifang; Cao, Yun			Determinants of Mammal and Bird Species Richness in China Based on Habitat Groups	PLOS ONE			English	Article							GLOBAL PATTERNS; SPATIAL SCALE; ENVIRONMENTAL DETERMINANTS; CONSERVATION BIOLOGY; GEOGRAPHIC PATTERNS; DIVERSITY PATTERNS; HUMAN-POPULATION; VASCULAR PLANTS; CLIMATE; ENERGY	Understanding the spatial patterns in species richness is a central issue in macroecology and biogeography. Analyses that have traditionally focused on overall species richness limit the generality and depth of inference. Spatial patterns of species richness and the mechanisms that underpin them in China remain poorly documented. We created a database of the distribution of 580 mammal species and 849 resident bird species from 2376 counties in China and established spatial linear models to identify the determinants of species richness and test the roles of five hypotheses for overall mammals and resident birds and the 11 habitat groups among the two taxa. Our result showed that elevation variability was the most important determinant of species richness of overall mammal and bird species. It is indicated that the most prominent predictors of species richness varied among different habitat groups: elevation variability for forest and shrub mammals and birds, temperature annual range for grassland and desert mammals and wetland birds, net primary productivity for farmland mammals, maximum temperature of the warmest month for cave mammals, and precipitation of the driest quarter for grassland and desert birds. Noteworthily, main land cover type was also found to obviously influence mammal and bird species richness in forests, shrubs and wetlands under the disturbance of intensified human activities. Our findings revealed a substantial divergence in the species richness patterns among different habitat groups and highlighted the group-specific and disparate environmental associations that underpin them. As we demonstrate, a focus on overall species richness alone might lead to incomplete or misguided understanding of spatial patterns. Conservation priorities that consider a broad spectrum of habitat groups will be more successful in safeguarding the multiple services of biodiversity.	[Xu, Haigen; Cao, Mingchang; Wu, Jun; Ding, Hui; Cui, Peng; Chen, Lian; Le, Zhifang; Cao, Yun] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Cai, Lei] Minist Environm Protect, Dept Nat Ecol Conservat, Beijing 100035, Peoples R China; [Lei, Juncheng; Wu, Yi] Nanjing Forestry Univ, Coll Forest Resources & Environm, Nanjing 210037, Jiangsu, Peoples R China; [Cao, Yun] Nanjing Univ, Dept Biol, Nanjing 210093, Jiangsu, Peoples R China	Nanjing Forestry University; Nanjing University	Xu, HG (corresponding author), Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China.	xhg@nies.org			National Key Technologies Research and Development Program [2012BAC01B01, 2008BAC 39B06, 2008BAC39B01]; Biodiversity Conservation Program of China	National Key Technologies Research and Development Program(National Key Technology R&D Program); Biodiversity Conservation Program of China	This work was funded by the National Key Technologies Research and Development Program (grants 2012BAC01B01, 2008BAC 39B06 and 2008BAC39B01) and the Biodiversity Conservation Program of China.	Benitez-Lopez A, 2014, ENVIRON CONSERV, V41, P132, DOI 10.1017/S0376892913000192; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Carnicer J, 2008, ACTA OECOL, V33, P253, DOI 10.1016/j.actao.2007.12.001; Chen SB, 2011, ECOL RES, V26, P949, DOI 10.1007/s11284-011-0850-3; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Currie DJ, 2001, ECOSYSTEMS, V4, P216, DOI 10.1007/s10021-001-0005-4; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Ding TS, 2006, J BIOGEOGR, V33, P683, DOI 10.1111/j.1365-2699.2006.01419.x; Editorial Committee of Fauna Sinicae, 1978, FAUN SIN; Evans KL, 2008, J ANIM ECOL, V77, P395, DOI 10.1111/j.1365-2656.2007.01332.x; Fielding AH, 1995, CONSERV BIOL, V9, P1466, DOI 10.1046/j.1523-1739.1995.09061466.x; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Graf RF, 2005, LANDSCAPE ECOL, V20, P703, DOI 10.1007/s10980-005-0063-7; GRAHAM GL, 1983, J MAMMAL, V64, P559, DOI 10.2307/1380511; Gronroos M, 2012, J ANIM ECOL, V81, P679, DOI 10.1111/j.1365-2656.2011.01938.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HOCK RJ, 1951, BIOL BULL-US, V101, P289, DOI 10.2307/1538547; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Huang JH, 2011, J SYST EVOL, V49, P81, DOI 10.1111/j.1759-6831.2011.00119.x; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; Iverson LR, 2001, ECOSYSTEMS, V4, P186, DOI 10.1007/s10021-001-0003-6; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kerr Jeremy, 2001, Trends in Ecology and Evolution, V16, P424, DOI 10.1016/S0169-5347(01)02226-1; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Lin Xin, 2009, Shengwu Duoyangxing, V17, P652, DOI 10.3724/SP.J.1003.2009.09065; Liu Che, 2014, Acta Scientiarum Naturalium Universitatis Pekinensis, V50, P429; Luo ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035514; Ma ZJ, 2009, ENVIRON MANAGE, V43, P1187, DOI 10.1007/s00267-008-9247-7; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Ministry of Environmental Protection, 2011, CHIN NAT BIOD CONS S; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moreno-Rueda G, 2007, ACTA OECOL, V32, P50, DOI 10.1016/j.actao.2007.03.006; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Poulsen BO, 2002, BIODIVERS CONSERV, V11, P1551, DOI 10.1023/A:1016839518172; Qian H, 2004, AM NAT, V163, P773, DOI 10.1086/383097; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Qian H, 2007, ECOGRAPHY, V30, P471, DOI 10.1111/j.0906-7590.2007.05025.x; Qian H, 2010, ECOL RES, V25, P629, DOI 10.1007/s11284-010-0695-1; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rittenhouse CD, 2012, CONSERV BIOL, V26, P821, DOI 10.1111/j.1523-1739.2012.01867.x; Rogers DI, 2010, EMU, V110, P307, DOI 10.1071/MU10024; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rovero F, 2014, DIVERS DISTRIB, V20, P1438, DOI 10.1111/ddi.12246; Shen SA, 2001, CHINAS TOPOGRAPHY; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Szewczak JM, 1998, GREAT BASIN NAT, V58, P66; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Tello JS, 2010, ECOGRAPHY, V33, P796, DOI 10.1111/j.1600-0587.2009.05991.x; Terribile LC, 2009, GLOBAL ECOL BIOGEOGR, V18, P123, DOI 10.1111/j.1466-8238.2008.00440.x; Trabucco A, 2009, CGIAR CONSORT SPATIA; Wang Y. X., 2003, COMPLETE CHECKLIST M; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Wang ZH, 2012, ECOGRAPHY, V35, P1160, DOI 10.1111/j.1600-0587.2012.07786.x; [WCMC UNEP], 2002, MOUNT MOUNT FOR; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Wu ZY, 2011, BIODIVERS SCI, V19, P1; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Xu HG, 2008, BIOSCIENCE, V58, P632, DOI 10.1641/B580710; Yan YJ, 2013, ECOL EVOL, V3, P4584, DOI 10.1002/ece3.847; Yang WJ, 2013, J BIOGEOGR, V40, P1415, DOI 10.1111/jbi.12108; Ying T.S., 2011, PLANT GEOGRAPHY CHIN; Zhang CJ, 2006, B BIOL FR BELG, V41, P4; Zhang JY, 2010, ENVIRON MONIT ASSESS, V166, P139, DOI 10.1007/s10661-009-0990-x; Zhang RZ, 2011, ZOOGEOGRAPHY CHINA; Zhao SQ, 2006, ECOL RES, V21, P890, DOI 10.1007/s11284-006-0048-2; Zhao X, 2011, J ARID ENVIRON, V75, P946, DOI 10.1016/j.jaridenv.2011.05.007; Zheng G., 2011, CHECKLIST CLASSIFICA	84	6	6	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143996	10.1371/journal.pone.0143996	http://dx.doi.org/10.1371/journal.pone.0143996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629903	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300134
J	Alexandar, V; Nayar, PG; Murugesan, R; Mary, B; Darshana, P; Ahmed, SSSJ				Alexandar, V; Nayar, Pradeep G.; Murugesan, R.; Mary, Beaulah; Darshana, P.; Ahmed, Shiek S. S. J.			CardioGenBase: A Literature Based Multi-Omics Database for Major Cardiovascular Diseases	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; EXPRESSION; GENES; PATHWAY; GWAS	Cardiovascular diseases (CVDs) account for high morbidity and mortality worldwide. Both, genetic and epigenetic factors are involved in the enumeration of various cardiovascular diseases. In recent years, a vast amount of multi-omics data are accumulated in the field of cardiovascular research, yet the understanding of key mechanistic aspects of CVDs remain uncovered. Hence, a comprehensive online resource tool is required to comprehend previous research findings and to draw novel methodology for understanding disease pathophysiology. Here, we have developed a literature-based database, CardioGenBase, collecting gene-disease association from Pubmed and MEDLINE. The database covers major cardiovascular diseases such as cerebrovascular disease, coronary artery disease (CAD), hypertensive heart disease, inflammatory heart disease, ischemic heart disease and rheumatic heart disease. It contains similar to 1,500 cardiovascular disease genes from similar to 2,4000 research articles. For each gene, literature evidence, ontology, pathways, single nucleotide polymorphism, protein-protein interaction network, normal gene expression, protein expressions in various body fluids and tissues are provided. In addition, tools like genedisease association finder and gene expression finder are made available for the users with figures, tables, maps and venn diagram to fit their needs. To our knowledge, CardioGenBase is the only database to provide gene-disease association for above mentioned major cardiovascular diseases in a single portal. CardioGenBase is a vital online resource to support genome-wide analysis, genetic, epigenetic and pharmacological studies.	[Alexandar, V; Murugesan, R.; Mary, Beaulah; Darshana, P.] Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Kelambakkam 603103, Tamil Nadu, India; [Nayar, Pradeep G.] Chettinad Acad Res & Educ, Chettinad Super Specialty Hosp, Dept Cardiol, Kelambakkam 603103, Tamil Nadu, India; [Ahmed, Shiek S. S. J.] Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Drug Discovery Lab, Dept Computat Biol, Kelambakkam 603103, Tamil Nadu, India		Ahmed, SSSJ (corresponding author), Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Drug Discovery Lab, Dept Computat Biol, Kelambakkam 603103, Tamil Nadu, India.	shiekssjahmed@gmail.com	R, Beaulah Mary/AAP-5283-2021					Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bober M, 2002, BIOINFORMATICS, V18, P1013, DOI 10.1093/bioinformatics/18.7.1013; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Hoffmeister A, 2001, AM J CARDIOL, V87, P262, DOI 10.1016/S0002-9149(00)01355-2; Jin W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/506283; Kohler R, 2010, PFLUG ARCH EUR J PHY, V460, P343, DOI 10.1007/s00424-009-0768-6; Kolker E, 2012, NUCLEIC ACIDS RES, V40, pD1093, DOI 10.1093/nar/gkr1177; Krysiak R, 2011, PHARMACOL REP, V63, P1151, DOI 10.1016/S1734-1140(11)70634-X; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Liu H, 2011, NUCLEIC ACIDS RES, V39, pD991, DOI 10.1093/nar/gkq1106; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Musunuru K, 2008, CIRC-CARDIOVASC GENE, V1, P66, DOI 10.1161/CIRCGENETICS.108.813675; Nanni L, 2006, J MOL CELL CARDIOL, V41, P934, DOI 10.1016/j.yjmcc.2006.08.009; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Palikhe A, 2007, TISSUE ANTIGENS, V69, P47, DOI 10.1111/j.1399-0039.2006.00735.x; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Sadaka M, 2013, ALEX J MED, V49, P323, DOI 10.1016/j.ajme.2013.01.005; Sarajlic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071537; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Taylor IW, 2012, PROTEOMICS, V12, P1706, DOI 10.1002/pmic.201100594; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461	27	15	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143188	10.1371/journal.pone.0143188	http://dx.doi.org/10.1371/journal.pone.0143188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624015	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600019
J	Federico, S; Redenti, S; Sturlese, M; Ciancetta, A; Kachler, S; Klotz, KN; Cacciari, B; Moro, S; Spalluto, G				Federico, Stephanie; Redenti, Sara; Sturlese, Mattia; Ciancetta, Antonella; Kachler, Sonja; Klotz, Karl-Norbert; Cacciari, Barbara; Moro, Stefano; Spalluto, Giampiero			The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives	PLOS ONE			English	Article							HUMAN A(3); A(2B) RECEPTORS; MAST-CELLS; ANTAGONISTS; POTENT; MUTAGENESIS; VALIDATION; XANTHINES; DISCOVERY; TEMPLATE	A new series of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine (PTP) derivatives has been developed in order to explore their affinity and selectivity profile at the four adenosine receptor subtypes. In particular, the PTP scaffold was conjugated at the C2 position with the 1-(3-trifluoromethyl-benzyl)-1H-pyrazole, a group believed to confer potency and selectivity toward the human (h) A(2B) adenosine receptor (AR) to the xanthine ligand 8-(1-(3-(trifluoromethyl) benzyl)-1H-pyrazol-4-yl)-1,3-dimethyl-1H-purine-2,6(3H, 7H)-dione (CVT 6975). Interestingly, the synthesized compounds turned out to be inactive at the hA(2B) AR but they displayed affinity at the hA(3) AR in the nanomolar range. The best compound of the series (6) shows both high affinity (hA(3) AR K-i = 11 nM) and selectivity (A(1)/A(3) and A(2)A/A(3) > 9090; A(2)B/A(3) > 909) at the hA(3) AR. To better rationalize these results, a molecular docking study on the four AR subtypes was performed for all the synthesized compounds. In addition, CTV 6975 and two close analogues have been subjected to the same molecular docking protocol to investigate the role of the 1-(3-trifluoromethyl-benzyl)-1H-pyrazole on the binding at the four ARs.	[Federico, Stephanie; Redenti, Sara; Spalluto, Giampiero] Univ Trieste, Dipartimento Sci Chim & Farmaceut, Trieste, Italy; [Sturlese, Mattia; Ciancetta, Antonella; Moro, Stefano] Univ Padua, Dipartimento Sci Farmaco, MMS, Padua, Italy; [Kachler, Sonja; Klotz, Karl-Norbert] Univ Wurzburg, Inst Pharmakol & Toxicol, D-97070 Wurzburg, Germany; [Cacciari, Barbara] Univ Ferrara, Dipartimento Sci Chim & Farmaceut, I-44100 Ferrara, Italy	University of Trieste; University of Padua; University of Wurzburg; University of Ferrara	Federico, S (corresponding author), Univ Trieste, Dipartimento Sci Chim & Farmaceut, Trieste, Italy.	sfederico@units.it; spalluto@units.it	Ciancetta, Antonella/AAS-8478-2020; Federico, Stephanie/E-8496-2018; Ciancetta, Antonella/L-9991-2017; Sturlese, Mattia/P-9473-2019; Moro, Stefano/A-2979-2012	Ciancetta, Antonella/0000-0002-7612-2050; Federico, Stephanie/0000-0003-2800-5287; Ciancetta, Antonella/0000-0002-7612-2050; Sturlese, Mattia/0000-0003-3944-0313; Moro, Stefano/0000-0002-7514-3802; SPALLUTO, GIAMPIERO/0000-0002-1957-7155; Klotz, Karl-Norbert/0000-0003-3553-3205	Italian Ministry for University and Research [200834TC4L_002, 200834TC4L_004]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by: Italian Ministry for University and Research, PRIN2008: protocol number 200834TC4L_002 (SM) and protocol number 200834TC4L_004 (GS SF); http://prin.miur.it/index.php?pag=2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; [Anonymous], GOLD SUIT VERS 5 2 1; [Anonymous], STARDR VERS 6 0; [Anonymous], 2014, MOE MOL OP ENV VERS; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baraldi PG, 2000, J MED CHEM, V43, P4768, DOI 10.1021/jm001047y; Baraldi PG, 2002, CURR PHARM DESIGN, V8, P2299, DOI 10.2174/1381612023392838; Baraldi PG, 2001, DRUG DEVELOP RES, V53, P225, DOI 10.1002/ddr.1191; Baraldi PG, 2009, PURINERG SIGNAL, V5, P3, DOI 10.1007/s11302-009-9140-8; Borea PA, 2015, PHARMACOL REV, V67, P74, DOI 10.1124/pr.113.008540; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Cheong SL, 2013, MED RES REV, V33, P235, DOI 10.1002/med.20254; Cheong SL, 2011, BIOORGAN MED CHEM, V19, P6120, DOI 10.1016/j.bmc.2011.08.026; Cheong SL, 2010, J MED CHEM, V53, P3361, DOI 10.1021/jm100049f; Ciancetta A, 2014, J CHEM INF MODEL, V54, P2243, DOI 10.1021/ci5002857; Colgan SP, 2013, J MOL MED, V91, P157, DOI 10.1007/s00109-012-0990-0; Cuzzolin A, 2015, MOLECULES, V20, P9977, DOI 10.3390/molecules20069977; de Zwart M, 1999, DRUG DEVELOP RES, V48, P95, DOI 10.1002/(SICI)1098-2299(199911)48:3<95::AID-DDR1>3.0.CO;2-B; DELEAN A, 1982, MOL PHARMACOL, V21, P5; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Eastwood P, 2011, ACS MED CHEM LETT, V2, P213, DOI 10.1021/ml100249e; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Feoktistov I, 2011, ADV PHARMACOL, V61, P115, DOI 10.1016/B978-0-12-385526-8.00005-9; Floris M, 2012, EUR J MED CHEM, V58, P248, DOI 10.1016/j.ejmech.2012.10.022; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fredholm BB, 2010, EXP CELL RES, V316, P1284, DOI 10.1016/j.yexcr.2010.02.004; Gao ZG, 2002, J BIOL CHEM, V277, P19056, DOI 10.1074/jbc.M110960200; GATTA F, 1993, EUR J MED CHEM, V28, P569, DOI 10.1016/0223-5234(93)90087-U; Harada H, 2001, J MED CHEM, V44, P170, DOI 10.1021/jm990499b; Headrick JP, 2013, PHARMACOL THERAPEUT, V140, P92, DOI 10.1016/j.pharmthera.2013.06.002; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Kalla RV, 2006, J MED CHEM, V49, P3682, DOI 10.1021/jm051268+; Kalla RV, 2009, PURINERG SIGNAL, V5, P21, DOI 10.1007/s11302-008-9119-x; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; KLOTZ KN, 1985, J BIOL CHEM, V260, P4659; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Michielan L, 2009, BIOORGAN MED CHEM, V17, P5259, DOI 10.1016/j.bmc.2009.05.038; Moro S, 2005, J MED CHEM, V48, P152, DOI 10.1021/jm049662f; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Pastorin G, 2003, J MED CHEM, V46, P4287, DOI 10.1021/jm030852k; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Stewart J.J.P., 1993, MOPAC 7; Taliani S, 2012, J MED CHEM, V55, P1490, DOI 10.1021/jm201177b; Vidal B, 2007, J MED CHEM, V50, P2732, DOI 10.1021/jm061333v; Webb TR, 2003, BIOORGAN MED CHEM, V11, P77, DOI 10.1016/S0968-0896(02)00323-1; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhong HY, 2006, AM J RESP CELL MOL, V35, P587, DOI 10.1165/rcmb.2005-0476OC; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143504	10.1371/journal.pone.0143504	http://dx.doi.org/10.1371/journal.pone.0143504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625265	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600033
J	Kost, TD; Gessler, C; Jansch, M; Flachowsky, H; Patocchi, A; Broggini, GAL				Kost, Thomas D.; Gessler, Cesare; Jaensch, Melanie; Flachowsky, Henryk; Patocchi, Andrea; Broggini, Giovanni A. L.			Development of the First Cisgenic Apple with Increased Resistance to Fire Blight	PLOS ONE			English	Article							MALUS X DOMESTICA; QUANTITATIVE TRAIT LOCUS; ERWINIA-AMYLOVORA; SCAB RESISTANCE; GENE; SYSTEM; QTL; QUANTIFICATION; IDENTIFICATION; RECOMBINASE	The generation and selection of novel fire blight resistant apple genotypes would greatly improve the management of this devastating disease, caused by Erwinia amylovora. Such resistant genotypes are currently developed by conventional breeding, but novel breeding technologies including cisgenesis could be an alternative approach. A cisgenic apple line C44.4.146 was regenerated using the cisgene FB_MR5 from wild apple Malus xrobusta 5 (Mr5), and the previously established method involving A. tumefaciens-mediated transformation of the fire blight susceptible cultivar 'Gala Galaxy' using the binary vector p9-Dao-FLPi. The line C44.4.146 was shown to carry only the cisgene FB_MR5, controlled by its native regulatory sequences and no transgenes were detected by PCR or Southern blot following heat induced recombinase-mediated elimination of the selectable markers. Although this line contains up to 452 bp of vector sequences, it still matches the original definition of cisgenesis. A single insertion of T-DNA into the genome of 'Gala Galaxy' in chromosome 16 was identified. Transcription of FB_MR5 in line C44.4.146 was similar to the transcription in classically bred descendants of Mr5. Three independent shoot inoculation experiments with a Mr5 avirulent strain of Erwinia amylovora were performed using scissors or syringe. Significantly lower disease symptoms were detected on shoots of the cisgenic line compared to those of untransformed 'Gala Galaxy'. Despite the fact that the pathogen can overcome this resistance by a single nucleotide mutation, this is, to our knowledge, the first prototype of a cisgenic apple with increased resistance to fire blight.	[Kost, Thomas D.; Gessler, Cesare; Broggini, Giovanni A. L.] ETH, Inst Integrat Biol IBZ, Plant Pathol, Zurich, Switzerland; [Jaensch, Melanie; Patocchi, Andrea; Broggini, Giovanni A. L.] Agroscope, Inst Plant Prod Sci, Wadenswil, Switzerland; [Jaensch, Melanie; Flachowsky, Henryk; Patocchi, Andrea; Broggini, Giovanni A. L.] JKI, Fed Res Ctr Cultivated Plants, Inst Breeding Res Fruit Crops, Dresden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Research Station Agroscope	Broggini, GAL (corresponding author), ETH, Inst Integrat Biol IBZ, Plant Pathol, Zurich, Switzerland.	giovanni.broggini@usys.ethz.ch	Flachowsky, Henryk/B-6828-2018; Broggini, Giovanni/N-7034-2016	Flachowsky, Henryk/0000-0003-1440-1895; Patocchi, Andrea/0000-0002-0919-2702; Broggini, Giovanni/0000-0002-1011-4090	Swiss Federal Office for Agriculture, project ZUEFOSII	Swiss Federal Office for Agriculture, project ZUEFOSII	The authors wish to acknowledge the financial support by the Swiss Federal Office for Agriculture (http://www.blw.admin.ch) project ZUEFOSII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2009, PLANT BIOTECHNOL J, V7, P266, DOI [10.1111/j.1467-7652.2008.00398.x, 10.1111/j.1467-7652.2009.00398.x]; Aldwinckle H, 1998, 8 INT WORKSH FIR BLI, V489, P269; Aldwinckle H. S., 1979, EPPO Bulletin, V9, P27, DOI 10.1111/j.1365-2338.1979.tb02223.x; Belfanti E, 2004, P NATL ACAD SCI USA, V101, P886, DOI 10.1073/pnas.0304808101; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; Broggini GAL, 2014, PLANT BIOTECHNOL J, V12, P728, DOI 10.1111/pbi.12177; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; Durel CE, 2009, GENOME, V52, P139, DOI [10.1139/G08-111, 10.1139/g08-111]; EFSA Panel on Genetically Modified Organisms, 2012, SCI OP ADDR SAF ASS; Emeriewen O, 2014, MOL BREEDING, V34, P407, DOI 10.1007/s11032-014-0043-1; Emeriewen OF, 2015, EUR J PLANT PATHOL, V141, P631, DOI 10.1007/s10658-014-0565-8; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fahrentrapp J, 2012, THESIS; Fahrentrapp J, 2013, TREE GENET GENOMES, V9, P237, DOI 10.1007/s11295-012-0550-3; Fazio G, 2007, 12 EUC S FRUIT BREED, V814, P59; Flachowsky H, 2009, PLANT BREEDING, V128, P217, DOI 10.1111/j.1439-0523.2008.01591.x; Frey JE, 2004, PLANT BREEDING, V123, P554, DOI 10.1111/j.1439-0523.2004.01033.x; Galli P, 2010, J PLANT PATHOL, V92, P219; Gessler C, 2007, ADV BIOCHEM ENG BIOT, V107, P113, DOI 10.1007/10_2007_053; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Gusberti M, 2012, PLANT DIS, V96, P1791, DOI 10.1094/PDIS-12-11-1058-RE; Hattasch C, 2009, J HORTIC SCI BIOTECH, P188; Hasler T, 2001, 9 INT WORKSH FIR BLI, V590, P73; Herzog K, 2012, GENE, V498, P41, DOI 10.1016/j.gene.2012.01.074; Hough L, 1944, P AM SOC HORT SCI; Janick J, 2006, HORTSCIENCE, V41, P8, DOI 10.21273/HORTSCI.41.1.8; Jones AL, 2000, FIRE BLIGHT, P235, DOI 10.1079/9780851992945.0235; Joshi SG, 2010, THESIS; Kellerhals M., 1994, Progress in temperate fruit breeding. Proceedings of the Eucarpia Fruit Breeding Section Meeting, Wadenswil/Einsiedeln, Switzerland, 30 August to 3 September, 1993., P117; Kellerhals M, 2014, AGRARFORSCH SCHWEIZ, V10, P414; Khan MA, 2006, MOL BREEDING, V17, P299, DOI 10.1007/s11032-006-9000-y; Krens FA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00286; Luo KM, 2007, PLANT BIOTECHNOL J, V5, P263, DOI 10.1111/j.1467-7652.2006.00237.x; Lusser M., 2011, JRC SCI TECHNICAL RE; Manulis S, 1998, PHYTOPARASITICA, V26, P223, DOI 10.1007/BF02981437; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; Milcevicova R, 2010, PLANT SCI, V179, P60, DOI 10.1016/j.plantsci.2010.04.013; Norelli JL, 2003, PLANT DIS, V87, P756, DOI 10.1094/PDIS.2003.87.7.756; Parravicini G, 2011, MOL PLANT PATHOL, V12, P493, DOI 10.1111/j.1364-3703.2010.00690.x; Peil A, 2007, PLANT BREEDING, V126, P470, DOI 10.1111/j.1439-0523.2007.01408.x; Peil A, 2014, ACTA HORTIC, V1056, P47; Peil A., 2009, INT J PLANT BREEDING, V3, P1, DOI DOI 10.3923/ijpbg.2009.1.10; Peil A., 2011, FRUIT VEG CEREAL SCI, V5, P118; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2012, R LANG ENV STAT COMP; Richter K, 1999, EUC S FRUIT BREED GE, V538, P267; Rikkerink HA, 2007, U.S. Patent Application, Patent No. [12/740,318, 12740318]; Schaart JG, 2004, PLANT BIOTECHNOL J, V2, P233, DOI 10.1111/j.1467-7652.2004.00067.x; Scheer C, 2009, OBSTBAU, V34, P168; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Schouten HJ, 2014, TREE GENET GENOMES, V10, P251, DOI 10.1007/s11295-013-0678-9; Szankowski I, 2009, TREE GENET GENOMES, V5, P349, DOI 10.1007/s11295-008-0191-8; Thomson SV, 2000, FIRE BLIGHT, P9, DOI 10.1079/9780851992945.0009; Turchek WW, 2004, DIS FRUITS VEGETABLE, P35; Vanblaere T, 2014, PLANT BIOTECHNOL J, V12, P2, DOI 10.1111/pbi.12110; Vanblaere T, 2011, J BIOTECHNOL, V154, P304, DOI 10.1016/j.jbiotec.2011.05.013; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogt I, 2013, NEW PHYTOL, V197, P1262, DOI 10.1111/nph.12094; Winslow CEA, 1920, J BACTERIOL, V5, P191, DOI 10.1128/JB.5.3.191-229.1920; Wurdig J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0291-8; Wurdig J, 2013, PLANT CELL TISS ORG, V115, P457, DOI 10.1007/s11240-013-0376-1	61	44	46	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143980	10.1371/journal.pone.0143980	http://dx.doi.org/10.1371/journal.pone.0143980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624292	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600083
J	Rusinek, D; Swierniak, M; Chmielik, E; Kowal, M; Kowalska, M; Cyplinska, R; Czarniecka, A; Piglowski, W; Korfanty, J; Chekan, M; Krajewska, J; Szpak-Ulczok, S; Jarzab, M; Widlak, W; Jarzab, B				Rusinek, Dagmara; Swierniak, Michal; Chmielik, Ewa; Kowal, Monika; Kowalska, Malgorzata; Cyplinska, Renata; Czarniecka, Agnieszka; Piglowski, Wojciech; Korfanty, Joanna; Chekan, Mykola; Krajewska, Jolanta; Szpak-Ulczok, Sylwia; Jarzab, Michal; Widlak, Wieslawa; Jarzab, Barbara			BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							CRIBRIFORM-MORULAR VARIANT; T1799A BRAF MUTATION; CANCER-CELLS; SIGNALING PATHWAY; TUMOR INITIATION; HIGH PREVALENCE; V600E MUTATION; BREAST-CANCER; B-RAF; N-RAS	Background The molecular mechanisms driving the papillary thyroid carcinoma (PTC) are still poorly understood. The most frequent genetic alteration in PTC is the BRAFV600E mutation-its impact may extend even beyond PTC genomic profile and influence the tumor characteristics and even clinical behavior. Methods In order to identify BRAF-dependent signature of early carcinogenesis in PTC, a transgenic mouse model with BRAFV600E-induced PTC was developed. Mice thyroid samples were used in microarray analysis and the data were referred to a human thyroid dataset. Results Most of BRAF(+) mice developed malignant lesions. Nevertheless, 16% of BRAF(+) mice displayed only benign hyperplastic lesions or apparently asymptomatic thyroids. After comparison of non-malignant BRAF(+) thyroids to BRAF(-) ones, we selected 862 significantly deregulated genes. When the mouse BRAF-dependent signature was transposed to the human HG-U133A microarray, we identified 532 genes, potentially indicating the BRAF signature (representing early changes, not related to developed malignant tumor). Comparing BRAF(+) PTCs to healthy human thyroids, PTCs without BRAF and RET alterations and RET(+), RAS(+) PTCs, 18 of these 532 genes displayed significantly deregulated expression in all subgroups. All 18 genes, among them 7 novel and previously not reported, were validated as BRAFV600E-specific in the dataset of independent PTC samples, made available by The Cancer Genome Atlas Project. Conclusion The study identified 7 BRAF-induced genes that are specific for BRAF V600E-driven PTC and not previously reported as related to BRAF mutation or thyroid carcinoma: MMD, ITPR3, AACS, LAD1, PVRL3, ALDH3B1, and RASA1. The full signature of BRAF-related 532 genes may encompass other BRAF-related important transcripts and require further study.	[Rusinek, Dagmara; Swierniak, Michal; Kowal, Monika; Kowalska, Malgorzata; Cyplinska, Renata; Krajewska, Jolanta; Szpak-Ulczok, Sylwia; Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Gliwice, Poland; [Swierniak, Michal] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Genom Med, Warsaw, Poland; [Chmielik, Ewa; Chekan, Mykola] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Tumor Pathol, Gliwice Branch, Gliwice, Poland; [Czarniecka, Agnieszka] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Oncol & Reconstruct Surg, Gliwice Branch, Gliwice, Poland; [Piglowski, Wojciech; Korfanty, Joanna] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Ctr Translat Res & Mol Biol Canc, Gliwice Branch, Gliwice, Poland; [Jarzab, Michal; Widlak, Wieslawa] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Radiotherapy & Chemotherapy 3, Gliwice Branch, Gliwice, Poland; [Widlak, Wieslawa] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Radiotherapy & Chemotherapy 2, Gliwice Branch, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Rusinek, D (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Nucl Med & Endocrine Oncol, Gliwice Branch, Gliwice, Poland.	Dagmara.Rusinek@io.gliwice.pl	Barbara, Jarzab/I-4654-2019; Widlak, Wieslawa/AAA-2608-2021; Jarząb, Michał/G-4319-2012; Jarząb, Barbara/AAI-7942-2020; Krajewska, Jolanta/AAW-9781-2020; Czarniecka, Agnieszka/I-5137-2014	Widlak, Wieslawa/0000-0002-8440-9414; Jarząb, Michał/0000-0002-2642-9724; Jarząb, Barbara/0000-0001-9811-9584; Czarniecka, Agnieszka/0000-0003-1249-7205	Polish National Science Center [N N401 612440]; Polish Ministry of Science and Higher Education [N401 101 32/2138]; WWAC	Polish National Science Center; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); WWAC	Polish National Science Center project N N401 612440: DR MS EC RC M. Kowal WWAC and Polish Ministry of Science and Higher Education project N401 101 32/2138 DR MS BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Brzezianska E, 2007, NEUROENDOCRINOL LETT, V28, P351; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chen DR, 2010, ANTICANCER RES, V30, P4135; Cheng SP, 2010, ONCOL REP, V23, P1721, DOI 10.3892/or_00000817; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Durand S, 2009, ENDOCR-RELAT CANCER, V16, P467, DOI 10.1677/ERC-08-0081; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fagin JA, 2004, J CLIN ENDOCR METAB, V89, P4264, DOI 10.1210/jc.2004-1426; Fagin JA, 2004, J ENDOCRINOL, V183, P249, DOI 10.1677/joe.1.05895; Faustino A, 2012, J CLIN ENDOCR METAB, V97, pE1139, DOI 10.1210/jc.2011-2748; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P2333, DOI 10.1210/jc.2011-3106; Hebrant A, 2007, EXP CELL RES, V313, P3276, DOI 10.1016/j.yexcr.2007.06.019; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Jin SH, 2008, INT J CANCER, V122, P1040, DOI 10.1002/ijc.23181; Jung CK, 2009, THYROID, V19, P905, DOI 10.1089/thy.2008.0332; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Li WN, 2014, BIOCHEM BIOPH RES CO, V450, P844, DOI 10.1016/j.bbrc.2014.06.075; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; Marchitti SA, 2010, J HISTOCHEM CYTOCHEM, V58, P765, DOI [10.1369/jhc.2010.955773, 10.1369/jhc.2009.955773]; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Mujoo K, 2014, ONCOTARGET, V5, P10222, DOI 10.18632/oncotarget.2655; Nakazawa T, 2013, INT J SURG PATHOL, V21, P379, DOI 10.1177/1066896912473355; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Nucera C, 2010, P NATL ACAD SCI USA, V107, P10649, DOI 10.1073/pnas.1004934107; Oler G, 2008, CLIN CANCER RES, V14, P4735, DOI 10.1158/1078-0432.CCR-07-4372; Orim F, 2014, THYROID, V24, P502, DOI 10.1089/thy.2013.0038; Pita JM, 2014, J CLIN ENDOCR METAB, V99, pE497, DOI 10.1210/jc.2013-1512; Rusinek D, 2011, J MOL ENDOCRINOL, V47, pR91, DOI 10.1530/JME-11-0023; Schuetze D, 2009, ARCH PATHOL LAB MED, V133, P803, DOI 10.1043/1543-2165-133.5.803; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Truta Brindusa, 2003, Fam Cancer, V2, P95, DOI 10.1023/A:1025762706854; Tuma RS, 2011, J NATL CANCER I, V103, P170, DOI 10.1093/jnci/djr016; Vasko V, 2005, J CLIN ENDOCR METAB, V90, P5265, DOI 10.1210/jc.2004-2353; Vasko V, 2003, J CLIN ENDOCR METAB, V88, P2745, DOI 10.1210/jc.2002-021186; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang YG, 2008, ENDOCR-RELAT CANCER, V15, P183, DOI 10.1677/ERC-07-0182; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Xu XL, 2003, CANCER RES, V63, P4561; Yachida S, 2009, AM J SURG PATHOL, V33, P1823, DOI 10.1097/PAS.0b013e3181b6da19	55	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143688	10.1371/journal.pone.0143688	http://dx.doi.org/10.1371/journal.pone.0143688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625260	Green Submitted, gold, Green Published			2022-12-26	WOS:000365891600044
J	Dong, J; Zhao, W; Shi, A; Toneff, M; Lydon, J; So, D; Li, Y				Dong, J.; Zhao, W.; Shi, A.; Toneff, M.; Lydon, J.; So, D.; Li, Y.			The PR status of the originating cell of ER/PR-negative mouse mammary tumors	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; IN-VIVO; EXPRESSION; GLAND; MODEL; IMMUNOHISTOCHEMISTRY; PROLIFERATION; TUMORIGENESIS; ONCOPROTEIN	Progesterone receptor (PR) is usually co-localized with estrogen receptor (ER) in normal mammary cells. It is not known whether ER/PR-negative human breast cancer arises from an ER/PR-negative cell or from an ER/PR-positive cell that later lost ER/PR. Using intraductal injection of a lentivirus to deliver both an oncogene (ErbB2) and a floxed green fluorescent protein (GFP) in PRCre/+ mice, whose Cre gene is under the control of the PR promoter, we were able to trace the PR status of the infected cells as they progressed to cancer. We found that the resulting early lesions stained negative for PR in most of the cells and usually retained GFP. The resulting tumors lacked ER and PR, and 75% (15/20) of them retained the GFP signal in all tumor cells, suggesting PR was never expressed throughout the evolution of a majority of these tumors. In conclusion, our data demonstrate that ErbB2-initiated ER/PR-negative mammary tumors primarily originate from the subset of the mammary epithelium that is negative for PR and probably ER as well. These findings also provide an explanation for why antihormonal therapy fails to prevent ER-negative breast cancers.	[Dong, J.; Zhao, W.; Shi, A.; Toneff, M.; So, D.; Li, Y.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Dong, J.; Toneff, M.; Lydon, J.; Li, Y.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Shi, A.] Jilin Univ, Hosp 1, Dept Breast Surg, Changchun, Peoples R China; [Li, Y.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Jilin University; Baylor College of Medicine	Li, Y (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza MS600, Houston, TX 77030 USA.	liyi@bcm.edu	; Li, Yi/A-7635-2009	shi, aiping/0000-0002-7272-453X; Li, Yi/0000-0002-9976-518X	NIH [CA124820, U54CA149196]; CDMRP [BC060332, BC085050, BC073703]; Mary Kay Foundation [TMKF042-14]; Dan L. Duncan Cancer Center [P30CA125123]; BCM SPORE career development award [P50-CA058183]; NATIONAL CANCER INSTITUTE [R01CA124820, P50CA186784, U54CA149196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP(United States Department of Defense); Mary Kay Foundation; Dan L. Duncan Cancer Center; BCM SPORE career development award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Vidya Sinha and Sarah Hein for stimulating discussion. This work was supported in part by funds from NIH CA124820 (to YL) and U54CA149196 (to YL; PI: Stephan Wong); from CDMRP BC060332 (to YL), BC085050 (to YL) and BC073703 (to YL) and from Mary Kay Foundation (TMKF042-14 (to YL) as well as by the resources from the Lester & Sue Smith Breast Center (P50 CA186784), the Dan L. Duncan Cancer Center (P30CA125123). JD was supported by BCM SPORE career development award (P50-CA058183).	Allred DC, 2001, ENDOCR-RELAT CANCER, V8, P47, DOI 10.1677/erc.0.0080047; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Aubele M, 2002, ANAL CELL PATHOL, V24, P69, DOI 10.1155/2002/371680; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Bu W, 2009, J MAMMARY GLAND BIOL, V14, P401, DOI 10.1007/s10911-009-9154-4; Clarke RB, 1997, CANCER RES, V57, P4987; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Du ZJ, 2007, CELL CYCLE, V6, P823, DOI 10.4161/cc.6.7.4074; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Edorh A, 1999, CELL MOL BIOL, V45, P831; Fendrick JL, 1998, J MAMMARY GLAND BIOL, V3, P7, DOI 10.1023/A:1018766000275; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; Haricharan S, 2014, ONCOGENE, V33, P5729, DOI 10.1038/onc.2013.521; Haricharan S, 2013, ELIFE, V2, DOI 10.7554/eLife.00996; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Heffelfinger SC, 2000, PATHOBIOLOGY, V68, P129, DOI 10.1159/000055913; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mukherjee A, 2006, GENESIS, V44, P601, DOI 10.1002/dvg.20257; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Reddy JP, 2009, J MAMMARY GLAND BIOL, V14, P405, DOI 10.1007/s10911-009-9157-1; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; Siwko SK, 2008, NEOPLASIA, V10, P653, DOI 10.1593/neo.08266; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Zeps N, 1998, DIFFERENTIATION, V62, P221, DOI 10.1046/j.1432-0436.1998.6250221.x	27	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4149	4154		10.1038/onc.2015.465	http://dx.doi.org/10.1038/onc.2015.465			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26640140	Green Accepted			2022-12-26	WOS:000381020900013
J	Park, UH; Kang, MR; Kim, EJ; Kwon, YS; Hur, W; Yoon, SK; Song, BJ; Park, JH; Hwang, JT; Jeong, JC; Um, SJ				Park, U-H; Kang, M-R; Kim, E-J; Kwon, Y-S; Hur, W.; Yoon, S. K.; Song, B-J; Park, J. H.; Hwang, J-T; Jeong, J-C; Um, S-J			ASXL2 promotes proliferation of breast cancer cells by linking ER alpha to histone methylation	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; H3K27 DEMETHYLASES; HISTOLOGIC GRADE; LSD1; TRANSCRIPTION; COACTIVATOR; MECHANISMS; CARCINOGENESIS; EPIGENETICS	Estrogen receptor alpha (ER alpha) has a pivotal role in breast carcinogenesis by associating with various cellular factors. Selective expression of additional sex comb-like 2 (ASXL2) in ER alpha-positive breast cancer cells prompted us to investigate its role in chromatin modification required for ERa activation and breast carcinogenesis. Here, we observed that ASXL2 interacts with ligand E2-bound ERa and mediates ERa activation. Chromatin immunoprecipitation-sequencing analysis supports a positive role of ASXL2 at ERa target gene promoters. ASXL2 forms a complex with histone methylation modifiers including LSD1, UTX and MLL2, which all are recruited to the E2-responsive genes via ASXL2 and regulate methylations at histone H3 lysine 4, 9 and 27. The preferential binding of the PHD finger of ASXL2 to the dimethylated H3 lysine 4 may account for its requirement for ERa activation. On ASXL2 depletion, the proliferative potential of MCF7 cells and tumor size of xenograft mice decreased. Together with our finding on the higher ASXL2 expression in ERa-positive patients, we propose that ASXL2 could be a novel prognostic marker in breast cancer.	[Park, U-H; Kwon, Y-S; Um, S-J] Sejong Univ, Dept Biosci & Biotechnol, 98 Kunja Dong,Cuungmuguan 614, Seoul 143747, South Korea; [Kang, M-R] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Ochang, Cheongwon, South Korea; [Kim, E-J] Dankook Univ, Dept Mol Biol, Gyeonggi Do, South Korea; [Hur, W.; Yoon, S. K.] Catholic Univ, Liver Res Ctr, Seoul, South Korea; [Hur, W.; Yoon, S. K.] Catholic Univ, Coll Med, WHO Collaborating Ctr Viral Hepatitis, Seoul, South Korea; [Song, B-J] Catholic Univ, Coll Med, Seoul St Marys Hosp, Breast Ctr,Dept Surg, Seoul, South Korea; [Park, J. H.; Hwang, J-T] Korea Food Res Inst, Songnam, Gyeonggi Do, South Korea; [Jeong, J-C] Dongguk Univ, Coll Oriental Med, Dept Biochem Mol Biol & Internal Med, Kyungpook, South Korea	Sejong University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dankook University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Korea Food Research Institute (KFRI); Dongguk University	Um, SJ (corresponding author), Sejong Univ, Dept Biosci & Biotechnol, 98 Kunja Dong,Cuungmuguan 614, Seoul 143747, South Korea.	umsj@sejong.ac.kr			National R&D program for Cancer Control [1120210]; Korea Food Research Institute; Basic Science Research Program through NRF grant, Republic of Korea [2014R1A2A1A11052685]	National R&D program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Food Research Institute; Basic Science Research Program through NRF grant, Republic of Korea	This study was supported in part by a grant of the National R&D program for Cancer Control (1120210), a grant from the Korea Food Research Institute, and a grant of the Basic Science Research Program through NRF grant (2014R1A2A1A11052685), Republic of Korea.	Akhavantabasi S, 2010, MAMM GENOME, V21, P388, DOI 10.1007/s00335-010-9268-4; Al-Dhaheri M, 2011, CANCER RES, V71, P2118, DOI 10.1158/0008-5472.CAN-10-2426; Alarmo EL, 2006, GENE CHROMOSOME CANC, V45, P411, DOI 10.1002/gcc.20307; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aravind L, 2012, CELL CYCLE, V11, P119, DOI 10.4161/cc.11.1.18475; Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Connolly R, 2012, J MAMMARY GLAND BIOL, V17, P191, DOI 10.1007/s10911-012-9263-3; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Dalvai M, 2010, J MAMMARY GLAND BIOL, V15, P19, DOI 10.1007/s10911-010-9167-z; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Gage M, 2012, J SURG ONCOL, V105, P444, DOI 10.1002/jso.21856; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Glinsky GV, 2004, CLIN CANCER RES, V10, P2272, DOI 10.1158/1078-0432.CCR-03-0522; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Gozgit JM, 2007, BRIT J CANCER, V97, P809, DOI 10.1038/sj.bjc.6603926; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hervouet E, 2013, EPIGENETICS-US, V8, P237, DOI 10.4161/epi.23790; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Lai HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073983; Lai HL, 2012, J MOL CELL CARDIOL, V53, P734, DOI 10.1016/j.yjmcc.2012.08.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Park UH, 2011, J BIOL CHEM, V286, P1354, DOI 10.1074/jbc.M110.177816; Pollock JA, 2012, ACS CHEM BIOL, V7, P1221, DOI 10.1021/cb300108c; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shen YQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-470; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stratmann A, 2012, MOL CELL ENDOCRINOL, V348, P12, DOI 10.1016/j.mce.2011.09.028; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776	52	28	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3742	3752		10.1038/onc.2015.443	http://dx.doi.org/10.1038/onc.2015.443			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26640146				2022-12-26	WOS:000379622800012
J	Gong, XY; Ahner, A; Roldan, A; Lukacs, GL; Thibodeau, PH; Frizzell, RA				Gong, Xiaoyan; Ahner, Annette; Roldan, Ariel; Lukacs, Gergely L.; Thibodeau, Patrick H.; Frizzell, Raymond A.			Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; HEAT-SHOCK PROTEINS; MOLTEN-GLOBULE STATE; ALPHA-CRYSTALLIN; IN-VITRO; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; UBIQUITIN LIGASES; FOLDING DEFECTS; QUALITY-CONTROL	A newly identified pathway for selective degradation of the common mutant of the cystic fibrosis transmembrane conductance regulator (CFTR), F508del, is initiated by binding of the small heat shock protein, Hsp27. Hsp27 collaborates with Ubc9, the E2 enzyme for protein SUMOylation, to selectively degrade F508del CFTR via the SUMO-targeted ubiquitin E3 ligase, RNF4 (RING finger protein 4) (1). Here, we ask what properties of CFTR are sensed by the Hsp27-Ubc9 pathway by examining the ability of NBD1(locus of the F508del mutation) to mimic the disposal of full-length (FL) CFTR. Similar to FL CFTR, F508del NBD1 expression was reduced 50-60% by Hsp27; it interacted preferentially with the mutant and was modified primarily by SUMO-2. Mutation of the consensus SUMOylation site, Lys447, obviated Hsp27-mediated F508del NBD1 SUMOylation and degradation. As for FL CFTR and NBD1 in vivo, SUMO modification using purified components in vitro was greater for F508del NBD1 versus WT and for the SUMO-2 paralog. Several findings indicated that Hsp27-Ubc9 targets the SUMOylation of a transitional, non-native conformation of F508del NBD1: (a) its modification decreased as [ATP] increased, reflecting stabilization of the nucleotide-binding domain by ligand binding; (b) a temperature-induced increase in intrinsic fluorescence, which reflects formation of a transitional NBD1-conformation, was followed by its SUMO modification; and (c) introduction of solubilizing or revertant mutations to stabilize F508del NBD1 reduced its SUMO modification. These findings indicate that the Hsp27-Ubc9 pathway recognizes a non-native conformation of mutant NBD1, which leads to its SUMO-2 conjugation and degradation by the ubiquitin-proteasome system.	[Gong, Xiaoyan; Ahner, Annette; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Thibodeau, Patrick H.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Roldan, Ariel; Lukacs, Gergely L.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University	Frizzell, RA (corresponding author), Childrens Hosp Pittsburgh UPMC, Rangos Res Ctr, Dept Cell Biol, 4401 Penn Ave,7116, Pittsburgh, PA 15224 USA.	frizzell@pitt.edu		Roldan, Ariel/0000-0002-8159-5450; Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health [R01-DK068196, R01-DK083284]; Cystic Fibrosis Foundation Therapeutics Grants [FRIZZE05X0, THIBOD09XX0]; Cystic Fibrosis Canada; Canadian Institute of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196, R01DK083284, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Grants; Cystic Fibrosis Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-DK068196 (to R. A. F.) and R01-DK083284 (to P. H. T.), by Cystic Fibrosis Foundation Therapeutics Grants FRIZZE05X0 (to R. A. F.) and THIBOD09XX0 (to P. H. T.), and by funds from the Cystic Fibrosis Canada and Canadian Institute of Health Research (to G. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bomberger JM, 2010, CHANNELS, V4, P150, DOI 10.4161/chan.4.3.11223; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Devaraneni PK, 2015, J BIOL CHEM, V290, P7980, DOI 10.1074/jbc.M114.634576; Dierick I, 2005, ANN MED, V37, P413, DOI 10.1080/07853890500296410; DOBSON CM, 1991, CIBA F SYMP, V161, P167; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Loo TW, 2005, J BIOENERG BIOMEMBR, V37, P501, DOI 10.1007/s10863-005-9499-3; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matsuo K, 2007, BIOPHYS J, V92, P4088, DOI 10.1529/biophysj.106.103515; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Patrick AE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00162; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	60	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					2004	2017		10.1074/jbc.M115.685628	http://dx.doi.org/10.1074/jbc.M115.685628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627832	Green Published, hybrid			2022-12-26	WOS:000368620700036
J	Marcus, T; Boch, S; Durka, W; Fischer, M; Gossner, MM; Muller, J; Schoning, I; Weisser, WW; Drees, C; Assmann, T				Marcus, Tamar; Boch, Steffen; Durka, Walter; Fischer, Markus; Gossner, Martin M.; Mueller, Joerg; Schoening, Ingo; Weisser, Wolfgang W.; Drees, Claudia; Assmann, Thorsten			Living in Heterogeneous Woodlands - Are Habitat Continuity or Quality Drivers of Genetic Variability in a Flightless Ground Beetle?	PLOS ONE			English	Article							FOREST MANAGEMENT INTENSITY; LICHEN LOBARIA-PULMONARIA; PAST LAND-USE; CARABID BEETLES; ENVIRONMENTAL-FACTORS; POPULATION-GENETICS; SPECIES COMPOSITION; PLANT DIVERSITY; SOIL PROPERTIES; COLEOPTERA	Although genetic diversity is one of the key components of biodiversity, its drivers are still not fully understood. While it is known that genetic diversity is affected both by environmental parameters as well as habitat history, these factors are not often tested together. Therefore, we analyzed 14 microsatellite loci in Abax parallelepipedus, a flightless, forest dwelling ground beetle, from 88 plots in two study regions in Germany. We modeled the effects of historical and environmental variables on allelic richness, and found for one of the regions, the Schorfheide-Chorin, a significant effect of the depth of the litter layer, which is a main component of habitat quality, and of the sampling effort, which serves as an inverse proxy for local population size. For the other region, the Schwabische Alb, none of the potential drivers showed a significant effect on allelic richness. We conclude that the genetic diversity in our study species is being driven by current local population sizes via environmental variables and not by historical processes in the studied regions. This is also supported by lack of genetic differentiation between local populations sampled from ancient and from recent woodlands. We suggest that the potential effects of former fragmentation and recolonization processes have been mitigated by the large and stable local populations of Abax parallelepipedus in combination with the proximity of the ancient and recent woodlands in the studied landscapes.	[Marcus, Tamar; Assmann, Thorsten] Univ Luneburg, Inst Ecol, Luneburg, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland; [Durka, Walter] UFZ Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Gossner, Martin M.; Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Schoening, Ingo] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Drees, Claudia] Univ Hamburg, Inst Zool, Bioctr Grindel, Hamburg, Germany	Leuphana University Luneburg; University of Bern; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; University of Potsdam; Max Planck Society; University of Hamburg	Marcus, T (corresponding author), Univ Luneburg, Inst Ecol, Luneburg, Germany.	marcus@leuphana.de	Fischer, Markus/C-6411-2008; Gossner, Martin M./J-2730-2015; Schöning, Ingo/D-3341-2009; Assmann, Thorsten/Q-9304-2017; Drees, Claudia/D-9353-2017; Durka, Walter/E-4667-2010; Weisser, Wolfgang W/B-9718-2014; Boch, Steffen/L-5436-2016	Fischer, Markus/0000-0002-5589-5900; Gossner, Martin M./0000-0003-1516-6364; Schöning, Ingo/0000-0002-9830-5026; Assmann, Thorsten/0000-0002-9203-769X; Drees, Claudia/0000-0003-2743-395X; Durka, Walter/0000-0002-6611-2246; Weisser, Wolfgang W/0000-0002-2757-8959; 	DFG (German Research Foundation) as a part of the PopGeneLand project [AS 309/3-1, 1374]	DFG (German Research Foundation) as a part of the PopGeneLand project(German Research Foundation (DFG))	The work has been funded by the DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) as a part of the PopGeneLand project (AS 309/3-1) in the framework of the Biodiversity Exploratories (SSP Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2009, AM NAT, V174, P255, DOI 10.1086/600085; Altermatt F, 2008, ECOL LETT, V11, P918, DOI 10.1111/j.1461-0248.2008.01203.x; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Assmann T, 1999, BIODIVERS CONSERV, V8, P1499, DOI 10.1023/A:1008974413376; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; Brandmayr P, 2009, J INSECT CONSERV, V13, P231, DOI 10.1007/s10841-008-9161-6; Brouat C, 2004, MOL ECOL, V13, P1815, DOI 10.1111/j.1365-294X.2004.02206.x; Brouwers NC, 2009, INSECT CONSERV DIVER, V2, P10, DOI 10.1111/j.1752-4598.2008.00041.x; BUSE A, 1988, HOLARCTIC ECOL, V11, P241; Butterfield J, 1995, FOREST ECOL MANAG, V79, P63, DOI 10.1016/0378-1127(95)03620-2; Cena CJ, 2006, MOL ECOL, V15, P303, DOI 10.1111/j.1365-294X.2005.02637.x; Chaabane K, 1996, ANN ZOOL FENN, V33, P97; COVINGTON WW, 1981, ECOLOGY, V62, P41, DOI 10.2307/1936666; CUENDET G, 1984, PEDOBIOLOGIA, V26, P421; DAY KR, 1993, FORESTRY, V66, P37, DOI 10.1093/forestry/66.1.37; DENBOER PJ, 1981, OECOLOGIA, V50, P39, DOI 10.1007/BF00378792; Desender K., 2002, How to protect or what we know about Carabid Beetles: from knowledge to application, from Wijster (1969) to Tuczno (2001), P227; Desender K., 2002, How to protect or what we know about Carabid Beetles: from knowledge to application, from Wijster (1969) to Tuczno (2001), P237; Desender K, 2004, IUFRO RES SER, V10, P117, DOI 10.1079/9780851998022.0117; Desender K., 2005, DIAS REPORTS, V114, P49; Desender K, 2005, CARABIDOLOGY 2003, P73; Deuschle J, 2008, B INSECTOL, V61, P73; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Engelhardt KAM, 2014, BIOL CONSERV, V179, P6, DOI 10.1016/j.biocon.2014.08.011; ESRI, 2012, ARCGIS REL 10 1; European Environment Agency, 2006, COR LAND COV 2006 DA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre MD, 2005, J BIOGEOGR, V32, P973, DOI 10.1111/j.1365-2699.2005.01258.x; Fahy O, 1998, FOREST ECOL MANAG, V110, P263, DOI 10.1016/S0378-1127(98)00285-0; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Flinn KM, 2007, ECOL APPL, V17, P452, DOI 10.1890/05-1963; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Franceschini G, 1997, EUR J SOIL BIOL, V33, P117; Galhidy L, 2006, PLANT ECOL, V183, P133, DOI 10.1007/s11258-005-9012-4; Gaublomme E, 2013, INSECT CONSERV DIVER, V6, P473, DOI 10.1111/icad.12002; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gillingham PK, 2012, ECOGRAPHY, V35, P831, DOI 10.1111/j.1600-0587.2011.07434.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gunther J, 2004, PEDOBIOLOGIA, V48, P159, DOI 10.1016/j.pedobi.2003.11.002; Hawes C, 2002, OECOLOGIA, V131, P612, DOI 10.1007/s00442-002-0916-6; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huber C, 2005, BIODIVERS CONSERV, V14, P1989, DOI 10.1007/s10531-004-2528-4; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jacquemyn H, 2004, MOL ECOL, V13, P211, DOI 10.1046/j.1365-294X.2003.02033.x; Jopp F, 2005, ECOL MODEL, V186, P389, DOI 10.1016/j.ecolmodel.2005.02.009; Judas M, 2002, J BIOGEOGR, V29, P491, DOI 10.1046/j.1365-2699.2002.00697.x; Juriado I, 2011, BIODIVERS CONSERV, V20, P1803, DOI 10.1007/s10531-011-0062-8; Jukes MR, 2001, FOREST ECOL MANAG, V148, P271, DOI 10.1016/S0378-1127(00)00530-2; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Koerner W, 1997, J ECOL, V85, P351, DOI 10.2307/2960507; Kohlpaintner M, 2009, PLANT SOIL, V314, P285, DOI 10.1007/s11104-008-9729-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kruck S, 2006, J PLANT NUTR SOIL SC, V169, P651, DOI 10.1002/jpln.200521903; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Lindroth C.H., 1985, CARABIDAE COLEOPTERA; LOREAU M, 1987, PEDOBIOLOGIA, V30, P173; LOREAU M, 1984, PEDOBIOLOGIA, V27, P269; LOREAU M, 1993, ACTA OECOL, V14, P247; Magura T., 2001, Web Ecology, V2, P7; Magura T, 2000, BIOL CONSERV, V93, P95, DOI 10.1016/S0006-3207(99)00073-7; Magura T, 2002, EUR J SOIL BIOL, V38, P291, DOI 10.1016/S1164-5563(02)01162-7; Marcus T, 2013, CONSERV GENET RESOUR, V5, P1151, DOI 10.1007/s12686-013-9985-6; Martinez A, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009003; NORDSTRM S, 1974, PEDOBIOLOGIA, V14, P1; Otalora MG, 2011, BIODIVERS CONSERV, V20, P1239, DOI 10.1007/s10531-011-0025-0; Oxbrough A, 2010, FOREST ECOL MANAG, V259, P2111, DOI 10.1016/j.foreco.2010.02.023; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterken G. F, 1993, WOODLAND CONSERVATIO; Petit S, 1998, BIODIVERS CONSERV, V7, P1549, DOI 10.1023/A:1008875403868; PHILLIPSON J, 1976, PEDOBIOLOGIA, V16, P258; POTT R, 1991, HUDELANDSCHAFTEN NOR; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reisch C, 2007, NORD J BOT, V25, P366, DOI 10.1111/j.0107-055X.2008.00188.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schall P, 2013, EUR J FOREST RES, V132, P379, DOI 10.1007/s10342-013-0681-6; Scheidegger C, 2012, ECOL EVOL, V2, P2223, DOI 10.1002/ece3.341; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schmitz MF, 1998, FOREST ECOL MANAG, V109, P137, DOI 10.1016/S0378-1127(98)00241-2; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Thiele H.U., 1977, CARABID BEETLES THEI, P369, DOI [DOI 10.1007/978-3-642-81154-8, 10.1007/978-3-642-81154-8]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandepitte K, 2007, MOL ECOL, V16, P4171, DOI 10.1111/j.1365-294X.2007.03473.x; Vellend M, 2004, ECOLOGY, V85, P3043, DOI 10.1890/04-0435; von Oheimb G, 2008, FOREST ECOL MANAG, V255, P1984, DOI 10.1016/j.foreco.2007.12.021; Wahbe TR, 2005, CAN J ZOOL, V83, P1460, DOI 10.1139/Z05-141; Wang ZS, 2006, BIOL CONSERV, V129, P551, DOI 10.1016/j.biocon.2005.11.022	102	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144217	10.1371/journal.pone.0144217	http://dx.doi.org/10.1371/journal.pone.0144217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641644	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700078
J	Bongio, NJ; Lampe, DJ				Bongio, Nicholas J.; Lampe, David J.			Inhibition of Plasmodium berghei Development in Mosquitoes by Effector Proteins Secreted from Asaia sp. Bacteria Using a Novel Native Secretion Signal	PLOS ONE			English	Article							MALARIA PARASITE DEVELOPMENT; ANOPHELES-GAMBIAE; ALKALINE-PHOSPHATASE; SYMBIOTIC BACTERIA; ESCHERICHIA-COLI; VECTOR MOSQUITOS; GENUS ASAIA; BIOLOGY; TRANSMISSION; INFECTIVITY	Novel interventions are needed to prevent the transmission of the Plasmodium parasites that cause malaria. One possible method is to supply mosquitoes with antiplasmodial effector proteins from bacteria by paratransgenesis. Mosquitoes have a diverse complement of midgut microbiota including the Gram-negative bacteria Asaia bogorensis. This study presents the first use of Asaia sp. bacteria for paratransgenesis against P. berghei. We identified putative secreted proteins from A. bogorensis by a genetic screen using alkaline phosphatase gene fusions. Two were secreted efficiently: a siderophore receptor protein and a YVTN beta-propeller repeat protein. The siderophore receptor gene was fused with antiplasmodial effector genes including the scorpine antimicrobial peptide and an anti-Pbs21 scFv-Shiva1 immunotoxin. Asaia SF2.1 secreting these fusion proteins were fed to mosquitoes and challenged with Plasmodium berghei-infected blood. With each of these effector constructs, significant inhibition of parasite development was observed. These results provide a novel and promising intervention against malaria transmission.	[Bongio, Nicholas J.; Lampe, David J.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA	Duquesne University	Lampe, DJ (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA.	lampe@duq.edu			National Institute of Allergy and Infectious Diseases [R15AI107735]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107735] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institute of Allergy and Infectious Diseases [http://www.niaid.nih.gov] award number R15AI107735 to DJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MT, 2013, MINI-REV MED CHEM, V13, P1879, DOI 10.2174/13895575113136660097; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; BROCKMAN RW, 1968, BIOCHEMISTRY-US, V7, P2554, DOI 10.1021/bi00847a016; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23; Drexler AL, 2008, TRENDS PARASITOL, V24, P333, DOI 10.1016/j.pt.2008.05.005; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Durvasula RV, 2008, EXP PARASITOL, V119, P94, DOI 10.1016/j.exppara.2007.12.020; Durvasula RV, 1997, P NATL ACAD SCI USA, V94, P3274, DOI 10.1073/pnas.94.7.3274; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Gouagna LC, 1998, TROP MED INT HEALTH, V3, P21, DOI 10.1046/j.1365-3156.1998.00156.x; HOFFMAN CS, 1985, P NATL ACAD SCI USA, V82, P5107, DOI 10.1073/pnas.82.15.5107; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Karunamoorthi K, 2014, INT J PREVENTIVE MED, V5, P529; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Manson P., 1897, British Medical Journal, Vii, P1786; McKenzie GJ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-39; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Mitraka E, 2013, PATHOG GLOB HEALTH, V107, P305, DOI 10.1179/2047773213Y.0000000106; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Raghavendra K, 2011, PARASITOL RES, V108, P757, DOI 10.1007/s00436-010-2232-0; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Shane JL, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01202-13; Sibley CH, 2014, MOL BIOCHEM PARASIT, V195, P107, DOI 10.1016/j.molbiopara.2014.06.001; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yamada Y, 2000, INT J SYST EVOL MICR, V50, P823, DOI 10.1099/00207713-50-2-823; Yoshida S, 2001, MOL BIOCHEM PARASIT, V113, P89, DOI 10.1016/S0166-6851(00)00387-X	47	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143541	10.1371/journal.pone.0143541	http://dx.doi.org/10.1371/journal.pone.0143541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636338	Green Submitted, gold, Green Published			2022-12-26	WOS:000366143800017
J	Tao, Y; Liu, J				Tao, Yong; Liu, Johne			The Majority of Resorptions in Old Mice Are Euploid	PLOS ONE			English	Article							PERI-OVULATORY PUTRESCINE; MOUSE EMBRYOS; MATERNAL AGE; MEIOSIS-I; ANEUPLOIDY; TRISOMY; ORIGIN; IMPLANTATION; SEGREGATION; MATURATION	Chromosomal abnormality is a leading cause of aging-related infertility, spontaneous abortion and congenital birth defects in humans. Karyotype analyses of spontaneously aborted human fetuses reveal high proportions (similar to 50%) being chromosomal abnormal with the majority being trisomies of various chromosomes. As a model organism, mice are widely used for studies of reproduction and reproductive aging. Like older women, older mice exhibit high incidences of early embryo death. However, it is not known if aneuploidy is prevalent amongst resorptions in older mice. We have karyotyped 65 retarded/resorbed fetuses in 10-month-old C57BL/6 mice, and found that 55 (84.6%+/- 8.8%, with 95% confidence) were euploid. Similarly, of 40 such fetuses from 17 month-old C57BL/6 mice, we found 38 (95 +/- 7%, with 95% confidence 95%) being euploid. Therefore, aneuploidy is not a leading cause of embryo death in older mice.	[Tao, Yong; Liu, Johne] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Liu, Johne] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Liu, Johne] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Liu, J (corresponding author), Ottawa Hosp, Res Inst, Gen Campus,501 Smyth Rd,Box 511, Ottawa, ON K1H 8L6, Canada.	jliu@ohri.ca		Liu, X. Johne/0000-0003-3381-5030	March of Dimes Foundation [6-FY13126]	March of Dimes Foundation(March of Dimes)	This work was supported by a research grant from March of Dimes Foundation (#6-FY13126, to XJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; ANGELL RR, 1991, HUM GENET, V86, P383; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; CHARD T, 1991, BAILLIERE CLIN OB GY, V5, P179, DOI 10.1016/S0950-3552(05)80077-X; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cukurcam S, 2007, HUM REPROD, V22, P815, DOI 10.1093/humrep/del442; Delhanty JDA, 2001, ANN HUM GENET, V65, P331, DOI 10.1017/S0003480001008739; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; EPSTEIN CJ, 1977, NATURE, V267, P615, DOI 10.1038/267615a0; EPSTEIN CJ, 1979, NATURE, V280, P144, DOI 10.1038/280144a0; EVANS EP, 1972, STAIN TECHNOL, V47, P229, DOI 10.3109/10520297209116541; FINN C. A., 1962, NATURE, V194, P499, DOI 10.1038/194499a0; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Gabriel AS, 2011, J MED GENET, V48, P433, DOI 10.1136/jmg.2010.088070; Geraedts J, 2011, HUM REPROD, V26, P3173, DOI 10.1093/humrep/der294; GOLBUS MS, 1981, CYTOGENET CELL GENET, V31, P84, DOI 10.1159/000131629; GOODLIN ROBERT C., 1965, J REPROD FERTIL, V9, P355, DOI 10.1530/jrf.0.0090355; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; GROPP A, 1974, CYTOGENET CELL GENET, V13, P511, DOI 10.1159/000130304; Haadsma ML, 2010, REPROD BIOMED ONLINE, V20, P191, DOI 10.1016/j.rbmo.2009.11.005; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; KAJII T, 1977, CYTOGENET CELL GENET, V18, P109, DOI 10.1159/000130756; Koehler KE, 2006, CURR BIOL, V16, pR579, DOI 10.1016/j.cub.2006.07.018; Kroon B, 2011, FERTIL STERIL, V95, P1827, DOI 10.1016/j.fertnstert.2010.11.065; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Liu XJ, 2016, CELL TISSUE RES, V363, P57, DOI 10.1007/s00441-015-2264-y; Liu XJ, 2012, AGING-US, V4, P723, DOI 10.18632/aging.100500; Liu XJ, 2012, CYTOSKELETON, V69, P670, DOI 10.1002/cm.21041; Massie JAM, 2011, FERTIL STERIL, V95, P970, DOI 10.1016/j.fertnstert.2010.07.1088; MAUDLIN I, 1977, J REPROD FERTIL, V50, P275, DOI 10.1530/jrf.0.0500275; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; Munne Santiago, 2002, Reprod Biomed Online, V4, P223; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pereira PNG, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-48; Sakakibara Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8550; Schieve LA, 2003, OBSTET GYNECOL, V101, P959, DOI 10.1016/S0029-7844(03)00121-2; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Tao Y, 2015, HUM REPROD, V30, P1867, DOI 10.1093/humrep/dev130; Tao Y, 2013, AGING CELL, V12, P42, DOI 10.1111/acel.12016; Theiler K., 1989, HOUSE MOUSE ATLAS EM, P44; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Yun Y, 2014, DEVELOPMENT, V141, P199, DOI 10.1242/dev.100206; Zaragoza MV, 2000, AM J HUM GENET, V66, P1807, DOI 10.1086/302951	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143360	10.1371/journal.pone.0143360	http://dx.doi.org/10.1371/journal.pone.0143360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636341	gold, Green Published, Green Submitted			2022-12-26	WOS:000366143800010
J	Bundgaard-Nielsen, RL; Baker, BJ; Kroos, CH; Harvey, M; Best, CT				Bundgaard-Nielsen, Rikke L.; Baker, Brett J.; Kroos, Christian H.; Harvey, Mark; Best, Catherine T.			Discrimination of Multiple Coronal Stop Contrasts in Wubuy (Australia): A Natural Referent Consonant Account	PLOS ONE			English	Article							LANGUAGE; PERCEPTION; ADULTS	Native speech perception is generally assumed to be highly efficient and accurate. Very little research has, however, directly examined the limitations of native perception, especially for contrasts that are only minimally differentiated acoustically and articulatorily. Here, we demonstrate that native speech perception may indeed be more difficult than is often assumed, where phonemes are highly similar, and we address the nature and extremes of consonant perception. We present two studies of native and non-native (English) perception of the acoustically and articulatorily similar four-way coronal stop contrast /tttt(rho)/ (apico-alveolar, apico-retroflex, lamino-dental, lamino-alveopalatal) of Wubuy, an indigenous language of Australia. The results show that all listeners find contrasts involving /t(rho)/ easy to discriminate, but that, for both groups, contrasts involving /ttt/ are much harder. Where the two groups differ, the results largely reflect native language (Wubuy vs English) attunement as predicted by the Perceptual Assimilation Model [1, 2, 3]. We also observe striking perceptual asymmetries in the native listeners' perception of contrasts involving the latter three stops, likely due to the differences in input frequency. Such asymmetries have not previously been observed in adults, and we propose a novel Natural Referent Consonant Hypothesis to account for the results.	[Bundgaard-Nielsen, Rikke L.; Kroos, Christian H.; Best, Catherine T.] Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia; [Bundgaard-Nielsen, Rikke L.; Kroos, Christian H.; Best, Catherine T.] Univ Western Sydney, Sch Humanities & Commun Arts, Sydney, NSW, Australia; [Bundgaard-Nielsen, Rikke L.] La Trobe Univ, Melbourne, Vic, Australia; [Baker, Brett J.] Univ Melbourne, Melbourne, Vic, Australia; [Kroos, Christian H.] Curtin Univ, Perth, WA 6845, Australia; [Harvey, Mark] Univ Newcastle, Newcastle, NSW 2300, Australia; [Best, Catherine T.] Haskins Labs Inc, New Haven, CT USA	Western Sydney University; Western Sydney University; La Trobe University; University of Melbourne; Curtin University; University of Newcastle; Yale University; Haskins Laboratories	Bundgaard-Nielsen, RL (corresponding author), Univ Western Sydney, MARCS Inst, Sydney, NSW, Australia.	rikkelou@gmail.com	Best, Catherine T/M-4547-2019; Harvey, Mark/G-7133-2013	Best, Catherine T/0000-0002-2447-2024; Baker, Brett/0000-0002-7012-4442; Harvey, Mark/0000-0001-9901-9921	Early Career Researcher Grant; University of Melbourne (ECR ) [601103]; University of Melbourne Early Career Researcher grant; University of Melbourne's Human Research Ethics Committee [1035119]	Early Career Researcher Grant; University of Melbourne (ECR )(University of Melbourne); University of Melbourne Early Career Researcher grant(University of Melbourne); University of Melbourne's Human Research Ethics Committee	The research was funded by and Early Career Researcher Grant awarded to Brett Baker by the University of Melbourne (ECR grant 601103 Perception of rich consonant contrasts in Wubuy', awarded 21 October 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Wubuy speakers and the Wubuy and Australian English listeners for their participation in this research project. We thank the editor of PLoS, Linda Polka, and an anonymous reviewer for comments which led to significant improvements in this paper. We would also like to thank the audiences at the Australian Languages Workshop 2011, SST 2014, at the Universities of Melbourne and Aarhus ('Biases in Perception' workshop), and at the Australian Linguistics Society Conference 2013, for their comments and insights. This research was funded by a University of Melbourne Early Career Researcher grant to the second author, and approved by the University of Melbourne's Human Research Ethics Committee [1035119].	Anderson V., 1997, P EUR 1997 5 C SPEEC, P389; [Anonymous], 2013, WORLD PHONOTACTICS D; Baker B., 2014, LANGUAGES LINGUISTIC, P139; Baker B, 2014, AUST J LINGUIST, V34, P307, DOI 10.1080/07268602.2014.898222; Baker Brett J., 2008, WORD STRUCTURE NGALA; BALISE RR, 1994, PHONETICA, V51, P99, DOI 10.1159/000261962; Best C., 2007, HONOR JAMES EMIL FLE, V1334, P1, DOI DOI 10.1075/LLLT.17.07BES; Best C. T., 1994, DEV SPEECH PERCEPTIO, P167; Best C. T., 1995, SPEECH PERCEPTION LI, P171; Best CC, 2003, LANG SPEECH, V46, P183, DOI 10.1177/00238309030460020701; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Bohn O-S, 2008, INPUT MATTERS SLA, P207; Bohn O-S, 2007, J ACOUST SOC AM, V121, P3187; Bohn OS, 2012, J PHONETICS, V40, P109, DOI 10.1016/j.wocn.2011.08.002; Bonte ML, 2005, CLIN NEUROPHYSIOL, V116, P2765, DOI 10.1016/j.clinph.2005.08.012; Bundgaard-Nielsen R. L., 2014, P 15 AUSTR INT SPEEC, P205; Bundgaard-Nielsen RikkeL., 2012, LAB PHONOL, V3, P133, DOI [10.1515/lp-2012-0009, DOI 10.1515/LP-2012-0009]; Butcher Andrew., 2012, QUANTITATIVE APPROAC, P133; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Commonwealth of Australia/AIATSIS, 2005, NAT IND LANG SURV RE; Cornell SA, 2013, J EXP PSYCHOL HUMAN, V39, P757, DOI 10.1037/a0030862; Dixon R. M. W., 1980, LANGUAGES AUSTR; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Evans N., 1992, AUST J LINGUIST, V12, P45, DOI DOI 10.1080/07268609208599471; Evans Nicholas., 1995, HDB PHONOLOGICAL THE, P723; Feldman LB, 2001, J EXP PSYCHOL HUMAN, V27, P680, DOI 10.1037//0096-1523.27.3.680; Flege J.E, 1995, SPEECH PERCEPTION LI, V92, P233, DOI DOI 10.1075/LLLT.17.08STR; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Goldstein L., 2003, PHONETICS PHONOLOGY, P159; Hamilton P.J., 1996, THESIS U TORONTO; Harvey M., 2003, PACIFIC LINGUISTICS, V552, P205; Heath J., 1980, NUNGGUBUYU MYTHS ETH; Heath Jeffrey., 1978, LINGUISTIC DIFFUSION; HEATH JEFFREY, 1984, FUNCTIONAL GRAMMAR N; Jakobson R., 1961, PRELIMINARIES SPEECH; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Ladefoged P., 2001, VOWELS CONSONANTS IN; Lahiri A, 2002, PHONOL PHONET, V4-1, P637; Laver J, 1994, PRINCIPLES PHONETICS; Maddieson, 1996, SOUNDS WORLDS LANGUA; MAY JG, 1981, LANG SPEECH, V24, P273, DOI 10.1177/002383098102400307; Mellor S., 2004, AUSTR ED REV, V47; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mitterer H, 2011, J EXP PSYCHOL HUMAN, V37, P496, DOI 10.1037/a0020989; OHala J.J., 1981, PAPERS PARASESSION L, P178; Ohala J.J., 1974, PAPERS PARASESSION N, P251; OHala J.J., 1993, HIST LINGUISTICS PRO, P237; Polka L, 2003, SPEECH COMMUN, V41, P221, DOI 10.1016/S0167-6393(02)00105-X; Polka L, 2001, J ACOUST SOC AM, V109, P2190, DOI 10.1121/1.1362689; Polka L., 2005, J ACOUST SOC AM, V117, P2398; Polka L, 2011, J PHONETICS, V39, P467, DOI 10.1016/j.wocn.2010.08.007; REPP BH, 1990, J ACOUST SOC AM, V88, P2080, DOI 10.1121/1.400105; Sagey E, 1990, THESIS; Steriade D., 2001, ROLE SPEECH PERCEPTI, P219; Steriade Donca., 1997, UCLA WORKING PAPERS, V3, P25; STEVENS KN, 1989, LANGUAGE, V65, P81, DOI 10.2307/414843; Studdert-Kennedy M, 2003, LANGUAGE EVOLUTION, P219; Sundara M, 2008, COGNITION, V106, P234, DOI 10.1016/j.cognition.2007.01.011; Sundara M, 2006, COGNITION, V100, P369, DOI 10.1016/j.cognition.2005.04.007; Tabain M, 1999, J PHONETICS, V27, P333, DOI 10.1006/jpho.1999.0099; TAFT M, 1975, J VERB LEARN VERB BE, V14, P638, DOI 10.1016/S0022-5371(75)80051-X; TAFT M, 1994, LANG COGNITIVE PROC, V9, P271, DOI 10.1080/01690969408402120; TAFT M, 1979, MEM COGNITION, V7, P263, DOI 10.3758/BF03197599; Tsuji S, 2015, COGNITION, V134, P252, DOI 10.1016/j.cognition.2014.10.009; Tsushima T., 2003, Acoustical Science and Technology, V24, P410, DOI 10.1250/ast.24.410; Tyler MD, 2014, DEV PSYCHOBIOL, V56, P210, DOI 10.1002/dev.21195; West P., 2000, P 5 SEM SPEECH PROD, P105	67	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142054	10.1371/journal.pone.0142054	http://dx.doi.org/10.1371/journal.pone.0142054			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CX9QI	26633651	Green Published, gold			2022-12-26	WOS:000366040000004
J	Pires, SM; Fischer-Walker, CL; Lanata, CF; Devleesschauwer, B; Hall, AJ; Kirk, MD; Duarte, ASR; Black, RE; Angulo, FJ				Pires, Sara M.; Fischer-Walker, Christa L.; Lanata, Claudio F.; Devleesschauwer, Brecht; Hall, Aron J.; Kirk, Martyn D.; Duarte, Ana S. R.; Black, Robert E.; Angulo, Frederick J.			Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food	PLOS ONE			English	Article							FOODBORNE ILLNESS; UNSPECIFIED AGENTS; BURDEN; INFECTIONS; PATHOGENS; CHILDREN	Background Diarrhoeal diseases are major contributors to the global burden of disease, particularly in children. However, comprehensive estimates of the incidence and mortality due to specific aetiologies of diarrhoeal diseases are not available. The objective of this study is to provide estimates of the global and regional incidence and mortality of diarrhoeal diseases caused by nine pathogens that are commonly transmitted through foods. Methods and Findings We abstracted data from systematic reviews and, depending on the overall mortality rates of the country, applied either a national incidence estimate approach or a modified Child Health Epidemiology Reference Group (CHERG) approach to estimate the aetiology-specific incidence and mortality of diarrhoeal diseases, by age and region. The nine diarrhoeal diseases assessed caused an estimated 1.8 billion (95% uncertainty interval [UI] 1.1-3.3 billion) cases and 599,000 (95% UI 472,000-802,000) deaths worldwide in 2010. The largest number of cases were caused by norovirus (677 million; 95% UI 468-1,153 million), enterotoxigenic Escherichia coli (ETEC) (233 million; 95% UI 154-380 million), Shigella spp. (188 million; 95% UI 94-379 million) and Giardia lamblia (179 million; 95% UI 125-263); the largest number of deaths were caused by norovirus (213,515; 95% UI 171,783-266,561), enteropathogenic E. coli (121,455; 95% UI 103,657-143,348), ETEC (73,041; 95% UI 55,474-96,984) and Shigella (64,993; 95% UI 48,966-92,357). There were marked regional differences in incidence and mortality for these nine diseases. Nearly 40% of cases and 43% of deaths caused by these nine diarrhoeal diseases occurred in children under five years of age. Conclusions Diarrhoeal diseases caused by these nine pathogens are responsible for a large disease burden, particularly in children. These aetiology-specific burden estimates can inform efforts to reduce diarrhoeal diseases caused by these nine pathogens commonly transmitted through foods.	[Pires, Sara M.; Duarte, Ana S. R.] Danish Tech Univ, Natl Food Inst, Copenhagen, Denmark; [Fischer-Walker, Christa L.; Black, Robert E.] Johns Hopkins Univ, Baltimore, MD USA; [Lanata, Claudio F.] Inst Invest Nutr, Lima, Peru; [Lanata, Claudio F.] US Naval Med Res Unit 6, Callao, Peru; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Devleesschauwer, Brecht] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, B-2000 Antwerp, Belgium; [Hall, Aron J.; Angulo, Frederick J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kirk, Martyn D.] Australian Natl Univ, Canberra, ACT, Australia	Technical University of Denmark; Johns Hopkins University; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Ghent University; Universite Catholique Louvain; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA; Australian National University	Pires, SM (corresponding author), Danish Tech Univ, Natl Food Inst, Copenhagen, Denmark.	smpi@food.dtu.dk	Pires, Sara/M-2506-2019; Lanata, Claudio F./N-7997-2018; Devleesschauwer, Brecht/G-9895-2018	Pires, Sara/0000-0002-7751-1509; Lanata, Claudio F./0000-0002-6994-7425; Devleesschauwer, Brecht/0000-0002-2867-6892; Kirk, Martyn/0000-0001-5432-5984; Ribeiro Duarte, Ana Sofia/0000-0002-8794-0542	World Health Organization under the Foodborne Disease Burden Epidemiology Reference Group; Bill and Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG)	World Health Organization under the Foodborne Disease Burden Epidemiology Reference Group; Bill and Melinda Gates Foundation through the Child Health Epidemiology Reference Group (CHERG)	The World Health Organization funded this study under the Foodborne Disease Burden Epidemiology Reference Group through contributions from member states and international agencies. The authors would also like to acknowledge the support from the Bill and Melinda Gates Foundation, who funded Dr. Claudio E. Lanata, Dr. Christa Fisher-Walker and Dr. Robert E. Black through the Child Health Epidemiology Reference Group (CHERG).r The World Health Organization funded this study under the Foodborne Disease Burden Epidemiology Reference Group through contributions from member states and international agencies. We would also like to acknowledge the support from the Bill and Melinda Gates Foundation, who funded Dr. Claudio E. Lanata, Dr. Christa Fisher-Walker and Prof. Robert E. Black through the Child Health Epidemiology Reference Group (CHERG).	Ahmed SM, 2014, LAN INFECT IN PRESS; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Flint JA, 2005, CLIN INFECT DIS, V41, P698, DOI 10.1086/432064; Hald T, WHO FOODBORNE UNPUB; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Kirk M, 2014, EMERG INFECT DIS, V20, P1857, DOI 10.3201/eid2011.131315; Kirk MD, 2010, PLOS MED UNPUB; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lake RJ, 2010, RISK ANAL, V30, P743, DOI 10.1111/j.1539-6924.2009.01269.x; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tauxe RV, 2010, INT J FOOD MICROBIOL, V139, pS16, DOI 10.1016/j.ijfoodmicro.2009.10.014; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Walker CLF, 2010, EPIDEMIOL INFECT, V138, P1215, DOI 10.1017/S0950268810000592; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768	23	213	221	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0142927	10.1371/journal.pone.0142927	http://dx.doi.org/10.1371/journal.pone.0142927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632843	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000007
J	Xiao, X; de Bettignies, T; Olsen, YS; Agusti, S; Duarte, CM; Wernberg, T				Xiao, Xi; de Bettignies, Thibaut; Olsen, Ylva S.; Agusti, Susana; Duarte, Carlos M.; Wernberg, Thomas			Sensitivity and Acclimation of Three Canopy-Forming Seaweeds to UVB Radiation and Warming	PLOS ONE			English	Article							TEMPERATURE-DEPENDENCE; SEA-SURFACE; B RADIATION; GROWTH; STRESS; LIGHT; PHOTOSYNTHESIS; GAMETOPHYTES; LAMINARIALES; COMMUNITIES	Canopy-forming seaweeds, as primary producers and foundation species, provide key ecological services. Their responses to multiple stressors associated with climate change could therefore have important knock-on effects on the functioning of coastal ecosystems. We examined interactive effects of UVB radiation and warming on juveniles of three habitat-forming subtidal seaweeds from Western Australia-Ecklonia radiata, Scytothalia dorycarpa and Sargassum sp. Fronds were incubated for 14 days at 16-30 degrees C with or without UVB radiation and growth, health status, photosynthetic performance, and light absorbance measured. Furthermore, we used empirical models from the metabolic theory of ecology to evaluate the sensitivity of these important seaweeds to ocean warming. Results indicated that responses to UVB and warming were species specific, with Sargassum showing highest tolerance to a broad range of temperatures. Scytothalia was most sensitive to elevated temperature based on the reduced maximum quantum yields of PSII; however, Ecklonia was most sensitive, according to the comparison of activation energy calculated from Arrhenius' model. UVB radiation caused reduction in the growth, physiological responses and thallus health in all three species. Our findings indicate that Scytothalia was capable of acclimating in response to UVB and increasing its light absorption efficiency in the UV bands, probably by up-regulating synthesis of photoprotective compounds. The other two species did not acclimate over the two weeks of exposure to UVB. Overall, UVB and warming would severely inhibit the growth and photosynthesis of these canopy-forming seaweeds and decrease their coverage. Differences in the sensitivity and acclimation of major seaweed species to temperature and UVB may alter the balance between species in future seaweed communities under climate change.	[Xiao, Xi] Zhejiang Univ, Ocean Coll, Xihu Dist, Peoples R China; [de Bettignies, Thibaut; Olsen, Ylva S.; Agusti, Susana; Duarte, Carlos M.; Wernberg, Thomas] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [de Bettignies, Thibaut; Olsen, Ylva S.; Agusti, Susana; Duarte, Carlos M.; Wernberg, Thomas] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Agusti, Susana; Duarte, Carlos M.] Inst Mediterrani Estudis Avancats, Dept Global Change Res, IMEDEA CSIC UIB, Esporles, Spain; [Agusti, Susana; Duarte, Carlos M.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	Zhejiang University; University of Western Australia; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; King Abdullah University of Science & Technology	Xiao, X (corresponding author), Zhejiang Univ, Ocean Coll, Xihu Dist, Peoples R China.	prana@zju.edu.cn; thomas.wernberg@uwa.edu.au	Duarte, Carlos M/A-7670-2013; xiao, xi/K-1027-2014; Agusti, Susana/G-2864-2017; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Olsen, Ylva S/B-7445-2013; Xiao, Xi/M-4661-2019; Wernberg, Thomas/B-4172-2010	Duarte, Carlos M/0000-0002-1213-1361; xiao, xi/0000-0002-9753-6586; Agusti, Susana/0000-0003-0536-7293; Olsen, Ylva S/0000-0003-4498-7057; Xiao, Xi/0000-0002-9753-6586; Wernberg, Thomas/0000-0003-1185-9745; de Bettignies, Thibaut/0000-0003-0565-1200	National Natural Science Foundation of China [21307106]; International Science & Technology Cooperation Program of China [2015DFA01410]; Australian Research Council [FT110100174]; Hermon Slade Foundation [HSF 13/13]; UWA Oceans Institute Visiting Grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Australian Research Council(Australian Research Council); Hermon Slade Foundation; UWA Oceans Institute Visiting Grant	This study was supported by the National Natural Science Foundation of China (grant no. 21307106 to XX), the International Science & Technology Cooperation Program of China (grant no. 2015DFA01410), the Australian Research Council (grant no. FT110100174 to TW) and the Hermon Slade Foundation (HSF 13/13 to TW). The authors thank E. Gates, M. Christensen, P. Pfeiffer, M. Comesana and H.C. Zhu for technical assistance. XX was funded by a UWA Oceans Institute Visiting Grant during her stay in Perth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2015, ESTUAR COAST, V38, P1126, DOI 10.1007/s12237-014-9790-9; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Altamirano M, 2003, AQUAT BOT, V75, P9, DOI 10.1016/S0304-3770(02)00149-3; Altamirano M, 2000, PHYCOLOGIA, V39, P50, DOI 10.2216/i0031-8884-39-1-50.1; Andrews S, 2014, MAR ECOL PROG SER, V495, P119, DOI 10.3354/meps10567; Banaszak AT, 2003, COMP SER PHOTOCHEM, V1, P329; Bartsch I, 2013, J PHYCOL, V49, P1061, DOI 10.1111/jpy.12125; Beach KS, 1997, CORAL REEFS, V16, P21, DOI 10.1007/s003380050055; Bearham D, 2013, MAR ECOL PROG SER, V476, P59, DOI 10.3354/meps10148; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Bennett S, 2015, ECOL LETT, V18, P714, DOI 10.1111/ele.12450; Bennett S, 2015, ECOL LETT, V18, P677, DOI 10.1111/ele.12446; Bischof K, 1999, PLANT BIOLOGY, V1, P435, DOI 10.1055/s-2007-978537; Bischof Kai, 2006, Reviews in Environmental Science and Bio/Technology, V5, P141, DOI 10.1007/s11157-006-0002-3; Caldwell MM, 2007, PHOTOCH PHOTOBIO SCI, V6, P252, DOI 10.1039/b700019g; Cruces E, 2012, LAT AM J AQUAT RES, V40, P822, DOI 10.3856/vol40-issue4-fulltext-1; de Bettignies T, 2015, ECOLOGY, V96, P850, DOI 10.1890/13-2365.1; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Duarte CM, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00063; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; ENRIQUEZ S, 1994, OECOLOGIA, V98, P121, DOI 10.1007/BF00341462; Fredersdorf J, 2009, OECOLOGIA, V160, P483, DOI 10.1007/s00442-009-1326-9; Gomez I, 2001, BOT MAR, V44, P9, DOI 10.1515/BOT.2001.002; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Llabres M, 2013, GLOBAL ECOL BIOGEOGR, V22, P131, DOI 10.1111/j.1466-8238.2012.00784.x; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Mark U, 1996, J PLANT PHYSIOL, V148, P49, DOI 10.1016/S0176-1617(96)80293-8; Martinez B, 2012, OECOLOGIA, V170, P341, DOI 10.1007/s00442-012-2324-x; Mohring MB, 2014, MAR ECOL PROG SER, V513, P85, DOI 10.3354/meps10916; Muller R, 2012, PHYCOL RES, V60, P27, DOI 10.1111/j.1440-1835.2011.00630.x; Navarro NP, 2010, MICRON, V41, P899, DOI 10.1016/j.micron.2010.06.004; Parages ML, 2013, ENVIRON EXP BOT, V91, P30, DOI 10.1016/j.envexpbot.2013.02.005; Phillips JA, 2011, CONSERV BIOL, V25, P913, DOI 10.1111/j.1523-1739.2011.01727.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quintano E, 2013, J SEA RES, V83, P47, DOI 10.1016/j.seares.2013.05.008; Rautenberger R, 2006, POLAR BIOL, V29, P988, DOI 10.1007/s00300-006-0141-6; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Rothausler E, 2011, J EXP MAR BIOL ECOL, V405, P33, DOI 10.1016/j.jembe.2011.05.018; Schmidt EC, 2012, AQUAT BOT, V100, P8, DOI 10.1016/j.aquabot.2012.03.004; Schmidt EC, 2009, MICRON, V40, P860, DOI 10.1016/j.micron.2009.06.003; Serisawa Y, 2004, FISHERIES SCI, V70, P189, DOI 10.1111/j.0919-9268.2004.00788.x; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Staehr PA, 2009, J PHYCOL, V45, P91, DOI 10.1111/j.1529-8817.2008.00635.x; Steen H, 2004, SARSIA, V89, P175, DOI 10.1080/00364820410005818; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Takeuchi Y, 1996, PLANT CELL PHYSIOL, V37, P181, DOI 10.1093/oxfordjournals.pcp.a028930; van de Poll WH, 2002, EUR J PHYCOL, V37, P59, DOI 10.1017/S0967026201003407; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017; WOOD WF, 1987, MAR BIOL, V96, P143, DOI 10.1007/BF00394848	54	25	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143031	10.1371/journal.pone.0143031	http://dx.doi.org/10.1371/journal.pone.0143031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630025	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300025
J	Barber, RC; Phillips, NR; Tilson, JL; Huebinger, RM; Shewale, SJ; Koenig, JL; Mitchel, JS; O'Bryant, SE; Waring, SC; Diaz-Arrastia, R; Chasse, S; Wilhelmsen, KC				Barber, Robert C.; Phillips, Nicole R.; Tilson, Jeffrey L.; Huebinger, Ryan M.; Shewale, Shantanu J.; Koenig, Jessica L.; Mitchel, Jeffrey S.; O'Bryant, Sid E.; Waring, Stephen C.; Diaz-Arrastia, Ramon; Chasse, Scott; Wilhelmsen, Kirk C.		Alzheimer's Dis Neuroimaging	Can Genetic Analysis of Putative Blood Alzheimer's Disease Biomarkers Lead to Identification of Susceptibility Loci?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MILD COGNITIVE IMPAIRMENT; CORONARY-HEART-DISEASE; WHITE-MATTER LESIONS; COMMON VARIANTS; MCP-1; COAGULATION; DEMENTIA; ATHEROSCLEROSIS	Although 24 Alzheimer's disease (AD) risk loci have been reliably identified, a large portion of the predicted heritability for AD remains unexplained. It is expected that additional loci of small effect will be identified with an increased sample size. However, the cost of a significant increase in Case-Control sample size is prohibitive. The current study tests whether exploring the genetic basis of endophenotypes, in this case based on putative blood biomarkers for AD, can accelerate the identification of susceptibility loci using modest sample sizes. Each endophenotype was used as the outcome variable in an independent GWAS. Endophenotypes were based on circulating concentrations of proteins that contributed significantly to a published blood-based predictive algorithm for AD. Endophenotypes included Monocyte Chemoattractant Protein 1 (MCP1), Vascular Cell Adhesion Molecule 1 (VCAM1), Pancreatic Polypeptide (PP), Beta2 Microglobulin (B2M), Factor VII (F7), Adiponectin (ADN) and Tenascin C (TN-C). Across the seven endophenotypes, 47 SNPs were associated with outcome with a p-value <= 1x10(-7). Each signal was further characterized with respect to known genetic loci associated with AD. Signals for several endophenotypes were observed in the vicinity of CR1, MS4A6A/MS4A4E, PICALM, CLU, and PTK2B. The strongest signal was observed in association with Factor VII levels and was located within the F7 gene. Additional signals were observed in MAP3K13, ZNF320, ATP9B and TREM1. Conditional regression analyses suggested that the SNPs contributed to variation in protein concentration independent of AD status. The identification of two putatively novel AD loci (in the Factor VII and ATP9B genes), which have not been located in previous studies despite massive sample sizes, highlights the benefits of an endophenotypic approach for resolving the genetic basis for complex diseases. The coincidence of several of the endophenotypic signals with known AD loci may point to novel genetic interactions and should be further investigated.	[Barber, Robert C.; Shewale, Shantanu J.; Koenig, Jessica L.; Mitchel, Jeffrey S.] Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76129 USA; [Barber, Robert C.; O'Bryant, Sid E.] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Phillips, Nicole R.] Univ Dallas, Dept Biol, Dallas, TX USA; [Tilson, Jeffrey L.; Wilhelmsen, Kirk C.] Univ N Carolina, Renaissance Comp Inst, Chapel Hill, NC USA; [Huebinger, Ryan M.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [O'Bryant, Sid E.] Univ N Texas, Hlth Sci Ctr, Dept Internal Med, Ft Worth, TX USA; [Waring, Stephen C.] Essentia Inst Rural Hlth, Duluth, MN USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Chasse, Scott] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Wilhelmsen, Kirk C.] Univ N Carolina, Dept Med Genet, Chapel Hill, NC USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Health Science Center; Uniformed Services University of the Health Sciences - USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Barber, RC (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76129 USA.	Robert.barber@unthsc.edu	Waring, Stephen/AAR-6870-2021	Waring, Stephen/0000-0002-9674-0083; O'Bryant, Sid/0000-0003-0582-5266; Diaz-Arrastia, Ramon/0000-0001-6051-3594	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904, RC2 AG036535]; Department of Defense [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institute of Aging [T32AG020494]; National Institute of General Medical Sciences [P30AG12300-20]; National INstitutes of Health [5R01DA030976, 5U01HG006487, 1U19HD077632, 1U01HG007437, 5P01DK058335, 5U24AA020024, 1UL1TR001111]; Renaissance Computing Institute (RENCI) at the University of North Carolina at Chapel Hill;  [5P01-DK058335];  [5U24 AA020024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006487, U01HG007437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036535, P30AG012300, T32AG020494, U01AG024904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030976] Funding Source: NIH RePORTER	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense(United States Department of Defense); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National INstitutes of Health; Renaissance Computing Institute (RENCI) at the University of North Carolina at Chapel Hill; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Texas Alzheimer's Research and Care Consortium (TARCC), which is funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders funded data generation for the TARCC cohort. The replication data set was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904; RC2 AG036535). ADNI is ALSO funded by the Department of Defense (award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. Investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Partial support and computer resources were provided by the Renaissance Computing Institute (RENCI) at the University of North Carolina at Chapel Hill. SJS, NRP, JSM acknowledge a National Institute of Aging Training grant (T32AG020494). RMH acknowledges a grant from the National Institute of General Medical Sciences (P30AG12300-20). KCW acknowledges grants from the National INstitutes of Health (5R01DA030976, 5U01HG006487, 1U19HD077632, 1U01HG007437, 5P01DK058335, 5U24AA020024 and 1UL1TR001111).; Partial support and computer resources were provided by the Renaissance Computing Institute (RENCI) at the University of North Carolina at Chapel Hill.; SJS, NRP, JSM acknowledge NIA Training grant T32 AG020494. RMH acknowledges a grant from NIGMS P30AG12300-20. KCW acknowledges grants 5R01DA030976, 5U01HG006487, 1U19HD077632, 1U01HG007437, 5P01-DK058335, 5U24 AA020024 and 1UL1TR001111.	Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Balendran N, 1999, J INVEST DERMATOL, V113, P322, DOI 10.1046/j.1523-1747.1999.00710.x; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1602/neurorx.1.2.213; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; den Heijer T, 2010, BRAIN, V133, P1163, DOI 10.1093/brain/awq048; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Didion JP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-34; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Ertekin-Taner N, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-31; Fujimaki T, 2009, THROMB HAEMOSTASIS, V101, P963, DOI 10.1160/TH08-11-0761; Galimberti D, 2006, NEUROBIOL AGING, V27, P1763, DOI 10.1016/j.neurobiolaging.2005.10.007; Gorman KF, 2012, EUR SPINE J, V21, P1905, DOI 10.1007/s00586-012-2389-6; Gorwood P, 2012, HUM GENET, V131, P803, DOI 10.1007/s00439-012-1145-7; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Ken-Dror G, 2010, J THROMB HAEMOST, V8, P2394, DOI 10.1111/j.1538-7836.2010.04035.x; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070269; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mansourian M, 2013, J RES MED SCI, V18, P610; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; Miyashita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058618; Murray AD, 2011, BRAIN, V134, P3684, DOI 10.1093/brain/awr259; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2011, DEMENT GERIATR COGN, V32, P55, DOI 10.1159/000330750; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakurai-Yamashita Y, 2006, CELL MOL NEUROBIOL, V26, P823, DOI 10.1007/s10571-006-9077-1; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Wassel CL, 2011, OBESITY, V19, P840, DOI 10.1038/oby.2010.229; Weidinger S, 2010, CURR OPIN ALLERGY CL, V10, P408, DOI 10.1097/ACI.0b013e32833d7d2d; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; Zakai NA, 2011, J THROMB HAEMOST, V9, P267, DOI 10.1111/j.1538-7836.2010.04149.x; Zee RYL, 2009, CIRC-CARDIOVASC GENE, V2, P57, DOI 10.1161/CIRCGENETICS.108.801969	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142360	10.1371/journal.pone.0142360	http://dx.doi.org/10.1371/journal.pone.0142360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625115	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600006
J	Mitsuishi, S; Nishimura, R; Ando, K; Tsujino, D; Utsunomiya, K				Mitsuishi, Sumie; Nishimura, Rimei; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori			Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?	PLOS ONE			English	Article							MONITORING-SYSTEM; FREQUENCY	Objective To investigate whether the occurrence of nocturnal asymptomatic hypoglycemia may be predicted based on fasting glucose levels and post-breakfast glucose fluctuations. Patients and Methods The study subjects comprised type 1 diabetic patients who underwent CGM assessments and received basal-bolus insulin therapy with long-acting insulin. The subjects were evaluated for I) fasting glucose levels and II) the range of post-breakfast glucose elevation (from fasting glucose levels to postprandial 1- and 2-hour glucose levels). The patients were divided into those with asymptomatic hypoglycemia during nighttime and those without for comparison. Optimal cut-off values were also determined for relevant parameters that could predict nighttime hypoglycemia by using ROC analysis. Results 64 patients (mean HbA1c 8.7 +/- 1.8%) were available for analysis. Nocturnal asymptomatic hypoglycemia occurred in 23 patients (35.9%). Fasting glucose levels (I) were significantly lower in those with hypoglycemia than those without (118 +/- 35 mg/dL vs. 179 +/- 65 mg/dL; P < 0.001). The range of post-breakfast glucose elevation (II) was significantly greater in those with hypoglycemia than in those without (postprandial 1-h, P = 0.003; postprandial 2-h, P = 0.005). The cut-off values determined for relevant factors were as follows: (I) fasting glucose level < 135 mg/dL (sensitivity 0.73/specificity 0.83/AUC 0.79, P < 0.001); and (II) 1-h postprandial elevation > 54 mg/dL (0.65/0.61/0.71, P = 0.006), 2-h postprandial elevation > 78 mg/dL (0.65/0.73/0.71, P = 0.005). Conclusions Nocturnal asymptomatic hypoglycemia was associated with increases in post- breakfast glucose levels in type 1 diabetes. Study findings also suggest that fasting glucose levels and the range of post-breakfast glucose elevation could help predict the occurrence of nocturnal asymptomatic hypoglycemia.	[Mitsuishi, Sumie; Nishimura, Rimei; Ando, Kiyotaka; Tsujino, Daisuke; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Jikei University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nishimura, R (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan.	rimei@jikei.ac.jp			Japan Diabetes Foundation; Kowa; Ono; Taishyo	Japan Diabetes Foundation; Kowa; Ono; Taishyo	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: R.N. has received research support from Japan Diabetes Foundation, has participated in speaker's bureau/advisory panels for Astellas, Astra Zeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Johnson & Johnson, Kissei, Kowa, Medtronic, Novo Nordisk, Ono, Sanofi, Taishyo, Takeda and Tanabe-Mitsubishi, and served as a consultant for Abbott, Boehringer Ingelheim, Eli Lilly, and Taisho. K.U. has received research support from Kowa, Ono and Taishyo, and has participated in speaker's bureau/advisory panels for Astellas, Astra Zeneca and Sanofi. All the other authors have no conflict of interest to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Banarer S, 2003, DIABETES, V52, P1195, DOI 10.2337/diabetes.52.5.1195; Choudhary P, 2013, DIABETIC MED, V30, P914, DOI 10.1111/dme.12175; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Hoi-Hansen T, 2005, DIABETOLOGIA, V48, P2437, DOI 10.1007/s00125-005-1946-5; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; Mauras N, 2007, PEDIATR DIABETES, V8, P199; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; PERRIELLO G, 1988, NEW ENGL J MED, V319, P1233, DOI 10.1056/NEJM198811103191901; Robinson RTCE, 2004, DIABETOLOGIA, V47, P312, DOI 10.1007/s00125-003-1292-4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SOMOGYI M, 1959, AM J MED, V26, P169, DOI 10.1016/0002-9343(59)90307-9; Suys B, 2006, DIABETES CARE, V29, P427, DOI 10.2337/diacare.29.02.06.dc05-1450; TATTERSALL RB, 1991, DIABETIC MED, V8, P49, DOI 10.1111/j.1464-5491.1991.tb01516.x; Tsujimoto T, 2014, DIABETES CARE, V37, P217, DOI 10.2337/dc13-0701; Wentholt IME, 2007, DIABETIC MED, V24, P527, DOI 10.1111/j.1464-5491.2007.02107.x; Weston PJ, 1999, DIABETIC MED, V16, P626, DOI 10.1046/j.1464-5491.1999.00121.x; Wiltshire EJ, 2006, J PAEDIATR CHILD H, V42, P758, DOI 10.1111/j.1440-1754.2006.00973.x; Woodward A, 2009, QJM-INT J MED, V102, P603, DOI 10.1093/qjmed/hcp082; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	27	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144041	10.1371/journal.pone.0144041	http://dx.doi.org/10.1371/journal.pone.0144041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625003	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600086
J	Kitadate, A; Ikeda, S; Teshima, K; Ito, M; Toyota, I; Hasunuma, N; Takahashi, N; Miyagaki, T; Sugaya, M; Tagawa, H				Kitadate, A.; Ikeda, S.; Teshima, K.; Ito, M.; Toyota, I.; Hasunuma, N.; Takahashi, N.; Miyagaki, T.; Sugaya, M.; Tagawa, H.			MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITOR; ONCOGENE-INDUCED SENESCENCE; TUMOR-SUPPRESSOR GENES; MYCOSIS-FUNGOIDES; MANTLE CELL; CANCER; P53; EXPRESSION; SAHA; VORINOSTAT	Multiple sequential genetic and epigenetic alterations underlie cancer development and progression. Overcoming cellular senescence is an early step in cancer pathogenesis. Here, we demonstrate that a noncoding regulatory RNA, microRNA-16 (miR-16), has the potential to induce cellular senescence. First, we examined the expression of miR-16 in primary cutaneous T-cell lymphoma (CTCL) and other non-Hodgkin T/natural killer (NK)-cell lymphomas and found that miR-16 was downregulated than that in the corresponding normal cells. Notably, miR-16 expression was reduced as the primary CTCL progressed from the early stage to the advanced stage. Next, we transduced CTCL cells with miR-16 to examine whether this miRNA exhibited tumor-suppressive effects in CTCL cells. In CTCL cells expressing wild-type p53, forced expression of miR-16 enhanced p21 expression via downregulation of the polycomb group protein Bmi1, thereby inducing cellular senescence. Alternatively, in CTCL cells lacking functional p53, miR-16 induced compensatory apoptosis. The miR-16 transfection significantly decreased senescent cells and increased apoptotic cells in p21-knockdown CTCL cells expressing wild-type p53, suggesting that the presence or absence of p21 may be the most important condition in the senescence-apoptosis switch in CTCL lymphomagenesis. Furthermore, we found that the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) restored the expression of miR-16 and its essential targets, induced senescence in CTCL cells expressing wild-type p53 and promoted apoptosis in cells with nonfunctional p53. Moreover, we found that other T/NK-cell lymphoma cell lines showed similar tumor-suppressive effects in response to miR-16 and SAHA and that these effects were dependent on p53 status. These results suggested that epigenetic silencing of miR-16 may be a key step during lymphoma development. Elucidation of the essential targets of miR-16 and SAHA provides a basis for the clinical application of SAHA in the treatment of CTCL and other non-Hodgkin T/NK-cell lymphomas.	[Kitadate, A.; Ikeda, S.; Teshima, K.; Ito, M.; Toyota, I.; Takahashi, N.; Tagawa, H.] Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, 1-1-1 Hondo, Akita 0108543, Japan; [Hasunuma, N.] Akita Univ, Dept Dermatol, Akita, Japan; [Miyagaki, T.; Sugaya, M.] Univ Tokyo, Dept Dermatol, Tokyo, Japan	Akita University; Akita University; University of Tokyo	Tagawa, H (corresponding author), Akita Univ, Grad Sch Med, Dept Hematol Nephrol & Rheumatol, 1-1-1 Hondo, Akita 0108543, Japan.	htagawa0279jp@yahoo.co.jp	菅谷, 誠/GWC-3786-2022; Miyagaki, Tomomitsu/AFP-0003-2022; Kitadate, Akihiro/AAD-7306-2020	Kitadate, Akihiro/0000-0003-3218-2446	JSPS KAKENHI [25461405]; Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation)	We wish to express our appreciation to Mr J Yamashita for his outstanding technical assistance. This work was supported by JSPS KAKENHI Grant Number 25461405 (Grant-in-Aid for Scientific Research (to HT)) and a Grant from the Uehara Memorial Foundation.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Al-Yacoub N, 2012, J INVEST DERMATOL, V132, P2263, DOI 10.1038/jid.2012.125; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui YX, 2009, BLOOD, V113, P5217, DOI 10.1182/blood-2008-06-160168; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Gallardo F, 2004, HAEMATOLOGICA, V89, P1401; Heider U, 2009, EUR J HAEMATOL, V82, P440, DOI 10.1111/j.1600-0609.2009.01239.x; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Janicke RU, 2007, CELL CYCLE, V6, P407; Jaffe ES, 2008, WORLD HLTH ORG CLASS, P269; Johmura Y, 2014, MOL CELL, V55, P73, DOI 10.1016/j.molcel.2014.05.003; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Krenning L, 2014, MOL CELL, V55, P59, DOI 10.1016/j.molcel.2014.05.007; Laharanne E, 2010, MODERN PATHOL, V23, P547, DOI 10.1038/modpathol.2009.196; Ling X, 2014, CANCER RES, V74, P7487, DOI 10.1158/0008-5472.CAN-14-0683; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Litvinov IV, 2014, CLIN CANCER RES, V20, P3799, DOI 10.1158/1078-0432.CCR-14-0307; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Manfe V, 2012, J INVEST DERMATOL, V132, P1487, DOI 10.1038/jid.2012.10; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; McGregor JM, 1999, J INVEST DERMATOL, V112, P317, DOI 10.1046/j.1523-1747.1999.00507.x; Miyagaki T, 2011, CLIN CANCER RES, V17, P7529, DOI 10.1158/1078-0432.CCR-11-1192; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Ralfkiaer E, 2008, WHO CLASSIFICATION T, P296; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Teshima K, 2014, ONCOGENE, V33, P2191, DOI 10.1038/onc.2013.177; TOSCA A, 1991, ANTICANCER RES, V11, P1433; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Weinberg RA, 2007, BIOL CANC; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Zhang CL, 2007, HUM PATHOL, V38, P995, DOI 10.1016/j.humpath.2006.10.021; Zhang CL, 2005, J INVEST DERMATOL, V125, P1045, DOI 10.1111/j.0022-202X.2005.23925.x; Zhang X, 2012, ONCOGENE, V31, P3002, DOI 10.1038/onc.2011.470	50	37	39	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3692	3704		10.1038/onc.2015.435	http://dx.doi.org/10.1038/onc.2015.435			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26640145				2022-12-26	WOS:000379622800008
J	Martinez, AIC; Weinhaupl, K; Lee, WK; Wolff, NA; Storch, B; Zerko, S; Konrat, R; Kozminski, W; Breuker, K; Thevenod, F; Coudevylle, N				Martinez, Ana-Isabel Cabedo; Weinhaeupl, Katharina; Lee, Wing-Kee; Wolff, Natascha A.; Storch, Barbara; Zerko, Szymon; Konrat, Robert; Kozminski, Wiktor; Breuker, Kathrin; Thevenod, Frank; Coudevylle, Nicolas			Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2) and the N-terminal Domain of Its Endocytic Receptor SLC22A17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ASSIGNMENT; LIPOCALIN NGAL; DISTAL NEPHRON; IMMUNE-SYSTEM; PROTEIN; IRON; CELLS; NMR; TRANSPORTERS; ALBUMINURIA	The neutrophil gelatinase-associated lipocalin (NGAL, also known as LCN2) and its cellular receptor (LCN2-R, SLC22A17) are involved in many physiological and pathological processes such as cell differentiation, apoptosis, and inflammation. These pleiotropic functions mainly rely on NGAL's siderophore-mediated iron transport properties. However, the molecular determinants underlying the interaction between NGAL and its cellular receptor remain largely unknown. Here, using solution-state biomolecular NMR in conjunction with other biophysical methods, we show that the N-terminal domain of LCN2-R is a soluble extracellular domain that is intrinsically disordered and interacts with NGAL preferentially in its apo state to form a fuzzy complex. The relatively weak affinity (approximate to 10 mu M) between human LCN2-R-NTD and apo NGAL suggests that the N terminus on its own cannot account for the internalization of NGAL by LCN2-R. However, human LCN2-R-NTD could be involved in the fine-tuning of the interaction between NGAL and its cellular receptor or in a biochemical mechanism allowing the receptor to discriminate between apo- and holo-NGAL.	[Martinez, Ana-Isabel Cabedo; Weinhaeupl, Katharina; Konrat, Robert; Coudevylle, Nicolas] Univ Vienna, Dept Computat & Struct Biol, Max F Perutz Labs, Campus Vienna Bioctr 5, A-1030 Vienna, Austria; [Lee, Wing-Kee; Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Fac Hlth, Sch Med, Chair Physiol Pathophysiol & Toxicol, Stockumer Str 12, D-58453 Witten, Germany; [Lee, Wing-Kee; Wolff, Natascha A.; Thevenod, Frank] Univ Witten Herdecke, Fac Hlth, Sch Med, ZBAF, Stockumer Str 12, D-58453 Witten, Germany; [Storch, Barbara; Breuker, Kathrin] Univ Innsbruck, CCB, Inst Organ Chem, Innrain 80-82, A-6020 Innsbruck, Austria; [Zerko, Szymon; Kozminski, Wiktor] Univ Innsbruck, CCB, Ctr Mol Biosci Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria; Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Zwirki i Wigury 101, PL-02089 Warsaw, Poland	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Witten Herdecke University; Witten Herdecke University; University of Innsbruck; University of Innsbruck; University of Warsaw	Coudevylle, N (corresponding author), Univ Vienna, Dept Computat & Struct Biol, Max F Perutz Labs, Campus Vienna Bioctr 5, A-1030 Vienna, Austria.	nicolas.coudevylle@univie.ac.at	Kozminski, Wiktor/M-1561-2013	Kozminski, Wiktor/0000-0003-2319-4525; Zerko, Szymon/0000-0002-0044-1100; Breuker, Kathrin/0000-0002-4978-0883; Lee, Wing-Kee/0000-0002-7352-4679; Weinhaupl, Katharina/0000-0002-9552-9876; Konrat, Robert/0000-0001-6489-4080	European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; Austrian Science Fund (FWF) [Y 372, P 24761, P 27347] Funding Source: researchfish	European Union from the European Regional Development Fund under the Operational Programme Innovative Economy; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Dr. Roland Strong (Division of Basic Sciences, Fred Hutchinson Cancer Research Center) for the gift of the pGEX-4T-hNGAL(C87S) vector. Part of the study was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by European Union from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Abouhamed M, 2007, AM J PHYSIOL-RENAL, V293, pF705, DOI 10.1152/ajprenal.00198.2007; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Correnti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043696; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Dizin E, 2013, AM J PHYSIOL-RENAL, V305, pF1053, DOI 10.1152/ajprenal.00006.2013; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Fila M, 2011, J PHYSIOL-LONDON, V589, P3611, DOI 10.1113/jphysiol.2011.209692; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Ganisl B, 2012, CHEMISTRYOPEN, V1, P260, DOI 10.1002/open.201200038; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Kazimierczuk K, 2006, J BIOMOL NMR, V36, P157, DOI 10.1007/s10858-006-9077-y; Kazimierczuk K, 2010, J MAGN RESON, V205, P286, DOI 10.1016/j.jmr.2010.05.012; Kazimierczuk K, 2009, J MAGN RESON, V197, P219, DOI 10.1016/j.jmr.2009.01.003; Keller R., 2004, COMPUTER AIDED RESON, V1; Koepsell H, 1998, NEWS PHYSIOL SCI, V13, P11; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Kurzbach D, 2013, BIOCHEMISTRY-US, V52, P5167, DOI 10.1021/bi400502c; Langelueddecke C, 2014, TOXICOL LETT, V226, P228, DOI 10.1016/j.toxlet.2014.01.049; Langelueddecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071586; Langelueddecke C, 2012, J BIOL CHEM, V287, P159, DOI 10.1074/jbc.M111.308296; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Schneider R, 2015, J AM CHEM SOC, V137, P1220, DOI 10.1021/ja511066q; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Stanek J, 2010, J BIOMOL NMR, V47, P65, DOI 10.1007/s10858-010-9411-2; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tollinger M, 2006, BIOCHEMISTRY-US, V45, P8885, DOI 10.1021/bi0607305; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V54, P81, DOI 10.1007/s10858-012-9652-3; Zawadzka-Kazimierczuk A, 2012, J BIOMOL NMR, V52, P329, DOI 10.1007/s10858-012-9613-x	47	25	25	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2917	2930		10.1074/jbc.M115.685644	http://dx.doi.org/10.1074/jbc.M115.685644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26635366	Green Published, hybrid			2022-12-26	WOS:000369626900029
J	Liu, ZH; Zhang, N; Shao, BJ; Panicker, SR; Fu, JX; McEver, RP				Liu, Zhenghui; Zhang, Nan; Shao, Bojing; Panicker, Sumith R.; Fu, Jianxin; McEver, Rodger P.			Replacing the Promoter of the Murine Gene Encoding P-selectin with the Human Promoter Confers Human-like Basal and Inducible Expression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE SYNTHASE GENE; IN-VIVO EXPRESSION; ADHESION MOLECULES; TRANSCRIPTIONAL REGULATION; LEUKOCYTE ADHESION; ENDOTHELIAL-CELLS; DEFICIENT MICE; KAPPA-B; CLONING; REQUIREMENTS	In humans and mice, megakaryocytes/platelets and endothelial cells constitutively synthesize P-selectin and mobilize it to the plasma membrane to mediate leukocyte rolling during inflammation. TNF-alpha, interleukin 1 beta, and LPS markedly increase P-selectin mRNA in mice but decrease P-selectin mRNA in humans. Transgenic mice bearing the entire human SELP gene recapitulate basal and inducible expression of human P-selectin and reveal human-specific differences in P-selectin function. Differences in the human SELP and murine Selp promoters account for divergent expression in vitro, but their significance in vivo is not known. Here we generated knockin mice that replace the 1.4-kb proximal Selp promoter with the corresponding SELP sequence (Selp(KI)). Selp(KI/KI) mice constitutively expressed more P-selectin on platelets and more P-selectin mRNA in tissues but only slightly increased P-selectin mRNA after injection of TNF-alpha or LPS. Consistent with higher basal expression, leukocytes rolled more slowly on P-selectin in trauma-stimulated venules of Selp(KI/KI) mice. However, TNF-alpha did not further reduce P-selectin-dependent rolling velocities. Blunted up-regulation of P-selectin mRNA during contact hypersensitivity reduced P-selectin-dependent inflammation in Selp(KI/-) mice. Higher basal P-selectin in Selp(KI/KI) mice compensated for this defect. Therefore, divergent sequences in a short promoter mediate most of the functionally significant differences in expression of human and murine P-selectin in vivo.	[Liu, Zhenghui; Shao, Bojing; Panicker, Sumith R.; Fu, Jianxin; McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Zhang, Nan; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	McEver, RP (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org	Panicker, Sumith/X-8830-2019	Zhang, Nan/0000-0002-6736-2781; Panicker, Sumith/0000-0001-8550-9436	National Institutes of Health [HL034363, HL085607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607, R37HL034363, R01HL034363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL034363 and HL085607. R.P.M. has interests in Selexys and Tetherex. The other authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily	AUCHAMPACH JA, 1994, GENE, V145, P251, DOI 10.1016/0378-1119(94)90015-9; BISCHOFF J, 1995, BIOCHEM BIOPH RES CO, V210, P174, DOI 10.1006/bbrc.1995.1643; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; BURNS SA, 1995, J THORAC CARDIOV SUR, V110, P924, DOI 10.1016/S0022-5223(05)80159-X; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; Chong BF, 2004, J IMMUNOL, V172, P1575, DOI 10.4049/jimmunol.172.3.1575; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Dore M, 1996, VET PATHOL, V33, P662, DOI 10.1177/030098589603300605; Hwang JM, 2004, J EXP MED, V199, P1223, DOI 10.1084/jem.20032016; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; Kunkel EJ, 1997, AM J PHYSIOL-HEART C, V272, pH1391, DOI 10.1152/ajpheart.1997.272.3.H1391; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McEver RP, 2015, CARDIOVASC RES, V107, P331, DOI 10.1093/cvr/cvv154; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; PAN JL, 1993, J BIOL CHEM, V268, P22600; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Ramos CL, 1997, BLOOD, V89, P3009, DOI 10.1182/blood.V89.8.3009; Rose SD, 1997, HUM MOL GENET, V6, P897, DOI 10.1093/hmg/6.6.897; SANDERS WE, 1992, BLOOD, V80, P795; Schweitzer KM, 1996, AM J PATHOL, V148, P165; SILBER A, 1994, LAB INVEST, V70, P163; Spitsin SV, 1996, MOL MED, V2, P226, DOI 10.1007/BF03401619; Staite ND, 1996, BLOOD, V88, P2973, DOI 10.1182/blood.V88.8.2973.bloodjournal8882973; Tchernychev B, 2003, J CELL BIOL, V163, P1145, DOI 10.1083/jcb.200310079; Thomas GP, 2000, EXP CELL RES, V258, P395, DOI 10.1006/excr.2000.4912; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; WELLER A, 1992, J BIOL CHEM, V267, P15176; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2015, J EXP MED, V212, P1267, DOI 10.1084/jem.20142358; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Yao LB, 1999, BLOOD, V94, P3820, DOI 10.1182/blood.V94.11.3820; Yu ZY, 2005, AM J PHYSIOL-RENAL, V288, pF214, DOI 10.1152/ajprenal.00258.2004; Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307; Zhang XO, 1996, J LEUKOCYTE BIOL, V59, P575, DOI 10.1002/jlb.59.4.575	44	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1441	1447		10.1074/jbc.M115.702126	http://dx.doi.org/10.1074/jbc.M115.702126			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26631722	Green Published, hybrid			2022-12-26	WOS:000368068300034
J	Watson, DM				Watson, David M.			Disproportionate Declines in Ground-Foraging Insectivorous Birds after Mistletoe Removal	PLOS ONE			English	Article							PARASITIC PLANTS; WOODLAND BIRDS; COMMUNITY STRUCTURE; SOUTHWEST ZIMBABWE; KEYSTONE RESOURCE; SEMIARID SAVANNA; BARTSIA-ALPINA; CLIMATE-CHANGE; FOREST; LITTER	Insectivorous birds have been recognized as disproportionately sensitive to land-use intensification and habitat loss, with those species feeding primarily on the ground exhibiting some of the most dramatic declines. Altered litter inputs and availability of epigeic arthropods have been suggested to underlie reduced abundances and shrinking distributions but direct evidence is lacking. I used a patch-scale removal experiment in southern Australia to evaluate whether ground-feeding insectivores are especially vulnerable to altered litter-fall. Building on work demonstrating the importance of mistletoe litter to nutrient dynamics, litter was reduced by removing mistletoe (Loranthaceae) from one set of eucalypt woodlands, responses of birds three years after mistletoe removal compared with otherwise similar control woodlands containing mistletoe. Despite not feeding on mistletoes directly, insectivores exhibited the greatest response to mistletoe removal. Among woodland residents, ground-foraging insectivores showed the most dramatic response; treatment woodlands losing an average of 37.4% of their pre-treatment species richness. Once these 19 species of ground-foraging insectivores were excluded, remaining woodland species showed no significant effect of mistletoe removal. This response reflects greater initial losses in treatment woodlands during the study (which coincided with a severe drought) and double the number of species returning to control woodlands (where mistletoe numbers and litter were not manipulated) post-drought. These findings support the productivity-based explanation of declining insectivores, suggesting diminished litter-fall reduced habitat quality for these birds via decreased availability of their preferred prey. In addition to altered prey availability, interactions between litter-fall and epigeic arthropods exemplify the importance of below-ground / above-ground linkages driving ecosystem function.	[Watson, David M.] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia	Charles Sturt University	Watson, DM (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia.	dwatson@csu.edu.au		David, Watson/0000-0003-1821-4632	Australian Research Council [DP034259]; Winnifred Violet Scott Trust; Charles Sturt University	Australian Research Council(Australian Research Council); Winnifred Violet Scott Trust; Charles Sturt University	This research was supported by the Australian Research Council (DP034259), the Winnifred Violet Scott Trust and Charles Sturt University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; I am grateful to the 18 Billabong Creek catchment landholders for allowing access to their properties and supporting all aspects of fieldwork and data collection. Matthew Herring was instrumental in organizing teams of volunteers for the mistletoe removal phase, and technicians from the Charles Sturt University Ecology Lab provided logistical support throughout. This research was supported by the Australian Research Council (DP034259), the Winnifred Violet Scott Trust and Charles Sturt University. Maggie Watson, Dale Nimmo and Karen Ikin provided constructive feedback on an earlier version of this manuscript and Simon McDonland (CSU SPAN) assisted with the figure.	Ameloot E, 2008, PLANT SOIL, V311, P255, DOI 10.1007/s11104-008-9640-2; [Anonymous], 1996, PRAIRIE CONSERVATION; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Bennett AF, 2011, EMU, V111, pI, DOI 10.1071/MUv111n1_ED; BOM CSIRO, 2014, STAT CLIM 2014 COMM; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Cullings K, 2010, SOIL BIOL BIOCHEM, V42, P1976, DOI 10.1016/j.soilbio.2010.07.018; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Facelli JM, 1991, BOT REV, V53, P12, DOI 10.1007/BF02858763; Fisher JP, 2013, NEW PHYTOL, V198, P222, DOI 10.1111/nph.12144; Fuller RJ, 2007, IBIS, V149, P261, DOI 10.1111/j.1474-919X.2007.00775.x; Hamer KC, 2015, BIOL CONSERV, V188, P82, DOI 10.1016/j.biocon.2014.09.026; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Luck GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063671; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; March WA, 2007, OECOLOGIA, V154, P339, DOI 10.1007/s00442-007-0835-7; Maron M, 2005, AUSTRAL ECOL, V30, P383, DOI 10.1111/j.1442-9993.2005.01480.x; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Ndagurwa HGT, 2014, PLANT SOIL, V383, P291, DOI 10.1007/s11104-014-2176-8; Ndagurwa HGT, 2014, PLANT ECOL, V215, P15, DOI 10.1007/s11258-013-0275-x; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Powell LL, 2015, BIOL CONSERV, V188, P1, DOI 10.1016/j.biocon.2015.03.025; Quested HM, 2008, PLANT SOIL, V311, P269, DOI 10.1007/s11104-008-9646-9; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Razeng E, 2015, J AVIAN BIOL, V46, P89, DOI 10.1111/jav.00475; Razeng E, 2012, EMU, V112, P149, DOI 10.1071/MU11099; Robinson SK, 1998, AUK, V115, P1; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Spasojevic MJ, 2011, OECOLOGIA, V165, P193, DOI 10.1007/s00442-010-1726-x; Stevens HC, 2013, EMU, V113, P112, DOI 10.1071/MU12063; Taylor S. C., 2008, VICTORIAN NAT, V125, P19; Totterman Stephen L., 2015, Corella, V39, P1; Usher M.B., 1993, Biodiversity Letters, V1, P54, DOI 10.2307/2999650; Watson D. M., 2010, TEMPERATE WOODLAND C, P159; Watson DM, 2015, BIOL CONSERV, V191, P830, DOI 10.1016/j.biocon.2015.08.035; Watson DM, 2012, P ROY SOC B-BIOL SCI, V279, P3853, DOI 10.1098/rspb.2012.0856; Watson DM, 2011, EMU, V111, P10, DOI 10.1071/MU09109; Watson DM, 2009, J ECOL, V97, P1151, DOI 10.1111/j.1365-2745.2009.01576.x; Watson DM, 2004, WILDLIFE RES, V31, P1, DOI 10.1071/WR03022; Watson DM, 2003, AUSTRAL ECOL, V28, P515, DOI 10.1046/j.1442-9993.2003.01308.x; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Yong DL, 2011, J TROP ECOL, V27, P1, DOI 10.1017/S0266467410000520; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2	44	16	17	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0142992	10.1371/journal.pone.0142992	http://dx.doi.org/10.1371/journal.pone.0142992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640895	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700011
J	Chen, K; Ding, AM; Liang, XH; Zhang, LP; Wang, L; Song, XM				Chen, Ke; Ding, Ai-Min; Liang, Xiao-Hua; Zhang, Li-Peng; Wang, Ling; Song, Xue-Mei			Effect of Contrast on Visual Spatial Summation in Different Cell Categories in Cat Primary Visual Cortex	PLOS ONE			English	Article							FAST-SPIKING INTERNEURONS; RAT FRONTAL-CORTEX; NONCLASSICAL RECEPTIVE-FIELD; PUTATIVE PYRAMIDAL NEURONS; STRIATE CORTEX; INHIBITORY NEURONS; CORTICAL-NEURONS; SYNAPTIC CONNECTIONS; PREFRONTAL CORTEX; MORPHOLOGICAL-CHARACTERISTICS	Multiple cell classes have been found in the primary visual cortex, but the relationship between cell types and spatial summation has seldom been studied. Parvalbumin-expressing inhibitory interneurons can be distinguished from pyramidal neurons based on their briefer action potential durations. In this study, we classified V1 cells into fast-spiking units (FSUs) and regular-spiking units (RSUs) and then examined spatial summation at high and low contrast. Our results revealed that the excitatory classical receptive field and the suppressive non-classical receptive field expanded at low contrast for both FSUs and RSUs, but the expansion was more marked for the RSUs than for the FSUs. For most V1 neurons, surround suppression varied as the contrast changed from high to low. However, FSUs exhibited no significant difference in the strength of suppression between high and low contrast, although the overall suppression decreased significantly at low contrast for the RSUs. Our results suggest that the modulation of spatial summation by stimulus contrast differs across populations of neurons in the cat primary visual cortex.	[Chen, Ke; Ding, Ai-Min; Liang, Xiao-Hua; Zhang, Li-Peng; Wang, Ling] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Song, Xue-Mei] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, K (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	chenke0703@163.com		Chen, Ke/0000-0003-2209-1452	Major State Basic Research Program of China [2013CB329401]; Natural Science Foundations of China [31300912, 91420105, 3100492]; China Postdoctoral Science Foundation [2012M521681, 2013T60844]; Fundamental Research Funds for the Central Universities [ZYGX2014J080]	Major State Basic Research Program of China(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Major State Basic Research Program of China (2013CB329401); Natural Science Foundations of China (31300912, 91420105, 3100492); China Postdoctoral Science Foundation (2012M521681, 2013T60844); Fundamental Research Funds for the Central Universities (ZYGX2014J080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Angelucci A, 2002, J NEUROSCI, V22, P8633; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chen K, 2014, VISION RES, V96, P87, DOI 10.1016/j.visres.2014.01.011; Chen K, 2013, CEREB CORTEX, V23, P283, DOI 10.1093/cercor/bhs012; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Descaizo VF, 2005, J NEUROPHYSIOL, V8, P1552; DYKES RW, 1988, BRAIN RES, V441, P48, DOI 10.1016/0006-8993(88)91382-0; Gibber M, 2001, NEUROREPORT, V12, P2293, DOI 10.1097/00001756-200107200-00049; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Huang XY, 2014, J NEUROSCI, V34, P4976, DOI 10.1523/JNEUROSCI.4116-13.2014; JONES JP, 1987, J NEUROPHYSIOL, V58, P1212, DOI 10.1152/jn.1987.58.6.1212; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Kuhlman SJ, 2011, NAT NEUROSCI, V14, P1121, DOI 10.1038/nn.2890; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; LI CY, 1995, J NEUROSCI METH, V57, P217, DOI 10.1016/0165-0270(94)00151-6; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Mruczek REB, 2012, J NEUROPHYSIOL, V108, P2725, DOI 10.1152/jn.00618.2012; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Povysheva NV, 2006, CEREB CORTEX, V16, P541, DOI 10.1093/cercor/bhj002; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Song XM, 2008, CEREB CORTEX, V18, P331, DOI 10.1093/cercor/bhm057; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Troyer TW, 1998, J NEUROSCI, V18, P5908; VOLKOV I O, 1989, Neirofiziologiya, V21, P613; West DC, 2006, CEREB CORTEX, V16, P200, DOI 10.1093/cercor/bhi098; Yokoi I, 2010, J NEUROPHYSIOL, V104, P1603, DOI 10.1152/jn.00160.2010; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	62	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144403	10.1371/journal.pone.0144403	http://dx.doi.org/10.1371/journal.pone.0144403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636580	Green Submitted, gold, Green Published			2022-12-26	WOS:000366143800088
J	Tchoubi, S; Sobngwi-Tambekou, J; Noubiap, JJN; Asangbeh, SL; Nkoum, BA; Sobngwi, E				Tchoubi, Sebastien; Sobngwi-Tambekou, Joelle; Noubiap, Jean Jacques N.; Asangbeh, Serra Lem; Nkoum, Benjamin Alexandre; Sobngwi, Eugene			Prevalence and Risk Factors of Overweight and Obesity among Children Aged 6-59 Months in Cameroon: A Multistage, Stratified Cluster Sampling Nationwide Survey	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PRESCHOOL-CHILDREN; EARLY DETERMINANTS; UNITED-STATES; BIRTH-WEIGHT; MORTALITY; COUNTRIES	Background Childhood obesity is one of the most serious public health challenges of the 21st century. The prevalence of overweight and obesity among children (<5 years) in Cameroon, based on weight-for-height index, has doubled between 1991 and 2006. This study aimed to determine the prevalence and risk factors of overweight and obesity among children aged 6 months to 5 years in Cameroon in 2011. Methods Four thousand five hundred and eighteen children (2205 boys and 2313 girls) aged between 6 to 59 months were sampled in the 2011 Demographic Health Survey (DHS) database. Body Mass Index (BMI) z-scores based on WHO 2006 reference population was chosen to estimate overweight (BMI z-score >2) and obesity (BMI for age >3). Regression analyses were performed to investigate risk factors of overweight/obesity. Results The prevalence of overweight and obesity was 8% (1.7% for obesity alone). Boys were more affected by overweight than girls with a prevalence of 9.7% and 6.4% respectively. The highest prevalence of overweight was observed in the Grassfield area (including people living in West and North-West regions) (15.3%). Factors that were independently associated with overweight and obesity included: having overweight mother (adjusted odds ratio (aOR) = 1.51; 95% CI 1.15 to 1.97) and obese mother (aOR = 2.19; 95% CI = 155 to 3.07), compared to having normal weight mother; high birth weight (aOR = 1.69; 95% CI 1.24 to 2.28) compared to normal birth weight; male gender (aOR = 1.56; 95% CI 1.24 to 1.95); low birth rank (aOR = 1.35; 95% CI 1.06 to 1.72); being aged between 13-24 months (aOR = 1.81; 95% CI = 1.21 to 2.66) and 25-36 months (aOR = 2.79; 95% CI 1.93 to 4.13) compared to being aged 45 to 49 months; living in the grassfield area (aOR = 2.65; 95% CI = 1.87 to 3.79) compared to living in Forest area. Muslim appeared as a protective factor (aOR = 0.67; 95% CI 0.46 to 0.95). compared to Christian religion. Conclusion This study underlines a high prevalence of early childhood overweight with significant disparities between ecological areas of Cameroon. Risk factors of overweight included high maternal BMI, high birth weight, male gender, low birth rank, aged between 13-36 months, and living in the Grassfield area while being Muslim appeared as a protective factor. Preventive strategies should be strengthened especially in Grassfield areas and should focus on sensitization campaigns to reduce overweight and obesity in mothers and on reinforcement of measures such as surveillance of weight gain during antenatal consultation and clinical follow-up of children with high birth weight. Meanwhile, further studies including nutritional characteristics are of great interest to understand the association with religion, child age and ecological area in this age group, and will help in refining preventive strategies against childhood overweight and obesity in Cameroon.	[Tchoubi, Sebastien; Sobngwi-Tambekou, Joelle] Minist Publ Hlth, Yaounde, Cameroon; [Asangbeh, Serra Lem; Nkoum, Benjamin Alexandre] Catholic Univ Cent Africa, Sch Hlth Sci, Yaounde, Cameroon; [Sobngwi-Tambekou, Joelle] Clinton Hlth Access Initiat, Yaounde, Cameroon; [Noubiap, Jean Jacques N.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Noubiap, Jean Jacques N.] Med Diagnost Ctr, Yaounde, Cameroon; [Sobngwi, Eugene] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Sobngwi, Eugene] Univ Yaounde I, Lab Mol Med & Metab, Ctr Biotechnol, Yaounde, Cameroon; [Sobngwi, Eugene] Yaounde Cent Hosp, Natl Obes Ctr, Yaounde, Cameroon	University of Cape Town; University of Cape Town; University of Yaounde I; University of Yaounde I	Sobngwi-Tambekou, J (corresponding author), Minist Publ Hlth, Yaounde, Cameroon.	sobngwijoelle@gmail.com		Noubiap, Jean Jacques/0000-0002-7722-9757				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Atkinson RL, 2005, OBESITY, P406; BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Fatemeh Taheri, 2012, BMC Res Notes, V5, P529, DOI 10.1186/1756-0500-5-529; Flores G, 2013, AM J CLIN NUTR, V97, P1178, DOI 10.3945/ajcn.112.052019; Foster BA, 2015, ACAD PEDIATR, V15, P353, DOI 10.1016/j.acap.2015.04.037; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Heppe DHM, 2013, PEDIATR RES, V73, P120, DOI 10.1038/pr.2012.145; Huus K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-42; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; Josse J, 2012, J SFDS, V153, P79; Jouret B, 2007, AM J CLIN NUTR, V85, P1643, DOI 10.1093/ajcn/85.6.1643; Kitsantas P, 2010, EARLY HUM DEV, V86, P563, DOI 10.1016/j.earlhumdev.2010.07.006; Kramoh KE, 2012, ANN CARDIOL ANGEIOL, V61, P145, DOI 10.1016/j.ancard.2012.04.020; Kuhle S, 2010, INT J PEDIATR OBES, V5, P88, DOI 10.3109/17477160903060028; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Link K, 2004, J CLIN ENDOCR METAB, V89, P5003, DOI 10.1210/jc.2004-0126; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Manios Y, 2013, PEDIAT DIABETES; MEASURE DHS/ICF International USAID, 2013, DESCR DEM HLTH SURV; Moraeus L, 2012, INT J OBESITY, V36, P969, DOI 10.1038/ijo.2012.79; Mosli RH, 2015, PEDIAT OBES; Mushtaq MU, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-114; Must A, 1996, AM J CLIN NUTR, V63, P445, DOI 10.1093/ajcn/63.3.445; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; OMS, 2003, 894 OMS; OMS, 2013, GLOB DAT CHILD GROWT; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Paciorek CJ, 2013, LANCET GLOB HEALTH, V1, pE300, DOI 10.1016/S2214-109X(13)70109-8; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; RAVELLI GP, 1979, AM J EPIDEMIOL, V109, P66, DOI 10.1093/oxfordjournals.aje.a112660; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Rustein S. O., 2004, 6 ORC MACR; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Seth A, 2013, INDIAN J PEDIATR, V80, P309, DOI 10.1007/s12098-012-0931-5; Shawky R.M., 2012, EGYPTIAN J MED HUMAN, V13, P11, DOI DOI 10.1016/J.EJMHG.2011.08.005; Singh GK, 2008, ANN EPIDEMIOL, V18, P682, DOI 10.1016/j.annepidem.2008.05.001; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tabacchi G, 2007, NUTR RES, V27, P587, DOI 10.1016/j.nutres.2007.06.001; van Stralen MM, 2012, OBES REV, V13, P29, DOI 10.1111/j.1467-789X.2011.00959.x; World Health Organization, GLOB DAT CHILD GROWT; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	48	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143215	10.1371/journal.pone.0143215	http://dx.doi.org/10.1371/journal.pone.0143215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636970	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800007
J	Ocelotl, J; Sanchez, J; Arroyo, R; Garcia-Gomez, BI; Gomez, I; Unnithan, GC; Tabashnik, BE; Bravo, A; Soberon, M				Ocelotl, Josue; Sanchez, Jorge; Arroyo, Raquel; Garcia-Gomez, Blanca I.; Gomez, Isabel; Unnithan, Gopalan C.; Tabashnik, Bruce E.; Bravo, Alejandra; Soberon, Mario			Binding and Oligomerization of Modified and Native Bt Toxins in Resistant and Susceptible Pink Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; BORDER MEMBRANE-VESICLES; FIELD-EVOLVED RESISTANCE; INSECT RESISTANCE; PORE FORMATION; MANDUCA-SEXTA; CRY1AC TOXIN; MECHANISM; CROPS; LEPIDOPTERA	Insecticidal proteins from Bacillus thuringiensis (Bt) are used extensively in sprays and transgenic crops for pest control, but their efficacy is reduced when pests evolve resistance. Better understanding of the mode of action of Bt toxins and the mechanisms of insect resistance is needed to enhance the durability of these important alternatives to conventional insecticides. Mode of action models agree that binding of Bt toxins to midgut proteins such as cadherin is essential for toxicity, but some details remain unresolved, such as the role of toxin oligomers. In this study, we evaluated how Bt toxin Cry1Ac and its genetically engineered counterpart Cry1AcMod interact with brush border membrane vesicles (BBMV) from resistant and susceptible larvae of Pectinophora gossypiella (pink bollworm), a global pest of cotton. Compared with Cry1Ac, Cry1AcMod lacks 56 amino acids at the amino-terminus including helix alpha-1; previous work showed that Cry1AcMod formed oligomers in vitro without cadherin and killed P. gossypiella larvae harboring cadherin mutations linked with > 1000-fold resistance to Cry1Ac. Here we found that resistance to Cry1Ac was associated with reduced oligomer formation and insertion. In contrast, Cry1AcMod formed oligomers in BBMV from resistant larvae. These results confirm the role of cadherin in oligomerization of Cry1Ac in susceptible larvae and imply that forming oligomers without cadherin promotes toxicity of Cry1AcMod against resistant P. gossypiella larvae that have cadherin mutations.	[Ocelotl, Josue; Sanchez, Jorge; Arroyo, Raquel; Garcia-Gomez, Blanca I.; Gomez, Isabel; Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Unnithan, Gopalan C.; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; University of Arizona	Bravo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62210, Morelos, Mexico.	bravo@ibt.unam.mx; mario@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475	Consejo Nacional de Ciencia y Tecnologia MX [179977]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IN205411-3]; United States Departament of Agriculture, National Research Initiativ [2008-03980]	Consejo Nacional de Ciencia y Tecnologia MX; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); United States Departament of Agriculture, National Research Initiativ	This work was funded by Consejo Nacional de Ciencia y Tecnologia MX 179977; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico IN205411-3; and United States Departament of Agriculture, National Research Initiative 2008-03980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Crickmore N, 2011, BACILLUS THURINGIENS; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Ihara H, 2008, J INVERTEBR PATHOL, V98, P177, DOI 10.1016/j.jip.2008.02.007; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Li YP, 2012, J INTEGR AGR, V11, P1845, DOI 10.1016/S2095-3119(12)60189-0; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Peng DH, 2010, APPL MICROBIOL BIOT, V85, P1033, DOI 10.1007/s00253-009-2142-1; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080496; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	38	13	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144086	10.1371/journal.pone.0144086	http://dx.doi.org/10.1371/journal.pone.0144086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633693	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000053
J	Sola-Campoy, PJ; Robles, F; Schwarzacher, T; Rejon, CR; de la Herran, R; Navajas-Perez, R				Sola-Campoy, Pedro J.; Robles, Francisca; Schwarzacher, Trude; Ruiz Rejon, Carmelo; de la Herran, Roberto; Navajas-Perez, Rafael			The Molecular Cytogenetic Characterization of Pistachio (Pistacia vera L.) Suggests the Arrest of Recombination in the Largest Heteropycnotic Pair HC1	PLOS ONE			English	Article							SATELLITE-DNA; SEX-CHROMOSOMES; REPETITIVE DNA; CENTROMERIC SATELLITE; NUCLEOTIDE-SEQUENCE; SILENE-LATIFOLIA; Y-CHROMOSOME; EVOLUTION; IDENTIFICATION; ORGANIZATION	This paper represents the first molecular cytogenetic characterization of the strictly dioecious pistachio tree (Pistacia vera L.). The karyotype was characterized by fluorescent in situ hybridization (FISH) with probes for 5S and 45S rDNAs, and the pistachio specific satellite DNAs PIVE-40, and PIVE-180, together with DAPI-staining. PIVE-180 has a monomeric unit of 176-178 bp and high sequence homology between family members; PIVE-40 has a 43 bp consensus monomeric unit, and is most likely arranged in higher order repeats (HORs) of two units. The P. vera genome is highly heterochromatic, and prominent DAPI positive blocks are detected in most chromosomes. Despite the difficulty in classifying chromosomes according to morphology, 10 out of 15 pairs (2n = 30) could be distinguished by their unique banding patterns using a combination of FISH probes. Significantly, the largest pair, designated HC1, is strongly heteropycnotic, shows differential condensation, and has massive enrichment in PIVE-40 repeats. There are two types of HC1 chromosomes (type-I and type-II) with differing PIVE-40 hybridization signal. Only type-I/II heterozygotes and type-I homozygotes individuals were found. We speculate that the differentiation between the two HC1 chromosomes is due to suppression of homologous recombination at meiosis, reinforced by the presence of PIVE-40 HORs and differences in PIVE-40 abundance. This would be compatible with a ZW sex-determination system in the pistachio tree.	[Sola-Campoy, Pedro J.; Robles, Francisca; Ruiz Rejon, Carmelo; de la Herran, Roberto; Navajas-Perez, Rafael] Univ Granada, Dept Genet, E-18071 Granada, Spain; [Schwarzacher, Trude] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Granada; University of Leicester	Navajas-Perez, R (corresponding author), Univ Granada, Dept Genet, Campus Fuentenueva S-N, E-18071 Granada, Spain.	rnavajas@ugr.es	Navajas-Pérez, Rafael/F-7122-2012; Rejón, Carmelo Ruiz/AAU-2107-2020; Robles Rodríguez, Francisca/K-3587-2014	Navajas-Pérez, Rafael/0000-0002-6147-3640; Robles Rodríguez, Francisca/0000-0003-1738-5325; De la Herran, Roberto/0000-0002-3772-4374; Schwarzacher, Trude/0000-0001-8310-5489	Ministerio de Ciencia e Innovacion of Spain [RYC-2011-08653, AGL2009-09094]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the project AGL2009-09094. P.J.S.-C. is an FPI scholar and R. N.-P. a Ramon y Cajal senior postdoctoral researcher (RYC-2011-08653), all funded by Ministerio de Ciencia e Innovacion of Spain (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saghir Mohannad G., 2010, Asian Journal of Plant Sciences, V9, P28; ALEXANDROV IA, 1988, CHROMOSOMA, V96, P443, DOI 10.1007/BF00303039; [Anonymous], PLANT TAXONOMY; Ashikawa I, 1994, DNA Res, V1, P67, DOI 10.1093/dnares/1.2.67; Ayaz E, 2009, NAT PROD RES, V23, P866, DOI 10.1080/14786410802263675; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bennett MD, 2012, ANGIOSPERM DNA C VAL; BLANCHETOT A, 1991, NUCLEIC ACIDS RES, V19, P929, DOI 10.1093/nar/19.4.929; Cermak T, 2008, CHROMOSOME RES, V16, P961, DOI 10.1007/s10577-008-1254-2; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Couceiro JF, 2013, CULTIVO PISTACHO; Cunado N, 2007, CHROMOSOME RES, V15, P825, DOI 10.1007/s10577-007-1166-6; Damasceno PC, 2010, CARYOLOGIA, V63, P229; de la Herran R, 2008, CYTOGENET GENOME RES, V121, P271, DOI 10.1159/000138896; De Souza Almeida CC, 2007, BOT J LINN SOC, V155, P541, DOI 10.1111/j.1095-8339.2007.00721.x; DEUMLING B, 1981, P NATL ACAD SCI-BIOL, V78, P338, DOI 10.1073/pnas.78.1.338; Divashuk MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085118; Fasihi Harandi O., 2001, Cahiers Options Mediterraneennes, V56, P35; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARRIDORAMOS MA, 1994, CYTOGENET CELL GENET, V65, P233, DOI 10.1159/000133637; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Ghaffari S. M., 2005, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P347; Ghaffari SM, 2002, ACTA HORTIC, P389, DOI 10.17660/ActaHortic.2002.591.59; Grabowska-Joachimiak A, 2011, CYTOGENET GENOME RES, V132, P203, DOI 10.1159/000321584; Heslop-Harrison JS, 2013, P NATL ACAD SCI USA, V110, P19974, DOI 10.1073/pnas.1319945110; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Hobza R, 2015, CHROMOSOME RES, V23, P561, DOI 10.1007/s10577-015-9496-2; Hormaza JI, 1996, AM J BOT, V83, P759, DOI 10.2307/2445853; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Huang S. F., 1989, Acta Botanica Austro Sinica, P161; Ila HB, 2003, J HORTIC SCI BIOTECH, V78, P35; Kafkas S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1326-6; Kejnovsky E, 2009, HEREDITY, V102, P533, DOI 10.1038/hdy.2009.17; Kipling D, 1995, THE TELOMERE; Kuhn GCS, 2008, CHROMOSOME RES, V16, P307, DOI 10.1007/s10577-007-1195-1; Kumar S, 2014, J GENET, V93, P241, DOI 10.1007/s12041-014-0326-7; Lan T, 2006, CYTOGENET GENOME RES, V114, P175, DOI 10.1159/000093335; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Macas J, 2002, BIOINFORMATICS, V18, P28, DOI 10.1093/bioinformatics/18.1.28; Mahendran B, 2006, GENE, V370, P51, DOI 10.1016/j.gene.2005.11.010; Ming R, 2014, PLANT GENETICS GENOM, P225; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Nakayama S, 2001, CHROMOSOME RES, V9, P469, DOI 10.1023/A:1011676328165; Natarajan G, 1978, TAXON, V27, P519; Navajas-Perez R, 2005, J MOL EVOL, V60, P391, DOI 10.1007/s00239-004-0199-0; Navajas-Perez R, 2009, CYTOGENET GENOME RES, V124, P81, DOI 10.1159/000200091; Navajas-Perez R, 2009, GENETICA, V135, P87, DOI 10.1007/s10709-008-9261-y; Navajas-Perez R, 2007, BIOINFORMATICS, V23, P767, DOI 10.1093/bioinformatics/btm005; Navajas-Perez R, 2009, MOL GENET GENOMICS, V281, P579, DOI 10.1007/s00438-009-0433-y; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Ozbek S, 1957, ANKARA U ZIRAAT FAKU, V3, P203; Pich U, 1996, CHROMOSOME RES, V4, P207, DOI 10.1007/BF02254961; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Pons J, 2003, HEREDITAS, V139, P28, DOI 10.1111/j.1601-5223.2003.01760.x; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu P.S., 1988, J CYTOLOGY GENETICS, V23, P219; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Schwarzacher T, 2000, PRACTICAL SITU HYBRI, V2; Sola-Campoy PJ, 2012, NEW INSIGHTS PLANT S, P1; Sousa A, 2013, CYTOGENET GENOME RES, V139, P107, DOI 10.1159/000345370; Steflova P, 2013, GENOME BIOL EVOL, V5, P769, DOI 10.1093/gbe/evt049; Stratikopoulos EE, 2002, CHROMOSOME RES, V10, P287, DOI 10.1023/A:1016567624117; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilkat EA, 2011, AUST J CROP SCI, V5, P288; Wang JP, 2012, P NATL ACAD SCI USA, V109, P13710, DOI 10.1073/pnas.1207833109; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WRIGHT JM, 1989, NUCLEIC ACIDS RES, V17, P5071, DOI 10.1093/nar/17.13.5071; Yonemori K., 2010, Acta Horticulturae, P133; Zohary M., 1952, Palestine Journal of Botany (Jerusalem Series), V5, P187	75	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143861	10.1371/journal.pone.0143861	http://dx.doi.org/10.1371/journal.pone.0143861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633808	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000026
J	Xie, YH; Tan, Y; Chongsuvivatwong, V; Wu, XH; Bi, FY; Hadler, SC; Jiraphongsa, C; Sornsrivichai, V; Lin, M; Quan, Y				Xie, Yihong; Tan, Yi; Chongsuvivatwong, Virasakdi; Wu, Xinghua; Bi, Fuyin; Hadler, Stephen C.; Jiraphongsa, Chuleeporn; Sornsrivichai, Vorasith; Lin, Mei; Quan, Yi			A Population-Based Acute Meningitis and Encephalitis Syndromes Surveillance in Guangxi, China, May 2007-June 2012	PLOS ONE			English	Article							BACTERIAL-MENINGITIS; CRYPTOCOCCAL MENINGITIS; CHILDREN; EPIDEMIOLOGY; DISEASE; VACCINATION; ELIMINATION; PROGRESS; ENGLAND; MEASLES	Objectives Acute meningitis and encephalitis (AME) are common diseases with the main pathogens being viruses and bacteria. As specific treatments are different, it is important to develop clinical prediction rules to distinguish aseptic from bacterial or fungal infection. In this study we evaluated the incidence rates, seasonal variety and the main etiologic agents of AME, and identified factors that could be used to predict the etiologic agents. Methods A population-based AME syndrome surveillance system was set up in Guigang City, Guangxi, involving 12 hospitals serving the study communities. All patients meeting the case definition were investigated. Blood and/or cerebrospinal fluid were tested for bacterial pathogens using culture or RT-PCR and serological tests for viruses using enzyme-linked immunosorbent assays. Laboratory testing variables were grouped using factor analysis. Multinomial logistic regression was used to predict the etiology of AME. Results From May 2007 to June 2012, the annual incidence rate of AME syndrome, and disease specifically caused by Japanese encephalitis (JE), other viruses, bacteria and fungi were 12.55, 0.58, 4.57, 0.45 and 0.14 per 100,000 population, respectively. The top three identified viral etiologic agents were enterovirus, mumps virus, and JE virus, and for bacteria/fungi were Streptococcus sp., Cryptococcus neoformans and Staphylococcus sp. The incidence of JE and other viruses affected younger populations and peaked from April to August. Alteration of consciousness and leukocytosis were more likely to be caused by JE, bacteria and fungi whereas CSF inflammation was associated with bacterial/fungal infection. Conclusions With limited predictive validity of symptoms and signs and routine laboratory tests, specific tests for JE virus, mumps virus and enteroviruses are required to evaluate the immunization impact and plan for further intervention. CSF bacterial culture cannot be omitted in guiding clinical decisions regarding patient treatment.	[Xie, Yihong; Tan, Yi; Wu, Xinghua; Bi, Fuyin; Lin, Mei; Quan, Yi] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Acute Infect Dis Prevent & Control, Nanning, Guangxi, Peoples R China; [Chongsuvivatwong, Virasakdi; Sornsrivichai, Vorasith] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkla, Thailand; [Hadler, Stephen C.] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Jiraphongsa, Chuleeporn] Minist Publ Hlth, Bur Epidemiol, IFETP, Bangkok, Thailand	Prince of Songkla University; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand	Xie, YH (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Acute Infect Dis Prevent & Control, Nanning, Guangxi, Peoples R China.	wallstreetxie@hotmail.com; cvirasak@gmail.com			AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC; China Ministry of Health and Youth Foundation of Guangxi [011GXNSFB018090]; Guangxi Science and Technology Bureau	AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC; China Ministry of Health and Youth Foundation of Guangxi; Guangxi Science and Technology Bureau	This study was supported by the AMES Surveillance project, Division of Global Disease Detection and Emergency Response, US CDC from 2007 to 2009, and was further supported by the China Ministry of Health and Youth Foundation of Guangxi (project ID: 011GXNSFB018090; http://kjxm.gxsti.net/), grant by Guangxi Science and Technology Bureau since 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Connolly K J, 1990, Infect Dis Clin North Am, V4, P599; Davison KL, 2003, ARCH DIS CHILD, V88, P662, DOI 10.1136/adc.88.8.662; Davison KL, 2003, EMERG INFECT DIS, V9, P234; Deng Xingchao, 2007, APPL PREV MED, V13, P33; Fuller DG, 2003, ANN TROP PAEDIATR, V23, P233, DOI 10.1179/027249303225007752; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Guangxi Zhuang Autonomous Region Statistic Bureau, 2008, GUANGX STAT YB; Guo JH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-376; Hinson VK, 2001, CURR OPIN NEUROL, V14, P369, DOI 10.1097/00019052-200106000-00017; Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Khayhan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072222; Kolski H, 1998, CLIN INFECT DIS, V26, P398, DOI 10.1086/516301; Lee TC, 2003, JPN J INFECT DIS, V56, P193; Li YX, 2014, EMERG INFECT DIS, V20, P61, DOI 10.3201/eid2001.120375; Lin MC, 2013, J MICROBIOL IMMUNOL; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luksic I, 2013, CROAT MED J, V54, P510, DOI 10.3325/cmj.2013.54.510; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Namani SA, 2014, J INFECT DEV COUNTR, V8, P823, DOI 10.3855/jidc.3553; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Ramakrishna C, 2013, FUTURE VIROL, V8, P259, DOI 10.2217/FVL.12.138; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Sandhu Hardeep S., 2012, Morbidity and Mortality Weekly Report, V61, P1008; Wall EC, 2014, CLIN INFECT DIS, V58, pE137, DOI 10.1093/cid/ciu057; Wang Meng, 2012, Disease Surveillance, V27, P435; WENGER JD, 1993, INFECT AGENT DIS, V2, P324; White K, 2012, DIAGN MICR INFEC DIS, V73, P27, DOI 10.1016/j.diagmicrobio.2012.02.010; Xiao Ge-xin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P808; Yin ZD, 2010, AM J TROP MED HYG, V83, P766, DOI 10.4269/ajtmh.2010.09-0748; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	36	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144366	10.1371/journal.pone.0144366	http://dx.doi.org/10.1371/journal.pone.0144366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633824	Green Published, gold			2022-12-26	WOS:000366040000082
J	Kim, SA; Lee, YM; Lee, HW; Jacobs, DR; Lee, DH				Kim, Se-A; Lee, Yu-Mi; Lee, Ho-Won; Jacobs, David R., Jr.; Lee, Duk-Hee			Can Inconsistent Association between Hypertension and Cognition in Elders be Explained by Levels of Organochlorine Pesticides?	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; BLOOD-PRESSURE; RISK; SERUM; HYPOPERFUSION; EXPOSURE; DISEASE; HEALTH	The relation between hypertension and cognition in elders remains unclear, and studies on the effect of antihypertensive drugs on cognition have demonstrated conflicting results. This study was performed to evaluate if the association between hypertension and cognition in elders differed depending on serum concentrations of organochlorine (OC) pesticides, common neurotoxic chemicals. Participants were 644 elders aged 60-85 years who participated in the National Health and Nutrition Examination Survey 1999-2002 and were able to complete a cognitive test. We selected 6 OC pesticides that were commonly detected in the elderly. Cognition was assessed by the Digit Symbol Substitution Test (DSST), a relevant tool for evaluating hypertension-related cognitive function, and low cognition was defined by the DSST score < 25th percentile. When OC pesticides were not considered in the analyses, elders with hypertension had about 1.7 times higher risk of low cognition than those without hypertension. However, in analyses stratified by serum concentrations of OC pesticides, the associations between hypertension and low cognition were stronger the higher the serum concentrations of p, p'-DDT, p, p'-DDE, beta-hexachlorocyclohexane, and trans-nonachlor increased. Among elders in the 3rd tertile of these pesticides, adjusted odds ratios were from 2.5 to 3.5. In contrast, hypertension was not clearly associated with the risk of low cognition in elders in the 1st tertile of these pesticides. Similar patterns were observed for the continuous DSST score dependent variable. The difference in the association between hypertension and DSST scores according to the levels of OC pesticides suggest a key role of OC pesticides in the development of hypertension-related cognitive impairment and may help to identify hypertensive elders who are at a high risk of cognitive impairment.	[Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea; [Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea; [Lee, Yu-Mi; Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ, Sch Med, Dept Neurol, Daegu, South Korea; [Lee, Ho-Won] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities	Lee, DH (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea.	lee_dh@knu.ac.kr		Jacobs, David/0000-0002-7232-0543	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]; National Research Foundation of Korea (NRF) - Korea government (MEST) [2013R1A2A2A01068254]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was financially supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013R1A2A2A01068254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birns J, 2006, J HUM HYPERTENS, V20, P1, DOI 10.1038/sj.jhh.1001940; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Fabrigoule C, 1998, BRAIN, V121, P135, DOI 10.1093/brain/121.1.135; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kalaria RN, 2004, J NEUROL SCI, V226, P75, DOI 10.1016/j.jns.2004.09.019; Kalback W, 2004, NEUROL RES, V26, P525, DOI 10.1179/016164104225017668; Kim KS, 2014, ASS ORGANOCHLORINE P; Kim SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130623; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Lee DH, 2012, ENVIRON INT, V47, P115, DOI 10.1016/j.envint.2012.06.009; Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x; Lind PM, 2012, ENVIRON HEALTH PERSP, V120, P38, DOI 10.1289/ehp.1103563; MORRISON G, 1971, B ENVIRON CONTAM TOX, V6, P48, DOI 10.1007/BF01559073; Parkin AJ, 1999, NEUROPSYCHOLOGY, V13, P539, DOI 10.1037/0894-4105.13.4.539; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495, DOI 10.1007/BF01055015; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Singh NK, 2013, HUM EXP TOXICOL, V32, P24, DOI 10.1177/0960327112456315; SPARKS DL, 1995, J NEUROL SCI, V131, P162, DOI 10.1016/0022-510X(95)00105-B; Spence JD, 1996, J HYPERTENS, V14, pS139; Suter OC, 2002, STROKE, V33, P1986, DOI 10.1161/01.STR.0000024523.82311.77; Tzourio C, 2014, HYPERTENSION, V63, P894, DOI 10.1161/HYPERTENSIONAHA.113.00147; van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785	27	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144205	10.1371/journal.pone.0144205	http://dx.doi.org/10.1371/journal.pone.0144205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630154	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300166
J	Kuzmina, A; Vaknin, K; Gdalevsky, G; Vyazmensky, M; Marks, RS; Taube, R; Engel, S				Kuzmina, Alona; Vaknin, Karin; Gdalevsky, Garik; Vyazmensky, Maria; Marks, Robert S.; Taube, Ran; Engel, Stanislav			Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP120 ENVELOPE GLYCOPROTEIN; SOLUBLE CD4; N-TERMINUS; CHEMOKINE; BINDING; ENTRY; RECEPTOR; PEPTIDE; COMPLEX	Chemokine G protein coupled receptors, principally CCR5 or CXCR4, function as co-receptors for HIV-1 entry into CD4(+) T cells. Initial binding of the viral envelope glycoprotein (Env) gp120 subunit to the host CD4 receptor induces a cascade of structural conformational changes that lead to the formation of a high-affinity co-receptor-binding site on gp120. Interaction between gp120 and the co-receptor leads to the exposure of epitopes on the viral gp41 that mediates fusion between viral and cell membranes. Soluble CD4 (sCD4) mimetics can act as an activation-based inhibitor of HIV-1 entry in vitro, as it induces similar structural changes in gp120, leading to increased virus infectivity in the short term but to virus Env inactivation in the long term. Despite promising clinical implications, sCD4 displays low efficiency in vivo, and in multiple HIV strains, it does not inhibit viral infection. This has been attributed to the slow kinetics of the sCD4-induced HIV Env inactivation and to the failure to obtain sufficient sCD4 mimetic levels in the serum. Here we present uniquely structured CCR5 co-receptor mimetics. We hypothesized that such mimetics will enhance sCD4-induced HIV Env inactivation and inhibition of HIV entry. Co-receptor mimetics were derived from CCR5 gp120-binding epitopes and functionalized with a palmitoyl group, which mediated their display on the surface of lipid-coated magnetic beads. CCR5-peptido-liposome mimetics bound to soluble gp120 and inhibited HIV-1 infectivity in a sCD4-dependent manner. We concluded that CCR5-peptidoliposomes increase the efficiency of sCD4 to inhibit HIV infection by acting as bait for sCD4-primed virus, catalyzing the premature discharge of its fusion potential.	[Kuzmina, Alona; Taube, Ran] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Vaknin, Karin; Gdalevsky, Garik; Engel, Stanislav] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Vyazmensky, Maria; Marks, Robert S.; Engel, Stanislav] Natl Inst Biotechnol Negev, Beer Sheva, Israel; [Marks, Robert S.] Ben Gurion Univ Negev, Fac Engn, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Taube, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel.	engels@bgu.ac.il; rantaube@bgu.ac.il	TAUBE, RAN/F-2029-2012; MARKS, ROBERT/AAS-4746-2020; Engel, Stanislav/G-2799-2013	TAUBE, RAN/0000-0002-2062-4537; Engel, Stanislav/0000-0001-5916-5190; Marks, Robert/0000-0002-9697-3805	Chief Scientist Office of the Ministry of Health, Israel [3-00000-7445]; HEZNEK grant from Ben-Gurion University of the Negev, Israel	Chief Scientist Office of the Ministry of Health, Israel; HEZNEK grant from Ben-Gurion University of the Negev, Israel	This study was supported by grant no. 3-00000-7445 from the Chief Scientist Office of the Ministry of Health, Israel and the HEZNEK grant from Ben-Gurion University of the Negev, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; De Feo CJ, 2012, VIRUSES-BASEL, V4, P3859, DOI 10.3390/v4123859; Devesa F, 2002, EUR J BIOCHEM, V269, P5163, DOI 10.1046/j.1432-1033.2002.03213.x; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Khurana S, 2005, J VIROL, V79, P6791, DOI 10.1128/JVI.79.11.6791-6800.2005; Kitagawa K, 2001, J ORG CHEM, V66, P1, DOI 10.1021/jo000895y; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Kuzmina A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-51; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lam SN, 2008, BIOORGAN MED CHEM, V16, P10113, DOI 10.1016/j.bmc.2008.10.005; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lee H, 2009, J PHYS CHEM B, V113, P13186, DOI 10.1021/jp9058966; Lobritz MA, 2010, VIRUSES-BASEL, V2, P1069, DOI 10.3390/v2051069; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Martin G, 2008, VIROLOGY, V381, P241, DOI 10.1016/j.virol.2008.08.039; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moseri A, 2014, FEBS J, V281, P3019, DOI 10.1111/febs.12839; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Selhorst P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-12; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Van Herrewege Y, 2008, J ANTIMICROB CHEMOTH, V61, P818, DOI 10.1093/jac/dkn042; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Young T, 2002, ANGEW CHEM INT EDIT, V41, P3449, DOI 10.1002/1521-3773(20020916)41:18<3449::AID-ANIE3449>3.0.CO;2-U; Zhukovsky MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013249	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144043	10.1371/journal.pone.0144043	http://dx.doi.org/10.1371/journal.pone.0144043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629902	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300144
J	Mahboub, P; Ottens, P; Seelen, M; t Hart, N; Van Goor, H; Ploeg, R; Martins, P; Leuvenink, H				Mahboub, Paria; Ottens, Petra; Seelen, Marc; t Hart, Nails; Van Goor, Harry; Ploeg, Rutger; Martins, Paulo; Leuvenink, Henri			Gradual Rewarming with Gradual Increase in Pressure during Machine Perfusion after Cold Static Preservation Reduces Kidney Ischemia Reperfusion Injury	PLOS ONE			English	Article							VIVO NORMOTHERMIC PERFUSION; RENAL-TRANSPLANTATION; SHEAR-STRESS; LIVER GRAFTS; OXYGEN; BIOMARKERS; LACTATE; STORAGE; DAMAGE; MODEL	In this study we evaluated whether gradual rewarming after the period of cold ischemia would improve organ quality in an Isolated Perfused Kidney Model. Left rat kidneys were statically cold stored in University of Wisconsin solution for 24 hours at 4 degrees C. After cold storage kidneys were rewarmed in one of three ways: perfusion at body temperature (38 degrees C), or rewarmed gradually from 10 degrees C to 38 degrees C with stabilization at 10 degrees C for 30 min and rewarmed gradually from 10 degrees C to 38 degrees C with stabilization at 25 degrees C for 30 min. In the gradual rewarming groups the pressure was increased stepwise to 40 mmHg at 10 degrees C and 70 mmHg at 25 degrees C to counteract for vasodilatation leading to low perfusate flows. Renal function parameters and injury biomarkers were measured in perfusate and urine samples. Increases in injury biomarkers such as aspartate transaminase and lactate dehydrogenase in the perfusate were lower in the gradual rewarming groups versus the control group. Sodium re-absorption was improved in the gradual rewarming groups and reached significance in the 25 degrees C group after ninety minutes of perfusion. HSP-70, ICAM-1, VCAM-1 mRNA expressions were decreased in the 10 degrees C and 25 degrees C groups. Based on the data kidneys that underwent gradual rewarming suffered less renal parenchymal, tubular injury and showed better endothelial preservation. Renal function improved in the gradual rewarming groups versus the control group.	[Mahboub, Paria; Ottens, Petra; Leuvenink, Henri] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen Transplant Ctr, Groningen, Netherlands; [Seelen, Marc] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [t Hart, Nails; Van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Ploeg, Rutger] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Mahboub, Paria; Martins, Paulo] Univ Massachusetts, Dept Surg, Div Transplantat, Worcester, MA 01605 USA	University of Groningen; University of Groningen; University of Groningen; University of Oxford; University of Massachusetts System; University of Massachusetts Worcester	Leuvenink, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen Transplant Ctr, Groningen, Netherlands.	h.g.d.leuvenink@umcg.nl	Martins, Paulo N./AAO-5680-2021; van+Goor, Harry/AAS-7712-2020	Martins, Paulo N./0000-0001-9333-0233; Leuvenink, Henri/0000-0001-5036-2999; van Goor, Harry/0000-0002-6670-1577	University Medical Center Groningen (UMCG)	University Medical Center Groningen (UMCG)	The study was funded by University Medical Center Groningen (UMCG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2002, CRIT CARE, V6, P322; Berendsen TA, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-6; Bickford RG, 1937, J PHYSIOL-LONDON, V89, P198, DOI 10.1113/jphysiol.1937.sp003473; Brasile L, 2002, TRANSPLANTATION, V73, P897, DOI 10.1097/00007890-200203270-00011; BURG MB, 1964, AM J PHYSIOL, V207, P983, DOI 10.1152/ajplegacy.1964.207.5.983; CERRA FB, 1977, SURGERY, V81, P534; DANPURE CJ, 1984, CELL BIOCHEM FUNCT, V2, P144, DOI 10.1002/cbf.290020305; den Dries SO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088521; Dutkowski R, 2006, AM J TRANSPLANT, V6, P903, DOI 10.1111/j.1600-6143.2006.01264.x; GRUNDMANN R, 1975, SURGERY, V77, P451; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hosgood S, 2006, BRIT J SURG, V93, P879, DOI 10.1002/bjs.5381; Hosgood SA, 2013, J SURG RES, V182, P153, DOI 10.1016/j.jss.2012.08.001; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; Jochmans I, 2011, ANN SURG, V254, P784, DOI 10.1097/SLA.0b013e3182368fa7; Kotanko P, 2000, NEPHRON, V84, P228, DOI 10.1159/000045582; Leducq N, 1998, BIOCHEM J, V336, P501; Ma ZW, 2014, BBA-MOL BASIS DIS, V1842, P1088, DOI 10.1016/j.bbadis.2014.04.002; Manekeller S, 2006, TRANSPL INT, V19, P667, DOI 10.1111/j.1432-2277.2006.00320.x; Minor T, 2013, AM J TRANSPLANT, V13, P1450, DOI 10.1111/ajt.12235; Minor T, 2000, CRYOBIOLOGY, V40, P182, DOI 10.1006/cryo.2000.2231; Miravete M, 2012, AM J PHYSIOL-RENAL, V302, pF1409, DOI 10.1152/ajprenal.00409.2011; Moers C, 2012, NEW ENGL J MED, V366, P770, DOI 10.1056/NEJMc1111038; Moers C, 2010, TRANSPLANTATION, V90, P966, DOI 10.1097/TP.0b013e3181f5c40c; Nicholson ML, 2013, AM J TRANSPLANT, V13, P1246, DOI 10.1111/ajt.12179; op den Dries S, 2013, AM J TRANSPLANT, V13, P1327, DOI 10.1111/ajt.12187; Roskott AM, 2010, TRANSPLANTATION, V90, P622, DOI 10.1097/TP.0b013e3181ebf796; Srivastava T, 2014, NEPHROL DIAL TRANSPL, V29, P65, DOI 10.1093/ndt/gft387; t'Hart NA, 2005, LIVER TRANSPLANT, V11, P1403, DOI 10.1002/lt.20510; van den Eijnden Mark M E D, 2003, Exp Clin Transplant, V1, P85; van Rijt WG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-9; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527	32	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143859	10.1371/journal.pone.0143859	http://dx.doi.org/10.1371/journal.pone.0143859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630031	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300115
J	Ming, X; Feng, YM; Liu, H; Zhang, Y; Zhou, L; Deng, J				Ming, Xin; Feng, Yuanming; Liu, Huan; Zhang, Ying; Zhou, Li; Deng, Jun			Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer	PLOS ONE			English	Article							BODY RADIATION-THERAPY; EARLY BREAST-CANCER; HEART-DISEASE; LONG-TERM; CARDIOVASCULAR-DISEASE; CHILDHOOD-CANCER; HODGKIN LYMPHOMA; RISK; MORTALITY; TOXICITY	Purpose To retrospectively evaluate the cardiac exposure in three cohorts of lung cancer patients treated with dynamic conformal arc therapy (DCAT), intensity-modulated radiotherapy (IMRT), or volumetric modulated arc therapy (VMAT) at our institution in the past seven years. Methods and Materials A total of 140 lung cancer patients were included in this institutional review board approved study: 25 treated with DCAT, 70 with IMRT and 45 with VMAT. All plans were generated in a same commercial treatment planning system and have been clinically accepted and delivered. The dose distribution to the heart and the effects of tumor laterality, the irradiated heart volume and the beam-to-heart distance on the cardiac exposure were investigated. Results The mean dose to the heart among all 140 plans was 4.5 Gy. Specifically, the heart received on average 2.3, 5.2 and 4.6 Gy in the DCAT, IMRT and VMAT plans, respectively. The mean heart doses for the left and right lung tumors were 4.1 and 4.8 Gy, respectively. No patients died with evidence of cardiac disease. Three patients (2%) with preexisting cardiac condition developed cardiac disease after treatment. Furthermore, the cardiac exposure was found to increase linearly with the irradiated heart volume while decreasing exponentially with the beam-to-heart distance. Conclusions Compared to old technologies for lung cancer treatment, modern radiotherapy treatment modalities demonstrated better heart sparing. But the heart dose in lung cancer radiotherapy is still higher than that in the radiotherapy of breast cancer and Hodgkin's disease where cardiac complications have been extensively studied. With strong correlations of mean heart dose with beam-to-heart distance and irradiated heart volume, cautions should be exercised to avoid long-term cardiac toxicity in the lung cancer patients undergoing radiotherapy.	[Ming, Xin; Feng, Yuanming; Zhang, Ying] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Ming, Xin; Zhang, Ying; Deng, Jun] Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA; [Liu, Huan; Deng, Jun] Yale New Haven Med Ctr, Dept Therapeut Radiol, New Haven, CT 06504 USA; [Zhou, Li] Sichuan Univ, West China Hosp, Ctr Canc, Ctr Radiat Phys & Technol, Chengdu 610064, Peoples R China	Tianjin University; Yale University; Yale University; Sichuan University	Deng, J (corresponding author), Yale Univ, Dept Therapeut Radiol, New Haven, CT 06520 USA.	jun.deng@yale.edu			Fellowship of China Scholarship Council [201206250086]	Fellowship of China Scholarship Council	This work was supported by the Fellowship of China Scholarship Council #201206250086.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; American Cancer Society, 2015, CANC FACTS FIG 2015; Andratschke N, 2011, RADIOTHER ONCOL, V100, P160, DOI 10.1016/j.radonc.2010.08.010; Belliere A, 2009, CANCER RADIOTHER, V13, P298, DOI 10.1016/j.canrad.2009.04.004; Bezjak A, 2014, NRG ONCOLOGY RTOG 08; Borger JH, 2007, INT J RADIAT ONCOL, V69, P1131, DOI 10.1016/j.ijrobp.2007.04.042; Bradley J, 2014, RAD THERAPY ONCOLOGY; Brenner DJ, 2014, JAMA INTERN MED, V174, P158, DOI 10.1001/jamainternmed.2013.11790; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Castellino SM, 2011, BLOOD, V117, P1806, DOI 10.1182/blood-2010-04-278796; Chargari Cyrus, 2013, Presse Med, V42, pe342, DOI 10.1016/j.lpm.2013.06.012; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Fakiris AJ, 2009, INT J RADIAT ONCOL, V75, P677, DOI 10.1016/j.ijrobp.2008.11.042; Gagliardi G, 2010, INT J RADIAT ONCOL, V76, pS77, DOI 10.1016/j.ijrobp.2009.04.093; Gai J, 2014, MED PHYS, V41, DOI [10.1118/1.4856175, DOI 10.1118/1.4856175]; Gayed I, 2009, INT J CARDIOVAS IMAG, V25, P487, DOI 10.1007/s10554-009-9440-7; Grills IS, 2003, INT J RADIAT ONCOL, V57, P875, DOI 10.1016/S0360-3016(03)00743-0; Hardy D, 2010, ANN ONCOL, V21, P1825, DOI 10.1093/annonc/mdq042; Holt A, 2011, INT J RADIAT ONCOL, V81, P1560, DOI 10.1016/j.ijrobp.2010.09.014; Hooning MJ, 2007, JNCI-J NATL CANCER I, V99, P365, DOI 10.1093/jnci/djk064; Jaworski C, 2013, J AM COLL CARDIOL, V61, P2319, DOI 10.1016/j.jacc.2013.01.090; Lally BE, 2007, CANCER-AM CANCER SOC, V110, P911, DOI 10.1002/cncr.22845; Lilenbaum R, 2008, RAD THERAPY ONCOLOGY; Little MP, 2012, INT J RADIAT ONCOL, V84, P1101, DOI 10.1016/j.ijrobp.2012.01.053; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Martel MK, 1998, INT J RADIAT ONCOL, V40, P155, DOI 10.1016/S0360-3016(97)00584-1; McGale P, 2011, RADIOTHER ONCOL, V100, P167, DOI 10.1016/j.radonc.2011.06.016; Merrow CE, 2012, J APPL CLIN MED PHYS, V14, P4110; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Prosnitz RG, 2005, SEMIN ONCOL, V32, pS71, DOI 10.1053/j.seminoncol.2005.03.013; Schytte T, 2010, ACTA ONCOL, V49, P1058, DOI 10.3109/0284186X.2010.504736; Steingart RM, 2013, SEMIN ONCOL, V40, P690, DOI 10.1053/j.seminoncol.2013.09.010; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Takeda A, 2009, INT J RADIAT ONCOL, V74, P363, DOI 10.1016/j.ijrobp.2008.08.012; Taylor CW, 2009, INT J RADIAT ONCOL, V73, P1061, DOI 10.1016/j.ijrobp.2008.05.066; Taylor CW, 2008, INT J RADIAT ONCOL, V72, P501, DOI 10.1016/j.ijrobp.2007.12.058; Taylor CW, 2007, INT J RADIAT ONCOL, V69, P1484, DOI 10.1016/j.ijrobp.2007.05.034; Taylor CW, 2011, RADIOTHER ONCOL, V100, P176, DOI 10.1016/j.radonc.2011.01.020; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; Videtic GMM, 2012, NRG ONCOLOGY RTOG 09; Wei X, 2008, INT J RADIAT ONCOL, V70, P707, DOI 10.1016/j.ijrobp.2007.10.056	47	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144211	10.1371/journal.pone.0144211	http://dx.doi.org/10.1371/journal.pone.0144211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630566	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300170
J	Lee, SH; Do, HS; Min, KJ				Lee, Shin-Hae; Do, Hyung-Seok; Min, Kyung-Jin			Effects of Essential Oil from Hinoki Cypress, Chamaecyparis obtusa, on Physiology and Behavior of Flies	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; LIFE-SPAN; IN-VITRO; ANTIBACTERIAL; LEAVES; L.; ANTIFUNGAL; DROSOPHILA; EXTRACT; STRESS	Phytoncides, which are volatile substances emitted from plants for protection against plant pathogens and insects, are known to have insecticidal, antimicrobial, and antifungal activities. In contrast to their negative effects on microorganisms and insects, phytoncides have been shown to have beneficial effects on human health. Essential oil from Hinoki cypress (Chamaecyparis obtusa) is mostly used in commercial products such as air purifiers. However, the physiological/behavioral impact of essential oil from C. obtusa on insects is not established. In this study, we tested the effects of essential oil extracted from C. obtusa on the physiologies and behaviors of Drosophila melanogaster and Musca domestica. Exposure to essential oil from C. obtusa decreased the lifespan, fecundity, locomotive activity, and developmental success rate of D. melanogaster. In addition, both fruit flies and house flies showed strong repellent behavioral responses to the essential oil, with duration times of about 5 hours at 70 mu g/ml. These results suggest that essential oil from C. obtusa can be used as a 'human-friendly' alternative insect repellent.	[Lee, Shin-Hae; Do, Hyung-Seok; Min, Kyung-Jin] Inha Univ, Dept Biol Sci, Inchon, South Korea	Inha University	Min, KJ (corresponding author), Inha Univ, Dept Biol Sci, Inchon, South Korea.	minkj@inha.ac.kr	Min, Kyung-Jin/AAG-5774-2020	Min, Kyung-Jin/0000-0001-5829-6842	National Research Foundation of Korea (NRF) - Korea government (MEST) [2015R1A2A2A01005580]; National Research Foundation of Korea (NRF) - Inha University [51753-01]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Research Foundation of Korea (NRF) - Inha University	This work was supported by National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2015R1A2A2A01005580, www.nrf.re.kr) and grant funded by Inha University (No 51753-01, www.inha.ac.kr) to KJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae D, 2012, PHARM BIOL, V50, P900, DOI 10.3109/13880209.2011.642886; Bahrndorff S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7101; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; CARSON CF, 1995, J APPL BACTERIOL, V78, P264, DOI 10.1111/j.1365-2672.1995.tb05025.x; Cheng SC, 2014, J AGR FOOD CHEM, V62, P4159, DOI 10.1021/jf500842v; Delaquis PJ, 2002, INT J FOOD MICROBIOL, V74, P101, DOI 10.1016/S0168-1605(01)00734-6; Fujimori H, 2009, J OLEO SCI, V58, P429, DOI 10.5650/jos.58.429; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Giatropoulos A, 2013, PARASITOL RES, V112, P1113, DOI 10.1007/s00436-012-3239-5; Hada B, 2013, J GERONTOL A-BIOL, V68, P226, DOI 10.1093/gerona/gls156; Ho CL, 2012, NAT PROD COMMUN, V7, P933; Hong EJ, 2004, BIOL PHARM BULL, V27, P863, DOI 10.1248/bpb.27.863; Huang Y, 2000, J STORED PROD RES, V36, P107, DOI 10.1016/S0022-474X(99)00040-5; Jeong EJ, 2014, FOOD CHEM TOXICOL, V64, P397, DOI 10.1016/j.fct.2013.12.003; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joo SS, 2010, J DERMATOL SCI, V60, P122, DOI 10.1016/j.jdermsci.2010.08.008; Juliano C, 2000, J ESSENT OIL RES, V12, P516, DOI 10.1080/10412905.2000.9699578; Kasuya H, 2013, NAT PROD COMMUN, V8, P515; Kawakami Kohei, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS27, DOI 10.1111/j.1440-1681.2004.04102.x; Ketoh GK, 2005, J STORED PROD RES, V41, P363, DOI 10.1016/j.jspr.2004.02.002; Ko J, 2015, BIOSCIENCE BIOTECHNO, P1; Lee GS, 2010, FITOTERAPIA, V81, P17, DOI 10.1016/j.fitote.2009.06.016; Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Lee JH, 2009, J MICROBIOL BIOTECHN, V19, P391, DOI 10.4014/jmb.0803.191; Lee SH, 2014, BIOGERONTOLOGY, V15, P153, DOI 10.1007/s10522-013-9487-7; Li Q, 2008, J BIOL REG HOMEOS AG, V22, P45; Mao GX, 2012, BIOMED ENVIRON SCI, V25, P317, DOI 10.3967/0895-3988.2012.03.010; Mihajilov-Krstev T, 2014, PLANTA MED, V80, P1698, DOI 10.1055/s-0034-1383182; MORROW PA, 1980, OECOLOGIA, V45, P209, DOI 10.1007/BF00346462; Mourey A, 2002, FOOD CONTROL, V13, P289, DOI 10.1016/S0956-7135(02)00026-9; Pala-Paul J, 2012, NAT PROD COMMUN, V7, P1383; Park HJ, 2014, CAN J PHYSIOL PHARM, V92, P95, DOI 10.1139/cjpp-2013-0224; Park IK, 2003, J STORED PROD RES, V39, P375, DOI 10.1016/S0022-474X(02)00030-9; Park YO, 2013, TOX RESEARCH, V29, P241, DOI 10.5487/TR.2013.29.4.241; Pekkala N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024560; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; Salafsky B, 2000, AM J TROP MED HYG, V62, P169, DOI 10.4269/ajtmh.2000.62.169; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Thany SH, 2015, MED VET ENTOMOL, V29, P99, DOI 10.1111/mve.12082; Tsunetsugu Yuko, 2010, Environmental Health and Preventive Medicine, V15, P27, DOI 10.1007/s12199-009-0091-z; Yang JK, 2007, FITOTERAPIA, V78, P149, DOI 10.1016/j.fitote.2006.09.026	42	12	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143450	10.1371/journal.pone.0143450	http://dx.doi.org/10.1371/journal.pone.0143450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624577	gold, Green Submitted, Green Published			2022-12-26	WOS:000365891600030
J	Ulbrich, F; Kaufmann, K; Roesslein, M; Wellner, F; Auwarter, V; Kempf, J; Loop, T; Buerkle, H; Goebel, U				Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Auwaerter, Volker; Kempf, Juergen; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich			Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NOBLE-GAS ARGON; NF-KAPPA-B; SH-SY5Y CELLS; DAMAGE; ACTIVATION; XENON; PATHWAYS; ROTENONE; RATS	Purpose Recently, the noble gas argon attracted significant attention due to its neuroprotective properties. However, the underlying molecular mechanism is still poorly understood. There is growing evidence that the extracellular regulated kinase 1/2 (ERK1/2) is involved in Argon's protective effect. We hypothesized that argon mediates its protective effects via the upstream located toll-like receptors (TLRs) 2 and 4. Methods Apoptosis in a human neuroblastoma cell line (SH-SY5Y) was induced using rotenone. Argon treatment was performed after induction of apoptosis with different concentrations (25, 50 and 75 Vol% in oxygen 21 Vol%, carbon dioxide and nitrogen) for 2 or 4 hours respectively. Apoptosis was analyzed using flow cytometry (annexin-V (AV)/propidiumiodide (PI)) staining, caspase-3 activity and caspase cleavage. TLR density on the cells' surface was analyzed using FACS and immunohistochemistry. Inhibition of TLR signaling and extracellular regulated kinase 1/2 (ERK1/2) were assessed by western blot, activity assays and FACS analysis. Results Argon 75 Vol% treatment abolished rotenone-induced apoptosis. This effect was attenuated dose-and time-dependently. Argon treatment was accompanied with a significant reduction of TLR2 and TLR4 receptor density and protein expression. Moreover, argon mediated increase in ERK1/2 phosphorylation was attenuated after inhibition of TLR signaling. ERK1/2 and TLR signaling inhibitors abolished the anti-apoptotic and cytoprotective effects of argon. Immunohistochemistry results strengthened these findings. Conclusion These findings suggest that argon-mediated anti-apoptotic and neuroprotective effects are mediated via inhibition of TLR2 and TLR4.	[Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich] Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Auwaerter, Volker; Kempf, Juergen] Univ Freiburg, Inst Forens Med, Forens Toxicol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Ulbrich, F (corresponding author), Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	felix.ulbrich@uniklinik-freiburg.de	Göbel, Ulrich/Q-7613-2016; Goebel, Ulrich M./AGG-1495-2022; Auwarter, Volker/D-1075-2012	Göbel, Ulrich/0000-0002-9991-3226; Auwarter, Volker/0000-0002-1883-2804	German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Alderliesten T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113575; Ali I, 2013, PULM CIRC, V3, P578, DOI 10.1086/674337; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Auwarter V, 2004, FORENSIC SCI INT, V143, P169, DOI 10.1016/j.forsciint.2004.02.043; Ben Mkaddem S, 2010, ONCOTARGET, V1, P741, DOI 10.18632/oncotarget.209; Brucken A, 2014, NEUROCRITICAL CARE; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gan XQ, 2014, BONE, V62, P67, DOI 10.1016/j.bone.2014.01.018; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Liu ZW, 2013, BIOL TRACE ELEM RES, V156, P262, DOI 10.1007/s12011-013-9857-7; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Monaghan TK, 2008, J MOL NEUROSCI, V36, P45, DOI 10.1007/s12031-008-9082-6; Spaggiari S, 2013, CELL CYCLE, V12, P2636, DOI 10.4161/cc.25650; Tan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102195; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Ulbrich F, 2015, J NEUROCHEMISTRY; Ulbrich F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115984; Vaisid T, 2013, BBA-MOL CELL RES, V1833, P2369, DOI 10.1016/j.bbamcr.2013.06.006; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	33	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143887	10.1371/journal.pone.0143887	http://dx.doi.org/10.1371/journal.pone.0143887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624894	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600067
J	Goto, K; Ishikawa, S; Honma, R; Tanimoto, K; Sakamoto, N; Sentani, K; Oue, N; Teishima, J; Matsubara, A; Yasui, W				Goto, K.; Ishikawa, S.; Honma, R.; Tanimoto, K.; Sakamoto, N.; Sentani, K.; Oue, N.; Teishima, J.; Matsubara, A.; Yasui, W.			The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation	ONCOGENE			English	Article							GENE-EXPRESSION; NONCODING RNAS; DOWN-REGULATION; NEUROBLASTOMA; CARCINOMA; INVASION; DIFFERENTIATION; CONTRIBUTES; PROGRESSION; METASTASIS	The transcribed-ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs, which are absolutely conserved (100%) between the orthologous regions of the human, rat and mouse genomes. Previous studies have described that several T-UCRs show differential expressions in cancers and might be involved in cancer development. We investigated the transcriptional levels of representative 26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC). A quantitative reverse transcription-polymerase chain reaction analysis revealed the downregulation of Uc. 158+A expression by a DNA methylation-associated mechanism, which was restored by 5-Aza-dC (5-aza-2'-deoxycytidine) treatment. Bisulfite genomic sequencing using cell lines and tissue samples demonstrated cancer-specific CpG hypermethylation in both GC and PCa. However, Uc. 416+A was only overexpressed in GC and we identified an miR-153 binding site in the possible regulatory region of Uc. 416+A using online databases. Along with a forced expression or knockdown of miR-153 in MKN-74 GC cells, the transcriptional levels of Uc. 416+A were significantly disturbed. A luciferase reporter gene assay supported the direct regulation of Uc. 416+A expression by miR-153. Furthermore, Uc. 416+A was associated with cell growth through the regulation of IGFBP6 (insulin-like growth factor-binding protein 6) in GC. These findings suggest an oncogenic role of Uc. 416+A in GC, which suggests that our approach would provide new insights into functional studies of T-UCRs in cancer biology.	[Goto, K.; Sakamoto, N.; Sentani, K.; Oue, N.; Yasui, W.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan; [Goto, K.; Teishima, J.; Matsubara, A.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Urol, Hiroshima, Japan; [Ishikawa, S.; Honma, R.] Hiroshima Univ, Sch Med, Hiroshima, Japan; [Tanimoto, K.] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Radiat Med, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Yasui, W (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	wyasui@hiroshima-u.ac.jp	Keiji, Tanimoto/U-1839-2019	Keiji, Tanimoto/0000-0003-4912-4197; Goto, Keisuke/0000-0002-3580-1401	Ministry of Education, Culture, Science, Sports and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; National Institute of Biomedical Innovation (Program for Promotion of Fundamental Studies in Health Sciences); National Cancer Center Research and Development Fund	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation (Program for Promotion of Fundamental Studies in Health Sciences); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	We thank Mr Shinichi Norimura for his excellent technical assistance. This work was carried out with the kind cooperation of the Research Center for Molecular Medicine of the Faculty of Medicine of Hiroshima University. We also thank the Analysis Center of Life Science of Hiroshima University for the use of their facilities. This work was supported, in part, by grants-in-aid for Cancer Research from the Ministry of Education, Culture, Science, Sports and Technology of Japan, and, in part, by a grant-in-aid for the Third Comprehensive. 10-Year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan, by the National Institute of Biomedical Innovation (Program for Promotion of Fundamental Studies in Health Sciences), and by the National Cancer Center Research and Development Fund.	Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; Bach LA, 2013, CLIN SCI, V124, P215, DOI 10.1042/CS20120343; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Braconi C, 2011, P NATL ACAD SCI USA, V108, P786, DOI 10.1073/pnas.1011098108; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fischbach NA, 2005, BLOOD, V105, P1456, DOI 10.1182/blood-2004-04-1583; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; Goto K, 2013, MOL CLIN ONCOL, V1, P235, DOI 10.3892/mco.2012.46; Hudson RS, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-13; Hur H, 2014, MOL BIOTECHNOL, V56, P64, DOI 10.1007/s12033-013-9682-4; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Liz J, 2014, MOL CELL, V55, P138, DOI 10.1016/j.molcel.2014.05.005; Lujambio A, 2010, ONCOGENE, V29, P6390, DOI 10.1038/onc.2010.361; Luo JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040127; Matsumura S, 2007, INT J CANCER, V120, P1689, DOI 10.1002/ijc.22433; Mestdagh P, 2010, ONCOGENE, V29, P3583, DOI 10.1038/onc.2010.106; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Naito Y, 2015, PATHOBIOLOGY, V82, P68, DOI 10.1159/000398809; Naito Y, 2014, ONCOL REP, V32, P1720, DOI 10.3892/or.2014.3333; Naito Y, 2014, CANCER SCI, V105, P228, DOI 10.1111/cas.12329; Oue N, 2003, CANCER SCI, V94, P901, DOI 10.1111/j.1349-7006.2003.tb01373.x; Oue N, 2014, ONCOGENE, V33, P3918, DOI 10.1038/onc.2013.364; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Oue N, 2015, CANCER SCI, V106, P951, DOI 10.1111/cas.12706; Oue N, 2014, INT J CANCER, V134, P1926, DOI 10.1002/ijc.28522; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; Scaruffi P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-441; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Watters KM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-184; Wu ZQ, 2013, PROSTATE, V73, P596, DOI 10.1002/pros.22600; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yuan Y, 2015, INT J CANCER, V136, P1333, DOI 10.1002/ijc.29103; Zhang L, 2013, CANCER RES, V73, P6435, DOI 10.1158/0008-5472.CAN-12-3308; Zhang ZL, 2015, ONCOTARGETS THER, V8, P357, DOI 10.2147/OTT.S78236	40	28	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3598	3606		10.1038/onc.2015.445	http://dx.doi.org/10.1038/onc.2015.445			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26640143	Green Submitted			2022-12-26	WOS:000379621500012
J	Helmich, KE; Pereira, JH; Gall, DL; Heins, RA; McAndrew, RP; Bingman, C; Deng, K; Holland, KC; Noguera, DR; Simmons, BA; Sale, KL; Ralph, J; Donohue, TJ; Adams, PD; Phillips, GN				Helmich, Kate E.; Pereira, Jose Henrique; Gall, Daniel L.; Heins, Richard A.; McAndrew, Ryan P.; Bingman, Craig; Deng, Kai; Holland, Keefe C.; Noguera, Daniel R.; Simmons, Blake A.; Sale, Kenneth L.; Ralph, John; Donohue, Timothy J.; Adams, Paul D.; Phillips, George N., Jr.			Structural Basis of Stereospecificity in the Bacterial Enzymatic Cleavage of beta-Aryl Ether Bonds in Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme structure; lignin degradation; plant cell wall; protein structure; stereoselectivity; X-ray crystallography; structural enzymology	GLUTATHIONE-S-TRANSFERASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; DEGRADATION; REFINEMENT; EVOLUTION; SYSTEM; PHENIX; MUTAGENESIS; DIFFRACTION	Lignin is a combinatorial polymer comprising monoaromatic units that are linked via covalent bonds. Although lignin is a potential source of valuable aromatic chemicals, its recalcitrance to chemical or biological digestion presents major obstacles to both the production of second-generation biofuels and the generation of valuable coproducts from lignin's monoaromatic units. Degradation of lignin has been relatively well characterized in fungi, but it is less well understood in bacteria. A catabolic pathway for the enzymatic breakdown of aromatic oligomers linked via -aryl ether bonds typically found in lignin has been reported in the bacterium Sphingobium sp. SYK-6. Here, we present x-ray crystal structures and biochemical characterization of the glutathione-dependent -etherases, LigE and LigF, from this pathway. The crystal structures show that both enzymes belong to the canonical two-domain fold and glutathione binding site architecture of the glutathione S-transferase family. Mutagenesis of the conserved active site serine in both LigE and LigF shows that, whereas the enzymatic activity is reduced, this amino acid side chain is not absolutely essential for catalysis. The results include descriptions of cofactor binding sites, substrate binding sites, and catalytic mechanisms. Because -aryl ether bonds account for 50-70% of all interunit linkages in lignin, understanding the mechanism of enzymatic -aryl ether cleavage has significant potential for informing ongoing studies on the valorization of lignin.	[Helmich, Kate E.; Bingman, Craig; Ralph, John] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Helmich, Kate E.; Gall, Daniel L.; Noguera, Daniel R.; Ralph, John; Donohue, Timothy J.] Univ Wisconsin, Wisconsin Energy Inst, United States Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA; [Pereira, Jose Henrique; Heins, Richard A.; McAndrew, Ryan P.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.; Adams, Paul D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Pereira, Jose Henrique; McAndrew, Ryan P.; Adams, Paul D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Gall, Daniel L.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Heins, Richard A.; Deng, Kai; Holland, Keefe C.; Simmons, Blake A.; Sale, Kenneth L.] Sandia Natl Labs, Biol & Engn Sci Ctr, Livermore, CA 94551 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Phillips, George N., Jr.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; Rice University	Donohue, TJ (corresponding author), Univ Wisconsin, Wisconsin Energy Inst, United States Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA.; Adams, PD (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Adams, PD (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.; Donohue, TJ (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Adams, PD (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA.	tdonohue@bact.wisc.edu; pdadams@lbl.gov; georgep@rice.edu	Ralph, John/C-3161-2009; Simmons, Blake/N-6022-2016; Adams, Paul David/A-1977-2013	Ralph, John/0000-0002-6093-4521; Simmons, Blake/0000-0002-1332-1810; Adams, Paul David/0000-0001-9333-8219; Noguera, Daniel/0000-0003-0372-3063	NIGMS, National Institutes of Health (NIH); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; United States Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NIH; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NCI; NIH [ACB-12002, AGM-12006, P41GM103399, S10RR027000]; NIGMS; University of Wisconsin (Madison, WI); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, U01GM098248, T32GM008349, R01GM109456] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin (Madison, WI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the staff of the Berkeley Center for Structural Biology at the Advanced Light Source of Lawrence Berkeley National Laboratory. The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health (NIH). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. The Joint Bio-Energy Institute is supported by the United States Department of Energy, Office of Science, Office of Biological and Environmental Research, through Grant DE-AC02-05CH11231. We thank Dr. Brian G. Fox and Dr. Christopher M. Bianchetti for helpful discussion and the NIH-funded Center for Eukaryotic Structural Genomics for general access to computers and equipment for the structural work. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Use of Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and by Michigan Technology Tri-Corridor Grant 085P1000817. Use of GM/CA@APS Sector 23 was supported by Federal funds NCI, NIH, Grant ACB-12002 and NIGMS, NIH, Grant AGM-12006. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIGMS, NIH, Grant P41GM103399. Small angle x-ray scattering studies were supported by funds from NIH Shared Instrumentation Grant S10RR027000 and the University of Wisconsin (Madison, WI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler E., 1957, TAPPI, V40, P294; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; Akiyama T, 2000, J WOOD SCI, V46, P414, DOI 10.1007/BF00776407; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Casalone E, 1998, FEBS LETT, V423, P122, DOI 10.1016/S0014-5793(98)00080-5; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIRR H, 1994, J MOL BIOL, V243, P72, DOI 10.1006/jmbi.1994.1631; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federici L, 2007, BIOCHEM J, V403, P267, DOI 10.1042/BJ20061707; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gall DL, 2014, J BIOL CHEM, V289, P8656, DOI 10.1074/jbc.M113.536250; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; JI XH, 1994, BIOCHEMISTRY-US, V33, P1043, DOI 10.1021/bi00171a002; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leonowicz A, 2001, J BASIC MICROB, V41, P185, DOI 10.1002/1521-4028(200107)41:3/4&lt;185::AID-JOBM185&gt;3.0.CO;2-T; Martinez AT, 2005, INT MICROBIOL, V8, P195; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Mathieu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080298; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Mills N, 2006, J AM CHEM SOC, V128, P13649, DOI 10.1021/ja0697875; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picart P, 2015, GREEN CHEM, V17, P4931, DOI [10.1039/C5GC01078K, 10.1039/c5gc01078k]; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Ralph J, 1999, J AGR FOOD CHEM, V47, P2991, DOI 10.1021/jf9901136; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reddy A. P., 2013, PLoS ONE, V8, pe77985, DOI 10.1371/journal.pone.0077985; Reiter J, 2013, GREEN CHEM, V15, P1373, DOI 10.1039/c3gc40295a; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Simmons CW, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0180-0; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Sugimoto T, 2002, HOLZFORSCHUNG, V56, P416, DOI 10.1515/HF.2002.064; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thuillier Anne, 2011, Int J Evol Biol, V2011, P938308, DOI 10.4061/2011/938308; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; Yennamalli R, 2014, J APPL CRYSTALLOGR, V47, P1153, DOI 10.1107/S160057671400939X; Zhou HN, 2011, J BIOL CHEM, V286, P4271, DOI 10.1074/jbc.M110.197822	70	27	28	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5234	5246		10.1074/jbc.M115.694307	http://dx.doi.org/10.1074/jbc.M115.694307			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26637355	hybrid, Green Published			2022-12-26	WOS:000371640600034
J	Posner, MG; Upadhyay, A; Abubaker, AA; Fortunato, TM; Vara, D; Canobbio, I; Bagby, S; Pula, G				Posner, Mareike G.; Upadhyay, Abhishek; Abubaker, Aisha Alsheikh; Fortunato, Tiago M.; Vara, Dina; Canobbio, Ilaria; Bagby, Stefan; Pula, Giordano			Extracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; CARDIOVASCULAR-DISEASE; STIMULATED PLATELETS; ACTIVATED PLATELETS; PHAGE DISPLAY; IN-VIVO; AGGREGATION; RECRUITMENT; DOMAINS; IDENTIFICATION	Extracellular fibrinogen-binding protein (Efb) from Staphylococcus aureus inhibits platelet activation, although its mechanism of action has not been established. In this study, we discovered that the N-terminal region of Efb (Efb-N) promotes platelet binding of fibrinogen and that Efb-N binding to platelets proceeds via two independent mechanisms: fibrinogen-mediated and fibrinogen-independent. By proteomic analysis of Efb-interacting proteins within platelets and confirmation by pull-down assays followed by immunoblotting, we identified P-selectin and multimerin-1 as novel Efb interaction partners. The interaction of both P-selectin and multimerin-1 with Efb is independent of fibrinogen. We focused on Efb interaction with P-selectin. Excess of P-selectin extracellular domain significantly impaired Efb binding by activated platelets, suggesting that P-selectin is the main receptor for Efb on the surface of activated platelets. Efb-N interaction with P-selectin inhibited P-selectin binding to its physiological ligand, P-selectin glycoprotein ligand-1 (PSGL-1), both in cell lysates and in cell-free assays. Because of the importance of P-selectin-PSGL-1 binding in the interaction between platelets and leukocytes, we tested human whole blood and found that Efb abolishes the formation of platelet-monocyte and platelet-granulocyte complexes. In summary, we present evidence that in addition to its documented anti-thrombotic activity, Efb can play an immunoregulatory role via inhibition of P-selectin-PSGL-1-dependent formation of platelet-leukocyte complexes.	[Posner, Mareike G.; Upadhyay, Abhishek; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Claverton Campus, Bath BA2 7AY, Avon, England; [Abubaker, Aisha Alsheikh; Fortunato, Tiago M.; Vara, Dina; Pula, Giordano] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Canobbio, Ilaria] Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, PV, Italy	University of Bath; University of Bath; University of Pavia	Bagby, S (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Campus, Bath BA2 7AY, Avon, England.	bsssb@bath.ac.uk	Pula, Giordano/AAU-9164-2021; Pula, Giordano/ABE-8596-2020; Vara, Dina/W-6349-2019; Posner, Mareike/AGK-4002-2022; Canobbio, Ilaria/L-7414-2013	Pula, Giordano/0000-0002-7769-1140; Posner, Mareike/0000-0002-3156-3071; Bagby, Stefan/0000-0003-2302-9511; Vara, Dina/0000-0002-3099-6748; Canobbio, Ilaria/0000-0002-9643-3403	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J002690/1, BB/J008176/1]; Wellcome Trust [ZR-W0258A]; British Heart Foundation [PG/15/40/31522]; Royal Society [RG120494]; Biotechnology and Biological Sciences Research Council [BB/M012409/1, BB/J008176/1] Funding Source: researchfish; BBSRC [BB/J008176/1, BB/M012409/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was possible thanks to grants from Biotechnology and Biological Sciences Research Council (BBSRC) (BB/J002690/1 and BB/J008176/1), Wellcome Trust (ZR-W0258A), British Heart Foundation (PG/15/40/31522), and Royal Society Grant RG120494. The authors declare that they have no conflicts of interest with the contents of this article.	Appeldoorn CCM, 2005, CIRCULATION, V111, P106, DOI 10.1161/01.CIR.0000151307.10576.02; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; BODEN MK, 1994, MOL MICROBIOL, V12, P599, DOI 10.1111/j.1365-2958.1994.tb01046.x; Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; COURTOIS G, 1986, EUR J BIOCHEM, V159, P61, DOI 10.1111/j.1432-1033.1986.tb09833.x; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Diaz JA, 2015, ARTERIOSCL THROM VAS, V35, P829, DOI 10.1161/ATVBAHA.114.304457; Fevre C, 2014, CELL MICROBIOL, V16, P1646, DOI 10.1111/cmi.12313; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Gremmel T, 2015, THROMB HAEMOSTASIS, V113, P806, DOI 10.1160/TH14-08-0690; HAMBURGER SA, 1990, BLOOD, V75, P550; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Jongerius I, 2012, J INNATE IMMUN, V4, P301, DOI 10.1159/000334604; KINLOUGHRATHBONE RL, 1977, THROMB HAEMOSTASIS, V37, P291; Ko YP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003816; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Kuznik BI, 2014, AM J MED SCI, V347, P206, DOI 10.1097/MAJ.0b013e3182831726; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Li J, 2015, CELL MOL LIFE SCI, V72, P2627, DOI 10.1007/s00018-015-1845-y; Myers D, 2002, J SURG RES, V108, P212, DOI 10.1006/jsre.2002.6552; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200; Pamuk GE, 2007, BLOOD COAGUL FIBRIN, V18, P297, DOI 10.1097/MBC.0b013e328010bd05; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Rossaint J, 2015, CARDIOVASC RES, V107, P386, DOI 10.1093/cvr/cvv048; Sels JWEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083198; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; SOUTHAN C, 1985, BIOCHEM J, V229, P723, DOI 10.1042/bj2290723; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; Vara DS, 2013, THROMB HAEMOSTASIS, V109, P1108, DOI 10.1160/TH12-10-0751; Wade D, 1998, BIOCHEM BIOPH RES CO, V248, P690, DOI 10.1006/bbrc.1998.9028; Wu WC, 2015, GLYCOCONJUGATE J, V32, P69, DOI 10.1007/s10719-014-9571-5; Xia Z, 1996, BRIT J HAEMATOL, V93, P204, DOI 10.1046/j.1365-2141.1996.445980.x; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zhang X, 2011, PLATELETS, V22, P228, DOI 10.3109/09537104.2010.543962	51	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2764	2776		10.1074/jbc.M115.678359	http://dx.doi.org/10.1074/jbc.M115.678359			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26627825	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000369626900017
J	Douglas, DN; Pu, CH; Lewis, JT; Bhat, R; Anwar-Mohamed, A; Logan, M; Lund, G; Addison, WR; Lehner, R; Kneteman, NM				Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Bhat, Rakesh; Anwar-Mohamed, Anwar; Logan, Michael; Lund, Garry; Addison, William R.; Lehner, Richard; Kneteman, Norman M.			Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA-CARBOXYLASE; HCV CORE PROTEIN; REACTIVE OXYGEN; ER STRESS; ENDOPLASMIC-RETICULUM; ELECTRON-TRANSPORT; GENE-EXPRESSION; RECEPTOR-ALPHA; MOUSE MODEL	Cytopathic effects are currently believed to contribute to hepatitis C virus (HCV)-induced liver injury and are readily observed in Huh7.5 cells infected with the JFH-1 HCV strain, manifesting as apoptosis highly correlated with growth arrest. Reactive oxygen species, which are induced by HCV infection, have recently emerged as activators of AMP-activated protein kinase. The net effect is ATP conservation via on/off switching of metabolic pathways that produce/consume ATP. Depending on the scenario, this can have either pro-survival or pro-apoptotic effects. We demonstrate reactive oxygen species-mediated activation of AMP-activated kinase in Huh7.5 cells during HCV (JFH-1)-induced growth arrest. Metabolic labeling experiments provided direct evidence that lipid synthesis is attenuated, and beta-oxidation is enhanced in these cells. A striking increase in nuclear peroxisome proliferator-activated receptor alpha, which plays a dominant role in the expression of beta-oxidation genes after ligand-induced activation, was also observed, and we provide evidence that peroxisome proliferator-activated receptor alpha is constitutively activated in these cells. The combination of attenuated lipid synthesis and enhanced beta-oxidation is not conducive to lipid accumulation, yet cellular lipids still accumulated during this stage of infection. Notably, the serum in the culture media was the only available source for polyunsaturated fatty acids, which were elevated (2-fold) in the infected cells, implicating altered lipid import/export pathways in these cells. This study also provided the first in vivo evidence for enhanced beta-oxidation during HCV infection because HCV-infected SCID/Alb-uPA mice accumulated higher plasma ketones while fasting than did control mice. Overall, this study highlights the reprogramming of hepatocellular lipid metabolism and bioenergetics during HCV infection, which are predicted to impact both the HCV life cycle and pathogenesis.	[Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Kneteman, Norman M.] Univ Alberta, Dept Surg, Edmonton, AB T6G 2E1, Canada; [Lehner, Richard] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2E1, Canada; [Lehner, Richard] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2E1, Canada; [Bhat, Rakesh; Anwar-Mohamed, Anwar; Logan, Michael; Addison, William R.] Univ Alberta, Dept Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Lund, Garry] Univ Alberta, KMT Hepatech Inc, Edmonton, AB T6G 2E1, Canada; [Douglas, Donna N.; Pu, Christopher Hao; Lewis, Jamie T.; Logan, Michael; Addison, William R.; Kneteman, Norman M.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Douglas, DN (corresponding author), Univ Alberta, Dept Surg, Katz Grp Rexall Ctr 6 010A, Edmonton, AB T6G 2E1, Canada.	donnad@ualberta.ca	Bhat, Rakesh/B-4320-2009; Anwar-Mohamed, Anwar/J-6973-2015; Bhat, Rakesh Kumar/AID-0687-2022	Anwar-Mohamed, Anwar/0000-0001-9214-7859; Bhat, Rakesh Kumar/0000-0001-7649-0470; Lehner, Richard/0000-0002-6008-1805	Canadian Institute of Health Research (CIHR/IRSC)	Canadian Institute of Health Research (CIHR/IRSC)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR/IRSC) (to N. M. K., D. N. D., and R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Ando M, 2008, LIVER INT, V28, P1158, DOI 10.1111/j.1478-3231.2008.01720.x; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001; Bartosch B, 2009, J HEPATOL, V50, P845, DOI 10.1016/j.jhep.2009.02.009; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; Bennett MJ, 2007, METHOD CELL BIOL, V80, P179, DOI 10.1016/S0091-679X(06)80009-9; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borowski P, 1999, ARCH VIROL, V144, P687, DOI 10.1007/s007050050536; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P7591, DOI 10.3748/wjg.v11.i48.7591; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Choi J, 2006, FREE RADICAL BIO MED, V41, P1488, DOI 10.1016/j.freeradbiomed.2006.08.008; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Deeb D, 2010, BIOCHEM PHARMACOL, V79, P350, DOI 10.1016/j.bcp.2009.09.006; Dharancy S, 2009, PPAR RES, V2009, DOI 10.1155/2009/357204; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Douglas DN, 2015, EUR J PHARMACOL, V759, P313, DOI 10.1016/j.ejphar.2015.03.022; Douglas DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009209; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gabriel C, 1997, J PHARMACOL TOXICOL, V38, P93, DOI 10.1016/S1056-8719(97)00066-X; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; GUNASEKAR PG, 1995, J NEUROSCI METH, V61, P15, DOI 10.1016/0165-0270(95)00018-P; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hsieh MJ, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-74; Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5; Knaevelsrud H, 2012, BBA-MOL CELL BIOL L, V1821, P1133, DOI 10.1016/j.bbalip.2012.01.001; Kneteman NM, 2012, LIVER TRANSPLANT, V18, P38, DOI 10.1002/lt.22400; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; KRAWCZYNSKI K, 1992, GASTROENTEROLOGY, V103, P622, DOI 10.1016/0016-5085(92)90856-T; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Martinez-Florez S, 2005, J NUTR, V135, P1359, DOI 10.1093/jn/135.6.1359; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meredith LW, 2013, J HEPATOL, V58, P1074, DOI 10.1016/j.jhep.2013.01.019; Merquiol E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024660; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Nelson D R, 2001, Clin Liver Dis, V5, P931, DOI 10.1016/S1089-3261(05)70202-6; Nourbakhsh M, 2013, J HEPATOL, V59, P336, DOI 10.1016/j.jhep.2013.03.022; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Possel H, 1997, FEBS LETT, V416, P175, DOI 10.1016/S0014-5793(97)01197-6; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Robinson LC, 2008, BIOCHEM BIOPH RES CO, V368, P593, DOI 10.1016/j.bbrc.2008.01.127; Rodrigues E, 2012, MAR DRUGS, V10, P1784, DOI 10.3390/md10081784; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Sansonno D, 2004, J VIRAL HEPATITIS, V11, P27, DOI 10.1046/j.1365-2893.2003.00474.x; Schaefer EAK, 2013, SEMIN LIVER DIS, V33, P358, DOI 10.1055/s-0033-1358524; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Seronello S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027436; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; Vance D. E., 1996, BIOCH LIPIDS LIPOPRO; Vescovo T, 2012, GASTROENTEROLOGY, V142, P644, DOI 10.1053/j.gastro.2011.11.033; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang T, 2010, J VIRAL HEPATITIS, V17, P784, DOI 10.1111/j.1365-2893.2009.01238.x; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Waterfield CJ, 1997, CHEM-BIOL INTERACT, V107, P157, DOI 10.1016/S0009-2797(97)00090-2; Wei EH, 2007, J BIOL CHEM, V282, P8027, DOI 10.1074/jbc.M605789200; Wen F, 2004, J MED VIROL, V72, P230, DOI 10.1002/jmv.10567; Wu CH, 2011, HEPATOLOGY, V54, P1966, DOI 10.1002/hep.24645; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Zhao LJ, 2005, EXP CELL RES, V305, P23, DOI 10.1016/j.yexcr.2004.12.024; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	127	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1974	1990		10.1074/jbc.M115.674861	http://dx.doi.org/10.1074/jbc.M115.674861			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627833	Green Published, hybrid			2022-12-26	WOS:000368620700034
J	Gao, Y; Wei, S; Song, B; Qin, J; Fang, H; Ji, Y; Zhang, R; Sun, SL; Xu, YM				Gao, Yuan; Wei, Sen; Song, Bo; Qin, Jie; Fang, Hui; Ji, Yan; Zhang, Rui; Sun, Shilei; Xu, Yuming			Homocysteine Level Is Associated with White Matter Hyperintensity Locations in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							SIGNAL HYPERINTENSITIES; PLASMA HOMOCYSTEINE; RISK-FACTORS; BRAIN; LEUKOARAIOSIS; AGE; DETERMINANTS; MRI; VULNERABILITY; POPULATION	Background and Purpose The relationship between plasma level of total homocysteine (tHcy) and white matter hyper-intensities (WMHs), especially in patients with acute ischemic stroke (AIS), is controversial. The present study investigated the association between these two as well as WMH locations in a large cohort of patients with AIS. Methods Consecutive patients were reviewed from a prospective ischemic stroke database. Clinical data, including tHcy level and WMHs, were assessed. WMHs were assessed using the Fazekas scale and Age-Related White Matter Changes (ARWMC) visual grading scale. The association between tHcy and WMH locations was investigated by using multivariate logistic regression analyses. Results A total of 923 out of 1,205 patients were examined. The average age was 58.9 +/- 11.9 years; 31.6% were female. Elevated tHcy level was significantly associated with WMHs. For the highest tHcy quartile, the odds ratio (OR) (95% confidence interval; CI) was 1.891 (1.257; 2.843) according to the Fazekas scale and 1.781 (1.185; 2.767) according to the ARWMC scale when compared to the lowest quartile. However, in a subgroup analysis, only WMHs in the periventricular area and left or right frontal areas were found to be independently associated with tHcy level. For the highest tHcy quartile, the OR (95% CI) was 1.761 (1.172; 2.648) for the periventricular WMHs, 1.768 (1.134; 2.756) for the left frontal WMHs, and 1.890 (1.206; 2.960) for the right frontal WMHs. Conclusions In patients with AIS, plasma tHcy level is related to WMHs, especially WMHs distributed within the periventricular and frontal areas.	[Gao, Yuan; Wei, Sen; Song, Bo; Qin, Jie; Fang, Hui; Ji, Yan; Zhang, Rui; Sun, Shilei; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.	xuyuming@zzu.edu.cn		Wei, Sen/0000-0002-1831-6818; Gao, Yuan/0000-0003-2596-4773				Chou PS, 2015, INTERN MED J, V45, P390, DOI 10.1111/imj.12704; Eikelboom JW, 2000, STROKE, V31, P1069, DOI 10.1161/01.STR.31.5.1069; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; Evers S, 1997, ARCH NEUROL-CHICAGO, V54, P1276, DOI 10.1001/archneur.1997.00550220074017; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; FAZEKAS F, 1988, STROKE, V19, P1285, DOI 10.1161/01.STR.19.10.1285; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Hooshmand B, 2013, BRAIN, V136, P2707, DOI 10.1093/brain/awt206; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; OLSZEWSKI AJ, 1993, FREE RADICAL BIO MED, V14, P683, DOI 10.1016/0891-5849(93)90151-J; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Payabvash S, 2011, STROKE, V42, P1255, DOI 10.1161/STROKEAHA.110.600940; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Sachdev P, 2004, ARCH NEUROL-CHICAGO, V61, P1369, DOI 10.1001/archneur.61.9.1369; SCHMIDT R, 1992, ARCH NEUROL-CHICAGO, V49, P825, DOI 10.1001/archneur.1992.00530320049011; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; Szolnoki Z, 2007, NEUROMOL MED, V9, P21, DOI 10.1385/NMM:9:1:21; Tran T., 2015, J SOUND VIB, V20, P1, DOI [10.1177/1077546315616522, DOI 10.1177/1077546315616522]; TSAI JC, 1994, P NATL ACAD SCI USA, V91, P6369, DOI 10.1073/pnas.91.14.6369; Tseng YL, 2009, J NEUROL SCI, V284, P36, DOI 10.1016/j.jns.2009.03.030; Valdes Hernandez MC, 2014, AM J NEURORADIOL, V35, P55, DOI [10.3174/ajnr.A3612, DOI 10.3174/AJNR.A3612]; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; WALDEMAR G, 1994, J NEUROL NEUROSUR PS, V57, P1458, DOI 10.1136/jnnp.57.12.1458; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	31	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144431	10.1371/journal.pone.0144431	http://dx.doi.org/10.1371/journal.pone.0144431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641086	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700120
J	Ocampo-Penuela, N; Pimm, SL				Ocampo-Penuela, Natalia; Pimm, Stuart L.			Elevational Ranges of Montane Birds and Deforestation in the Western Andes of Colombia	PLOS ONE			English	Article							RAIN-FOREST BIRDS; CLIMATE-CHANGE; CONSERVATION; BIODIVERSITY; RESPONSES; FRAGMENTATION; EXTINCTIONS; SHIFTS; BIOGEOGRAPHY; COMMUNITIES	Deforestation causes habitat loss, fragmentation, degradation, and can ultimately cause extinction of the remnant species. Tropical montane birds face these threats with the added natural vulnerability of narrower elevational ranges and higher specialization than lowland species. Recent studies assess the impact of present and future global climate change on species' ranges, but only a few of these evaluate the potentially confounding effect of lowland deforestation on species elevational distributions. In the Western Andes of Colombia, an important biodiversity hotspot, we evaluated the effects of deforestation on the elevational ranges of montane birds along altitudinal transects. Using point counts and mist-nets, we surveyed six altitudinal transects spanning 2200 to 2800m. Three transects were forested from 2200 to 2800m, and three were partially deforested with forest cover only above 2400m. We compared abundance-weighted mean elevation, minimum elevation, and elevational range width. In addition to analysing the effect of deforestation on 134 species, we tested its impact within trophic guilds and habitat preference groups. Abundance-weighted mean and minimum elevations were not significantly different between forested and partially deforested transects. Range width was marginally different: as expected, ranges were larger in forested transects. Species in different trophic guilds and habitat preference categories showed different trends. These results suggest that deforestation may affect species' elevational ranges, even within the forest that remains. Climate change will likely exacerbate harmful impacts of deforestation on species' elevational distributions. Future conservation strategies need to account for this by protecting connected forest tracts across a wide range of elevations.	[Ocampo-Penuela, Natalia; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Duke University	Ocampo-Penuela, N (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	no19@duke.edu	Ocampo-Peñuela, Natalia/X-2458-2019; pimm, stuart/ABF-1082-2020	Ocampo-Peñuela, Natalia/0000-0002-5120-7226; 	National Science Foundation Doctoral Dissertation Improvement Grant [1434281]; Rufford Foundation [14204-1]; Explorer's Club Exploration Fund Grant; Ideawild; Duke University Graduate School Dissertation Research Travel Award: International; Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Rufford Foundation; Explorer's Club Exploration Fund Grant; Ideawild; Duke University Graduate School Dissertation Research Travel Award: International; Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean	This work was supported by National Science Foundation Doctoral Dissertation Improvement Grant #1434281 (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5234), the Rufford Foundation Small grants programme #14204-1 (http://www.rufford.org/), the Explorer's Club Exploration Fund Grant (https://explorers.org/expeditions/funding/expedition_grants), Ideawild (http://www.ideawild.org/), Duke University Graduate School Dissertation Research Travel Award: International (https://gradschool.duke.edu/financial-support/find-funding/dissertation-research-travel-award-international), and Duke Center for Latin American and Caribbean Studies Graduate Student Research Awards for Research in Latin America and the Caribbean (http://latinamericancaribbean.duke.edu/funding/graduate-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Becker A, 2007, MT RES DEV, V27, P58, DOI 10.1659/0276-4741(2007)27[58:EALUSA]2.0.CO;2; Bibby C., 1993, BIRD CENSUS TECHNIQU; BirdLife International, 2014, IUCN RED LIST BIRDS; Blackburn TM, 1996, PHILOS T R SOC B, V351, P897, DOI 10.1098/rstb.1996.0083; Bohning-Gaese K, 2004, ADV ECOL RES, V35, P211, DOI 10.1016/S0065-2504(04)35010-5; Bohorquez Clara Isabel, 2003, Ornitologia Neotropical, V14, P67; BRASH AR, 1987, BIOL CONSERV, V39, P97, DOI 10.1016/0006-3207(87)90028-0; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1999, J ANIM ECOL, V68, P1061, DOI 10.1046/j.1365-2656.1999.00353.x; Buckland S.T., 2001, pi; Canaday C, 1996, BIOL CONSERV, V77, P63, DOI 10.1016/0006-3207(95)00115-8; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cuervo Andres M., 2003, Bulletin of the British Ornithologists' Club, V123, P7; del Hoyo J., 2015, HDB BIRDS WORLD ALIV; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Fundacion Colibri, 2015, INV FAUN FLOR RES NA; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris GM, 2005, CONSERV BIOL, V19, P1957, DOI 10.1111/j.1523-1739.2005.00307.x; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2011, NAT CONSERVACAO, V9, P152, DOI 10.4322/natcon.2011.021; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; La Sorte Frank A, 2010, Proc Biol Sci, V277, P3401, DOI 10.1098/rspb.2010.0612; Laurance SGW, 2004, ECOL APPL, V14, P1344, DOI 10.1890/03-5194; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Lee TM, 2005, BIOL CONSERV, V122, P193, DOI 10.1016/j.biocon.2004.07.005; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Moura NG, 2013, BIOL CONSERV, V167, P339, DOI 10.1016/j.biocon.2013.08.023; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Dea N, 2007, BIODIVERS CONSERV, V16, P1131, DOI 10.1007/s10531-006-9095-9; Ocampo-Penuela N, 2014, CONSERV BIOL, V28, P1260, DOI 10.1111/cobi.12312; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Powell George V. N., 1994, Bird Conservation International, V4, P161; Powell GVN, 2004, CONSERV BIOL, V18, P500, DOI 10.1111/j.1523-1739.2004.00044.x; R Core Team, 2015, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Renjifo LM, 2001, ECOL APPL, V11, P14, DOI 10.1890/1051-0761(2001)011[0014:EONAAL]2.0.CO;2; Renjifo Luis Miguel, 1997, Ornithological Monographs, V48, P577; Restrepo C, 1998, ECOL APPL, V8, P170, DOI 10.1890/1051-0761(1998)008[0170:ROUBTA]2.0.CO;2; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Robbins MB, 1999, AUK, V116, P305, DOI 10.2307/4089365; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodriguez JP, 2002, ECOL APPL, V12, P238; Rosselli Loreta, 1994, Bird Conservation International, V4, P143; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209; Stiles FG, 2014, SPECIES LISTS BIRDS; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; White RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121849; WILCOVE DS, 1985, ECOLOGY, V66, P1211, DOI 10.2307/1939174	76	8	11	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143311	10.1371/journal.pone.0143311	http://dx.doi.org/10.1371/journal.pone.0143311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641477	Green Submitted, Green Published, gold			2022-12-26	WOS:000366902700014
J	Wang, HZ; Chu, ZZ; Chen, CC; Cao, AC; Tong, X; Ouyang, CB; Yuan, QH; Wang, MN; Wu, ZK; Wang, HH; Wang, SB				Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Cao, Ao-cheng; Tong, Xin; Ouyang, Can-bin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin			Recombinant Passenger Proteins Can Be Conveniently Purified by One-Step Affinity Chromatography	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; ESCHERICHIA-COLI; TEV PROTEASE; FUSION PARTNERS; EXPRESSION; PURIFICATION; VECTORS; TAGS; CONSTRUCTION; SOLUBILITY	Fusion tag is one of the best available tools to date for enhancement of the solubility or improvement of the expression level of recombinant proteins in Escherichia coli. Typically, two consecutive affinity purification steps are often necessitated for the purification of passenger proteins. As a fusion tag, acyl carrier protein (ACP) could greatly increase the soluble expression level of Glucokinase (GlcK), alpha-Amylase (Amy) and GFP. When fusion protein ACP-G2-GlcK-Histag and ACP-G2-Amy-Histag, in which a protease TEV recognition site was inserted between the fusion tag and passenger protein, were coexpressed with protease TEV respectively in E. coli, the efficient intracellular processing of fusion proteins was achieved. The resulting passenger protein GlcK-Histag and Amy-Histag accumulated predominantly in a soluble form, and could be conveniently purified by one-step Nichelating chromatography. However, the fusion protein ACP-GFP-Histag was processed incompletely by the protease TEV coexpressed in vivo, and a large portion of the resulting target protein GFP-Histag aggregated in insoluble form, indicating that the intracellular processing may affect the solubility of cleaved passenger protein. In this context, the soluble fusion protein ACP-GFP-Histag, contained in the supernatant of E. coli cell lysate, was directly subjected to cleavage in vitro by mixing it with the clarified cell lysate of E. coli over-expressing protease TEV. Consequently, the resulting target protein GFP-Histag could accumulate predominantly in a soluble form, and be purified conveniently by one-step Ni-chelating chromatography. The approaches presented here greatly simplify the purification process of passenger proteins, and eliminate the use of large amounts of pure site-specific proteases.	[Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Tong, Xin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin] South China Agr Univ, Coll Life Sci, Guangzhou 541642, Guangdong, Peoples R China; [Wang, Hua-zhen; Chu, Zhi-zhan; Chen, Chang-chao; Tong, Xin; Yuan, Qi-hang; Wang, Mi-nan; Wu, Zhong-kun; Wang, Hai-hong; Wang, Sheng-bin] Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou 541642, Guangdong, Peoples R China; [Cao, Ao-cheng; Ouyang, Can-bin] Chinese Acad Agr Sci, Inst Plant Protect, Dept Pesticides, Minist Agr, Beijing 100193, Peoples R China; [Cao, Ao-cheng; Ouyang, Can-bin] State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Wang, SB (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou 541642, Guangdong, Peoples R China.	swwl@scau.edu.cn		wang, huazhen/0000-0002-4875-1829	Special Nonprofit Agricultural Industrial Research Fund of China [201103027]	Special Nonprofit Agricultural Industrial Research Fund of China	This work was supported by Special Nonprofit Agricultural Industrial Research Fund of China (201103027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Special Nonprofit Agricultural Industrial Research Fund of China (201103027).	BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Berlec A, 2013, J IND MICROBIOL BIOT, V40, P257, DOI 10.1007/s10295-013-1235-0; Bird LE, 2011, METHODS, V55, P29, DOI 10.1016/j.ymeth.2011.08.002; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Rodriguez VB, 2006, BIOTECHNOL PROGR, V22, P718, DOI 10.1021/bp060057a; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Douette P, 2005, BIOCHEM BIOPH RES CO, V333, P686, DOI 10.1016/j.bbrc.2005.05.164; Eisenmesser EZ, 2000, PROTEIN EXPRES PURIF, V20, P186, DOI 10.1006/prep.2000.1283; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fernandes Pedro, 2010, Enzyme Res, V2010, P862537, DOI 10.4061/2010/862537; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kuo WHK, 2011, BIOTECHNOL LETT, V33, P1075, DOI 10.1007/s10529-011-0554-3; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; Li YF, 2011, BIOTECHNOL LETT, V33, P869, DOI 10.1007/s10529-011-0533-8; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Pacheco B, 2012, PROTEIN EXPRES PURIF, V81, P33, DOI 10.1016/j.pep.2011.08.030; Pal M, 2009, DRUG DISCOV TODAY, V14, P784, DOI 10.1016/j.drudis.2009.05.013; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Shih YP, 2005, PROTEIN SCI, V14, P936, DOI 10.1110/ps.041129605; Su Y, 2007, J BIOTECHNOL, V129, P373, DOI 10.1016/j.jbiotec.2007.01.015; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	28	3	3	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143598	10.1371/journal.pone.0143598	http://dx.doi.org/10.1371/journal.pone.0143598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641240	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700022
J	Escott-Price, V; Kirov, G; Rees, E; Isles, AR; Owen, MJ; O'Donovan, MC				Escott-Price, Valentina; Kirov, George; Rees, Elliott; Isles, Anthony R.; Owen, Michael J.; O'Donovan, Michael C.			No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci	PLOS ONE			English	Article							PARENT; GENES; TWIN	Most genetic studies assume that the function of a genetic variant is independent of the parent from which it is inherited, but this is not always true. The best known example of parent-of-origin effects arises with respect to alleles at imprinted loci. In classical imprinting, characteristically, either the maternal or paternal copy is expressed, but not both. Only alleles present in one of the parental copies of the gene, the expressed copy, is likely to contribute to disease. It has been postulated that imprinting is important in central nervous system development, and that consequently, imprinted loci may be involved in schizophrenia. If this is true, allowing for parent-of-origin effects might be important in genetic studies of schizophrenia. Here, we use genome-wide association data from one of the world's largest samples (N = 695) of parent schizophrenia-offspring trios to test for parent-of-origin effects. To maximise power, we restricted our analyses to test two main hypotheses. If imprinting plays a disproportionate role in schizophrenia susceptibility, we postulated a) that alleles showing robust evidence for association to schizophrenia from previous genome-wide association studies should be enriched for parent-of-origin effects and b) that genes at loci imprinted in humans or mice should be enriched both for genome-wide significant associations, and in our sample, for parent-of-origin effects. Neither prediction was supported in the present study. We have shown, that it is unlikely that parent-of-origin effects or imprinting play particularly important roles in schizophrenia, although our findings do not exclude such effects at specific loci nor do they exclude such effects among rare alleles.	[Escott-Price, Valentina; Kirov, George; Rees, Elliott; Isles, Anthony R.; Owen, Michael J.; O'Donovan, Michael C.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Escott-Price, V (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales.	EscottPriceV@cf.ac.uk	O'Donovan, Michael C/P-7005-2018	O'Donovan, Michael C/0000-0001-7073-2379; Escott-Price, Valentina/0000-0003-1784-5483; Isles, Anthony/0000-0002-7587-5712; Rees, Elliott/0000-0002-6168-9222	Medical Research Council (MRC) [G0800509, G0801418]; Stanley Medical Research Institute; Merck Genome Research Foundation; Herman Foundation; Janssen Research Foundation; Medical Research Council [G0801418, G0800509, MR/L023784/2, MR/L010305/1] Funding Source: researchfish; MRC [MR/L023784/2, G0800509, G0801418] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stanley Medical Research Institute; Merck Genome Research Foundation; Herman Foundation; Janssen Research Foundation(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC) Centre Grant G0800509 and Program Grant G0801418. Genotyping was funded by multiple grants to the Stanley Center for Psychiatric Research at the Broad Institute from the Stanley Medical Research Institute, The Merck Genome Research Foundation and the Herman Foundation. Funding for recruitment was provided by the Janssen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Guilmatre A, 2012, CLIN GENET, V81, P201, DOI 10.1111/j.1399-0004.2011.01790.x; Ingason A, 2011, AM J PSYCHIAT, V168, P408, DOI 10.1176/appi.ajp.2010.09111660; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Niemitz E., 2014, NAT GENET, V46, P219; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruderfer DM, 2011, MOL PSYCHIATR, V16, P887, DOI 10.1038/mp.2011.34; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberger DR, 1986, NEUROLOGY SCHIZOPHRE, P387; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144172	10.1371/journal.pone.0144172	http://dx.doi.org/10.1371/journal.pone.0144172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633303	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000066
J	Fiset, J; Tessier, N; Millien, V; Lapointe, FJ				Fiset, Jessica; Tessier, Nathalie; Millien, Virginie; Lapointe, Francois-Joseph			Phylogeographic Structure of the White-Footed Mouse and the Deer Mouse, Two Lyme Disease Reservoir Hosts in Quebec	PLOS ONE			English	Article							EREMICUS SPECIES GROUP; BORRELIA-BURGDORFERI; GENETIC-STRUCTURE; PEROMYSCUS-MANICULATUS; POPULATION-GENETICS; DISTANCE MATRICES; LEUCOPUS; PATTERNS; MODEL; MICE	Modification of a species range is one of many consequences of climate change and is driving the emergence of Lyme disease in eastern Canada. The primary reservoir host of the bacteria responsible for Lyme disease, Borrelia burgdorferi, is the white-footed mouse (Peromyscus leucopus), whose range is rapidly shifting north into southern Quebec. The deer mouse, P. maniculatus, is occurring over most Quebec province and is a less competent host for B. burgdorferi. Here, we compared the phylogeographic structure of both Peromyscus species in Quebec. Using a combination of multiple mitochondrial DNA markers and phylogeographic methods, we detected an ongoing and rapid expansion of P. leucopus, while P. maniculatus appears more stable. Haplotype and populations networks indicated that populations of P. maniculatus exhibit more genetic structure than P. leucopus across the study area. Furthermore, significant and consistent genetic divergences between populations of the two species on both sides of the St. Lawrence River suggest that distinct lineages of P. leucopus and P. maniculatus with different ancestral origins colonized Southern Quebec following the Last Glacial Maximum. The phylogeographic structure of pathogens is expected to mirror the structure observed in their reservoir hosts. As different strains of Borrelia burgdorferi may be associated with different levels of pathogenicity and immune responses of their hosts, our results are helpful at better understanding the pattern of spread of Lyme disease in a zone of emergence, and associated risk for human populations.	[Fiset, Jessica; Tessier, Nathalie; Lapointe, Francois-Joseph] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Tessier, Nathalie] Minist Forets Faune & Parcs, Longueuil, PQ, Canada; [Millien, Virginie] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	Universite de Montreal; McGill University	Millien, V (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	virginie.millien@mcgill.ca	Millien, Virginie/D-6457-2013	Millien, Virginie/0000-0002-1390-766X	Quebec Government (Fonds Vert, PACC26 - Ouranos); QCBS Excellence Award; NSERC	Quebec Government (Fonds Vert, PACC26 - Ouranos); QCBS Excellence Award; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Quebec Government (Fonds Vert, PACC26 - Ouranos) to VM and FJL and a QCBS Excellence Award to JF. VM is supported by the NSERC Discovery Grant Program. URLs: http://www.ouranos.ca/en/scientific-program/impacts-adaptation/ecosystem-biodiversity.php; http://qcbs.ca/resources/student-grants/excellence-awards/; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bradley RD, 2007, J MAMMAL, V88, P1146, DOI 10.1644/06-MAMM-A-342R.1; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Ditchfield AD, 2000, MOL ECOL, V9, P1307, DOI 10.1046/j.1365-294x.2000.01013.x; Dooley JL, 1996, OECOLOGIA, V105, P81, DOI 10.1007/BF00328794; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Fu YX, 1997, GENETICS, V147, P915; Graham WR, 2004, FAUNMAP ELECT DATABA; GRANT PR, 1976, CAN J ZOOL, V54, P2156, DOI 10.1139/z76-249; Griekspoor A, 2005, 4PEAKS PROGRAM HELPS; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hibbard C. W., 1968, P6; Hooper E. T., 1968, P27; Houghton J. T., 2001, CLIMATE CHANGE 2001; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lapointe FJ, 2010, TRENDS MICROBIOL, V18, P341, DOI 10.1016/j.tim.2010.03.009; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; Marrotte RR, 2014, MOL ECOL, V23, P3983, DOI 10.1111/mec.12847; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKenna MC, 1997, CLASSIFICATION MAMMA; Myers P, 2009, GLOBAL CHANGE BIOL, V15, P1434, DOI 10.1111/j.1365-2486.2009.01846.x; Noel S, 2005, PARASITOLOGY, V131, P237, DOI 10.1017/S0031182005007584; OGDEN NH, 2008, INT J HEALTH GEOGR, V22, P7; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Olsen JB, 1996, MOL MAR BIOL BIOTECH, V5, P259; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Polihronakis M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-195; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAND PW, 1993, J MED ENTOMOL, V30, P614, DOI 10.1093/jmedent/30.3.614; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P145, DOI 10.1006/mpev.2000.0841; Riddle BR, 2000, MOL PHYLOGENET EVOL, V17, P161, DOI 10.1006/mpev.2000.0842; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogic A, 2013, ECOL EVOL, V3, P2075, DOI 10.1002/ece3.620; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rowe KC, 2006, MOL ECOL, V15, P4003, DOI 10.1111/j.1365-294X.2006.03063.x; Roy-Dufresne E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080724; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Shipp-Pennock MA, 2005, J MAMMAL, V86, P803, DOI 10.1644/1545-1542(2005)086[0803:SOTWMP]2.0.CO;2; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; SLATKIN M, 1991, GENETICS, V129, P555; Stanek G, 2009, CURR OPIN INFECT DIS, V22, P450, DOI 10.1097/QCO.0b013e32832ee880; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P597; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Tessier N, 2004, CAN J ZOOL, V82, P1832, DOI 10.1139/Z04-173; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wolff JO, 1996, OECOLOGIA, V108, P529, DOI 10.1007/BF00333730; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x	79	18	19	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144112	10.1371/journal.pone.0144112	http://dx.doi.org/10.1371/journal.pone.0144112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633555	gold, Green Submitted, Green Published			2022-12-26	WOS:000366040000059
J	Lu, L; Guo, L; Gauba, E; Tian, J; Wang, L; Tandon, N; Shankar, M; Beck, SJ; Du, YF; Du, H				Lu, Lin; Guo, Lan; Gauba, Esha; Tian, Jing; Wang, Lu; Tandon, Neha; Shankar, Malini; Beck, Simon J.; Du, Yifeng; Du, Heng			Transient Cerebral Ischemia Promotes Brain Mitochondrial Dysfunction and Exacerbates Cognitive Impairments in Young 5xFAD Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; CYCLOPHILIN-D; AMYLOID-BETA; MOUSE MODEL; CELL-DEATH; DYNAMICS; FISSION; DEMENTIA	Alzheimer's disease (AD) is heterogeneous and multifactorial neurological disorder; and the risk factors of AD still remain elusive. Recent studies have highlighted the role of vascular factors in promoting the progression of AD and have suggested that ischemic events increase the incidence of AD. However, the detailed mechanisms linking ischemic insult to the progression of AD is still largely undetermined. In this study, we have established a transient cerebral ischemia model on young 5xFAD mice and their non-transgenic (nonTg) littermates by the transient occlusion of bilateral common carotid arteries. We have found that transient cerebral ischemia significantly exacerbates brain mitochondrial dysfunction including mitochondrial respiration deficits, oxidative stress as well as suppressed levels of mitochondrial fusion proteins including optic atrophy 1 (OPA1) and mitofusin 2 (MFN2) in young 5xFAD mice resulting in aggravated spatial learning and memory. Intriguingly, transient cerebral ischemia did not induce elevation in the levels of cortical or mitochondrial Amyloid beta (A beta) 1-40 or 1-42 levels in 5xFAD mice. In addition, the glucose-and oxygen-deprivation- induced apoptotic neuronal death in A-treated neurons was significantly mitigated by mitochondria-targeted antioxidant mitotempo which suppresses mitochondrial superoxide levels. Therefore, the simplest interpretation of our results is that young 5xFAD mice with pre-existing AD-like mitochondrial dysfunction are more susceptible to the effects of transient cerebral ischemia; and ischemic events may exacerbate dementia and worsen the outcome of AD patients by exacerbating mitochondrial dysfunction.	[Lu, Lin; Guo, Lan; Gauba, Esha; Tian, Jing; Wang, Lu; Tandon, Neha; Shankar, Malini; Beck, Simon J.; Du, Heng] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75083 USA; [Lu, Lin; Wang, Lu; Du, Yifeng; Du, Heng] Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan 250100, Shandong, Peoples R China	University of Texas System; University of Texas Dallas; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, YF (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan 250100, Shandong, Peoples R China.	duyifeng2013@163.com; heng.du@utdallas.edu	Gauba, Esha/AAN-4475-2020	Gauba, Esha/0000-0002-1757-6765	National Institute on Aging [R00AG037716]; Alzheimer's Association [NIRG-12-242803]; National Science Foundation of China [131271145, 1381200847]; National Science Foundation of Shandong [2013JQB14007]; NIH [R00AG037716]; NSFC [131271145, 1381200847]; SDNSF [2013JQB14007]; NATIONAL INSTITUTE ON AGING [R00AG037716] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong(Natural Science Foundation of Shandong Province); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); SDNSF; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging (R00AG037716), Alzheimer's Association (NIRG-12-242803), National Science Foundation of China (131271145, 1381200847), and National Science Foundation of Shandong (2013JQB14007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study is supported by research funding from NIH (R00AG037716), Alzheimer's Association (NIRG-12-242803), NSFC (131271145, 1381200847) and SDNSF (2013JQB14007).	Bonda DJ, 2010, DRUG AGING, V27, P181, DOI 10.2165/11532140-000000000-00000; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cook M, 2015, AGE AGEING, V44, P695, DOI 10.1093/ageing/afv061; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Doll DN, 2015, STROKE, V46, P1681, DOI 10.1161/STROKEAHA.115.009099; Du C, 1996, J CEREBR BLOOD F MET, V16, P195, DOI 10.1097/00004647-199603000-00003; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Eimer WA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-2; Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gan XQ, 2014, BBA-MOL BASIS DIS, V1842, P220, DOI 10.1016/j.bbadis.2013.11.009; Girard SD, 2013, J ALZHEIMERS DIS, V33, P781, DOI 10.3233/JAD-2012-120982; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kemppainen S, 2014, BEHAV BRAIN RES, V275, P15, DOI 10.1016/j.bbr.2014.08.050; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; Martorell-Riera A, 2014, EMBO J, V33, P2388, DOI 10.15252/embj.201488327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; NAGY Z, 1995, DEMENTIA, V6, P21, DOI 10.1159/000106918; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Pimentel-Coelho PM, 2013, NEUROBIOL AGING, V34, P679, DOI 10.1016/j.neurobiolaging.2012.06.025; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2014, DRUG DISCOV TODAY, V19, P951, DOI 10.1016/j.drudis.2014.03.020; Rojas S, 2013, NEUROBIOL AGING, V34, P1790, DOI 10.1016/j.neurobiolaging.2012.12.027; Ryu SW, 2015, MOL CELLS, V38, P89, DOI 10.14348/molcells.2015.2285; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Silvestrini M, 2011, J ALZHEIMERS DIS, V25, P719, DOI 10.3233/JAD-2011-101968; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Sun YY, 2015, STROKE, V46, P1947, DOI 10.1161/STROKEAHA.115.009162; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Troncoso JC, 2008, ANN NEUROL, V64, P168, DOI 10.1002/ana.21413; Ugarte-Uribe B, 2014, BIOL CHEM, V395, P297, DOI 10.1515/hsz-2013-0234; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Venna VR, 2014, STROKE, V45, P3101, DOI 10.1161/STROKEAHA.114.006553; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wappler EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063206; White L, 2002, ANN NY ACAD SCI, V977, P9, DOI 10.1111/j.1749-6632.2002.tb04794.x; Winters A, 2012, TRANSL STROKE RES, V3, P279, DOI 10.1007/s12975-012-0148-y; Yates D, 2013, NAT REV NEUROSCI, V14, P156, DOI 10.1038/nrn3463; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yoshioka H, 2011, J NEUROTRAUM, V28, P649, DOI 10.1089/neu.2010.1662; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997; Zhang QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033722; Zhen G, 2007, J NEUROSCI METH, V166, P73, DOI 10.1016/j.jneumeth.2007.06.029; Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039; Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005	69	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144068	10.1371/journal.pone.0144068	http://dx.doi.org/10.1371/journal.pone.0144068			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632816	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000049
J	Jacques, CN; Jenks, JA; Grovenburg, TW; Klaver, RW				Jacques, Christopher N.; Jenks, Jonathan A.; Grovenburg, Troy W.; Klaver, Robert W.			Influence of Habitat and Intrinsic Characteristics on Survival of Neonatal Pronghorn	PLOS ONE			English	Article							WHITE-TAILED DEER; FUNCTIONAL-RESPONSES; POPULATION-DYNAMICS; LARGE HERBIVORES; BIRTH SYNCHRONY; SITE SELECTION; CALF SURVIVAL; HOME-RANGE; MORTALITY; FAWNS	Increased understanding of the influence of habitat (e.g., composition, patch size) and intrinsic (e.g., age, birth mass) factors on survival of neonatal pronghorn (Antilocapra americana) is a prerequisite to successful management programs, particularly as they relate to population dynamics and the role of population models in adaptive species management. Nevertheless, few studies have presented empirical data quantifying the influence of habitat variables on survival of neonatal pronghorn. During 2002-2005, we captured and radiocollared 116 neonates across two sites in western South Dakota. We documented 31 deaths during our study, of which coyote (Canis latrans) predation (n = 15) was the leading cause of mortality. We used known fate analysis in Program MARK to investigate the influence of intrinsic and habitat variables on neonatal survival. We generated a priori models that we grouped into habitat and intrinsic effects. The highest-ranking model indicated that neonate mortality was best explained by site, percent grassland, and open water habitat; 90-day survival (0.80; 90% CI = 0.71-0.88) declined 23% when grassland and water increased from 80.1 to 92.3% and 0.36 to 0.40%, respectively, across 50% natal home ranges. Further, our results indicated that grassland patch size and shrub density were important predictors of neonate survival; neonate survival declined 17% when shrub density declined from 5.0 to 2.5 patches per 100 ha. Excluding the site covariates, intrinsic factors (i. e., sex, age, birth mass, year, parturition date) were not important predictors of survival of neonatal pronghorns. Further, neonatal survival may depend on available land cover and interspersion of habitats. We have demonstrated that maintaining minimum and maximum thresholds for habitat factors (e. g., percentages of grassland and open water patches, density of shrub patches) throughout natal home ranges will in turn, ensure relatively high (> 0.50) neonatal survival rates, especially as they relate to coyote predation. Thus, landscape level variables (particularly percentages of open water, grassland habitats, and shrub density) should be incorporated into the development or implementation of pronghorn management plans across sagebrush steppe communities of the western Dakotas, and potentially elsewhere within the geographic range of pronghorn.	[Jacques, Christopher N.; Jenks, Jonathan A.; Grovenburg, Troy W.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Klaver, Robert W.] Iowa State Univ, US Geol Survey, Iowa Cooperat Fish & Wildlife Res Unit, Ames, IA USA	South Dakota State University; Iowa State University; United States Department of the Interior; United States Geological Survey	Jacques, CN (corresponding author), Western Illinois Univ, Dept Biol Sci, Macomb, IL 61455 USA.	cn-jacques@wiu.edu	Jenks, Jonathan A/B-7321-2009		Federal Aid in Wildlife Restoration [75103]; National Park Service; Pope and Young Club; Safari Club International; South Dakota State University	Federal Aid in Wildlife Restoration; National Park Service; Pope and Young Club; Safari Club International; South Dakota State University	Funding was provided by Federal Aid in Wildlife Restoration administered by South Dakota Department of Game, Fish and Parks, Study No. 75103, the National Park Service administered through the South Dakota Cooperative Fish and Wildlife Research Unit at South Dakota State University, the Pope and Young Club, Safari Club International, and South Dakota State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AW, 1991, J WILDLIFE MANAGE, V55, P222, DOI 10.2307/3809143; Andrew NG, 1997, WILDLIFE SOC B, V25, P823; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Autenrieth, 1982, P PRONGH ANT WORKSH, V10, P112; Autenrieth R.E., 1984, P BIENNIAL PRONGHORN, V11, P49; Autenrieth R. E., 1975, WILDLIFE MONOGR, V42, P3; Barber-Meyer S.M., 2008, Wildlife Biology in Practice, V4, P8; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Barbknecht AE, 2011, J WILDLIFE MANAGE, V75, P646, DOI 10.1002/jwmg.100; Barrett M.W., 1978, Proceedings of the Pronghorn Antelope Workshop, V8, P429; BARRETT MW, 1981, J WILDLIFE MANAGE, V45, P120, DOI 10.2307/3807880; BARRETT MW, 1984, J WILDLIFE MANAGE, V48, P542, DOI 10.2307/3801187; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Bleich VC, 1997, WILDLIFE MONOGR, P1; BLOOD DA, 1970, J WILDLIFE MANAGE, V34, P451, DOI 10.2307/3799032; Bowyer RT, 2006, DIVERS DISTRIB, V12, P244, DOI 10.1111/j.1366-9516.2006.00247.x; Brinkman TJ, 2002, WILDLIFE SOC B, V30, P258; Broyles B, 1995, WILDLIFE SOC B, V23, P663; BURGER LD, 1994, J WILDLIFE MANAGE, V58, P249, DOI 10.2307/3809387; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Byers J.A., 1997, AM PRONGHORN SOCIAL; BYERS JA, 1990, BEHAV ECOL SOCIOBIOL, V26, P157; Canon SK, 1997, J WILDLIFE MANAGE, V61, P1134, DOI 10.2307/3802111; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooch EG, 2015, PROGRAM MARK GENTLE, P633; Devries JH, 2003, J WILDLIFE MANAGE, V67, P551, DOI 10.2307/3802713; ESTES R D, 1976, East African Wildlife Journal, V14, P135; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; Fichter E, 1974, INT UNION CONSERVATI, V1, P352; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gregg MA, 2001, J WILDLIFE MANAGE, V65, P19, DOI 10.2307/3803271; Grovenburg TW, 2014, WILDLIFE SOC B, V38, P89, DOI 10.1002/wsb.366; Grovenburg TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108797; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2011, AM MIDL NAT, V166, P147, DOI 10.1674/0003-0031-166.1.147; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Gustine DD, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)165[1:CSOWCI]2.0.CO;2; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Jacques CN, 2007, J WILDLIFE MANAGE, V71, P737, DOI 10.2193/2005-685; Jacques CN, 2014, J WILDLIFE MANAGE, V78, P164, DOI 10.1002/jwmg.634; Jacques CN, 2011, J WILDLIFE MANAGE, V75, P221, DOI 10.1002/jwmg.23; Jacques CN, 2009, J WILDLIFE MANAGE, V73, P1282, DOI 10.2193/2009-039; Jacques CN, 2009, J MAMMAL, V90, P433, DOI 10.1644/07-MAMM-A-395.1; Johnson JR, 1999, PLANTS BLACK HILLS B; Johnson W. F., 1988, SOIL SURVEY HARDING; Kalvels J., 1982, SOIL SURVEY FALL RIV; KANTRUD HA, 1993, J SOIL WATER CONSERV, V48, P238; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; Kitchen D.W., 1974, Wildlife Monogr, VNo. 38, P1; Kohlmann SG, 2004, PRONGHORN ECOLOGY MA, P645; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Larson G.E., 1999, GRASSLAND PLANTS S D; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Moreau G, 2012, J APPL ECOL, V49, P611, DOI 10.1111/j.1365-2664.2012.02134.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; O'Gara Bart W., 2004, P809; O'Gara Bart W., 2004, P337; Ockenfels RA, 1992, P PRONGHORN ANTELOPE, V15, P78; OGara BW, 2004, PRONGHORN ECOLOGY MA, P675; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Poole KG, 2007, J MAMMAL, V88, P139, DOI 10.1644/06-MAMM-A-127R1.1; RILEY SJ, 1984, J WILDLIFE MANAGE, V48, P1302, DOI 10.2307/3801790; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Schroeder M.A., 1999, BIRDS OF THE WORLD; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith Joe T., 2004, Prairie Naturalist, V36, P213; Sovada MA, 2000, J WILDLIFE MANAGE, V64, P820, DOI 10.2307/3802752; THORNE ET, 1976, J WILDLIFE MANAGE, V40, P330, DOI 10.2307/3800433; TRAINER C. E., 1983, 12 OR DEP FISH WILDL; TUCKER RD, 1983, J RANGE MANAGE, V36, P110, DOI 10.2307/3897995; Tucker RD, 1980, P ANN C W ASS FISH W, V60, P620; Van Moorter B, 2013, ECOGRAPHY, V36, P323, DOI 10.1111/j.1600-0587.2012.07291.x; Von Gunten BL, 1978, P BIEN PRONG ANTELOP, V8, P349; Webb SL, 2007, J WILDLIFE MANAGE, V71, P555, DOI 10.2193/2006-189; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wissel C, 1988, EVOL ECOL, V2, P102, DOI 10.1007/BF02067271; Yoakum Jim D., 2004, P409	87	10	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144026	10.1371/journal.pone.0144026	http://dx.doi.org/10.1371/journal.pone.0144026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630484	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300139
J	Kelley, NJ; Schmeichel, BJ				Kelley, Nicholas J.; Schmeichel, Brandon J.			Thinking about Death Reduces Delay Discounting	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; MORTALITY SALIENCE; SELF-ESTEEM; SYMBOLIC IMMORTALITY; CULTURAL WORLDVIEW; PERSPECTIVE; DEPLETION; THOUGHTS; BEHAVIOR; DEFENSE	The current study tested competing predictions regarding the effect of mortality salience on delay discounting. One prediction, based on evolutionary considerations, was that reminders of death increase the value of the present. Another prediction, based in part on construal level theory, was that reminders of death increase the value of the future. One-hundred eighteen participants thought about personal mortality or a control topic and then completed an inter-temporal choice task pitting the chance to gain $50 now against increasingly attractive rewards three months later. Consistent with the hypothesis inspired by construal theory, participants in the mortality salience condition traded $50 now for $66.67 in three months, whereas participants in the dental pain salience condition required $72.84 in three months in lieu of $50 now. Thus, participants in the mortality salience condition discounted future monetary gains less than other participants, suggesting that thoughts of death may increase the subjective value of the future.	[Kelley, Nicholas J.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Schmeichel, Brandon J.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA	Northwestern University; Texas A&M University System; Texas A&M University College Station	Kelley, NJ (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	nicholasjkelley@gmail.com						Arndt J, 1997, PSYCHOL SCI, V8, P379, DOI 10.1111/j.1467-9280.1997.tb00429.x; Bastian B, 2013, SOC PSYCHOL PERS SCI, V4, P215, DOI 10.1177/1948550612451156; Ben-Ari OT, 1999, J PERS SOC PSYCHOL, V76, P35, DOI 10.1037/0022-3514.76.1.35; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Carver CS, 2001, PERS SOC PSYCHOL REV, V5, P345, DOI 10.1207/S15327957PSPR0504_4; CHAPMAN GB, 1995, MED DECIS MAKING, V15, P373, DOI 10.1177/0272989X9501500408; Cox CR, 2009, HEALTH PSYCHOL, V28, P746, DOI 10.1037/a0016388; Dechesne M, 2003, J PERS SOC PSYCHOL, V84, P722, DOI 10.1037/0022-3514.84.4.722; Ferraro R, 2005, J CONSUM RES, V32, P65, DOI 10.1086/429601; Florian V, 1998, J PERS SOC PSYCHOL, V74, P725, DOI 10.1037/0022-3514.74.3.725; Fujita K, 2006, J PERS SOC PSYCHOL, V90, P351, DOI 10.1037/0022-3514.90.3.351; Gailliot MT, 2006, J PERS SOC PSYCHOL, V91, P49, DOI 10.1037/0022-3514.91.1.49; Goldenberg JL, 1999, J PERS SOC PSYCHOL, V77, P1173, DOI 10.1037/0022-3514.77.6.1173; Greenberg J, 2000, PERS SOC PSYCHOL B, V26, P91, DOI 10.1177/0146167200261009; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P1015, DOI 10.1037/a0022403; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hart J, 2010, BRIT J SOC PSYCHOL, V49, P425, DOI 10.1348/014466610X485465; Haselton MG, 2009, SOC COGNITION, V27, P733, DOI 10.1521/soco.2009.27.5.733; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; King LA, 2009, PSYCHOL SCI, V20, P1459, DOI 10.1111/j.1467-9280.2009.02466.x; Landau MJ, 2011, SELF IDENTITY, V10, P64, DOI 10.1080/15298860903557243; Leary MR, 1997, PSYCHOL INQ, V8, P26, DOI 10.1207/s15327965pli0801_4; Litton RJ, 1979, BROKEN CONNECTION DE; MISCHEL W, 1973, J PERS SOC PSYCHOL, V28, P172, DOI 10.1037/h0035716; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Pyszczynski T, 2000, CURR DIR PSYCHOL SCI, V9, P156, DOI 10.1111/1467-8721.00083; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; Simon L, 1997, J PERS SOC PSYCHOL, V72, P1132, DOI 10.1037/0022-3514.72.5.1132; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Vail KE, 2012, PERS SOC PSYCHOL REV, V16, P303, DOI 10.1177/1088868312440046; VALLACHER RR, 1987, PSYCHOL REV, V94, P3, DOI 10.1037/0033-295X.94.1.3; Vess M, 2008, J RES PERS, V42, P1376, DOI 10.1016/j.jrp.2008.04.007; Wade-Benzoni KA, 2012, PSYCHOL SCI, V23, P704, DOI 10.1177/0956797612443967; Weber EU, 2007, PSYCHOL SCI, V18, P516, DOI 10.1111/j.1467-9280.2007.01932.x; Wegner, 2014, THEORY ACTION IDENTI; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010	43	14	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144228	10.1371/journal.pone.0144228	http://dx.doi.org/10.1371/journal.pone.0144228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26630664	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000365926300171
J	Redding, DW; Mooers, AO				Redding, David W.; Mooers, Arne O.			Ranking Mammal Species for Conservation and the Loss of Both Phylogenetic and Trait Diversity	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; EXTINCTION RISK; BIODIVERSITY; PRIORITIES; PREDICTORS; PATTERNS; FUTURE	The 'edge of existence' (EDGE) prioritisation scheme is a new approach to rank species for conservation attention that aims to identify species that are both isolated on the tree of life and at imminent risk of extinction as defined by the World Conservation Union (IUCN). The self-stated benefit of the EDGE system is that it effectively captures unusual 'unique' species, and doing so will preserve the total evolutionary history of a group into the future. Given the EDGE metric was not designed to capture total evolutionary history, we tested this claim. Our analyses show that the total evolutionary history of mammals preserved is indeed much higher if EDGE species are protected than if at-risk species are chosen randomly. More of the total tree is also protected by EDGE species than if solely threat status or solely evolutionary distinctiveness were used for prioritisation. When considering how much trait diversity is captured by IUCN and EDGE prioritisation rankings, interestingly, preserving the highest-ranked EDGE species, or indeed just the most threatened species, captures more total trait diversity compared to sets of randomly-selected at-risk species. These results suggest that, as advertised, EDGE mammal species contribute evolutionary history to the evolutionary tree of mammals non-randomly, and EDGE-style rankings among endangered species can also capture important trait diversity. If this pattern holds for other groups, the EDGE prioritisation scheme has greater potential to be an efficient method to allocate scarce conservation effort.	[Redding, David W.; Mooers, Arne O.] Simon Fraser Univ, BISC, Burnaby, BC V5A 1S6, Canada; [Redding, David W.; Mooers, Arne O.] Simon Fraser Univ, IRMACS, Burnaby, BC V5A 1S6, Canada; [Redding, David W.] UCL, Dept Genet Evolut & Environm, CBER, London, England	Simon Fraser University; Simon Fraser University; University of London; University College London	Redding, DW (corresponding author), Simon Fraser Univ, BISC, Burnaby, BC V5A 1S6, Canada.	dwredding@gmail.com	Redding, David/M-1766-2019	Redding, David/0000-0001-8615-1798	NSERC Canada Discovery Grant; Ecosystem Services for Poverty Alleviation (ESPA) programme [NE-J001570-1]; Systematics Association (UK)	NSERC Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ecosystem Services for Poverty Alleviation (ESPA) programme; Systematics Association (UK)	This work was supported by: NSERC Canada Discovery Grant (AOM); Ecosystem Services for Poverty Alleviation (ESPA) programme (project no. NE-J001570-1) & Systematics Association (UK) (DWR).	Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Bowen BW, 2005, CONSERV BIOL, V19, P1037, DOI 10.1111/j.1523-1739.2005.00100.x; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Curnick DJ, 2015, ANIM CONSERV, V18, P303, DOI 10.1111/acv.12185; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Eklund J, 2011, PHILOS T R SOC B, V366, P2661, DOI 10.1098/rstb.2011.0114; Faith Daniel P., 2008, P99; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; Faller B, 2008, J THEOR BIOL, V251, P286, DOI 10.1016/j.jtbi.2007.11.034; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2014, CURR BIOL, V24, P1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Latiolais JM, 2006, MOL PHYLOGENET EVOL, V41, P436, DOI 10.1016/j.ympev.2006.05.027; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Magnuson-Ford K, 2009, BIOL CONSERV, V142, P1787, DOI 10.1016/j.biocon.2009.03.020; Maherali H, 2007, SCIENCE, P316; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Red List of Endangered Species, 2012, RED LIST END SPEC; Redding DW, 2008, J THEOR BIOL, V251, P606, DOI 10.1016/j.jtbi.2007.12.006; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Veron S, 2017, BIOL REV, V92, P271, DOI 10.1111/brv.12228; Waldron A, 2013, P NATL ACAD SCI; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N; ZSL (Zological Society of London), 2011, EDGE EX EV DIST GLOB	44	13	13	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0141435	10.1371/journal.pone.0141435	http://dx.doi.org/10.1371/journal.pone.0141435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630179	Green Published, gold			2022-12-26	WOS:000365926300006
J	Takahashi, T; Agarikuchi, T; Kurebayashi, Y; Shibahara, N; Suzuki, C; Kishikawa, A; Fukushima, K; Takano, M; Suzuki, F; Wada, H; Otsubo, T; Ikeda, K; Minami, A; Suzuki, T				Takahashi, Tadanobu; Agarikuchi, Takashi; Kurebayashi, Yuuki; Shibahara, Nona; Suzuki, Chihiro; Kishikawa, Akiko; Fukushima, Keijo; Takano, Maiko; Suzuki, Fumie; Wada, Hirohisa; Otsubo, Tadamune; Ikeda, Kiyoshi; Minami, Akira; Suzuki, Takashi			Easy and Rapid Detection of Mumps Virus by Live Fluorescent Visualization of Virus-Infected Cells	PLOS ONE			English	Article							SIALIDASE SUBSTRATE	Mumps viruses show diverse cytopathic effects (CPEs) of infected cells and viral plaque formation (no CPE or no plaque formation in some cases) depending on the viral strain, highlighting the difficulty in mumps laboratory studies. In our previous study, a new sialidase substrate, 2-(benzothiazol-2-yl)-4-bromophenyl 5-acetamido-3,5-dideoxy-alpha-D-glycero-D-galacto- 2-nonulopyranosidonic acid (BTP3-Neu5Ac), was developed for visualization of sialidase activity. BTP3-Neu5Ac can easily and rapidly perform histochemical fluorescent visualization of influenza viruses and virus-infected cells without an antiviral antibody and cell fixation. In the present study, the potential utility of BTP3-Neu5Ac for rapid detection of mumps virus was demonstrated. BTP3-Neu5Ac could visualize dot-blotted mumps virus, virus-infected cells, and plaques (plaques should be called focuses due to staining of infected cells in this study), even if a CPE was not observed. Furthermore, virus cultivation was possible by direct pick-up from a fluorescent focus. In conventional methods, visible appearance of the CPE and focuses often requires more than 6 days after infection, but the new method with BTP3-Neu5Ac clearly visualized infected cells after 2 days and focuses after 4 days. The BTP3-Neu5Ac assay is a precise, easy, and rapid assay for confirmation and titration of mumps virus.	[Takahashi, Tadanobu; Agarikuchi, Takashi; Kurebayashi, Yuuki; Shibahara, Nona; Suzuki, Chihiro; Kishikawa, Akiko; Fukushima, Keijo; Takano, Maiko; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Shibahara, Nona; Suzuki, Fumie; Wada, Hirohisa] Shizuoka City Inst Environm Sci & Publ Hlth, Shizuoka, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780	Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Kurata Memorial Hitachi Science and Technology Foundation; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation; Shimabara Science Promotion Foundation; Research Foundation for the Electrotechnology of Chubu; Pharmacological Research Foundation, Tokyo; Consortium of Universities and Local Communities in Shizuoka; Tokyo Biomarker Innovation Research Association (TOBIRA); Japan Foundation for Aging and Health; University of Shizuoka; JSPS KAKENHI [26670064, 15H05644]	Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Kurata Memorial Hitachi Science and Technology Foundation; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation(Izumi Science and Technology Foundation); Shimabara Science Promotion Foundation; Research Foundation for the Electrotechnology of Chubu(Research Foundation for the Electrotechnology of Chubu); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Consortium of Universities and Local Communities in Shizuoka; Tokyo Biomarker Innovation Research Association (TOBIRA); Japan Foundation for Aging and Health; University of Shizuoka; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by a grant from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, the Kurata Memorial Hitachi Science and Technology Foundation, the Futaba Electronics Memorial Foundation, Tokai Foundation for Technology, Takahashi Industrial and Economic Research Foundation, Izumi Science and Technology Foundation, The Shimabara Science Promotion Foundation, Research Foundation for the Electrotechnology of Chubu, The Pharmacological Research Foundation, Tokyo, The Consortium of Universities and Local Communities in Shizuoka, Tokyo Biomarker Innovation Research Association (TOBIRA), Japan Foundation for Aging and Health, University of Shizuoka, and JSPS KAKENHI Grant Number (challenging Exploratory Research, 26670064; Young Scientists A, 15H05644).	CASTELLS E, 1990, ARCH VIROL, V115, P277, DOI 10.1007/BF01310536; Clarke DK, 2000, J VIROL, V74, P4831, DOI 10.1128/JVI.74.10.4831-4838.2000; FLANAGAN TD, 1970, APPL MICROBIOL, V19, P360, DOI 10.1128/AEM.19.2.360-366.1970; Forcic D, 2010, VACCINE, V28, P1887, DOI 10.1016/j.vaccine.2009.11.049; Hatchette TF, 2009, J CLIN VIROL, V46, P381, DOI 10.1016/j.jcv.2009.09.024; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; LENNETTE DA, 1975, J CLIN MICROBIOL, V2, P81; Malayan J, 2013, INDIAN J VIROL, V24, P166, DOI 10.1007/s13337-013-0143-2; Matsubara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065281; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okajima K, 2013, JPN J INFECT DIS, V66, P561, DOI 10.7883/yoken.66.561; Puri M, 2009, J VIROL, V83, P6347, DOI 10.1128/JVI.00596-09; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; WAXHAM MN, 1986, VIROLOGY, V151, P286, DOI 10.1016/0042-6822(86)90050-4	18	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144038	10.1371/journal.pone.0144038	http://dx.doi.org/10.1371/journal.pone.0144038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629699	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300142
J	Jiang, X; Jao, J; Neapolitan, R				Jiang, Xia; Jao, Jeremy; Neapolitan, Richard			Learning Predictive Interactions Using Information Gain and Bayesian Network Scoring	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPISTATIC INTERACTIONS; DISEASE; INFERENCE; ALGORITHM; RISK; GENE	Background The problems of correlation and classification are long-standing in the fields of statistics and machine learning, and techniques have been developed to address these problems. We are now in the era of high-dimensional data, which is data that can concern billions of variables. These data present new challenges. In particular, it is difficult to discover predictive variables, when each variable has little marginal effect. An example concerns Genome-wide Association Studies (GWAS) datasets, which involve millions of single nucleotide polymorphism (SNPs), where some of the SNPs interact epistatically to affect disease status. Towards determining these interacting SNPs, researchers developed techniques that addressed this specific problem. However, the problem is more general, and so these techniques are applicable to other problems concerning interactions. A difficulty with many of these techniques is that they do not distinguish whether a learned interaction is actually an interaction or whether it involves several variables with strong marginal effects. Methodology/Findings We address this problem using information gain and Bayesian network scoring. First, we identify candidate interactions by determining whether together variables provide more information than they do separately. Then we use Bayesian network scoring to see if a candidate interaction really is a likely model. Our strategy is called MBS-IGain. Using 100 simulated datasets and a real GWAS Alzheimer's dataset, we investigated the performance of MBS-IGain. Conclusions/Significance When analyzing the simulated datasets, MBS-IGain substantially out-performed nine previous methods at locating interacting predictors, and at identifying interactions exactly. When analyzing the real Alzheimer's dataset, we obtained new results and results that substantiated previous findings. We conclude that MBS-IGain is highly effective at finding interactions in high-dimensional datasets. This result is significant because we have increasingly abundant high-dimensional data in many domains, and to learn causes and perform prediction/classification using these data, we often must first identify interactions.	[Jiang, Xia; Jao, Jeremy] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA; [Neapolitan, Richard] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine	Jiang, X (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15213 USA.	xij6@pitt.edu			National Library of Medicine [R00LM010822, R01LM011663]; NATIONAL LIBRARY OF MEDICINE [R00LM010822, R01LM011663] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Library of Medicine grants number R00LM010822 and R01LM011663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, CATEGORICAL DATA ANA; Chen L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-344; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Chickering M, 1996, LEARNING DATA ARTIFI; COOPER GF, 1990, ARTIF INTELL, V42, P393, DOI 10.1016/0004-3702(90)90060-D; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Friedman N, 2002, J COMPUT BIOL, V9, P331, DOI 10.1089/10665270252935494; Friedman N, 2005, P 4 ANN INT C COMP M; Friedman N, 2003, MACH LEARN, V20, P201; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heckerman D, 1995, MSRTR9409 MICR RES; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Jiang X, 2015, GENET EPIDEMIOL, V39, P173, DOI 10.1002/gepi.21889; Jiang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-89; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Jiang X, 2010, DATA MIN KNOWL DISC, V20, P328, DOI 10.1007/s10618-009-0151-4; Jiang X, 2009, J BIOMED INFORM, V42, P90, DOI 10.1016/j.jbi.2008.05.013; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mandel B., 2012, P 2 WORKSH LANG SOC, P27; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Meng Yan, 2007, BMC Proc, V1 Suppl 1, pS56; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2007, P EVOBIO 2007; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Neapolitan R.E., 2007, PROBABILISTIC METHOD, P177; Neapolitan RE, 1989, PROBABILISTIC REASON; Neapolitan RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117658; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Segal E, 2005, J MACH LEARN RES, V6, P557; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Soulakis ND, 2015, J AM MED INFORM ASSN, V22, P299, DOI 10.1093/jamia/ocu017; Spinola M, 2001, AM J HUM GENET, V55, P27; Spirtes P., 2000, CAUSATION PREDICTION; Suzuki J, 1999, IEICE T FUND ELECTR, VE82A, P2237; Turner SD, 2008, ASHG 2008 ANN M; Tycko B, 2004, ARCH NEUROL-CHICAGO, V61, P1434, DOI 10.1001/archneur.61.9.1434; Wan X, 2010, BIOINFORMATICS, V26, P30, DOI 10.1093/bioinformatics/btp622; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	58	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143247	10.1371/journal.pone.0143247	http://dx.doi.org/10.1371/journal.pone.0143247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624895	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000365891600022
J	Zhang, XJ; MacDonald, BT; Gao, HL; Shamashkin, M; Coyle, AJ; Martinez, RV; He, X				Zhang, Xinjun; MacDonald, Bryan T.; Gao, Huilan; Shamashkin, Michael; Coyle, Anthony J.; Martinez, Robert V.; He, Xi			Characterization of Tiki, a New Family of Wnt-specific Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEX-PHEROMONES; HEAD; OXIDATION; MECHANISM	The Wnt family of secreted glycolipoproteins plays pivotal roles in development and human diseases. Tiki family proteins were identified as novel Wnt inhibitors that act by cleaving the Wnt amino-terminal region to inactivate specific Wnt ligands. Tiki represents a new metalloprotease family that is dependent on Mn2+/Co2+ but lacks known metalloprotease motifs. The Tiki extracellular domain shares homology with bacterial TraB/PrgY proteins, known for their roles in the inhibition of mating pheromones. The TIKI/TraB fold is predicted to be distantly related to structures of additional bacterial proteins and may use a core beta-sheet within an alpha+beta-fold to coordinate conserved residues for catalysis. In this study, using assays for Wnt3a cleavage and signaling inhibition, we performed mutagenesis analyses of human TIKI2 to examine the structural prediction and identify the active site residues. We also established an in vitro assay for TIKI2 protease activity using FRET peptide substrates derived from the cleavage motifs of Wnt3a and Xenopus wnt8 (Xwnt8). We further identified two pairs of potential disulfide bonds that reside outside the beta-sheet catalytic core but likely assist the folding of the TIKI domain. Finally, we systematically analyzed TIKI2 cleavage of the 19 human WNT proteins, of which we identified 10 as potential TIKI2 substrates, revealing the hydrophobic nature of Tiki cleavage sites. Our study provides insights into the Tiki family of proteases and its Wnt substrates.	[Zhang, Xinjun; MacDonald, Bryan T.; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Gao, Huilan; Shamashkin, Michael; Coyle, Anthony J.; Martinez, Robert V.] Pfizer, Ctr Therapeut Innovat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Pfizer	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu			National Institutes of Health [RO1-GM057603, RO1-AR060359]; Massachusetts Life Science Center [MLSC 80253-01]; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center - National Institutes of Health [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Science Center; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center - National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	An American Cancer Society Research Professor. Supported by National Institutes of Health Grants RO1-GM057603 and RO1-AR060359, by Grant MLSC 80253-01 from the Massachusetts Life Science Center, and by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (funded by National Institutes of Health Grant P30 HD-18655). To whom correspondence should be addressed. Tel.: 617-919-2257; Fax: 617-919-2771; E-mail: xi.he@childrens.harvard.edu.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bazan JF, 2013, DEV CELL, V25, P225, DOI 10.1016/j.devcel.2013.04.019; Chandler JR, 2008, J BACTERIOL, V190, P1172, DOI 10.1128/JB.01327-07; Chandler JR, 2005, J BACTERIOL, V187, P4830, DOI 10.1128/JB.187.14.4830-4843.2005; Chandler JR, 2004, PEPTIDES, V25, P1377, DOI 10.1016/j.peptides.2003.10.020; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Dunny GM, 2013, ANNU REV GENET, V47, P457, DOI 10.1146/annurev-genet-111212-133449; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Meyer BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371500; Morar M, 2012, BIOCHEMISTRY-US, V51, P1740, DOI 10.1021/bi201790u; Rawlings N. D., 2004, HDB PROTEOLYTIC ENZY, P231; Sanchez-Pulido L, 2013, BIOINFORMATICS, V29, P2371, DOI 10.1093/bioinformatics/btt412; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	22	30	34	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2435	2443		10.1074/jbc.M115.677807	http://dx.doi.org/10.1074/jbc.M115.677807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26631728	hybrid, Green Published			2022-12-26	WOS:000369610400032
J	Leong, V; Goswami, U				Leong, Victoria; Goswami, Usha			Acoustic-Emergent Phonology in the Amplitude Envelope of Child-Directed Speech	PLOS ONE			English	Article								When acquiring language, young children may use acoustic spectro-temporal patterns in speech to derive phonological units in spoken language (e.g., prosodic stress patterns, syllables, phonemes). Children appear to learn acoustic-phonological mappings rapidly, without direct instruction, yet the underlying developmental mechanisms remain unclear. Across different languages, a relationship between amplitude envelope sensitivity and phonological development has been found, suggesting that children may make use of amplitude modulation (AM) patterns within the envelope to develop a phonological system. Here we present the Spectral Amplitude Modulation Phase Hierarchy (S-AMPH) model, a set of algorithms for deriving the dominant AM patterns in child-directed speech (CDS). Using Principal Components Analysis, we show that rhythmic CDS contains an AM hierarchy comprising 3 core modulation timescales. These timescales correspond to key phonological units: prosodic stress (Stress AM, similar to 2 Hz), syllables (Syllable AM, similar to 5 Hz) and onset-rime units (Phoneme AM, similar to 20 Hz). We argue that these AM patterns could in principle be used by naive listeners to compute acoustic-phonological mappings without lexical knowledge. We then demonstrate that the modulation statistics within this AM hierarchy indeed parse the speech signal into a primitive hierarchically-organised phonological system comprising stress feet (proto-words), syllables and onset-rime units. We apply the S-AMPH model to two other CDS corpora, one spontaneous and one deliberately-timed. The model accurately identified 72-82% (freely-read CDS) and 90-98% (rhythmically-regular CDS) stress patterns, syllables and onset-rime units. This in-principle demonstration that primitive phonology can be extracted from speech AMs is termed Acoustic-Emergent Phonology (AEP) theory. AEP theory provides a set of methods for examining how early phonological development is shaped by the temporal modulation structure of speech across languages. The S-AMPH model reveals a crucial developmental role for stress feet (AMs similar to 2 Hz). Stress feet underpin different linguistic rhythm typologies, and speech rhythm underpins language acquisition by infants in all languages.	[Leong, Victoria; Goswami, Usha] Univ Cambridge, Ctr Neurosci Educ, Dept Psychol, Cambridge, England	University of Cambridge	Leong, V (corresponding author), Univ Cambridge, Ctr Neurosci Educ, Dept Psychol, Cambridge, England.	vvec2@cam.ac.uk	Leong, Victoria/G-5778-2013	Leong, Victoria/0000-0003-0666-9445; Goswami, Usha/0000-0001-7858-2336	Harold Hyam Wingate Foundation Research Scholarship; Lucy Cavendish College Junior Research Fellowship; Medical Research Council [G0902375]; MRC [G0902375] Funding Source: UKRI	Harold Hyam Wingate Foundation Research Scholarship; Lucy Cavendish College Junior Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by a Harold Hyam Wingate Foundation Research Scholarship and a Lucy Cavendish College Junior Research Fellowship to VL, and by a grant from the Medical Research Council to UG (G0902375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a Harold Hyam Wingate Foundation Research Scholarship and a Lucy Cavendish College Junior Research Fellowship to VL, and by a grant from the Medical Research Council to UG (G0902375). We thank Richard Turner for the use of his PCA scripts, and Michael Stone for the use of his code.		0	59	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144411	10.1371/journal.pone.0144411	http://dx.doi.org/10.1371/journal.pone.0144411			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641472	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700113
J	Zheljazkov, VD; Gawde, A; Cantrell, CL; Astatkie, T; Schlegel, V				Zheljazkov, Valtcho D.; Gawde, Archana; Cantrell, Charles L.; Astatkie, Tess; Schlegel, Vicki			Distillation Time as Tool for Improved Antimalarial Activity and Differential Oil Composition of Cumin Seed Oil	PLOS ONE			English	Article							ARTEMISIA-ANNUA L.; ANTIOXIDANT CAPACITY; YIELD; ASSAY	A steam distillation extraction kinetics experiment was conducted to estimate essential oil yield, composition, antimalarial, and antioxidant capacity of cumin (Cuminum cyminum L.) seed (fruits). Furthermore, regression models were developed to predict essential oil yield and composition for a given duration of the steam distillation time (DT). Ten DT durations were tested in this study: 5, 7.5, 15, 30, 60, 120, 240, 360, 480, and 600 min. Oil yields increased with an increase in the DT. Maximum oil yield (content, 2.3 g/100 seed), was achieved at 480 min; longer DT did not increase oil yields. The concentrations of the major oil constituents alpha-pinene (0.14-0.5% concentration range), beta-pinene (3.7-10.3% range),gamma-cymene (5-7.3% range),gamma-terpinene (1.8-7.2% range), cumin aldehyde (50-66% range), alpha-terpinen-7-al (3.8-16% range), and beta-terpinen-7-al (12-20% range) varied as a function of the DT. The concentrations of alpha-pinene, beta-pinene, gamma-cymene, gamma-terpinene in the oil increased with the increase of the duration of the DT; alpha-pinene was highest in the oil obtained at 600 min DT, beta-pinene and alpha-terpinene reached maximum concentrations in the oil at 360 min DT; gamma-cymene reached a maximum in the oil at 60 min DT, cumin aldehyde was high in the oils obtained at 5-60 min DT, and low in the oils obtained at 240-600 min DT, gamma-terpinen-7-al reached maximum in the oils obtained at 480 or 600 min DT, whereas beta-terpinen-7-al reached a maximum concentration in the oil at 60 min DT. The yield of individual oil constituents (calculated from the oil yields and the concentration of a given compound at a particular DT) increased and reached a maximum at 480 or 600 min DT. The antimalarial activity of the cumin seed oil obtained during the 0-5 and at 5-7.5 min DT time-frames was twice higher than the antimalarial activity of the oils obtained at the other DT. This study opens the possibility for distinct marketing and utilization for these improved oils. The antioxidant capacity of the oil was highest in the oil obtained at 30 min DT and lowest in the oil from 360 min DT. The Michaelis-Menton and the Power nonlinear regression models developed in this study can be utilized to predict essential oil yield and composition of cumin seed at any given duration of DT and may also be useful to compare previous reports on cumin oil yield and composition. DT can be utilized to obtain cumin seed oil with improved antimalarial activity, improved antioxidant capacity, and with various compositions.	[Zheljazkov, Valtcho D.] Oregon State Univ, Columbia Basin Agr Res Ctr, Adams, OR 97810 USA; [Gawde, Archana; Cantrell, Charles L.] USDA, Nat Prod Utilizat Res Unit, Agr Res Serv, University, MS 38677 USA; [Astatkie, Tess] Dalhousie Univ, Fac Agr, Truro, NS B2N 5E3, Canada; [Schlegel, Vicki] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA	Oregon State University; United States Department of Agriculture (USDA); Dalhousie University; University of Nebraska System; University of Nebraska Lincoln	Zheljazkov, VD (corresponding author), Oregon State Univ, Columbia Basin Agr Res Ctr, 48037 Cty 788 Rd, Adams, OR 97810 USA.	Valtcho.jeliazkov@oregonstate.edu	Astatkie, Tessema/J-7231-2012	Astatkie, Tessema/0000-0002-9779-8789; Gawde, Archana/0000-0002-6495-3850	University of Wyoming Outreach School; Department of Plant Science; ARS [ARS-0429247] Funding Source: Federal RePORTER	University of Wyoming Outreach School; Department of Plant Science; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was provided in part by the University of Wyoming Outreach School and the Department of Plant Science allocations to Valtcho D. Jeliazkov (V.D. Zheljazkov).; The authors thank Jeremiah Vardiman from the University of Wyoming Sheridan Research and Extension Center for their help with the laboratory work, the extraction and measurements of the essential oils, and Rochelle Koltiska for proofreading the manuscript. The authors also thank Solomon Green III for technical assistance at the National Center for Natural Products Research in Oxford, MS and USDA-ARS. Financial support was provided in part by the University of Wyoming Outreach School and the Department of Plant Science allocations to Valtcho D. Jeliazkov (V.D. Zheljazkov).	Alsheik EAMO, 2009, Patent number application, Patent No. [WO 2009139672 A1, 2009139672]; Azeez S, 2008, CHEMISTRY OF SPICES, P211, DOI 10.1079/9781845934057.0211; BADR FH, 1990, FOOD CHEM, V38, P273, DOI 10.1016/0308-8146(90)90184-6; Bameri Z., 2013, International Research Journal of Applied and Basic Sciences, V6, P286; Bates D., 2007, NONLINEAR REGRESSION; Bharate SB, 2007, BIOORGAN MED CHEM, V15, P87, DOI 10.1016/j.bmc.2006.10.006; Cannon JB, 2013, IND CROP PROD, V41, P214, DOI 10.1016/j.indcrop.2012.04.021; Chaubey MK, 2008, J OLEO SCI, V57, P171, DOI 10.5650/jos.57.171; Deepak, 2013, INDIAN J TRADIT KNOW, V12, P300; Dobreva K., 2009, Trakia Journal of Sciences, V7, P191; Ferreira JFS, 2013, IND CROP PROD, V41, P294, DOI 10.1016/j.indcrop.2012.05.005; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; Gohari A. R., 2011, Pharmacognosy Journal, V3, P1, DOI 10.5530/pj.2011.25.1; Huang DJ, 2002, J AGR FOOD CHEM, V50, P1815, DOI 10.1021/jf0113732; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Montgomery D.C., 2013, DESIGN ANAL EXPT; SAS Institute Inc, 2010, SAS STAT 9 3 US GUID; Stojanov N, 1973, CUMIN OUR MED PLANTS, P266; Topalo VD, 1962, ITALIAN CUMIN CUMINU, P246; Zheljazkov VD, 2013, HORTSCIENCE, V48, P1393, DOI 10.21273/HORTSCI.48.11.1393; Zheljazkov VD, 2013, HORTSCIENCE, V48, P1288, DOI 10.21273/HORTSCI.48.10.1288; Zheljazkov VD, 2013, J OLEO SCI, V62, P665, DOI 10.5650/jos.62.665; Zheljazkov VD, 2013, J OLEO SCI, V62, P195, DOI 10.5650/jos.62.195; Zheljazkov VD, 2012, J OLEO SCI, V61, P537, DOI 10.5650/jos.61.537	24	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144120	10.1371/journal.pone.0144120	http://dx.doi.org/10.1371/journal.pone.0144120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641276	Green Published, gold			2022-12-26	WOS:000366902700058
J	Lee, YE; An, J; Lee, KH; Kim, SS; Song, HJ; Pyeon, H; Nam, H; Kang, K; Joo, KM				Lee, Young Eun; An, Jaeyeol; Lee, Kee-Hang; Kim, Sung Su; Song, Hye Jin; Pyeon, Heejang; Nam, Hyun; Kang, Kyeongjin; Joo, Kyeung Min			The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; INFLAMMATORY MECHANISMS; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; PRECURSOR CELLS; BRAIN; TRANSPLANTATION; DISEASE; THERAPY	Neurodegenerative diseases provoke robust immunological reactions in the central nervous system (CNS), which further deteriorate the neural tissue damage. We hypothesized that the expression levels of indoleamine 2,3-dioxygenase (IDO), an enzyme that has potent immune suppressive activities, in neural stem cells (NSCs) would have synergistic therapeutic effects against neurodegenerative diseases, since NSCs themselves have low IDO expression. In this study, the synergistic immune suppressive effects of rat fetal NSCs expressing IDO (rfNSCs-IDO) were validated by mixed leukocyte reaction (MLR) in vitro and an experimental autoimmune encephalomyelitis (EAE) animal model in vivo. rfNSCs-IDO showed significantly more suppressive effects on T cell proliferation in the MLR compared to control rfNSCs (rfNSCs-Cont). Importantly, IDO inhibition using 1-methyl-DL-tryptophan (1-MT), an IDO inhibitor, reversed the synergistic effects, confirming IDO-specific effects in rfNSCs-IDO. In the EAE animal model, systemic rfNSCs-IDO injections resulted in significant local immune suppression in the cervical lymph nodes and CNS, evidenced by a reduction in the number of activated T lymphocytes and an increase in regulatory T cell numbers, which induced significantly fewer clinical symptoms and faster recovery. In contrast, rfNSCs-Cont failed to reduce symptoms in the EAE animal models, although they showed local immune suppression, which was significantly less than that in rfNSCs-IDO. Taken together, IDO expression in NSCs synergistically potentiates the immune suppression activities of NSCs and could be applicable for the development of therapeutic modalities against various neurodegenerative diseases.	[Lee, Young Eun; Lee, Kee-Hang; Kim, Sung Su; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Song, Hye Jin; Pyeon, Heejang; Kang, Kyeongjin; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Suwon, South Korea; [Joo, Kyeung Min] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Lee, Young Eun; An, Jaeyeol; Lee, Kee-Hang; Kim, Sung Su; Song, Hye Jin; Pyeon, Heejang; Nam, Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, KM (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	kangk@skku.edu; kmjoo@skku.edu			Ministry of Food and Drug Safety [14172MFDS974]; Samsung Biomedical Research Institute; Samsung Biomedical Research Institute in Samsung Medical Center	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Samsung Biomedical Research Institute(Samsung); Samsung Biomedical Research Institute in Samsung Medical Center(Samsung)	This research was supported by a grant (14172MFDS974) from Ministry of Food and Drug Safety in 2014 and Samsung Biomedical Research Institute grant. The Samsung Biomedical Research Institute in Samsung Medical Center provided partial financial support for research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2011, BRAIN RES, V1416, P51, DOI 10.1016/j.brainres.2011.08.009; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Bonnamain V, 2012, STEM CELLS, V30, P2342, DOI 10.1002/stem.1199; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Chen YH, 2009, NAT MED, V15, P1215, DOI 10.1038/nm.2025; Chiarugi A, 2001, J NEUROCHEM, V77, P1310, DOI 10.1046/j.1471-4159.2001.00335.x; Choi SA, 2015, CANCER GENE THER, V22, P302, DOI 10.1038/cgt.2015.25; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Cid MP, 2011, NEUROSCIENCE, V189, P337, DOI 10.1016/j.neuroscience.2011.05.005; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Doeppner TR, 2012, STEM CELLS, V30, P1297, DOI 10.1002/stem.1098; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Giusto E, 2014, EXP NEUROL, V260, P19, DOI 10.1016/j.expneurol.2013.03.009; Hermann DM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00291; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hsu YC, 2007, CELL TRANSPLANT, V16, P133; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jones BJ, 2007, PLACENTA, V28, P1174, DOI 10.1016/j.placenta.2007.07.001; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Krause D, 2011, AM J PATHOL, V179, P1360, DOI 10.1016/j.ajpath.2011.05.048; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lanz TV, 2010, STEM CELLS DEV, V19, P657, DOI 10.1089/scd.2009.0385; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Martino G, 2011, BRAIN, V134, P1585, DOI 10.1093/brain/awr115; Matysiak M, 2008, J NEUROIMMUNOL, V193, P12, DOI 10.1016/j.jneuroim.2007.07.025; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Morando S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt94; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Schwartz M, 2006, J NEUROIMMUNE PHARM, V1, P4, DOI 10.1007/s11481-005-9010-2; Seger J, 2010, MEM I OSWALDO CRUZ, V105, P263, DOI 10.1590/S0074-02762010000300004; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; SHIN TY, 1995, J NEUROIMMUNOL, V56, P171, DOI 10.1016/0165-5728(94)00144-D; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Taupin P, 2009, CURR ALZHEIMER RES, V6, P461, DOI 10.2174/156720509790147151; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Zhang X, 2012, CURR GENE THER, V12, P423, DOI 10.2174/156652312802762590; Zhou D, 2006, P NATL ACAD SCI USA, V103, P19057, DOI 10.1073/pnas.0607242103	56	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144298	10.1371/journal.pone.0144298	http://dx.doi.org/10.1371/journal.pone.0144298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636969	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800070
J	Skagseth, O; Slotte, A; Stenevik, EK; Nash, RDM				Skagseth, Oystein; Slotte, Aril; Stenevik, Erling Kare; Nash, Richard D. M.			Characteristics of the Norwegian Coastal Current during Years with High Recruitment of Norwegian Spring Spawning Herring (Clupea harengus L.)	PLOS ONE			English	Article							COD GADUS-MORHUA; NORTH-SEA; LARVAL RETENTION; FISH; POPULATIONS; STOCK; ABUNDANCE; TEMPERATURE; VARIABILITY; ADVECTION	Norwegian Spring Spawning herring (NSSH) Clupea harengus L. spawn on coastal banks along the west coast of Norway. The larvae are generally transported northward in the Norwegian Coastal Current (NCC) with many individuals utilizing nursery grounds in the Barents Sea. The recruitment to this stock is highly variable with a few years having exceptionally good recruitment. The principal causes of recruitment variability of this herring population have been elusive. Here we undertake an event analysis using data between 1948 and 2010 to gain insight into the physical conditions in the NCC that coincide with years of high recruitment. In contrast to a typical year when northerly upwelling winds are prominent during spring, the years with high recruitment coincide with predominantly southwesterly winds and weak upwelling in spring and summer, which lead to an enhanced northward coastal current during the larval drift period. Also in most peak recruitment years, low-salinity anomalies are observed to propagate northward during the spring and summer. It is suggested that consistent southwesterly (downwelling) winds and propagating low-salinity anomalies, both leading to an enhanced northward transport of larvae, are important factors for elevated recruitment. At the same time, these conditions stabilize the coastal waters, possibly leading to enhanced production and improved feeding potential along the drift route to Barents Sea. Further studies on the drivers of early life history mortality can now be undertaken with a better understanding of the physical conditions that prevail during years when elevated recruitment occurs in this herring stock.	[Skagseth, Oystein; Slotte, Aril; Stenevik, Erling Kare; Nash, Richard D. M.] Inst Marine Res, N-5024 Bergen, Norway; [Skagseth, Oystein] Bjerknes Ctr Climate Res, Bergen, Norway	Institute of Marine Research - Norway; Bjerknes Centre for Climate Research	Skagseth, O (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	oystein.skagseth@imr.no		Nash, Richard/0000-0003-0958-149X	Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway; Norwegian Research Council project EPOCASA [229774]	Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway; Norwegian Research Council project EPOCASA	This research was partially supported by the Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway, and the Norwegian Research Council project EPOCASA grant no. 229774. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for helpful comments by anonymous reviewers and to Ken Drinkwater for providing useful comments on an earlier version of the manuscript. This research was partially supported by the Pelagic and Oceanography and Climate Research Groups of the Institute of Marine Research, Norway, and the Norwegian Research Council project EPOCASA grant no. 229774.	[Anonymous], 1988, DEV ATMOSPHERIC SCI; Aure J, 1993, FISK HAV, V6, P7; BARTSCH J, 1989, NATURE, V340, P632, DOI 10.1038/340632a0; Churchill JH, 2011, FISH OCEANOGR, V20, P32, DOI 10.1111/j.1365-2419.2010.00563.x; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1966, FISH INVEST 2, V2, P25; Cushing DH, 1975, MARINE ECOLOGY FISHE; de Barros P, 1998, ICES J MAR SCI, V55, P454, DOI 10.1006/jmsc.1997.0347; Dickey-Collas M, 2014, ICES J MAR SCI, V71, P2300, DOI 10.1093/icesjms/fst215; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; DRAGESUND O, 1970, Fiskeridirektoratets Skrifter Serie Havundersokelser, V15, P381; Dragesund O., 1971, Fiskeridirektoratets Skr (Havundersok), V16, P49; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fiksen O, 2002, CAN J FISH AQUAT SCI, V59, P211, DOI 10.1139/F02-002; Fossum P, 1996, ICES J MAR SCI, V53, P51, DOI 10.1006/jmsc.1996.0005; Helland-Hansen B., 1909, REP NORWEGIAN FISHER, V2, P1; Hjort J., 1926, Journal du Conseil Copenhague, V1, P5; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Holst JC, 1998, ICES J MAR SCI, V55, P987, DOI 10.1006/jmsc.1998.0371; Holst Jens Christian, 2004, P203; Hufnagl M, 2015, PROG OCEANOGR, V138, P486, DOI 10.1016/j.pocean.2014.04.029; Husebo A, 2009, ICES J MAR SCI, V66, P1710, DOI 10.1093/icesjms/fsp150; ICES, 2013, 2012ACOM15 ICES CM; Iden KA, 1997, DEN NORSKE LOS, P129; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Johansen GO, 2004, CAN J FISH AQUAT SCI, V61, P343, DOI 10.1139/F03-168; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Mantzouni I, 2010, P R SOC B, DOI [10.1098/rspb2009.1906, DOI 10.1098/RSPB2009.1906]; Nash RDM, 2009, FISH RES, V95, P88, DOI 10.1016/j.fishres.2008.08.003; NICHOLS JH, 1989, RAP PROCES, V191, P160; Parada C, 2008, AFR J MAR SCI, V30, P437, DOI 10.2989/AJMS.2008.30.3.1.635; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; Petitgas P., 2009, 2009E25 ICES CM; Petitgas P, 2013, FISH OCEANOGR, V22, P121, DOI 10.1111/fog.12010; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rottingen I, 1989, BIOL FISHERIES NORWE, P165; Runge JA, 2010, PROG OCEANOGR, V87, P251, DOI 10.1016/j.pocean.2010.09.016; Saetre R, 2002, SARSIA, V87, P167, DOI 10.1080/003648202320205247; Saetre R, 2002, ICES J MAR SCI, V59, P725, DOI 10.1006/jmsc.2002.1180; SINCLAIR M, 1984, CAN J FISH AQUAT SCI, V41, P1055, DOI 10.1139/f84-123; Sinclair M, 1988, MARINE POPULATIONS E; Sinclair M, 2015, FISH RES, V172, P401, DOI 10.1016/j.fishres.2015.07.026; Skagseth O., 2008, ARCTIC SUBARCTIC OCE, P45, DOI DOI 10.1007/978-1-4020-6774-7_3; Skagseth O, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006996; Skaret G, 2015, ICES J MAR SCI, V72, P2313, DOI 10.1093/icesjms/fsv087; Slotte A, 2000, J FISH BIOL, V56, P138; Stenevik EK, 2012, FISH OCEANOGR, V21, P363, DOI 10.1111/j.1365-2419.2012.00631.x; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; TORESEN R, 1991, FISH RES, V10, P317, DOI 10.1016/0165-7836(91)90083-R; Toresen R, 2002, ICES MAR SCI S, V215, P532; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Vikebo FB, 2012, ICES J MAR SCI, V69, P1298, DOI 10.1093/icesjms/fss083; Vikebo FB, 2010, ICES J MAR SCI, V67, P1948, DOI 10.1093/icesjms/fsq084	54	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144117	10.1371/journal.pone.0144117	http://dx.doi.org/10.1371/journal.pone.0144117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636759	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800041
J	Teng, RY; Hu, Y; Zhou, JC; Seifer, B; Chen, YX; Shen, JG; Wang, LB				Teng, Rongyue; Hu, Yan; Zhou, Jichun; Seifer, Benjamin; Chen, Yongxia; Shen, Jianguo; Wang, Linbo			Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107	PLOS ONE			English	Article							C-MYC; EXPRESSION; CHEMOTHERAPY; INHIBITION; MIR-107; GROWTH; DEATH	Higher Lin28 expression is associated with worse pathologic tumor responses in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy. However, the characteristics of Lin28 and its mechanism of action in chemotherapy resistance is still unclear. In this study, we found that transfection of Lin28 into gastric cancer cells (MKN45 and MKN28) increased their resistance to the chemo-drugs oxaliplatin (OXA), paclitaxel (PTX), doxorubicin (ADM), and fluorouracil (5-Fu) compared with gastric cancer cells transfected with a control vector. When knockdown Lin28 expression by Lin28 small interfering RNA (siRNA) was evaluated in vitro, we found that the resistance to chemo-drugs was reduced. Furthermore, we found that Lin28 up-regulates C-myc and P-gp and down-regulates Cylin D1. Finally, we found that miR-107 is a target microRNA of Lin28 and that it participates in the mechanism of chemotherapy resistance. Our results suggest that the Lin28/miR-107 pathway could be one of many signaling pathways regulated by Lin28 and associated with gastric cancer chemo-resistance.	[Teng, Rongyue; Hu, Yan; Chen, Yongxia; Shen, Jianguo; Wang, Linbo] Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China; [Hu, Yan; Zhou, Jichun] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China; [Seifer, Benjamin] Yale Univ, Postgrad Res Associate, Sch Med, Dept Ob Gyn & Reprod Sci, New Haven, CT USA	Zhejiang University; Zhejiang University; Yale University	Shen, JG (corresponding author), Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou, Zhejiang, Peoples R China.	drshenjianguo@yahoo.com.cn; wanglinbo@medmail.com.cn	wang, lili/HDL-7210-2022; Zhou, Jichun/Q-8646-2019; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022	Zhou, Jichun/0000-0002-0727-4034; 	ZHEJIANG Provincial Natural Science Foundation of CHINA [LQ13H160014]	ZHEJIANG Provincial Natural Science Foundation of CHINA(Natural Science Foundation of Zhejiang Province)	Support was provided by ZHEJIANG Provincial Natural Science Foundation of CHINA: LQ13H160014 [http://www.zjnsf.gov.cn/b/home.aspx].	Calcagno DQ, 2008, WORLD J GASTROENTERO, V14, P5962, DOI 10.3748/wjg.14.5962; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Feng L, 2012, MED ONCOL, V29, P856, DOI 10.1007/s12032-011-9823-1; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim YJ, 2011, HEAD NECK-J SCI SPEC, V33, P1458, DOI 10.1002/hed.21611; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Piao LZ, 2012, MOL THER, V20, P1261, DOI 10.1038/mt.2012.67; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Teng RY, 2013, ONCOTARGETS THER, V6, P1341, DOI 10.2147/OTT.S45705; van Jaarsveld MTM, 2010, INT J BIOCHEM CELL B, V42, P1282, DOI 10.1016/j.biocel.2010.01.014; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wang CG, 2011, CANCER BIOL THER, V11, P615, DOI 10.4161/cbt.11.7.14688; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xu CY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0382-x; Yang GF, 2004, WORLD J GASTROENTERO, V10, P491, DOI 10.3748/wjg.v10.i4.491	24	37	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143716	10.1371/journal.pone.0143716	http://dx.doi.org/10.1371/journal.pone.0143716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636340	Green Submitted, gold, Green Published			2022-12-26	WOS:000366143800024
J	Yin, XL; Zhang, TW; Su, XY; Ji, Y; Ye, P; Fu, HH; Fan, SQ; Shen, YY; Gavine, PR; Gu, Y				Yin, Xiaolu; Zhang, Tianwei; Su, Xinying; Ji, Yan; Ye, Peng; Fu, Haihua; Fan, Shuqiong; Shen, Yanying; Gavine, Paul R.; Gu, Yi			Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; C-MET; CLEAR-CELL; LUNG-CANCER; AMPLIFICATION; EXPRESSION; TARGET; TUMORS; PROTOONCOGENE; MUTATIONS	To investigate the relationships between Chromosome 7 gain, mesenchymal-epithelial transition factor (MET) gene copy number increase and MET protein overexpression in Chinese patients with papillary renal cell carcinoma (PRCC), immunohistochemistry (IHC), immunofluorescence (IF) and fluorescence in situ hybridization (FISH) were performed on 98 formalin-fixed, paraffin-embedded (FFPE) PRCC samples. Correlations between MET gene copy number increase, Chromosome 7 gain and MET protein overexpression were analyzed statistically. A highly significant correlation was observed between the percentage of tumor cells with MET gene copy number >= 3 and CEP7 copy number >= 3 (R-2 = 0.90, p<0.001) across two subtypes of PRCC. In addition, the percentage of tumor cells with MET gene copy number >= 3 was found to increase along with increases in MET IHC score. This correlation was further confirmed in those PRCC tumor cells with average MET gene copy number >5 using combined IF and FISH methodology. Overall, this study provides evidence that Chromosome 7 gain drives MET gene copy number increase in PRCC tumors, and appears to subsequently lead to an increase in MET protein overexpression in these tumor cells. This supports MET activation as a potential therapeutic target in sporadic PRCC.	[Yin, Xiaolu; Zhang, Tianwei; Su, Xinying; Ye, Peng; Fu, Haihua; Fan, Shuqiong; Gavine, Paul R.; Gu, Yi] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Ji, Yan] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Shen, Yanying] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Pathol, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Yin, XL (corresponding author), AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China.	lucy.yin@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	Authors affiliated with AstraZeneca are full-time employees and/or stakeholders of AstraZeneca. This study is fully funded by AstraZeneca. The funder provided support in the form of salaries for authors (YX, ZT, SX, JY, YP, FH, FS, GP and GY). The specific roles of these authors are articulated in the "author contributions" section. In addition to the salaries, this study was completed in AstraZeneca's facility and using AstraZeneca's resources.; We thank AstraZeneca for sponsoring this study.	Albiges L, 2014, CLIN CANCER RES, V20, P3411, DOI 10.1158/1078-0432.CCR-13-2173; Arai E, 2011, INT J CLIN EXP PATHO, V4, P58; Balint I, 2009, J CLIN PATHOL, V62, P892, DOI 10.1136/jcp.2009.066423; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Brunelli M, 2003, MODERN PATHOL, V16, P1053, DOI 10.1097/01.MP.0000090924.90762.94; Choi JS, 2006, J KOREAN MED SCI, V21, P672, DOI 10.3346/jkms.2006.21.4.672; Choueiri TK, 2013, J CLIN ONCOL, V31, P181, DOI 10.1200/JCO.2012.43.3383; Corless CL, 1996, DIAGN MOL PATHOL, V5, P53, DOI 10.1097/00019606-199603000-00009; Delahunt B, 1997, MODERN PATHOL, V10, P537; Dharmawardana PG, 2004, CURR MOL MED, V4, P855, DOI 10.2174/1566524043359674; Fay AP, 2014, CLIN CANCER RES, V20, P3361, DOI 10.1158/1078-0432.CCR-14-0690; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Henke RP, 2002, VIRCHOWS ARCH, V440, P604, DOI 10.1007/s004280100519; Hughson MD, 1998, CANCER GENET CYTOGEN, V106, P93, DOI 10.1016/S0165-4608(98)00068-5; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Moch H, 1998, J PATHOL, V184, P424; Motzer RJ, 2002, J CLIN ONCOL, V20, P2376, DOI 10.1200/JCO.2002.11.123; Nakajima M, 1999, CANCER, V85, P1894; Schmidt L, 1997, NAT GENET, V16, P68, DOI 10.1038/ng0597-68; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Schuller AG, 2015, CLIN CANC R IN PRESS; Sweeney P, 2002, J UROLOGY, V168, P51, DOI 10.1016/S0022-5347(05)64830-6; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Wadt KAW, 2012, FAM CANCER, V11, P535, DOI 10.1007/s10689-012-9542-6; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yap TA, 2011, CURR DRUG TARGETS, V12, P2045; Zhuang ZP, 1998, NAT GENET, V20, P66, DOI 10.1038/1727	30	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143468	10.1371/journal.pone.0143468	http://dx.doi.org/10.1371/journal.pone.0143468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636767	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800013
J	Zhang, C; Ge, RC; Zhang, JW; Chen, YJ; Wang, HZ; Wei, JH; Li, RF				Zhang, Chao; Ge, Rongchao; Zhang, Junwen; Chen, Yajuan; Wang, Hongzhi; Wei, Jianhua; Li, Ruifen			Identification and Expression Analysis of a Novel HbCIPK2-Interacting Ferredoxin from Halophyte H. brevisubulatum	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASE; PLANT FERREDOXIN; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ENHANCES TOLERANCE; SULFITE REDUCTASE; ELECTRON-TRANSFER; HEAT-STRESS; PHOSPHORYLATION; ACTIVATION	Ferredoxin is a small iron-sulfer protein involved in various one-eletron transfer pathways. Little is known about how ferredoxin is regulated to distribute electron under abiotic stress. Our previous study has showed that HbCIPK2 conferred salinity and drought tolerance. Thus, we hypothesized that HbCIPK2 could mediate the activities of interacting partners as a signal transducer. In this report, we identified a novel HbCIPK2-interacting ferredoxin (HbFd1) from halophyte Hordeum brevisubulatum by yeast two-hybrid screens, confirmed this interaction by BiFC in vivo and CoIP in vitro, and presented the expression pattern of HbFd1. HbFd1 was down-regulated under salinity and cold stress but up-regulated under PEG stress, its expression showed tissue-specific, mainly in shoot chloroplast, belonging to leaf-type subgroup. Moreover, HbCIPK2 could recruit HbFd1 to the nucleus for their interaction. The C-terminal segment in HbFd1 protein was involved in the interaction with HbCIPK2. These results provided insight into the connection between CBL-CIPK signaling network and Fd-dependent metabolic pathways.	[Zhang, Chao; Chen, Yajuan; Wang, Hongzhi; Wei, Jianhua; Li, Ruifen] Beijing Acad Agr & Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing Key Lab Agr Genet Resources & Biotechnol, Beijing, Peoples R China; [Ge, Rongchao] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China; [Zhang, Junwen] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100005, Peoples R China; [Zhang, Junwen] Peking Union Med Coll, Beijing 100005, Peoples R China	Beijing Academy of Agriculture & Forestry; Hebei Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wei, JH (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing Key Lab Agr Genet Resources & Biotechnol, Beijing, Peoples R China.	weijianhua@baafs.net.cn; liruifen@aliyun.com			National Natural Science Foundation of China [31271785]; National Transgenic Major Program of China [2014ZX0800917B]; Beijing Natural Science Foundation [5132010]; Beijing Academy of Agriculture and Forestry Sciences [KJCX20140202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Academy of Agriculture and Forestry Sciences	This work was supported by National Natural Science Foundation of China to RL (31271785), http://www.nsfc.gov.cn/, National Transgenic Major Program of China to JW (2014ZX0800917B), http://www.nmp.gov.cn/, Beijing Natural Science Foundation to RL (5132010), http://www.bjnsf.org/, Special Grant for Innovative Ability Improvement from Beijing Academy of Agriculture and Forestry Sciences to JW and RL (KJCX20140202), http://www.baafs.net.cn/ and Grant for Institute Innovation Team from Beijing Academy of Agriculture and Forestry Sciences to RL, http://www.baafs.net.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; Drerup MM, 2013, MOL PLANT, V6, P559, DOI 10.1093/mp/sst009; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Frohnecke N, 2015, FEBS LETT, V589, P31, DOI 10.1016/j.febslet.2014.11.020; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hirasawa M, 2009, MOL PLANT, V2, P407, DOI 10.1093/mp/ssn098; Kameda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021947; Li RF, 2012, PLANT CELL ENVIRON, V35, P1582, DOI 10.1111/j.1365-3040.2012.02511.x; Li RF, 2009, PROG NAT SCI-MATER, V19, P667, DOI 10.1016/j.pnsc.2008.06.030; Lin YH, 2015, NEW BIOTECHNOL, V32, P235, DOI 10.1016/j.nbt.2014.12.001; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Lin YH, 2010, PLANT SCI, V179, P450, DOI 10.1016/j.plantsci.2010.07.006; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Meena MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123640; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Peden EA, 2013, J BIOL CHEM, V288, P35192, DOI 10.1074/jbc.M113.483727; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Romina DC, 2011, PLANT MOL BIOL, V76, P535, DOI [10.1007/s11103-011-9786-9, DOI 10.1007/S11103-011-9786-9]; Saitoh T, 2006, J BIOL CHEM, V281, P10482, DOI 10.1074/jbc.M510530200; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	22	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144132	10.1371/journal.pone.0144132	http://dx.doi.org/10.1371/journal.pone.0144132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636581	Green Submitted, gold, Green Published			2022-12-26	WOS:000366143800046
J	Yassine, HN; Trenchevska, O; Ramrakhiani, A; Parekh, A; Koska, J; Walker, RW; Billheimer, D; Reaven, PD; Yen, FT; Nelson, RW; Goran, MI; Nedelkov, D				Yassine, Hussein N.; Trenchevska, Olgica; Ramrakhiani, Ambika; Parekh, Aarushi; Koska, Juraj; Walker, Ryan W.; Billheimer, Dean; Reaven, Peter D.; Yen, Frances T.; Nelson, Randall W.; Goran, Michael I.; Nedelkov, Dobrin			The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides	PLOS ONE			English	Article							APOC-III; RICH LIPOPROTEINS; INSULIN; GENE; CIII; LDL; CARBOHYDRATE; INHIBITION; MUTATIONS; KINETICS	Introduction Apolipoprotein C-III (apoC-III) regulates triglyceride (TG) metabolism. In plasma, apoC-III exists in non-sialylated (apoC-III0a without glycosylation and apoC-III0b with glycosylation), monosialylated (apoC-III1) or disialylated (apoC-III2) proteoforms. Our aim was to clarify the relationship between apoC-III sialylation proteoforms with fasting plasma TG concentrations. Methods In 204 non-diabetic adolescent participants, the relative abundance of apoC-III plasma proteoforms was measured using mass spectrometric immunoassay. Results Compared with the healthy weight subgroup (n = 16), the ratios of apoC-III0a, apoC-III0b, and apoC-III1 to apoC-III2 were significantly greater in overweight (n = 33) and obese participants (n = 155). These ratios were positively correlated with BMI z-scores and negatively correlated with measures of insulin sensitivity (Si). The relationship of apoC-III1 / apoC-III2 with Si persisted after adjusting for BMI (p = 0.02). Fasting TG was correlated with the ratio of apoC-III0a / apoC-III2 (r = 0.47, p<0.001), apoC-III0b / apoC-III2 (r = 0.41, p<0.001), apoC-III1 / apoC-III2 (r = 0.43, p<0.001). By examining apoC-III concentrations, the association of apoC-III proteoforms with TG was driven by apoC-III0a (r = 0.57, p<0.001), apoC-III0b (r = 0.56. p<0.001) and apoC-III1 (r = 0.67, p<0.001), but not apoC-III2 (r = 0.006, p = 0.9) concentrations, indicating that apoC-III relationship with plasma TG differed in apoC-III2 compared with the other proteoforms. Conclusion We conclude that apoC-III0a, apoC-III0b, and apoC-III1, but not apoC-III2 appear to be under metabolic control and associate with fasting plasma TG. Measurement of apoC-III proteoforms can offer insights into the biology of TG metabolism in obesity.	[Yassine, Hussein N.; Ramrakhiani, Ambika; Parekh, Aarushi] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA; [Trenchevska, Olgica; Nelson, Randall W.; Nedelkov, Dobrin] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Koska, Juraj; Reaven, Peter D.] Phoenix Vet Affairs Med Ctr, Dept Med, Phoenix, AZ USA; [Walker, Ryan W.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Goran, Michael I.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Billheimer, Dean] Univ Arizona, Biostat Consulting Lab, Tucson, AZ USA; [Yen, Frances T.] Univ Lorraine, URAFPA, INSERM, Vandoeuvre Les Nancy, France	University of Southern California; Arizona State University; Arizona State University-Tempe; University of Southern California; Icahn School of Medicine at Mount Sinai; University of Arizona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Yassine, HN (corresponding author), Univ So Calif, Dept Med, Los Angeles, CA 90089 USA.	hyassine@usc.edu	Yen, Frances T/G-9175-2014; Nedelkov, Dobrin/I-3603-2013	Yen, Frances T/0000-0001-8740-4304; 	National Institute of Heart, Lung and Blood [K23HL107389]; American Heart Association [12CRP11750017]; USC CTSI pilot [UL1TR000130]; National Institute of Diabetes And Digestive and Kidney Diseases [R01DK082542, R24DK090958]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL107389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082542, R24DK090958] Funding Source: NIH RePORTER	National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); USC CTSI pilot; National Institute of Diabetes And Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Yassine was supported by K23HL107389 from National Institute of Heart, Lung and Blood, 12CRP11750017 from the American Heart Association and USC CTSI pilot UL1TR000130. Mass spectrometry work was supported by Awards R01DK082542 and R24DK090958 from the National Institute of Diabetes And Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batal R, 2000, J LIPID RES, V41, P706; Bondarenko PV, 1999, J LIPID RES, V40, P543; BOSELLO O, 1985, ANN NUTR METAB, V29, P33, DOI 10.1159/000176951; BREWER HB, 1974, J BIOL CHEM, V249, P4975; Breyer ED, 1999, J LIPID RES, V40, P1875; Caron S, 2011, ARTERIOSCL THROM VAS, V31, P513, DOI 10.1161/ATVBAHA.110.220723; CATAPANO AL, 1987, CHEM PHYS LIPIDS, V45, P39, DOI 10.1016/0009-3084(87)90038-7; CHEN M, 1994, J LIPID RES, V35, P1918; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Cruz ML, 2002, DIABETES CARE, V25, P1631, DOI 10.2337/diacare.25.9.1631; FALKO JM, 1980, METABOLISM, V29, P654, DOI 10.1016/0026-0495(80)90110-9; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gaudet D, 2015, NEW ENGL J MED, V373, P438, DOI 10.1056/NEJMoa1400283; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harvey SB, 2009, J PROTEOME RES, V8, P603, DOI 10.1021/pr800751x; Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206; HOLDSWORTH G, 1982, J CLIN INVEST, V69, P932, DOI 10.1172/JCI110532; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; KASHYAP ML, 1981, J LIPID RES, V22, P800; Katrine T-BS, 2012, P NATL ACAD SCI USA, V109, P9893; Li WW, 1995, J CLIN INVEST, V96, P2601, DOI 10.1172/JCI118324; Lindbohm N, 1999, CLIN CHIM ACTA, V285, P69, DOI 10.1016/S0009-8981(99)00107-2; Mann CJ, 1997, J BIOL CHEM, V272, P31348, DOI 10.1074/jbc.272.50.31348; Marucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070159; Mauger JF, 2006, J LIPID RES, V47, P1212, DOI 10.1194/jlr.M500455-JLR200; Millar JS, 2001, ATHEROSCLEROSIS, V154, P1, DOI 10.1016/S0021-9150(00)00697-3; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Nelson RW, 2011, J AM SOC MASS SPECTR, V22, P960, DOI 10.1007/s13361-011-0094-z; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; ROGHANI A, 1988, J BIOL CHEM, V263, P17925; Savinova OV, 2015, ATHEROSCLEROSIS, V240, P520, DOI 10.1016/j.atherosclerosis.2015.04.793; Savinova OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104833; Trenchevska O, 2015, METHODS; VAITH P, 1978, BIOCHIM BIOPHYS ACTA, V541, P234, DOI 10.1016/0304-4165(78)90396-3; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; WINDLER E, 1985, J LIPID RES, V26, P556; WITZTUM JL, 1978, DIABETES, V27, P1215, DOI 10.2337/diabetes.27.12.1215; Yassine HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115320; ZANNIS VI, 1985, ADV HUM GENET, V14, P125; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	44	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144138	10.1371/journal.pone.0144138	http://dx.doi.org/10.1371/journal.pone.0144138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633899	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000062
J	Schneider, JS; Seyfried, TN; Choi, HS; Kidd, SK				Schneider, Jay S.; Seyfried, Thomas N.; Choi, Hyo-S.; Kidd, Sarah K.			Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; MPTP; MICE; BRAIN; RECOVERY; SYSTEM; ACID; SYNAPTOSOMES; PRIMATES; PROMOTES	Background Preclinical and clinical studies have previously shown that systemic administration of GM1 ganglioside has neuroprotective and neurorestorative properties in Parkinson's disease (PD) models and in PD patients. However, the clinical development of GM1 for PD has been hampered by its animal origin (GM1 used in previous studies was extracted from bovine brains), limited bioavailability, and limited blood brain barrier penetrance following systemic administration. Objective To assess an alternative therapeutic approach to systemic administration of brain-derived GM1 to enhance GM1 levels in the brain via enzymatic conversion of polysialogangliosides into GM1 and to assess the neuroprotective potential of this approach. Methods We used sialidase from Vibrio cholerae (VCS) to convert GD1a, GD1b and GT1b gangliosides to GM1. VCS was infused by osmotic minipump into the dorsal third ventricle in mice over a 4-week period. After the first week of infusion, animals received MPTP injections (20 mg/kg, s.c., twice daily, 4 hours apart, for 5 consecutive days) and were euthanized 2 weeks after the last injection. Results VCS infusion resulted in the expected change in ganglioside expression with a significant increase in GM1 levels. VCS-treated animals showed significant sparing of striatal dopamine (DA) levels and substantia nigra DA neurons following MPTP administration, with the extent of sparing of DA neurons similar to that achieved with systemic GM1 administration. Conclusion The results suggest that enzymatic conversion of polysialogangliosides to GM1 may be a viable treatment strategy for increasing GM1 levels in the brain and exerting a neuroprotective effect on the damaged nigrostriatal DA system.	[Schneider, Jay S.; Kidd, Sarah K.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Seyfried, Thomas N.; Choi, Hyo-S.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Jefferson University; Boston College	Schneider, JS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jay.schneider@jefferson.edu		Seyfried, Thomas/0000-0003-1491-3989	Michael J. Fox Foundation for Parkinson's Research; Michael J. Fox Foundation	Michael J. Fox Foundation for Parkinson's Research; Michael J. Fox Foundation	Funding was provided to JSS by the Michael J. Fox Foundation for Parkinson's Research (https://www.michaeljfox.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Michael J. Fox Foundation.	Anderson DW, 2006, EUR J NEUROSCI, V24, P3174, DOI 10.1111/j.1460-9568.2006.05192.x; Arthur JR, 2013, NEUROCHEM RES, V38, P866, DOI 10.1007/s11064-013-0992-5; CHIBA K, 1985, BIOCHEM BIOPH RES CO, V128, P1228, DOI 10.1016/0006-291X(85)91071-X; DATE I, 1991, J NEUROSCI RES, V28, P525, DOI 10.1002/jnr.490280409; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Denny CA, 2006, J NEUROSCI RES, V83, P1028, DOI 10.1002/jnr.20798; Dhanushkodi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029285; GRIGORIADIS DE, 1989, J NEUROSCI, V9, P2664; Hadaczek P, 2015, EXP NEUROL, V263, P177, DOI 10.1016/j.expneurol.2014.10.010; HADJICONSTANTINOU M, 1986, NEUROPHARMACOLOGY, V25, P1075; Hauser EC, 2004, BIOCHEM GENET, V42, P241, DOI 10.1023/B:BIGI.0000034429.55418.71; HERRERO MT, 1993, NEUROSCIENCE, V56, P965, DOI 10.1016/0306-4522(93)90142-3; JONSSON G, 1984, J NEUROSCI RES, V12, P459, DOI 10.1002/jnr.490120229; Kasperzyk JL, 2004, J NEUROCHEM, V89, P645, DOI 10.1046/j.1471-4159.2004.02381.x; Kidd SK, 2011, NEUROSCIENCE, V194, P189, DOI 10.1016/j.neuroscience.2011.08.010; Lau YS, 2003, METH MOLEC MED, V79, P465; LEW R, 1991, BRAIN RES, V539, P239, DOI 10.1016/0006-8993(91)91627-D; Malisan F, 2005, IUBMB LIFE, V57, P477, DOI 10.1080/15216540500167179; ODERFELDNOWAK B, 1984, J NEUROSCI RES, V12, P409, DOI 10.1002/jnr.490120225; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PILEBLAD E, 1985, NEUROPHARMACOLOGY, V24, P689, DOI 10.1016/0028-3908(85)90114-5; Pope-Coleman A, 1998, RESTOR NEUROL NEUROS, V12, P255; Pope-Coleman K, 2000, SYNAPSE, V36, P120; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; Schneider JS, 1998, NEUROLOGY, V50, P1630, DOI 10.1212/WNL.50.6.1630; SCHNEIDER JS, 1989, EXP NEUROL, V105, P177, DOI 10.1016/0014-4886(89)90117-9; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; SCHNEIDER JS, 1995, J NEUROSCI RES, V42, P117, DOI 10.1002/jnr.490420113; Schneider JS, 2015, J NEUROLOGICAL SCI; SEYFRIED TN, 1978, J NEUROCHEM, V31, P21, DOI 10.1111/j.1471-4159.1978.tb12428.x; TILSON HA, 1988, J NEUROSCI RES, V19, P88, DOI 10.1002/jnr.490190112; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Yang LJS, 2006, P NATL ACAD SCI USA, V103, P11057, DOI 10.1073/pnas.0604613103; ZALESKA MM, 1987, NEUROSCI LETT, V82, P107, DOI 10.1016/0304-3940(87)90179-0	35	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143351	10.1371/journal.pone.0143351	http://dx.doi.org/10.1371/journal.pone.0143351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629687	gold, Green Submitted, Green Published			2022-12-26	WOS:000365926300042
J	Sliwowski, R; Jadczak, L; Hejna, R; Wieczorek, A				Sliwowski, Robert; Jadczak, Lukasz; Hejna, Rafal; Wieczorek, Andrzej			The Effects of Individualized Resistance Strength Programs on Knee Muscular Imbalances in Junior Elite Soccer Players	PLOS ONE			English	Article							ISOKINETIC STRENGTH; HAMSTRING INJURY; TRAINING-PROGRAM; YOUTH SOCCER; PREVENTION; QUADRICEPS; ASYMMETRY; CHILDREN; STRAINS; ABILITY	The purpose of this study was to investigate the effects of a resistance training program on the muscular strength of soccer players' knees that initially presented unilateral and bilateral differences. For this study, a team of 24 male well-trained junior soccer players was divided into two strength program training groups: a Resistance Training Control Group (RTCG) composed of 10 players that did not have muscular imbalances and a Resistance Training Experimental Group (RTEG) composed of 14 players that had muscular imbalances. All players followed a resistance training program for six weeks, two times per week, during the transition period. The program of individualized strength training consisted of two parts. The first part, which was identical in terms of the choice of training loads, was intended for both training groups and contained two series of exercises including upper and lower body exercises. The second part of the program was intended only for RTEG and consisted of two additional series for the groups of muscles that had identified unilateral and bilateral differences. The applied program showed various directions in the isokinetic profile of changes. In the case of RTCG, the adaptations related mainly to the quadriceps muscle (the peak torque (PT) change for the dominant leg was statistically significant (p < 0.05)). There were statistically significant changes in RTEG (p < 0.05) related to PT for the hamstrings in both legs, which in turn resulted in an increase in the conventional hamstring/quadriceps ratio (H/Q). It is interesting that the statistically significant (p < 0.05) changes were noted only for the dominant leg. No statistically significant changes in bilateral differences (BD) were noted in either group. These results indicate that individualized resistance training programs could provide additional benefits to traditional strength training protocols to improve muscular imbalances in post-adolescent soccer players.	[Sliwowski, Robert; Jadczak, Lukasz; Wieczorek, Andrzej] Univ Sch Phys Educ Poznan, Dept Team Sports Games, Poznan, Poland; [Hejna, Rafal] Rehasport Clin FIFA Med Ctr Excellence, Dept Physiotherapy, Poznan, Poland		Sliwowski, R (corresponding author), Univ Sch Phys Educ Poznan, Dept Team Sports Games, Poznan, Poland.	robertsliwowski@wp.pl		Sliwowski, Robert/0000-0002-6689-9536				Amiri-Khorasani M, 2011, J STRENGTH COND RES, V25, P1647, DOI 10.1519/JSC.0b013e3181db9f41; Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Bangsbo J., 1994, FITNESS TRAINING FOO; Behringer M, 2010, PEDIATRICS, V126, pE1199, DOI 10.1542/peds.2010-0445; Brito J, 2010, ISOKINET EXERC SCI, V18, P211, DOI 10.3233/IES-2010-0386; Christou M, 2006, J STRENGTH COND RES, V20, P783, DOI 10.1519/00124278-200611000-00010; Clark R, 2005, PHYS THER SPORT, V6, P67, DOI 10.1016/j.ptsp.2005.02.003; Cometti G, 2001, INT J SPORTS MED, V22, P45, DOI 10.1055/s-2001-11331; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; Daneshjoo A, 2013, BIOL SPORT, V30, P281, DOI [10.5604/20831862.1077554, 10.5604/20881862.1077554]; Daneshjoo A, 2013, J HUM KINET, V36, P45, DOI [10.2478/hukin-2013-0005, 10.2478/hukin-2013-0074]; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051568; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050979; Dauty M, 2003, ISOKINET EXERC SCI, V11, P139; Ebben WP, 2009, INT J SPORT PHYSIOL, V4, P84, DOI 10.1123/ijspp.4.1.84; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Faigenbaum AD, 2013, PEDIATR EXERC SCI, V25, P591, DOI 10.1123/pes.25.4.591; Fousekis K, 2011, BRIT J SPORT MED, V45, P709, DOI 10.1136/bjsm.2010.077560; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Gioftsidou A., 2008, SPORT SCI HLTH, V2, P101, DOI DOI 10.1007/S11332-008-0047-5; Golik-Peric D, 2011, J HUM KINET, V30, P29, DOI 10.2478/v10078-011-0070-5; Grygorowicz M, 2010, BIOL SPORT, V27, P47, DOI 10.5604/20831862.907793; Holcomb WR, 2007, J STRENGTH COND RES, V21, P41; Houweling TAW, 2009, ISOKINET EXERC SCI, V17, P213, DOI 10.3233/IES-2009-0356; Iga J, 2009, SCAND J MED SCI SPOR, V19, P714, DOI 10.1111/j.1600-0838.2008.00822.x; Kotzamanidis C, 2005, J STRENGTH COND RES, V19, P369; Lehance C, 2009, SCAND J MED SCI SPOR, V19, P243, DOI 10.1111/j.1600-0838.2008.00780.x; MacKay M, 2004, J SCI MED SPORT, V7, P58, DOI 10.1016/S1440-2440(04)80045-8; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Small K, 2009, J STRENGTH COND RES, V23, P1077, DOI 10.1519/JSC.0b013e318194df5c; Taskin H, 2008, J STRENGTH COND RES, V22, P1481, DOI 10.1519/JSC.0b013e318181fd90; Tourny-Chollet C, 2002, ISOKINET EXERC SCI, V10, P183, DOI 10.3233/IES-2002-0102; Wong PL, 2010, J STRENGTH COND RES, V24, P653, DOI 10.1519/JSC.0b013e3181aa36a2	36	16	16	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144021	10.1371/journal.pone.0144021	http://dx.doi.org/10.1371/journal.pone.0144021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630271	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300137
J	de Rosa, M; Barbiroli, A; Giorgetti, S; Mangione, PP; Bolognesi, M; Ricagno, S				de Rosa, Matteo; Barbiroli, Alberto; Giorgetti, Sofia; Mangione, Patrizia P.; Bolognesi, Martino; Ricagno, Stefano			Decoding the Structural Bases of D76N beta 2-Microglobulin High Amyloidogenicity through Crystallography and Asn-Scan Mutagenesis	PLOS ONE			English	Article							SYSTEMIC AMYLOIDOSIS; STABILITY; PROTEINS; DYNAMICS; ROLES; MODEL	D76N is the first natural variant of human beta-2 microglobulin (beta 2m) so far identified. Contrary to the wt protein, this mutant readily forms amyloid fibres in physiological conditions, leading to a systemic and severe amyloidosis. Although the Asp76Asn mutant has been extensively characterized, the molecular bases of its instability and aggregation propensity remain elusive. In this work all Asp residues of human beta 2m were individually substituted to Asn; D-to-N mutants (D34N, D38N, D53N, D59N, D96N and D98N) were characterised in terms of thermodynamic stability and aggregation propensity. Moreover, crystal structures of the D38N, D53N, D59N and D98N variants were solved at high-resolution (1.24-1.70 angstrom). Despite showing some significant variations in their thermal stabilities, none showed the dramatic drop in melting temperature (relative to the wt protein) as observed for the pathogenic mutant. Consistently, none of the variants here described displayed any increase in aggregation propensity under the experimental conditions tested. The crystal structures confirmed that D-to-N mutations are generally well tolerated, and lead only to minor reorganization of the side chains in close proximity of the mutated residue. D38N is the only exception, where backbone readjustments and a redistribution of the surface electrostatic charges are observed. Overall, our results suggest that neither removing negative charges at sites 34, 38, 53, 59, 96 and 98, nor the difference in beta 2m pI, are the cause of the aggressive phenotype observed in D76N. We propose that the dramatic effects of the D76N natural mutation must be linked to effects related to the crucial location of this residue within the beta 2m fold.	[de Rosa, Matteo; Bolognesi, Martino; Ricagno, Stefano] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Barbiroli, Alberto] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, I-20133 Milan, Italy; [Giorgetti, Sofia; Mangione, Patrizia P.] Univ Pavia, Ist Biochim A Castellani, Dipartimento Med Mol, I-27100 Pavia, Italy; [Bolognesi, Martino] Univ Milan, CIMAINA, I-20133 Milan, Italy; [Bolognesi, Martino] Univ Milan, CNR, Ist Biofis, I-20133 Milan, Italy	University of Milan; University of Milan; University of Pavia; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Ricagno, S (corresponding author), Univ Milan, Dipartimento Biosci, Via Celoria 26, I-20133 Milan, Italy.	stefano.ricagno@unimi.it	de Rosa, Matteo/AAG-7615-2021; Bolognesi, Martino/B-7924-2017; Ricagno, Stefano/AAH-9763-2020; Ricagno, Stefano/G-1456-2015; de Rosa, Matteo/I-3214-2018; Giorgetti, Sofia/AAD-4341-2019	de Rosa, Matteo/0000-0002-8634-5426; Bolognesi, Martino/0000-0002-9253-5170; Ricagno, Stefano/0000-0001-6678-5873; Ricagno, Stefano/0000-0001-6678-5873; de Rosa, Matteo/0000-0002-8634-5426; Giorgetti, Sofia/0000-0001-9438-6511; BARBIROLI, ALBERTO GIUSEPPE/0000-0003-1678-5431; Mangione, Palma/0000-0003-0260-1400	Italian Ministry of University and Research [FIRB RBFR109EOS]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This study was funded by Italian Ministry of University and Research: Project FIRB RBFR109EOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Halabelian L, 2014, J BIOL CHEM, V289, P3318, DOI 10.1074/jbc.M113.524157; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; ODANI H, 1990, BIOCHEM BIOPH RES CO, V168, P1223, DOI 10.1016/0006-291X(90)91159-P; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Raimondi S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-159; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Santambrogio C, 2010, PROTEIN SCI, V19, P1386, DOI 10.1002/pro.419; Schneider B, 2014, ACTA CRYSTALLOGR D, V70, P2413, DOI 10.1107/S1399004714014631; Stoppini M, 2015, J BIOL CHEM, V290, P9951, DOI 10.1074/jbc.R115.639799; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103	22	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144061	10.1371/journal.pone.0144061	http://dx.doi.org/10.1371/journal.pone.0144061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625273	Green Published, gold			2022-12-26	WOS:000365891600089
J	Di Maso, V; Mediavilla, MG; Vascotto, C; Lupo, F; Baccarani, U; Avellini, C; Tell, G; Tiribelli, C; Croce, LS				Di Maso, Vittorio; Mediavilla, Maria Gabriela; Vascotto, Carlo; Lupo, Francesco; Baccarani, Umberto; Avellini, Claudio; Tell, Gianluca; Tiribelli, Claudio; Croce, Lory Saveria			Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis	PLOS ONE			English	Article							BASE EXCISION-REPAIR; HEPATOCELLULAR-CARCINOMA; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; REACTIVE OXYGEN; FACTOR-I; DNA-DAMAGE; LIVER; EXPRESSION; PATHOGENESIS; ACTIVATION	Objective Human Hepatocellular Carcinoma (HCC) is the fifth most frequent neoplasm worldwide and the most serious complication of long-standing chronic liver diseases (CLD). Its development is associated with chronic inflammation and sustained oxidative stress. Deregulation of apurinic apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1), a master regulator of cellular response to oxidative stress, has been associated with poor prognosis in several cancers including HCC. Design In the present study we investigated the APE1/Ref-1 mRNA levels in cirrhotic and HCC tissues obtained during HCC resection. The possible protective role of APE1/Ref-1 against oxidative stress and apoptosis was evaluated in vitro in immortalized human hepatocytes (IHH) over-expressing APE1/Ref-1. Results APE1/Ref-1 was up-regulated in HCC, regulation occurring at the transcriptional level. APE1/Ref-1 mRNA content increased with the progression of liver disease with the transcriptional up-regulation present in cirrhosis significantly increased in HCC. The up-regulation was higher in the less differentiated cancers. In vitro, over-expression of APE1/Ref-1 in normal hepatocytes conferred cell protection against oxidative stress and it was associated with BAX inhibition and escape from apoptosis. Conclusion APE1/Ref-1 is up-regulated in HCC and this over-expression correlates with cancer aggressiveness. The up-regulation occurs at the transcriptional level and it is present in the earliest phases of hepatocarcinogenesis. The APE-1/Ref-1 over-expression is associated with hepatocyte survival and inhibits BAX activation and apoptosis. These data suggest a possible role of APE1/Ref-1 over-expression both in hepatocyte survival and HCC development calling attention to this molecule as a promising marker for HCC diagnosis and treatment.	[Di Maso, Vittorio; Mediavilla, Maria Gabriela; Tell, Gianluca; Tiribelli, Claudio; Croce, Lory Saveria] FIF, Area Sci Pk Basovizza, Trieste, Italy; [Vascotto, Carlo; Baccarani, Umberto; Avellini, Claudio; Tell, Gianluca] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Lupo, Francesco] Univ Turin, Chirurg Gen Ctr Trapianto Fegato 2, Turin, Italy; [Tiribelli, Claudio; Croce, Lory Saveria] Univ Trieste, Dipartimento Sci Med, Trieste, Italy	University of Udine; University of Turin; University of Trieste	Croce, LS (corresponding author), FIF, Area Sci Pk Basovizza, Trieste, Italy.	lcroce@units.it	croce', lory saveria l/E-2565-2011; Tiribelli, Claudio/A-4716-2014	croce', lory saveria l/0000-0001-9890-7011; Tell, Gianluca/0000-0001-8845-6448; vascotto, carlo/0000-0003-4431-029X; Tiribelli, Claudio/0000-0001-6596-7595	AIRC (Associazione Italiana ricerca per ilcancro) from FVG; European Association for the Study of the Liver (EASL); Fondazione Italiana Fegato (Area Science Park Basovizza. Trieste, Italia, FIF)	AIRC (Associazione Italiana ricerca per ilcancro) from FVG(Fondazione AIRC per la ricerca sul cancro); European Association for the Study of the Liver (EASL); Fondazione Italiana Fegato (Area Science Park Basovizza. Trieste, Italia, FIF)	AIRC (Associazione Italiana ricerca per ilcancro, regional grant from FVG to CT and GT) Part of this work was granted by a Sheila Sherlock Short Term Fellowship of the European Association for the Study of the Liver (EASL). Part of the work was supported by an intramural research grant by Fondazione Italiana Fegato (Area Science Park Basovizza. Trieste, Italia, FIF).	Avellini C, 2010, TRANSPL P, V42, P1204, DOI 10.1016/j.transproceed.2010.03.045; Bartsch H, 2004, CANCER DETECT PREV, V28, P385, DOI 10.1016/j.cdp.2004.07.004; Bhattacharyya A, 2009, GASTROENTEROLOGY, V136, P2258, DOI 10.1053/j.gastro.2009.02.014; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Cesaratto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070909; Child CG, 1964, LIVER PORTAL HYPERTE, P50; Cun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055313; Da Cruz Sandrine, 2008, V432, P101, DOI 10.1007/978-1-59745-028-7_7; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Fabregat I, 2007, LIVER INT, V27, P155, DOI 10.1111/j.1478-3231.2006.01409.x; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Ferber MJ, 2003, ONCOGENE, V22, P3813, DOI 10.1038/sj.onc.1206528; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Jackson EB, 2005, NUCLEIC ACIDS RES, V33, P3303, DOI 10.1093/nar/gki641; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Kakolyris S, 1998, BRIT J CANCER, V77, P1169, DOI 10.1038/bjc.1998.194; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Kawanishi S, 2006, ANTIOXID REDOX SIGN, V8, P1047, DOI 10.1089/ars.2006.8.1047; Kelley MR, 2001, CLIN CANCER RES, V7, P824; Kim MH, 2013, J CLIN INVEST, V123, P3211, DOI 10.1172/JCI65521; Kitada T, 2001, J HEPATOL, V35, P613, DOI 10.1016/S0168-8278(01)00171-4; Kojiro M, 2005, BEST PRACT RES CL GA, V19, P39, DOI 10.1016/j.bpg.2004.10.007; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045; Li MX, 2008, FREE RADICAL BIO MED, V45, P592, DOI 10.1016/j.freeradbiomed.2008.05.007; Lirussi L, 2012, MOL BIOL CELL, V23, P4079, DOI 10.1091/mbc.E12-04-0299; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Manghisi G, 1998, HEPATOLOGY, V28, P751; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Mitra S, 2007, DNA REPAIR, V6, P461, DOI 10.1016/j.dnarep.2006.10.010; Nam SW, 2005, HEPATOLOGY, V42, P809, DOI 10.1002/hep.20878; Nguyen TH, 2005, J HEPATOL, V43, P1031, DOI 10.1016/j.jhep.2005.05.036; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prieto-Alamo MJ, 1999, CARCINOGENESIS, V20, P415, DOI 10.1093/carcin/20.3.415; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Puglisi F, 2002, ONCOL REP, V9, P11; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Schutz-Geschwender A, 2004, QUANTITATIVE 2 COLOR; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Song JM, 2013, J CLIN BIOCHEM NUTR, V52, P112, DOI 10.3164/jcbn.12-95; Sumiyoshi S, 2013, WORLD J HEPATOL, V5, P206, DOI 10.4254/wjh.v5.i4.206; Takeba Y, 2012, CANCER CHEMOTH PHARM, V69, P1545, DOI 10.1007/s00280-012-1862-6; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2013, J HEPATOL, V58, P365, DOI 10.1016/j.jhep.2012.09.018; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Tichopad A, 2004, MOL CELL PROBE, V18, P45, DOI 10.1016/j.mcp.2003.09.001; Unnikrishnan A, 2009, FREE RADICAL BIO MED, V46, P1488, DOI 10.1016/j.freeradbiomed.2009.02.021; Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Vierck Janet L., 2000, Methods in Cell Science, V22, P313, DOI 10.1023/A:1017581302281; Wu HH, 2010, ONCOGENE, V29, P4330, DOI 10.1038/onc.2010.178; Xiong JJ, 2008, BIOSCI BIOTECH BIOCH, V72, P3206, DOI 10.1271/bbb.80415; Yang S, 2005, MOL CANCER THER, V4, P1923, DOI 10.1158/1535-7163.MCT-05-0229; Yang S, 2007, CARCINOGENESIS, V28, P2382, DOI 10.1093/carcin/bgm128	60	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143289	10.1371/journal.pone.0143289	http://dx.doi.org/10.1371/journal.pone.0143289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624999	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600023
J	Field, H; Jordan, D; Edson, D; Morris, S; Melville, D; Parry-Jones, K; Broos, A; Divljan, A; McMichael, L; Davis, R; Kung, N; Kirkland, P; Smith, C				Field, Hume; Jordan, David; Edson, Daniel; Morris, Stephen; Melville, Debra; Parry-Jones, Kerryn; Broos, Alice; Divljan, Anja; McMichael, Lee; Davis, Rodney; Kung, Nina; Kirkland, Peter; Smith, Craig			Spatiotemporal Aspects of Hendra Virus Infection in Pteropid Bats (Flying-Foxes) in Eastern Australia	PLOS ONE			English	Article							MORBILLIVIRUS PNEUMONIA; HORSES; TRANSMISSION; PREVALENCE; MOVEMENTS; OUTBREAK; DISEASE; HUMANS	Hendra virus (HeV) causes highly lethal disease in horses and humans in the eastern Australian states of Queensland (QLD) and New South Wales (NSW), with multiple equine cases now reported on an annual basis. Infection and excretion dynamics in pteropid bats (flying-foxes), the recognised natural reservoir, are incompletely understood. We sought to identify key spatial and temporal factors associated with excretion in flying-foxes over a 2300 km latitudinal gradient from northern QLD to southern NSW which encompassed all known equine case locations. The aim was to strengthen knowledge of Hendra virus ecology in flying-foxes to improve spillover risk prediction and exposure risk mitigation strategies, and thus better protect horses and humans. Monthly pooled urine samples were collected from under roosting flying-foxes over a three-year period and screened for HeV RNA by quantitative RT-PCR. A generalised linear model was employed to investigate spatiotemporal associations with HeV detection in 13,968 samples from 27 roosts. There was a non-linear relationship between mean HeV excretion prevalence and five latitudinal regions, with excretion moderate in northern and central QLD, highest in southern QLD/northern NSW, moderate in central NSW, and negligible in southern NSW. Highest HeV positivity occurred where black or spectacled flying-foxes were present; nil or very low positivity rates occurred in exclusive grey-headed flying-fox roosts. Similarly, little red flying-foxes are evidently not a significant source of virus, as their periodic extreme increase in numbers at some roosts was not associated with any concurrent increase in HeV detection. There was a consistent, strong winter seasonality to excretion in the southern QLD/northern NSW and central NSW regions. This new information allows risk management strategies to be refined and targeted, mindful of the potential for spatial risk profiles to shift over time with changes in flying-fox species distribution.	[Field, Hume; Edson, Daniel; Melville, Debra; Broos, Alice; McMichael, Lee; Kung, Nina; Smith, Craig] Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Jordan, David; Morris, Stephen] Wollongbar Primary Ind Inst, Dept Primary Ind, Wollongbar, NSW, Australia; [Parry-Jones, Kerryn; Divljan, Anja] Univ Sydney, Sch Biol Sci, Inst Wildlife Res, Sydney, NSW 2006, Australia; [Davis, Rodney; Kirkland, Peter] Elizabeth Macarthur Agr Inst, Dept Primary Ind, Menangle, NSW, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Edson, Daniel] Dept Agr, Canberra, ACT, Australia; [Divljan, Anja] Australian Museum, Sydney, NSW 2000, Australia; [McMichael, Lee] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Kung, Nina] Biosecur Queensland, Dept Agr & Fisheries, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; NSW Department of Primary Industries; University of Sydney; EcoHealth Alliance; Australian Museum; University of Queensland; Queensland Department of Agriculture & Fisheries	Field, H (corresponding author), Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Brisbane, Qld, Australia.	hume.field@ecohealthalliance.org; david.jordan@dpi.nsw.gov.au	Kung, Nina Y/H-1260-2012; Kirkland, Peter/AAC-6731-2019; Jordan, David/P-7281-2019; McMichael, Lee UQ/C-7948-2018; Morris, Stephen G/E-8680-2013	McMichael, Lee UQ/0000-0002-7675-4859; Morris, Stephen G/0000-0003-2551-9717; Broos, Alice/0000-0001-7593-1000	State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; Queensland Department of Agriculture and Fisheries; NSW Department of Primary Industries	State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; Queensland Department of Agriculture and Fisheries; NSW Department of Primary Industries	This research was funded by the State of Queensland (http://www.qld.gov.au), the State of New South Wales (https://www.nsw.gov.au) and the Commonwealth of Australia (http://www.australia.gov.au) under the National Hendra Virus Research Program. HF was core-funded by the Queensland Department of Agriculture and Fisheries; PK and DJ were core-funded by the NSW Department of Primary Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldock F. C., 1996, Singapore Veterinary Journal, V20, P57; Ball MC, 2014, AUST VET J, V92, P213, DOI 10.1111/avj.12170; Biosecurity Queensland, BIOS QUEENSL WHAT IS; Breed A, 2011, PLOS ONE, V6; Breed AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061316; Breed AC, 2010, EMERG INFECT DIS, V16, P1997, DOI 10.3201/eid1612.100879; Butler DG, 2018, ASREML R REFERENCE M; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Churchill S, 2008, AUSTR BATS, V2nd; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140670; Edson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125881; Epstein JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067584; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field HE, 2000, AUST VET J, V78, P279, DOI 10.1111/j.1751-0813.2000.tb11758.x; Field HE, THESIS; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, CURR OPIN VIROL, V1, P658, DOI 10.1016/j.coviro.2011.10.025; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Goldspink LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128835; Hall L, 2009, WILD AUSTR GUIDE BAT; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K., 1996, Communicable Diseases Intelligence, V20, P476; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hasselquist Nilsson, 2009, MATERNAL TRANSFER AN; Hawley Altizer, 2011, DIS ECOLOGY MEETS EC; Hooper PT, 1997, VET PATHOL, V34, P312, DOI 10.1177/030098589703400407; Hooper PT, 1996, AUST VET J, V74, P244, DOI 10.1111/j.1751-0813.1996.tb15414.x; Mahalingam S, 2012, LANCET, V12; McCormack JG, 1996, CLIN INFECT DIS, V23, P273; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; PARRYJONES KA, 1992, WILDLIFE RES, V19, P331, DOI 10.1071/WR9920331; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Scanlan JC, 2015, ECOHEALTH, V12, P121, DOI 10.1007/s10393-014-0920-4; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Smith CS, 2014, PLOS ONE, V9, P1; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Wang H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003831; Young P., 1997, RECENT ADV MICROBIOL; Zoetis, ZOET VACC BOOSTS FIG	50	50	50	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144055	10.1371/journal.pone.0144055	http://dx.doi.org/10.1371/journal.pone.0144055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625128	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600087
J	Mattsson, A; Karrman, A; Pinto, R; Brunstrom, B				Mattsson, Anna; Karrman, Anna; Pinto, Rui; Brunstrom, Bjorn			Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid ( PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors	PLOS ONE			English	Article							PPAR-ALPHA AGONIST; PERFLUORINATED COMPOUNDS; ALLANTOIC FLUID; PERFLUOROALKYL ACIDS; DEVELOPMENTAL CARDIOTOXICITY; SERUM CONCENTRATIONS; COMMUNITY EXPOSURE; TEMPORAL TRENDS; GENE-EXPRESSION; AMINO-COMPOUNDS	Untargeted metabolic profiling of body fluids in experimental animals and humans exposed to chemicals may reveal early signs of toxicity and indicate toxicity pathways. Avian embryos develop separately from their mothers, which gives unique possibilities to study effects of chemicals during embryo development with minimal confounding factors from the mother. In this study we explored blood plasma and allantoic fluid from chicken embryos as matrices for revealing metabolic changes caused by exposure to chemicals during embryonic development. Embryos were exposed via egg injection on day 7 to the environmental pollutant perfluorooctanoic acid (PFOA), and effects on the metabolic profile on day 12 were compared with those caused by GW7647 and rosiglitazone, which are selective agonists to peroxisome-proliferator activated receptor a (PPAR alpha) and PPAR gamma, respectively. Analysis of the metabolite concentrations from allantoic fluid by Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) showed clear separation between the embryos exposed to GW7647, rosiglitazone, and vehicle control, respectively. In blood plasma only GW7647 caused a significant effect on the metabolic profile. PFOA induced embryo mortality and increased relative liver weight at the highest dose. Sublethal doses of PFOA did not significantly affect the metabolic profile in either matrix, although single metabolites appeared to be altered. Neonatal mortality by PFOA in the mouse has been suggested to be mediated via activation of PPAR alpha. However, we found no similarity in the metabolite profile of chicken embryos exposed to PFOA with those of embryos exposed to PPAR agonists. This indicates that PFOA does not activate PPAR pathways in our model at concentrations in eggs and embryos well above those found in wild birds. The present study suggests that allantoic fluid and plasma from chicken embryos are useful and complementary matrices for exploring effects on the metabolic profile resulting from chemical exposure during embryonic development.	[Mattsson, Anna; Brunstrom, Bjorn] Uppsala Univ, Dept Environm Toxicol, Evolutionary Biol Ctr, Uppsala, Sweden; [Karrman, Anna] Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Pinto, Rui] Umea Univ, Chem Dept KBC, Computat Life Sci Cluster CLiC, Umea, Sweden	Uppsala University; Orebro University; Umea University	Mattsson, A (corresponding author), Uppsala Univ, Dept Environm Toxicol, Evolutionary Biol Ctr, Uppsala, Sweden.	Anna.Mattsson@ebc.uu.se		Mattsson, Anna/0000-0002-5328-6255	Swedish Research Council Formas [216-2012-899]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This research was funded by a grant to BB from the Swedish Research Council Formas, grant number: 216-2012-899, http://www.formas.se/en/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2007, TOXICOL SCI, V98, P571, DOI 10.1093/toxsci/kfm110; Albrecht PP, 2013, TOXICOL SCI, V131, P568, DOI 10.1093/toxsci/kfs318; Andersen ME, 2008, TOXICOL SCI, V102, P3, DOI 10.1093/toxsci/kfm270; Arukwe A, 2013, AQUAT TOXICOL, V130, P219, DOI 10.1016/j.aquatox.2012.12.026; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bouhifd M, 2013, J APPL TOXICOL, V33, P1365, DOI 10.1002/jat.2874; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Chue J, 2011, FEBS J, V278, P1027, DOI 10.1111/j.1742-4658.2011.08032.x; Emmett EA, 2006, J OCCUP ENVIRON MED, V48, P771, DOI 10.1097/01.jom.0000233380.13087.37; Emmett EA, 2006, J OCCUP ENVIRON MED, V48, P759, DOI 10.1097/01.jom.0000232486.07658.74; Feng Y, 2007, APPL MAGN RESON, V32, P257, DOI 10.1007/s00723-007-0027-y; Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163; Gebbink WA, 2012, ENVIRON POLLUT, V162, P40, DOI 10.1016/j.envpol.2011.10.011; Geiger SD, 2014, CHEMOSPHERE, V98, P78, DOI 10.1016/j.chemosphere.2013.10.005; GILL TS, 1994, GEN COMP ENDOCR, V96, P255, DOI 10.1006/gcen.1994.1180; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; Hohlweg A, 1999, GEN COMP ENDOCR, V114, P378, DOI 10.1006/gcen.1999.7274; Holmstrom KE, 2010, ENVIRON SCI TECHNOL, V44, P4083, DOI 10.1021/es100028f; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jiang QX, 2013, J TOXICOL ENV HEAL A, V76, P635, DOI 10.1080/15287394.2013.789415; Jiang QX, 2012, TOXICOLOGY, V293, P97, DOI 10.1016/j.tox.2012.01.005; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Karrman A, 2006, CHEMOSPHERE, V64, P1582, DOI 10.1016/j.chemosphere.2005.11.040; Kato K, 2014, ENVIRON SCI TECHNOL, V48, P9600, DOI 10.1021/es501811k; Kennedy GL, 2004, CRIT REV TOXICOL, V34, P351, DOI 10.1080/10408440490464705; Kerger BD, 2011, DRUG CHEM TOXICOL, V34, P396, DOI 10.3109/01480545.2011.582502; Kim S, 2011, ENVIRON SCI TECHNOL, V45, P7465, DOI 10.1021/es202408a; Lam J, 2014, ENVIRON HEALTH PERSP, V122, P1040, DOI 10.1289/ehp.1307923; Lankova D, 2013, TALANTA, V117, P318, DOI 10.1016/j.talanta.2013.08.040; Lau C, 2006, TOXICOL SCI, V90, P510, DOI 10.1093/toxsci/kfj105; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lindstrom AB, 2011, ENVIRON SCI TECHNOL, V45, P7954, DOI 10.1021/es2011622; Manzetti S, 2014, CHEM RES TOXICOL, V27, P713, DOI 10.1021/tx500014w; Mondal D, 2014, ENVIRON HEALTH PERSP, V122, P187, DOI 10.1289/ehp.1306613; Nilsson H, 2010, ENVIRON SCI TECHNOL, V44, P2150, DOI 10.1021/es9034733; Norden M, 2013, ENVIRON SCI POLLUT R, P1; O'Brien JM, 2009, TOXICOL LETT, V190, P134, DOI 10.1016/j.toxlet.2009.07.004; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Palkar PS, 2010, TOXICOLOGY, V276, P79, DOI 10.1016/j.tox.2010.07.008; Paul AG, 2009, ENVIRON SCI TECHNOL, V43, P386, DOI 10.1021/es802216n; Peng SY, 2013, J PHARMACEUT BIOMED, V86, P56, DOI 10.1016/j.jpba.2013.07.014; Piechotta R, 1998, COMP BIOCHEM PHYS A, V120, P325, DOI 10.1016/S1095-6433(98)10033-8; Pinkas A, 2010, NEUROTOXICOL TERATOL, V32, P182, DOI 10.1016/j.ntt.2009.11.004; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; Ramirez T, 2013, ALTEX-ALTERN ANIM EX, V30, P209, DOI 10.14573/altex.2013.2.209; Rosen MB, 2008, TOXICOL PATHOL, V36, P592, DOI 10.1177/0192623308318208; Route WT, 2014, ENVIRON SCI TECHNOL, V48, P6653, DOI 10.1021/es501055d; Rudel H, 2011, ENVIRON SCI POLLUT R, V18, P1457, DOI 10.1007/s11356-011-0501-9; Sakr CJ, 2007, J OCCUP ENVIRON MED, V49, P1086, DOI 10.1097/JOM.0b013e318156eca3; Schmidek A, 2001, GEN COMP ENDOCR, V123, P235, DOI 10.1006/gcen.2001.7650; Scholz B, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-12; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Stromqvist M, 2012, COMP BIOCHEM PHYS C, V156, P29, DOI 10.1016/j.cbpc.2012.03.004; Takacs ML, 2007, TOXICOL SCI, V95, P108, DOI 10.1093/toxsci/kfl135; tenBusch M, 1997, COMP BIOCHEM PHYS A, V116, P131; tenBusch M, 1997, COMP BIOCHEM PHYS A, V116, P125; van Esterik JCJ, 2015, ARCH TOXICOL, P1; Vanden Heuvel JP, 2006, TOXICOL SCI, V92, P476, DOI 10.1093/toxsci/kfl014; Vicente J, 2012, SCI TOTAL ENVIRON, V416, P468, DOI 10.1016/j.scitotenv.2011.11.085; Wang Z, 2014, ENVIRON INT, V69, P166, DOI 10.1016/j.envint.2014.04.006; White SS, 2007, TOXICOL SCI, V96, P133, DOI 10.1093/toxsci/kfl177; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Winquist A, 2014, ENV HLTH PERSPECT; Wolf CJ, 2007, TOXICOL SCI, V95, P462, DOI 10.1093/toxsci/kfl159; Wolf CJ, 2014, TOXICOLOGY, V316, P43, DOI 10.1016/j.tox.2013.12.002; Wolf DC, 2008, TOXICOL PATHOL, V36, P632, DOI 10.1177/0192623308318216; Xie Y, 2003, BIOCHEM PHARMACOL, V66, P749, DOI 10.1016/S0006-2952(03)00386-1; Xie Y, 2002, LIPIDS, V37, P139, DOI 10.1007/s11745-002-0873-7; Yanai J, 2008, J TOXICOL ENV HEAL A, V71, P131, DOI 10.1080/15287390701613280; Zhang LY, 2014, TOXICOL APPL PHARM, V279, P275, DOI 10.1016/j.taap.2014.06.020; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13	74	11	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143780	10.1371/journal.pone.0143780	http://dx.doi.org/10.1371/journal.pone.0143780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624992	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600050
J	Meng, QY; Huang, LZ; Sun, YY; Bai, YJ; Wang, B; Yu, WZ; Zhao, MW; Li, XX				Meng, Qingyu; Huang, Lvzhen; Sun, Yaoyao; Bai, Yujing; Wang, Bin; Yu, Wenzhen; Zhao, Mingwei; Li, Xiaoxin			Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY GENES; ASSOCIATION; VARIANTS; POPULATION; PREVALENCE; LOCI; MACULOPATHY; POLYMORPHISMS	Purpose To investigate the effect of genetic variants in the high-density lipoprotein (HDL) metabolic pathway and risk factors on neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) in China. Methods A total of 742 Chinese subjects, including 221 controls, 230 cases with nAMD, and 291 cases with PCV, were included in the present study. Five single nucleotide polymorphisms (SNPs) from three genes in the HDL metabolic pathway (HDLMP) including cholesteryl ester transfer protein (CETP), hepatic lipase (LIPC) and lipoprotein lipase (LPL) were genotyped in all study subjects with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Risk factors including gender, hypertension, hyperlipidemia, diabetes mellitus, and coronary artery disease were identified. Chi-square tests or Fisher's exact tests were applied to discover associations between SNPs and risk factors for PCV and nAMD. Gene-gene interactions and gene-environment interactions were evaluated by the multifactor-dimensionality reduction (MDR) method. Results CETP rs3764261 were significantly associated with an increased risk for PCV (odds ratio (OR) = 1.444, P = 0.0247). LIPC rs1532085 conferred an increased risk for PCV (OR = 1.393, P = 0.0094). We found no association between PCV and LPL rs12678919, LIPC rs10468017 or CETP rs173539. No association was found between five SNPs with nAMD. Regarding risk factors, females were found to have significantly decreased risks for both PCV and nAMD (P = 0.006 and 0.001, respectively). Coronary artery disease (CAD) was a risk factor in PCV patients but played a protective role in nAMD patients. Hyperlipidemia was associated with PCV but not with nAMD. Neither hypertension nor diabetes mellitus was associated with PCV or nAMD. The MDR analysis revealed that a three-locus model with rs12678919, rs1532085, and gender was the best model for nAMD, while a five-locus model consisting of rs10468017, rs3764261, rs1532085, gender, and hyperlipidemia was best for PCV. Conclusion Our large-sample study suggested that CETP rs3764261 conferred an increased risk for PCV. We also first found the association between rs1532085 and PCV. The result of present study also showed that gender and CAD are associated with PCV and nAMD. Significant association was found between hyperlipidemia and PCV but not nAMD.	[Meng, Qingyu; Huang, Lvzhen; Sun, Yaoyao; Bai, Yujing; Wang, Bin; Yu, Wenzhen; Zhao, Mingwei; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Meng, Qingyu; Huang, Lvzhen; Sun, Yaoyao; Bai, Yujing; Wang, Bin; Yu, Wenzhen; Zhao, Mingwei; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Meng, Qingyu; Huang, Lvzhen; Sun, Yaoyao; Bai, Yujing; Wang, Bin; Yu, Wenzhen; Zhao, Mingwei; Li, Xiaoxin] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China	Peking University	Zhao, MW (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	zhaomingwei@medmail.com.cn; drlixiaoxin@163.com			National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81100666, 81170854]; Research Fund for Science and Technology Program of Beijing [Z121100005312006]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for Science and Technology Program of Beijing	This study was supported by the National Basic Research Program of China (973 Program; #2011CB510200), National Natural Science Foundation of China Grant (81100666, 81170854), and the Research Fund for Science and Technology Program of Beijing (No. Z121100005312006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Cackett P, 2011, OPHTHALMOLOGY, V118, P846, DOI 10.1016/j.ophtha.2010.09.026; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cheng CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7063; Cheung CMG, 2014, OPHTHALMOLOGY, V121, P1598, DOI 10.1016/j.ophtha.2014.02.004; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; Fauser S, 2011, INVEST OPHTH VIS SCI, V52, P5525, DOI 10.1167/iovs.10-6827; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; HOLZ FG, 1994, ARCH OPHTHALMOL-CHIC, V112, P402, DOI 10.1001/archopht.1994.01090150132035; Joachim N, 2015, OPHTHALMOLOGY; Jonasson F, 2014, OPHTHALMOLOGY, V121, P1766, DOI 10.1016/j.ophtha.2014.03.013; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2003, OPHTHALMOLOGY, V110, P636, DOI 10.1016/S0161-6420(02)01448-3; Klein R, 1999, PROG RETIN EYE RES, V18, P371, DOI 10.1016/S1350-9462(98)00025-1; Klein R, 2014, AM J OPHTHALMOL, V158, P513, DOI 10.1016/j.ajo.2014.05.027; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee J, 2013, EYE, V27, P266, DOI 10.1038/eye.2012.276; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu K, 2014, OPHTHALMOLOGY, V121, P911, DOI 10.1016/j.ophtha.2013.10.042; Ma L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092469; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Merle BMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079848; Nakata I, 2013, INVEST OPHTH VIS SCI, V54, P6068, DOI 10.1167/iovs.13-11605; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nguyen-Khoa BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1280, DOI 10.1001/archopht.126.9.1280; Nishino Y, 2014, PREV MED, V67, P41, DOI 10.1016/j.ypmed.2014.06.029; Peter I, 2011, AM J OPHTHALMOL, V152, P1005, DOI 10.1016/j.ajo.2011.05.016; Radovica I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064191; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Schaeffeler E, 2008, CLIN CHEM, V54, P1637, DOI 10.1373/clinchem.2008.103457; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Socias ME, 2015, WOMENS HLTH ISSUES; Suhy A, 2015, PHARMACOGENET GENOM, V25, P394, DOI 10.1097/FPC.0000000000000151; Sun C, 2009, OPHTHALMOLOGY, V116, P1913, DOI 10.1016/j.ophtha.2009.03.046; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian J, 2012, INVEST OPHTH VIS SCI, V53, P4262, DOI 10.1167/iovs.11-8542; Tian J, 2012, PHARMACOGENOMICS, V13, P779, DOI [10.2217/PGS.12.53, 10.2217/pgs.12.53]; Tinetti ME, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4984; Tserentsoodol N, 2006, MOL VIS, V12, P1319; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Wang SB, 2014, BR J OPHTHALMOL; Woo SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132771; Xu HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108103; Yang SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118500; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005; Zheng W, 2014, J LIPID RES	60	11	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143924	10.1371/journal.pone.0143924	http://dx.doi.org/10.1371/journal.pone.0143924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624898	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600076
J	Li, X; Li, YJ; Arendt, CS; Hochstrasser, M				Li, Xia; Li, Yanjie; Arendt, Cassandra S.; Hochstrasser, Mark			Distinct Elements in the Proteasomal beta 5 Subunit Propeptide Required for Autocatalytic Processing and Proteasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 20S PROTEASOME; ACTIVE-SITE FORMATION; IN-VIVO DEGRADATION; PROTEIN-DEGRADATION; CRYSTAL-STRUCTURE; S-PROTEASOMES; CORE PARTICLE; YEAST; MATURATION; BIOGENESIS	Eukaryotic 20S proteasome assembly remains poorly understood. The subunits stack into four heteroheptameric rings; three inner-ring subunits (beta 1, beta 2, and beta 5) bear the protease catalytic residues and are synthesized with N-terminal propeptides. These propeptides are removed autocatalytically late in assembly. In Saccharomyces cerevisiae, beta 5 (Doa3/Pre2) has a 75-residue propeptide, beta 5pro, that is essential for proteasome assembly and can work in trans. We show that deletion of the poorly conserved N-terminal half of the beta 5 propeptide nonetheless causes substantial defects in proteasome maturation. Sequences closer to the cleavage site have critical but redundant roles in both assembly and self-cleavage. A conserved histidine two residues upstream of the autocleavage site strongly promotes processing. Surprisingly, although beta 5pro is functionally linked to the Ump1 assembly factor, trans-expressed beta 5pro associates only weakly with Ump1-containing precursors. Several genes were identified as dosage suppressors of trans-expressed beta 5pro mutants; the strongest encoded the beta 7 proteasome subunit. Previous data suggested that beta 7 and beta 5pro have overlapping roles in bringing together two half-proteasomes, but the timing of beta 7 addition relative to half-mer joining was unclear. Here we report conditions where dimerization lags behind beta 7 incorporation into the half-mer. Our results suggest that beta 7 insertion precedes half-mer dimerization, and the beta 7 tail and beta 5 propeptide have unequal roles in half-mer joining.	[Li, Xia; Li, Yanjie; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA; [Arendt, Cassandra S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Li, Xia] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Arendt, Cassandra S.] 13417 Kinder Pass, Austin, TX 78727 USA	Yale University; University of Chicago; University of California System; University of California San Diego	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM046904, GM083050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R37GM046904, R01GM083050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM046904 and GM083050 (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Bai M, 2014, BIOMOLECULES, V4, P662, DOI 10.3390/biom4030662; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FRENTZEL S, 1994, J MOL BIOL, V236, P975, DOI 10.1016/0022-2836(94)90003-5; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2011, CURR TOP MED CHEM, V11, P2850, DOI 10.2174/156802611798281320; Gu ZC, 2014, CELL MOL LIFE SCI, V71, P4729, DOI 10.1007/s00018-014-1699-8; Guthrie C., 2002, GUIDE YEAST GENETICS; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hinnebusch Alan G., 1994, Seminars in Cell Biology, V5, P417, DOI 10.1006/scel.1994.1049; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kock M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7123; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Li Y., 2015, CURR PROTOC CELL BIO, V67; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Matias AC, 2010, BIOCHEM SOC T, V38, P29, DOI 10.1042/BST0380029; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ohkuni K, 2014, GENETICS, V196, P1041, DOI 10.1534/genetics.114.161224; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Velichutina I, 2004, EMBO J, V23, P500, DOI 10.1038/sj.emboj.7600059; Verbrugge SE, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0529-1; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	61	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1991	+		10.1074/jbc.M115.677047	http://dx.doi.org/10.1074/jbc.M115.677047			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26627836	Green Published, hybrid			2022-12-26	WOS:000368620700035
J	Liu, YW; Zhang, LX; Wang, C; Roy, S; Shen, JZ				Liu, Yiwei; Zhang, Lingxin; Wang, Chuan; Roy, Shama; Shen, Jianzhong			Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 EXPRESSION; SMOOTH-MUSCLE-CELLS; P2Y(2) RECEPTOR; P2X7 RECEPTOR; FACTOR GENE; C-FOS; ATHEROSCLEROSIS; MICE; AP-1; THROMBOSIS	We recently reported that the P2Y2 receptor (P2Y2R) is the predominant nucleotide receptor expressed in human coronary artery endothelial cells (HCAEC) and that P2Y2R activation by ATP or UTP induces dramatic up-regulation of tissue factor (TF), a key initiator of the coagulation cascade. However, the molecular mechanism of this P2Y2R-TF axis remains unclear. Here, we report the role of a newly identified AP-1 consensus sequence in the TF gene promoter and its original binding components in P2Y2R regulation of TF transcription. Using bioinformatics tools, we found that a novel AP-1 site at -1363 bp of the human TF promoter region is highly conserved across multiple species. Activation of P2Y2R increased TF promoter activity and mRNA expression in HCAEC. Truncation, deletion, and mutation of this distal AP-1 site all significantly suppressed TF promoter activity in response to P2Y2R activation. EMSA and ChIP assays further confirmed that upon P2Y2R activation, c-Jun, ATF-2, and Fra-1, but not the typical c-Fos, bound to the new AP-1 site. In addition, loss-of-function studies using siRNAs confirmed a positive transactivation role of c-Jun and ATF-2 but unexpectedly revealed a strong negative role of Fra-1 in P2Y2R-induced TF up-regulation. Furthermore, we found that P2Y2R activation promoted ERK1/2 phosphorylation through Src, leading to Fra-1 activation, whereas Rho/JNK mediated P2Y2R-induced activation of c-Jun and ATF-2. These findings reveal the molecular basis for P2Y G protein-coupled receptor control of endothelial TF expression and indicate that targeting the P2Y2R-Fra-1-TF pathway may be an attractive new strategy for controlling vascular inflammation and thrombogenicity associated with endothelial dysfunction.	[Liu, Yiwei; Zhang, Lingxin; Wang, Chuan; Roy, Shama; Shen, Jianzhong] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 4306G Walker Bldg, Auburn, AL 36849 USA	Auburn University System; Auburn University	Shen, JZ (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 4306G Walker Bldg, Auburn, AL 36849 USA.	jzs0019@auburn.edu	Shen, Jianzhong/AAH-8184-2019	Liu, Yiwei/0000-0002-9979-6269	American Heart Association [12SDG8850011]; Auburn University [IGP150301]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125279] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Auburn University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Scientist Development Award 12SDG8850011 from the American Heart Association ( to J. S.) and by Auburn University Intramural Grant Program IGP150301 ( to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aljada A, 2002, J CLIN ENDOCR METAB, V87, P1419, DOI 10.1210/jc.87.3.1419; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bickford JS, 2013, J LIPID RES, V54, P1915, DOI 10.1194/jlr.M037382; Budagian V, 2003, J BIOL CHEM, V278, P1549, DOI 10.1074/jbc.M206383200; Burnstock Geoffrey, 2011, Front Biosci (Elite Ed), V3, P896; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; Cui MZ, 1996, J BIOL CHEM, V271, P2731, DOI 10.1074/jbc.271.5.2731; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Gavala ML, 2010, J BIOL CHEM, V285, P34288, DOI 10.1074/jbc.M110.142091; Gebhard C, 2012, THROMB HAEMOSTASIS, V107, P884, DOI 10.1160/TH11-09-0624; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guns PJDF, 2010, BRIT J PHARMACOL, V159, P326, DOI 10.1111/j.1476-5381.2009.00497.x; Hechler B, 2008, CIRCULATION, V118, P754, DOI 10.1161/CIRCULATIONAHA.108.788927; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Jarvis B, 2000, DRUGS, V60, P347, DOI 10.2165/00003495-200060020-00012; Kellerman D, 2008, PULM PHARMACOL THER, V21, P600, DOI 10.1016/j.pupt.2007.12.003; Lau OCF, 2014, CLIN OPHTHALMOL, V8, P327, DOI 10.2147/OPTH.S39699; Lee R, 2012, J THROMB HAEMOST, V10, P1965, DOI 10.1111/j.1538-7836.2012.04842.x; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Ma WS, 2013, J BIOL CHEM, V288, P15481, DOI 10.1074/jbc.M112.445510; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; Rajasekaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041611; Robson SC, 2005, SEMIN THROMB HEMOST, V31, P217, DOI 10.1055/s-2005-869527; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; Seye CI, 2007, PURINERG SIGNAL, V3, P153, DOI 10.1007/s11302-006-9047-6; Seye CI, 2012, J BIOL CHEM, V287, P10535, DOI 10.1074/jbc.M111.313189; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Shen JZ, 2010, CIRC RES, V106, P902, DOI 10.1161/CIRCRESAHA.109.198069; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Verheugt FWA, 2013, CIRCULATION, V128, P2058, DOI 10.1161/CIRCULATIONAHA.113.002250; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; Yan SF, 1998, P NATL ACAD SCI USA, V95, P8298, DOI 10.1073/pnas.95.14.8298; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	46	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1553	1563		10.1074/jbc.M115.681163	http://dx.doi.org/10.1074/jbc.M115.681163			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26631725	Green Published, hybrid			2022-12-26	WOS:000368620700001
J	Chen, XD; Winckler, B; Lu, M; Cheng, HW; Yuan, ZY; Yang, YJ; Jin, L; Ye, WM				Chen, Xingdong; Winckler, Bjorn; Lu, Ming; Cheng, Hongwei; Yuan, Ziyu; Yang, Yajun; Jin, Li; Ye, Weimin			Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China	PLOS ONE			English	Article							STREPTOCOCCUS-ANGINOSUS; TOOTH LOSS; CANCER; INFECTION; HYGIENE; HEALTH; ASSOCIATION; DYSPLASIA; SEQUENCES; DNA	Poor oral health has been linked with an increased risk of esophageal squamous cell carcinoma (ESCC). We investigated whether alteration of oral microbiota is associated with ESCC risk. Fasting saliva samples were collected from 87 incident and histopathologicallly diagnosed ESCC cases, 63 subjects with dysplasia and 85 healthy controls. All subjects were also interviewed with a questionnaire. V3-V4 region of 16S rRNA was amplified and sequenced by 454-pyrosequencing platform. Carriage of each genus was compared by means of multivariate-adjusted odds ratios derived from logistic regression model. Relative abundance was compared using Metastats method. Beta diversity was estimated using Unifrac and weighted Unifrac distances. Principal coordinate analysis (PCoA) was applied to ordinate dissimilarity matrices. Multinomial logistic regression was used to compare the coordinates between different groups. ESCC subjects had an overall decreased microbial diversity compared to control and dysplasia subjects (P<0.001). Decreased carriage of genera Lautropia, Bulleidia, Catonella, Corynebacterium, Moryella, Peptococcus and Cardio-bacterium were found in ESCC subjects compared to non-ESCC subjects. Multinomial logistic regression analyses on PCoA coordinates also revealed that ESCC subjects had significantly different levels for several coordinates compared to non-ESCC subjects. In conclusion, we observed a correlation between altered salivary bacterial microbiota and ESCC risk. The results of our study on the saliva microbiome are of particular interest as it reflects the shift in microbial communities. Further studies are warranted to verify this finding, and if being verified, to explore the underlying mechanisms.	[Chen, Xingdong; Winckler, Bjorn; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Xingdong; Yuan, Ziyu; Yang, Yajun; Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Chen, Xingdong; Yuan, Ziyu; Yang, Yajun; Jin, Li] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Xingdong; Lu, Ming; Yuan, Ziyu; Yang, Yajun; Jin, Li; Ye, Weimin] Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China; [Lu, Ming] Shandong Univ, Qilu Hosp, Clin Epidemiol Unit, Jinan 250100, Peoples R China; [Cheng, Hongwei] Taixing Peoples Hosp, Taixing, Peoples R China	Karolinska Institutet; Fudan University; Fudan University; Shandong University	Lu, M (corresponding author), Fudan Taizhou Inst Hlth Sci, Taizhou, Peoples R China.	lvming@sdu.edu.cn	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; ye, weimin/0000-0002-6859-4648	Natural Science Foundation of China [81072358, 81273151]; Science and Technology Committee of Shandong Province [2012GSF11857]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shandong Province	This work was supported by a grant from Natural Science Foundation of China (81072358, 81273151), and a grant from Science and Technology Committee of Shandong Province (2012GSF11857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2001, CANCER CAUSE CONTROL, V12, P847, DOI 10.1023/A:1012290009545; Abnet CC, 2008, CANCER EPIDEM BIOMAR, V17, P3062, DOI 10.1158/1055-9965.EPI-08-0558; Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; Dar NA, 2013, BRIT J CANCER, V109, P1367, DOI 10.1038/bjc.2013.437; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Guha N, 2007, AM J EPIDEMIOL, V166, P1159, DOI 10.1093/aje/kwm193; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Mariotti E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-120; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morita E, 2003, CANCER SCI, V94, P492, DOI 10.1111/j.1349-7006.2003.tb01471.x; Nair J, 1996, CRIT REV TOXICOL, V26, P149, DOI 10.3109/10408449609017928; Narikiyo M, 2004, CANCER SCI, V95, P569, DOI 10.1111/j.1349-7006.2004.tb02488.x; Nasrollahzadeh D, 2012, BRIT J CANCER, V107, P888, DOI 10.1038/bjc.2012.332; Nyren O, 2002, TXB CANC EPIDEMIOLOG, P137; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Salaspuro MP, 2003, CRIT REV CL LAB SCI, V40, P183, DOI 10.1080/713609333; Sasaki H, 1998, CANCER RES, V58, P2991; Sato F, 2011, HEAD NECK-J SCI SPEC, V33, P1628, DOI 10.1002/hed.21649; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sepehr A, 2005, ANTICANCER RES, V25, P543; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Urbanek C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-233; von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yu GQ, 2014, CANCER EPIDEM BIOMAR, V23, P735, DOI 10.1158/1055-9965.EPI-13-0855; Zhuang M, 2012, CHINA PLOS ONE, V7, DOI [10.1371/journal.pone.0048341, DOI 10.1371/JOURNAL.PONE.0048341]	39	97	106	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143603	10.1371/journal.pone.0143603	http://dx.doi.org/10.1371/journal.pone.0143603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641451	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700023
J	Ge, PF; Dong, CX; Ren, XL; Weiderpass, E; Zhang, CJ; Fan, HQ; Zhang, J; Zhang, YR; Xi, J				Ge, Pengfei; Dong, Caixia; Ren, Xiaolan; Weiderpass, Elisabete; Zhang, Chouji; Fan, Haoqiang; Zhang, Jing; Zhang, Yongrui; Xi, Jinen			The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HIGH-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; RISK-FACTOR; MORTALITY; ADULTS	Background Dyslipidemia is a major health problem in China and an important modifiable cardiovascular disease (CVD) risk factor. This study aimed to describe the prevalence of dyslipidemia and low high density lipoprotein cholesterol (HDL-cholesterol) and associated risk factors among adults in rural northwest China. Methods In a cross-sectional analyses involving 2,980 adults aged >18 years, information on the demographics, cigarette smoking, alcohol consumption, education, and medical history was collected via face-to-face interviews. Blood samples were collected to determine total cholesterol (TC), low-density lipoprotein cholesterol (LDL-cholesterol), and HDL-cholesterol, and triglycerides (TG) levels. Results The prevalence of high TC, high LDL-cholesterol, low HDL-cholesterol, and high TG were 1.0%, 0.6%, 60.9%, and 13.7%, respectively. TC, LDL-cholesterol, and TG increased with age in females. Elevated TC was more common in females than in males. The prevalence of low HDL-cholesterol was 67.6% in males and 55.4% in females. Current smokers, those with less education, those who were overweight or obese, and those with large waist circumference were more likely to have low HDL-cholesterol (p<0.05). Multivariable regression showed that male gender showed an association with low HDL-cholesterol (OR 2.10, 95% CI 1.68-2.61), age >= 60 years (OR 0.80, 95% CI 0.64-0.99), BMI (BMI = 24-27.9, OR 1.27, 95% CI 1.04-1.54, p = 0.02 and BMI >= 28, OR 1.56, 95% CI 1.10-2.20, p = 0.01) and enlarged waist circumference (OR 2.10, 95% CI 1.51-2.92). Non-alcohol drinker was associated with low HDL-cholesterol levels (OR 0.72, 95% CI 0.53-0.99, p = 0.04). Conclusions This study found that the prevalence of low HDL-cholesterol was 67.6% and 55.4% for males and females. Male gender, non-alcohol drinker, BMI and central obesity were important risk factors for low HDL-cholesterol in Chinese adults.	[Ge, Pengfei; Dong, Caixia; Ren, Xiaolan; Zhang, Chouji; Fan, Haoqiang; Zhang, Jing; Zhang, Yongrui; Xi, Jinen] Gansu Ctr Dis Control & Prevent, Inst Noncommunicable Chron Dis, Lanzhou 730000, Gansu, Peoples R China; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland	UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Samfundet Folkhalsan	Dong, CX (corresponding author), Gansu Ctr Dis Control & Prevent, Inst Noncommunicable Chron Dis, 230 Donggang Western Rd, Lanzhou 730000, Gansu, Peoples R China.	dongcaixia2008@163.com	Weiderpass, Elisabete/M-4029-2016; Weiderpass, Elisabete/AAP-2747-2021	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128	Chinese government	Chinese government	Financial and technical support was provided by the Chinese government and the Chinese Center for Disease Control and Prevention in facilitating this survey.; We gratefully acknowledge the financial and technical support provided by the Chinese government and the Chinese Center for Disease Control and Prevention in facilitating this survey. We also thank the field team from the Centers for Disease Control and Prevention in the surveillance areas for their contributions to data collection. We also thank the local community health doctors and nurses for providing fieldwork assistants. We thank all of the individuals who participated in the present survey.	Alwaili K, 2010, EXPERT REV CARDIOVAS, V8, P413, DOI [10.1586/erc.10.4, 10.1586/ERC.10.4]; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Ascaso Juan F, 2004, Am J Cardiovasc Drugs, V4, P299, DOI 10.2165/00129784-200404050-00003; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bruckert E, 2005, CURR MED RES OPIN, V21, P1927, DOI 10.1185/030079905X74871; Cai L, 2012, J ATHEROSCLER THROMB, V19, P159, DOI 10.5551/jat.10116; Chalmers J, 1999, J HYPERTENS, V17, P151; Choi Sun-Ja, 2011, Osong Public Health Res Perspect, V2, P94, DOI 10.1016/j.phrp.2011.07.006; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Elisaf M., 2000, IDRUGS, V3, P156; Gao Ya, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P432; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jia W P, 2002, Obes Rev, V3, P157; Li Jian-hong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P607; Li Jian-hong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P414; Lin Y, 2010, VASC HEALTH RISK MAN, V6, P73; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Peasey A, 2005, ALCOHOL ALCOHOLISM, V40, P431, DOI 10.1093/alcalc/agh161; Reddy KS, 1998, CIRCULATION, V97, P596; Rodgers A, 1998, LANCET, V352, P1801; Rutherford JN, 2010, ASIA PAC J CLIN NUTR, V19, P57; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Toth PP, 2009, POL ARCH MED WEWN, V119, P667, DOI 10.20452/pamw.801; Wang B, 2012, ATHEROSCLEROSIS, V223, P512, DOI 10.1016/j.atherosclerosis.2012.06.009; WHO publishes definitive atlas on global heart disease and stroke epidemic, 2004, INDIAN J MED SCI, V58, P405; Wu JY, 2010, PREV MED, V51, P412, DOI 10.1016/j.ypmed.2010.08.013; Wu ZS, 2001, CIRCULATION, V103, P462; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329; 赵文华, 2012, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V46, P477	37	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144104	10.1371/journal.pone.0144104	http://dx.doi.org/10.1371/journal.pone.0144104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640891	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700056
J	Sinishaw, MA; Gebregergs, GB; Shiferaw, MB				Sinishaw, Mulusew Alemneh; Gebregergs, Gebremedhin Berhe; Shiferaw, Melashu Balew			Distribution and Availability of Essential Tuberculosis Diagnostic Items in Amhara Region, Ethiopia	PLOS ONE			English	Article								Adequate supplies of tuberculosis laboratory reagents and consumables are necessary for tuberculosis diagnosis and monitoring of treatment response. This study assessed the distribution and stock levels of laboratory commodities used in tuberculosis control in health centers of Amhara region, Ethiopia. A cross-sectional study was conducted in 82 health centers, among 801, providing sputum microscopy services. Stock levels were calculated, and distribution of reagents and consumables assessed. Thirty three (40.2%) health centers were under stocked for at least one of the key items for tuberculosis diagnosis at the time of visit. Fifteen (18.3%) health centers had no stocks of at least one of the key items (methylene blue (11%), carbol fuchsin (11%), acid alcohol (8.5%) and sputum cups (3.7%)). Of the 82 health centers, 77 (93.9%) did not fulfill the criteria for effective distribution of tuberculosis laboratory reagents and consumables. There were many health centers that had no or only low stocks of key tuberculosis laboratory reagents and consumables as a result of ineffective distribution system. It is necessary to strengthen supply chain management to ensure uninterrupted TB diagnostic service.	[Sinishaw, Mulusew Alemneh; Shiferaw, Melashu Balew] Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia; [Gebregergs, Gebremedhin Berhe] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Sinishaw, MA (corresponding author), Bahir Dar Reg Hlth Res Lab Ctr, Bahir Dar, Ethiopia.	mulusewalemneh@yahoo.com	Shiferaw, Melashu/GPT-3320-2022; Sinishaw, Mulusew Alemneh/AAN-8447-2021	Sinishaw, Mulusew Alemneh/0000-0002-5737-7496; Shiferaw, Melashu Balew/0000-0002-5066-0758	Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development [AID-OAA-A-10-00020]; American people through the United States Agency for International Development (USAID)	Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), United States Agency for International Development, financially supported this study through TB CARE I under the terms of Agreement No. AID-OAA-A-10-00020. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Amhara National Regional State Health Bureau, 2013, REG HLTH BUR ANN REP; Amhara National Regional State Health Bureau, 2012, REG HLTH BUR ANN REP; Arney L, 2014, GLOBAL HLTH SCI PRAC, V2; Butao D, 2009, 1 USAID DELIVER PROJ; Desale A, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.46.1969; Ethiopian Federal Ministry of Health, 2014, WHY TB EV NAT TB CON; Ethiopian Health & Nutrition Research Institute and Federal Ministry of Health of Ethiopia, 2009, GUID QUAL ASS SMEAR; Global HIV/AIDS Initiative Nigeria, 2011, GHAIN LAB END PROJ M; Harries AD, 2009, INT J TUBERC LUNG D, V13, P1194; Kagoma C, 2011, ASSESSMENT ANG UNPUB; Nigatu A, 2009, IMPACT ETHIOPIAN NAT; PROJECT Program Medicine Integration UD, 2012, TURN POL PRACT TIGR, P1; Taylor J., 2001, PHARM J, V267, P128; Ugandan Ministry of Health Health, COMM MAN LOG SYST PE; World Health Organization, 2006, STRAT APPR STRENGTH; World Health Organization, 2011, GUID SPEC MAN TB LAB	16	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0141032	10.1371/journal.pone.0141032	http://dx.doi.org/10.1371/journal.pone.0141032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641097	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700003
J	Angel, LP; Wells, MR; Rodriguez-Malagon, MA; Tew, E; Speakman, JR; Arnould, JPY				Angel, Lauren P.; Wells, Melanie R.; Rodriguez-Malagon, Marlenne A.; Tew, Emma; Speakman, John R.; Arnould, John P. Y.			Sexual Size Dimorphism and Body Condition in the Australasian Gannet	PLOS ONE			English	Article							BLUE-FOOTED BOOBY; DISCRIMINANT FUNCTION-ANALYSIS; PENGUINS EUDYPTULA-MINOR; BLACK-LEGGED KITTIWAKES; PORT PHILLIP BAY; FORAGING BEHAVIOR; MORUS-SERRATOR; BREEDING SUCCESS; WANDERING ALBATROSSES; MONOMORPHIC SEABIRD	Sexual size dimorphism is widespread throughout seabird taxa and several drivers leading to its evolution have been hypothesised. While the Australasian Gannet (Morus serrator) has previously been considered nominally monomorphic, recent studies have documented sexual segregation in diet and foraging areas, traits often associated with size dimorphism. The present study investigated the sex differences in body mass and structural size of this species at two colonies (Pope's Eye, PE; Point Danger, PD) in northern Bass Strait, southeastern Australia. Females were found to be 3.1% and 7.3% heavier (2.74 +/- 0.03, n = 92; 2.67 +/- 0.03 kg, n = 43) than males (2.66 +/- 0.03, n = 92; 2.48 +/- 0.03 kg, n = 43) at PE and PD, respectively. Females were also larger in wing ulna length (0.8% both colonies) but smaller in bill depth (PE: 2.2%; PD: 1.7%) than males. Despite this dimorphism, a discriminant function provided only mild accuracy in determining sex. A similar degree of dimorphism was also found within breeding pairs, however assortative mating was not apparent at either colony (R-2 < 0.04). Using hydrogen isotope dilution, a body condition index was developed from morphometrics to estimate total body fat (TBF) stores, where TBF(%) = 24.43+1.94*(body mass/wing ulna length) -0.58* tarsus length (r(2) = 0.84, n = 15). This index was used to estimate body composition in all sampled individuals. There was no significant difference in TBF(%) between the sexes for any stage of breeding or in any year of the study at either colony suggesting that, despite a greater body mass, females were not in a better condition than males. While the driving mechanism for sexual dimorphism in this species is currently unknown, studies of other Sulids indicate segregation in foraging behaviour, habitat and diet may be a contributing factor.	[Angel, Lauren P.; Wells, Melanie R.; Rodriguez-Malagon, Marlenne A.; Tew, Emma; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Speakman, John R.] Univ Aberdeen, Inst Environm & Biol Sci, Aberdeen, Scotland	Deakin University; University of Aberdeen	Angel, LP (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	langel@deakin.edu.au		Wells, Melanie/0000-0003-2817-8743; Angel, Lauren/0000-0002-8696-3945	Holsworth Wildlife Research Endowment	Holsworth Wildlife Research Endowment	The research was financially supported by the Holsworth Wildlife Research Endowment.	Castillo-Guerrero JA, 2011, J ORNITHOL, V152, P269, DOI 10.1007/s10336-010-0575-z; AMAT JA, 1993, COLON WATERBIRD, V16, P213, DOI 10.2307/1521441; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Barbraud C, 1998, J AVIAN BIOL, V29, P161, DOI 10.2307/3677194; Barker S., 2012, GEOGRAPHIC VARIATION; Bijleveld AI, 2009, BEHAV ECOL, V20, P736, DOI 10.1093/beheco/arp054; Bosch M, 1996, J FIELD ORNITHOL, V67, P534; Bunce A, 2001, ICES J MAR SCI, V58, P904, DOI 10.1006/jmsc.2001.1083; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; CHOUDHURY S, 1992, ANIM BEHAV, V44, P171, DOI 10.1016/S0003-3472(05)80768-7; Cleasby IR, 2015, MAR ECOL PROG SER, V518, P1, DOI 10.3354/meps11112; Coulson J. C., 2009, Ringing & Migration, V24, P233; CROXALL JP, 1995, OIKOS, V73, P399, DOI 10.2307/3545964; Daniel C, 2007, AUST J ZOOL, V55, P377, DOI 10.1071/ZO07073; Dechaume-Moncharmont FX, 2011, AUK, V128, P78, DOI 10.1525/auk.2011.10129; Einoder Luke D., 2008, Marine Ornithology, V36, P167; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Erikstad KE, 1998, ECOLOGY, V79, P1781; EVANS DR, 1993, J FIELD ORNITHOL, V64, P472; Ewing AD, 2005, EMU, V105, P137, DOI 10.1071/MU03061; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; FLINT EN, 1984, AUK, V101, P288, DOI 10.1093/auk/101.2.288; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Forero MG, 2001, CAN J ZOOL, V79, P1414, DOI 10.1139/cjz-79-8-1414; GALES R, 1989, PHYSIOL ZOOL, V62, P147, DOI 10.1086/physzool.62.1.30160003; GILARDI JD, 1992, COLON WATERBIRD, V15, P148, DOI 10.2307/1521367; Golet GH, 1999, OECOLOGIA, V120, P530, DOI 10.1007/s004420050887; Gonzalez-Solis J, 2005, SEXUAL SEGREGATION V, P1; Green Jonathan A., 2010, Endangered Species Research, V10, P269, DOI 10.3354/esr00223; GUERRA M, 1995, BEHAVIOUR, V132, P479, DOI 10.1163/156853995X00162; Guggenheimer S, 2012, SEPARATION SEXES STA; HALLIDAY D, 1977, BIOMED MASS SPECTROM, V4, P82, DOI 10.1002/bms.1200040205; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hennicke JC, 2014, MAR ECOL PROG SER, V499, P259, DOI 10.3354/meps10664; Hobday A. J, 2014, DEV ADAPTATION OPTIO; Hobday AJ, 2015, APPLIED STUDIES IN CLIMATE ADAPTATION, P77; Hull Cindy L., 1996, Marine Ornithology, V24, P23; Ismar SMH, 2010, THESIS; Ismar SMH, 2014, WILSON J ORNITHOL, V126, P417, DOI 10.1676/13-203.1; Kato A, 2008, AUK, V125, P588, DOI 10.1525/auk.2008.06273; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Layton HN, 2000, COMP BIOCHEM PHYS A, V126, P295, DOI 10.1016/S1095-6433(00)00212-9; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lormee H, 2005, IBIS, V147, P307, DOI 10.1111/j.1474-919x.2005.00404.x; Lormee H, 2003, IBIS, V145, P212, DOI 10.1046/j.1474-919X.2003.00106.x; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Mata AJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P202, DOI 10.1086/498354; MONAGHAN P, 1989, J ANIM ECOL, V58, P261, DOI 10.2307/4999; Moseley C, 2012, J EXP MAR BIOL ECOL, V422, P29, DOI 10.1016/j.jembe.2012.04.002; Mullers RHE, 2009, ARDEA, V97, P89, DOI 10.5253/078.097.0111; Navarro J, 2009, ZOOLOGY, V112, P128, DOI 10.1016/j.zool.2008.05.001; NELSON J.B., 1978, SULIDAE GANNETS BOOB; NELSON JB, 1966, IBIS, V108, P584, DOI 10.1111/j.1474-919X.1966.tb07210.x; O'Dwyer TW, 2007, AUST J ZOOL, V55, P155, DOI 10.1071/ZO07005; Patterson SA, 2011, MOL PHYLOGENET EVOL, V58, P181, DOI 10.1016/j.ympev.2010.11.021; Pyk TM, 2013, J ORNITHOL, V154, P299, DOI 10.1007/s10336-012-0894-3; Renner M, 1998, COLON WATERBIRD, V21, P444, DOI 10.2307/1521659; Renner M, 1999, EMU, V99, P74, DOI 10.1071/MU99009C; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; RISING JD, 1989, AUK, V106, P666; Ropert-Coudert Y, 2005, OSTRICH, V76, P212, DOI 10.2989/00306520509485495; Ruckstuhl KE, 2005, SEXUAL SEGREGATION V, P1; Schamber JL, 2009, J AVIAN BIOL, V40, P49, DOI 10.1111/j.1600-048X.2008.04462.x; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schultner J, 2013, FUNCT ECOL, V27, P45, DOI 10.1111/j.1365-2435.2012.02058.x; Selander RK, 1972, SSATDOM CA; Serrano-Meneses MA, 2006, OIKOS, V113, P385, DOI 10.1111/j.0030-1299.2006.14246.x; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Shaffer SA, 2006, PHYSIOL BIOCHEM ZOOL, V79, P836, DOI 10.1086/504611; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Stauss C, 2012, MAR ECOL PROG SER, V457, P151, DOI 10.3354/meps09734; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; Viblanc VA, 2012, PHYSIOL BIOCHEM ZOOL, V85, P533, DOI 10.1086/667540; WARHAM J, 1977, NEW ZEAL J ZOOL, V4, P73, DOI 10.1080/03014223.1977.9517938; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; WEIMERSKIRCH H, 1994, ANIM BEHAV, V47, P472, DOI 10.1006/anbe.1994.1065; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; WINGHAM EJ, 1984, EMU, V84, P129, DOI 10.1071/MU9840129; Zavalaga CB, 2009, WILSON J ORNITHOL, V121, P739, DOI 10.1676/09-19.1	87	15	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0142653	10.1371/journal.pone.0142653	http://dx.doi.org/10.1371/journal.pone.0142653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637116	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800001
J	Liu, FW; Liu, FC; Wang, YR; Tsai, HI; Yu, HP				Liu, Fu-Wei; Liu, Fu-Chao; Wang, Yu-Ren; Tsai, Hsin-I; Yu, Huang-Ping			Aloin Protects Skin Fibroblasts from Heat Stress-Induced Oxidative Stress Damage by Regulating the Oxidative Defense System	PLOS ONE			English	Article							ANTIOXIDANT; VERA; HYPERTHERMIA; GLUTATHIONE; MITOCHONDRIA; ALOESIN; ENZYMES; HSP70; CELLS; GEL	Oxidative stress is commonly involved in the pathogenesis of skin damage induced by environmental factors, such as heat stress. Skin fibroblasts are responsible for the connective tissue regeneration and the skin recovery from injury. Aloin, a bioactive compound in Aloe vera, has been reported to have various pharmacological activities, such as anti-inflammatory effects. The aim of this study was to investigate the protective effect of aloin against heat stress-mediated oxidative stress in human skin fibroblast Hs68 cells. Hs68 cells were first incubated at 43 degrees C for 30 min to mimic heat stress. The study was further examined if aloin has any effect on heat stress-induced oxidative stress. We found that aloin protected Hs68 cells against heat stress-induced damage, as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and lactate dehydrogenase assay. Aloin protected Hs68 cells by regulating reactive oxygen species production and increasing the levels of glutathione, cytosolic and mitochondrial superoxide dismutase. Aloin also prevented the elevation of thiobarbituric acid reactive substances and the reduction of 8-OH-dG induced by heat stress. These results indicated that aloin protected human skin fibroblasts from heat stress-induced oxidative stress damage by regulating the oxidative defense system.	[Liu, Fu-Wei] Taichung Vet Gen Hosp, Dept Phys Med & Rehabil, Puli Branch, Nantou, Taiwan; [Liu, Fu-Chao; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Liu, Fu-Chao; Wang, Yu-Ren; Tsai, Hsin-I; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Taichung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University	Yu, HP (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	yubirmingham@yahoo.com	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053	National Science Council [NSC102-2314-B-182A-051-MY3, NSC103-2314-B-182-046-MY2]; Chang Gung Memorial Hospital [CMRPG3B1053, CMRPG3E1551, CMRPG3E1541]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC102-2314-B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1053 and CMRPG3E1551) to Huang-Ping Yu. Support was also provided by the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1541) to Fu-Chao Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from the National Science Council (NSC1022314- B-182A-051-MY3) and Chang Gung Memorial Hospital (CMRPG3B1053 and CMRPG3E1551) to Huang-Ping Yu. Support was also provided by the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1541) to Fu-Chao Liu.	Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Bergmeyer HU., 1974, METHODS ENZYMATIC AN, P574, DOI [10.1016/B978-0-12-091302-2.50010-4, DOI 10.1016/B978-0-12-091302-2.50010-4]; Brenneisen P, 1997, FREE RADICAL BIO MED, V22, P515, DOI 10.1016/S0891-5849(96)00404-2; Calabrese V, 2002, J NEUROSCI RES, V68, P65, DOI 10.1002/jnr.10177; Cole L, 2007, INT J PHARM, V333, P10, DOI 10.1016/j.ijpharm.2006.09.047; Dinh HKB, 2001, PHYSIOL GENOMICS, V7, P3, DOI 10.1152/physiolgenomics.2001.7.1.3; Eberlein-Konig B, 1998, J AM ACAD DERMATOL, V38, P45, DOI 10.1016/S0190-9622(98)70537-7; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fox LT, 2015, J PHARM PHARMACOL, V67, P96, DOI 10.1111/jphp.12311; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Harlev E, 2012, PLANTA MED, V78, P843, DOI 10.1055/s-0031-1298453; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hegazy SK, 2012, WORLD J GASTROENTERO, V18, P2026, DOI 10.3748/wjg.v18.i17.2026; Hu Y, 2003, J AGR FOOD CHEM, V51, P7788, DOI 10.1021/jf034255i; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x; Kumar S, 2010, J ASIAN NAT PROD RES, V12, P360, DOI 10.1080/10286021003775327; LIN PS, 1991, RADIAT RES, V126, P43, DOI 10.2307/3578169; Malyshev IY, 2000, PHYSIOL RES, V49, P99; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Monika Mahajan, 2013, American Journal of Biochemistry and Molecular Biology, V3, P81; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Niciforovic A, 2007, RUSS J PHYS CHEM A+, V81, P1463, DOI 10.1134/S0036024407090221; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Park G, 2012, SKIN PHARMACOL PHYS, V25, P93, DOI 10.1159/000335257; Park MY, 2011, LIFE SCI, V88, P486, DOI 10.1016/j.lfs.2011.01.010; SANO M, 1986, Journal of Free Radicals in Biology and Medicine, V2, P41, DOI 10.1016/0748-5514(86)90122-4; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Sharma P., 2012, AFR J BIOTECHNOL, V11, P184, DOI DOI 10.5897/AJB11.2185; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sorrell JM, 2007, CELL TISSUE RES, V327, P499, DOI 10.1007/s00441-006-0317-y; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tabuchi Y, 2013, INT J HYPERTHER, V29, P38, DOI 10.3109/02656736.2012.753163; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Walrand S, 2003, CLIN CHIM ACTA, V331, P103, DOI 10.1016/S0009-8981(03)00086-X; Wamer WG, 2003, FREE RADICAL BIO MED, V34, P233, DOI 10.1016/S0891-5849(02)01242-X; Yagi A, 2002, PLANTA MED, V68, P957, DOI 10.1055/s-2002-35666; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	41	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143528	10.1371/journal.pone.0143528	http://dx.doi.org/10.1371/journal.pone.0143528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637174	gold, Green Published, Green Submitted			2022-12-26	WOS:000366143800016
J	Nam, HS; Kwon, I; Lee, BH; Kim, H; Kim, J; An, S; Lee, OH; Lee, PH; Kim, HO; Namgoong, H; Kim, YD; Heo, JH				Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Lee, Phil Hyu; Kim, Hyun Ok; Namgoong, Hyun; Kim, Young Dae; Heo, Ji Hoe			Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery	PLOS ONE			English	Article							MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; BONE-MARROW; DOPAMINERGIC-NEURONS; THERAPEUTIC BENEFIT; FUNCTIONAL RECOVERY; ARTERY OCCLUSION; IN-VIVO; RATS	Background The efficacy of mesenchymal stem cell (MSC) transplantation in ischemic stroke might depend on the timing of administration. We investigated the optimal time point of MSC transplantation. After MSC treatment, we also investigated the expression of matrix metalloproteinases (MMPs), which play a role in vascular and tissue remodeling. Methods Human bone marrow-derived MSCs (2 x 10(6), passage 5) were administrated intravenously after permanent middle cerebral artery occlusion (MCAO) was induced in male Sprague-Dawley rats. First, we determined the time point of MSC transplantation that led to maximal neurological recovery at 1 h, 1 day, and 3 days after MCAO. Next, we measured activity of MMP-2 and MMP-9, neurological recovery, infarction volume, and vascular density after transplanting MSCs at the time that led to maximal neurological recovery. Results Among the MSC-transplanted rats, those of the MSC 1-hour group showed maximal recovery in the rotarod test (P = 0.023) and the Longa score (P = 0.018). MMP-2 activity at 1 day after MCAO in the MSC 1-hour group was significantly higher than that in the control group (P = 0.002), but MMP-9 activity was not distinct. The MSC 1-hour group also showed smaller infarction volume and higher vascular density than did the control group. Conclusions In a permanent model of rodent MCAO, very early transplantation of human MSCs (1 h after MCAO) produced greater neurological recovery and decreased infraction volume. The elevation of MMP-2 activity and the increase in vascular density after MSC treatment suggest that MSCs might help promote angiogenesis and lead to neurological improvement during the recovery phase after ischemic stroke.	[Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Lee, Phil Hyu; Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea; [Nam, Hyo Suk; Kwon, Il; Lee, Bo Hyung; Kim, Haejin; Kim, Jayoung; An, Sunho; Lee, Ok-Hee; Kim, Young Dae; Heo, Ji Hoe] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kim, Hyun Ok] Yonsei Univ, Coll Med, Severance Hosp, Yonsei Cell Therapy Ctr,Dept Lab Med, Seoul, South Korea; [Namgoong, Hyun] Univ Calif Los Angeles, Microbiol Immunol & Mol Genet, Los Angeles, CA USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles	Heo, JH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea.	jhheo@yuhs.ac		Lee, Phil Hyu/0000-0001-9931-8462; NAM, HYO SUK/0000-0002-4415-3995; Kim, Hyun Ok/0000-0002-4964-1963; Kwon, Il/0000-0001-9449-5646; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Young Dae/0000-0001-5750-2616	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [HI08C2149]; Korea Government Ministry of Education, Science and Technology [2009-0069165]; Korea Research Foundation Grant - Korean Government [KRF-2007-331-E00126]; Yonsei University College of Medicine [6-2011-0095]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1005913]	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea; Korea Government Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research Foundation Grant - Korean Government(National Research Foundation of KoreaKorean Government); Yonsei University College of Medicine(General Electric); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149) (JHH), a grant from the Korea Government Ministry of Education, Science and Technology under Grant (2009-0069165) (HSN), a Korea Research Foundation Grant funded by the Korean Government (KRF-2007-331-E00126) (HSN), a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0095) (HSN), and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A1005913) (IK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barichello T, 2014, EXP BIOL MED, V239, P225, DOI 10.1177/1535370213508354; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Bronckaers A, 2014, PHARMACOL THERAPEUT, V143, P181, DOI 10.1016/j.pharmthera.2014.02.013; Brumm AJ, 2012, NAT MED, V18, P1609, DOI 10.1038/nm.2990; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choi SA, 2007, CURR NEUROVASC RES, V4, P89, DOI 10.2174/156720207780637252; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kim SH, 2008, CURR NEUROVASC RES, V5, P28; Kim SJ, 2013, J STROKE, V15, P27, DOI 10.5853/jos.2013.15.1.27; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Li WY, 2008, CELL TRANSPLANT, V17, P1045, DOI 10.3727/096368908786991551; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lin TN, 2000, J CEREBR BLOOD F MET, V20, P387, DOI 10.1097/00004647-200002000-00021; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lucivero V, 2007, NEUROL SCI, V28, P165, DOI 10.1007/s10072-007-0814-0; Rosenberg GA, 1996, J CEREBR BLOOD F MET, V16, P360, DOI 10.1097/00004647-199605000-00002; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Yanev P, 2012, STROKE, V43, P3436, DOI 10.1161/STROKEAHA.111.642686; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang J, 2013, EXPERT OPIN BIOL TH, V13, P1229, DOI 10.1517/14712598.2013.804507; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273	50	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144218	10.1371/journal.pone.0144218	http://dx.doi.org/10.1371/journal.pone.0144218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637168	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800058
J	Ren, LJ; Cai, JJ; Liang, J; Li, WP; Sun, ZH				Ren, Lijie; Cai, Jingjing; Liang, Jie; Li, Weiping; Sun, Zhonghua			Impact of Cardiovascular Risk Factors on Carotid Intima-Media Thickness and Degree of Severity: A Cross-Sectional Study	PLOS ONE			English	Article							YOUNG-ADULTS; DEPRESSIVE SYMPTOMS; ARTERY; ATHEROSCLEROSIS; STROKE; PROGRESSION; HYPERTENSION; PLAQUE; ASSOCIATION; POPULATION	Objective Age, hypertension, dyslipidemia and diabetes are common cardiovascular risk factors (CVRFs) that contribute to the development of atherosclerosis in cardiovascular system including carotid artery disease. However, the impact of these risk factors on the increased carotid intima-media thickness (cIMT) and degree of carotid severity remains to be further clarified. This study aims to evaluate the relationship between CVRFs and degree of carotid severity and cIMT in high-risk subjects. Methods Four thousand and three hundred ninety-four subjects with one or more risk factors were retrospectively reviewed in this study. Patients were divided into different groups based on age, the type and quantity of CVRFs. cIMT and degree of carotid artery stenosis were measured and analyzed based on carotid ultrasound imaging with findings compared to the CVRFs to determine the correlation between these variables. Results Aging was significantly associated with degree of severity (P < 0.05) and cIMT was significantly increased with age (P < 0.05). Individual CVRF analysis shows that hypertension was more related to the degree of severity than dyslipidemia and diabetes with corresponding abnormal cIMT rates being 79.39%, 72.98% and 32.37%, respectively. The prevalence of carotid atherosclerosis were 20.06%, 22.88% and 28.63%, respectively corresponding to patients with zero, one and more than one chronic diseases. The percentage of abnormal cIMT in hypertensive patient group with dyslipidemia is significantly higher than the other groups (P< 0.05). Conclusions This study shows a direct correlation between the degree of carotid severity and cIMT and cardiovascular risk factors, especially with age and hypertension. Carotid atherosclerosis is closely related to the number of cardiovascular risk factors.	[Ren, Lijie; Cai, Jingjing] Anhui Med Univ, Clin Med Coll, Peoples Hosp 2, Dept Shenzhen, Shenzhen, Guangdong, Peoples R China; [Ren, Lijie; Cai, Jingjing; Liang, Jie] Shenzhen Second Peoples Hosp, Dept Neurol, Shenzhen, Guangdong, Peoples R China; [Liang, Jie] Guangzhou Med Univ, Clin Med Coll, Peoples Hosp 2, Dept Shenzhen, Shenzhen, Guangdong, Peoples R China; [Li, Weiping] Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China; [Sun, Zhonghua] Curtin Univ, Dept Med Radiat Sci, Perth, WA 6845, Australia	Anhui Medical University; Second People's Hospital of Shenzhen; Guangzhou Medical University; Second People's Hospital of Shenzhen; Curtin University	Li, WP (corresponding author), Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China.	liweiping60@yahoo.com.cn	Sun, Zhonghua/B-3125-2010; 黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022; Sun, Zhonghua/N-1648-2019	Sun, Zhonghua/0000-0002-7538-4761; Sun, Zhonghua/0000-0002-7538-4761	Shenzhen Development and Reform Commission [2012110]; Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform [20120830145119425]; Guangdong Province Science and Technology Project [2013B021800102]; Shenzhen Knowledge Innovation Program [20130322131035]; Shenzhen-based research project [JCYJ20140414170821262]	Shenzhen Development and Reform Commission; Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform; Guangdong Province Science and Technology Project; Shenzhen Knowledge Innovation Program; Shenzhen-based research project	This work was supported in part by Shenzhen Development and Reform Commission project "Shenzhen stroke screening and prevention public service platform" (2012110), the Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform (20120830145119425), Guangdong Province Science and Technology Project (2013B021800102), Shenzhen Knowledge Innovation Program (20130322131035) and Shenzhen-based research project (JCYJ20140414170821262).; This work was supported in part by Shenzhen Development and Reform Commission project "Shenzhen stroke screening and prevention public service platform" (2012110), the Shenzhen-based chronic disease tracking and monitoring and control of public service platform cloud platform (20120830145119425), Guangdong Province Science and Technology Project (2013B021800102), Shenzhen Knowledge Innovation Program (20130322131035) and Shenzhen-based research project (JCYJ20140414170821262).	Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bots ML, 2012, J AM COLL CARDIOL, V60, P1599, DOI 10.1016/j.jacc.2011.12.061; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Chirinos DA, 2015, J BEHAV MED, V38, P284, DOI 10.1007/s10865-014-9599-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conner W T, 1998, Evid Based Cardiovasc Med, V2, P71, DOI 10.1016/S1361-2611(98)80064-X; Herder M, 2012, STROKE, V43, P1818, DOI 10.1161/STROKEAHA.111.646596; Kabir AA, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.07.016; KANNEL WB, 1988, AM J CARDIOL, V62, P1109, DOI 10.1016/0002-9149(88)90558-9; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Liang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085927; Liapis CD, 2001, STROKE, V32, P2782, DOI 10.1161/hs1201.099797; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mostaza JM, 2015, ATHEROSCLEROSIS, V242, P377, DOI 10.1016/j.atherosclerosis.2015.07.028; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naqvi TZ, 2014, JACC-CARDIOVASC IMAG, V7, P1025, DOI 10.1016/j.jcmg.2013.11.014; Niu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067809; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pall D, 2003, CEREBROVASC DIS, V15, P167, DOI 10.1159/000068834; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Paul TK, 2005, AM J CARDIOL, V95, P469, DOI 10.1016/j.amjcard.2004.10.013; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Rothwell PM, 2000, LANCET, V355, P19, DOI 10.1016/S0140-6736(99)04470-0; Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745; Santos IS, 2015, ATHEROSCLEROSIS, V240, P529, DOI 10.1016/j.atherosclerosis.2015.04.800; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617; Sztajzel R, 2005, SWISS MED WKLY, V135, P635; Talelli P, 2007, J CLIN NEUROSCI, V14, P1067, DOI 10.1016/j.jocn.2006.06.019; Tattersall MC, 2014, STROKE, V45, P3257, DOI 10.1161/STROKEAHA.114.005669; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tsivgoulis G, 2006, STROKE, V37, P1913, DOI 10.1161/01.STR.0000226399.13528.0a; Urbina EM, 2009, CIRCULATION, V119, P2913, DOI 10.1161/CIRCULATIONAHA.108.830380; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; van der Meer IM, 2003, STROKE, V34, P2374, DOI 10.1161/01.STR.0000088643.07108.19; van Rooy MJ, 2014, CURR MED CHEM, V21, P2121; WALDSTEIN SR, 1991, PSYCHOL BULL, V110, P451, DOI 10.1037/0033-2909.110.3.451; Weingartner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013467; Yang YP, 2015, MED SCI MONITOR, V21, P2467, DOI 10.12659/MSM.894693; Yuan C, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/179686; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang FL, 2014, INT J CLIN EXP MED, V7, P5412	51	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144182	10.1371/journal.pone.0144182	http://dx.doi.org/10.1371/journal.pone.0144182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636669	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800054
J	Yin, P; Xu, JQ; He, SS; Liu, FH; Yin, J; Wan, CR; Mei, C; Yin, YL; Xu, XL; Xia, ZF				Yin, Peng; Xu, Jianqin; He, Shasha; Liu, Fenghua; Yin, Jie; Wan, Changrong; Mei, Chen; Yin, Yulong; Xu, Xiaolong; Xia, Zhaofei			Endoplasmic Reticulum Stress in Heat- and Shake-Induced Injury in the Rat Small Intestine	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; ER-STRESS; MONITORING AUTOPHAGY; TRIGGERS AUTOPHAGY; ANTIOXIDANT SYSTEM; SIGNALING PATHWAYS; INDUCED APOPTOSIS; GENE-EXPRESSION; DISEASE	We investigated the mechanisms underlying damage to rat small intestine in heat- and shake-induced stress. Eighteen Sprague-Dawley rats were randomly divided into a control group and a 3-day stressed group treated 2 h daily for 3 days on a rotary platform at 35 degrees C and 60 r/min. Hematoxylin and eosin-stained paraffin sections of the jejunum following stress revealed shedding of the villus tip epithelial cells and lamina propria exposure. Apoptosis increased at the villus tip and extended to the basement membrane. Photomicro-graphs revealed that the microvilli were shorter and sparser; the nuclear envelope invaginated and gaps in the karyolemma increased; and the endoplasmic reticulum (ER) swelled significantly. Gene microarray analysis assessed 93 differentially expressed genes associated with apoptosis, ER stress, and autophagy. Relevant genes were compiled from the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) data-bases. Forty-one genes were involved in the regulation of apoptosis, fifteen were related to autophagy, and eleven responded to ER stress. According to KEGG, the apoptosis pathways, mitogen-activated protein kinase(MAPK) signaling pathway, the mammalian target of rapamycin (mTOR) signaling pathway, and regulation of autophagy were involved. Caspase-3 (Casp3), caspase12 (Casp12), and microtubule-associate proteins 1 light chain 3 (LC3) increased significantly at the villus tip while mTOR decreased; phosphorylated-AKT (P-AKT) decreased. ER stress was involved and induced autophagy and apoptosis in rat intestinal damage following heat and shake stress. Bioinformatic analysis will help determine the underlying mechanisms in stress-induced damage in the small intestine.	[Yin, Peng; Xu, Jianqin; He, Shasha; Wan, Changrong; Xu, Xiaolong; Xia, Zhaofei] China Agr Univ, Coll Vet Med, BUA TCVM Teaching & Researching Team, Beijing, Peoples R China; [Liu, Fenghua; Mei, Chen] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Yin, Jie; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China	Beijing University of Agriculture; China Agricultural University; Beijing University of Agriculture; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Xia, ZF (corresponding author), China Agr Univ, Coll Vet Med, BUA TCVM Teaching & Researching Team, Beijing, Peoples R China.	liufenghua1209@126.com; yinyulong@isa.ac.cn; zhaofeixiacau@126.com		Xia, zhaofei/0000-0002-7567-1007; xu, xiaolong/0000-0003-3333-0906	National Natural Science Foundation of China [31572584, 31272478]; National Twelve-Five Technological Supported Plan of China [2011BAD34B01]; PHR (IHLB); Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects [201003060-9/10]; Chinese Academy of Science STS Project [KFJ-EW-STS-063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelve-Five Technological Supported Plan of China; PHR (IHLB); Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects; Chinese Academy of Science STS Project	This work was supported by grants from National Natural Science Foundation of China (No. 31572584 and No. 31272478), National Twelve-Five Technological Supported Plan of China (No. 2011BAD34B01), PHR (IHLB), Research Fund for the Doctoral Program of Higher Education of China and Ministry of Agriculture, Public Service Sectors Agriculture Research Projects (No. 201003060-9/10), and The Chinese Academy of Science STS Project (KFJ-EW-STS-063). The authors are thankful for the help from the members of CAU-BUA TCVM teaching & research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; HB, 1994, HOSP PRACT OFF ED, V29, P8; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KREGEL KC, 1988, J APPL PHYSIOL, V64, P2582, DOI 10.1152/jappl.1988.64.6.2582; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039120; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moriwaki Y, 1993, Nihon Geka Gakkai Zasshi, V94, P1017; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Novosad VL, 2013, AM J PHYSIOL-GASTR L, V305, pG418, DOI 10.1152/ajpgi.00166.2013; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shu B., 2013, THESIS; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wan CR, 2014, RES VET SCI, V96, P355, DOI 10.1016/j.rvsc.2014.01.008; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu HH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-19; Yan XH, 2012, AUTOPHAGY, V8, P213, DOI 10.4161/auto.8.2.18563; Yin J, 2014, J ANIM SCI, V92, P612, DOI 10.2527/jas.2013-6986; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122893; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin J, 2013, J FOOD AGRIC ENVIRON, V11, P132; Yin Peng, 2013, BIOTECHNOLOGY INDIAN, V8, P1561; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu J, 2013, STRESS, V16, P99, DOI 10.3109/10253890.2012.680526; Yu J, 2010, INT J HYPERTHER, V26, P538, DOI 10.3109/02656736.2010.481276; Yu J, 2010, COMP BIOCHEM PHYS A, V156, P119, DOI 10.1016/j.cbpa.2010.01.008; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	55	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143922	10.1371/journal.pone.0143922	http://dx.doi.org/10.1371/journal.pone.0143922			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636675	gold, Green Published, Green Submitted			2022-12-26	WOS:000366143800033
J	Basset, Y; Cizek, L; Cuenoud, P; Didham, RK; Novotny, V; Odegaard, F; Roslin, T; Tishechkin, AK; Schmidl, J; Winchester, NN; Roubik, DW; Aberlenc, HP; Bail, J; Barrios, H; Bridle, JR; Castano-Meneses, G; Corbara, B; Curletti, G; da Rocha, WD; De Bakker, D; Delabie, JHC; Dejean, A; Fagan, LL; Floren, A; Kitching, RL; Medianero, E; de Oliveira, EG; Orivel, J; Pollet, M; Rapp, M; Ribeiro, SP; Roisin, Y; Schmidt, JB; Sorensen, L; Lewinsohn, TM; Leponce, M				Basset, Yves; Cizek, Lukas; Cuenoud, Philippe; Didham, Raphael K.; Novotny, Vojtech; Odegaard, Frode; Roslin, Tomas; Tishechkin, Alexey K.; Schmidl, Juergen; Winchester, Neville N.; Roubik, David W.; Aberlenc, Henri-Pierre; Bail, Johannes; Barrios, Hector; Bridle, Jonathan R.; Castano-Meneses, Gabriela; Corbara, Bruno; Curletti, Gianfranco; da Rocha, Wesley Duarte; De Bakker, Domir; Delabie, Jacques H. C.; Dejean, Alain; Fagan, Laura L.; Floren, Andreas; Kitching, Roger L.; Medianero, Enrique; de Oliveira, Evandro Gama; Orivel, Jerome; Pollet, Marc; Rapp, Mathieu; Ribeiro, Servio P.; Roisin, Yves; Schmidt, Jesper B.; Sorensen, Line; Lewinsohn, Thomas M.; Leponce, Maurice			Arthropod Distribution in a Tropical Rainforest: Tackling a Four Dimensional Puzzle	PLOS ONE			English	Article							BETA-DIVERSITY; SPECIES RICHNESS; HERBIVOROUS INSECTS; ASSEMBLAGES; TREES; SPECIALIZATION; BIODIVERSITY; SIMILARITY; TURNOVER; STRATEGY	Quantifying the spatio-temporal distribution of arthropods in tropical rainforests represents a first step towards scrutinizing the global distribution of biodiversity on Earth. To date most studies have focused on narrow taxonomic groups or lack a design that allows partitioning of the components of diversity. Here, we consider an exceptionally large dataset (113,952 individuals representing 5,858 species), obtained from the San Lorenzo forest in Panama, where the phylogenetic breadth of arthropod taxa was surveyed using 14 protocols targeting the soil, litter, understory, lower and upper canopy habitats, replicated across seasons in 2003 and 2004. This dataset is used to explore the relative influence of horizontal, vertical and seasonal drivers of arthropod distribution in this forest. We considered arthropod abundance, observed and estimated species richness, additive decomposition of species richness, multiplicative partitioning of species diversity, variation in species composition, species turnover and guild structure as components of diversity. At the scale of our study (2km of distance, 40m in height and 400 days), the effects related to the vertical and seasonal dimensions were most important. Most adult arthropods were collected from the soil/litter or the upper canopy and species richness was highest in the canopy. We compared the distribution of arthropods and trees within our study system. Effects related to the seasonal dimension were stronger for arthropods than for trees. We conclude that: (1) models of beta diversity developed for tropical trees are unlikely to be applicable to tropical arthropods; (2) it is imperative that estimates of global biodiversity derived from mass collecting of arthropods in tropical rainforests embrace the strong vertical and seasonal partitioning observed here; and (3) given the high species turnover observed between seasons, global climate change may have severe consequences for rainforest arthropods.	[Basset, Yves; Roubik, David W.] STRI Res, Smithsonian Trop Res Inst, Panama City 080814, Panama; [Basset, Yves; Cizek, Lukas; Novotny, Vojtech] Univ South Bohemia, Biol Faculy, Ceske Budejovice 37005, Czech Republic; [Basset, Yves; Barrios, Hector; Medianero, Enrique] Univ Panama, Panama City 080814, Panama; [Cizek, Lukas; Novotny, Vojtech] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Ceske Budejovice 37005, Czech Republic; [Cuenoud, Philippe] Museum Hist Nat Ville Geneve, Dept Arthropodes & Entomol 1, CH-1208 Geneva, Switzerland; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Land & Water, Perth, WA 6009, Australia; [Odegaard, Frode] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Roslin, Tomas] Swedish Univ Agr Sci, Dept Ecol, SE-75007 Uppsala, Sweden; [Tishechkin, Alexey K.] Natl Museum Nat Hist, Dept Entomol, Washington, DC 20013 USA; [Schmidl, Juergen] Univ Erlangen Nurnberg, Dept Biol, D-91058 Erlangen, Germany; [Winchester, Neville N.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Aberlenc, Henri-Pierre] Cirad, Ctr Biol Gest Populat, F-34988 Montferrier Sur Lez, France; [Bridle, Jonathan R.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TH, Avon, England; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Fac Ciencias, Queretaro 76230, Mexico; [Corbara, Bruno] Univ Clermont Ferrand 2, Photochim Mol & Macromol Lab, CNRS, UMR 6023, F-63177 Clermont Ferrand, France; [Corbara, Bruno] Univ Blaise Pascal, F-63000 Clermont Ferrand, France; [Curletti, Gianfranco] Museo Civ Storia Nat, I-10022 Carmagnola, Italy; [da Rocha, Wesley Duarte] Univ Fed Minas Gerais, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; [De Bakker, Domir] Operat Directorate Nat Environm, Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Delabie, Jacques H. C.] Convenio UESC CEPLAC, Ctr Pesquisas Cacau, BR-45600000 Itabuna, Brazil; [Delabie, Jacques H. C.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, Brazil; [Dejean, Alain] Univ Toulouse 3, UMR EcoFoG, F-31062 Toulouse, France; [Fagan, Laura L.] Western Australia Dept Agr & Food Biosecur & Regu, Perth, WA 6151, Australia; [Floren, Andreas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany; [Kitching, Roger L.] Griffith Univ, Sch Environm, Nathan, Qld 4111, Australia; [de Oliveira, Evandro Gama] Ctr Univ Una, Ciencias Biol, BR-30180100 Belo Horizonte, MG, Brazil; [Orivel, Jerome] CNRS, UMR EcoFoG, F-97379 Kourou, France; [Pollet, Marc] Res Inst Nat & Forest, Res Grp Species Divers, B-1070 Brussels, Belgium; [Ribeiro, Servio P.] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, BR-35400000 Ouro Preto, MG, Brazil; [Roisin, Yves] Univ Libre Bruxelles, Evolutionary Biol & Ecol, B-1050 Brussels, Belgium; [Lewinsohn, Thomas M.] Univ Estadual Campinas, Dept Biol Anim, BR-13083870 Campinas, SP, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Universidad de Panama; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Norwegian Institute Nature Research; Swedish University of Agricultural Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Erlangen Nuremberg; University of Victoria; CIRAD; Institut de Recherche pour le Developpement (IRD); University of Bristol; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universidade Federal de Minas Gerais; Universidade Estadual de Santa Cruz; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wurzburg; Griffith University; Centro Universitario UNA; AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Research Institute for Nature & Forest; Universidade Federal de Ouro Preto; Universite Libre de Bruxelles; Universidade Estadual de Campinas	Basset, Y (corresponding author), STRI Res, Smithsonian Trop Res Inst, Panama City 080814, Panama.	bassety@si.edu	Novotny, Vojtech/G-9434-2014; Basset, Yves F/B-6642-2014; Didham, Raphael K/B-5953-2011; Lewinsohn, Thomas M/D-5880-2012; Ribeiro, Sérvio/G-1887-2012; Roslin, Tomas/E-8648-2016; Cizek, Lukas/G-7905-2014; Cizek, Lukas/K-7111-2015; Ribeiro, Sérvio Pontes/AAG-1146-2020	Novotny, Vojtech/0000-0001-7918-8023; Basset, Yves F/0000-0002-1942-5717; Lewinsohn, Thomas M/0000-0001-5950-5343; Ribeiro, Sérvio/0000-0002-0191-8759; Roslin, Tomas/0000-0002-2957-4791; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Ribeiro, Sérvio Pontes/0000-0002-0191-8759; Dejean, Alain/0000-0002-3561-2248; Roisin, Yves/0000-0001-6635-3552; Orivel, Jerome/0000-0002-5636-3228; Delabie, Jacques Hubert Charles/0000-0002-2695-1061; Bridle, Jonathan/0000-0002-5999-0307; CORBARA, Bruno/0000-0003-4232-8234	SolVin-Solvay SA; STRI; United Nations Environment Programme; Smithsonian Institution (Walcott Fund); European Science Foundation; Global Canopy Programme; Czech Science foundation GACR grant [14-36098G]; European Social Fund; Czech Ministry of Education [CZ.1.07/2.3.00/20.0064]; U.S. National Science Fundation [DEB-0841885]; Australian Research Council [FT100100040]; CNPq; "Investissement d'Avenir'' grant [ANR-10-LABX-25-01]; Norwegian Research Council; Grant Agency of the Czech Republic [14-36098G]	SolVin-Solvay SA(Solvay SA); STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); United Nations Environment Programme; Smithsonian Institution (Walcott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); European Science Foundation(European Science Foundation (ESF)European Commission); Global Canopy Programme; Czech Science foundation GACR grant; European Social Fund(European Social Fund (ESF)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); U.S. National Science Fundation; Australian Research Council(Australian Research Council); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Investissement d'Avenir'' grant(French National Research Agency (ANR)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	Core funding was provided from SolVin-Solvay SA, STRI, the United Nations Environment Programme, the Smithsonian Institution (Walcott Fund), the European Science Foundation, and the Global Canopy Programme. YB and HB are members of the Sistema Nacional de Investigacion of the SENACYT in Panama, and acknowledge the help of the Smithsonian Tropical Research Institute and Maestria Centroamericana de Entomologia, Universidad de Panama, during the preparation of the IBISCA-Panama project. YB was supported by Czech Science foundation GACR grant 14-36098G, European Social Fund and Czech Ministry of Education CZ.1.07/2.3.00/20.0064 and U.S. National Science Fundation DEB-0841885. RLK acknowledges the Queensland Government for provision of a visiting fellowship under its Queensland/Smithsonian Institution Scheme. RKD was supported by an Australian Research Council Future Fellowship FT100100040. SPR was supported by CNPq. JO was supported by a "Investissement d'Avenir'' grant managed by the Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-25-01). FO's research was funded by the Norwegian Research Council. VN was supported by the Grant Agency of the Czech Republic (14-36098G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; BASSET Y, 2003, ARTHROPODS TROPICAL; Basset Yves, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V77, P39; Basset Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136623; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; BIGGER M, 1976, NATURE, V259, P207, DOI 10.1038/259207a0; Blackburn TM, 2002, GLOBAL ECOL BIOGEOGR, V11, P185, DOI 10.1046/j.1466-822X.2002.00290.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Dauby G, 2012, ECOGRAPHY, V35, P661, DOI 10.1111/j.1600-0587.2011.06860.x; DeVries PJ, 1999, BIOL J LINN SOC, V68, P333, DOI 10.1111/j.1095-8312.1999.tb01175.x; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Feener DH, 1998, OECOLOGIA, V116, P191, DOI 10.1007/s004420050579; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Gomes-Westphalen JS, 2012, REV BIOL TROP, V60, P1025; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Grotan V, 2014, ECOGRAPHY, V37, P509, DOI 10.1111/ecog.00635; Hamilton AJ, 2013, OECOLOGIA, V171, P357, DOI 10.1007/s00442-012-2434-5; Holt Robert D., 1993, P77; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; Kitching RL, 2013, ECOGRAPHY, V36, P675, DOI 10.1111/j.1600-0587.2012.00023.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Odegaard F, 2004, ECOL ENTOMOL, V29, P76, DOI 10.1111/j.0307-6946.2004.00580.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pokon R, 2005, J TROP ECOL, V21, P595, DOI 10.1017/S0266467405002567; Ricklefs Robert E., 1993, P350; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; Soininen J, 2010, BIOSCIENCE, V60, P433, DOI 10.1525/bio.2010.60.6.7; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Speight MR, 2003, ARTHROPODS OF TROPICAL FORESTS, P380; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Stork N.E., 1997, CANOPY ARTHROPODS; Stork NE, 2014, J BIOGEOGR, V41, P421, DOI 10.1111/jbi.12223; Stork NE, 2013, INSECT CONSERV DIVER, V6, P67, DOI 10.1111/j.1752-4598.2012.00188.x; Weaver P. L., 2004, SAN LORENZO PROTECTE; Wolda H., 1987, P69; WOLDA H, 1989, OECOLOGIA, V80, P437, DOI 10.1007/BF00380064	52	69	78	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144110	10.1371/journal.pone.0144110	http://dx.doi.org/10.1371/journal.pone.0144110			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633187	Green Published, gold, Green Accepted			2022-12-26	WOS:000366040000058
J	Cheng, W; Liu, FF; Wang, Z; Zhang, Y; Zhao, YX; Zhang, QY; Jiang, F				Cheng, Wen; Liu, Fangfang; Wang, Zhe; Zhang, Yun; Zhao, Yu-Xia; Zhang, Qunye; Jiang, Fan			Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia	PLOS ONE			English	Article							APOPTOSIS-INDUCING-LIGAND; VASCULAR INFLAMMATION; HEALTHY-ADULTS; OSTEOPROTEGERIN; ATHEROSCLEROSIS; ASSOCIATIONS; INVOLVEMENT; ARTHRITIS; MARKER; CELLS	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a multi-functional cytokine, which is involved in the pathophysiological processes of cardiovascular and metabolic diseases. Previously, we demonstrated that TRAIL stimulated lipid uptake and foam cell formation in macrophages in vitro. Several clinical studies have suggested that the serum concentration of TRAIL may be increased in humans with elevated blood cholesterol; however, the current data appear to be inconclusive in this regard. In the present study, we examined the relationships between the serum TRAIL concentration and cholesterol levels in 352 generally healthy subjects undergoing the routine annual health check. We showed that there were significant correlations between TRAIL concentration and levels of total and low-density lipoprotein cholesterols. The level of TRAIL was significantly elevated in subjects with hypercholesterolemia, although this relationship might be also associated with changes of other metabolic factors. Moreover, we showed that the level of blood cholesterol was significantly higher in subjects in the upper quartile of serum TRAIL. In conclusion, our data demonstrate that the serum TRAIL concentration is elevated in people with hypercholesterolemia.	[Cheng, Wen; Liu, Fangfang; Zhang, Yun; Zhang, Qunye; Jiang, Fan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Wang, Zhe] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250012, Shandong, Peoples R China; [Zhao, Yu-Xia] Qilu Hosp, Dept Tradit Chinese Med, Jinan 250012, Shandong, Peoples R China; [Jiang, Fan] Shandong Univ, Sch Med, Dept Pathophysiol, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Qilu Hosp, Dept Tradit Chinese Med, 107 Wen Hua Xi Rd, Jinan 250012, Shandong, Peoples R China.	yxzhao@sdu.edu.cn; fjiang@sdu.edu.cn	Jiang, Fan/B-7753-2013	Jiang, Fan/0000-0001-9466-2192	National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [91539102]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC))	This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2012CB518603); National Natural Science Foundation of China (91539102); State Program of National Natural Science Foundation of China for Innovative Research Group (81021001).; The authors thank Xiao-Wei Wang for technical assistance in sample collection and processing. This work was partially supported by the following research grants: the National 973 Basic Research Program of China (2012CB518603); National Natural Science Foundation of China (91539102); State Program of National Natural Science Foundation of China for Innovative Research Group (81021001).	Ashley DT, 2011, METABOLISM, V60, P994, DOI 10.1016/j.metabol.2010.10.001; Azab NA, 2012, CLIN RHEUMATOL, V31, P1359, DOI 10.1007/s10067-012-2023-3; Bernardi S, 2012, CURR DRUG TARGETS, V13, P1215, DOI 10.2174/138945012802002357; Bisgin A, 2012, DIABETES RES CLIN PR, V96, pE84, DOI 10.1016/j.diabres.2012.02.028; Brombo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058225; Castellino G, 2010, RHEUMATOLOGY, V49, P1173, DOI 10.1093/rheumatology/keq064; Chaemsaithong P, 2013, J MATERN-FETAL NEO M, V26, P1568, DOI 10.3109/14767058.2013.783811; Cheng W, 2014, VASC PHARMACOL, V63, P135, DOI 10.1016/j.vph.2014.10.004; Choi JW, 2006, CLIN CHIM ACTA, V365, P113, DOI 10.1016/j.cca.2005.08.004; Choi JW, 2005, ANN HEMATOL, V84, P728, DOI 10.1007/s00277-005-1077-6; Choi JW, 2004, ANN CLIN LAB SCI, V34, P400; Corazza N, 2009, ANN NY ACAD SCI, V1171, P50, DOI 10.1111/j.1749-6632.2009.04905.x; Davenport C, 2012, EUR J CLIN INVEST, V42, P1173, DOI 10.1111/j.1365-2362.2012.02703.x; Deftereos S, 2012, HEART, V98, P214, DOI 10.1136/heartjnl-2011-300339; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Genc S, 2009, NEUROL SCI, V30, P263, DOI 10.1007/s10072-009-0047-5; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Holven KB, 2014, ATHEROSCLEROSIS, V233, P561, DOI 10.1016/j.atherosclerosis.2014.01.022; Kang S, 2010, ENDOCRINOLOGY, V151, P5638, DOI 10.1210/en.2009-0478; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Liu FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087059; Lub-de Hooge MN, 2004, SHOCK, V22, P186, DOI 10.1097/01.shk.0000132486.82177.ec; Lub-de Hooge MN, 2005, ANN RHEUM DIS, V64, P854, DOI 10.1136/ard.2004.029058; Mariani SM, 1998, EUR J IMMUNOL, V28, P973, DOI 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Neve A, 2014, CLIN EXP MED, V14, P115, DOI 10.1007/s10238-012-0226-1; O'Sullivan EP, 2010, DIABETES-METAB RES, V26, P496, DOI 10.1002/dmrr.1109; Perik PJ, 2006, ACTA ONCOL, V45, P175, DOI 10.1080/02841860500482225; Schaefer U, 2007, FRONT BIOSCI, V12, P3813, DOI 10.2741/2354; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Tornese G, 2014, ACTA DIABETOL, V51, P239, DOI 10.1007/s00592-013-0507-5; Yalcin AD, 2012, MED SCI MONITOR, V18, pPI11, DOI 10.12659/MSM.882504; Yan XH, 2009, IMMUNOGENETICS, V61, P551, DOI 10.1007/s00251-009-0389-4	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144015	10.1371/journal.pone.0144015	http://dx.doi.org/10.1371/journal.pone.0144015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633016	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000043
J	Fujiwara, Y; Kobayashi, S; Nagano, H; Kanai, M; Hatano, E; Toyoda, M; Ajiki, T; Takashima, Y; Yoshimura, K; Hamada, A; Minami, H; Ioka, T				Fujiwara, Yutaka; Kobayashi, Shogo; Nagano, Hiroaki; Kanai, Masashi; Hatano, Etsuo; Toyoda, Masanori; Ajiki, Tetsuo; Takashima, Yuki; Yoshimura, Kenichi; Hamada, Akinobu; Minami, Hironobu; Ioka, Tatsuya			Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)	PLOS ONE			English	Article							CHEMOTHERAPY IMPROVES SURVIVAL; PHASE-II; HILAR CHOLANGIOCARCINOMA; NUCLEOSIDE TRANSPORTERS; LIVER-REGENERATION; CARCINOMA; CISPLATIN; MULTICENTER; RESECTION; PLASMA	Background Biliary tract cancer (BTC) patients who have undergone surgical resection with major hepatectomy cannot tolerate the standard gemcitabine regimen (1,000 mg/m(2) on days 1, 8, and 15 every 4 weeks) due to severe toxicities such as myelosuppression. Our dose-finding study of adjuvant gemcitabine therapy for biliary tract cancer following major hepatectomy determined that the recommended dose is 1,000 mg/m(2) on days 1 and 15 every 4 weeks. Here, we evaluate the pharmacokinetics and pharmacodynamics of gemcitabine in these subjects. Methods We evaluated BTC patients scheduled to undergo surgical resection with major hepatectomy followed by gemcitabine therapy. A pharmacokinetic evaluation of gemcitabine and its main metabolite, 2',2'-difluorodeoxyuridine (dFdU), was conducted at the initial administration of gemcitabine, which was given by intravenous infusion over 30 min at a dose of 800-1,000 mg/m(2). Physical examination and adverse events were monitored for 12 weeks. Results Thirteen patients were enrolled from August 2011 to January 2013, with 12 ultimately completing the pharmacokinetic study. Eight patients had hilar cholangiocarcinoma, three had intrahepatic cholangiocarcinoma, and one had superficial spreading type cholangiocarcinoma. The median interval from surgery to first administration of gemcitabine was 65.5 days (range, 43-83 days). We observed the following toxicities: neutropenia (n = 11, 91.7%), leukopenia (n = 10, 83.3%), thrombocytopenia (n = 6, 50.0%), and infection (n = 5, 41.7%). Grade 3 or 4 neutropenia was observed in 25% (n = 3) of patients. There were differences in clearance of gemcitabine and dFdU between our subjects and the subjects who had not undergone hepatectomy. Conclusion Major hepatectomy did not affect the pharmacokinetics of gemcitabine or dFdU.	[Fujiwara, Yutaka; Toyoda, Masanori; Minami, Hironobu] Kobe Univ, Grad Sch Med, Div Med Oncol & Hematol, Kobe, Hyogo 657, Japan; [Fujiwara, Yutaka] Natl Canc Ctr, Dept Expt Therapeut, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan; [Kobayashi, Shogo; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Kanai, Masashi] Kyoto Univ Hosp, Outpatient Oncol Unit, Kyoto 606, Japan; [Hatano, Etsuo] Kyoto Univ Hosp, Grad Sch Med, Dept Surg, Kyoto 606, Japan; [Ajiki, Tetsuo] Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 657, Japan; [Takashima, Yuki; Hamada, Akinobu] Natl Canc Ctr, Res Inst, Dept Clin Pharmacol, Fundamental Innovat Oncol Core, Tokyo 104, Japan; [Yoshimura, Kenichi] Kanazawa Univ, Innovat Clin Res Ctr, Kanazawa, Ishikawa, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan	Kobe University; National Cancer Center - Japan; Osaka University; Kyoto University; Kyoto University; Kobe University; National Cancer Center - Japan; Kanazawa University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Fujiwara, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Med Oncol & Hematol, Kobe, Hyogo 657, Japan.	yutakafu@ncc.go.jp	Hatano, Etsuro/AAX-2407-2020; Fujiwara, Yutaka/ABB-4863-2020	Hatano, Etsuro/0000-0003-3407-1918; Fujiwara, Yutaka/0000-0001-6981-0800; Minami, Hironobu/0000-0001-8630-9145	Eli Lilly; Taiho; Yakult	Eli Lilly(Eli Lilly); Taiho; Yakult	The authors have the following interests: Y. Fujiwara has received research funding from Eli Lilly. M. Kanai has received research funding from Taiho. E. Hatano has received research funding from Eli Lilly. T. Ioka has received research funding from Taiho and Yakult and has honoraria from Eli Lilly, Taiho, and Yakult. The research funding from Eli Lilly, Taiho and Yakult does not relate to this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials as detailed online in the guide for authors.	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Andre T, 2004, ANN ONCOL, V15, P1339, DOI 10.1093/annonc/mdh351; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Bapiro TE, 2011, CANCER CHEMOTH PHARM, V68, P1243, DOI 10.1007/s00280-011-1613-0; BISMUTH H, 1992, ANN SURG, V215, P31, DOI 10.1097/00000658-199201000-00005; Ducreux M, 2005, EUR J CANCER, V41, P398, DOI 10.1016/j.ejca.2004.10.026; Ebrahem Q, 2012, ONCOTARGET, V3, P1137, DOI 10.18632/oncotarget.597; Eckel F, 2007, BRIT J CANCER, V96, P896, DOI 10.1038/sj.bjc.6603648; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P463, DOI 10.1007/s00534-008-1358-2; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; Gallardo JO, 2001, ANN ONCOL, V12, P1403, DOI 10.1023/A:1012543223020; Goto T, 2009, BRIT J SURG, V96, P4; Hata S, 2004, LIVER TRANSPLANT, V10, P65, DOI 10.1002/lt.20006; Hatano E, 2009, J JAPAN SURG SOC; Japan EL, 2013, COMMUNICATION, P10; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kobayashi S, 2014, CANCER CHEMOTH PHARM, V74, P699, DOI 10.1007/s00280-014-2543-4; Kume M, 2009, 47 ANN M JAP SOC CLI; Leonard GD, 2005, EXPERT OPIN PHARMACO, V6, P211, DOI 10.1517/14656566.6.2.211; Mackey JR, 1998, CANCER RES, V58, P4349; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Murakami Y, 2009, ANN SURG, V250, P950, DOI 10.1097/SLA.0b013e3181b0fc8b; Murakami Y, 2009, J GASTROINTEST SURG, V13, P1470, DOI 10.1007/s11605-009-0900-0; Nagakawa Takukazu, 2002, J Hepatobiliary Pancreat Surg, V9, P569, DOI 10.1007/s005340200076; Nakagami M, 1998, TRANSPLANT P, V30, P195, DOI 10.1016/S0041-1345(97)01229-3; Oh SH, 2007, GASTROENTEROLOGY, V132, P1077, DOI 10.1053/j.gastro.2007.01.001; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Rao S, 2005, BRIT J CANCER, V92, P1650, DOI 10.1038/sj.bjc.6602576; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Takahara T, 2012, CANCER CHEMOTH PHARM, V69, P1127, DOI 10.1007/s00280-011-1805-7; Thongprasert S, 2005, ANN ONCOL, V16, P279, DOI 10.1093/annonc/mdi046; Tsavaris N, 2004, INVEST NEW DRUG, V22, P193, DOI 10.1023/B:DRUG.0000011797.09549.53; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Xu Y, 2004, J CHROMATOGR B, V802, P263, DOI 10.1016/j.jchromb.2003.11.038	34	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143072	10.1371/journal.pone.0143072	http://dx.doi.org/10.1371/journal.pone.0143072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633034	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000008
J	Davis, WT; Drymon, JM; Powers, SP				Davis, William T.; Drymon, J. Marcus; Powers, Sean P.			Spatial and Dietary Overlap Creates Potential for Competition between Red Snapper (Lutjanus campechanus) and Vermilion snapper (Rhomboplites aurorubens)	PLOS ONE			English	Article							REEF; FISHERIES; MANAGEMENT; PERFORMANCE; MORTALITY; ECOLOGY; HABITAT; GROWTH; AGE	Understanding the complex nature of direct and indirect species interactions is a critical precursor to successful resource management. In the northern Gulf of Mexico fisheries ecosystem, red snapper (Lutjanus campechanus) and vermilion snapper (Rhomboplites aurorubens) are two commercially harvested species within a larger reef fish complex. These two species share similar habitats and diets; however, little is known about how these species partition habitat and dietary resources. In this study we examined the extent of spatial and dietary overlap between red snapper and vermilion snapper, and experimentally compared their feeding behavior. Field data from multiple gear types demonstrates that red snapper and vermilion snapper frequently cohabited reefs in the northern Gulf of Mexico, and Pianka's niche overlap indices suggest significantly overlapping diets. Experimental manipulations show that red snapper are the dominant forager of the two species, as red snapper foraging alone ate more shrimp per fish than vermilion snapper in both the single species (p = 0.003) and mixed species (p = 0.02) treatments. In addition, red snapper ate significantly more shrimp per fish in the mixed species treatment than in the single species treatment (p = 0.04). Vermilion snapper shrimp consumption per fish did not differ significantly between mixed and single species treatments. Cumulatively, our results suggest that spatial and dietary overlap could lead to competition between red and vermilion snapper in the study area; however, conclusively determining the existence of such competition would require further research.	[Davis, William T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Drymon, J. Marcus; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Drymon, J. Marcus; Powers, Sean P.] Dauphin Isl Sea Lab, Ctr Ecosyst Based Fishery Management, Dauphin Isl, AL 36528 USA	Princeton University; University of South Alabama; Dauphin Island Sea Lab	Drymon, JM (corresponding author), Univ S Alabama, Dept Marine Sci, LSCB Room 25, Mobile, AL 36688 USA.	mdrymon@disl.org		Powers, Sean/0000-0002-4770-9944	National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program [NOAA-NMFS-SE-2010-2001772]	National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program	This work was funded through a grant from the National Oceanic and Atmospheric Administration (NOAA) Fisheries Marine Fisheries Initiative (MARFIN) program (grant number NOAA-NMFS-SE-2010-2001772) to SPP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumariage D. S., 1966, FLA STATE BOARD CONS; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Chipps Steven R., 2007, P473; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Connell JH, 1975, ECOLOGY EVOLUTION CO, V460, P490; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; FABLE WA, 1980, CONTRIB MAR SCI, V23, P115; Fodrie FJ, 2008, ECOLOGY, V89, P3268, DOI 10.1890/07-1679.1; Geers T. M., 2014, DEEP SEA RES 2; Gotelli N. J., 2015, ECOSIMR NULL MODEL A, DOI 10.5281/zenodo.16522; Gregalis KC, 2012, T AM FISH SOC, V141, P1453, DOI 10.1080/00028487.2012.703154; GRIMES CB, 1982, B MAR SCI, V32, P277; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hixon MA, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P449; Johnson MW, 2010, T AM FISH SOC, V139, P1136, DOI 10.1577/T09-179.1; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Link JS, 2002, FISHERIES, V27, P18; McCawley JR, 2007, POPULATION ECOLOGY F, P77; NMFS, 2013, EC PROGR; Pianka E.R., 1976, P114; Saari CR, 2014, FISH B-NOAA, V112, P261, DOI 10.7755/FB.112.4.3; Sabo JL, 1997, CAN J FISH AQUAT SCI, V54, P2609, DOI 10.1139/cjfas-54-11-2609; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Simons JD, 2013, B MAR SCI, V89, P135, DOI 10.5343/bms.2011.1130; Simonsen KA, 2015, ENVIRON BIOL FISH, V98, P811, DOI 10.1007/s10641-014-0317-9; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Tarnecki JH, 2015, MAR COAST FISH, V7, P135, DOI 10.1080/19425120.2015.1020402; Topping DT, 2011, FISH RES, V112, P77, DOI 10.1016/j.fishres.2011.08.013; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Waters JR, 1996, EC SUMMARY COMMERCIA, P63; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425; Wells RJD, 2007, AM FISH S S, V60, P39	36	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144051	10.1371/journal.pone.0144051	http://dx.doi.org/10.1371/journal.pone.0144051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630481	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300149
J	Dorin-Semblat, D; Demarta-Gatsi, C; Hamelin, R; Armand, F; Carvalho, TG; Moniatte, M; Doerig, C				Dorin-Semblat, Dominique; Demarta-Gatsi, Claudia; Hamelin, Romain; Armand, Florence; Carvalho, Teresa Gil; Moniatte, Marc; Doerig, Christian			Malaria Parasite-Infected Erythrocytes Secrete PfCK1, the Plasmodium Homologue of the Pleiotropic Protein Kinase Casein Kinase 1	PLOS ONE			English	Article							FALCIPARUM; PHOSPHORYLATION; IDENTIFICATION; REVEALS; INVASION; CELL; INHIBITORS; EXPRESSION; GENE; RESISTANCE	Casein kinase 1 (CK1) is a pleiotropic protein kinase implicated in several fundamental processes of eukaryotic cell biology. Plasmodium falciparum encodes a single CK1 isoform, PfCK1, that is expressed at all stages of the parasite's life cycle. We have previously shown that the pfck1 gene cannot be disrupted, but that the locus can be modified if no loss-of-function is incurred, suggesting an important role for this kinase in intra-erythrocytic asexual proliferation. Here, we report on the use of parasite lines expressing GFP- or His-tagged PfCK1 from the endogenous locus to investigate (i) the dynamics of PfCK1 localisation during the asexual cycle in red blood cells, and (ii) potential interactors of PfCK1, so as to gain insight into the involvement of the enzyme in specific cellular processes. Immunofluorescence analysis reveals a dynamic localisation of PfCK1, with evidence for a pool of the enzyme being directed to the membrane of the host erythrocyte in the early stages of infection, followed by a predominantly intra-parasite localisation in trophozoites and schizonts and association with micronemes in merozoites. Furthermore, we present strong evidence that a pool of enzymatically active PfCK1 is secreted into the culture supernatant, demonstrating that PfCK1 is an ectokinase. Our interactome experiments and ensuing kinase assays using recombinant PfCK1 to phosphorylate putative interactors in vitro suggest an involvement of PfCK1 in many cellular processes such as mRNA splicing, protein trafficking, ribosomal, and host cell invasion.	[Dorin-Semblat, Dominique] Inst Natl Transfus Sanguine, UMR S1134, F-75015 Paris, France; [Demarta-Gatsi, Claudia] Inst Pasteur, Unite Biol Interact Hote Parasites, F-75015 Paris, France; [Hamelin, Romain; Armand, Florence; Moniatte, Marc] Ecole Polytech Fed Lausanne, Prote Core Facil, CH-1015 Lausanne, Switzerland; [Carvalho, Teresa Gil; Doerig, Christian] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia	UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Monash University	Doerig, C (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	christian.doerig@monash.edu	Dorin-Semblat, Dominique/P-5845-2017; Carvalho, Teresa/P-4333-2019; Doerig, Christian/Q-9900-2019	Dorin-Semblat, Dominique/0000-0002-8162-4573; Carvalho, Teresa/0000-0002-4947-371X; Moniatte, Marc/0000-0003-2235-4523	Inserm; Ecole Polytechnique Federale de Lausanne (EPFL); European Commission (MALSIG), Monash University; European Commission (ANTIMAL FP7 Projects), Monash University; European Commission (EviMalaR Network of Excellence), Monash University; Australian National Health and Medical Research Council (NHMRC)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ecole Polytechnique Federale de Lausanne (EPFL); European Commission (MALSIG), Monash University; European Commission (ANTIMAL FP7 Projects), Monash University; European Commission (EviMalaR Network of Excellence), Monash University; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Research in the Doerig laboratory leading to this report was supported by Inserm, Ecole Polytechnique Federale de Lausanne (EPFL), the European Commission (MALSIG and ANTIMAL FP7 Projects and EviMalaR Network of Excellence), Monash University, and the Australian National Health and Medical Research Council (NHMRC).	Abdi AI, 2013, MICROBIOL-SGM, V159, P2533, DOI 10.1099/mic.0.070409-0; Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Babu P, 2002, J CELL SCI, V115, P4957, DOI 10.1242/jcs.00203; Barik S, 1997, J BIOL CHEM, V272, P26132, DOI 10.1074/jbc.272.42.26132; Ben Rached F, 2012, BIOL CELL, V104, P34, DOI 10.1111/boc.201100081; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Carter R, 1993, Methods Mol Biol, V21, P67; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dan-Goor M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079287; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; Doerig C, 2015, NATURE REV MICROBIOL; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Donald RGK, 2005, MOL BIOCHEM PARASIT, V141, P15, DOI 10.1016/j.molbiopara.2005.01.011; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dorin D, 2005, MOL MICROBIOL, V55, P184, DOI 10.1111/j.1365-2958.2004.04393.x; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Dorin-Semblat D, 2008, EUKARYOT CELL, V7, P279, DOI 10.1128/EC.00245-07; Ezougou CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087695; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Harmse L, 2001, BIOCHEM PHARMACOL, V62, P341, DOI 10.1016/S0006-2952(01)00644-X; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Knight JR, 2012, KINOME, V1, P1; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Regev-Rudzki N, 2013, CELL, V153, P1120, DOI 10.1016/j.cell.2013.04.029; Roth AF, 2011, MOL BIOL CELL, V22, P2702, DOI 10.1091/mbc.E11-02-0115; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; Sebolt-Leopold JS, 2004, CURR PHARM DESIGN, V10, P1907, DOI 10.2174/1381612043384439; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Singh M, 2009, MOL CELL PROTEOMICS, V8, P2102, DOI 10.1074/mcp.M900029-MCP200; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Talevich E, 2012, PHILOS T R SOC B, V367, P2607, DOI 10.1098/rstb.2012.0014; Tarrab-Hazdai R, 2005, J PARASITOL, V91, P756, DOI 10.1645/GE-458R.1; Team RC, 2011, R A LANGUAGE AND ENV; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Walter J, 2000, J BIOL CHEM, V275, P23523, DOI 10.1074/jbc.M002850200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-490	58	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0139591	10.1371/journal.pone.0139591	http://dx.doi.org/10.1371/journal.pone.0139591			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629826	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300003
J	Garcia-Perez, R; Revilla-Nuin, B; Martinez, CM; Bernabe-Garcia, A; Mazo, AB; Paricio, PP				Garcia-Perez, Rocio; Revilla-Nuin, Beatriz; Martinez, Carlos M.; Bernabe-Garcia, Angel; Baroja Mazo, Alberto; Parrilla Paricio, Pascual			Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response?	PLOS ONE			English	Article							COLORECTAL-CANCER; BRANCH LIGATION; HYPERTROPHY; EMBOLIZATION; METASTASES; RESECTION; BETA; INDUCTION; OCCLUSION; MECHANISM	Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a two-stage hepatectomy technique which can be associated with a hypertrophic stimulus on the future liver remnant (FLR) stronger than other techniques-such as portal vein ligation (PVL). However, the reason of such hypertrophy is still unclear, but it is suggested that liver transection combined with portal vein ligation (ALPPS) during the first stage of this technique may play a key role. The aim of this study is to compare the hypertrophic stimulus on the FLR and the clinical changes associated with both ALPPS and PVL in a rat surgical model. For this purpose, three groups of SD rats were used, namely ALPPS (n = 30), PVL (n = 30) and sham-treated (n = 30). The second stage of ALPPS (hepatectomy of the atrophic lobes), was performed at day 8. Blood and FLR samples were collected at 1, 24, 48 hours, 8 days and 12 weeks after the surgeries. ALPPS provoked a greater degree of hypertrophy of the FLR than the PVL at 48 hours and 8 days (p<0.05). The molecular pattern was also different, with the highest expression of IL-1 beta at 24h, IL-6 at 8 days, and HGF and TNF-alpha at 48 hours and 8 days (p<0.05). ALPPS also brought about a mild proliferative stimulus at 12 weeks, with a higher expression of HGF and TGF-beta (p<0.05) than PVL. Clinically, ALPPS caused a significant liver damage during the first 48 hours, with a recovery of liver function at day 8. In conclusion, ALPPS seems to induce higher functional hypertrophy on the FLR than PVL at day 8. Such regenerative response seems to be leaded by a complex interaction between promitogenic (IL-6, HGF, TNF-alpha) and antiproliferative (IL1-beta and TGF-beta) cytokines.	[Garcia-Perez, Rocio; Revilla-Nuin, Beatriz; Martinez, Carlos M.; Bernabe-Garcia, Angel; Baroja Mazo, Alberto; Parrilla Paricio, Pascual] IMIB LAIB Res Ctr, Dept Surg, Expt Surg Unit, El Palmar, Murcia, Spain; [Revilla-Nuin, Beatriz; Martinez, Carlos M.; Parrilla Paricio, Pascual] CIBERehd, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Martinez, CM (corresponding author), IMIB LAIB Res Ctr, Dept Surg, Expt Surg Unit, El Palmar, Murcia, Spain.	cmmarti@um.es	Bernabé-García, Ángel/AAB-2934-2020; Martinez, Carlos M./E-4986-2016; Baroja-Mazo, Alberto/E-6270-2016	Bernabé-García, Ángel/0000-0002-2266-5949; Martinez, Carlos M./0000-0003-3307-1326; Baroja-Mazo, Alberto/0000-0001-5212-5006	Fundacion Cajamurcia [FFIS/CM10/002]	Fundacion Cajamurcia	This work was supported by the Fundacion Cajamurcia (www.fundacioncajamurcia.es), grant FFIS/CM10/002. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Abraldes JG, 2006, WORLD J GASTROENTERO, V12, P6577, DOI 10.3748/wjg.v12.i41.6577; Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; Aller MA, 2012, WORLD J HEPATOL, V4, P199, DOI 10.4254/wjh.v4.i7.199; Aussilhou B, 2008, J GASTROINTEST SURG, V12, P297, DOI 10.1007/s11605-007-0410-x; Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Bird TG, 2013, LANCET, V381, P23; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Boulton R, 1997, HEPATOLOGY, V26, P49; BRAUN L, 1988, P NATL ACAD SCI USA, V85, P1539, DOI 10.1073/pnas.85.5.1539; Broering DC, 2002, J GASTROINTEST SURG, V6, P905, DOI 10.1016/S1091-255X(02)00122-1; CHARI RS, 1995, AM J SURG, V169, P126, DOI 10.1016/S0002-9610(99)80120-2; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Ferko A, 2001, HEPATO-GASTROENTEROL, V48, P475; Figueras J, 2014, WORLD J SURG, V38, P1520, DOI 10.1007/s00268-014-2540-0; Furrer K, 2008, HEPATOLOGY, V47, P1615, DOI 10.1002/hep.22164; Heinrich S, 2013, J SURG ONCOL, V107, P579, DOI 10.1002/jso.23138; Iocca HA, 2003, AM J PATHOL, V163, P465, DOI 10.1016/S0002-9440(10)63676-0; Kim Robin D, 2008, Semin Intervent Radiol, V25, P92, DOI 10.1055/s-2008-1076679; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P556; Lambotte L, 2000, J HEPATOL, V32, P940, DOI 10.1016/S0168-8278(00)80098-7; Liska V, 2012, HEPATO-GASTROENTEROL, V59, P496, DOI 10.5754/hge10265; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mueller L, 2003, J SURG RES, V114, P146, DOI 10.1016/S0022-4804(03)00252-X; NAKATSUKASA H, 1990, LAB INVEST, V63, P171; Niehues SM, 2010, EUR J MED RES, V15, P345, DOI 10.1186/2047-783X-15-8-345; Ogiso T, 2007, J HEPATOL, V47, P816, DOI 10.1016/j.jhep.2007.06.017; Oldhafer KJ, 2014, WORLD J SURG, V38, P1504, DOI 10.1007/s00268-013-2401-2; ROZGA J, 1986, AM J PATHOL, V125, P300; Schadde E, 2014, WORLD J SURG, V38, P1510, DOI 10.1007/s00268-014-2513-3; Schlegel A, 2014, ANN SURG, V260, P839, DOI 10.1097/SLA.0000000000000949; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; SCHWEIZER W, 1995, J HEPATOL, V23, P71, DOI 10.1016/0168-8278(95)80313-0; Sotiropoulos GC, 2013, ANN SURG, V257, pE26, DOI 10.1097/SLA.0b013e3182942e4a; Tanaka K, 2007, J GASTROINTEST SURG, V11, P1154, DOI 10.1007/s11605-007-0221-0; Tashiro S, 2009, J HEPATO-BILIARY-PAN, V16, P292, DOI 10.1007/s00534-009-0058-x; Thenappan A, 2010, HEPATOLOGY, V51, P1373, DOI 10.1002/hep.23449; Tschuor C, 2013, EJSO-EUR J SURG ONC, V39, P1230, DOI 10.1016/j.ejso.2013.08.009; Wilms C, 2008, ANN SURG, V247, P825, DOI 10.1097/SLA.0b013e31816a9d7c; Yao LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105511; Zhong Z, 2010, LIVER TRANSPLANT, V16, P181, DOI 10.1002/lt.21966	47	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144096	10.1371/journal.pone.0144096	http://dx.doi.org/10.1371/journal.pone.0144096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630386	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300158
J	Mishra, S; Jakkala, K; Srinivasan, R; Arumugam, M; Ranjeri, R; Gupta, P; Rajeswari, H; Ajitkumar, P				Mishra, Saurabh; Jakkala, Kishor; Srinivasan, Ramanujam; Arumugam, Muthu; Ranjeri, Raghavendra; Gupta, Prabuddha; Rajeswari, Haryadi; Ajitkumar, Parthasarathi			NDK Interacts with FtsZ and Converts GDP to GTP to Trigger FtsZ Polymerisation - A Novel Role for NDK	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE KINASE; DIVISION PROTEIN FTSZ; MYCOBACTERIUM-TUBERCULOSIS FTSZ; MICROTUBULE ASSEMBLY INVITRO; BETA-GAMMA DIMERS; ESCHERICHIA-COLI; CELL-DIVISION; BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-BINDING	Introduction Nucleoside diphosphate kinase (NDK), conserved across bacteria to humans, synthesises NTP from NDP and ATP. The eukaryotic homologue, the NDPK, uses ATP to phosphorylate the tubulin-bound GDP to GTP for tubulin polymerisation. The bacterial cytokinetic protein FtsZ, which is the tubulin homologue, also uses GTP for polymerisation. Therefore, we examined whether NDK can interact with FtsZ to convert FtsZ-bound GDP and/or free GDP to GTP to trigger FtsZ polymerisation. Methods Recombinant and native NDK and FtsZ proteins of Mycobacterium smegmatis and Mycobacterium tuberculosis were used as the experimental samples. FtsZ polymersation was monitored using 90 degrees light scattering and FtsZ polymer pelleting assays. The gamma 32P-GTP synthesised by NDK from GDP and gamma 32P-ATP was detected using thin layer chromatography and quantitated using phosphorimager. The FtsZ bound P-32-GTP was quantitated using phosphorimager, after UV-crosslinking, followed by SDS-PAGE. The NDK-FtsZ interaction was determined using Ni2+-NTA-pulldown assay and co-immunoprecipitation of the recombinant and native proteins in vitro and ex vivo, respectively. Results NDK triggered instantaneous polymerisation of GDP-precharged recombinant FtsZ in the presence of ATP, similar to the polymerisation of recombinant FtsZ (not GDP-precharged) upon the direct addition of GTP. Similarly, NDK triggered polymerisation of recombinant FtsZ (not GDP-precharged) in the presence of free GDP and ATP as well. Mutant NDK, partially deficient in GTP synthesis from ATP and GDP, triggered low level of polymerisation of MsFtsZ, but not of MtFtsZ. As characteristic of NDK's NTP substrate non-specificity, it used CTP, TTP, and UTP also to convert GDP to GTP, to trigger FtsZ polymerisation. The NDK of one mycobacterial species could trigger the polymerisation of the FtsZ of another mycobacterial species. Both the recombinant and the native NDK and FtsZ showed interaction with each other in vitro and ex vivo, alluding to the possibility of direct phosphorylation of FtsZ-bound GDP by NDK. Conclusion Irrespective of the bacterial species, NDK interacts with FtsZ in vitro and ex vivo and, through the synthesis of GTP from FtsZ-bound GDP and/or free GDP, and ATP (CTP/TTP/UTP), triggers FtsZ polymerisation. The possible biological context of this novel activity of NDK is presented.	[Mishra, Saurabh; Jakkala, Kishor; Srinivasan, Ramanujam; Arumugam, Muthu; Ranjeri, Raghavendra; Gupta, Prabuddha; Rajeswari, Haryadi; Ajitkumar, Parthasarathi] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Ajitkumar, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	ajitkpartha@gmail.com	Muthu, Arumugam/AGO-2371-2022; Muthu, Arumugam/G-3336-2018; MISHRA, SAURABH/N-5686-2017; Srinivasan, Ramanujam/AAY-7779-2021	Muthu, Arumugam/0000-0003-4697-6925; Muthu, Arumugam/0000-0003-4697-6925; MISHRA, SAURABH/0000-0003-1590-884X; Srinivasan, Ramanujam/0000-0001-8071-6110; Gupta, Prabuddha/0000-0003-1009-2781	Indian Council of Medical Research, Government of India [63/72/2001-BMS]; DBT Programme Support - Pathogen Biology; UGC-CAS; DST-FIST; CSIR SRF; DBT-RA; DBT	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); DBT Programme Support - Pathogen Biology; UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences); DST-FIST(Department of Science & Technology (India)); CSIR SRF(Council of Scientific & Industrial Research (CSIR) - India); DBT-RA; DBT(Department of Biotechnology (DBT) India)	Funded by Research grant (63/72/2001-BMS) from the Indian Council of Medical Research, Government of India, to PA; DBT-funded Centre of Excellence in Tuberculosis Research, to PA; DBT Programme Support - Pathogen Biology - to Biological Sciences Division, Indian Institute of Science; UGC-CAS, and DST-FIST support to the MCB Dep't., Indian Institute of Science; CSIR SRF to SM; DBT-RA to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal SJ, 1999, BIOCHEMISTRY-US, V38, P4701, DOI 10.1021/bi9827565; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arumugam M., 2009, THESIS; Arumugam M, 2013, ACTA BIOCHIM POL, V60, P199; Arumugam Muthu, 2012, Open Biochem J, V6, P71, DOI 10.2174/1874091X01206010071; BERG P, 1953, NATURE, V172, P1008, DOI 10.1038/1721008a0; Bernard MA, 2000, J BIOENERG BIOMEMBR, V32, P259, DOI 10.1023/A:1005537013120; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; BOMINAAR AA, 1993, EMBO J, V12, P2275, DOI 10.1002/j.1460-2075.1993.tb05881.x; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; BURNS RG, 1981, EUR J BIOCHEM, V117, P515; CASHEL M, 1969, J CHROMATOGR, V40, P103, DOI 10.1016/S0021-9673(01)96624-5; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Cuello F, 2003, J BIOL CHEM, V278, P7220, DOI 10.1074/jbc.M210304200; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Erickson HP, 1996, J CELL BIOL, V135, P5, DOI 10.1083/jcb.135.1.5; Feucht A, 2005, MICROBIOL-SGM, V151, P2053, DOI 10.1099/mic.0.27899-0; FREESE E, 1979, J GEN MICROBIOL, V115, P193, DOI 10.1099/00221287-115-1-193; Gandhi VV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002078; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Georgescauld F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057867; Gupta P, 2009, THESIS; Gupta P, 2008, BIOCHEM BIOPH RES CO, V368, P445, DOI 10.1016/j.bbrc.2008.01.115; Gupta P, 2010, ACTA BIOCH BIOPH SIN, V42, P58, DOI 10.1093/abbs/gmp105; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; HUITOREL P, 1984, EUR J BIOCHEM, V144, P233, DOI 10.1111/j.1432-1033.1984.tb08455.x; JACOBS M, 1979, EUR J BIOCHEM, V99, P613, DOI 10.1111/j.1432-1033.1979.tb13294.x; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; KADRMAS EF, 1991, BIOCHIM BIOPHYS ACTA, V1074, P339, DOI 10.1016/0304-4165(91)90083-S; Kapatral V, 2000, J BACTERIOL, V182, P1333, DOI 10.1128/JB.182.5.1333-1339.2000; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; Kim YJ, 2014, INFECT IMMUN, V82, P3252, DOI 10.1128/IAI.02007-14; KIMURA N, 1990, BIOCHEM BIOPH RES CO, V168, P99, DOI 10.1016/0006-291X(90)91680-Q; Kirkpatrick CL, 2011, CURR OPIN MICROBIOL, V14, P691, DOI 10.1016/j.mib.2011.09.011; KOWLURU A, 1994, BIOCHEMISTRY-US, V33, P12495, DOI 10.1021/bi00207a017; KREBS HA, 1953, BIOCHIM BIOPHYS ACTA, V12, P172, DOI 10.1016/0006-3002(53)90136-X; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Kumar K, 2010, FUTURE MED CHEM, V2, P1305, DOI [10.4155/fmc.10.220, 10.4155/FMC.10.220]; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LECROISEY A, 1995, BIOCHEMISTRY-US, V34, P12445, DOI 10.1021/bi00038a043; Leung AKW, 2004, J MOL BIOL, V342, P953, DOI 10.1016/j.jmb.2004.07.061; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; MITANI T, 1977, BIOCHEM BIOPH RES CO, V77, P1118, DOI 10.1016/S0006-291X(77)80094-6; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Mukhopadhyay S, 1997, J BIOL CHEM, V272, P17815, DOI 10.1074/jbc.272.28.17815; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Neuhard J, 1987, ESCHERICHIA COLI SAL, P445; NICKERSON JA, 1984, J BIOL CHEM, V259, P1297; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; OHTSUKI K, 1986, BIOCHIM BIOPHYS ACTA, V882, P322, DOI 10.1016/0304-4165(86)90254-0; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Parks R.E., 1973, ENZYMES, V8, P307, DOI [10.1016/S1874-6047(08)60069-4, DOI 10.1016/S1874-6047(08)60069-4]; PENNINGROTH SM, 1977, J MOL BIOL, V115, P643, DOI 10.1016/0022-2836(77)90108-5; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; Raman K, 2009, MOL BIOSYST, V5, P1740, DOI [10.1039/B905817F, 10.1039/b905817f]; RAY NB, 1992, CURR TOP CELL REGUL, V33, P343; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Schaertl S, 1998, J BIOL CHEM, V273, P5662, DOI 10.1074/jbc.273.10.5662; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Snider NT, 2015, N-S ARCH PHARMACOL, V388, P189, DOI 10.1007/s00210-014-1046-5; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; TEPPER AD, 1994, J BIOL CHEM, V269, P32175; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Wieland T, 2007, N-S ARCH PHARMACOL, V374, P373, DOI 10.1007/s00210-006-0126-6; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911	88	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143677	10.1371/journal.pone.0143677	http://dx.doi.org/10.1371/journal.pone.0143677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630542	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000365926300080
J	Russell-Smith, J; Yates, CP; Edwards, AC; Whitehead, PJ; Murphy, BP; Lawes, MJ				Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.; Whitehead, Peter J.; Murphy, Brett P.; Lawes, Michael J.			Deriving Multiple Benefits from Carbon Market-Based Savanna Fire Management: An Australian Example	PLOS ONE			English	Article							MONSOONAL NORTHERN AUSTRALIA; KAKADU NATIONAL-PARK; CALLITRIS-INTRATROPICA CUPRESSACEAE; TROPICAL SAVANNAS; SMALL MAMMALS; SENSITIVE VEGETATION; FREQUENCY MATTERS; SANDSTONE HEATH; LAND-MANAGEMENT; ARNHEM PLATEAU	Carbon markets afford potentially useful opportunities for supporting socially and environmentally sustainable land management programs but, to date, have been little applied in globally significant fire-prone savanna settings. While fire is intrinsic to regulating the composition, structure and dynamics of savanna systems, in north Australian savannas frequent and extensive late dry season wildfires incur significant environmental, production and social impacts. Here we assess the potential of market-based savanna burning greenhouse gas emissions abatement and allied carbon biosequestration projects to deliver compatible environmental and broader socio-economic benefits in a highly biodiverse north Australian setting. Drawing on extensive regional ecological knowledge of fire regime effects on fire-vulnerable taxa and communities, we compare three fire regime metrics (seasonal fire frequency, proportion of long-unburnt vegetation, fire patch-size distribution) over a 15-year period for three national parks with an indigenously (Aboriginal) owned and managed market-based emissions abatement enterprise. Our assessment indicates improved fire management outcomes under the emissions abatement program, and mostly little change or declining outcomes on the parks. We attribute improved outcomes and putative biodiversity benefits under the abatement program to enhanced strategic management made possible by the market-based mitigation arrangement. For these same sites we estimate quanta of carbon credits that could be delivered under realistic enhanced fire management practice, using currently available and developing accredited Australian savanna burning accounting methods. We conclude that, in appropriate situations, market-based savanna burning activities can provide transformative climate change mitigation, ecosystem health, and community benefits in northern Australia, and, despite significant challenges, potentially in other fire-prone savanna settings.	[Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.; Whitehead, Peter J.] Charles Darwin Univ, Darwin Ctr Bushfires Res, Darwin, NT 0909, Australia; [Russell-Smith, Jeremy; Whitehead, Peter J.] North Australian Indigenous Land & Sea Management, Darwin, NT, Australia; [Russell-Smith, Jeremy; Yates, Cameron P.; Edwards, Andrew C.] Australian Natl Univ, Long Term Ecol Res Network, Canberra, ACT, Australia; [Murphy, Brett P.; Lawes, Michael J.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia	Charles Darwin University; Australian National University; Charles Darwin University	Russell-Smith, J (corresponding author), Charles Darwin Univ, Darwin Ctr Bushfires Res, Darwin, NT 0909, Australia.	jeremy.russell-smith@cdu.edu.au	Murphy, Brett Patrick/A-3991-2011; Lawes, Michael J/N-2132-2013	Murphy, Brett Patrick/0000-0002-8230-3069; Lawes, Michael J/0000-0002-2381-6147; Russell-Smith, Jeremy/0000-0003-1489-2866	Long-term Ecological Research Network, Australian National University, Canberra; Department of Environment, Government of Australia, Canberra	Long-term Ecological Research Network, Australian National University, Canberra; Department of Environment, Government of Australia, Canberra	This work was supported by the Long-term Ecological Research Network, Australian National University, Canberra, toJR-S, and by the Department of Environment (and predecessor agencies), Government of Australia, Canberra, to JR-S, CPY, ACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2012, AUSTRAL ECOL, V37, P658, DOI 10.1111/j.1442-9993.2011.02334.x; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Barrow PH, 2008, ROLE FIRE ECOLOGY LE; Beringer J, 2015, GLOBAL CHANGE BIOL, V21, P62, DOI 10.1111/gcb.12686; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; BOWMAN DMJS, 1993, J BIOGEOGR, V20, P373, DOI 10.2307/2845586; Brazill-Boast J, 2011, EMU, V111, P304, DOI 10.1071/MU10064; Bureau of Meteorology (BoM), 2014, STAT CLIM 2014; Bustamante M, 2014, GLOBAL CHANGE BIOL, V20, P3270, DOI 10.1111/gcb.12591; CoA (Commonwealth of Australia), 2015, CARB CRED CARB FARM; CoA (Commonwealth of Australia), 2015, EM RED FUND; CoA (Commonwealth of Australia), 2012, CARB FARM RED GREENH; CoA (Commonwealth of Australia), 2012, NAT PROT AMH PLAT SA; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cook G. D., 2009, Culture, ecology and economy of fire management in North Australian savannas: rekindling the Wurrk tradition, P313; Cook GD, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P321; Djoeroemana S, 2007, INTEGRATED RURAL DEV; Dyer R., 2001, SAVANNA BURNING UNDE; Edwards A, 2015, INT J WILDLAND FIRE; Edwards AC, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P169; Edwards AC, 2009, INT J WILDLAND FIRE, V18, P127, DOI 10.1071/WF08008; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; FAO, 2007, 151 FAO UN; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Fisher R, 2015, CARBON ACCOUNTING AND SAVANNA FIRE MANAGEMENT, P57; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Fraser F, 2003, ECOLOGICAL MANAGEMEN, V4; Fui LH, 2012, WORLD FORESTS, V12, P357, DOI 10.1007/978-94-007-2144-9_10; Garde M, 2009, MANAGING FIRE REGIME, P86; Gardner TA, 2012, BIOL CONSERV, V154, P61, DOI 10.1016/j.biocon.2011.11.018; George M., 2014, RESPECT CENTRAL ROLE; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Griffiths AD, 2015, BIOL CONSERV, V186, P337, DOI 10.1016/j.biocon.2015.03.021; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Johnston FH, 2002, MED J AUSTRALIA, V176, P535, DOI 10.5694/j.1326-5377.2002.tb04551.x; Kerins S., 2012, PEOPLE COUNTRY VITAL, P26; Lawes MJ, 2011, OECOLOGIA, V166, P229, DOI 10.1007/s00442-010-1829-4; Lawes MJ, 2015, INT J WILDLAND FIRE, V24, P712, DOI 10.1071/WF14163; Lawrence D, 2000, KAKADU MAKING NATL P; Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013; Legge S, 2008, WILDLIFE RES, V35, P33, DOI 10.1071/WR07016; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; Lowe L, 1995, J ORTHOPTERA RES; Lyster R, 2011, ENVIRON SCI POLICY, V14, P118, DOI 10.1016/j.envsci.2010.11.008; McLean I, 2014, BCOM0348 MEAT LIV AU; Mertz O, 2009, HUM ECOL, V37, P281, DOI 10.1007/s10745-009-9249-y; Meyer CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017671; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Murphy B.P., 2009, MANAGING FIRE REGIME; Murphy BP, 2015, J APPL ECOL, V52, P980, DOI 10.1111/1365-2664.12455; Murphy BP, 2010, GLOBAL CHANGE BIOL, V16, P331, DOI 10.1111/j.1365-2486.2009.01933.x; NLAWT (Northern Australia Land and Water Taskforce), 2009, SUST DEV NO AUSTR; Oliveira SLJ, 2015, FIRE ECOLOGY, V11; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Pfeifer M, 2013, ENVIRON CONSERV, V40, P241, DOI 10.1017/S0376892912000379; Price O, 2003, INT J WILDLAND FIRE, V12, P227, DOI 10.1071/WF03040; Price OF, 2012, INT J WILDLAND FIRE, V21, P297, DOI 10.1071/WF10079; Prior LD, 2007, ECOL RES, V22, P228, DOI 10.1007/s11284-006-0011-2; Radford IJ, 2012, AUSTRAL ECOL, V37, P926, DOI 10.1111/j.1442-9993.2011.02352.x; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Ritchie D, 2009, CULTURE ECOLOGY EC S; Russell-Smith J, 1998, J APPL ECOL, V35, P829, DOI 10.1111/j.1365-2664.1998.tb00002.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2002, BIOL CONSERV, V104, P91, DOI 10.1016/S0006-3207(01)00157-4; Russell-Smith J, 2013, CLIMATIC CHANGE, V121, P1; Russell-Smith J, 2014, BIODIVERSITY ENV CHA, P335; Russell-Smith J, 2009, INT J WILDLAND FIRE, V18, P1, DOI 10.1071/WF08009; Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018; Russell-Smith J, 2006, INT J WILDLAND FIRE, V15, P551, DOI 10.1071/WF05112; Russell-Smith J, 2006, INT J WILDLAND FIRE, V15, P541, DOI 10.1071/WF05111; Russell-Smith J, 2006, AUST J BOT, V54, P479, DOI 10.1071/BT05133; Russell-Smith J, 2013, FRONT ECOL ENVIRON, V11, pE55, DOI 10.1890/120251; Russell-Smith J, 2012, J BIOGEOGR, V39, P1303, DOI 10.1111/j.1365-2699.2012.02679.x; Russell-Smith J, 2010, ECOL APPL, V20, P1615, DOI 10.1890/09-1553.1; RUSSELLSMITH J, 1992, BIOL CONSERV, V59, P51, DOI 10.1016/0006-3207(92)90713-W; RussellSmith J, 1997, J APPL ECOL, V34, P748, DOI 10.2307/2404920; Sankaran M., 2013, ENCY BIODIVERSITY, P58, DOI DOI 10.1016/B978-0-12-384719-5.00355-5; Setterfield SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059144; Setterfield SA, 2010, DIVERS DISTRIB, V16, P854, DOI 10.1111/j.1472-4642.2010.00688.x; Skroblin A, 2013, EMU, V113, P309, DOI 10.1071/MU12075; SoE, 2011, AUSTR STAT ENV 2011; Standard) VVC, 2015, VM0029 METH AV FOR D; Tacconi L, 2003, 38 CIFOR; Townsend SA, 2000, J HYDROL, V229, P118, DOI 10.1016/S0022-1694(00)00165-7; UN, 1997, REP C PART ITS 21 SE; UNFCCC (United Nations Framework Convention on Climate Change), 2005, FCCCKPCMP20058; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; van Vliet N, 2012, GLOBAL ENV CHANGE, V22; Walsh D, 2014, RANGELAND J, V36, P313, DOI 10.1071/RJ13122; Williams M.A.J., 1991, MONSOONAL AUSTR LAND, P5; Williams Richard J., 2002, P281; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Williams RJ, 1998, INT J WILDLAND FIRE, V8, P227, DOI 10.1071/WF9980227; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski JCZ, 2013, EMU, V113, P319, DOI 10.1071/MU12109; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; Woinarski J. C. Z., 2014, STRATEGY CONSERVATIO; Woinarski JCZ, 2005, WILDLIFE RES, V32, P377, DOI 10.1071/WR03008; Woinarski JCZ, 2001, AUSTRAL ECOL, V26, P360, DOI 10.1046/j.1442-9993.2001.01121.x; Woinarski JCZ, 1992, CONSERVATION STATUS; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yates CP, 2008, INT J WILDLAND FIRE, V17, P768, DOI 10.1071/WF07150; Yibarbuk D, 2001, J BIOGEOGR, V28, P325, DOI 10.1046/j.1365-2699.2001.00555.x; Ziembicki Mark R., 2015, Therya, V6, P169, DOI 10.12933/therya-15-236	107	49	49	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143426	10.1371/journal.pone.0143426	http://dx.doi.org/10.1371/journal.pone.0143426			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630453	Green Published, gold			2022-12-26	WOS:000365926300049
J	Hidaka, M; Gotoh, A; Shimizu, T; Minamisawa, K; Imamura, H; Uchida, T				Hidaka, Masafumi; Gotoh, Aina; Shimizu, Taiki; Minamisawa, Kiwamu; Imamura, Hiromi; Uchida, Takafumi			Visualization of NO3-/NO2- Dynamics in Living Cells by Fluorescence Resonance Energy Transfer ( FRET) Imaging Employing a Rhizobial Two-component Regulatory System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; BRADYRHIZOBIUM-JAPONICUM; NITRATE ASSIMILATION; VEGETABLE INTAKE; IN-VIVO; PROTEIN; ANTITERMINATION; OPERON; THERAPEUTICS; REDUCTASE	Nitrate (NO3-) and nitrite (NO2-) are the physiological sources of nitric oxide (NO), a key biological messenger molecule. NO3-/NO2- exerts a beneficial impact on NO homeostasis and its related cardiovascular functions. To visualize the physiological dynamics of NO3-/NO2- for assessing the precise roles of these anions, we developed a genetically encoded intermolecular fluorescence resonance energy transfer (FRET)-based indicator, named sNOOOpy (sensor for NO3-/NO2- in physiology), by employing NO3-/NO2--induced dissociation of NasST involved in the denitrification system of rhizobia. The in vitro use of sNOOOpy shows high specificity for NO3- and NO2-, and its FRET signal is changed in response to NO3-/NO2- in the micromolar range. Furthermore, both an increase and decrease in cellular NO3- concentration can be detected. sNOOOpy is very simple and potentially applicable to a wide variety of living cells and is expected to provide insights into NO3-/NO2- dynamics in various organisms, including plants and animals.	[Hidaka, Masafumi; Gotoh, Aina; Shimizu, Taiki; Uchida, Takafumi] Tohoku Univ, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan; [Minamisawa, Kiwamu] Tohoku Univ, Dept Environm Life Sci, Sendai, Miyagi 9808577, Japan; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan	Tohoku University; Tohoku University; Kyoto University	Uchida, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci,Mol Enzymol, Aoba Ku, 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp	Imamura, Hiromi/AAD-5109-2019; Minamisawa, Kiwamu/C-1585-2017	Imamura, Hiromi/0000-0002-1896-0443; Minamisawa, Kiwamu/0000-0001-7302-4079; Gotoh, Aina/0000-0002-0979-2265; Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24780092, 26850042, 26252065, 26252064, 26660287]; BRAIN; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry [25028A]; Grants-in-Aid for Scientific Research [26850042, 26252065, 26291027, 26252064] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BRAIN; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by Grants-in-aid for Young Scientist (B) 24780092 and 26850042 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.r Supported by BRAIN and Grant-in-aid for Scientific Research (A) 26252065 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.r Supported by Grant-in-aid for Scientific Research (A) 26252064, Grant-in-aid for Challenging Exploratory Research 26660287 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry Grant 25028A. To whom correspondence should be addressed: Molecular Enzymology, Dept. of Molecular Cell Science, Graduate School of Agricultural Science, Tohoku University, 1-1 Amamiya, Tsutsumidori, Aoba, Sendai, Miyagi 981-8555, Japan. Tel.: 81-22-717-8775; Fax: 81-22-717-8778; E-mail: uchidat@biochem.tohoku.ac.jp.	Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Butler AR, 2008, CIRCULATION, V117, P2151, DOI 10.1161/CIRCULATIONAHA.107.753814; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2006, NITRIC OXIDE-BIOL CH, V15, P359, DOI 10.1016/j.niox.2006.01.013; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Luque-Almagro VM, 2013, J BIOL CHEM, V288, P29692, DOI 10.1074/jbc.M113.459032; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; McKnight GM, 1999, BRIT J NUTR, V81, P349, DOI 10.1017/S000711459900063X; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; Patterson G, 2001, J CELL SCI, V114, P837; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sanchez C, 2014, ENVIRON MICROBIOL, V16, P3263, DOI 10.1111/1462-2920.12546; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang YP, 2011, CURR OPIN LIPIDOL, V22, P11, DOI 10.1097/MOL.0b013e328341942c; Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054; Wang BM, 2012, APPL ENVIRON MICROB, V78, P6558, DOI 10.1128/AEM.01720-12; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wilson SA, 1996, EMBO J, V15, P5907, DOI 10.1002/j.1460-2075.1996.tb00977.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	37	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2260	2269		10.1074/jbc.M115.687632	http://dx.doi.org/10.1074/jbc.M115.687632			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26631727	Green Published, hybrid			2022-12-26	WOS:000369610400017
J	Misra, BB; de Armas, E; Tong, ZH; Chen, SX				Misra, Biswapriya B.; de Armas, Evaldo; Tong, Zhaohui; Chen, Sixue			Metabolomic Responses of Guard Cells and Mesophyll Cells to Bicarbonate	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; INDUCED STOMATAL CLOSURE; INTEGRATED METHOD; PROTEIN-KINASE; CROP YIELD; RISING CO2; PLANTS; PHOTOSYNTHESIS; ARABIDOPSIS; MECHANISMS	Anthropogenic CO2 presently at 400 ppm is expected to reach 550 ppm in 2050, an increment expected to affect plant growth and productivity. Paired stomatal guard cells (GCs) are the gate-way for water, CO2, and pathogen, while mesophyll cells (MCs) represent the bulk cell-type of green leaves mainly for photosynthesis. We used the two different cell types, i.e., GCs and MCs from canola (Brassica napus) to profile metabolomic changes upon increased CO2 through supplementation with bicarbonate (HCO3-). Two metabolomics platforms enabled quantification of 268 metabolites in a time-course study to reveal short-term responses. The HCO3- responsive metabolomes of the cell types differed in their responsiveness. The MCs demonstrated increased amino acids, phenylpropanoids, redox metabolites, auxins and cytokinins, all of which were decreased in GCs in response to HCO3-. In addition, the GCs showed differential increases of primary C-metabolites, N-metabolites (e.g., purines and amino acids), and defense-responsive pathways (e.g., alkaloids, phenolics, and flavonoids) as compared to the MCs, indicating differential C/N homeostasis in the cell-types. The metabolomics results provide insights into plant responses and crop productivity under future climatic changes where elevated CO2 conditions are to take center-stage.	[Misra, Biswapriya B.; Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA; [de Armas, Evaldo] Thermo Fisher Sci, Training Inst, W Palm Beach, FL 33407 USA; [Tong, Zhaohui] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; Thermo Fisher Scientific; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chen, SX (corresponding author), Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA.	schen@ufl.edu	Tong, Zhaohui/HGC-0747-2022; CHEN, SI/GZL-4800-2022; Misra, Biswapriya B./D-2055-2012	Misra, Biswapriya B./0000-0003-2589-6539	National Science Foundation [MCB-1158000]; U.S. National Science Foundation grant [MCB-1158000]; Div Of Molecular and Cellular Bioscience [1158000] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. National Science Foundation grant(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation grant MCB-1158000 to SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Fei Wang in the Tong lab is thanked for technical assistance with GC-MS analysis. This work was supported by the U.S. National Science Foundation grant MCB-1158000 to SC.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Assmann SM, 1999, PLANT CELL ENVIRON, V22, P629, DOI 10.1046/j.1365-3040.1999.00408.x; Azoulay-Shemer T, 2015, PLANT J, V83, P567, DOI 10.1111/tpj.12916; Baba M, 2011, PLANT CELL PHYSIOL, V52, P1302, DOI 10.1093/pcp/pcr078; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Beardall J, 1998, CAN J BOT, V76, P1010, DOI 10.1139/b98-079; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chen SX, 2000, J BIOL CHEM, V275, P22955, DOI 10.1074/jbc.M002768200; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Daloso DM, 2015, PLANT CELL ENVIRON, V38, P2353, DOI 10.1111/pce.12555; Dubovskaya LV, 2011, NEW PHYTOL, V191, P57, DOI 10.1111/j.1469-8137.2011.03661.x; During H., 2015, VITIS J GRAPEVINE RE, V42, P65; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Evans JR, 1996, PLANT PHYSIOL, V110, P339, DOI 10.1104/pp.110.2.339; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Fukayama H, 2011, FIELD CROP RES, V121, P195, DOI 10.1016/j.fcr.2010.11.018; Geissler N, 2010, PLANTA, V231, P583, DOI 10.1007/s00425-009-1064-6; Gillespie KM, 2012, PLANT CELL ENVIRON, V35, P169, DOI 10.1111/j.1365-3040.2011.02427.x; Grapov D., 2014, DEVIUMWEB VERSION 0, DOI [10.5281/zenodo.12879, DOI 10.5281/ZENODO.12879]; HAMPP R, 1982, PLANT PHYSIOL, V70, P1582, DOI 10.1104/pp.70.6.1582; HARRIS PJ, 1980, J SCI FOOD AGR, V31, P959, DOI 10.1002/jsfa.2740310914; Haworth M, 2015, AM J BOT, V102, P677, DOI 10.3732/ajb.1400508; Hu HH, 2015, PLANT PHYSIOL, V169, P1168, DOI 10.1104/pp.15.00646; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Hutzler P, 1998, J EXP BOT, V49, P953, DOI 10.1093/jexbot/49.323.953; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jin XF, 2013, PLANT CELL, V25, P4789, DOI 10.1105/tpc.113.119800; Joudoi T, 2013, PLANT CELL, V25, P558, DOI 10.1105/tpc.112.105049; Kafer C, 2004, FRONT BIOSCI-LANDMRK, V9, P1611; Kamennaya NA, 2015, METAB ENG, V29, P76, DOI 10.1016/j.ymben.2015.03.002; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043583; Kolla VA, 2007, PLANTA, V225, P1421, DOI 10.1007/s00425-006-0450-6; Kolla VA, 2007, PHYSIOL PLANTARUM, V130, P91, DOI 10.1111/j.1399-3054.2007.00887.x; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kuehn H., 2008, CURR PROTOC BIOINFOR, V22, P7; Lammertyn J, 2001, J EXP BOT, V52, P1769, DOI 10.1093/jexbot/52.362.1769; Levine LH, 2008, ADV SPACE RES, V42, P1917, DOI 10.1016/j.asr.2008.07.014; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Li X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03433; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Matrosova A, 2015, NEW PHYTOL, V208, P1126, DOI 10.1111/nph.13566; Medeiros DB, 2015, PLANT CELL ENVIRON, V38, P1457, DOI 10.1111/pce.12517; Misra BB, 2015, METABOLOMICS, V11, P1478, DOI 10.1007/s11306-015-0825-4; Misra BB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00334; Misra BB, 2014, TRENDS PLANT SCI, V19, P637, DOI 10.1016/j.tplants.2014.05.005; Miyagi A, 2011, METABOLOMICS, V7, P524, DOI 10.1007/s11306-010-0272-1; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; MRINALINI T, 1982, NEW PHYTOL, V91, P413, DOI 10.1111/j.1469-8137.1982.tb03320.x; Papadimitropoulos MEP, 2015, COMBINED STRESSES PL, P49; Perez-Lopez U, 2009, PHYSIOL PLANTARUM, V135, P29, DOI 10.1111/j.1399-3054.2008.01174.x; Price GD, 2011, PLANT PHYSIOL, V155, P20, DOI 10.1104/pp.110.164681; Prior SA, 2004, ENCY PLANT CROP SCI, P648; Qiu QS, 2008, PHOTOSYNTH RES, V97, P155, DOI 10.1007/s11120-008-9310-5; Ramanan R, 2012, ALGAE-SEOUL, V27, P295, DOI 10.4490/algae.2012.27.4.295; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Runion GB, 2010, NEW FOREST, V39, P275, DOI 10.1007/s11056-009-9170-7; Scheible WR, 1997, PLANT CELL, V9, P783, DOI 10.1105/tpc.9.5.783; Shinde S, 2015, J EXP BOT, V66, P4001, DOI 10.1093/jxb/erv197; Sokal R. R., 1995, BIOMETRY PRINCIPLES, P337; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Sun YC, 2015, GLOBAL CHANGE BIOL, V21, P2739, DOI 10.1111/gcb.12858; Tallis MJ, 2010, NEW PHYTOL, V186, P415, DOI 10.1111/j.1469-8137.2010.03184.x; Tian W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7057; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Watkins JM, 2014, PLANT PHYSIOL, V164, P1707, DOI 10.1104/pp.113.233528; Wei AL, 2015, ECOTOX ENVIRON SAFE, V114, P198, DOI 10.1016/j.ecoenv.2015.01.024; Wei AL, 2013, ECOTOX ENVIRON SAFE, V98, P41, DOI 10.1016/j.ecoenv.2013.09.029; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68; Yamano T, 2015, P NATL ACAD SCI USA, P01659; Yi HL, 2012, ECOTOX ENVIRON SAFE, V78, P281, DOI 10.1016/j.ecoenv.2011.11.035; Zhang S, 2015, J EXP BOT, V66, P1951, DOI 10.1093/jxb/eru538; Ziska L, 2008, CLIMATIC CHANGE, V91, P395, DOI 10.1007/s10584-008-9418-9; Ziska LH, 2005, GLOBAL CHANGE BIOL, V11, P1798, DOI 10.1111/j.1365-2486.2005.001029.x; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	92	25	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144206	10.1371/journal.pone.0144206	http://dx.doi.org/10.1371/journal.pone.0144206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641455	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700077
J	Hager, C; Keubler, LM; Biernot, S; Dietrich, J; Buchheister, S; Buettner, M; Bleich, A				Haeger, Christine; Keubler, Lydia M.; Biernot, Svenja; Dietrich, Jana; Buchheister, Stephanie; Buettner, Manuela; Bleich, Andre			Time to Integrate to Nest Test Evaluation in a Mouse DSS-Colitis Model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LABORATORY MICE; INTESTINAL INFLAMMATION; INDICATOR; RODENTS; PAIN; CD14; QTL; IBD	Severity assessment in laboratory animals is an important issue regarding the implementation of the 3R concept into biomedical research and pivotal in current EU regulations. In mouse models of inflammatory bowel disease severity assessment is usually undertaken by clinical scoring, especially by monitoring reduction of body weight. This requires daily observance and handling of each mouse, which is time consuming, stressful for the animal and necessitates an experienced observer. The time to integrate to nest test (TINT) is an easily applicable test detecting disturbed welfare by measuring the time interval mice need to integrate nesting material to an existing nest. Here, TINT was utilized to assess severity in a mouse DSS-colitis model. TINT results depended on the group size of mice maintained per cage with most consistent time intervals measured when co-housing 4 to 5 mice. Colitis was induced with 1% or 1.5% DSS in group-housed WT and Cd14-deficient mice. Higher clinical scores and loss of body weight were detected in 1.5% compared to 1% DSS treated mice. TINT time intervals showed no dose dependent differences. However, increased clinical scores, body weight reductions, and increased TINT time intervals were detected in Cd14(-/-) compared to WT mice revealing mouse strain related differences. Therefore, TINT is an easily applicable method for severity assessment in a mouse colitis model detecting CD14 related differences, but not dose dependent differences. As TINT revealed most consistent results in group-housed mice, we recommend utilization as an additional method substituting clinical monitoring of the individual mouse.	[Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; Hannover Med Sch, Cent Anim Facil, Hannover, Germany	Hannover Medical School; Hannover Medical School	Bleich, A (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany.	bleich.andre@mh-hannover.de		Dietrich, Jana/0000-0001-7211-3168				Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2; Bleich EM, 2010, INT J EXP PATHOL, V91, P281, DOI 10.1111/j.1365-2613.2009.00701.x; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; COOPER HS, 1993, LAB INVEST, V69, P238; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; de Buhr MF, 2009, INFLAMM BOWEL DIS, V15, P1824, DOI 10.1002/ibd.21030; Deacon RMJ, 2006, NAT PROTOC, V1, P2828, DOI 10.1038/nprot.2006.171; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Dieleman LA, 1997, SCAND J GASTROENTERO, V32, P99; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Gaskill BN, 2013, JOVE-J VIS EXP, DOI 10.3791/51012; Gaskill BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032799; Gaudio E, 1999, DIGEST DIS SCI, V44, P1458, DOI 10.1023/A:1026620322859; Huet O, 2013, SHOCK, V39, P488, DOI 10.1097/SHK.0b013e3182939831; Jirkof P, 2013, LAB ANIM-UK, V47, P274, DOI 10.1177/0023677213493409; Jirkof P, 2013, LAB ANIM-UK, V47, P153, DOI 10.1177/0023677213475603; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Rock ML, 2014, J AM ASSOC LAB ANIM, V53, P24; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143824	10.1371/journal.pone.0143824	http://dx.doi.org/10.1371/journal.pone.0143824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637175	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800030
J	Landry, M; Comeau, AM; Derome, N; Cusson, M; Levesque, RC				Landry, Mathieu; Comeau, Andre M.; Derome, Nicolas; Cusson, Michel; Levesque, Roger C.			Composition of the Spruce Budworm (Choristoneura fumiferana) Midgut Microbiota as Affected by Rearing Conditions	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GYPSY-MOTH; GUT; DIGESTION; BACTERIA; COMMUNITY; INSECTS	The eastern spruce budworm (Choristoneura fumiferana) is one of the most destructive forest insect pests in Canada. Little is known about its intestinal microbiota, which could play a role in digestion, immune protection, communication and/or development. The present study was designed to provide a first characterization of the effects of rearing conditions on the taxonomic diversity and structure of the C. fumiferana midgut microbiota, using a culture-independent approach. Three diets and insect sources were examined: larvae from a laboratory colony reared on a synthetic diet and field-collected larvae reared on balsam fir or black spruce foliage. Bacterial DNA from the larval midguts was extracted to amplify and sequence the V6-V8 region of the 16S rRNA gene, using the Roche 454 GS-FLX technology. Our results showed a dominance of Proteobacteria, mainly Pseudomonas spp., in the spruce budworm midgut, irrespective of treatment group. Taxonomic diversity of the midgut microbiota was greater for larvae reared on synthetic diet than for those collected and reared on host plants, a difference that is likely accounted for by several factors. A greater proportion of bacteria from the phylum Bacteroidetes in insects fed artificial diet constituted the main difference between this group and those reared on foliage; within the phylum Proteobacteria, the presence of the genus Bradyrhizobium was also unique to insects reared on artificial diet. Strikingly, a Bray-Curtis analysis showed important differences in microbial diversity among the treatment groups, pointing to the importance of diet and environment in defining the spruce budworm midgut microbiota.	[Landry, Mathieu; Derome, Nicolas; Levesque, Roger C.] Univ Laval, IBIS, Quebec City, PQ, Canada; [Landry, Mathieu; Levesque, Roger C.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Comeau, Andre M.] Dalhousie Univ, Dept Pharmacol, CGEB IMR, Halifax, NS B3H 4H7, Canada; [Derome, Nicolas] Univ Laval, Fac Sci & Genie, Quebec City, PQ G1K 7P4, Canada; [Cusson, Michel] Nat Resources Canada, Laurentian Forest Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Dalhousie University; Laval University; Natural Resources Canada	Levesque, RC (corresponding author), Univ Laval, IBIS, Quebec City, PQ, Canada.	rclevesq@ibis.ulaval.ca	Cusson, Michel/AAG-9036-2019; Levesque, Roger C./ABD-8407-2021	Levesque, Roger/0000-0001-8315-5937	NSERC Discovery grant [171350-2012]; Genome Quebec	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Quebec	This research was funded by grants to R. C. Levesque, M. Cusson (NSERC Discovery grant #171350-2012 and in part by Genome Quebec).; We express our gratitude to members of the next generation sequencing platform and bioinformatics platform at the Institut de biologie integrative et des systemes (IBIS), Universite Laval, and to Catherine Beliveau for technical assistance with the PCR work. We thank Dr. D. Pureswaran (Natural Resources Canada, Quebec City) for providing the field-collected larvae. This research was funded by grants to R. C. Levesque, M. Cusson (NSERC Discovery grant #171350-2012 and in part by Genome Quebec).	Altschul SF, J MOL BIOL, V990, P403; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dobson AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7312; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kudo T, 1998, EXTREMOPHILES, V2, P155, DOI 10.1007/s007920050055; Machado VE, 2014, J VECTOR DIS, V51, P137; MCMORRAN A, 1965, CAN ENTOMOL, V97, P58, DOI 10.4039/Ent9758-1; Pang Anthony S D, 2010, Open Microbiol J, V4, P26, DOI 10.2174/1874285801004010026; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Quezada-Garcia R, 2014, CAN ENTOMOL, V146, P219, DOI 10.4039/tce.2013.72; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; van Frankenhuyzen K, 2010, J INVERTEBR PATHOL, V103, P124, DOI 10.1016/j.jip.2009.12.008	23	17	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144077	10.1371/journal.pone.0144077	http://dx.doi.org/10.1371/journal.pone.0144077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636571	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800039
J	Ross, AI; Schenk, T; Hesse, C				Ross, Alasdair Iain; Schenk, Thomas; Hesse, Constanze			The Effect of Gaze Position on Reaching Movements in an Obstacle Avoidance Task	PLOS ONE			English	Article							EYE-HAND COORDINATION; AUTOMATIC AVOIDANCE; PERIPHERAL-VISION; REFERENCE FRAMES; VISUAL FEEDBACK; ARM MOVEMENTS; HEAD; LOCALIZATION; TARGET; MEMORY	Numerous studies have addressed the issue of where people look when they perform hand movements. Yet, very little is known about how visuomotor performance is affected by fixation location. Previous studies investigating the accuracy of actions performed in visual periphery have revealed inconsistent results. While movements performed under full visual-feedback (closed-loop) seem to remain surprisingly accurate, open-loop as well as memory-guided movements usually show a distinct bias (i.e. overestimation of target eccentricity) when executed in periphery. In this study, we aimed to investigate whether gaze position affects movements that are performed under full-vision but cannot be corrected based on a direct comparison between the hand and target position. To do so, we employed a classical visuomotor reaching task in which participants were required to move their hand through a gap between two obstacles into a target area. Participants performed the task in four gaze conditions: free-viewing (no restrictions on gaze), central fixation, or fixation on one of the two obstacles. Our findings show that obstacle avoidance behaviour is moderated by fixation position. Specifically, participants tended to select movement paths that veered away from the obstacle fixated indicating that perceptual errors persist in closed-loop vision conditions if they cannot be corrected effectively based on visual feedback. Moreover, measuring the eye-movement in a free-viewing task (Experiment 2), we confirmed that naturally participants' prefer to move their eyes and hand to the same spatial location.	[Ross, Alasdair Iain; Hesse, Constanze] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Schenk, Thomas] Univ Munich, Clin Neuropsychol, Munich, Germany	University of Aberdeen; University of Munich	Hesse, C (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen, Scotland.	c.hesse@abdn.ac.uk	Hesse, Constanze/H-2941-2016; S, T/GXF-0648-2022; S, T/GRY-0013-2022	Hesse, Constanze/0000-0002-4395-0781; 				BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; BARD C, 1985, CAN J PSYCHOL, V39, P151, DOI 10.1037/h0080120; Beurze SM, 2006, J NEUROPHYSIOL, V96, P352, DOI 10.1152/jn.01362.2005; BIGUER B, 1984, EXP BRAIN RES, V55, P462; BIGUER B, 1982, EXP BRAIN RES, V46, P301; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; BOCK O, 1993, BEHAV BRAIN RES, V56, P77, DOI 10.1016/0166-4328(93)90023-J; BOCK O, 1986, EXP BRAIN RES, V64, P476, DOI 10.1007/BF00340484; Brown LE, 2005, EXP BRAIN RES, V165, P97, DOI 10.1007/s00221-005-2285-y; Cavina-Pratesi C, 2013, J VISION, V13, DOI 10.1167/13.5.15; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; de Grave DDJ, 2008, J VISION, V8, DOI 10.1167/8.7.5; de Haan AM, 2014, ACTA PSYCHOL, V150, P94, DOI 10.1016/j.actpsy.2014.04.007; DEAN J, 1994, EXP BRAIN RES, V97, P497; Dessing JC, 2012, J VISION, V12, DOI 10.1167/12.11.17; Elliott D, 1999, HUM MOVEMENT SCI, V18, P121, DOI 10.1016/S0167-9457(99)00004-4; Franz VH, 2010, THE OPTOTRAK TOOLBOX, V15, P2010; Goodale M. A., 1997, PARIETAL LOBE CONTRI, P447; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe M, 2000, VIS COGN, V7, P43, DOI 10.1080/135062800394676; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Henriques DYP, 2000, EXP BRAIN RES, V132, P179, DOI 10.1007/s002210000340; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; McIntosh RD, 2004, NEUROPSYCHOLOGIA, V42, P1107, DOI 10.1016/j.neuropsychologia.2003.11.023; McIntosh RD, 2004, P ROY SOC B-BIOL SCI, V271, P15, DOI 10.1098/rspb.2003.2545; Menger R, 2015, PSYCHONOMIC B REV, P1; Menger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059294; Menger R, 2012, ACTA PSYCHOL, V141, P1, DOI 10.1016/j.actpsy.2012.06.006; Mitra AR, 2010, NEUROPSYCHOLOGIA, V48, P1742, DOI 10.1016/j.neuropsychologia.2010.02.023; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Nielsen KE, 1999, NEUROPSYCHOLOGIA, V37, P267, DOI 10.1016/S0028-3932(98)00080-3; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rice NJ, 2006, EXP BRAIN RES, V174, P176, DOI 10.1007/s00221-006-0435-5; Ross AI, 2014, ACTA PSYCHOL, V151, P74, DOI 10.1016/j.actpsy.2014.05.019; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Schindler I, 2004, NAT NEUROSCI, V7, P779, DOI 10.1038/nn1273; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Selen LPJ, 2011, VISION RES, V51, P898, DOI 10.1016/j.visres.2011.01.004; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; VERCHER JL, 1994, EXP BRAIN RES, V99, P507	50	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144193	10.1371/journal.pone.0144193	http://dx.doi.org/10.1371/journal.pone.0144193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636966	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800056
J	Tolios, A; Teupser, D; Holdt, LM				Tolios, Alexander; Teupser, Daniel; Holdt, Lesca M.			Preanalytical Conditions and DNA Isolation Methods Affect Telomere Length Quantification in Whole Blood	PLOS ONE			English	Article							CIGARETTE-SMOKING; CANCER; MUTATIONS; DISEASE; TISSUE	Telomeres are located at chromosome ends and their length (TL) has been associated with aging and human diseases such as cancer. Whole blood DNA is frequently used for TL measurements but the influence of preanalytical conditions and DNA isolation methods on TL quantification has not been thoroughly investigated. To evaluate potential preanalytical as well as methodological bias on TL, anonymized leftover EDTA-whole blood samples were pooled according to leukocyte counts and were incubated with and without actinomycin D to induce apoptosis as a prototype of sample degradation. DNA was isolated from fresh blood pools and after freezing at -80 degrees C. Commercially available kits using beads (Invitrogen), spin columns (Qiagen, Macherey-Nagel and 5prime) or precipitation (Stratec/ Invisorb) and a published isopropanol precipitation protocol (IPP) were used for DNA isolation. TL was assessed by qPCR, and normalized to the single copy reference gene 36B4 using two established single-plex and a new multiplex protocol. We show that the method of DNA isolation significantly affected TL (e.g. 1.86-fold longer TL when comparing IPP vs. Invitrogen). Sample degradation led to an average TL decrease of 22% when using all except for one DNA isolation method (5prime). Preanalytical storage conditions did not affect TL with exception of samples that were isolated with the 5prime kit, where a 27% increase in TL was observed after freezing. Finally, performance of the multiplex qPCR protocol was comparable to the single-plex assays, but showed superior time-and cost-effectiveness and required >80% less DNA. Findings of the current study highlight the need for standardization of whole blood processing and DNA isolation in clinical study settings to avoid preanalytical bias of TL quantification and show that multiplex assays may improve TL/SCG measurements.	[Tolios, Alexander; Teupser, Daniel; Holdt, Lesca M.] Univ Munich, Inst Lab Med, Munich, Germany	University of Munich	Holdt, LM (corresponding author), Univ Munich, Inst Lab Med, Munich, Germany.	lesca.holdt@med.uni-muenchen.de			Invitrogen; Qiagen; Marcherey-Nagel; 5prime; Stratec	Invitrogen; Qiagen; Marcherey-Nagel; 5prime; Stratec	The authors thank the companies (Invitrogen, Qiagen, Marcherey-Nagel, 5prime, Stratec) for their support and kind supply of reagents used in this study.	Anchordoquy TJ, 2007, CELL PRESERV TECHNOL, V5, P180, DOI 10.1089/cpt.2007.0511; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P1, DOI 10.1016/j.mrfmmm.2011.11.005; Armanios M, 2012, MUTAT RES-FUND MOL M, V730, P52, DOI 10.1016/j.mrfmmm.2011.10.013; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Eisenberg DTA, 2015, AM J HUM BIOL, V27, P570, DOI 10.1002/ajhb.22690; Gertler R, 2008, CANCER-AM CANCER SOC, V112, P2173, DOI 10.1002/cncr.23419; Ghatak Souvik, 2013, J Biomol Tech, V24, P224, DOI 10.7171/jbt.13-2404-001; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Krstajic D, 2015, INT J EPIDEMIOL, V44, P1738, DOI 10.1093/ije/dyv167; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1739, DOI 10.1093/ije/dyv170; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1686, DOI 10.1093/ije/dyv169; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mu YC, 2012, MED ONCOL, V29, P893, DOI 10.1007/s12032-011-9866-3; Nagami Kazuyuki, 2002, J Toxicol Sci, V27, P191, DOI 10.2131/jts.27.191; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poon SSS, 2001, METHOD CELL BIOL, V64, P69; Rajatileka S, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-105; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Valls-Bautista C, 2015, J SURG ONCOL, V111, P899, DOI 10.1002/jso.23894; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; Verhulst S, 2015, INT J EPIDEMIOL, V44, P1683, DOI 10.1093/ije/dyv166; Whyte MKB, 1997, J LEUKOCYTE BIOL, V62, P195, DOI 10.1002/jlb.62.2.195; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Zanet DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057787; Zhang B, 2012, ONCOGENE, V31, P1, DOI 10.1038/onc.2011.214	47	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143889	10.1371/journal.pone.0143889	http://dx.doi.org/10.1371/journal.pone.0143889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636575	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800032
J	Chae, YN; Kim, TH; Kim, MK; Shin, CY; Jung, IH; Sohn, YS; Son, MH				Chae, Yu-Na; Kim, Tae-Hyoung; Kim, Mi-Kyung; Shin, Chang-Yell; Jung, Il-Hoon; Sohn, Yong Sung; Son, Moon-Ho			Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOPLASMIC-RETICULUM STRESS; GLP-1 ANALOG LIRAGLUTIDE; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; FOOD-INTAKE; GLYCEMIC CONTROL; IV INHIBITOR; SITAGLIPTIN; METABOLISM	Although dipeptidyl peptidase 4 (DPP4) is an adipokine known to positively correlate with adiposity, the effects of pharmacological DPP4 inhibition on body composition have not been fully understood. This study was aimed to assess the effects of DPP4 inhibitors on adiposity for the first time in the established obese mice model. The weight loss effects of multiple DPP4 inhibitors were compared after a 4 week treatment in diet-induced obese mice. In addition, a 2 week study was performed to explore and compare the acute effects of evogliptin, a novel DPP4 inhibitor, and exenatide, a glucagon-like peptide-1 (GLP-1) analogue, on whole body composition, energy consumption, various plasma adipokines and gene expression in white adipose tissue (WAT). After the 4 week treatment, weight loss and blood glucose reductions were consistently observed with multiple DPP4 inhibitors. Moreover, after 2-week treatment, evogliptin dose-dependently reduced whole body fat mass while increasing the proportion of smaller adipocytes. However, insulin sensitivity or plasma lipid levels were not significantly altered. In addition to increased active GLP-1 levels by plasma DPP4 inhibition, evogliptin also enhanced basal metabolic rate without reduction in caloric intake, in contrast to exenatide; this finding suggested evogliptin's effects may be mediated by pathways other than via GLP-1. Evogliptin treatment also differentially increased Ppargc1a expression, a key metabolic regulator, in WAT, but not in skeletal muscle and brown adipose tissue. The increased expression of the downstream mitochondrial gene, Cox4i1, was also suggestive of the potential metabolic alteration in WAT by DPP4 inhibitors. We are the first to demonstrate that pharmacological DPP4 inhibition by evogliptin directly causes fat loss in established obese mice. In contradistinction to exenatide, the fat-loss effect of DPP4 inhibitor is partly attributed to enhanced energy expenditure along with metabolic changes in WAT. These results provide insight into the regulation of energy storage in WAT caused by DPP4 inhibition.	[Chae, Yu-Na; Kim, Tae-Hyoung; Kim, Mi-Kyung; Shin, Chang-Yell; Jung, Il-Hoon; Sohn, Yong Sung; Son, Moon-Ho] Dong A ST Co Ltd, Res Inst, Yongin 446905, Gyeonggi Do, South Korea		Son, MH (corresponding author), Dong A ST Co Ltd, Res Inst, Yongin 446905, Gyeonggi Do, South Korea.	ssonmh@donga.co.kr			Dong-A ST Co., Ltd.	Dong-A ST Co., Ltd.	This research was funded by Dong-A ST Co., Ltd. The funder provided support in the form of salaries for all authors [YNC, THK, MKK, CYS, IHJ, YSS, and MHS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abernathy RP, 1996, AM J CLIN NUTR, V63, P448; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Baggio LL, 2004, GASTROENTEROLOGY, V127, P546, DOI 10.1053/j.gastro.2004.04.063; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bergman AJ, 2006, CLIN THER, V28, P55, DOI 10.1016/j.clinthera.2006.01.015; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Boschmann M, 2009, J CLIN ENDOCR METAB, V94, P846, DOI 10.1210/jc.2008-1400; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Cahn A, 2013, EXPERT OPIN EMERG DR, V18, P245, DOI 10.1517/14728214.2013.807796; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannavino J, 2014, J PHYSIOL-LONDON, V592, P4575, DOI 10.1113/jphysiol.2014.275545; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Challa TD, 2012, J BIOL CHEM, V287, P6421, DOI 10.1074/jbc.M111.310342; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; Elfers CT, 2012, HORM RES PAEDIAT, V78, P47, DOI 10.1159/000338464; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flint A, 2013, DIABETES OBES METAB, V15, P958, DOI 10.1111/dom.12108; Flint A, 2000, INT J OBESITY, V24, P288, DOI 10.1038/sj.ijo.0801126; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Fukuda-Tsuru S, 2014, EUR J PHARMACOL, V723, P207, DOI 10.1016/j.ejphar.2013.11.030; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Goldsmith F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126177; Guillet C, 2012, OBES REV, V13, P51, DOI 10.1111/j.1467-789X.2012.01037.x; Hamamoto S, 2013, DIABETES OBES METAB, V15, P153, DOI 10.1111/dom.12005; Horowitz M, 2012, DIABETES RES CLIN PR, V97, P258, DOI 10.1016/j.diabres.2012.02.016; Kern M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038744; Kim HJ, 2011, BIOORG MED CHEM LETT, V21, P3809, DOI 10.1016/j.bmcl.2011.04.029; Kim MK, 2012, LIFE SCI, V90, P21, DOI 10.1016/j.lfs.2011.10.007; Kirino Y, 2011, AM J PHYSIOL-ENDOC M, V300, pE372, DOI 10.1152/ajpendo.00319.2010; Kirno Y, 2009, BIOL PHARM BULL, V32, P463, DOI 10.1248/bpb.32.463; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Ostenson CG, 2013, DIABETES METAB SYNDR, V6, P171, DOI 10.2147/DMSO.S41827; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Rosmaninho-Salgado J, 2012, PEPTIDES, V37, P49, DOI 10.1016/j.peptides.2012.06.014; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Scheen AJ, 2012, EXPERT OPIN PHARMACO, V13, P81, DOI 10.1517/14656566.2012.642866; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Son MH, 2010, INT J OBESITY, V34, P547, DOI 10.1038/ijo.2009.253; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Thomas L, 2009, J PHARMACOL EXP THER, V328, P556, DOI 10.1124/jpet.108.143966; Vendrell J, 2011, ENDOCRINOLOGY, V152, P4072, DOI 10.1210/en.2011-1070; Verhoef SPM, 2013, OBES RES CLIN PRACT, V7, pE8, DOI 10.1016/j.orcp.2012.03.001; Vyas AK, 2012, CARDIOVASC ENDOCRINO, V1, P74, DOI 10.1097/XCE.0b013e32835bfb24; Wendel AA, 2009, LIPIDS, V44, P975, DOI 10.1007/s11745-009-3348-9; Wu YJ, 2015, METABOLISM, V64, P226, DOI 10.1016/j.metabol.2014.08.006; Yo K, 2013, AM J PHYSIOL-ENDOC M, V304, pE331, DOI 10.1152/ajpendo.00098.2012; Zambrowicz B, 2013, CLIN THER, V35, P273, DOI 10.1016/j.clinthera.2013.01.010	60	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144064	10.1371/journal.pone.0144064	http://dx.doi.org/10.1371/journal.pone.0144064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633898	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000048
J	Chaudhuri, D; Ghate, NB; Panja, S; Das, A; Mandal, N				Chaudhuri, Dipankar; Ghate, Nikhil Baban; Panja, Sourav; Das, Abhishek; Mandal, Nripendranath			Wild Edible Fruit of Prunus nepalensis Ser. (Steud), a Potential Source of Antioxidants, Ameliorates Iron Overload-Induced Hepatotoxicity and Liver Fibrosis in Mice	PLOS ONE			English	Article							HEPATOPROTECTIVE ACTIVITY; SUPEROXIDE; EXTRACTS; FERRITIN; ASSAY; ACID; L.; HYDROXYPROLINE; LEAVES; RATS	The antioxidant and restoration potentials of hepatic injury by Prunus nepalensis Ser. (Steud), a wild fruit plant from the Northeastern region of India, were investigated. The fruit extract (PNME) exhibited excellent antioxidant and reducing properties and also scavenged the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical (IC50 = 30.92 +/- 0.40 mu g/ml). PNME demonstrated promising scavenging potency, as assessed by the scavenging of different reactive oxygen and nitrogen species. Moreover, the extract revealed an exceptional iron chelation capacity with an IC50 of 25.64 +/- 0.60 mu g/ml. The extract induced significant improvement of hepatic injury and liver fibrosis against iron overload induced hepatotoxicity in mice in a dose-dependent manner, and this effect was supported by different histopathological studies. The phytochemical constitutions and their identification by HPLC confirmed the presence of purpurin, tannic acid, methyl gallate, reserpine, gallic acid, ascorbic acid, catechin and rutin. The identified compounds were investigated for their individual radical scavenging and iron chelation activity; some compounds exhibited excellent radical scavenging and iron chelation properties, but most were toxic towards normal cells (WI-38). On the other hand, crude PNME was found to be completely nontoxic to normal cells, suggesting its feasibility as a safe oral drug. The above study suggests that different phytochemicals in PNME contributed to its free radical scavenging and iron chelation activity; however, further studies are required to determine the pathway in which PNME acts to treat iron-overload diseases.	[Chaudhuri, Dipankar; Ghate, Nikhil Baban; Panja, Sourav; Das, Abhishek; Mandal, Nripendranath] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute	Mandal, N (corresponding author), Bose Inst, Div Mol Med, P 1-12,CIT Rd, Kolkata 700054, W Bengal, India.	mandaln@rediffmail.com	Chudhuri, Dipankar/AAU-6215-2021; Mandal, Nripendranath/ABC-3918-2020; Ghate, Nikhil/T-4153-2017; PANJA, SOURAV/AAA-7163-2022; Panja, Sourav/AFO-5798-2022	Mandal, Nripendranath/0000-0002-8733-3566; Ghate, Nikhil/0000-0002-4447-3737; Panja, Sourav/0000-0001-8540-5266; Chaudhuri, Dipankar/0000-0001-7991-0469				Adikwu E., 2013, Pharmacology and Pharmacy, V4, P84; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Agrahar-Murugkar D, 2005, ECOL FOOD NUTR, V44, P207, DOI 10.1080/03670240590953025; Anusha M, 2011, INDIAN J PHARMACOL, V43, P563, DOI 10.4103/0253-7613.84973; Arabshahi-Delouee S, 2007, FOOD CHEM, V102, P1233, DOI 10.1016/j.foodchem.2006.07.013; Arthur MJP, 1996, J GASTROEN HEPATOL, V11, P1124, DOI 10.1111/j.1440-1746.1996.tb01840.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BARRY M, 1971, LANCET, V1, P100; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; Bothwell T.H., 1979, IRON METABOLISM MAN; Buege J A, 1978, Methods Enzymol, V52, P302; Chatha SAS, 2006, GRASAS ACEITES, V57, P328; Chaudhuri D, 2012, ASIAN J PHARM CLIN R, V5, P193, DOI DOI 10.1186/0717-6287-47-24; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Galleano Monica, 2004, Molecular Aspects of Medicine, V25, P141, DOI 10.1016/j.mam.2004.02.015; Ghate NB., 2013, INT J PHARM BIO SCI, V4, P373; Ghate NB, 2014, CYTOTECHNOLOGY, V66, P209, DOI 10.1007/s10616-013-9553-7; Ghate NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082293; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harborne J.B., 1995, PHYTOCHEMICAL DICT H; HARRISON PM, 1977, SEMIN HEMATOL, V14, P55; Hassan S, 2009, TOXICOL LETT, P189; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; HERSHKO C, 1994, IRON METABOLISM HLTH, P391; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hynes MJ, 2002, J INORG BIOCHEM, V90, P18, DOI 10.1016/S0162-0134(02)00383-5; Janbaz KH, 2002, FITOTERAPIA, V73, P557, DOI 10.1016/S0367-326X(02)00217-4; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Khatri A, 2009, J ETHNOPHARMACOL, V122, P1, DOI 10.1016/j.jep.2008.10.043; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; Kokate C.K., 2003, TXB PHARMACOGNOSY, V1st ed., P330; Koncic MZ, 2011, MOLECULES, V16, P6232, DOI 10.3390/molecules16086232; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; OBRIEN RT, 1974, ANN NY ACAD SCI, V232, P221, DOI 10.1111/j.1749-6632.1974.tb20588.x; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; ROTHMAN RJ, 1992, MOL PHARMACOL, V42, P703; Ryan T. P., 1992, REV TOXICOL, V22, P119; Sabir SM, 2012, FOOD CHEM, V131, P741, DOI 10.1016/j.foodchem.2011.09.026; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; Stief TW, 2003, MED HYPOTHESES, V60, P567, DOI 10.1016/S0306-9877(03)00026-4; Sudha G., 2011, INT J CURR PHARM RES, V3, P137; Tam TF, 2003, CURR MED CHEM, V10, P983, DOI 10.2174/0929867033457593; Tapan S., 2011, INT J PHARM PHARM SC, V3, P233; Taylor BS, 1997, ARCH SURG-CHICAGO, V132, P1177; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; YATES WR, 1987, DRUG ALCOHOL DEPEN, V20, P155, DOI 10.1016/0376-8716(87)90065-2; Yildirim A, 2001, J AGR FOOD CHEM, V49, P4083, DOI 10.1021/jf0103572; Zhou J., 2011, ENCY TRADITIONAL CHI	61	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144280	10.1371/journal.pone.0144280	http://dx.doi.org/10.1371/journal.pone.0144280			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633891	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000076
J	El-Sayed, ASA; Yassin, MA; Ali, GS				El-Sayed, Ashraf S. A.; Yassin, Marwa A.; Ali, Gul Shad			Transcriptional and Proteomic Profiling of Aspergillus flavipes in Response to Sulfur Starvation	PLOS ONE			English	Article							L-METHIONINASE PRODUCTION; CYSTATHIONINE GAMMA-LYASE; SACCHAROMYCES-CEREVISIAE; SULFATE TRANSPORT; AMINO-ACIDS; MOLECULAR CHARACTERIZATION; INHIBITORY-ACTIVITY; CYSTEINE SYNTHASE; NEUROSPORA-CRASSA; FILAMENTOUS FUNGI	Aspergillus flavipes has received considerable interest due to its potential to produce therapeutic enzymes involved in sulfur amino acid metabolism. In natural habitats, A. flavipes survives under sulfur limitations by mobilizing endogenous and exogenous sulfur to operate diverse cellular processes. Sulfur limitation affects virulence and pathogenicity, and modulates proteome of sulfur assimilating enzymes of several fungi. However, there are no previous reports aimed at exploring effects of sulfur limitation on the regulation of A. flavipes sulfur metabolism enzymes at the transcriptional, post-transcriptional and proteomic levels. In this report, we show that sulfur limitation affects morphological and physiological responses of A. flavipes. Transcription and enzymatic activities of several key sulfur metabolism genes, ATP-sulfurylase, sulfite reductase, methionine permease, cysteine synthase, cystathionine beta- and gamma-lyase, glutathione reductase and glutathione peroxidase were increased under sulfur starvation conditions. A 50 kDa protein band was strongly induced by sulfur starvation, and the proteomic analyses of this protein band using LC-MS/MS revealed similarity to many proteins involved in the sulfur metabolism pathway.	[El-Sayed, Ashraf S. A.; Yassin, Marwa A.] Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt; [El-Sayed, Ashraf S. A.; Ali, Gul Shad] Univ Florida, Dept Plant Pathol, Mid Florida Res & Educ Ctr, Apopka, FL 32703 USA	Egyptian Knowledge Bank (EKB); Zagazig University; State University System of Florida; University of Florida	El-Sayed, ASA (corresponding author), Zagazig Univ, Dept Bot & Microbiol, Fac Sci, Zagazig 44519, Egypt.	Ashrafzu@ufl.edu; gsali@ufl.edu			Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida	Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida	This work was supported by funds to G.S.A. from the Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds to G.S.A. from the Florida Agriculture Experiment Station, Institute of Food and Agricultural Sciences at the University of Florida.	Amich J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003573; Anderson M.E., 1985, J METH ENZYMOL, V113, P548, DOI DOI 10.1016/S0076-6879(85)13073-9; Bai ZQ, 2014, FITOTERAPIA, V95, P194, DOI 10.1016/j.fitote.2014.03.021; BARROW CJ, 1994, J NAT PROD, V57, P471, DOI 10.1021/np50106a005; Brzywczy J, 2002, YEAST, V19, P29, DOI 10.1002/yea.798; Brzywczy J, 2007, RES MICROBIOL, V158, P428, DOI 10.1016/j.resmic.2007.03.002; Brzywczy J, 2011, FUNGAL GENET BIOL, V48, P104, DOI 10.1016/j.fgb.2010.10.002; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Ferreira MED, 2006, MOL GENET GENOMICS, V276, P450, DOI 10.1007/s00438-006-0154-4; Desai PR, 2011, J BIOL CHEM, V286, P41183, DOI 10.1074/jbc.M111.272377; DEVITO PC, 1964, J BACTERIOL, V88, P1341, DOI 10.1128/JB.88.5.1341-1348.1964; El-Sayed AS, 2015, ACTA BIOL HUNG, V66, P119, DOI 10.1556/ABiol.66.2015.1.10; El-Sayed AS, 2013, J MICROBIOL BIOTECHN, V23, P499, DOI 10.4014/jmb.1208.08070; El-Sayed AS, 2012, ENZYME MICROB TECH, V51, P200, DOI 10.1016/j.enzmictec.2012.06.004; El-Sayed AS, 2010, APPL MICROBIOL BIOT, V86, P445, DOI 10.1007/s00253-009-2303-2; El-Sayed ASA, 2014, ENZYME MICROB TECH, V54, P59, DOI 10.1016/j.enzmictec.2013.10.004; El-Sayed ASA, 2011, J MICROBIOL, V49, P130, DOI 10.1007/s12275-011-0259-2; El-Sayed ASA, 2009, J BASIC MICROB, V49, P331, DOI 10.1002/jobm.200800318; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Esbelin J, 2013, PHOTOCHEM PHOTOBIOL, V89, P758, DOI 10.1111/php.12037; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; HALLENBECK PC, 1989, J BACTERIOL, V171, P3008, DOI 10.1128/jb.171.6.3008-3015.1989; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hebert A, 2013, APPL ENVIRON MICROB, V79, P1200, DOI 10.1128/AEM.03259-12; Irmler S, 2008, APPL ENVIRON MICROB, V74, P99, DOI 10.1128/AEM.00745-07; Jiang T, 2004, J ASIAN NAT PROD RES, V6, P249, DOI 10.1080/1028602031000147384; KETTER JS, 1988, MOL CELL BIOL, V8, P1504, DOI 10.1128/MCB.8.4.1504; Khalaf SA, 2009, CURR MICROBIOL, V58, P219, DOI 10.1007/s00284-008-9311-9; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kwon YJ, 2012, J NAT PROD, V75, P271, DOI 10.1021/np200720v; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Lima PD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002855; MARESCA B, 1978, J BACTERIOL, V135, P987, DOI 10.1128/JB.135.3.987-992.1978; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; NATORFF R, 1993, MOL GEN GENET, V238, P185, DOI 10.1007/BF00279546; Natorff R, 2003, MOL MICROBIOL, V49, P1081, DOI 10.1046/j.1365-2958.2003.03617.x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Parente AFA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022810; Pilsyk S, 2007, FUNGAL GENET BIOL, V44, P715, DOI 10.1016/j.fgb.2006.11.007; Pilsyk S, 2009, ACTA BIOCHIM POL, V56, P375; Piotrowska M, 2000, MOL GEN GENET, V264, P276, DOI 10.1007/s004380000319; Raper KB, 1965, GENUS ASPERGILLUS GE; Reveal Brad S, 2012, BMC Res Notes, V5, P339, DOI 10.1186/1756-0500-5-339; Rochfort S, 2005, J ANTIBIOT, V58, P279, DOI 10.1038/ja.2005.34; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; Stalder D, 2013, P NATL ACAD SCI USA, V110, P19995, DOI 10.1073/pnas.1320029110; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; van de Kamp M, 1999, J BACTERIOL, V181, P7228, DOI 10.1128/JB.181.23.7228-7234.1999; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Warrilow AGS, 2000, J EXP BOT, V51, P985, DOI 10.1093/jexbot/51.347.985; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GX, 2004, J NAT PROD, V67, P328, DOI 10.1021/np030353m	64	20	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144304	10.1371/journal.pone.0144304	http://dx.doi.org/10.1371/journal.pone.0144304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633307	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000080
J	Jancuchova-Laskova, J; Landova, E; Frynta, D				Jancuchova-Laskova, Jitka; Landova, Eva; Frynta, Daniel			Experimental Crossing of Two Distinct Species of Leopard Geckos, Eublepharis angramainyu and E. macularius: Viability, Fertility and Phenotypic Variation of the Hybrids	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; HETERONOTIA-BINOEI GEKKONIDAE; PRINCIPAL-COMPONENTS-ANALYSIS; DRAGON LIZARDS AGAMIDAE; POSTZYGOTIC ISOLATION; IRANIAN PLATEAU; BODY SHAPE; INTERSPECIFIC HYBRIDIZATION; OUTBREEDING DEPRESSION; NATURAL HYBRIDIZATION	Hybridization between distinct species of animals and subsequent genetic introgression plays a considerable role in the speciation process and the emergence of adaptive characters. Fitness of between-species hybrids usually sharply decreases with the divergence time of the concerned species and the divergence depth, which still allows for a successful crossing differs among principal clades of vertebrates. Recently, a review of hybridization events among distinct lizard species revealed that lizards belong to vertebrates with a highly developed ability to hybridize. In spite of this, reliable reports of experimental hybridizations between genetically fairly divergent species are only exceptional. Here, we show the results of the crossing of two distinct allopatric species of eyelid geckos possessing temperature sex determination and lacking sex chromosomes: Eublepharis macularius distributed in Pakistan/Afghanistan area and E. angramainyu, which inhabits Mesopotamia and adjacent areas. We demonstrated that F-1 hybrids were viable and fertile, and the introgression of E. angramainyu genes into the E. macularius genome can be enabled via a backcrossing. The examined hybrids (except those of the F-2 generation) displayed neither malformations nor a reduced survival. Analyses of morphometric and coloration traits confirmed phenotypic distinctness of both parental species and their F-1 hybrids. These findings contrast with long-term geographic and an evolutionary separation of the studied species. Thus, the occurrence of fertile hybrids of comparably divergent species, such as E. angramainyu and E. macularius, may also be expected in other taxa of squamates. This would violate the current estimates of species diversity in lizards.	[Jancuchova-Laskova, Jitka; Landova, Eva; Frynta, Daniel] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	Charles University Prague	Frynta, D (corresponding author), Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic.	frynta@centrum.cz	Lásková, Jitka Jančúchová/V-1899-2019; Frynta, Daniel/L-7350-2016; Landova, Eva/R-8759-2017	Frynta, Daniel/0000-0002-1375-7972; Landova, Eva/0000-0001-8365-8710	Grant Agency of the Academy of Sciences of the Czech Republic [IAA 601410803]; Specific Academic Research Projects Competition [SVV-2015-260208]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Specific Academic Research Projects Competition	This study was supported by the Grant Agency of the Academy of Sciences of the Czech Republic project no. IAA 601410803 and by the Specific Academic Research Projects Competition project no. SVV-2015-260208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S.C., 1999, LIZARDS IRAN SOC STU; Sanchez-Guillen RA, 2012, EVOLUTION, V66, P690, DOI 10.1111/j.1558-5646.2011.01469.x; [Anonymous], 2005, EYELASH GECKOS CARE; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Arnold SJ, 1996, EVOLUTION, V50, P1024, DOI 10.1111/j.1558-5646.1996.tb02343.x; Arntzen JW, 2014, BIOL J LINN SOC, V113, P604, DOI 10.1111/bij.12358; Arrieta RS, 2013, BIOL J LINN SOC, V110, P528, DOI 10.1111/bij.12153; AUTUMN K, 1995, J HERPETOL, V29, P157, DOI 10.2307/1564552; Baranwal VK, 2012, J EXP BOT, V63, P6309, DOI 10.1093/jxb/ers291; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; BAUR B, 1984, Salamandra, V20, P70; Berry OF, 2006, CONSERV GENET, V7, P427, DOI 10.1007/s10592-005-9054-0; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Bragg WK, 2000, BIOL J LINN SOC, V69, P319, DOI 10.1006/bijl.1999.0359; BRANCH B., 1984, J HERPETOL ASS AFRIC, V30, P1; Breuil M, 2000, W INDIAN IGUANA SPEC, V3, P11; Brochu CA, 2000, COPEIA, P657, DOI 10.1643/0045-8511(2000)000[0657:PRADTO]2.0.CO;2; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; BULL JJ, 1987, CAN J ZOOL, V65, P1421, DOI 10.1139/z87-224; BULL JJ, 1988, J EVOLUTION BIOL, V2, P177; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Buskirk James R., 2005, Salamandra, V41, P21; CAPULA M, 1993, BIOCHEM SYST ECOL, V21, P373, DOI 10.1016/0305-1978(93)90028-P; Capula M, 2002, AMPHIBIA-REPTILIA, V23, P313, DOI 10.1163/15685380260449199; CUELLAR O, 1972, J GENET, V61, P14, DOI 10.1007/BF02984098; Darevsky Ilya S., 1993, Herpetozoa, V6, P3; DAREVSKY IS, 1984, J HERPETOL, V18, P277, DOI 10.2307/1564081; Darwin C, 1859, ORIGIN SPECIES MEANS; Devitt TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-245; Dobson AP, 1996, CONSERVATION BIODIVE; Dobzhansky T, 1936, GENETICS, V21, P113; Dobzhansky T., 1937; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Fitzpatrick BM, 2007, P NATL ACAD SCI USA, V104, P15793, DOI 10.1073/pnas.0704791104; Fitzpatrick BM, 2004, EVOLUTION, V58, P1865; FLORES D, 1994, PHYSIOL BEHAV, V55, P1067, DOI 10.1016/0031-9384(94)90389-1; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Frydlova P, 2011, AMPHIBIA-REPTILIA, V32, P27, DOI 10.1163/017353710X532184; Frynta Daniel, 1997, Acta Societatis Zoologicae Bohemicae, V61, P3; Fuller RC, 2008, EVOLUTION, V62, P3056, DOI 10.1111/j.1558-5646.2008.00518.x; Galan Pedro, 2002, Boletin de la Asociacion Herpetologica Espanola, V13, P28; Garland Theodore Jr., 1994, P240; Georges A, 2002, ZOOL J LINN SOC-LOND, V134, P401, DOI 10.1046/j.1096-3642.2002.00007.x; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Godinho R, 2005, AMPHIBIA-REPTILIA, V26, P271, DOI 10.1163/156853805774408667; Grabe Julian, 2014, Biawak, V8, P79; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2004, EVOLUTION, V58, P1588; Gutsche Alexander, 2004, Salamandra, V40, P201; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Herrel A, 2001, BIOL J LINN SOC, V74, P305, DOI 10.1006/bijl.2001.0579; Herrington SJ, 2008, T AM FISH SOC, V137, P158, DOI 10.1577/T07-044.1; Hiadlovska Z, 2013, BIOL J LINN SOC, V108, P225, DOI 10.1111/j.1095-8312.2012.01997.x; Hoser R., 1988, Litteratura Serpentium English Edition, V8, P134; Huang V, 2012, PHYSIOL BEHAV, V107, P121, DOI 10.1016/j.physbeh.2012.06.014; Huxley J, 1940, NEW SYSTEMATICS, P185; Jancuchova-Laskova J, 2015, CURR ZOOL, V61, P155; KARL SA, 1995, J HERED, V86, P262, DOI 10.1093/oxfordjournals.jhered.a111579; Kearney M, 2005, PHYSIOL BIOCHEM ZOOL, V78, P316, DOI 10.1086/430033; Kearney M, 2004, AM NAT, V164, P803, DOI 10.1086/425986; Kinney ME, 2013, ZOO BIOL, V32, P172, DOI 10.1002/zoo.21050; Kohler J, 2012, SALAMANDRA, V48, P1; Kratochvil L, 2003, CAN J ZOOL, V81, P1112, DOI 10.1139/Z03-078; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Kratochvil L, 2006, BIOL J LINN SOC, V88, P527, DOI 10.1111/j.1095-8312.2006.00627.x; LaDage LD, 2006, BEHAVIOUR, V143, P1033, DOI 10.1163/156853906778623644; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; LeClere JB, 2012, J HERPETOL, V46, P257, DOI 10.1670/10-260; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Lopez-Fernandez H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001294; Lourenco JM, 2013, J EVOLUTION BIOL, V26, P38, DOI 10.1111/jeb.12031; Lucker H, 2002, ELAPHE, V10, P49; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Macey JR, 2000, MOL PHYLOGENET EVOL, V14, P479, DOI 10.1006/mpev.1999.0722; Machado T, 2014, MOL PHYLOGENET EVOL, V71, P1, DOI 10.1016/j.ympev.2013.10.003; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; Miralles L, 2014, J SEA RES, V86, P69, DOI 10.1016/j.seares.2013.11.009; MORITZ C, 1987, EVOLUTION, V41, P1252, DOI 10.1111/j.1558-5646.1987.tb02464.x; MORITZ C, 1983, SCIENCE, V220, P735, DOI 10.1126/science.220.4598.735; Mouthereau F, 2012, TECTONOPHYSICS, V532, P27, DOI 10.1016/j.tecto.2012.01.022; Mouthereau F, 2011, GEOL MAG, V148, P726, DOI 10.1017/S0016756811000306; Muller HJ, 1942, BIOL S, V6, P71; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; Nichols P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2272; Olave M, 2011, MOL PHYLOGENET EVOL, V61, P381, DOI 10.1016/j.ympev.2011.07.006; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; ORR HA, 1989, GENETICS, V121, P527; Peek Ron, 2009, Lacerta, V67, P251; Placyk JS, 2012, CONSERV GENET, V13, P649, DOI 10.1007/s10592-012-0315-4; Pokorna M, 2010, CHROMOSOME RES, V18, P809, DOI 10.1007/s10577-010-9154-7; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; POLET G, 2002, P 16 WORK M IUCN SSC, P86; Pouyani ER, 2010, ZOOL J LINN SOC-LOND, V158, P641, DOI 10.1111/j.1096-3642.2009.00553.x; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Presgraves DC, 2010, AM NAT, V176, pS45, DOI 10.1086/657058; Price TD, 2002, EVOLUTION, V56, P2083; Rassmann K, 1997, J ZOOL, V242, P729, DOI 10.1111/j.1469-7998.1997.tb05822.x; Reifova R, 2011, J ORNITHOL, V152, P1063, DOI 10.1007/s10336-011-0700-7; Rhen T, 2000, GEN COMP ENDOCR, V118, P322, DOI 10.1006/gcen.2000.7477; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Robbins TR, 2014, J HERED, V105, P226, DOI 10.1093/jhered/est093; Robbins TR, 2010, J ANIM ECOL, V79, P137, DOI 10.1111/j.1365-2656.2009.01594.x; Rykena S, 1996, ISRAEL J ZOOL, V42, P171; RYKENA S, 1978, Salamandra, V14, P147; Rykena S., 1991, Mitteilungen aus dem Zoologischen Museum in Berlin, V67, P55; Rykena S, 2002, MERTENSIELLA, V13, P78; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Schilde Maik, 2004, Asiatic Herpetological Research, V10, P120; Schumer M, 2014, ELIFE, V3, DOI 10.7554/eLife.02535; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shine R, 2004, CAN J ZOOL, V82, P1091, DOI 10.1139/Z04-086; Smid J, 2012, ACTA HERPETOL, V7, P139; Smit JHW, 2013, TECTONOPHYSICS, V602, P176, DOI 10.1016/j.tecto.2012.10.032; Smith SA, 2005, EVOLUTION, V59, P2433; SOMERS KM, 1989, SYST ZOOL, V38, P169, DOI 10.2307/2992386; SOMERS KM, 1986, SYST ZOOL, V35, P359, DOI 10.2307/2413387; Starostova Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064715; Starostova Z, 2009, AM NAT, V174, pE100, DOI 10.1086/603610; Stelkens R, 2009, EVOLUTION, V63, P884, DOI 10.1111/j.1558-5646.2008.00599.x; Strasburg JL, 2005, MOL ECOL, V14, P2755, DOI 10.1111/j.1365-294X.2005.02627.X; Amaral AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085814; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P73, DOI 10.1163/1568538053693369; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P65, DOI 10.1163/1568538053693323; Thompson GG, 2005, AMPHIBIA-REPTILIA, V26, P55, DOI 10.1163/1568538053693332; Trobisch Dietmar, 2005, Eidechse, V16, P25; True JR, 1996, GENETICS, V142, P819; Turelli M, 2000, GENETICS, V154, P1663; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; UZZELL T, 1975, COPEIA, P204; Van der Sluijs I, 2008, J EVOLUTION BIOL, V21, P480, DOI 10.1111/j.1420-9101.2007.01495.x; VIETS BE, 1993, J EXP ZOOL, V265, P679, DOI 10.1002/jez.1402650610; Vines TH, 2003, EVOLUTION, V57, P1876; Vitt LJ, 1997, P NATL ACAD SCI USA, V94, P3828, DOI 10.1073/pnas.94.8.3828; Wagner E., 1980, Q REV BIOL, V55, P21; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; WILSON AC, 1974, P NATL ACAD SCI USA, V71, P2843, DOI 10.1073/pnas.71.7.2843; WRIGHT JW, 1968, COPEIA, P128; Zhang PJ, 2014, AQUAT MAMM, V40, P5, DOI 10.1578/AM.40.1.2014.5; Zinenko O. I., 2003, Vestnik Zoologii, V37, P101; Zinenko Oleksander, 2004, Mertensiella, V15, P17	157	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143630	10.1371/journal.pone.0143630	http://dx.doi.org/10.1371/journal.pone.0143630			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633648	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000018
J	Wang, JT; Chang, SC; Chang, FY; Fung, CP; Chuang, YC; Chen, YS; Shiau, YR; Tan, MC; Wang, HY; Lai, JF; Huang, IW; Lauderdale, TLY				Wang, Jann-Tay; Chang, Shan-Chwen; Chang, Feng-Yee; Fung, Chang-Phone; Chuang, Yin-Ching; Chen, Yao-Shen; Shiau, Yih-Ru; Tan, Mei-Chen; Wang, Hui-Ying; Lai, Jui-Fen; Huang, I-Wen; Lauderdale, Tsai-Ling Yang			Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; MEDIATED QUINOLONE RESISTANCE; URINARY-TRACT-INFECTIONS; CTX-M; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; MULTIPLEX PCR; TRENDS SMART; ENTEROBACTERIACEAE; AMPC	Longitudinal nationwide surveillance data on antimicrobial non-susceptibility and prevalence of extended-spectrum beta-lactamases (ESBLs) as well as AmpC beta-lactamases producers among Escherichia coli from different sources in the community settings are limited. Such data may impact treatment practice. The present study investigated E. coli from outpatients and patients visiting emergency rooms collected by the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. A total of 3481 E. coli isolates were studied, including 2153 (61.9%) from urine and 1125 (32.3%) from blood samples. These isolates were collected biennially between 2002 and 2012 from a total of 28 hospitals located in different geographic regions of Taiwan. Minimum inhibitory concentrations (MIC) were determined using methods recommended by the Clinical Laboratory Standards Institute (CLSI). The prevalence and factors associated with the presence of ESBL and AmpC beta-lactamase-producers were determined. Significant increases in non-susceptibility to most beta-lactams and ciprofloxacin occurred during the study period. By 2012, non-susceptibility to cefotaxime and ciprofloxacin reached 21.1% and 26.9%, respectively. The prevalence of ESBL- and AmpC-producers also increased from 4.0% and 5.3%, respectively, in 2002-2004, to 10.7% for both in 2010-2012 (P < 0.001). The predominant ESBL and AmpC beta-lactamase genes were CTX-M and CMY-types, respectively. Non-susceptibility of urine isolates to nitrofurantoin remained at around 8% and to fosfomycin was low (0.7%) but to cefazolin (based on the 2014 CLSI urine criteria) increased from 11.5% in 2002-2004 to 23.9% in 2010-2012 (P < 0.001). Non-susceptibility of isolates from different specimen types was generally similar, but isolates from elderly patients were significantly more resistant to most antimicrobial agents and associated with the presence of ESBL-and AmpC-beta-lactamases. An additional concern is that decreased ciprofloxacin susceptibility (MIC 0.12-1 mg/L) was as high as 25% in isolates from all age groups, including those from pediatric patients. Our data indicated that there is a need to re-evaluate appropriate treatment selection for community-acquired infections in Taiwan. Identification of community reservoirs of multidrug-resistant E. coli is also warranted.	[Wang, Jann-Tay; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Jann-Tay; Shiau, Yih-Ru; Tan, Mei-Chen; Wang, Hui-Ying; Lai, Jui-Fen; Huang, I-Wen; Lauderdale, Tsai-Ling Yang] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei 10764, Taiwan; [Chang, Feng-Yee] Triserv Gen Hosp, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chang, Feng-Yee] Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Med, Kaohsiung, Taiwan; [Chen, Yao-Shen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital; Chi Mei Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Lauderdale, TLY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	lauderdale@nhri.org.tw	wang, hui/GRS-4730-2022	WANG, JANN-TAY/0000-0002-0924-3469; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Health Research Institutes [IV-101-PP-01, IV-102-PP-01]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This project was supported by an intramural grant from the National Health Research Institutes (IV-101-PP-01 and IV-102-PP-01).	Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Balode A, 2013, INT J ANTIMICROB AG, V41, P527, DOI 10.1016/j.ijantimicag.2013.02.022; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bouchillon Sam, 2012, Open Microbiol J, V6, P74; Bouchillon SK, 2013, CLIN THER, V35, P872, DOI 10.1016/j.clinthera.2013.03.022; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Carbonnel A, 2013, J ANTIMICROB CHEMOTH, V68, P954, DOI 10.1093/jac/dks464; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dudley MN, 2013, CLIN INFECT DIS, V56, P1301, DOI 10.1093/cid/cit017; EDBERG SC, 1983, J CLIN MICROBIOL, V18, P1287, DOI 10.1128/JCM.18.6.1287-1291.1983; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hanson ND, 2008, ANTIMICROB AGENTS CH, V52, P3814, DOI 10.1128/AAC.00877-08; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hawser SP, 2010, INT J ANTIMICROB AG, V36, P293, DOI 10.1016/j.ijantimicag.2010.05.012; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Ironmonger D, 2015, J ANTIMICROB CHEMOTH, V70, P1744, DOI 10.1093/jac/dkv043; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karlowsky JA, 2013, ANTIMICROB AGENTS CH, V57, P5600, DOI 10.1128/AAC.01485-13; Kuo SC, 2014, EMERG INFECT DIS, V20, P1386, DOI 10.3201/eid2008.140341; Labreche MJ, 2012, AM J HEALTH-SYST PH, V69, P1863, DOI 10.2146/ajhp110464; Lee CH, 2015, J MICROBIOL IMMUNOL, V48, P269, DOI 10.1016/j.jmii.2013.08.010; McDonald LC, 2001, ANTIMICROB AGENTS CH, V45, P3084, DOI 10.1128/AAC.45.11.3084-3091.2001; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; Oteo J, 2010, CURR OPIN INFECT DIS, V23, P320, DOI 10.1097/QCO.0b013e3283398dc1; Pascual V, 2015, J ANTIMICROB CHEMOTH, V70, P899, DOI 10.1093/jac/dku468; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Piddock LJV, 1999, DRUGS, V58, P11, DOI 10.2165/00003495-199958002-00003; Pitout JDD, 2013, CURR PHARM DESIGN, V19, P257, DOI 10.2174/138161213804070348; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1525, DOI 10.1128/AAC.50.4.1525-1527.2006; Poulou A, 2014, J CLIN MICROBIOL, V52, P1483, DOI 10.1128/JCM.03361-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rooney PJ, 2009, J ANTIMICROB CHEMOTH, V64, P635, DOI 10.1093/jac/dkp220; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sanchez GV, 2014, J ANTIMICROB CHEMOTH, V69, P3259, DOI 10.1093/jac/dku282; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Solomkin JS, 2010, CLIN INFECT DIS, V50, P133, DOI 10.1086/649554; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tan TY, 2011, DIAGN MICR INFEC DIS, V70, P423, DOI 10.1016/j.diagmicrobio.2011.03.008; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Theuretzbacher U, 2015, J ANTIMICROB CHEMOTH, V70, P2177, DOI 10.1093/jac/dkv157; Valles J, 2003, CHEST, V123, P1615, DOI 10.1378/chest.123.5.1615; Wang JT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-486; World Health Organization, 2013, TECHN CONS STRAT GLO; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0	49	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144103	10.1371/journal.pone.0144103	http://dx.doi.org/10.1371/journal.pone.0144103			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632819	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000056
J	Bonasera, SJ; Schenk, AK; Luxenberg, EJ; Wang, XD; Basbaum, A; Tecott, LH				Bonasera, Stephen J.; Schenk, A. Katrin; Luxenberg, Evan J.; Wang, Xidao; Basbaum, Allan; Tecott, Laurence H.			Mice Lacking Serotonin 2C Receptors Have increased Affective Responses to Aversive Stimuli	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; VENTRAL TEGMENTAL AREA; PAIN-RELATED BEHAVIOR; ACOUSTIC STARTLE; SHOCK SENSITIZATION; NEUROPATHIC PAIN; 5-HT RECEPTORS; ULTRASONIC VOCALIZATION; 5-HT2A/2C RECEPTORS; MESSENGER-RNAS	Although central serotonergic systems are known to influence responses to noxious stimuli, mechanisms underlying serotonergic modulation of pain responses are unclear. We proposed that serotonin 2C receptors (5-HT(2C)Rs), which are expressed within brain regions implicated in sensory and affective responses to pain, contribute to the serotonergic modulation of pain responses. In mice constitutively lacking 5-HT(2C)Rs (2CKO mice) we found normal baseline sensory responses to noxious thermal, mechanical and chemical stimuli. In contrast, 2CKO mice exhibited a selective enhancement of affect-related ultrasonic after-discharge vocalizations in response to footshock. Enhanced affect-related responses to noxious stimuli were also exhibited by 2CKO mice in a fear-sensitized startle assay. The extent to which a brief series of unconditioned footshocks produced enhancement of acoustic startle responses was markedly increased in 2CKO mice. As mesolimbic dopamine pathways influence affective responses to noxious stimuli, and these pathways are disinhibited in 2CKO mice, we examined the sensitivity of footshock-induced enhancement of startle to dopamine receptor blockade. Systemic administration of the dopamine D-2/D-3 receptor antagonist raclopride selectively reduced footshock-induced enhancement of startle without influencing baseline acoustic startle responses. We propose that 5-HT(2C)Rs regulate affective behavioral responses to unconditioned aversive stimuli through mechanisms involving the disinhibition of ascending dopaminergic pathways.	[Bonasera, Stephen J.; Luxenberg, Evan J.] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Schenk, A. Katrin; Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Wang, Xidao; Basbaum, Allan] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonasera, SJ (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Div Geriatr, Omaha, NE 68198 USA.	sbonasera@unmc.edu		Bonasera, Stephen/0000-0001-6808-2821	National Institutes of Health (NIH) [MH065983]; Brookdale National Fellowship Program; NIH [AG026043, NS014627, DA29204, DA11177]; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014627, R37NS014627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG026043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011177, R01DA029204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brookdale National Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from National Institutes of Health (NIH) MH065983 and the Brookdale National Fellowship Program (SJB), NIH AG026043 (SJB, AKS), NIH NS014627, DA29204 (AB, XW), and NIH DA11177 (LHT).	Abdallah L, 2009, J NEUROSCI, V29, P8156, DOI 10.1523/JNEUROSCI.3905-08.2009; Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Basura GJ, 2000, SYNAPSE, V38, P216, DOI 10.1002/1098-2396(200011)38:2<216::AID-SYN12>3.0.CO;2-5; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Borszcz GS, 2003, NEUROBIOL LEARN MEM, V79, P212, DOI 10.1016/S1074-7427(03)00002-9; BORSZCZ GS, 1994, PHARMACOL BIOCHEM BE, V49, P827, DOI 10.1016/0091-3057(94)90230-5; BORSZCZ GS, 1993, BEHAV NEUROSCI, V107, P678; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DAVIS M, 1989, BEHAV NEUROSCI, V103, P495, DOI 10.1037/0735-7044.103.3.495; DEUTCH AY, 1985, BRAIN RES, V333, P143, DOI 10.1016/0006-8993(85)90134-9; Di Giovanni G, 2011, RECEPT SER, P215, DOI 10.1007/978-1-60761-941-3_11; Di Matteo V, 2008, PROG BRAIN RES, V172, P7, DOI 10.1016/S0079-6123(08)00902-3; Drago A, 2009, AM J MED GENET B, V150B, P601, DOI 10.1002/ajmg.b.30864; Falls WA, 2002, CURRENT PROTOCOLS NE; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Freitas RL, 2008, EXP NEUROL, V213, P410, DOI 10.1016/j.expneurol.2008.07.003; Gifkins A, 2002, BEHAV NEUROSCI, V116, P785, DOI 10.1037//0735-7044.116.5.785; Girard P, 2006, PHARMACOL RES, V54, P195, DOI 10.1016/j.phrs.2006.04.008; Gobert A, 2000, SYNAPSE, V36, P205, DOI 10.1002/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Grillon C, 2004, BEHAV NEUROSCI, V118, P916, DOI 10.1037/0735-7044.118.5.916; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Guo JD, 2009, NEUROSCIENCE, V164, P1776, DOI 10.1016/j.neuroscience.2009.09.028; Han JS, 2005, J NEUROSCI METH, V141, P261, DOI 10.1016/j.jneumeth.2004.07.005; Harte SE, 2011, NEUROSCIENCE, V172, P460, DOI 10.1016/j.neuroscience.2010.10.055; Honda M, 2006, NEUROPHARMACOLOGY, V51, P866, DOI 10.1016/j.neuropharm.2006.05.031; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hutson PH, 2000, NEUROPHARMACOLOGY, V39, P2318, DOI 10.1016/S0028-3908(00)00089-7; Jeong CY, 2004, EUR J PHARMACOL, V502, P205, DOI 10.1016/j.ejphar.2004.08.048; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; JOURDAN D, 1995, PAIN, V63, P237, DOI 10.1016/0304-3959(95)00049-X; Kjorsvik A, 2001, BRAIN RES, V910, P179, DOI 10.1016/S0006-8993(01)02652-X; Kurihara T, 2003, PHARMACOL BIOCHEM BE, V74, P841, DOI 10.1016/S0091-3057(03)00014-5; LAPPALAINEN J, 1995, GENOMICS, V27, P274, DOI 10.1006/geno.1995.1042; Lerer B, 2001, MOL PSYCHIATR, V6, P579, DOI 10.1038/sj.mp.4000883; LEVINE JD, 1984, BRAIN RES, V296, P121, DOI 10.1016/0006-8993(84)90517-1; Liu FY, 2010, BRAIN RES, V1330, P45, DOI 10.1016/j.brainres.2010.03.010; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu S, 2007, NEUROSCIENCE, V146, P1677, DOI 10.1016/j.neuroscience.2007.02.064; Mickey BJ, 2012, J NEUROSCI, V32, P9344, DOI 10.1523/JNEUROSCI.1260-12.2012; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Nakae A, 2008, EUR J NEUROSCI, V27, P2373, DOI 10.1111/j.1460-9568.2008.06205.x; Nakai K, 2010, EUR J PAIN, V14, P999, DOI 10.1016/j.ejpain.2010.04.008; Obata H, 2004, PAIN, V108, P163, DOI 10.1016/j.pain.2003.12.019; OEI TPS, 1980, NEUROSCI BIOBEHAV R, V4, P161, DOI 10.1016/0149-7634(80)90014-7; Okada M, 2004, MOL PSYCHIATR, V9, P55, DOI 10.1038/sj.mp.4001357; Ormazabal MJ, 1999, BRAIN RES, V845, P130, DOI 10.1016/S0006-8993(99)01839-9; Pennanen L, 2013, NEUROPSYCHOPHARMACOL, V38, P957, DOI 10.1038/npp.2012.258; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pompeiano M., 1994, MOL BRAIN RES, V23, P163; Richardson R, 2000, BEHAV BRAIN RES, V110, P109, DOI 10.1016/S0166-4328(99)00189-8; Rocha BA, 2002, J NEUROSCI, V22, P10039; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Spuz CA, 2012, J PAIN, V13, P328, DOI 10.1016/j.jpain.2011.12.007; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; Van Nobelen M, 2006, NEUROSCIENCE, V137, P707, DOI 10.1016/j.neuroscience.2005.08.061; Wei H, 2008, PHARMACOL RES, V57, P469, DOI 10.1016/j.phrs.2008.05.007; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8; Wohr M, 2005, NEUROBIOL LEARN MEM, V84, P228, DOI 10.1016/j.nlm.2005.07.004; WRIGHT DE, 1995, J COMP NEUROL, V351, P357, DOI 10.1002/cne.903510304; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029	67	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142906	10.1371/journal.pone.0142906	http://dx.doi.org/10.1371/journal.pone.0142906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630489	gold, Green Published			2022-12-26	WOS:000365926300019
J	Cao, CH; Chen, JH; Lyu, CQ; Yu, J; Zhao, W; Wang, Y; Zou, DR				Cao, Chunhua; Chen, Jianhua; Lyu, Chengqi; Yu, Jia; Zhao, Wei; Wang, Yi; Zou, Derong			Bioinformatics Analysis of the Effects of Tobacco Smoke on Gene Expression	PLOS ONE			English	Article							CIGARETTE-SMOKE; BETA-CATENIN; LUNG-CANCER; BIOACTIVATION; METABOLISM; PACKAGE; CYP1A1	This study was designed to explore the effects of tobacco smoke on gene expression through bioinformatics analyses. Gene expression profile GSE17913 was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in buccal mucosa tissues between 39 active smokers and 40 never smokers were identified. Gene Ontology (GO) and pathway enrichment analyses of DEGs were performed, followed by protein-protein interaction (PPI) network, transcriptional regulatory network as well as miRNA-target regulatory network construction. In total, 88 up-regulated DEGs and 106 down-regulated DEGs were identified. Among these DEGs, cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1) and CYP1B1 were enriched in the Metabolism of xenobiotics by cytochrome P450 pathway. In the PPI network, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (YWHAZ), and CYP1A1 were hub genes. In the transcriptional regulatory network, transcription factors of MYC associated factor X (MAX) and upstream transcription factor 1 (USF1) regulated many overlapped DEGs. In addition, protein tyrosine phosphatase, receptor type, D (PTPRD) was regulated by multiple miRNAs in the miRNA-DEG regulatory network. CYP1A1, CYP1B1, YWHAZ and PTPRD, and TF of MAX and USF1 may have the potential to be used as biomarkers and therapeutic targets in tobacco smoke-related pathological changes.	[Cao, Chunhua; Lyu, Chengqi; Yu, Jia; Zhao, Wei; Wang, Yi; Zou, Derong] Shanghai Jiao Tong Univ, Dept Stomatol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Chen, Jianhua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, JH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai Key Lab Psychot Disorders, Shanghai 200030, Peoples R China.	chenjhv@hotmail.com; derongzou@qq.com			Shanghai Health and Family Planning Commission [20134Y192]; foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital [1517]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]; Science and Technology Commission of Shanghai Municipality [12JC1407301]; Shanghai Natural Science Foundation [12ZR1447200]; Natural Science Foundation of China [81470714, 31400825]	Shanghai Health and Family Planning Commission; foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai Key Laboratory of Psychotic Disorders; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Youth Research Project of Shanghai Health and Family Planning Commission (20134Y192), the foundation of Shanghai Jiao Tong University Affiliated Sixth People's Hospital (1517), Shanghai Key Laboratory of Psychotic Disorders (13dz2260500), the Science and Technology Commission of Shanghai Municipality (12JC1407301), Shanghai Natural Science Foundation (12ZR1447200) and the Natural Science Foundation of China (81470714, 31400825).	Barbieri SS, 2007, FASEB J, V21, P1831, DOI 10.1096/fj.06-7557com; Boyle JO, 2010, CANCER PREV RES, V3, P266, DOI 10.1158/1940-6207.CAPR-09-0192; Brody JS, 2012, INT J CANCER, V131, P2754, DOI 10.1002/ijc.27829; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Donetti E, 2010, ARCH ORAL BIOL, V55, P815, DOI 10.1016/j.archoralbio.2010.07.001; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Godschalk RWL, 2003, J BIOCHEM MOL BIOL, V36, P1; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gritz ER, 2005, CANCER EPIDEM BIOMAR, V14, P2287, DOI 10.1158/1055-9965.EPI-05-0224; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Humans IWGotEoCRt Organization WH Cancer IAfRo, 2004, TOB SMOK INV SMOK TH; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Lee JEA, 2014, AIMS GENET, V1, P81, DOI 10.3934/genet.2014.1.81; Li J, 2013, NUCL ACIDS RES; Lin P, 2003, LUNG CANCER-J IASLC, V42, P255, DOI 10.1016/S0169-5002(03)00359-3; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Mayne ST, 2005, JNCI-J NATL CANCER I, V97, P1319, DOI 10.1093/jnci/dji306; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niemiec P, 2015, INT J MOL SCI, V16, P13203, DOI 10.3390/ijms160613203; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pantarotto J, 2007, BJU INT, V99, P564, DOI 10.1111/j.1464-410X.2006.06656.x; Pickett G, 2009, TOXICOL SCI; Powell CA, 1999, CLIN CANCER RES, V5, P2025; Sanchez AP, 2011, AM J PHYSIOL-RENAL, V301, pF271, DOI 10.1152/ajprenal.00221.2011; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHIMADA T, 1989, CANCER RES, V49, P6304; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stucker I, 2000, PHARMACOGENETICS, V10, P617, DOI 10.1097/00008571-200010000-00005; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Uppstad H, 2010, TOXICOL LETT, V192, P221, DOI 10.1016/j.toxlet.2009.10.025; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; World Health Organization, 2006, WHO FACTS ALC VIOL I; Wu Li-An, 2007, Zhonghua Kou Qiang Yi Xue Za Zhi, V42, P559; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	39	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143377	10.1371/journal.pone.0143377	http://dx.doi.org/10.1371/journal.pone.0143377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629988	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300045
J	Fisher, R; Stark, C; Ridd, P; Jones, R				Fisher, Rebecca; Stark, Clair; Ridd, Peter; Jones, Ross			Spatial Patterns in Water Quality Changes during Dredging in Tropical Environments	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; SEDIMENT DISPERSION; PHYSICAL IMPACTS; COASTAL WATERS; POWER ANALYSIS; TURBIDITY; SEA; VARIABILITY; DISTURBANCE	Dredging poses a potential risk to tropical ecosystems, especially in turbidity-sensitive environments such as coral reefs, filter feeding communities and seagrasses. There is little detailed observational time-series data on the spatial effects of dredging on turbidity and light and defining likely footprints is a fundamental task for impact prediction, the EIA process, and for designing monitoring projects when dredging is underway. It is also important for public perception of risks associated with dredging. Using an extensive collection of in situ water quality data (73 sites) from three recent large scale capital dredging programs in Australia, and which included extensive pre-dredging baseline data, we describe relationships with distance from dredging for a range of water quality metrics. Using a criterion to define a zone of potential impact of where the water quality value exceeds the 80th percentile of the baseline value for turbidity-based metrics or the 20th percentile for the light based metrics, effects were observed predominantly up to three km from dredging, but in one instance up to nearly 20 km. This upper (similar to 20 km) limit was unusual and caused by a local oceanographic feature of consistent unidirectional flow during the project. Water quality loggers were located along the principal axis of this flow (from 200 m to 30 km) and provided the opportunity to develop a matrix of exposure based on running means calculated across multiple time periods (from hours to one month) and distance from the dredging, and summarized across a broad range of percentile values. This information can be used to more formally develop water quality thresholds for benthic organisms, such as corals, filter-feeders (e.g. sponges) and seagrasses in future laboratory-and field-based studies using environmentally realistic and relevant exposure scenarios, that may be used to further refine distance based analyses of impact, potentially further reducing the size of the dredging footprint.	[Fisher, Rebecca; Jones, Ross] Australian Inst Marine Sci, Perth, WA, Australia; [Fisher, Rebecca; Stark, Clair; Ridd, Peter; Jones, Ross] Western Australian Marine Sci Inst, Perth, WA, Australia; [Fisher, Rebecca; Jones, Ross] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Stark, Clair; Ridd, Peter] James Cook Univ, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia	Australian Institute of Marine Science; University of Western Australia; James Cook University	Fisher, R (corresponding author), Australian Inst Marine Sci, Perth, WA, Australia.	r.fisher@aims.gov.au	Fisher, Rebecca/C-5459-2011; Jones, Ross/N-4651-2013; Stark, Clair/O-2189-2017	Fisher, Rebecca/0000-0001-5148-6731; Jones, Ross/0000-0003-1661-4149; Stark, Clair/0000-0003-3598-724X	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node	Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node	This project was funded by the Western Australian Marine Science Institution as part of the WAMSI Dredging Science Node, and made possible through investment from Chevron Australia, Woodside Energy Limited, BHP Billiton as environmental offsets and by co-investment from the WAMSI Joint Venture partners. This research was also enabled by data provided by Woodside Energy Ltd, Rio Tinto Iron Ore and Chevron. The commercial investors and data providers had no role in the data analysis, data interpretation, the decision to publish or in the preparation of the manuscript.	ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; [Anonymous], 2012, AD ILL VERS CS6 COMP; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Anthony K.R.N., 2000, P 9 INT COR REEF S, V1, P239; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; ANZECC/ARMCANZ, 2001, AUSTR NZ GUID FRESH; Bak RPM, 1978, MARINE POLLUTION B, V9, P14; Bates DM, 1992, STAT MODELS S; Bivand, 2015, PACKAGE RGDAL BINDIN; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Bray R.N., 2008, ENV ASPECTS DREDGING; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll SS, 2000, CONSERV BIOL, V14, P1893, DOI 10.1111/j.1523-1739.2000.99432.x; Cavanaugh J., 1997, STAT PROBABILITY LET, V31, P201; CEDA, 2015, ENV MON PROC; Chapman M. G., 1998, Journal of Aquatic Ecosystem Stress and Recovery, V6, P235, DOI 10.1023/A:1009987403481; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Cole RG, 2001, ENVIRON MONIT ASSESS, V69, P85, DOI 10.1023/A:1010756729485; Cryer JD, 2008, TIME SERIES ANAL APP, P249, DOI DOI 10.1007/978-0-387-75959-3_11; Cutroneo L, 2012, J SOIL SEDIMENT, V12, P797, DOI 10.1007/s11368-012-0486-0; Doorn-Groen S., 2007, TERRA AQUA, V108, P3; Duclos PA, 2013, J COASTAL RES, V29, P25, DOI 10.2112/JCOASTRES-D-12-00148.1; EPA, 2011, ENV ASS GUID MAR DRE, P36; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; ESRI, 2013, ARCGIS DESKT V10 2; Evans RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051668; Fairweather P.G., 1991, MARINE FRESHWATER RE, V42, P555, DOI DOI 10.1071/MF9910555; Foster T., 2010, 108 PIANC ENV COMM; Fox D, 2001, UNDERSTANDING NEW AN; Fredette TJ, 2004, MAR POLLUT BULL, V49, P93, DOI 10.1016/j.marpolbul.2004.01.014; GBRMPA, 2012, US HYDR NUM MOD DRED; Geosciences Australia, 2004, GEOD COAST 100K 2004; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Green R., 1979, SAMPLING DESIGN STAT; Hanley JR, 2011, APPEA J, P273; Hanley N, 1993, COST BENEFIT ANAL EN, V499; Harris CA, 2014, ENVIRON SCI TECHNOL, V48, P3100, DOI 10.1021/es4047507; Hitchcock DR, 2004, J COASTAL RES, V20, P101, DOI 10.2112/1551-5036(2004)20[101:PIOMAD]2.0.CO;2; Johnston JSA, 1981, ENVIRON MANAGE, V5, P427; Jones R, 2015, MAR POLLUT BULL, V100, P13, DOI 10.1016/j.marpolbul.2015.08.021; Jones R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137112; Kirk J. T. O., 1984, PERSPECTIVES SO HEMI; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kleypas JA, 1999, AM ZOOL, V39, P146; Koskela R. W., 2002, 10 PAC C MAR SCI TEC; Larcombe P, 2001, SEDIMENTOLOGY, V48, P811, DOI 10.1046/j.1365-3091.2001.00396.x; LARCOMBE P, 1995, CORAL REEFS, V14, P163, DOI 10.1007/BF00367235; Macdonald RK, 2013, MAR POLLUT BULL, V74, P82, DOI 10.1016/j.marpolbul.2013.07.026; McArthur C, 2002, P 3 SPEC C DREDG DRE, P1; McCook L.J., 2015, SYNTHESIS CURRENT KN; MILLARD SP, 1986, ESTUAR COAST SHELF S, V22, P637, DOI 10.1016/0272-7714(86)90018-1; Morton J, 1977, US FISH WILDLIFE SER, V94, P1; Mulligan M, 2009, FREIGHT LOG COUNC WA; Murrell P, 2014, GRIDBASE INTEGRATION; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; NICHOLS M, 1990, ENVIRON GEOL WATER S, V15, P31, DOI 10.1007/BF01704879; Orpin AR, 2012, CONT SHELF RES, V47, P55, DOI 10.1016/j.csr.2012.06.013; Orpin AR, 2004, MAR POLLUT BULL, V49, P602, DOI 10.1016/j.marpolbul.2004.03.020; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Ruffin KK, 1998, ESTUAR COAST SHELF S, V47, P579, DOI 10.1006/ecss.1998.0366; Spearman J, 2015, MAR POLLUT BULL, V94, P260, DOI 10.1016/j.marpolbul.2015.01.025; Stoddart J, 2004, CORALS DAMPIER HARBO, P9; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Trimarchi S, 2007, ECOPORTS MONOGRAPH S, V24; Tuszynski Jarek, 2013, CATOOLS TOOLS MOVING; Underwood A.J., 1994, ECOLOGICAL APPL, V4, P4, DOI DOI 10.2307/1942110; VANDERVEER HW, 1985, NETH J SEA RES, V19, P183, DOI 10.1016/0077-7579(85)90022-5; VBKO, 2003, PROT FIELD MEAS SED; Wolanski E, 1992, WATER ENVIRON RES, V1992, P910; Wood S., 2013, GAMM4 GEN ADDITIVE M; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zeileis A, 2005, J STAT SOFTW, V14, P1, DOI [10.18637/jss.v014.i06, DOI 10.18637/JSS.V014.I06]	75	43	43	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143309	10.1371/journal.pone.0143309	http://dx.doi.org/10.1371/journal.pone.0143309			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630575	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000365926300040
J	Pagano, AF; Demangel, R; Brioche, T; Jublanc, E; Bertrand-Gaday, C; Candau, R; Dechesne, CA; Dani, C; Bonnieu, A; Py, G; Chopard, A				Pagano, Allan F.; Demangel, Remi; Brioche, Thomas; Jublanc, Elodie; Bertrand-Gaday, Christelle; Candau, Robin; Dechesne, Claude A.; Dani, Christian; Bonnieu, Anne; Py, Guillaume; Chopard, Angele			Muscle Regeneration with Intermuscular Adipose Tissue (IMAT) Accumulation Is Modulated by Mechanical Constraints	PLOS ONE			English	Article							SIDE POPULATION CELLS; MYOGENIC STEM-CELL; SKELETAL-MUSCLE; SATELLITE CELLS; FIBRO/ADIPOGENIC PROGENITORS; MESENCHYMAL PROGENITORS; ALTERED INFLAMMATION; SOLEUS MUSCLE; INJURY; GROWTH	Sports trauma are able to induce muscle injury with fibrosis and accumulation of intermuscular adipose tissue (IMAT), which affect muscle function. This study was designed to investigate whether hypoactivity would influence IMAT accumulation in regenerating mouse skeletal muscle using the glycerol model of muscle regeneration. The animals were immediately hindlimb unloaded for 21 days after glycerol injection into the tibialis anterior (TA) muscle. Muscle fiber and adipocyte cross-sectional area (CSA) and IMAT accumulation were determined by histomorphometric analysis. Adipogenesis during regenerative processes was examined using RT-qPCR and Western blot quantification. Twenty-one days of hindlimb unloading resulted in decreases of 38% and 50.6% in the muscle weight/body weight ratio and CSA, respectively, in soleus muscle. Glycerol injection into TA induced IMAT accumulation, reaching 3% of control normal-loading muscle area. This IMAT accumulation was largely inhibited in unloading conditions (0.09%) and concomitant with a marked reduction in perilipin and FABP4 protein content, two key markers of mature adipocytes. Induction of PPAR. and C/EBP alpha mRNA, two markers of adipogenesis, was also decreased. Furthermore, the protein expression of PDGFR alpha, a cell surface marker of fibro/adipogenic progenitors, was much lower in regenerating TA from the unloaded group. Exposure of regenerating muscle to hypoactivity severely reduces IMAT development and accumulation. These results provide new insight into the mechanisms regulating IMAT development in skeletal muscle and highlight the importance of taking into account the level of mechanical constraint imposed on skeletal muscle during the regeneration processes.	[Pagano, Allan F.; Demangel, Remi; Brioche, Thomas; Jublanc, Elodie; Bertrand-Gaday, Christelle; Candau, Robin; Bonnieu, Anne; Py, Guillaume; Chopard, Angele] Univ Montpellier, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Dechesne, Claude A.; Dani, Christian] Univ Nice Sophia Antipolis, INSERM, U1091, iBV,CNRS,UMR7277, F-06107 Nice, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Chopard, A (corresponding author), Univ Montpellier, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	angele.chopard@univ-montp1.fr	F., Pagano Allan/AAQ-3930-2020; DANI, Christian/G-3639-2014; BERTRAND-GADAY, Christelle/ABA-8619-2021; Bonnieu, Anne/ABA-7182-2020	DANI, Christian/0000-0003-3228-0230; BERTRAND-GADAY, Christelle/0000-0003-0461-2402; PAGANO, Allan F./0000-0003-0717-2377; candau, robin/0000-0002-5930-8750	Centre National d'Etudes Spatiales (CNES)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	This work was supported by the Centre National d'Etudes Spatiales (CNES).	Abraham ST, 2006, J CELL BIOCHEM, V97, P621, DOI 10.1002/jcb.20669; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Andrianjafiniony T, 2010, AM J PHYSIOL-CELL PH, V299, pC307, DOI 10.1152/ajpcell.00069.2010; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arrighi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.79; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Aurora AB, 2014, CELL STEM CELL, V15, P15, DOI 10.1016/j.stem.2014.06.009; Baldwin Kenneth M, 2013, Front Physiol, V4, P284, DOI 10.3389/fphys.2013.00284; Birbrair A, 2013, STEM CELLS DEV, V22, P2298, DOI 10.1089/scd.2012.0647; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Boppart MD, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00310; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; Gratas-Delamarche A, 2014, FREE RADICAL RES, V48, P93, DOI 10.3109/10715762.2013.847528; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Heslop L, 2000, J CELL SCI, V113, P2299; Hirose T, 2008, J APPL PHYSIOL, V104, P170, DOI 10.1152/japplphysiol.00463.2006; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Judson RN, 2013, FEBS J, V280, P4100, DOI 10.1111/febs.12370; KAWAI H, 1990, ACTA NEUROPATHOL, V80, P192, DOI 10.1007/BF00308923; Kohno S, 2012, J APPL PHYSIOL, V112, P1773, DOI 10.1152/japplphysiol.00103.2012; Kurahashi M, 2013, AM J PHYSIOL-GASTR L, V304, pG823, DOI 10.1152/ajpgi.00001.2013; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lukjanenko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071084; Madaro L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/438675; Maffioletti SM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/964010; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Motohashi N, 2008, AM J PATHOL, V173, P781, DOI 10.2353/ajpath.2008.070902; Mozdziak PE, 1998, EUR J APPL PHYSIOL O, V78, P136, DOI 10.1007/s004210050398; Nguyen HX, 2003, J PHYSIOL-LONDON, V550, P347, DOI 10.1113/jphysiol.2003.040907; Pagano AF, 2014, MED SCI SPORT EXER, V46, P1314, DOI 10.1249/MSS.0000000000000237; Pirot N, 2014, AM J PHYSIOL-LUNG C, V306, pL775, DOI 10.1152/ajplung.00200.2013; Pisani DF, 2010, BIOCHEM BIOPH RES CO, V396, P767, DOI 10.1016/j.bbrc.2010.05.021; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; SCHULTZ E, 1994, J APPL PHYSIOL, V76, P266, DOI 10.1152/jappl.1994.76.1.266; Sciorati C, 2015, CELL MOL LIFE SCI, V72, P2135, DOI 10.1007/s00018-015-1857-7; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Takegahara Y, 2014, EXP CELL RES, V324, P105, DOI 10.1016/j.yexcr.2014.03.021; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653; Zhang BT, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-87; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	62	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144230	10.1371/journal.pone.0144230	http://dx.doi.org/10.1371/journal.pone.0144230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629696	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300172
J	Sperling, O; Earles, JM; Secchi, F; Godfrey, J; Zwieniecki, MA				Sperling, Or; Earles, J. Mason; Secchi, Francesca; Godfrey, Jessie; Zwieniecki, Maciej A.			Frost Induces Respiration and Accelerates Carbon Depletion in Trees	PLOS ONE			English	Article							CARBOHYDRATE DYNAMICS; PLANT RESPIRATION; STEM RESPIRATION; COLD-ACCLIMATION; TEMPERATURE; MORTALITY; AVOIDANCE; TOLERANCE; BACTERIAL; DROUGHT	Cellular respiration depletes stored carbohydrates during extended periods of limited photosynthesis, e.g. winter dormancy or drought. As respiration rate is largely a function of temperature, the thermal conditions during such periods may affect non-structural carbohydrate (NSC) availability and, ultimately, recovery. Here, we surveyed stem responses to temperature changes in 15 woody species. For two species with divergent respirational response to frost, P. integerrima and P. trichocarpa, we also examined corresponding changes in NSC levels. Finally, we simulated respiration-induced NSC depletion using historical temperature data for the western US. We report a novel finding that tree stems significantly increase respiration in response to near freezing temperatures. We observed this excess respiration in 13 of 15 species, deviating 10% to 170% over values predicted by the Arrhenius equation. Excess respiration persisted at temperatures above 0 degrees C during warming and reoccurred over multiple frost-warming cycles. A large adjustment of NSCs accompanied excess respiration in P. integerrima, whereas P. trichocarpa neither excessively respired nor adjusted NSCs. Over the course of the years included in our model, frost-induced respiration accelerated stem NSC consumption by 8.4 mg (glucose eq.) cm(-3) yr(-1) on average in the western US, a level of depletion that may continue to significantly affect spring NSC availability. This novel finding revises the current paradigm of low temperature respiration kinetics.	[Sperling, Or; Earles, J. Mason; Godfrey, Jessie; Zwieniecki, Maciej A.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Earles, J. Mason] Univ Calif Davis, Ecol Grad Grp, Davis, CA 95616 USA; [Secchi, Francesca] Univ Turin, Dept Agr Forest & Food Sci DISAFA, I-10095 Grugliasco, TO, Italy	University of California System; University of California Davis; University of California System; University of California Davis; University of Turin	Sperling, O (corresponding author), Univ Calif Davis, Dept Plant Sci, PES 2316,One Shields Ave, Davis, CA 95616 USA.	orsperling@gmail.com; jmearles@ucdavis.edu		Zwieniecki, Maciej/0000-0002-3774-4455; Sperling, Or/0000-0002-4007-4341	California Pistachio Research Board (Fresno, CA); U.S. Environmental Protection Agency STAR Fellowship program	California Pistachio Research Board (Fresno, CA); U.S. Environmental Protection Agency STAR Fellowship program(United States Environmental Protection Agency)	This work was funded by the California Pistachio Research Board (Fresno, CA). JME received funding from the U.S. Environmental Protection Agency STAR Fellowship program.	Adams HD, 2013, NEW PHYTOL, V197, P1142, DOI 10.1111/nph.12102; Arrhenius S., 1889, Z PHYS CHEM, V4, P96, DOI [DOI 10.1515/ZPCH-1889-0408, 10.1515/zpch-1889-0408]; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; BURKE MJ, 1976, ANNU REV PLANT PHYS, V27, P507, DOI 10.1146/annurev.pp.27.060176.002451; Carey EV, 1997, OECOLOGIA, V111, P19, DOI 10.1007/s004420050203; Cesaraccio C, 2001, INT J BIOMETEOROL, V45, P161; Dickman LT, 2015, PLANT CELL ENVIRON, V38, P729, DOI 10.1111/pce.12441; Eccel E, 2013, INTERPOL T HOURLY IN; Eccel E, 2010, ITAL J AGROMETEOROL, V15, P45; Edwards NT, 1996, TREE PHYSIOL, V16, P433; Flanagan LB, 2005, AGR FOREST METEOROL, V130, P237, DOI 10.1016/j.agrformet.2005.04.002; FLINT HL, 1967, CAN J PLANT SCI, V47, P229, DOI 10.4141/cjps67-043; GLASS ML, 1985, J EXP BIOL, V114, P37; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hincha DK, 1996, J PLANT PHYSIOL, V147, P604, DOI 10.1016/S0176-1617(96)80053-8; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; KLIKOFF LG, 1966, NATURE, V212, P529, DOI 10.1038/212529a0; Lenne T, 2010, PLANT CELL ENVIRON, V33, P1731, DOI 10.1111/j.1365-3040.2010.02178.x; Leyva A, 2008, BIOLOGICALS, V36, P134, DOI 10.1016/j.biologicals.2007.09.001; Lintunen A, 2014, ANN BOT-LONDON, V114, P1711, DOI 10.1093/aob/mcu190; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Melcher PJ, 2000, INT J PLANT SCI, V161, P369, DOI 10.1086/314271; Noguchi K, 2015, NEW PHYTOL; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; Sevanto S, 2014, J EXP BOT, V65, P1751, DOI 10.1093/jxb/ert467; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Seymour RS, 2001, BIOSCIENCE REP, V21, P223, DOI 10.1023/A:1013608627084; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; WILLAMAN J. J., 1930, PLANT PHYSIOL, V5, P535, DOI 10.1104/pp.5.4.535	33	32	32	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144124	10.1371/journal.pone.0144124	http://dx.doi.org/10.1371/journal.pone.0144124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629819	Green Published, gold			2022-12-26	WOS:000365926300163
J	Suzuki, R; Kikuchi, S; Harada, T; Mimura, N; Minami, J; Ohguchi, H; Yoshida, Y; Sagawa, M; Gorgun, G; Cirstea, D; Cottini, F; Jakubikova, J; Tai, YT; Chauhan, D; Richardson, PG; Munshi, N; Ando, K; Utsugi, T; Hideshima, T; Anderson, KC				Suzuki, Rikio; Kikuchi, Shohei; Harada, Takeshi; Mimura, Naoya; Minami, Jiro; Ohguchi, Hiroto; Yoshida, Yasuhiro; Sagawa, Morihiko; Gorgun, Gullu; Cirstea, Diana; Cottini, Francesca; Jakubikova, Jana; Tai, Yu-Tzu; Chauhan, Dharminder; Richardson, Paul G.; Munshi, Nikhil; Ando, Kiyoshi; Utsugi, Teruhiro; Hideshima, Teru; Anderson, Kenneth C.			Combination of a Selective HSP90 alpha/beta Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells	PLOS ONE			English	Article							PROTEIN 90 INHIBITOR; PHASE-I; ANTITUMOR-ACTIVITY; BRAF INHIBITION; HSP90 INHIBITOR; CANCER; RESISTANCE; KINASE; APOPTOSIS; MUTATION	Heat shock protein (HSP) 90 inhibitors have shown significant anti-tumor activities in preclinical settings in both solid and hematological tumors. We previously reported that the novel, orally available HSP90 alpha/beta inhibitor TAS-116 shows significant anti-MM activities. In this study, we further examined the combination effect of TAS-116 with a RAS-RAF-MEK-ERK signaling pathway inhibitor in RAS-or BRAF-mutated MM cell lines. TAS-116 monotherapy significantly inhibited growth of RAS-mutated MM cell lines and was associated with decreased expression of downstream target proteins of the RAS-RAF-MEK-ERK signaling pathway. Moreover, TAS-116 showed synergistic growth inhibitory effects with the farnesyltransferase inhibitor tipifarnib, the BRAF inhibitor dabrafenib, and the MEK inhibitor selumetinib. Importantly, treatment with these inhibitors paradoxically enhanced p-C-Raf, p-MEK, and p-ERK activity, which was abrogated by TAS-116. TAS-116 also enhanced dabrafenib-induced MM cytotoxicity associated with mitochondrial damage-induced apoptosis, even in the BRAF-mutated U266 MM cell line. This enhanced apoptosis in RAS-mutated MM triggered by combination treatment was observed even in the presence of bone marrow stromal cells. Taken together, our results provide the rationale for novel combination treatment with HSP90 alpha/beta inhibitor and RAS-RAF-MEK-ERK signaling pathway inhibitors to improve outcomes in patients with in RAS-or BRAF-mutated MM.	[Suzuki, Rikio; Kikuchi, Shohei; Harada, Takeshi; Mimura, Naoya; Minami, Jiro; Ohguchi, Hiroto; Yoshida, Yasuhiro; Sagawa, Morihiko; Gorgun, Gullu; Cirstea, Diana; Cottini, Francesca; Jakubikova, Jana; Tai, Yu-Tzu; Chauhan, Dharminder; Richardson, Paul G.; Hideshima, Teru; Anderson, Kenneth C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA; [Suzuki, Rikio; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Hematol Oncol, Isehara, Kanagawa 25911, Japan; [Utsugi, Teruhiro] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki, Japan; [Munshi, Nikhil] Harvard Univ, Sch Med, Dana Farber Canc Inst, VA Boston Healthcare Syst,Jerome Lipper Multiple, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tokai University; Taiho Pharmaceutical; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Anderson, KC (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	kenneth_anderson@dfci.harvard.edu	Munshi, Nikhil/ABE-2338-2021; Kikuchi, Shohei/AAF-6775-2020; Suzuki, Rikio/AAJ-6675-2021; Jakubikova, Jana/ABE-5761-2020	Kikuchi, Shohei/0000-0002-0961-6253; Jakubikova, Jana/0000-0003-2593-569X; Cottini, Francesca/0000-0001-8676-7840	National Institutes of Health [P50-100707, PO1-CA078378, PO1-155258, RO1-CA050947, RO1-178264, IO1-BX001584]; SENSHIN Medical Research Foundation; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA178264, P01CA078378, R01CA050947] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the National Institutes of Health Grants (http://grants.nih.gov/grants/oer.htm) P50-100707, PO1-CA078378, and PO1-155258 (K.C.A., N.M.); RO1-CA050947 (K.C.A.) and RO1-178264 (T.H., K.C.A.); IO1-BX001584 (N.M.); and SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/) (R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva J, 2012, MOL CANCER THER, V11, P2633, DOI 10.1158/1535-7163.MCT-12-0615; Andrulis M, 2013, CANCER DISCOV, V3, P862, DOI 10.1158/2159-8290.CD-13-0014; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Barrott JJ, 2013, FEBS J, V280, P1381, DOI 10.1111/febs.12147; Chng WJ, 2008, LEUKEMIA, V22, P2280, DOI 10.1038/leu.2008.142; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; Ding HS, 2014, HAEMATOLOGICA, V99, P60, DOI 10.3324/haematol.2013.087734; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Gollob JA, 2006, SEMIN ONCOL, V33, P392, DOI 10.1053/j.seminoncol.2006.04.002; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hideshima T, 2006, CLIN CANCER RES, V12, P5887, DOI 10.1158/1078-0432.CCR-05-2501; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Hideshima T, 2011, INT J HEMATOL, V94, P344, DOI 10.1007/s12185-011-0917-5; Hoang B, 2006, BLOOD, V107, P4484, DOI 10.1182/blood-2005-09-3926; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Khong T, 2011, MOL CANCER THER, V10, P1909, DOI 10.1158/1535-7163.MCT-11-0174; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Leow CCY, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.1; Lin L, 2015, NAT GENET; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Mulligan G, 2014, BLOOD, V123, P632, DOI 10.1182/blood-2013-05-504340; Nakadate Y, 2014, INT J CANCER, V134, P2146, DOI 10.1002/ijc.28550; Nakashima T, 2010, CLIN CANCER RES, V16, P2792, DOI 10.1158/1078-0432.CCR-09-3112; Ohkubo S, 2015, MOL CANCER THER, V14, P14, DOI 10.1158/1535-7163.MCT-14-0219; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajan A, 2011, CLIN CANCER RES, V17, P6831, DOI 10.1158/1078-0432.CCR-11-0821; Scaltriti M, 2012, CLIN CANCER RES, V18, P4508, DOI 10.1158/1078-0432.CCR-11-2138; Sharman JP, 2014, CL LYMPH MYELOM LEUK, V14, pE161, DOI 10.1016/j.clml.2014.06.004; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Spagnolo F, 2014, ONCOTARGET, V5, P10206, DOI 10.18632/oncotarget.2602; Suzuki R, 2015, LEUKEMIA, V29, P510, DOI 10.1038/leu.2014.300; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tai YT, 2007, BLOOD, V110, P1656, DOI 10.1182/blood-2007-03-081240; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yasui H, 2006, BRIT J HAEMATOL, V132, P385, DOI 10.1111/j.1365-2141.2005.05860.x; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850; Zhang L, 2014, ONCOTARGET, V5, P1132, DOI 10.18632/oncotarget.1584; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	53	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143847	10.1371/journal.pone.0143847	http://dx.doi.org/10.1371/journal.pone.0143847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630652	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300111
J	Adams, S; Manfield, I; Stockley, P; Carre, IA				Adams, Sally; Manfield, Ian; Stockley, Peter; Carre, Isabelle A.			Revised Morning Loops of the Arabidopsis Circadian Clock Based on Analyses of Direct Regulatory Interactions	PLOS ONE			English	Article							PSEUDO-RESPONSE REGULATORS; LATE-ELONGATED-HYPOCOTYL; RHYTHMS; OSCILLATOR; CCA1; EXPRESSION; THALIANA; LIGHT; LHY; ROLES	The network structure of the plant circadian clock is complex and direct regulatory interactions between individual components have proven particularly difficult to predict from genetic analyses. Here, we systematically investigate in vivo binding interactions between the morning-specific transcription factor, LATE ELONGATED HYPOCOTYL (LHY) and the promoters of other components of the network. We then demonstrate the functionality of these interactions by testing the responsiveness of the target gene to an ethanol-induced change in expression level of the LHY protein. We uncover novel, negative autoregulatory feedback loops from LHY and the closely related CIRCADIAN CLOCK ASSOCIATED-1 (CCA1) onto their own and each other's expression. Furthermore we show that LHY acts as a repressor of all other clock components, including PSEUDO-RESPONSE REGULATORs (PRRs) 9 and 7, which were previously thought to be positive regulatory targets. These experimental results lead to a substantial revision of the morning loops of the clock.	[Adams, Sally; Carre, Isabelle A.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Manfield, Ian; Stockley, Peter] Univ Leeds, Astbury Ctr, Leeds, W Yorkshire, England	University of Warwick; University of Leeds	Carre, IA (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	isabelle.carre@warwick.ac.uk	CARRE, Isabelle A/D-8802-2011	CARRE, Isabelle A/0000-0002-0548-7378; Manfield, Iain/0000-0003-3765-0325; Stockley, Peter/0000-0002-1360-2751; Adams, Sally/0000-0002-3353-7459	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F022832/1]; BBSRC [BB/F022832/1, BB/F021143/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022832/1, BB/F021143/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC) to IAC and PS (Ref: BB/F022832/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Carre I, 2013, SEMIN CELL DEV BIOL, V24, P393, DOI 10.1016/j.semcdb.2013.03.011; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Fogelmark K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003705; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; Hsu PY, 2013, ELIFE, V2, DOI 10.7554/eLife.00473; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Knowles SM, 2008, J BIOL RHYTHM, V23, P463, DOI 10.1177/0748730408326749; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Lu SX, 2012, PLANT PHYSIOL, V158, P1079, DOI 10.1104/pp.111.189670; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Pokhilko A, 2012, MOL SYST BIOL, P8; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rugnone ML, 2013, P NATL ACAD SCI USA, V110, P12120, DOI 10.1073/pnas.1302170110; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Spensley M, 2009, PLANT CELL, V21, P2606, DOI 10.1105/tpc.109.069898; Wang Y, 2011, PLANT CELL, V23, P486, DOI 10.1105/tpc.110.081661; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yakir E, 2009, PLANT PHYSIOL, V150, P844, DOI 10.1104/pp.109.137414	33	70	75	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143943	10.1371/journal.pone.0143943	http://dx.doi.org/10.1371/journal.pone.0143943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625126	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600078
J	Chen, SX; Liu, JL; Yang, M; Lai, W; Ye, LT; Chen, J; Hou, XH; Ding, H; Zhang, WW; Wu, YH; Liu, XY; Huang, SF; Yu, XY; Xiao, DZ				Chen, Shaoxian; Liu, Juli; Yang, Min; Lai, Wen; Ye, Litong; Chen, Jing; Hou, Xinghua; Ding, Hong; Zhang, Wenwei; Wu, Yueheng; Liu, Xiaoying; Huang, Shufang; Yu, Xiyong; Xiao, Dingzhang			Fn14, a Downstream Target of the TGF-beta Signaling Pathway, Regulates Fibroblast Activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN DERMAL FIBROBLASTS; SKELETAL-MUSCLE ATROPHY; SYSTEMIC-SCLEROSIS; WEAK INDUCER; HYPERTROPHIC SCAR; APOPTOSIS TWEAK; GENE-EXPRESSION; RECEPTOR; FIBROSIS	Fibrosis, the hallmark of human injuries and diseases such as serious burns, is characterized by excessive collagen synthesis and myofibroblast accumulation. Transforming growth factor-beta (TGF-beta), a potent inducer of collagen synthesis, has been implicated in fibrosis in animals. In addition to TGF-beta, fibroblast growth factor-inducible molecule 14 (Fn14) has been reported to play an important role in fibrotic diseases, such as cardiac fibrosis. However, the function and detailed regulatory mechanism of Fn14 in fibrosis are unclear. Here, we investigated the effect of Fn14 on the activation of human dermal fibroblasts. In normal dermal fibroblasts, TGF-beta signaling increased collagen production and Fn14 expression. Furthermore, Fn14 siRNA blocked extracellular matrix gene expression; even when TGF-beta signaling was activated by TGF-beta 1, fibroblast activation remained blocked in the presence of Fn14 siRNA. Overexpressing Fn14 increased extracellular matrix gene expression. In determining the molecular regulatory mechanism, we discovered that SMAD4, an important TGF-beta signaling co-mediator, bound to the Fn14 promoter and activated Fn14 transcription. Taken together, these results indicate that the TGF-beta signaling pathway activates Fn14 expression through the transcription factor SMAD4 and that activated Fn14 expression increases extracellular matrix synthesis and fibroblast activation. Therefore, Fn14 may represent a promising approach to preventing the excessive accumulation of collagen or ECM in skin fibrosis.	[Chen, Shaoxian; Yang, Min; Chen, Jing; Hou, Xinghua; Ding, Hong; Zhang, Wenwei; Wu, Yueheng; Liu, Xiaoying; Huang, Shufang; Yu, Xiyong; Xiao, Dingzhang] Guangdong Acad Med Sci, Med Res Dept, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Liu, Juli] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Yang, Min] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Lai, Wen] Guangdong Acad Med Sci, Guangdong Gen Hosp, Burn & Wound Repair Surg, Guangzhou, Guangdong, Peoples R China; [Ye, Litong] Guangzhou Mil Command PLA, Gen Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Theater Command General Hospital	Yu, XY (corresponding author), Guangdong Acad Med Sci, Med Res Dept, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China.	yuxycn@aliyun.com; dzhxiao@163.com			National Key Basic Research Program of China [2012CB526602]; Science and Technology Planning Project of Guangzhou [11C26040747, 201510010210]; Guangdong Medical Research Foundation [B2012012, A2014028]; Guangdong Construction Strong Medicine Scientific Research [20122178, 20122179]; Science and Technology Planning Project of Guangdong Province [2014A020212226, 2014A020212674]; National Natural Science Foundation of China [30901468]	National Key Basic Research Program of China(National Basic Research Program of China); Science and Technology Planning Project of Guangzhou; Guangdong Medical Research Foundation; Guangdong Construction Strong Medicine Scientific Research; Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Key Basic Research Program of China (grant numbers: 2012CB526602 to Xiyong Yu), the Science and Technology Planning Project of Guangzhou; (grant numbers: 11C26040747 and 201510010210 to Dingzhang Xiao), the Guangdong Medical Research Foundation (grant numbers: B2012012 to Shaoxian Chen, A2014028 to Dingzhang Xiao), the Guangdong Construction Strong Medicine Scientific Research (grant numbers: 20122178 to Min Yang, 20122179 to Shaoxian Chen), the Science and Technology Planning Project of Guangdong Province (grant numbers: 2014A020212226 to Dingzhang Xiao, 2014A020212674 to Shaoxian Chen), and The National Natural Science Foundation of China (grant numbers: 30901468 to Yueheng Wu).	Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Chen HN, 2012, MOL BIOL REP, V39, P8231, DOI 10.1007/s11033-012-1671-3; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Chou WC, 2003, MOL BIOL CELL, V14, P1279, DOI 10.1091/mbc.E02-07-0375; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doerner JL, 2015, J INVEST DERMATOL, V135, P1986, DOI 10.1038/jid.2015.124; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Huang W, 2014, J CELL PHYSIOL, V229, P580, DOI 10.1002/jcp.24480; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Kim HJ, 2010, J INVEST DERMATOL, V130, P706, DOI 10.1038/jid.2009.302; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Novoyatleva T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00050; Novoyatleva T, 2013, CYTOKINE, V64, P43, DOI 10.1016/j.cyto.2013.05.009; Novoyatleva T, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0325-x; Pannu J, 2004, ARTHRITIS RHEUM-US, V50, P1566, DOI 10.1002/art.20225; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; PELTONEN J, 1990, ARTHRITIS RHEUM-US, V33, P1829, DOI 10.1002/art.1780331211; Poveda J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00447; Rorison P, 2010, BURNS, V36, P89, DOI 10.1016/j.burns.2009.03.008; Sacnun MP, 2011, REUMATOL CLIN, V7, P61, DOI 10.1016/j.reuma.2010.02.003; Sato S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00018; Son A, 2013, MUCOSAL IMMUNOL, V6, P1131, DOI 10.1038/mi.2013.10; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Tajrishi MM, 2014, CYTOKINE GROWTH F R, V25, P215, DOI 10.1016/j.cytogfr.2013.12.004; Tajrishi MM, 2014, BIOCHEM BIOPH RES CO, V446, P1219, DOI 10.1016/j.bbrc.2014.03.084; Takagawa S, 2003, J INVEST DERMATOL, V121, P41, DOI 10.1046/j.1523-1747.2003.12308.x; Tecalco-Cruz AC, 2012, J BIOL CHEM, V287, P26764, DOI 10.1074/jbc.M112.386599; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; Ucero AC, 2013, BBA-MOL BASIS DIS, V1832, P1744, DOI 10.1016/j.bbadis.2013.05.032; UITTO J, 1985, P NATL ACAD SCI USA, V82, P5935, DOI 10.1073/pnas.82.17.5935; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Varkey M, 2014, TISSUE ENG PT A, V20, P716, DOI 10.1089/ten.TEA.2013.0434; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia YM, 2012, CLIN IMMUNOL, V145, P108, DOI 10.1016/j.clim.2012.08.008	50	20	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143802	10.1371/journal.pone.0143802	http://dx.doi.org/10.1371/journal.pone.0143802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625141	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600052
J	Tovar, DA; Zhan, W; Rajan, SS				Tovar, David A.; Zhan, Wang; Rajan, Sunder S.			A Rotational Cylindrical fMRI Phantom for Image Quality Control	PLOS ONE			English	Article							RELAXATION-TIMES; FUNCTIONAL MRI; CORTEX; ASSURANCE; DYNAMICS; REVEALS; DISEASE; TISSUE; BRAIN; TESLA	Purpose A novel phantom for image quality testing for functional magnetic resonance imaging (fMRI) scans is described. Methods The cylindrical, rotatable, similar to 4.5L phantom, with eight wedge-shaped compartments, is used to simulate rest and activated states. The compartments contain NiCl2 doped agar gel with alternating concentrations of agar (1.4%, 1.6%) to produce T1 and T2 values approximating brain grey matter. The Jacard index was used to compare the image distortions for echo planar imaging (EPI) and gradient recalled echo (GRE) scans. Contrast to noise ratio ((CNR)) was compared across the imaging volume for GRE and EPI. Results The mean T2 for the two agar concentrations were found to be 106.5 +/- 4.8, 94.5 +/- 4.7 ms, and T1 of 1500 +/- 40 and 1485 +/- 30 ms, respectively. The Jacard index for GRE was generally found to be higher than for EPI (0.95 versus 0.8). The CNR varied from 20 to 50 across the slices and echo times used for EPI scans, and from 20 to 40 across the slices for the GRE scans. The phantom provided a reproducible CNR over 25 days. Conclusions The phantom provides a quantifiable signal change over a head-size imaging volume with EPI and GRE sequences, which was used for image quality assessment.	[Tovar, David A.; Rajan, Sunder S.] US FDA, Div Biomed Phys, Silver Spring, MD 20993 USA; [Zhan, Wang] Univ Maryland, Maryland Neuroimaging Ctr, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park	Rajan, SS (corresponding author), US FDA, Div Biomed Phys, Silver Spring, MD 20993 USA.	Sunder.Rajan@fda.hhs.gov		Tovar, David/0000-0002-5449-6289				Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; Carlson T, 2006, NEUROIMAGE, V32, P892, DOI 10.1016/j.neuroimage.2006.03.059; Cheng H, 2006, MAGN RESON IMAGING, V24, P301, DOI 10.1016/j.mri.2005.12.012; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Edden RAE, 2010, J MAGN RESON IMAGING, V32, P982, DOI 10.1002/jmri.22306; Ehrlich S, 2012, PSYCHOL MED, V42, P267, DOI 10.1017/S003329171100119X; El-Sharkawy AM, 2006, MAGN RESON MATER PHY, V19, P223, DOI 10.1007/s10334-006-0050-2; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Geissler A, 2007, J MAGN RESON IMAGING, V25, P1263, DOI 10.1002/jmri.20935; Geng XJ, 2009, NEUROIMAGE, V47, P1341, DOI 10.1016/j.neuroimage.2009.04.024; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Laufs H, 2012, NEUROIMAGE, V62, P1056, DOI 10.1016/j.neuroimage.2012.01.039; Luders E, 2002, NEUROREPORT, V13, P2371, DOI 10.1097/01.wnr.0000049603.85580.da; Maitra R, 2010, NEUROIMAGE, V50, P124, DOI 10.1016/j.neuroimage.2009.11.070; McGonigle DJ, 2012, NEUROIMAGE, V62, P1116, DOI 10.1016/j.neuroimage.2012.01.023; MENON RS, 1993, MAGNET RESON MED, V30, P380, DOI 10.1002/mrm.1910300317; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ohno Seiichiro, 2008, Magn Reson Med Sci, V7, P131; Olsrud J, 2008, MAGN RESON IMAGING, V26, P279, DOI 10.1016/j.mri.2007.06.010; Pell GS, 2004, NEUROIMAGE, V21, P707, DOI 10.1016/j.neuroimage.2003.09.059; Peters F, 2009, BRAIN, V132, P1833, DOI 10.1093/brain/awp075; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Rombouts S, 2007, CLIN APPL FUNCTION B; Soltysik DA, 2011, NEUROIMAGE, V56, P1329, DOI 10.1016/j.neuroimage.2011.03.023; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; Van de Moortele P. F, 2008, P INT SOC MAG RESON, P2464	34	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143172	10.1371/journal.pone.0143172	http://dx.doi.org/10.1371/journal.pone.0143172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625264	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600017
J	Hauf, K; Kayumov, A; Gloge, F; Forchhammer, K				Hauf, Ksenia; Kayumov, Airat; Gloge, Felix; Forchhammer, Karl			The Molecular Basis of TnrA Control by Glutamine Synthetase in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; ATP; glutamate; glutamine; transcription regulation; transcription factor TnrA; glutamine synthetase; Bacillus subtilis	TRANSCRIPTION FACTOR TNRA; GENE-EXPRESSION; NITROGEN-METABOLISM; ESCHERICHIA-COLI; PROTEIN; COMPLEXES; MECHANISM; INSIGHTS; RECOGNITION; HOMEOSTASIS	TnrA is a master regulator of nitrogen assimilation in Bacillus subtilis. This study focuses on the mechanism of how glutamine synthetase (GS) inhibits TnrA function in response to key metabolites ATP, AMP, glutamine, and glutamate. We suggest a model of two mutually exclusive GS conformations governing the interaction with TnrA. In the ATP-bound state (A-state), GS is catalytically active but unable to interact with TnrA. This conformation was stabilized by phosphorylated l-methionine sulfoximine (MSX), fixing the enzyme in the transition state. When occupied by glutamine (or its analogue MSX), GS resides in a conformation that has high affinity for TnrA (Q-state). The A- and Q-state are mutually exclusive, and in agreement, ATP and glutamine bind to GS in a competitive manner. At elevated concentrations of glutamine, ATP is no longer able to bind GS and to bring it into the A-state. AMP efficiently competes with ATP and prevents formation of the A-state, thereby favoring GS-TnrA interaction. Surface plasmon resonance analysis shows that TnrA bound to a positively regulated promoter fragment binds GS in the Q-state, whereas it rapidly dissociates from a negatively regulated promoter fragment. These data imply that GS controls TnrA activity at positively controlled promoters by shielding the transcription factor in the DNA-bound state. According to size exclusion and multiangle light scattering analysis, the dodecameric GS can bind three TnrA dimers. The highly interdependent ligand binding properties of GS reveal this enzyme as a sophisticated sensor of the nitrogen and energy state of the cell to control the activity of DNA-bound TnrA.	[Hauf, Ksenia; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany; [Kayumov, Airat] Kazan Fed Univ, Dept Genet, Kremlevskaya 18, Kazan 420008, Russia; [Gloge, Felix] Wyatt Technol Europe, Hochstr 12a, D-56307 Dernbach, Germany	Eberhard Karls University of Tubingen; Kazan Federal University	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de	Kayumov, Airat/M-6725-2013	Kayumov, Airat/0000-0001-7195-1557	Deutsche Forschungsgemeinschaft [Fo195/9-2]; German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov" [A/12/75478, A/12/25777, 91583699]; DAAD [50015537]; Russian Foundation for Basic Research (RFBR) [15-04-02583a]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov"(Deutscher Akademischer Austausch Dienst (DAAD)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fo195/9-2; German Academic Exchange Service (DAAD) Russian-German Program "Michail Lomonosov" Grants A/12/75478, A/12/25777, and 91583699; DAAD research fellowship for Ph.D. students and young scientists 50015537; and Russian Foundation for Basic Research (RFBR) Grant 15-04-02583a. The authors declare that they have no conflicts of interest with the contents of this article.	ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Blencke HM, 2006, ARCH MICROBIOL, V185, P136, DOI 10.1007/s00203-005-0078-0; Brown SW, 1996, J BACTERIOL, V178, P2450, DOI 10.1128/jb.178.8.2450-2454.1996; Commichau FM, 2008, J BACTERIOL, V190, P3557, DOI 10.1128/JB.00099-08; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; DEUEL TF, 1974, J BIOL CHEM, V249, P257; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Fedorova K, 2013, FEBS LETT, V587, P1293, DOI 10.1016/j.febslet.2013.03.015; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Forchhammer K, 2016, FEBS J, V283, P425, DOI 10.1111/febs.13584; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Hart DJ, 1999, NUCLEIC ACIDS RES, V27, P1063, DOI 10.1093/nar/27.4.1063; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Ikeda TP, 1996, J MOL BIOL, V259, P589, DOI 10.1006/jmbi.1996.0342; Kayumov A, 2011, FEBS J, V278, P1779, DOI 10.1111/j.1742-4658.2011.08102.x; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; MARTINVERSTRAETE I, 1994, J MOL BIOL, V241, P178, DOI 10.1006/jmbi.1994.1487; Matos RG, 2010, PROTEIN J, V29, P394, DOI 10.1007/s10930-010-9265-1; MEEK TD, 1980, BIOCHEMISTRY-US, V19, P5513, DOI 10.1021/bi00565a008; Mirouze N, 2015, MICROBIOLOGYOPEN, V4, P423, DOI 10.1002/mbo3.249; Murray DS, 2013, J BIOL CHEM, V288, P35801, DOI 10.1074/jbc.M113.519496; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; SAXILD HH, 1987, J BACTERIOL, V169, P2977, DOI 10.1128/jb.169.7.2977-2983.1987; Schumacher MA, 2015, GENE DEV, V29, P451, DOI 10.1101/gad.254714.114; Stevenson CEM, 2013, NUCLEIC ACIDS RES, V41, P7009, DOI 10.1093/nar/gkt523; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; WEDLER FC, 1976, J BIOL CHEM, V251, P7530; Wray LV, 2008, MOL MICROBIOL, V68, P277, DOI 10.1111/j.1365-2958.2008.06162.x; Wray LV, 2007, J BACTERIOL, V189, P20, DOI 10.1128/JB.01238-06; Wray LV, 2010, J BACTERIOL, V192, P5018, DOI 10.1128/JB.00509-10; Wray LV, 2000, J MOL BIOL, V300, P29, DOI 10.1006/jmbi.2000.3846; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x	42	18	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3483	3495		10.1074/jbc.M115.680991	http://dx.doi.org/10.1074/jbc.M115.680991			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26635369	hybrid, Green Published			2022-12-26	WOS:000370854500029
J	Frey, WD; Kim, J				Frey, Wesley D.; Kim, Joomyeong			Tissue-Specific Contributions of Paternally Expressed Gene 3 in Lactation and Maternal Care of Mus musculus	PLOS ONE			English	Article							IMPRINTED GENE; PEG3; BEHAVIOR; MICE; APEG3	Paternally Expressed Gene 3 (Peg3) is an imprinted gene that controls milk letdown and maternal-caring behaviors. In this study, a conditional knockout allele has been developed in Mus musculus to further characterize these known functions of Peg3 in a tissue-specific manner. The mutant line was first crossed with a germline Cre. The progeny of this cross displayed growth retardation phenotypes. This is consistent with those seen in the previous mutant lines of Peg3, confirming the usefulness of the new mutant allele. The mutant line was subsequently crossed individually with MMTV-and Nkx2.1-Cre lines to test Peg3's roles in the mammary gland and hypothalamus, respectively. According to the results, the milk letdown process was impaired in the nursing females with the Peg3 mutation in the mammary gland, but not in the hypothalamus. This suggests that Peg3's roles in the milk letdown process are more critical in the mammary gland than in the hypothalamus. In contrast, one of the maternal-caring behaviors, nest-building, was interrupted in the females with the mutation in both MMTV-and Nkx2.1-driven lines. Overall, this is the first study to introduce a conditional knockout allele of Peg3 and to further dissect its contribution to mammalian reproduction in a tissue-specific manner.	[Frey, Wesley D.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Frey, Wesley/0000-0003-0392-5714	National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).; We would like to thank Dr. Hana Kim, Corey Bretz, Arundhati Bakshi and Terri Cain for their careful reading and discussion of the manuscript. We would also like to thank HK for helping with mouse illustrations, Austin Wong for helping with mammary gland isolations, TC for assisting in tissue isolation and CB for helping to make the bedding analysis more comprehendible. This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).	Angoa-Perez M, 2013, JOVE-J VIS EXP, DOI 10.3791/50978; Champagne FA, 2009, BEHAV NEUROSCI, V123, P469, DOI 10.1037/a0015060; Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58; Choo JH, 2008, GENE, V409, P28, DOI 10.1016/j.gene.2007.10.036; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Frey WD, 2014, GENE, V540, P251, DOI 10.1016/j.gene.2014.02.056; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; Neville MC, 2001, PEDIATR CLIN N AM, V48, P13, DOI 10.1016/S0031-3955(05)70283-2; Plante I, 2011, JOVE-J VIS EXP, DOI 10.3791/2828; Rich ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098839; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Yuan TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019233	21	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144459	10.1371/journal.pone.0144459	http://dx.doi.org/10.1371/journal.pone.0144459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640945	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700128
J	Murata, J; Matsumoto, E; Morimoto, K; Koyama, T; Satake, H				Murata, Jun; Matsumoto, Erika; Morimoto, Kinuyo; Koyama, Tomotsugu; Satake, Honoo			Generation of Triple-Transgenic Forsythia Cell Cultures as a Platform for the Efficient, Stable, and Sustainable Production of Lignans	PLOS ONE			English	Article							PINORESINOL LARICIRESINOL REDUCTASE; GENE-EXPRESSION; ARYLTETRALIN LIGNANS; DOWN-REGULATION; LINUM-ALBUM; BIOSYNTHESIS; ARABIDOPSIS; SESAMIN; PLANTS; GROWTH	Sesamin is a furofuran lignan biosynthesized from the precursor lignan pinoresinol specifically in sesame seeds. This lignan is shown to exhibit anti-hypertensive activity, protect the liver from damages by ethanol and lipid oxidation, and reduce lung tumor growth. Despite rapidly elevating demand, plant sources of lignans are frequently limited because of the high cost of locating and collecting plants. Indeed, the acquisition of sesamin exclusively depends on the conventional extraction of particular Sesamum seeds. In this study, we have created the efficient, stable and sustainable sesamin production system using triple-transgenic Forsythia koreana cell suspension cultures, U18i-CPi-Fk. These transgenic cell cultures were generated by stably introducing an RNAi sequence against the pinoresinol-glucosylating enzyme, UGT71A18, into existing CPi-Fk cells, which had been created by introducing Sesamum indicum sesamin synthase (CYP81Q1) and an RNA interference (RNAi) sequence against pinoresinol/lariciresinol reductase (PLR) into F. koreanna cells. Compared to its transgenic prototype, U18i-CPi-Fk displayed 5-fold higher production of pinoresinol aglycone and 1.4-fold higher production of sesamin, respectively, while the wildtype cannot produce sesamin due to a lack of any intrinsic sesamin synthase. Moreover, red LED irradiation of U18i-CPi-Fk specifically resulted in 3.0-fold greater production in both pinoresinol aglycone and sesamin than production of these lignans under the dark condition, whereas pinoresinol production was decreased in the wildtype under red LED. Moreover, we developed a procedure for sodium alginate-based long-term storage of U18i-CPiFk in liquid nitrogen. Production of sesamin in U18i-CPi-Fk re-thawed after six-month cryopreservation was equivalent to that of non-cryopreserved U18i-CPi-Fk. These data warrant on-demand production of sesamin anytime and anywhere. Collectively, the present study provides evidence that U18i-CP-Fk is an unprecedented platform for efficient, stable, and sustainable production of sesamin, and shows that a transgenic and specific light-regulated Forsythia cell-based metabolic engineering is a promising strategy for the acquisition of rare and beneficial lignans.	[Murata, Jun; Matsumoto, Erika; Morimoto, Kinuyo; Koyama, Tomotsugu; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan	Suntory Holdings Ltd	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto 6190284, Japan.	satake@sunbor.or.jp	Murata, Jun/AAN-9101-2020; Koyama, Tomotsugu/AAM-2243-2020	Murata, Jun/0000-0001-7867-330X; 	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan	Plant Factory project of the Ministry of Economy, Trade and Industry, Japan	This work is supported by the Plant Factory project of the Ministry of Economy, Trade and Industry, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Ayella AK, 2007, MOL NUTR FOOD RES, V51, P1518, DOI 10.1002/mnfr.200700233; Babst BA, 2014, J EXP BOT, V65, P4191, DOI 10.1093/jxb/eru192; Babu PR, 2013, GENE, V513, P156, DOI 10.1016/j.gene.2012.10.040; Badejo AA, 2009, PLANT CELL PHYSIOL, V50, P423, DOI 10.1093/pcp/pcn206; Bahabadi S. E., 2014, Journal of Medicinal Plants, V13, P46; Bahabadi SE, 2012, J PLANT PHYSIOL, V169, P487, DOI 10.1016/j.jplph.2011.12.006; Bahabadi SE, 2011, PLANT BIOTECHNOL REP, V5, P367, DOI 10.1007/s11816-011-0190-3; Barvkar VT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-175; Bayindir U, 2008, PLANT J, V55, P810, DOI 10.1111/j.1365-313X.2008.03558.x; Bharti AK, 1997, PHOTOCHEM PHOTOBIOL, V65, P765, DOI 10.1111/j.1751-1097.1997.tb01923.x; Bhattacharyya D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-748; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cutillo F, 2003, J AGR FOOD CHEM, V51, P6165, DOI 10.1021/jf034644c; Davin Laurence B., 2003, Phytochemistry Reviews, V2, P257, DOI 10.1023/B:PHYT.0000046175.83729.b5; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Dima O, 2015, PLANT CELL, V27, P695, DOI 10.1105/tpc.114.134643; Farhi M, 2011, NAT BIOTECHNOL, V29, P1072, DOI 10.1038/nbt.2054; Griesser M, 2008, PLANT PHYSIOL, V146, P1528, DOI 10.1104/pp.107.114280; Hano C, 2006, PLANTA, V223, P975, DOI 10.1007/s00425-005-0156-1; Harmatha Juraj, 2003, Phytochemistry Reviews, V2, P321, DOI 10.1023/B:PHYT.0000045494.98645.a3; Hata N, 2013, PLANT BIOTECHNOL-NAR, V30, P1, DOI 10.5511/plantbiotechnology.12.1021a; Hata N, 2012, ENVIRON EXP BOT, V75, P212, DOI 10.1016/j.envexpbot.2011.07.004; Hemmati S, 2007, FEBS LETT, V581, P603, DOI 10.1016/j.febslet.2007.01.018; Kim HJ, 2009, PLANT CELL PHYSIOL, V50, P2200, DOI 10.1093/pcp/pcp156; Kim IA, 2010, J PLANT BIOL, V53, P233, DOI 10.1007/s12374-010-9110-2; Lao JM, 2014, PLANT J, V79, P517, DOI 10.1111/tpj.12577; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Leonard E, 2009, NAT CHEM BIOL, V5, P292, DOI 10.1038/nchembio.160; Malik S, 2014, PHYTOCHEM REV, V13, P893, DOI 10.1007/s11101-014-9345-5; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Marques JV, 2013, J BIOL CHEM, V288, P466, DOI 10.1074/jbc.M112.400689; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Morimoto K, 2013, BIOL PHARM BULL, V36, P1519, DOI 10.1248/bpb.b13-00437; Morimoto K, 2011, PLANT BIOTECHNOL-NAR, V28, P331, DOI 10.5511/plantbiotechnology.11.0420a; Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961; Nakano D, 2002, BIOL PHARM BULL, V25, P1247, DOI 10.1248/bpb.25.1247; Niino T, 2005, PLANT BIOTECHNOL-NAR, V22, P105, DOI [10.5511/plantbiotechnology.22.105, DOI 10.5511/PLANTBIOTECHNOLOGY.22.105]; Ogawa Y, 2012, PLANT CELL PHYSIOL, V53, P943, DOI 10.1093/pcp/pcs038; Ogita S, 2003, NATURE, V423, P823, DOI 10.1038/423823a; Oliva A, 2002, PESTIC BIOCHEM PHYS, V72, P45, DOI 10.1006/pest.2002.2582; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; Ono E, 2010, PLANT BIOTECHNOL-NAR, V27, P317, DOI 10.5511/plantbiotechnology.27.317; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Renouard S, 2014, J PLANT PHYSIOL, V171, P1372, DOI 10.1016/j.jplph.2014.06.005; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sarasan V, 2006, IN VITRO CELL DEV-PL, V42, P206; Satake H, 2015, METABOLITES, V5, P270, DOI 10.3390/metabo5020270; Satake H, 2013, J AGR FOOD CHEM, V61, P11721, DOI 10.1021/jf4007104; Sirato-Yasumoto S, 2001, J AGR FOOD CHEM, V49, P2647, DOI 10.1021/jf001362t; Sugimoto K, 2014, P NATL ACAD SCI USA, V111, P7144, DOI 10.1073/pnas.1320660111; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Truan JS, 2012, NUTR CANCER, V64, P65, DOI 10.1080/01635581.2012.630165; Umezawa Toshiaki, 2003, Phytochemistry Reviews, V2, P371, DOI 10.1023/B:PHYT.0000045487.02836.32; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang LH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0225-3; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852; Wu K, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-35; Yazaki K., 1999, PLANT BIOTECHNOL-NAR, V16, P335, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.16.335; Yousefzadi M, 2012, PLANT PHYSIOL BIOCH, V56, P41, DOI 10.1016/j.plaphy.2012.04.010; Yousefzadi M, 2010, BIOTECHNOL LETT, V32, P1739, DOI 10.1007/s10529-010-0343-4	68	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144519	10.1371/journal.pone.0144519	http://dx.doi.org/10.1371/journal.pone.0144519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641084	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700138
J	Guo, LY; Qu, J; Zheng, C; Cao, Y; Zhang, T; Lu, HB; Hu, JZ				Guo, Liyun; Qu, Jin; Zheng, Cheng; Cao, Yong; Zhang, Tao; Lu, Hongbin; Hu, Jianzhong			Preparation and Characterization of a Novel Decellularized Fibrocartilage "Book" Scaffold for Use in Tissue Engineering	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX SCAFFOLDS; MESENCHYMAL STEM-CELLS; BONE INTERFACE; BIOLOGICAL SCAFFOLD; TENDON; MODEL; JOINT	At the tendon-to-bone insertion, there is a unique transitional structure: tendon, non-calcified fibrocartilage, calcified fibrocartilage, and bone. The reconstruction of this special graded structure after defects or damage is an important but challenging task in orthopedics. In particular, reconstruction of the fibrocartilage zone has yet to be successfully achieved. In this study, the development of a novel book-shape scaffold derived from the extracellular matrix of fibrocartilage was reported. Specifically, fibrocartilage from the pubic symphysis was obtained from rabbits and sliced into the shape of a book (dimensions: 10 mm x 3 mm x 1 mm) with 10 layers, each layer (akin to a page of a book) with a thickness of 100-mu m. These fibrocartilage "book" scaffolds were decellularized using sequentially 3 freeze-thaw cycles, 0.1% Triton X-100 with 1.5 M KCl, 0.25% trypsin, and a nuclease. Histology and DNA quantification analysis confirmed substantial removal of cells from the fibrocartilage scaffolds. Furthermore, the quantities of DNA, collagen, and glycosaminoglycan in the fibrocartilage were markedly reduced following decellularization. Scanning electron microscopy confirmed that the intrinsic ultrastructure of the fibrocartilage tissue was well preserved. Therefore, the results of this study suggest that the novel "book" fibrocartilage scaffold could have potential applications in tissue engineering.	[Guo, Liyun; Qu, Jin; Zheng, Cheng; Zhang, Tao; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China; [Guo, Liyun] Changzhi Med Coll, Peace Hosp, Dept Rehabil Med, Changzhi 046000, Shanxi, Peoples R China; [Zheng, Cheng] Hosp Wuhan Sports Univ, Dept Orthopaed, Wuhan 430079, Hubei, Peoples R China; [Cao, Yong; Hu, Jianzhong] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China	Central South University; Changzhi Medical College; Wuhan Sports University; Central South University	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com; jianzhonghu@hotmail.com	Zheng, Cheng/AIA-7877-2022	Zheng, Cheng/0000-0003-1726-0258	National Natural Science Foundation of China [81171699, 84172072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (NO. 81171699 and NO. 84172072).	Aubin H, 2013, TISSUE ENG PART C-ME, V19, P970, DOI [10.1089/ten.tec.2012.0712, 10.1089/ten.TEC.2012.0712]; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897; Chen K, 2013, J TISSUE ENG REGEN M; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050; Gao JZ, 1996, J ANAT, V188, P367; Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Hjorthaug GA, 2015, J ORTHOP RES, V33, P216, DOI 10.1002/jor.22756; Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110; Lu HX, 2012, J BIOMED MATER RES A, V100A, P2507, DOI 10.1002/jbm.a.34150; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016; Qu J, 2013, J ORTHOP RES, V31, P1713, DOI 10.1002/jor.22412; Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Weeks Kenneth D 3rd, 2014, Instr Course Lect, V63, P443; Xu Y, 2015, J BIOMED MATER RES B, V103, P670, DOI 10.1002/jbm.b.33231; Xue JX, 2013, BIOMATERIALS, V34, P2624, DOI 10.1016/j.biomaterials.2012.12.011; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zang MQ, 2013, PLAST RECONSTR SURG, V132, p549E, DOI 10.1097/PRS.0b013e3182a013fc; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	29	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144240	10.1371/journal.pone.0144240	http://dx.doi.org/10.1371/journal.pone.0144240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636672	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800061
J	He, WM; He, HM; Zhu, MY				He, Wenming; He, Hongming; Zhu, Mingyong			Calcium Nodules as a Proxy for Quaternary Paleoclimate Change on China's Loess Plateau	PLOS ONE			English	Article							CARBONATE NODULES; PALEOSOLS; SOILS; CLASSIFICATION	Different proxies have been used to investigate Quaternary paleoclimate change. Here, we used weathering of calcium nodules in paleosols on China's Loess Plateau as a proxy for Quaternary paleoclimate changes to provide an alternative indicator of these changes. Paleosol and carbonate nodules were collected from Luochuan and Lantian counties in Shaanxi Province, China. We found that this approach allowed quantitative reconstruction of temperature, rainfall, soil mineral composition, and the effects of weathering and leaching. The changes in carbonate content in the loess and paleosol sequences were controlled by alternating dry and wet climatic conditions. Nodule formation conditions were directly affected by the leaching and migration of elements. The loess and paleosol sequences developed calcium nodules, and their formation was closely related to the rainfall and leaching characteristics of the paleoclimate. The paleoclimate and soil minerals affected the vegetation types and directly influenced changes in the soil. During formation of the calcium nodules, the surface vegetation evolved slowly, and the number of species and quantity of vegetation both decreased.	[He, Wenming] Jiaying Univ, Sch Chem & Environm, Meizhou, Guangdong, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Northwest Agr & Forestry Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [He, Wenming; He, Hongming; Zhu, Mingyong] Minist Water Resources, Yangling, Shaanxi, Peoples R China; [Zhu, Mingyong] Minnan Normal Univ, Dept Hist & Sociol, Zhangzhou, Fujian, Peoples R China	Jiaying University; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; MinNan Normal University	He, HM (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.	hongming.he@yahoo.com	He, Hongming/A-4161-2010	Mingyong, Zhu/0000-0001-6849-1692	Hundred-Talents Project of the Chinese Academy of Sciences [2011009]; National Natural Science Foundation of China [501100001809, 41072137]; Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences [10502]; Key Research Program of the Chinese Academy of Sciences [KZZD-EW-04]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB03020300]; State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [10501-192, K318009902-1402]	Hundred-Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau	We are grateful for research grants from the Hundred-Talents Project of the Chinese Academy of Sciences (2011009, Hongming He), the National Natural Science Foundation of China (Grant No. 501100001809 and No. 41072137), the Innovation Frontier Project of the Institute of Soil and Water Conservation of the Chinese Academy of Sciences (10502), the Key Research Program of the Chinese Academy of Sciences (Grant No. KZZD-EW-04), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB03020300), and the State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (10501-192, K318009902-1402).	Ballestrero T, 2006, PRACTICAL HDB GROUND, P207; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Gallet S, 1996, CHEM GEOL, V133, P67, DOI 10.1016/S0009-2541(96)00070-8; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Han JM, 1997, QUATERN INT, V37, P37, DOI 10.1016/1040-6182(96)00005-5; Kraus MJ, 2007, PALAEOGEOGR PALAEOCL, V245, P444, DOI 10.1016/j.palaeo.2006.09.011; Lee H, 2014, GEOARCHAEOLOGY, V29, P326, DOI 10.1002/gea.21478; [刘恋 Liu Lian], 2011, [第四纪研究, Quaternary Sciences], V31, P506; Liu LA, 2010, CHINESE SCI BULL, V55, P2926, DOI 10.1007/s11434-010-4073-8; Liu T, 2004, LOESS ENV; Lu H. Y., 1999, ACTA SEDIMENT SIN, V17, P226, DOI [10.3969/j.issn.1000-0550.1999.02.011, DOI 10.3969/J.ISSN.1000-0550.1999.02.011]; Lu Y, 2006, ARID LAND GEOGRAPHY, V28, P450; MACK GH, 1993, GEOL SOC AM BULL, V105, P129, DOI 10.1130/0016-7606(1993)105&lt;0129:COP&gt;2.3.CO;2; MAGARITZ M, 1981, GEODERMA, V25, P157, DOI 10.1016/0016-7061(81)90033-1; MAYNARD JB, 1992, J GEOL, V100, P279, DOI 10.1086/629632; Nettleton WD, 2000, CATENA, V41, P61, DOI 10.1016/S0341-8162(00)00109-0; [欧阳椿陶 OUYANG Chuntao], 2007, [地理学报, Acta Geographica Sinica], V62, P518; RETALLACK GJ, 1993, GEOL SOC AM BULL, V105, P1635, DOI 10.1130/0016-7606(1993)105<1635:COPDAR>2.3.CO;2; Retallack GJ, 2010, GEOLOGY, V38, P403, DOI 10.1130/G30514.1; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Sheldon ND, 2002, J GEOL, V110, P687, DOI 10.1086/342865; Shuang GS, 2005, J SOIL WATER CONSERV, V19, P109; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Wanas HA, 2006, SEDIMENT GEOL, V183, P243, DOI 10.1016/j.sedgeo.2005.09.013; Wen Q.Z., 1989, GEOCHEMISTRY CHINESE	25	12	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143928	10.1371/journal.pone.0143928	http://dx.doi.org/10.1371/journal.pone.0143928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633304	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000031
J	Srinivasan, P; Thrower, EC; Loganathan, G; Balamurugan, AN; Subramanian, VS; Gorelick, FS; Said, HM				Srinivasan, Padmanabhan; Thrower, Edwin C.; Loganathan, Gopalakrishnan; Balamurugan, A. N.; Subramanian, Veedamali S.; Gorelick, Fred S.; Said, Hamid M.			Chronic Nicotine Exposure In Vivo and In Vitro Inhibits Vitamin B1 (Thiamin) Uptake by Pancreatic Acinar Cells	PLOS ONE			English	Article							CHRONIC ALCOHOL EXPOSURE; DIFFERENTIAL EXPRESSION; SMOKING; DEFICIENCY; TOBACCO; PRESERVATION; INFLAMMATION; SECRETION; INSULIN; GLUCOSE	Thiamin (vitamin B1), a member of the water-soluble family of vitamins, is essential for normal cellular functions; its deficiency results in oxidative stress and mitochondrial dysfunction. Pancreatic acinar cells (PAC) obtain thiamin from the circulation using a specific carrier-mediated process mediated by both thiamin transporters -1 and -2 (THTR-1 and THTR-2; encoded by the SLC19A2 and SLC19A3 genes, respectively). The aim of the current study was to examine the effect of chronic exposure of mouse PAC in vivo and human PAC in vitro to nicotine (a major component of cigarette smoke that has been implicated in pancreatic diseases) on thiamin uptake and to delineate the mechanism involved. The results showed that chronic exposure of mice to nicotine significantly inhibits thiamin uptake in murine PAC, and that this inhibition is associated with a marked decrease in expression of THTR-1 and THTR-2 at the protein, mRNA and hnRNAs level. Furthermore, expression of the important thiamin-metabolizing enzyme, thiamin pyrophosphokinase (TPKase), was significantly reduced in PAC of mice exposed to nicotine. Similarly, chronic exposure of cultured human PAC to nicotine (0.5 mu M, 48 h) significantly inhibited thiamin uptake, which was also associated with a decrease in expression of THTR-1 and THTR-2 proteins and mRNAs. This study demonstrates that chronic exposure of PAC to nicotine impairs the physiology and the molecular biology of the thiamin uptake process. Furthermore, the study suggests that the effect is, in part, mediated through transcriptional mechanism(s) affecting the SLC19A2 and SLC19A3 genes.	[Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] VA Med Ctr, Dept Med Res, Long Beach, CA 90822 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Srinivasan, Padmanabhan; Subramanian, Veedamali S.; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA USA; [Loganathan, Gopalakrishnan; Balamurugan, A. N.] Univ Louisville, Dept Surg, Clin Islet Cell Lab, Cardiovasc Innovat Inst, Louisville, KY 40292 USA; [Thrower, Edwin C.] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Gorelick, Fred S.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT USA; [Gorelick, Fred S.] Vet Affairs Healthcare Syst, West Haven, CT USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Louisville; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Said, HM (corresponding author), VA Med Ctr, Dept Med Res, Long Beach, CA 90822 USA.	hmsaid@uci.edu			National Institutes of Health [AA018071, DK56061]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056061, R01DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institutes of Health (AA018071 and DK56061) and the Department of Veterans Affairs.	Alexandre M, 2011, PANCREATOLOGY, V11, P469, DOI 10.1159/000332196; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; Askari MDF, 2005, J CANCER RES CLIN, V131, P639, DOI 10.1007/s00432-005-0002-7; Balamurugan AN, 2012, TRANSPLANTATION, V93, P693, DOI 10.1097/TP.0b013e318247281b; Balamurugan AN, 2010, TRANSPLANTATION, V89, P954, DOI 10.1097/TP.0b013e3181d21e9a; BETTENDORFF L, 1995, J NEUROCHEM, V64, P2013; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Chowdhury P, 2002, EXP BIOL MED, V227, P445, DOI 10.1177/153537020222700708; Chowdhury P, 2008, LANGENBECK ARCH SURG, V393, P547, DOI 10.1007/s00423-007-0267-1; Chowdhury P, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-1; Di YP, 2012, J BIOL CHEM, V287, P27948, DOI 10.1074/jbc.M111.334375; DOI R, 1995, PANCREAS, V10, P154, DOI 10.1097/00006676-199503000-00008; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; JAMIESON NV, 1989, TRANSPLANT P, V21, P1292; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Lindkvist B, 2008, PANCREAS, V37, P288, DOI 10.1097/MPA.0b013e31816a7744; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenfels AB, 1999, GASTROENTEROL CLIN N, V28, P673, DOI 10.1016/S0889-8553(05)70080-7; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mee L, 2009, AM J PHYSIOL-GASTR L, V297, pG197, DOI 10.1152/ajpgi.00092.2009; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; PRASANNAN KG, 1977, EXPERIENTIA, V33, P169, DOI 10.1007/BF02124046; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; RATHANASWAMI P, 1991, BIOCHEM INT, V24, P1057; RATHANASWAMI P, 1991, BIOCHEM INT, V25, P577; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Shugrue CA, 2012, AM J PHYSIOL-GASTR L, V303, pG723, DOI 10.1152/ajpgi.00082.2012; Singh L, 2008, DIGEST DIS SCI, V53, P2569, DOI 10.1007/s10620-007-0162-1; SINGH M, 1982, AM J CLIN NUTR, V36, P500, DOI 10.1093/ajcn/36.3.500; Slattery ML, 2003, CANCER EPIDEM BIOMAR, V12, P882; Srinivasan P, 2015, AM J PHYSIOL-GASTR L, V309, pG750, DOI 10.1152/ajpgi.00226.2015; Srinivasan P, 2014, AM J PHYSIOL-GASTR L, V307, pG941, DOI 10.1152/ajpgi.00278.2014; Srinivasan P, 2014, AM J PHYSIOL-GASTR L, V306, pG631, DOI 10.1152/ajpgi.00420.2013; Srinivasan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078853; Subramanian VS, 2012, AM J PHYSIOL-GASTR L, V302, pG572, DOI 10.1152/ajpgi.00484.2011; Subramanya SB, 2011, AM J PHYSIOL-GASTR L, V301, pG896, DOI 10.1152/ajpgi.00308.2011; Thrower E, 2015, CANCERS, V7, P723, DOI 10.3390/cancers7020723; TODO S, 1989, JAMA-J AM MED ASSOC, V261, P711, DOI 10.1001/jama.261.5.711; Ulrich CM, 2001, CANCER EPIDEM BIOMAR, V10, P875; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; WETSCHER GJ, 1995, FREE RADICAL BIO MED, V18, P877, DOI 10.1016/0891-5849(94)00221-5; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Word B, 2013, INT J TOXICOL, V32, P23, DOI 10.1177/1091581812465902; Xu H, 2007, EUR RESPIR J, V30, P633, DOI 10.1183/09031936.00014107; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x	53	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143575	10.1371/journal.pone.0143575	http://dx.doi.org/10.1371/journal.pone.0143575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633299	Green Published, gold			2022-12-26	WOS:000366040000017
J	Brannelly, LA; Hunter, DA; Lenger, D; Scheele, BC; Skerratt, LF; Berger, L				Brannelly, Laura A.; Hunter, David A.; Lenger, Daniel; Scheele, Ben C.; Skerratt, Lee F.; Berger, Lee			Dynamics of Chytridiomycosis during the Breeding Season in an Australian Alpine Amphibian	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; PCR ASSAY; DISEASE; MORTALITY; SURVIVAL; FROGS; POPULATIONS; PREVALENCE; IMPACT	Understanding disease dynamics during the breeding season of declining amphibian species will improve our understanding of how remnant populations persist with endemic infection, and will assist the development of management techniques to protect disease-threatened species from extinction. We monitored the endangered Litoria verreauxii alpina (alpine treefrog) during the breeding season through capture-mark-recapture (CMR) studies in which we investigated the dynamics of chytridiomycosis in relation to population size in two populations. We found that infection prevalence and intensity increased throughout the breeding season in both populations, but infection prevalence and intensity was higher (3.49 and 2.02 times higher prevalence and intensity, respectively) at the site that had a 90-fold higher population density. This suggests that Bd transmission is density-dependent. Weekly survival probability was related to disease state, with heavily infected animals having the lowest survival. There was low recovery from infection, especially when animals were heavily infected with Bd. Sympatric amphibian species are likely to be reservoir hosts for the disease and can play an important role in the disease ecology of Bd. Although we found 0% prevalence in crayfish (Cherax destructor), we found that a sympatric amphibian (Crinia signifera) maintained 100% infection prevalence at a high intensity throughout the season. Our results demonstrate the importance of including infection intensity into CMR disease analysis in order to fully understand the implications of disease on the amphibian community. We recommend a combined management approach to promote lower population densities and ensure consistent progeny survival. The most effective management strategy to safeguard the persistence of this susceptible species might be to increase habitat area while maintaining a similar sized suitable breeding zone and to increase water flow and area to reduce drought.	[Brannelly, Laura A.; Lenger, Daniel; Scheele, Ben C.; Skerratt, Lee F.; Berger, Lee] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia; [Hunter, David A.] NSW Dept Premier & Cabinet, Off Environm & Heritage, Ecosyst & Threatened Species, Albury, NSW, Australia	James Cook University; Office of Environment & Heritage - New South Wales	Brannelly, LA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld 4811, Australia.	laura.brannelly@my.jcu.edu.au	Brannelly, Laura A/V-2589-2019	Brannelly, Laura A/0000-0003-2975-9494; Skerratt, Lee/0000-0003-3471-7512; Scheele, Benjamin/0000-0001-7284-629X; Hunter, David/0000-0002-7330-7500; Berger, Lee/0000-0001-9227-5439	Australian Research Council [FT100100375, LP110200240, DP120100811]; Taronga Zoo	Australian Research Council(Australian Research Council); Taronga Zoo	The project was funded by the Australian Research Council Grants FT100100375, LP110200240 and DP120100811 and Taronga Zoo, received by LFS, LB and DAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataille A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3127; Beatty S, 2005, HYDROBIOLOGIA, V549, P219, DOI 10.1007/s10750-005-5443-0; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, 2016, ANIM CONSERV, V19, P153, DOI 10.1111/acv.12230; Brannelly LA, 2015, DIS AQUAT ORGAN, V112, P229, DOI 10.3354/dao02817; Brannelly LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038473; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Choquet R., 2004, Animal Biodiversity and Conservation, V27, P207; Conn PB, 2009, J APPL ECOL, V46, P486, DOI 10.1111/j.1365-2664.2008.01597.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Grogan L., 2015, THESIS; Grogan LF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004015; Hunter D., 2009, PREVALENCE AMPHIBIAN; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Korfel CA, 2014, DIS AQUAT ORGAN, V109, P177, DOI 10.3354/dao02749; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2011, J APPL ECOL, V48, P873, DOI 10.1111/j.1365-2664.2011.02005.x; Newell DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058559; Osborne W, 1999, DECLINES DISAPPEARAN, V1, P145; Phillott AD, 2013, CONSERV BIOL, V27, P1058, DOI 10.1111/cobi.12073; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Ryder JJ, 2007, OIKOS, V116, P2017, DOI 10.1111/j.2007.0030-1299.15863.x; Sapsford SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082425; Scheele BC, 2015, BIOL CONSERV, V182, P36, DOI 10.1016/j.biocon.2014.11.032; Scheele BC, 2014, CONSERV BIOL, V28, P1195, DOI 10.1111/cobi.12322; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Terrell VCK, 2014, J WILDLIFE DIS, V50, P56, DOI 10.7589/2013-01-016; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	44	30	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143629	10.1371/journal.pone.0143629	http://dx.doi.org/10.1371/journal.pone.0143629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629993	Green Accepted, Green Published, gold			2022-12-26	WOS:000365926300075
J	Frate, L; Acosta, ATR; Cabido, M; Hoyos, L; Carranza, ML				Frate, Ludovico; Acosta, Alicia T. R.; Cabido, Marcelo; Hoyos, Laura; Carranza, Maria Laura			Temporal Changes in Forest Contexts at Multiple Extents: Three Decades of Fragmentation in the Gran Chaco (1979-2010), Central Argentina	PLOS ONE			English	Article							HABITAT LOSS; SPATIAL-PATTERNS; SPECIES RICHNESS; TROPICAL DEFORESTATION; COVER CHANGE; DRY FORESTS; LAND-USE; SCALES; DISTURBANCE; EDGE	The context in which a forest exists strongly influences its function and sustainability. Unveiling the multi-scale nature of forest fragmentation context is crucial to understand how human activities affect the spatial patterns of forests across a range of scales. However, this issue remains almost unexplored in subtropical ecosystems. In this study, we analyzed temporal changes (1979-2010) in forest contexts in the Argentinean dry Chaco at multiple extents. We classified forests over the last three decades based on forest context amount (Pf) and structural connectivity (Pff), which were measured using a moving window approach fixed at eight different extents (from local, similar to 6 ha, to regional, similar to 8300 ha). Specific multi-scale forest context profiles (for the years 1979 and 2010) were defined by projecting Pf vs. Pff mean values and were compared across spatial extents. The distributions of Pf across scales were described by scalograms and their shapes over time were compared. The amount of agricultural land and rangelands across the scales were also analyzed. The dry Chaco has undergone an intensive process of fragmentation, resulting in a shift from landscapes dominated by forests with gaps of rangelands to landscapes where small forest patches are embedded in agricultural lands. Multi-scale fragmentation analysis depicted landscapes in which local exploitation, which perforates forest cover, occurs alongside extensive forest clearings, reducing forests to small and isolated patches surrounded by agricultural lands. In addition, the temporal diminution of Pf's variability along with the increment of the mean slope of the Pf's scalograms, indicate a simplification of the spatial pattern of forest over time. The observed changes have most likely been the result of the interplay between human activities and environmental constraints, which have shaped the spatial patterns of forests across scales. Based on our results, strategies for the conservation and sustainable management of the dry Chaco should take into account both the context of each habitat location and the scales over which a forest pattern might be preserved, altered or restored.	[Frate, Ludovico; Carranza, Maria Laura] Univ Molise, Dipartimento Biosci & Terr, Envix Lab, I-86090 Pesche, IS, Italy; [Frate, Ludovico] CNR, IBAF, Rome, Italy; [Acosta, Alicia T. R.] Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy; [Cabido, Marcelo; Hoyos, Laura] Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal UNC CONICET, RA-5000 Cordoba, Argentina; [Cabido, Marcelo; Hoyos, Laura] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina	University of Molise; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Roma Tre University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Carranza, ML (corresponding author), Univ Molise, Dipartimento Biosci & Terr, Envix Lab, I-86090 Pesche, IS, Italy.	carranza@unimol.it	Carranza, Maria Laura/AAB-3367-2021; Frate, Ludovico/N-2737-2013; Alicia T. R, T R Acosta/E-3653-2012; Carranza, Maria Laura/E-7698-2012	Carranza, Maria Laura/0000-0001-5753-890X; Frate, Ludovico/0000-0001-6663-6843; Alicia T. R, T R Acosta/0000-0001-6572-3187; Carranza, Maria Laura/0000-0001-5753-890X				Aguilar R, 2004, OECOLOGIA, V138, P513, DOI 10.1007/s00442-003-1451-9; Alves DS, 2002, INT J REMOTE SENS, V23, P2903, DOI 10.1080/01431160110096791; Anderson J.R., 1976, LAND USE LAND COVER; Torrella SA, 2013, FOREST ECOL MANAG, V307, P147, DOI 10.1016/j.foreco.2013.07.016; Bar Massada A, 2010, LANDSCAPE ECOL, V25, P711, DOI 10.1007/s10980-010-9452-7; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Boletta PE, 2006, FOREST ECOL MANAG, V228, P108, DOI 10.1016/j.foreco.2006.02.045; BUCHER EH, 1982, ECOL STUD, V42, P48; Cabido M, 1994, PHYTOCOENOLOGIA, V24, P423, DOI 10.1127/phyto/24/1994/423; Cabido Marcelo, 1992, Documents Phytosociologiques, V14, P447; Cabrera A.L, 1976, REGIONES FITOGEOGR F; Caceres DM, 2015, J AGRAR CHANGE, V15, P116, DOI 10.1111/joac.12057; Cagnolo L, 2006, BIOL CONSERV, V132, P510, DOI 10.1016/j.biocon.2006.05.012; Carr DL, 2009, POPUL ENVIRON, V30, P222, DOI 10.1007/s11111-009-0090-4; Carranza M. L, 1992, LILLOA 37, V1, P75; Carranza ML, 2015, LANDSCAPE URBAN PLAN, V143, P238, DOI 10.1016/j.landurbplan.2015.08.006; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; De Casenave JL, 1998, AUK, V115, P425, DOI 10.2307/4089201; De Marco P, 2004, BIODIVERS CONSERV, V13, P1245, DOI 10.1023/B:BIOC.0000019402.51193.e8; Diaz-Varela ER, 2010, FOREST ECOL MANAG, V258, P2490; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Frate L, 2014, REMOTE SENS-BASEL, V6, P9298, DOI 10.3390/rs6109298; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gonzalez M, 2010, FOREST ECOL MANAG, V259, P266, DOI 10.1016/j.foreco.2009.10.010; Grau HR, 2005, ENVIRON CONSERV, V32, P140, DOI 10.1017/S0376892905002092; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Honey-Roses J, 2009, LAND DEGRAD DEV, V20, P22, DOI 10.1002/ldr.874; Hoyos LE, 2013, APPL VEG SCI, V16, P260, DOI 10.1111/j.1654-109X.2012.01218.x; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Carranza ML, 2014, EUR J REMOTE SENS, V47, P793, DOI 10.5721/EuJRS20144745; Lescano JN, 2015, ACTA OECOL, V65-66, P41, DOI 10.1016/j.actao.2015.05.002; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer D.B., 2002, CONSERVING FOREST BI; lzquierdo A E., 2008, ENVIRON MANAGE, V90, P858; Mairota P, 2015, INT J APPL EARTH OBS, V34, P96, DOI 10.1016/j.jag.2014.07.003; Mastrangelo ME, 2014, BIOL CONSERV, V179, P63, DOI 10.1016/j.biocon.2014.08.020; Matteucci S. D., 2012, J GEOGR GEOL, V4, DOI 10.5539/jgg.v4n3p15; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; McGarigal K., 2005, ISSUES PERSPECTIVES, P112, DOI DOI 10.1017/CBO9780511614415.013; McGarigal K., QUANTIFYING TERRESTR; Morello J., 2006, SITUACION AMBIENTAL, P83; Pellissier V, 2013, J VEG SCI, V24, P9, DOI 10.1111/j.1654-1103.2012.01435.x; Grau HR, 2008, ECOL SOC, V13; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Riitters K, 2000, CONSERV ECOL, V4, DOI 10.5751/ES-00209-040203; Riitters KH, 2002, ECOSYSTEMS, V5, P815, DOI 10.1007/s10021-002-0209-2; Riitters KH, 2005, ECOL INDIC, V5, P273, DOI 10.1016/j.ecolind.2005.04.003; Riitters KH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00653; Saura S, 2014, J APPL ECOL, V51, P171, DOI 10.1111/1365-2664.12179; SAYAGO M, 1969, Boletin de la Academia Nacional de Ciencias (Cordoba), V46, P123; Southworth J, 2001, MT RES DEV, V21, P276, DOI 10.1659/0276-4741(2001)021[0276:TIOALI]2.0.CO;2; Steininger MK, 2001, ENVIRON CONSERV, V28, P127, DOI 10.1017/S0376892901000133; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wickham JD, 2007, LANDSCAPE ECOL, V22, P481, DOI 10.1007/s10980-006-9054-6; Wickham JD, 2008, LANDSCAPE ECOL, V23, P891, DOI 10.1007/s10980-008-9258-z; Wiens JA, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P3; Zaccarelli N, 2008, ECOL INDIC, V8, P841, DOI 10.1016/j.ecolind.2007.01.010; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zak MR, 2002, APPL VEG SCI, V5, P213, DOI 10.1111/j.1654-109X.2002.tb00551.x; Zuidema PA, 1996, ENVIRON CONSERV, V23, P290, DOI 10.1017/S037689290003914X; Zurlini G, 2007, LANDSCAPE ECOL, V22, P705, DOI 10.1007/s10980-006-9055-5	69	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142855	10.1371/journal.pone.0142855	http://dx.doi.org/10.1371/journal.pone.0142855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630387	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300018
J	Hoeper, MM; Behr, J; Held, M; Grunig, E; Vizza, CD; Vonk-Noordegraaf, A; Lange, TJ; Claussen, M; Grohe, C; Klose, H; Olsson, KM; Zelniker, T; Neurohr, C; Distler, O; Wirtz, H; Opitz, C; Huscher, D; Pittrow, D; Gibbs, JSR				Hoeper, Marius M.; Behr, Juergen; Held, Matthias; Grunig, Ekkehard; Vizza, C. Dario; Vonk-Noordegraaf, Anton; Lange, Tobias J.; Claussen, Martin; Grohe, Christian; Klose, Hans; Olsson, Karen M.; Zelniker, Thomas; Neurohr, Claus; Distler, Oliver; Wirtz, Hubert; Opitz, Christian; Huscher, Doerte; Pittrow, David; Gibbs, J. Simon R.			Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ARTERIAL-HYPERTENSION; LUNG-DISEASE; ASPIRE REGISTRY; BOSENTAN	Background Pulmonary hypertension (PH) is a common finding in patients with chronic fibrosing idiopathic interstitial pneumonias (IIP). Little is known about the response to pulmonary vasodilator therapy in this patient population. COMPERA is an international registry that prospectively captures data from patients with various forms of PH receiving pulmonary vasodilator therapies. Methods We retrieved data from COMPERA to compare patient characteristics, treatment patterns, response to therapy and survival in newly diagnosed patients with idiopathic pulmonary arterial hypertension (IPAH) and PH associated with IIP (PH-IIP). Results Compared to patients with IPAH (n = 798), patients with PH-IIP (n = 151) were older and predominantly males. Patients with PH-IIP were treated predominantly with phosphodiesterase-5 inhibitors (88% at entry, 87% after 1 year). From baseline to the first follow-up visit, the median improvement in 6MWD was 30 m in patients with IPAH and 24.5 m in patients with PH-IIP (p = 0.457 for the difference between both groups). Improvements in NYHA functional class were observed in 22.4% and 29.5% of these patients, respectively (p = 0.179 for the difference between both groups). Survival rates were significantly worse in PH-IIP than in IPAH (3-year survival 34.0 versus 68.6%; p<0.001). Total lung capacity, NYHA class IV, and mixed-venous oxygen saturation were independent predictors of survival in patients with PH-IIP. Conclusions Patients with PH-IIP have a dismal prognosis. Our results suggest that pulmonary vasodilator therapy may be associated with short-term functional improvement in some of these patients but it is unclear whether this treatment affects survival.	[Hoeper, Marius M.; Olsson, Karen M.] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Hoeper, Marius M.; Olsson, Karen M.] Hannover Med Sch, German Ctr Lung Res DZL, Hannover, Germany; [Behr, Juergen; Neurohr, Claus] Univ Munich, Dept Internal Med 5, Munich, Germany; [Held, Matthias] Mission Med Hosp, Dept Internal Med Resp Med & Cardiol, Wurzburg, Germany; [Grunig, Ekkehard] Univ Heidelberg Hosp, Heidelberg, Germany; [Vizza, C. Dario] Univ Roma La Sapienza, Dept Cardiovasc & Resp Dis, I-00185 Rome, Italy; [Vonk-Noordegraaf, Anton] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands; [Lange, Tobias J.] Univ Med Ctr Regensburg, Div Pneumol, Dept Internal Med 2, Regensburg, Germany; [Claussen, Martin] LungenClin, Grosshansdorf, Germany; [Grohe, Christian] ELK Thorax Ctr, Dept Resp Med, Berlin, Germany; [Klose, Hans] Univ Med Ctr Hamburg Eppendorf, Dept Resp Med, Ctr Oncol, Hamburg, Germany; [Zelniker, Thomas] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Distler, Oliver] Univ Zurich Hosp, Div Rheumatol, CH-8091 Zurich, Switzerland; [Wirtz, Hubert] Univ Leipzig, Dept Resp Med, D-04109 Leipzig, Germany; [Opitz, Christian] DRK Kliniken Berlin Kopenick, Dept Cardiol, Berlin, Germany; [Huscher, Doerte] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Huscher, Doerte] German Rheumatism Res Ctr, Epidemiol Unit, Berlin, Germany; [Pittrow, David] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, D-01062 Dresden, Germany; [Gibbs, J. Simon R.] Univ London Imperial Coll Sci Technol & Med, Dept Cardiol, Natl Heart & Lung Inst, London, England	Hannover Medical School; Hannover Medical School; University of Munich; University of Wurzburg; Ruprecht Karls University Heidelberg; Sapienza University Rome; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Regensburg; Grosshansdorf Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Zurich; University Zurich Hospital; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Technische Universitat Dresden; Imperial College London	Hoeper, MM (corresponding author), Hannover Med Sch, Dept Resp Med, Hannover, Germany.	hoeper.marius@mh-hannover.de	Vizza, Carmine Dario/AAC-5540-2020; Zelniker, Thomas/GVT-0143-2022; Hoeper, Marius C/Z-1546-2019; Distler, Oliver/AAE-6225-2019; Opitz, Christian/L-3438-2019; Pittrow, David/AAY-5042-2021	Vizza, Carmine Dario/0000-0002-3540-4983; Hoeper, Marius C/0000-0001-9086-2293; Distler, Oliver/0000-0002-0546-8310; vonk noordegraaf, anton/0000-0002-4057-758X; Huscher, Dorte/0000-0001-9070-0761; Zelniker, Thomas/0000-0002-6444-8598	Actelion; Bayer; GSK; Pfizer	Actelion; Bayer(Bayer AG); GSK(GlaxoSmithKline); Pfizer(Pfizer)	The registry is investigator-initiated and currently supported by unrestricted grants from Actelion, Bayer, GSK, and Pfizer. The funders were not involved at all in this analysis or in preparing the manuscript. The authors without the help of medical writers wrote the paper.	Behr J, 2008, EUR RESPIR J, V31, P1357, DOI 10.1183/09031936.00171307; Behr J, 2015, EUR RESPIR J, V46, P186, DOI 10.1183/09031936.00217614; Brewis MJ, 2015, EUR RESPIR J, V46, P1378, DOI 10.1183/13993003.02307-2014; Corte TJ, 2009, THORAX, V64, P883, DOI 10.1136/thx.2008.112847; Corte TJ, 2014, AM J RESP CRIT CARE, V190, P208, DOI 10.1164/rccm.201403-0446OC; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Hoeper MM, 2011, INT J CARDIOL, V154, pS45, DOI 10.1016/S0167-5273(11)70492-2; Humbert M, 2014, CIRCULATION, V130, P2189, DOI 10.1161/CIRCULATIONAHA.114.006974; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Kimura M, 2013, RESPIRATION, V85, P456, DOI 10.1159/000345221; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Minai OA, 2012, RESP MED, V106, P1613, DOI 10.1016/j.rmed.2012.07.013; Nathan SD, 2008, RESPIRATION, V76, P288, DOI 10.1159/000114246; Raghu G, 2013, EUR RESPIR J, V42, P1622, DOI 10.1183/09031936.00104612; Raghu G, 2013, ANN INTERN MED, V158, P641, DOI 10.7326/0003-4819-158-9-201305070-00003; Rivera-Lebron BN, 2013, CHEST, V144, P564, DOI 10.1378/chest.12-2298; Seeger W, 2013, J AM COLL CARDIOL, V62, pD109, DOI 10.1016/j.jacc.2013.10.036; Seibold JR, 2010, ARTHRITIS RHEUM-US, V62, P2101, DOI 10.1002/art.27466; Shorr AF, 2007, EUR RESPIR J, V30, P715, DOI 10.1183/09031936.00107206; Tanabe N, 2015, RESPIROLOGY, V20, P805, DOI 10.1111/resp.12530; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	27	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0141911	10.1371/journal.pone.0141911	http://dx.doi.org/10.1371/journal.pone.0141911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630396	Green Published, Green Accepted, gold			2022-12-26	WOS:000365926300008
J	Huang, HR; Chen, X; Li, DL; He, Y; Li, Y; Du, ZY; Zhang, K; DiPaola, R; Goodin, S; Zheng, X				Huang, Huarong; Chen, Xuan; Li, Dongli; He, Yan; Li, Yu; Du, Zhiyun; Zhang, Kun; DiPaola, Robert; Goodin, Susan; Zheng, Xi			Combination of alpha-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; CULTURED IN-VITRO; NUCLEAR-LOCALIZATION; SIGNALING PATHWAYS; PANCREATIC-CANCER; ANALOGS; CHEMOPREVENTION; ADENOCARCINOMA; BCL-2; CHEMOTHERAPY	alpha-Tomatine is a glycoalkaloid found in tomatoes and curcumin is a major yellow pigment of turmeric. In the present study, the combined effect of these two compounds on prostate cancer cells was studied. Treatment of different prostate cancer cells with curcumin or alpha-tomatine alone resulted in growth inhibition and apoptosis in a concentration-dependent manner. Combinations of alpha-tomatine and curcumin synergistically inhibited the growth and induced apoptosis in prostate cancer PC-3 cells. Effects of the alpha-tomatine and curcumin combination were associated with synergistic inhibition of NF-kappa B activity and a potent decrease in the expression of its downstream gene Bcl-2 in the cells. Moreover, strong decreases in the levels of phospho-Akt and phosphor-ERK1/2 were found in PC-3 cells treated with alpha-tomatine and curcumin in combination. In animal experiment, SCID mice with PC-3 xenograft tumors were treated with alpha-tomatine and curcumin. Combination of alpha-tomatine and curcumin more potently inhibited the growth of PC-3 tumors than either agent alone. Results from the present study indicate that alpha-tomatine in combination with curcumin may be an effective strategy for inhibiting the growth of prostate cancer.	[Huang, Huarong; Chen, Xuan; He, Yan; Du, Zhiyun; Zhang, Kun; Zheng, Xi] Guangdong Univ Technol, Allan H Conney Lab Anticanc Res, Guangzhou, Guangdong, Peoples R China; [Li, Dongli] Wuyi Univ, Dept Chem & Environm Engn, Jiangmen City, Guangdong, Peoples R China; [Li, Yu] Guangdong Ind Tech Coll, Dept Environm Engn, Guangzhou, Guangdong, Peoples R China; [DiPaola, Robert; Goodin, Susan] Canc Inst New Jersey, New Brunswick, NJ USA	Guangdong University of Technology; Wuyi University; Guangdong Industry Polytechnic; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Zheng, X (corresponding author), Guangdong Univ Technol, Allan H Conney Lab Anticanc Res, Guangzhou, Guangdong, Peoples R China.	xizhengch2006@163.com			Guangdong Province, Leadership grant; National Natural Science Foundation of China [81272452, 21102020, 21272043]; National Cancer Institute [P30-CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	Guangdong Province, Leadership grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Guangdong Province, Leadership grant 2011 (http://pro.gdstc.gov.cn/egrantweb/), National Natural Science Foundation of China, 81272452, 21102020 and 21272043 (http://www.nsfc.gov.cn/), National Cancer Institute, P30-CA072720 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bommareddy A, 2013, ANTICANCER RES, V33, P4163; Boztas AO, 2013, MOL PHARMACEUT, V10, P2676, DOI 10.1021/mp400101k; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Choi SH, 2012, J AGR FOOD CHEM, V60, P3891, DOI 10.1021/jf3003027; Connors SK, 2012, NUTR CANCER, V64, P4, DOI 10.1080/01635581.2012.630158; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Gioeli D, 1999, CANCER RES, V59, P279; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guo JL, 2013, MOL CELL BIOCHEM, V382, P103, DOI 10.1007/s11010-013-1723-6; Hasima Noor, 2012, Int J Biochem Mol Biol, V3, P328; Huang HR, 2014, J AGR FOOD CHEM, V62, P10752, DOI 10.1021/jf504058f; Khor TO, 2006, CANCER RES, V66, P613, DOI 10.1158/0008-5472.CAN-05-2708; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lee KH, 2009, EUR J MED CHEM, V44, P3195, DOI 10.1016/j.ejmech.2009.03.020; Lee ST, 2013, PHYTOMEDICINE, V20, P1297, DOI 10.1016/j.phymed.2013.07.002; Lee ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057708; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Li YW, 2014, CANCER METAST REV, V33, P629, DOI 10.1007/s10555-013-9478-9; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nambiar D, 2013, NUTR CANCER, V65, P12, DOI 10.1080/01635581.2013.785006; Pan MH, 2001, J AGR FOOD CHEM, V49, P1464, DOI 10.1021/jf001129v; Paule B, 2007, WORLD J UROL, V25, P477, DOI 10.1007/s00345-007-0175-6; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Ross JS, 2004, CLIN CANCER RES, V10, P2466, DOI 10.1158/1078-0432.CCR-0543-3; Seruga B, 2011, J CLIN ONCOL, V29, P3686, DOI 10.1200/JCO.2010.34.3996; Shankar S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-16; Shankar S, 2007, INT J ONCOL, V30, P905; Shieh JM, 2011, CELL BIOCHEM BIOPHYS, V60, P297, DOI 10.1007/s12013-011-9152-1; Shih YW, 2009, FOOD CHEM TOXICOL, V47, P1985, DOI 10.1016/j.fct.2009.05.011; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Somers-Edgar TJ, 2011, INVEST NEW DRUG, V29, P87, DOI 10.1007/s10637-009-9339-0; Stein MN, 2012, CLIN CANCER RES, V18, P1848, DOI 10.1158/1078-0432.CCR-11-1805; Su CC, 2010, INT J MOL MED, V26, P217, DOI 10.3892/ijmm_00000455; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Thomas BM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0719-0; Tomsik P, 2013, BIOMED PAP, V157, P153, DOI 10.5507/bp.2013.031; Uzgare AR, 2005, INT J BIOCHEM CELL B, V37, P707, DOI 10.1016/j.biocel.2004.11.018; Wei XC, 2013, ANTICANCER RES, V33, P1343; Wei XC, 2012, ONCOL LETT, V4, P279, DOI 10.3892/ol.2012.710; Xi Z, 2007, CLIN CANCER RES, V13, P5480, DOI 10.1158/1078-0432.CCR-07-0242; Yang CF, 2013, CURR PHARM DESIGN, V19, P1966; Yang JY, 2015, INT J CLIN EXP PATHO, V8, P9272; Zhao CG, 2010, BIOORGAN MED CHEM, V18, P2388, DOI 10.1016/j.bmc.2010.03.001; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zheng X, 2012, INT J ONCOL, V41, P2269, DOI 10.3892/ijo.2012.1651; Zhou DY, 2014, MOL MED REP, V10, P1315, DOI 10.3892/mmr.2014.2380	52	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144293	10.1371/journal.pone.0144293	http://dx.doi.org/10.1371/journal.pone.0144293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630272	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300177
J	Ma, ZH; Qin, YT; Wang, YF; Zhao, XF; Zhang, FF; Tang, JH; Fu, ZY				Ma, Zhihui; Qin, Yongtian; Wang, Yafei; Zhao, Xiaofeng; Zhang, Fangfang; Tang, Jihua; Fu, Zhiyuan			Proteomic Analysis of Silk Viability in Maize Inbred Lines and Their Corresponding Hybrids	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; HOMOCYSTEINE HYDROLASE GENE; INITIATION-FACTOR 5A; TRANSGENIC TOBACCO; CYTOKININ HOMEOSTASIS; ARABIDOPSIS-THALIANA; S-ADENOSYLMETHIONINE; OVER-EXPRESSION; CELL; BIOSYNTHESIS	A long period of silk viability is critical for a good seed setting rate in maize (Zea mays L.), especially for inbred lines and hybrids with a long interval between anthesis and silking. To explore the molecular mechanism of silk viability and its heterosis, three inbred lines with different silk viability characteristics (Xun928, Lx9801, and Zong3) and their two hybrids (Xun928xZong3 and Lx9801xZong3) were analyzed at different developmental stages by a proteomic method. The differentially accumulated proteins were identified by mass spectrometry and classified into metabolism, protein biosynthesis and folding, signal transduction and hormone homeostasis, stress and defense responses, and cellular processes. Proteins involved in nutrient (methionine) and energy (ATP) supply, which support the pollen tube growth in the silk, were important for silk viability and its heterosis. The additive and dominant effects at a single locus, as well as complex epistatic interactions at two or more loci in metabolic pathways, were the primary contributors for mid-parent heterosis of silk viability. Additionally, the proteins involved in the metabolism of anthocyanins, which indirectly negatively regulate local hormone accumulation, were also important for the mid-parent heterosis of silk viability. These results also might imply the developmental dependence of heterosis, because many of the differentially accumulated proteins made distinct contributions to the heterosis of silk viability at specific developmental stages.	[Ma, Zhihui; Wang, Yafei; Zhao, Xiaofeng; Zhang, Fangfang; Tang, Jihua; Fu, Zhiyuan] Henan Agr Univ, Coll Agron, Key Lab Wheat & Maize Crops Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Qin, Yongtian] Hebi Acad Agr Sci, Hebi 458030, Peoples R China	Henan Agricultural University	Fu, ZY (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Wheat & Maize Crops Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.	fuzhiyuan2004@163.com	Zhang, Fang/HHN-2153-2022	fu, zhiyuan/0000-0002-9078-5133	National Natural Science Foundation of China [31271732]; National High Technology Research and Development Program of China [2014CB138203]; State Key Laboratory of Wheat and Maize Crop Science [SKL2014ZH-09]; Shanghai Science and Technology Committee [11DZ2272100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Laboratory of Wheat and Maize Crop Science; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the National Natural Science Foundation of China (31271732), the National High Technology Research and Development Program of China (2014CB138203), the State Key Laboratory of Wheat and Maize Crop Science (SKL2014ZH-09) and the Shanghai Science and Technology Committee (11DZ2272100).	Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; BASSETTI P, 1993, CROP SCI, V33, P271, DOI 10.2135/cropsci1993.0011183X003300020011x; Bauly JM, 2000, PLANT PHYSIOL, P124; BOEKEMA EJ, 1992, BIOCHIM BIOPHYS ACTA, V1098, P131, DOI 10.1016/S0005-2728(05)80328-7; Bonnett OT, 1966, U ILLINOIS AGR EXP S, V721; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Dresselhaus T, 1999, PLANT MOL BIOL, V39, P1063, DOI 10.1023/A:1006176819213; Dresselhaus T, 2009, CURR OPIN PLANT BIOL, V12, P773, DOI 10.1016/j.pbi.2009.09.015; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HESLOPHARRISON Y, 1984, ACTA BOT NEERL, V33, P81, DOI 10.1111/j.1438-8677.1984.tb01774.x; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hoecker N, 2008, PROTEOMICS, V8, P3882, DOI 10.1002/pmic.200800023; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Huanhuan S., 2011, AFRICAN J BIOTECHNOL, V10, P19035; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; Kakimoto T, 2003, J PLANT RES, V116, P233, DOI 10.1007/s10265-003-0095-5; Kiran NS, 2006, J EXP BOT, V57, P985, DOI 10.1093/jxb/erj084; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Rodo AP, 2008, J EXP BOT, V59, P2673, DOI 10.1093/jxb/ern137; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Tanaka H, 1997, PLANT MOL BIOL, V35, P981, DOI 10.1023/A:1005896711321; Tanaka H, 1996, PLANT SCI, V113, P167, DOI 10.1016/0168-9452(95)04289-X; Thompson JE, 2004, TRENDS PLANT SCI, V9, P174, DOI 10.1016/j.tplants.2004.02.008; Waie B, 2003, PLANT SCI, V164, P727, DOI 10.1016/S0168-9452(03)00030-X; Wang J, 2011, PLANT CELL PHYSIOL, V52, P2200, DOI 10.1093/pcp/pcr152; Xu XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-294; Yoon S, 2012, BIOPROC BIOSYST ENG, V35, P173, DOI 10.1007/s00449-011-0640-x; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; Zhang XY, 2013, MOL PLANT, V6, P1661, DOI 10.1093/mp/sst071	55	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144050	10.1371/journal.pone.0144050	http://dx.doi.org/10.1371/journal.pone.0144050			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630375	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300148
J	Spengler, S; Mess, F; Woll, A				Spengler, Sarah; Mess, Filip; Woll, Alexander			Do Media Use and Physical Activity Compete in Adolescents? Results of the MoMo Study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; WEIGHT STATUS; ELECTRONIC MEDIA; CHILDRENS HEALTH; OBESITY; YOUTH; PATTERNS; KIGGS; TIME; ASSOCIATIONS	Purpose The displacement hypothesis predicts that physical activity and media use compete in adolescents; however, findings are inconsistent. A more differentiated approach at determining the co-occurrence of physical activity and media use behaviors within subjects may be warranted. The aim of this study was to determine the co-occurrence of physical activity and media use by identifying clusters of adolescents with specific behavior patterns including physical activity in various settings (school, sports club, leisure time) and different types of media use (watching TV, playing console games, using PC / Internet). Methods Cross-sectional data of 2,083 adolescents (11-17 years) from all over Germany were collected between 2009 and 2012 in the Motorik-Modul Study. Physical activity and media use were self-reported. Cluster analyses (Ward's method and K-means analysis) were used to identify behavior patterns of boys and girls separately. Results Eight clusters were identified for boys and seven for girls. The clusters demonstrated that a high proportion of boys (33%) as well as girls (42%) show low engagement in both physical activity and media use, irrespective of setting or type of media. Other adolescents are engaged in both behaviors, but either physical activity (35% of boys, 27% of girls) or media use (31% of boys and girls) predominates. These adolescents belong to different clusters, whereat in most clusters either one specific setting of physical activity or a specific combination of different types of media predominates. Conclusion The results of this study support to some extent the hypothesis that media use and physical activity compete: Very high media use occurred with low physical activity behavior, but very high activity levels co-occurred with considerable amounts of time using any media. There was no evidence that type of used media was related to physical activity levels, neither setting of physical activity was related to amount of media use in any pattern.	[Spengler, Sarah; Mess, Filip] Tech Univ Munich, Dept Sport & Hlth Sci, D-80290 Munich, Germany; [Woll, Alexander] Karlsruhe Inst Technol, Inst Sports & Sports Sci, D-76021 Karlsruhe, Germany	Technical University of Munich; Helmholtz Association; Karlsruhe Institute of Technology	Spengler, S (corresponding author), Tech Univ Munich, Dept Sport & Hlth Sci, D-80290 Munich, Germany.	sarah.spengler@tum.de	; Mess, Filip/J-7090-2016	Spengler, Sarah/0000-0001-6706-9297; Mess, Filip/0000-0002-9506-524X	Shanghai Municipal Commission of Health and Family Planning [20124026]	Shanghai Municipal Commission of Health and Family Planning	This study was partly supported by a funding (No. 20124026) from the Shanghai Municipal Commission of Health and Family Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus Klaus, 2011, MULTIVARIATE ANALYSE; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; BIDDLE SJH, 2004, J R SOC PROMO HEALTH, V124, P29; Bos K., 2009, MOTORIK MODUL STUDIE, V1st; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; De Bourdeaudhuij I, 2013, PEDIATR OBES, V8, P367, DOI 10.1111/j.2047-6310.2012.00117.x; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Gorely T, 2007, J BEHAV MED, V30, P521, DOI 10.1007/s10865-007-9126-3; Gracia-Marco L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-971; Gubbels JS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-77; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hancox RJ, 2006, INT J OBESITY, V30, P171, DOI 10.1038/sj.ijo.0803071; Jago R, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-59; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Kilpatrick M, 2005, J AM COLL HEALTH, V54, P87, DOI 10.3200/JACH.54.2.87-94; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2007, BUNDESGESUNDHEITSBLA, V50, P643, DOI 10.1007/s00103-007-0225-7; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P762, DOI 10.1007/s00103-014-1974-8; Lange M, 2014, BUNDESGESUNDHEITSBLA, V57, P747, DOI 10.1007/s00103-014-1973-9; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Liu JH, 2010, J PHYS ACT HEALTH, V7, P465, DOI 10.1123/jpah.7.4.465; Manz K, 2014, BUNDESGESUNDHEITSBLA, V57, P840, DOI 10.1007/s00103-014-1986-4; Marshall SJ, 2002, PEDIATR EXERC SCI, V14, P401, DOI 10.1123/pes.14.4.401; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; MUTZ DC, 1993, COMMUN RES, V20, P51, DOI 10.1177/009365093020001003; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Rey-Lopez JP, 2012, PEDIATR OBES, V7, P240, DOI 10.1111/j.2047-6310.2011.00021.x; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Romer D, 2013, J ADOLESCENT HEALTH, V52, P613, DOI 10.1016/j.jadohealth.2012.11.012; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sisson SB, 2010, J ADOLESCENT HEALTH, V47, P309, DOI 10.1016/j.jadohealth.2010.02.016; Spengler S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-242; te Velde SJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-16; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Vella SA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-113; Wagner MO, 2014, INT J EPIDEMIOL, V43, P1410, DOI 10.1093/ije/dyt098; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	37	26	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0142544	10.1371/journal.pone.0142544	http://dx.doi.org/10.1371/journal.pone.0142544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX8BI	26629688	gold, Green Published			2022-12-26	WOS:000365926300012
J	Hollander, FA; Van Dyck, H; San Martin, G; Titeux, N				Hollander, Franck A.; Van Dyck, Hans; San Martin, Gilles; Titeux, Nicolas			Nest Predation Deviates from Nest Predator Abundance in an Ecologically Trapped Bird	PLOS ONE			English	Article							SHRIKES LANIUS-COLLURIO; HABITAT SELECTION; SITE SELECTION; PARENTAL BEHAVIOR; LANDSCAPE; SURVIVAL; FOREST; FOOD; CONCEALMENT; RISK	In human-modified environments, ecological traps may result from a preference for low-quality habitat where survival or reproductive success is lower than in high-quality habitat. It has often been shown that low reproductive success for birds in preferred habitat types was due to higher nest predator abundance. However, between-habitat differences in nest predation may only weakly correlate with differences in nest predator abundance. An ecological trap is at work in a farmland bird (Lanius collurio) that recently expanded its breeding habitat into open areas in plantation forests. This passerine bird shows a strong preference for forest habitat, but it has a higher nest success in farmland. We tested whether higher abundance of nest predators in the preferred habitat or, alternatively, a decoupling of nest predator abundance and nest predation explained this observed pattern of maladaptive habitat selection. More than 90% of brood failures were attributed to nest predation. Nest predator abundance was more than 50% higher in farmland, but nest predation was 17% higher in forest. Differences between nest predation on actual shrike nests and on artificial nests suggested that parent shrikes may facilitate nest disclosure for predators in forest more than they do in farmland. The level of caution by parent shrikes when visiting their nest during a simulated nest predator intrusion was the same in the two habitats, but nest concealment was considerably lower in forest, which contributes to explaining the higher nest predation in this habitat. We conclude that a decoupling of nest predator abundance and nest predation may create ecological traps in human-modified environments.	[Hollander, Franck A.; Van Dyck, Hans; San Martin, Gilles; Titeux, Nicolas] Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, ELI, Louvain La Neuve, Belgium; [San Martin, Gilles] Ctr wallon Rech Agron, Dept Sci Vivant, Unite Protect Plantes & Ecotoxicol, Gembloux, Belgium; [Titeux, Nicolas] LIST, Environm Res & Innovat ERIN, Esch Sur Alzette, Luxembourg; [Titeux, Nicolas] Forest Sci Ctr Catalonia CEMFOR CTFC, InForest Joint Res Unit CSIC CTFC CREAF, Solsona, Spain	Universite Catholique Louvain; Luxembourg Institute of Science & Technology; Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC)	Titeux, N (corresponding author), Catholic Univ Louvain, Behav Ecol & Conservat Grp, Biodivers Res Ctr, ELI, Louvain La Neuve, Belgium.	nicolas.titeux@ctfc.es	Titeux, Nicolas/G-4723-2016; Titeux, Nicolas/AAD-4439-2019; San Martin, Gilles/B-7827-2015	Titeux, Nicolas/0000-0002-7719-7417; Titeux, Nicolas/0000-0002-7719-7417; San Martin, Gilles/0000-0002-0434-9416	FRIA PhD-grant from the Fonds de la Recherche Scientifique-FNRS in Belgium; National Research Fund of Luxembourg [C12/SR/3985735 COLLURIO]	FRIA PhD-grant from the Fonds de la Recherche Scientifique-FNRS in Belgium(Fonds de la Recherche Scientifique - FNRS); National Research Fund of Luxembourg(Luxembourg National Research Fund)	FAH was funded by a FRIA PhD-grant from the Fonds de la Recherche Scientifique-FNRS in Belgium (http://www.fnrs.be). NT was financially supported by the National Research Fund of Luxembourg (C12/SR/3985735 COLLURIO project) (http://www.fnr.lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Bonnington C, 2015, ANIM CONSERV, V18, P529, DOI 10.1111/acv.12206; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cote IM, 1997, CONSERV BIOL, V11, P395, DOI 10.1046/j.1523-1739.1997.95410.x; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Eggers S, 2005, OIKOS, V111, P150, DOI 10.1111/j.0030-1299.2005.13802.x; Eggers S, 2008, BEHAV ECOL, V19, P1056, DOI 10.1093/beheco/arn063; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Fontaine JJ, 2007, OIKOS, V116, P1887, DOI 10.1111/j.2007.0030-1299.16043.x; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Fuller R.J., 2012, BIRDS HABITAT RELATI; Gilroy JJ, 2011, ANIM CONSERV, V14, P620, DOI 10.1111/j.1469-1795.2011.00480.x; Griesser M, 2007, CONSERV BIOL, V21, P767, DOI 10.1111/j.1523-1739.2007.00675.x; Hawlena D, 2010, CONSERV BIOL, V24, P803, DOI 10.1111/j.1523-1739.2010.01477.x; Hollander FA, 2015, J INSECT CONSERV, V19, P1011, DOI 10.1007/s10841-015-9817-y; Hollander FA, 2013, FUNCT ECOL, V27, P702, DOI 10.1111/1365-2435.12077; Hollander FA, 2012, BEHAV ECOL SOCIOBIOL, V66, P777, DOI 10.1007/s00265-012-1325-4; Hollander FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025703; HOLWAY DA, 1991, CONDOR, V93, P575, DOI 10.2307/1368189; Hothorn RT, 2014, HDB STAT ANAL USING; Karlsson S, 2004, ORNIS FENNICA, V81, P97; Latif QS, 2011, OIKOS, V120, P1139, DOI 10.1111/j.1600-0706.2010.18835.x; Lefranc N., 1997, SHRIKES GUIDE SHRIKE; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; Luginbuhl JM, 2001, J FIELD ORNITHOL, V72, P556, DOI 10.1648/0273-8570-72.4.556; Marasinghe MG, 2008, STAT COMPUT SER, P1, DOI 10.1007/978-0-387-77372-8_1; Martin T.E., 1992, Current Ornithology, V9, P163; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; Marzluff JM, 2006, BIOL CONSERV, V130, P301, DOI 10.1016/j.biocon.2005.12.026; Maurer G, 2003, ANIM BEHAV, V65, P1045, DOI 10.1006/anbe.2003.2148; MONTGOMERIE RD, 1988, Q REV BIOL, V63, P167, DOI 10.1086/415838; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; Olsson Viking, 1995, Ornis Svecica, V5, P101; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; Pelech SA, 2010, OIKOS, V119, P841, DOI 10.1111/j.1600-0706.2009.17786.x; Powell LL, 2010, CONDOR, V112, P800, DOI 10.1525/cond.2010.100152; Ralph C.J., 1993, PSWGTR144WWW USDA; Rastogi AD, 2006, ANIM BEHAV, V72, P933, DOI 10.1016/j.anbehav.2006.03.006; Remes V, 2005, BEHAV ECOL SOCIOBIOL, V58, P326, DOI 10.1007/s00265-005-0910-1; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2007, CONDOR, V109, P109, DOI 10.1650/0010-5422(2007)109[109:ISHFAE]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Rodewald AD, 2002, J WILDLIFE MANAGE, V66, P634, DOI 10.2307/3803130; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Roos S, 2004, J ANIM ECOL, V73, P117, DOI 10.1111/j.1365-2656.2004.00786.x; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Roos Steffan, 2007, Osnabruecker Naturwissenschaftliche Mitteilungen, V32, P167; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schmidt KA, 1999, OIKOS, V85, P151, DOI 10.2307/3546801; Schmidt KA, 2001, ECOLOGY, V82, P2937, DOI 10.1890/0012-9658(2001)082[2937:INPISB]2.0.CO;2; Shochat E, 2005, OIKOS, V111, P159, DOI 10.1111/j.0030-1299.2005.13907.x; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Soderstrom B, 2001, J INSECT CONSERV, V143, P567; Soderstrom B, 2011, J ORNITHOL, V152, P313, DOI 10.1007/s10336-010-0587-8; SONERUD GA, 1987, ORNIS SCAND, V18, P323, DOI 10.2307/3676904; Storch D, 1999, EVOL ECOL, V13, P591, DOI 10.1023/A:1006765422475; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; Strnad M, 2012, ORNIS FENNICA, V89, P206; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; WAITE RK, 1984, ORNIS SCAND, V15, P55, DOI 10.2307/3676003; Weidinger K, 2002, J ANIM ECOL, V71, P424, DOI 10.1046/j.1365-2656.2002.00611.x; Weldon AJ, 2006, CONSERV BIOL, V20, P1300, DOI 10.1111/j.1523-1739.2006.00403.x; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; Wilson RR, 1998, CONDOR, V100, P673, DOI 10.2307/1369748; Zanette L, 2006, OECOLOGIA, V147, P632, DOI 10.1007/s00442-005-0330-y; [No title captured]	68	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144098	10.1371/journal.pone.0144098	http://dx.doi.org/10.1371/journal.pone.0144098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624619	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600093
J	Canalis, E; Schilling, L; Yee, SP; Lee, SK; Zanotti, S				Canalis, Ernesto; Schilling, Lauren; Yee, Siu-Pok; Lee, Sun-Kyeong; Zanotti, Stefano			Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Notch receptors are determinants of cell fate and function and play a central role in skeletal development and bone remodeling. Hajdu Cheney syndrome, a disease characterized by osteoporosis and fractures, is associated with NOTCH2 mutations resulting in a truncated stable protein and gain-of-function. We created a mouse model reproducing the Hajdu Cheney syndrome by introducing a 6955C -> T mutation in the Notch2 locus leading to a Q2319X change at the amino acid level. Notch2Q2319X heterozygous mutants were smaller and had shorter femurs than controls; and at 1 month of age they exhibited cancellous and cortical bone osteopenia. As the mice matured, cancellous bone volume was restored partially in male but not female mice, whereas cortical osteopenia persisted in both sexes. Cancellous bone histomorphometry revealed an increased number of osteoclasts and bone resorption, without a decrease in osteoblast number or bone formation. Osteoblast differentiation and function were not affected in Notch2(Q2319X) cells. The pre-osteoclast cell pool, osteoclast differentiation, and bone resorption in response to receptor activator of nuclear factor kappa B ligand in vitro were increased in Notch2(Q2319X) mutants. These effects were suppressed by the gamma-secretase inhibitor LY450139. In conclusion, Notch2(Q2319X) mice exhibit cancellous and cortical bone osteopenia, enhanced osteoclastogenesis, and increased bone resorption.	[Canalis, Ernesto; Schilling, Lauren; Zanotti, Stefano] Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Canalis, Ernesto; Lee, Sun-Kyeong; Zanotti, Stefano] Univ Connecticut, Hlth Ctr, Dept Med, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Genet, Farmington, CT 06030 USA; [Yee, Siu-Pok] Univ Connecticut, Hlth Ctr, Dept Genome Sci Biol, Farmington, CT 06030 USA; [Lee, Sun-Kyeong] Univ Connecticut, Hlth Ctr, Ctr Aging, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut	Canalis, E (corresponding author), Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), Univ Connecticut, Hlth Ctr, Dept Med, Farmington, CT 06030 USA.	canalis@uchc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK045227]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045227] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK045227 from the National Institute of Diabetes and Digestive and Kidney Diseases. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguila HL, 2012, J BONE MINER RES, V27, P1030, DOI 10.1002/jbmr.1553; Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Avela K, 2011, AM J MED GENET A, V155A, P595, DOI 10.1002/ajmg.a.33510; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Breit S, 2006, BLOOD, V108, P1151, DOI 10.1182/blood-2005-12-4956; BROWN DM, 1976, J PEDIATR-US, V88, P573, DOI 10.1016/S0022-3476(76)80009-1; Canalis E, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0200-y; Canalis E, 2013, J BIOL CHEM, V288, P25614, DOI 10.1074/jbc.M113.470492; Canalis E, 2013, ENDOCRINOLOGY, V154, P623, DOI 10.1210/en.2012-1732; CHENEY WD, 1965, AMER J ROENTGENOL RA, V94, P595; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dallas DJ, 1999, BONE, V25, P9, DOI 10.1016/S8756-3282(99)00099-X; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Descartes M, 2014, CLIN DYSMORPHOL, V23, P88, DOI 10.1097/MCD.0000000000000034; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gray MJ, 2012, EUR J HUM GENET, V20, P122, DOI 10.1038/ejhg.2011.125; Habets RAJ, 2015, J BIOL CHEM, V290, P14705, DOI 10.1074/jbc.M115.643676; HAJDU N, 1948, BRIT J RADIOL, V21, P42, DOI 10.1259/0007-1285-21-241-42; Halleux C, 2012, METHODS MOL BIOL, V816, P55, DOI 10.1007/978-1-61779-415-5_5; HEFLEY T, 1981, AM J PHYSIOL, V240, pC234, DOI 10.1152/ajpcell.1981.240.5.C234; Herrmann M, 2011, OSTEOPOROSIS RESEARCH: ANIMAL MODELS, P57, DOI 10.1007/978-0-85729-293-3_6; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; Jacome-Galarza CE, 2011, J BONE MINER RES, V26, P1207, DOI 10.1002/jbmr.324; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kovall RA, 2008, ONCOGENE, V27, P5099, DOI 10.1038/onc.2008.223; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Mun SH, 2014, ARTHRITIS RHEUMATOL, V66, P2482, DOI 10.1002/art.38723; Mun SH, 2013, J BONE MINER RES, V28, P948, DOI 10.1002/jbmr.1787; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e37; Nazarenko I, 2002, NUCLEIC ACIDS RES, V30, P2089, DOI 10.1093/nar/30.9.2089; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pereira RMR, 2002, J CELL BIOCHEM, V85, P252, DOI 10.1002/jcb.10125; Plotkin LI, 2015, J BIOL CHEM, V290, P18934, DOI 10.1074/jbc.M115.642090; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Sahlgren C, 2006, REGEN MED, V1, P195, DOI 10.2217/17460751.1.2.195; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seibel Markus J, 2005, Clin Biochem Rev, V26, P97; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Tu XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002577; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yuan ZY, 2012, J BIOL CHEM, V287, P34904, DOI 10.1074/jbc.M112.403287; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zanotti S, 2015, J CELL PHYSIOL, V230, P1689, DOI 10.1002/jcp.24928; Zanotti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086757; Zanotti S, 2013, J BIOL CHEM, V288, P624, DOI 10.1074/jbc.M112.340455; Zanotti S, 2012, CALCIFIED TISSUE INT, V90, P69, DOI 10.1007/s00223-011-9541-x; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5	82	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	191	4					1538	1551		10.1074/jbc.M115.685453	http://dx.doi.org/10.1074/jbc.M115.685453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	VC7QW	26627824	hybrid, Green Published			2022-12-26	WOS:000434592700001
J	Berry, RH; Qu, J; John, SWM; Howell, GR; Jakobs, TC				Berry, Ryan H.; Qu, Juan; John, Simon W. M.; Howell, Gareth R.; Jakobs, Tatjana C.			Synapse Loss and Dendrite Remodeling in a Mouse Model of Glaucoma	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CLASSICAL COMPLEMENT CASCADE; DBA/2J MICE; OPTIC-NERVE; POSTSYNAPTIC DENSITIES; QUANTITATIVE-ANALYSIS; AMPA RECEPTORS; PROTEINS; PSD-95; DEGENERATION	It has been hypothesized that synaptic pruning precedes retinal ganglion cell degeneration in glaucoma, causing early dysfunction to retinal ganglion cells. To begin to assess this, we studied the excitatory synaptic inputs to individual ganglion cells in normal mouse retinas and in retinas with ganglion cell degeneration from glaucoma (DBA/2J), or following an optic nerve crush. Excitatory synapses were labeled by AAV2-mediated transfection of ganglion cells with PSD-95-GFP. After both insults the linear density of synaptic inputs to ganglion cells decreased. In parallel, the dendritic arbors lost complexity. We did not observe any cells that had lost dendritic synaptic input while preserving a normal or near-normal morphology. Within the temporal limits of these observations, dendritic remodeling and synapse pruning thus appear to occur near-simultaneously.	[Berry, Ryan H.; Qu, Juan; Jakobs, Tatjana C.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [John, Simon W. M.; Howell, Gareth R.] Jackson Lab, Bar Harbor, ME 04609 USA; [John, Simon W. M.] Howard Hughes Med Inst, Jackson Lab, Bar Harbor, ME USA; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Jackson Laboratory; Howard Hughes Medical Institute; Jackson Laboratory; Tufts University	Howell, GR (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Gareth.Howell@jax.org; Tatjana_Jakobs@meei.harvard.edu		Jakobs, Tatjana/0000-0002-8104-9206	National Eye Institute [EY019703, EY021525, EY14104]; Research to Prevent Blindness; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY019703, R01EY021525, P30EY014104, R01EY022092] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute (http://www.nei.nih.gov/) grant EY019703 (TJ); National Eye Institute grant EY021525 (GH); National Eye Institute core grant EY14104 (MEEI); Grants from Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and the Massachusetts Lions Eye Research Fund (http://www.masslionseyeresearch.org/). SJ is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Ebihara T, 2003, J NEUROSCI, V23, P2170; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Danaf RN, 2015, J NEUROSCI, V35, P2329, DOI 10.1523/JNEUROSCI.1419-14.2015; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Famiglietti EV, 2005, J COMP NEUROL, V484, P357, DOI 10.1002/cne.20433; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Kalesnykas G, 2012, INVEST OPHTH VIS SCI, V53, P3847, DOI 10.1167/iovs.12-9712; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koizumi A, 2011, J COMP NEUROL, V519, P341, DOI 10.1002/cne.22522; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Lye-Barthel M, 2013, INVEST OPHTH VIS SCI, V54, P909, DOI 10.1167/iovs.12-10109; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rosen AM, 2010, ADV EXP MED BIOL, V703, P75, DOI 10.1007/978-1-4419-5635-4_6; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sumbul U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4512; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; WASSLE H, 1981, PROC R SOC SER B-BIO, V212, P157, DOI 10.1098/rspb.1981.0032; WONG ROL, 1992, EUR J NEUROSCI, V4, P1387, DOI 10.1111/j.1460-9568.1992.tb00164.x	56	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144341	10.1371/journal.pone.0144341	http://dx.doi.org/10.1371/journal.pone.0144341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637126	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800078
J	Girardello, R; Tasselli, S; Baranzini, N; Valvassori, R; de Eguileor, M; Grimaldi, A				Girardello, Rossana; Tasselli, Stefano; Baranzini, Nicolo; Valvassori, Roberto; de Eguileor, Magda; Grimaldi, Annalisa			Effects of Carbon Nanotube Environmental Dispersion on an Aquatic Invertebrate, Hirudo medicinalis	PLOS ONE			English	Article							AROMATIC-HYDROCARBONS; SILVER NANOPARTICLES; IMMUNE-RESPONSE; ACUTE TOXICITY; GENOTOXICITY; COMPLEX; METALS; GROWTH	The recent widespread applications of nanomaterials, because of their properties, opens new scenarios that affect their dispersal in the environment. In particular multiwall carbon nanotubes (MWCNTs), despite their qualities, seem to be harmful for animals and humans. To evaluate possible toxic effects caused by carbon nanotube environmental dispersion, with regard to aquatic compartment, we proposed as experimental model a freshwater invertebrate: Hirudo medicinalis. In the present study we analyse acute and chronic immune responses over a short (1, 3, 6 and 12 hours) and long time (from 1 to 5 weeks) exposure to MWCNTs by optical, electron and immunohistochemical approaches. In the exposed leeches angiogenesis and fibroplasia accompanied by massive cellular migration occur. Immunocytochemical characterization using specific markers shows that in these inflammatory processes the monocyte-macrophages (CD45(+), CD68(+)) are the most involved cells. These immunocompetent cells are characterized by sequence of events starting from the expression of pro-inflammatory cytokines (in particular IL-18), and amyloidogenensis. Our combined experimental approaches, basing on high sensitive inflammatory response can highlight adverse effects of nanomaterials on aquatic organisms and could be useful to assess the MWCNTs impact on aquatic, terrestrial animal and human health.	[Girardello, Rossana; Tasselli, Stefano; Baranzini, Nicolo; Valvassori, Roberto; de Eguileor, Magda; Grimaldi, Annalisa] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	University of Insubria	Grimaldi, A (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.	annalisa.grimaldi@uninsubria.it	Baranzini, Nicoló/AAK-9531-2021; Baranzini, Nicolò/AFW-4561-2022; Tasselli, Stefano/B-8017-2018	Tasselli, Stefano/0000-0002-0787-5710; Baranzini, Nicolo/0000-0001-6996-4797; Girardello, Rossana/0000-0001-8605-6037	MIUR (Ministero dell'Universita' e della Ricerca) PRIN; CARIPLO foundation [CUPJ31J11004830003]	MIUR (Ministero dell'Universita' e della Ricerca) PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO foundation(Fondazione Cariplo)	This work was supported by the MIUR (Ministero dell'Universita' e della Ricerca) PRIN (program of scientific research of major national interest) 2010-2011 to MdeE and by CARIPLO foundation 2012 (Grant number CUPJ31J11004830003, URL http://www.fondazionecariplo.it) to VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2015, INT J NANOTECHNOL, V10, P1; Alboni S, 2011, BRAIN BEHAV IMMUN, V25, P483, DOI 10.1016/j.bbi.2010.11.011; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Ali D, 2014, CHEMOSPHERE, V104, P134, DOI 10.1016/j.chemosphere.2013.10.081; Alloy MM, 2011, ECOTOX ENVIRON SAFE, V74, P1839, DOI 10.1016/j.ecoenv.2011.06.020; Banni M, 2009, CHEMOSPHERE, V77, P902, DOI 10.1016/j.chemosphere.2009.08.041; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Benedetti M, 2007, AQUAT TOXICOL, V85, P167, DOI 10.1016/j.aquatox.2007.08.009; Bouraoui Z, 2009, ECOTOX ENVIRON SAFE, V72, P1893, DOI 10.1016/j.ecoenv.2009.05.011; Chang XF, 2009, J HAZARD MATER, V166, P728, DOI 10.1016/j.jhazmat.2008.11.126; Cornelis G, 2010, ENVIRON CHEM, V7, P298, DOI 10.1071/EN10013; Coutris C, 2012, NANOTOXICOLOGY, V6, P186, DOI 10.3109/17435390.2011.569094; de Eguileor M, 2000, TISSUE CELL, V32, P40; de Eguileor M, 1999, J INVERTEBR PATHOL, V74, P14, DOI 10.1006/jipa.1999.4850; de Eguileor M, 2000, TISSUE CELL, V32, P437; de Eguileor M, 2003, CURR PHARM DESIGN, V9, P133, DOI 10.2174/1381612033392198; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Di Giorgio ML, 2011, MUTAT RES-GEN TOX EN, V722, P20, DOI 10.1016/j.mrgentox.2011.02.008; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007; Edgington AJ, 2010, ENVIRON TOXICOL CHEM, V29, P2511, DOI 10.1002/etc.309; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Fleeger JW, 2007, ENVIRON TOXICOL CHEM, V26, P1677, DOI 10.1897/06-397R.1; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Funahashi S, 2015, J CLIN BIOCHEM NUTR, V56, P111, DOI 10.3164/jcbn.14-92; Girardello R., 2015, J NANOMEDICINE NANOT, V6, P323, DOI DOI 10.4172/2157-7439.1000323; GORCHEV HG, 1984, WHO CHRON, V38, P104; Grimaldi A., 2004, ISJ, V1, P38; Grimaldi A, 2006, CURR PHARM DESIGN, V12, P3033, DOI 10.2174/138161206777947443; Grimaldi A, 2012, ISJ-INVERT SURVIV J, V9, P153; Grimaldi A, 2012, CELL TISSUE RES, V350, P491, DOI 10.1007/s00441-012-1503-8; Hayashi Y, 2012, ENVIRON SCI TECHNOL, V46, P4166, DOI 10.1021/es3000905; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kennedy AJ, 2009, ENVIRON TOXICOL CHEM, V28, P1930, DOI 10.1897/09-024.1; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Macagno ER, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-407; Maria VL, 2011, COMP BIOCHEM PHYS C, V154, P56, DOI 10.1016/j.cbpc.2011.02.004; MOORE RD, 1960, J ULTRA MOL STRUCT R, V4, P113, DOI 10.1016/S0022-5320(60)90047-2; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Petersen EJ, 2011, ENVIRON SCI TECHNOL, V45, P9837, DOI 10.1021/es201579y; Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001; Roberts AP, 2007, ENVIRON SCI TECHNOL, V41, P3025, DOI 10.1021/es062572a; Schorn T, 2015, CELL TISSUE RES, V359, P853, DOI 10.1007/s00441-014-2058-7; Shoults-Wilson WA, 2011, ECOTOXICOLOGY, V20, P385, DOI 10.1007/s10646-010-0590-0; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Simate GS, 2012, ENVIRON INT, V39, P38, DOI 10.1016/j.envint.2011.09.006; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Tettamanti G, 2006, CURR MED CHEM, V13, P2737, DOI 10.2174/092986706778521986; Tettamanti G, 2005, BIOL CELL, V97, P557, DOI 10.1042/BC20040085; Tettamanti G, 2004, BIOL CELL, V96, P443, DOI 10.1016/j.biolcel.2004.04.008; Tettamanti G, 2003, TISSUE CELL, V35, P199, DOI 10.1016/S0040-8166(03)00027-2; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Zhang LJ, 2014, ECOTOX ENVIRON SAFE, V103, P29, DOI 10.1016/j.ecoenv.2014.01.041	55	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144361	10.1371/journal.pone.0144361	http://dx.doi.org/10.1371/journal.pone.0144361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636582	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800081
J	Nogueira, M; Brandini, FP; Codina, JCU				Nogueira Junior, Miodeli; Brandini, Frederico Pereira; Ugaz Codina, Juan Carlos			Diel Vertical Dynamics of Gelatinous Zooplankton (Cnidaria, Ctenophora and Thaliacea) in a Subtropical Stratified Ecosystem (South Brazilian Bight)	PLOS ONE			English	Article							NORTHWESTERN MEDITERRANEAN-SEA; GEGENBAURI ULJANIN TUNICATA; VILLEFRANCHE-SUR-MER; BLACK-SEA; DOLIOLUM-DENTICULATUM; PLANKTONIC CNIDARIANS; MESOPELAGIC COMMUNITY; MIGRATION PATTERNS; NORTHEAST ATLANTIC; ADRIATIC SEA	The diel vertical dynamics of gelatinous zooplankton in physically stratified conditions over the 100-m isobath (similar to 110 km offshore) in the South Brazilian Bight (26 degrees 45'S; 47 degrees 33'W) and the relationship to hydrography and food availability were analyzed by sampling every six hours over two consecutive days. Zooplankton samples were taken in three depth strata, following the vertical structure of the water column, with cold waters between 17 and 13.1 degrees C, influenced by the South Atlantic Central Water (SACW) in the lower layer (>70m); warm (>20 degrees C) Tropical Water in the upper 40 m; and an intermediate thermocline with a deep chlorophyll-a maximum layer (0.3-0.6 mg m(-3)). Two distinct general patterns were observed, emphasizing the role of (i) physical and (ii) biological processes: (i) a strong influence of the vertical stratification, with most zooplankton absent or little abundant in the lower layer. The influence of the cold SACW on the bottom layer apparently restricted the vertical occupation of most species, which typically inhabit epipelagic warm waters. Even among migratory species, only a few (Aglaura hemistoma, Abylopsis tetragona eudoxids, Beroe sp., Thalia democratica, Salpa fusiformis) crossed the thermocline and reached the bottom layer. (ii) A general tendency of partial migrations, with variable intensity depending on the different species and developmental stages; populations tended to be more widely distributed through the water column during daylight, and to become more aggregated in the upper layer during the night, which can be explained based on the idea of the "hungersatiation hypothesis", maximizing feeding and minimizing the chances of being predated.	[Nogueira Junior, Miodeli] Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Brandini, Frederico Pereira] Univ Sao Paulo, Inst Oceanog, Dept Oceanog Biol, Sao Paulo, Brazil; [Ugaz Codina, Juan Carlos] Univ Fed Paraiba, Dept Zool, Programa Pos Grad Zool, Curitiba, Parana, Brazil	Universidade Federal da Paraiba; Universidade de Sao Paulo; Universidade Federal da Paraiba	Nogueira, M (corresponding author), Univ Fed Paraiba, Dept Sistemat & Ecol, BR-58059900 Joao Pessoa, Paraiba, Brazil.	miodeli@gmail.com	Brandini, Frederico/C-9402-2012; Júnior, Miodeli Nogueira/M-2211-2013	Júnior, Miodeli Nogueira/0000-0001-5409-8312	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474165/2004-3, 140945/2007-5]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/21290-1, 2011/09880-8]; USA National Science Foundation through the InterAmerican Institute of Global Change Research [GEO-0452325, CRN 2076]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USA National Science Foundation through the InterAmerican Institute of Global Change Research	This study was undertaken as part of the PROPELL project (Dinamica das interacoes fisicobiologicas no sistema pelagico da plataforma continental Sudeste do Brasil), supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq.;www.cnpq.br, project no 474165/2004-3). This investigation also received funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/, project no 2011/21290-1). MNJ had a scholarship from CNPq (PhD grant no 140945/2007-5) and from FAPESP (post-doctoral grant no 2011/09880-8 and JCUC from the USA National Science Foundation (http://www.nsf.gov/, Grant GEO-0452325) through the InterAmerican Institute of Global Change Research (http://www.iai.int/, grant CRN 2076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves N, 2015, ARCH MICROBIOL, V197, P165, DOI 10.1007/s00203-014-1035-6; Amaral W.J.A., 1997, Atlantica, V19, P51; Andersen V., 1998, P125; ANDERSEN V, 1992, J PLANKTON RES, V14, P1155, DOI 10.1093/plankt/14.8.1155; Andersen V, 2001, J PLANKTON RES, V23, P243, DOI 10.1093/plankt/23.3.243; Andersen V, 1998, OCEANOL ACTA, V21, P655, DOI 10.1016/S0399-1784(98)90007-X; ANDERSEN V, 1994, J PLANKTON RES, V16, P337, DOI 10.1093/plankt/16.4.337; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MI, AUSTRAL ECOL, V26, P32; ANDERSON PAV, 1985, B MAR SCI, V37, P460; ANDERSON PAV, 1977, SCIENCE, V197, P186, DOI 10.1126/science.17918; Apablaza P, 2006, INVEST MAR, V34, P83; ARKETT SA, 1985, BIOL BULL-US, V169, P297, DOI 10.2307/1541483; Baumgartner MF, 2011, MAR ECOL PROG SER, V423, P167, DOI 10.3354/meps08931; BERNER LD, 1961, LIMNOL OCEANOGR, V6, P205, DOI 10.4319/lo.1961.6.2.0205; Bigelow E. B., 1937, Report on the Danish Oceanographical Expeditions 1908-10 to the Mediterranean, V2, P1; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boltovskoy D, 2002, OCEANOL ACTA, V25, P271, DOI 10.1016/S0399-1784(02)01199-4; Boltovskoy D., 1999, S ATLANTIC ZOOPLANKT; Brandini FP, 2014, CONT SHELF RES, V89, P61, DOI 10.1016/j.csr.2013.08.002; Chae J, 2008, J ENVIRON BIOL, V29, P585; Cohen JH, 2009, OCEANOGR MAR BIOL, V47, P77; Cottier FR, 2006, LIMNOL OCEANOGR, V51, P2586, DOI 10.4319/lo.2006.51.6.2586; Daniel R., 1977, SPECIAL PUBLICATION, P124; de Castro B. M, 2006, AMBIENTE OCEANOGRAFI, P11; Esnal Graciela B., 1999, P1409; Falkenhaug T, 1996, MAR ECOL PROG SER, V140, P59, DOI 10.3354/meps140059; Frank TM, 1997, J PLANKTON RES, V19, P1975, DOI 10.1093/plankt/19.12.1975; Gibbons MJ, 1997, J MAR BIOL ASSOC UK, V77, P493, DOI 10.1017/S0025315400071824; Gibson DM, 2002, J PLANKTON RES, V24, P703, DOI 10.1093/plankt/24.7.703; Gibson DM, 2000, J PLANKTON RES, V22, P1485, DOI 10.1093/plankt/22.8.1485; Guerrero E, 2013, MAR ECOL-EVOL PERSP, V34, P71, DOI 10.1111/maec.12027; Haraldsson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086595; HARBISON GR, 1979, LIMNOL OCEANOGR, V24, P1081, DOI 10.4319/lo.1979.24.6.1081; HARDY AC, 1947, J MAR BIOL ASSOC UK, V26, P467, DOI 10.1017/S0025315400013722; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; HIROTA J, 1974, FISH B-NOAA, V72, P295; Huber AMR, 2011, LIMNOL OCEANOGR, V56, P695, DOI 10.4319/lo.2011.56.2.0695; HUNTLEY M, 1982, MAR BIOL, V71, P23, DOI 10.1007/BF00396989; JOHANNESSEN OM, 1968, CONTRIBUTIONS I OCEA, V10, P1; Kaartvedt S, 2011, LIMNOL OCEANOGR, V56, P2189, DOI 10.4319/lo.2011.56.6.2189; Larson RJ, 1986, STUD FAUNA CURACAO C, V213, P191; LAVAL P, 1992, MAR ECOL PROG SER, V79, P235; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Liu SH, 2003, J PLANKTON RES, V25, P1069, DOI 10.1093/plankt/25.9.1069; Lopes RM, 2007, AN ACAD BRAS CIENC, V79, P369, DOI 10.1590/S0001-37652007000300002; Lucic D, 2011, ACTA ADRIAT, V52, P159; Lucic D, 2009, MAR ECOL-EVOL PERSP, V30, P16, DOI 10.1111/j.1439-0485.2008.00264.x; Macias D, 2010, MAR ECOL PROG SER, V408, P79, DOI 10.3354/meps08566; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Matsuura Y., 1985, CULTURA, V38, P1439, DOI DOI 10.1590/S0102-261X2009000100007; Menard F, 1997, OCEANOL ACTA, V20, P733; MILLS CE, 1983, J PLANKTON RES, V5, P619, DOI 10.1093/plankt/5.5.619; MOORE HILARY B., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V2, P559; Moreira G.S., 1973, PUBLICATIONS SETO MA, V20, P537; MUSAEVA E I, 1971, Okeanologiya, V11, P1098; Musaeva E.I., 1976, Trudy Instituta Okeanologii Akademii Nauk SSSR, V105, P171; Mutlu E, 1999, MAR BIOL, V135, P603, DOI 10.1007/s002270050661; Mutlu E, 1999, MAR BIOL, V135, P589, DOI 10.1007/s002270050660; Nagata RM, 2014, J MAR BIOL ASSOC UK, V94, P1387, DOI 10.1017/S0025315414000617; Neumann-Leitao S, 2008, J PLANKTON RES, V30, P795, DOI 10.1093/plankt/fbn040; Nogueira M, 2014, CONT SHELF RES, V89, P93, DOI 10.1016/j.csr.2014.02.022; Oliveira OMP, 2010, 3 INT JELL BLOOMS S, P85; PAFFENHOFER GA, 1995, CONT SHELF RES, V15, P255, DOI 10.1016/0278-4343(94)E0004-6; PAGES F, 1992, S AFR J ZOOL, V27, P50, DOI 10.1080/02541858.1992.11448262; PAGES F, 1994, POLAR BIOL, V14, P243; PAGES F, 1991, HYDROBIOLOGIA, V216, P355, DOI 10.1007/BF00026486; PALMA S, 1985, INVEST PESQ, V49, P261; PALMA S, 2004, INVEST MAR, V32, P47; Patriti G., 1964, Recueil des Travaux de la Station Marine de l'Endoume, VNo. 51, P185; Pearre S, 2003, BIOL REV, V78, P1, DOI 10.1017/S146479310200595X; PEARRE S JR, 1979, Journal of Plankton Research, V1, P29, DOI 10.1093/plankt/1.1.29; Pernica P., 2013, LIMNOL OCEANOGR FLUI, V3, P279, DOI DOI 10.1215/21573689-2409149; Pierrot-Bults A.C., 2003, Zoologische Verhandelingen (Leiden), V345, P297; PUGH PR, 1984, PROG OCEANOGR, V13, P461, DOI 10.1016/0079-6611(84)90016-8; PUGH PR, 1974, J MAR BIOL ASSOC UK, V54, P25, DOI 10.1017/S0025315400022086; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Ralston DK, 2007, J PLANKTON RES, V29, P803, DOI 10.1093/plankt/fbm061; Rinke K, 2007, FRESHWATER BIOL, V52, P137, DOI 10.1111/j.1365-2427.2006.01687.x; ROE HSJ, 1984, PROG OCEANOGR, V13, P425, DOI 10.1016/0079-6611(84)90015-6; Russell F. S., 1925, Journal of the Marine Biological Association Plymouth NS, V13, P769; Sainmont J, 2013, THEOR ECOL-NETH, V6, P241, DOI 10.1007/s12080-012-0174-0; Saltzman J, 1997, DEEP-SEA RES PT I, V44, P931, DOI 10.1016/S0967-0637(97)00006-X; Sardou J, 1996, OCEANOL ACTA, V19, P645; Schlitzer R., 2012, OCEAN DATA VIEW; Sekino T, 1999, EVOL ECOL, V13, P267, DOI 10.1023/A:1006797101565; Tamaki A, 2010, ESTUAR COAST SHELF S, V86, P125, DOI 10.1016/j.ecss.2009.11.005; Tew KS, 2005, MAR ECOL PROG SER, V292, P181, DOI 10.3354/meps292181; TSUDA A, 1992, DEEP-SEA RES, V39, pS219, DOI 10.1016/S0198-0149(11)80013-0; UYE S, 1990, MAR BIOL, V104, P389, DOI 10.1007/BF01314341; Vannucci M., 1963, S Bol Inst oceanogr S Paulo, V13, P143; Vereshchaka AL, 2002, OCEANOLOGY+, V42, P811; Vinogradov M. E., 1970, VERTICAL DISTRIBUTIO; VINOGRADOV ME, 1985, MAR BIOL, V89, P95, DOI 10.1007/BF00392881; WIEBE PH, 1979, MAR BIOL, V53, P249, DOI 10.1007/BF00952433; Zar JH., 2010, BIOSTAT ANAL, V5th	98	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144161	10.1371/journal.pone.0144161	http://dx.doi.org/10.1371/journal.pone.0144161			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637179	gold, Green Submitted, Green Published			2022-12-26	WOS:000366143800051
J	Anstoetz, M; Rose, TJ; Clark, MW; Yee, LH; Raymond, CA; Vancov, T				Anstoetz, Manuela; Rose, Terry J.; Clark, Malcolm W.; Yee, Lachlan H.; Raymond, Carolyn A.; Vancov, Tony			Novel Applications for Oxalate-Phosphate-Amine Metal-Organic-Frameworks (OPA-MOFs): Can an Iron-Based OPA-MOF Be Used as Slow-Release Fertilizer?	PLOS ONE			English	Article							ENHANCED EFFICIENCY FERTILIZERS; AMMONIA VOLATILIZATION; PHOSPHORUS; NITROGEN; SOIL; MAIZE; ACCUMULATION; MOBILIZATION; AGRICULTURE; RHIZOSPHERE	A porous iron-based oxalate-phosphate-amine metal-organic framework material (OPA-MOF) was investigated as a microbially-induced slow-release nitrogen (N) and phosphorus (P) fertilizer. Seedling growth, grain yields, nutrient uptake of wheat plants, and soil dynamics in incubated soil, were investigated using OPA-MOF vs standard P (triple-superphosphate) and N (urea) fertilizers in an acidic Ferralsol at two application rates (equivalent 120 and 40 kg N ha(-1)). While urea hydrolysis in the OPA-MOF treatment was rapid, conversion of ammonium to nitrate was significantly inhibited compared to urea treatment. Reduced wheat growth in OPA-MOF treatments was not caused by N-deficiency, but by limited P-bioavailability. Two likely reasons were slow P-mobilisation from the OPA-MOF or rapid P-binding in the acid soil. P-uptake and yield in OPA-MOF treatments were significantly higher than in nil-P controls, but significantly lower than in conventionally-fertilised plants. OPA-MOF showed potential as enhanced efficiency N fertilizer. However, as P-bioavailability was insufficient to meet plant demands, further work should determine if P-availability may be enhanced in alkaline soils, or whether central ions other than Fe, forming the inorganic metal-P framework in the MOF, may act as a more effective P-source in acid soils.	[Anstoetz, Manuela; Clark, Malcolm W.; Yee, Lachlan H.] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Clark, Malcolm W.; Yee, Lachlan H.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia; [Rose, Terry J.; Raymond, Carolyn A.; Vancov, Tony] So Cross Univ, Southern Cross Plant Sci, Lismore, NSW 2480, Australia; [Vancov, Tony] Wollongbar Primary Ind Inst, NSW Dept Primary Ind, Wollongbar, NSW 2477, Australia	Southern Cross University; Southern Cross University; Southern Cross University; NSW Department of Primary Industries	Anstoetz, M (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	manuela.anstoetz@scu.edu.au	Vancov, Tony/Q-4142-2019; Vancov, Tony/A-6408-2010; Yee, Lachlan H./B-6856-2008; Raymond, Carolyn A/P-4764-2017; Clark, M W/Q-4875-2017	Vancov, Tony/0000-0001-5227-7405; Yee, Lachlan H./0000-0002-7258-2076; Raymond, Carolyn A/0000-0003-2887-9267; Rose, Terry/0000-0001-5386-6818; Anstoetz, Manuela/0000-0002-0580-5786	Grains Research and Development Corporation Grant [51426]; Australian Postgraduate Award - Australian Government Department of Education and Training	Grains Research and Development Corporation Grant(Grains R&D Corp); Australian Postgraduate Award - Australian Government Department of Education and Training	This work was supported by Grains Research and Development Corporation Grant Project No 51426 (http://www.grdc.com.au/). MA was funded by an Australian Postgraduate Award (3.5 years), a scholarship for living support granted by the Australian Government Department of Education and Training (https://education.gov.au/australian-postgraduate-awards). The funders had a role in the decision to publish (publishing results was part of the grant agreement); the funders had no role in data collection and analysis, or preparation of the manuscript.	Abu-Shandi K, 2003, CRYSTENGCOMM, P180, DOI 10.1039/b303498d; Ahmed OH, 2010, INT J PHYS SCI, V5, P2198; Ahmed OH, 2008, ACTA AGR SCAND B-S P, V58, P182, DOI 10.1080/09064710701478271; Alef K, 1995, METHODS APPL SOIL MI; Barroso CB, 2006, BRAZ J MICROBIOL, V37, P434, DOI 10.1590/S1517-83822006000400006; Bovill WD, 2013, CROP PASTURE SCI, V64, P179, DOI 10.1071/CP13135; Brady N.C, 2000, NATURE PROPERTIES SO; Cailleau G, 2004, NATURWISSENSCHAFTEN, V91, P191, DOI 10.1007/s00114-004-0512-1; Certini G, 2000, J PLANT NUTR SOIL SC, V163, P173, DOI 10.1002/(SICI)1522-2624(200004)163:2<173::AID-JPLN173>3.0.CO;2-H; Chalk PM, 2015, NUTR CYCLING AGROECO; Chang WJ, 2001, J SOLID STATE CHEM, V157, P233, DOI 10.1006/jssc.2000.9081; Chen D, 2008, AUST J SOIL RES, V46, P289, DOI 10.1071/SR07197; Chen DL, 2010, SOIL BIOL BIOCHEM, V42, P660, DOI 10.1016/j.soilbio.2009.12.014; Choudhury A, 1999, J MATER CHEM, V9, P3113, DOI 10.1039/a906663b; Choudhury A, 2000, CHEM-EUR J, V6, P1168, DOI 10.1002/(SICI)1521-3765(20000403)6:7<1168::AID-CHEM1168>3.3.CO;2-J; Clemente-Leon M, 2008, INORG CHEM, V47, P9111, DOI 10.1021/ic801165b; de Magalhaes JV, 1998, J PLANT NUTR, V21, P1753, DOI 10.1080/01904169809365520; Echigo T, 2010, CAN MINERAL, V48, P1329, DOI 10.3749/canmin.48.5.1329; Ehlers K, 2010, SOIL BIOL BIOCHEM, V42, P558, DOI 10.1016/j.soilbio.2009.11.025; Farha OK, 2010, ACCOUNTS CHEM RES, V43, P1166, DOI 10.1021/ar1000617; He ZL, 1999, SOIL SCI, V164, P750, DOI 10.1097/00010694-199910000-00006; Husson O, 2013, PLANT SOIL, V362, P389, DOI 10.1007/s11104-012-1429-7; International V, 2014, GENSTAT WINDOWS; Jiang YC, 2003, CHEM MATER, V15, P1633, DOI 10.1021/cm021701t; JONES DL, 1994, PLANT SOIL, V166, P247, DOI 10.1007/BF00008338; Lucassen ECHET, 2004, BIOGEOCHEMISTRY, V67, P249, DOI 10.1023/B:BIOG.0000015342.40992.cb; Mandal S, 2007, CHEM-EUR J, V13, P968, DOI 10.1002/chem.200601026; Maspoch D, 2007, CHEM SOC REV, V36, P770, DOI 10.1039/b501600m; MOODY PW, 1994, AUST J SOIL RES, V32, P1015, DOI 10.1071/SR9941015; Neeraj S, 2001, J CHEM SOC DALTON, P289, DOI 10.1039/b007980o; Rao S. N. S., 1999, SOIL MICROBIOLOGY; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Rayment G.E., 2011, SOIL CHEM METHODS AU; Reuter DJ., 1997, PLANT ANAL INTERPRET, P241, DOI 10.1071/9780643101265; Rochester I, 2015, CROP PASTURE SCI, V66, P689, DOI 10.1071/CP14301; ROMER W, 1986, PLANT SOIL, V91, P221, DOI 10.1007/BF02181789; Rose TJ, 2007, J PLANT NUTR SOIL SC, V170, P404, DOI 10.1002/jpln.200625163; Rose TJ, 2010, PLANT SOIL, V326, P159, DOI 10.1007/s11104-009-9990-4; Rose TJ, 2013, MATCHING SOIL NUTR S; Scharer M, 2009, EUR J SOIL SCI, V60, P386, DOI 10.1111/j.1365-2389.2009.01135.x; Smieja-Krol B, 2014, ENVIRON SCI POLLUT R, V21, P7227, DOI 10.1007/s11356-014-2700-7; Strom L, 2002, SOIL BIOL BIOCHEM, V34, P703, DOI 10.1016/S0038-0717(01)00235-8; Stumm W, 1995, AQUATIC CHEM CHEM EQ, V3rd, DOI [DOI 10.1094/ASBCMOA-BEER-13, 10.1094/asbcmoa-beer-13]; Timilsena YP, 2015, J SCI FOOD AGR, V95, P1131, DOI 10.1002/jsfa.6812; Van Zwieten L, 2015, PLANT SOIL, V395, P7, DOI 10.1007/s11104-015-2427-3; Vandamme E, 2014, NUTR CYCL AGROECOSYS, V98, P187, DOI 10.1007/s10705-014-9605-1; Vu DT, 2008, PLANT SOIL, V304, P21, DOI 10.1007/s11104-007-9516-x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zerulla W, 2001, BIOL FERT SOILS, V34, P79, DOI 10.1007/s003740100380	49	32	34	8	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144169	10.1371/journal.pone.0144169	http://dx.doi.org/10.1371/journal.pone.0144169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633174	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000065
J	Benedict, KM; Gow, SP; McAllister, TA; Booker, CW; Hannon, SJ; Checkley, SL; Noyes, NR; Morley, PS				Benedict, Katharine M.; Gow, Sheryl P.; McAllister, Tim A.; Booker, Calvin W.; Hannon, Sherry J.; Checkley, Sylvia L.; Noyes, Noelle R.; Morley, Paul S.			Antimicrobial Resistance in Escherichia coli Recovered from Feedlot Cattle and Associations with Antimicrobial Use	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; WESTERN CANADA; HUMAN HEALTH; MANNHEIMIA-HAEMOLYTICA; UNDIFFERENTIATED FEVER; ANIMAL ORIGIN; FOOD ANIMALS; BACTERIA; CALVES; SUSCEPTIBILITY	The objectives of this study were to estimate the prevalence of antimicrobial resistance (AMR) and to investigate the associations between exposures to antimicrobial drugs (AMDs) and AMR in fecal non-type specific Escherichia coli (NTSEC) recovered from a large population of feedlot cattle. Two-stage random sampling was used to select individually identified cattle for enrollment, which were sampled at arrival and then a second time later in the feeding period. Advanced regression techniques were used to estimate resistance prevalences, and to investigate associations between AMD exposures in enrolled cattle and penmates and AMR identified in NTSEC recovered from the second sample set. Resistance was most commonly detected to tetracycline, streptomycin, and sulfisoxazole, and was rarely identified for critically important AMDs. All cattle were exposed to AMDs in feed, and 45% were treated parenterally. While resistance prevalence generally increased during the feeding period, most AMD exposures were not significantly associated with AMR outcomes. Exposures of enrolled cattle to tetracycline were associated with increased resistance to tetracycline and trimethoprim sulfa, while beta-lactam exposures were associated with decreased likelihood of detecting streptomycin resistance. Pen-level AMD exposure measures were not associated with resistance outcomes. These findings suggest that tetracycline treatment of feedlot cattle can be associated with modest increases in risk for recovery of resistant NTSEC, but the numerous treatments with an advanced macrolide (tulathromycin) were not associated with detectable increases in resistance in NTSEC. All cattle were exposed to in-feed treatments of tetracycline and this could limit the ability to identify the full impact of these exposures, but these exposures varied for enrolled cattle varied, providing an opportunity to evaluate a dose response. While AMD exposures were not associated with detectably increased risks for resistance to critically important AMDs, rare resistance outcomes and infrequent exposure to other important AMDs (e.g., cephalosporins) limited our ability to rigorously investigate questions regarding factors that can influence resistance to these important AMDs.	[Benedict, Katharine M.; Noyes, Noelle R.; Morley, Paul S.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA; [Gow, Sheryl P.] Univ Saskatchewan, Lab Foodborne Zoonoses, Publ Hlth Agcy Canada, Saskatoon, SK, Canada; [McAllister, Tim A.] Univ Lethbridge, Lethbridge Res Ctr, Lethbridge, AB T1K 3M4, Canada; [Booker, Calvin W.; Hannon, Sherry J.] Feedlot Hlth Management Serv Ltd, Okotoks, AB, Canada; [Checkley, Sylvia L.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	Colorado State University; Public Health Agency of Canada; University of Saskatchewan; University of Lethbridge; University of Calgary	Morley, PS (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.	paul.morley@colostate.edu	Morley, Paul/T-1721-2019; Morley, Paul S/C-9960-2009; McAllister, Tim A./R-9201-2017	Morley, Paul S/0000-0001-8138-2714; McAllister, Tim A./0000-0002-8266-6513; Checkley, Sylvia/0000-0002-9118-2721; Noyes, Noelle/0000-0001-6149-1008	Advancing Canadian Agriculture and Agri-Food (ACAAF) Program; Alberta Beef Producers [0007- 038RDB]; Canadian Cattlemen's Association, Beef Cattle Research Council [BCRC 6.41]; Public Health Agency of Canada; Colorado State University	Advancing Canadian Agriculture and Agri-Food (ACAAF) Program(Agriculture & Agri Food Canada); Alberta Beef Producers; Canadian Cattlemen's Association, Beef Cattle Research Council; Public Health Agency of Canada; Colorado State University	This research was supported by grants from the Advancing Canadian Agriculture and Agri-Food (ACAAF) Program, http://www.agr.gc.ca/eng/?id=1251739303866, 2006-2011; from the Alberta Beef Producers, http://www.albertabeef.org/, 2006-2008 (Project Number 0007- 038RDB); and from the Canadian Cattlemen's Association, Beef Cattle Research Council, http://www.beefresearch.ca/, 2006-2008 (Project Number BCRC 6.41). The Public Health Agency of Canada (http://www.phac-aspc.gc.ca/lfz-llczoa/) provided additional funding for broth microdilution susceptibility testing and to support data analysis and report preparation. Publication costs were provided by the Colorado State University Libraries Open Access Research and Scholarship Fund. Dr. Gow is employed by the Public Health Agency of Canada and was involved in this research as part of her duties assigned by that government agency. She was substantively involved in the study design, conduct, analysis, and reporting of this research. Drs. Booker and Hannon are affiliated with the commercial company Feedlot Health Management Services, Ltd. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. They were substantively involved in the study design, conduct, analysis, and reporting of this research.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akwar HT, 2008, CAN J VET RES, V72, P202; Alexander TW, 2008, VET MICROBIOL, V130, P165, DOI 10.1016/j.vetmic.2008.01.001; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Barton MD, 1998, AUST VET J, V76, P177, DOI 10.1111/j.1751-0813.1998.tb10124.x; Benedict KM, 2014, EPIDEMIOL INFECT, V142, P2314, DOI 10.1017/S0950268813003300; Benedict KM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-216; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; Booker CW, 2007, VET THER, V8, P183; Booker CW, 1999, CAN VET J, V40, P40; Bywater R, 2006, VET MICROBIOL, V118, P158, DOI 10.1016/j.vetmic.2006.09.005; Caprioli A, 2000, INT J ANTIMICROB AG, V14, P295, DOI 10.1016/S0924-8579(00)00140-0; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Checkley SL, 2008, CAN J VET RES, V72, P101; Checkley SL, 2010, CAN VET J, V51, P853; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; McDermott PF, 2002, ANIM BIOTECHNOL, V13, P71, DOI 10.1081/ABIO-120005771; McGeer AJ, 1998, CAN MED ASSOC J, V159, P1119; Morley PS, 2011, FOODBORNE PATHOG DIS, V8, P87, DOI 10.1089/fpd.2010.0632; National Research Council Subcommittee on Beef Cattle Nutrition, 2000, NUTR REQ BEEF CATTL, Vxiv; Noyes N, 2015, EPIDEMIOL I IN PRESS; Noyes NR, 2014, J VET INTER IN PRESS; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Platt TM, 2008, AM J VET RES, V69, P988, DOI 10.2460/ajvr.69.8.988; Rao S, 2010, FOODBORNE PATHOG DIS, V7, P449, DOI 10.1089/fpd.2009.0400; Schunicht OC, 2002, CAN VET J, V43, P940; Schunicht OC, 2002, CAN VET J, V43, P355; Simjee S, 2008, J ANTIMICROB CHEMOTH, V61, P228, DOI 10.1093/jac/dkm423; Singer RS, 2014, CURR OPIN MICROBIOL, V19, P1, DOI 10.1016/j.mib.2014.05.014; Thibodeau A, 2008, CAN J VET RES, V72, P129; Wagner BA, 2003, AM J VET RES, V64, P1570, DOI 10.2460/ajvr.2003.64.1570; Witte W, 2000, INT J ANTIMICROB AG, V14, P321, DOI 10.1016/S0924-8579(00)00144-8	38	31	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143995	10.1371/journal.pone.0143995	http://dx.doi.org/10.1371/journal.pone.0143995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633649	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000039
J	De, P; Amin, AG; Valli, E; Perkins, MD; McNeil, M; Chatterjee, D				De, Prithwiraj; Amin, Anita G.; Valli, Eloise; Perkins, Mark D.; McNeil, Michael; Chatterjee, Delphi			Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CELL-WALL; DIAGNOSIS; MTB/RIF; LAM; DNA	Globally, tuberculosis is slowly declining each year and it is estimated that 37 million lives were saved between 2000 and 2013 through effective diagnosis and treatment. Currently, diagnosis relies on demonstration of the bacteria, Mycobacterium tuberculosis (Mtb), in clinical specimens by serial sputum microscopy, culture and molecular testing. Commercial immunoassay lateral flow kits developed to detect Mtb lipoglycan lipoarabinomannan (LAM) in urine as a marker of active TB exhibit poor sensitivity, especially in immunocompetent individuals, perhaps due to low abundance of the analyte. Our present study was designed to develop methods to validate the presence of LAM in a quantitative fashion in human urine samples obtained from culture-confirmed TB patients. Herein we describe, a consolidated approach for isolating LAM from the urine and quantifying D-arabinose as a proxy for LAM, using Gas Chromatography/Mass Spectrometry. 298 urine samples obtained from a repository were rigorously analyzed and shown to contain varying amounts of LAM-equivalent ranging between similar to 10-40 ng/mL. To further substantiate that D-arabinose detected in the samples originated from LAM, tuberculostearic acid, the unique 10-methyloctadecanoic acid present at the phosphatidylinositol end of LAM was also analyzed in a set of samples and found to be present confirming that the D-arabinose was indeed derived from LAM. Among the 144 samples from culture-negative TB suspects, 30 showed presence of D-arabinose suggesting another source of the analyte, such as disseminated TB or from non-tuberculosis mycobacterium. Our work validates that LAM is present in the urine samples of culture-positive patients in small but readily detectable amounts. The study further substantiates LAM in urine as a powerful biomarker for active tuberculosis.	[De, Prithwiraj; Amin, Anita G.; McNeil, Michael; Chatterjee, Delphi] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Valli, Eloise; Perkins, Mark D.] FIND, CH-1202 Geneva, Switzerland	Colorado State University; Foundation For Innovative New Diagnostics	Chatterjee, D (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, 1682 Campus Delivery, Ft Collins, CO 80523 USA.	Delphi.Chatterjee@colostate.edu	McNeil, Michael/G-3325-2019; De, Prithwiraj/S-1199-2019	De, Prithwiraj/0000-0003-4499-2147; Valli, Eloise/0000-0002-1499-3176	Bill and Melinda Gates Foundation [OPP1039621]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill and Melinda Gates Foundation funded the OPP1039621 under which the study was undertaken. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhamidi S, 2012, ANAL BIOCHEM, V421, P240, DOI 10.1016/j.ab.2011.10.046; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; Finley-Jones HJ, 2008, J ANAL ATOM SPECTROM, V23, P1214, DOI 10.1039/b804048f; Gardiner JL, 2015, J EXP MED, V212, P1759, DOI 10.1084/jem.20151468; HALL CL, 1979, ANNU REV MED, V30, P199, DOI 10.1146/annurev.me.30.020179.001215; Hamasur B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123457; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; LARSSON L, 1987, J CLIN MICROBIOL, V25, P893, DOI 10.1128/JCM.25.5.893-896.1987; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; LEOPOLD K, 1993, ANAL BIOCHEM, V208, P57, DOI 10.1006/abio.1993.1008; Lindqvist L, 1997, J CHROMATOGR A, V767, P325, DOI 10.1016/S0021-9673(96)01062-X; Peter JG, 2012, INT J TUBERC LUNG D, V16, P1108, DOI 10.5588/ijtld.11.0614; Peter JG, 2012, LANCET INFECT DIS, V12, P825, DOI 10.1016/S1473-3099(12)70220-7; Petrone L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/589471; Petrone L, 2014, J INFECTION, V68, P591, DOI 10.1016/j.jinf.2014.02.008; Petrucci R, 2015, J CLIN MICROBIOL, V53, P336, DOI 10.1128/JCM.02548-14; Ruiz-Matute AI, 2011, J CHROMATOGR B, V879, P1226, DOI 10.1016/j.jchromb.2010.11.013; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; Small PM, 2010, NEW ENGL J MED, V363, P1070, DOI 10.1056/NEJMe1008496; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Treumann A, 2002, J MOL BIOL, V316, P89, DOI 10.1006/jmbi.2001.5317; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Wood R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-47; World Health Organization, 2014, GLOB TUB REP	33	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144088	10.1371/journal.pone.0144088	http://dx.doi.org/10.1371/journal.pone.0144088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633829	gold, Green Submitted, Green Published			2022-12-26	WOS:000366040000054
J	Lee, JS; Jeong, SW; Cho, SW; Juhn, JP; Kim, KW				Lee, Jun-Seok; Jeong, Seo-Won; Cho, Sung-Wook; Juhn, Joon-Pyo; Kim, Ki-Won			Relationship between Initial Telomere Length, Initial Telomerase Activity, Age, and Replicative Capacity of Nucleus Pulposus Chondrocytes in Human Intervertebral Discs: What Is a Predictor of Replicative Potential?	PLOS ONE			English	Article							DONOR AGE; LIFE-SPAN; IN-VITRO; CELLS; DEGENERATION; SENESCENCE; MODEL; TRANSPLANTATION; EXPRESSION; ORIGIN	There is evidence that telomere length (TL), telomerase activity (TA), and age are related to the replicative potential of human nucleus pulposus chondrocytes (NPCs). However, it has not yet been established if any of these factors can serve as predictors of the replicative potential of NPCs. To establish predictors of the replicative potential of NPCs, we evaluated potential relationships between replicative capacity of NPCs, initial TL (telomere length at the first passage), initial TA (telomerase activity at the first passage), and age. Nucleus pulposus specimens were obtained from 14 patients of various ages undergoing discectomy. NPCs were serially cultivated until the end of their replicative lifespans. Relationships among cumulative population doubling level (PDL), initial TL, initial TA, and age were analyzed. Initial TA was negatively correlated with age (r = -0.674, P = 0.008). However, no correlation between initial TL and age was observed. Cumulative PDL was also negatively correlated with age (r = -0.585, P = 0.028). Although the cumulative PDL appeared to increase with initial TL or initial TA, this trend was not statistically significant. In conclusion, age is the sole predictor of the replicative potential of human NPCs, and replicative potential decreases with age. Initial TL and initial TA are not predictors of replicative potential, and can serve only as reference values.	[Lee, Jun-Seok; Cho, Sung-Wook; Juhn, Joon-Pyo; Kim, Ki-Won] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Lee, Jun-Seok; Jeong, Seo-Won; Kim, Ki-Won] Catholic Univ Korea, Med Res Inst, Yeouido St Marys Hosp, Dept Orthoped Res, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, JS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Dept Orthoped Surg, Coll Med, Seoul, South Korea.	junband@naver.com			Catholic Medical Research Foundation	Catholic Medical Research Foundation	This work was supported by the Catholic Medical Research Foundation: JSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the Catholic Medical Research Foundation.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bojesen SE, 2013, J INTERN MED, V274, P399, DOI 10.1111/joim.12083; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chung SA, 2007, SPINE, V32, P1188, DOI 10.1097/BRS.0b013e31805471a3; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Del Bufalo D, 2005, CELL DEATH DIFFER, V12, P1429, DOI 10.1038/sj.cdd.4401670; Demerath EW, 2004, HUM BIOL, V76, P127, DOI 10.1353/hub.2004.0018; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Gruber HE, 2002, SPINE, V27, P1626, DOI 10.1097/00007632-200208010-00007; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hegewald AA, 2011, J TISSUE ENG REGEN M, V5, P275, DOI 10.1002/term.312; Hiyama A, 2008, J ORTHOP RES, V26, P589, DOI 10.1002/jor.20584; Imai Y, 2007, SPINE, V32, P1303, DOI 10.1097/BRS.0b013e3180593238; Jeong SW, 2014, SPINE J, V14, P499, DOI 10.1016/j.spinee.2013.06.099; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Karavassilis Maria E, 2013, Longev Healthspan, V2, P3, DOI 10.1186/2046-2395-2-3; Kim KW, 2008, ASIAN SPINE J, V2, P1, DOI 10.4184/asj.2008.2.1.1; Kim KW, 2009, SPINE J, V9, P658, DOI 10.1016/j.spinee.2009.04.018; Kim KW, 2005, SPINE, V30, P1373, DOI 10.1097/01.brs.0000166155.48168.0e; Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005; Ksiazek K, 2007, EXP GERONTOL, V42, P840, DOI 10.1016/j.exger.2007.04.012; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af; Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Murillo-Ortiz B, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-99; Okuma M, 2000, J ORTHOPAED RES, V18, P988, DOI 10.1002/jor.1100180620; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Parsch D, 2002, ARTHRITIS RHEUM, V46, P2911, DOI 10.1002/art.10626; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rodrigues-Pinto R, 2014, EUR SPINE J, V23, P1803, DOI 10.1007/s00586-014-3305-z; Saretzki G, 2002, ANN NY ACAD SCI, V959, P24, DOI 10.1111/j.1749-6632.2002.tb02079.x; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Sobajima S, 2008, SPINE J, V8, P888, DOI 10.1016/j.spinee.2007.09.011; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wu JH, 2014, J ORTHOP RES, V32, P159, DOI 10.1002/jor.22474; Wu JH, 2011, TISSUE ENG PT A, V17, P2407, DOI [10.1089/ten.tea.2011.0132, 10.1089/ten.TEA.2011.0132]; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yang LQ, 2001, MECH AGEING DEV, V122, P1685, DOI 10.1016/S0047-6374(01)00280-9; Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144177	10.1371/journal.pone.0144177	http://dx.doi.org/10.1371/journal.pone.0144177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633809	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000068
J	Millares, L; Perez-Brocal, V; Ferrari, R; Gallego, M; Pomares, X; Garcia-Nunez, M; Monton, C; Capilla, S; Monso, E; Moya, A				Millares, Laura; Perez-Brocal, Vicente; Ferrari, Rafaela; Gallego, Miguel; Pomares, Xavier; Garcia-Nunez, Marian; Monton, Concepcion; Capilla, Silvia; Monso, Eduard; Moya, Andres			Functional Metagenomics of the Bronchial Microbiome in COPD	PLOS ONE			English	Article							LUNG-CANCER; COMMUNITY; EXACERBATIONS; PATHOGENESIS; DYNAMICS; RESOURCE; DATABASE; THERAPY; NUMBER; RISK	The course of chronic obstructive pulmonary disease (COPD) is frequently aggravated by exacerbations, and changes in the composition and activity of the microbiome may be implicated in their appearance. The aim of this study was to analyse the composition and the gene content of the microbial community in bronchial secretions of COPD patients in both stability and exacerbation. Taxonomic data were obtained by 16S rRNA gene amplification and pyrosequencing, and metabolic information through shotgun metagenomics, using the Metagenomics RAST server (MG-RAST), and the PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) programme, which predict metagenomes from 16S data. Eight severe COPD patients provided good quality sputum samples, and no significant differences in the relative abundance of any phyla and genera were found between stability and exacerbation. Bacterial biodiversity (Chao1 and Shannon indexes) did not show statistical differences and beta-diversity analysis (Bray-Curtis dissimilarity index) showed a similar microbial composition in the two clinical situations. Four functional categories showed statistically significant differences with MG-RAST at KEGG level 2: in exacerbation, Cell growth and Death and Transport and Catabolism decreased in abundance [1.6 (0.2-2.3) vs 3.6 (3.3-6.9), p = 0.012; and 1.8 (0-3.3) vs 3.6 (1.8-5.1), p = 0.025 respectively], while Cancer and Carbohydrate Metabolism increased [0.8 (0-1.5) vs 0 (0-0.5), p = 0.043; and 7 (6.4-9) vs 5.9 (6.3-6.1), p = 0.012 respectively]. In conclusion, the bronchial microbiome as a whole is not significantly modified when exacerbation symptoms appear in severe COPD patients, but its functional metabolic capabilities show significant changes in several pathways.	[Millares, Laura; Garcia-Nunez, Marian] Fundacio Parc Tauli, Sabadell, Spain; [Millares, Laura; Pomares, Xavier; Garcia-Nunez, Marian; Monton, Concepcion; Monso, Eduard] CIBERES, CIBER Enfermedades Resp, Bunyola, Spain; [Millares, Laura; Garcia-Nunez, Marian; Monso, Eduard] Univ Autonoma Barcelona, Esfera UAB, E-08193 Barcelona, Spain; [Millares, Laura; Garcia-Nunez, Marian] Fundacio Insitut Invest Germans Trias & Pujol, Badalona, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Genom & Hlth Area, Valencia, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] CIBERESP, Barcelona, Spain; [Perez-Brocal, Vicente; Ferrari, Rafaela; Moya, Andres] Univ Valencia, ICBiBE, Evolutionary Genet Unit, Valencia, Spain; [Gallego, Miguel; Pomares, Xavier; Monton, Concepcion; Monso, Eduard] Hosp Univ Parc Tauli, Dept Resp Med, Sabadell, Spain; [Capilla, Silvia] Hosp Univ Parc Tauli, Dept Microbiol, Sabadell, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Valencia; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Millares, L (corresponding author), Fundacio Parc Tauli, Sabadell, Spain.	lmillares@tauli.cat	Garcia, Marian/GXN-2696-2022; FERRARI, RAFAELA/ABB-7060-2020; Moya, Andrés/A-8190-2008; Garcia, Marian/F-9170-2013; Perez Brocal, Vicente/K-3627-2014	FERRARI, RAFAELA/0000-0002-5243-2695; Moya, Andrés/0000-0002-2867-1119; Garcia, Marian/0000-0002-5158-3758; Perez Brocal, Vicente/0000-0002-1927-9676; Capilla, Silvia/0000-0002-7274-2973; Pomares, Xavier/0000-0002-2783-414X	Sociedad Catalana de Neumologia; Fundacio Catalana de Neumologia; Fundacio Parc Tauli; Marato de TV3; Sociedad Espanola de Neumologia y Cirugia Toracica; Fundacion Menarini; Ministerio de Economia y Competitividad (Spain) [SAF2012-31187]; Generalitat Valenciana (Spain) [Prometeo/2009/092]; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	Sociedad Catalana de Neumologia; Fundacio Catalana de Neumologia; Fundacio Parc Tauli; Marato de TV3; Sociedad Espanola de Neumologia y Cirugia Toracica; Fundacion Menarini(Menarini Group); Ministerio de Economia y Competitividad (Spain)(Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES)	This work was supported by Sociedad Catalana de Neumologia (http://www.socapnet.org); Fundacio Catalana de Neumologia (http://www.ccfundacions.cat/fundacions/fundacio-catalana-de-pneumologia-fucap); Fundacio Parc Tauli (https://www.tauli.cat/tauli/cat/fpt/fpt.htm); Marato de TV3 (http://www.tv3.cat/marato/es/); Sociedad Espanola de Neumologia y Cirugia Toracica (http://www.separ.es/); Fundacion Menarini (http://www.menarini.es/); Ministerio de Economia y Competitividad (Spain) (http://www.idi.mineco.gob.es/) [SAF2012-31187]; Generalitat Valenciana (Spain) [Prometeo/2009/092] and Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) (http://www.ciberisciii.es/). CIBERES is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, Am Rev Respir Dis, V136, P1285; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Barreiro E, 2013, FREE RADICAL BIO MED, V65, P859, DOI 10.1016/j.freeradbiomed.2013.08.006; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carr R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105776; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davenport M, 2014, INFLAMM BOWEL DIS, V20, P723, DOI 10.1097/MIB.0000000000000011; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Gallego M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-103; Garcia-Nunez M, 2014, J CLIN MICROBIOL, V52, P4217, DOI 10.1128/JCM.01967-14; Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368; Greenblum S, 2015, CELL, V160, P583, DOI 10.1016/j.cell.2014.12.038; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Iwai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095726; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer F, 2012, GENOME BIOL, V13, DOI 10.1186/gb4042; Millares L, 2014, EUR J CLIN MICROBIOL, V33, P1101, DOI 10.1007/s10096-013-2044-0; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Pomares X, 2011, INT J CHRONIC OBSTR, V6, P449, DOI 10.2147/COPD.S23655; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rangelov K, 2014, CLIN CHEST MED, V35, P87, DOI 10.1016/j.ccm.2013.09.012; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroedl C, 2012, CURR OPIN PULM MED, V18, P131, DOI 10.1097/MCP.0b013e32834f2080; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shannon CE, 1997, M D COMPUT, V14, P306; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wei X, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-175; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	48	33	38	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144448	10.1371/journal.pone.0144448	http://dx.doi.org/10.1371/journal.pone.0144448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632844	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000084
J	Xie, JD; Huang, Y; Chen, DT; Pan, JH; Bi, BT; Feng, KY; Huang, W; Zeng, WA				Xie, Jing-Dun; Huang, Yang; Chen, Dong-Tai; Pan, Jia-Hao; Bi, Bing-Tian; Feng, Kun-Yao; Huang, Wan; Zeng, Wei-An			Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; DRUG-INTERACTIONS; IN-VITRO; CLINICAL-IMPLICATIONS; OVEREXPRESSING CELLS; CYTOCHROME-P450 3A; PHARMACOKINETICS; BINDING; VIVO	Fentanyl, a potent opioid analgesic that is used to treat cancer pain, is commonly administered with paclitaxel in advanced tumors. However, the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanism of action is not well studied. The purpose of this study was to investigate the effect of fentanyl on the hepatotoxicity of paclitaxel and its potential mechanisms of action. Pharmacokinetic parameters of paclitaxel were tested using reversed phase high-performance liquid chromatography (RP-HPLC). Aspartate transaminase (AST), alanine aminotransferase (ALT), and mouse liver histopathology were examined. Moreover, the cytotoxicity of anti-carcinogens was examined using 1-(4, 5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), and the intracellular accumulation of doxorubicin and rhodamine 123 was detected by flow cytometry. Furthermore, the expression of ABCB1 and the activity of ABCB1 ATPase and CYP3A4 were also examined. In this study, the co-administration of fentanyl and paclitaxel prolonged the half-life (t(1/2)) of paclitaxel from 1.455 hours to 2.344 hours and decreased the clearance (CL) from 10.997 ml/h to 7.014 ml/h in mice. Fentanyl significantly increased the levels of ALT in mice to 88.2 U/L, which is more than 2-fold higher than the level detected in the control group, and it increased the histological damage in mouse livers. Furthermore, fentanyl enhanced the cytotoxicity of anti-carcinogens that are ABCB1 substrates and increased the accumulation of doxorubicin and rhodamine 123. Additionally, fentanyl stimulated ABCB1 ATPase activity and inhibited CYP3A4 activity in the liver microsomes of mice. Our study indicates that the obvious hepatotoxicity during this co-administration was due to the inhibition of CYP3A4 activity and ABCB1 transport activity. These findings suggested that the accumulation-induced hepatotoxicity of paclitaxel when it is combined with fentanyl should be avoided.	[Xie, Jing-Dun; Huang, Yang; Chen, Dong-Tai; Pan, Jia-Hao; Huang, Wan; Zeng, Wei-An] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Bi, Bing-Tian; Feng, Kun-Yao] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Clin Trial Ctr,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Zeng, WA (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Anesthesiol,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zengwa@mail.sysu.edu.cn			Natural Science Foundation of China [81271246]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant (No. 81271246) from the Natural Science Foundation of China (http://www.nsfc.gov.cn/).	Al-Farsi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00157; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Andersen Anders, 2006, BMC Clin Pharmacol, V6, P2, DOI 10.1186/1472-6904-6-2; Brozik A, 2011, EXPERT OPIN DRUG MET, V7, P623, DOI 10.1517/17425255.2011.562892; Bujedo Borja Mugabure, 2012, J Opioid Manag, V8, P177, DOI 10.5055/jom.2012.0114; Dagenais C, 2004, BIOCHEM PHARMACOL, V67, P269, DOI 10.1016/j.bcp.2003.08.027; Dai CL, 2009, BIOCHEM PHARMACOL, V78, P355, DOI 10.1016/j.bcp.2009.04.023; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Englund G, 2014, DRUG METAB DISPOS, V42, P441, DOI 10.1124/dmd.113.054932; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Fu LW, 2004, CANCER CHEMOTH PHARM, V53, P349, DOI 10.1007/s00280-003-0742-5; Goh IXW, 2013, SINGAP MED J, V54, P131, DOI 10.11622/smedj.2013044; Henthorn TK, 1999, J PHARMACOL EXP THER, V289, P1084; Honjo Y, 2001, CANCER RES, V61, P6635; Hsu PW, 2013, J AGR FOOD CHEM, V61, P4464, DOI 10.1021/jf3052384; King S, 2011, PALLIATIVE MED, V25, P525, DOI 10.1177/0269216311406313; KLEIN HO, 1982, CIRCULATION, V65, P998, DOI 10.1161/01.CIR.65.5.998; Lee CK, 2011, BIOPHARM DRUG DISPOS, V32, P245, DOI 10.1002/bdd.754; Lin JH, 2003, CLIN PHARMACOKINET, V42, P59, DOI 10.2165/00003088-200342010-00003; Lin JH, 1998, CLIN PHARMACOKINET, V35, P361, DOI 10.2165/00003088-199835050-00003; Ling SY, 2014, BRIT J CLIN PHARMACO, V77, P1039, DOI 10.1111/bcp.12309; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercer SL, 2011, CURR TOP MED CHEM, V11, P1157; Miller AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060685; MORDEL A, 1993, CLIN PHARMACOL THER, V53, P457, DOI 10.1038/clpt.1993.51; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Pawar M, 2007, EUR J PHARMACOL, V563, P92, DOI 10.1016/j.ejphar.2007.01.059; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Rabindran SK, 2000, CANCER RES, V60, P47; Shi S, 2010, INT J PHARMACEUT, V383, P264, DOI 10.1016/j.ijpharm.2009.09.025; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Yamazaki M, 2001, J PHARMACOL EXP THER, V296, P723; Yang XN, 2008, J ETHNOPHARMACOL, V117, P408, DOI 10.1016/j.jep.2008.02.021; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang JY, 2007, CANCER BIOL THER, V6, P1413; Zhao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113478; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x	39	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143701	10.1371/journal.pone.0143701	http://dx.doi.org/10.1371/journal.pone.0143701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633878	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000020
J	Li, PS; Thomas, DC; Saunders, RMK				Li, Pui-Sze; Thomas, Daniel C.; Saunders, Richard M. K.			Phylogenetic Reconstruction, Morphological Diversification and Generic Delimitation of Disepalum (Annonaceae)	PLOS ONE			English	Article							GENUS GONIOTHALAMUS ANNONACEAE; ASIMINA-TRILOBA ANNONACEAE; CHLOROPLAST DNA REGIONS; POLLEN-TUBE GROWTH; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENETICS; SPORODERM DEVELOPMENT; DEVELOPMENTAL EVENTS; DIPTEROCARP FOREST; BASAL ANGIOSPERMS	Taxonomic delimitation of Disepalum (Annonaceae) is contentious, with some researchers favoring a narrow circumscription following segregation of the genus Enicosanthellum. We reconstruct the phylogeny of Disepalum and related taxa based on four chloroplast and two nuclear DNA regions as a framework for clarifying taxonomic delimitation and assessing evolutionary transitions in key morphological characters. Maximum parsimony, maximum likelihood and Bayesian methods resulted in a consistent, well-resolved and strongly supported topology. Disepalum s.l. is monophyletic and strongly supported, with Disepalum s. str. and Enicosanthellum retrieved as sister groups. Although this topology is consistent with both taxonomic delimitations, the distribution of morphological synapomorphies provides greater support for the inclusion of Enicosanthellum within Disepalum s.l. We propose a novel infrageneric classification with two subgenera. Subgen. Disepalum (= Disepalum s. str.) is supported by numerous synapomorphies, including the reduction of the calyx to two sepals and connation of petals. Subgen. Enicosanthellum lacks obvious morphological synapomorphies, but possesses several diagnostic characters (symplesiomorphies), including a trimerous calyx and free petals in two whorls. We evaluate changes in petal morphology in relation to hypotheses of the genetic control of floral development and suggest that the compression of two petal whorls into one and the associated fusion of contiguous petals may be associated with the loss of the pollination chamber, which in turn may be associated with a shift in primary pollinator. We also suggest that the formation of pollen octads may be selectively advantageous when pollinator visits are infrequent, although this would only be applicable if multiple ovules could be fertilized by each octad; since the flowers are apocarpous, this would require an extragynoecial compitum to enable intercarpellary growth of pollen tubes. We furthermore infer that the monocarp fruit stalks are likely to have evolved independently from those in other Annonaceae genera and may facilitate effective dispersal by providing a color contrast within the fruit.	[Li, Pui-Sze; Thomas, Daniel C.; Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Saunders, RMK (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	saunders@hku.hk	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761; Thomas, Daniel Caspar/0000-0002-1307-6042	Hong Kong Research Grants Council [HKU777211]; RMKS; DCT	Hong Kong Research Grants Council(Hong Kong Research Grants Council); RMKS; DCT	This research was funded by a grant from the Hong Kong Research Grants Council (HKU777211; http://www.ugc.edu.hk/eng/rgc/index.htm), awarded to RMKS and DCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Ban N.T., 1975, BOT ZH MOSCOW LENING, V60, P808; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brewer PB, 2004, DEVELOPMENT, V131, P4035, DOI 10.1242/dev.01279; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Couvreur TLP, 2008, MOL PHYLOGENET EVOL, V47, P302, DOI 10.1016/j.ympev.2008.01.018; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Couvreur TLP, 2009, SYSTEMATIC BOT MONOG, V87, P1; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Diels L, 1930, NOTIZBLATT BOT GARTE, V10, P886; DNYANSAGAR V. R., 1954, LLOYDIA [CINCINNATI], V17, P263; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JA, 2012, BOT J LINN SOC, V169, P190, DOI 10.1111/j.1095-8339.2012.01241.x; Drummond A.J., 2010, GENEIOUS VERSION 5 4; ELMER ADE, 1913, LEAFL PHILIPP BOT, V5, P1705; Endress PK, 2007, CURR OPIN PLANT BIOL, V10, P52, DOI 10.1016/j.pbi.2006.11.007; Endress PK, 2009, AM J BOT, V96, P22, DOI 10.3732/ajb.0800047; ENDRESS PK, 1982, TAXON, V31, P48, DOI 10.2307/1220588; Erkens RHJ, 2008, BLUMEA, V53, P407, DOI 10.3767/000651908X608052; Erkens RHJ, 2014, TAXON, V63, P1244, DOI 10.12705/636.34; Erkens RHJ, 2009, J BIOGEOGR, V36, P2338, DOI 10.1111/j.1365-2699.2009.02162.x; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Fero M, 2014, SYST BOT, V39, P17, DOI 10.1600/036364414X678071; Fries RE, 1959, NATURL PFLANZ, P1; GABARAYEVA NI, 1992, GRANA, V31, P213, DOI 10.1080/00173139209432033; GABARAYEVA NI, 1993, GRANA, V32, P210, DOI 10.1080/00173139309429984; GUINET P, 1990, REV PALAEOBOT PALYNO, V64, P109, DOI 10.1016/0034-6667(90)90124-2; Harder LD, 2008, INT J PLANT SCI, V169, P59, DOI 10.1086/523364; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hooker JD, 1860, T LINN SOC, V23; Hotta M, 1989, OCCAS PAPERS KAGOSHI, P16; JOHNSON DM, 1989, BRITTONIA, V41, P356, DOI 10.2307/2807547; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; King G., 1892, NAT HIST, V61, P1; KRAL ROBERT, 1960, BRITTONIA, V12, P233, DOI 10.2307/2805119; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LOOCKERMAN DJ, 1996, SAMPLING GREEN WORLD, P205; Lora J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-129; Lyew J, 2007, AM J BOT, V94, P1170, DOI 10.3732/ajb.94.7.1170; MAAS PJM, 1988, P K NED AKAD C BIOL, V91, P243; Maddison WP, 2011, MESQUITE MODULAR SYS; Meade A, 2014, BAYESTRAITS VERSION; Merrill E.D., 1926, U CALIF PUBL BOT, V13, P131; Miller M.A., 2010, P GAT COMP ENV WORKS; Momose K, 2005, ECOL STU AN, V174, P104; Momose K, 1998, BIOTROPICA, V30, P444, DOI 10.1111/j.1744-7429.1998.tb00078.x; Nagamitsu T, 1997, AM J BOT, V84, P208, DOI 10.2307/2446082; Neubig KM, 2010, AM J BOT, V97, pE52, DOI 10.3732/ajb.1000128; Nylander JAA., 2004, MRMODELTEST 2 2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; PACINI E, 1985, PLANT SYST EVOL, V149, P155, DOI 10.1007/BF00983304; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A., 2009, TRACER VERSION 1 5; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roubik D., 2005, POLLINATION ECOLOGY; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Saunders RMK, 2010, BIOL REV, V85, P571, DOI 10.1111/j.1469-185X.2009.00116.x; Savolainen V, 1995, PL SYST EVOL, V197, P712; Scheunert A, 2014, MOL PHYLOGENET EVOL, V70, P296, DOI 10.1016/j.ympev.2013.09.023; Schmidt V, 2004, OIKOS, V106, P551, DOI 10.1111/j.0030-1299.2004.12769.x; Silberbauer-Gottsberger I, 2003, TAXON, V52, P701, DOI 10.2307/3647345; Sinclair J., 1955, Gardens' Bulletin, V14, P149; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Su YCF, 2008, MOL PHYLOGENET EVOL, V48, P188, DOI 10.1016/j.ympev.2008.03.028; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Swofford D., 2003, PHYLOGENETIC ANAL US; Tang C, 2014, THESIS; Tang CC, 2015, MOL PHYLOGENET EVOL, V92, P124, DOI 10.1016/j.ympev.2015.06.016; Tang CC, 2015, DATA BRIEF, V4, P410, DOI 10.1016/j.dib.2015.06.021; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thomas DC, 2015, PERSPECT PLANT ECOL, V17, P1, DOI 10.1016/j.ppees.2014.11.001; Thomas DC, 2012, TAXON, V61, P559, DOI 10.1002/tax.613006; TOBE H, 1986, AM J BOT, V73, P475, DOI 10.2307/2444251; Tsou CH, 2007, PLANT SYST EVOL, V263, P13, DOI 10.1007/s00606-006-0471-4; Tsou CH, 2003, AM J BOT, V90, P832, DOI 10.3732/ajb.90.6.832; Tsou CH, 2002, AM J BOT, V89, P734, DOI 10.3732/ajb.89.5.734; Turner IM, 2008, NORD J BOT, V26, P329, DOI 10.1111/j.1756-1051.2008.00359.x; van Heusden ECH, 1992, BLUMEA, P1, DOI DOI 10.1111/J.1756-1051.1993.TB00089.X; van SAK., 1992, BIBLIOTHECA BOT, V142, P1; Vandenbussche M, 2009, PLANT CELL, V21, P2269, DOI 10.1105/tpc.109.065862; WAHA M, 1987, Pollen et Spores, V29, P31; WALKER J. W., 1971, Contributions, Grey Herbarium, Harvard University.; Wang XF, 2012, NEW PHYTOL, V193, P253, DOI 10.1111/j.1469-8137.2011.03912.x; WHEELWRIGHT NT, 1985, AM NAT, V126, P777, DOI 10.1086/284453; Xue B, 2012, TAXON, V61, P1021, DOI 10.1002/tax.615009; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	101	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143481	10.1371/journal.pone.0143481	http://dx.doi.org/10.1371/journal.pone.0143481			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630651	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300051
J	Zhang, EL; Guo, QY; Gao, HY; Xu, RX; Teng, SY; Wu, YJ				Zhang, Erli; Guo, Qianyun; Gao, Haiyang; Xu, Ruixia; Teng, Siyong; Wu, Yongjian			Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway	PLOS ONE			English	Article							GOTO-KAKIZAKI RAT; CELLULAR SENESCENCE; DNA-DAMAGE; LOW BIOAVAILABILITY; DIABETES-MELLITUS; P53; SIRT1; MECHANISMS; ATHEROSCLEROSIS; TRANSCRIPTION	Endothelial senescence plays crucial roles in diabetic vascular complication. Recent evidence indicated that transient hyperglycaemia could potentiate persistent diabetic vascular complications, a phenomenon known as "metabolic memory." Although SIRT1 has been demonstrated to mediate high glucose-induced endothelial senescence, whether and how "metabolic memory" would affect endothelial senescence through SIRT1 signaling remains largely unknown. In this study, we investigated the involvement of SIRT1 axis as well as the protective effects of resveratrol (RSV) and metformin (MET), two potent SIRT1 activators, during the occurrence of "metabolic memory" of cellular senescence (senescent "memory"). Human umbilical vascular endothelial cells (HUVECs) were cultured in either normal glucose (NG)/high glucose (HG) media for 6 days, or 3 days of HG followed by 3 days of NG (HN), with or without RSV or MET treatment. It was shown that HN incubation triggered persistent downregulation of deacetylase SIRT1 and upregulation of acetyltransferase p300, leading to sustained hyperacetylation (at K382) and activation of p53, and subsequent p53/p21-mediated senescent "memory." In contrast, senescent "memory" was abrogated by overexpression of SIRT1 or knockdown of p300. Interestingly, we found that SIRT1 and p300 could regulate each other in response to HN stimulation, suggesting that a delicate balance between acetyltransferases and deacetylases may be particularly important for sustained acetylation and activation of non-histone proteins (such as p53), and eventually the occurrence of "metabolic memory." Furthermore, we found that RSV or MET treatment prevented senescent "memory" by modulating SIRT1/p300/p53/p21 pathway. Notably, early and continuous treatment of MET, but not RSV, was particularly important for preventing senescent "memory." In conclusion, short-term high glucose stimulation could induce sustained endothelial senescence via SIRT1/p300/p53/p21 pathway. RVS or MET treatment could enhance SIRT1-mediated signaling and thus protect against senescent "memory" independent of their glucose lowering mechanisms. Therefore, they may serve as promising therapeutic drugs against the development of "metabolic memory."	[Zhang, Erli; Guo, Qianyun; Gao, Haiyang; Xu, Ruixia; Teng, Siyong; Wu, Yongjian] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Dept Cardiol, Cardiovasc Inst,Fuwai Hosp, Beijing 100730, Peoples R China; [Zhang, Erli; Guo, Qianyun; Gao, Haiyang; Xu, Ruixia; Teng, Siyong; Wu, Yongjian] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Erli; Guo, Qianyun; Gao, Haiyang; Xu, Ruixia; Teng, Siyong; Wu, Yongjian] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, YJ (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Dept Cardiol, Cardiovasc Inst,Fuwai Hosp, Beijing 100730, Peoples R China.; Wu, YJ (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.; Wu, YJ (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	aricho1985@163.com	xu, rui/GRX-5734-2022	Wu, Yongjian/0000-0002-5590-8396	National Natural Science Foundation of China [91339103]; Chinese Scholarship Council [201406210335]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council)	The authors are supported by the National Natural Science Foundation of China (91339103) (to YW) and Chinese Scholarship Council (201406210335) (to EZ).	Arunachalam G, 2014, BRIT J PHARMACOL, V171, P523, DOI 10.1111/bph.12496; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kulkarni S. S., 2014, BIOCH BIOPHYS ACTA; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Novelle MG, 2015, AGEING RES REV, V21, P1, DOI 10.1016/j.arr.2015.01.002; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reed SM, 2015, CANCERS, V7, P30, DOI 10.3390/cancers7010030; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003; Scolnick DM, 1997, CANCER RES, V57, P3693; Smoliga JM, 2014, MOLECULES, V19, P17154, DOI 10.3390/molecules191117154; Szkudelski T, 2014, BIOCH BIOPHYS ACTA; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; Triggle CR, 2010, J AM SOC HYPERTENS, V4, P102, DOI 10.1016/j.jash.2010.02.004; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Vahtola E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-5; Vahtolaa E, 2008, J HYPERTENS, V26, P334, DOI 10.1097/HJH.0b013e3282f293c8; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883; Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416; Zhong Q, 2010, J CELL BIOCHEM, V110, P1306, DOI 10.1002/jcb.22644	36	73	75	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143814	10.1371/journal.pone.0143814	http://dx.doi.org/10.1371/journal.pone.0143814			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629991	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300105
J	Zhang, T; Zhang, R; Zhang, L; Zhang, ZH; Hou, R; Wang, HR; Loeffler, IK; Watson, DG; Kennedy, MW				Zhang, Tong; Zhang, Rong; Zhang, Liang; Zhang, Zhihe; Hou, Rong; Wang, Hairui; Loeffler, I. Kati; Watson, David G.; Kennedy, Malcolm W.			Changes in the Milk Metabolome of the Giant Panda (Ailuropoda melanoleuca) with Time after Birth - Three Phases in Early Lactation and Progressive Individual Differences	PLOS ONE			English	Article							INTERACTION LIQUID-CHROMATOGRAPHY; JAPANESE BLACK BEAR; MASS-SPECTROMETRY; CHEMICAL-CHARACTERIZATION; BOVINE COLOSTRUM; URSUS-AMERICANUS; TAMMAR WALLABY; POLAR BEAR; OLIGOSACCHARIDES; NMR	Ursids (bears) in general, and giant pandas in particular, are highly altricial at birth. The components of bear milks and their changes with time may be uniquely adapted to nourish relatively immature neonates, protect them from pathogens, and support the maturation of neonatal digestive physiology. Serial milk samples collected from three giant pandas in early lactation were subjected to untargeted metabolite profiling and multivariate analysis. Changes in milk metabolites with time after birth were analysed by Principal Component Analysis, Hierarchical Cluster Analysis and further supported by Orthogonal Partial Least Square-Discriminant Analysis, revealing three phases of milk maturation: days 1-6 (Phase 1), days 7-20 (Phase 2), and beyond day 20 (Phase 3). While the compositions of Phase 1 milks were essentially indistinguishable among individuals, divergences emerged during the second week of lactation. OPLS regression analysis positioned against the growth rate of one cub tentatively inferred a correlation with changes in the abundance of a trisaccharide, isoglobotriose, previously observed to be a major oligosaccharide in ursid milks. Three artificial milk formulae used to feed giant panda cubs were also analysed, and were found to differ markedly in component content from natural panda milk. These findings have implications for the dependence of the ontogeny of all species of bears, and potentially other members of the Carnivora and beyond, on the complexity and sequential changes in maternal provision of micrometabolites in the immediate period after birth.	[Zhang, Tong; Zhang, Rong; Watson, David G.] Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Zhang, Rong] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Zhang, Liang; Zhang, Zhihe; Hou, Rong; Wang, Hairui; Loeffler, I. Kati] Northern Suburb, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan Provinc, Peoples R China; [Kennedy, Malcolm W.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland	University of Strathclyde; Guangzhou University of Chinese Medicine; University of Glasgow	Kennedy, MW (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Graham Kerr Bldg, Glasgow, Lanark, Scotland.	malcolm.kennedy@glasgow.ac.uk			International Science and Technology Cooperation Program of China (ISTCP) [2011DFA33530]; Sichuan International Science and Technology Cooperation [2011HH0043]; Scottish Life Sciences Alliance	International Science and Technology Cooperation Program of China (ISTCP); Sichuan International Science and Technology Cooperation; Scottish Life Sciences Alliance	Funding was provided by International Science and Technology Cooperation Program of China (ISTCP) (grant 2011DFA33530) to RH, ZZ, LZ, HW, and MWK; Sichuan International Science and Technology Cooperation (grant 2011HH0043) to RH, ZZ, LZ, HW, and MWK; and Scottish Life Sciences Alliance to TZ, RZ, and DGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aernouts B, 2011, ANAL CHIM ACTA, V705, P88, DOI 10.1016/j.aca.2011.04.018; Boudonck KJ, 2009, METABOLOMICS, V5, P375, DOI 10.1007/s11306-009-0160-8; Brennan AJ, 2007, J DAIRY SCI, V90, pE66, DOI 10.3168/jds.2006-483; DEROCHER AE, 1993, CAN J ZOOL, V71, P561, DOI 10.1139/z93-077; Edwards Mark S., 1997, International Zoo Yearbook, V35, P90, DOI 10.1111/j.1748-1090.1997.tb01195.x; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; Harzia H, 2013, J DAIRY SCI, V96, P6440, DOI 10.3168/jds.2013-6808; Hedberg GE, 2011, ZOO BIOL, V30, P550, DOI 10.1002/zoo.20375; Holt C, 2012, J EVOLUTION BIOL, V25, P1253, DOI 10.1111/j.1420-9101.2012.02509.x; HUDSON GJ, 1984, VET REC, V115, P252, DOI 10.1136/vr.115.10.252; IVERSON SJ, 1992, LIPIDS, V27, P940, DOI 10.1007/BF02535877; JENNESS R, 1972, J MAMMAL, V53, P34, DOI 10.2307/1378825; Kelly V, 2013, J DAIRY SCI, V96, P7684, DOI 10.3168/jds.2013-6972; Klein MS, 2010, J DAIRY SCI, V93, P1539, DOI 10.3168/jds.2009-2563; Lane JA, 2012, INT J FOOD MICROBIOL, V157, P182, DOI 10.1016/j.ijfoodmicro.2012.04.027; Langer P, 2008, ZOOLOGY, V111, P148, DOI 10.1016/j.zool.2007.06.007; Langer P, 2009, J MAMMAL, V90, P332, DOI 10.1644/08-MAMM-A-071.1; Lintzenich BA, 2006, POLAR BEAR NUTR GUID; Liu XZ, 2005, ZOO BIOL, V24, P393, DOI 10.1002/zoo.20056; Loeffler IK, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P377, DOI 10.1017/CBO9780511542244.017; Loeffler IK, 2007, P INT WORKSH REH REL; Marincola FC, 2012, J MATERN-FETAL NEO M, V25, P62, DOI 10.3109/14767058.2012.715436; Melzer N, 2013, J DAIRY SCI, V96, P1521, DOI 10.3168/jds.2012-5743; Nakamura T, 2003, COMP BIOCHEM PHYS B, V135, P439, DOI 10.1016/S1096-4959(03)00093-9; Nakamura T, 2003, J DAIRY SCI, V86, P1315, DOI 10.3168/jds.S0022-0302(03)73715-1; Oftedal OT, 2012, ANIMAL, V6, P355, DOI 10.1017/S1751731111001935; OFTEDAL OT, 1993, BRIT J NUTR, V70, P59, DOI 10.1079/BJN19930105; Pratico G, 2014, NAT PROD RES, V28, P95, DOI 10.1080/14786419.2013.843180; RAMSAY MA, 1986, AM NAT, V127, P735, DOI 10.1086/284522; Ruhaak LR, 2012, BMB REP, V45, P442, DOI 10.5483/BMBRep.2012.45.8.161; Russo M, 2013, ANAL BIOANAL CHEM, V405, P4617, DOI 10.1007/s00216-012-6699-7; Scano P, 2014, J DAIRY SCI; Skibiel AL, 2013, J ANIM ECOL, V82, P1254, DOI 10.1111/1365-2656.12095; Smilowitz JT, 2013, J NUTR, V143, P1709, DOI 10.3945/jn.113.178772; Sundekilde UK, 2013, METABOLITES, V3, P204, DOI 10.3390/metabo3020204; Sundekilde UK, 2011, J AGR FOOD CHEM, V59, P7360, DOI 10.1021/jf202057x; ten Bruggencate SJM, 2014, NUTR REV, V72, P377, DOI 10.1111/nure.12106; Trott JF, 2003, BIOL REPROD, V68, P929, DOI 10.1095/biolreprod.102.005934; Urashima T, 1997, BBA-GEN SUBJECTS, V1334, P247, DOI 10.1016/S0304-4165(96)00101-8; Urashima T, 2004, COMP BIOCHEM PHYS B, V139, P587, DOI 10.1016/j.cbpc.2004.07.012; Urashima T, 2003, COMP BIOCHEM PHYS B, V136, P887, DOI 10.1016/j.cbpc.2003.09.001; Urashima T, 2000, BBA-GEN SUBJECTS, V1475, P395, DOI 10.1016/S0304-4165(00)00103-3; Urashima T, 1999, BBA-GEN SUBJECTS, V1472, P290, DOI 10.1016/S0304-4165(99)00134-8; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Weiss GA, 2012, ADV NUTR, V3, p483S, DOI 10.3945/an.111.001651; Zhang R, 2014, J CHROMATOGR A, V1362, P168, DOI 10.1016/j.chroma.2014.08.039; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065880; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738; Zivkovic AM, 2011, ADV NUTR, V2, P284, DOI 10.3945/an.111.000455	49	6	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143417	10.1371/journal.pone.0143417	http://dx.doi.org/10.1371/journal.pone.0143417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630345	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300048
J	Adetiba, E; Olugbara, OO				Adetiba, Emmanuel; Olugbara, Oludayo O.			Improved Classification of Lung Cancer Using Radial Basis Function Neural Network with Affine Transforms of Voss Representation	PLOS ONE			English	Article							NEVER SMOKERS; DNA-SEQUENCES; MUTATION; COMMON; FEEDFORWARD; SCALE	Lung cancer is one of the diseases responsible for a large number of cancer related death cases worldwide. The recommended standard for screening and early detection of lung cancer is the low dose computed tomography. However, many patients diagnosed die within one year, which makes it essential to find alternative approaches for screening and early detection of lung cancer. We present computational methods that can be implemented in a functional multi-genomic system for classification, screening and early detection of lung cancer victims. Samples of top ten biomarker genes previously reported to have the highest frequency of lung cancer mutations and sequences of normal biomarker genes were respectively collected from the COSMIC and NCBI databases to validate the computational methods. Experiments were performed based on the combinations of Z-curve and tetrahedron affine transforms, Histogram of Oriented Gradient (HOG), Multilayer perceptron and Gaussian Radial Basis Function (RBF) neural networks to obtain an appropriate combination of computational methods to achieve improved classification of lung cancer biomarker genes. Results show that a combination of affine transforms of Voss representation, HOG genomic features and Gaussian RBF neural network perceptibly improves classification accuracy, specificity and sensitivity of lung cancer biomarker genes as well as achieving low mean square error.	[Olugbara, Oludayo O.] Durban Univ Technol, ICT, ZA-4000 Durban, South Africa; Durban Univ Technol, Soc Res Grp, ZA-4000 Durban, South Africa	Durban University of Technology; Durban University of Technology	Olugbara, OO (corresponding author), Durban Univ Technol, ICT, POB 1334, ZA-4000 Durban, South Africa.	oludayoo@dut.ac.za	Adetiba, Emmanuel/AAC-4129-2022	Adetiba, Emmanuel/0000-0001-9227-7389	Durban University of Technology Research and Postgraduate Support Directorate	Durban University of Technology Research and Postgraduate Support Directorate	Funded by the Durban University of Technology Research and Postgraduate Support Directorate.	Abo-Zahhad Mohammed, 2012, International Journal of Information Technology and Computer Science, V4, P22, DOI 10.5815/ijitcs.2012.08.03; Adetiba E, 2011, INT J COMPUTER APPL, V20, P39; Adetiba E., 2014, INT J ENG TECHNOL, V14, P151; Adetiba Emmanuel, 2015, ScientificWorldJournal, V2015, P786013, DOI 10.1155/2015/786013; Akhtar M, 2007, IEEE INT WORK GENOM, P54; Alberts B, 2002, ION CHANNELS ELECT P; Bo L., 2014, P INT C IT CONV SEC, P1; CHEN DS, 1994, IEEE T NEURAL NETWOR, V5, P467, DOI 10.1109/72.286917; Chen Y, 2013, GENET MOL BIOL, V36, P455, DOI 10.1590/S1415-47572013000300022; CHENG YH, 1994, 1994 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOL 1-7, P797, DOI 10.1109/ICNN.1994.374280; Cornfield J, 2009, INT J EPIDEMIOL, V38, P1175, DOI 10.1093/ije/dyp289; Cristea PD, 2003, SIGNAL PROCESS, V83, P871, DOI 10.1016/S0165-1684(02)00477-2; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Daramola S., 2011, J EMERGING TRENDS EN, V2, P74; DERKS EPPA, 1995, CHEMOMETR INTELL LAB, V28, P49, DOI 10.1016/0169-7439(94)00082-T; Dimitrova N, 2006, P 14 ANN ACM INT C M, P1017, DOI [https://doi.org/10.1145/1180639.1180861, DOI 10.1145/1180639.1180861]; Eisner R, 2005, P IEEE S COMP INT BI, V00, P1; Er MJ, 2002, IEEE T NEURAL NETWOR, V13, P697, DOI 10.1109/TNN.2002.1000134; Erik R, INTERPRETING HLTH BE, DOI [10.1007/978-3-319-11544-3_1, DOI 10.1007/978-3-319-11544-3_1]; Forbes SA, 2010, NUCLEIC ACIDS RES; Gardner MW, 1998, ATMOS ENVIRON, V32, P2627, DOI 10.1016/S1352-2310(97)00447-0; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; Gebejes A, 2013, PROC C INFORM MANAG, V3, P375; Guan P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-103; Juergens Rosalyn A, 2006, J Natl Compr Canc Netw, V4, P595; Kurban T, 2009, SENSORS-BASEL, V9, P6312, DOI 10.3390/s90806312; Lee CC, 1999, IEEE T SYST MAN CY B, V29, P674, DOI 10.1109/3477.809023; Lin Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034457; LOEB LA, 1984, CANCER RES, V44, P5940; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Marshall HM, 2013, J THORAC DIS, V5, pS524, DOI 10.3978/j.issn.2072-1439.2013.09.06; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907; Nguyen TT, 2007, P 2007 IEEE INT C RE, P234; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Oyang YJ, 2005, IEEE T NEURAL NETWOR, V16, P225, DOI 10.1109/TNN.2004.836229; Packenham JP, 1995, CLIN CANCER RES, V1, P687; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Popescu Marius-Constantin, 2009, WSEAS Transactions on Circuits and Systems, V8, P579; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Ramani RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058772; Ravi S, LUNG CANC RES PREVEN; Razzak Mina, 2013, Nat Rev Clin Oncol, V10, P246, DOI 10.1038/nrclinonc.2013.43; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rushdi A, 2008, IEEE INT WORKSH GEN, P1; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Sanchez MS, 1996, CHEMOMETR INTELL LAB, V33, P101, DOI 10.1016/0169-7439(95)00089-5; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Santo E, 2007, IEEE INT WORK GENOM, P46; Sasaki H, 2007, ONCOL REP, V18, P623; Shao JF, 2013, J MATH BIOL, V67, P433, DOI 10.1007/s00285-012-0564-3; Shapiro LG., 2001, COMPUTER VISION, V1, P1; Sharma S, 2011, 2011 IEEE 17TH PACIFIC RIM INTERNATIONAL SYMPOSIUM ON DEPENDABLE COMPUTING (PRDC), P71, DOI [10.1109/PRDC.2011.18, 10.1109/ICCCET.2011.5762441]; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Thakur S, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/564904; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Yu B, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, P369; Yu H, 2011, IEEE T IND ELECTRON, V58, P5438, DOI 10.1109/TIE.2011.2164773; Zhang GQP, 2000, IEEE T SYST MAN CY C, V30, P451, DOI 10.1109/5326.897072; Zhang R, 2014, CURR GENOMICS, V15, P78, DOI 10.2174/1389202915999140328162433; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	63	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143542	10.1371/journal.pone.0143542	http://dx.doi.org/10.1371/journal.pone.0143542			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625358	Green Published, gold			2022-12-26	WOS:000365891600035
J	Kuroda, K; Kiyono, T; Isogai, E; Masuda, M; Narita, M; Okuno, K; Koyanagi, Y; Fukuda, T				Kuroda, Kengo; Kiyono, Tohru; Isogai, Emiko; Masuda, Mizuki; Narita, Moe; Okuno, Katsuya; Koyanagi, Yukako; Fukuda, Tomokazu			Immortalization of Fetal Bovine Colon Epithelial Cells by Expression of Human Cyclin D1, Mutant Cyclin Dependent Kinase 4, and Telomerase Reverse Transcriptase: An In Vitro Model for Bacterial Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; HUMAN FIBROBLASTS; WALL COMPONENTS; CUTTING EDGE; SV40-MEDIATED IMMORTALIZATION; SALMONELLA-TYPHIMURIUM; PATHOGEN RECOGNITION; PATTERN-RECOGNITION; DIFFERENTIAL ROLES	Cattle are the economically important animals in human society. They are essential for the production of livestock products such as milk and meats. The production efficiency of livestock products is negatively impacted by infection with zoonotic pathogens. To prevent and control infectious diseases, it is important to understand the interaction between cattle tissue and pathogenic bacteria. In this study, we established an in vitro infection model of an immortalized bovine colon-derived epithelial cell line by transducing the cells with lentiviral vectors containing genes encoding cell cycle regulators cyclin D1, mutant cyclin dependent kinase 4 (CDK4), and human telomerase reverse transcriptase (TERT). The established cell line showed continuous cell proliferation, expression of epithelial markers, and an intact karyotype, indicating that the cells maintained their original nature as colon-derived epithelium. Furthermore, we exposed the established cell line to two strains of Salmonella enterica and EHEC. Interestingly, S. Typhimurium showed higher affinity for the established cell line and invaded the cytoplasm than S. Enteritidis. Quantitative RT-PCR revealed that gene expression of Toll-like receptor 1 (TLR1), TLR 2 and TLR 3, whereas TLR 4, 5 and 6 were not detectable in established cells. Our established immortalized colon-derived epithelial cell should be a useful tool for studies evaluating the molecular mechanisms underlying bacterial infection.	[Kuroda, Kengo; Isogai, Emiko; Masuda, Mizuki; Narita, Moe; Okuno, Katsuya; Koyanagi, Yukako; Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 980, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Carcinogenesis & Canc Prevent, Chuo Ku, Tokyo 104, Japan	Tohoku University; National Cancer Center - Japan	Kiyono, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 980, Japan.	tkiyono@ncc.go.jp; tomofukuda@bios.tohoku.ac.jp	Fukuda, Tomokazu/O-1257-2018	Fukuda, Tomokazu/0000-0001-8456-0483				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bai H, 2014, ANIM SCI J, V85, P799, DOI 10.1111/asj.12202; Bridger PS, 2010, VET IMMUNOL IMMUNOP, V137, P54, DOI 10.1016/j.vetimm.2010.04.010; Costa LF, 2012, RES VET SCI, V93, P1, DOI 10.1016/j.rvsc.2012.03.002; Desmarets LMB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-71; Donai K, 2014, J BIOTECHNOL, V176, P50, DOI 10.1016/j.jbiotec.2014.02.017; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Fukuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001776; Fukuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054312; Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hoshino K, 1999, J IMMUNOL, V162, P3749; Isogai E, 2005, COMP IMMUNOL MICROB, V28, P363, DOI 10.1016/j.cimid.2005.10.001; Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kuroda K, 2015, J CELL BIOCHEM, V116, P205, DOI 10.1002/jcb.24963; LAX AJ, 1995, BRIT VET J, V151, P351, DOI 10.1016/S0007-1935(95)80126-X; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Loret S, 2009, RES VET SCI, V87, P123, DOI 10.1016/j.rvsc.2008.12.002; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Means TK, 1999, J IMMUNOL, V163, P3920; Miyazawa K, 2010, HISTOCHEM CELL BIOL, V133, P125, DOI 10.1007/s00418-009-0648-3; Ozer HL, 1996, EXP GERONTOL, V31, P303, DOI 10.1016/0531-5565(95)00024-0; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pagan R, 1996, EXP CELL RES, V222, P333, DOI 10.1006/excr.1996.0043; Pan D, 2015, VET IMMUNOL IMMUNOP, V165, P14, DOI 10.1016/j.vetimm.2015.03.006; Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880; Qin XY, 2012, CANCER BIOL THER, V13, P296, DOI 10.4161/cbt.18942; RANKIN JD, 1966, VET REC, V78, P706, DOI 10.1136/vr.78.21.706; RAY FA, 1990, J CELL BIOCHEM, V42, P13, DOI 10.1002/jcb.240420103; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687; Rosselin M, 2011, MICROBIOL-SGM, V157, P839, DOI 10.1099/mic.0.044941-0; Roy P, 2002, AVIAN DIS, V46, P17, DOI 10.1637/0005-2086(2002)046[0017:ROSIFP]2.0.CO;2; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; SMITH BP, 1984, AM J VET RES, V45, P59; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Takaya A, 2005, CELL MICROBIOL, V7, P79, DOI 10.1111/j.1462-5822.2004.00435.x; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Yoshimura A, 1999, J IMMUNOL, V163, P1; Younis EE, 2009, RES VET SCI, V87, P373, DOI 10.1016/j.rvsc.2009.04.006; Zeiler M, 2007, CELLS TISSUES ORGANS, V186, P229, DOI 10.1159/000107947	54	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143473	10.1371/journal.pone.0143473	http://dx.doi.org/10.1371/journal.pone.0143473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624883	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600031
J	Cramer, CK; Yoon, SW; Reinsvold, M; Joo, KM; Norris, H; Hood, RC; Adamson, JD; Klein, RC; Kirsch, DG; Oldham, M				Cramer, C. K.; Yoon, S. W.; Reinsvold, M.; Joo, K. M.; Norris, H.; Hood, R. C.; Adamson, J. D.; Klein, R. C.; Kirsch, D. G.; Oldham, M.			Treatment Planning and Delivery of Whole Brain Irradiation with Hippocampal Avoidance in Rats	PLOS ONE			English	Article							RADIOTHERAPY; METASTASES; RADIATION; ACCURACY; MEMORY	Background Despite the clinical benefit of whole brain radiotherapy (WBRT), patients and physicians are concerned by the long-term impact on cognitive functioning. Many studies investigating the molecular and cellular impact of WBRT have used rodent models. However, there has not been a rodent protocol comparable to the recently reported Radiation Therapy Oncology Group (RTOG) protocol for WBRT with hippocampal avoidance (HA) which is intended to spare cognitive function. The aim of this study was to develop a hippocampal-sparing WBRT protocol in Wistar rats. Methods The technical and clinical challenges encountered in hippocampal sparing during rat WBRT are substantial. Three key challenges were identified: hippocampal localization, treatment planning, and treatment localization. Hippocampal localization was achieved with sophisticated imaging techniques requiring deformable registration of a rat MRI atlas with a high resolution MRI followed by fusion via rigid registration to a CBCT. Treatment planning employed a Monte Carlo dose calculation in SmART-Plan and creation of 0.5cm thick lead blocks custom-shaped to match DRR projections. Treatment localization necessitated the on-board image-guidance capability of the XRAD C225Cx micro-CT/micro-irradiator (Precision X-Ray). Treatment was accomplished with opposed lateral fields with 225 KVp X-rays at a current of 13mA filtered through 0.3mm of copper using a 40x40mm square collimator and the lead blocks. A single fraction of 4Gy was delivered (2Gy per lateral field) with a 41 second beam on time per field at a dose rate of 304.5 cGy/min. Dosimetric verification of hippocampal sparing was performed using radiochromic film. In vivo verification of HA was performed after delivery of a single 4Gy fraction either with or without HA using gamma-H2Ax staining of tissue sections from the brain to quantify the amount of DNA damage in rats treated with HA, WBRT, or sham-irradiated (negative controls). Results The mean dose delivered to radiochromic film beneath the hippocampal block was 0.52Gy compared to 3.93Gy without the block, indicating an 87% reduction in the dose delivered to the hippocampus. This difference was consistent with doses predicted by Monte Carlo dose calculation. The Dose Volume Histogram (DVH) generated via Monte Carlo simulation showed an underdose of the target volume (brain minus hippocampus) with 50% of the target volume receiving 100% of the prescription isodose as a result of the lateral blocking techniques sparing some midline thalamic and subcortical tissue. Staining of brain sections with anti-phospho-Histone H2A.X (reflecting double-strand DNA breaks) demonstrated that this treatment protocol limited radiation dose to the hippocampus in vivo. The mean signal intensity from gamma-H2Ax staining in the cortex was not significantly different from the signal intensity in the cortex of rats treated with WBRT (5.40 v. 5.75, P = 0.32). In contrast, the signal intensity in the hippocampus of rats treated with HA was significantly lower than rats treated with WBRT (4.55 v. 6.93, P = 0.012). Conclusion Despite the challenges of planning conformal treatments for small volumes in rodents, our dosimetric and in vivo data show that WBRT with HA is feasible in rats. This study provides a useful platform for further application and refinement of the technique.	[Cramer, C. K.; Yoon, S. W.; Reinsvold, M.; Joo, K. M.; Norris, H.; Adamson, J. D.; Klein, R. C.; Kirsch, D. G.; Oldham, M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA; [Klein, R. C.] Durham VA, Dept Psychiat, Durham, NC USA; [Kirsch, D. G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Joo, K. M.] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Klein, R. C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Duke University; Duke University; Sungkyunkwan University (SKKU); Duke University	Cramer, CK (corresponding author), Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA.	Christina.Cramer@duke.edu	Adamson, Justus/AAM-5335-2021	Adamson, Justus/0000-0002-7868-5631; Yoon, Suk Whan "Paul"/0000-0002-0313-8131	NIAID [K02AI093866]; Radiation Oncology departmental support; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI093866] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Radiation Oncology departmental support; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by K02AI093866 from the NIAID (awarded to DGK). The remainder of the research was funded by Radiation Oncology departmental support (start up funds) awarded to DGK.	Bache ST, 2015, MED PHYS, V42, P846, DOI 10.1118/1.4905489; Barlind A, 2010, EXP BRAIN RES, V201, P781, DOI 10.1007/s00221-009-2095-8; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Gondi V, 2014, J CLIN ONCOL, V32, P3810, DOI 10.1200/JCO.2014.57.2909; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Li J, 2007, J CLIN ONCOL, V25, P1260, DOI 10.1200/JCO.2006.09.2536; Linninger AA, 2008, IEEE T BIOMEDICAL EN, V55; Marsh JC, 2010, INT J RADIAT ONCOL, V76, P504, DOI 10.1016/j.ijrobp.2009.02.038; Meyers CA, 2004, J CLIN ONCOL, V22, P157, DOI 10.1200/JCO.2004.05.128; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Newton J, 2011, MED PHYS, V38, P6754, DOI 10.1118/1.3663675; Parihar VK, 2014, TRANSL CANCER RES, V3, P124, DOI 10.3978/j.issn.2218-676X.2013.06.02; Parihar VK, 2013, P NATL ACAD SCI USA, V110, P12822, DOI 10.1073/pnas.1307301110; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Rankine LJ, 2013, PHYS MED BIOL, V58, P7791, DOI 10.1088/0031-9155/58/21/7791; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41	17	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143208	10.1371/journal.pone.0143208	http://dx.doi.org/10.1371/journal.pone.0143208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636762	gold, Green Published, Green Submitted			2022-12-26	WOS:000366143800006
J	Dong, XJ; Tsuji, J; Labadorf, A; Roussos, P; Chen, JF; Myers, RH; Akbarian, S; Weng, ZP				Dong, Xianjun; Tsuji, Junko; Labadorf, Adam; Roussos, Panos; Chen, Jiang-Fan; Myers, Richard H.; Akbarian, Schahram; Weng, Zhiping			The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN GENOME; EPIGENETIC DYSREGULATION; HISTONE MODIFICATIONS; TRINUCLEOTIDE REPEAT; PREFRONTAL CORTEX; CELL IDENTITY; EPH RECEPTORS; CHROMATIN; ENHANCERS	Huntington's disease (HD) is an autosomal-dominant neurodegenerative disorder resulting from expansion of CAG repeats in the Huntingtin (HTT) gene. Previous studies have shown mutant HTT can alter expression of genes associated with dysregulated epigenetic modifications. One of the most widely studied chromatin modifications is trimethylated lysine 4 of histone 3 (H3K4me3). Here, we conducted the first comprehensive study of H3K4me3 ChIP-sequencing in neuronal chromatin from the prefrontal cortex of six HD cases and six non-neurologic controls, and its association with gene expression measured by RNA-sequencing. We detected 2,830 differentially enriched H3K4me3 peaks between HD and controls, with 55% of them down-regulated in HD. Although H3K4me3 signals are expected to be associated with mRNA levels, we found an unexpected discordance between altered H3K4me3 peaks and mRNA levels. Gene ontology (GO) term enrichment analysis of the genes with differential H3K4me3 peaks, revealed statistically significantly enriched GO terms only in the genes with down-regulated signals in HD. The most frequently implicated biological process terms are organ morphogenesis and positive regulation of gene expression. More than 9,000 H3K4me3 peaks were located not near any recognized transcription start sites and approximately 36% of these "distal" peaks co-localized to known enhancer sites. Six transcription factors and chromatin remodelers are differentially enriched in HD H3K4me3 distal peaks, including EZH2 and SUZ12, two core subunits of the polycomb repressive complex 2 (PRC2). Moreover, PRC2 repressive state was significantly depleted in HD-enriched peaks, suggesting the epigenetic role of PRC2 inhibition associated with up-regulated H3K4me3 in Huntington's disease. In summary, our study provides new insights into transcriptional dysregulation of Huntington's disease by analyzing the differentiation of H3K4me3 enrichment.	[Dong, Xianjun; Tsuji, Junko; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01003 USA; [Labadorf, Adam; Chen, Jiang-Fan; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Labadorf, Adam; Myers, Richard H.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Roussos, Panos; Akbarian, Schahram] Mt Sinai Sch Med, Dept Psychiat, Friedman Brain Inst, New York, NY USA; [Roussos, Panos] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Myers, Richard H.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Boston University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01003 USA.	zhiping.weng@umassmed.edu	Dong, Xianjun/N-3867-2014	Dong, Xianjun/0000-0002-8052-9320; Chen, Jiang-Fan/0000-0002-0446-3956; Tsuji, Junko/0000-0003-0139-3750; Labadorf, Adam/0000-0002-0753-8992	Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke [R01 NS073947]; National Institute of Mental Health [R01 MH106056]; NSF-EArly-concept Grants for Exploratory Research (EAGER) [PHY-1444389]; National Institutes of Health (NIH/NIA) [R01AG050986]; Veterans Affairs [BX002395]; PHS [HHSN-271-2013-00030C]; Division Of Physics [1444389] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH106056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050986] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF-EArly-concept Grants for Exploratory Research (EAGER); National Institutes of Health (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke (R01 NS073947; Epigenetic Markers in Huntington's disease Brain) National Institute of Mental Health (R01 MH106056; Higher Order Chromatin and Genetic Risk for Schizophrenia). The authors would like to acknowledge the Harvard Brain Tissue Resource Center McLean Hospital, Belmont, Massachusetts for providing the HD tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anshul Kundaje of Stanford University and the NIH Roadmap Epigenomics Consortium (nihroadmap.nih.gov/epigenomics/) for providing chromatin state data. We thank Iris Cheung for conducting ChIP-seq assays and the UMASS flow cytometry and sequencing cores for help with the experiments. This work was supported by the Jerry McDonald HD Research Fund and Public Health Service, National Institutes of Health grants, National Institute of Neurological disorders and stroke (R01 NS073947; Epigenetic Markers in Huntington's disease Brain) National Institute of Mental Health (R01 MH106056; Higher Order Chromatin and Genetic Risk for Schizophrenia), NSF-EArly-concept Grants for Exploratory Research (EAGER) (PHY-1444389), National Institutes of Health (NIH/NIA R01AG050986, Roussos) and the Veterans Affairs (Merit grant BX002395, Roussos). We would like to acknowledge the Harvard Brain Tissue Resource Center McLean Hospital (Belmont, Massachusetts), which is supported in part by PHS contract, HHSN-271-2013-00030C for providing the HD tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bai G, 2015, HUM MOL GENET, V24, P1441, DOI 10.1093/hmg/ddu561; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bharadwaj R, 2013, J NEUROSCI, V33, P11839, DOI 10.1523/JNEUROSCI.1252-13.2013; Biagioli M, 2015, HUM MOL GENET, V24, P2442, DOI 10.1093/hmg/ddv006; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Connor C, 2010, EPIGENETICS-US, V5, P392, DOI 10.4161/epi.5.5.11874; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hoss AG, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0083-3; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; Huntington G., 1872, MED SURG REP, V26, P320; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee J, 2013, NEUROTHERAPEUTICS, V10, P664, DOI 10.1007/s13311-013-0206-5; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milavetz BI, 2002, VIROLOGY, V294, P170, DOI 10.1006/viro.2001.1308; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Ng CW, 2013, P NATL ACAD SCI USA, V110, P2354, DOI 10.1073/pnas.1221292110; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ravache M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014311; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Rosas HD, 2014, NEUROLOGY, V82, P850, DOI 10.1212/WNL.0000000000000187; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shulha HP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003433; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Shulha HP, 2012, ARCH GEN PSYCHIAT, V69, P314, DOI 10.1001/archgenpsychiatry.2011.151; SOTREL A, 1991, NEUROLOGY, V41, P1117, DOI 10.1212/WNL.41.7.1117; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Unland R, 2014, J NEURO-ONCOL, V116, P237, DOI 10.1007/s11060-013-1313-1; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Villar-Menendez I, 2013, NEUROMOL MED, V15, P295, DOI 10.1007/s12017-013-8219-0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang J, 2012, NUCL ACIDS RES; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	88	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144398	10.1371/journal.pone.0144398	http://dx.doi.org/10.1371/journal.pone.0144398			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636336	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800087
J	Wang, SW; Yu, J; Suvira, M; Setlow, P; Li, YQ				Wang, Shiwei; Yu, Jing; Suvira, Milomir; Setlow, Peter; Li, Yong-qing			Uptake of and Resistance to the Antibiotic Berberine by Individual Dormant, Germinating and Outgrowing Bacillus Spores as Monitored by Laser Tweezers Raman Spectroscopy	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUBTILIS; ACID; DNA	Berberine, an alkaloid originally extracted from the plant Coptis chinensis and other herb plants, has been used as a pharmacological substance for many years. The therapeutic effect of berberine has been attributed to its interaction with nucleic acids and blocking cell division. However, levels of berberine entering individual microbial cells minimal for growth inhibition and its effects on bacterial spores have not been determined. In this work the kinetics and levels of berberine accumulation by individual dormant and germinated spores were measured by laser tweezers Raman spectroscopy and differential interference and fluorescence microscopy, and effects of berberine on spore germination and outgrowth and spore and growing cell viability were determined. The major conclusions from this work are that: (1) colony formation from B. subtilis spores was blocked similar to 99% by 25 mu g/mL berberine plus 20 mu g/mL INF55 (a multidrug resistance pump inhibitor); (2) 200 mu g/mL berberine had no effect on B. subtilis spore germination with L-valine, but spore outgrowth was completely blocked; (3) berberine levels accumulated in single spores germinating with >= 25 mu g/mL berberine were > 10 mg/mL; (4) fluorescence microscopy showed that germinated spores accumulated high-levels of berberine primarily in the spore core, while dormant spores accumulated very low berberine levels primarily in spore coats; and (5) during germination, uptake of berberine began at the time of commitment (T-1) and reached a maximum after the completion of CaDPA release (T-release) and spore cortex lysis (T-lysis).	[Wang, Shiwei; Yu, Jing; Li, Yong-qing] E Carolina Univ, Dept Phys, Greenville, NC 27858 USA; [Suvira, Milomir; Setlow, Peter] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA	University of North Carolina; East Carolina University	Li, YQ (corresponding author), E Carolina Univ, Dept Phys, Greenville, NC 27858 USA.	liy@ecu.edu		Suvira, Milomir/0000-0003-2086-1388	Army Research Office [W911NF-12-2-0024, W911F-09-1-0286]; Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory	Army Research Office; Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory	This work was supported by a grant from the Army Research Office under contract number W911NF-12-2-0024 and by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Army Research Office under contract number W911NF-12-2-0024 and by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to Barbara Setlow for assistance with one experiment.	AMIN AH, 1969, CAN J MICROBIOL, V15, P1067, DOI 10.1139/m69-190; Ball AR, 2006, ACS CHEM BIOL, V1, P594, DOI 10.1021/cb600238x; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; DAVIDSON MW, 1977, NUCLEIC ACIDS RES, V4, P2697, DOI 10.1093/nar/4.8.2697; Domadia PN, 2008, BIOCHEMISTRY-US, V47, P3225, DOI 10.1021/bi7018546; Kong LB, 2011, NAT PROTOC, V6, P625, DOI 10.1038/nprot.2011.307; Kong LB, 2010, ANAL CHEM, V82, P8717, DOI 10.1021/ac1022327; Kong WJ, 2012, APPL MICROBIOL BIOT, V96, P503, DOI 10.1007/s00253-012-4302-y; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Mao LY, 2011, CURR MICROBIOL, V63, P198, DOI 10.1007/s00284-011-9967-4; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Olguin-Araneda V, 2015, RES MICROBIOL, V166, P236, DOI 10.1016/j.resmic.2014.07.017; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; Setlow P, 2012, FOOD MICROBIOLOGY FU, V4th, P45; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Taylor CT, 1999, EUR J PHARMACOL, V368, P111, DOI 10.1016/S0014-2999(99)00023-0; Tomkiewicz D, 2010, ANTIMICROB AGENTS CH, V54, P3219, DOI 10.1128/AAC.01715-09; Wang SW, 2015, J BACTERIOL, V197, P1095, DOI 10.1128/JB.02490-14; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; Yi XA, 2010, J BACTERIOL, V192, P3424, DOI 10.1128/JB.00326-10; Zhang PF, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3494567; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	26	6	6	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144183	10.1371/journal.pone.0144183	http://dx.doi.org/10.1371/journal.pone.0144183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636757	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800055
J	Crockett, T; Wright, N; Thornquist, S; Ariel, M; Wessel, R				Crockett, Thomas; Wright, Nathaniel; Thornquist, Stephen; Ariel, Michael; Wessel, Ralf			Turtle Dorsal Cortex Pyramidal Neurons Comprise Two Distinct Cell Types with Indistinguishable Visual Responses	PLOS ONE			English	Article							SUBTYPE-SPECIFIC GENES; SPINY STELLATE; IN-VIVO; INTERNEURONS; LAYER; CLASSIFICATION; PROJECTIONS; EXCITATION; MORPHOLOGY; DIVERSITY	A detailed inventory of the constituent pieces in cerebral cortex is considered essential to understand the principles underlying cortical signal processing. Specifically, the search for pyramidal neuron subtypes is partly motivated by the hypothesis that a subtype-specific division of labor could create a rich substrate for computation. On the other hand, the extreme integration of individual neurons into the collective cortical circuit promotes the hypothesis that cellular individuality represents a smaller computational role within the context of the larger network. These competing hypotheses raise the important question to what extent the computational function of a neuron is determined by its individual type or by its circuit connections. We created electrophysiological profiles from pyramidal neurons within the sole cellular layer of turtle visual cortex by measuring responses to current injection using whole-cell recordings. A blind clustering algorithm applied to these data revealed the presence of two principle types of pyramidal neurons. Brief diffuse light flashes triggered membrane potential fluctuations in those same cortical neurons. The apparently network driven variability of the visual responses concealed the existence of subtypes. In conclusion, our results support the notion that the importance of diverse intrinsic physiological properties is minimized when neurons are embedded in a synaptic recurrent network.	[Crockett, Thomas; Wright, Nathaniel; Thornquist, Stephen; Wessel, Ralf] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Ariel, Michael] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO USA	Washington University (WUSTL); Saint Louis University	Crockett, T (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	thomas.crockett@wustl.edu			National Science Foundation CRCNS grant [1308159]; Whitehall Foundation [20121221]; NSF CRCNS grant [1308159]; Direct For Computer & Info Scie & Enginr [1308159] Funding Source: National Science Foundation	National Science Foundation CRCNS grant; Whitehall Foundation; NSF CRCNS grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was funded by National Science Foundation CRCNS grant (#1308159, RW) and by the Whitehall Foundation, grant number (#20121221, RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mahmood Hosseini for his help in developing the computational model. This research was supported by a Whitehall Foundation grant #20121221 and a NSF CRCNS grant #1308159 to R. Wessel.	Andjelic S, 2009, J NEUROPHYSIOL, V101, P641, DOI 10.1152/jn.91094.2008; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Battaglia D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00013; Bekkers JM, 2013, TRENDS NEUROSCI, V36, P429, DOI 10.1016/j.tins.2013.04.005; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brumback A, 2014, NEUROLOGY S7, V82, pS329; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; CALVIN WH, 1976, J NEUROPHYSIOL, V39, P420, DOI 10.1152/jn.1976.39.2.420; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; Colombe JB, 2004, J COMP NEUROL, V471, P333, DOI 10.1002/cne.20037; CONNORS BW, 1986, J NEUROSCI, V6, P164; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Desan P.H., 1984, THESIS; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Fournier J, 2015, CURR OPIN NEUROBIOL, V31, P119, DOI 10.1016/j.conb.2014.09.006; Gallopin T, 2006, CEREB CORTEX, V16, P1440, DOI 10.1093/cercor/bhj081; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HELLER SB, 1987, ANAT EMBRYOL, V175, P505, DOI 10.1007/BF00309685; Helmstaedter M, 2009, CEREB CORTEX, V19, P938, DOI 10.1093/cercor/bhn138; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; KRIEGSTEIN AR, 1987, J NEUROSCI, V7, P2488; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; Larkum ME, 2008, J NEUROPHYSIOL, V99, P683, DOI 10.1152/jn.01076.2007; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Mancilla JG, 1998, VISUAL NEUROSCI, V15, P979, DOI 10.1017/S0952523898155190; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Molyneaux BJ, 2015, NEURON, V85, P275, DOI 10.1016/j.neuron.2014.12.024; Molyneaux BJ, 2009, J NEUROSCI, V29, P12343, DOI 10.1523/JNEUROSCI.6108-08.2009; Moore CI, 2010, CELL, V142, P184, DOI 10.1016/j.cell.2010.07.005; MULLIGAN KA, 1990, J COMP NEUROL, V296, P531, DOI 10.1002/cne.902960403; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; REINER A, 2000, EVOLUTIONARY DEV BIO, P83; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sachidhanandam S, 2013, NAT NEUROSCI, V16, P1671, DOI 10.1038/nn.3532; Saha D, 2011, J COMP PHYSIOL A, V197, P153, DOI 10.1007/s00359-010-0596-3; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Senseman DM, 1996, VISUAL NEUROSCI, V13, P963, DOI 10.1017/S0952523800009196; SHEN JM, 1986, J NEUROPHYSIOL, V56, P1626, DOI 10.1152/jn.1986.56.6.1626; Shepherd GM, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00030; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; SMITH LM, 1980, J COMP NEUROL, V190, P445, DOI 10.1002/cne.901900304; Soltesz I., 2006, DIVERSITY NEURONAL M; Sosulina L, 2006, MOL CELL NEUROSCI, V33, P57, DOI 10.1016/j.mcn.2006.06.005; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Swanson L. W., 2003, BRAIN ARCHITECTURE U; TAKAHASHI K, 1965, J NEUROPHYSIOL, V28, P908, DOI 10.1152/jn.1965.28.5.908; Thorndike R. L., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Ulinski P., 2007, P195; ULINSKI PS, 1986, J COMP NEUROL, V254, P529, DOI 10.1002/cne.902540406; Wang Y, 2006, NAT NEUROSCI, V9, P534, DOI 10.1038/nn1670; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	71	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144012	10.1371/journal.pone.0144012	http://dx.doi.org/10.1371/journal.pone.0144012			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633877	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000041
J	Lake, RJ; Devleesschauwer, B; Nasinyama, G; Havelaar, AH; Kuchenmuller, T; Haagsma, JA; Jensen, HH; Jessani, N; de Noordhout, CM; Angulo, FJ; Ehiri, JE; Molla, L; Agaba, F; Aungkulanon, S; Kumagai, Y; Speybroeck, N				Lake, Robin J.; Devleesschauwer, Brecht; Nasinyama, George; Havelaar, Arie H.; Kuchenmueller, Tanja; Haagsma, Juanita A.; Jensen, Helen H.; Jessani, Nasreen; de Noordhout, Charline Maertens; Angulo, Frederick J.; Ehiri, John E.; Molla, Lindita; Agaba, Friday; Aungkulanon, Suchunya; Kumagai, Yuko; Speybroeck, Niko			National Studies as a Component of the World Health Organization Initiative to Estimate the Global and Regional Burden of Foodborne Disease	PLOS ONE			English	Article							ALBANIA	Background The World Health Organization (WHO) initiative to estimate the global burden of foodborne diseases established the Foodborne Diseases Burden Epidemiology Reference Group (FERG) in 2007. In addition to global and regional estimates, the initiative sought to promote actions at a national level. This involved capacity building through national foodborne disease burden studies, and encouragement of the use of burden information in setting evidence-informed policies. To address these objectives a FERG Country Studies Task Force was established and has developed a suite of tools and resources to facilitate national burden of foodborne disease studies. This paper describes the process and lessons learned during the conduct of pilot country studies under the WHO FERG initiative. Findings Pilot country studies were initiated in Albania, Japan and Thailand in 2011 and in Uganda in 2012. A brief description of each study is provided. The major scientific issue is a lack of data, particularly in relation to disease etiology, and attribution of disease burden to foodborne transmission. Situation analysis, knowledge translation, and risk communication to achieve evidence-informed policies require specialist expertise and resources. Conclusions The FERG global and regional burden estimates will greatly enhance the ability of individual countries to fill data gaps and generate national estimates to support efforts to reduce the burden of foodborne disease.	[Lake, Robin J.] Inst Environm Sci & Res, Christchurch, New Zealand; [Devleesschauwer, Brecht] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Devleesschauwer, Brecht] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Devleesschauwer, Brecht; de Noordhout, Charline Maertens; Speybroeck, Niko] Catholic Univ Louvain, Fac Publ Hlth, Inst Hlth & Soc, B-1200 Brussels, Belgium; [Devleesschauwer, Brecht; Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Nasinyama, George] Makerere Univ, Kampala, Uganda; [Kuchenmueller, Tanja] WHO Reg Off Europe, Div Informat Evidence Res & Innovat, Copenhagen, Denmark; [Haagsma, Juanita A.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Jensen, Helen H.] Iowa State Univ, Ames, IA USA; [Jessani, Nasreen] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Angulo, Frederick J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Ehiri, John E.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Molla, Lindita] Inst Publ Hlth, Hlth & Environm Dept, Food Safety & Nutr Sect, Tirana, Albania; [Agaba, Friday] Minist Hlth, Natl Drug Author, Kampala, Uganda; [Aungkulanon, Suchunya] Minist Publ Hlth, Int Hlth Policy Program, Bangkok, Thailand; [Kumagai, Yuko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan	Institute of Environmental Science & Research (ESR) - New Zealand; Ghent University; Institute of Tropical Medicine (ITM); Universite Catholique Louvain; State University System of Florida; University of Florida; Makerere University; World Health Organization; Erasmus University Rotterdam; Erasmus MC; Iowa State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; University of Arizona; Ministry of Public Health - Thailand; University of Tokyo	Lake, RJ (corresponding author), Inst Environm Sci & Res, Christchurch, New Zealand.	rob.lake@esr.cri.nz	Havelaar, Arie H./P-8495-2014; NASINYAMA, GEORGE/GVS-7396-2022; Nasinyama, George/AAN-3148-2020; Jessani, Nasreen/AAB-5518-2020; Devleesschauwer, Brecht/G-9895-2018	Havelaar, Arie H./0000-0002-6456-5460; Jessani, Nasreen/0000-0002-1160-3099; Devleesschauwer, Brecht/0000-0002-2867-6892; Jensen, Helen/0000-0001-6878-1729; Speybroeck, Niko/0000-0003-3322-3502	World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	This study was commissioned and paid for by the World Health Organization (WHO). Copyright in the original work on which this article is based belongs to WHO. The authors have been given permission to publish this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, apart from Tanja Kuchenmuller who is an employee of WHO and participated in the country studies described in the article, and the writing.	Agaba F., 2015, FERG WHO IN EST GLOB; [Anonymous], 2008, WHO IN EST GLOB BURD; [Anonymous], 2001, NATL BURDEN DIS STUD; Bennett G., 2011, KNOWLEDGE TRANSLATIO; Codex Alimentarius Commission, 632007 CACGL; Devleesschauwer B, 2013, J Nepal Health Res Counc, V11, P221; Etienne Carissa F, 2013, J Health Popul Nutr, V31, P1; Fabiana A, 2007, J MED VIROL, V79, P1844, DOI 10.1002/jmv.21001; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Institute for Health Metrics and Evaluation, 2013, COUNTR PROF; Kangethe E., 2011, SITUATION ANAL IMPRO; Kumagai Y, 2015, B WORLD HEALTH ORGAN, V93, P540, DOI 10.2471/BLT.14.148056; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Sejdini A, 2011, ANN TROP MED PARASIT, V105, P241, DOI 10.1179/136485911X12987676649584; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; UNICEF, 2013, ALB CHILDR ALB HLTH; Valenciano M, 2004, EURO SURVEILL, V9; [No title captured]	20	12	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0140319	10.1371/journal.pone.0140319	http://dx.doi.org/10.1371/journal.pone.0140319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633010	Green Published, gold, Green Submitted			2022-12-26	WOS:000366040000001
J	Spracklen, BD; Kalamandeen, M; Galbraith, D; Gloor, E; Spracklen, DV				Spracklen, B. D.; Kalamandeen, M.; Galbraith, D.; Gloor, E.; Spracklen, D. V.			A Global Analysis of Deforestation in Moist Tropical Forest Protected Areas	PLOS ONE			English	Article							CLIMATE-CHANGE; PERFORMANCE; LOCATION; PARKS	Protected areas (PAs) have been established to conserve tropical forests, but their effectiveness at reducing deforestation is uncertain. To explore this issue, we combined high resolution data of global forest loss over the period 2000-2012 with data on PAs. For each PA we quantified forest loss within the PA, in buffer zones 1, 5, 10 and 15 km outside the PA boundary as well as a 1 km buffer within the PA boundary. We analysed 3376 tropical and subtropical moist forest PAs in 56 countries over 4 continents. We found that 73% of PAs experienced substantial deforestation pressure, with >0.1% a(-1) forest loss in the outer 1 km buffer. Forest loss within PAs was greatest in Asia (0.25% a(-1)) compared to Africa (0.1% a(-1)), the Neotropics (0.1% a(-1)) and Australasia (Australia and Papua New Guinea; 0.03% a(-1)). We defined performance (P) of a PA as the ratio of forest loss in the inner 1 km buffer compared to the loss that would have occurred in the absence of the PA, calculated as the loss in the outer 1 km buffer corrected for any difference in deforestation pressure between the two buffers. To remove the potential bias due to terrain, we analysed a subset of PAs (n = 1804) where slope and elevation in inner and outer 1 km buffers were similar (within 1 degrees and 100 m, respectively). We found 41% of PAs in this subset reduced forest loss in the inner buffer by at least 25% compared to the expected inner buffer forest loss (P<0.75). Median performance (<(P)over tilde>) of subset reserves was 0.87, meaning a reduction in forest loss within the PA of 13%. We found PAs were most effective in Australasia ((P) over tilde = 0.16), moderately successful in the Neotropics ((P) over tilde = 0.72) and Africa ((P) over tilde = 0.83), but ineffective in Asia ((P) over tilde = 1). We found many countries have PAs that give little or no protection to forest loss, particularly in parts of Asia, west Africa and central America. Across the tropics, the median effectiveness of PAs at the national level improved with gross domestic product per capita. Whilst tropical and subtropical moist forest PAs do reduce forest loss, widely varying performance suggests substantial opportunities for improved protection, particularly in Asia.	[Spracklen, B. D.; Spracklen, D. V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Kalamandeen, M.; Galbraith, D.; Gloor, E.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Spracklen, B. D.] Rowans, Thomastown AB54 6AJ, Huntly, Scotland	University of Leeds; University of Leeds	Spracklen, BD (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	b10spracklen@gmail.com	Galbraith, David/AAE-8162-2019; Spracklen, Dominick/AAA-6257-2019; Spracklen, Dominick V/B-4890-2014	Galbraith, David/0000-0002-5555-4823; Kalamandeen, Michelle/0000-0001-5385-7444	United Bank of Carbon (UBoC); Natural Environment Research Council [NE/G015015/1]; NERC [NE/F005806/1, NE/K01644X/1] Funding Source: UKRI; Natural Environment Research Council [NE/F005806/1, NE/K01644X/1] Funding Source: researchfish	United Bank of Carbon (UBoC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors acknowledge the United Bank of Carbon (UBoC) and a Natural Environment Research Council grant (NE/G015015/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Beresford AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065370; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Clark NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065298; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; FAO, 2010, GLOBAL FOREST RESOUR; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Huang CQ, 2007, REMOTE SENS ENVIRON, V106, P460, DOI 10.1016/j.rse.2006.09.016; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; NELSON A, 2009, PROTECTED AREA EFFEC; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Scharlemann JPW, 2010, ORYX, V44, P352, DOI 10.1017/S0030605310000542; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; WorldBank, 2015, WORLDWIDE GOVERNANCE; Wright SJ, 2007, ECOL APPL, V17, P1259, DOI 10.1890/06-1330.1	37	79	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143886	10.1371/journal.pone.0143886	http://dx.doi.org/10.1371/journal.pone.0143886			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26632842	Green Published, gold			2022-12-26	WOS:000366040000028
J	Anegawa, E; Kotorii, N; Ishimaru, Y; Okuro, M; Sakai, N; Nishino, S				Anegawa, Emiko; Kotorii, Nozomu; Ishimaru, Yuji; Okuro, Masashi; Sakai, Noriaki; Nishino, Seiji			Chronic Powder Diet After Weaning Induces Sleep, Behavioral, Neuroanatomical, and Neurophysiological Changes in Mice	PLOS ONE			English	Article							AGED SAMP8 MICE; SOFT-DIET; MAST-CELLS; BRAIN HISTAMINE; SPATIAL MEMORY; DENTATE GYRUS; MOLAR TEETH; MASTICATORY FUNCTION; DAYTIME SLEEPINESS; COGNITIVE FUNCTION	The purpose of this study is to clarify the effects of chronic powder diet feeding on sleep patterns and other physiological/anatomical changes in mice. C57BL/6 male mice were divided into two groups from weaning: a group fed with solid food (SD) and a group fed with powder food (PD), and sleep and physiological and anatomical changes were compared between the groups. PD exhibited less cranial bone structure development and a significant weight gain. Furthermore, these PD mice showed reduced number of neurogenesis in the hippocampus. Sleep analysis showed that PD induced attenuated diurnal sleep/wake rhythm, characterized by increased sleep during active period and decreased sleep during rest period. With food deprivation (FD), PD showed less enhancement of wake/locomotor activity compared to SD, indicating reduced food-seeking behavior during FD. These results suggest that powder feeding in mice results in a cluster of detrimental symptoms caused by abnormal energy metabolism and anatomical/neurological changes.	[Anegawa, Emiko; Kotorii, Nozomu; Ishimaru, Yuji; Okuro, Masashi; Sakai, Noriaki; Nishino, Seiji] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Sleep & Circadian Neurobiol Lab,Sleep Res Ctr, Palo Alto, CA 94304 USA; [Anegawa, Emiko] Kurume Univ, Sch Med, Dept Oral & Maxillofacial Surg, Kurume, Fukuoka 830, Japan; [Anegawa, Emiko] Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa 232, Japan	Stanford University; Kurume University; Yokohama City University	Nishino, S (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Sleep & Circadian Neurobiol Lab,Sleep Res Ctr, Palo Alto, CA 94304 USA.	nishino@stanfrod.edu			Mishima Kaiun Foundation	Mishima Kaiun Foundation	EA received a research grant from Mishima Kaiun Foundation. http://www.mishima-kaiun.or.jp/assist/gakujutu.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Aoki H, 2005, GERONTOLOGY, V51, P369, DOI 10.1159/000088700; Bauer KW, 2009, PREV MED, V48, P284, DOI 10.1016/j.ypmed.2008.12.021; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Borsini F, 2002, PSYCHOPHARMACOLOGY, V163, P121, DOI 10.1007/s00213-002-1155-6; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; Enomoto A, 2010, EUR J ORTHODONT, V32, P66, DOI 10.1093/ejo/cjp060; FUJISE T, 1993, BRAIN RES BULL, V32, P555, DOI 10.1016/0361-9230(93)90307-W; Fujise T, 1998, P SOC EXP BIOL MED, V217, P228; GALLI SJ, 1987, AM J PATHOL, V127, P191; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Goto S, 2015, ANGLE ORTHOD, V85, P969, DOI 10.2319/102214-765.1; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Guan Z, 2008, SLEEP, V31, P627, DOI 10.1093/sleep/31.5.627; Hamada Y, 2014, OBESITY, V22, pE62, DOI 10.1002/oby.20715; Hashimoto K, 2011, ARCH ORAL BIOL, V56, P1610, DOI 10.1016/j.archoralbio.2011.06.015; Hichijo N, 2014, J ORAL REHABIL, V41, P581, DOI 10.1111/joor.12171; Ho YJ, 2002, BEHAV BRAIN RES, V136, P1, DOI 10.1016/S0166-4328(02)00089-X; Ishizuka T, 2010, BRAIN RES, V1313, P97, DOI 10.1016/j.brainres.2009.11.058; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; JOHNSON D, 1992, NEUROCHEM RES, V17, P939, DOI 10.1007/BF00993271; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; KATSAROS C, 1994, EUR J ORTHODONT, V16, P353, DOI 10.1093/ejo/16.5.353; KILIARIDIS S, 1985, EUR J ORTHODONT, V7, P273, DOI 10.1093/ejo/7.4.273; Kubo K, 2005, BRAIN RES, V1057, P191, DOI 10.1016/j.brainres.2005.07.038; KUSHIDA CA, 1985, ELECTROEN CLIN NEURO, V61, P61, DOI 10.1016/0013-4694(85)91073-9; Kushida S, 2008, NEUROSCI LETT, V439, P208, DOI 10.1016/j.neulet.2008.05.017; Li J, 2011, AM J CLIN NUTR, V94, P709, DOI 10.3945/ajcn.111.015164; MAEYAMA K, 1983, J NEUROCHEM, V41, P128, DOI 10.1111/j.1471-4159.1983.tb11823.x; Mitome M, 2005, NEUROREPORT, V16, P249, DOI 10.1097/00001756-200502280-00009; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Miura H, 2000, J ORAL REHABIL, V27, P731, DOI 10.1046/j.1365-2842.2000.00590.x; Ogawa A, 2003, NEUROSCIENCE, V120, P1081, DOI 10.1016/S0306-4522(03)00214-8; Oka K, 2003, J DENT RES, V82, P491, DOI 10.1177/154405910308200617; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Onozuka M, 2002, BEHAV BRAIN RES, V133, P197, DOI 10.1016/S0166-4328(02)00006-2; Onozuka M, 1999, BRAIN RES, V826, P148, DOI 10.1016/S0006-8993(99)01255-X; Onozuka M, 2000, BEHAV BRAIN RES, V108, P145, DOI 10.1016/S0166-4328(99)00145-X; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Ranawana V, 2010, NUTR RES, V30, P382, DOI 10.1016/j.nutres.2010.06.002; Ranawana V, 2010, NUTR RES, V30, P246, DOI 10.1016/j.nutres.2010.02.004; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Resta O, 2003, J INTERN MED, V253, P536, DOI 10.1046/j.1365-2796.2003.01133.x; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Scherder E, 2008, J ORAL REHABIL, V35, P324, DOI 10.1111/j.1365-2842.2007.01842.x; Shan L, 2015, NAT REV NEUROL, V11, P401, DOI 10.1038/nrneurol.2015.99; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Stephens R, 2004, APPETITE, V43, P211, DOI 10.1016/j.appet.2004.07.006; Takigami K, 2002, J SHIGA U MED SCI, V17, P29; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Watanabe K, 2002, BEHAV BRAIN RES, V128, P19, DOI 10.1016/S0166-4328(01)00268-6; Watanabe K, 2001, EXP GERONTOL, V36, P283, DOI 10.1016/S0531-5565(00)00216-3; Wilkinson L, 2002, APPETITE, V38, P235, DOI 10.1006/appe.2002.0473; Yamamoto T, 2001, BRAIN RES, V902, P255, DOI 10.1016/S0006-8993(01)02410-6; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yanagisawa Y, 1985, Shoni Shikagaku Zasshi, V23, P962; Zhu Y, 2015, INT J FOOD SCI NUTR, V66, P135, DOI 10.3109/09637486.2014.979317	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143909	10.1371/journal.pone.0143909	http://dx.doi.org/10.1371/journal.pone.0143909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630494	gold, Green Published			2022-12-26	WOS:000365926300119
J	Luci, C; Bekri, S; Bihl, F; Pini, J; Bourdely, P; Nouhen, K; Malgogne, A; Walzer, T; Braud, VM; Anjuere, F				Luci, Carmelo; Bekri, Selma; Bihl, Franck; Pini, Jonathan; Bourdely, Pierre; Nouhen, Kelly; Malgogne, Angelique; Walzer, Thierry; Braud, Veronique M.; Anjuere, Fabienne			NKp46(+) Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ROR-GAMMA-T; SIMPLEX-VIRUS TYPE-2; MOUSE NK CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; B-CELL; MUCOSAL; ACTIVATION; DIFFERENTIATION	Innate and adaptive immune cells work in concert to generate efficient protection at mucosal surface. Vaginal mucosa is an epithelial tissue that contains innate and adaptive immune effector cells. Our previous studies demonstrated that vaginal administration of Cholera toxin -based vaccines generate antigen-specific CD8 T cells through the stimulation of local dendritic cells (DC). Innate lymphoid cells (ILC) are a group of lymphocytes localized in epithelial tissues that have important immune functions against pathogens and in tissue homeostasis. Their contribution to vaccine-induced mucosal T cell responses is an important issue for the design of protective vaccines. We report here that the vaginal mucosa contains a heterogeneous population of NKp46(+) ILC that includes conventional NK cells and ILC1-like cells. We show that vaginal NKp46(+) ILC dampen vaccine-induced CD8 T cell responses generated after local immunization. Indeed, in vivo depletion of NKp46(+) ILC with anti-NK1.1 antibody or NKG2D blockade increases the magnitude of vaginal OVA-specific CD8 T cells. Furthermore, such treatments also increase the number of DC in the vagina. NKG2D ligands being expressed by vaginal DC but not by CD8 T cells, these results support that NKp46(+) ILC limit mucosal CD8 T cell responses indirectly through the NKG2D-dependent elimination of vaginal DC. Our data reveal an unappreciated role of NKp46(+) ILC in the regulation of mucosal CD8 T cell responses.	[Luci, Carmelo; Bekri, Selma; Bihl, Franck; Bourdely, Pierre; Nouhen, Kelly; Malgogne, Angelique; Braud, Veronique M.; Anjuere, Fabienne] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; [Luci, Carmelo; Bekri, Selma; Bihl, Franck; Bourdely, Pierre; Nouhen, Kelly; Malgogne, Angelique; Braud, Veronique M.; Anjuere, Fabienne] CNRS, Unite Mixte Rech 7275, Sophia Antipolis, France; [Luci, Carmelo; Anjuere, Fabienne] INSERM, Inst Pharmacol Mol & Cellulaire, F-75654 Paris 13, France; [Pini, Jonathan] Univ Nice Sophia Antipolis, CNRS, Unite Mixte Rech 7370, Lab PhysioMed Mol, F-06189 Nice, France; [Walzer, Thierry] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, INSERM,U1111,Unite Mixte Rech 5308,Ctr Int Rech I, F-69365 Lyon, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Luci, C (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France.	luci@ipmc.cnrs.fr	braud, veronique M/I-4597-2013; Walzer, Thierry/L-9418-2014; LUCI, Carmelo/ABA-6373-2021; Anjuere-Casile, Fabienne/O-5779-2016	braud, veronique M/0000-0001-8213-3947; Walzer, Thierry/0000-0002-0857-8179; LUCI, Carmelo/0000-0001-9687-4164; Anjuere-Casile, Fabienne/0000-0003-3144-8652; Bekri, Selma/0000-0003-2045-386X; BIHL, Franck/0000-0002-8808-8152	EU FP7 Euroneut-41 Consortium; National Research Agency (ANR) [ANR-11-LABX-0028-01]; SIDACTION, Canceropole Provence Alpes Cote d'Azur, French National Agency	EU FP7 Euroneut-41 Consortium; National Research Agency (ANR)(French National Research Agency (ANR)); SIDACTION, Canceropole Provence Alpes Cote d'Azur, French National Agency	Support was provided by SIDACTION, Canceropole Provence Alpes Cote d'Azur, French National Agency in the form of salaries for authors Selma Bekri and Kelly Nouhen; the EU FP7 Euroneut-41 Consortium; and the National Research Agency, (ANR) through the "Investments for the Future" LABEX SIGNALIFE: program reference # ANR-11-LABX-0028-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Anjuere F, 2012, CLIN MICROBIOL INFEC, V18, P117, DOI 10.1111/j.1469-0691.2012.03995.x; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Barao I, 2011, BLOOD, V117, P7032, DOI 10.1182/blood-2010-11-316653; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Crouse J, 2014, TRENDS IMMUNOL; Crouse J, 2014, IMMUNITY, V40, P961, DOI 10.1016/j.immuni.2014.05.003; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; ELSON CO, 1989, CURR TOP MICROBIOL, V146, P29; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Hervouet C, 2014, MUCOSAL IMMUNOL, V7, P280, DOI 10.1038/mi.2013.45; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Hervouet C, 2010, J IMMUNOL, V184, P4842, DOI 10.4049/jimmunol.0901695; HOLMGREN J, 1981, NATURE, V292, P413, DOI 10.1038/292413a0; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Luci C, 2006, J IMMUNOL, V176, P2749, DOI 10.4049/jimmunol.176.5.2749; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Morandi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039170; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rouzaire P, 2012, EUR J IMMUNOL, V42, P80, DOI 10.1002/eji.201141820; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Welsh RM, 2013, VIROLOGY, V435, P37, DOI 10.1016/j.virol.2012.10.005; Xu HC, 2014, IMMUNITY, V40, P949, DOI 10.1016/j.immuni.2014.05.004	56	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143224	10.1371/journal.pone.0143224	http://dx.doi.org/10.1371/journal.pone.0143224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630176	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300036
J	Viprey, M; Caillet, P; Canat, G; Jaglal, S; Haesebaert, J; Chapurlat, R; Schott, AM				Viprey, Marie; Caillet, Pascal; Canat, Guillaume; Jaglal, Susan; Haesebaert, Julie; Chapurlat, Roland; Schott, Anne-Marie			Low Osteoporosis Treatment Initiation Rate in Women after Distal Forearm or Proximal Humerus Fracture: A Healthcare Database Nested Cohort Study	PLOS ONE			English	Article							HIP FRACTURE; FOLLOW-UP; FRAGILITY FRACTURE; RADIAL FRACTURE; WRIST FRACTURES; POPULATION; TRAUMA; EPIDEMIOLOGY; PREVALENCE; GUIDELINES	Treatment initiation rates following fragility fractures have often been reported to be low and in recent years numerous programs have been implemented worldwide to increase them. This study aimed at describing osteoporosis (OP) treatment initiation in a representative sample of women who were hospitalized for a distal forearm fracture (DFF) or proximal humerus fracture (PHF) in 2009-2011 in France. The data source was a nationwide sample of 600,000 individuals, extracted from the French National Insurance Healthcare System database. All women aged 50 years and older who were hospitalized for a DFF or PHF between 2009 and 2011 and who had not received any OP treatment in the preceding 12 months were included in a retrospective cohort study. OP treatments initiated during the year following the fracture were analyzed. From 2009 to 2011, 729 women were hospitalized for a DFF or a PHF and 284 were on OP treatment at the time of the fracture occurrence. Among the 445 women who had no prevalent OP treatment, 131 (29.4%) received supplementation treatment only (vitamin D and/or calcium) and 42 (9.4%) received a pharmacologic OP treatment in the year following their fracture. Pharmacological OP treatments included bisphosphonates (n = 21), strontium ranelate (n = 14), hormone replacement therapy (n = 4), or raloxifene (n = 3). General practitioners prescribed 75% of initial OP treatments. Despite the guidelines published in 2006 and the numerous initiatives to promote post-fracture OP treatment, OP treatment initiation rate in women who were hospitalized for a fragility fracture remained low in 2009-2011 in France.	[Viprey, Marie; Caillet, Pascal; Canat, Guillaume; Haesebaert, Julie; Schott, Anne-Marie] Hosp Civils Lyon, Pole Informat Med, Evaluat, Rech, Lyon, France; [Viprey, Marie; Caillet, Pascal; Chapurlat, Roland; Schott, Anne-Marie] Univ Lyon 1, Fac Med Lyon Est, F-69365 Lyon, France; [Caillet, Pascal] Ctr Hosp Univ Amiens, Dept Epidemiol Hyg Hosp & Sante Publ, Amiens, France; [Caillet, Pascal; Chapurlat, Roland; Schott, Anne-Marie] INSERM, U1033, F-69008 Lyon, France; [Canat, Guillaume] Ctr Hosp Univ Reunion, Grp Hosp Sud Reunion, Dept Informat Med, St Pierre, France; [Jaglal, Susan] Univ Toronto, Dept Phys Therapy, Toronto Rehabil Inst, UHN Chair, Toronto, ON, Canada; [Chapurlat, Roland] Hosp Civils Lyon, Grp Hosp Edouard Herriot, Serv Rhumatol & Pathol Osseuse, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Reunion; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; CHU Lyon	Viprey, M (corresponding author), Hosp Civils Lyon, Pole Informat Med, Evaluat, Rech, Lyon, France.	marie.viprey@chu-lyon.fr	HAESEBAERT, JULIE/E-7141-2017; Caillet, Pascal/K-5299-2019; CHAPURLAT, ROLAND/AAU-1165-2021; Haesebaert, Julie/AAN-1702-2020; Schott, Anne-Marie/V-7580-2018; Viprey, Marie/AAH-2856-2020	HAESEBAERT, JULIE/0000-0001-9109-5604; Caillet, Pascal/0000-0001-5667-7887; Haesebaert, Julie/0000-0001-9109-5604; Schott, Anne-Marie/0000-0003-3337-4474; Viprey, Marie/0000-0002-3281-1970; Jaglal, Susan/0000-0002-2930-1443				Andrade SE, 2003, ARCH INTERN MED, V163, P2052, DOI 10.1001/archinte.163.17.2052; Bahari S, 2007, INJURY, V38, P759, DOI 10.1016/j.injury.2006.11.007; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Boudou L, 2011, OSTEOPOROSIS INT, V22, P2099, DOI 10.1007/s00198-011-1638-6; Briot K, 2012, JOINT BONE SPINE, V79, P304, DOI 10.1016/j.jbspin.2012.02.014; Cadarette SM, 2005, J RHEUMATOL, V32, P550; Canoui-Poitrine F, 2010, BONE, V47, P790, DOI 10.1016/j.bone.2010.06.026; Cuddihy MT, 1999, OSTEOPOROSIS INT, V9, P469, DOI 10.1007/s001980050172; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; De Roquefeuille L, 2009, PRATIQUES ORG SOINS, P40; Diez-Perez A, 2011, BONE, V49, P493, DOI 10.1016/j.bone.2011.05.007; Eisman J, 2004, J BONE MINER RES, V19, P1969, DOI 10.1359/JBMR.040905; Elliot-Gibson V, 2004, OSTEOPOROSIS INT, V15, P767, DOI 10.1007/s00198-004-1675-5; Freedman KB, 2000, J BONE JOINT SURG AM, V82A, P1063, DOI 10.2106/00004623-200008000-00001; GAY JDL, 1974, CAN MED ASSOC J, V111, P156; Hajcsar EE, 2000, CAN MED ASSOC J, V163, P819; Haute Autorite de Sante, 2006, PREV DIAGN TRAIT OST; Huot L, 2008, OSTEOPOROSIS INT, V19, P1047, DOI 10.1007/s00198-008-0587-1; Jaglal SB, 2005, J BONE MINER RES, V20, P898, DOI 10.1359/JBMR.041231; Juby AG, 2002, OSTEOPOROSIS INT, V13, P205, DOI 10.1007/s001980200015; Khan SA, 2001, ARCH INTERN MED, V161, P1309, DOI 10.1001/archinte.161.10.1309; Latry P, 2010, EUR J CLIN PHARMACOL, V66, P743, DOI 10.1007/s00228-010-0819-0; Leslie WD, 2012, OSTEOPOROSIS INT, V23, P1623, DOI 10.1007/s00198-011-1630-1; MALLMIN H, 1993, CALCIFIED TISSUE INT, V52, P269, DOI 10.1007/BF00296650; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P357, DOI 10.1007/BF01622198; Maravic M, 2014, ORTHOP TRAUMATOL-SUR, V100, P931, DOI 10.1016/j.otsr.2014.09.017; Maravic M, 2010, ORTHOP TRAUMATOL-SUR, V96, P662, DOI 10.1016/j.otsr.2010.04.012; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; Noize P, 2009, PHARMACOEPIDEM DR S, V18, P310, DOI 10.1002/pds.1717; PECK WA, 1993, AM J MED, V94, P646; Prior JC, 2015, BONE, V71, P237, DOI 10.1016/j.bone.2014.10.026; Reymondier A, 2013, OSTEOPOROSIS INT, V24, P559, DOI 10.1007/s00198-012-1999-5; Roux A, 2012, ORTHOP TRAUMATOL-SUR, V98, P715, DOI 10.1016/j.otsr.2012.05.013; Sale JEM, 2011, OSTEOPOROSIS INT, V22, P2067, DOI 10.1007/s00198-011-1544-y; Solomon DH, 2004, AM J MED, V117, P919, DOI 10.1016/j.amjmed.2004.06.040; Talbot JC, 2007, INJURY, V38, P1236, DOI 10.1016/j.injury.2007.03.004	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143842	10.1371/journal.pone.0143842	http://dx.doi.org/10.1371/journal.pone.0143842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630534	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300110
J	Zwolak, A; Szuster-Ciesielska, A; Daniluk, J; Slabczynska, O; Kandefer-Szerszen, M				Zwolak, Agnieszka; Szuster-Ciesielska, Agnieszka; Daniluk, Jadwiga; Slabczynska, Olga; Kandefer-Szerszen, Martyna			Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NITROSODIETHYLAMINE-INDUCED HEPATOCARCINOGENESIS; NONALCOHOLIC STEATOHEPATITIS; LIPID-PEROXIDATION; ACID; RATS; MICE; INFLAMMATION; STEATOSIS; CYTOKINES	Introduction and Aims Toll-like receptor 4 and proinflammatory cytokines play a central role in the progression of nonalcoholic fatty liver disease. We investigated IL-1, IL-6 and TNF alpha production and toll-like receptor 4 in both-obese and lean patients with non-alcoholic fatty liver disease who met different sets of metabolic syndrome criteria and linked the results with the disease burden. Materials and Methods 95 subjects were divided into four groups depending on the following criteria: presence or absence of metabolic syndrome and/or non-alcoholic fatty liver disease, glucose tolerance (prediabetes or normoglycemia) and BMI value (obese or lean). We determined the levels of IL-1 beta, IL-6, TNF alpha, and monocyte toll-like receptor 4 expression in fresh blood as well as in blood cultures treated with lipopolysaccharide with or without metformin, alphaketoglutarate or phosphatidylcholine supplementation. Results The blood leukocytes of patients with non-alcoholic fatty liver disease are hypersensitive to lipopolysaccharide treatment and produce elevated levels of pro-inflammatory cytokines in response to ex vivo treatment with lipopolysaccharide. Moreover, they overexpress toll-like receptor-4. Hyperreactivity was typical mainly for obese patients with non-alcoholic fatty liver disease together with metabolic syndrome and decreased with the severity of disease. Metformin was the most effective in attenuation of hyperreactivity in all groups of patients with non-alcoholic fatty liver disease, but in obese patients the effectiveness of metformin was weaker than in lean. The reduction of cytokine level by metformin was accompanied by the decrease in toll-like receptor-4 expression. phosphatidylcholine also attenuated hyperreactivity to lipopolysaccharide but mainly in obese patients. Alpha ketoglutarate did not modulate cytokines' level and toll-like receptor 4 expression in non-alcoholic fatty liver disease patients. Conclusions Metformin and phosphatidylcholine attenuated lipopolysaccharide induced toll-like receptor 4 overexpression and overproduction of pro-inflammatory cytokines; however, their efficacy depended on combined presence of non-alcoholic fatty liver disease, metabolic syndrome and obesity.	[Zwolak, Agnieszka; Daniluk, Jadwiga] Med Univ Lublin, Chair Internal Med, Lublin, Poland; [Zwolak, Agnieszka; Daniluk, Jadwiga] Med Univ Lublin, Dept Internal Nursing, Lublin, Poland; [Zwolak, Agnieszka] Med Univ Lublin, Dept & Clin Endocrinol, Lublin, Poland; [Daniluk, Jadwiga] Med Univ Lublin, Dept & Clin Gastroenterol, Lublin, Poland; [Szuster-Ciesielska, Agnieszka; Slabczynska, Olga; Kandefer-Szerszen, Martyna] Marie Curie Sklodowska Univ, Dept Virol & Immunol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Maria Curie-Sklodowska University	Zwolak, A (corresponding author), Med Univ Lublin, Chair Internal Med, Lublin, Poland.	zwolakag@wp.pl		Daniluk, Jadwiga/0000-0002-0635-2221	Medical University of Lublin Seed Funding Program for Basic Research [DS 506/2014]	Medical University of Lublin Seed Funding Program for Basic Research	This study was supported by the Medical University of Lublin Seed Funding Program for Basic Research (No DS 506/2014) to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2010, J PHARMACOL EXP THER, V334, P206, DOI 10.1124/jpet.109.164970; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bullard KM, 2013, DIABETES CARE, V36, P2286, DOI 10.2337/dc12-2563; Celinski K, 2014, J PHYSIOL PHARMACOL, V65, P75; Chung SJ, 2014, LIFE SCI, V108, P88, DOI 10.1016/j.lfs.2014.05.013; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Dakshayani KB, 2006, FUND CLIN PHARMACOL, V20, P477, DOI 10.1111/j.1472-8206.2006.00422.x; Dakshayani KB, 2006, J MED FOOD, V9, P90, DOI 10.1089/jmf.2006.9.90; de la Rosa LC, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.125; Dyson J, 2014, DIGEST DIS, V32, P597, DOI 10.1159/000360511; Dyson JK, 2014, FRONTLINE GASTROENTE, V5, P211, DOI 10.1136/flgastro-2013-100403; Harrison AP, 2008, J PHYSIOL PHARMACOL, V59, P91; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hassan K, 2014, WORLD J GASTROENTERO, V20, P12082, DOI 10.3748/wjg.v20.i34.12082; Hyun Bobae, 2013, Immune Netw, V13, P123, DOI 10.4110/in.2013.13.4.123; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Jung YY, 2013, KOREAN J PHYSIOL PHA, V17, P209, DOI 10.4196/kjpp.2013.17.3.209; Kesar V, 2014, LIVER INT, V34, P184, DOI 10.1111/liv.12315; Kim NH, 2014, LIVER INT, V34, P604, DOI 10.1111/liv.12454; Krawczyk K, 2009, J PHYSIOL PHARMACOL, V60, P71; Kumar Ramesh, 2013, Indian J Endocrinol Metab, V17, P665, DOI 10.4103/2230-8210.113758; Lee HS, 2014, LIFE SCI, V118, P7, DOI 10.1016/j.lfs.2014.09.027; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Lemoine M, 2009, LIVER INT, V29, P1431, DOI 10.1111/j.1478-3231.2009.02022.x; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Mao JW, 2015, INT J CLIN EXP PATHO, V8, P3648; Miura K, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/362847; Niebergall LJ, 2011, BBA-MOL CELL BIOL L, V1811, P1177, DOI 10.1016/j.bbalip.2011.06.021; Niemiec T, 2011, J PHYSIOL PHARMACOL, V62, P37; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Subramanian P, 2008, REDOX REP, V13, P78, DOI 10.1179/135100008X259178; Surapaneni KM, 2014, J PHYSIOL PHARMACOL, V65, P67; Tsochatzis EA, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/831670; Zhang WF, 2014, ANN HEPATOL, V13, P489, DOI 10.1016/S1665-2681(19)31247-5; Zheng J, 2015, FRONT MED; Zheng J, 2015, FRONT MED-PRC, V9, P173, DOI 10.1007/s11684-015-0384-0; Zwolak A, MEDIATORS I IN PRESS	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143851	10.1371/journal.pone.0143851	http://dx.doi.org/10.1371/journal.pone.0143851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629827	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300113
J	Su, Y; Chen, CP; Huang, LT; Yan, JH; Huang, Y				Su, Yang; Chen, Caiping; Huang, Linting; Yan, Jianhua; Huang, Ying			Schizosaccharomyces pombe Homologs of Human DJ-1 Are Stationary Phase-Associated Proteins That Are Involved in Autophagy and Oxidative Stress Resistance	PLOS ONE			English	Article							DISEASE-ASSOCIATED PROTEIN; ATF1 TRANSCRIPTION FACTOR; FISSION YEAST; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; GLYOXALASE III; KINASE; CELLS; HSP31	The Parkinson's disease protein DJ-1 is involved in various cellular functions including detoxification of dicarbonyl compounds, autophagy and oxidative stress response. DJ-1 homologs are widely found in both prokaryotes and eukaryotes, constituting a superfamily of proteins that appear to be involved in stress response. Schizosaccharomyces pombe contains six DJ-1 homologs, designated Hsp3101-Hsp3105 and Sdj1 (previously named SpDJ-1). Here we show that deletion of any one of these six genes somehow affects autophagy during prolonged stationary phase. Furthermore, deletions of each of these DJ-1 homologs result in reduced stationary phase survival. Deletion of sdj1 also increases the sensitivity of stationary-phase cells to oxidative stress induced by hydrogen peroxide (H2O2) whereas overexpression of sdj1 has the opposite effect. Consistent with their role in stationary phase, expression of hsp3101, hsp3102, hsp3105 and sdj1, and to a lesser extent hsp3103 and hsp3104, is increased in stationary phase. The induction of hsp3101, hsp3102, hsp3105 and sdj1 involves the Sty1-regulated transcription factor Atf1 but not the transcription factor Pap1. Our results firmly establish that S. pombe homologs of DJ-1 are stationary-phase associated proteins and are likely involved in autophagy and antioxidant defense in stationary phase of S. pombe cells.	[Su, Yang; Chen, Caiping; Huang, Linting; Yan, Jianhua; Huang, Ying] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genet, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Huang, Y (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Microbes & Funct Genet, Nanjing, Jiangsu, Peoples R China.	yhuang@njnu.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Science Foundation of China [31170065]; Innovation Project for College Graduates of Jiangsu Province [KYLX_0710]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project for College Graduates of Jiangsu Province	This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD; http://jsycw.ec.js.edu.cn/), National Science Foundation of China Grant (31170065; http://www.nsfc.gov.cn/) and Innovation Project for College Graduates of Jiangsu Province to S.Y. (KYLX_0710; http://www.ec.js.edu. cn/art/2014/6/6/art_4266_150387.html).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Bankapalli K, 2015, J BIOL CHEM, V290, P26491, DOI 10.1074/jbc.M115.673624; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2011, AUTOPHAGY, V7, P1093, DOI 10.4161/auto.7.10.15492; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Ohi R, 1996, GENE, V174, P315, DOI 10.1016/0378-1119(96)00085-6; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Ren HG, 2010, CANCER LETT, V297, P101, DOI 10.1016/j.canlet.2010.05.001; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Tsai CJ, 2015, J BIOL CHEM; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Yuen HF, 2008, CANCER EPIDEM BIOMAR, V17, P3593, DOI 10.1158/1055-9965.EPI-08-0214; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86; Zhao Z, 2009, BIOCHEM J, V422, P483, DOI 10.1042/BJ20090743; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143888	10.1371/journal.pone.0143888	http://dx.doi.org/10.1371/journal.pone.0143888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624998	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600068
J	Johnson, JL; He, J; Ramadass, M; Pestonjamasp, K; Kiosses, WB; Zhang, JZ; Catz, SD				Johnson, Jennifer L.; He, Jing; Ramadass, Mahalakshmi; Pestonjamasp, Kersi; Kiosses, William B.; Zhang, Jinzhong; Catz, Sergio D.			Munc13-4 Is a Rab11-binding Protein That Regulates Rab11-positive Vesicle Trafficking and Docking at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; intracellular trafficking; NADPH oxidase; neutrophil; Rab; Munc13-4; Rab11; Rab27; recycling endosome; super-resolution microscopy	FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; OPTICAL RECONSTRUCTION MICROSCOPY; BLADDER UMBRELLA CELLS; HUMAN-NEUTROPHILS; STRUCTURAL BASIS; NADPH OXIDASE; MYOSIN-V; EXOCYTOSIS; RAB11; SECRETION	The small GTPase Rab11 and its effectors control trafficking of recycling endosomes, receptor replenishment and the up-regulation of adhesion and adaptor molecules at the plasma membrane. Despite recent advances in the understanding of Rab11-regulated mechanisms, the final steps mediating docking and fusion of Rab11-positive vesicles at the plasma membrane are not fully understood. Munc13-4 is a docking factor proposed to regulate fusion through interactions with SNAREs. In hematopoietic cells, including neutrophils, Munc13-4 regulates exocytosis in a Rab27a-dependent manner, but its possible regulation of other GTPases has not been explored in detail. Here, we show that Munc13-4 binds to Rab11 and regulates the trafficking of Rab11-containing vesicles. Using a novel Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) assay, we demonstrate that Munc13-4 binds to Rab11a but not to dominant negative Rab11a. Immunoprecipitation analysis confirmed the specificity of the interaction between Munc13-4 and Rab11, and super-resolution microscopy studies support the interaction of endogenous Munc13-4 with Rab11 at the single molecule level in neutrophils. Vesicular dynamic analysis shows the common spatio-temporal distribution of Munc13-4 and Rab11, while expression of a calcium binding-deficient mutant of Munc13-4 significantly affected Rab11 trafficking. Munc13-4-deficient neutrophils showed normal endocytosis, but the trafficking, up-regulation, and retention of Rab11-positive vesicles at the plasma membrane was significantly impaired. This correlated with deficient NADPH oxidase activation at the plasma membrane in response to Rab11 interference. Our data demonstrate that Munc13-4 is a Rab11-binding partner that regulates the final steps of Rab11-positive vesicle docking at the plasma membrane.	[Johnson, Jennifer L.; He, Jing; Ramadass, Mahalakshmi; Zhang, Jinzhong; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Light Microscopy Core Facil, La Jolla, CA 92037 USA; [Pestonjamasp, Kersi] Univ Calif San Diego, Canc Ctr Microscopy Shared Resource, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Zhang, Jinzhong/E-5670-2012	Zhang, Jinzhong/0000-0002-2540-2749; Catz, Sergio/0000-0002-1873-0277; Pestonjamasp, Kersi/0000-0001-8586-303X	U.S. Public Health Service [HL088256, GM105894]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105894] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Public Health Service Grants HL088256 and GM105894 (to S. D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; COCKCROFT S, 1991, BIOCHEM J, V275, P127, DOI 10.1042/bj2750127; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, J BIOL CHEM, V286, P5647, DOI 10.1074/jbc.M110.184762; Johnson JL, 2005, TRAFFIC, V6, P667, DOI 10.1111/j.1600-0854.2005.00308.x; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Khandelwal P, 2013, MOL BIOL CELL, V24, P1007, DOI 10.1091/mbc.E12-08-0568; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lall P, 2013, BBA-PROTEINS PROTEOM, V1834, P2679, DOI 10.1016/j.bbapap.2013.09.005; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Meeager M. M., 2007, NAT IMMUNOL, V8, P257; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Mudrakola HV, 2009, STRUCTURE, V17, P1433, DOI 10.1016/j.str.2009.09.008; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Sugawara K, 2009, GENES CELLS, V14, P445, DOI 10.1111/j.1365-2443.2009.01285.x; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; Xu K., 2013, FAR FIELD OPTICAL NA, P27; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888	45	43	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3423	3438		10.1074/jbc.M115.705871	http://dx.doi.org/10.1074/jbc.M115.705871			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26637356	Green Published, hybrid			2022-12-26	WOS:000370854500025
J	Hagmann-von Arx, P; Manicolo, O; Perkinson-Gloor, N; Weber, P; Grob, A; Lemola, S				Hagmann-von Arx, Priska; Manicolo, Olivia; Perkinson-Gloor, Nadine; Weber, Peter; Grob, Alexander; Lemola, Sakari			Gait in Very Preterm School-Aged Children in Dual-Task Paradigms	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXECUTIVE FUNCTION; MOTOR DEVELOPMENT; INDEPENDENT WALKING; AEROBIC CAPACITY; CONCURRENT TASK; SELF-WORTH; ATTENTION; BORN; COORDINATION	Objective The control of gait requires executive and attentional functions. As preterm children show executive and attentional deficits compared to full-term children, performing concurrent tasks that impose additional cognitive load may lead to poorer walking performance in preterm compared to full-term children. Knowledge regarding gait in preterm children after early childhood is scarce. We examined straight walking and if it is more affected in very preterm than in full-term children in dual-task paradigms. Study design Twenty preterm children with very low birth-weight (<= 1500 g), 24 preterm children with birth-weight > 1500 g, and 44 full-term children, born between 2001 and 2006, were investigated. Gait was assessed using an electronic walkway system (GAITRite) while walking without a concurrent task (single-task) and while performing one concurrent (dual-task) or two concurrent (triple-task) tasks. Spatio-temporal gait parameters (gait velocity, cadence, stride length, single support time, double support time), normalized gait parameters (normalized velocity, normalized cadence, normalized stride length) and gait variability parameters (stride velocity variability, stride length variability) were analyzed. Results In dual- and triple-task conditions children showed decreased gait velocity, cadence, stride length, as well as increased single support time, double support time and gait variability compared to single-task walking. Further, results showed systematic decreases in stride velocity variability from preterm children with very low birth weight (<= 1500 g) to preterm children with birth weight > 1500 g to full-term children. There were no significant interactions between walking conditions and prematurity status. Conclusions Dual and triple tasking affects gait of preterm and full-term children, confirming previous results that walking requires executive and attentional functions. Birth-weight dependent systematic changes in stride velocity variability indicate poorer walking performance in preterm children who were less mature at birth.	[Hagmann-von Arx, Priska; Manicolo, Olivia; Perkinson-Gloor, Nadine; Grob, Alexander; Lemola, Sakari] Univ Basel, Dept Psychol, Basel, Switzerland; [Weber, Peter] Univ Childrens Hosp Basel, Div Neuropediat & Dev Med, Basel, Switzerland	University of Basel; University of Basel	Hagmann-von Arx, P (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	priska.hagmann@unibas.ch	Lemola, Sakari/A-2659-2008; Grob, Alexander/AAU-5842-2021	Lemola, Sakari/0000-0002-1314-6194; 	Swiss National Science Foundation [143962]; Research Fund of the University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Research Fund of the University of Basel	This research was financially supported by the Swiss National Science Foundation (Project: Sleep, cognitive, and socio-emotional development in preterm children during middle and late childhood Grant number: 143962), and the Research Fund of the University of Basel. SL, PH, PW, AG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538; Anderson V, 2002, CHILD NEUROPSYCHOL, V8, P69, DOI 10.1076/chin.8.2.69.8725; Bejerot S, 2013, AGGRESSIVE BEHAV, V39, P453, DOI 10.1002/ab.21489; Bejerot S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-68; Belmonti V, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00880; Belmonti V, 2013, EXP BRAIN RES, V227, P131, DOI 10.1007/s00221-013-3495-3; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Bloem BR, 2001, EXP BRAIN RES, V137, P478, DOI 10.1007/s002210000672; Bouffard M, 1996, ADAPT PHYS ACT Q, V13, P61, DOI 10.1123/apaq.13.1.61; CANTELL MH, 1994, ADAPT PHYS ACT Q, V11, P115, DOI 10.1123/apaq.11.2.115; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cherng RJ, 2009, GAIT POSTURE, V29, P204, DOI 10.1016/j.gaitpost.2008.08.003; Chester VL, 2006, CLIN BIOMECH, V21, P726, DOI 10.1016/j.clinbiomech.2006.02.007; Clemm H, 2012, PEDIATRICS, V129, pE97, DOI 10.1542/peds.2011-0326; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; Erikson C, 2003, ACTA PAEDIATR, V92, P197; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goyen TA, 2009, ARCH DIS CHILD, V94, P298, DOI 10.1136/adc.2007.134692; Gozzo Y, 2009, NEUROIMAGE, V48, P458, DOI 10.1016/j.neuroimage.2009.06.046; Grob A., 2009, INTELLIGENCE DEV SCA; Hagmann-von Arx P, 2014, NEUROPSYCHOBIOLOGY, V70, P244, DOI 10.1159/000369026; Hagmann-von Arx P, 2012, Z KINDER JUG-PSYCH, V40, P41, DOI 10.1024/1422-4917/a000148; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; HOF AL, 1996, GAIT POSTURE, V4, P222; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Jaekel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065219; Jeng SF, 1997, MED SCI SPORT EXER, V29, P370, DOI 10.1097/00005768-199703000-00012; Jeng SF, 2008, GAIT POSTURE, V27, P340, DOI 10.1016/j.gaitpost.2007.04.012; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Lemola S, 2015, EUR PSYCHOL, V20, P128, DOI 10.1027/1016-9040/a000207; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Lythgo N, 2009, GAIT POSTURE, V30, P502, DOI 10.1016/j.gaitpost.2009.07.119; Gabriel MAM, 2009, ACTA PAEDIATR, V98, P1815, DOI 10.1111/j.1651-2227.2009.01475.x; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Muhaidat J, 2013, PHYSIOTHER THEOR PR, V29, P351, DOI 10.3109/09593985.2012.752056; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nuysink J, 2013, EARLY HUM DEV, V89, P693, DOI 10.1016/j.earlhumdev.2013.04.016; Odberg MD, 2011, ACTA PAEDIATR, V100, P284, DOI 10.1111/j.1651-2227.2010.02096.x; Petermann F., 2008, MOVEMENT ASSESSMENT, V2nd ed.; Petermann F., 2011, WECHSLER INTELLIGENC; Piek J., 2000, DEV MED CHILD NEUROL, V37, P976, DOI DOI 10.1080/713671115; Piek JP, 2006, HUM MOVEMENT SCI, V25, P65, DOI 10.1016/j.humov.2005.10.011; Piek JP, 2005, BRIT J EDUC PSYCHOL, V75, P453, DOI 10.1348/000709904X24573; Rinehart NJ, 2006, DEV MED CHILD NEUROL, V48, P819, DOI 10.1017/S0012162206001769; Ritter BC, 2013, EUR J PEDIATR, V172, P473, DOI 10.1007/s00431-012-1906-2; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Saigal S, 2007, PEDIATRICS, V119, pE562, DOI 10.1542/peds.2006-2328; Schoemaker MM, 2004, ADAPT PHYS ACT Q, V11, P130; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Skinner RA, 2001, HUM MOVEMENT SCI, V20, P73, DOI 10.1016/S0167-9457(01)00029-X; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Stansfield BW, 2003, GAIT POSTURE, V17, P81, DOI 10.1016/S0966-6362(02)00062-0; Storvold GV, 2013, EARLY HUM DEV, V89, P655, DOI 10.1016/j.earlhumdev.2013.04.010; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Yang YR, 2007, GAIT POSTURE, V25, P185, DOI 10.1016/j.gaitpost.2006.03.007; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Zwicker JG, 2012, EUR J PAEDIATR NEURO, V16, P573, DOI 10.1016/j.ejpn.2012.05.005	75	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144363	10.1371/journal.pone.0144363	http://dx.doi.org/10.1371/journal.pone.0144363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ1YS	26641492	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700104
J	Cuomo, RE; Garland, CF; Gorham, ED; Mohr, SB				Cuomo, Raphael E.; Garland, Cedric F.; Gorham, Edward D.; Mohr, Sharif B.			Low Cloud Cover-Adjusted Ultraviolet B Irradiance Is Associated with High Incidence Rates of Leukemia: Study of 172 Countries	PLOS ONE			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; CANCER-RISK; EXPRESSION; SURVIVAL; CELLS	There are 52,380 cases of leukemia and 24,090 deaths from it in the US annually. Its causes are unknown and no preventive strategies have been implemented. We hypothesized that leukemia is due mainly to vitamin D deficiency, which is due mainly to low solar ultraviolet B (UVB) irradiance. To test this hypothesis, we estimated age-standardized cloud-cover-adjusted winter UVB irradiance using cloud cover data from the International Satellite Cloud Climatology Project, latitudes of population centroids, and standard astronomical calculations. Incidence rates for 172 countries, available from the International Agency for Cancer Research, were plotted according to cloud-adjusted UVB irradiance. We used multiple regression to account for national differences in elevation and average life expectancy. Leukemia incidence rates were inversely associated with cloud-adjusted UVB irradiance in males (rho <= 0.01) and females (rho <= 0.01) in both hemispheres. There were few departures from the trend line, which was parabolic when plotted with the equator at the center of the display, northern hemisphere countries on the right side and southern hemisphere countries on the left. The bivariate association displayed by the polynomial trend line indicated that populations at higher latitudes had at least two times the risk of leukemia compared to equatorial populations. The association persisted in males (rho <= 0.05) and females (rho <= 0.01) after controlling for elevation and life expectancy. Incidence rates of leukemia were inversely associated with solar UVB irradiance. It is plausible that the association is due to vitamin D deficiency. This would be consistent with laboratory studies and a previous epidemiological study. Consideration should be given to prudent use of vitamin D for prevention of leukemia.	[Cuomo, Raphael E.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, La Jolla, CA 92093 USA; [Cuomo, Raphael E.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Garland, Cedric F.; Gorham, Edward D.; Mohr, Sharif B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Cuomo, RE (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Global Hlth, La Jolla, CA 92093 USA.	raphael.e.cuomo@gmail.com		Cuomo, Raphael/0000-0002-8179-0619				Abe E, 1981, P NATL ACAD SCI US, V78; Cancer Research UK, 2014, LEUK ALL SUBT COMB K; Cuomo RE, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.23773; Fong WF, 2005, INT J BIOCHEM CELL B, V37, P427, DOI 10.1016/j.biocel.2004.05.021; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Grigalavicius M, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.22941; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; HONMA Y, 1983, P NATL ACAD SCI-BIOL, V80, P201, DOI 10.1073/pnas.80.1.201; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 DAT; Jenab M., 2010, BMJ, V350, pb5500; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee HJ, 2014, CANCER-AM CANCER SOC, V120, P521, DOI 10.1002/cncr.28368; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Lopes N, 2012, ANTICANCER RES, V32, P249; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Mohr SB, 2008, BREAST J, V14, P255, DOI 10.1111/j.1524-4741.2008.00571.x; Mohr SB, 2011, AM J PREV MED, V41, P68, DOI 10.1016/j.amepre.2011.04.003; *NAT AER SPAC ADM, SOL RAD EARTH SYST; *NAT AER SPAC ADM, INT SAT CLOUD CLIM P; National Cancer Institute, 2014, LEUKEMIA; Naz A, 2013, PAK J MED SCI, V29, P10, DOI 10.12669/pjms.291.2764; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Portland State University, COUNTR GEOGR DAT; Sekeres M., 2014, ACUTE MYELOID LEUKEM; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Vieth R, 2012, SCAND J CLIN LAB INV, V72, P144, DOI 10.3109/00365513.2012.682893; Wang X, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-5; Wang XF, 2009, IMECE 2008: PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, VOL 5, P25; Wang XN, 1997, P SOC EXP BIOL MED, V215, P399, DOI 10.3181/00379727-215-44150; World Health Organization, WHO GLOB INF; Xie Y, 2003, CANCER-AM CANCER SOC, V97, P2229, DOI 10.1002/cncr.11316	32	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144308	10.1371/journal.pone.0144308	http://dx.doi.org/10.1371/journal.pone.0144308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637119	Green Published, gold, Green Submitted			2022-12-26	WOS:000366143800071
J	Mettrop, IS; Cusell, C; Kooijman, AM; Lamers, LPM				Mettrop, Ivan S.; Cusell, Casper; Kooijman, Annemieke M.; Lamers, Leon P. M.			Short-Term Summer Inundation as a Measure to Counteract Acidification in Rich Fens	PLOS ONE			English	Article							WATER-LEVEL FLUCTUATION; MOBILIZATION; BRYOPHYTES; SEDIMENTS; DYNAMICS; AMMONIUM; IMPACTS; NITRATE; CLIMATE; PEAT	In regions with intensive agriculture, water level fluctuation in wetlands has generally become constricted within narrow limits. Water authorities are, however, considering the re-establishment of fluctuating water levels as a management tool in biodiverse, base-rich fens ('rich fens'). This includes temporary inundation with surface water from ditches, which may play an important role in counteracting acidification in order to conserve and restore biodiversity. Inundation may result in an increased acid neutralizing capacity (ANC) for two reasons: infiltration of base-rich inundation water into peat soils, and microbial alkalinity generation under anaerobic conditions. The main objectives of this study were to test whether short-term (2 weeks) summer inundation is more effective than short-term winter inundation to restore the ANC in the upper 10 cm of non-floating peat soils, and to explain potential differences. Large-scale field experiments were conducted for five years in baserich fens and Sphagnum-dominated poor fens. Winter inundation did not result in increased porewater ANC, because infiltration was inhibited in the waterlogged peat and evapotranspiration rates were relatively low. Also, low temperatures limit microbial alkalinity generation. In summer, however, when temperature and evapotranspiration rates are higher, inundation resulted in increased porewater Ca and HCO3- concentrations, but only in areas with characteristic rich fen bryophytes. This increase was not only due to stronger infiltration into the soil, but also to higher microbial alkalinity generation under anaerobic conditions. In contrast, porewater ANC did not increase in Sphagnum-plots as a result of the ability of Sphagnum spp. to acidify their environment. In both rich and poor fens, flooding-induced P-mobilization remained sufficiently low to safeguard P-limited vegetation. NO3- and NH4+ dynamics showed no considerable changes either. In conclusion, short-term summer inundation with base-rich and nutrient-poor surface water is considered beneficial in the management of non-floating rich fens, and much more effective than winter inundation.	[Mettrop, Ivan S.; Cusell, Casper; Kooijman, Annemieke M.] Univ Amsterdam, IBED, NL-1090 GE Amsterdam, Netherlands; [Mettrop, Ivan S.; Cusell, Casper; Lamers, Leon P. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, NL-6525 Nijmegen, Netherlands	University of Amsterdam; Radboud University Nijmegen	Mettrop, IS (corresponding author), Univ Amsterdam, IBED, POB 94248, NL-1090 GE Amsterdam, Netherlands.	I.Mettrop@uva.nl	Lamers, Leon P.M./A-8718-2012; Kooijman, Annemieke/S-5762-2016	Lamers, Leon P.M./0000-0003-3769-2154; Mettrop, Ivan/0000-0001-7143-9086	Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation; Water Management Authority Reest Wieden; Province of Overijssel; Natuurmonumenten	Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation; Water Management Authority Reest Wieden; Province of Overijssel; Natuurmonumenten	This research was funded by Kennisnetwerk Ontwikkeling en Beheer Natuurkwaliteit (O+BN) of the Dutch Ministry of Economic Affairs, Agriculture and Innovation, the Water Management Authority Reest & Wieden, the Province of Overijssel, and Natuurmonumenten.	BAKER LA, 1986, WATER AIR SOIL POLL, V31, P89, DOI 10.1007/BF00630822; Bronstert A, 2003, RISK ANAL, V23, P545, DOI 10.1111/1539-6924.00335; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Clapham AR, 1940, J ECOL, V28, P71, DOI 10.2307/2256163; Clymo R.S., 1963, ANN BOT, V27, P71; Cusell C., 2013, 2013OBN171LZ MIN EC; Cusell C, 2015, ECOL ENG, V77, P127, DOI 10.1016/j.ecoleng.2015.01.025; Cusell C, 2013, J APPL ECOL, V50, P998, DOI 10.1111/1365-2664.12096; Gorham E., 1987, Effects of atmospheric pollutants on forests, wetlands and agricultural ecosystems NATO ASI Series G: Ecological Sciences, Vol. 16., P493; Kooijman AM, 2006, APPL VEG SCI, V9, P205, DOI 10.1658/1402-2001(2006)9[205:HARIFW]2.0.CO;2; Kooijman A. M., 2012, Lindbergia, V35, P42; KOOIJMAN AM, 1992, BIOL CONSERV, V59, P139, DOI 10.1016/0006-3207(92)90573-6; KOOIJMAN AM, 1994, AQUAT BOT, V48, P133, DOI 10.1016/0304-3770(94)90080-9; Kundzewicz ZW, 2006, CLIM RES, V31, P51, DOI 10.3354/cr031051; Lamers LPM, 2015, BIOL REV, V90, P182, DOI 10.1111/brv.12102; Lamers LPM, 1998, ENVIRON SCI TECHNOL, V32, P199, DOI 10.1021/es970362f; Lamers LPM, 1998, WATER AIR SOIL POLL, V105, P95, DOI 10.1023/A:1005083526455; LINDSAY W. L., 1960, SOIL SCI SOC AMER PROC, V24, P177; Mettrop IS, 2015, ECOL ENG, V85, P226, DOI 10.1016/j.ecoleng.2015.09.077; Mettrop IS, 2014, SOIL BIOL BIOCHEM, V68, P317, DOI 10.1016/j.soilbio.2013.10.023; PATRICK WH, 1974, SCIENCE, V186, P53, DOI 10.1126/science.186.4158.53; Paulissen MPCP, 2004, NEW PHYTOL, V164, P451, DOI 10.1111/j.1469-8137.2004.01196.x; Ponnamperuma F. N., 1984, Flooding and plant growth, P9; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; SMOLDERS A, 1993, AQUAT BOT, V46, P247, DOI 10.1016/0304-3770(93)90005-H; Stumm W., 1996, AQUATIC CHEM CHEM EQ, V3rd ed., DOI [10.5860/choice.33-6312, DOI 10.5860/CHOICE.33-6312]; Van Wirdum G., 1992, FENS BOGS NETHERLAND, P323; vanDiggelen R, 1996, J VEG SCI, V7, P809, DOI 10.2307/3236459; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; Verhoeven JTA, 2011, APPL VEG SCI, V14, P149, DOI 10.1111/j.1654-109X.2010.01113.x; Vorenhout M, 2011, INT J ENVIRON AN CH, V91, P801, DOI 10.1080/03067319.2010.535123; Wheeler BD, 2000, J ECOL, V88, P187, DOI 10.1046/j.1365-2745.2000.00455.x; Whitworth KL, 2014, ALKALINITY CAPTURE M; Zak D, 2010, ECOL APPL, V20, P1336, DOI 10.1890/08-2053.1	34	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144006	10.1371/journal.pone.0144006	http://dx.doi.org/10.1371/journal.pone.0144006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637121	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800036
J	Smetanova, M; Bolfikova, BC; Randi, E; Caniglia, R; Fabbri, E; Galaverni, M; Kutal, M; Hulva, P				Smetanova, Milena; Bolfikova, Barbora Cerna; Randi, Ettore; Caniglia, Romolo; Fabbri, Elena; Galaverni, Marco; Kutal, Miroslav; Hulva, Pavel			From Wolves to Dogs, and Back: Genetic Composition of the Czechoslovakian Wolfdog	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; RE-IMPLEMENTATION; N-E; SOFTWARE; CONSERVATION; PROGRAM; ADAPTATION; INFERENCE; REVEALS; HISTORY	The Czechoslovakian Wolfdog is a unique dog breed that originated from hybridization between German Shepherds and wild Carpathian wolves in the 1950s as a military experiment. This breed was used for guarding the Czechoslovakian borders during the cold war and is currently kept by civilian breeders all round the world. The aim of our study was to characterize, for the first time, the genetic composition of this breed in relation to its known source populations. We sequenced the hypervariable part of the mtDNA control region and genotyped the Amelogenin gene, four sex-linked microsatellites and 39 autosomal microsatellites in 79 Czechoslovakian Wolfdogs, 20 German Shepherds and 28 Carpathian wolves. We performed a range of population genetic analyses based on both empirical and simulated data. Only two mtDNA and two Y-linked haplotypes were found in Czechoslovakian Wolfdogs. Both mtDNA haplotypes were of domestic origin, while only one of the Y-haplotypes was shared with German Shepherds and the other was unique to Czechoslovakian Wolfdogs. The observed inbreeding coefficient was low despite the small effective population size of the breed, possibly due to heterozygote advantages determined by introgression of wolf alleles. Moreover, Czechoslovakian Wolfdog genotypes were distinct from both parental populations, indicating the role of founder effect, drift and/or genetic hitchhiking. The results revealed the peculiar genetic composition of the Czechoslovakian Wolfdog, showing a limited introgression of wolf alleles within a higher proportion of the dog genome, consistent with the reiterated backcrossing used in the pedigree. Artificial selection aiming to keep wolf-like phenotypes but dog-like behavior resulted in a distinctive genetic composition of Czechoslovakian Wolfdogs, which provides a unique example to study the interactions between dog and wolf genomes.	[Smetanova, Milena; Bolfikova, Barbora Cerna] Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic; [Randi, Ettore; Caniglia, Romolo; Fabbri, Elena; Galaverni, Marco] ISPRA, Lab Genet, Ozzano Dell Emilia, BO, Italy; [Randi, Ettore] Aalborg Univ, Dept 18, Sect Environm Engn, Aalborg, Denmark; [Kutal, Miroslav] Mendel Univ Brno, Fac Forestry & Wood Technol, Inst Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Hulva, Pavel] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Hulva, Pavel] Univ Ostrava, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic	Czech University of Life Sciences Prague; Italian Institute for Environmental Protection & Research (ISPRA); Aalborg University; Mendel University in Brno; Charles University Prague; University of Ostrava	Bolfikova, BC (corresponding author), Czech Univ Life Sci Prague, Fac Trop AgriSci, Prague, Czech Republic.	bolfikova@ftz.czu.cz	Kutal, Miroslav/B-9612-2014; Bolfikova, Barbora Cerna/I-6620-2019	Kutal, Miroslav/0000-0003-3857-5419; Bolfikova, Barbora Cerna/0000-0001-8059-4889; CANIGLIA, Romolo/0000-0002-3641-9490; Galaverni, Marco/0000-0002-2648-1506	Internal Grant Agency of Czech University of Life Sciences Prague [IGA 20155014]; Ministry of Finance of the Czech Republic, Norway [EHP-CZ02-OV-1-022-2015]; Charles University in Prague [260208/2015]	Internal Grant Agency of Czech University of Life Sciences Prague; Ministry of Finance of the Czech Republic, Norway; Charles University in Prague	The study was funded by: Internal Grant Agency of Czech University of Life Sciences Prague (IGA 20155014) for BCB and MS; Ministry of Finance of the Czech Republic, Norway Grants (EHP-CZ02-OV-1-022-2015) for MK, PH and BCB; Charles University in Prague (SVV 260208/2015) for PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Belkihr K, 2004, 5000 CNRS UMR; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Bigi D, 2015, ANIMAL FIRSTVIEW, P1; Caniglia R, 2014, J MAMMAL, V95, P41, DOI 10.1644/13-MAMM-A-039; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Cilova D, 2011, J VET BEHAV, V6, P60; Clarke B.C., 1996, Royal Society Philosophical Transactions Biological Sciences, V351, P723; De Lavigne G, 2015, FREE RANGING DOGS ST, P447; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Freedman A. H., 2014, PLOS GENET, V10; Glemin S, 2003, EVOLUTION, V57, P2678; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hartl K, 2002, CESKOSLOVENSY VLCAK, P1; Hoban S, 2014, MOL ECOL, V23, P2383, DOI 10.1111/mec.12741; Hundertmark KJ, 2010, CONSERV GENET, V11, P139, DOI 10.1007/s10592-009-0013-z; Huson HJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-71; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Leroy G, 2009, ANIM GENET, V40, P333, DOI 10.1111/j.1365-2052.2008.01843.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Nagasawa M, 2015, OBSTET GYNECOL SURV, V70, P450, DOI 10.1097/01.ogx.0000469196.99143.92; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Randi E, 2014, PLOS ONE, V9, P13; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Voorbij AMWY, 2014, J VET INTERN MED, V28, P1770, DOI 10.1111/jvim.12448; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	45	14	14	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0143807	10.1371/journal.pone.0143807	http://dx.doi.org/10.1371/journal.pone.0143807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636975	Green Published, Green Submitted, gold			2022-12-26	WOS:000366143800028
J	Bai, T; Wang, L; Wang, DW; Yuan, XB; Bai, W; Yang, Q; Yang, X				Bai, Tao; Wang, Li; Wang, Dongwen; Yuan, Xiaobin; Bai, Wei; Yang, Qin; Yang, Xian			Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014	PLOS ONE			English	Article							KIDNEY CANCER; UNITED-STATES; MORTALITY; TRENDS; RISK; EUROPE; METAANALYSIS; DISEASE	Objectives RCC is the most common solid renal malignancy in adults worldwide. To provide the insight of clinicopathologica epidemiological characteristics and change tendencies of renal cell carcinoma (RCC), 2154 cases were collected from Shanxi Province of China, including diagnose time, age, gender, tumor size, Fuhrman grade, tumor stage, tumor location, local advance or distant metastasis and first symptom from 2005 to 2014. This retrospectively investigation, as its general objective, was to analyze the clinicopathologica epidemiological characteristics and the change tendencies of RCC. Methods Between 2005 and 2014, 2154 patients who were diagnosed with RCC in three large tertiary hospitals at Shanxi Province were included. The patients' demographic features, pathological diagnoses and metastatic statuses were analyzed. Statistics methods include the chi- squared test, analysis of variance, Spearman's correlation analysis, Logistic regression and ARIMA modeling. Results Of the 2154 included patients, the constituent ratio of female /male was 63.1% and 36.9%, with the median age of 57 years old. Fuhrman grade distributions differed significantly between males and females (p = 0.024). Also, a significant difference in tumor size was found by different clinical stages (p < 0.001), with a linear correlation (p < 0.001). Moreover, Spearman's analysis indicated tumor grade has a negative correlation with female (p = 0.009) and a positive correlation with tumor size (p = 0.000). It was found that the tumor diameter is bigger in the left side (p = 0.022). Furthermore, the metastasis rate was higher in the bigger tumor (p < 0.001) and the left-sided tumors (p = 0.027). Logistic regression also showed that tumor size is a risk factor for metastasis (OR = 1.724). The risk of local advance or distant metastasis in the left kidney was 1.6-fold greater than that of the right kidney. From 2005 to 2014 the number of RCC cases gradually increased (mainly for pathological grade II and III, but grade I and IV), while the average tumor size decreased, showing the severity increase mildly. Base on the results of a time series analysis-prediction the average RCC size would continue to decrease from the first quarter of 2015 to the fourth quarter of 2016. Conclusions The cases of RCC increased from 2005 to 2014 with clear cell type as the main pathological type in this population. The characteristics in the constituent ratios of the RCC vary depending on gender, pathological grade, tumor size, and location, which may be the important factors impacting treatment and prognosis.	[Bai, Tao; Wang, Dongwen; Yuan, Xiaobin] Shanxi Med Univ, Dept Urol, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Wang, Li] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Shanxi, Peoples R China; [Bai, Wei] Shanxi Canc Hosp, Dept Pathol, Taiyuan, Shanxi, Peoples R China; [Yang, Qin] Shanxi Prov Peoples Hosp, Dept Pathol, Taiyuan, Shanxi, Peoples R China; [Yang, Xian] Shanxi Med Univ, Dept Pathol, Hosp 1, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University	Wang, DW (corresponding author), Shanxi Med Univ, Dept Urol, Hosp 1, Taiyuan, Shanxi, Peoples R China.	wangdongwen1973@126.com			Natural Science Foundation of Shanxi Province [2014011038-4]; Medical Research Foundation of WU Jieping [320.6750.13122]; Youth Innovation Research Fund of the First Hospital of Shanxi Medical University [YC1429]	Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Medical Research Foundation of WU Jieping; Youth Innovation Research Fund of the First Hospital of Shanxi Medical University	This work was supported by the Natural Science Foundation of Shanxi Province (No. 2014011038-4), Medical Research Foundation of WU Jieping (No. 320.6750.13122) and the Youth Innovation Research Fund of the First Hospital of Shanxi Medical University (YC1429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron M, 2008, EUR UROL, V54, P133, DOI 10.1016/j.eururo.2007.12.001; Bosetti C, 2011, EUR UROL, V60, P1, DOI 10.1016/j.eururo.2011.03.047; Capitanio U, 2015, LANCET; China Ccogftdatousdi, 2014, CHINA CCOGFTDATOUSDI, P4; De P, 2014, CANCER CAUSE CONTROL, V25, P1271, DOI 10.1007/s10552-014-0427-x; Ferlay J, 2014, GLOBOCAN 2012 CANC I; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gandaglia G, 2014, CUAJ-CAN UROL ASSOC, V8, P247, DOI 10.5489/cuaj.1760; Gu L, 2002, J PRACTICAL ONCOLOGY, V15, P1; Guha N, 2012, LANCET ONCOL, V13, P1192, DOI 10.1016/S1470-2045(12)70485-0; Hofmann JN, 2015, EPIDEMIOLOGY, V26, P59, DOI 10.1097/EDE.0000000000000205; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Ingimarsson JP, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-72; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1730, DOI 10.1158/1055-9965.EPI-09-0045; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; [李鸣 LI Ming], 2010, [中华泌尿外科杂志, Chinese Journal of Urology], V31, P77; Lipworth L, 2014, BJU INT, DOI [10.1111/bju.12950.25307281, DOI 10.1111/BJU.12950.25307281]; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; [马建辉 MA Jian-hui], 2009, [中华泌尿外科杂志, Chinese Journal of Urology], V30, P511; Mindrup SR, 2005, BJU INT, V95, P31, DOI 10.1111/j.1464-410X.2005.05243.x; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Rabjerg M, 2014, APMIS, V122, P708, DOI 10.1111/apm.12282; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sauter G, 2004, PATHOLOGY GENETICS T; Weikert S, 2008, AM J EPIDEMIOL, V167, P438, DOI 10.1093/aje/kwm321; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Wu Jieping, 1991, PRACTICAL UROLOGICAL, P230; Zastrow S, 2014, UROL INT, V92, P462, DOI 10.1159/000356325; Zhao Z., 2013, CLIN ANAL 1068 CASES; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002; 张斯良, 2006, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V15, P430	33	7	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144246	10.1371/journal.pone.0144246	http://dx.doi.org/10.1371/journal.pone.0144246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633179	Green Submitted, Green Published, gold			2022-12-26	WOS:000366040000072
J	Durand, MJ; Murphy, SA; Schaefer, KK; Hunter, SK; Schmit, BD; Gutterman, DD; Hyngstrom, AS				Durand, Matthew J.; Murphy, Spencer A.; Schaefer, Kathleen K.; Hunter, Sandra K.; Schmit, Brian D.; Gutterman, David D.; Hyngstrom, Allison S.			Impaired Hyperemic Response to Exercise Post Stroke	PLOS ONE			English	Article							BRACHIAL-ARTERY; SHEAR-STRESS; FLOW; ULTRASOUND; PEOPLE; LIMB	Individuals with chronic stroke have reduced perfusion of the paretic lower limb at rest; however, the hyperemic response to graded muscle contractions in this patient population has not been examined. This study quantified blood flow to the paretic and non-paretic lower limbs of subjects with chronic stroke after submaximal contractions of the knee extensor muscles and correlated those measures with limb function and activity. Ten subjects with chronic stroke and ten controls had blood flow through the superficial femoral artery quantified with ultrasonography before and immediately after 10 second contractions of the knee extensor muscles at 20, 40, 60, and 80% of the maximal voluntary contraction (MVC) of the test limb. Blood flow to the paretic and non-paretic limb of stroke subjects was significantly reduced at all load levels compared to control subjects even after normalization to lean muscle mass. Of variables measured, increased blood flow after an 80% MVC was the single best predictor of paretic limb strength, the symmetry of strength between the paretic and non-paretic limbs, coordination of the paretic limb, and physical activity. The impaired hemodynamic response to high intensity contractions was a better predictor of lower limb function than resting perfusion measures. Stroke-dependent weakness and atrophy of the paretic limb do not explain the reduced hyperemic response to muscle contraction alone as the response is similarly reduced in the non-paretic limb when compared to controls. These data may suggest a role for perfusion therapies to optimize rehabilitation post stroke.	[Durand, Matthew J.] Med Coll Wisconsin, Dept Phys Med & Rehabil, Milwaukee, WI 53226 USA; [Durand, Matthew J.; Gutterman, David D.] Med Coll Wisconsin, Dept Med, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [Murphy, Spencer A.; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53201 USA; [Schaefer, Kathleen K.; Hunter, Sandra K.; Hyngstrom, Allison S.] Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53201 USA	Medical College of Wisconsin; Medical College of Wisconsin; Marquette University; Marquette University	Hyngstrom, AS (corresponding author), Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53201 USA.	allison.hyngstrom@marquette.edu			National Center for Advancing Translational Sciences, National Institutes of Health [8UL1TR000055]; National Institute of Neurological Disorders and Stroke, National Institutes of Health [1R21NS088818, R01-NS079751]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079751, R21NS088818] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number 8UL1TR000055 (AH and MD) and National Institute of Neurological Disorders and Stroke, National Institutes of Health 1R21NS088818 (AH, MD, DG) and R01-NS079751 (BS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Billinger SA, 2009, STROKE, V40, P3086, DOI 10.1161/STROKEAHA.109.550889; Billinger SA, 2009, CEREBROVASC DIS, V27, P552, DOI 10.1159/000214218; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175; Hafer-Macko CE, 2008, J REHABIL RES DEV, V45, P261, DOI 10.1682/JRRD.2007.02.0040; Hyngstrom AS, 2012, AM J PHYS MED REHAB, V91, P33, DOI 10.1097/PHM.0b013e31823caac0; Ivey FM, 2004, CEREBROVASC DIS, V18, P283, DOI 10.1159/000080353; Knorr S, 2011, Exp Brain Res, V214, P303, DOI 10.1007/s00221-011-2826-5; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; PAFFENBARGER RS, 1986, ACTA MED SCAND, P85; Scherbakov N, 2015, J AM MED DIR ASSOC, V16, P272, DOI 10.1016/j.jamda.2014.12.007; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Thijssen DHJ, 2008, AM J PHYSIOL-HEART C, V295, pH1927, DOI 10.1152/ajpheart.00405.2008; Tieges Z, 2015, ARCH PHYS MED REHAB, V96, P15, DOI 10.1016/j.apmr.2014.08.015; Xiong L, 2014, J NEUROL SCI, V337, P141, DOI 10.1016/j.jns.2013.11.036	18	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144023	10.1371/journal.pone.0144023	http://dx.doi.org/10.1371/journal.pone.0144023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630380	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300138
J	Xu, W; He, LX; Liu, CF; Rong, J; Shi, YY; Song, WL; Zhang, T; Wang, LJ				Xu, Wei; He, Linxi; Liu, Chunfeng; Rong, Jian; Shi, Yongyan; Song, Wenliang; Zhang, Tao; Wang, Lijie			The Effect of Infection Control Nurses on the Occurrence of Pseudomonas aeruginosa Healthcare-Acquired Infection and Multidrug-Resistant Strains in Critically-Ill Children	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE; NOSOCOMIAL INFECTION; CIPROFLOXACIN; PREVENTION; GUIDELINES; HOSPITALS; ICU	Background Healthcare-acquired Pseudomonas aeruginosa (P. aeruginosa) infections in the Pediatric Intensive Care Unit (PICU), which have a high incidence, increase treatment costs and mortality, and seriously threaten the safety of critically ill children. It is essential to seek convenient and effective methods to control and prevent healthcare-acquired infections (HAIs). This research was conducted to study the effect of infection control nurses on the occurrence of P. aeruginosa HAIs and multi-drug resistance (MDR) strains in PICU. Methods The clinical data was divided into two groups, with the age ranging from 1 month to 14 years. One group of the critically ill patients(N = 3,722) was admitted to PICU from 2007 to 2010, without the management of infection control nurses. The other group of the critically ill patients (N = 3,943) was admitted to PICU from 2011 to 2013, with the management of infection control nurses. Compare the mortality, morbidity and the incidence of acquired P. aeruginosa infections to evaluate the effect of infection control nurses. Results After implementation of the post of infection control nurses, the patient's overall mortality fell from 4.81% to 3.73%. Among the patients with endotracheal intubation more than 48 hours, the incidence of endotracheal intubation-related pneumonia decreased from 44.6% to 34.32%. The mortality of patients with endotracheal intubation decreased from 16.96% to 10.17%, and the morbidity of HAIs with P. aeruginosa decreased from 1.89% to 1.07%. The mutual different rate (MDR) dropped from 67.95% to 44.23%. There were remarkable differences in these rates between the two groups (p< 0.05). Conclusion Implementing the post of infection control nurses is associated with effectively reducing the HAI rate, especially the incidence and morbidity of P. aeruginosa HAIs, reducing PICU mortality, improving P. aeruginosa drug resistance.	[Xu, Wei; He, Linxi; Liu, Chunfeng; Rong, Jian; Shi, Yongyan; Song, Wenliang; Zhang, Tao; Wang, Lijie] China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China	China Medical University	Xu, W (corresponding author), China Med Univ, Shengjing Hosp, Dept Pediat, Shenyang, Liaoning, Peoples R China.	tomxu.123@163.com			National Natural Science Foundation of China (NSFC) [81270726]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC, 81270726) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony M, 2013, ARCH DIS CHILD-FETAL, V98, pF549, DOI 10.1136/archdischild-2012-303540; Bayani M, 2013, INT J MOL CELL MED, V2, P204; Chen XX, 2014, J MICROBIOL IMMUNOL; degli Atti MC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-494; Di Pasquale M, 2014, CRIT CARE MED, V42, P303, DOI 10.1097/CCM.0b013e3182a272a2; Falagas ME, 2009, PEDIATR INFECT DIS J, V28, P123, DOI 10.1097/INF.0b013e31818a5dbd; Farias JA, 2004, INTENS CARE MED, V30, P918, DOI 10.1007/s00134-004-2225-5; Folgori L, 2014, PEDIATR INFECT DIS J, V33, P929, DOI 10.1097/INF.0000000000000339; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hewer SCL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004197.pub4; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Joo EJ, 2011, MICROB DRUG RESIST, V17, P305, DOI 10.1089/mdr.2010.0170; Joseph NM, 2013, J CLIN DIAGN RES, V7, P2170, DOI 10.7860/JCDR/2013/6113.3461; Kaminski C, 2011, CRIT CARE, V15, DOI 10.1186/cc10136; Lewis GJ, 2012, INFECT CONT HOSP EP, V33, P368, DOI 10.1086/664763; Lopes JMM, 2007, BRAZ J INFECT DIS, V11, P515, DOI 10.1590/S1413-86702007000500013; Micek ST, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0926-5; Niederman MS, 2010, CLIN INFECT DIS, V51, pS12, DOI 10.1086/653035; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Oncul O, 2014, BURNS, V40, P835, DOI 10.1016/j.burns.2013.11.003; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Peng Y, 2014, AM J INFECT CONTROL, V42, P1308, DOI 10.1016/j.ajic.2014.08.006; PROULX F, 1994, CRIT CARE MED, V22, P1025, DOI 10.1097/00003246-199406000-00023; Rajkumari N, 2014, J GLOB INFECT DIS, V6, P182, DOI 10.4103/0974-777X.145250; Rex JH, 1996, J CLIN MICROBIOL, V34, P816, DOI 10.1128/JCM.34.4.816-817.1996; Saini H, 2015, INT J ANTIMICROB AG, V45, P359, DOI 10.1016/j.ijantimicag.2014.11.008; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Soule BM, 1997, AM J INFECT CONTROL, V25, P289, DOI 10.1016/S0196-6553(97)90019-5; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Touw DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015016; Tumbarello M, 2011, EPIDEMIOL INFECT, V139, P1740, DOI 10.1017/S0950268810003055; Tumbarello M, 2013, INTENS CARE MED, V39, P682, DOI 10.1007/s00134-013-2828-9; Veltman ES, 2015, J INFECTION, V70, P307, DOI 10.1016/j.jinf.2014.10.002; Zhang QL, 2012, INT J INFECT DIS, V16, pE628, DOI 10.1016/j.ijid.2012.03.014	35	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143692	10.1371/journal.pone.0143692	http://dx.doi.org/10.1371/journal.pone.0143692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630032	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300085
J	Zhao, YL; Schwartz, EA; Palmer, GM; Zennadi, R				Zhao, Yulin; Schwartz, Evan A.; Palmer, Gregory M.; Zennadi, Rahima			MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease	FASEB JOURNAL			English	Article						sickle red cells; leukocytes; MEK inhibitors; adhesion	ACTIVATED PROTEIN-KINASE; FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; POLYMORPHONUCLEAR LEUKOCYTES; HOMOTYPIC ADHESION; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; POTENTIAL ROLE; HEART-FAILURE; MAP KINASE	In sickle cell disease (SCD), treatment of recurrent vasoocclusive episodes, leading to pain crises and organ damage, is still a therapeutic challenge. Vasoocclusion is caused primarily by adherence of homozygous for hemoglobin S (SS) red blood cells (SSRBCs) and leukocytes to the endothelium. We tested the therapeutic benefits of MEK1/2 inhibitors in reversing vasoocclusion in nude and humanized SCD mouse models of acute vasoocclusive episodes using intravital microscopy. Administration of 0.2, 0.3, 1, or 2 mg/kg MEK1/2 inhibitor to TNF-alpha-pretreated nude mice before human SSRBC infusion inhibited SSRBC adhesion in inflamed vessels, prevented the progression of vasoocclusion, and reduced SSRBC organ sequestration. By use of a more clinically relevant protocol, 0.3 or 1 mg/kg MEK1/2 inhibitor given to TNF-alpha-pretreated nude mice after human SSRBC infusion and onset of vasoocclusion reversed SSRBC adhesion and vasoocclusion and restored blood flow. In SCD mice, 0.025, 0.05, or 0.1 mg/kg MEK1/2 inhibitor also reversed leukocyte and erythrocyte adhesion after the inflammatory trigger of vasoocclusion and improved microcirculatory blood flow. Cell adhesion was reversed by shedding of endothelial E-selectin, P-selectin, and v3 integrin, and leukocyte CD44 and 2 integrin. Thus, MEK1/2 inhibitors, by targeting the adhesive function of SSRBCs and leukocytes, could represent a valuable therapeutic intervention for acute sickle cell vasoocclusive crises.	[Zhao, Yulin; Schwartz, Evan A.; Zennadi, Rahima] Duke Univ, Med Ctr, Div Hematol, Durham, NC 27710 USA; [Palmer, Gregory M.; Zennadi, Rahima] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Palmer, Gregory M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Zennadi, R (corresponding author), Duke Univ, Med Ctr, Box 2615, Durham, NC 27710 USA.	rahima.zennadi@duke.edu	Palmer, Gregory M/C-6910-2008	Palmer, Gregory M/0000-0003-2955-8297	U.S. National Blood Foundation; Duke School of Medicine; GlaxoSmithKline	U.S. National Blood Foundation; Duke School of Medicine; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by award from the U.S. National Blood Foundation, bridge funding from Duke School of Medicine, and research funding from GlaxoSmithKline (to R.Z.).	Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Capodici C, 1998, J CLIN INVEST, V102, P165, DOI 10.1172/JCI592; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Chantrathammachart P, 2012, BLOOD, V120, P636, DOI 10.1182/blood-2012-04-424143; Chiou E, 2015, INT J BIOCHEM CELL B, V65, P40, DOI 10.1016/j.biocel.2015.05.013; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hebbel RP, 1997, J CLIN INVEST, V100, pS83; Herrera-Garcia A, 2013, EUR J IMMUNOL, V43, P55, DOI 10.1002/eji.201242805; Ichioka S, 2007, WOUND REPAIR REGEN, V15, P572, DOI 10.1111/j.1524-475X.2007.00265.x; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Iverson C., 2008, ASCO NCI ANN M MOL M; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Jozsef L, 2002, BRIT J PHARMACOL, V135, P1167, DOI 10.1038/sj.bjp.0704561; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; King MR, 2004, ANN BIOMED ENG, V32, P803, DOI 10.1023/B:ABME.0000030256.37022.02; Kohno Michiaki, 2003, Prog Cell Cycle Res, V5, P219; KURANTSINMILLS J, 1987, MICROVASC RES, V34, P152, DOI 10.1016/0026-2862(87)90050-1; Lai HH, 2011, PAIN, V152, P2117, DOI 10.1016/j.pain.2011.05.017; Landsberger M, 2007, ATHEROSCLEROSIS, V190, P43, DOI 10.1016/j.atherosclerosis.2006.02.009; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Li J, 2014, J CLIN INVEST, V124, P1483, DOI 10.1172/JCI72305; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; Milella Michele, 2003, Rev Clin Exp Hematol, V7, P160; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Pignatelli P, 2005, BLOOD, V106, P1992, DOI 10.1182/blood-2005-03-1247; Pillinger MH, 1996, J BIOL CHEM, V271, P12049, DOI 10.1074/jbc.271.20.12049; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; THOMPSON HL, 1993, BIOCHEM J, V290, P483, DOI 10.1042/bj2900483; Townes T M, 1989, Prog Clin Biol Res, V316A, P47; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Wang N, 2011, J CELL BIOCHEM, V112, P1920, DOI 10.1002/jcb.23112; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Weekes CD, 2013, CLIN CANCER RES, V19, P1232, DOI 10.1158/1078-0432.CCR-12-3529; WORTHEN GS, 1994, J CLIN INVEST, V94, P815, DOI 10.1172/JCI117401; Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zennadi R, 2008, BLOOD, V112, P3474, DOI 10.1182/blood-2008-01-134346; Zennadi R, 2007, BLOOD, V110, P2708, DOI 10.1182/blood-2006-11-056101; Zennadi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110306; Zennadi R, 2012, BLOOD, V119, P1217, DOI 10.1182/blood-2011-03-344440; Zouki C, 2001, FASEB J, V15, P25	49	7	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1171	1186		10.1096/fj.15-278481	http://dx.doi.org/10.1096/fj.15-278481			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26631480				2022-12-26	WOS:000370387800015
J	Ceci, M; Pio, G; Kuzmanovski, V; Dzeroski, S				Ceci, Michelangelo; Pio, Gianvito; Kuzmanovski, Vladimir; Dzeroski, Saso			Semi-Supervised Multi-View Learning for Gene Network Reconstruction	PLOS ONE			English	Article							LARGE-SCALE ORGANIZATION; REGULATORY NETWORKS; EXPRESSION DATA; CLASSIFICATION; DISCOVERY; INFERENCE; VIEW	The task of gene regulatory network reconstruction from high-throughput data is receiving increasing attention in recent years. As a consequence, many inference methods for solving this task have been proposed in the literature. It has been recently observed, however, that no single inference method performs optimally across all datasets. It has also been shown that the integration of predictions from multiple inference methods is more robust and shows high performance across diverse datasets. Inspired by this research, in this paper, we propose a machine learning solution which learns to combine predictions from multiple inference methods. While this approach adds additional complexity to the inference process, we expect it would also carry substantial benefits. These would come from the automatic adaptation to patterns on the outputs of individual inference methods, so that it is possible to identify regulatory interactions more reliably when these patterns occur. This article demonstrates the benefits (in terms of accuracy of the reconstructed networks) of the proposed method, which exploits an iterative, semi-supervised ensemble-based algorithm. The algorithm learns to combine the interactions predicted by many different inference methods in the multi-view learning setting. The empirical evaluation of the proposed algorithm on a prokaryotic model organism (E. coli) and on a eukaryotic model organism (S. cerevisiae) clearly shows improved performance over the state of the art methods. The results indicate that gene regulatory network reconstruction for the real datasets is more difficult for S. cerevisiae than for E. coli. The software, all the datasets used in the experiments and all the results are available for download at the following link: http://figshare.com/articles/ Semi_supervised_Multi_View_Learning_for_Gene_Network_Reconstruction/1604827.	[Ceci, Michelangelo; Pio, Gianvito] Univ Bari Aldo Moro, Dept Comp Sci, I-70125 Bari, Italy; [Kuzmanovski, Vladimir; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana 1000, Slovenia; [Kuzmanovski, Vladimir; Dzeroski, Saso] Jozef Stefan Int Postgrad Sch, Ljubljana 1000, Slovenia	Universita degli Studi di Bari Aldo Moro; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Pio, G (corresponding author), Univ Bari Aldo Moro, Dept Comp Sci, Via Orabona 4, I-70125 Bari, Italy.	gianvito.pio@uniba.it; vladimir.kuzmanovski@ijs.si	Kuzmanovski, Vladimir/Z-3137-2019; Dzeroski, Saso/ABH-2758-2021; Pio, Gianvito/AAH-9841-2019	Kuzmanovski, Vladimir/0000-0001-7355-1581; Dzeroski, Saso/0000-0003-2363-712X; Pio, Gianvito/0000-0003-2520-3616; Ceci, Michelangelo/0000-0002-6690-7583	Slovenian Research Agency [P2-0103]; European Commission [ICT-2013-612944 MAESTRA, ICT-2013- 604102 HBP]; European Social Fund [CCI2007-SI051PO001]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Commission(European CommissionEuropean Commission Joint Research Centre); European Social Fund(European Social Fund (ESF))	The authors acknowledge the financial support of the Slovenian Research Agency via the grant P2-0103, and the European Commission via the grants ICT-2013-612944 MAESTRA and ICT-2013- 604102 HBP, as well as the grant CCI2007SI051PO001 through the European Social Fund for co-financing postgraduate studies in the context of the Operational Programme for Human Resources Development for the period 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Sabrina Hempel and Jurgen Kurths for providing the datasets used in the experimental evaluation. We acknowledge the financial support of the Slovenian Research Agency, via the grant P2-0103, and the European Commission via the grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP, as well as the grant CCI2007-SI051PO001 through the European Social Fund for co-financing postgraduate studies in the context of the Operational Programme for Human Resources Development for the period 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Atias N, 2012, COMMUN ACM, V55, P88, DOI 10.1145/2160718.2160738; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyd Kendrick, 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P451, DOI 10.1007/978-3-642-40994-3_29; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bulyk ML, 2005, NAT BIOTECHNOL, V23, P942, DOI 10.1038/nbt0805-942; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Efron B, 1994, INTRO BOOTSTRAP; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Emmert-Streib Frank, 2012, Frontiers in Genetics, V3, P8, DOI [10.3389/fgene.2012.00313, 10.3389/fgene.2012.00008]; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guo HY, 2008, KNOWL INF SYST, V17, P287, DOI 10.1007/s10115-008-0127-5; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hempel S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-292; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Li D, 2006, PROTEOMICS, V6, P456, DOI 10.1002/pmic.200500228; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053; Pio G, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S4; Provost F, 2001, MACH LEARN, V42, P203, DOI 10.1023/A:1007601015854; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Smith VA., 2002, BIOINFORMATICS, V18, pS216; Stojanova D, 2012, DATA MIN KNOWL DISC, V25, P378, DOI 10.1007/s10618-012-0278-6; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vilalta R, 2002, ARTIF INTELL REV, V18, P77, DOI 10.1023/A:1019956318069; Whalen S, 2013, IEEE DATA MINING, P807, DOI 10.1109/ICDM.2013.21	39	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144031	10.1371/journal.pone.0144031	http://dx.doi.org/10.1371/journal.pone.0144031			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641091	Green Submitted, gold, Green Published			2022-12-26	WOS:000366902700048
J	de Lucio, A; Martinez-Ruiz, R; Merino, FJ; Bailo, B; Aguilera, M; Fuentes, I; Carmena, D				de Lucio, Aida; Martinez-Ruiz, Rocio; Merino, Francisco J.; Bailo, Begona; Aguilera, Maria; Fuentes, Isabel; Carmena, David			Molecular Genotyping of Giardia duodenalis Isolates from Symptomatic Individuals Attending Two Major Public Hospitals in Madrid, Spain	PLOS ONE			English	Article							DAY-CARE-CENTERS; REFRACTORY GIARDIASIS; CRYPTOSPORIDIUM SPP.; PARASITIC INFECTIONS; HELICOBACTER-PYLORI; CHILDREN; LAMBLIA; IDENTIFICATION; TRANSMISSION; EPIDEMIOLOGY	Background The flagellate protozoan Giardia duodenalis is an enteric parasite causing human giardiasis, a major gastrointestinal disease of global distribution affecting both developing and industrialised countries. In Spain, sporadic cases of giardiasis have been regularly identified, particularly in pediatric and immigrant populations. However, there is limited information on the genetic variability of circulating G. duodenalis isolates in the country. Methods In this longitudinal molecular epidemiological study we report the diversity and frequency of the G. duodenalis assemblages and sub-assemblages identified in 199 stool samples collected from 184 individual with symptoms compatible with giardiasis presenting to two major public hospitals in Madrid for the period December 2013-January 2015. G. duodenalis cysts were initially detected by conventional microscopy and/or immunochomatography on stool samples. Confirmation of the infection was performed by direct immunofluorescence and real-time PCR methods. G. duodenalis assemblages and sub-assemblages were determined by multi-locus genotyping of the glutamate dehydrogenase (GDH) and beta-giardin (BG) genes of the parasite. Sociodemographic and clinical features of patients infected with G. duodenalis were also analysed. Principal findings Of 188 confirmed positive samples from 178 giardiasis cases a total of 124 G. duodenalis isolates were successfully typed at the GDH and/or the BG loci, revealing the presence of sub-assemblages BIV (62.1%), AII (15.3%), BIII (4.0%), AI (0.8%), and AIII (0.8%). Additionally, 6.5% of the isolates were only characterised at the assemblage level, being all of them assigned to assemblage B. Discordant genotype results AII/AIII or BIII/BIV were also observed in 10.5% of DNA isolates. A large number of multi-locus genotypes were identified in G. duodenalis assemblage B, but not assemblage A, isolates at both the GDH and BG loci, confirming the high degree of genetic variability observed in other molecular surveys. BIV was the most prevalent genetic variant of G. duodenalis found in individuals with symptomatic giardiasis in the population under study. Conclusions Human giardiasis is an ongoing public health problem in Spain affecting primarily young children under four years of age but also individuals of all age groups. Our typing and sub-typing results demonstrate that assemblage B is the most prevalent G. duodenalis assemblage circulating in patients with clinical giardiasis in Central Spain. Our analyses also revealed a large genetic variability in assemblage B (but not assemblage A) isolates of the parasite, corroborating the information obtained in similar studies in other geographical regions. We believe that molecular data presented here provide epidemiological evidence at the population level in support of the existence of genetic exchange within assemblages of G. duodenalis.	[de Lucio, Aida; Bailo, Begona; Aguilera, Maria; Fuentes, Isabel; Carmena, David] Carlos III Hlth Inst, Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain; [Martinez-Ruiz, Rocio] Univ Hosp Puerta Hierro Majadahonda, Microbiol & Clin Parasitol Serv, Madrid, Spain; [Merino, Francisco J.] Univ Hosp Severo Ochoa, Microbiol Serv, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Puerta de Hierro-Majadahonda; Severo Ochoa University Hospital	Carmena, D (corresponding author), Carlos III Hlth Inst, Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain.	dacarmena@isciii.es	Carmena, David/S-4049-2019	Carmena, David/0000-0002-4015-8553; Merino Fernandez, Francisco Jesus/0000-0001-9180-2479	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain [CP12/03081, PI13/01106]; FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain [CP12/03081, PI13/01106]	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain; FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain	This work was supported by research projects CP12/03081, Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain (DC), research project PI13/01106, Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain (IF).; This project was funded by research projects CP12/03081 and PI13/01106, FIS Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197; Almeida AA, 2006, J EUKARYOT MICROBIOL, V53, pS177, DOI 10.1111/j.1550-7408.2006.00222.x; Alonso-Sanz M, 1995, Enferm Infecc Microbiol Clin, V13, P90; Andersson JO, 2012, TRENDS PARASITOL, V28, P46, DOI 10.1016/j.pt.2011.11.002; Ankarklev J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-65; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Aydin AF, 2004, DIAGN MICR INFEC DIS, V50, P147, DOI 10.1016/j.diagmicrobio.2004.06.001; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Ballweber LR, 2010, TRENDS PARASITOL, V26, P180, DOI 10.1016/j.pt.2010.02.005; Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011; Berkman DS, 2002, LANCET, V359, P564, DOI 10.1016/S0140-6736(02)07744-9; Cardona GA, 2011, SCI TOTAL ENVIRON, V412, P101, DOI 10.1016/j.scitotenv.2011.09.076; Carmena D., 2012, WORLD J CLIN INFECT, V2, P1, DOI DOI 10.5495/WJCID.V2.I1.1; Cobo F, 2016, J IMMIGR MINOR HEALT, V18, P8, DOI 10.1007/s10903-014-0141-5; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Cooper MA, 2010, J INFECT DIS, V202, P1713, DOI 10.1086/657142; Dado D, 2012, PARASITOL RES, V111, P2419, DOI 10.1007/s00436-012-3100-x; Eldash Hanaa H, 2013, J Egypt Soc Parasitol, V43, P509; Elghareeb Azza S, 2015, Trop Parasitol, V5, P36, DOI 10.4103/2229-5070.149919; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Flecha MJ, 2015, TROP MED INT HEALTH, V20, P1213, DOI 10.1111/tmi.12535; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Garcia LS, 2003, J CLIN MICROBIOL, V41, P209, DOI 10.1128/JCM.41.1.209-212.2003; Gautret P, 2012, EURO SURVEILL, V17; Goni P, 2012, EUR J CLIN MICROBIOL, V31, P2077, DOI 10.1007/s10096-012-1544-7; Goni P, 2010, ENFERM INFEC MICR CL, V28, P710, DOI 10.1016/j.eimc.2010.04.010; Gonzalez-Moreno O, 2011, PARASITOL RES, V108, P87, DOI 10.1007/s00436-010-2044-2; Gutierrez JM, 2013, TRAVEL MED INFECT DI, V11, P126, DOI 10.1016/j.tmaid.2012.10.004; Haque R, 2009, CLIN INFECT DIS, V48, P1191, DOI 10.1086/597580; Homan WL, 2001, INT J PARASITOL, V31, P822, DOI 10.1016/S0020-7519(01)00183-7; Ignatius R, 2014, CLIN MICROBIOL INFEC, V20, pO783, DOI 10.1111/1469-0691.12596; Jerlstrom-Hultqvist J, 2010, GUT MICROBES, V1, P379, DOI 10.4161/gmic.1.6.13608; Gutierrez-Cisneros MJ, 2011, ENFERM INFEC MICR CL, V29, P201, DOI 10.1016/j.eimc.2010.09.005; Julio C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-22; Kosuwin R, 2010, GENE, V449, P1, DOI 10.1016/j.gene.2009.09.010; Krumkamp R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003568; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Lopez-Velez R, 2003, AM J TROP MED HYG, V69, P115, DOI 10.4269/ajtmh.2003.69.115; Manser M, 2014, CLIN MICROBIOL INFEC, V20, pO65, DOI 10.1111/1469-0691.12297; Manzardo Christian, 2008, Travel Med Infect Dis, V6, P4, DOI 10.1016/j.tmaid.2007.11.002; Mateo M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000075; Minetti C, 2015, J CLIN MICROBIOL, V53, P3133, DOI 10.1128/JCM.00715-15; Morch K, 2008, J INFECTION, V56, P268, DOI 10.1016/j.jinf.2008.01.013; Nabarro LEB, 2015, CLIN MICROBIOL INFEC, V21, P791, DOI 10.1016/j.cmi.2015.04.019; NASH TE, 1985, J INFECT DIS, V152, P64, DOI 10.1093/infdis/152.1.64; Nguyen TKT, 2012, EUR J CLIN MICROBIOL, V31, P623, DOI 10.1007/s10096-011-1332-9; Oberhelman RA, 2001, PEDIATR INFECT DIS J, V20, P792, DOI 10.1097/00006454-200108000-00014; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Read C, 2002, INT J PARASITOL, V32, P229, DOI 10.1016/S0020-7519(01)00340-X; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Requena-Mendez A, 2014, CLIN MICROBIOL INFEC, V20, pO135, DOI 10.1111/1469-0691.12327; Robertson LJ, 2013, GIARDIA FOODBORNE PA, P13; RodriguezHernandez J, 1996, EUR J EPIDEMIOL, V12, P291, DOI 10.1007/BF00145419; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Sahagun J, 2008, EUR J CLIN MICROBIOL, V27, P81, DOI 10.1007/s10096-007-0404-3; Soriano JM, 2011, TROP BIOMED, V28, P557; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teodorovic S, 2007, EUKARYOT CELL, V6, P1421, DOI 10.1128/EC.00138-07; Verweij JJ, 2003, MOL CELL PROBE, V17, P223, DOI 10.1016/S0890-8508(03)00057-4; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Yadav P, 2014, INDIAN J MED MICROBI, V32, P378, DOI 10.4103/0255-0857.142236; Zeyrek Dost, 2008, Turkiye Parazitoloji Dergisi, V32, P4	67	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143981	10.1371/journal.pone.0143981	http://dx.doi.org/10.1371/journal.pone.0143981			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641082	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700039
J	Kelly, VJ; Winkler, T; Venegas, JG; Kone, M; Hamilos, DL; Afshar, R; Cho, JL; Luster, AD; Medoff, BD; Harris, RS				Kelly, Vanessa J.; Winkler, Tilo; Venegas, Jose G.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott			Allergic Non-Asthmatic Adults Have Regional Pulmonary Responses to Segmental Allergen Challenge	PLOS ONE			English	Article							BRAIN TRANSFER CONSTANTS; BLOOD-FLOW DISTRIBUTION; TIME UPTAKE DATA; GRAPHICAL EVALUATION; VENTILATION DEFECTS; AIRWAY RESPONSE; F-18-FDG UPTAKE; ATOPIC ASTHMA; GAS-EXCHANGE; INFLAMMATION	Background Allergic non-asthmatic (ANA) adults experience upper airway symptoms of allergic disease such as rhinorrhea, congestion and sneezing without symptoms of asthma. The aim of this study was to utilize PET-CT functional imaging to determine whether allergen challenge elicits a pulmonary response in ANA subjects or whether their allergic disease is truly isolated to the upper airways. Methods In 6 ANA subjects, bronchoalveolar lavages (BAL) were performed at baseline and 24h after instillation of an allergen and a diluent in separate lung lobes. After instillation (10h), functional imaging was performed to quantify and compare regional perfusion, ventilation, fractional gas content (Fgas), and glucose uptake rate (Ki) between the baseline, diluent and allergen lobes. BAL cell counts were also compared. Results In ANA subjects, compared to the baseline and diluent lobes, perfusion and ventilation were significantly lower in the allergen lobe (median [inter-quartile range], baseline vs. diluent vs. allergen: Mean-normalized perfusion; 0.87 [0.85-0.97] vs. 0.90 [0.86-0.98] vs. 0.59 [0.55-0.67]; p<0.05. Mean-normalized ventilation 0.89 [0.88-0.98] vs. 0.95 [0.89-1.02] vs. 0.63 [0.52-0.67], p< 0.05). In contrast, no significant differences were found in Fgas between baseline, diluent and allergen lobes or in Ki. Total cell counts, eosinophil and neutrophil cell counts (cells/ml BAL) were significantly greater in the allergen lobe compared to the baseline lobe (all P<0.05). Conclusions Despite having no clinical symptoms of a lower airway allergic response (cough and wheeze) allergic non-asthmatic subjects have a pulmonary response to allergen exposure which manifests as reduced ventilation and perfusion.	[Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Pulm, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Crit Care & Rheumatol, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Allergy, Boston, MA 02114 USA; [Kelly, Vanessa J.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Div Immunol, Boston, MA 02114 USA; [Kelly, Vanessa J.; Winkler, Tilo; Venegas, Jose G.; Kone, Mamary; Hamilos, Daniel L.; Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.; Harris, R. Scott] Harvard Univ, Sch Med, Boston, MA USA; [Winkler, Tilo; Venegas, Jose G.] Massachusetts Gen Hosp, Dept Anaesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Afshar, Roshi; Cho, Josalyn L.; Luster, Andrew D.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Harris, RS (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Pulm, Boston, MA 02114 USA.	rsharris@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020; Winkler, Tilo/B-5337-2009; Cho, Josalyn/ABF-8931-2021	Luster, Andrew/0000-0001-9679-7912; Winkler, Tilo/0000-0002-7276-5550; Cho, Josalyn/0000-0002-0367-4495; Medoff, Benjamin/0000-0002-2558-0449	National Institutes of Health [HL088297, AI040618, AI095261, HL086717]; American Heart Association [12POST11820025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088297, R01HL086717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095261, R01AI040618, R37AI040618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health: BDM HL088297, ADL AI040618 and AI095261, RSH HL086717; and American Heart Association, VJK 12POST11820025.	Bergeron C, 2010, CAN RESPIR J, V17, pE85, DOI 10.1155/2010/318029; Boulay ME, 2002, CLIN EXP ALLERGY, V32, P1441, DOI 10.1046/j.1365-2745.2002.01508.x; Campana L, 2009, J APPL PHYSIOL, V106, P1293, DOI 10.1152/japplphysiol.91428.2008; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; FICK RB, 1987, J APPL PHYSIOL, V63, P1147, DOI 10.1152/jappl.1987.63.3.1147; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2011, J NUCL MED, V52, P1713, DOI 10.2967/jnumed.110.086355; Hopkins SR, 2007, J APPL PHYSIOL, V103, P240, DOI 10.1152/japplphysiol.01289.2006; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; LAM S, 1991, J ALLERGY CLIN IMMUN, V87, P842, DOI 10.1016/0091-6749(91)90131-7; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Lopuhaa CE, 2002, CLIN EXP ALLERGY, V32, P1720, DOI 10.1046/j.1365-2222.2002.01542.x; MARSHALL BE, 1994, INTENS CARE MED, V20, P291, DOI 10.1007/BF01708968; MARSHALL BE, 1994, INTENS CARE MED, V20, P379, DOI 10.1007/BF01720916; Meerschaert J, 1999, AM J RESP CRIT CARE, V159, P619, DOI 10.1164/ajrccm.159.2.9806053; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; Oettgen HC, 2012, ALLERGY; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Schroeder T, 2007, J NUCL MED, V48, P1889, DOI 10.2967/jnumed.107.041079; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; Tgavalekos NT, 2007, EUR RESPIR J, V29, P1174, DOI 10.1183/09031936.00113606; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; West JB, 2012, RESP PHYSL ESSENTIAL, Vviii	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143976	10.1371/journal.pone.0143976	http://dx.doi.org/10.1371/journal.pone.0143976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640951	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700038
J	Miyashita, A; Fukushima, S; Nakahara, S; Yamashita, J; Tokuzumi, A; Aoi, J; Ichihara, A; Kanemaru, H; Jinnin, M; Ihn, H				Miyashita, Azusa; Fukushima, Satoshi; Nakahara, Satoshi; Yamashita, Junji; Tokuzumi, Aki; Aoi, Jun; Ichihara, Asako; Kanemaru, Hisashi; Jinnin, Masatoshi; Ihn, Hironobu			Investigation of FOXM1 as a Potential New Target for Melanoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; DOWN-REGULATION; INDUCE APOPTOSIS; EXPRESSION; CELLS; CARCINOGENESIS; SUPPRESSION; INHIBITION; IPILIMUMAB; REGULATOR	Recent studies have shown that immunotherapies and molecular targeted therapies are effective for advanced melanoma. Non-antigen-specific immunotherapies such as immuno-checkpoint blockades have been shown to be effective in the treatment of advanced melanoma. However, the response rates remain low. To improve their efficacy, they should be combined with antigen-specific immunotherapy. Elevated expression of the transcription factor, Forkhead box M1 (FOXM1), has been reported in various human cancers, and it has been shown to have potential as a target for immunotherapy. The purpose of this study was to investigate the FOXM1 expression in human melanoma samples and cell lines, to evaluate the relationship between the FOXM1 expression and the clinical features of melanoma patients and to investigate the association between the FOXM1 and MAPK and PI3K/AKT pathways in melanoma cell lines. We conducted the quantitative reverse transcription PCR (qRT-PCR) and Western blotting analyses of melanoma cell lines, and investigated melanoma and nevus tissue samples by qRT-PCR and immunohistochemistry. We performed MEK siRNA and PI3K/AKT inhibitor studies and FOXM1 siRNA studies in melanoma cell lines. We found that FOXM1 was expressed in all of the melanoma cell lines, and was expressed in 49% of primary melanomas, 67% of metastatic melanomas and 10% of nevi by performing immunohistochemical staining. Metastatic melanoma samples exhibited significantly higher mRNA levels of FOXM1 (p = 0.004). Primary melanomas thicker than 2 mm were also more likely to express FOXM1. Patients whose primary melanoma expressed FOXM1 had a significantly poorer overall survival compared to patients without FOXM1 expression (p = 0.024). Downregulation of FOXM1 by siRNA significantly inhibited the proliferation of melanoma cells, and blockade of the MAPK and PI3K/AKT pathways decreased the FOXM1 expression in melanoma cell lines. In conclusion, FOXM1 is considered to be a new therapeutic target for melanoma.	[Miyashita, Azusa; Fukushima, Satoshi; Nakahara, Satoshi; Yamashita, Junji; Tokuzumi, Aki; Aoi, Jun; Ichihara, Asako; Kanemaru, Hisashi; Jinnin, Masatoshi; Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan	Kumamoto University	Fukushima, S (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, 1-1-1 Honjo, Kumamoto, Japan.	satoshi.fukushima.tb@gmail.com	Kanemaru, Hisashi/AAC-3258-2022	Kanemaru, Hisashi/0000-0003-3725-6213; Fukushima, Satoshi/0000-0002-0622-7682	JSPS [23791280, 25870545, 15K09772, 15K19694]; National Cancer Center Research and Development Fund [23-A-22]; scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan; Grants-in-Aid for Scientific Research [15K19694] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) 23791280, 25870545, 15K09772 and 15K19694, the National Cancer Center Research and Development Fund (23-A-22) and the scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a JSPS Grant-in-Aid for Young Scientists (B) 23791280, 25870545, 15K09772 and 15K19694, the National Cancer Center Research and Development Fund (23-A-22) and the scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042598; Feng YM, 2013, MOL CANCER RES, V11, P834, DOI 10.1158/1541-7786.MCR-13-0007; Fukushima S, 2009, J IMMUNOTHER, V32, P219, DOI 10.1097/CJI.0b013e318194b63b; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huynh KM, 2011, J CELL PHYSIOL, V226, P194, DOI 10.1002/jcp.22326; JANITZ M, 1994, MOL REPROD DEV, V38, P231, DOI 10.1002/mrd.1080380215; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kageshita T, 1999, AM J PATHOL, V154, P745, DOI 10.1016/S0002-9440(10)65321-7; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McArthur GA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00161; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034329; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang M, 2011, ONCOTARGET, V2, P1218; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yokomine K, 2010, INT J CANCER, V126, P2153, DOI 10.1002/ijc.24836	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144241	10.1371/journal.pone.0144241	http://dx.doi.org/10.1371/journal.pone.0144241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640950	gold, Green Submitted, Green Published			2022-12-26	WOS:000366902700083
J	Zhou, ZM; Ding, XH; Yang, Q; Hu, J; Shang, XJ; Huang, XJ; Ge, L; Zhou, TF				Zhou, Zhiming; Ding, Xianhui; Yang, Qian; Hu, Jia; Shang, Xianjin; Huang, Xianjun; Ge, Liang; Zhou, Taofeng			Association between Single-Nucleotide Polymorphisms of the Tyrosine Kinase Receptor B (Tr kappa B) and Post-Stroke Depression in China	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; N-ACETYLSEROTONIN; GLOBAL BURDEN; STROKE; MECHANISMS; NTRK2; BDNF; RISK	Background Polymorphisms of the brain-derived neurotrophic factor (BDNF) have been investigated as candidate genes for post-stroke depression (PSD), and its receptor, neurotrophic tyrosine kinase receptor B (TrkB), has been associated with depression. However, no further data have yet reported the association between PSD and polymorphisms in TrkB. This study aims to investigate whether a relationship exists between TrkB polymorphisms and PSD. Methods A total of 312 depression patients (PSD patients) and 472 non-depression patient controls (NPSD patients) were recruited. All patients were evaluated using the Hamilton Rating Scale for Depression (HAMD) to determine depression severity, and PSD patients were diagnosed in accordance with DSM-V criteria. Three single-nucleotide polymorphisms (SNPs), namely, rs1187323, rs1212171, and rs1778929, in the TrkB gene were genotyped by high-resolution melt analysis. Results The SNP rs1778929 was significantly more associated with incident PSD in participants with the TT genotype than in those with CC (OR 0.482, 95% CI: 0.313-0.744). In terms of rs1187323, stroke was significantly more associated with incident depression in participants with the AC genotype than in those with AA (OR 0.500, 95% CI: 0.368-0.680). The minor allele (T) of rs1778929 (P = 0.024, OR = 0.725, 95% CI = 0.590-0.890) and the minor allele (C) of rs1187323 (P = 0.000, OR = 0.598, 95% CI = 0.466-0.767) were found to be significantly associated with PSD. Neither genotype nor allele frequencies of rs1212171 showed statistically significant differences between PSD and NPSD patients. Conclusions The results suggest that rs1778929 and rs1187323 in the TrkB gene are significantly associated with post-stroke depression in the Chinese population. Further studies are necessary to confirm our findings.	[Zhou, Zhiming; Ding, Xianhui; Yang, Qian; Hu, Jia; Shang, Xianjin; Huang, Xianjun; Ge, Liang; Zhou, Taofeng] Yijishan Hosp, Wannan Med Coll, Dept Neurol, Wuhu, Anhui, Peoples R China	Wannan Medical College	Zhou, ZM (corresponding author), Yijishan Hosp, Wannan Med Coll, Dept Neurol, Wuhu, Anhui, Peoples R China.	neuro_depar@hotmail.com			National Natural Science Foundation of China [81171110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 81171110, awarded to Dr. Zhiming Zhou).	Avdoshina V, 2013, JAIDS-J ACQ IMM DEF, V64, P138, DOI 10.1097/QAI.0b013e3182a468e9; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Feng C, 2014, SCI WORLD J, DOI 10.1155/2014/521349; Gazal M, 2012, NEUROCHEM RES, V37, P583, DOI 10.1007/s11064-011-0647-3; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Li J, 2014, J AFFECT DISORDERS, V168, P373, DOI 10.1016/j.jad.2014.07.011; Lin E, 2009, REJUV RES, V12, P387, DOI 10.1089/rej.2009.0871; Loubinoux I, 2012, J CELL MOL MED, V16, P1961, DOI 10.1111/j.1582-4934.2012.01555.x; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; O'Donnell M, 2009, LANCET NEUROL, V8, P306, DOI 10.1016/S1474-4422(09)70024-9; Oxenkrug G, 2012, AGING DIS, V3, P330; Paolucci S, 2005, ACTA PSYCHIAT SCAND, V112, P272, DOI 10.1111/j.1600-0447.2005.00590.x; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Yang LL, 2011, INT J GERIATR PSYCH, V26, P495, DOI 10.1002/gps.2552; Zhou ZM, 2011, CLIN CHEM LAB MED, V49, P185, DOI 10.1515/CCLM.2011.039	22	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144301	10.1371/journal.pone.0144301	http://dx.doi.org/10.1371/journal.pone.0144301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26641254	Green Published, Green Submitted, gold			2022-12-26	WOS:000366902700094
J	Szulcek, R; van Bezu, J; Boonstra, J; van Loon, JJWA; Amerongen, GPV				Szulcek, Robert; van Bezu, Jan; Boonstra, Johannes; van Loon, Jack J. W. A.; Amerongen, Geerten P. van Nieuw			Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically	PLOS ONE			English	Article							CELL RESPONSE; SHEAR-STRESS; MICROGRAVITY; GROWTH; CYTOSKELETON; IMPEDANCE; JUNCTIONS	Background Endothelial cells (EC) guard vascular functions by forming a dynamic barrier throughout the vascular system that sensitively adapts to 'classical' biomechanical forces, such as fluid shear stress and hydrostatic pressure. Alterations in gravitational forces might similarly affect EC integrity, but remain insufficiently studied. Methods In an unique approach, we utilized Electric Cell-substrate Impedance Sensing (ECIS) in the gravity-simulators at the European Space Agency (ESA) to study dynamic responses of human EC to simulated micro-and hyper-gravity as well as to classical forces. Results Short intervals of micro-or hyper-gravity evoked distinct endothelial responses. Stimulated micro-gravity led to decreased endothelial barrier integrity, whereas hyper-gravity caused sustained barrier enhancement by rapid improvement of cell-cell integrity, evidenced by a significant junctional accumulation of VE-cadherin (p = 0.011), significant enforcement of peripheral F-actin (p = 0.008) and accompanied by a slower enhancement of cell-matrix interactions. The hyper-gravity triggered EC responses were force dependent and nitricoxide (NO) mediated showing a maximal resistance increase of 29.2 +/- 4.8 ohms at 2g and 60.9 +/- 6.2 ohms at 4g vs. baseline values that was significantly suppressed by NO blockage (p = 0.011). Conclusion In conclusion, short-term application of hyper-gravity caused a sustained improvement of endothelial barrier integrity, whereas simulated micro-gravity weakened the endothelium. In clear contrast, classical forces of shear stress and hydrostatic pressure induced either short-lived or no changes to the EC barrier. Here, ECIS has proven a powerful tool to characterize subtle and distinct EC gravity-responses due to its high temporal resolution, wherefore ECIS has a great potential for the study of gravity-responses such as in real space flights providing quantitative assessment of a variety of cell biological characteristics of any adherent growing cell type in an automated and continuous fashion.	[Szulcek, Robert; van Bezu, Jan; Amerongen, Geerten P. van Nieuw] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands; [Szulcek, Robert] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Pulmonol, Amsterdam, Netherlands; [Boonstra, Johannes] Univ Utrecht, Fac Sci, Dept Cellular Architecture & Dynam, Utrecht, Netherlands; [van Loon, Jack J. W. A.] European Space Agcy, Estec, DESC, TEC MMG Lab, NL-2200 AG Noordwijk, Netherlands; [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] Acad Ctr Dent ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; European Space Agency; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Szulcek, R (corresponding author), Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Dept Physiol, Amsterdam, Netherlands.	r.szulcek@vumc.nl	Szulcek, Robert/D-7229-2013	Szulcek, Robert/0000-0003-0450-7338; van Loon, Jack/0000-0001-9051-6016	Dutch Lung Foundation; Netherlands CardioVascular Research Initiative [2012-08]; Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences; Netherlands Heart Foundation [2011T072]; Netherlands Space Office (NSO) NWO [MG-057]	Dutch Lung Foundation; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Space Office (NSO) NWO	We acknowledge the support from the Dutch Lung Foundation, Netherlands CardioVascular Research Initiative under grant number 2012-08 awarded to the Phaedra consortium (www.phaedraresearch.nl), the Dutch Heart Foundation, Dutch Federation of University Medical Centers, The Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences. GPvNA was supported by The Netherlands Heart Foundation grant 2011T072. JJWAvL was supported by Netherlands Space Office (NSO) NWO grant MG-057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Antonutto G, 2003, EUR J APPL PHYSIOL, V90, P283, DOI 10.1007/s00421-003-0884-5; Biolo G, 2003, CURR OPIN CLIN NUTR, V6, P31, DOI 10.1097/00075197-200301000-00006; Brennan LM, 2012, TOXICOL IN VITRO, V26, P736, DOI 10.1016/j.tiv.2012.03.010; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Curtis TM, 2009, LAB CHIP, V9, P2176, DOI [10.1039/b901314h, 10.1039/b901314b]; Davidson JM, 1999, FASEB J, V13, P325, DOI 10.1096/fasebj.13.2.325; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2013, J CELL SCI, V126, P2545, DOI 10.1242/jcs.124529; DePaola N, 2001, ANN BIOMED ENG, V29, P648, DOI 10.1114/1.1385811; Farahani RM, 2008, INT WOUND J, V5, P552, DOI 10.1111/j.1742-481X.2008.00438.x; Fomina G A, 2009, Aviakosm Ekolog Med, V43, P11; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Gulino-Debrac D, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24180; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Koyama T, 2009, PFLUG ARCH EUR J PHY, V457, P711, DOI 10.1007/s00424-008-0544-z; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; POLLARD EC, 1965, J THEOR BIOL, V8, P113, DOI 10.1016/0022-5193(65)90097-4; Spisni E, 2003, J CELL PHYSIOL, V197, P198, DOI 10.1002/jcp.10344; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; Szulcek R, 2013, CARDIOVASC RES, V99, P471, DOI 10.1093/cvr/cvt075; Todd P, 1989, ASGSB Bull, V2, P95; Todd P, 1977, BIOPROCESSING SPACE, P103; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; van Loon JJWA, 2003, J BIOMECH ENG-T ASME, V125, P342, DOI 10.1115/1.1574521; Vanloon J, 2008, P LIF SPAC LIF EARTH, P663; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Yoshikawa N, 1997, CELL CALCIUM, V22, P189, DOI 10.1016/S0143-4160(97)90012-9; Zhang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413708	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144269	10.1371/journal.pone.0144269	http://dx.doi.org/10.1371/journal.pone.0144269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26637177	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800065
J	Conrad, MO; Gadhoke, B; Scheidt, RA; Schmit, BD				Conrad, Megan O.; Gadhoke, Bani; Scheidt, Robert A.; Schmit, Brian D.			Effect of Tendon Vibration on Hemiparetic Arm Stability in Unstable Workspaces	PLOS ONE			English	Article							SOMATOSENSORY STIMULATION; MUSCLE VIBRATION; MOTOR CONTROL; PROPRIOCEPTIVE CONTRIBUTIONS; REACHING MOVEMENTS; IMPEDANCE CONTROL; FINAL POSITION; SENSORY LOSS; STROKE; ADAPTATION	Sensory stimulation of wrist musculature can enhance stability in the proximal arm and may be a useful therapy aimed at improving arm control post-stroke. Specifically, our prior research indicates tendon vibration can enhance stability during point-to-point arm movements and in tracking tasks. The goal of the present study was to investigate the influence of forearm tendon vibration on endpoint stability, measured at the hand, immediately following forward arm movements in an unstable environment. Both proximal and distal workspaces were tested. Ten hemiparetic stroke subjects and 5 healthy controls made forward arm movements while grasping the handle of a two-joint robotic arm. At the end of each movement, the robot applied destabilizing forces. During some trials, 70 Hz vibration was applied to the forearm flexor muscle tendons. 70 Hz was used as the stimulus frequency as it lies within the range of optimal frequencies that activate the muscle spindles at the highest response rate. Endpoint position, velocity, muscle activity and grip force data were compared before, during and after vibration. Stability at the endpoint was quantified as the magnitude of oscillation about the target position, calculated from the power of the tangential velocity data. Prior to vibration, subjects produced unstable, oscillating hand movements about the target location due to the applied force field. Stability increased during vibration, as evidenced by decreased oscillation in hand tangential velocity.	[Conrad, Megan O.] Oakland Univ, Dept Ind & Syst Engn, Rochester, MI 48063 USA; [Gadhoke, Bani; Scheidt, Robert A.; Schmit, Brian D.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	Oakland University; Marquette University	Conrad, MO (corresponding author), Oakland Univ, Dept Ind & Syst Engn, Rochester, MI 48063 USA.	conrad@oakland.edu	Scheidt, Robert A/F-5047-2010	Scheidt, Robert A/0000-0002-2024-5051; Conrad, Megan/0000-0002-8180-9789	NIH [R01-NS052509]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded through a NIH Research Grant R01-NS052509 to BDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2003, EXP BRAIN RES, V148, P277, DOI 10.1007/s00221-002-1256-9; Bernier P, 1998, J NEUROPHYSIOL, V98, P1815; Burdet E, 2004, P ANN INT IEEE EMBS, V26, P4491; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Canning CG, 1999, ARCH PHYS MED REHAB, V80, P66, DOI 10.1016/S0003-9993(99)90309-X; CAREY LM, 1993, ARCH PHYS MED REHAB, V74, P602, DOI 10.1016/0003-9993(93)90158-7; CAVALLARI P, 1989, EXP BRAIN RES, V78, P465; Celnik P, 2007, ARCH PHYS MED REHAB, V88, P1369, DOI 10.1016/j.apmr.2007.08.001; Conforto AB, 2007, J NEUROL, V254, P333, DOI 10.1007/s00415-006-0364-z; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Conrad MO, 2011, J NEUROPHYSIOL, V106, P1480, DOI 10.1152/jn.00404.2010; Conrad MO, 2011, NEUROREHAB NEURAL RE, V25, P61, DOI 10.1177/1545968310378507; Conrad Megan O, 2009, Biomed Sci Instrum, V45, P286; CORDO P, 1995, J NEUROPHYSIOL, V74, P1675, DOI 10.1152/jn.1995.74.4.1675; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; GRACIES JM, 1991, J PHYSIOL-LONDON, V434, P151, DOI 10.1113/jphysiol.1991.sp018463; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; HAGBARTH K. E., 1966, BRAIN RES, V2, P201, DOI 10.1016/0006-8993(66)90029-1; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hay L, 1996, EXP BRAIN RES, V108, P129; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Judkins T, 2014, J NEUROPHYSIOL, V111, P868, DOI 10.1152/jn.00314.2012; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; Kamper DG, 2001, ANN BIOMED ENG, V29, P1122, DOI 10.1114/1.1424918; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; Kossev A, 1999, MUSCLE NERVE, V22, P946, DOI 10.1002/(SICI)1097-4598(199907)22:7<946::AID-MUS22>3.0.CO;2-O; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; McCrea PH, 2005, J NEUROPHYSIOL, V94, P2999, DOI 10.1152/jn.00732.2004; MILNER TE, 1993, EXP BRAIN RES, V94, P522; Milner TE, 1998, EXP BRAIN RES, V122, P309, DOI 10.1007/s002210050519; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Osu R, 2003, J NEUROPHYSIOL, V90, P3255, DOI 10.1152/jn.00073.2003; Perreault EJ, 2001, EXP BRAIN RES, V141, P312, DOI 10.1007/s002210100880; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Romaiguere P, 2003, COGNITIVE BRAIN RES, V16, P74, DOI 10.1016/S0926-6410(02)00221-5; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; SANES JN, 1985, HUM NEUROBIOL, V4, P101; Sangani SG, 2007, MUSCLE NERVE, V36, P694, DOI 10.1002/mus.20852; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Scheidt RA, 2007, J NEUROPHYSIOL, V98, P3600, DOI 10.1152/jn.00121.2007; Scheidt RA, 2007, J NEUROPHYSIOL, V97, P2824, DOI 10.1152/jn.00870.2006; Scheidt RA, 2010, EXP BRAIN RES, V204, P239, DOI 10.1007/s00221-010-2308-1; Siggelkow S, 1999, MUSCLE NERVE, V22, P1544, DOI 10.1002/(SICI)1097-4598(199911)22:11<1544::AID-MUS9>3.3.CO;2-#; Smania N, 2003, ARCH PHYS MED REHAB, V84, P1692, DOI 10.1053/S0003-9993(03)00277-6; Smith L, 2005, J REHABIL RES DEV, V42, P787, DOI 10.1682/JRRD.2005.02.0041; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Srungboonmee KA, 2011, MARQUETTE U PUBILCAT; Sullivan JE, 2008, TOP STROKE REHABIL, V15, P200, DOI 10.1310/tsr1503-200; Trumbower RD, 2008, IEEE ENG MED BIO, P3558, DOI 10.1109/IEMBS.2008.4649974; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Westlake KP, 2005, PHYS THER, V27, P872; Wu CW, 2006, ARCH PHYS MED REHAB, V87, P351, DOI 10.1016/j.apmr.2005.11.019; Wu CWH, 2005, NEUROIMAGE, V27, P872, DOI 10.1016/j.neuroimage.2005.05.055	68	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144377	10.1371/journal.pone.0144377	http://dx.doi.org/10.1371/journal.pone.0144377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633892	Green Published, Green Submitted, gold			2022-12-26	WOS:000366040000083
J	Dai, XX; Zhang, MQ; Lu, YJ; Miao, YL; Zhou, CY; Sun, SC; Xiong, B				Dai, Xiaoxin; Zhang, Mianqun; Lu, Yajuan; Miao, Yilong; Zhou, Changyin; Sun, Shaochen; Xiong, Bo			Melamine Impairs Female Fertility via Suppressing Protein Level of Juno in Mouse Eggs	PLOS ONE			English	Article							ZONA-PELLUCIDA; MAMMALIAN FERTILIZATION; MOLECULAR-BASIS; ASTACIN FAMILY; FETUIN-B; SPERM; FUSION; OOCYTE; IZUMO; MICE	Melamine is an organic nitrogenous compound widely used as an industrial chemical, and it has been recently reported by us that melamine has a toxic effect on the female reproductive system in mice, and renders females subfertile; the molecular basis, however, has not been adequately assessed. In the present study, we explore the underlying mechanism regarding how melamine compromises fertility in the mouse. The data showed that melamine exposure significantly impaired the fertilization capability of the egg during in vitro fertilization. To further figure out the cause, we analyzed ovastacin localization and protein level, the sperm binding ability of zona pellucida, and ZP2 cleavage status in unfertilized eggs from melamine fed mice, and no obvious differences were found between control and treatment groups. However, the protein level of Juno on the egg plasma membrane in the high-dose feeding group indeed significantly decreased compared to the control group. Thus, these data suggest that melamine compromises female fertility via suppressing Juno protein level on the egg membrane.	[Dai, Xiaoxin; Zhang, Mianqun; Lu, Yajuan; Miao, Yilong; Zhou, Changyin; Sun, Shaochen; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 20095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 20095, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			Natural Science Foundation of Jiangsu Province [BK20150677]; National Natural Science Foundation [31571545]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was funded by BK20150677 (www.jstd.gov.cn), Natural Science Foundation of Jiangsu Province, to BX; and 31571545 (www.nsfc.gov.cn), National Natural Science Foundation, to BX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri JA, 2003, J CELL SCI, V116, P2149, DOI 10.1242/jcs.00430; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Bianchi E, 2014, CELL CYCLE, V13, P2019, DOI 10.4161/cc.29461; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BOCK M, 1957, BRIT J PHARM CHEMOTH, V12, P1; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Clark GF, 2011, REPRODUCTION, V142, P377, DOI 10.1530/REP-11-0118; Cook HA, 2005, ELECTROPHORESIS, V26, P1576, DOI 10.1002/elps.200410058; Coonrod SA, 1999, DEV BIOL, V207, P334, DOI 10.1006/dbio.1998.9161; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Duan X, 2015, HUM REPROD, V30, P1643, DOI 10.1093/humrep/dev091; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Gupta SK, 2012, CELL TISSUE RES, V349, P665, DOI 10.1007/s00441-011-1319-y; Hau AKC, 2009, J AM SOC NEPHROL, V20, P245, DOI 10.1681/ASN.2008101065; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Ohnami N, 2012, BIOL OPEN, V1, P640, DOI 10.1242/bio.20121420; Skinner CG, 2010, J MED TOXICOL, V6, P50, DOI 10.1007/s13181-010-0038-1; Stocker W, 2014, BIOL CHEM, V395, P1195, DOI 10.1515/hsz-2014-0189; Wassarman PA, 2004, EUR J OBSTET GYN R B, V115, pS57, DOI 10.1016/j.ejogrb.2004.01.025; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178	24	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144248	10.1371/journal.pone.0144248	http://dx.doi.org/10.1371/journal.pone.0144248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633308	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000073
J	de Souza, DA; Borges, AC; Santana, AC; Oliver, C; Jamur, MC				de Souza Junior, Devandir Antonio; Borges, Antonio Carlos; Santana, Ana Carolina; Oliver, Constance; Jamur, Maria Celia			Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors	PLOS ONE			English	Article							IN-VITRO; TRYPTASE; EXPRESSION; GROWTH; PROLIFERATION; INHIBITION; INVOLVEMENT; MECHANISMS; MIGRATION; SURVIVAL	Mast cell proteases are thought to be involved with tumor progression and neo-vascularization. However, their exact role is still unclear. The present study was undertaken to further elucidate the function of specific subtypes of recombinant mouse mast cell proteases (rmMCP-6 and 7) in neo-vascularization. SVEC4-10 cells were cultured on Geltrex (R) with either rmMCP-6 or 7 and tube formation was analyzed by fluorescence microscopy and scanning electron microscopy. Additionally, the capacity of these proteases to induce the release of angiogenic factors and pro and anti-angiogenic proteins was analyzed. Both rmMCP-6 and 7 were able to stimulate tube formation. Scanning electron microscopy showed that incubation with the proteases induced SVEC4-10 cells to invade the gel matrix. However, the expression and activity of metalloproteases were not altered by incubation with the mast cell proteases. Furthermore, rmMCP-6 and rmMCP-7 were able to induce the differential release of angiogenic factors from the SVEC4-10 cells. rmMCP-7 was more efficient in stimulating tube formation and release of angiogenic factors than rmMCP-6. These results suggest that the subtypes of proteases released by mast cells may influence endothelial cells during in vivo neo-vascularization.	[de Souza Junior, Devandir Antonio; Borges, Antonio Carlos; Santana, Ana Carolina; Oliver, Constance; Jamur, Maria Celia] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Jamur, MC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol & Pathogen Bioagents, Ribeirao Preto, SP, Brazil.	mjamur@fmrp.usp.br	Jamur, Maria Celia/L-5520-2016	Jamur, Maria Celia/0000-0001-7065-8543; Borges, Antonio Carlos/0000-0003-0023-6403	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [150022/2012-3]; FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia);  [11/10363-8];  [09/54013-0]	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia); ; 	Funding was provided by FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/); Post Doctoral Fellowship 11/10363-8 to DASJ and Equipment Grant 09/54013-0 to MCJ; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br) Fellowship to MCJ and ACB Post Doctoral Fellowship 150022/2012-3, FAEPA (Fundacao de Apoio ao Ensino, Pesquisa e Assistencia, http://www.faepa.br) Grant to MCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P8890; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Ammendola M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/154702; Askou AL, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.64; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bles N, 2010, BLOOD, V116, P3219, DOI 10.1182/blood-2010-01-265611; Bodnar RJ, 2006, CIRC RES, V98, P617, DOI 10.1161/01.RES.0000209968.66606.10; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cates AM, 2015, RHEUMATOLOGY, V54, P1114, DOI 10.1093/rheumatology/keu431; Ch'ng S, 2006, MODERN PATHOL, V19, P149, DOI 10.1038/modpathol.3800474; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Compton SJ, 1998, J IMMUNOL, V161, P1939; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; Cui Y, 2014, J IMMUNOL, V193, P4783, DOI 10.4049/jimmunol.1302947; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; de Souza DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040790; de Souza DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/142359; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dyduch G, 2012, POL J PATHOL, V63, P1; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fu YN, 2011, J HISTOCHEM CYTOCHEM, V59, P463, DOI 10.1369/0022155411401748; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellhaus A, 2006, MOL HUM REPROD, V12, P389, DOI 10.1093/molehr/gal044; Gillis P, 1999, J CELL SCI, V112, P2049; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Hallgren J, 2014, EUR J IMMUNOL, V44, P33, DOI 10.1002/eji.201344262; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Jamur Maria Celia, 2011, Front Biosci (Schol Ed), V3, P1390; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; Kato M, 2003, BIOCHEM BIOPH RES CO, V301, P1109, DOI 10.1016/S0006-291X(03)00093-7; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Krishnaswamy Guha, 2006, Methods Mol Biol, V315, P13; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Kumar S, 2012, AM J PATHOL, V181, P1056, DOI 10.1016/j.ajpath.2012.05.022; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Leber TM, 1997, ANAL BIOCHEM, V249, P24, DOI 10.1006/abio.1997.2170; Lee WS, 2015, AM J CANCER RES, V5, P101; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu MG, 2014, MOL MED REP, V10, P2177, DOI 10.3892/mmr.2014.2457; Lu C, 2005, CHINESE MED J-PEKING, V118, P1900; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maciel Thiago T, 2015, F1000Prime Rep, V7, P09, DOI 10.12703/P7-09; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Mangia A, 2011, HISTOPATHOLOGY, V58, P1096, DOI 10.1111/j.1365-2559.2011.03842.x; da Silva EZM, 2014, J HISTOCHEM CYTOCHEM, V62, P698, DOI 10.1369/0022155414545334; Marichal T, 2013, CANCER IMMUNOL RES, V1, P269, DOI 10.1158/2326-6066.CIR-13-0119; Marinaccio C, 2014, LEUKEMIA RES, V38, P1374, DOI 10.1016/j.leukres.2014.09.007; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Marchini-Alves CMM, 2012, J HISTOCHEM CYTOCHEM, V60, P386, DOI 10.1369/0022155412438886; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Neufeld G, 2001, Surg Oncol Clin N Am, V10, P339; Neufeld G, 2006, CANCER METAST REV, V25, P373, DOI 10.1007/s10555-006-9011-5; Niu JL, 2013, J PHARMACOL EXP THER, V347, P288, DOI 10.1124/jpet.113.207316; Olivera Ana, 2014, Methods Mol Biol, V1192, P3, DOI 10.1007/978-1-4939-1173-8_1; Pappa CA, 2015, CANCER INVEST, V33, P137, DOI 10.3109/07357907.2015.1008639; Pastorello EA, 2014, INT ARCH ALLERGY IMM, V164, P97, DOI 10.1159/000360164; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Ribatti D, 2012, BBA-MOL BASIS DIS, V1822, P2, DOI 10.1016/j.bbadis.2010.11.010; Ribatti D, 2011, INT J DEV BIOL, V55, P99, DOI 10.1387/ijdb.103138dr; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; SCHWARTZ LB, 1987, AM REV RESPIR DIS, V135, P1186; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Singer J, 2014, ALLERGY, V69, P137, DOI 10.1111/all.12276; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Subramanian M, 2014, J CELL BIOCHEM, V115, P1974, DOI 10.1002/jcb.24869; Szukiewicz D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/437576; Tahir A, 2013, J CANCER RES THER, V9, P387, DOI 10.4103/0973-1482.119311; Ullah E, 2013, J CANCER RES THER, V9, P701, DOI 10.4103/0973-1482.126487; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yang XH, 2012, J BIOL CHEM, V287, P6490, DOI 10.1074/jbc.M111.254631; Zhi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060960	92	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144081	10.1371/journal.pone.0144081	http://dx.doi.org/10.1371/journal.pone.0144081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633538	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000052
J	Feiss, M; Min, JY; Sultana, S; Patel, P; Sippy, J				Feiss, Michael; Min, Jea Young; Sultana, Sawsan; Patel, Priyal; Sippy, Jean			DNA Packaging Specificity of Bacteriophage N15 with an Excursion into the Genetics of a Cohesive End Mismatch	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; TERMINASE BINDING-SITE; LAMBDA-DNA; ESCHERICHIA-COLI; VIRAL-DNA; PHAGE-LAMBDA; TAILED-BACTERIOPHAGES; NUCLEOPROTEIN COMPLEX; ANGSTROM RESOLUTION; PORTAL PROTEIN	During DNA replication by the lambda-like bacteriophages, immature concatemeric DNA is produced by rolling circle replication. The concatemers are processed into mature chromosomes with cohesive ends, and packaged into prohead shells, during virion assembly. Cohesive ends are generated by the viral enzyme terminase, which introduces staggered nicks at cos, an approx. 200 bp-long sequence containing subsites cosQ, cosN and cosB. Interactions of cos subsites of immature concatemeric DNA with terminase orchestrate DNA processing and packaging. To initiate DNA packaging, terminase interacts with cosB and nicks cosN. The cohesive ends of N15 DNA differ from those of lambda at 2/12 positions. Genetic experiments show that phages with chromosomes containing mismatched cohesive ends are functional. In at least some infections, the cohesive end mismatch persists through cyclization and replication, so that progeny phages of both allelic types are produced in the infected cell. N15 possesses an asymmetric packaging specificity: N15 DNA is not packaged by phages lambda or 21, but surprisingly, N15-specific terminase packages lambda DNA. Implications for genetic interactions among lambda-like bacteriophages are discussed.	[Feiss, Michael; Min, Jea Young; Sultana, Sawsan; Patel, Priyal; Sippy, Jean] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa	Sippy, J (corresponding author), Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.	jean-sippy@uiowa.edu			National Science Foundation [MCB-0717620, MCB-1158495]; National Institutes of Health, United States awards [5R01GM088186, 5R01GM051611]; University of Iowa Department of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088186, R01GM051611] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, United States awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Department of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by funding from National Science Foundation awards MCB-0717620 and MCB-1158495, the National Institutes of Health, United States awards 5R01GM088186 and 5R01GM051611 (www.nih.gov/), and the University of Iowa Department of Microbiology.; MF and JS dedicate this work to the late Erich W. Six, for decades our lively colleague and friend. Erich always liked a good phage yarn. This project was supported by funding from National Science Foundation awards MCB-0717620 and MCB-1158495, National Institutes of Health, United States awards 5R01GM088186 and 5R01GM051611 (www.nih.gov/), and the University of Iowa Department of Microbiology.	Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Al-Zahrani AS, 2009, J BIOL CHEM, V284, P24490, DOI 10.1074/jbc.M109.025007; Arber W., 1983, LAMBDA, P433; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; BEAR SE, 1984, J VIROL, V52, P966, DOI 10.1128/JVI.52.3.966-972.1984; BECKER A, 1977, VIROLOGY, V78, P291, DOI 10.1016/0042-6822(77)90100-3; BECKER A, 1990, J BACTERIOL, V172, P2819, DOI 10.1128/jb.172.6.2819-2824.1990; Benini S, 2013, ACTA CRYSTALLOGR F, V69, P376, DOI 10.1107/S1744309113004399; Black LW, 2015, VIROLOGY; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Catalano C.E., 2005, VIRAL GENOME PACKAGI; CATALANO CE, 1995, MOL MICROBIOL, V16, P1075, DOI 10.1111/j.1365-2958.1995.tb02333.x; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; CUE D, 1993, P NATL ACAD SCI USA, V90, P9290, DOI 10.1073/pnas.90.20.9290; Cue D, 2001, J MOL BIOL, V311, P233, DOI 10.1006/jmbi.2001.4840; CUE D, 1992, J MOL BIOL, V228, P58, DOI 10.1016/0022-2836(92)90491-2; CUE D, 1992, J MOL BIOL, V228, P72, DOI 10.1016/0022-2836(92)90492-3; CUE D, 1993, J MOL BIOL, V234, P594, DOI 10.1006/jmbi.1993.1614; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; Dhar A, 2005, J MOL BIOL, V347, P71, DOI 10.1016/j.jmb.2004.12.041; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; FEISS M, 1979, VIROLOGY, V92, P190, DOI 10.1016/0042-6822(79)90224-1; FEISS M, 1985, J MOL BIOL, V186, P759, DOI 10.1016/0022-2836(85)90395-X; Feiss M, 1981, BACTERIOPHAGE ASSEMB, P213; Feiss M, 2015, VIROLOGY, V482, P260, DOI 10.1016/j.virol.2015.03.027; Feiss M, 2010, GENETICS, V184, P43, DOI 10.1534/genetics.109.108548; FRACKMAN S, 1984, J MOL BIOL, V180, P283, DOI 10.1016/S0022-2836(84)80005-4; FRACKMAN S, 1985, J MOL BIOL, V183, P225, DOI 10.1016/0022-2836(85)90215-3; Furth M., 1983, LAMBDA 2, P145; Gao S, 2011, J BIOL CHEM, V286, P3944, DOI 10.1074/jbc.M110.196907; GRANSTON AE, 1988, MOL GEN GENET, V212, P149, DOI 10.1007/BF00322458; Hang JQ, 2001, BIOCHEMISTRY-US, V40, P13370, DOI 10.1021/bi011126r; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; HIGGINS RR, 1988, CELL, V54, P765, DOI 10.1016/S0092-8674(88)91021-5; HIGGINS RR, 1994, EMBO J, V13, P6152, DOI 10.1002/j.1460-2075.1994.tb06962.x; HIGGINS RR, 1994, EMBO J, V13, P6162, DOI 10.1002/j.1460-2075.1994.tb06963.x; Kosturko L., 1989, NUCLEIC ACIDS RES, V17, P329; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; Maluf NK, 2006, MOL MICROBIOL, V61, P1, DOI 10.1111/j.1365-2958.2006.05214.x; Maluf NK, 2006, BIOCHEMISTRY-US, V45, P15259, DOI 10.1021/bi0615036; MILLER G, 1988, MOL GEN GENET, V212, P157, DOI 10.1007/BF00322459; MURRAY K, 1975, NATURE, V254, P262, DOI 10.1038/254262a0; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Newcomb WW, 1999, J VIROL, V73, P4239, DOI 10.1128/JVI.73.5.4239-4250.1999; Oliveira L, 2013, VIRUS RES, V173, P247, DOI 10.1016/j.virusres.2013.01.021; Ortega ME, 2006, BIOCHEMISTRY-US, V45, P5180, DOI 10.1021/bi052284b; PAL SK, 1988, J BACTERIOL, V172, P2819; Przech AJ, 2003, J VIROL, V77, P9613, DOI 10.1128/JVI.77.17.9613-9621.2003; Rao VB, 2008, ANN REV GENETICS ANN, P647; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rixon FJ, 2014, CURR OPIN VIROL, V5, P105, DOI 10.1016/j.coviro.2014.02.003; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Sippy J, 2015, VIROLOGY, V476, P115, DOI 10.1016/j.virol.2014.11.028; STERNBERG N, 1983, J BACTERIOL, V153, P800, DOI 10.1128/JB.153.2.800-812.1983; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; Wieczorek DJ, 2001, GENETICS, V158, P495; Wu H, 2002, MOL MICROBIOL, V45, P1631, DOI 10.1046/j.1365-2958.2002.03114.x; WU WF, 1988, GENETICS, V119, P477; XIN W, 1993, J MOL BIOL, V230, P492, DOI 10.1006/jmbi.1993.1166; XU SY, 1991, J MOL BIOL, V220, P281, DOI 10.1016/0022-2836(91)90013-V; Yang G, 2003, VIROLOGY, V305, P276, DOI 10.1006/viro.2002.1602; Yang Q, 1997, BIOCHEMISTRY-US, V36, P2744, DOI 10.1021/bi9622682; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016	71	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0141934	10.1371/journal.pone.0141934	http://dx.doi.org/10.1371/journal.pone.0141934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633301	Green Submitted, gold, Green Published			2022-12-26	WOS:000366040000003
J	Gutierrez, S; Descamps, B; Vanhove, C				Gutierrez, Shandra; Descamps, Benedicte; Vanhove, Christian			MRI-Only Based Radiotherapy Treatment Planning for the Rat Brain on a Small Animal Radiation Research Platform (SARRP)	PLOS ONE			English	Article							DOSE CALCULATIONS; SIMULATION	Computed tomography (CT) is the standard imaging modality in radiation therapy treatment planning (RTP). However, magnetic resonance (MR) imaging provides superior soft tissue contrast, increasing the precision of target volume selection. We present MR-only based RTP for a rat brain on a small animal radiation research platform (SARRP) using probabilistic voxel classification with multiple MR sequences. Six rat heads were imaged, each with one CT and five MR sequences. The MR sequences were: T1-weighted, T2-weighted, zero-echo time (ZTE), and two ultra-short echo time sequences with 20 mu s (UTE1) and 2 ms (UTE2) echo times. CT data were manually segmented into air, soft tissue, and bone to obtain the RTP reference. Bias field corrected MR images were automatically segmented into the same tissue classes using a fuzzy c-means segmentation algorithm with multiple images as input. Similarities between segmented CT and automatic segmented MR (ASMR) images were evaluated using Dice coefficient. Three ASMR images with high similarity index were used for further RTP. Three beam arrangements were investigated. Dose distributions were compared by analysing dose volume histograms. The highest Dice coefficients were obtained for the ZTE-UTE2 combination and for the T1-UTE1-T2 combination when ZTE was unavailable. Both combinations, along with UTE1-UTE2, often used to generate ASMR images, were used for further RTP. Using 1 beam, MR based RTP underestimated the dose to be delivered to the target (range: 1.4%-7.6%). When more complex beam configurations were used, the calculated dose using the ZTE-UTE2 combination was the most accurate, with 0.7% deviation from CT, compared to 0.8% for T1-UTE1-T2 and 1.7% for UTE1-UTE2. The presented MR-only based workflow for RTP on a SARRP enables both accurate organ delineation and dose calculations using multiple MR sequences. This method can be useful in longitudinal studies where CT's cumulative radiation dose might contribute to the total dose.	[Gutierrez, Shandra; Descamps, Benedicte; Vanhove, Christian] Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium	Ghent University; IMEC	Gutierrez, S (corresponding author), Univ Ghent, iMinds Med IT Dept, Med Image & Signal Proc Grp, B-9000 Ghent, Belgium.	shandra.gutierrezdiaz@ugent.be	Vanhove, Christian/I-2095-2019	Vanhove, Christian/0000-0002-3988-5980	Ghent University; GROUP-ID consortium of Ghent University; iMinds	Ghent University(Ghent University); GROUP-ID consortium of Ghent University; iMinds	This work is funded by iMinds and Ghent University. CV is supported by the GROUP-ID consortium of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird EGA, 2002, BRIT J RADIOL, V75, P937, DOI 10.1259/bjr.75.900.750937; Bazalova M, 2011, MED PHYS, V38, P3039, DOI 10.1118/1.3589138; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bolcaen J, 2014, J NEUROONC; Cherry SR, 2004, PHYS MED BIOL, V49, pR13, DOI 10.1088/0031-9155/49/3/R01; Eilertsen K, 2008, ACTA ONCOL, V47, P1294, DOI 10.1080/02841860802256426; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Fiorentino A, 2013, CLIN TRANSL ONCOL, V15, P754, DOI 10.1007/s12094-012-0992-y; Hsu SH, 2013, PHYS MED BIOL, V58, P8419, DOI 10.1088/0031-9155/58/23/8419; Johanson A, 2013, ACTA ONCOL, V52, P1369, DOI 10.3109/0284186X.2013.819119; Johansson A, 2011, MED PHYS, V38, P2708, DOI 10.1118/1.3578928; Keereman V, 2010, J NUCL MED, V51, P812, DOI 10.2967/jnumed.109.065425; Li CM, 2009, LECT NOTES COMPUT SC, V5636, P288; Shukla Divya, 2005, J Cancer Res Ther, V1, P235; Siewerdsen JH, 2004, MED PHYS, V31, P3506, DOI 10.1118/1.1819789; Sorensen T., 1948, BIOL SKAR, V5, P1; Vanhoof SJ, 2013, DEV VALIDATION TREAT, P361; Verhaegen F, 2014, Z MED PHYS, V24, P323, DOI 10.1016/j.zemedi.2014.02.004; Verhaegen F, 2011, PHYS MED BIOL, V56, pR55, DOI 10.1088/0031-9155/56/12/R01	19	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0143821	10.1371/journal.pone.0143821	http://dx.doi.org/10.1371/journal.pone.0143821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633302	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000024
J	Nelveg-Kristensen, KE; Madsen, MB; Torp-Pedersen, C; Kober, L; Egfjord, M; Rasmussen, HB; Hansen, PR				Nelveg-Kristensen, Karl Emil; Madsen, Majbritt Busk; Torp-Pedersen, Christian; Kober, Lars; Egfjord, Martin; Rasmussen, Henrik Berg; Hansen, Peter Riis			Pharmacogenetic Risk Stratification in Angiotensin-Converting Enzyme Inhibitor-Treated Patients with Congestive Heart Failure: A Retrospective Cohort Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; DELETION POLYMORPHISM; BLOOD-PRESSURE; MORTALITY; SURVIVAL; ASSOCIATION; GENE; DETERMINANTS; MANAGEMENT; RECEPTORS	Background Evidence for pharmacogenetic risk stratification of angiotensin-converting enzyme inhibitor (ACEI) treatment is limited. Therefore, in a cohort of ACEI-treated patients with congestive heart failure (CHF), we investigated the predictive value of two pharmacogenetic scores that previously were found to predict ACEI efficacy in patients with ischemic heart disease and hypertension, respectively. Score A combined single nucleotide polymorphisms (SNPs) of the angiotensin II receptor type 1 gene (rs275651 and rs5182) and the bradykinin receptor B1 gene (rs12050217). Score B combined SNPs of the angiotensin-converting enzyme gene (rs4343) and ABO blood group genes (rs495828 and rs8176746). Methods Danish patients with CHF enrolled in the previously reported Echocardiography and Heart Outcome Study were included. Subjects were genotyped and categorized according to pharmacogenetic scores A and B of <= 1, 2 and >= 3 each, and followed for up to 10 years. Difference in cumulative incidences of cardiovascular death and all-cause death were assessed by the cumulative incidence estimator. Survival was modeled by Cox proportional hazard analyses. Results We included 667 patients, of whom 80% were treated with ACEIs. Differences in cumulative incidences of cardiovascular death (P = 0.346 and P = 0.486) and all-cause death (P = 0.515 and P = 0.486) were not significant for score A and B, respectively. There was no difference in risk of cardiovascular death or all-cause death between subjects with score A <= 1 vs. 2 (HR 1.03 [95% CI 0.79-1.34] and HR 1.11 [95% CI 0.88-1.42]), score A <= 1 vs. >= 3 (HR 0.80 [95% CI 0.59-1.08] and HR 0.91 [95% CI 0.70-1.20]), score B <= 1 vs. 2 ( HR 1.02 [95% CI 0.78-1.32] and HR 0.98 [95% CI 0.77-1.24]), and score B <= 1 vs. >= 3 ( HR 1.03 [95% CI 0.75-1.41] and HR 1.05 [95% CI 0.79-1.40]), respectively. Conclusions We found no association between either of the analyzed pharmacogenetic scores and fatal outcomes in ACEI-treated patients with CHF.	[Nelveg-Kristensen, Karl Emil; Hansen, Peter Riis] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Majbritt Busk; Rasmussen, Henrik Berg] Copenhagen Univ Hosp, Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark; [Kober, Lars] Copenhagen Univ Hosp, Ctr Heart, Rigshosp, Copenhagen, Denmark; [Egfjord, Martin] Copenhagen Univ Hosp, Dept Nephrol, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Aalborg University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nelveg-Kristensen, KE (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	karl.emil.kristensen@regionh.dk	Hansen, Peter Riis/AAR-7659-2020	Kober, Lars/0000-0002-6635-1466; Hansen, Peter Riis/0000-0002-9056-535X; Busk Madsen, Majbritt/0000-0003-2123-8483	Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society [10092792/DSF]; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society; Lundbeck Foundation(Lundbeckfonden)	The present study is part of the Individualized Drug Therapy Based on Pharmacogenetics: Focus on Carboxylesterase 1 (INDICES) project, which was funded by grant 10092792/DSF from the Danish Council for Strategic Research, Programme Commission on Individuals, Disease and Society URL:http://ufm.dk/en/research-and-innovation/councils-and-commissions/former-councils-and-commissions/the-danish-council-for-strategic-research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Andersson B, 1996, J AM COLL CARDIOL, V28, P162, DOI 10.1016/0735-1097(96)00098-8; Arnett DK, 2005, CIRCULATION, V111, P3374, DOI 10.1161/CIRCULATIONAHA.104.504639; BALL SG, 1993, LANCET, V342, P821; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0; Batenburg WW, 2006, J HYPERTENS, V24, P1355, DOI 10.1097/01.hjh.0000234116.17778.63; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Brugts JJ, 2010, EUR HEART J, V31, P1854, DOI 10.1093/eurheartj/ehq169; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Chung CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056119; Deng MC, 1997, INT J CARDIOL, V61, P261, DOI 10.1016/S0167-5273(97)00163-0; Elliott WJ, 1996, CLIN PHARMACOL THER, V60, P582, DOI 10.1016/S0009-9236(96)90155-1; Feldman RD, 2014, ANN REV PHARM TOXICO; Furberg CD, 2001, J AM COLL CARDIOL, V37, P1456, DOI 10.1016/S0735-1097(01)01161-5; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Joseph PG, 2014, CLIN CARDIOL, V37, P48, DOI 10.1002/clc.22200; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Mas S, 2011, PHARMACOGENET GENOM, V21, P531, DOI 10.1097/FPC.0b013e328348c6db; McNamara DM, 2004, J AM COLL CARDIOL, V44, P2019, DOI 10.1016/j.jacc.2004.08.048; Ng ACC, 2008, INT J CARDIOL, V129, P198, DOI 10.1016/j.ijcard.2007.07.014; OSBORN JL, 1981, J PHARMACOL EXP THER, V216, P265; Petersen M, 2012, PHARMACOGENET GENOM, V22, P709, DOI 10.1097/FPC.0b013e3283540286; Petersen M, 2011, BRIT J CLIN PHARMACO, V71, P556, DOI 10.1111/j.1365-2125.2010.03868.x; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rogg H, 1996, EUR HEART J, V17, P1112; Schelleman H, 2004, DRUGS, V64, P1801, DOI 10.2165/00003495-200464160-00006; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shah Apurva D, 2005, Clin Cardiol, V28, P551; Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; Talameh Jasmine A, 2012, Curr Heart Fail Rep, V9, P23, DOI 10.1007/s11897-011-0076-2; Torp-Pedersen C, 2008, EUR J HEART FAIL, V10, P89, DOI 10.1016/j.ejheart.2007.10.012; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Zhuo JL, 2011, PEPTIDES, V32, P1551, DOI 10.1016/j.peptides.2011.05.012	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144195	10.1371/journal.pone.0144195	http://dx.doi.org/10.1371/journal.pone.0144195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633885	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000069
J	Chen, H; Beasley, A; Hu, YH; Chen, XX				Chen, Hao; Beasley, Andrea; Hu, Yuhui; Chen, Xiaoxin			A Zebrafish Model for Studies on Esophageal Epithelial Biology	PLOS ONE			English	Article							DIGESTIVE-SYSTEM; ACTIVATION; EXPRESSION; MORPHOGENESIS; CARCINOMA; LIMB; SOX2; P63	Mammalian esophagus exhibits a remarkable change in epithelial structure during the transition from embryo to adult. However, the molecular mechanisms of esophageal epithelial development are not well understood. Zebrafish (Danio rerio), a common model organism for vertebrate development and gene function, has not previously been characterized as a model system for esophageal epithelial development. In this study, we characterized a piece of non-keratinized stratified squamous epithelium similar to human esophageal epithelium in the upper digestive tract of developing zebrafish. Under the microscope, this piece was detectable at 5dpf and became stratified at 7dpf. Expression of esophageal epithelial marker genes (Krt5, P63, Sox2 and Pax9) was detected by immunohistochemistry and in situ hybridization. Knockdown of P63, a gene known to be critical for esophageal epithelium, disrupted the development of this epithelium. With this model system, we found that Pax9 knockdown resulted in loss or disorganization of the squamous epithelium, as well as down-regulation of the differentiation markers Krt4 and Krt5. In summary, we characterized a region of stratified squamous epithelium in the zebrafish upper digestive tract which can be used for functional studies of candidate genes involved in esophageal epithelial biology.	[Chen, Hao; Beasley, Andrea; Hu, Yuhui; Chen, Xiaoxin] N Carolina Cent Univ, JLC BBRI, Canc Res Program, Durham, NC 27707 USA; [Chen, Xiaoxin] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27599 USA	University of North Carolina; North Carolina Central University; University of North Carolina; University of North Carolina Chapel Hill	Chen, XX (corresponding author), N Carolina Cent Univ, JLC BBRI, Canc Res Program, Durham, NC 27707 USA.	lchen@nccu.edu			National Institutes of Health, National Cancer Institute [U54 CA156735];  [NIH/U54-CA156735-05-5714]; NATIONAL CANCER INSTITUTE [U54CA156735] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health, National Cancer Institute, U54 CA156735. XC received the funding; http://grantome.com/grant/NIH/U54-CA156735-05-5714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2010, AQUAT TOXICOL, V96, P53, DOI 10.1016/j.aquatox.2009.09.015; Chen HC, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-188; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; Gerber JK, 2002, J PATHOL, V197, P293, DOI 10.1002/path.1115; Hu B, 2010, ORAL ONCOL, V46, P31, DOI 10.1016/j.oraloncology.2009.09.008; Ingham PW, 1997, HUM MOL GENET, V6, P1755, DOI 10.1093/hmg/6.10.1755; Jiang M, 2015, J CLIN INVEST, V125, P1557, DOI 10.1172/JCI78850; JOHNS BAE, 1952, J ANAT, V86, P431; Korzh S, 2011, DEV BIOL, V359, P262, DOI 10.1016/j.ydbio.2011.08.024; Lee KB, 2014, CANCER LETT, V353, P124, DOI 10.1016/j.canlet.2014.07.016; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Ma XL, 2006, INT J CANCER, V118, P139, DOI 10.1002/ijc.21295; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Piazzolla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5226; Rishniw M, 2011, ANN NY ACAD SCI, V1232, P309, DOI 10.1111/j.1749-6632.2011.06071.x; Sadler KC, 2013, ZEBRAFISH, V10, P129, DOI 10.1089/zeb.2013.1500; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143878	10.1371/journal.pone.0143878	http://dx.doi.org/10.1371/journal.pone.0143878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630178	Green Published, gold, Green Submitted			2022-12-26	WOS:000365926300116
J	de Oliveira, PRB; da Costa, CA; de Bem, GF; Cordeiro, VSC; Santos, IB; de Carvalho, LCRM; da Conceicao, EPS; Lisboa, PC; Ognibene, DT; Sousa, PJC; Martins, GR; da Silva, AJR; de Moura, RS; Resende, AC				de Oliveira, Paola Raquel B.; da Costa, Cristiane A.; de Bem, Graziele F.; Cordeiro, Viviane S. C.; Santos, Izabelle B.; de Carvalho, Lenize C. R. M.; da Conceicao, Ellen Paula S.; Lisboa, Patrcia Cristina; Ognibene, Dayane T.; Sousa, Pergentino Jose C.; Martins, Gabriel R.; da Silva, Antonio Jorge R.; de Moura, Roberto S.; Resende, Angela C.			Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion	PLOS ONE			English	Article							INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; PATHOGENIC MECHANISM; GENE-EXPRESSION; DISEASE; ANTIOXIDANT; PROANTHOCYANIDINS; IDENTIFICATION; PROCYANIDINS; PROGRESSION	The aim of this study was to investigate the effect of a polyphenol-rich Acai seed extract (ASE, 300 mg/kg-1d-1) on adiposity and hepatic steatosis in mice that were fed a high-fat (HF) diet and its underlying mechanisms based on hepatic lipid metabolism and oxidative stress. Four groups were studied: C57BL/6 mice that were fed with standard diet (10% fat, Control), 10% fat + ASE (ASE), 60% fat (HF), and 60% fat + ASE (HF + ASE) for 12 weeks. We evaluated the food intake, body weight gain, serum glucose and lipid profile, hepatic cholesterol and triacyglycerol (TG), hepatic expression of pAMPK, lipogenic proteins (SREBP-1c, pACC, ACC, HMG-CoA reductase) and cholesterol excretion transporters, ABCG5 and ABCG8. We also evaluated the steatosis in liver sections and oxidative stress. ASE reduced body weight gain, food intake, glucose levels, accumulation of cholesterol and TG in the liver, which was associated with a reduction of hepatic steatosis. The increased expressions of SREBP-1c and HMG-CoA reductase and reduced expressions of pAMPK and pACC/ACC in HF group were antagonized by ASE. The ABCG5 and ABCG8 transporters expressions were increased by the extract. The antioxidant effect of ASE was demonstrated in liver of HF mice by restoration of SOD, CAT and GPx activities and reduction of the increased levels of malondialdehyde and protein carbonylation. In conclusion, ASE substantially reduced the obesity and hepatic steatosis induced by HF diet by reducing lipogenesis, increasing cholesterol excretion and improving oxidative stress in the liver, providing a nutritional resource for prevention of obesity-related adiposity and hepatic steatosis.	[de Oliveira, Paola Raquel B.; da Costa, Cristiane A.; de Bem, Graziele F.; Cordeiro, Viviane S. C.; Santos, Izabelle B.; de Carvalho, Lenize C. R. M.; Ognibene, Dayane T.; de Moura, Roberto S.; Resende, Angela C.] Univ Estado Rio De Janeiro, Inst Biol, Dept Pharmacol, Rio De Janeiro, Brazil; [da Conceicao, Ellen Paula S.; Lisboa, Patrcia Cristina] Univ Estado Rio De Janeiro, Inst Biol, Dept Physiol Sci, Rio De Janeiro, Brazil; [Sousa, Pergentino Jose C.] Fed Univ Para, Dept Pharm, BR-66059 Belem, Para, Brazil; [Martins, Gabriel R.; da Silva, Antonio Jorge R.] Univ Fed Rio de Janeiro, IPPN, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Para; Universidade Federal do Rio de Janeiro	Resende, AC (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Dept Pharmacol, Rio De Janeiro, Brazil.	angelaresende.uerj@gmail.com	Ognibene, Dayane/AAA-9560-2019; Lisboa, Patricia C./H-8336-2015; da Silva, Antonio J R/C-4476-2013; Costa, Cristiane Aguiar/AAF-8475-2021; Moura, Egberto/ABA-6188-2021; Lisboa, Patricia Cristina PCL/Q-6132-2016; Martins, Gabriel Rocha/H-4018-2018; Resende, Angela C Castro/M-8632-2017; Resende, Angela/ABC-3489-2021; de, Graziele/AAB-6394-2019; da Silva, Antonio Jorge Ribeiro/N-4020-2019; de, Graziele Freitas/I-8787-2019	Ognibene, Dayane/0000-0002-8740-4504; Lisboa, Patricia C./0000-0002-2477-4364; da Silva, Antonio J R/0000-0002-7579-420X; Costa, Cristiane Aguiar/0000-0003-1927-1794; Martins, Gabriel Rocha/0000-0003-0469-1841; Resende, Angela C Castro/0000-0002-7465-6171; Resende, Angela/0000-0002-7465-6171; de, Graziele/0000-0002-9094-1597; da Silva, Antonio Jorge Ribeiro/0000-0002-7579-420X; Conceicao Furber, Ellen/0000-0003-0370-1032	National Council of Scientific and Technological Development (CNPq) [304974/2013-7]; Rio de Janeiro State Research Agency (FAPERJ) [E-26/111.784/2013]	National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was conducted with grants from the National Council of Scientific and Technological Development (CNPq, no 304974/2013-7) and Rio de Janeiro State Research Agency (FAPERJ, no E-26/111.784/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279; Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; de Oliveira PRB, 2010, J CARDIOVASC PHARM, V56, P619, DOI 10.1097/FJC.0b013e3181f78da4; Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chiva-Blanch G, 2013, CLIN NUTR, V32, P200, DOI 10.1016/j.clnu.2012.08.022; Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018; da Costa CA, 2012, N-S ARCH PHARMACOL, V385, P1199, DOI 10.1007/s00210-012-0798-z; Guerra JFD, 2011, J CLIN BIOCHEM NUTR, V49, P188, DOI 10.3164/jcbn.11-02; de Moura RS, 2012, PHYTOMEDICINE, V19, P262, DOI 10.1016/j.phymed.2011.11.004; de Souza MO, 2012, NUTR RES, V32, P976, DOI 10.1016/j.nutres.2012.10.001; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373; Hardie DG, 1997, BIOCHEM SOC T, V25, P1229, DOI 10.1042/bst0251229; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jornayvaz FR, 2015, MOL CELL ENDOCRINOL, V10; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Kohjima M, 2008, INT J MOL MED, V21, P507; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Mateos-Martin ML, 2012, ANAL BIOANAL CHEM, V402, P1327, DOI 10.1007/s00216-011-5557-3; Marliss EB, 2013, REV ENDOCR METAB DIS; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007; Monagas M, 2010, J PHARMACEUT BIOMED, V51, P358, DOI 10.1016/j.jpba.2009.03.035; Nagata Kiyoshi, 2007, Journal of Toxicological Sciences, V32, P453, DOI 10.2131/jts.32.453; Peng ZK, 2001, J AGR FOOD CHEM, V49, P26, DOI 10.1021/jf000670o; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Ratziu V, 2010, HEPATOLOGY, V51, P445, DOI 10.1002/hep.23270; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Rocha APM, 2007, VASC PHARMACOL, V46, P97, DOI 10.1016/j.vph.2006.08.411; Rodrigues RB, 2006, J AGR FOOD CHEM, V54, P4162, DOI 10.1021/jf058169p; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Seo JB, 2011, EXP MOL MED, V43, P205, DOI 10.3858/emm.2011.43.4.025; Snoussi C, 2014, J NUTR BIOCHEM, V25, P557, DOI 10.1016/j.jnutbio.2014.01.006; Stringano E, 2011, ANAL CHEM, V83, P4147, DOI 10.1021/ac2003856; Tsuda T, 2004, BIOCHEM BIOPH RES CO, V316, P149, DOI 10.1016/j.bbrc.2004.02.031; Udani JK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-45; Wu N, 2013, BBA-MOL BASIS DIS, V1832, P1560, DOI 10.1016/j.bbadis.2013.04.024; Yao Y, 2010, J AGR FOOD CHEM, V58, P770, DOI [10.1021/jf903234c, 10.1021/jf101415v]; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	53	71	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143721	10.1371/journal.pone.0143721	http://dx.doi.org/10.1371/journal.pone.0143721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630290	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300087
J	Hui, SP; Nag, TC; Ghosh, S				Hui, Subhra Prakash; Nag, Tapas Chandra; Ghosh, Sukla			Characterization of Proliferating Neural Progenitors after Spinal Cord Injury in Adult Zebrafish	PLOS ONE			English	Article							RADIAL GLIAL-CELLS; STEM-CELLS; VENTRICULAR ZONE; PRECURSOR CELLS; CEREBRAL-CORTEX; OLIGODENDROCYTE PRECURSORS; MOLECULAR CHARACTERIZATION; ULTRASTRUCTURAL ANALYSIS; NEURONAL REGENERATION; SONIC HEDGEHOG	Zebrafish can repair their injured brain and spinal cord after injury unlike adult mammalian central nervous system. Any injury to zebrafish spinal cord would lead to increased proliferation and neurogenesis. There are presences of proliferating progenitors from which both neuronal and glial loss can be reversed by appropriately generating new neurons and glia. We have demonstrated the presence of multiple progenitors, which are different types of proliferating populations like Sox2(+) neural progenitor, A2B5(+) astrocyte/ glial progenitor, NG2(+) oligodendrocyte progenitor, radial glia and Schwann cell like progenitor. We analyzed the expression levels of two common markers of dedifferentiation like msx-b and vimentin during regeneration along with some of the pluripotency associated factors to explore the possible role of these two processes. Among the several key factors related to pluripotency, pou5f1 and sox2 are upregulated during regeneration and associated with activation of neural progenitor cells. Uncovering the molecular mechanism for endogenous regeneration of adult zebrafish spinal cord would give us more clues on important targets for future therapeutic approach in mammalian spinal cord repair and regeneration.	[Hui, Subhra Prakash; Ghosh, Sukla] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata 700009, W Bengal, India; [Nag, Tapas Chandra] All India Inst Med Sci, Dept Anat, New Delhi 110029, India	University of Calcutta; All India Institute of Medical Sciences (AIIMS) New Delhi	Ghosh, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, 92 APC Rd, Kolkata 700009, W Bengal, India.	suklagh2010@gmail.com	NAG, TAPAS CHANDRA/R-6285-2019	NAG, TAPAS CHANDRA/0000-0002-6962-0844	Department of Biotechnology, Ministry of Science and Technology, Govt. of India [BT/PR5489/AAQ/03/245/2004, DBT/BT/PR13953/AAQ/03/523/2010]; Council of Scientific and Industrial Research, Govt. of India	Department of Biotechnology, Ministry of Science and Technology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Biotechnology (Grant no. BT/PR5489/AAQ/03/245/2004 and DBT/BT/PR13953/AAQ/03/523/2010), Ministry of Science and Technology, Govt. of India to Sukla Ghosh. S. P. Hui is recipient of a senior research fellowship from the Council of Scientific and Industrial Research, Govt. of India.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Becker CG, 2015, DEV CELL, V32, P516, DOI 10.1016/j.devcel.2015.01.001; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Eguizabal C, 2013, SEMIN REPROD MED, V31, P82, DOI 10.1055/s-0032-1331802; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; FOKSEANG J, 1994, J NEUROSCI RES, V37, P219, DOI 10.1002/jnr.490370208; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Gaete M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-13; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; GARDINER DM, 1986, DEV BIOL, V118, P488, DOI 10.1016/0012-1606(86)90020-5; Girolamo F, 2011, NEUROBIOL DIS, V43, P678, DOI 10.1016/j.nbd.2011.05.021; Girolamo Francesco, 2010, Italian Journal of Anatomy and Embryology, V115, P95; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; GOTOW T, 1979, CELL TISSUE RES, V201, P207; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Han SSW, 2004, GLIA, V45, P1, DOI 10.1002/glia.10282; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Hinsch K, 2007, NEUROSCIENCE, V146, P679, DOI 10.1016/j.neuroscience.2007.01.071; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Hui SP, 2013, DEV DYNAM, V242, P847, DOI 10.1002/dvdy.23976; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Ju B, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.10; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; KASAI N, 1983, BRAIN RES, V277, P155, DOI 10.1016/0006-8993(83)90918-6; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kirkham M, 2014, STEM CELL REP, V2, P507, DOI 10.1016/j.stemcr.2014.01.018; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Knapp D, 2012, CURR OPIN GENET DEV, V22, P485, DOI 10.1016/j.gde.2012.09.006; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kuscha V, 2012, J COMP NEUROL, V520, P3604, DOI 10.1002/cne.23115; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Lyck L, 2008, J HISTOCHEM CYTOCHEM, V56, P201, DOI 10.1369/jhc.7A7187.2007; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MARGOTTA V, 1991, J HIRNFORSCH, V32, P485; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Mujtaba T, 1999, DEV BIOL, V214, P113, DOI 10.1006/dbio.1999.9418; Munoz R, 2015, DEV BIOL, V408, P229, DOI 10.1016/j.ydbio.2015.03.009; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nieburgs Herbert E., 1967, DIAGNOSTIC CELL PATH, P15; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; NOLL E, 1993, DEVELOPMENT, V118, P563; Odelberg SJ, 2004, PLOS BIOL, V2, P1068, DOI 10.1371/journal.pbio.0020232; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ogai K, 2014, NEUROSCI RES, V88, P84, DOI 10.1016/j.neures.2014.07.010; OHARA CM, 1992, DEV DYNAM, V193, P103, DOI 10.1002/aja.1001930202; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Ruffini F, 2004, AM J PATHOL, V165, P2167, DOI 10.1016/S0002-9440(10)63266-X; SAIDA K, 1986, ACTA NEUROPATHOL, V71, P251, DOI 10.1007/BF00688047; Satoh A, 2008, DEV GROWTH DIFFER, V50, P743, DOI 10.1111/j.1440-169X.2008.01072.x; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Scolding NJ, 1999, NEUROSCIENCE, V89, P1, DOI 10.1016/S0306-4522(98)00548-X; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; SIMON HG, 1995, DEV DYNAM, V202, P1, DOI 10.1002/aja.1002020102; Sirbulescu RF, 2013, PHYSL FISHES, P405; Sirbulescu RF, 2015, DEV NEUROBIOL, V75, P39, DOI 10.1002/dneu.22210; Sirbulescu RF, 2014, DEV NEUROBIOL, V74, P934, DOI 10.1002/dneu.22176; Sousa S, 2012, BIOL OPEN, V1, P915, DOI 10.1242/bio.2012877; STENSAAS LJ, 1977, J NEUROCYTOL, V6, P269, DOI 10.1007/BF01175191; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Tsupykov O, 2015, MICROSC RES TECHNIQ, V78, P128, DOI 10.1002/jemt.22454; UGRUMOV MV, 1979, CELL TISSUE RES, V201, P295; Walder S, 2003, DEV GENES EVOL, V213, P625, DOI 10.1007/s00427-003-0364-2; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; WARF BC, 1991, J NEUROSCI, V11, P2477; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Welstead G Grant, 2008, J Vis Exp, DOI 10.3791/734; Wen CM, 2010, COMP BIOCHEM PHYS A, V156, P224, DOI 10.1016/j.cbpa.2010.02.003; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236	124	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143595	10.1371/journal.pone.0143595	http://dx.doi.org/10.1371/journal.pone.0143595			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630262	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300067
J	Jeschke, A; Bonitz, M; Simon, M; Peters, S; Baum, W; Schett, G; Ruether, W; Niemeier, A; Schinke, T; Amling, M				Jeschke, Anke; Bonitz, Martin; Simon, Maciej; Peters, Stephanie; Baum, Wolfgang; Schett, Georg; Ruether, Wolfgang; Niemeier, Andreas; Schinke, Thorsten; Amling, Michael			Deficiency of Thrombospondin-4 in Mice Does Not Affect Skeletal Growth or Bone Mass Acquisition, but Causes a Transient Reduction of Articular Cartilage Thickness	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MOUSE MODELS; RHEUMATOID-ARTHRITIS; HYP MICE; PEX GENE; OSTEOARTHRITIS; EXPRESSION; DEFECTS; MINERALIZATION; SUSCEPTIBILITY	Although articular cartilage degeneration represents a major public health problem, the underlying molecular mechanisms are still poorly characterized. We have previously utilized genome-wide expression analysis to identify specific markers of porcine articular cartilage, one of them being Thrombospondin-4 (Thbs4). In the present study we analyzed Thbs4 expression inmice, thereby confirming its predominant expression in articular cartilage, but also identifying expression in other tissues, including bone. To study the role of Thbs4 in skeletal development and integrity we took advantage of a Thbs4-deficient mousemodel that was analyzed by undecalcified bone histology. We found that Thbs4-deficientmice do not display phenotypic differences towards wildtype littermates in terms of skeletal growth or bone mass acquisition. Since Thbs4 has previously been found over-expressed in bones of Phex-deficient Hyp mice, we additionally generated Thbs4-deficient Hyp mice, but failed to detect phenotypic differences towards Hyp littermates. With respect to articular cartilage we found that Thbs4-deficient mice display transient thinning of articular cartilage, suggesting a protective role of Thbs4 for joint integrity. Gene expression analysis using porcine primary cells revealed that Thbs4 is not expressed by synovial fibroblasts and that it represents the only member of the Thbs gene family with specific expression in articular, but not in growth plate chondrocytes. In an attempt to identify specific molecular effects of Thbs4 we treated porcine articular chondrocytes with human THBS4 in the absence or presence of conditioned medium from porcine synovial fibroblasts. Here we did not observe a significant influence of THBS4 on proliferation, metabolic activity, apoptosis or gene expression, suggesting that it does not act as a signaling molecule. Taken together, our data demonstrate that Thbs4 is highly expressed in articular chondrocytes, where its presence in the extracellular matrix is required for articular cartilage integrity.	[Jeschke, Anke; Bonitz, Martin; Simon, Maciej; Peters, Stephanie; Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany; [Simon, Maciej; Ruether, Wolfgang; Niemeier, Andreas] Univ Med Ctr Hamburg Eppendorf, Dept Orthoped, D-20246 Hamburg, Germany; [Baum, Wolfgang; Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Baum, Wolfgang; Schett, Georg] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Amling, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, D-20246 Hamburg, Germany.	amling@uke.uni-hamburg.de			Deutsche Forschungsgemeinschaft [AM103/21-1, SPP1468-IMMUNOBONE]; SYBIL [602300]; IMI; European Community [602300]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SYBIL; IMI; European Community(European Commission)	The work was supported by the following: Deutsche Forschungsgemeinschaft (AM103/21-1, SPP1468-IMMUNOBONE) [http://www.dfg.de/]; Seventh Framework Programme under grant agreement no602300 (SYBIL) [http://www.sybil-fp7.eu/]; and IMI-funded project BTCure [http://www.imi.europa.eu/].; We thank Dr. George Kolias (Fleming Institute, Vari, Greece) for kindly providing Tg197 TNFtg mice. This work was supported by grants from the Deutsche Forschungsgemeinschaft (AM103/21-1, SPP1468-IMMUNOBONE), the European Community's Seventh Framework Programme under grant agreement no602300 (SYBIL), and the IMI-funded project BTCure.	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Conaghan PG, 2014, ANN RHEUM DIS, V73, P1442, DOI 10.1136/annrheumdis-2013-204660; ECAROT B, 1992, J BONE MINER RES, V7, P215; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Elefteriou F, 2011, BONE, V49, P1242, DOI 10.1016/j.bone.2011.08.021; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Frolova EG, 2014, MATRIX BIOL, V37, P35, DOI 10.1016/j.matbio.2014.02.003; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Gabrielsen A, 2007, J MOL CELL CARDIOL, V42, P870, DOI 10.1016/j.yjmcc.2006.12.016; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Magnussen RA, 2008, CLIN ORTHOP RELAT R, V466, P952, DOI 10.1007/s11999-007-0097-z; Martin J A, 2001, Iowa Orthop J, V21, P1; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mustonen E, 2008, BIOCHEM BIOPH RES CO, V373, P186, DOI 10.1016/j.bbrc.2008.05.164; Narouz-Ott L, 2000, J BIOL CHEM, V275, P37110, DOI 10.1074/jbc.M007223200; Okamura N, 2010, OSTEOARTHR CARTILAGE, V18, P839, DOI 10.1016/j.joca.2009.08.013; Paetzold H, 2012, EUR CELLS MATER, V23, P209, DOI 10.22203/eCM.v023a16; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Posey KL, 2008, CELL MOL LIFE SCI, V65, P687, DOI 10.1007/s00018-007-7485-0; Raducanu A, 2009, J BIOL CHEM, V284, P23780, DOI 10.1074/jbc.M109.039347; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Schelbergen RF, 2014, ANN RHEUM DIS; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Seitz S, 2013, BONE, V53, P231, DOI 10.1016/j.bone.2012.12.009; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003; Stenina OI, 2007, ARTERIOSCL THROM VAS, V27, P1886, DOI 10.1161/ATVBAHA.107.141713; Stenina-Adognravi O, 2013, CURR OPIN LIPIDOL, V24, P401, DOI 10.1097/MOL.0b013e3283642912; Stock M, 2013, ARTHRITIS RHEUM-US, V65, P2310, DOI 10.1002/art.38054; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Triche R, 2013, FOOT ANKLE CLIN, V18, P1, DOI 10.1016/j.fcl.2012.12.001; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P1447, DOI 10.1016/j.joca.2012.07.010; Vo N, 2013, J ORTHOP RES, V31, P831, DOI 10.1002/jor.22204; Xu L, 2015, OSTEOARTHR CARTILAGE, V23, P933, DOI 10.1016/j.joca.2015.02.011; Zwerina J, 2005, ANN NY ACAD SCI, V1051, P716, DOI 10.1196/annals.1361.116	47	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144272	10.1371/journal.pone.0144272	http://dx.doi.org/10.1371/journal.pone.0144272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629997	Green Published, gold			2022-12-26	WOS:000365926300175
J	Li, Y; Jia, ZX; Niu, WQ; Wang, JW; Zhang, MZ				Li, Yuan; Jia, Zongxia; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi			Effect of Post-Infiltration Soil Aeration at Different Growth Stages on Growth and Fruit Quality of Drip-Irrigated Potted Tomato Plants (Solanum lycopersicum)	PLOS ONE			English	Article							PROLONGED ROOT HYPOXIA; OXYGEN DEFICIENCY; PHYSIOLOGICAL-RESPONSES; WATER; YIELD; ETHYLENE; VEGETABLES; SYSTEMS	Soil hydraulic principles suggest that post-infiltration hypoxic conditions would be induced in the plant root-zone for drip-irrigated tomato production in small pots filled with natural soil. No previous study specifically examined the response of tomato plants (Solanum lycopersicum) at different growth stages to low soil aeration under these conditions. A 2 x 6 factorial experiment was conducted to quantify effects of no post-infiltration soil aeration versus aeration during 5 different periods (namely 27-33, 34-57, 58-85, 86-99, and 27-99 days after sowing), on growth and fruit quality of potted single tomato plants that were sub-surface trickle-irrigated every 2 days at 2 levels. Soil was aerated by injecting 2.5 liters of air into each pot through the drip tubing immediately after irrigation. Results showed that post-infiltration aeration, especially during the fruit setting (34-57 DAS) and enlargement (58-85 DAS) growth stages, can positively influence the yield, root dry weight and activity, and the nutritional (soluble solids and vitamin C content), taste (titratable acidity), and market quality (shape and firmness) of the tomato fruits. Interactions between irrigation level and post-infiltration aeration on some of these fruit quality parameters indicated a need for further study on the dynamic interplay of air and water in the root zone of the plants under the conditions of this experiment.	[Li, Yuan; Jia, Zongxia; Niu, Wenquan; Wang, Jingwei] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling 712100, Shaanxi, Peoples R China; [Li, Yuan; Niu, Wenquan; Wang, Jingwei; Zhang, Mingzhi] Northwest A&F Univ, Inst Water Saving Agr Arid Areas China, Yangling 712100, Shaanxi, Peoples R China; [Jia, Zongxia] Dezhou Prospecting & Designing Inst Water Conserv, Dezhou 253000, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China; Northwest A&F University - China	Niu, WQ (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China.	nwq@vip.sina.com		li, yuan/0000-0001-6884-1699	China 863 Plan [2011AA100507]; National 111 Project of China [B12007]	China 863 Plan(National High Technology Research and Development Program of China); National 111 Project of China(Ministry of Education, China - 111 Project)	This work is supported jointly by China 863 Plan (2011AA100507) and the National 111 Project of China (No. B12007).	AHRENS MJ, 1990, PHYSIOL PLANTARUM, V78, P8, DOI 10.1111/j.1399-3054.1990.tb08707.x; Aldrich HT, 2010, J SCI FOOD AGR, V90, P2548, DOI 10.1002/jsfa.4116; Ashraf M. A., 2012, African Journal of Agricultural Research, V7, P1976; Bhattarai SP, 2008, IRRIGATION SCI, V26, P439, DOI 10.1007/s00271-008-0112-5; Bhattarai S.P., 2008, AQUAPONICS J, V49, P29; Bhattarai SP, 2005, ADV AGRON, V88, P313, DOI 10.1016/s0065-2113(05)88008-3; Bhattarai SP, 2006, SCI HORTIC-AMSTERDAM, V108, P278, DOI 10.1016/j.scienta.2006.02.011; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; BRADFORD KJ, 1981, HORTSCIENCE, V16, P25; BRADFORD KJ, 1982, PLANT PHYSIOL, V70, P1508, DOI 10.1104/pp.70.5.1508; BRADFORD KJ, 1983, PLANT PHYSIOL, V73, P475, DOI 10.1104/pp.73.2.475; BRYCE JH, 1982, SOIL SCI, V134, P111, DOI 10.1097/00010694-198208000-00005; Chang J, 2013, FRONT ECOL ENVIRON, V11, P43, DOI 10.1890/100223; Chen JL, 2014, AGR WATER MANAGE, V146, P131, DOI 10.1016/j.agwat.2014.07.026; Chen JL, 2013, AGR WATER MANAGE, V129, P152, DOI 10.1016/j.agwat.2013.07.011; Chen JinPing, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1589; Costa J. M., 2005, Tomatoes, P1, DOI 10.1079/9780851993966.0001; Cussler E.L., 1997, DIFFUSION MASS TRANS; DAVIES JN, 1981, CRC CR REV FOOD SCI, V15, P205, DOI 10.1080/10408398109527317; Dresboll DB, 2012, PLANT SOIL, V357, P161, DOI 10.1007/s11104-012-1135-5; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Ezin Vincent, 2010, Braz. J. Plant Physiol., V22, P131, DOI 10.1590/S1677-04202010000200007; Gao J.F, 2006, EXPT TECHNIQUES PLAN, P203; Gould WA, 1992, TOMATO PRODUCTION PR; HALL C. B., 1964, PROC AMER SOC HORT SCI, V84, P507; Hanson B., 2007, Irrigation and Drainage Systems, V21, P109, DOI 10.1007/s10795-007-9023-5; Harmanto, 2005, AGR WATER MANAGE, V71, P225, DOI 10.1016/j.agwat.2004.09.003; Heuvelink E., 2005, CROP PRODUCTION SCI; Horchani F, 2008, J AGRON CROP SCI, V194, P297, DOI 10.1111/j.1439-037X.2008.00313.x; Horchani F, 2009, J AGRON CROP SCI, V195, P313, DOI 10.1111/j.1439-037X.2009.00363.x; Horchani F, 2011, PLANT SIGNAL BEHAV, V6, P1, DOI 10.4161/psb.6.1.13880; Hui Y.H., 2010, HDB FRUIT VEGETABLE; JACKSON MB, 1994, AGRON J, V86, P775, DOI 10.2134/agronj1994.00021962008600050006x; Jongen W.M, 2002, FRUIT VEGETABLE PROC, P1; KARLEN DL, 1983, COMMUN SOIL SCI PLAN, V14, P699, DOI 10.1080/00103628309367401; Klaring HP, 2009, SCI HORTIC-AMSTERDAM, V122, P17, DOI 10.1016/j.scienta.2009.03.029; Kozlowski TT, EFFECTS FLOODING GRO, P47; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Maboko M. M., 2008, South African Journal of Plant and Soil, V25, P178; Marrero T. R., 1972, J PHYS CHEM A, V1, P113, DOI DOI 10.1063/1.3253094); Mbonihankuye C, 2013, ACTA HORTIC, V1007, P535; MEEK BD, 1983, SOIL SCI SOC AM J, V47, P631, DOI 10.2136/sssaj1983.03615995004700040004x; Morard P, 2000, J PLANT NUTR, V23, P1063, DOI 10.1080/01904160009382082; Nahar K., 2012, Bangladesh Journal of Agricultural Research, V37, P355, DOI 10.3329/bjar.v37i2.11240; Narolia Rajeev Kumar, 2012, Agricultural Science Digest, V32, P281; Niu WQ, 2012, CLEAN-SOIL AIR WATER, V40, P1364, DOI 10.1002/clen.201100417; PAULSON KN, 1974, J FOOD SCI, V39, P354, DOI 10.1111/j.1365-2621.1974.tb02893.x; Pieper JR, 2009, J SCI FOOD AGR, V89, P177, DOI 10.1002/jsfa.3437; Rao R, 2003, HORTTECHNOLOGY, V13, P610, DOI 10.21273/HORTTECH.13.4.0610; RAWLS WJ, 1982, T ASAE, V25, P1316; Shao GC, 2014, SCI WORLD J, DOI 10.1155/2014/457937; SOJKA RE, 1980, SOIL SCI, V130, P350, DOI 10.1097/00010694-198012000-00010; SOJKA RE, 1992, SOIL SCI, V154, P269, DOI 10.1097/00010694-199210000-00003; Su NH, 2005, J HYDROL, V313, P158, DOI 10.1016/j.jhydrol.2005.02.025; Walter S, 2004, ACTA HORTIC, P499, DOI 10.17660/ActaHortic.2004.659.66; Wang JF, 2008, PLANT SOIL, V302, P45, DOI 10.1007/s11104-007-9453-8; WATADA AE, 1976, J FOOD SCI, V41, P856, DOI [10.1111/j.1365-2621.1976.tb00738.x, 10.1111/j.1365-2621.1976.tb00738_41_4.x]; Weaver E, 1927, ROOT DEV VEGETABLE C, P180; Wen GaiJuan, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P113; Zhao SJ, 1998, GUIDANCE PHYS EXPT P, P56	60	15	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143322	10.1371/journal.pone.0143322	http://dx.doi.org/10.1371/journal.pone.0143322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630675	Green Submitted, gold, Green Published			2022-12-26	WOS:000365926300041
J	Lin, DM; Ma, J; Xue, YY; Wang, ZQ				Lin, Duomao; Ma, Jun; Xue, Yanyan; Wang, Zhaoqi			Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; KAPPA-B PATHWAY; INFARCTION; MICE; INVOLVEMENT; INHIBITION; ACTIVATION; EXPRESSION; RECEPTORS	To investigate the impacts and related mechanisms of penehyclidine hydrochloride (PHC) on ischemia/reperfusion (I/R)-induced myocardial injury. A rat model of myocardial I/R injury was established by the ligation of left anterior descending coronary artery for 30 min followed by 3 h perfusion. Before I/R, the rats were pretreated with or without PHC. Cardiac function was measured by echocardiography. The activities/levels of myocardial enzymes, oxidants and antioxidant enzymes were detected. Evans blue/TTC double staining was performed to assess infarct size. Cardiomyocyte apoptosis was evaluated by TUNEL assay. The release of inflammatory cytokines and inflammatory mediators was detected by ELISA. Western blot was performed to analyze the expression of COX-2, I kappa B, p-I kappa B and NF-kappa B. Meanwhile, the rats were given a single injection of H-PHC before I/R. The effects of PHC on myocardial infarct and cardiac function were investigated after 7 days post-reperfusion. We found that PHC remarkably improved cardiac function, alleviated myocardial injury by decreasing myocardial enzyme levels and attenuated oxidative stress in a dose-dependent manner. Additionally, PHC preconditioning significantly reduced infarct size and the apoptotic rate of cardiomyocytes. Administration of PHC significantly decreased serum TNF-alpha, IL-1 beta, IL-6 and PGE(2) levels and myocardium COX-2 level. Meanwhile, the expression levels of p-I kappa B and NF-kappa B were downregulated, while I kappa B expression was upregulated. H-PHC also exerted long-term cardioprotection in a rat model of I/R injury by decreasing infarct size and improving cardiac function. These results suggest that PHC can efficiently protect the rats against I/R-induced myocardial injury.	[Lin, Duomao; Ma, Jun; Xue, Yanyan; Wang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing 100029, Peoples R China	Capital Medical University	Ma, J (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing 100029, Peoples R China.	majun7689@163.com			National Nature Science Foundation of China [81471902]; Beijing Health System High-Level Health Technical Talents Cultivation Fund [2013-2-004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Health System High-Level Health Technical Talents Cultivation Fund	The work was supported by the National Nature Science Foundation of China (Grant Number 81471902) (URL: www.nsfc.gov.cn) and Beijing Health System High-Level Health Technical Talents Cultivation Fund (Grant Number 2013-2-004) (URL: www.bjwsrc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravinthan A, 2015, J GINSENG RES, V39, P206, DOI 10.1016/j.jgr.2014.12.001; Cai DS, 2010, EUR J ANAESTH, V27, P824, DOI 10.1097/EJA.0b013e32833b650f; Chen KC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/873010; Chen ZC, 2013, EXP THER MED, V5, P1089, DOI 10.3892/etm.2013.942; Chien SJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0583-x; Di Paola R, 2009, INTENS CARE MED, V35, P687, DOI 10.1007/s00134-008-1334-y; Du XJ, 2014, MOL BIOL REP, V41, P3853, DOI 10.1007/s11033-014-3252-0; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Han XY, 2005, BIOORG MED CHEM LETT, V15, P1979, DOI 10.1016/j.bmcl.2005.02.071; Huang CS, 2014, J SURG RES, V188, P260, DOI 10.1016/j.jss.2013.12.011; Li DY, 1999, AM HEART J, V137, P1145, DOI 10.1016/S0002-8703(99)70375-3; Li XR, 2014, J THORAC DIS, V6, P1271, DOI 10.3978/j.issn.2072-1439.2014.07.22; Liu FC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/568634; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Lysiak JJ, 2005, J ANDROL, V26, P129; Ma TF, 2013, SYNAPSE, V67, P865, DOI 10.1002/syn.21693; Maekawa N, 2002, J AM COLL CARDIOL, V39, P1229, DOI 10.1016/S0735-1097(02)01738-2; Moghadam AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0773-6; Niessen HWM, 2003, CARDIOVASC RES, V60, P68, DOI 10.1016/S0008-6363(03)00324-9; Peng FL, 2014, GENET MOL RES, V13, P7503, DOI 10.4238/2014.September.12.17; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; Sima N, 2011, MED HYPOTHESES, V76, P607, DOI 10.1016/j.mehy.2011.01.013; Song CL, 2014, INT J MOL SCI, V15, P17442, DOI 10.3390/ijms151017442; Souza DG, 2005, MEM I OSWALDO CRUZ, V100, P59, DOI 10.1590/S0074-02762005000900011; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Wang B, 2006, TOXICOL LETT, V161, P115, DOI 10.1016/j.toxlet.2005.08.007; Wang J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/970156; Wang LS, 2015, INT J CLIN EXP PATHO, V8, P4830; Wang MJ, 2009, P NATL ACAD SCI USA, V106, P17499, DOI 10.1073/pnas.0908924106; Wang PN, 2015, EXP THER MED, V9, P603, DOI 10.3892/etm.2014.2087; Wang XM, 2015, CELL PHYSIOL BIOCHEM, V35, P676, DOI 10.1159/000369728; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wang Y, 2013, NEUROL RES, V35, P1022, DOI 10.1179/1743132813Y.0000000247; Wang Y, 2011, INT J NEUROSCI, V121, P442, DOI 10.3109/00207454.2011.570611; Wang YP, 2014, J SURG RES, V186, P390, DOI 10.1016/j.jss.2013.07.041; Xia A, 2014, EVID-BASED COMPL ALT, V2014, DOI [10. 1155/ 2014/ 573745, DOI 10.1155/2014/573745, 10.1155/2014/573745]; Xiao HT, 2012, DRUG DES DEV THER, V6, P317, DOI 10.2147/DDDT.S36555; Yu CC, 2013, NEURAL REGEN RES, V8, P622, DOI 10.3969/j.issn.1673-5374.2013.07.006; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zengyong Q, 2011, INT J MOL SCI, V12, P1991; Zhan J, 2007, SHOCK, V28, P727, DOI 10.1097/shk.0b013e31805565b1; Zhang J, 2014, INT J CLIN EXP MED, V7, P4107; Zhang Y, 2011, WORLD J GASTROENTERO, V17, P254, DOI 10.3748/wjg.v17.i2.254; Zhu J, 2014, ARCH MED SCI, V10, P855, DOI 10.5114/aoms.2014.46206	45	21	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0138051	10.1371/journal.pone.0138051	http://dx.doi.org/10.1371/journal.pone.0138051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26632817	gold, Green Published, Green Submitted			2022-12-26	WOS:000365926300002
J	Wang, TM; Huang, HP; Li, JD; Hong, SW; Lo, WC; Lu, TW				Wang, Ting-Ming; Huang, Hsing-Po; Li, Jia-Da; Hong, Shih-Wun; Lo, Wei-Ching; Lu, Tung-Wu			Leg and Joint Stiffness in Children with Spastic Diplegic Cerebral Palsy during Level Walking	PLOS ONE			English	Article							COORDINATE SYSTEM; GAIT PATTERN; KNEE; AGE; MOMENTS; TORQUES; ANKLE; POWER	Individual joint deviations are often identified in the analysis of cerebral palsy (CP) gait. However, knowledge is limited as to how these deviations affect the control of the locomotor system as a whole when striving to meet the demands of walking. The current study aimed to bridge the gap by describing the control of the locomotor system in children with diplegic CP in terms of their leg stiffness, both skeletal and muscular components, and associated joint stiffness during gait. Twelve children with spastic diplegia CP and 12 healthy controls walked at a self-selected pace in a gait laboratory while their kinematic and forceplate data were measured and analyzed during loading response, mid-stance, terminal stance and pre-swing. For calculating the leg stiffness, each of the lower limbs was modeled as a nonlinear spring, connecting the hip joint center and the corresponding center of pressure, with varying stiffness that was calculated as the slope (gradient) of the axial force vs. the deformation curve. The leg stiffness was further decomposed into skeletal and muscular components considering the alignment of the lower limb. The ankle, knee and hip of the limb were modeled as revolute joints with torsional springs whose stiffness was calculated as the slope of the moment vs. the angle curve of the joint. Independent t-tests were performed for between-group comparisons of all the variables. The CP group significantly decreased the leg stiffness but increased the joint stiffness during stance phase, except during terminal stance where the leg stiffness was increased. They appeared to rely more on muscular contributions to achieve the required leg stiffness, increasing the muscular demands in maintaining the body posture against collapse. Leg stiffness plays a critical role in modulating the kinematics and kinetics of the locomotor system during gait in the diplegic CP.	[Wang, Ting-Ming; Lu, Tung-Wu] Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei 10764, Taiwan; [Huang, Hsing-Po; Li, Jia-Da; Hong, Shih-Wun; Lo, Wei-Ching; Lu, Tung-Wu] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lu, TW (corresponding author), Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei 10764, Taiwan.	twlu@ntu.edu.tw						Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/00004694-200209000-00020; Chen HL, 2006, GAIT POSTURE, V23, P69, DOI 10.1016/j.gaitpost.2004.12.001; Chen SC, 2011, GAIT POSTURE, V33, P695, DOI 10.1016/j.gaitpost.2011.03.004; Chien HL, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500422; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Crenna P, 2005, GAIT POSTURE, V21, P311, DOI 10.1016/j.gaitpost.2004.03.005; Davis RB, 1996, GAIT POSTURE, V4, P224, DOI 10.1016/0966-6362(95)01045-9; Delp S, 1989, COMPUTER GRAPHIC SYS, V22, P1001; DeVita P, 2000, J GERONTOL A-BIOL, V55, pB593, DOI 10.1093/gerona/55.12.B593; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Farley CT, 1999, J BIOMECH, V32, P267, DOI 10.1016/S0021-9290(98)00170-5; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; Galli M, 2008, GAIT POSTURE, V28, P502, DOI 10.1016/j.gaitpost.2008.03.001; Granata KP, 2002, J ELECTROMYOGR KINES, V12, P127, DOI 10.1016/S1050-6411(02)00003-2; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Gunther M, 2002, J BIOMECH, V35, P1459, DOI 10.1016/S0021-9290(02)00183-5; Hunter JP, 2002, MED SCI SPORT EXER, V34, P478, DOI 10.1097/00005768-200203000-00015; Lark SD, 2003, CLIN BIOMECH, V18, P848, DOI 10.1016/S0268-0033(03)00150-5; Lin CJ, 2000, GAIT POSTURE, V11, P224, DOI 10.1016/S0966-6362(00)00049-7; Lu TW, 2007, MED SCI SPORT EXER, V39, P1651, DOI 10.1249/mss.0b013e3180dc9970; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Ounpuu S, 1996, JOINT KINETICS METHO, V4, P62, DOI [10.1016/09666362(95)01044-0, DOI 10.1016/0966-6362(95)01044-0]; Seyfarth A, 2002, J BIOMECH, V35, P649, DOI 10.1016/S0021-9290(01)00245-7; Soylu AR, 2006, HUM MOVEMENT SCI, V25, P767, DOI 10.1016/j.humov.2006.05.002; Thelen DG, 2003, MUSCLE NERVE, V27, P486, DOI 10.1002/mus.10357; Wei IP, 2009, J MECH, V25, P279, DOI 10.1017/S1727719100002732; Wren TAL, 2005, J PEDIATR ORTHOPED, V25, P79, DOI 10.1097/00004694-200501000-00018	30	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143967	10.1371/journal.pone.0143967	http://dx.doi.org/10.1371/journal.pone.0143967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26629700	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300132
J	Furch, ACU; Buxa, SV; van Bel, AJE				Furch, Alexandra C. U.; Buxa, Stefanie V.; van Bel, Aart J. E.			Similar Intracellular Location and Stimulus Reactivity, but Differential Mobility of Tailless (Vicia faba) and Tailed Forisomes (Phaseolus vulgaris) in Intact Sieve Tubes	PLOS ONE			English	Article							OCCLUSION GENE FAMILY; P-PROTEIN CRYSTALS; CA2+ CHANNELS; ELEMENT; PHLOEM; SIGNALS; MULTIFLORUS; DISPERSION; RESPONSES; REVEALS	Sieve elements of legumes contain forisomes-fusiform protein bodies that are responsible for sieve-tube occlusion in response to damage or wound signals. Earlier work described the existence of tailless and tailed forisomes. This study intended to quantify and compare location and position of tailless (in Vicia faba) and tailed (in Phaseolus vulgaris) forisomes inside sieve elements and to assess their reactivity and potential mobility in response to a remote stimulus. Location (distribution within sieve elements) and position (forisome tip contacts) of more than altogether 2000 forisomes were screened in 500 intact plants by laser scanning confocal microscopy in the transmission mode. Furthermore, we studied the dispersion of forisomes at different locations in different positions and their positional behaviour in response to distant heat shocks. Forisome distribution turned out to be species-specific, whereas forisome positions at various locations were largely similar in bushbean (Phaseolus) and broadbean (Vicia). In general, the tailless forisomes had higher dispersion rates in response to heat shocks than the tailed forisomes and forisomes at the downstream (basal) end dispersed more frequently than those at the upstream end (apical). In contrast to the tailless forisomes that only oscillate in response to heat shocks, downstream-located tailed forisomes can cover considerable distances within sieve elements. This displacement was prevented by gentle rubbing of the leaf (priming) before the heat shock. Movement of these forisomes was also prohibited by Latrunculin A, an inhibitor of actin polymerization. The apparently active mobility of tailed forisomes gives credence to the idea that at least the latter forisomes are not free-floating, but connected to other sieve-element structures.	[Furch, Alexandra C. U.] Univ Jena, Inst Gen Bot & Plant Physiol, Jena, Germany; [Buxa, Stefanie V.] Univ Giessen, Inst Phytopathol & Appl Zool, Res Ctr BioSyst Land Use & Nutr, D-35390 Giessen, Germany; [van Bel, Aart J. E.] Univ Giessen, Inst Gen Bot, Plant Cell Biol Res Grp, D-35390 Giessen, Germany	Friedrich Schiller University of Jena; Justus Liebig University Giessen; Justus Liebig University Giessen	van Bel, AJE (corresponding author), Univ Giessen, Inst Gen Bot, Plant Cell Biol Res Grp, D-35390 Giessen, Germany.	a.vanbel@outlook.com			Justus Liebig University	Justus Liebig University	ACUF was funded by the Justus Liebig University by a 'Just'us postdoc grant' and a 'Margarete Bieber grant'. SVB was funded by the Justus Liebig University by a 'graduated grant'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstead JA, 2012, PLANT CELL PHYSIOL, V53, P1033, DOI 10.1093/pcp/pcs046; Appel HM, 2014, OECOLOGIA, V175, P1257, DOI 10.1007/s00442-014-2995-6; Behnke HD, 1990, SIEVE ELEMENTS COMP; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Cayla T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118122; Degli Agosti R., 2014, ARCH SCI, V57, P125, DOI 10.1093/aob/mcx155; Ernst AM, 2012, P NATL ACAD SCI USA, V109, pE1980, DOI 10.1073/pnas.1202999109; Ernst AM, 2011, PLANT SIGNAL BEHAV, V6, P151, DOI 10.4161/psb.6.1.14308; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; Furch ACU, 2007, J EXP BOT, V58, P2827, DOI 10.1093/jxb/erm143; Furch ACU, 2009, PLANT CELL, V21, P2118, DOI 10.1105/tpc.108.063107; Groscurth S, 2012, BIOMACROMOLECULES, V13, P3076, DOI 10.1021/bm3008499; Hafke J.B., 2013, PHLOEM MOL CELL BIOL, P122; Hafke JB, 2013, PLANT PHYSIOL, V162, P707, DOI 10.1104/pp.113.216218; Hafke JB, 2009, PLANT SIGNAL BEHAV, V4, P968, DOI 10.4161/psb.4.10.9671; Huda KMK, 2013, J EXP BOT, V64, P3099, DOI 10.1093/jxb/ert182; Jekat SB, 2012, PLANT SIGNAL BEHAV, V7, P1918; Knoblauch M, 2003, NAT MATER, V2, P600, DOI 10.1038/nmat960; Knoblauch M, 1998, PLANT CELL, V10, P35, DOI 10.1105/tpc.10.1.35; Knoblauch M, 2001, PLANT CELL, V13, P1221, DOI 10.1105/tpc.13.5.1221; Knoblauch M, 2012, PLANT CELL ENVIRON, V35, P1419, DOI 10.1111/j.1365-3040.2012.02499.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kumar R, 2015, J PLANT BIOL, V58, P75, DOI 10.1007/s12374-014-0541-z; LAWTON DM, 1978, ANN BOT-LONDON, V42, P353, DOI 10.1093/oxfordjournals.aob.a085467; LAWTON DM, 1978, PROTOPLASMA, V97, P1, DOI 10.1007/BF01276386; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Muller B, 2014, ANN BOT-LONDON, V113, P1121, DOI 10.1093/aob/mcu036; Pelissier HC, 2008, PLANT CELL PHYSIOL, V49, P1699, DOI 10.1093/pcp/pcn141; Peters WS, 2007, ANN BOT-LONDON, V100, P101, DOI 10.1093/aob/mcm080; Peters WS, 2006, J EXP BOT, V57, P3091, DOI 10.1093/jxb/erl072; Peters WS, 2010, AM J BOT, V97, P797, DOI 10.3732/ajb.0900328; Ruping B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-219; Schwan S, 2009, BIOPHYS CHEM, V139, P99, DOI 10.1016/j.bpc.2008.10.008; Thorpe MR, 2010, PLANT CELL ENVIRON, V33, P259, DOI 10.1111/j.1365-3040.2009.02079.x; Tuteja N, 2010, TRENDS BIOTECHNOL, V28, P102, DOI 10.1016/j.tibtech.2009.11.005; van Bel AJE, 2014, J EXP BOT, V65, P1761, DOI 10.1093/jxb/ert425; van Bel AJE, 2011, PLANT SCI, V181, P325, DOI 10.1016/j.plantsci.2011.05.008; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; vanBel AJE, 1996, J EXP BOT, V47, P1129, DOI 10.1093/jxb/47.Special_Issue.1129; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; ZAWADZKI T, 1991, PHYSIOL PLANTARUM, V83, P601, DOI 10.1111/j.1399-3054.1991.tb02475.x; Zielonka S, 2014, PLANT MOL BIOL, V86, P51, DOI 10.1007/s11103-014-0211-z	44	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143920	10.1371/journal.pone.0143920	http://dx.doi.org/10.1371/journal.pone.0143920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624625	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600075
J	Gokhale, S; Gadgil, C				Gokhale, Sucheta; Gadgil, Chetan			Ranking of Reactions Based on Sensitivity of Protein Noise Depends on the Choice of Noise Measure	PLOS ONE			English	Article							EUKARYOTIC GENE-EXPRESSION; SYSTEMS; KINETICS; MODELS; TRANSCRIPTION; NETWORKS	Gene expression is a stochastic process. Identification of the step maximally affecting noise in the protein level is an important aspect of investigation of gene product distribution. There are numerous experimental and theoretical studies that seek to identify this important step. However, these studies have used two different measures of noise, viz. coefficient of variation and Fano factor, and have compared different processes leading to contradictory observations regarding the important step. In this study, we performed systematic global and local sensitivity analysis on two models of gene expression to investigate relative contribution of reaction rate parameters to steady state noise in the protein level using both the measures of noise. We analytically and computationally showed that the ranking of parameters based on the sensitivity of the noise to variation in a given parameter is a strong function of the choice of the noise measure. If the Fano factor is used as the noise measure, translation is the important step whereas for coefficient of variation, transcription is the important step. We derived an analytical expression for local sensitivity and used it to explain the distinct contributions of each reaction parameter to the two measures of noise. We extended the analysis to a generic linear catalysis reaction system and observed that the reaction network topology was an important factor influencing the local sensitivity of the two measures of noise. Our study suggested that, for the analysis of contributions of reactions to the noise, consideration of both the measures of noise is important.	[Gokhale, Sucheta; Gadgil, Chetan] CSIR Natl Chem Lab, Chem Engn & Proc Dev Div, Pune, Maharashtra, India; [Gadgil, Chetan] CSIR Inst Genom & Integrat Biol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Gokhale, S (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Berlin, Germany.	sucheta.gokhale@mdc-berlin.de; cj.gadgil@ncl.res.in			Council of Scientific and Industrial Research; Engineering Research Board, Department of Science and Technology grant	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Engineering Research Board, Department of Science and Technology grant	SG: Council of Scientific and Industrial Research (fellowship/assistantship). CG: Science and Engineering Research Board, Department of Science and Technology grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; DACOL DK, 1984, J MATH PHYS, V25, P2716, DOI 10.1063/1.526478; Degasperi A, 2008, LECT NOTES COMPUT SC, V5016, P1; Dhananjaneyulu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035958; Gadgil C, 2005, B MATH BIOL, V67, P901, DOI 10.1016/j.bulm.2004.09.009; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gronlund A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2867; Gunawan R, 2005, BIOPHYS J, V88, P2530, DOI 10.1529/biophysj.104.053405; Kierzek AM, 2001, J BIOL CHEM, V276, P8165, DOI 10.1074/jbc.M006264200; Kim D, 2007, BIOPHYS J, V92, P379, DOI 10.1529/biophysj.106.085084; Kim KH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002344; Kim KH, 2010, MATH BIOSCI, V226, P109, DOI 10.1016/j.mbs.2010.04.004; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Komorowski M, 2009, BIOPHYS J, V96, P372, DOI 10.1016/j.bpj.2008.09.052; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rathinam M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3280166; Rocco A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016002; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Vilar JMG, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062703; Vilar JMG, 2013, BIOPHYS J, V104, P2574, DOI 10.1016/j.bpj.2013.04.032; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143867	10.1371/journal.pone.0143867	http://dx.doi.org/10.1371/journal.pone.0143867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625133	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600061
J	Liu, ZJ; Liu, KJ; Li, H; Zhang, XY; Jin, GY; Cheng, KW				Liu, Zhijian; Liu, Kejun; Li, Hao; Zhang, Xinyu; Jin, Guangya; Cheng, Kewei			Artificial Neural Networks-Based Software for Measuring Heat Collection Rate and Heat Loss Coefficient of Water-in-Glass Evacuated Tube Solar Water Heaters	PLOS ONE			English	Article							PERFORMANCE; TEMPERATURE; SYSTEM	Measurements of heat collection rate and heat loss coefficient are crucial for the evaluation of in service water-in-glass evacuated tube solar water heaters. However, conventional measurement requires expensive detection devices and undergoes a series of complicated procedures. To simplify the measurement and reduce the cost, software based on artificial neural networks for measuring heat collection rate and heat loss coefficient of water-in-glass evacuated tube solar water heaters was developed. Using multilayer feed-forward neural networks with back-propagation algorithm, we developed and tested our program on the basis of 915 measured samples of water-in-glass evacuated tube solar water heaters. This artificial neural networks-based software program automatically obtained accurate heat collection rate and heat loss coefficient using simply "portable test instruments" acquired parameters, including tube length, number of tubes, tube center distance, heat water mass in tank, collector area, angle between tubes and ground and final temperature. Our results show that this software (on both personal computer and Android platforms) is efficient and convenient to predict the heat collection rate and heat loss coefficient due to it slow root mean square errors in prediction. The software now can be downloaded from http://t.cn/RLPKF08.	[Liu, Zhijian; Jin, Guangya] North China Elect Power Univ, Dept Power Engn, Sch Energy Power & Mech Engn, Baoding 071003, Hebei, Peoples R China; [Liu, Kejun] Sichuan Univ, Coll Software Engn, Chengdu 610064, Sichuan, Peoples R China; [Li, Hao] Sichuan Univ, Coll Chem, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xinyu] China Acad Bldg Res, Natl Ctr Qual Supervis & Testing Solar Heating Sy, Beijing 100013, Peoples R China; [Cheng, Kewei] Arizona State Univ, Ira A Fulton Schools Engn, Sch CIDSE, Tempe, AZ USA	North China Electric Power University; Sichuan University; Sichuan University; Arizona State University; Arizona State University-Tempe	Liu, ZJ (corresponding author), North China Elect Power Univ, Dept Power Engn, Sch Energy Power & Mech Engn, Baoding 071003, Hebei, Peoples R China.	zhijianliu@ncepul.edu.cn	Zhang, Xinyu/J-5624-2017; Li, Hao/J-6893-2013	Zhang, Xinyu/0000-0003-3796-6004; Li, Hao/0000-0002-7577-1366; Liu, Zhijian/0000-0003-1841-2671	Fundamental Research Funds for the Central Universities [2015MS108]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the Fundamental Research Funds for the Central Universities, No. 2015MS108.	Alfaro-Ayala JA, 2015, ENERG CONVERS MANAGE, V94, P472, DOI 10.1016/j.enconman.2015.01.091; Budihardjo I, 2007, SOL ENERGY, V81, P1460, DOI 10.1016/j.solener.2007.03.002; Dayhoff JE, 2001, CANCER, V91, P1615, DOI 10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L; Dowson M, 2012, ENERG BUILDINGS, V49, P173, DOI 10.1016/j.enbuild.2012.02.007; Fan LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071977; Hopfield J. J., 1988, CIRCUITS DEVICES MAG, V4, P3; HORIKAWA S, 1992, IEEE T NEURAL NETWOR, V3, P801, DOI 10.1109/72.159069; Porras-Prieto CJ, 2014, SOL ENERGY, V110, P365, DOI 10.1016/j.solener.2014.09.030; Jin W, 2000, SIGN PROC P 2000 WCC SIGN PROC P 2000 WCC; Johansson E. M., 1991, International Journal of Neural Systems, V2, P291, DOI 10.1142/S0129065791000261; Kalogirou SA, 2006, SOL ENERGY, V80, P248, DOI 10.1016/j.solener.2005.03.003; Kulkarni GN, 2009, ENERG CONVERS MANAGE, V50, P837, DOI 10.1016/j.enconman.2008.09.019; Kumar R, 2013, ENERG BUILDINGS, V65, P352, DOI 10.1016/j.enbuild.2013.06.007; Li H, 2012, ENERG BUILDINGS, V47, P107, DOI 10.1016/j.enbuild.2011.11.035; Liu LQ, 2010, RENEW SUST ENERG REV, V14, P301, DOI 10.1016/j.rser.2009.08.005; Liu ZJ, 2015, ENERGIES, V8, P8814, DOI 10.3390/en8088814; Mekhilef S, 2011, RENEW SUST ENERG REV, V15, P1777, DOI 10.1016/j.rser.2010.12.018; Morrison GL, 2004, SOL ENERGY, V76, P135, DOI 10.1016/j.solener.2003.07.024; Nahar NM, 2003, ENERG BUILDINGS, V35, P239, DOI 10.1016/S0378-7788(02)00091-9; Piaggi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013624; Press CS, 2011, SPECIFICATION DOMEST; Shah LJ, 2007, SOL ENERGY, V81, P822, DOI 10.1016/j.solener.2006.09.007; SMITS JRM, 1994, CHEMOMETR INTELL LAB, V22, P165, DOI 10.1016/0169-7439(93)E0035-3; Standardization IOf, SOL HEAT DOM WAT HEA; Svozil D, 1997, CHEMOMETR INTELL LAB, V39, P43, DOI 10.1016/S0169-7439(97)00061-0; Tang RS, 2006, ENERG CONVERS MANAGE, V47, P60, DOI 10.1016/j.enconman.2005.03.013; Tang RS, 2009, ENERGY, V34, P1387, DOI 10.1016/j.energy.2009.06.014; Wang PY, 2014, ENERG CONVERS MANAGE, V77, P315, DOI 10.1016/j.enconman.2013.08.019; Wu JS, 2011, ENERG BUILDINGS, V43, P1685, DOI 10.1016/j.enbuild.2011.03.008; Yao KG, 2015, ENRGY PROCED, V70, P332, DOI 10.1016/j.egypro.2015.02.131; Zhang XY, 2014, ENERG CONVERS MANAGE, V78, P386, DOI 10.1016/j.enconman.2013.10.070	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143624	10.1371/journal.pone.0143624	http://dx.doi.org/10.1371/journal.pone.0143624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624613	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600039
J	Risor, MW; Thomsen, LR; Sanggaard, KW; Nielsen, TA; Thogersen, IB; Lukassen, MV; Rossen, L; Garcia-Ferrer, I; Guevara, T; Scavenius, C; Meinjohanns, E; Gomis-Ruth, FX; Enghild, JJ				Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Nielsen, Tania A.; Thogersen, Ida B.; Lukassen, Marie V.; Rossen, Litten; Garcia-Ferrer, Irene; Guevara, Tibisay; Scavenius, Carsten; Meinjohanns, Ernst; Gomis-Rueth, F. Xavier; Enghild, Jan J.			Enzymatic and Structural Characterization of the Major Endopeptidase in the Venus Flytrap Digestion Fluid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CATHEPSIN-B; CRYSTAL-STRUCTURE; CYSTEINE PROTEASES; PAPAIN PRECURSOR; IONIZATION CHARACTERISTICS; SUBSTRATE-SPECIFICITY; STRUCTURE VALIDATION; PEPTIDE LIBRARY; PROTEIN; PLANTS	Carnivorous plants primarily use aspartic proteases during digestion of captured prey. In contrast, the major endopeptidases in the digestive fluid of the Venus flytrap (Dionaea muscipula) are cysteine proteases (dionain-1 to -4). Here, we present the crystal structure of mature dionain-1 in covalent complex with inhibitor E-64 at 1.5 angstrom resolution. The enzyme exhibits an overall protein fold reminiscent of other plant cysteine proteases. The inactive glycosylated pro-form undergoes autoprocessing and self-activation, optimally at the physiologically relevant pH value of 3.6, at which the protective effect of the pro-domain is lost. The mature enzyme was able to efficiently degrade a Drosophila fly protein extract at pH 4 showing high activity against the abundant Lys- and Arg-rich protein, myosin. The substrate specificity of dionain-1 was largely similar to that of papain with a preference for hydrophobic and aliphatic residues in subsite S-2 and for positively charged residues in S-1. A tentative structure of the pro-domain was obtained by homology modeling and suggested that a pro-peptide Lys residue intrudes into the S-2 pocket, which is more spacious than in papain. This study provides the first analysis of a cysteine protease from the digestive fluid of a carnivorous plant and confirms the close relationship between carnivorous action and plant defense mechanisms.	[Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Thogersen, Ida B.; Lukassen, Marie V.; Rossen, Litten; Scavenius, Carsten; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Risor, Michael W.; Thomsen, Line R.; Sanggaard, Kristian W.; Nielsen, Tania A.; Enghild, Jan J.] Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Garcia-Ferrer, Irene; Guevara, Tibisay; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab,Dept Struct Biol, Maria Maeztu Unit Excellence, Barcelona Sci Pk,C Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain; [Meinjohanns, Ernst] DuPont Ind Biosci, DK-8220 Brabrand, Denmark	Aarhus University; Aarhus University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.; Enghild, JJ (corresponding author), Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark.	jje@mbg.au.dk	; Scavenius, Carsten/Q-5941-2017	Vestergaard Lukassen, Marie/0000-0003-3237-2696; Scavenius, Carsten/0000-0002-4304-0681; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Enghild, Jan Johannes/0000-0001-9292-9172	European agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Danish agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Spanish agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]; Catalan agency [FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, MDM-2014-0435, BIO2013-49320-EXP, 2014SGR9]	European agency; Danish agency; Spanish agency; Catalan agency	This work was supported in part by grants from European, Danish, Spanish, and Catalan agencies (FP7-PEOPLE-2011-ITN-290246 "RAPID"; FP7-HEALTH-2012-306029-2 "TRIGGER"; BFU2012-32862; MDM-2014-0435; BIO2013-49320-EXP; and 2014SGR9). The Department of Structural Biology of the Institut de Biologia Molecular de Barcelona is a "Maria de Maeztu" Unit of Excellence of the Spanish Ministry of Economy and Competitiveness. Traveling and synchrotron data collection were supported in part by the European Synchrotron Radiation Facility. The authors declare that they have no conflicts of interest with the contents of this article.	Adlassnig W, 2012, PLANT J, V71, P303, DOI 10.1111/j.1365-313X.2012.04997.x; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Santamaria ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128323; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; GREENAWAY W, 1990, NEW PHYTOL, V114, P581, DOI 10.1111/j.1469-8137.1990.tb00428.x; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Katerelos NA, 1996, FEBS LETT, V392, P35, DOI 10.1016/0014-5793(96)00697-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konno K, 2004, PLANT J, V37, P370, DOI 10.1046/j.1365-313X.2003.01968.x; Kreuzwieser J, 2014, J EXP BOT, V65, P755, DOI 10.1093/jxb/ert455; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Libiakova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104424; Maciel FM, 2011, ACTA PHYSIOL PLANT, V33, P1867, DOI 10.1007/s11738-011-0730-z; Markin VS, 2008, PLANT SIGNAL BEHAV, V3, P778, DOI 10.4161/psb.3.10.6041; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MELLOR GW, 1993, BIOCHEM J, V290, P289, DOI 10.1042/bj2900289; MELLOR GW, 1993, BIOCHEM J, V294, P201, DOI 10.1042/bj2940201; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Noble MA, 2000, BIOCHEM J, V351, P723, DOI 10.1042/0264-6021:3510723; Paszota P, 2014, BBA-PROTEINS PROTEOM, V1844, P374, DOI 10.1016/j.bbapap.2013.11.009; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; REA PA, 1984, PLANT CELL ENVIRON, V7, P363, DOI 10.1111/j.1365-3040.1984.tb01424.x; Reis FCG, 2007, FEBS J, V274, P1224, DOI 10.1111/j.1742-4658.2007.05666.x; REVELL DF, 1993, GENE, V127, P221, DOI 10.1016/0378-1119(93)90723-G; ROBINS RI, 1980, NEW PHYTOL, V86, P401, DOI 10.1111/j.1469-8137.1980.tb01681.x; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; SCALA J, 1969, PLANT PHYSIOL, V44, P367, DOI 10.1104/pp.44.3.367; Scherzer S, 2013, CURR BIOL, V23, P1649, DOI 10.1016/j.cub.2013.07.028; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Takahashi K, 2009, CARNIV PL NEWSL, V38, P75; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; TAYLOR MAJ, 1995, PROTEIN ENG, V8, P59, DOI 10.1093/protein/8.1.59; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; VERNET T, 1990, J BIOL CHEM, V265, P16661; VERNET T, 1995, J BIOL CHEM, V270, P10838, DOI 10.1074/jbc.270.18.10838; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	76	13	14	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2271	2287		10.1074/jbc.M115.672550	http://dx.doi.org/10.1074/jbc.M115.672550			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26627834	Green Published, hybrid			2022-12-26	WOS:000369610400018
J	Yoshikawa, K; Aikawa, S; Kojima, Y; Toya, Y; Furusawa, C; Kondo, A; Shimizu, H				Yoshikawa, Katsunori; Aikawa, Shimpei; Kojima, Yuta; Toya, Yoshihiro; Furusawa, Chikara; Kondo, Akihiko; Shimizu, Hiroshi			Construction of a Genome-Scale Metabolic Model of Arthrospira platensis NIES-39 and Metabolic Design for Cyanobacterial Bioproduction	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; SPIRULINA-PLATENSIS; ESCHERICHIA-COLI; CARBON-DIOXIDE; GREEN-ALGA; ETHANOL; RECONSTRUCTION; BIOSYNTHESIS; NETWORK; GENES	Arthrospira (Spirulina) platensis is a promising feedstock and host strain for bioproduction because of its high accumulation of glycogen and superior characteristics for industrial production. Metabolic simulation using a genome-scale metabolic model and flux balance analysis is a powerful method that can be used to design metabolic engineering strategies for the improvement of target molecule production. In this study, we constructed a genome-scale metabolic model of A. platensis NIES-39 including 746 metabolic reactions and 673 metabolites, and developed novel strategies to improve the production of valuable metabolites, such as glycogen and ethanol. The simulation results obtained using the metabolic model showed high consistency with experimental results for growth rates under several trophic conditions and growth capabilities on various organic substrates. The metabolic model was further applied to design a metabolic network to improve the autotrophic production of glycogen and ethanol. Decreased flux of reactions related to the TCA cycle and phosphoenolpyruvate reaction were found to improve glycogen production. Furthermore, in silico knockout simulation indicated that deletion of genes related to the respiratory chain, such as NAD(P)H dehydrogenase and cytochrome-c oxidase, could enhance ethanol production by using ammonium as a nitrogen source.	[Yoshikawa, Katsunori; Kojima, Yuta; Toya, Yoshihiro; Furusawa, Chikara; Shimizu, Hiroshi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka 5650871, Japan; [Yoshikawa, Katsunori; Aikawa, Shimpei; Kojima, Yuta; Furusawa, Chikara; Kondo, Akihiko; Shimizu, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Aikawa, Shimpei; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Furusawa, Chikara] RIKEN, Quantitat Biol Ctr, Suita, Osaka 5650874, Japan	Osaka University; Japan Science & Technology Agency (JST); Kobe University; RIKEN	Shimizu, H (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	shimizu@ist.osaka-u.ac.jp	Furusawa, Chikara/N-6103-2015; Shimizu, Hiroshi/C-3688-2017; Kondo, Akihiko/A-2130-2015; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Shimizu, Hiroshi/0000-0002-8986-0861; Furusawa, Chikara/0000-0003-3554-4975; Toya, Yoshihiro/0000-0001-9670-6961; Aikawa, Shimpei/0000-0001-9202-0225	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN	Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, JAPAN.	Aikawa S, 2013, ENERG ENVIRON SCI, V6, P1844, DOI 10.1039/c3ee40305j; Aikawa S, 2012, BIORESOURCE TECHNOL, V108, P211, DOI 10.1016/j.biortech.2012.01.004; Angermayr SA, 2009, CURR OPIN BIOTECH, V20, P257, DOI 10.1016/j.copbio.2009.05.011; Aoyama K, 1997, J FERMENT BIOENG, V83, P17, DOI 10.1016/S0922-338X(97)87320-5; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Cogne G, 2003, BIOTECHNOL BIOENG, V84, P667, DOI 10.1002/bit.10808; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; ERNST A, 1984, ARCH MICROBIOL, V140, P120, DOI 10.1007/BF00454913; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fujisawa T, 2010, DNA RES, V17, P85, DOI 10.1093/dnares/dsq004; Gao ZX, 2012, ENERG ENVIRON SCI, V5, P9857, DOI 10.1039/c2ee22675h; Hasunuma T, 2013, J EXP BOT, V64, P2943, DOI 10.1093/jxb/ert134; Joseph A, 2013, BIOSCI BIOTECH BIOCH, V77, P966, DOI 10.1271/bbb.120921; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klanchui A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-71; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Lee KH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100196; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MARQUEZ FJ, 1993, J FERMENT BIOENG, V76, P408, DOI 10.1016/0922-338X(93)90034-6; Meechai A, 2004, BIOTECHNOL BIOPROC E, V9, P506, DOI 10.1007/BF02933494; MIKI W, 1986, B JPN SOC SCI FISH, V52, P1225; Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ohira Y, 2009, KAGAKU KOGAKU RONBUN, V35, P553, DOI 10.1252/kakoronbunshu.35.553; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; Park JH, 2011, BIOTECHNOL BIOENG, V108, P934, DOI 10.1002/bit.22995; PEARCE J, 1969, J GEN MICROBIOL, V55, P371, DOI 10.1099/00221287-55-3-371; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; QUOC KP, 1993, BIOCHIM BIOPHYS ACTA, V1168, P94, DOI 10.1016/0005-2760(93)90271-A; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k; Segre D., 2012, PLOS COMPUT BIOL, V8; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64; Ueno Y, 1998, J FERMENT BIOENG, V86, P38, DOI 10.1016/S0922-338X(98)80031-7; Vazquez-Bermudez MF, 2000, J BACTERIOL, V182, P211, DOI 10.1128/JB.182.1.211-215.2000; VINCENZINI M, 1990, J BACTERIOL, V172, P2791, DOI 10.1128/jb.172.5.2791-2792.1990; Vonshak A., 2002, SPIRULINA PLATENSIS; Vu TT, 2013, BIOTECHNOL J, V8, P619, DOI 10.1002/biot.201200315; Yoshikawa K, 2011, APPL MICROBIOL BIOT, V92, P347, DOI 10.1007/s00253-011-3559-x; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858	47	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0144430	10.1371/journal.pone.0144430	http://dx.doi.org/10.1371/journal.pone.0144430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640947	Green Published, gold, Green Submitted			2022-12-26	WOS:000366902700119
J	Egan, AM; Sweeney, T; Hayes, M; O'Doherty, JV				Egan, Aine M.; Sweeney, Torres; Hayes, Maria; O'Doherty, John V.			Prawn Shell Chitosan Has Anti-Obesogenic Properties, Influencing Both Nutrient Digestibility and Microbial Populations in a Pig Model	PLOS ONE			English	Article							GUT MICROBIOTA; BODY-WEIGHT; GASTROINTESTINAL-TRACT; SMALL-INTESTINE; FOOD-INTAKE; OBESITY; LEPTIN; LACTOBACILLUS; INSULIN; DIETARY	The potential of natural products to prevent obesity have been investigated, with evidence to suggest that chitosan has anti-obesity effects. The current experiment investigated the anti-obesity potential of prawn shell derived chitosan on a range of variables relevant to obesity in a pig model. The two dietary treatment groups included in this 63 day study were: T1) basal diet and T2) basal diet plus 1000 ppm chitosan (n = 20 gilts per group (70 +/- 0.90 kg). The parameter categories which were assessed included: performance, nutrient digestibility, serum leptin concentrations, nutrient transporter and digestive enzyme gene expression and gut microbial populations. Pigs offered chitosan had reduced feed intake and final body weight (P<0.001), lower ileal digestibility of dry matter (DM), gross energy (GE) (P<0.05) and reduced coefficient of apparent total tract digestibility (CATTD) of gross energy and nitrogen (P<0.05) when compared to the basal group. Fatty acid binding protein 2 (FABP2) gene expression was down-regulated in pigs offered chitosan (P = 0.05) relative to the basal diet. Serum leptin concentrations increased (P<0.05) in animals offered the chitosan diet compared to pigs offered the basal diet. Fatness traits, back-fat depth (mm), fat content (kg), were significantly reduced while lean meat (%) was increased (P<0.05) in chitosan supplemented pigs. Pigs offered chitosan had decreased numbers of Firmicutes in the colon (P < 0.05), and Lactobacillus spp. in both the caecum (P < 0.05) and colon (P <0.001). Bifidobacteria populations were increased in the caecum of animals offered the chitosan diet (P < 0.05). In conclusion, these findings suggest that prawn shell chitosan has potent anti-obesity/body weight control effects which are mediated through multiple biological systems in vivo.	[Egan, Aine M.; O'Doherty, John V.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Sweeney, Torres] Univ Coll Dublin, Sch Vet Med, Dublin 4, Ireland; [Hayes, Maria] TEAGASC, Food Res Ctr, Dublin 15, Ireland	University College Dublin; University College Dublin; Teagasc	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X	Marine Institute [MFFRI/07/01]; Department of Agriculture, Food and the Marine	Marine Institute; Department of Agriculture, Food and the Marine	This study was supported financially (Grant-Aid Agreement No. MFFRI/07/01) under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013.	[Anonymous], 2012, NUTR REQ SWIN; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; CAMPBELL RG, 1988, J ANIM SCI, V66, P676; Cardinelli CS, 2015, OBES SURG, V25, P346, DOI 10.1007/s11695-014-1525-2; CLOSE WH, 1994, PRINCIPLES OF PIG SCIENCE, P123; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dyer CJ, 1999, DOMEST ANIM ENDOCRIN, V16, P145, DOI 10.1016/S0739-7240(99)00011-9; Gajda AM, 2015, PROSTAG LEUKOTR ESS, V93, P9, DOI 10.1016/j.plefa.2014.10.001; Han LK, 1999, INT J OBESITY, V23, P174, DOI 10.1038/sj.ijo.0800806; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heim G, 2014, THE BRITISH JOURNAL, P1; Houseknecht KL, 2003, NUTR RES REV, V16, P83, DOI 10.1079/NRR200256; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MCCARTHY JF, 1977, CAN J ANIM SCI, V57, P131, DOI 10.4141/cjas77-015; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Mott CR, 2008, POULTRY SCI, V87, P2215, DOI 10.3382/ps.2008-00101; MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0; O'Connell JM, 2006, ANIM FEED SCI TECH, V127, P73, DOI 10.1016/j.anifeedsci.2005.09.002; O'Shea CJ, 2012, J ANIM SCI, V90, P3848, DOI 10.2527/jas.2011-4461; O'Shea CJ, 2011, J ANIM SCI, V89, P1366, DOI 10.2527/jas.2010-2922; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; SAS Institute Inc, 2004, SAS US GUID; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Shiraishi T, 2000, PHYSIOL BEHAV, V71, P251, DOI 10.1016/S0031-9384(00)00341-3; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Sweeney T, 2012, BRIT J NUTR, V108, P1226, DOI 10.1017/S0007114511006751; Tran G., 2004, TABLE COMPOSITION NU, V1st ed.; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630	43	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2015	10	12							e0144127	10.1371/journal.pone.0144127	http://dx.doi.org/10.1371/journal.pone.0144127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY1CH	26636332	Green Submitted, Green Published, gold			2022-12-26	WOS:000366143800045
J	Frandsen, SK; Gibot, L; Madi, M; Gehl, J; Rols, MP				Frandsen, Stine Krog; Gibot, Laure; Madi, Moinecha; Gehl, Julie; Rols, Marie-Pierre			Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURES; IRREVERSIBLE ELECTROPORATION; BLADDER-CANCER; CUTANEOUS METASTASES; ELECTROCHEMOTHERAPY; SKIN; ELECTROPERMEABILIZATION; MECHANISMS; BLEOMYCIN; ABLATION	Background Calcium electroporation describes the use of high voltage electric pulses to introduce supraphysiological calcium concentrations into cells. This promising method is currently in clinical trial as an anti-cancer treatment. One very important issue is the relation between tumor cell kill efficacy-and normal cell sensitivity. Methods Using a 3D spheroid cell culture model we have tested the effect of calcium electroporation and electrochemotherapy using bleomycin on three different human cancer cell lines: a colorectal adenocarcinoma (HT29), a bladder transitional cell carcinoma (SW780), and a breast adenocarcinoma (MDA-MB231), as well as on primary normal human dermal fibroblasts (HDF-n). Results The results showed a clear reduction in spheroid size in all three cancer cell spheroids three days after treatment with respectively calcium electroporation (p<0.0001) or electrochemotherapy using bleomycin (p<0.0001). Strikingly, the size of normal fibroblast spheroids was neither affected after calcium electroporation nor electrochemotherapy using bleomycin, indicating that calcium electroporation, like electrochemotherapy, will have limited adverse effects on the surrounding normal tissue when treating with calcium electroporation. The intracellular ATP level, which has previously been shown to be depleted after calcium electroporation, was measured in the spheroids after treatment. The results showed a dramatic decrease in the intracellular ATP level (p<0.01) in all four spheroid types-malignant as well as normal. Conclusion In conclusion, calcium electroporation seems to be more effective in inducing cell death in cancer cell spheroids than in a normal fibroblast spheroid, even though intracellular ATP level is depleted in all spheroid types after treatment. These results may indicate an important therapeutic window for this therapy; although further studies are needed in vivo and in patients to investigate the effect of calcium electroporation on surrounding normal tissue when treating tumors.	[Frandsen, Stine Krog; Gehl, Julie] Univ Copenhagen, Herlev Hosp, Dept Oncol, Ctr Expt Drug & Gene Electrotransfer, DK-2730 Herlev, Denmark; [Gibot, Laure; Madi, Moinecha; Rols, Marie-Pierre] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Gibot, Laure; Madi, Moinecha; Rols, Marie-Pierre] Univ Toulouse, UPS, Inst Pharmacol & Biol Struct, Toulouse, France	University of Copenhagen; Herlev & Gentofte Hospital; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Gehl, J (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Oncol, Ctr Expt Drug & Gene Electrotransfer, DK-2730 Herlev, Denmark.	Karen.Julie.Gehl@regionh.dk; Marie-Pierre.Rols@ipbs.fr	Gibot, Laure/AAD-8507-2020; ROLS, Marie-Pierre/GLV-6546-2022; rols, marie-pierre/AAU-8093-2021	Gibot, Laure/0000-0001-7255-4123; Frandsen, Stine/0000-0002-3133-5351; rols, marie-pierre/0000-0003-3100-6272; Gehl, Julie/0000-0003-3829-0210	University of Copenhagen [ECOST-STSM-TD1104-14339, TD1104]; ANR Astrid PIERGEN [ANR-12-ASTR-0039-01]; Department de Mayotte; Acta Oncologica Foundation	University of Copenhagen; ANR Astrid PIERGEN(French National Research Agency (ANR)); Department de Mayotte; Acta Oncologica Foundation	SKF-grant, University of Copenhagen, The experimental work was performed during the Short-Term Scientific Mission (Grant ECOST-STSM-TD1104-14339) under the networking efforts of COST Action TD1104; LG-grant, ANR Astrid PIERGEN, ANR-12-ASTR-0039-01; MM-grant, Department de Mayotte; JG-research fellow of the Royal Swedish Academy of Science supported by the Acta Oncologica Foundation; MPR-ANR Astrid PIERGEN, ANR-12-ASTR-0039-01. Research was conducted in the scope of the EBAM European Associated Laboratory. This report is the result of networking efforts of COST Action TD1104 (http://www.electroporation.net). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2011, CANCER RES, V71, P3753, DOI 10.1158/0008-5472.CAN-11-0451; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Canatella PJ, 2004, BIOPHYS J, V86, P3260, DOI 10.1016/S0006-3495(04)74374-X; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Dubois C, 2014, CANCER CELL, V26, P19, DOI 10.1016/j.ccr.2014.04.025; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Frandsen SK, 2014, BBA-GEN SUBJECTS, V1840, P1204, DOI 10.1016/j.bbagen.2013.12.003; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Fyfe AJ, 2010, J ROY COLL PHYS EDIN, V40, P213, DOI 10.4997/JRCPE.2010.306; Gibot L, 2013, J MEMBRANE BIOL, V246, P745, DOI 10.1007/s00232-013-9535-x; Gibot L, 2013, J CONTROL RELEASE, V167, P138, DOI 10.1016/j.jconrel.2013.01.021; Haynes MD, 2005, INT J MOL MED, V16, P3; Heller R, 2002, TECHNOL CANCER RES T, V1, P385, DOI 10.1177/153303460200100509; Herbsleb M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-31; Jiang CL, 2015, IEEE T BIO-MED ENG, V62, P4, DOI 10.1109/TBME.2014.2367543; Kee ST, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P1, DOI 10.1007/978-1-4419-8363-3; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Matthiessen LW, 2012, ACTA ONCOL, V51, P713, DOI 10.3109/0284186X.2012.685524; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Miklavcic D, 2012, MED BIOL ENG COMPUT, V50, P1213, DOI 10.1007/s11517-012-0991-8; Mir LM, 2006, EJC SUPPL, V4, P14, DOI 10.1016/j.ejcsup.2006.08.003; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; NICE, 2013, EL MET SKIN TUM NONS; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Spratt DE, 2014, J CLIN ONCOL, V32, P3144, DOI 10.1200/JCO.2014.55.4634; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Thompson GL, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.055005; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vasquez JL, 2012, BIOELECTROCHEMISTRY, V88, P127, DOI 10.1016/j.bioelechem.2012.08.001; Vasquez JL, 2015, J UROLOGY, V193, P1009, DOI 10.1016/j.juro.2014.09.039; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	38	59	59	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2015	10	12							e0144028	10.1371/journal.pone.0144028	http://dx.doi.org/10.1371/journal.pone.0144028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX9QI	26633834	gold, Green Published, Green Submitted			2022-12-26	WOS:000366040000047
J	Chen, Z; Gallie, DR				Chen, Zhong; Gallie, Daniel R.			Ethylene Regulates Energy- Dependent Non-Photochemical Quenching in Arabidopsis through Repression of the Xanthophyll Cycle	PLOS ONE			English	Article							VIOLAXANTHIN DE-EPOXIDASE; PHOTOSYSTEM-II ANTENNA; LIGHT-HARVESTING COMPLEXES; INDUCED STOMATAL CLOSURE; FOLIAR GAS-EXCHANGE; CHLOROPHYLL FLUORESCENCE; RESPONSE PATHWAY; SINGLET OXYGEN; ENDOPLASMIC-RETICULUM; PHOTOOXIDATIVE STRESS	Energy-dependent (qE) non-photochemical quenching (NPQ) thermally dissipates excess absorbed light energy as a protective mechanism to prevent the over reduction of photosystem II and the generation of reactive oxygen species (ROS). The xanthophyll cycle, induced when the level of absorbed light energy exceeds the capacity of photochemistry, contributes to qE. In this work, we show that ethylene regulates the xanthophyll cycle in Arabidopsis. Analysis of eto1-1, exhibiting increased ethylene production, and ctr1-3, exhibiting constitutive ethylene response, revealed defects in NPQ resulting from impaired de-epoxidation of violaxanthin by violaxanthin de-epoxidase (VDE) encoded by NPQ1. Elevated ethylene signaling reduced the level of active VDE through decreased NPQ1 promoter activity and impaired VDE activation resulting from a lower transthylakoid membrane pH gradient. Increasing the concentration of CO2 partially corrected the ethylene-mediated defects in NPQ and photosynthesis, indicating that changes in ethylene signaling affect stromal CO2 solubility. Increasing VDE expression in eto1-1 and ctr1-3 restored light-activated de-epoxidation and qE, reduced superoxide production and reduced photoinhibition. Restoring VDE activity significantly reversed the small growth phenotype of eto1-1 and ctr1-3 without altering ethylene production or ethylene responses. Our results demonstrate that ethylene increases ROS production and photosensitivity in response to high light and the associated reduced plant stature is partially reversed by increasing VDE activity.	[Chen, Zhong; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			AgroFresh, Inc; University of California Agricultural Experiment Station	AgroFresh, Inc; University of California Agricultural Experiment Station(University of California System)	This work was supported by AgroFresh, Inc and the University of California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles F, 1992, ETHYLENE PLANT BIOL; Achnine L, 1999, PHYSIOL PLANTARUM, V106, P246, DOI 10.1034/j.1399-3054.1999.106215.x; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; [Anonymous], 1901, BOT CENTRALBL BEIH; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Asada K., 1987, PHOTOINHIBITION, P227; BARENYI B, 1985, PLANTA, V163, P218, DOI 10.1007/BF00393510; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Bohm F, 1997, J AM CHEM SOC, V119, P621, DOI 10.1021/ja962512c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRATT CE, 1995, PHOTOSYNTH RES, V45, P169, DOI 10.1007/BF00032588; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Bugos RC, 1999, PLANT PHYSIOL, V121, P207, DOI 10.1104/pp.121.1.207; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Chang C, 2001, BIOESSAYS, V23, P619, DOI 10.1002/bies.1087; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Chen JF, 2010, PLANT MOL BIOL, V74, P405, DOI 10.1007/s11103-010-9686-4; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen Z, 2012, PLANT PHYSIOL BIOCH, V58, P66, DOI 10.1016/j.plaphy.2012.06.010; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Conklin PL, 2000, GENETICS, V154, P847; Corbin DR, 2001, PLANT PHYSIOL, V126, P1116, DOI 10.1104/pp.126.3.1116; D'Haese D, 2004, J THEOR BIOL, V227, P175, DOI 10.1016/j.jtbi.2003.10.011; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Desikan R, 2005, PLANT PHYSIOL, V137, P831, DOI 10.1104/pp.104.056994; Desikan R, 2006, PLANT J, V47, P907, DOI 10.1111/j.1365-313X.2006.02842.x; Eskling M, 1997, PHYSIOL PLANTARUM, V100, P806, DOI 10.1034/j.1399-3054.1997.1000407.x; FELDMAN LJ, 1984, ANNU REV PLANT PHYS, V35, P223, DOI 10.1146/annurev.arplant.35.1.223; Finazzi G, 2004, P NATL ACAD SCI USA, V101, P12375, DOI 10.1073/pnas.0404798101; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; FOYER CH, 2005, ADV PHOTOSYNTHESIS R, V19, P241; Frahry G, 2001, PLANTA, V212, P175, DOI 10.1007/s004250000376; Frank H. A., 1993, CAROTENOIDS PHOTOSYN, P252, DOI [10.1007/978-94-011-2124-8_8, DOI 10.1007/978-94-011-2124-8_8]; GENTY B, 1990, PLANT PHYSIOL BIOCH, V28, P1; GILMORE AM, 1991, J CHROMATOGR, V543, P137, DOI 10.1016/S0021-9673(01)95762-0; Golan T, 2006, PLANT CELL ENVIRON, V29, P879, DOI 10.1111/j.1365-3040.2005.01467.x; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; GUNDERSON CA, 1991, PLANT PHYSIOL, V95, P337, DOI 10.1104/pp.95.1.337; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; HARAUX F, 1980, BIOCHIM BIOPHYS ACTA, V592, P153, DOI 10.1016/0005-2728(80)90122-X; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Havaux M, 2000, PLANT PHYSIOL, V124, P273, DOI 10.1104/pp.124.1.273; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; HOPE AB, 1985, AUST J PLANT PHYSIOL, V12, P9, DOI 10.1071/PP9850009; HORTON P, 1983, BIOCHIM BIOPHYS ACTA, V724, P404, DOI 10.1016/0005-2728(83)90100-7; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1994, PLANT PHYSIOL, V106, P415, DOI 10.1104/pp.106.2.415; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Hyodo H., 1991, PLANT HORMONE ETHYLE; Jahns P, 2002, FEBS LETT, V519, P99, DOI 10.1016/S0014-5793(02)02719-9; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Ji YS, 2013, MOL PLANT, V6, P11, DOI 10.1093/mp/sss150; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kalituho L, 2007, PLANTA, V225, P423, DOI 10.1007/s00425-006-0356-3; KAYS SJ, 1980, NATURE, V285, P51, DOI 10.1038/285051a0; Kereiche S, 2010, FEBS LETT, V584, P759, DOI 10.1016/j.febslet.2009.12.031; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Klee HJ, 2004, PLANT PHYSIOL, V135, P660, DOI 10.1104/pp.104.040998; KRAUSE GH, 1973, BIOCHIM BIOPHYS ACTA, V292, P715, DOI 10.1016/0005-2728(73)90019-4; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; KYLE DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4070, DOI 10.1073/pnas.81.13.4070; KYLE DJ, 1987, TOPICS PHOTOSYNTHESI, V9, P197; LEVITT LK, 1987, PLANT PHYSIOL, V85, P318, DOI 10.1104/pp.85.2.318; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LIM BP, 1992, BIOCHIM BIOPHYS ACTA, V1126, P178; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MADHAVAN S, 1983, PLANT CELL PHYSIOL, V24, P569; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melis A, 1999, TRENDS PLANT SCI, V4, P130, DOI 10.1016/S1360-1385(99)01387-4; Merritt F, 2001, PLANT CELL PHYSIOL, V42, P223, DOI 10.1093/pcp/pce030; MISHRA NP, 1993, J PHOTOCH PHOTOBIO B, V19, P19, DOI 10.1016/1011-1344(93)80088-Q; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; OJA V, 1986, BIOCHIM BIOPHYS ACTA, V849, P355, DOI 10.1016/0005-2728(86)90147-7; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; PALLAGHY CK, 1972, PLANT PHYSIOL, V49, P275, DOI 10.1104/pp.49.2.275; PALLAS JE, 1982, PLANT PHYSIOL, V70, P598, DOI 10.1104/pp.70.2.598; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P184, DOI 10.1016/0003-9861(92)90658-J; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Pogson BJ, 2000, PHILOS T ROY SOC B, V355, P1395, DOI 10.1098/rstb.2000.0701; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; ROBERTS CS, 1995, PLANT MOL BIOL, V29, P303, DOI 10.1007/BF00043654; Rossel JB, 2007, PLANT CELL, V19, P4091, DOI 10.1105/tpc.106.045898; ROTTENBERG H, 1993, BIOCHIM BIOPHYS ACTA, V1183, P161, DOI 10.1016/0005-2728(93)90014-7; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SEREK M, 1995, PHYSIOL PLANTARUM, V94, P229, DOI 10.1111/j.1399-3054.1995.tb05305.x; Sewelam N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070289; SHARMA PK, 1992, PHYSIOL PLANTARUM, V86, P623, DOI 10.1111/j.1399-3054.1992.tb02179.x; SIEFERMANN D, 1975, ARCH BIOCHEM BIOPHYS, V171, P70, DOI 10.1016/0003-9861(75)90008-9; Sielewiesiuk J., 1997, CELL MOL BIOL LETT, V2, P59; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova Anna N, 2005, Sci STKE, V2005, pcm4, DOI 10.1126/stke.2762005cm4; STROTMANN H, 1990, EUR J BIOCHEM, V193, P879, DOI 10.1111/j.1432-1033.1990.tb19412.x; Sutherland MW, 1997, FREE RADICAL RES, V27, P283, DOI 10.3109/10715769709065766; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2009, PLANT PHYSIOL, V149, P1560, DOI 10.1104/pp.108.134122; Tanaka Y, 2005, PLANT PHYSIOL, V138, P2337, DOI 10.1104/pp.105.063503; TAYLOR GE, 1986, PLANT PHYSIOL, V82, P653, DOI 10.1104/pp.82.3.653; THOLEN D, 2004, PLANT PHYSIOL, V134, P1803, DOI DOI 10.1104/pp.103.034389; Tholen D, 2008, PLANT SIGNAL BEHAV, V3, P108, DOI 10.4161/psb.3.2.4968; vanWijk KJ, 1996, J BIOL CHEM, V271, P9627, DOI 10.1074/jbc.271.16.9627; Vogel JP, 1998, P NATL ACAD SCI USA, V95, P4766, DOI 10.1073/pnas.95.8.4766; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; WOODROW L, 1988, J EXP BOT, V39, P667, DOI 10.1093/jxb/39.6.667; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Wrona M, 2004, FREE RADICAL BIO MED, V36, P1094, DOI 10.1016/j.freeradbiomed.2004.02.005; Yamamoto HY, 1999, ADV PHOTOSYNTH, V8, P293; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Young TE, 2004, PLANT J, V40, P813, DOI 10.1111/j.1365-313X.2004.02255.x; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhong SW, 2010, PLANT SIGNAL BEHAV, V5, P739, DOI 10.4161/psb.5.6.11698; Zhong SW, 2009, P NATL ACAD SCI USA, V106, P21431, DOI 10.1073/pnas.0907670106	150	12	13	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0144209	10.1371/journal.pone.0144209	http://dx.doi.org/10.1371/journal.pone.0144209			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630486	Green Submitted, Green Published, gold			2022-12-26	WOS:000365926300169
J	Zhang, RP; Liu, HH; Liu, JY; Hu, JW; Yan, XP; Wang, DMC; Li, L; Wang, JW				Zhang, Rong-Ping; Liu, He-He; Liu, Jun-Ying; Hu, Ji-Wei; Yan, Xi-Ping; Wang, Ding-Min-Cheng; Li, Liang; Wang, Ji-Wen			Transcriptional Profiling Identifies Location-Specific and Breed-Specific Differentially Expressed Genes in Embryonic Myogenesis in Anas Platyrhynchos	PLOS ONE			English	Article							SKELETAL-MUSCLE DEVELOPMENT; PHOSPHATIDYLINOSITOL 3-KINASE; DISTAL ARTHROGRYPOSIS; MOLECULAR-CLONING; MYOSIN ISOFORMS; SATELLITE CELLS; COLLAGEN TYPES; TROPONIN-I; TISSUE; PATHWAY	Skeletal muscle growth and development are highly orchestrated processes involving significant changes in gene expressions. Differences in the location-specific and breed-specific genes and pathways involved have important implications for meat productions and meat quality. Here, RNA-Seq was performed to identify differences in the muscle deposition between two muscle locations and two duck breeds for functional genomics studies. To achieve those goals, skeletal muscle samples were collected from the leg muscle (LM) and the pectoral muscle (PM) of two genetically different duck breeds, Heiwu duck (H) and Peking duck (P), at embryonic 15 days. Functional genomics studies were performed in two experiments: Experiment 1 directly compared the location-specific genes between PM and LM, and Experiment 2 compared the two breeds (H and P) at the same developmental stage (embryonic 15 days). Almost 13 million clean reads were generated using Illumina technology (Novogene, Beijing, China) on each library, and more than 70% of the reads mapped to the Peking duck (Anas platyrhynchos) genome. A total of 168 genes were differentially expressed between the two locations analyzed in Experiment 1, whereas only 8 genes were differentially expressed when comparing the same location between two breeds in Experiment 2. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) were used to functionally annotate DEGs (differentially expression genes). The DEGs identified in Experiment 1 were mainly involved in focal adhesion, the PI3K-Akt signaling pathway and ECM-receptor interaction pathways (corrected P-value<0.05). In Experiment 2, the DEGs were associated with only the ribosome signaling pathway (corrected P-value<0.05). In addition, quantitative real-time PCR was used to confirm 15 of the differentially expressed genes originally detected by RNA-Seq. A comparative transcript analysis of the leg and pectoral muscles of two duck breeds not only improves our understanding of the location-specific and breed-specific genes and pathways but also provides some candidate molecular targets for increasing muscle products and meat quality by genetic control.	[Zhang, Rong-Ping; Liu, He-He; Liu, Jun-Ying; Hu, Ji-Wei; Yan, Xi-Ping; Wang, Ding-Min-Cheng; Li, Liang; Wang, Ji-Wen] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Yaan 625014, Peoples R China	Sichuan Agricultural University	Wang, JW (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Yaan 625014, Peoples R China.	wjw2886166@163.com	Li, Liang/AAG-7614-2020	Li, Liang/0000-0001-9139-5025; Wang, Jiwen/0000-0001-8568-7654	National Waterfowl Industrial Technology System, Beijing, China [CARS-43-6]; National Natural Science Foundation of China, Beijing, China [31301964]; Breeding of Multiple Crossbreeding System in Waterfowl, Sichuan, China [2011NZ00998]; Innovation Research Project, Sichuan, China [13TD0034]; Modernization Industry Chain, Sichuan, China [2014NZ0030-1]	National Waterfowl Industrial Technology System, Beijing, China; National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Breeding of Multiple Crossbreeding System in Waterfowl, Sichuan, China; Innovation Research Project, Sichuan, China; Modernization Industry Chain, Sichuan, China	This study was supported by the National Waterfowl Industrial Technology System (No. CARS-43-6, Beijing, China), the National Natural Science Foundation of China (No. 31301964, Beijing, China), the Breeding of Multiple Crossbreeding System in Waterfowl (2011NZ00998, Sichuan, China), Innovation Research Project (13TD0034, Sichuan, China), and the Modernization Industry Chain (2014NZ0030-1, Sichuan, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-262; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Bai QF, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-8; BAILEY AJ, 1979, NATURE, V278, P67, DOI 10.1038/278067a0; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Cagnazzo M, 2006, J ANIM SCI, V84, P1; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Chen X, 2012, J APPL ANIM RES, V40, P284, DOI 10.1080/09712119.2012.672311; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; DUANCE VC, 1977, FEBS LETT, V79, P248, DOI 10.1016/0014-5793(77)80797-7; Duboc V, 2011, DEVELOPMENT, V138, P5301, DOI 10.1242/dev.074153; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; Gomes AV, 2002, IUBMB LIFE, V54, P323, DOI 10.1080/15216540216037; Grant RW, 2013, ANIM GENET, V44, P560, DOI 10.1111/age.12035; Gu L, 2014, PLOS ONE, V9; Gurnett CA, 2010, HUM MOL GENET, V19, P1165, DOI 10.1093/hmg/ddp587; HAMALAINEN N, 1995, MICROSC RES TECHNIQ, V30, P381, DOI 10.1002/jemt.1070300505; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kadi F, 2005, PFLUG ARCH EUR J PHY, V451, P319, DOI 10.1007/s00424-005-1406-6; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Kimber E, 2006, NEUROLOGY, V67, P597, DOI 10.1212/01.wnl.0000230168.05328.f4; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; LEHTO M, 1985, J BONE JOINT SURG BR, V67, P820, DOI 10.1302/0301-620X.67B5.3902851; Li P, 2006, AM J PHYSIOL-CELL PH, V290, pC1461, DOI 10.1152/ajpcell.00532.2005; Li Y, 2010, INT J BIOL SCI, V6, P350; Liu HH, 2010, CAN J ANIM SCI, V90, P179, DOI 10.4141/CJAS09061; Matyas G, 2007, HUM GENET, V122, P23, DOI 10.1007/s00439-007-0371-x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mofarrahi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022882; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Omojola A. B., 2007, International Journal of Poultry Science, V6, P329; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Robinson P, 2007, FASEB J, V21, P896, DOI 10.1096/fj.06-6899com; Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; SCHULER F, 1995, J CELL SCI, V108, P3795; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Sollero BP, 2011, ANIM GENET, V42, P600, DOI 10.1111/j.1365-2052.2011.02186.x; Solomon J. K. Q., 2006, Livestock Research for Rural Development, V18, P154; Sporer KRB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-143; Stenzel T, 2008, POL J VET SCI, V11, P245; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Taylor V, 2000, MOL CELL BIOL, V20, P6860, DOI 10.1128/MCB.20.18.6860-6871.2000; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; van der Ven P F, 1991, Neuromuscul Disord, V1, P211, DOI 10.1016/0960-8966(91)90027-P; Velleman SG, 2002, J ANIM SCI, V80, pE8; Wang HH, 2014, INDIAN J BIOCHEM BIO, V51, P271; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang R-P, 2014, POULTRY SCI; Zhang YY, 2011, LIVEST SCI, V135, P76, DOI 10.1016/j.livsci.2010.06.070; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	67	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2015	10	12							e0143378	10.1371/journal.pone.0143378	http://dx.doi.org/10.1371/journal.pone.0143378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX8BI	26630129	Green Published, Green Submitted, gold			2022-12-26	WOS:000365926300046
J	Amiri, P; Deihim, T; Taherian, R; Karimi, M; Gharibzadeh, S; Asghari-Jafarabadi, M; Shiva, N; Azizi, F				Amiri, Parisa; Deihim, Tina; Taherian, Reza; Karimi, Mehrdad; Gharibzadeh, Safoora; Asghari-Jafarabadi, Mohammad; Shiva, Niloofar; Azizi, Fereidoun			Factors Affecting Gender Differences in the Association between Health-Related Quality of Life and Metabolic Syndrome Components: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SF-36; WOMEN; MEN; AGE	Objective Using structural equation modeling, this study is one of the first efforts aimed at assessing influential factors causing gender differences in the association between health-related quality of life (HRQoL) and metabolic syndrome. Methods A sample of 950 adults, from Tehran Lipid and Glucose Study were recruited for this cross sectional study in 2005-2007. Health-related quality of life was assessed using the Iranian version of SF-36. Metabolic syndrome components (MetSCs) and physical and mental HRQoL were considered as continuous latent constructs explaining the variances of their observed components. Structural equation modeling was performed to examine the association between the constructs of MetSCs and the physical and mental HRQoL within the two gender groups. Results Based on the primary hypothesis, MetSCs and HRQoL were fitted in a model. The negative effect of MetSCs on HRQoL was found to be significant only in the physical domain and only in women. The proportion of all the cardio-metabolic risk factors as well as subscales of physical HRQoL that have been explained via the two constructs of MetSCs and HRQoL, respectively, were significantly higher in women. Physical activity in both men (beta = 3.19, p < 0.05) and women (beta = 3.94, p < 0.05), age (beta = -3.28, p < 0.05), education (beta = 2.63, p < 0.05) only in women and smoking (beta = 2.28, p < 0.05) just in men, directly affected physical HRQoL. Regarding the mental domain, physical activity (beta = 3.37, p < 0.05) and marital status (beta = 3.44, p < 0.05) in women and age (beta = 2.01, p < 0.05) in men were direct effective factors. Age and education in women as well as smoking in men indirectly affected physical HRQoL via MetSCs. Conclusion Gender differences in the association between MetSCs and physical HRQoL could mostly be attributed to the different structures of both MetSCs and physical HRQoL constructs in men and women. Age and smoking are the most important socio-behavioral factors which could affect this gender-specific association in the mental domain.	[Amiri, Parisa; Deihim, Tina; Taherian, Reza; Karimi, Mehrdad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Res Ctr Social Determinants Hlth, Tehran, Iran; [Amiri, Parisa; Deihim, Tina; Taherian, Reza; Karimi, Mehrdad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Deihim, Tina; Taherian, Reza] Shahid Beheshti Univ Med Sci, Students Res Comm, Tehran, Iran; [Karimi, Mehrdad; Gharibzadeh, Safoora] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Gharibzadeh, Safoora; Shiva, Niloofar; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran; [Asghari-Jafarabadi, Mohammad] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Tabriz University of Medical Science	Azizi, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran.	azizi@endocrine.ac.ir	Gharibzadeh, Safoora/J-9914-2017; amiri, parisa/K-1575-2017; Azizi, Fereidoun/ABD-4136-2021; Jafarabadi, Mohammmad Asghari/A-7478-2017	Gharibzadeh, Safoora/0000-0003-4535-4040; amiri, parisa/0000-0002-6693-1057; Azizi, Fereidoun/0000-0002-6470-2517; Jafarabadi, Mohammmad Asghari/0000-0003-3284-9749; Karimi, Mehrdad/0000-0001-8952-5839				Amiri P, 2014, DIABETIC MED, V31, P854, DOI 10.1111/dme.12443; Amiri P, 2010, J WOMENS HEALTH, V19, P1201, DOI 10.1089/jwh.2009.1710; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Bardage C, 2001, J CLIN EPIDEMIOL, V54, P172, DOI 10.1016/S0895-4356(00)00293-6; Cherepanov D, 2011, MED CARE, V49, P1021, DOI 10.1097/MLR.0b013e31822ebed9; Choo J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003954; Corica F, 2008, INT J OBESITY, V32, P185, DOI 10.1038/sj.ijo.0803687; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Frisman GH, 2009, EUR J CARDIOVASC NUR, V8, P207, DOI 10.1016/j.ejcnurse.2009.01.004; HAYS RD, 1994, J CONSULT CLIN PSYCH, V62, P441; Kumari M, 2004, ANN EPIDEMIOL, V14, P250, DOI 10.1016/j.annepidem.2003.09.011; Laudisio A, 2013, EUR J NUTR, V52, P307, DOI 10.1007/s00394-012-0337-1; LEHMAN AF, 1992, EVAL PROGRAM PLANN, V15, P7, DOI 10.1016/0149-7189(92)90055-Y; Levinger I, 2009, INT J CARDIOL, V133, P281, DOI 10.1016/j.ijcard.2007.11.046; Lidfeldt J, 2003, DIABETES OBES METAB, V5, P106, DOI 10.1046/j.1463-1326.2003.00250.x; Mercier C, 1998, COMMUNITY MENT HLT J, V34, P487, DOI 10.1023/A:1018790429573; Moller-Leimkuhler Anne Maria, 2007, Dialogues Clin Neurosci, V9, P71; Momenan AA, 2012, ARCH IRAN MED, V15, P279, DOI 012155/AIM.007; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Morimoto T, 2006, QUAL LIFE RES, V15, P537, DOI 10.1007/s11136-005-3033-2; Nakamura PM, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-98; Park S. S., 2005, RES CLIN PRACT, V91, P381, DOI DOI 10.1016/J.DIABRES.2010.11.010; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Simon GE, 1998, MED CARE, V36, P567, DOI 10.1097/00005650-199804000-00012; Sohn YJ, 2011, QUAL LIFE RES, V20, P583, DOI 10.1007/s11136-010-9789-z; Treaster DE, 2004, ERGONOMICS, V47, P495, DOI 10.1080/00140130310001638171; Tziallas D, 2012, EUR J CARDIOVASC NUR, V11, P297, DOI 10.1016/j.ejcnurse.2011.02.004; Unden Anna-Lena, 2006, Gend Med, V3, P295, DOI 10.1016/S1550-8579(06)80218-4; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wilson D, 1999, PREV MED, V29, P139, DOI 10.1006/pmed.1999.0523; WOOD W, 1989, PSYCHOL BULL, V106, P249, DOI 10.1037/0033-2909.106.2.249	31	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143167	10.1371/journal.pone.0143167	http://dx.doi.org/10.1371/journal.pone.0143167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7OL	26625120	Green Published, Green Submitted, gold			2022-12-26	WOS:000365891600015
J	Bernardo, A; Wang, S; St Amand, P; Bai, GH				Bernardo, Amy; Wang, Shan; St Amand, Paul; Bai, Guihua			Using Next Generation Sequencing for Multiplexed Trait-Linked Markers in Wheat	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; RUST RESISTANCE GENES; MOLECULAR MARKERS; HEXAPLOID WHEAT; IDENTIFICATION; VALIDATION; CLONING; PCR; GBS	With the advent of next generation sequencing (NGS) technologies, single nucleotide polymorphisms (SNPs) have become the major type of marker for genotyping in many crops. However, the availability of SNP markers for important traits of bread wheat (Triticum aestivum L.) that can be effectively used in marker-assisted selection (MAS) is still limited and SNP assays for MAS are usually uniplex. A shift from uniplex to multiplex assays will allow the simultaneous analysis of multiple markers and increase MAS efficiency. We designed 33 locus-specific markers from SNP or indel-based marker sequences that linked to 20 different quantitative trait loci (QTL) or genes of agronomic importance in wheat and analyzed the amplicon sequences using an Ion Torrent Proton Sequencer and a custom allele detection pipeline to determine the genotypes of 24 selected germplasm accessions. Among the 33 markers, 27 were successfully multiplexed and 23 had 100% SNP call rates. Results from analysis of "kompetitive allele-specific PCR" (KASP) and sequence tagged site (STS) markers developed from the same loci fully verified the genotype calls of 23 markers. The NGS-based multiplexed assay developed in this study is suitable for rapid and high-throughput screening of SNPs and some indel-based markers in wheat.	[Bernardo, Amy] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Wang, Shan; Bai, Guihua] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [St Amand, Paul; Bai, Guihua] ARS, USDA, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA	Kansas State University; Kansas State University; United States Department of Agriculture (USDA)	Bai, GH (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	guihua.bai@ars.usda.gov	bai, guihua/L-6374-2019	bai, guihua/0000-0002-1194-319X	National Research Initiative Competitive Grants CAP from the USDA National Institute of Food and Agriculture [2011-68002-30029]; US Wheat and Barley Scab Initiative; ARS [ARS-0424855] Funding Source: Federal RePORTER	National Research Initiative Competitive Grants CAP from the USDA National Institute of Food and Agriculture; US Wheat and Barley Scab Initiative(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project is partly funded by the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture and US Wheat and Barley Scab Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; AKHUNOV E, 2009, THEOR APPL GENET, V119, P507, DOI DOI 10.1007/s00122-009-1059-5; [Anonymous], 2013, CEREAL GENOMICS; Batley J., 2007, Association mapping in plants, P95, DOI 10.1007/978-0-387-36011-9_6; Beales J, 2005, THEOR APPL GENET, V110, P1099, DOI 10.1007/s00122-005-1938-3; Bekele WA, 2013, PLANT BIOTECHNOL J, V11, P1112, DOI 10.1111/pbi.12106; Berard A, 2009, PLANT BIOTECHNOL J, V7, P364, DOI 10.1111/j.1467-7652.2009.00404.x; Bernardo AN, 2013, CROP SCI, V53, P755, DOI 10.2135/cropsci2012.07.0446; Bernardo AN, 2012, MOL BREEDING, V29, P477, DOI 10.1007/s11032-011-9565-y; Bradic M, 2011, METHODS MOL BIOL, V772, P193, DOI 10.1007/978-1-61779-228-1_11; Cabral AL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0340-1; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Garcia M, 2014, METHODS MOL BIOL, V1145, P21, DOI 10.1007/978-1-4939-0446-4_2; He CL, 2014, METHODS MOL BIOL, V1145, P75, DOI 10.1007/978-1-4939-0446-4_7; He XY, 2009, GENET RESOUR CROP EV, V56, P311, DOI 10.1007/s10722-008-9365-3; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Lin M, 2015, THEOR APPL GENET, V128, P1385, DOI 10.1007/s00122-015-2513-1; Liu SB, 2014, THEOR APPL GENET, V127, P1039, DOI 10.1007/s00122-014-2277-z; Liu SB, 2013, GENETICS, V195, P263, DOI 10.1534/genetics.113.152330; Liu SY, 2014, CROP SCI, V54, P1304, DOI 10.2135/cropsci2013.08.0564; Masouleh AK, 2009, PLANT BIOTECHNOL J, V7, P355, DOI 10.1111/j.1467-7652.2009.00411.x; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Neelam K, 2013, MOL BREEDING, V31, P233, DOI 10.1007/s11032-012-9773-0; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ramirez-Gonzalez RH, 2015, BIOINFORMATICS; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Rife TW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1404-9; Rithidech Kanokporn, 2003, Methods Mol Biol, V226, P295; Schnable Lab, 2001, GEN MULT AMPL SEQ GB; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467	44	23	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143890	10.1371/journal.pone.0143890	http://dx.doi.org/10.1371/journal.pone.0143890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625271	Green Submitted, Green Published, gold			2022-12-26	WOS:000365891600069
J	Han, SF; Hoffman, MD; Proctor, AR; Vella, JB; Mannoh, EA; Barber, NE; Kim, HJ; Jung, KW; Benoit, DSW; Choe, R				Han, Songfeng; Hoffman, Michael D.; Proctor, Ashley R.; Vella, Joseph B.; Mannoh, Emmanuel A.; Barber, Nathaniel E.; Kim, Hyun Jin; Jung, Ki Won; Benoit, Danielle S. W.; Choe, Regine			Non-Invasive Monitoring of Temporal and Spatial Blood Flow during Bone Graft Healing Using Diffuse Correlation Spectroscopy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE ENGINEERED PERIOSTEUM; CEREBRAL HEMODYNAMICS; OXYGENATION; VALIDATION; STRENGTH; BRAIN; INDEX	Vascular infiltration and associated alterations in microvascular blood flow are critical for complete bone graft healing. Therefore, real-time, longitudinal measurement of blood flow has the potential to successfully predict graft healing outcomes. Herein, we non-invasively measure longitudinal blood flow changes in bone autografts and allografts using diffuse correlation spectroscopy in a murine femoral segmental defect model. Blood flow was measured at several positions proximal and distal to the graft site before implantation and every week post-implantation for a total of 9 weeks (autograft n = 7 and allograft n = 10). Measurements of the ipsilateral leg with the graft were compared with those of the intact contralateral control leg. Both autografts and allografts exhibited an initial increase in blood flow followed by a gradual return to baseline levels. Blood flow elevation lasted up to 2 weeks in autografts, but this duration varied from 2 to 6 weeks in allografts depending on the spatial location of the measurement. Intact contralateral control leg blood flow remained at baseline levels throughout the 9 weeks in the autograft group; however, in the allograft group, blood flow followed a similar trend to the graft leg. Blood flow difference between the graft and contralateral legs (Delta rBF), a parameter defined to estimate graft-specific changes, was elevated at 1-2 weeks for the autograft group, and at 2-4 weeks for the allograft group at the proximal and the central locations. However, distal to the graft, the allograft group exhibited significantly greater Delta rBF than the autograft group at 3 weeks post-surgery (p < 0.05). These spatial and temporal differences in blood flow supports established trends of delayed healing in allografts versus autografts.	[Han, Songfeng] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Hoffman, Michael D.; Proctor, Ashley R.; Vella, Joseph B.; Mannoh, Emmanuel A.; Barber, Nathaniel E.; Kim, Hyun Jin; Jung, Ki Won; Benoit, Danielle S. W.; Choe, Regine] Univ Rochester, Dept Biomed Engn, Rochester, NY 14623 USA; [Hoffman, Michael D.; Vella, Joseph B.; Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Dept Orthopaed, Rochester, NY 14642 USA; [Hoffman, Michael D.; Vella, Joseph B.; Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Vella, Joseph B.] Univ Rochester, Med Ctr, Dept Otolaryngol Head & Neck Surg, Rochester, NY 14642 USA; [Benoit, Danielle S. W.] Univ Rochester, Dept Chem Engn, Rochester, NY 14627 USA; [Benoit, Danielle S. W.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Choe, Regine] Univ Rochester, Dept Elect & Comp Engn, New York, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Choe, R (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14623 USA.	Regine_Choe@urmc.rochester.edu	Vella, Joe/AAF-1801-2022; Han, Songfeng/J-3682-2019; Vella, Joe/AFG-8321-2022	Benoit, Danielle/0000-0001-7137-8164; Choe, Regine/0000-0001-5851-4504; Jung, Ki Won/0000-0001-9847-3532	American Academy of Facial Plastic and Reconstructive Surgery; AAFPRS Leslie Bernstein Resident Research Grant [352604]; River Campus Libraries at University of Rochester; National Institute of Health [K99/R00-CA126187]; NIH [T32 AR053459, R01 AR064200]; National Science Foundation; NSF CBET [1507384]; New York State Stem Cell Science NYSTEM IDEA [C028099]; NATIONAL CANCER INSTITUTE [K99CA126187, R00CA126187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307, T32AR053459, R01AR064200, P50AR054041] Funding Source: NIH RePORTER	American Academy of Facial Plastic and Reconstructive Surgery; AAFPRS Leslie Bernstein Resident Research Grant; River Campus Libraries at University of Rochester; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NSF CBET(National Science Foundation (NSF)); New York State Stem Cell Science NYSTEM IDEA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the American Academy of Facial Plastic and Reconstructive Surgery (https://urldefense.proofpoint.com/v2/url?u=h ttp-3A__www.aafprs.org_MEMBERS_p_Bernstein-5FGrant-5FProgram.aspx&d=BQIGaQ&c=4sF48jRm VAe_CH-k9mXYXEGfSnM3bY53YSKuLUQRxhA&r=YZ-H6tH3kAQHt_KCVP40k94pSMGPut24SLe OiQlSeIw&m=1HSKreSnWv3Ul4fV6WUTX9acARh FMdCHqzWuke_-hYI&s=FGHDV-aKar_tD8jOhsJd 2B0eyo-Ch-yBstPJmeQcJzc&e=), AAFPRS Leslie Bernstein Resident Research Grant 352604 to JBV, River Campus Libraries at University of Rochester (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.library.rochester.edu_&d=BQIGaQ&c=4sF48j RmVAe_CH-k9mXYXEGfSnM3bY53YSKuLUQRxh A&r=YZ-H6tH3kAQHt_KCVP40k94pSMGPut24SLe OiQlSeIw&m=1HSKreSnWv3Ul4fV6WUTX9acARh FMdCHqzWuke_-hYI&s=IEXSdpkRuUYM4Sh9a ALUZXwX3Bc64ssg01KO6pyMHO0&e= - funding for data deposition to RC), the National Institute of Health (https://urldefense.proofpoint.com/v2/url?u=h ttp-3A__www.nih.gov_&d=BQIGaQ&c=4sF48jRmVAe_CH-k9mXYXEGfSnM3b Y53YSKuLUQRxhA&r=YZ-H6tH3kAQHt_KCVP40k94pSMGPut24SLeOiQlSeIw&m=1HSKre SnWv3Ul4fV6WUTX9acARhFMdCHqzWuke_-h YI&s=4tSMJc-vqSHITSNGUIeeDIJb i0G37NF7T8vCDlijwDg&e=), K99/R00-CA126187 (RC), NIH T32 AR053459 (MDH), NIH R01 AR064200 (DSWB), the National Science Foundation (https://urldefense.proofpoint.com/v2/url?u=http-3A__www.nsf.gov_&d=BQIGaQ&c=4sF48jRmVAe_CH-k9mXYXEGfSnM3bY53YSKuLUQRxhA&r=YZ-H6tH3kAQHt_KCVP40k94pSMGPut24SLeOiQlSe Iw&m=1HSKreSnWv3Ul4fV6WUTX9acARhFMd CHqzWuke_-hYI&s=rHCrH67pB6paJ8gmcZp27Db zOlKTM2wXQwziP2mt1pk&e=), NSF CBET 1507384 (RC), and New York State Stem Cell Science (https://urldefense.proofpoint.com/v2/url?u=http-3A__stemcell.ny.gov_&d=BQIGaQ&c=4sF48 jRmVAe_CH-k9mXYXEGfSnM3bY53YSKuLUQRxh A&r=YZ-H6tH3kAQHt_KCVP40k94pSMGPut24SLeOiQlSe Iw&m=1HSKreSnWv3Ul4fV6WUTX9acARhFMd CHqzWuke_-hYI&s=uo8r7PJDqXgwqu7W1vLAp HAGrHNxVR-yujouqkQMtfQ&e=) NYSTEM IDEA, C028099 (DSWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, DIFFUSE PHOTON PROBE; BRUETON RN, 1993, NATO ADV SCI INST SE, V247, P121; Buckley EM, 2009, OPT EXPRESS, V17, P12571, DOI 10.1364/OE.17.012571; Carp S, 2014, BIOMEDICAL OPTICS, V2014; Carp SA, 2010, BIOMED OPT EXPRESS, V1, P553, DOI 10.1364/BOE.1.000553; Chang H, 2012, STEM CELL TRANSL MED, V1, P480, DOI 10.5966/sctm.2011-0056; Dehghani H, 2009, COMMUN NUMER METH EN, V25, P711, DOI 10.1002/cnm.1162; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Durduran T, 2004, OPT LETT, V29, P1766, DOI 10.1364/OL.29.001766; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T., 2004, NONINVASIVE MEASUREM; Durduran T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3425884; Dyke JP, 2010, ANN NY ACAD SCI, V1192, P95, DOI 10.1111/j.1749-6632.2009.05376.x; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Evans SF, 2013, TISSUE ENG PART B-RE, V19, P147, DOI [10.1089/ten.teb.2012.0216, 10.1089/ten.TEB.2012.0216]; Farzam P, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.055001; Farzam P, 2014, PHYSIOL MEAS, V35, P1469, DOI 10.1088/0967-3334/35/7/1469; Gagnon L, 2008, OPT EXPRESS, V16, P15514, DOI 10.1364/OE.16.015514; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Han SF, 2015, BIOMED OPT EXPRESS, V6, P2695, DOI 10.1364/BOE.6.002695; He L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.086003; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hoffman MD, 2015, BIOMATERIALS, V52, P426, DOI 10.1016/j.biomaterials.2015.02.064; Hoffman MD, 2014, ACTA BIOMATER, V10, P3431, DOI 10.1016/j.actbio.2014.04.012; Hoffman MD, 2013, BIOMATERIALS, V34, P8887, DOI 10.1016/j.biomaterials.2013.08.005; Hornicek FJ, 2001, CLIN ORTHOP RELAT R, P87; Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978; Irwin D, 2011, BIOMED OPT EXPRESS, V2, P1969, DOI 10.1364/BOE.2.001969; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Kalfas I H, 2001, Neurosurg Focus, V10, pE1; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Koo H, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-89; Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52; McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890; Melnyk M, 2008, ARCH ORTHOP TRAUM SU, V128, P1159, DOI 10.1007/s00402-007-0543-0; Menon C, 2003, CANCER RES, V63, P7232; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P1173, DOI 10.1364/BOE.1.001173; Reynolds DG, 2007, J BIOMECH, V40, P3178, DOI 10.1016/j.jbiomech.2007.04.004; Roche-Labarbe N, 2010, HUM BRAIN MAPP, V31, P341, DOI 10.1002/hbm.20868; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Serrat MA, 2009, NAT PROTOC, V4, P1749, DOI 10.1038/nprot.2009.190; Shang Y, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876216; Tomlinson RE, 2013, BONE RES, V1, P311, DOI 10.4248/BR201304002; Tu YK, 2000, J HAND SURG-AM, V25A, P46; Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50; Xie C, 2007, TISSUE ENG, V13, P435, DOI 10.1089/ten.2006.0182; Yu GQ, 2005, CLIN CANCER RES, V11, P3543, DOI 10.1158/1078-0432.CCR-04-2582; Yu GQ, 2007, OPT EXPRESS, V15, P1064, DOI 10.1364/OE.15.001064; Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zirak P, 2010, BIOMED OPT EXPRESS, V1, P1443, DOI 10.1364/BOE.1.001443	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143891	10.1371/journal.pone.0143891	http://dx.doi.org/10.1371/journal.pone.0143891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26625352	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600070
J	Hansen, L; Schmidt-Christensen, A; Gupta, S; Fransen-Pettersson, N; Hannibal, TD; Reizis, B; Santamaria, P; Holmberg, D				Hansen, Lisbeth; Schmidt-Christensen, Anja; Gupta, Shashank; Fransen-Pettersson, Nina; Hannibal, Tine D.; Reizis, Boris; Santamaria, Pere; Holmberg, Dan			E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2-2; REGULATORY T-CELLS; INTERFERON-ALPHA; VIRAL-INFECTION; NOD MOUSE; DESTRUCTION; INSULITIS; EXPRESSION; INITIATION; CROSSTALK	Autoimmune diabetes is a consequence of immune-cell infiltration and destruction of pancreatic beta-cells in the islets of Langerhans. We analyzed the cellular composition of the insulitic lesions in the autoimmune-prone non-obese diabetic (NOD) mouse and observed a peak in recruitment of plasmacytoid dendritic cells (pDCs) to NOD islets around 8-9 weeks of age. This peak coincides with increased spontaneous expression of type-1-IFN response genes and CpG(1585) induced production of IFN-alpha from NOD islets. The transcription factor E2-2 is specifically required for the maturation of pDCs, and we show that knocking out E2-2 conditionally in CD11c(+) cells leads to a reduced recruitment of pDCs to pancreatic islets and reduced CpG(1585) induced production of IFN-alpha during insulitis. As a consequence, insulitis has a less aggressive expression profile of the Th1 cytokine IFN-gamma and a markedly reduced diabetes incidence. Collectively, these observations demonstrate a disease-promoting role of E2-2 dependent pDCs in the pancreas during autoimmune diabetes in the NOD mouse.	[Hansen, Lisbeth; Gupta, Shashank; Fransen-Pettersson, Nina; Hannibal, Tine D.; Holmberg, Dan] Univ Copenhagen, Dept Immunol & Microbiol, Copehagen, Denmark; [Hansen, Lisbeth; Schmidt-Christensen, Anja; Gupta, Shashank; Fransen-Pettersson, Nina; Hannibal, Tine D.; Holmberg, Dan] Lund Univ, Dept Expt Med Sci, Immunol Sect, Lund, Sweden; [Reizis, Boris] Columbia Univ, Columbia Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Santamaria, Pere] Univ Calgary, JMDRC, Calgary, AB T2N 1N4, Canada; [Santamaria, Pere] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Snyder Inst Chron Dis, Calgary, AB T2N 1N4, Canada; [Santamaria, Pere] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Copenhagen; Lund University; Columbia University; University of Calgary; University of Calgary; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Holmberg, D (corresponding author), Univ Copenhagen, Dept Immunol & Microbiol, Copehagen, Denmark.	dan.holmberg@med.lu.se	Santamaria, Pere/ABF-6823-2021; Schmidt-Christensen, Anja/L-6284-2016	Schmidt-Christensen, Anja/0000-0001-5813-9118; Reizis, Boris/0000-0003-1140-7853; Hannibal, Tine/0000-0001-8036-6704; Fransen Pettersson, Nina/0000-0002-5049-1544	Vetenskapsradet [K2013-67X07929-27-3]; Lundbeck Foundation [R67-2010-5653]; Novo Nordisk Fonden [NNF14OC0010957] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571] Funding Source: NIH RePORTER	Vetenskapsradet(Swedish Research Council); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Vetenskapsradet K2013-67X07929-27-3 to DH and by the Lundbeck Foundation R67-2010-5653 to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Beaudoin L, 2014, EUR J IMMUNOL, V44, P1454, DOI 10.1002/eji.201343910; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Chen XQ, 2008, CLIN IMMUNOL, V129, P413, DOI 10.1016/j.clim.2008.08.013; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Diana J, 2011, J EXP MED, V208, P729, DOI 10.1084/jem.20101692; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Guery L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00059; Hinkmann C, 2008, HORM METAB RES, V40, P767, DOI 10.1055/s-2008-1080896; Hollis-Moffatt JE, 2005, DIABETES, V54, P2820, DOI 10.2337/diabetes.54.9.2820; Hook SM, 2011, J CLIN ENDOCR METAB, V96, pE2072, DOI 10.1210/jc.2011-0463; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEIJON K, 1995, J AUTOIMMUN, V8, P347, DOI 10.1006/jaut.1995.0027; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Makino S, 1980, Jikken Dobutsu, V29, P1; Pallotta MT, 2014, J CELL MOL MED, V18, P2082, DOI 10.1111/jcmm.12360; Quah HS, 2014, DIABETES, V63, P1032, DOI 10.2337/db13-1210; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Schmidt-Christensen A, 2013, DIABETOLOGIA, V56, P2669, DOI 10.1007/s00125-013-3024-8; Tsai S, 2013, J IMMUNOL, V191, P70, DOI 10.4049/jimmunol.1300168; Vuckovic S, 2007, CLIN IMMUNOL, V123, P281, DOI 10.1016/j.clim.2007.03.002; Welzen-Coppens JMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055071; Wikstrom I, 2006, J IMMUNOL, V177, P6723, DOI 10.4049/jimmunol.177.10.6723; Xia CQ, 2014, J IMMUNOL, V193, P1024, DOI 10.4049/jimmunol.1303230	32	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0144090	10.1371/journal.pone.0144090	http://dx.doi.org/10.1371/journal.pone.0144090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624013	Green Published, gold, Green Submitted			2022-12-26	WOS:000365891600091
J	Plaut, RD; Stibitz, S				Plaut, Roger D.; Stibitz, Scott			Improvements to a Markerless Allelic Exchange System for Bacillus anthracis	PLOS ONE			English	Article							YYCFG 2-COMPONENT SYSTEM; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; GENE REPLACEMENT; LYTIC ENZYMES; STAPHYLOCOCCUS-AUREUS; BORDETELLA-PERTUSSIS; ADENINE METHYLATION; SPORE GERMINATION; DNA	A system was previously developed for conducting I-SceI-mediated allelic exchange in Bacillus anthracis. In this system, recombinational loss of a chromosomally-integrated allelic exchange vector is stimulated by creation of a double-stranded break within the vector by the homing endonuclease I-SceI. Although this system is reasonably efficient and represents an improvement in the tools available for allelic exchange in B. anthracis, researchers are nonetheless required to "pick and patch" colonies in order to identify candidate "exchangeants." In the present study, a number of improvements have been made to this system: 1) an improved I-SceI-producing plasmid includes oriT so that both plasmids can now be introduced by conjugation, thus avoiding the need for preparing electro-competent cells of each integration intermediate; 2) antibiotic markers have been changed to allow the use of the system in select agent strains; and 3) both plasmids have been marked with fluorescent proteins, allowing the visualization of plasmid segregation on a plate and obviating the need for "picking and patching." These modifications have made the process easier, faster, and more efficient, allowing for parallel construction of larger numbers of mutant strains. Using this improved system, the genes encoding the tripartite anthrax toxin were deleted singly and in combination from plasmid pXO1 of Sterne strain 34F2. In the course of this study, we determined that DNA transfer to B. anthracis could be accomplished by conjugation directly from a methylation-competent E. coli strain.	[Plaut, Roger D.; Stibitz, Scott] US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Plaut, RD (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Roger.Plaut@fda.hhs.gov	Plaut, Roger D./B-2340-2013	Plaut, Roger D./0000-0002-0883-972X	NIH/NIAID Middle Atlantic Regional Center of Excellence [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	NIH/NIAID Middle Atlantic Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID Middle Atlantic Regional Center of Excellence grant U54 AI057168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; ARMSTRONG KA, 1984, J MOL BIOL, V175, P331, DOI 10.1016/0022-2836(84)90352-8; Bernhards CB, 2015, J BACTERIOL, V197, P326, DOI 10.1128/JB.02344-14; Bernhards CB, 2014, J BACTERIOL, V196, P3399, DOI 10.1128/JB.01899-14; BOGOSIAN G, 1993, GENE, V133, P17, DOI 10.1016/0378-1119(93)90219-S; Brahmbhatt TN, 2007, INFECT IMMUN, V75, P5233, DOI 10.1128/IAI.00660-07; COHEN A, 1968, COLD SPRING HARB SYM, V33, P635, DOI 10.1101/SQB.1968.033.01.071; COHEN A, 1968, P NATL ACAD SCI USA, V61, P61, DOI 10.1073/pnas.61.1.61; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; DENEER HG, 1987, J BACTERIOL, V169, P995, DOI 10.1128/jb.169.3.995-1002.1987; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Giebel JD, 2009, J BACTERIOL, V191, P5569, DOI 10.1128/JB.00408-09; GRAY GS, 1983, MOL BIOL EVOL, V1, P57; Heffron JD, 2010, J BACTERIOL, V192, P763, DOI 10.1128/JB.01380-09; Heffron JD, 2009, J BACTERIOL, V191, P2237, DOI 10.1128/JB.01598-08; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Klimowicz AK, 2010, MICROBIOL-SGM, V156, P3575, DOI 10.1099/mic.0.039925-0; Lambert EA, 2008, J BACTERIOL, V190, P7601, DOI 10.1128/JB.01054-08; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; MARRERO R, 1995, GENE, V152, P75, DOI 10.1016/0378-1119(94)00647-B; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MURPHY E, 1985, MOL GEN GENET, V200, P33, DOI 10.1007/BF00383309; O'Neil JP, 1994, FOCUS, V16, P106; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Simm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036720; Simon R., 1983, NAT BIOTECHNOL, V1, P784, DOI [10.1038/nbt1183-784, DOI 10.1038/NBT1183-784]; STIBITZ S, 1986, GENE, V50, P133, DOI 10.1016/0378-1119(86)90318-5; STIBITZ S, 1994, J BACTERIOL, V176, P7260, DOI 10.1128/JB.176.23.7260-7266.1994; Szurmant H, 2007, METHOD ENZYMOL, V422, P396, DOI 10.1016/S0076-6879(06)22020-2; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Vasudevan P, 2009, J BACTERIOL, V191, P6012, DOI 10.1128/JB.00604-09; Voros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103326; Voros A, 2013, MICROBIOL-SGM, V159, P2283, DOI 10.1099/mic.0.069674-0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0142758	10.1371/journal.pone.0142758	http://dx.doi.org/10.1371/journal.pone.0142758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7OL	26624016	gold, Green Published, Green Submitted			2022-12-26	WOS:000365891600010
J	Sun, LM; Liao, K; Wang, DY				Sun, Lingmei; Liao, Kai; Wang, Dayong			Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans	PLOS ONE			English	Article							RETIGERIC ACID B; NATURAL-PRODUCTS; DRUG DISCOVERY; RESISTANCE; VIRULENCE; THERAPY	Background The first step in infection by Candida albicans is adhesion to host cells or implanted medical devices and this followed by hyphal growth and biofilm formation. Yeast-to-hyphal transition has long been identified as a key factor in fungal virulence. Following biofilm formation, C. albicans is usually less sensitive or insensitive to antifungals. Therefore, development of new antifungals with inhibitory action on adhesion, yeast-hyphal transition and biofilm formation by C. albicans is very necessary. Methods The effects of magnolol and honokiol on hypha growth were investigated using different induction media. Their inhibitory effects were determined using the 2,3-bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide assay, and biofilm thickness and viability were observed by a confocal scanning laser microscope. Mammalian cells were used in adhesion assays. Genes related to hyphae development and cell adhesions were analyzed by real-time reverse transcription-polymerase chain reaction. The exogenous cyclic adenosine monophosphate was used to determine the mechanisms of action of magnolol and honokiol. Caenorhabditis elegans was used as an in vivo model to estimate the antifungal activities of magnolol and honokiol. Results and conclusions Magnolol and honokiol inhibited adhesion, the transition from yeast to hypha, and biofilm formation by C. albicans through the Ras1-cAMP-Efg1 pathway. Moreover, magnolol and honokiol prolonged the survival of nematodes infected by C. albicans. Magnolol and honokiol have potential inhibitory effects against biofilm formation by C. albicans. General Significance This study provides useful information towards the development of new strategies to reduce the incidence of C. albicans biofilm-associated infection.	[Sun, Lingmei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Liao, Kai] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Wang, Dayong] Southeast Univ, Sch Med, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China	Sun, LM (corresponding author), Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China.	sunlingmei@seu.edu.cn; dayongw@seu.edu.cn	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Natural Science Foundation of China [81302814]; Jiangsu Province Natural Science Foundation [BK20130640, BK20140624]; Doctoral Fund of Ministry of Education of China [20120092120068]; China Postdoctoral Science Foundation [2012M511182]; Fundamental Research Funds of Southeast University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds of Southeast University	This work was supported by grants from the National Natural Science Foundation of China (No. 81302814), Jiangsu Province Natural Science Foundation (No. BK20130640 and BK20140624), Doctoral Fund of Ministry of Education of China (No. 20120092120068), China Postdoctoral Science Foundation (No. 2012M511182), and Fundamental Research Funds of Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes PMDS, 2014, DIAGN MICR INFEC DIS, V79, P222, DOI 10.1016/j.diagmicrobio.2013.09.016; Ahariz M, 2010, MED DEVICES-EVID RES, V3, P33; Alexander BD, 1997, DRUGS, V54, P657, DOI 10.2165/00003495-199754050-00002; Bang KH, 2000, ARCH PHARM RES, V23, P46, DOI 10.1007/BF02976465; Bauer A, 2014, NAT PROD REP, V31, P35, DOI 10.1039/c3np70058e; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Chang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041624; Chen G, 2014, EUR J PHARM SCI, V65, P21, DOI 10.1016/j.ejps.2014.09.001; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; de Freitas MM, 2011, IMPLANT DENT, V20, pE14, DOI 10.1097/ID.0b013e31820fb99e; Jacobo-Salcedo MD, 2011, NAT PROD COMMUN, V6, P1121; Fazly A, 2013, P NATL ACAD SCI USA, V110, P13594, DOI 10.1073/pnas.1305982110; Feldman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093225; Ferreira AV, 2013, MYCOPATHOLOGIA, V175, P265, DOI 10.1007/s11046-013-9638-z; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; FONZI WA, 1993, GENETICS, V134, P717; Harvey A, 2010, IDRUGS, V13, P70; Hogan DA, 2009, FUTURE MICROBIOL, V4, P1263, DOI 10.2217/FMB.09.106; Inigo M, 2012, INT J ARTIF ORGANS, V35, P780, DOI 10.5301/ijao.5000170; Jin J, 2010, LETT APPL MICROBIOL, V51, P351, DOI 10.1111/j.1472-765X.2010.02900.x; Larsen B, 2006, YEAST, V23, P795, DOI 10.1002/yea.1394; Lopez-Ribot JL, 2005, CURR BIOL, V15, pR453, DOI 10.1016/j.cub.2005.06.020; Miller LG, 2001, CLIN INFECT DIS, V32, P1110, DOI 10.1086/319613; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06; Ruhnke M, 2014, CLIN MICROBIOL INFEC, V20, P11, DOI 10.1111/1469-0691.12622; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Sun LM, 2010, J APPL MICROBIOL, V108, P341, DOI 10.1111/j.1365-2672.2009.04429.x; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Tobudic S, 2013, MYCOSES, V56, P623, DOI 10.1111/myc.12079; Toenjes KA, 2005, ANTIMICROB AGENTS CH, V49, P963, DOI 10.1128/AAC.49.3.963-972.2005; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002	38	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2015	10	2							e0117695	10.1371/journal.pone.0117695	http://dx.doi.org/10.1371/journal.pone.0117695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9IY	26640948	Green Published, gold, Green Submitted			2022-12-26	WOS:000350683900036
J	Sun, L; Tian, JL; Yin, QQ; Xiao, J; Li, JQ; Guo, YJ; Feng, GS; Peng, XX; Qi, H; Xu, F; Jiao, WW; Shen, C; Shen, AD				Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Feng, Guo-shuang; Peng, Xiao-xia; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong			Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less	PLOS ONE			English	Article							PEDIATRIC TUBERCULOSIS; SKIN-TEST; INFECTION; DIAGNOSIS; AGE	Interferon Gamma Release Assays (IGRAs) were developed for the indirect or immunologic diagnosis of tuberculosis infection; however, they have also been used to assist in difficult to diagnose cases of tuberculosis disease in adults, and to a lesser extent, in children, especially in those under 5 years old. We evaluated the utility of using an IGRA in pediatric tuberculosis in younger children in a hospital setting. The diagnostic accuracy of T-SPOT. TB and TST was assessed in 117 children with active tuberculosis and 413 children with respiratory tract infection. Sensitivity and specificity were calculated for the tests used individually and together. Concordance was also calculated. Sensitivity of T-SPOT. TB (82.9%) was higher than TST (78.6% using a 5mm cut-off), especially in children confirmed to have TB. T-SPOT. TB was more specific than TST using a 5mm cut-off (96.1% vs. 70.9%). Combining T-SPOT. TB and TST results improved the sensitivity to 96.6%. In conclusion, the results of the current study indicate that T-SPOT. TB has good sensitivity and specificity, supporting its use among patients of this age. A combination of IGRA and TST would be useful additions to assist in the diagnosis of childhood TB.	[Sun, Lin; Tian, Jian-ling; Yin, Qing-qin; Xiao, Jing; Li, Jie-qiong; Guo, Ya-jie; Qi, Hui; Xu, Fang; Jiao, Wei-wei; Shen, Chen; Shen, A-dong] Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China; [Feng, Guo-shuang; Peng, Xiao-xia] Capital Med Univ, Beijing Childrens Hosp, Ctr Clin Epidemiol & Evidence Based Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, AD (corresponding author), Capital Med Univ, Key Lab Major Dis Children & Natl Key Discipline, Beijing Key Lab Pediat Resp Infect Dis,Beijing Ch, Beijing Pediat Res Inst,Minist Educ,Natl Clin Res, Beijing, Peoples R China.	shenad16@hotmail.com	孙, 琳/HGE-6966-2022; shen, chen/AAC-2458-2020		National Science and Technology Major Project of China [2013ZX10003003-004]; National Natural Science Foundation of China [81200064]; Collaborative Innovation Center of Infectious Diseases [PXM2014_014226_000011]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Infectious Diseases	This work was supported by National Science and Technology Major Project of China (2013ZX10003003-004), National Natural Science Foundation of China (no. 81200064) and Collaborative Innovation Center of Infectious Diseases (no. PXM2014_014226_000011).	Blandinieres A, 2013, J INFECTION, V67, P391, DOI 10.1016/j.jinf.2013.06.011; Carvalho ACC, 2013, INFECTION, V41, P827, DOI 10.1007/s15010-013-0450-y; Committee On Infectious Diseases AAOP, 2009, RED BOOK REP COMM IN; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Cruz AT, 2010, PEDIATR REV, V31, P13, DOI 10.1542/pir.31-1-13; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Haimi-Cohen Y, 2001, CLIN INFECT DIS, V33, P1786, DOI 10.1086/323984; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2009, PEDIATRICS, V123, P38, DOI 10.1542/peds.2008-0611; PAVIC I, 2011, PEDIATR INFECT DIS J, V30, P866, DOI DOI 10.1097/INF.0B013E318220C52A; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Schopfer K, 2014, EUR J PEDIATR, V173, P331, DOI 10.1007/s00431-013-2161-x; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Sun L, 2010, CHINESE MED J-PEKING, V123, P2786, DOI 10.3760/cma.j.issn.0366-6999.2010.20.007; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tuberculosis NTSG, 2002, REP 4 NAT EP SAMPL S, V2, P3; World Health Organization, 2014, GLOB TUB REP; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Zar HJ, 2010, EXPERT REV ANTI-INFE, V8, P277, DOI [10.1586/eri.10.9, 10.1586/ERI.10.9]	21	107	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2015	10	12							e0143820	10.1371/journal.pone.0143820	http://dx.doi.org/10.1371/journal.pone.0143820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ1YS	26640948	gold, Green Published, Green Submitted			2022-12-26	WOS:000366902700029
